PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Pitia, AM; Minagawa, I; Uera, N; Hamano, KI; Sugawara, Y; Nagura, Y; Hasegawa, Y; Oyamada, T; Sasada, H; Kohsaka, T				Pitia, Ali Mohammed; Minagawa, Itaru; Uera, Naoto; Hamano, Koh-Ichi; Sugawara, Yasushi; Nagura, Yoshio; Hasegawa, Yoshihisa; Oyamada, Toshifumi; Sasada, Hiroshi; Kohsaka, Tetsuya			Expression of insulin-like factor 3 hormone-receptor system in the reproductive organs of male goats	CELL AND TISSUE RESEARCH			English	Article						INSL3; RXFP2; INSL3 hormone-receptor system; Male reproductive organs; Goat	LEYDIG-CELLS; VAS-DEFERENS; IMMUNOCYTOCHEMICAL LOCALIZATION; SPLICE VARIANTS; RELAXIN-BINDING; MESSENGER-RNA; BASAL-CELLS; RAT TESTIS; PEPTIDE; INSL3	Relaxin-like factor (RLF), generally known as insulin-like factor 3 (INSL3), is essential for testis descent during fetal development. However, its role in adult males is not fully understood. We investigate the function of INSL3 in male Saanen goats by identifying cell types expressing its receptor, relaxin/insulin-like family peptide receptor (RXFP)2 and by characterizing the developmental expression pattern of INSL3 and RXFP2 and the binding of INSL3 to target cells in the male reproductive system. A highly specific RXFP2 antibody that co-localizes with an anti-FLAG antibody in HEK-293 cells recognizes RXFP2-transcript-expressing cells in the testis. INSL3 and RXFP2 mRNA expression is upregulated in the testis, starting from puberty. INSL3 mRNA and protein expression has been detected in Leydig cells, whereas RXFP2 mRNA and protein localize to Leydig cells, to meiotic and post-meiotic germ cells and to the epithelium and smooth muscle of the cauda epididymis and vas deferens. INSL3 binds to all of these tissues and cell types, with the exception of Leydig cells, in a hormone-specific and saturable manner. These results provide evidence for a functional intra- and extra-testicular INSL3 ligand-receptor system in adult male goats.	[Pitia, Ali Mohammed; Minagawa, Itaru; Uera, Naoto; Kohsaka, Tetsuya] Shizuoka Univ, Fac Agr, Anim Reprod & Physiol, Shizuoka 4228529, Japan; [Pitia, Ali Mohammed; Minagawa, Itaru; Kohsaka, Tetsuya] Gifu Univ, United Grad Sch Agr Sci, Div Anim Resource Prod, Gifu 5011193, Japan; [Hamano, Koh-Ichi] Shinshu Univ, Fac Agr, Minami Minowa, Nagano 3994598, Japan; [Sugawara, Yasushi; Nagura, Yoshio] Natl Livestock Breeding Ctr, Nagano Stn, Livestock Breeding Div, Saku 385007, Japan; [Hasegawa, Yoshihisa] Kitasato Univ, Sch Vet Med, Anim Sci High Tech Res Ctr, Towada, Aomori 0348628, Japan; [Oyamada, Toshifumi] Kitasato Univ, Sch Vet Med, Vet Pathol, Towada, Aomori 0348628, Japan; [Sasada, Hiroshi] Kitasato Univ, Sch Vet Med, Anim Reprod, Towada, Aomori 0348628, Japan; [Kohsaka, Tetsuya] Shizuoka Univ, Fac Agr, Dept Appl Biol Chem, Anim Reprod & Physiol,Suruga Ku, Shizuoka 4228529, Japan	Kohsaka, T (reprint author), Shizuoka Univ, Fac Agr, Anim Reprod & Physiol, Shizuoka 4228529, Japan.	t-kohsaka@agr.shizuoka.ac.jp			Japan Society for the Promotion of Science [24580408, 15K07691]	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (nos. 24580408 and 15K07691 to T. Kohsaka).	Abdel-Aziz M, 2010, LOHMANN INF, V45, P42; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Bogatcheva NV, 2003, MOL ENDOCRINOL, V17, P2639, DOI 10.1210/me.2003-0096; Okawa H, 1999, BRIT J PHARMACOL, V127, P123, DOI 10.1038/sj.bjp.0702539; Goyal HO, 2000, ANAT REC, V259, P1, DOI 10.1002/(SICI)1097-0185(20000501)259:1<1::AID-AR1>3.0.CO;2-2; KOHSAKA T, 1993, BIOL CHEM H-S, V374, P203, DOI 10.1515/bchm3.1993.374.1-6.203; Kubota Y, 2002, MOL HUM REPROD, V8, P900, DOI 10.1093/molehr/8.10.900; Franca LR, 1999, TISSUE CELL, V31, P274, DOI 10.1054/tice.1999.0044; Pathirana IN, 2012, REGUL PEPTIDES, V178, P102, DOI 10.1016/j.regpep.2012.07.003; Svendsen AM, 2008, ENDOCRINOLOGY, V149, P1113, DOI 10.1210/en.2007-0412; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Andonian S, 1999, J ANDROL, V20, P145; Siqin, 2010, ANIM SCI J, V81, P681, DOI 10.1111/j.1740-0929.2010.00801.x; Kohsaka T, 1998, BIOL REPROD, V59, P991, DOI 10.1095/biolreprod59.4.991; Siqin, 2013, BIOL CHEM, V394, P1181, DOI 10.1515/hsz-2012-0357; Kumagai J, 2002, J BIOL CHEM, V277, P31283, DOI 10.1074/jbc.C200398200; Kato S, 2010, J ENDOCRINOL, V207, P135, DOI 10.1677/JOE-10-0149; Muda M, 2005, MOL HUM REPROD, V11, P591, DOI 10.1093/molehr/gah205; Hombach-Klonisch S, 1999, MOL REPROD DEV, V53, P135, DOI 10.1002/(SICI)1098-2795(199906)53:2<135::AID-MRD2>3.0.CO;2-J; Scott DJ, 2006, J BIOL CHEM, V281, P34942, DOI 10.1074/jbc.M602728200; KUOPIO T, 1989, DEVELOPMENT, V107, P213; Bigoni R, 2001, BRIT J CLIN PHARMACO, V51, P355, DOI 10.1046/j.1365-2125.2001.01356.x; Johnson KJ, 2010, BIOL REPROD, V83, P774, DOI 10.1095/biolreprod.110.085175; Ivell R, 2009, HUM REPROD UPDATE, V15, P463, DOI 10.1093/humupd/dmp011; Anand-Ivell R, 2009, BIOL REPROD, V81, P480, DOI 10.1095/biolreprod.109.077552; KERR JB, 1988, DEVELOPMENT, V103, P535; YEUNG CH, 1994, BIOL REPROD, V50, P917, DOI 10.1095/biolreprod50.4.917; Menzies JRW, 1999, EUR J PHARMACOL, V385, P217, DOI 10.1016/S0014-2999(99)00700-1; Kawamura K, 2004, P NATL ACAD SCI USA, V101, P7323, DOI 10.1073/pnas.0307061101; McKinnell C, 2005, ENDOCRINOLOGY, V146, P4536, DOI 10.1210/en.2005-0676; Svendsen AM, 2008, MOL CELL ENDOCRINOL, V296, P10, DOI 10.1016/j.mce.2008.07.014; Zimmermann S, 1999, MOL ENDOCRINOL, V13, P681, DOI 10.1210/me.13.5.681; Gorlov IP, 2002, HUM MOL GENET, V11, P2309, DOI 10.1093/hmg/11.19.2309; Shum WWC, 2008, CELL, V135, P1108, DOI 10.1016/j.cell.2008.10.020; Anand-Ivell RJK, 2006, BIOL REPROD, V74, P945, DOI 10.1095/biolreprod.105.048165; VERI JP, 1993, J ANDROL, V14, P23; Minagawa I, 2012, BIOCHEM J, V441, P265, DOI 10.1042/BJ20111107; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; Hombach-Klonisch S, 2004, BIOL REPROD, V71, P1079, DOI 10.1095/biolrepod.103.024752; Feng S, 2007, BIOL REPROD, V77, P671, DOI 10.1095/biolreprod.107.060442; Kamat AA, 2004, ENDOCRINOLOGY, V145, P4712, DOI 10.1210/en.2004-0515; Callander GE, 2009, AM J PHYSIOL-CELL PH, V296, P1058; Dorak T., 2006, REAL TIME PCR, P63; Filonzi M, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-29; Hadziselimovic Faruk, 2007, Int Braz J Urol, V33, P407, DOI 10.1590/S1677-55382007000300015; Huang Z, 2012, BIOL REPROD, V87, P1; Kern Y, 2009, ENDOCRINOLOGY, V150, P2419; Koeva Yvetta A, 2008, Folia Med (Plovdiv), V50, P37; Kohsaka T, 2013, TXB REPROD DEV, P41; Kohsaka Tetsuya, 2013, Ital J Anat Embryol, V118, P23; Minagawa I, 2014, J ENDOCRINOL, V220, P247, DOI 10.1530/JOE-13-0430; Seiler Petra, 2000, International Journal of Andrology, V23, P65, DOI 10.1046/j.1365-2605.2000.00210.x; Siqin, 2010, NIHON CHIKUSAN GAKKA, V81, P1, DOI DOI 10.2508/CHIKUSAN.81.1	53	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	NOV	2015	362	2					407	420		10.1007/s00441-015-2206-8		14	Cell Biology	Cell Biology	CV8EN	WOS:000364513100012		
J	Hashitani, H; Mitsui, R; Masaki, S; Van Heiden, DF				Hashitani, Hikaru; Mitsui, Retsu; Masaki, Shota; Van Heiden, Dirk F.			Pacemaker role of pericytes in generating synchronized spontaneous Ca2+ transients in the myenteric microvasculature of the guinea-pig gastric antrum	CELL CALCIUM			English	Article						Pericyte; T-type Ca2+ channels; Capillaries; Ca2+ transients; Myenteric microvasculature	INTERSTITIAL-CELLS; SMOOTH-MUSCLE; T-TYPE; CALCIUM-CHANNELS; SMALL-INTESTINE; IN-SITU; MESENTERIC ARTERIOLES; SUBUROTHELIAL VENULES; SUBMUCOSAL VENULES; MOUSE BLADDER	Properties of spontaneous Ca2+ transients in the myenteric microvasculature of the guinea-pig stomach were investigated. Specifically, we explored the spatio-temporal origin of Ca2+ transients and the role of voltage-dependent Ca2+ channels (VDCCs) in their intercellular synchrony using fluorescence Ca2+ imaging and immunohistochemistry. The microvasculature generated spontaneous Ca2+ transients that were independent of both Ca2+ transients in interstitial cells of Cajal (ICC) and neural activity. Spontaneous Ca2+ transients were highly synchronous along the length of microvasculature, and appeared to be initiated in pericytes and spread to arteriolar smooth muscle cells (SMCs). In most cases, the generation or synchrony of Ca2+ transients was not affected by blockers of L-type VDCCs. In nifedipine-treated preparations, synchronous spontaneous Ca2+ transients were readily blocked by Ni2+, mibefradil or ML216, blockers for T-type VDCCs. These blockers also suppressed the known T-type VDCC dependent component of ICC Ca2+ transients or slow waves. Spontaneous Ca2+ transients were also suppressed by caffeine, tetracaine or cyclopiazonic acid (CPA). After the blockade of both L- and T-type VDCCs, asynchronous Ca2+ transients were generated in pericytes on precapillary arterioles and/or capillaries but not in arteriolar SMCs, and were abolished by CPA or nominally Ca2+ free solution. Together these data indicate that pericytes in the myenteric microvasculature may act as the origin of synchronous spontaneous Ca2+ transients. Pericyte Ca2+ transients arise from Ca2+ release from the sarco-endoplasmic reticulum and the opening of 1-type Ca2+ VDCCs is required for their synchrony and propagation to arteriolar SMCs. (C) 2015 Elsevier Ltd. All rights reserved.	[Hashitani, Hikaru; Mitsui, Retsu; Masaki, Shota] Nagoya City Univ, Grad Sch Med Sci, Dept Cell Physiol, Nagoya, Aichi 4678601, Japan; [Van Heiden, Dirk F.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia	Hashitani, H (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Cell Physiol, Nagoya, Aichi 4678601, Japan.	hasitani@med.nagoya-cu.ac.jp			Japan Society for Promotion of the Science (JSPS) [22390304, 21659377]	This study was supported by Grant-in-Aid for Scientific Research (B) (No. 22390304) and Grant-in-Aid for Challenging Exploratory Research (No. 21659377) from The Japan Society for Promotion of the Science (JSPS) to H.H.	Abd El-Rahman R.R., 2003, AM J PHYSIOL-HEART C, V304, pH58; BOUSKELA E, 1992, AM J PHYSIOL, V262, pH478; Kito Y, 2005, AM J PHYSIOL-CELL PH, V288, pC710, DOI 10.1152/ajpcell.00361.2004; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Xiang ZX, 2011, ACS CHEM NEUROSCI, V2, P730, DOI 10.1021/cn200090z; Dickens EJ, 1999, J PHYSIOL-LONDON, V514, P515, DOI 10.1111/j.1469-7793.1999.515ae.x; Haddock RE, 2005, J PHYSIOL-LONDON, V566, P645, DOI 10.1113/jphysiol.2005.086405; CUEVAS P, 1984, ANAT EMBRYOL, V170, P155, DOI 10.1007/BF00319000; WIEDEMAN MP, 1957, CIRC RES, V5, P641; Mitsui R, 2015, PFLUG ARCH EUR J PHY, V467, P1327, DOI 10.1007/s00424-014-1576-1; Zhang QL, 2008, AM J PHYSIOL-RENAL, V294, pF656, DOI 10.1152/ajprenal.00493.2007; Gibbons SJ, 2009, J CELL MOL MED, V13, P4422, DOI 10.1111/j.1582-4934.2008.00623.x; Hansen PB, 2001, CIRC RES, V89, P630, DOI 10.1161/hh1901.097126; Wu DM, 2003, AM J PHYSIOL-HEART C, V284, pH2083, DOI 10.1152/ajpheart.01007.2002; Van Helden DF, 2000, CLIN EXP PHARMACOL P, V27, P1014; Ishizaki E, 2009, J PHYSIOL-LONDON, V587, P2233, DOI 10.1113/jphysiol.2009.169003; Gustafsson F, 2001, AM J PHYSIOL-HEART C, V280, pH582; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Suzuki H, 2000, J PHYSIOL-LONDON, V525, P105, DOI 10.1111/j.1469-7793.2000.00105.x; NEILD TO, 1990, J PHYSIOL-LONDON, V420, P247; Hennig GW, 2004, J PHYSIOL-LONDON, V556, P585, DOI 10.1113/jphysiol.2003.059055; Choi KH, 2011, GEN PHYSIOL BIOPHYS, V30, P100, DOI 10.4149/gpb_2011_01_100; Morita H, 1999, CIRC RES, V85, P596; Hashitani H, 2011, J UROLOGY, V185, P2382, DOI 10.1016/j.juro.2011.02.046; Shimizu Y, 2014, VASC PHARMACOL, V60, P84, DOI 10.1016/j.vph.2014.01.002; Park KJ, 2006, AM J PHYSIOL-CELL PH, V290, pC1411, DOI 10.1152/ajpcell.00447.2005; Sakagami K, 1999, J PHYSIOL-LONDON, V521, P637, DOI 10.1111/j.1469-7793.1999.00637.x; Imtiaz MS, 2007, BIOPHYS J, V92, P3843, DOI 10.1526/biophysj.106.095687; Mitsui R, 2013, BRIT J PHARMACOL, V170, P968, DOI 10.1111/bph.12347; Fernandez-Klett F, 2010, P NATL ACAD SCI USA, V107, P22290, DOI 10.1073/pnas.1011321108; Sanders KM, 2014, PHYSIOL REV, V94, P859, DOI 10.1152/physrev.00037.2013; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Kuo IY, 2010, J CEREBR BLOOD F MET, V30, P1226, DOI 10.1038/jcbfm.2010.11; Fu YY, 2013, AM J PHYSIOL-GASTR L, V304, pG1, DOI 10.1152/ajpgi.00209.2012; Sergeant GP, 2001, AM J PHYSIOL-CELL PH, V280, pC1349; Kito Y, 2003, J PHYSIOL-LONDON, V553, P803, DOI 10.1113/jphysiol.2003.051334; HIROSE K, 1993, BIOCHEM BIOPH RES CO, V194, P726, DOI 10.1006/bbrc.1993.1882; Yamamoto Y, 2001, J PHYSIOL-LONDON, V535, P181, DOI 10.1111/j.1469-7793.2001.00181.x; Parsons SP, 2012, AM J PHYSIOL-CELL PH, V302, pC1055, DOI 10.1152/ajpcell.00334.2011; Tsai AG, 2003, PHYSIOL REV, V83, P933, DOI 10.1152/physrev.00034.2002; Zheng HF, 2014, AM J PHYSIOL-CELL PH, V306, pC705, DOI 10.1152/ajpcell.00390.2013; Borysova L, 2013, CELL CALCIUM, V54, P163, DOI 10.1016/j.ceca.2013.06.001; HUNDLEY WG, 1988, AM J PHYSIOL, V254, pH67; Peng HL, 2001, CIRC RES, V88, P810, DOI 10.1161/hh0801.089603; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Kotecha N, 2005, AM J PHYSIOL-HEART C, V289, pH1326, DOI 10.1152/ajpheart.00323.2005; Burdyga T, 2014, J VASC RES, V51, P190, DOI 10.1159/000362687; Zhang T, 2011, J PHYSIOL-LONDON, V589, P2383, DOI 10.1113/jphysiol.2010.202937; HIRST GDS, 1977, J PHYSIOL-LONDON, V273, P263; Spencer NJ, 2003, AUTON NEUROSCI-BASIC, V104, P73, DOI 10.1016/S1566-0702(02)00292-8; Kotecha N, 1995, J PHYSIOL-LONDON, V489, P849; Hashitani H, 2012, BRIT J PHARMACOL, V167, P1723, DOI 10.1111/j.1476-5381.2012.02125.x; Jensen LJ, 2004, BRIT J PHARMACOL, V142, P709, DOI 10.1038/sj.bjp.0705841; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Mitsui R, 2013, HISTOCHEM CELL BIOL, V140, P189, DOI 10.1007/s00418-012-1074-5; Dickens EJ, 2001, J PHYSIOL-LONDON, V531, P827, DOI 10.1111/j.1469-7793.2001.0827h.x; PARKER I, 1991, J PHYSIOL-LONDON, V433, P229; Van Helden DF, 2000, J PHYSIOL-LONDON, V524, P245; VANHELDEN DF, 1993, J PHYSIOL-LONDON, V471, P465; van Helden DF, 2003, J PHYSIOL-LONDON, V548, P271, DOI 10.1113/jphysiol.2002.033720	60	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4160	1532-1991		CELL CALCIUM	Cell Calcium	NOV	2015	58	5					442	456		10.1016/j.ceca.2015.06.012		15	Cell Biology	Cell Biology	CW1CV	WOS:000364728100003		
J	Limatola, N; Chun, JT; Kyozuka, K; Santella, L				Limatola, Nunzia; Chun, Jong T.; Kyozuka, Keiichiro; Santella, Luigia			Novel Ca2+ increases in the maturing oocytes of starfish during the germinal vesicle breakdown	CELL CALCIUM			English	Article						Meiosis; Cell cycle; Calcium; Starfish; Oocyte; Actin	MATURATION-PROMOTING FACTOR; SEA-URCHIN EGGS; BETA-GAMMA-SUBUNIT; CALCIUM-RELEASE; ACTIN CYTOSKELETON; MEIOTIC MATURATION; INOSITOL 1,4,5-TRISPHOSPHATE; ENDOPLASMIC-RETICULUM; CORTICAL ACTIN; G-PROTEIN	It has been known that the intracellular Ca2+ level transiently rises at the specific stages of mitosis such as the moment of nuclear envelope breakdown and at the metaphase-anaphase transition. Comparable intracellular Ca2+ increases may also take place during meiosis, as was intermittently reported in mouse, Xenopus, and starfish oocytes. In a majority of starfish species, the maturing oocytes display an intracellular Ca2+ increase within few minutes after the addition of the maturation hormone, 1-methyladenine (1-MA). Although starfish oocytes at meiosis also manifest a Ca2+ increase at the time of polar body extrusion, a similar Ca2+ increase has never been observed during the envelope breakdown of the nucleus (germinal vesicle, GV). Here, we report, for the first time, the existence of an additional Ca2+ response in the maturing oocytes of Asterina pectinifera at the time of GV breakdown. In contrast to the immediate early Ca2+ response to 1-MA, which is independent of external Ca2+ and takes a form of intracellular Ca2+ wave traveling three times as fast as that in the fertilized eggs, this late stage Ca2+ response comprised a train of numerous spikes representing Ca2+ influx. These Ca2+ spikes coinciding with GV breakdown were mostly eliminated when the GV was removed from the oocytes prior to the addition of 1-MA, suggesting that the Ca2+ spikes are rather a consequence of the GV breakdown. In support of the idea that these Ca2+ spikes play a physiological role, the oocytes matured in calcium-free seawater had a higher rate of cleavage failure 2 h after the fertilization in natural seawater. Specific inhibitors of L-type Ca2+ channels, verapamil and diltiazem, severely suppressed the amplitude of the individual Ca2+ spikes, but not their frequencies. On the other hand, latrunculin-A (LAT-A), which promotes net depolymerization of the actin cytoskeleton, had a dual effect on this late Ca2+ response. When added immediately after the hormone-dependent period, LAT-A inhibited the occurrence (frequency) of the spikes in a dose-dependent manner, but the amplitude of the prevailing Ca2+ spikes itself was rather significantly increased. These results suggest that the cortical actin cytoskeleton and some nuclear factors may play a role in regulating ion channel activities during this stage of meiotic progression. (C) 2015 Elsevier Ltd. All rights reserved.	[Limatola, Nunzia; Chun, Jong T.; Santella, Luigia] Stn Zool A Dohrn, Biol & Evolut Marine Organisms, I-80121 Naples, Italy; [Kyozuka, Keiichiro] Tohoku Univ, Res Ctr Marine Biol, Aomori, Japan	Chun, JT (reprint author), Stn Zool A Dohrn, Biol & Evolut Marine Organisms, Villa Comunale 1, I-80121 Naples, Italy.	chun@szn.it			SZN PhD fellwship	The authors are grateful to Prof. G. Kumano and his staffs at the Asamushi Research Center for Marine Biology in Japan for hosting L.S. and L.N. for the on-site experiments, and to F. Iamunno and R. Graziano for the TEM imaging services. Special thanks go to Dr. A. Puppo and Mr. G. Gragnaniello for the technical assistance in microinjection and computer graphics. NL has been financially supported by SZN PhD fellwship.	Jaffe LF, 2002, CELL CALCIUM, V32, P217, DOI 10.1016/S0143-4060(02)00157-4; EISEN A, 1984, J CELL BIOL, V99, P1878, DOI 10.1083/jcb.99.5.1878; DALE B, 1979, NATURE, V282, P89, DOI 10.1038/282089a0; CANTIELLO HF, 1991, AM J PHYSIOL, V261, pC882; GUERRIER P, 1978, ANN BIOL ANIM BIOCH, V18, P441, DOI 10.1051/rnd:19780315; Santella L, 1998, BIOCHEM BIOPH RES CO, V252, P1, DOI 10.1006/bbrc.1998.9583; Moccia F, 2006, DEV BIOL, V294, P24, DOI 10.1016/j.ydbio.2006.02.011; Santella L, 2000, J BIOL CHEM, V275, P8301, DOI 10.1074/jbc.275.12.8301; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; Furukawa K, 1997, J NEUROSCI, V17, P8178; WASSERMAN WJ, 1980, P NATL ACAD SCI-BIOL, V77, P1534, DOI 10.1073/pnas.77.3.1534; Chun JT, 2009, ACTA PHYSIOL, V195, P61, DOI 10.1111/j.1748-1716.2008.01921.x; Gokina NI, 2002, AM J PHYSIOL-HEART C, V282, pH1410, DOI 10.1152/ajpheart.00441.2001; Iwasaki H, 2002, J BIOL CHEM, V277, P2763, DOI 10.1074/jbc.M108839200; Sun L, 2004, J CELL BIOL, V165, P63, DOI 10.1083/jcb.200309138; Calaghan SC, 2004, PROG BIOPHYS MOL BIO, V84, P29, DOI [10.1016/S0079-6107(03)00057-9, 10.1016/S0073-6107(03)00057-9]; JAFFE LA, 1994, DEV BIOL, V164, P579, DOI 10.1006/dbio.1994.1225; SANTELLA L, 1994, BIOCHEM BIOPH RES CO, V203, P674, DOI 10.1006/bbrc.1994.2235; Machaca K, 2004, DEV BIOL, V275, P170, DOI 10.1016/j.ydbio.2004.08.004; Nusco GA, 2002, BIOCHEM BIOPH RES CO, V290, P1015, DOI 10.1006/bbrc.2001.6286; PICARD A, 1984, DEV BIOL, V104, P357, DOI 10.1016/0012-1606(84)90091-5; KANATANI H, 1969, NATURE, V221, P273, DOI 10.1038/221273a0; Nusco GA, 2006, BIOCHEM BIOPH RES CO, V348, P109, DOI 10.1016/j.bbrc.2006.07.023; Turvey MR, 2005, J CELL SCI, V118, P971, DOI 10.1242/jcs.01693; NEMOTO S, 1980, DEV GROWTH DIFFER, V22, P315; CARROLL J, 1994, DEVELOPMENT, V120, P3507; KISHIMOTO T, 1981, DEV BIOL, V81, P177, DOI 10.1016/0012-1606(81)90360-2; Lim D, 2003, J BIOL CHEM, V278, P42505, DOI 10.1074/jbc.M301851200; Ullah A, 2014, PROG MOL BIOL TRANSL, V123, P83, DOI 10.1016/B978-0-12-397897-4.00006-1; NEMOTO SI, 1982, DEV GROWTH DIFFER, V24, P429; Chun JT, 2013, BIOCHEM BIOPH RES CO, V441, P301, DOI 10.1016/j.bbrc.2013.09.103; GILKEY JC, 1978, J CELL BIOL, V76, P448, DOI 10.1083/jcb.76.2.448; Russo GL, 1996, DEVELOPMENT, V122, P1995; Hamaguchi Y, 2001, CELL STRUCT FUNCT, V26, P627, DOI 10.1247/csf.26.627; Chun JT, 2014, BIOCHEM BIOPH RES CO, V450, P1166, DOI 10.1016/j.bbrc.2014.06.057; Yazaki I, 2015, ZYGOTE, V23, P426, DOI 10.1017/S0967199414000033; DOREE M, 1978, EXP CELL RES, V115, P251, DOI 10.1016/0014-4827(78)90279-3; HeilChapdelaine RA, 1996, DEV BIOL, V177, P204, DOI 10.1006/dbio.1996.0156; TERASAKI M, 1994, J CELL SCI, V107, P1797; KIKUYAMA M, 1991, DEV GROWTH DIFFER, V33, P633; MOODY WJ, 1985, DEV BIOL, V112, P396, DOI 10.1016/0012-1606(85)90412-9; MCPHERSON SM, 1992, J CELL BIOL, V116, P1111, DOI 10.1083/jcb.116.5.1111; SCHROEDER TE, 1981, J CELL BIOL, V90, P362, DOI 10.1083/jcb.90.2.362; TOMBES RM, 1992, J CELL BIOL, V117, P799, DOI 10.1083/jcb.117.4.799; Lim D, 2002, FASEB J, V16, P1050, DOI 10.1096/fj.02-0021com; Puppo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003588; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; Vasilev F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039231; RIDGWAY EB, 1977, P NATL ACAD SCI USA, V74, P623, DOI 10.1073/pnas.74.2.623; MOREAU M, 1978, NATURE, V272, P251, DOI 10.1038/272251a0; SCHROEDER TE, 1983, DEV BIOL, V98, P373, DOI 10.1016/0012-1606(83)90366-4; POENIE M, 1985, NATURE, V315, P147, DOI 10.1038/315147a0; WITCHEL HJ, 1990, DEV BIOL, V141, P393, DOI 10.1016/0012-1606(90)90393-W; Santella L, 2004, TRENDS BIOCHEM SCI, V29, P400, DOI 10.1016/j.tibs.2004.06.009; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; SANO K, 1980, DEV BIOL, V78, P242, DOI 10.1016/0012-1606(80)90333-4; STRICKER SA, 1995, DEV BIOL, V170, P496, DOI 10.1006/dbio.1995.1232; KAO JPY, 1990, J CELL BIOL, V111, P183, DOI 10.1083/jcb.111.1.183; POENIE M, 1986, SCIENCE, V233, P886, DOI 10.1126/science.3755550; STEINHARDT R, 1977, DEV BIOL, V58, P185, DOI 10.1016/0012-1606(77)90084-7; Miyazaki S, 2006, SEMIN CELL DEV BIOL, V17, P233, DOI 10.1016/j.semcdb.2006.02.007; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; CHIBA K, 1990, DEV BIOL, V140, P300, DOI 10.1016/0012-1606(90)90080-3; CHIBA K, 1993, MOL BIOL CELL, V4, P1027; Chun JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014100; Chun J.T., 2013, ENCY BIOL CHEM, V2, P640; Enserink JM, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-11; JAFFE LA, 1993, J CELL BIOL, V121, P775, DOI 10.1083/jcb.121.4.775; Kyozuka Keiichiro, 2008, Dev Biol, V320, P426, DOI 10.1016/j.ydbio.2008.05.549; Kyozuka K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006296; Santella L, 2015, BIOCHEM BIOPH RES CO, V460, P104, DOI 10.1016/j.bbrc.2015.03.028; Santella L., 2011, SCI CHINA LIFE SCI, P733; Wang Y, 2002, J NEUROCHEM, V82, P945, DOI 10.1046/j.1471-4159.2002.01059.x	73	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4160	1532-1991		CELL CALCIUM	Cell Calcium	NOV	2015	58	5					500	510		10.1016/j.ceca.2015.08.002		11	Cell Biology	Cell Biology	CW1CV	WOS:000364728100008		
J	Hamano, R; Wu, XQ; Wang, YT; Oppenheim, JJ; Chen, X				Hamano, Ryoko; Wu, Xueqiang; Wang, Yitao; Oppenheim, Joost J.; Chen, Xin			Characterization of MT-2 cells as a human regulatory T cell-like cell line	CELLULAR & MOLECULAR IMMUNOLOGY			English	Editorial Material									[Hamano, Ryoko; Wu, Xueqiang; Oppenheim, Joost J.; Chen, Xin] NCI, Mol Immunoregulat Lab, Canc Inflammat Program, Ctr Canc Res, Frederick, MD 21701 USA; [Hamano, Ryoko] Kanazawa Univ, Div Rheumatol, Kanazawa, Ishikawa, Japan; [Wang, Yitao; Chen, Xin] Univ Macau, State Key Lab Qual Res Chinese Med, Inst Chinese Med Sci, Macau, Peoples R China	Chen, X (reprint author), Univ Macau, Rm 7039,Bldg N22,Ave Univ, Taipa, Macau, Peoples R China.	xchen@umac.mo					Chen X, 2011, INT IMMUNOPHARMACOL, V11, P1489, DOI 10.1016/j.intimp.2011.05.018; Chen SM, 2006, INT IMMUNOL, V18, P269, DOI 10.1093/intimm/dxh366; Chen X, 2010, EUR J IMMUNOL, V40, P1099, DOI 10.1002/eji.200940022; Costantino CM, 2008, EUR J IMMUNOL, V38, P921, DOI 10.1002/eji.200738104; MIYOSHI I, 1981, NATURE, V294, P770, DOI 10.1038/294770a0; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Chen X, 2007, J IMMUNOL, V179, P154; Hill SA, 1999, VIROLOGY, V263, P273, DOI 10.1006/viro.1999.9922; Jones KS, 2008, NAT MED, V14, P429, DOI 10.1038/nm1745; Maeda M, 2014, INT J ONCOL, V45, P2522, DOI 10.3892/ijo.2014.2682	10	0	0	CHIN SOCIETY IMMUNOLOGY	BEING	5 DONGDAN SANTIAO, DONGCHEN DISTRICT, BEING, 100005, PEOPLES R CHINA	1672-7681	2042-0226		CELL MOL IMMUNOL	Cell. Mol. Immunol.	NOV	2015	12	6					780	782		10.1038/cmi.2014.123		3	Immunology	Immunology	CV8HO	WOS:000364523600015		
J	Li, T; Ma, SG; Li, B; Wang, MH; Wang, YC				Li Te; Ma Shugen; Li Bin; Wang Minghui; Wang Yuechao			Fuzzy Theory Based Control Method for an In-pipe Robot to Move in Variable Resistance Environment	CHINESE JOURNAL OF MECHANICAL ENGINEERING			English	Article						screw drive; in-pipe robot; fuzzy control; torque control	MECHANISM	Most of the existing screw drive in-pipe robots cannot actively adjust the maximum traction capacity, which limits the adaptability to the wide range of variable environment resistance, especially in curved pipes. In order to solve this problem, a screw drive in-pipe robot based on adaptive linkage mechanism is proposed. The differential property of the adaptive linkage mechanism allows the robot to move without motion interference in the straight and varied curved pipes by adjusting inclining angles of rollers self-adaptively. The maximum traction capacity of the robot can be changed by actively adjusting the inclining angles of rollers. In order to improve the adaptability to the variable resistance, a torque control method based on the fuzzy controller is proposed. For the variable environment resistance, the proposed control method can not only ensure enough traction force, but also limit the output torque in a feasible region. In the simulations, the robot with the proposed control method is compared to the robot with fixed inclining angles of rollers. The results show that the combination of the torque control method and the proposed robot achieves the better adaptability to the variable resistance in the straight and curved pipes.	[Li Te; Ma Shugen; Li Bin; Wang Minghui; Wang Yuechao] Chinese Acad Sci, Shenyang Inst Automat, State Key Lab Robot, Shenyang 110016, Peoples R China; [Li Te] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Ma Shugen] Ritsumeikan Univ, Dept Robot, Shiga 5258577, Japan	Wang, MH (reprint author), Chinese Acad Sci, Shenyang Inst Automat, State Key Lab Robot, Shenyang 110016, Peoples R China.	mhwang@sia.cn			National Natural Science Foundation of China [61273345]	Supported by National Natural Science Foundation of China(Grant No. 61273345)	AI-DABBAGH R D, 2014, ADV ENG SOFTWARE, V78, P60; Fateh MM, 2014, NONLINEAR DYNAM, V78, P2195, DOI 10.1007/s11071-014-1590-z; Liu QY, 2013, MECHATRONICS, V23, P419, DOI 10.1016/j.mechatronics.2013.03.004; Lee D, 2012, MECH MACH THEORY, V56, P52, DOI 10.1016/j.mechmachtheory.2012.05.004; Zhang YS, 2014, CHIN J MECH ENG-EN, V27, P880, DOI 10.3901/CJME.2014.0619.114; Kishi T, 2013, IEEE INT C INT ROBOT, P3297, DOI 10.1109/IROS.2013.6696825; Aymerich FX, 2011, IEEE INT CONF FUZZY, P751; Hu Z, 2005, IEEE T ROBOT, V21, P781, DOI 10.1109/TRO.2005.852258; Kuwada A, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS, VOLS 1-5, P989, DOI 10.1109/ROBIO.2007.4522298; Zagler A, 2003, IEEE INT CONF ROBOT, P2954; Kwon YS, 2012, IEEE T ROBOT, V28, P681, DOI 10.1109/TRO.2012.2183049; Park JJ, 2013, INT CONF UBIQ ROBOT, P55; Liu Y, 2011, CHIN J MECH ENG-EN, V24, P264, DOI 10.3901/CJME.2011.02.264; Kim HM, 2013, IEEE INT C INT ROBOT, P252; BROEKHOVEN E V, 2004, IEEE INT C FUZZ SYST, P1537; Hirose S, 1999, ICRA '99: IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-4, PROCEEDINGS, P2309, DOI 10.1109/ROBOT.1999.770450; ICAKOGAWA A, 2013, INT S ROB ISR SEOUL, P1; IWASHINA S, 1994, INT S MICR HUM SCI N, P41; KAKOGAWA A, 2014, ROBOTICA, P1; Li Te, 2014, Journal of Mechanical Engineering, V50, DOI 10.3901/JME.2014.17.008; LI Te, 2015, SCI CHINA TECHNOL SC, V58, P1; Liu Qingyou, 2014, Robot, V36, DOI 10.13973/j.cnki.robot.2014.0711; Qiao JW, 2013, IEEE-ASME T MECH, V18, P799, DOI 10.1109/TMECH.2012.2184294	23	0	0	EDITORIAL OFFICE CHINESE JOURNAL MECHANICAL ENGINEERING	BEIJING	22 BAIWANZHUANG DAJIE, BEIJING, 100037, PEOPLES R CHINA	1000-9345	2192-8258		CHIN J MECH ENG-EN	Chin. J. Mech. Eng.	NOV	2015	28	6					1213	1221		10.3901/CJME.2015.0717.096		9	Engineering, Mechanical	Engineering	CW1CZ	WOS:000364728500016		
J	Thornton, JA; Slawski, TM; Lin, H				Thornton, Jeffrey A.; Slawski, Thomas M.; Lin, Hebin			Salinization: the ultimate threat to temperate lakes, with particular reference to Southeastern Wisconsin (USA)	CHINESE JOURNAL OF OCEANOLOGY AND LIMNOLOGY			English	Article						salinization; temperate lakes; chloride concentrations; salt management	WATER; SALT; SEA	Many lakes in Southeastern Wisconsin (the metropolitan-Milwaukee area) are gradually becoming increasingly "salty". While these waterbodies would not be considered presently to be saline lakes, there has been a rapid increase in the chloride concentrations in most of these lakes over the last 30 years, with the lakes increasing from a mean chloride concentration of about 19 mg/L to over 100 mg/L in some cases. While ecological impacts can be expected when chloride values exceed 250 mg/L, the rate of increase presents a basis for concern, especially since the underlying geology of the region is based on limestone/dolomite which is deficient in chlorides. Thus, the origin of the chlorides is anthropogenic: human and industrial wastewaters (treatment of which has effected improvements in trophic status but has not affected other water-borne contaminants) and winter de-icing practices based upon large quantities of sodium chloride are major contributors to the increasing concentrations of chloride in the region's waterways. Without taking remedial measures, the rate of salinization is expected to continue to increase, resulting, ultimately, in the alteration of the freshwater systems in the region.	[Thornton, Jeffrey A.; Slawski, Thomas M.; Lin, Hebin] Int Environm Management Serv Ltd, New Berlin, WI 53151 USA; [Thornton, Jeffrey A.] Texas State Univ, Meadows Ctr Water & Environm, San Marcos, TX 78666 USA; [Thornton, Jeffrey A.] Kobe Univ, Grad Sch Human Dev & Environm, Nada Ku, Kobe, Hyogo 6578501, Japan; [Slawski, Thomas M.] Southeastern Wisconsin Reg Planning Commiss, Waukesha, WI 53187 USA	Thornton, JA (reprint author), Int Environm Management Serv Ltd, POB 510373, New Berlin, WI 53151 USA.	IEMS@aol.com			International Conference on Salt Lake Research	The authors gratefully acknowledge the financial support of the organizing committee of the International Conference on Salt Lake Research which facilitated their attendance at the 12th conference, held during July 2014 in Langfang near Beijing, China.	Corsi SR, 2015, SCI TOTAL ENVIRON, V508, P488, DOI 10.1016/j.scitotenv.2014.12.012; Jackson RB, 2005, P NATL ACAD SCI USA, V102, P14487, DOI 10.1073/pnas.0507389102; Marsalek J, 2003, WATER SCI TECHNOL, V48, P61; Micklin P, 2008, SCI AM, V298, P64; Corsi SR, 2010, ENVIRON SCI TECHNOL, V44, P7376, DOI 10.1021/es101333u; Smol JP, 2007, P NATL ACAD SCI USA, V104, P12395, DOI 10.1073/pnas.0702777104; CARPELAN LH, 1958, LIMNOL OCEANOGR, V3, P373; Lofgren S, 2001, WATER AIR SOIL POLL, V130, P863, DOI 10.1023/A:1013895215558; Baldwin A K, 2012, 20105064 US GEOL SUR; Baldwin A K, 2013, 20105174 US GEOL SUR; BEETON ALFRED M., 1965, LIMNOL OCEANOGR, V10, P240; Cohen M J, 2014, HAZARDS TOLL COSTS I; Dela-Hart. UNDATED, WATER SOFTENERS ENV; Howard G, 2006, PROTECTING GROUNDWAT, P275; Lillie R A, 1983, WISCONSIN DEP NATURA, V138; Lins T J., 2010, WISCONSIN NATURAL RE; Miles A K, 2009, 20091276 US GEOL SUR; NCDC (National Climatic Data Center), 2002, CLIM 2001 ANN REV SI; Robertson Dale M., 2000, Lake and Reservoir Management, V16, P155; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 1982, 54 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2009, 176 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 1998, 124 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 1995, 93 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2002, 253 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2011, 193 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2007, 300 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2010, 143 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2006, 161 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2004, 146 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2009, 155 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 1981, 53 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 1997, 226 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2012, 134 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2003, 144 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2005, 273 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 1998, 227 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2005, SE WISCONSIN REGIONA, V42, P1; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2000, 134 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2008, 60 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 1993, 82 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2007, 48 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2000, 40 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2008, 173 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2001, 140 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2006, 230 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 1990, 182 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2006, 48 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2001, 262 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2003, 53 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 1996, 222 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2009, 181 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2009, 302 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 1994, 181 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 1999, 130 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2006, 122 SEWRPC; SEWRPC (Southeastern Wisconsin Regional Planning Commission), 2010, 226 SEWRPC; Stefan H G, 2008, STUDY ENV EFFECTS DE; U. S. Geological Survey, 2012, 20121238 US GEOL SUR; Williams W D, 1998, GUIDELINES LAKE MANA, V6	59	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING, 100717, PEOPLES R CHINA	0254-4059	1993-5005		CHIN J OCEANOL LIMN	Chin. J. Oceanol. Limnol.	NOV	2015	33	6					1461	1475		10.1007/s00343-015-4368-3		15	Limnology; Oceanography	Marine & Freshwater Biology; Oceanography	CV8DC	WOS:000364506200013		
J	Lin, HB; Thornton, JA; Shadrin, N				Lin, Hebin; Thornton, Jeffrey A.; Shadrin, Nickolai			A watershed-based adaptive knowledge system for developing ecosystem stakeholder partnerships	CHINESE JOURNAL OF OCEANOLOGY AND LIMNOLOGY			English	Article						ecosystem services; information transformation; integrated ecosystem management; stakeholder partnerships; transaction costs; watersheds	ENVIRONMENTAL SERVICES; DESIGNING PAYMENTS; MANAGEMENT; CONSERVATION; GOVERNANCE; LESSONS; ISSUES	This study proposes a Watershed-based Adaptive Knowledge System (WAKES) to consistently coordinate multiple stakeholders in developing sustainable partnerships for ecosystem management. WAKES is extended from the institutional mechanism of Payments for Improving Ecosystem Services at the Watershed-scale (PIES-W). PIES-W is designed relating to the governance of ecosystem services fl ows focused on a lake as a resource stock connecting its infl owing and outfl owing rivers within its watershed. It explicitly realizes the values of conservation services provided by private land managers and incorporates their activities into the public organizing framework for ecosystem management. It implicitly extends the "upstream-to-downstream" organizing perspective to a broader vision of viewing the ecosystems as comprised of both "watershed landscapes" and "marine landscapes". Extended from PIES-W, WAKES specifies two corresponding feedback: Framework I and II. Framework I is a relationship matrix comprised of three input-output structures of primary governance factors intersecting three subsystems of a watershed with regard to ecosystem services and human stakeholders. Framework II is the Stakeholder-and-Information structure channeling five types of information among four stakeholder groups in order to enable the feedbacks mechanism of Framework I. WAKES identifies the rationales behind three fundamental information transformations, illustrated with the Transboundary Diagnostic Analysis and the Strategic Action Program of the Bermejo River Binational Basin. These include (1) translating scientific knowledge into public information within the Function-and-Service structure corresponding to the ecological subsystem, (2) incorporating public perceptions into political will within the Service- and- Value structure corresponding to the economic subsystem, and (3) integrating scientific knowledge, public perceptions and political will into management options within the Value-and-Stakeholder structure corresponding to the social subsystem. This study seeks to share a vision of social adaptation for a global sustainable future through developing a network to adopt contributions from and forming partnerships among all ecosystem stakeholders.	[Lin, Hebin; Thornton, Jeffrey A.] Int Environm Management Serv Ltd, New Berlin, WI 53151 USA; [Thornton, Jeffrey A.] Texas State Univ, Meadows Ctr Water & Environm, San Marcos, TX 78666 USA; [Thornton, Jeffrey A.] Kobe Univ, Grad Sch Human Dev & Environm, Nada Ku, Kobe, Hyogo 6578501, Japan; [Shadrin, Nickolai] Inst Biol Southern Seas, Sevastopol 299011, Russia; [Shadrin, Nickolai] Chinese Acad Geol Sci GAGS, Key Lab Saline Lake Resources & Environm, Beijing 100037, Peoples R China	Lin, H (reprint author), Int Environm Management Serv Ltd, POB 510373, New Berlin, WI 53151 USA.	hebin.lin@gmail.com			organizing committee of the International Conference on Salt Lake Research, Beijing, China	The authors gratefully acknowledge the financial support of the organizing committee of the International Conference on Salt Lake Research, held during 2014 in Beijing, China.	Agarwal C, 2007, FAIR DEALS WATERSHED; Reed MS, 2015, J ENVIRON MANAGE, V151, P472, DOI 10.1016/j.jenvman.2014.11.010; Wunscher T, 2008, ECOL ECON, V65, P822, DOI 10.1016/j.ecolecon.2007.11.014; Lin Hebin, 2013, Lakes & Reservoirs Research and Management, V18, P81, DOI 10.1111/lre.12015; Ferraro PJ, 2008, ECOL ECON, V65, P810, DOI 10.1016/j.ecolecon.2007.07.029; Cranford M, 2011, ECOL ECON, V71, P89, DOI 10.1016/j.ecolecon.2011.08.007; Habron G, 2003, ENVIRON MANAGE, V31, P29, DOI 10.1007/s00267-002-2763-y; Kemkes RJ, 2010, ECOL ECON, V69, P2069, DOI 10.1016/j.ecolecon.2009.11.032; Kosoy N, 2010, ECOL ECON, V69, P1228, DOI 10.1016/j.ecolecon.2009.11.002; Lin Hebin, 2012, Lakes & Reservoirs Research and Management, V17, P207, DOI 10.1111/lre.12003; Redford KH, 2009, CONSERV BIOL, V23, P785, DOI 10.1111/j.1523-1739.2009.01271.x; Farley J, 2010, ECOL ECON, V69, P2060, DOI 10.1016/j.ecolecon.2010.06.010; Williamson OE, 1998, ECONOMIST, V146, P23, DOI 10.1023/A:1003263908567; Lin Hebin, 2012, Lakes & Reservoirs Research and Management, V17, P191, DOI 10.1111/lre.12004; Jack BK, 2008, P NATL ACAD SCI USA, V105, P9465, DOI 10.1073/pnas.0705503104; Engel S, 2008, ECOL ECON, V65, P663, DOI 10.1016/j.ecolecon.2008.03.011; Wunder S, 2008, ENVIRON DEV ECON, V13, P279, DOI 10.1017/S1355770X08004282; Leimona B, 2015, ECOSYST SERV, V12, P16, DOI 10.1016/j.ecoser.2014.12.012; Kosoy N, 2008, GEOFORUM, V39, P2073, DOI 10.1016/j.geoforum.2008.08.007; Jin SM, 2013, REMOTE SENS ENVIRON, V132, P159, DOI 10.1016/j.rse.2013.01.012; Arocena-Francisco H, 2003, ENV SERVICE PAYMENTS; Asquith N, 2007, FAIR DEALS WATERSHED; Blignaut J, 2008, S AFRICA INVENTORY C; Bracer C, 2007, ORG GOVERNANCE FOSTE; Bulte EH, 2008, ENVIRON DEV ECON, V13, P245, DOI 10.1017/S1355770X08004348; Caribbean Natural Resources Institute (CANARI), 2002, WHO PAYS FOR WAT; China Committee for International Cooperation on Environment and Development (CCICED), 2006, EC MECH POL CHIN; Chiotha D, 2008, POTENTIAL PAYMENT EC; Das R, 2014, DESALINATION, V336, P97, DOI 10.1016/j.desal.2013.12.026; Davis L., 1971, I CHANGE AM EC GROWT; FAO - Food and Agriculture Organization of the Unietd Nations, 2004, 3 FAO; Forest Trends, 2007, GETT START INTR PRIM; Gutman P., 2003, GOODWILL PAYMENTS EN; Hartmann J, 2004, MARKETING ENV SERVIC; Holling C. S., 1978, ADAPTIVE ENV ASSESSM; Huang M, 2007, WATERSHED BASED PAYM; King N, 2008, FAIR DEALS WATERSHED; Klein PG, 1999, ENCY LAW EC, P456; Landell-Mills N., 2002, INSTRUMENTS SUSTAINA; Lin H, 2014, EC INCENTIVES MARINE, P69; Lin H., 2012, J ENVIRON SCI ENG, VB1, P1167; Lin H, 2013, AQUAT SCI TECHNOL, V1, P119; Mayrand K., 2004, PAYMENTS ENV SERVICE; McAfee M, 2010, ANN ASSOC AM GEOGR, V100, P579; McIntosh S, 2007, FAIR DEALS WATERSHED; MEA, 2005, EC HUM WELL BEING SY; Mwangi S., 2008, PAYMENT ECOSYSTEM SE; OAS, 2000, TRANSB DIAGN AN BIN; OAS, 2010, STRAT ACT PROGR BIN; Randimby N A, 2008, INVENTORY INITIATIVE; Ruhweza A, 2008, INVENTORY PES SCHEME; Scurrah-Ehrhart C, 2006, TANZANIA INVENTORY P; Simley J D, 2009, NATL MAP HYDROGRAPHY; Southgate D., 2009, Journal of Sustainable Forestry, V28, P497, DOI 10.1080/10549810902794493; Swallow B, 2007, CONDITIONS EFFECTIVE; U. S. Geological Survey (USGS) U. S. Department of Agriculture (USDA), 2012, FED STAND PROC NAT W; UNEP, 2004, GLOB INT WAT ASS PAT; United States Agency for International Development (USAID), 2007, LESS BEST PRACT PROP; Van Noordwijk M, 2010, CES COS CIS PARADIGM; Williamson O. E., 1985, EC I CAPITALISM FIRM; Wunder S., 2005, PAYMENTS ENV SERVICE	61	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING, 100717, PEOPLES R CHINA	0254-4059	1993-5005		CHIN J OCEANOL LIMN	Chin. J. Oceanol. Limnol.	NOV	2015	33	6					1476	1488		10.1007/s00343-015-4366-5		13	Limnology; Oceanography	Marine & Freshwater Biology; Oceanography	CV8DC	WOS:000364506200014		
J	Wu, C; Kato, TS; Ji, RP; Zizola, C; Brunjes, DL; Deng, Y; Akashi, H; Armstrong, HF; Kennel, PJ; Thomas, T; Forman, DE; Hall, J; Chokshi, A; Bartels, MN; Mancini, D; Seres, D; Schulze, PC				Wu, Christina; Kato, Tomoko S.; Ji, Ruiping; Zizola, Cynthia; Brunjes, Danielle L.; Deng, Yue; Akashi, Hirokazu; Armstrong, Hilary F.; Kennel, Peter J.; Thomas, Tiffany; Forman, Daniel E.; Hall, Jennifer; Chokshi, Aalap; Bartels, Matthew N.; Mancini, Donna; Seres, David; Schulze, P. Christian			Supplementation of L-Alanyl-L-Glutamine and Fish Oil Improves Body Composition and Quality of Life in Patients With Chronic Heart Failure	CIRCULATION-HEART FAILURE			English	Article						echocardiography; heart failure; metabolism; muscle, skeletal; quality of life	POLYUNSATURATED FATTY-ACIDS; PLACEBO-CONTROLLED TRIAL; INDEPENDENT RISK-FACTOR; SKELETAL-MUSCLE; INSULIN-RESISTANCE; GENE-EXPRESSION; DOUBLE-BLIND; METABOLISM; CARDIOMYOPATHY; EXERCISE	Background-Skeletal muscle dysfunction and exercise intolerance are clinical hallmarks of patients with heart failure. These have been linked to a progressive catabolic state, skeletal muscle inflammation, and impaired oxidative metabolism. Previous studies suggest beneficial effects of omega-3 polyunsaturated fatty acids and glutamine on exercise performance and muscle protein balance. Methods and Results-In a randomized double-blind, placebo-controlled trial, 31 patients with heart failure were randomized to either L-alanyl-L-glutamine (8 g/d) and polyunsaturated fatty acid (6.5 g/d) or placebo (safflower oil and milk powder) for 3 months. Cardiopulmonary exercise testing, dual-energy x-ray absorptiometry, 6-minute walk test, hand grip strength, functional muscle testing, echocardiography, and quality of life and lateral quadriceps muscle biopsy were performed at baseline and at follow-up. Oxidative capacity and metabolic gene expression were analyzed on muscle biopsies. No differences in muscle function, echocardiography, 6-minute walk test, or hand grip strength and a nonsignificant increase in peak VO2 in the treatment group were found. Lean body mass increased and quality of life improved in the active treatment group. Molecular analysis revealed no differences in muscle fiber composition, fiber cross-sectional area, gene expression of metabolic marker genes (PGC1, CPT1, PDK4, and GLUT4), and skeletal muscle oxidative capacity. Conclusions-The combined supplementation of L-alanyl-L-glutamine and polyunsaturated fatty acid did not improve exercise performance or muscle function but increased lean body mass and quality of life in patients with chronic stable heart failure. These findings suggest potentially beneficial effects of high-dose nutritional polyunsaturated fatty acids and amino acid supplementations in patients with chronic stable heart failure.	[Wu, Christina; Ji, Ruiping; Zizola, Cynthia; Deng, Yue; Armstrong, Hilary F.; Kennel, Peter J.; Thomas, Tiffany; Forman, Daniel E.; Hall, Jennifer; Chokshi, Aalap; Bartels, Matthew N.; Mancini, Donna; Seres, David; Schulze, P. Christian] Columbia Univ, Med Ctr, Dept Med, Div Cardiol, New York, NY 10032 USA; [Armstrong, Hilary F.] Columbia Univ, Med Ctr, Dept Surg, Div Cardiothorac Surg, New York, NY 10032 USA; [Kato, Tomoko S.] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med & Organ Transplantat, Osaka, Japan	Schulze, PC (reprint author), Columbia Univ, Med Ctr, Ctr Adv Cardiac Care, Div Cardiol,Dept Med, 622 West 168th St,PH 10,Room 203, New York, NY 10032 USA.	pcs2121@cumc.columbia.edu			National Heart, Lung and Blood Institute [K23 HL095742-01, P30 HL101272-01, UL1 RR 024156, HL073029]; Herbert and Florence Irving Scholar Award	This work was supported by grants from the National Heart, Lung and Blood Institute (K23 HL095742-01, P30 HL101272-01, UL1 RR 024156, and HL073029) and the Herbert and Florence Irving Scholar Award to Dr Schulze.	Smith GI, 2011, AM J CLIN NUTR, V93, P402, DOI 10.3945/ajcn.110.005611; Zhang LY, 2013, CIRC-HEART FAIL, V6, P1039, DOI 10.1161/CIRCHEARTFAILURE.112.000228; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Depre C, 1998, NAT MED, V4, P1269, DOI 10.1038/3253; Hoffman JR, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-8; Doehner W, 2005, J AM COLL CARDIOL, V46, P1019, DOI 10.1016/j.jacc.2005.02.093; Alves WF, 2010, ANN VASC SURG, V24, P461, DOI 10.1016/j.avsg.2010.01.005; Chokshi A, 2012, CIRCULATION, V125, P2844, DOI 10.1161/CIRCULATIONAHA.111.060889; Jump DB, 2012, J LIPID RES, V53, P2525, DOI 10.1194/jlr.R027904; RECTOR TS, 1992, AM HEART J, V124, P1017, DOI 10.1016/0002-8703(92)90986-6; Scognamiglio R, 2004, AM HEART J, V147, P1106, DOI 10.1016/j.ahj.2003.12.003; DREXLER H, 1992, CIRCULATION, V85, P1751; Khogali SEO, 2002, NUTRITION, V18, P123, DOI 10.1016/S0899-9007(01)00768-7; Bowtell JL, 2002, NUTRITION, V18, P222, DOI 10.1016/S0899-9007(01)00795-X; Scognamiglio R, 2004, AGING CLIN EXP RES, V16, P443; Li GP, 2011, J LIPID RES, V52, P971, DOI 10.1194/jlr.M013748; Drosatos K, 2011, AM J PHYSIOL-ENDOC M, V300, pE489, DOI 10.1152/ajpendo.00569.2010; Aquilani R, 2008, EUR J HEART FAIL, V10, P1127, DOI 10.1016/j.ejheart.2008.09.002; Clugston RD, 2011, J LIPID RES, V52, P2021, DOI 10.1194/jlr.M017368; Chen JH, 2011, CIRCULATION, V123, P584, DOI 10.1161/CIRCULATIONAHA.110.971853; Khan RS, 2013, J CARDIOVASC PHARM, V61, P345, DOI 10.1097/FJC.0b013e318283d845; Nodari S, 2011, J AM COLL CARDIOL, V57, P870, DOI 10.1016/j.jacc.2010.11.017; Engel JM, 2009, ACTA ANAESTH SCAND, V53, P1317, DOI 10.1111/j.1399-6576.2009.02084.x; Grau T, 2011, CRIT CARE MED, V39, P1263, DOI 10.1097/CCM.0b013e31820eb774; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Rogero MM, 2006, NUTRITION, V22, P564, DOI 10.1016/j.nut.2005.11.002; Hambrecht R, 2002, J AM COLL CARDIOL, V39, P1175, DOI 10.1016/S0735-1097(02)01736-9; Gibala MJ, 2001, INT J SPORT NUTR EXE, V11, P87; Stangl R, 2011, J SURG RES, V166, P95, DOI 10.1016/j.jss.2009.09.047; Francis GS, 2010, CIRCULATION, V122, P644, DOI 10.1161/CIR.0b013e3181ecbd97; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Stumvoll M, 1999, KIDNEY INT, V55, P778, DOI 10.1046/j.1523-1755.1999.055003778.x; Aquilani R, 2008, AM J CARDIOL, V101, p104E, DOI 10.1016/j.amjcard.2008.03.008; Carubelli V, 2015, HEART FAIL REV, V20, P39, DOI 10.1007/s10741-014-9436-9; Tavazzi L, 2008, LANCET, V372, P1223, DOI 10.1016/S0140-6736(08)61239-8; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Lindenfeld J, 2010, J CARD FAIL, V16, pe1, DOI DOI 10.1016/J.CARDFAIL.2010.04.004; Lombardi Carlo, 2014, Clin Med Insights Cardiol, V8, P39, DOI 10.4137/CMC.S14016; Shahzad Khurram, 2011, Curr Clin Pharmacol, V6, P288; van Norren K, 2009, BRIT J CANCER, V100, P713, DOI 10.1038/sj.bjc.6604905	41	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1941-3289	1941-3297		CIRC-HEART FAIL	Circ.-Heart Fail.	NOV	2015	8	6					1077	1087		10.1161/CIRCHEARTFAILURE.115.002073		11	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CW1SQ	WOS:000364772000009		
J	Thoonen, R; Giovanni, S; Govindan, S; Lee, DI; Wang, GR; Calamaras, TD; Takimoto, E; Kass, DA; Sadayappan, S; Blanton, RM				Thoonen, Robrecht; Giovanni, Shewit; Govindan, Suresh; Lee, Dong I.; Wang, Guang-Rong; Calamaras, Timothy D.; Takimoto, Eiki; Kass, David A.; Sadayappan, Sakthivel; Blanton, Robert M.			Molecular Screen Identifies Cardiac Myosin-Binding Protein-C as a Protein Kinase G-I alpha Substrate	CIRCULATION-HEART FAILURE			English	Article						cyclic GMP-dependent protein kinase type I; heart failure; leucine zippers; myosin-binding protein C; ventricular remodeling	SYSTOLIC HEART-FAILURE; DIASTOLIC FUNCTION; CLINICAL STATUS; PHOSPHORYLATION; INHIBITION; MICE; CGMP; HYPERTROPHY; SILDENAFIL; DISEASE	Background-Pharmacological activation of cGMP-dependent protein kinase G I (PKGI) has emerged as a therapeutic strategy for humans with heart failure. However, PKG-activating drugs have been limited by hypotension arising from PKG-induced vasodilation. PKGI alpha antiremodeling substrates specific to the myocardium might provide targets to circumvent this limitation, but currently remain poorly understood. Methods and Results-We performed a screen for myocardial proteins interacting with the PKGI alpha leucine zipper (LZ)-binding domain to identify myocardial-specific PKGI alpha antiremodeling substrates. Our screen identified cardiac myosin-binding protein-C (cMyBP-C), a cardiac myocyte-specific protein, which has been demonstrated to inhibit cardiac remodeling in the phosphorylated state, and when mutated leads to hypertrophic cardiomyopathy in humans. GST pulldowns and precipitations with cGMP-conjugated beads confirmed the PKGI alpha-cMyBP-C interaction in myocardial lysates. In vitro studies demonstrated that purified PKGI alpha phosphorylates the cMyBP-C M-domain at Ser-273, Ser-282, and Ser-302. cGMP induced cMyBP-C phosphorylation at these residues in COS cells transfected with PKGI alpha, but not in cells transfected with LZ mutant PKGI alpha, containing mutations to disrupt LZ substrate binding. In mice subjected to left ventricular pressure overload, PKGI alpha activation with sildenafil increased cMyBP-C phosphorylation at Ser-273 compared with untreated mice. cGMP also induced cMyBP-C phosphorylation in isolated cardiac myocytes. Conclusions-Taken together, these data support that PKGI alpha and cMyBP-C interact in the heart and that cMyBP-C is an anti remodeling PKGI alpha kinase substrate. This study provides the first identification of a myocardial-specific PKGI alpha LZ-dependent antiremodeling substrate and supports further exploration of PKGI alpha myocardial LZ substrates as potential therapeutic targets for heart failure.	[Thoonen, Robrecht; Wang, Guang-Rong; Calamaras, Timothy D.; Blanton, Robert M.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA; [Blanton, Robert M.] Tufts Med Ctr, Div Cardiol, Boston, MA 02111 USA; [Giovanni, Shewit] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Govindan, Suresh; Sadayappan, Sakthivel] Loyola Univ Chicago, Div Hlth Sci, Dept Cell & Mol Physiol, Maywood, IL USA; [Lee, Dong I.; Takimoto, Eiki; Kass, David A.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Takimoto, Eiki] Univ Tokyo, Dept Cardiovasc Med, Tokyo, Japan	Blanton, RM (reprint author), Tufts Med Ctr, Mol Cardiol Res Inst, 800 Washington St, Boston, MA 02111 USA.	rblanton@tuftsmedicalcenter.org			National Institutes of Health [R01HL105826, K02HL114749, 1R03AG042367, 1KL2TR001063-01]; American Heart Association Midwest Fellowships [13POST14720024]; American Heart Association [10SDG2630161]; T. Franklin Williams Scholarship Award; Atlantic Philanthropies, Inc.; John A. Hartford Foundation; Association of Specialty Professors; American College of Cardiology	Dr Sadayappan was supported by National Institutes of Health grants (R01HL105826 and K02HL114749). Dr Govindan was supported by American Heart Association Midwest Fellowships (13POST14720024). Dr Blanton was supported by National Institutes of Health (1R03AG042367 and 1KL2TR001063-01), the American Heart Association (10SDG2630161), and a T. Franklin Williams Scholarship Award. Funding for the Williams Award was provided by Atlantic Philanthropies, Inc., the John A. Hartford Foundation, the Association of Specialty Professors, and the American College of Cardiology.	Redfield MM, 2013, JAMA-J AM MED ASSOC, V309, P1268, DOI 10.1001/jama.2013.2024; Colson BA, 2012, J MOL CELL CARDIOL, V53, P609, DOI 10.1016/j.yjmcc.2012.07.012; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; Patrucco E, 2014, P NATL ACAD SCI USA, V111, P12925, DOI 10.1073/pnas.1414364111; Yang QL, 2001, CARDIOVASC RES, V51, P80, DOI 10.1016/S0008-6363(01)00273-5; Sadayappan S, 2011, CIRC RES, V109, P141, DOI 10.1161/CIRCRESAHA.111.242560; Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Flashman E, 2004, CIRC RES, V94, P1279, DOI 10.1161/01.RES.0000127175.21818.C2; Chen HH, 2012, J AM COLL CARDIOL, V60, P2305, DOI 10.1016/j.jacc.2012.07.056; Tong CW, 2015, CIRC-HEART FAIL, V8, P595, DOI 10.1161/CIRCHEARTFAILURE.114.001585; Hayashi M, 2001, J AM COLL CARDIOL, V37, P1820, DOI 10.1016/S0735-1097(01)01233-5; Lukowski R, 2010, P NATL ACAD SCI USA, V107, P5646, DOI 10.1073/pnas.1001360107; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Hofmann F, 2005, J BIOL CHEM, V280, P1, DOI 10.1074/jbc.R400035200; Frantz S, 2013, EUR HEART J, V34, P1233, DOI 10.1093/eurheartj/ehr445; Rosas PC, 2015, CIRC-HEART FAIL, V8, P582, DOI 10.1161/CIRCHEARTFAILURE.114.001550; Guazzi M, 2007, J AM COLL CARDIOL, V50, P2136, DOI 10.1016/j.jacc.2007.07.079; Lee DI, 2015, NATURE, V519, P472, DOI 10.1038/nature14332; Guazzi M, 2011, CIRC-HEART FAIL, V4, P8, DOI 10.1161/CIRCHEARTFAILURE.110.944694; FRANCIOSA JA, 1978, JAMA-J AM MED ASSOC, V240, P443, DOI 10.1001/jama.240.5.443; Fraysse B, 2012, J MOL CELL CARDIOL, V52, P1299, DOI 10.1016/j.yjmcc.2012.03.009; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; El-Armouche A, 2007, J MOL CELL CARDIOL, V43, P223, DOI 10.1016/j.yjmcc.2007.05.003; Lee DI, 2010, BASIC RES CARDIOL, V105, P337, DOI 10.1007/s00395-010-0084-5; Chen PP, 2012, CIRCULATION, V126, P1194, DOI 10.1161/CIRCULATIONAHA.111.089219; Bishu K, 2011, CIRCULATION, V124, P2882, DOI 10.1161/CIRCULATIONAHA.111.048520; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Kato M, 2012, J BIOL CHEM, V287, P41342, DOI 10.1074/jbc.M112.421040; Blanton RM, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003731; Calamaras TD, 2015, FREE RADICAL BIO MED, V82, P137, DOI 10.1016/j.freeradbiomed.2015.01.007; Kong QW, 2013, CIRC-HEART FAIL, V6, P1268, DOI 10.1161/CIRCHEARTFAILURE.113.000575; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393	35	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1941-3289	1941-3297		CIRC-HEART FAIL	Circ.-Heart Fail.	NOV	2015	8	6					1115	1122		10.1161/CIRCHEARTFAILURE.115.002308		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CW1SQ	WOS:000364772000013		
J	Yamamoto, Y; Lin, PJC; Beraldi, E; Zhang, F; Kawai, Y; Leong, J; Katsumi, H; Fazli, L; Fraser, R; Cullis, PR; Gleave, M				Yamamoto, Yoshiaki; Lin, Paulo J. C.; Beraldi, Eliana; Zhang, Fan; Kawai, Yoshihisa; Leong, Jeffrey; Katsumi, Hidemasa; Fazli, Ladan; Fraser, Robert; Cullis, Pieter R.; Gleave, Martin			siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays ProgressionWhen Combined with Androgen Receptor Cotargeting in Enzalutamide-Resistant Prostate Cancer	CLINICAL CANCER RESEARCH			English	Article							IN-VIVO; ANTISENSE OLIGONUCLEOTIDES; CASTRATION-RESISTANT; ANTITUMOR-ACTIVITY; GENE-EXPRESSION; DELIVERY; STRESS; SURVIVAL; TUMORS; GROWTH	Purpose: Lipid nanoparticle (LNP) formulations facilitate tumor uptake and intracellular processing through an enhanced permeation and retentioneffect (EPR), and currentlymultipleproducts are undergoing clinical evaluation. Clusterin (CLU) is a cytoprotective chaperone induced by androgen receptor (AR) pathway inhibition to facilitate adaptive survival pathway signaling and treatment resistance. In our study, we investigated the efficacy of siRNA tumor delivery using LNP systems in an enzalutamide-resistant (ENZ-R) castration-resistant prostate cancer (CRPC) model. Experimental Design: Gene silencing of a luciferase reporter gene in the PC-3M-luc stable cell line was first assessed in subcutaneous and metastatic PC-3 xenograft tumors. Upon validation, the effect of LNP siRNA targeting CLU in combination with AR antisense oligonucleotides (ASO) was assessed in ENZ-R CRPC LNCaP in vitro and in vivo models. Results: LNP LUC-siRNA silenced luciferase expression in PC3M- luc subcutaneous xenograft and metastatic models. LNP CLUsiRNA potently suppressed CLU and AR ASO-induced CLU and AKTand ERK phosphorylation in ENZ-R LNCaP cells in vitro, more potently inhibiting ENZ-R cell growth rates and increased apoptosis when compared with AR-ASO monotherapy. In subcutaneous ENZ-R LNCaP xenografts, combinatory treatment of LNP CLU-siRNA plus AR-ASO significantly suppressed tumor growth and serum PSA levels compared with LNP LUC-siRNA (control) and AR-ASO. Conclusions: LNP siRNA can silence target genes in vivo and enable inhibition of traditionally non-druggable genes like CLU and other promising cotargeting approaches in ENZ-R CRPC therapeutics. (C)2015 AACR.	[Yamamoto, Yoshiaki; Beraldi, Eliana; Zhang, Fan; Kawai, Yoshihisa; Leong, Jeffrey; Fazli, Ladan; Gleave, Martin] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V6H 3Z6, Canada; [Yamamoto, Yoshiaki; Beraldi, Eliana; Zhang, Fan; Kawai, Yoshihisa; Leong, Jeffrey; Fazli, Ladan; Gleave, Martin] Univ British Columbia, Dept Urol Sci, Vancouver, BC V6H 3Z6, Canada; [Yamamoto, Yoshiaki; Kawai, Yoshihisa] Yamaguchi Univ, Grad Sch Med, Dept Urol, Ube, Yamaguchi 755, Japan; [Lin, Paulo J. C.; Katsumi, Hidemasa; Fraser, Robert; Cullis, Pieter R.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6H 3Z6, Canada	Gleave, M (reprint author), Univ British Columbia, Vancouver Prostate Ctr, 2660 Oak St, Vancouver, BC V6H 3Z6, Canada.	m.gleave@ubc.ca			Canadian Institutes of Health Research (CIHR) Emerging Team Grant: Personalized siRNA-Based Nanomedicines [FRN:111627]	This work was supported by the Canadian Institutes of Health Research (CIHR) Emerging Team Grant: Personalized siRNA-Based Nanomedicines (FRN:111627).	Tam YYC, 2013, NANOMED-NANOTECHNOL, V9, P665, DOI 10.1016/j.nano.2012.11.006; Zhang YX, 2011, MOL CANCER THER, V10, P2309, DOI 10.1158/1535-7163.MCT-11-0329; Lamoureux F, 2011, CANCER RES, V71, P5838, DOI 10.1158/0008-5472.CAN-11-0994; Li SD, 2008, J CONTROL RELEASE, V126, P77, DOI 10.1016/j.jconrel.2007.11.002; Love KT, 2010, P NATL ACAD SCI USA, V107, P1864, DOI 10.1073/pnas.0910603106; Kuruma H, 2013, MOL CANCER THER, V12, P567, DOI 10.1158/1535-7163.MCT-12-0798; Basha G, 2011, MOL THER, V19, P2186, DOI 10.1038/mt.2011.190; Yamamoto Y, 2015, CLIN CANCER RES, V21, P1675, DOI 10.1158/1078-0432.CCR-14-1108; Zellweger T, 2001, J PHARMACOL EXP THER, V298, P934; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Jayaraman M, 2012, ANGEW CHEM INT EDIT, V51, P8529, DOI 10.1002/anie.201203263; Miyake H, 2000, CANCER RES, V60, P2547; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Yang J, 2012, NANOMEDICINE-UK, V7, P1297, DOI 10.2217/NNM.12.14; Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602; Burel SA, 2013, NUCLEIC ACID THER, V23, P213, DOI 10.1089/nat.2013.0422; Ambegia E, 2005, BBA-BIOMEMBRANES, V1669, P155, DOI 10.1016/j.bbamem.2005.02.001; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Matsumoto H, 2013, CANCER RES, V73, P5206, DOI 10.1158/0008-5472.CAN-13-0359; Gilleron J, 2013, NAT BIOTECHNOL, V31, P638, DOI 10.1038/nbt.2612; Shiota M, 2012, CANCER RES, V72, P5261, DOI 10.1158/0008-5472.CAN-12-0254; Shiota M, 2011, MOL CANCER RES, V9, P1755, DOI 10.1158/1541-7786.MCR-11-0379; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291; Zoubeidi A, 2010, CLIN CANCER RES, V16, P1088, DOI 10.1158/1078-0432.CCR-09-2917; Trougakos IP, 2009, CLIN CANCER RES, V15, P48, DOI 10.1158/1078-0432.CCR-08-1805; Maier MA, 2013, MOL THER, V21, P1570, DOI 10.1038/mt.2013.124; Seth PP, 2009, J MED CHEM, V52, P10, DOI 10.1021/jm801294h; Zoubeidi A, 2010, MOL CANCER RES, V8, P119, DOI 10.1158/1541-7786.MCR-09-0277; Leung SYL, 2000, PROSTATE, V44, P156, DOI 10.1002/1097-0045(20000701)44:2<156::AID-PROS8>3.0.CO;2-8; Ammar H, 2008, J BIOL CHEM, V283, P12851, DOI 10.1074/jbc.M800403200; Tabernero J, 2013, CANCER DISCOV, V3, P406, DOI 10.1158/2159-8290.CD-12-0429; Zanardi TA, 2012, J PHARMACOL EXP THER, V343, P489, DOI 10.1124/jpet.112.197426; Li N, 2013, ONCOGENE, V32, P1933, DOI 10.1038/onc.2012.212; Belliveau NM, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.28; Lee JB, 2012, INT J CANCER, V131, pE781, DOI 10.1002/ijc.27361; Lin PJC, 2014, CLIN LIPIDOL, V9, P317, DOI 10.2217/CLP.14.27; Mui BL, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.66; Rajeev KG, 2015, CHEMBIOCHEM, V16, P903, DOI 10.1002/cbic.201500023; Rungta RL, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.65; Zhang F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6775	42	1	1	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1078-0432	1557-3265		CLIN CANCER RES	Clin. Cancer Res.	NOV 1	2015	21	21					4845	4855		10.1158/1078-0432.CCR-15-0866		11	Oncology	Oncology	CV7WW	WOS:000364488100014		
J	Tanaka, K; Sasayama, T; Mizukawa, K; Takata, K; Sulaiman, NS; Nishihara, M; Kohta, M; Sasaki, R; Hirose, T; Itoh, T; Kohmura, E				Tanaka, Kazuhiro; Sasayama, Takashi; Mizukawa, Katsu; Takata, Kumi; Sulaiman, Nor Shazrina; Nishihara, Masamitsu; Kohta, Masaaki; Sasaki, Ryohei; Hirose, Takanori; Itoh, Tomoo; Kohmura, Eiji			Combined IDH1 mutation and MGMT methylation status on long-term survival of patients with cerebral low-grade glioma	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Low grade glioma; MGMT methylation; IDH1 mutation; Prognostic factor	PROMOTER METHYLATION; MOLECULAR CLASSIFICATION; RADIATION-THERAPY; RANDOMIZED-TRIAL; DIFFUSE GLIOMAS; II GLIOMAS; OLIGODENDROGLIOMA; GLIOBLASTOMA; TEMOZOLOMIDE; RESECTION	Objective: The management of low-grade glioma (LGG) still remains controversial because the effectiveness of early and extensive resection is unclear, and the use of radiation therapy or chemotherapy is not well-defined. In particular, the importance of prognostic factors for survival remains a matter of discussion. The purpose of this study was to validate prognostic factors for survival in patients with LGG. Materials and methods: A consecutive series of 55 patients with WHO grade II LGG treated in our institute between 1983 and 2013 were retrospectively reviewed to determine the prognostic factors for survival. All data were retrospectively analyzed from the aspect of baseline characteristics, pathological findings, genetic change, surgical treatments, adjuvant therapies, and survival time. Cox multivariate analysis was performed to determine the prognostic factors for survival. Results: There were 28 patients with diffuse astrocytoma (DA), 21 patients with oligodendroglioma (OG), and 6 patients with oligoastrocytoma (OA) diagnosed on initial surgery. The median overall survival was 193 months and fifteen patients (27.3%) died. A mutation in isocitrate dehydrogenase-1 (IDH1) was found in 72.9% of LGG, and this mutation was positively correlated with methylation of 06-methylguanine-DNA methyltransferase (MGMT) (p = 0.02). A better prognosis was significantly associated with combined IDH1 mutation and MGMT methylation status (both positive vs both negative, HR 0.079 [95% Cl 0.008-0.5791, p =0.012), as well as histology (OG vs DA and OA, HR 0.158 [95% CI 0.022-0.674], p =0.011) and tumor size (<6 cm vs >6 cm, HR 0.120 [95% Cl 0.017-0.595], p =0.008). Conclusions: Tumor histology, size and IDH-mutation status are important predictors for prolonged overall survival in patients with LGG and may provide a reliable tool for standardizing future treatment strategies. (C) 2015 Elsevier B.V. All rights reserved.	[Tanaka, Kazuhiro; Sasayama, Takashi; Mizukawa, Katsu; Takata, Kumi; Nishihara, Masamitsu; Kohta, Masaaki; Kohmura, Eiji] Kobe Univ, Grad Sch Med, Dept Neurosurg, Kobe, Hyogo 6500017, Japan; [Sulaiman, Nor Shazrina; Sasaki, Ryohei] Kobe Univ, Grad Sch Med, Dept Radiat Oncol, Kobe, Hyogo 6500017, Japan; [Hirose, Takanori] Kobe Univ, Grad Sch Med, Dept Pathol Reg Commun, Kobe, Hyogo 6500017, Japan; [Itoh, Tomoo] Kobe Univ, Grad Sch Med, Dept Diagnost Pathol, Kobe, Hyogo 6500017, Japan	Tanaka, K (reprint author), Kobe Univ, Grad Sch Med, Dept Neurosurg, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kazutana@med.kobe-u.ac.jp					Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Buckner JC, 2003, J CLIN ONCOL, V21, P251, DOI 10.1200/JCO.2003.06.023; Jenkins RB, 2006, CANCER RES, V66, P9852, DOI 10.1158/0008-5472.CAN-06-1796; Weiler M, 2012, CURR OPIN NEUROL, V25, P767, DOI 10.1097/WCO.0b013e32835a0217; Kaloshi G, 2007, NEUROLOGY, V68, P1831, DOI 10.1212/01.wnl.0000262034.26310.a2; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Gupta R, 2011, J CLIN PATHOL, V64, P835, DOI 10.1136/jclinpath-2011-200227; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479; Pignatti F, 2002, J CLIN ONCOL, V20, P2076, DOI 10.1200/JCO.2002.08.121; Mandonnet E, 2003, ANN NEUROL, V53, P524, DOI 10.1002/ana.10528; Ahmadi R, 2012, J NEURO-ONCOL, V109, P15, DOI 10.1007/s11060-012-0863-y; van den Bent MJ, 2005, LANCET, V366, P985, DOI 10.1016/S0140-6736(05)67070-5; Jakola AS, 2012, JAMA-J AM MED ASSOC, V308, P1881, DOI 10.1001/jama.2012.12807; Kim YH, 2010, AM J PATHOL, V177, P2708, DOI 10.2353/ajpath.2010.100680; Vlassenbroeck I, 2008, J MOL DIAGN, V10, P332, DOI 10.2353/jmoldx.2008.070169; Hartmann C, 2011, CLIN CANCER RES, V17, P4588, DOI 10.1158/1078-0432.CCR-10-3194; Karim ABMF, 1996, INT J RADIAT ONCOL, V36, P549, DOI 10.1016/S0360-3016(96)00352-5; Rivera AL, 2010, NEURO-ONCOLOGY, V12, P116, DOI 10.1093/neuonc/nop020; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Houillier C, 2010, NEUROLOGY, V75, P1560, DOI 10.1212/WNL.0b013e3181f96282; Boots-Sprenger SHE, 2013, MODERN PATHOL, V26, P922, DOI 10.1038/modpathol.2012.166; Duffau H, 2008, J NEUROSURG, V109, P461, DOI 10.3171/JNS/2008/109/9/0461; Ishii T, 2013, NEUROPATHOLOGY, V33, P299, DOI 10.1111/j.1440-1789.2012.01349.x; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Shaw EG, 2008, J NEUROSURG, V109, P835, DOI 10.3171/JNS/2008/109/11/0835; Leu S, 2013, NEURO-ONCOLOGY, V15, P469, DOI 10.1093/neuonc/nos317; van den Bent MJ, 2011, LANCET ONCOL, V12, P583, DOI 10.1016/S1470-2045(11)70057-2; Maldaun MVC, 2014, J NEUROSURG, V121, P810, DOI 10.3171/2014.6.JNS132285; Okita Y, 2012, INT J ONCOL, V41, P1325, DOI 10.3892/ijo.2012.1564; Uehara K, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-104	34	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	NOV	2015	138						37	44		10.1016/j.clineuro.2015.07.019		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CW1CI	WOS:000364726800008		
J	Takahashi, S; Tanizaki, Y; Kimura, H; Akaji, K; Nakazawa, M; Yoshida, K; Mihara, B				Takahashi, Satoshi; Tanizaki, Yoshio; Kimura, Hiroaki; Akaji, Kazunori; Nakazawa, Masaki; Yoshida, Kazunari; Mihara, Ban			Hemodynamic stress distribution reflects ischemic clinical symptoms of patients with moyamoya disease	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Moyamoya disease; Cerebral blood flow; Xenon CT; Automated ROI; Hemodynamic stress distribution; hdSD; Spontaneous occlusion of the circle of Willis	CEREBRAL-BLOOD-FLOW; COMPUTED-TOMOGRAPHY; PERFUSION CHARACTERISTICS; PULMONARY-EDEMA; ACETAZOLAMIDE; BYPASS; BRAIN	Objective: Currently, the probability of diagnosing asymptomatic moyamoya disease is increasing. In this study, we consider a less invasive method for predicting future ischemic symptoms in patients with moyamoya disease. Methods: We reviewed cerebral blood flow (CBF)-related data obtained by xenon CT imaging (XeCT) in six patients with ischemic-type or asymptomatic moyamoya disease. The data were obtained as volume data using a 320-row Cr, and applied to the automated region-of-interest-determining software (3DSRT) and converted to standardized images. Eight CBF-related parameters, including CBF value, cerebrovascular reserve capacity (CVRC), and hemodynamic distribution (hdSD), were compared between asymptomatic hemispheres and ischemic symptomatic hemispheres. A significant difference was determined by a two-sample t test. A difference with p < 0.05 was considered significant. When statistically significant differences between parameters of asymptomatic hemispheres and ischemic symptomatic hemispheres were identified, cut-off points were calculated with receiver operating characteristic (ROC) curves. Change in the parameters before and after bypass surgery was also assessed. Results: Of the eight CBF-related parameters evaluated, statistically significant differences between the asymptomatic hemispheres and ischemic hemispheres were observed in the CBF value of the MCA region (CBF-MCA), both at rest and after acetazolamide loading, and in the hdSD, also both at rest and after acetazolamide loading. Of the four statistically significant parameters, ROC analysis revealed that the hdSD at rest and CBF-MCA after acetazolamide loading were the most sensitive and specific parameters (threshold 1.2, sensitivity 1, specificity 1 for hdSD at rest, and threshold 26.44 mL/100 g/min, sensitivity 1, specificity 1 for CBF-MCA after acetazolamide loading). From the CBF data obtained both before and after surgery from the three patients who had undergone direct bypass surgeries, the hdSD was higher than the threshold of 1.2 before surgery but decreased to lower than the threshold of 1.2 after surgery. Ischemic symptoms also resolved after surgery. Conclusions: The data showed that hdSD at rest and CBF-MCA after acetazolamide loading reflects ischemic symptoms of patients with moyamoya disease. Thus, these parameters could be used as ischemic symptom markers for following patients with moyamoya disease. hdSD at rest is important because it is less invasive and can be performed without acetazolamide loading. (C) 2015 Elsevier B.V. All rights reserved.	[Takahashi, Satoshi; Tanizaki, Yoshio; Akaji, Kazunori] Mihara Mem Hosp, Inst Brain & Blood Vessels, Dept Neurosurg, Isesaki, Gunma 3720006, Japan; [Takahashi, Satoshi; Yoshida, Kazunari] Keio Univ, Sch Med, Dept Neurosurg, Shinjuku Ku, Tokyo 1068582, Japan; [Kimura, Hiroaki; Mihara, Ban] Mihara Mem Hosp, Inst Brain & Blood Vessels, Dept Neurol, Isesaki, Gunma 3720006, Japan; [Nakazawa, Masaki] Mihara Mem Hosp, Inst Brain & Blood Vessels, Dept Image Diag, Isesaki, Gunma 3720006, Japan	Takahashi, S (reprint author), Keio Univ, Sch Med, Dept Neurosurg, Shinjuku Ku, Shinano Machi 35, Tokyo 1068582, Japan.	satoshi710@mac.com					SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288; Marushima A, 2011, WORLD NEUROSURG, V76, P304, DOI 10.1016/j.wneu.2011.02.004; SUZUKI J, 1983, STROKE, V14, P104; OGAWA A, 1990, ACTA NEUROCHIR, V105, P30, DOI 10.1007/BF01664854; Schubert GA, 2014, STROKE, V45, P101, DOI 10.1161/STROKEAHA.113.003370; Takahashi S, 2015, J STROKE CEREBROVASC, V24, P635, DOI 10.1016/j.jstrokecerebrovasdis.2014.10.010; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; KUDO T, 1968, NEUROLOGY, V18, P485; Honda M, 2012, NEUROL MED-CHIR, V52, P488; Schubert GA, 2012, TRANSL STROKE RES, V3, P122, DOI 10.1007/s12975-011-0107-z; Schubert GA, 2009, J NEUROTRAUM, V26, P2225, DOI 10.1089/neu.2009.0924; Miyamoto S, 2014, STROKE, V45, P1415, DOI 10.1161/STROKEAHA.113.004386; Vogiatzis I, 2013, HIPPOKRATIA, V17, P177; Burke GM, 2009, NEUROSURG FOCUS, V26, P1; CAMPBELL. D. A., 1958, BRIT JOUR OPHTHALMOL, V42, P732, DOI 10.1136/bjo.42.12.732; Hoshi Hiroaki, 1994, Journal of Nuclear Medicine, V35, P44; Kashiwagi S, 1996, Acta Neurol Scand Suppl, V166, P85; Kuroda S, 2015, NEUROL MED-CHIR, V55, P194, DOI 10.2176/nmc.ra.2014-0305; Mesiwala AH, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/2/E15; Takahashi S, 2015, J STROKE CEREBROVASC, V24, P939, DOI 10.1016/j.jstrokecerebrovasdis.2014.12.010; Takeuchi Ryo, 2006, Radiat Med, V24, P538, DOI 10.1007/s11604-006-0054-x; Zimmermann S, 2014, HEART LUNG, V43, P124, DOI [10.1016/j.hrtlng.2013.11.008, 10.1016/j.hrtIng.2013.11.008]	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	NOV	2015	138						104	110		10.1016/j.clineuro.2015.08.010		7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CW1CI	WOS:000364726800019		
J	Yamaguchi, M; Ebihara, KI; Itakura, M				Yamaguchi, Masatake; Ebihara, Ken-ichi; Itakura, Mitsuhiro			Multiscale thermodynamic analysis on hydrogen-induced intergranular cracking in an alloy steel with segregated solutes	CORROSION REVIEWS			English	Article						first-principles calculations; hydrogen-induced intergranular embrittlement; mobile hydrogen; steel; threshold stress intensity factor	NI-CR STEEL; BRITTLE-FRACTURE; IRON; DECOHESION; TOUGHNESS; STRENGTH	A multiscale analysis has been conducted on hydrogen-induced intergranular cracking at ambient temperature in medium strength (840 MPa) Ni-Cr steel with antimony, tin, and phosphorous segregation. Combining first-principles calculations and fracture mechanics experiments, a multiscale relationship between threshold stress intensity factor (K-th) and cohesive energy of grain boundary (the ideal work of interfacial separation, 2 gamma(int)) was revealed. The K-th was found to decrease rapidly under a certain threshold of 2 gamma(int), where the 2 gamma(int) decreases mainly by mobile hydrogen segregation on fracture surfaces. This segregation is considered to arise during formation of the fracture surfaces under thermodynamic equilibrium in slow crack growth. The resulting strong decohesion probably makes it difficult to emit dislocations at the microcrack tip region, leading to a large reduction in stress intensity factor. Our analysis based on this mobile hydrogen decohesion demonstrates that the K-th decreases dramatically within a low and narrow range of hydrogen content in iron lattice in high-strength steels.	[Yamaguchi, Masatake; Ebihara, Ken-ichi] Japan Atom Energy Agcy, Ctr Computat Sci & E Syst, Tokai, Ibaraki 3191195, Japan; [Yamaguchi, Masatake] Kyoto Univ, Elements Strategy Initiat Struct Mat, Sakyo Ku, Kyoto 6068501, Japan; [Itakura, Mitsuhiro] Japan Atom Energy Agcy, Ctr Computat Sci & E Syst, Kashiwa, Chiba 2770871, Japan	Yamaguchi, M (reprint author), Japan Atom Energy Agcy, Ctr Computat Sci & E Syst, Tokai, Ibaraki 3191195, Japan.	yamaguchi.masatake@jaea.go.jp			Elements Strategy Initiative for Structural Materials through the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Cross-ministerial Strategic Innovation Promotion Program through the Cabinet Office of Japan	The first-principles calculations were performed on the supercomputer (Fujitsu BX900) system in Japan Atomic Energy Agency. The authors appreciate helpful discussion with J. Kameda. This study is partly supported by the Elements Strategy Initiative for Structural Materials through the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by the Cross-ministerial Strategic Innovation Promotion Program through the Cabinet Office of Japan.	KAMEDA J, 1981, METALL TRANS A, V12, P31, DOI 10.1007/BF02648505; Yamaguchi M, 2012, PHILOS MAG, V92, P1349, DOI 10.1080/14786435.2011.645077; JOKL ML, 1989, ACTA METALL MATER, V37, P87; McMahon CJ, 2001, ENG FRACT MECH, V68, P773, DOI 10.1016/S0013-7944(00)00124-7; Yamaguchi M, 2014, PHILOS MAG, V94, P2131, DOI 10.1080/14786435.2014.906757; KIMURA A, 1983, J JPN I MET, V47, P807; JOKL ML, 1980, MET SCI, V14, P375; KAMEDA J, 1983, METALL TRANS A, V14, P903, DOI 10.1007/BF02644295; JOKL ML, 1980, ACTA METALL MATER, V28, P1479, DOI 10.1016/0001-6160(80)90048-6; MOODY NR, 1990, RES MECH, V30, P143; WANG JS, 1991, SCRIPTA METALL MATER, V25, P1339, DOI 10.1016/0956-716X(91)90411-S; HIRTH JP, 1980, METALL TRANS A, V11, P1501, DOI 10.1007/BF02654514; BANDYOPADHYAY N, 1983, METALL TRANS A, V14, P881, DOI 10.1007/BF02644292; KAMEDA J, 1981, METALL TRANS A, V12, P2039, DOI 10.1007/BF02644173; BERNSTEI.IM, 1970, METALL TRANS, V1, P3143; Gangloff RP, 2003, COMPREHENSIVE STRUCT, P31; HIRTH JP, 1980, METALL TRANS A, V11, P861, DOI 10.1007/BF02654700; MCMAHON CJ, 1991, MATER CHARACT, V26, P269, DOI 10.1016/1044-5803(91)90017-X; Rice JR, 1976, EFFECT HYDROGEN BEHA, P455; Vehoff H, 1997, TOP APPL PHYS, V73, P215; Yamaguchi M, 2014, INT HYDR C IHC 2012, P747	21	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-6005	2191-0316		CORROS REV	Corros. Rev.	NOV	2015	33	6			SI		547	557		10.1515/corrrev-2015-0039		11	Electrochemistry; Metallurgy & Metallurgical Engineering; Materials Science, Coatings & Films	Electrochemistry; Metallurgy & Metallurgical Engineering; Materials Science	CV8ZZ	WOS:000364578400022		
J	Yoshida, Y; Kumagai, Y; Mizuno, M; Isomura, K; Nakamura, Y; Kishida, H; Saito, G				Yoshida, Yukihiro; Kumagai, Yoshihide; Mizuno, Motohiro; Isomura, Kazuhide; Nakamura, Yuto; Kishida, Hideo; Saito, Gunzi			Improved Dynamic Properties of Charge-Transfer-Type Supramolecular Rotor Composed of Coronene and F(4)TCNQ	CRYSTAL GROWTH & DESIGN			English	Article							SOLID-STATE; AROMATIC-HYDROCARBONS; TRANSFER COMPLEXES; MOLECULAR ROTORS; CRYSTAL; ENERGY; FERROELECTRICITY; TRIPHENYLENE; MANIPULATION; TRANSITION	A charge-transfer (CT)-type supramolecular rotor, (coronene)(2)F(4)TCNQ was obtained by vacuum co-sublimation. The CT complex has an unprecedented crystal structure consisting only of DDA-type alternating pi-columns of coronene (D) and electron acceptor (A), and coronene molecules with a pronounced undulating structure form no C H center dot center dot center dot F hydrogen bonds with adjacent F(4)TCNQ molecules in the side-by-side direction. These structural features are in contrast with those reported for (coronene)F(4)TCNQ that has DA-type alternating pi-columns, which was obtained by diffusion in dichloromethane/pentane. Coronene molecules in the present complex undergo an in-plane rotation in the gigahertz region at 233 K, which is 3 orders of magnitude faster than that in (coronene)F(4)TCNQ Furthermore, the activation energy for the rotation was found to be about half of the value reported for (coronene)F(4)TCNQ These results clearly demonstrate that dynamic properties of the assemblies (CT complexes) can be varied by changing the assembly method (crystallization method), even when the parts (molecules) used as rotator and stator components are the same.	[Yoshida, Yukihiro; Saito, Gunzi] Meijo Univ, Fac Agr, Tempaku Ku, Nagoya, Aichi 4688502, Japan; [Kumagai, Yoshihide; Mizuno, Motohiro] Kanazawa Univ, Grad Sch Nat Sci & Technol, Dept Chem, Kanazawa, Ishikawa 9201192, Japan; [Isomura, Kazuhide; Nakamura, Yuto; Kishida, Hideo] Nagoya Univ, Dept Appl Phys, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Saito, Gunzi] Toyota Phys & Chem Res Inst, Nagakute, Aichi 4801192, Japan	Yoshida, Y (reprint author), Meijo Univ, Fac Agr, Tempaku Ku, Shiogamaguchi 1-501, Nagoya, Aichi 4688502, Japan.	yyoshida@meijo-u.ac.jp			JSPS KAKENHI grant [23225005, 25288041, 26110512]	The authors thank Hiromi Hayama for experimental support. This work was supported by JSPS KAKENHI grant nos. 23225005, 25288041, and 26110512.	Akutagawaa T, 2008, DALTON T, P6335, DOI 10.1039/b808748b; Mahns B, 2014, CRYST GROWTH DES, V14, P1338, DOI 10.1021/cg401841n; GAVEZZOTTI A, 1988, ACTA CRYSTALLOGR B, V44, P427, DOI 10.1107/S0108768188001600; Akutagawa T, 2009, NAT MATER, V8, P342, DOI [10.1038/nmat2377, 10.1038/NMAT2377]; Ballardini R, 2001, ACCOUNTS CHEM RES, V34, P445, DOI 10.1021/ar000170g; Feng XL, 2009, NAT MATER, V8, P421, DOI [10.1038/nmat2427, 10.1038/NMAT2427]; Ogi S, 2010, CHEM-EUR J, V16, P8285, DOI 10.1002/chem.201000276; Shinkai S, 2005, B CHEM SOC JPN, V78, P40, DOI 10.1246/bcsj.78.40; Ye Q, 2011, CRYST GROWTH DES, V11, P4175, DOI 10.1021/cg2007556; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Yoshida Y, 2013, CHEM-EUR J, V19, P12313, DOI 10.1002/chem.201300578; Kinbara K, 2005, CHEM REV, V105, P1377, DOI 10.1021/cr030071r; MORI T, 1984, B CHEM SOC JPN, V57, P627, DOI 10.1246/bcsj.57.627; BLOEMBERGEN N, 1948, PHYS REV, V73, P679, DOI 10.1103/PhysRev.73.679; Akutagawa T, 2010, CHEM-ASIAN J, V5, P520, DOI 10.1002/asia.200900407; Burla MC, 2005, J APPL CRYSTALLOGR, V38, P381, DOI 10.1107/S002188980403225X; Mochida T, 2013, CRYST GROWTH DES, V13, P4460, DOI 10.1021/cg400954x; CHEN MML, 1976, J AM CHEM SOC, V98, P1647, DOI 10.1021/ja00423a001; Fukino T, 2014, SCIENCE, V344, P499, DOI 10.1126/science.1252120; Vogelsberg CS, 2012, CHEM SOC REV, V41, P1892, DOI 10.1039/c1cs15197e; EMGE TJ, 1981, MOL CRYST LIQ CRYST, V65, P161, DOI 10.1080/00268948108082132; Kato T, 1999, J CHEM PHYS, V110, P249, DOI 10.1063/1.478100; Matta CF, 2003, CHEM-EUR J, V9, P1940, DOI 10.1002/chem.200204626; Jose D, 2010, J PHYS CHEM LETT, V1, P1363, DOI 10.1021/jz1003507; Kottas GS, 2005, CHEM REV, V105, P1281, DOI 10.1021/cr0300993; Brydges S, 2002, COORDIN CHEM REV, V233, P75, DOI 10.1016/S0010-8545(02)00098-X; Custelcean R, 2001, CHEM REV, V101, P1963, DOI 10.1021/cr000021b; Horiuchi S, 2006, CHEM PHYS, V325, P78, DOI 10.1016/j.chemphys.2005.09.025; KISTENMACHER TJ, 1982, ACTA CRYSTALLOGR B, V38, P1193, DOI 10.1107/S0567740882005275; Ecija D, 2011, ANGEW CHEM INT EDIT, V50, P3872, DOI 10.1002/anie.201007370; Yoshida Y, 2015, CRYST GROWTH DES, V15, P1389, DOI 10.1021/cg5017774; Mochida T, 2003, B CHEM SOC JPN, V76, P2321, DOI 10.1246/bcsj.76.2321; HOIJTINK GJ, 1959, MOL PHYS, V2, P85, DOI 10.1080/00268975900100081; Robertazzi A, 2011, CRYSTENGCOMM, V13, P3293, DOI 10.1039/c0ce00819b; BOYD RK, 1974, J PHYS CHEM SOLIDS, V35, P1355, DOI 10.1016/S0022-3697(74)80240-4; Tashiro K, 2000, J AM CHEM SOC, V122, P7921, DOI 10.1021/ja000356a; METZGER RM, 1982, J CHEM PHYS, V77, P6203, DOI 10.1063/1.443821; Todorov PD, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3282331; SUMMERVILLE RH, 1976, J AM CHEM SOC, V98, P7240, DOI 10.1021/ja00439a023; Wheeler SE, 2012, CRYSTENGCOMM, V14, P6140, DOI 10.1039/c2ce25630d; WHELAND RC, 1975, J ORG CHEM, V40, P3101, DOI 10.1021/jo00909a019; FYFE CA, 1971, CAN J CHEMISTRY, V49, P3332, DOI 10.1139/v71-554; Karlen SD, 2010, P NATL ACAD SCI USA, V107, P14973, DOI 10.1073/pnas.1008213107; Sheldrick G.M., 1997, SHELXL 97; Yoshida Y, 2014, EUR J INORG CHEM, P3871, DOI 10.1002/ejic.201400119	45	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	NOV	2015	15	11					5513	5518		10.1021/acs.cgd.5b01138		6	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CV6BP	WOS:000364356000041		
J	Kikugawa, N; Baumbach, R; Brooks, JS; Terashima, T; Uji, S; Maeno, Y				Kikugawa, Naoki; Baumbach, Ryan; Brooks, James S.; Terashima, Taichi; Uji, Shinya; Maeno, Yoshiteru			Single-Crystal Growth of a Perovskite Ruthenate SrRuO3 by the Floating-Zone Method	CRYSTAL GROWTH & DESIGN			English	Article							MAGNETIC-PROPERTIES; SR2RUO4; SUPERCONDUCTIVITY; SR3RU2O7; DISORDER; BEHAVIOR	We report single-crystal growth of a perovskite ruthenate SrRuO3 by the floating-zone method using an infrared image furnace. By employing a cold trap for the growth, we prevented the evaporated RuO2 from coating the inner surface of a quartz tube and were thereby able to maintain a stable molten zone during the growth. Powder X-ray and Laue diffraction measurements confirmed the quality of the grown single crystal. The crystal was cut into a 1.4 mm X 1.4 mm X 3.0 mm rectangle that was characterized by magnetic susceptibility, magnetization, and specific heat measurements. The crystal showed a ferromagnetic transition with a Curie temperature of 163.5 K, and the coercive field was as low as 0.004 T. The residual resistivity was 1.05 mu Omega cm, corresponding to a residual resistivity ratio of 192. These results indicate that the grown crystal is high-quality. Electrical resistivity measurements show temperature-squared behavior, revealing that a Fermi-liquid-like electron-electron scattering is dominant. Together with a large electronic specific heat coefficient with 30 mJ K-2 mol(-1), we confirm that the ferromagnetic SrRuO3 is a strongly correlated material.	[Kikugawa, Naoki; Terashima, Taichi; Uji, Shinya] Natl Inst Mat Sci, Sakura Ku, Tsukuba, Ibaraki 3050003, Japan; [Kikugawa, Naoki; Baumbach, Ryan; Brooks, James S.] Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Uji, Shinya] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058577, Japan; [Maeno, Yoshiteru] Kyoto Univ, Dept Phys, Kyoto 6068502, Japan	Kikugawa, N (reprint author), Natl Inst Mat Sci, Sakura Ku, Tsukuba, Ibaraki 3050003, Japan.	kikugawa.naoki@nims.go.jp			overseas researcher dispatch program in NIMS	We acknowledge H. Kitazawa, H. Mamiya, M. Imai, H. Aoki, and K. Nakazato for support and H. Yamase for fruitful comments and discussion throughout the study. N.K. acknowledges the support of the overseas researcher dispatch program in NIMS.	Fang Z, 2003, SCIENCE, V302, P92, DOI 10.1126/science.1089408; Maeno Y, 1997, J PHYS SOC JPN, V66, P1405, DOI 10.1143/JPSJ.66.1405; Mackenzie AP, 1998, PHYS REV B, V58, P13318; Kikugawa N, 2003, J PHYS SOC JPN, V72, P237, DOI 10.1143/JPSJ.72.237; Tian W, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2430941; KOBAYASHI H, 1994, MATER RES BULL, V29, P1271, DOI 10.1016/0025-5408(94)90151-1; Maeno Y, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.011009; Borzi RA, 2007, SCIENCE, V315, P214, DOI 10.1126/science.1134796; Mao ZQ, 1999, PHYS REV B, V60, P610, DOI 10.1103/PhysRevB.60.610; Padhan P, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2217187; Alexander CS, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.024415; Yoshimura K, 1999, PHYS REV LETT, V83, P4397, DOI 10.1103/PhysRevLett.83.4397; Mackenzie AP, 1998, PHYS REV LETT, V80, P161, DOI 10.1103/PhysRevLett.80.161; Capogna L, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.076602; Perry RS, 2004, J CRYST GROWTH, V271, P134, DOI 10.1016/j.jcrysgro.2004.07.082; Cao G, 1997, PHYS REV B, V56, P321, DOI 10.1103/PhysRevB.56.321; Perry RS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.166602; Koster G, 2012, REV MOD PHYS, V84, P253, DOI 10.1103/RevModPhys.84.253; RANDALL JJ, 1959, J AM CHEM SOC, V81, P2629, DOI 10.1021/ja01520a007; MAENO Y, 1994, NATURE, V372, P532, DOI 10.1038/372532a0; Kikugawa N, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.014701; Mao ZQ, 2000, MATER RES BULL, V35, P1813, DOI 10.1016/S0025-5408(00)00378-0; Kiyama T, 1998, J PHYS SOC JPN, V67, P307, DOI 10.1143/JPSJ.67.307; Ikeda S, 2000, PHYS REV B, V62, pR6089, DOI 10.1103/PhysRevB.62.R6089; Shai DE, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.087004; Ikeda SI, 2002, J CRYST GROWTH, V237, P787, DOI 10.1016/S0022-0248(01)02033-4; LONGO JM, 1968, J APPL PHYS, V39, P1327, DOI 10.1063/1.1656282; Zhou M, 2005, MATER RES BULL, V40, P942, DOI 10.1016/j.materresbull.2005.03.004; Anwar MS, 2015, APPL PHYS EXPRESS, V8, DOI 10.7567/APEX.8.019202; SCHWERER FC, 1970, PHYS REV B, V2, P1575, DOI 10.1103/PhysRevB.2.1575; Sow C, 2013, J APPL PHYS, V113, DOI 10.1063/1.4795125	31	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	NOV	2015	15	11					5573	5577		10.1021/acs.cgd.5b01248		5	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CV6BP	WOS:000364356000050		
J	Seki, K				Seki, Koki			Capitalizing on Desire: Reconfiguring "the Social' and the Government of Poverty in the Philippines	DEVELOPMENT AND CHANGE			English	Article							CITIZENSHIP; MANILA; CITY	Tracing the contours of the social' is of critical importance today, since there is a widely shared understanding that the social' has been undergoing a fundamental mutation under the encroaching influence of globalization and neoliberalism. This mutation means that a population and its risks are increasingly administered and managed through the nurturing of free subjects, productive citizens and active communities. By focusing on conditional cash transfers as a poverty-alleviation programme in the Philippines, this study examines how the contemporary government of poverty attempts to realize social inclusion through the nurturing of desires, habits and dispositions that are conducive to an investment in human capital'. The study argues that such regimes produce various forms of exclusion and counterclaims by the beneficiaries, and that these counterclaims, which reflect the popular notions of patronage and clientelism, have serious implications for envisioning the alternative configuration of the social'.	[Seki, Koki] Hiroshima Univ, Cultural Anthropol & Southeast Asian Studies, Grad Sch, Int Dev & Cooperat IDEC, Hiroshima 730, Japan	Seki, K (reprint author), Hiroshima Univ, Cultural Anthropol & Southeast Asian Studies, Grad Sch, Int Dev & Cooperat IDEC, Hiroshima 730, Japan.	seki@hiroshima-u.ac.jp			JSPS [24520913]	The author is very grateful to three anonymous reviewers and the editors for their insightful views and helpful comments on earlier drafts of this essay. The author is indebted to the people of Barangay Malanday, Marikina City, especially Juliet Reyes and Bella Cinco for their continuous support and helpful comments on my research. This work is supported by JSPS KAKENHI Grant Number 24520913.	Feher M, 2009, PUBLIC CULTURE, V21, P21, DOI 10.1215/08992363-2008-019; Kanna A, 2010, CULT ANTHROPOL, V25, P100, DOI 10.1111/j.1548-1360.2009.01053.x; HARVEY D, 1989, GEOGR ANN B, V71, P3, DOI 10.2307/490503; Lazar S, 2004, CRIT ANTHROPOL, V24, P301, DOI 10.1177/0308275X04045423; Osborne T, 1999, ENVIRON PLANN D, V17, P737, DOI 10.1068/d170737; Shatkin G, 2004, URBAN STUD, V41, P2469, DOI 10.1080/00420980412331297636; Shatkin G, 2000, URBAN STUD, V37, P2357, DOI 10.1080/00420980020002841; Ansell A, 2014, ZERO HUNGER: POLITICAL CULTURE AND ANTIPOVERTY POLICY IN NORTHEAST BRAZIL, P1, DOI 10.5149/northcarolina/9781469613970.001.0001; Auyero Javier, 2000, POOR PEOPLES POLITIC; Barry A., 1996, FOUCAULT POLITICAL R; Blanc-Szanton M. C., 1972, RIGHT SURVIVE SUBSIS; Brenner N., 2002, SPACES NEOLIBERALISM; Burchell G., 1991, FOUCAULT EFFECT STUD; Cannell Fenella, 1999, POWER INTIMACY CHRIS; Collier S. J., 2005, GLOBAL ASSEMBLAGES T, P22; Dean M., 2010, GOVT POWER RULE MODE; Donzelot Jacques, 1979, POLICING FAMILIES; Ferguson J., 2009, ANTIPODE, V41, P166, DOI DOI 10.1111/J.1467-8330.2009.00721.X; Fiszbein A, 2009, CONDITIONAL CASH TRA, DOI http://dx.doi.org/10.1596/978-0-8213-7352-1; Garrido M., 2008, PHILIPPINE STUDIES, V56, P443; Kerkvliet B., 1991, EVERYDAY POLITICS PH; Li T.M., 2007, WILL IMPROVE GOVT DE; Miller P., 2008, GOVERNING PRESENT AD; Muehlebach A, 2012, MORAL NEOLIBERAL WEL; Ong A, 2006, NEOLIBERALISM EXCEPT; Ong A, 2005, GLOBAL ASSEMBLAGES T; Pinches M., 1999, CULTURE PRIVILEGE CA, P1; Pinches M., 1994, CULTURAL IDENTITY UR, P13; Roniger L., 1994, DEMOCRACY CLIENTELIS; Rose N., 1999, POWERS FREEDOM REFRA; Rose Nicholas, 1996, FOUCAULT POLITICAL R, P37; Salaverria L., 2010, PHILIPPINE DAILY INQ; Schaffer F. C., 2005, 21 I ADV STUD; Seki K., 2012, PHILIPPINE STUDIES, V60, P187; Seki K., 2010, JAPANESE REV CULTURA, V11, P67; Shatkin G., 2007, COLLECTIVE ACTION UR; Shatkin G, 2008, ENVIRON PLANN A, V40, P383, DOI 10.1068/a38439; Shore C, 2011, POLICY WORLDS ANTHR, P1; Szanton D. L., 1981, ESTANCIA TRANSITION; Vigilia W., 2010, MALAYA NEWS     0921	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-155X	1467-7660		DEV CHANGE	Dev. Change	NOV	2015	46	6					1253	1276		10.1111/dech.12200		24	Planning & Development	Public Administration	CW0VM	WOS:000364707800002		
J	Shigetomi, Y; Nansai, K; Kagawa, S; Tohno, S				Shigetomi, Yosuke; Nansai, Keisuke; Kagawa, Shigemi; Tohno, Susumu			Trends in Japanese households' critical-metals material footprints	ECOLOGICAL ECONOMICS			English	Article						Household consumption; Material footprint; Critical metal; Low carbon technology; Multiregional input-output analysis	INPUT-OUTPUT-ANALYSIS; LOW-CARBON TECHNOLOGIES; ENERGY-REQUIREMENTS; INTERNATIONAL-TRADE; WATER FOOTPRINT; DYNAMIC-ANALYSIS; CO2 EMISSIONS; CONSUMPTION; STOCKS; FLOWS	This study adopts the concept of material footprint (MF), an indicator for consumption-based material extraction via international trade, and identifies the relationship between the MFs of critical metals for low-carbon technologies - neodymium, cobalt, and platinum - and Japanese household consumption through a multiregional input-output approach using the global link input-output model. We focus solely on the impact of changes in consumption patterns caused by demographic change on the structures of the MFs from 2005 to 2035. As a result, the total MFs of neodymium, cobalt, and platinum in 2035 are estimated to be 11%, 6.6% and 4.7% lower than in 2005, respectively. In terms of commodity sectors, the MFs of the three metals induced by "passenger motor cars" are estimated to decrease most between 2005 and 2035. Finally, we carried out an assessment of the extent to which the products dealt with under current Japanese recycling laws cover the MFs calculated for 2035. This indicates that continued enforcement of the recycling laws can play an important role in alerting consumers to the MFs of critical metals, particularly neodymium. For improving the accuracy of the above estimates, further studies need to incorporate other future trends like technologies and trade. (C) 2015 The Authors. Published by Elsevier B.V.	[Shigetomi, Yosuke; Tohno, Susumu] Kyoto Univ, Grad Sch Energy Sci, Sakyo Ku, Kyoto 6068501, Japan; [Shigetomi, Yosuke; Nansai, Keisuke] Natl Inst Environm Studies, Ctr Mat Cycles & Waste Management Res, Tsukuba, Ibaraki 3058506, Japan; [Kagawa, Shigemi] Kyushu Univ, Fac Econ, Higashi Ku, Fukuoka 8128581, Japan	Shigetomi, Y (reprint author), Kyoto Univ, Grad Sch Energy Sci, Sakyo Ku, Kyoto 6068501, Japan.	shigetomi.yosuke.46w@st.kyoto-u.ac.jp			JSPS [26241031, 25281065, 24360210, 26 . 4971]	This research was supported in part by JSPS Grant-in-Aid for Scientific Research (A) (No. 26241031), JSPS Grant-in-Aid for Scientific Research (B) (No. 25281065 and No. 24360210) and JSPS Grant-in-Aid for JSPS Fellows (No. 26 . 4971). We would like to thank two anonymous reviewers who provided very helpful comments. We are also grateful to Nigel Harle of Gronsveld, the Netherlands, for his critical editing of our English.	Elshkaki A, 2013, RESOUR POLICY, V38, P241, DOI 10.1016/j.resourpol.2013.04.002; Cucek L, 2012, J CLEAN PROD, V34, P9, DOI 10.1016/j.jclepro.2012.02.036; Wiedmann T, 2010, ECON SYST RES, V22, P19, DOI 10.1080/09535311003612591; Pachauri S, 2002, ENERG POLICY, V30, P511, DOI 10.1016/S0301-4215(01)00119-7; Hubacek K, 2009, J CLEAN PROD, V17, P1241, DOI 10.1016/j.jclepro.2009.03.011; Bruckner M, 2012, GLOBAL ENVIRON CHANG, V22, P568, DOI 10.1016/j.gloenvcha.2012.03.011; Chen WQ, 2012, ECOL ECON, V81, P92, DOI 10.1016/j.ecolecon.2012.06.008; Takahashi K, 2014, ATMOS ENVIRON, V97, P406, DOI 10.1016/j.atmosenv.2014.04.028; Peters GP, 2008, ECOL ECON, V65, P13, DOI 10.1016/j.ecolecon.2007.10.014; Nansai K, 2015, ENVIRON SCI TECHNOL, V49, P2022, DOI 10.1021/es504255r; Munksgaard J, 2000, ENERG ECON, V22, P423, DOI 10.1016/S0140-9883(99)00033-X; Park HC, 2007, ENERG POLICY, V35, P2839, DOI 10.1016/j.enpol.2006.10.002; Muller DB, 2006, P NATL ACAD SCI USA, V103, P16111, DOI 10.1073/pnas.0603375103; Hertwich EG, 2005, ENVIRON SCI TECHNOL, V39, P4673, DOI 10.1021/es0497375; Feng KS, 2011, ECON SYST RES, V23, P371, DOI 10.1080/09535314.2011.638276; Hoekstra AY, 2014, SCIENCE, V344, P1114, DOI 10.1126/science.1248365; O'Neill BC, 2010, P NATL ACAD SCI USA, V107, P17521, DOI 10.1073/pnas.1004581107; Arto I, 2014, ECON SYST RES, V26, P327, DOI 10.1080/09535314.2014.939949; Nansai K, 2012, ENVIRON SCI TECHNOL, V46, P155, DOI 10.1021/es202007b; Du XY, 2011, ENVIRON SCI TECHNOL, V45, P4096, DOI 10.1021/es102836s; Elshkaki A, 2013, J CLEAN PROD, V59, P260, DOI 10.1016/j.jclepro.2013.07.003; Munksgaard J, 2001, ENERG POLICY, V29, P327, DOI 10.1016/S0301-4215(00)00120-8; Peters GP, 2008, CLIMATIC CHANGE, V86, P51, DOI 10.1007/s10584-007-9280-1; Schoer K, 2013, ENVIRON SCI TECHNOL, V47, P14282, DOI 10.1021/es404166f; Davis SJ, 2010, P NATL ACAD SCI USA, V107, P5687, DOI 10.1073/pnas.0906974107; Lenzen M, 2004, ECOL ECON, V49, P375, DOI 10.1016/j.ecolecon.2004.01.019; Druckman A, 2012, ECOL ECON, V84, P153, DOI 10.1016/j.ecolecon.2012.09.008; Graedel TE, 2004, ENVIRON SCI TECHNOL, V38, P1242, DOI 10.1021/es030433c; Kronenberg T, 2009, ECOL ECON, V68, P2637, DOI 10.1016/j.ecolecon.2009.04.016; Peters GP, 2011, P NATL ACAD SCI USA, V108, P8903, DOI 10.1073/pnas.1006388108; Weinzettel J, 2013, GLOBAL ENVIRON CHANG, V23, P433, DOI 10.1016/j.gloenvcha.2012.12.010; Reck BK, 2008, ENVIRON SCI TECHNOL, V42, P3394, DOI 10.1021/es072108I; Harper EM, 2012, ENVIRON SCI TECHNOL, V46, P1079, DOI 10.1021/es201874e; Hertwich EG, 2009, ENVIRON SCI TECHNOL, V43, P6414, DOI 10.1021/es803496a; Moran D, 2014, ECON SYST RES, V26, P245, DOI 10.1080/09535314.2014.935298; Galli A, 2012, ECOL INDIC, V16, P100, DOI 10.1016/j.ecolind.2011.06.017; Lenzen M, 2012, NATURE, V486, P109, DOI 10.1038/nature11145; [Anonymous], 2005, FIES FAM INC EXP SUR; Lenzen M, 2012, ENVIRON SCI TECHNOL, V46, P8374, DOI 10.1021/es300171x; Druckman A, 2009, ECOL ECON, V68, P2066, DOI 10.1016/j.ecolecon.2009.01.013; Tukker A, 2013, ECON SYST RES, V25, P50, DOI 10.1080/09535314.2012.761952; Wiedmann T, 2007, ECOL ECON, V61, P15, DOI 10.1016/j.ecolecon.2006.12.003; Wiedenhofer D, 2013, ENERG POLICY, V63, P696, DOI 10.1016/j.enpol.2013.07.035; Steen-Olsen K, 2012, ENVIRON SCI TECHNOL, V46, P10883, DOI 10.1021/es301949t; Kerkhof AC, 2009, ECOL ECON, V68, P1160, DOI 10.1016/j.ecolecon.2008.08.004; Wackernagel M, 2002, P NATL ACAD SCI USA, V99, P9266, DOI 10.1073/pnas.142033699; [Anonymous], 2005, CONS CONF SURV; Nansai K, 2014, ENVIRON SCI TECHNOL, V48, P1391, DOI 10.1021/es4033452; Dietzenbacher E, 2013, ECON SYST RES, V25, P71, DOI 10.1080/09535314.2012.761180; Shigetomi Y, 2014, ENVIRON SCI TECHNOL, V48, P6069, DOI 10.1021/es404939d; Nansai K, 2009, ECON SYST RES, V21, P267, DOI 10.1080/09535310903541587; Duarte R, 2014, ECON SYST RES, V26, P410, DOI 10.1080/09535314.2014.903231; Hoekstra AY, 2012, P NATL ACAD SCI USA, V109, P3232, DOI 10.1073/pnas.1109936109; International Energy Agency(IEA), 2011, TECHN ROADM EL PLUG; IPSS National Institute of Population Social Security Research, 2013, POP STAT JAP; IPSS National Institute of Population Social Security Research, 2012, POP STAT JAP; Kablak G., 2013, RESOUR CONSERV RECY, V73, P17; Kablak G., 2013, RESOUR CONSERV RECY, V76, P21; Kagawa S., 2015, GLOB ENV CH IN PRESS; Lenzen M., 2004, ECON SYST RES, V16, P391, DOI [10.1080/0953531042000304272, DOI 10.1080/0953531042000304272]; Matthews H. S., 2008, ECOL ECON, V66, P379; McLellan B.C., 2013, ENERGY STRATEGY REV, V2, P190, DOI DOI 10.1016/J.ESR.2013.04.004); Miller E.R., 2009, INPUT OUTPUT ANAL FD; Nansai K., 2013, COMMON GROUND; Nansai K., 2013, SUSTAINABILITY PRACT; Schreyer P., 2013, 21 INT INP OUTP C 3; Wiedmann T.O., 2013, P NATL ACAD SCI US; Wood R, 2014, ECON SYST RES, V26, P387, DOI 10.1080/09535314.2014.960913; Yamano N., 2012, FRONTIERS INT INPUT, V80	69	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8009	1873-6106		ECOL ECON	Ecol. Econ.	NOV	2015	119						118	126		10.1016/j.ecolecon.2015.08.010		9	Ecology; Economics; Environmental Sciences; Environmental Studies	Environmental Sciences & Ecology; Business & Economics	CV9KF	WOS:000364605400011		
J	Moran, D; Lenzen, M; Kanemoto, K; Geschke, A				Moran, Daniel; Lenzen, Manfred; Kanemoto, Keiichiro; Geschke, Arne			Can EEMRIO analyses establish the occurrence of ecologically unequal exchange? Response	ECOLOGICAL ECONOMICS			English	Editorial Material									[Moran, Daniel] NTNU, Programme Ind Ecol, Trondheim, Norway; [Lenzen, Manfred; Geschke, Arne] Univ Sydney, ISA, Sch Phys, Sydney, NSW 2006, Australia; [Kanemoto, Keiichiro] Kyushu Univ, IDSSS, Fukuoka 812, Japan	Moran, D (reprint author), NTNU, Programme Ind Ecol, Trondheim, Norway.							0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8009	1873-6106		ECOL ECON	Ecol. Econ.	NOV	2015	119						419	419		10.1016/j.ecolecon.2015.09.003		1	Ecology; Economics; Environmental Sciences; Environmental Studies	Environmental Sciences & Ecology; Business & Economics	CV9KF	WOS:000364605400039		
J	Downey, MH; Searle, R; Bellur, S; Geiger, A; Maitner, BS; Ohm, JR; Tuda, M; Miller, TEX				Downey, Michelle H.; Searle, Rebecca; Bellur, Sunil; Geiger, Adam; Maitner, Brian S.; Ohm, Johanna R.; Tuda, Midori; Miller, Tom E. X.			A comparative approach to testing hypotheses for the evolution of sex-biased dispersal in bean beetles	Ecology and Evolution			English	Article						Bean beetle; inbreeding; mating system; polygyny; sex-biased dispersal	CALLOSOBRUCHUS-MACULATUS COLEOPTERA; INBREEDING DEPRESSION; POPULATION-DYNAMICS; GENETIC-EVIDENCE; F COLEOPTERA; SEED BEETLES; ACTIVE FORM; BRUCHIDAE; FITNESS; COMPETITION	Understanding the selective forces that shape dispersal strategies is a fundamental goal of evolutionary ecology and is increasingly important in changing, human-altered environments. Sex-biased dispersal (SBD) is common in dioecious taxa, and understanding variation in the direction and magnitude of SBD across taxa has been a persistent challenge. We took a comparative, laboratory-based approach using 16 groups (species or strains) of bean beetles (genera Acanthoscelides, Callosobruchus, and Zabrotes, including 10 strains of one species) to test two predictions that emerge from dominant hypotheses for the evolution of SBD: (1) groups that suffer greater costs of inbreeding should exhibit greater SBD in favor of either sex (inbreeding avoidance hypothesis) and (2) groups with stronger local mate competition should exhibit greater male bias in dispersal (kin competition avoidance hypothesis). We used laboratory experiments to quantify SBD in crawling dispersal, the fitness effects of inbreeding, and the degree of polygyny (number of female mates per male), a proxy for local mate competition. While we found that both polygyny and male-biased dispersal were common across bean beetle groups, consistent with the kin competition avoidance hypothesis, quantitative relationships between trait values did not support the predictions. Across groups, there was no significant association between SBD and effects of inbreeding nor SBD and degree of polygyny, using either raw values or phylogenetically independent contrasts. We discuss possible limitations of our experimental approach for detecting the predicted relationships, as well as reasons why single-factor hypotheses may be too simplistic to explain the evolution of SBD.	[Downey, Michelle H.; Searle, Rebecca; Bellur, Sunil; Geiger, Adam; Maitner, Brian S.; Ohm, Johanna R.; Miller, Tom E. X.] Rice Univ, Dept Biosci, Program Ecol & Evolutionary Biol, Houston, TX 77005 USA; [Maitner, Brian S.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Ohm, Johanna R.] Penn State Univ, Ctr Infect Dis Dynam, Dept Biol, University Pk, PA 16803 USA; [Tuda, Midori] Kyushu Univ, Lab Insect Nat Enemies, Div Agr Bioresource Sci, Dept Bioresource Sci,Fac Agr, Fukuoka 8128581, Japan; [Tuda, Midori] Kyushu Univ, Fac Agr, Inst Biol Control, Fukuoka 8128581, Japan	Miller, TEX (reprint author), Rice Univ, Dept Biosci, Program Ecol & Evolutionary Biol, Houston, TX 77005 USA.	tom.miller@rice.edu			Godwin Assistant Professorship at Rice University	This work was supported by the Godwin Assistant Professorship at Rice University.	Rankin DJ, 2008, EVOLUTION, V62, P622, DOI 10.1111/j.1558-5646.2007.00315.x; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; SANOFUJII I, 1984, J STORED PROD RES, V20, P153, DOI 10.1016/0022-474X(84)90024-9; SANOFUJII I, 1986, J STORED PROD RES, V22, P115, DOI 10.1016/0022-474X(86)90003-2; Neubert MG, 2000, ECOLOGY, V81, P1613, DOI 10.1890/0012-9658(2000)081[1613:DADCAS]2.0.CO;2; UTIDA S, 1972, J STORED PROD RES, V8, P111, DOI 10.1016/0022-474X(72)90028-8; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Gandon S, 1999, J THEOR BIOL, V200, P345, DOI 10.1006/jtbi.1999.0994; Dullinger S, 2004, J ECOL, V92, P241, DOI 10.1111/j.0022-0477.2004.00872.x; Miller TEX, 2011, ECOLOGY, V92, P2141, DOI 10.1890/11-0028.1; Perrin N, 2000, AM NAT, V155, P116, DOI 10.1086/303296; Miller TEX, 2013, ECOL LETT, V16, P354, DOI 10.1111/ele.12049; Perrin N, 1999, AM NAT, V154, P282, DOI 10.1086/303236; Fox CW, 2011, EVOL ECOL, V25, P25, DOI 10.1007/s10682-010-9376-3; Arnqvist G, 2005, BEHAV ECOL, V16, P123, DOI 10.1093/beheco/arh119; Innocent TM, 2010, J EVOLUTION BIOL, V23, P1374, DOI 10.1111/j.1420-9101.2010.02015.x; Dobson FS, 2013, ANIM BEHAV, V85, P299, DOI 10.1016/j.anbehav.2012.11.014; Cano JM, 2008, MOL ECOL, V17, P3234, DOI 10.1111/j.1365-294X.2008.03837.x; Cutrera AP, 2005, MOL ECOL, V14, P2511, DOI 10.1111/j.1365-294X.2005.02551.x; Hutchings JA, 2002, P ROY SOC B-BIOL SCI, V269, P2487, DOI 10.1098/rspb.2002.2176; Fox CW, 2011, EVOLUTION, V65, P246, DOI 10.1111/j.1558-5646.2010.01108.x; Dowling DK, 2007, EVOLUTION, V61, P194, DOI 10.1111/j.1558-5646.2007.00016.x; MESSINA FJ, 1985, ANN ENTOMOL SOC AM, V78, P201; Shaw AK, 2014, J ANIM ECOL, V83, P1256, DOI 10.1111/1365-2656.12232; Fraser DJ, 2004, MOL ECOL, V13, P67, DOI 10.1046/j.1365-294X.2003.02038.x; Arnqvist G, 2010, P ROY SOC B-BIOL SCI, V277, P1345, DOI 10.1098/rspb.2009.2026; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Hammond RL, 2006, P ROY SOC B-BIOL SCI, V273, P479, DOI 10.1098/rspb.2005.3257; Roze D, 2005, AM NAT, V166, P708, DOI 10.1086/497543; Lindstrom J, 1998, P ROY SOC B-BIOL SCI, V265, P483; Nagy M, 2007, P R SOC B, V274, P3019, DOI 10.1098/rspb.2007.1008; Meier CM, 2011, OIKOS, V120, P1459, DOI 10.1111/j.1600-0706.2011.19487.x; Tuda M, 2006, MOL ECOL, V15, P3541, DOI 10.1111/j.1365-294X.2006.03030.x; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Duarte LC, 2003, EVOLUTION, V57, P638; Strevens CMJ, 2011, J ANIM ECOL, V80, P282, DOI 10.1111/j.1365-2656.2010.01768.x; Miller TEX, 2011, AM NAT, V177, P549, DOI 10.1086/659628; Kerth G, 2002, MOL ECOL, V11, P1491, DOI 10.1046/j.1365-294X.2002.01528.x; Fox CW, 2008, EVOLUTION, V62, P2236, DOI 10.1111/j.1558-5646.2008.00441.x; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; Caswell H., 2001, MATRIX POPULATION MO; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; SU Y.-S., 2014, R2JAGS PACKAGE RUNNI; Tuda M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106268	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7758			ECOL EVOL	Ecol. Evol.	NOV	2015	5	21					4819	4828		10.1002/ece3.1753		10	Ecology	Environmental Sciences & Ecology	CV5WF	WOS:000364341400008		
J	Honma, A; Mappes, J; Valkonen, JK				Honma, Atsushi; Mappes, Johanna; Valkonen, Janne K.			Warning coloration can be disruptive: aposematic marginal wing patterning in the wood tiger moth	Ecology and Evolution			English	Article						Aposematism; camouflage; crypsis; defense; disruptive coloration; predation	EXPERIENCED PREDATORS; ANIMAL CAMOUFLAGE; DISTASTEFUL PREY; BUTTERFLY LARVA; BRIGHT COLORS; EVOLUTION; SIGNAL; CONSPICUOUSNESS; AVOIDANCE; DETECTABILITY	Warning (aposematic) and cryptic colorations appear to be mutually incompatible because the primary function of the former is to increase detectability, whereas the function of the latter is to decrease it. Disruptive coloration is a type of crypsis in which the color pattern breaks up the outline of the prey, thus hindering its detection. This delusion can work even when the prey's pattern elements are highly contrasting; thus, it is possible for an animal's coloration to combine both warning and disruptive functions. The coloration of the wood tiger moth (Parasemia plantaginis) is such that the moth is conspicuous when it rests on vegetation, but when it feigns death and drops to the grass- and litter-covered ground, it is hard to detect. This death-feigning behavior therefore immediately switches the function of its coloration from signaling to camouflage. We experimentally tested whether the forewing patterning of wood tiger moths could function as disruptive coloration against certain backgrounds. Using actual forewing patterns of wood tiger moths, we crafted artificial paper moths and placed them on a background image resembling a natural litter and grass background. We manipulated the disruptiveness of the wing pattern so that all (marginal pattern) or none (nonmarginal pattern) of the markings extended to the edge of the wing. Paper moths, each with a hidden palatable food item, were offered to great tits (Parus major) in a large aviary where the birds could search for and attack the moths according to their detectability. The results showed that prey items with the disruptive marginal pattern were attacked less often than prey without it. However, the disruptive function was apparent only when the prey was brighter than the background. These results suggest that warning coloration and disruptive coloration can work in concert and that the moth, by feigning death, can switch the function of its coloration from warning to disruptive.	[Honma, Atsushi; Mappes, Johanna; Valkonen, Janne K.] Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Biol Interact, Jyvaskyla 40014, Finland; [Honma, Atsushi] Univ Shiga Prefecture, Sch Environm Sci, Dept Ecosyst Studies, Hikone City, Shiga 5228533, Japan	Honma, A (reprint author), Univ Shiga Prefecture, 2500 Hassaka Cho, Hikone City, Shiga 5228533, Japan.	honma.tetrix@gmail.com			Biotieteiden ja Ympariston Tutkimuksen Toimikunta [SA-252411]	Biotieteiden ja Ympariston Tutkimuksen Toimikunta, (Grant/Award Number: 'SA-252411').	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Andersson M.B., 1994, SEXUAL SELECTION; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351; Stevens M, 2009, PHILOS T R SOC B, V364, P481, DOI 10.1098/rstb.2008.0216; Bohlin T, 2008, ANIM BEHAV, V76, P577, DOI 10.1016/j.anbehav.2008.02.012; Lyytinen A, 2004, BEHAV ECOL, V15, P982, DOI 10.1093/beheco/arh102; Stevens M, 2012, P ROY SOC B-BIOL SCI, V279, P417, DOI 10.1098/rspb.2011.1932; Bohlin T, 2012, BIOL J LINN SOC, V105, P806, DOI 10.1111/j.1095-8312.2011.01834.x; SILLENTULLBERG B, 1985, OECOLOGIA, V67, P411, DOI 10.1007/BF00384948; Lindstedt C, 2009, EVOLUTION, V63, P469, DOI 10.1111/j.1558-5646.2008.00561.x; Exnerova A, 2007, BEHAV ECOL, V18, P148, DOI 10.1093/beheco/arl061; PAPAGEORGIS C, 1975, AM SCI, V63, P522; [Anonymous], 2011, R LANG ENV STAT COMP; Wuster W, 2004, P ROY SOC B-BIOL SCI, V271, P2495, DOI 10.1098/rspb.2004.2894; ROPER TJ, 1994, OIKOS, V69, P115, DOI 10.2307/3545290; Husak JF, 2006, ETHOLOGY, V112, P572, DOI 10.1111/j.1439-0310.2005.01189.x; Marples NM, 2005, EVOLUTION, V59, P933; Gamberale-Stille G, 1999, EVOL ECOL, V13, P579, DOI 10.1023/A:1006741626575; Clusella Trullas S, 2007, J THERM BIOL, V32, P235, DOI 10.1016/j.jtherbio.2007.01.003; Lindstrom L, 1999, NATURE, V397, P249, DOI 10.1038/16692; Gamberale-Stille G, 2000, ANIM BEHAV, V60, P95, DOI 10.1006/anbe.2000.1435; Speed MP, 2007, EVOLUTION, V61, P623, DOI 10.1111/j.1558-5646.2007.00054.x; Nokelainen O, 2014, J ANIM ECOL, V83, P598, DOI 10.1111/1365-2656.12169; Riipi M, 2001, NATURE, V413, P512, DOI 10.1038/35097061; Tullberg BS, 2005, P ROY SOC B-BIOL SCI, V272, P1315, DOI 10.1098/rspb.2005.3079; Summers K, 2001, P NATL ACAD SCI USA, V98, P6227, DOI 10.1073/pnas.101134898; Cuthill IC, 2006, BEHAV ECOL, V17, P828, DOI 10.1093/beheco/arl015; Stevens M, 2007, P R SOC B, V274, P1457, DOI 10.1098/rspb.2007.0220; ROPER TJ, 1987, ANIM BEHAV, V35, P739, DOI 10.1016/S0003-3472(87)80110-0; Fraser S, 2007, P R SOC B, V274, P1325, DOI 10.1098/rspb.2007.0153; Sandre SL, 2010, BEHAVIOUR, V147, P1121, DOI 10.1163/000579510X507001; Stevens M, 2006, P R SOC B, V273, P2433, DOI 10.1098/rspb.2006.3614; Ruxton GD, 2009, EVOL ECOL, V23, P491, DOI 10.1007/s10682-008-9247-3; Webster RJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0501; HOUDE AE, 1990, SCIENCE, V248, P1405, DOI 10.1126/science.248.4961.1405; Stobbe N, 2008, P ROY SOC B-BIOL SCI, V275, P1535, DOI 10.1098/rspb.2008.0209; Endler JA, 2004, AM NAT, V163, P532, DOI 10.1086/382662; GUILFORD T, 1986, ANIM BEHAV, V34, P286, DOI 10.1016/0003-3472(86)90034-5; Lindstedt C, 2011, BEHAV ECOL, V22, P580, DOI 10.1093/beheco/arr017; Merilaita S, 2005, P ROY SOC B-BIOL SCI, V272, P665, DOI 10.1098/rspb.2004.3000; Maia R, 2013, METHODS ECOL EVOL, V4, P906, DOI 10.1111/2041-210X.12069; Jones CD, 2004, VISION RES, V44, P83, DOI 10.1016/j.visres.2003.08.014; Summers K, 1999, P ROY SOC B-BIOL SCI, V266, P2141; GITTLEMAN JL, 1980, NATURE, V286, P149, DOI 10.1038/286149a0; Marshall NJ, 2000, PHILOS T ROY SOC B, V355, P1243, DOI 10.1098/rstb.2000.0676; Marples NM, 2011, EVOL ECOL, V25, P737, DOI 10.1007/s10682-010-9434-x; Hart NS, 2000, J COMP PHYSIOL A, V186, P375, DOI 10.1007/s003590050437; JARVI T, 1981, OIKOS, V36, P267, DOI 10.2307/3544623; Nokelainen O, 2012, P ROY SOC B-BIOL SCI, V279, P257, DOI 10.1098/rspb.2011.0880; Pearson PM, 2002, VISION RES, V42, P1547, DOI 10.1016/S0042-6989(02)00067-6; Sherratt TN, 2005, TRENDS ECOL EVOL, V20, P414, DOI 10.1016/j.tree.2005.05.010; Cuthill IC, 2005, NATURE, V434, P72, DOI 10.1038/nature03312; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; Cott H. B., 1940, ADAPTIVE COLORATION; Edmunds M, 1974, DEFENCE ANIMALS SURV; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; Hegna R. H., 2013, P R SOC B, V280, P1755; Hegna RH, 2014, EVOL ECOL, V28, P1003, DOI 10.1007/s10682-014-9734-7; Mappes J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6016; Rasband W. S., 1997, IMAGE J; Rothschild M., 1975, COEVOLUTION ANIMALS, P20; Ruxton G. D., 2004, AVOIDING ATTACK; Schaefer M. H., 2006, P R SOC B, V273, P2427, DOI DOI 10.1098/RSPB.2006.3615; Stevens M., 2011, ANIMAL CAMOUFLAGE ME; Thayer G. H., 1909, CONCEALING COLORATIO; Troscianko J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073733; Valkonen J. K., 2012, ECOL EVOL, V2, P1971	67	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2045-7758			ECOL EVOL	Ecol. Evol.	NOV	2015	5	21					4863	4874		10.1002/ece3.1736		12	Ecology	Environmental Sciences & Ecology	CV5WF	WOS:000364341400012		
J	Yamasaki, R; Asakawa, H; Fukuma, T; Haruyama, T				Yamasaki, Ryota; Asakawa, Hitoshi; Fukuma, Takeshi; Haruyama, Tetsuya			Structural and Electrochemical Properties of Self-organized HFBI Membranes on Different Types of Substrates	ELECTROCHEMISTRY			English	Article						Hydrophobin; Self-organized Membrane; Electrode Modification; Atomic Force Microscopy (AFM)	RECONSTRUCTED SURFACE; PROTEIN LAYER; HYDROPHOBINS; AU(111); FORCE; SPECTROSCOPY; MICROSCOPY; MONOLAYERS; ELECTRODE; CARRIER	The HFBI protein, a type of hydrophobin, from Trichoderma reesei self-organizes in an orderly manner at either air/water or water/solid interfaces. The structural and electrochemical properties of self-organized membranes on different types of solid substrates (electrode materials) were investigated. Two types of substrates, highly oriented pyrolytic graphite (HOPG) and single crystal Au(111), were used for this study. Atomic force microscopy (AFM) showed that the self-organized HFBI membranes (prepared at the air/water interface) exhibited different structures on the two types of electrodes. In terms of the electrochemical results, both HFBI/HOPG and HFBI/Au(111) electrodes performed electrochemical reactions. Self-organized HFBI membranes did not provide insulation from electron transfer. Our findings that HFBI can be tagged with functional proteins, such as enzymes, by genetic fusion and utilized as a molecular carrier to fabricate molecular interfaces on an electrode. (C) The Electrochemical Society of Japan, All rights reserved.	[Yamasaki, Ryota; Haruyama, Tetsuya] Kyushu Inst Technol, Dept Biol Funct Engn, Div Funct Interface Engn, Kitakyushu Sci & Res Pk, Fukuoka 8080196, Japan; [Yamasaki, Ryota; Haruyama, Tetsuya] Kyushu Inst Technol, Res Ctr Ecofitting Technol, Kitakyushu Sci & Res Pk, Fukuoka 8080196, Japan; [Yamasaki, Ryota; Asakawa, Hitoshi; Fukuma, Takeshi; Haruyama, Tetsuya] Japan Sci & Technol Agcy JST, Adv Catalyt Transformat Program Carbon Utilizat A, Tokyo 1020076, Japan; [Asakawa, Hitoshi; Fukuma, Takeshi] Kanazawa Univ, Div Elect Engn & Comp Sci, Kanazawa, Ishikawa 9201192, Japan; [Asakawa, Hitoshi; Fukuma, Takeshi] Kanazawa Univ, BioAFM Frontier Res Ctr, Kanazawa, Ishikawa 9201192, Japan	Haruyama, T (reprint author), Kyushu Inst Technol, Dept Biol Funct Engn, Div Funct Interface Engn, Kitakyushu Sci & Res Pk, Fukuoka 8080196, Japan.	haruyama@life.kyutech.ac.jp			Japan Science and Technology Agency (JST); Advanced Catalytic Transformation Program for Carbon Utilization (ACT-C); Japan-Finland Joint Research Program; JSPS KAKENHI [26600005]	This research was supported financially partly by the Japan Science and Technology Agency (JST), Advanced Catalytic Transformation Program for Carbon Utilization (ACT-C), and partly by the Japan Science and Technology Agency (JST), Japan-Finland Joint Research Program, and partly by JSPS KAKENHI Grant Number 26600005.	Linder M, 2001, BIOMACROMOLECULES, V2, P511, DOI 10.1021/bm0001493; Paananen A, 2003, BIOCHEMISTRY-US, V42, P5253, DOI 10.1021/bi034031t; TANISHIRO Y, 1981, SURF SCI, V111, P395, DOI 10.1016/0039-6028(81)90397-6; TAKAYANAGI K, 1988, SURF SCI, V205, P637, DOI 10.1016/0039-6028(88)90306-8; ALBRECHT TR, 1991, J APPL PHYS, V69, P668, DOI 10.1063/1.347347; Frey BL, 1996, ANAL CHEM, V68, P3187, DOI 10.1021/ac9605861; Linder MB, 2005, FEMS MICROBIOL REV, V29, P877, DOI 10.1016/j.femsre.2005.01.004; Hakanpaa J, 2006, PROTEIN SCI, V15, P2129, DOI 10.1110/ps.062326706; Hoogenboom BW, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2202638; LU DR, 1991, J COLLOID INTERF SCI, V144, P271, DOI 10.1016/0021-9797(91)90258-A; Kondo T, 2007, J PHYS CHEM C, V111, P13197, DOI 10.1021/jp072601j; Sunde M, 2008, MICRON, V39, P773, DOI 10.1016/j.micron.2007.08.003; Takatsuji Y, 2013, COLLOID SURFACE B, V112, P186, DOI 10.1016/j.colsurfb.2013.07.051; Yamashita I, 2001, THIN SOLID FILMS, V393, P12, DOI 10.1016/S0040-6090(01)01083-5; Iwanaga A, 2011, COLLOID SURFACE B, V84, P395, DOI 10.1016/j.colsurfb.2011.01.032; Sader JE, 2004, APPL PHYS LETT, V84, P1801, DOI 10.1063/1.1667267; Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789; Sato K, 2006, ELECTROCHEM COMMUN, V8, P725, DOI 10.1016/j.elecom.2006.03.001; Asakawa H, 2009, LANGMUIR, V25, P8841, DOI 10.1021/la900974n; Szilvay GR, 2007, BIOCHEMISTRY-US, V46, P2345, DOI 10.1021/bi602358h; Fukuma T, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/3/033003; Pauling L., 1960, NATURE CHEM BOND, P235; Santore M., 2001, LANGMUIR, V17, P3006; Umeza N, 2014, ELECTROCHEMISTRY, V82, P346, DOI 10.5796/electrochemistry.82.346; Yamasaki K., 2014, COLLOID SURFACE B, V123, P803	25	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	NOV	2015	83	11					969	973		10.5796/electrochemistry.83.969		5	Electrochemistry	Electrochemistry	CV9NV	WOS:000364614800004		
J	Egashira, M				Egashira, Minato			Factors Influencing Iron utilization of Iron Compound/Carbon Nanofiber Composite Electrode	ELECTROCHEMISTRY			English	Article						Alkaline Secondary Batteries; Iron Negative Electrode; Carbon Nanofiber	AIR BATTERY; ALKALINE-SOLUTION; CARBON COMPOSITE; FE/C COMPOSITE; REDUCTION; ANODE	A comparative study of composite electrodes consisting of nanoparticles of iron compounds with fibrous nanocarbon in alkaline electrolyte was conducted to ascertain the morphological or composition factors that can increase the iron capacity. The preparation method and the iron content of a composite electrode affect the capacity per unit of iron mass. Particularly by increasing the iron content using a solution process, the capacity can be increased considerably up to ca. 460 mAh (g Fe)(-1) for an Fe(OH)(x)/carbon composite. Such improved iron utilization in these composites suggests a catalytic effect of some intermediate species. Addition of a model candidate of an intermediate species, FeOOH, even of only 3 wt%, can improve the iron utilization in a Fe(OH)(x)/carbon composite. (C) The Electrochemical Society of Japan, All rights reserved.	Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa 2550880, Japan	Egashira, M (reprint author), Nihon Univ, Coll Bioresource Sci, 1866 Kameino, Fujisawa, Kanagawa 2550880, Japan.	egashira.minato@nihon-u.ac.jp			JSPS Kakenhi [25410250]	This work was supported by JSPS Kakenhi grant No. 25410250. The VGCF<SUP>TM</SUP>-X sample was kindly provided by Showa Denko K.K., Japan.	Hang BT, 2008, J POWER SOURCES, V178, P393, DOI 10.1016/j.jpowsour.2007.12.012; OJEFORS L, 1978, J POWER SOURCES, V2, P287, DOI 10.1016/0378-7753(78)85019-8; Egashira M, 2015, ELECTROCHEMISTRY, V83, P354, DOI 10.5796/electrochemistry.83.354; HAUPT S, 1987, LANGMUIR, V3, P873, DOI 10.1021/la00078a003; Hang BT, 2006, J POWER SOURCES, V155, P461, DOI 10.1016/j.jpowsour.2005.04.010; Periasamy P, 1996, J POWER SOURCES, V58, P35, DOI 10.1016/0378-7753(95)02274-0; VIJAYAMOHANAN K, 1991, J POWER SOURCES, V34, P269, DOI 10.1016/0378-7753(91)80093-D; Kao CY, 2011, J POWER SOURCES, V196, P5746, DOI 10.1016/j.jpowsour.2010.12.076; Huang KC, 2007, ELECTROCHEM COMMUN, V9, P1907, DOI 10.1016/j.elecom.2007.05.001; Egashira M, 2014, ELECTROCHEMISTRY, V82, P273, DOI 10.5796/electrochemistry.82.273; Egashira M, 2008, J POWER SOURCES, V183, P399, DOI 10.1016/j.jpowsour.2008.05.009; Urbaniak J, 2010, J SOLID STATE ELECTR, V14, P1629, DOI 10.1007/s10008-010-1004-1; MICKA K, 1987, J POWER SOURCES, V19, P315, DOI 10.1016/0378-7753(87)87007-6; CERNY J, 1993, J POWER SOURCES, V45, P267, DOI 10.1016/0378-7753(93)80016-I; Hang BT, 2005, ELECTROCHEM SOLID ST, V8, pA476, DOI 10.1149/1.1999914; Casellato U, 2006, ELECTROCHIM ACTA, V51, P5669, DOI 10.1016/j.electacta.2006.01.057; SILVER HG, 1970, J ELECTROCHEM SOC, V117, P5, DOI 10.1149/1.2407439; MACDONALD DD, 1978, ELECTROCHIM ACTA, V23, P781, DOI 10.1016/0013-4686(78)80039-5; Kao CY, 2010, J POWER SOURCES, V195, P2399, DOI 10.1016/j.jpowsour.2009.08.008; Hang BT, 2005, J POWER SOURCES, V143, P256, DOI 10.1016/j.jpwsour.2004.11.044; BLURTON KF, 1979, J POWER SOURCES, V4, P263, DOI 10.1016/0378-7753(79)80001-4; ANDERSSON B, 1976, J ELECTROCHEM SOC, V123, P824, DOI 10.1149/1.2132940; Scrosati B., 1997, MODERN BATTERIES, P292	23	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	NOV	2015	83	11					984	988		10.5796/electrochemistry.83.984		5	Electrochemistry	Electrochemistry	CV9NV	WOS:000364614800007		
J	Kitta, M; Kuratani, K; Tabuchi, M; Kataoka, R; Kiyobayashi, T; Kohyama, M				Kitta, Mitsunori; Kuratani, Kentaro; Tabuchi, Mitsuharu; Kataoka, Riki; Kiyobayashi, Tetsu; Kohyama, Masanori			Design of a Sodium-ion Cell with a Carbon-free Li4Ti5O12 Negative Electrode	ELECTROCHEMISTRY			English	Article						Carbon-free Electrode; Full-cell Configuration; Li4Ti5O12; Sodium-ion Battery	TITANIUM-OXIDE ANODE; HIGH-RATE CAPABILITY; SPINEL LI4TI5O12; STORAGE MECHANISM; CATHODE MATERIAL; LI INSERTION; BATTERIES; PARTICLE; SIZE	In order to design a safe and practical Na-ion cell, the electrochemical properties of a conduction additive-free Li4Ti5O12 (LTO) electrode were investigated. The charge-discharge properties of LTO electrodes with/without conductive carbon additives are similar to each other in half-cell experiments, while the irreversible capacity fading of the carbon-free electrode is much smaller than that of the carbon-added electrode. A full cell consisting of alpha-NaFeO2 and carbon-free LTO electrodes shows a capacity of more than 90 mAh g(-1) after 50 cycles without Na-metal deposition. The current density capabilities of both electrodes are comparable, indicating that the rate-determining process of the charge-discharge reaction is the ionic conduction of Na+ in the Li4Ti5O12 crystal, not electronic conduction. (C) The Electrochemical Society of Japan, All rights reserved.	[Kitta, Mitsunori; Kuratani, Kentaro; Tabuchi, Mitsuharu; Kataoka, Riki; Kiyobayashi, Tetsu; Kohyama, Masanori] Natl Inst Adv Ind Sci & Technol, Environm & Energy Dept, Res Inst Electrochem Energy, Ikeda, Osaka 5638577, Japan	Kitta, M (reprint author), Natl Inst Adv Ind Sci & Technol, Environm & Energy Dept, Res Inst Electrochem Energy, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan.	m-kitta@aist.go.jp					Kavan L, 2003, J ELECTROCHEM SOC, V150, pA1000, DOI 10.1149/1.1581262; Takami N, 2013, J POWER SOURCES, V244, P469, DOI 10.1016/j.jpowsour.2012.11.055; Zhao L, 2012, CHINESE PHYS B, V21, DOI 10.1088/1674-1056/21/2/028201; Li JR, 2005, ELECTROCHEM COMMUN, V7, P894, DOI 10.1016/j.elecom.2005.06.012; Song MS, 2012, CHEM COMMUN, V48, P516, DOI 10.1039/c1cc16462g; Yabuuchi N, 2012, NAT MATER, V11, P512, DOI [10.1038/nmat3309, 10.1038/NMAT3309]; Cheng L, 2010, J MATER CHEM, V20, P595, DOI 10.1039/b914604k; Oh Y, 2014, J MATER CHEM A, V2, P2023, DOI 10.1039/c3ta14347c; Tang YF, 2008, ELECTROCHEM COMMUN, V10, P1513, DOI 10.1016/j.elecom.2008.07.049; Yu XQ, 2013, NANO LETT, V13, P4721, DOI 10.1021/nl402263g; Yabuuchi N, 2014, CHEM REV, V114, P11636, DOI 10.1021/cr500192f; Senguttuvan P, 2011, CHEM MATER, V23, P4109, DOI 10.1021/cm202076g; Cao Q, 2007, ELECTROCHEM COMMUN, V9, P1228, DOI 10.1016/j.elecom.2007.01.017; Prakash AS, 2010, CHEM MATER, V22, P2857, DOI 10.1021/cm100071z; Chou SL, 2011, J PHYS CHEM C, V115, P16220, DOI 10.1021/jp2039256; DOEFF MM, 1994, J ELECTROCHEM SOC, V141, pL145, DOI 10.1149/1.2059323; Kitta M, 2014, ELECTROCHIM ACTA, V148, P175, DOI 10.1016/j.electacta.2014.10.050; Sauvage F, 2007, INORG CHEM, V46, P3289, DOI 10.1021/ic0700250; Yi TF, 2014, J POWER SOURCES, V246, P505, DOI 10.1016/j.jpowsour.2013.08.005; TAKEDA Y, 1994, MATER RES BULL, V29, P659, DOI 10.1016/0025-5408(94)90122-8; Guerfi A, 2003, J POWER SOURCES, V119, P88, DOI 10.1016/S0378-7753(03)00131-9; Hasegawa G, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201400730; Kavan L, 2002, ELECTROCHEM SOLID ST, V5, pA39, DOI 10.1149/1.1432783; Okada S., 2009, LITHIUM ION RECHARGE, P53, DOI 10.1002/9783527629022.ch4; Shannon D. R., 1976, ACTA CRYSTALLOGR A, V32, P751; Sun Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2878; Takami N, 2009, J ELECTROCHEM SOC, V156, pA128, DOI 10.1149/1.3043441; Yao M, 2007, J ELECTROCHEM SOC, V154, pA709, DOI 10.1149/1.2737353	28	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	NOV	2015	83	11					989	992		10.5796/electrochemistry.83.989		4	Electrochemistry	Electrochemistry	CV9NV	WOS:000364614800008		
J	Fukumitsu, H; Omori, M; Terada, K; Suehiro, S				Fukumitsu, Hitoshi; Omori, Miho; Terada, Kenji; Suehiro, Shogo			Development of In Situ Cross-Sectional Raman Imaging of LiCoO2 Cathode for Li-ion Battery	ELECTROCHEMISTRY			English	Article						In Situ Raman; Lithium Battery; Reaction Distribution; LiCoO2	MAGNETIC-RESONANCE OBSERVATION; NEGATIVE-ELECTRODE; LITHIUM BATTERIES; GRAPHITE; MICROSCOPY; INTERCALATION; PERFORMANCE; TOMOGRAPHY; PARTICLES; CELLS	A novel in situ Raman imaging technique has been developed to visualize the Li-ion battery reaction during the charge/discharge operation. A specially designed cell enables to measure Raman spectra at high speed so that the in situ measurements are carried out during the reaction. The distribution of the state of charge in cross-section of LiCoO2 cathode has been visualized as a demonstration. Inhomogeneous state of charge distribution is observed and there are some active materials where Li+ does not completely return after discharging. This technique enables to evaluate not only the electrode performance but also battery degradation, and thus may promote the realization of the next generation batteries. (C) The Electrochemical Society of Japan, All rights reserved.	[Fukumitsu, Hitoshi; Omori, Miho; Terada, Kenji; Suehiro, Shogo] Sumika Chem Anal Serv SCAS Ltd, Technol Innovat Ctr, Konohana Ku, Osaka 5540022, Japan	Fukumitsu, H (reprint author), Sumika Chem Anal Serv SCAS Ltd, Technol Innovat Ctr, Konohana Ku, 3-1-135 Kasugade Naka, Osaka 5540022, Japan.	hitoshi.fukumitsu@scas.co.jp			New Energy and Industrial Technology Developing Organization (NEDO) [P10009]	This study was financially supported by New Energy and Industrial Technology Developing Organization (NEDO) (project code: P10009).	Liu G, 2012, J ELECTROCHEM SOC, V159, pA214, DOI 10.1149/2.024203jes; Chevallier F, 2003, ELECTROCHEM SOLID ST, V6, pA225, DOI 10.1149/1.1612011; Stancovski V, 2014, J APPL ELECTROCHEM, V44, P23, DOI 10.1007/s10800-013-0628-0; Inaba M, 1997, J RAMAN SPECTROSC, V28, P613, DOI 10.1002/(SICI)1097-4555(199708)28:8<613::AID-JRS138>3.0.CO;2-T; Nakagawa H, 2013, J POWER SOURCES, V236, P138, DOI 10.1016/j.jpowsour.2013.02.060; Verma P, 2010, ELECTROCHIM ACTA, V55, P6332, DOI 10.1016/j.electacta.2010.05.072; Patel KK, 2003, J POWER SOURCES, V122, P144, DOI [10.1016/S0378-7753(03)00399-9, 10.1016/s0378-7753(03)00399-9]; OHZUKU T, 1994, J ELECTROCHEM SOC, V141, P2972, DOI 10.1149/1.2059267; Ender M, 2012, J ELECTROCHEM SOC, V159, pA972, DOI 10.1149/2.033207jes; Letellier M, 2007, CARBON, V45, P1025, DOI 10.1016/j.carbon.2006.12.018; Dokko K, 2003, J PHYS CHEM B, V107, P12549, DOI 10.1021/jp034977c; Baddour-Hadjean R, 2010, CHEM REV, V110, P1278, DOI 10.1021/cr800344k; Zheng HH, 2010, J ELECTROCHEM SOC, V157, pA1060, DOI 10.1149/1.3459878; Shearing PR, 2010, ELECTROCHEM COMMUN, V12, P374, DOI 10.1016/j.elecom.2009.12.038; Chung KY, 2006, J POWER SOURCES, V163, P185, DOI 10.1016/j.jpowsour.2005.12.063; Ishida N, 2014, J POWER SOURCES, V248, P1118, DOI 10.1016/j.jpowsour.2013.09.121; Chen-Wiegart YCK, 2013, ELECTROCHEM COMMUN, V28, P127, DOI 10.1016/j.elecom.2012.12.021; Lei JL, 2005, J PHYS CHEM B, V109, P952, DOI 10.1021/jp046027c; Scrosati B, 2010, J POWER SOURCES, V195, P2419, DOI 10.1016/j.jpowsour.2009.11.048; Cronin JS, 2013, J POWER SOURCES, V233, P174, DOI 10.1016/j.jpowsour.2013.01.060; Christensen J, 2006, J ELECTROCHEM SOC, V153, pA560, DOI 10.1149/1.2172535; Fukumitsu H, 2015, ELECTROCHEMISTRY, V83, P2, DOI 10.5796/electrochemistry.83.2; Kehrwald D, 2011, J ELECTROCHEM SOC, V158, pA1393, DOI 10.1149/2.079112jes; Luo Y, 2004, ELECTROCHEM SOLID ST, V7, pE1, DOI 10.1149/1.1627972; Nishi T, 2013, J ELECTROCHEM SOC, V160, pA1785, DOI 10.1149/2.061310jes; Sikha G, 2004, J ELECTROCHEM SOC, V151, pA1104, DOI 10.1149/1.1759972; Yang J., 2015, J POWER SOURCES, V282, P294	27	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	NOV	2015	83	11					993	996		10.5796/electrochemistry.83.993		4	Electrochemistry	Electrochemistry	CV9NV	WOS:000364614800009		
J	Yang, GF; Sun, T; Wang, JL; Li, XN				Yang, Guangfei; Sun, Tao; Wang, Jianliang; Li, Xianneng			Modeling the nexus between carbon dioxide emissions and economic growth	ENERGY POLICY			English	Article						Carbon dioxide emissions; Environmental Kuznets curve; Symbolic regression; Genetic programming	ENVIRONMENTAL KUZNETS CURVE; PANEL-DATA ANALYSIS; CO2 EMISSIONS; ENERGY-CONSUMPTION; INCOME; TRADE; CHINA; HYPOTHESIS; TECHNOLOGY; COUNTRIES	The effects of economic growth on the environment have received increased attention as global warming and other environmental problems become more serious. Many empirical studies explain the nexus between carbon dioxide emissions and economic growth with such models as the environmental Kuznets curve (EKC) theory. However, the assumptions of these models have never received strict verification with a large available data set and therefore may not be appropriate to describe the relationship. In this study, the nexus is modeled for 67 countries from 1971 to 2010 using a novel symbolic regression method. From the experimental results, several conclusions as follows could be reached. Firstly, there is no universal model fitting every country, and symbolic regression could discover a set of reasonable models for a specific country or region. Secondly, four models, including the inverted N-shaped, M-shaped, inverted U-shaped and monotonically increasing, are frequently found without domain experts' intervention in these countries, whereas the M-shaped model has received little attention in previous studies but exhibits promising performance. Thirdly, the relationship is diversified due to the difference of regions and economic development, where developed countries generally follow the inverted N-shaped and M-shaped models to explain the relationship, whereas developing countries are more likely to refer to the inverted N-shaped, inverted U-shaped and monotonically increasing models. Finally, several policy suggestions are presented. (c) 2015 Elsevier Ltd. All rights reserved.	[Yang, Guangfei; Sun, Tao] Dalian Univ Technol, Sch Management Sci & Engn, Dalian, Peoples R China; [Wang, Jianliang] China Univ Petr, Sch Business Adm, Beijing, Peoples R China; [Li, Xianneng] Waseda Univ, Grad Sch Informat Prod & Syst, Kitakyushu, Fukuoka, Japan	Yang, GF (reprint author), Dalian Univ Technol, Sch Management Sci & Engn, Dalian, Peoples R China.	gfyang@dlut.edu.cn; statdut@mail.dlut.edu.cn; wangjianliang305@163.com; xianneng.li@gmail.com			National Natural Science Foundation of China [71001016]	This work is supported by the National Natural Science Foundation of China (71001016).	Ahmed Khalid, 2014, Management of Environmental Quality: An International Journal, V25, DOI 10.1108/MEQ-03-2013-0017; Akaike H, 1976, MATH SCI, V14, P5; Pao HT, 2010, ENERG POLICY, V38, P7850, DOI 10.1016/j.enpol.2010.08.045; Iwata H, 2011, APPL ENERG, V88, P1986, DOI 10.1016/j.apenergy.2010.11.005; Kaika D, 2013, ENERG POLICY, V62, P1392, DOI 10.1016/j.enpol.2013.07.131; Iwata H, 2010, ENERG POLICY, V38, P4057, DOI 10.1016/j.enpol.2010.03.031; Lee CC, 2009, REV AGR ECON, V31, P751, DOI 10.1111/j.1467-9353.2009.01465.x; Fodha M, 2010, ENERG POLICY, V38, P1150, DOI 10.1016/j.enpol.2009.11.002; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Kuznets S, 1955, AM ECON REV, V45, P1; Nasir M, 2011, ENERG POLICY, V39, P1857, DOI 10.1016/j.enpol.2011.01.025; Cole MA, 2004, ECOL ECON, V48, P71, DOI 10.1016/j.ecolecon.2003.09.007; Richmond AK, 2006, ECOL ECON, V56, P176, DOI 10.1016/j.ecolecon.2005.01.011; Wang SS, 2011, ENERG POLICY, V39, P4870, DOI 10.1016/j.enpol.2011.06.032; Apergis N, 2009, ENERG POLICY, V37, P3282, DOI 10.1016/j.enpol.2009.03.048; AUTY R, 1985, RESOUR POLICY, V11, P275, DOI 10.1016/0301-4207(85)90045-5; Esmaeili A, 2009, ENERG POLICY, V37, P371, DOI 10.1016/j.enpol.2008.08.022; Tamazian A, 2009, ENERG POLICY, V37, P246, DOI 10.1016/j.enpol.2008.08.025; Jin YC, 2008, IEEE T SYST MAN CY C, V38, P397, DOI 10.1109/TSMCC.2008.919172; Song T, 2008, CHINA ECON REV, V19, P381, DOI 10.1016/j.chieco.2007.10.001; Shahbaz M, 2014, RENEW SUST ENERG REV, V34, P325, DOI 10.1016/j.rser.2014.03.022; Friedl B, 2003, ECOL ECON, V45, P133, DOI 10.1016/S0921-8009(03)00008-9; Niu SW, 2011, ENERG POLICY, V39, P2121, DOI 10.1016/j.enpol.2011.02.003; Miah MD, 2010, ENERG POLICY, V38, P4643, DOI 10.1016/j.enpol.2010.04.022; Aslanidis N, 2009, APPL ECON, V41, P803, DOI 10.1080/00036840601018994; Ren SG, 2014, ENERG POLICY, V69, P624, DOI 10.1016/j.enpol.2014.02.032; Farhani S, 2014, ENERG POLICY, V71, P189, DOI 10.1016/j.enpol.2014.04.030; Alkhathlan K, 2013, ENERG POLICY, V62, P1525, DOI 10.1016/j.enpol.2013.07.068; Schmalensee R, 1998, REV ECON STAT, V80, P15, DOI 10.1162/003465398557294; Chow GC, 2014, PAC ECON REV, V19, P1, DOI 10.1111/1468-0106.12048; Akbostanci E, 2009, ENERG POLICY, V37, P861, DOI 10.1016/j.enpol.2008.09.088; Lindmark M, 2002, ECOL ECON, V42, P333, DOI 10.1016/S0921-8009(02)00108-8; Vennemo H, 2009, RESOUR ENERGY ECON, V31, P139, DOI 10.1016/j.reseneeco.2009.03.003; Azlina AA, 2014, ENERG POLICY, V73, P598, DOI 10.1016/j.enpol.2014.05.046; Dinda S, 2004, ECOL ECON, V49, P431, DOI 10.1016/j.ecolecon.2004.02.011; Roach T, 2013, ENERG POLICY, V59, P931, DOI 10.1016/j.enpol.2013.04.029; Lise W, 2006, ENERG POLICY, V34, P1841, DOI 10.1016/j.enpol.2004.12.021; Bernstein PA, 2006, ENERG ECON, V28, P742, DOI 10.1016/j.eneco.2006.07.003; Jaunky VC, 2011, ENERG POLICY, V39, P1228, DOI 10.1016/j.enpol.2010.11.050; Halkos GE, 2001, ENERG ECON, V23, P191, DOI 10.1016/S0140-9883(00)00063-3; Vladislavleva E, 2013, RENEW ENERG, V50, P236, DOI 10.1016/j.renene.2012.06.036; Kristrom B, 2005, ENERG POLICY, V33, P1223, DOI 10.1016/j.enpol.2003.11.020; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Kohler M, 2013, ENERG POLICY, V63, P1042, DOI 10.1016/j.enpol.2013.09.022; Halicioglu F, 2009, ENERG POLICY, V37, P1156, DOI 10.1016/j.enpol.2008.11.012; Martinez-Zarzoso I, 2004, ECON LETT, V82, P121, DOI 10.1016/j.econlet.2003.07.008; Kotanchek ME, 2010, GEN EVOL COMP SER, P55, DOI 10.1007/978-1-4419-1626-6_4; Lau LS, 2014, ENERG POLICY, V68, P490, DOI 10.1016/j.enpol.2014.01.002; Azomahou T, 2006, J PUBLIC ECON, V90, P1347, DOI 10.1016/j.jpubeco.2005.09.005; Galeotti M, 2006, ECOL ECON, V57, P152, DOI 10.1016/j.ecolecon.2005.03.031; Arouri M, 2014, J ENERGY DEV, V39, P149; Bao Q., 2006, J WORLD EC, V11, P48; Boqiang L., 2009, MANAG WORLD, V4, P27; Chattopadhyay I, 2013, P NATL ACAD SCI USA, V110, P12990, DOI 10.1073/pnas.1214559110; Cho CH, 2014, ENERG SOURCE PART B, V9, P120, DOI 10.1080/15567241003773192; Dijkgraaf E., 2001, NOTE TESTING ENV KUZ; Friedlingstein P, 2014, NAT GEOSCI, V7, P709, DOI [10.1038/ngeo2248, 10.1038/NGEO2248]; GROSSMAN GM, 1993, MEXICO-U.S. FREE TRADE AGREEMENT, P13; Haghnejad A., 2012, J ACAD RES EC, V4, P149; Han C., 2013, J EC DEV, V38, P47; HANNAN EJ, 1979, J ROY STAT SOC B MET, V41, P190; Hill R.J., 2002, AUST ECON PAP, V41, P239, DOI 10.1111/1467-8454.00162; Jayanthakumaran K, 2012, ENERG POLICY, V42, P450, DOI 10.1016/j.enpol.2011.12.010; Juanwei L., 2011, CHINA POPUL RESOUR E, V21, P132; Koza J. R., 1994, GENETIC PROGRAMMING; Koza J.R., 1992, GENETIC PROGRAMMING; Kunnas J., 2007, SCANDINAVIAN EC HIST, V55, P101, DOI 10.1080/03585520701435970; Langdon W. B., 2002, FDN GENETIC PROGRAMM; Lieb C. M., 2003, DISCUSSION PAPER SER, V2003; Lim J., 1997, SEOUL J EC, V10, P273; Meadows D. H., 1972, LIMITS GROWTH; Moomaw W. R., 1997, ENVIRON DEV ECON, V2, P451, DOI DOI 10.1017/S1355770X97000247; Yavuz NC, 2014, ENERG SOURCE PART B, V9, P229, DOI 10.1080/15567249.2011.567222; Yunfeng Y, 2010, ENERG POLICY, V38, P350	74	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0301-4215	1873-6777		ENERG POLICY	Energy Policy	NOV	2015	86						104	117		10.1016/j.enpol.2015.06.031		14	Energy & Fuels; Environmental Sciences; Environmental Studies	Energy & Fuels; Environmental Sciences & Ecology	CV4OJ	WOS:000364246100010		
J	Hosoe, N				Hosoe, Nobuhiro			Nuclear power plant shutdown and alternative power plant installation scenarios - A nine-region spatial equilibrium analysis of the electric power market in Japan	ENERGY POLICY			English	Article						Great East Japan Earthquake; Nuclear power station; Power prices; Interregional transmission		After the Great East Japan Earthquake and the subsequent nuclear accident, nuclear power stations cannot be presumed perfectly safe any longer and can be hardly allowed to restart in Japan. We develop a nine-region spatial equilibrium model for Japan's power market and simulate two-part situations: (a) none of the nuclear power plants can operate any longer and (b) gas turbine combined cycle (GTCC) power plants are installed to cover the lost nuclear capacity. When all the nuclear power plants are shut down, the average power prices would rise by 1,5-3 yen/kWh. By replacing that lost capacity with GTCC power plants, we could compress the average price rise as high as 0.5-1.5 yen/kWh compared with the status quo. Their impact would differ by region on the basis of the share of nuclear power in their plant portfolios. After the nuclear power plant shutdown, regions with abundant nuclear capacity would not be able to afford to sell their power to other regions, which would cause less serious congestion at the inter-regional transmission links. The installation of GTCC power plants would make the plant portfolios more similar among regions and, thus, reduce inter-regional transmission further, which would very rarely cause congestion. (c) 2015 Elsevier Ltd. All rights reserved.	Natl Grad Inst Policy Studies, Minato Ku, Tokyo 1068677, Japan	Hosoe, N (reprint author), Natl Grad Inst Policy Studies, Minato Ku, 7-22-1 Roppongi, Tokyo 1068677, Japan.	nhosoe@grips.ac.jp			JSPS KAKENHI [25590055, 15K13014]; Policy Research Center at GRIPS; TEPCO Memorial Foundation	The author gratefully acknowledges useful comments and suggestions provided by Tomoki Ishikura, members of research workshops at the Economic and Social Research Institute, the Research Institute of Economy, Trade and Industry (RIETI), and the Central Research Institute of Electric Power Industry, and three anonymous referees. This study is conducted as a part of the "Energy and Industrial Structural Change after the Fukushima Nuclear Accident" project undertaken at RIETI. This work is supported by JSPS KAKENHI (Grant nos. 25590055, 15K13014), the Policy Research Center at GRIPS, and TEPCO Memorial Foundation. The usual disclaimer applies.	Agency of Natural Resources and Energy, DENR JUK GAIYOU; Akiyama S., 2011, REV URBAN REGIONAL D, V23, P114; [Anonymous], 2015, NIKKEI          0319; Hosoe N, 2009, ENERG POLICY, V37, P4313, DOI 10.1016/j.enpol.2009.05.045; Deloitte Tohmatsu, 2012, 3 M INT TRANSM LINK; Federation of Electric Power Companies of Japan, 2014, GENSH EN ZUM SHU 201; Hattori T., 2003, ADV WORKSH REG COMP; Kanemoto Y., 2006, SEISAKU HYOKA MIKURO; Nagata Y., 2011, 11022 SERC CENTR RES; National Diet of Japan, 2012, OFF REP FUK NUCL ACC; Takayama T, 1971, SPATIAL TEMPORAL PRI; Tanaka M., 2007, DENRYOKU SHIJO NI OK, P101	12	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0301-4215	1873-6777		ENERG POLICY	Energy Policy	NOV	2015	86						416	432		10.1016/j.enpol.2015.07.021		17	Energy & Fuels; Environmental Sciences; Environmental Studies	Energy & Fuels; Environmental Sciences & Ecology	CV4OJ	WOS:000364246100039		
J	Kamide, N; Kamiya, R; Nakazono, T; Ando, M				Kamide, Naoto; Kamiya, Ryo; Nakazono, Tetsuharu; Ando, Masataka			Reference values for hand grip strength in Japanese community-dwelling elderly: a meta-analysis	Environmental Health and Preventive Medicine			English	Article						Japanese; Elderly; Hand grip strength; Reference values; Meta-analysis	BONE-MINERAL DENSITY; PHYSICAL PERFORMANCE; PEOPLE DETERMINATION; WOMEN; SARCOPENIA; OLDER; FALLS; AGE; DIAGNOSIS; CONSENSUS	Objectives Reference values for hand grip strength in Japanese community-dwelling elderly independent in activities of daily living (ADLs) were calculated by meta-analysis. Methods Papers reporting data on hand grip strength in elderly Japanese adults a parts per thousand yen60 years of age and independent in ADLs were retrieved from electronic databases. Data were extracted from the selected papers and the weighted mean for hand grip strength by sex was calculated by random effect model. The association of hand grip strength with age and body weight was also analyzed using meta-regression analysis. Results Data for 15,784 individuals (5216 men and 10,568 women; mean age 67.0-79.8 years) were extracted from 97 sets of data from 33 papers. The weighted mean for hand grip strength was calculated as 33.11 kg [95 % CI 32.27-33.96] in men and 20.92 kg [95 % CI 20.45-21.39] in women. A significant negative correlation was also seen between hand grip strength and age. Conclusions The mean hand grip strength of elderly people calculated in this study can be used as a reference value for the hand grip strength of Japanese community-dwelling elderly who are independent in ADLs. However, age needs to be considered in reference values for hand grip strength.	[Kamide, Naoto] Kitasato Univ, Sch Allied Hlth Sci, Minami Ku, Sagamihara, Kanagawa 2520373, Japan; [Kamide, Naoto] Kitasato Univ, Grad Sch Med Sci, Sagamihara, Kanagawa 2520373, Japan; [Kamiya, Ryo] Seirei Hamamatsu City Rehabil Hosp, Dept Rehabil, Hamamatsu, Shizuoka 4338511, Japan; [Nakazono, Tetsuharu] Kitasato Univ East Hosp, Dept Rehabil, Sagamihara, Kanagawa 2520328, Japan; [Ando, Masataka] Ushioda Gen Hosp, Dept Rehabil, Yokohama, Kanagawa 2300001, Japan	Kamide, N (reprint author), Kitasato Univ, Sch Allied Hlth Sci, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.	naokami@kitasato-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [25870703]	This study was partially funded by the Ministry of Education, Culture, Sports, Science and Technology (Grant-in-Aid for Young Scientists (B) No. 25870703). The funder had no role in study design, data collection and analysis, or the decision to publish.	Ando M, 2013, SOGO RIHABIRITESHON, V41, P961; Suzuki T, 2008, J BONE MINER RES, V23, P1309, DOI [10.1359/jbmr.080328, 10.1359/JBMR.080328]; Sugiura Y, 2013, ARCH GERONTOL GERIAT, V57, P319, DOI 10.1016/j.archger.2013.06.006; Kanagae M, 2006, TOHOKU J EXP MED, V210, P11, DOI 10.1620/tjem.210.11; Yoshimatsu T, 2013, GERIATR GERONTOL INT, V13, P351, DOI 10.1111/j.1447-0594.2012.00906.x; Sasaki H, 2007, AM J MED, V120, P337, DOI 10.1016/j.amjmed.2006.04.018; Bohannon RW, 2001, PERCEPT MOTOR SKILL, V93, P323, DOI 10.2466/PMS.93.5.323-328; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146; Viechtbauer W, 2010, J STAT SOFTW, V36, P1; Kwon J, 2007, GERONTOLOGY, V53, P322, DOI 10.1159/000103257; Yoshimura N, 2011, J ORTHOP SCI, V16, P768, DOI 10.1007/s00776-011-0160-1; Nakamura K, 2012, NUTRITION, V28, P357, DOI 10.1016/j.nut.2011.05.013; Johan A, 1997, EUR RESPIR J, V10, P2825, DOI 10.1183/09031936.97.10122825; Yoshihara A, 2009, GERONTOLOGY, V55, P387, DOI 10.1159/000222429; Nakamura K, 2006, OSTEOPOROSIS INT, V17, P1202, DOI 10.1007/s00198-006-0132-z; Morita M, 2005, AGING CLIN EXP RES, V17, P211; Kubota H, 2012, ARCH GERONTOL GERIAT, V54, pE68, DOI 10.1016/j.archger.2011.06.027; Akune T, 2014, GERIATR GERONTOL INT, V14, P695, DOI 10.1111/ggi.12155; Tanimoto Y, 2013, GERIATR GERONTOL INT, V13, P958, DOI 10.1111/ggi.12037; Ishizaki T, 2011, J EPIDEMIOL, V21, P176, DOI 10.2188/jea.JE20100138; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Aoyagi Y, 2009, GERONTOLOGY, V55, P523, DOI 10.1159/000236326; Nakagawa K, 2007, J PHYS THER SCI, V19, P235, DOI 10.1589/jpts.19.235; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Kamide N, 2011, GERIATR GERONTOL INT, V11, P445, DOI 10.1111/j.1447-0594.2011.00704.x; Syddall H, 2003, AGE AGEING, V32, P650, DOI 10.1093/ageing/afg111; Suzuki T, 2004, J BONE MINER METAB, V22, P602, DOI 10.1007/s00774-004-0530-2; Aoyagi K, 2001, BMC Geriatr, V1, P3, DOI 10.1186/1471-2318-1-3; Asakawa Y, 2008, J JPN PHYS THERAPY A, V35, P229; Bohannon Richard W, 2007, J Geriatr Phys Ther, V30, P28; Edo A, 2012, JPN J HLTH PROM PHYS, V2, P47; Fujiwara N, 1999, B SOC MED, V17, P29; Goto R, 2012, J AICHI SOC PHYS THE, V24, P60; Gushiken S, 2003, J PHYS MED, V14, P241; Hatta M, 1993, SOUGOU RIHABILITATIO, V21, P489; Hirota C, 2008, JPN J GERIATR, V45, P647; Inagaki A, 2012, JPN J NURS HLTH SCI, V10, P47; Iwase H, 2012, JPN J HLTH PROMOTION, V2, P101; Kamide N, 2012, J CLIN GERONTOL GERI, V3, P122; Kono R, 2009, JPN J GERIATR, V46, P55; Lad Umesh Pralhadrao, 2013, J Clin Diagn Res, V7, P51, DOI 10.7860/JCDR/2012/5026.2668; Michishita R, 2013, JPN J PHYS FIT SPORT, V62, P283; Miyabara Y, 2004, J JPN PHYS THERAPY A, V31, P155; Murata S, 2006, J PHYS THER SCI, V21, P437; Muzembo BA, 2014, ENVIRON HEALTH PREV, V19, P21, DOI 10.1007/s12199-013-0350-x; Nakamura I, 2006, RIGAKURYOHO KAGAKU, V21, P335, DOI 10.1589/rika.21.335; Nakao H, 2006, J PHYS THER SCI, V18, P73, DOI 10.1589/jpts.18.73; Nakazono T, 2014, J PHYS THER SCI, V26, P1729, DOI 10.1589/jpts.26.1729; Okazaki D, 2002, J HIROSHIMA PHYS THE, V11, P20; R Core Team, 2015, R LANG ENV STAT COMP; Tanaka Kiyoji, 1995, Applied Human Science, V14, P65	52	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	NOV	2015	20	6					441	446		10.1007/s12199-015-0485-z		6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CV3GJ	WOS:000364146700006		
J	Anai, A; Ueda, K; Harada, K; Katoh, T; Fukumoto, K; Wei, CN				Anai, Akane; Ueda, Kimiyo; Harada, Koichi; Katoh, Takahiko; Fukumoto, Kumiko; Wei, Chang-Nian			Determinant factors of the difference between self-reported weight and measured weight among Japanese	Environmental Health and Preventive Medicine			English	Article						Obesity; Self-reported weight (SR-weight); Measured weight (M-weight); Self-reported height (SR-height); Measured height (M-height)	BODY-MASS INDEX; HEIGHT; HEALTH; COHORT; MORTALITY; VALIDITY; POPULATION; OBESITY; RISK; RELIABILITY	Objectives To assess the difference between self-reported and measured weight values in Japanese men and women and to determine the underlying determinants of the differences between self-reported and measured values. Methods The data were collected from 363 general Japanese individuals aged 16-88 years living in Kumamoto prefecture. Participants completed a self-administered questionnaire designed for this study with self-reported weight and height values. Measured weight and height were measured immediately after questionnaire completion. Paired t-tests identified differences between self-reported and measured values by sex. Multiple-stepwise regression analysis examined the independent variables' effects on the differences between self-reported and measured weights. Results Significant differences were found between self-reported and measured values for both sexes (p < 0.001). There was a significant negative relationship between the difference in an individual's self-reported and measured weight in each sex, with higher measured weight individuals more likely to underestimate their weight. Multiple-stepwise regression analysis models explained 12.1 % (p < 0.01), 11.3 % (p < 0.01), and 5.6 % (p < 0.01) of the variance in all participants, men, and women, respectively. Significant effects were found for age, weight measurement frequency, and measured weight in total participants, weight measurement frequency, and measured weight for men, and age for women. Conclusions In this study, the mean absolute value of the weight and height variances proved the unreliability of self-reported weight and height values. This study's findings suggest self-reported weight inaccuracy especially for obese populations. This should be adjusted when using it in epidemiological studies and healthcare planning.	[Anai, Akane; Katoh, Takahiko; Wei, Chang-Nian] Kumamoto Univ, Dept Publ Hlth, Fac Life Sci, Kumamoto 8608556, Japan; [Ueda, Kimiyo] Kumamoto Univ, Sch Hlth Sci, Dept Community Hlth Nursing, Kumamoto 8608556, Japan; [Harada, Koichi] Kumamoto Hlth Sci Univ, Dept Med Technol, Fac Hlth Sci, Kumamoto, Japan; [Fukumoto, Kumiko] Kyushu Univ Nursing & Social Welf, Tomio, Tamana, Japan	Anai, A (reprint author), Kumamoto Univ, Dept Publ Hlth, Fac Life Sci, 1-1-1 Honjou, Kumamoto 8608556, Japan.	akanan07@gmail.com			Program for Leading Graduate Schools "HIGO'' (Health life science: Interdisciplinary and Glocal Oriented), MEXT, Japan	We would like to thank all participants in this study. We express our sincere appreciation to the staff members of the Department of Preventive and Environmental Medicine and the Department of Public Health, Faculty of Life Sciences, Kumamoto University. This work was supported in part by Program for Leading Graduate Schools "HIGO'' (Health life science: Interdisciplinary and Glocal Oriented), MEXT, Japan.	Takachi R, 2008, AM J EPIDEMIOL, V167, P59, DOI 10.1093/aje/kwm263; Bostrom G, 1997, INT J EPIDEMIOL, V26, P860, DOI 10.1093/ije/26.4.860; Brener ND, 2003, J ADOLESCENT HEALTH, V32, P281, DOI 10.1016/S1054-139X(02)00708-5; Lawlor DA, 2002, AGE AGEING, V31, P169, DOI 10.1093/ageing/31.3.169; Mikolajczyk RT, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-40; Villanueva EV, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-11; Niedhammer I, 2000, INT J OBESITY, V24, P1111, DOI 10.1038/sj.ijo.0801375; BRESLOW L, 1980, PREV MED, V9, P469, DOI 10.1016/0091-7435(80)90042-0; Knai C, 2007, ECON HUM BIOL, V5, P392, DOI 10.1016/j.ehb.2007.08.002; Nawaz H, 2001, AM J PREV MED, V20, P294, DOI 10.1016/S0749-3797(01)00293-8; Kuczmarski MF, 2001, J AM DIET ASSOC, V101, P28, DOI 10.1016/S0002-8223(01)00008-6; Giacchi M, 1998, INT J OBESITY, V22, P673, DOI 10.1038/sj.ijo.0800646; Bolton-Smith C, 2000, J EPIDEMIOL COMMUN H, V54, P143, DOI 10.1136/jech.54.2.143; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Nakamura K, 1999, J BIOSOC SCI, V31, P555, DOI 10.1017/S0021932099005556; KAPLAN GA, 1983, AM J EPIDEMIOL, V117, P292; Kawai M, 2011, BREAST CANCER RES TR, V128, P817, DOI 10.1007/s10549-011-1381-x; Strauss RS, 1999, INT J OBESITY, V23, P904, DOI 10.1038/sj.ijo.0800971; Sasazuki S, 2011, J EPIDEMIOL, V21, P417, DOI 10.2188/jea.JE20100180; Iso H, 2006, CIRCULATION, V113, P195, DOI 10.1161/CIRCULATIONAHA.105.581355; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Belloc N B, 1972, Prev Med, V1, P409, DOI 10.1016/0091-7435(72)90014-X; Belloc N B, 1973, Prev Med, V2, P67, DOI 10.1016/0091-7435(73)90009-1; Dietary Guidelines Advisory Committee, 2000, REP DIET GUID ADV CO; Epstein FH, 1992, OBESITY, P330; Fukao A, 1995, J EPIDEMIOL, V5, P153; Ganong WF, 1987, REV MED PHYSL; Hayashi R, 2005, J EPIDEMIOL, V15, P70, DOI 10.2188/jea.15.70; Jeffery RW, 1996, ADDICT BEHAV, V21, P517; Kenk J, 2009, EUR J EPIDEMIOL, V24, P83; Ministry of Health Labour and Welfare Japan, OV NAT HLTH NUTR SUR; Naganuma T, 2008, AM J EPIDEMIOL, V168, P1425, DOI 10.1093/aje/kwn282; Ohno Y, 2001, J Epidemiol, V11, P144; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125; Serena L, 2009, ANN ACAD MED SINGAP, V38, P66; Tsugane S, 2001, J EPIDEMIOL S6, V11, P24; Tsuji I, 1998, J Epidemiol, V8, P258; Wad K, 2005, INT J OBESITY, V29, P1093; WHO Regional Office for Europe, CHALLENGE OBESITY WH; World Health Organization, 1995, WHO TECH REP SER, V854; World Health Organization, 1997, OB PREV MAN GLOB EP	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	NOV	2015	20	6					447	454		10.1007/s12199-015-0489-8		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CV3GJ	WOS:000364146700007		
J	Ikeda, M; Nakatsuka, H; Watanabe, T; Shimbo, S				Ikeda, Masayuki; Nakatsuka, Haruo; Watanabe, Takao; Shimbo, Shinichiro			Estimation of daily cadmium intake from cadmium in blood or cadmium in urine	Environmental Health and Preventive Medicine			English	Article						Cadmium in blood; Cadmium in urine; Dietary cadmium intake; Estimation; Japan	JAPANESE GENERAL-POPULATION; EXPOSURE; AREAS; WOMEN; RICE; LEAD; FARMERS	Objectives It would be quite convenient if daily dietary cadmium intake (Cd-D) can be estimated either from Cd in blood (Cd-B) or from Cd in urine (Cd-U). The aim of the study was to examine if Cd-D can be estimated from Cd-B or Cd-U. Methods The data available in a previous publication were employed for regression analyses between Cd-D and Cd-B, and between Cd-D and Cd-U. 30 sites in various prefectures throughout Japan were surveyed and 20 adult women/site on average provided food duplicate, peripheral blood, and second morning urine samples. Geometric means were taken as representative values and employed in regression analyses. Results Cd-D, Cd-B, and Cd-U-cr [i.e., Cd-U after correction for creatinine (cr) concentration] distributed in ranges of 12.5-70.5 mu g/day, 0.46-3.98 mu g/l, and 1.16-11.02 mu g/g cr, respectively. A close correlation was observed between Cd-D and Cd-B, and also between Cd-D and Cd-U-cr with r = 0.76 and r = 0.79 (p < 0.001 for both), respectively. Both regression lines passed close to the origins. Application of 1.23 mu g Cd/l blood and 1.26 mu g Cd/g cr in urine (average levels for adult Japanese women) to the regression equations gave 16.5 and 11.5 mu g Cd/day. Conclusions The analyses suggested that it may be possible to estimate Cd-D from Cd-B or Cd-U. Cd-B-based estimation should be more respected. As variations in the estimation parameters and estimated values are inherent to field surveys, care should be taken in the application of the study results. Application on a group basis (and not on an individual basis) should be considered.	[Ikeda, Masayuki] Kyoto Ind Hlth Assoc, Kyoto 6048472, Japan; [Nakatsuka, Haruo] Miyagi Univ, Sch Nursing, Taiwa, Miyagi 9813298, Japan; [Watanabe, Takao] Tohoku Bunkyo Univ, Fac Human Sci, Dept Childhood Educ, Yamagata 9902316, Japan; [Shimbo, Shinichiro] Kyoto Womens Univ, Kyoto 6058501, Japan	Ikeda, M (reprint author), Kyoto Ind Hlth Assoc, Kyoto 6048472, Japan.	m-71-ikeda@nifty.com					Horiguchi H, 2013, ENVIRON INT, V56, P1, DOI 10.1016/j.envint.2013.03.001; Yamagami T, 2008, INT ARCH OCC ENV HEA, V81, P263, DOI 10.1007/s00420-007-0206-z; Ezaki T, 2003, INT ARCH OCC ENV HEA, V76, P186, DOI 10.1007/s00420-002-0389-2; Watanabe T, 1996, SCI TOTAL ENVIRON, V184, P191, DOI 10.1016/0048-9697(96)05100-5; Ikeda M, 2011, INT ARCH OCC ENV HEA, V84, P139, DOI 10.1007/s00420-010-0542-2; Ikeda M, 2000, SCI TOTAL ENVIRON, V249, P373, DOI 10.1016/S0048-9697(99)00527-6; Ikeda M, 2005, INT ARCH OCC ENV HEA, V78, P533, DOI 10.1007/s00420-005-0612-z; Watanabe T, 1996, INT ARCH OCC ENV HEA, V68, P305, DOI 10.1007/BF00409415; ACHESON KJ, 1980, AM J CLIN NUTR, V33, P1147; Ikeda M, 2004, INT ARCH OCC ENV HEA, V77, P227, DOI 10.1007/s00420-003-0499-5; Shimbo S, 2001, SCI TOTAL ENVIRON, V281, P165, DOI 10.1016/S0048-9697(01)00844-0; Ikeda M, 2000, INT ARCH OCC ENV HEA, V73, P15, DOI 10.1007/PL00007933; Esumi & Co, EXC STAT; Food Safety Committee Japan, 2008, DOC SAF DIET CADM IN; Hara Y, 2013, CHRONIC CADMIUM POIS, P42; Ichihara K., 1990, STAT BIOSCIENCE; International Programme on Chemical Safety (IPCS), 1992, ENV HLTH CRIT I34 CA; Internatlional Programme on Chemical Safety (IPCS), 1992, ENV HLTH CRIT 135 CA; National Institute of Health and Nutrition Japan, 2015, NAT HLTH NUTR SURV 2, P68; Saito H., 2013, CHRONIC CADMIUM POIS, P56; WATANABE T, 1985, ENVIRON RES, V37, P33, DOI 10.1016/0013-9351(85)90047-7	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	NOV	2015	20	6					455	459		10.1007/s12199-015-0479-x		5	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CV3GJ	WOS:000364146700008		
J	Ooki, S				Ooki, Syuichi			Birth defects after assisted reproductive technology according to the method of treatment in Japan: nationwide data between 2004 and 2012	Environmental Health and Preventive Medicine			English	Article						Birth defects; In vitro fertilization (IVF); Intracytoplasmic sperm injection (ICSI); Frozen-thawed embryo transfer (FET); Nationwide multi-year data	IN-VITRO FERTILIZATION; CHILDREN BORN; OUTCOME DATA; METAANALYSIS; EMBRYOS; ICSI; RISK; IVF; INCREASE; INFANTS	Objectives The purpose of the present study was to analyze birth defects (congenital anomalies) after assisted reproductive technology (ART) according to the method of treatment, namely in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI) and frozen-thawed embryo transfer (FET). Methods Individual lists of all ART pregnancies resulting in birth defects from birth year 2004 to 2012 presented in the annual reports by the Japan Society of Obstetrics and Gynecology were used as the initial sources of information. Relative risks (RRs) with the corresponding 95 % confidence intervals (CIs) were calculated with IVF as the reference group when calculating RR of ICSI for IVF, and with FET as the reference group when calculating the RR of fresh embryo transfer for FET. Results In total, 2725 stillbirths or live births with birth defects were analyzed. The prevalence of birth defects was slightly yet significantly higher in ICSI compared with IVF throughout the study period (RR = 1.15, 95 % CI 1.02-1.29) and in the 2004-2006 period (RR = 1.26, 95 % CI 1.00-1.58). The prevalence of birth defects was significantly higher for fresh embryo transfer compared with FET in the 2004-2006 period (RR = 1.39, 95 % CI 1.12-1.72). The prevalence of birth defects in multiple births was significantly lower in fresh embryo transfer compared with FET (RR = 0.70, 95 % CI 0.55-0.90, live births of 2007-2012). Conclusions The present descriptive epidemiological study suggests that the impacts of different ART methods on birth defects might differ.	Ishikawa Prefectural Nursing Univ, Dept Hlth Sci, Kahoku, Ishikawa 9291210, Japan	Ooki, S (reprint author), Ishikawa Prefectural Nursing Univ, Dept Hlth Sci, 1-1 Gakuendai, Kahoku, Ishikawa 9291210, Japan.	sooki@ishikawa-nu.ac.jp			JSPS KAKENHI [15H04785]	I would like to thank Toshimi Ooma for assistance with data analysis. This work was supported by JSPS KAKENHI Grant Number 15H04785.	Maheshwari A, 2012, FERTIL STERIL, V98, P368, DOI 10.1016/j.fertnstert.2012.05.019; Wen J, 2012, FERTIL STERIL, V97, P1331, DOI 10.1016/j.fertnstert.2012.02.053; Wennerholm UB, 2009, HUM REPROD, V24, P2158, DOI 10.1093/humrep/dep125; Mayor S, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3191; Kallen B, 2010, BIRTH DEFECTS RES A, V88, P137, DOI 10.1002/bdra.20645; Lie RT, 2005, INT J EPIDEMIOL, V34, P696, DOI 10.1093/ije/dyi363; Rimm AA, 2004, J ASSIST REPROD GEN, V21, P437, DOI 10.1007/s10815-004-8760-8; Hansen M, 2005, HUM REPROD, V20, P328, DOI 10.1093/humrep/deh593; Olson CK, 2005, FERTIL STERIL, V84, P1308, DOI 10.1016/j.fertnstert.2005.03.086; Hansen M, 2013, HUM REPROD UPDATE, V19, P330, DOI 10.1093/humupd/dmt006; Pinborg A, 2012, ACTA OBSTET GYN SCAN, V91, P1245, DOI 10.1111/j.1600-0412.2012.01500.x; Davies MJ, 2012, NEW ENGL J MED, V366, P1803, DOI 10.1056/NEJMoa1008095; Yin L, 2013, BIRTH DEFECTS RES A, V97, P744, DOI 10.1002/bdra.23116; Belva F, 2008, HUM REPROD, V23, P2227, DOI 10.1093/humrep/den254; Ooki S, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/285706	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	NOV	2015	20	6					460	465		10.1007/s12199-015-0486-y		6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CV3GJ	WOS:000364146700009		
J	Furuya, H				Furuya, Hiroyuki			Estimation of reproduction number and probable vector density of the first autochthonous dengue outbreak in Japan in the last 70 years	Environmental Health and Preventive Medicine			English	Article						Dengue; Epidemic curve; Mathematical modeling; Urban; Behavioral and environmental factors	AEDES-ALBOPICTUS; FEVER; TOKYO	Ojectives The first autochthonous case of dengue fever in Japan since 1945 was reported on August 27, 2014. Infection was transmitted by Aedes albopictus mosquitoes in Tokyo's Yoyogi Park. A total of 65 cases with no history of overseas travel and who may have been infected around the park were reported as of September 5, 2014. To quantify infection risk of the local epidemic, the reproduction number and vector density per person at the onset of the epidemic were estimated. Methods The estimated probability distribution and the number of female mosquitoes per person (MPP) were determined from the data of the initial epidemic. Results The estimated distribution R (0i) for the initial epidemic was fitted to a Gamma distribution using location parameter 4.25, scale parameter 0.19, and shape parameter 7.76 with median 7.78 and IQR (7.21-8.40). The MPP was fitted to a normal distribution with mean 5.71 and standard deviation 0.53. Conclusions Both estimated reproduction number and vector density per person at the onset of the epidemic were higher than previously reported values. These results indicate the potential for dengue outbreaks in places with elevated vector density per person, even in dengue non-endemic countries. To investigate the cause of this outbreak, further studies will be needed, including assessments of social, behavioral, and environmental factors that may have contributed to this epidemic by altering host and vector conditions in the park.	Tokai Univ, Sch Med, Basic Clin Sci & Publ Hlth, Isehara, Kanagawa 2591193, Japan	Furuya, H (reprint author), Tokai Univ, Sch Med, Basic Clin Sci & Publ Hlth, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	furuya@is.icc.u-tokai.ac.jp			JSPS KAKENHI [25460631]	The author thanks the organizer and participants of 2014 Infectious Disease Modeling Course for discussions regarding future dengue epidemics in Japan. This work was partially supported by JSPS KAKENHI Grant Number 25460631.	Hsieh YH, 2009, AM J TROP MED HYG, V80, P66; Oki M, 2013, EPIDEMIOL INFECT, V141, P2612, DOI 10.1017/S0950268813000447; Hsieh YH, 2009, TROP MED INT HEALTH, V14, P628, DOI 10.1111/j.1365-3156.2009.02277.x; Tsuda Yoshio, 2012, Medical Entomology and Zoology, V63, P223, DOI 10.7601/mez.63.223; Favier C, 2006, TROP MED INT HEALTH, V11, P332, DOI 10.1111/j.1365-3156.2006.01560.x; Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1; Chowell G, 2007, MATH BIOSCI, V208, P571, DOI 10.1016/j.mbs.2006.11.011; Kutsuna S, 2015, EMERG INFECT DIS, V21, P517, DOI [10.3201/eid2103/141662, 10.3201/eid2103.141662]; Arima Yuzo, 2014, Western Pac Surveill Response J, V5, P27, DOI 10.5365/WPSAR.2014.5.3.007; BURKE DS, 1988, AM J TROP MED HYG, V38, P172; Chastel C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00070; Degallier Nicolas, 2009, Rev Saude Publica, V43, P1, DOI [10.1590/S0034-89102009000100001, 10.1590/s0034-89102009000100001]; Kojima G, 2014, EMERG INFECT DIS, V2015, P21; Oki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048258; Schmidt-Chanasit J, 2014, EURO SURVEILL, V19, P2014; Tsuda Y, 2015, JPN J INFECT DI 0313, DOI [10.7883/yoken.JJID.2014.576, DOI 10.7883/Y0KEN.JJID.2014.576]	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	NOV	2015	20	6					466	471		10.1007/s12199-015-0488-9		6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CV3GJ	WOS:000364146700010		
J	Kato, H; Fujii, S; Takahashi, M; Matsumoto, M; Hirata-Koizumi, M; Ono, A; Hirose, A				Kato, Hina; Fujii, Sakiko; Takahashi, Mika; Matsumoto, Mariko; Hirata-Koizumi, Mutsuko; Ono, Atsushi; Hirose, Akihiko			Repeated Dose and Reproductive/Developmental Toxicity of Perfluorododecanoic Acid in Rats	ENVIRONMENTAL TOXICOLOGY			English	Article						perfluorododecanoic acid; repeated dose toxicity; reproductive toxicity; developmental toxicity; screening test; rat; perfluoroalkyl carboxylic acid	ACTIVATED RECEPTOR-ALPHA; PERFLUORINATED ALKYLATED SUBSTANCES; CARBON-CHAIN LENGTH; AMMONIUM PERFLUOROOCTANOATE; PEROXISOME PROLIFERATORS; PPAR-ALPHA; PERFLUOROALKYL ACIDS; PLACENTAL GROWTH; FATTY-ACIDS; LIVER	Perfluoroalkyl carboxylic acids (PFCAs) are a series of environmental contaminants that have received attention because of their possible adverse effects on wildlife and human health. Although many toxicological studies have been performed on perfluorooctanoic acid with carbon chain length C8, available toxicity data on PFCAs with longer chains are still insufficient to evaluate their hazard. A combined repeated dose and reproductive/developmental toxicity screening study for perfluorododecanoic acid (PFDoA; C12) was conducted in accordance with OECD guideline 422 to fill these toxicity data gaps. PFDoA was administered by gavage to male and female rats at 0.1, 0.5, or 2.5 mg/kg/day. The administration of PFDoA at 0.5 and 2.5 mg/kg/day for 42-47 days mainly affected the liver, in which hypertrophy, necrosis, and inflammatory cholestasis were noted. Body weight gain was markedly inhibited in the 2.5 mg/kg/day group, and a decrease in hematopoiesis in the bone marrow and atrophic changes in the spleen, thymus, and adrenal gland were also observed. Regarding reproductive/developmental toxicity, various histopathological changes, including decreased spermatid and spermatozoa counts, were observed in the male reproductive organs, while continuous diestrous was observed in the females of the 2.5 mg/kg/day group. Seven of twelve females receiving 2.5 mg/kg/day died during late pregnancy while four other females in this group did not deliver live pups. No reproductive or developmental parameters changed at 0.1 or 0.5 mg/kg/day. Based on these results, the NOAELs of PFDoA were concluded to be 0.1 mg/kg/day for repeated dose toxicity and 0.5 mg/kg/day for reproductive/developmental toxicity. (C) 2014 Wiley Periodicals, Inc.	[Kato, Hina; Takahashi, Mika; Matsumoto, Mariko; Hirata-Koizumi, Mutsuko; Ono, Atsushi; Hirose, Akihiko] Natl Inst Hlth Sci, Biol Safety Res Ctr, Div Risk Assessment, Setagaya Ku, Tokyo 1588501, Japan; [Fujii, Sakiko] Safety Res Inst Chem Cpds Co Ltd, Kiyota Ku, Sapporo, Hokkaido 0040839, Japan	Hirose, A (reprint author), Natl Inst Hlth Sci, Biol Safety Res Ctr, Div Risk Assessment, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	hirose@nihs.go.jp			Health and Labour Sciences Research Grant, Ministry of Health, Labour and Welfare, Japan; Ministry of Health, Labour and Welfare, Japan;  [H22-Kenki-Ippan-006];  [H25-Kenki-Ippan-007]	Contract grant sponsor: Health and Labour Sciences Research Grant, Ministry of Health, Labour and Welfare, Japan.; Contract grant numbers: H22-Kenki-Ippan-006, H25-Kenki-Ippan-007; Contract grant sponsor: Ministry of Health, Labour and Welfare, Japan	Li YF, 2011, TOXICOL LETT, V205, P265, DOI 10.1016/j.toxlet.2011.06.015; Shi ZM, 2009, TOXICOL LETT, V188, P192, DOI 10.1016/j.toxlet.2009.04.014; Hoff PT, 2004, ENVIRON HEALTH PERSP, V112, P681, DOI 10.1289/ehp.6479; Harada KH, 2011, ENVIRON INT, V37, P1183, DOI 10.1016/j.envint.2011.04.011; Shi ZM, 2010, TOXICOL LETT, V192, P179, DOI 10.1016/j.toxlet.2009.10.016; HAMID J, 1974, BRIT J EXP PATHOL, V55, P94; Fujii Y, 2012, CHEMOSPHERE, V86, P315, DOI 10.1016/j.chemosphere.2011.10.035; Jensen AA, 2008, INT J ANDROL, V31, P161, DOI 10.1111/j.1365-2605.2008.00870.x; Kudo N, 2002, CHEM-BIOL INTERACT, V139, P301, DOI 10.1016/S0009-2797(02)00006-6; Bartholomeusz RK, 1999, BIOL REPROD, V61, P46, DOI 10.1095/biolreprod61.1.46; Ohmori K, 2003, TOXICOLOGY, V184, P135, DOI 10.1016/S0300-483X(02)00573-5; Inoue Y, 2012, ARCH ENVIRON CON TOX, V62, P672, DOI 10.1007/s00244-011-9730-7; Green S, 1995, MUTAT RES-FUND MOL M, V333, P101, DOI 10.1016/0027-5107(95)00136-0; Hirata-Koizumi M, 2012, J TOXICOL SCI, V37, P63; Ahrens L, 2009, CHEMOSPHERE, V76, P151, DOI 10.1016/j.chemosphere.2009.03.053; Corton JC, 2000, MUTAT RES-FUND MOL M, V448, P139, DOI 10.1016/S0027-5107(99)00232-8; Kunacheva C, 2011, CHEMOSPHERE, V83, P737, DOI 10.1016/j.chemosphere.2011.02.059; OGLE TF, 1990, BIOL REPROD, V43, P276, DOI 10.1095/biolreprod43.2.276; Ding LN, 2009, J PROTEOME RES, V8, P2882, DOI 10.1021/pr9000256; Wang TY, 2012, ENVIRON GEOCHEM HLTH, V34, P301, DOI 10.1007/s10653-011-9422-2; BOOKSTAFF RC, 1990, TOXICOL APPL PHARM, V104, P322, DOI 10.1016/0041-008X(90)90306-F; Clara M, 2008, WATER SCI TECHNOL, V58, P59, DOI 10.2166/wst.2008.641; Tao L, 2006, ENVIRON SCI TECHNOL, V40, P7642, DOI 10.1021/es061513u; Van de Vijver,KI, 2007, ENVIRON SCI TECHNOL, V41, P315, DOI 10.1021/es060827e; GRIFFITH FD, 1980, AM IND HYG ASSOC J, V41, P576, DOI 10.1080/15298668091425301; Biegel LB, 2001, TOXICOL SCI, V60, P44, DOI 10.1093/toxsci/60.1.44; Feng YX, 2010, REPROD TOXICOL, V30, P429, DOI 10.1016/j.reprotox.2010.05.010; Shi ZM, 2007, TOXICOL SCI, V98, P206, DOI 10.1093/toxsci/kfm070; Perkins RG, 2004, DRUG CHEM TOXICOL, V27, P361, DOI 10.1081/DCT-200039773; Guruge KS, 2005, J ENVIRON MONITOR, V7, P371, DOI 10.1039/b412532k; Haug LS, 2009, ENVIRON SCI TECHNOL, V43, P2131, DOI 10.1021/es802827u; Shi ZM, 2010, TOXICOL SCI, V114, P285, DOI 10.1093/toxsci/kfq014; Haug LS, 2011, ENVIRON SCI TECHNOL, V45, P7991, DOI 10.1021/es103456h; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Murakami M, 2009, CHEMOSPHERE, V74, P487, DOI 10.1016/j.chemosphere.2008.10.018; Thompson J, 2011, MAR POLLUT BULL, V62, P2869, DOI 10.1016/j.marpolbul.2011.09.002; Rosol TJ, 2001, TOXICOL PATHOL, V29, P41, DOI 10.1080/019262301301418847; Kudo N, 2006, BIOL PHARM BULL, V29, P1952, DOI 10.1248/bpb.29.1952; Yang Q, 2002, BIOCHEM PHARMACOL, V63, P1893, DOI 10.1016/S0006-2952(02)00923-1; Prevedouros K, 2006, ENVIRON SCI TECHNOL, V40, P32, DOI 10.1021/es0512475; O'Connor JC, 2002, TOXICOL SCI, V69, P79, DOI 10.1093/toxsci/69.1.79; PERMADI H, 1993, XENOBIOTICA, V23, P761; Shi ZM, 2009, REPROD TOXICOL, V27, P352, DOI 10.1016/j.reprotox.2009.02.008; Holden PR, 1999, J MOL ENDOCRINOL, V22, P1, DOI 10.1677/jme.0.0220001; BIEGEL LB, 1995, TOXICOL APPL PHARM, V134, P18, DOI 10.1006/taap.1995.1164; Olsen GW, 2012, ENVIRON SCI TECHNOL, V46, P6330, DOI 10.1021/es300604p; Nishikoori H, 2011, CHEMOSPHERE, V84, P1125, DOI 10.1016/j.chemosphere.2011.04.036; Falandysz J, 2006, ENVIRON SCI TECHNOL, V40, P748, DOI 10.1021/es051799n; Chang SC, 2008, TOXICOL SCI, V104, P40, DOI 10.1093/toxsci/kfn057; Feng YX, 2009, TOXICOL LETT, V190, P224, DOI 10.1016/j.toxlet.2009.07.020; Zhang H, 2008, TOXICOL APPL PHARM, V227, P16, DOI 10.1016/j.taap.2007.09.026; Wolf CJ, 2012, REPROD TOXICOL, V33, P546, DOI 10.1016/j.reprotox.2011.09.009; Moriyama T, 2008, J TOXICOL SCI, V33, P537, DOI 10.2131/jts.33.537; ATSDR (Agency for Toxic Substances and Disease Registry), 2009, TOX PROF PE IN PRESS, P404; Hood RD, 2006, DEV REPROD TOXICOLOG, P425; JALAS, 1987, GUID AN EXP; Kemper RA, 2003, PERFLUOROOCTAN UNPUB, pAR226; Kotsuji F, 1986, Nihon Sanka Fujinka Gakkai Zasshi, V38, P1713; Martin JW, 2003, ENVIRON TOXICOL CHEM, V22, P196; MOE, 2006, STAND REL CAR MAN LA; Narita K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028136; OECD, 2009, GUID DOC HIST EV END, V106; OECD, 1996, ORG EC COOP DEV OECD; Shallie PD, 2012, WEBMED CENTRAL BIOCH, V3; UK COT, 2006, COT STAT TOL RISK DA; US EPA, PERFL AC PFOA FLUOR	66	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1520-4081	1522-7278		ENVIRON TOXICOL	Environ. Toxicol.	NOV	2015	30	11					1244	1263		10.1002/tox.21996		20	Environmental Sciences; Toxicology; Water Resources	Environmental Sciences & Ecology; Toxicology; Water Resources	CW1WH	WOS:000364782100002		
J	Kurai, T; Morey, SR; Wani, SP; Watanabe, T				Kurai, Tomohiro; Morey, Shamitha R.; Wani, Suhas P.; Watanabe, Takeshi			Efficient rates of nitrogenous fertiliser for irrigated sweet sorghum cultivation during the post-rainy season in the semi-arid tropics	EUROPEAN JOURNAL OF AGRONOMY			English	Article						Sorghum bicolor (L.) Moench; Nitrogen use efficiency; Plant growth analysis; Economically optimum nitrogen rate	RELATIVE GROWTH-RATE; GRAIN-SORGHUM; SEEDLING VIGOR; YIELD; INDIA; ASSIMILATION; BIOMASS; PLANTS; ZONE; SOIL	Sorghum (Sorghum bicolor (L.) Moench) is a multipurpose crop with high tolerance to environmental stresses. To meet the increased demand for food and biofuel, current agricultural practices rely on the excessive use of inorganic nitrogen (N) fertiliser. However, excessive N fertiliser has resulted in negative environmental effects. In view of the varied N use efficiency (NUE) of plants under different environmental conditions, the aim of this study was to evaluate the efficient rates of N fertiliser in semi-arid tropics for sweet sorghum cultivation during post-rainy season by maximising NUE without compromising yield. Field experiments were conducted on two sweet sorghum cultivars with four different N fertilisation rates (0, 63,90 and 150 kg N ha(-1)) during the post-rainy season in India. Grain and stalk yields increased with N fertiliser, but significantly only up to 90 kg N ha(-1). The observed increases in grain yield were attributed by increases in kernel numbers. Corresponding with the differences in biomass, both relative growth rate (RGR) and crop growth rate (CGR) increased with N fertilisation rate up to 90 kg N ha(-1). Component analyses of RGR and CGR revealed that both net assimilation rate (NAR) and leaf area index (LAI) significantly contributed with increasing rates of N fertiliser applications. Furthermore, studies of NUE indices showed that agronomic N use efficiency (ANUE, indicating yield production per unit of fertiliser N) responded comparably up to 90 kg N ha(-1), and decreased significantly thereafter. Analysis of ANUE components showed that the decline in ANUE at 150 kg N ha(-1) was due to a decrease in physiological N use efficiency (PNUE), indicating that the absorbed N was not utilised efficiently for biomass and yield production, but merely accumulated. These results together suggest that 90 kg N ha(-1) is an efficient N fertilisation rate suggested among the tested treatments for sustainable sweet sorghum cultivation during the post-rainy season in the semi-arid tropics. (C) 2015 Elsevier B.V. All rights reserved.	[Kurai, Tomohiro; Morey, Shamitha R.; Wani, Suhas P.; Watanabe, Takeshi] Int Crops Res Inst Semi Arid Trop, Patancheru 502324, Telangana, India; [Watanabe, Takeshi] Japan Int Res Ctr Agr Sci, Tsukuba, Ibaraki 3058666, Japan	Kurai, T (reprint author), Int Crops Res Inst Semi Arid Trop, Patancheru 502324, Telangana, India.	t.kurai@cgiar.org			Ministry of Agriculture, Forestry and Fisheries, Japan	This work was part of the research project 'Development of sustainable soil fertility management for sorghum and sweet sorghum through effective use of biological nitrification inhibition (BNI)' funded by grants from the Ministry of Agriculture, Forestry and Fisheries, Japan.	Aerts R, 2000, ADV ECOL RES, V30, P1; Muchow RC, 1998, FIELD CROP RES, V56, P209, DOI 10.1016/S0378-4290(97)00132-9; Useche A, 2010, ANN BOT-LONDON, V105, P333, DOI 10.1093/aob/mcp284; Cassman KG, 1996, FIELD CROP RES, V47, P1, DOI 10.1016/0378-4290(95)00101-8; Sheriff G, 2005, REV AGR ECON, V27, P542, DOI 10.1111/j.1467-9353.2005.00263.x; Cisse N, 2003, CROP SCI, V43, P824; HONS FM, 1986, AGRON J, V78, P1069; Kurai T, 2011, PLANT BIOTECHNOL J, V9, P826, DOI 10.1111/j.1467-7652.2011.00592.x; Hunt R, 2002, ANN BOT-LONDON, V90, P485, DOI 10.1093/aob/mcf214; MOLL RH, 1982, AGRON J, V74, P562; Vanlauwe B, 2011, PLANT SOIL, V339, P35, DOI 10.1007/s11104-010-0462-7; Sahrawat KL, 2013, COMMUN SOIL SCI PLAN, V44, P1011, DOI 10.1080/00103624.2012.750339; Shipley B, 2006, FUNCT ECOL, V20, P565, DOI 10.1111/j.1365-2435.2006.01135.x; Vinutha KS, 2014, SUGAR TECH, V16, P133, DOI 10.1007/s12355-014-0302-9; Slewinski TL, 2012, J EXP BOT, V63, P4647, DOI 10.1093/jxb/ers124; ELLIS RH, 1992, PLANT GROWTH REGUL, V11, P249, DOI 10.1007/BF00024563; Uchino H, 2013, JARQ-JPN AGR RES Q, V47, P65; Wadas W, 2009, PLANT SOIL ENVIRON, V55, P33; Almodares A, 2009, AFR J AGR RES, V4, P772; Bachmaier M., 2012, Agricultural Sciences, V3, P331, DOI 10.4236/as.2012.33037; Dalvi U.S., 2013, J ACAD IND RES, V1, P431; El-Swaify S.A., 1985, ADV SOIL SCI, V1, P1, DOI DOI 10.1007/978-1-4612-5046-3_; Filho J.E.A., 1977, S ASIA; Gerik TJ, 2004, AGRON J, V96, P1222; Hirel B, 2007, J EXP BOT, V58, P2369, DOI 10.1093/jxb/erm097; Mace ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3320; LOCKE MA, 1988, SOIL TILL RES, V12, P223, DOI 10.1016/0167-1987(88)90013-X; Mahama GY, 2014, AGRON J, V106, P1623, DOI 10.2134/agronj14.0092; Miller AJ, 2004, PLANT SOIL, V274, P1, DOI DOI 10.1007/S11104-004-0965-1; Paterson A.H., 2010, P 19 WORLD C SOIL SC, V2008, P362; Prasad R., 2008, INT J PLANT GENOMICS, P104; Quezada C, 2013, CIENC INVESTIG AGRAR, V40, P375, DOI 10.4067/S0718-16202013000200012; Ramu K, 2012, SCI TOTAL ENVIRON, V438, P9, DOI 10.1016/j.scitotenv.2012.08.005; Reddy B.V.S., 2012, SAT EJOURNAL, V10, P1, DOI DOI 10.1016/J.BIOMBIOE.2014.03.052; Rego TJ, 1998, J AGR SCI, V131, P417, DOI 10.1017/S0021859698006005; SAEED M, 1986, CROP SCI, V26, P346; Sahrawat KL, 2002, COMMUN SOIL SCI PLAN, V33, P3757, DOI 10.1081/CSS-120015920; Teetor VH, 2011, IND CROP PROD, V34, P1293, DOI 10.1016/j.indcrop.2010.09.010	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1161-0301	1873-7331		EUR J AGRON	Eur. J. Agron.	NOV	2015	71						63	72		10.1016/j.eja.2015.07.010		10	Agronomy	Agriculture	CV9KL	WOS:000364606000007		
J	Kitamura, T; Torii, S; Oka, N; Horai, T; Itatani, K; Yoshii, T; Nakamura, Y; Shibata, M; Tamura, T; Araki, H; Matsunaga, Y; Sato, H; Miyaji, K				Kitamura, Tadashi; Torii, Shinzo; Oka, Norihiko; Horai, Tetsuya; Itatani, Keiichi; Yoshii, Takeshi; Nakamura, Yuki; Shibata, Miyuki; Tamura, Tomoki; Araki, Haruna; Matsunaga, Yoshikiyo; Sato, Hajime; Miyaji, Kagami			Impact of the entry site on late outcome in acute Stanford type B aortic dissection	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article						Acute type B aortic dissection; Aortic event; Aortic intervention; Entry; Outcome	INTERNATIONAL REGISTRY; ENDOVASCULAR REPAIR; STENT GRAFTS; TRIAL; IRAD; PREDICTORS; EFFICACY; SOCIETY; ADSORB	OBJECTIVES: This study aimed to investigate whether the entry site of acute type B aortic dissection affects late outcomes. METHODS: Inpatient and outpatient records were retrospectively reviewed. RESULTS: We identified 224 cases of acute type B aortic dissection between 1998 and 2013. Of these 224 patients, 168 were men and the age was 64.2 +/- 12.6 (range 23-94) years, from which 130 presented with the entry at a location downstream of the distal aortic arch, 67 with the entry at the outer curvature of the distal aortic arch and 27 with the entry at the inner curvature. At the initial presentation, 127 patients had descending false lumen thrombosis. The 30-day mortality rate was 2%, and 8% of patients had malperfusion. The entry at the outer curvature was associated with a higher risk of 30-day mortality. Patients with the entry at a location downstream were significantly older, and had a higher chance for primarily thrombosed descending false lumen and a lower risk of malperfusion. At follow-up (6.0 +/- 4.1 years), the actuarial survival rates were 97, 83 and 60%, freedoms from open aortic surgery were 96, 91 and 86%, aortic intervention were 73, 66 and 63% and aortic events were 71, 60 and 52% at 1, 5 and 10 years, respectively. Multivariate logistic regression analysis revealed that the outer curvature entry and maximum aortic diameter were correlated with open aortic surgery, aortic intervention and aortic events. Of the 127 patients with primarily thrombosed false lumen, the outer curvature entry was significantly correlated with aortic events. CONCLUSIONS: The primary entry at the outer curvature of the distal aortic arch, as well as the large aortic diameter, is associated with a higher risk of late open aortic surgery, aortic intervention and aortic events in acute type B aortic dissection. Thus, the entry site should be taken into consideration in the establishment of an appropriate treatment indication of type B aortic dissection.	[Kitamura, Tadashi; Torii, Shinzo; Oka, Norihiko; Horai, Tetsuya; Itatani, Keiichi; Yoshii, Takeshi; Nakamura, Yuki; Shibata, Miyuki; Tamura, Tomoki; Araki, Haruna; Matsunaga, Yoshikiyo; Miyaji, Kagami] Kitasato Univ, Sch Med, Dept Cardiovasc Surg, Sagamihara, Kanagawa 2520374, Japan; [Sato, Hajime] Natl Inst Publ Hlth, Dept Hlth Policy & Technol Assessment, Wako, Saitama 3510197, Japan	Kitamura, T (reprint author), Kitasato Univ, Sch Med, Dept Cardiovasc Surg, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	funcorogash@hotmail.com					Amano Jun, 2013, Gen Thorac Cardiovasc Surg, V61, P578, DOI 10.1007/s11748-013-0289-2; White RA, 2011, J VASC SURG, V53, P1082, DOI 10.1016/j.jvs.2010.11.124; Tolenaar JL, 2013, J VASC SURG, V58, P1220, DOI 10.1016/j.jvs.2013.05.031; Pearce BJ, 2008, ANN VASC SURG, V22, P742, DOI 10.1016/j.avsg.2008.08.035; Trimarchi S, 2010, CIRCULATION, V122, P1283, DOI 10.1161/CIRCULATIONAHA.109.929422; Lombardi JV, 2012, J VASC SURG, V55, P629, DOI 10.1016/j.jvs.2011.10.022; Suzuki T, 2003, CIRCULATION, V108, P312, DOI 10.1161/01.cir.0000087386.07204.09; Clough RE, 2012, J VASC SURG, V55, P914, DOI 10.1016/j.jvs.2011.11.005; Nienaber CA, 2009, CIRCULATION, V120, P2519, DOI 10.1161/CIRCULATIONAHA.109.886408; Brunkwall J, 2012, EUR J VASC ENDOVASC, V44, P31, DOI 10.1016/j.ejvs.2012.03.023; Nozdrzykowski M, 2013, EUR J CARDIO-THORAC, V44, pE165, DOI 10.1093/ejcts/ezt291; Fattori R, 2013, JACC-CARDIOVASC INTE, V6, P876, DOI 10.1016/j.jcin.2013.05.003; Brunkwall J, 2014, EUR J VASC ENDOVASC, V48, P285, DOI 10.1016/j.ejvs.2014.05.012; Kirkwood ML, 2010, VASC ENDOVASC SURG, V44, P440, DOI 10.1177/1538574410371525; Loewe C, 2012, ANN THORAC SURG, V93, P1215, DOI 10.1016/j.athoracsur.2011.12.020; Nienaber CA, 2013, CIRC-CARDIOVASC INTE, V6, P407, DOI 10.1161/CIRCINTERVENTIONS.113.000463; Jonker FHW, 2012, ANN THORAC SURG, V94, P1223, DOI 10.1016/j.athoracsur.2012.05.040; Scali ST, 2013, J VASC SURG, V58, P10, DOI 10.1016/j.jvs.2012.12.071; Feng JX, 2013, J VASC SURG, V57, p44S, DOI 10.1016/j.jvs.2012.06.117; Grabenwoger M, 2012, EUR J CARDIO-THORAC, V42, P17, DOI 10.1093/ejcts/ezs107; Kitamura T, 2014, EUR J CARDIO-THORAC, V46, P432, DOI 10.1093/ejcts/ezu012; Kuwano Hiroyuki, 2012, Gen Thorac Cardiovasc Surg, V60, P680, DOI 10.1007/s11748-012-0119-y; Nienaber CA, 2010, J THORAC CARDIOV SUR, V140, pS101, DOI 10.1016/j.jtcvs.2010.07.026; Sueyoshi E, 2004, CIRCULATION S2, V110, pII256, DOI 10.1161/01.CIR.0000138386.48852.b6; van Bogerijen GHW, 2014, J VASC SURG, V59, P1134, DOI 10.1016/j.jvs.2014.01.042	25	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	NOV	2015	48	5					655	662		10.1093/ejcts/ezu531		9	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CW1PG	WOS:000364762900006		
J	Nagamine, H; Miyazaki, M; Wakabayashi, N; Sugita, H; Hara, H; Kawase, Y				Nagamine, Hiroshi; Miyazaki, Manami; Wakabayashi, Naohiro; Sugita, Hiroaki; Hara, Hiroiku; Kawase, Yushi			Clinical significance of a false lumen pathway through the arch in acute type A aortic dissection and its influence on cervical branch compromise	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article						Acute type A aortic dissection; False lumen pathways through the aortic arch; Cervical branch compromise	PRIMARY ENTRY TEAR; CEREBRAL MALPERFUSION; INTRAMURAL HEMATOMA; REPAIR; REPLACEMENT; LOCATION; PATTERNS; STROKE	OBJECTIVES: Upon onset of acute type A aortic dissection, the aortic true lumen generally becomes fixed around the supra-aortic branches in the greater curvature and Botallo's ligament in the lesser curvature of the aortic arch. Therefore, the pathways of the false lumen through the arch can be categorized as anterior, bilateral and posterior. We investigated the relationship between a false lumen pathway through the arch and cervical branch compromise, stratified by primary tear location. METHODS: Sixty-four consecutive patients with acute type A aortic dissection underwent emergency surgery at our institution between March 2005 and October 2013. Of these, 40 cases (63%) were DeBakey type I, 15 cases (23%) were type II and 9 cases (14%) were type III-D (retrograde type A). We conducted a retrospective review of preoperative computed tomographic angiography using three-dimensional image post-processing tools for 43 cases, excluding 15 cases with type II and 6 cases with type I for which preoperative digital image data were not available. RESULTS:Of the 43 cases, 14, 18 and 11 revealed anterior, bilateral and posterior pathways, respectively. Twenty-one cases (49%) showed a primary intimal tear in the ascending aorta (8 anterior, 12 bilateral and 1 posterior), 12 cases (28%) showed a primary intimal tear in the aortic arch (5 anterior, 3 bilateral and 4 posterior) and 10 cases (23%) showed a primary intimal tear in the descending aorta (1 anterior, 3 bilateral and 6 posterior). Twelve of the 14 anterior pathway cases (86%) had a total of 26 supra-aortic branch compromises, 13 of the 18 bilateral pathway cases (72%) had a total of 20 supra-aortic branch compromises, while only 4 of the 11 posterior pathway cases (36%) had a total of four supra-aortic branch compromises. None of the 11 posterior pathway cases had a dissection extending into all 3 supra-aortic branches. CONCLUSIONS:Posterior pathway cases generally showed primary tear locations in the arch or descending aorta, and cervical branch compromise was rare. Aortic dissections tended to extend into the cervical branches through the anterior side of the aortic arch. A false lumen pathway through the arch was strongly associated with cervical branch compromise in acute type A aortic dissections.	[Nagamine, Hiroshi; Miyazaki, Manami; Wakabayashi, Naohiro; Sugita, Hiroaki; Hara, Hiroiku; Kawase, Yushi] Yokohama Sakae Kyosai Hosp, Dept Thorac & Cardiovasc Surg, Yokohama, Kanagawa 2478581, Japan	Nagamine, H (reprint author), Yokohama Sakae Kyosai Hosp, Dept Thorac & Cardiovasc Surg, 132 Katsura Cho, Yokohama, Kanagawa 2478581, Japan.	hiroshi-nagamine@arion.ocn.ne.jp					Grimm M, 2008, ANN THORAC SURG, V86, P453, DOI 10.1016/j.athoracsur.2008.03.078; Weiss G, 2012, EUR J CARDIO-THORAC, V42, P571, DOI 10.1093/ejcts/ezs056; Westaby S, 2002, ANN THORAC SURG, V73, P707, DOI 10.1016/S0003-4975(01)03449-X; O'Neill S, 2006, J VASC SURG, V43, P1103, DOI 10.1016/j.jvs.2006.02.015; Nakamura Y, 2011, ANN THORAC SURG, V92, P336, DOI 10.1016/j.athoracsur.2010.12.065; Nagamine H, 2013, EUR J CARDIO-THORAC, V44, P146, DOI 10.1093/ejcts/ezs631; Takami Y, 2012, CLIN CARDIOL, V35, P500, DOI 10.1002/clc.21991; KILNER PJ, 1993, CIRCULATION, V88, P2235; Uchida N, 2011, EUR J CARDIO-THORAC, V40, P1066, DOI 10.1016/j.ejcts.2011.02.074; Estrera AL, 2006, J THORAC CARDIOV SUR, V132, P1404, DOI 10.1016/j.jtcvs.2006.07.026; Dziodzio T, 2011, ANN THORAC SURG, V91, P724, DOI 10.1016/j.athoracsur.2010.11.056; Subramanian S, 2012, ANN THORAC SURG, V94, P1230, DOI 10.1016/j.athoracsur.2012.04.094; Rajagopal K, 2007, BIOMECH MODEL MECHAN, V6, P345, DOI 10.1007/s10237-006-0069-3; Kazui T, 1996, J THORAC CARDIOV SUR, V112, P973, DOI 10.1016/S0022-5223(96)70097-1; Shiono M, 2006, ANN THORAC SURG, V82, P1665, DOI 10.1016/j.athoracsur.2006.05.112; Loewe C, 2012, ANN THORAC SURG, V93, P1215, DOI 10.1016/j.athoracsur.2011.12.020; Inoue Y, 2011, J THORAC CARDIOV SUR, V141, P354, DOI 10.1016/j.jtcvs.2010.11.010; Hiratzka LF, 2010, CIRCULATION, V121, pE266, DOI 10.1161/CIR.0b013e3181d4739e; Uchida K, 2013, EUR J CARDIO-THORAC, V44, P366, DOI 10.1093/ejcts/ezt040; Tanaka H, 2005, ANN THORAC SURG, V80, P72, DOI 10.1016/j.athersacsur.2004.12.049; Schachner T, 2012, EUR J CARDIO-THORAC, V42, P577, DOI 10.1093/ejcts/ezs021; Hanafusa Y, 2002, ANN THORAC SURG, V74, pS1836, DOI 10.1016/S0003-4975(02)04141-3; Ergin MA, 1996, GLENNS THORACIC CARD, V1, P2273; Komiya Tatsuhiko, 2009, Interact Cardiovasc Thorac Surg, V8, P306, DOI 10.1510/icvts.2008.190223; Wan Ab Naim WN, 2014, SCI WORLD J, V2014	25	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	NOV	2015	48	5					671	678		10.1093/ejcts/ezu474		8	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CW1PG	WOS:000364762900009		
J	Adachi, H; Tsuboi, M; Nishii, T; Yamamoto, T; Nagashima, T; Ando, K; Ishikawa, Y; Woo, T; Watanabe, K; Kumakiri, Y; Maehara, T; Morohoshi, T; Nakayama, H; Masuda, M				Adachi, Hiroyuki; Tsuboi, Masahiro; Nishii, Teppei; Yamamoto, Taketsugu; Nagashima, Takuya; Ando, Kohei; Ishikawa, Yoshihiro; Woo, Tekkan; Watanabe, Katsuya; Kumakiri, Yutaka; Maehara, Takamitsu; Morohoshi, Takao; Nakayama, Haruhiko; Masuda, Munetaka			Influence of visceral pleural invasion on survival in completely resected non-small-cell lung cancer	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article						Non-small-cell lung cancer; Postoperative; Visceral pleura; Visceral pleural invasion	CLASSIFICATION; IMPACT; PROPOSAL; STAGE	OBJECTIVES: Although the prognostic implications of visceral pleural invasion (VPI) are well established, it remains controversial whether the extent of VPI affects survival in patients with completely resected non-small-cell lung cancer (NSCLC). In addition, the impact of VPI according to nodal status is unclear. We evaluated the influence of the extent of pleural invasion on survival by analysing a multicentre retrospective database of patients who had undergone surgery for NSCLC. METHODS: We retrospectively reviewed the clinicopathological characteristics and outcomes of 639 patients with NSCLC who underwent anatomic complete resection from 2005 to 2007 at nine hospitals affiliated with the Yokohama Consortium of Thoracic Surgeons. RESULTS: The median follow-up was 65.0 months. The extent of pleural invasion was PL0 in 462 patients, PL1 in 135 and PL2 in 42. The 5-year overall survival rate was significantly higher in patients with PL0 tumours (75.9%) than in those with PL1 (63.6%) or PL2 tumours (54.1%). On subgroup analysis according to nodal status, PL0 was associated with a higher survival rate than that of PL1 or PL2 tumours in patients with N0 or N1 metastasis, but not in those with N2 metastasis. There was no difference between PL1 and PL2 in any subgroup. CONCLUSIONS: Our results suggest that the presence of VPI, rather than the extent, has an impact on postoperative survival in patients with NSCLC who have N0 or N1 metastasis. Because very few previous studies have addressed the effects of VPI in patients with N1 disease, further re-evaluation of the prognostic impact of VPI is necessary in this subgroup of patients.	[Adachi, Hiroyuki; Tsuboi, Masahiro; Nishii, Teppei; Yamamoto, Taketsugu; Nagashima, Takuya; Ando, Kohei; Ishikawa, Yoshihiro; Woo, Tekkan; Watanabe, Katsuya; Kumakiri, Yutaka; Maehara, Takamitsu; Morohoshi, Takao; Nakayama, Haruhiko; Masuda, Munetaka] Yokohama City Univ, Dept Surg, Yokohama, Kanagawa 232, Japan	Adachi, H (reprint author), Yokosuka Kyosai Hosp, Dept Gen Thorac Surg, 1-16 Yonegahama Dori, Yokosuka, Kanagawa 2388558, Japan.	adachi-fam@m2.gyao.ne.jp					Fujimoto T, 2006, J THORAC CARDIOV SUR, V132, P499, DOI 10.1016/j.jtcvs.2006.04.019; Kawase A, 2013, J THORAC ONCOL, V8, P606, DOI 10.1097/JTO.0b013e31828632b8; [Anonymous], 2013, ANN ONCOL, DOI [DOI 10.1093/ANNONC/MDS274, 10.1093/annonc/mds274]; Osaki T, 2004, ANN THORAC SURG, V77, P1769, DOI 10.1016/j.athoracsur.2003.10.058; Manac'h D, 2001, ANN THORAC SURG, V71, P1088, DOI 10.1016/S0003-4975(00)02649-7; Neri S, 2014, ANN SURG, V260, P383, DOI 10.1097/SLA.0000000000000617; Gorai A, 2015, EUR J CARDIO-THORAC, V47, P653, DOI 10.1093/ejcts/ezu244; Kudo Y, 2012, LUNG CANCER, V78, P153, DOI 10.1016/j.lungcan.2012.08.004; Travis WD, 2008, J THORAC ONCOL, V3, P1384, DOI 10.1097/JTO.0b013e31818e0d9f; Yoshida J, 2009, J THORAC ONCOL, V4, P959, DOI 10.1097/JTO.0b013e3181a85d5e; ICHINOSE Y, 1995, J THORAC CARDIOV SUR, V110, P601, DOI 10.1016/S0022-5223(95)70090-0; Shimizu K, 2004, J THORAC CARDIOV SUR, V127, P1574, DOI 10.1016/j.jtevs.2003.11.017; Kawase A, 2010, J THORAC ONCOL, V5, P1784, DOI 10.1097/JTO.0b013e3181eedd9c; Fan C, 2013, RADIAT ONCOL, V9, P286; Hammar SP, 1994, PULMONARY PATHOLOGY, P1138; Sobin LH, 2002, UICC INT UNION CANC, P97; Sobin LH, 2009, INT UNION CANC TNM C, P136	17	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	NOV	2015	48	5					691	697		10.1093/ejcts/ezu515		7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CW1PG	WOS:000364762900012		
J	Ando, T; Omasa, M; Kondo, T; Yamada, T; Sato, M; Menju, T; Aoyama, A; Sato, T; Chen, F; Sonobe, M; Date, H				Ando, Takeshi; Omasa, Mitsugu; Kondo, Takayuki; Yamada, Tetsu; Sato, Masaaki; Menju, Toshi; Aoyama, Akihiro; Sato, Toshihiko; Chen, Fengshi; Sonobe, Makoto; Date, Hiroshi			Predictive factors of myasthenic crisis after extended thymectomy for patients with myasthenia gravis	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article						Myasthenia gravis; Predictive factor; Anti-acetylcholine receptor antibody; Postoperative myasthenic crisis; Extended thymectomy	TRANSSTERNAL THYMECTOMY; THERAPY; COMPLICATIONS; MORTALITY	OBJECTIVES: Postoperative myasthenic crisis (POMC) is one of the serious complications after extended thymectomy for patients with myasthenia gravis (MG). This study aims to clarify the risk factors of POMC occurrence. METHODS: The clinical data of 55 MG patients (25 male, 30 female; median age, 51 years) who underwent extended thymectomy at Kyoto University from 2000 to 2013 were retrospectively reviewed. Surgical outcomes and pre- and perioperative predictive factors of POMC were analysed. RESULTS: The preoperative Myasthenia Gravis Foundation of America stage was I, II, III and IV in 24, 22, 8 and 1 patients, respectively. Ten patients (18.2%) developed POMC; 6 required prolonged intubation over 24 h and 4 required reventilatory support. All patients were weaned after 5.6 (2-26) days of ventilator support, and were discharged. Univariate analysis revealed a correlation with a high preoperative anti-acetylcholine receptor antibody titre (P = 0.009), history of myasthenic crisis (MC) (P = 0.0004) and unstable MG after preoperative medical therapy (P = 0.003). Multivariate logistic regression analysis showed history of MC (odds ratio, 11.84; 95% confidential interval, 1.05-372; P = 0.045) and unstable MG (odds ratio, 29.45; 95% confidential interval, 2.00-1063; P = 0.013) independently predicted POMC. The surgical response rate was not significantly different between the two groups (66.7% with POMC, 85.4% without POMC; P = 0.334). CONCLUSIONS: POMC occurred more frequently in unstable MG before surgery or in patients with a history of MC. Adequate preoperative medical therapy and perioperative care should be provided to these patients.	[Ando, Takeshi; Omasa, Mitsugu; Yamada, Tetsu; Sato, Masaaki; Menju, Toshi; Aoyama, Akihiro; Sato, Toshihiko; Chen, Fengshi; Sonobe, Makoto; Date, Hiroshi] Kyoto Univ Hosp, Dept Thorac Surg, Kyoto 606, Japan; [Kondo, Takayuki] Kyoto Univ Hosp, Dept Community Network & Collaborat Med, Kyoto 606, Japan	Omasa, M (reprint author), Kyoto Univ, Grad Sch Med, Dept Thorac Surg, Sakyo Ku, 54 Kawara Cho, Kyoto 6068507, Japan.	omasa@kuhp.kyoto-u.ac.jp					Watanabe A, 2004, J THORAC CARDIOV SUR, V127, P868, DOI 10.1016/S0022-5223(03)01517-4; Thomas CE, 1997, NEUROLOGY, V48, P1253; HATTON PD, 1989, ANN THORAC SURG, V47, P838; Bril V, 2012, ANN NY ACAD SCI, V1275, P1, DOI 10.1111/j.1749-6632.2012.06767.x; Zielinski M, 2004, EUR J CARDIO-THORAC, V26, P407, DOI 10.1016/j.ejcts.2004.01.037; Bulkley GB, 1997, ANN SURG, V226, P324, DOI 10.1097/00000658-199709000-00012; Kalita J, 2014, J NEUROL SCI, V342, P127, DOI 10.1016/j.jns.2014.05.002; Nam TS, 2011, J CLIN NEUROSCI, V18, P1185, DOI 10.1016/j.jocn.2011.01.011; Leuzzi G, 2014, EUR J CARDIO-THORAC, V45, pE76, DOI 10.1093/ejcts/ezt641; Gronseth GS, 2000, NEUROLOGY, V55, P7; Kas J, 2001, ANN THORAC SURG, V72, P1691, DOI 10.1016/S0003-4975(01)03080-6; Berrouschot J, 1997, CRIT CARE MED, V25, P1228, DOI 10.1097/00003246-199707000-00027; Masaoka A, 1996, ANN THORAC SURG, V62, P853; Alshekhlee A, 2009, NEUROLOGY, V72, P1548, DOI 10.1212/WNL.0b013e3181a41211; Lacomis D, 2005, NEUROCRIT CARE, V3, P189, DOI 10.1385/Neurocrit.Care2005;03:189-194; Bulkley GB, 1997, ANN SURG, V226, P334; Gajdos P, 2012, COCHRANE DB SYST REV, V12; Jensen Paul, 2008, J Clin Neuromuscul Dis, V9, P352, DOI 10.1097/CND.0b013e3181660807; Yamada Y, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-226	19	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	NOV	2015	48	5					705	709		10.1093/ejcts/ezu530		5	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CW1PG	WOS:000364762900014		
J	Imasaka, K; Yasaka, M; Tayama, E; Tomita, Y				Imasaka, Ken-ichi; Yasaka, Masahiro; Tayama, Eiki; Tomita, Yukihiro			Obstructive carotid and/or intracranial artery disease rarely affects the incidence of haemodynamic ischaemic stroke during cardiac surgery: a study on brain perfusion single-photon emission computed tomography with acetazolamide	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article						Single-photon emission computed tomography; Cardiac surgery; Ischaemic stroke; Carotid occlusive disease; Cerebral haemodynamics	BYPASS-SURGERY; RANDOMIZED-TRIAL; ENDARTERECTOMY; STENOSIS; MORTALITY; OCCLUSION; VOLUME; RISK	OBJECTIVES: Ischaemic stroke is a major complication of cardiac surgery. The optimal strategies for operating on patients with obstructive carotid and/or intracranial artery disease (CIAD) are controversial. We aimed to clarify whether single-photon emission computed tomography (SPECT) with acetazolamide, to quantify the cerebral perfusion reserve, could predict the risk of haemodynamic ischaemic stroke during cardiac surgery. METHODS: The incidence of stroke related to obstructive CIAD and the corresponding autoregulatory reserve were prospectively assessed in 514 consecutive patients who underwent elective cardiac surgery with cardiopulmonary bypass (n = 484) and off-pump coronary artery bypass grafting (n = 30) between 2009 and 2013. Preoperative cerebral blood flow and its reactivity to acetazolamide were quantitatively determined in patients (n = 88) with obstructive CIAD, diagnosed by carotid ultrasonography and/or magnetic resonance angiography. RESULTS: An impaired cerebral perfusion reserve was identified in 1 (1.1%) of the 88 patients. This patient underwent prophylactic superficial temporal artery to middle cerebral artery anastomosis 1 month before coronary artery bypass surgery. Subsequently, the patient underwent conventional coronary artery bypass surgery, without experiencing perioperative stroke. Seven (1.4%) patients died in-hospital mortality and 5 (1.0%) experienced perioperative stroke. However, no patients experienced perioperative haemodynamic ischaemic stroke. CONCLUSIONS: It is unusual for CIAD to affect the incidence of haemodynamic ischaemic stroke during cardiac surgery. Brain perfusion SPECT with acetazolamide is effective for narrowing down patients at high risk of ischaemic stroke during cardiac surgery. Meanwhile, the application of brain perfusion single-photon emission tomography should be confined only to patients with obstructive CIAD because it is an expensive examination tool.	[Imasaka, Ken-ichi; Tayama, Eiki; Tomita, Yukihiro] Natl Hosp Org Kyushu Med Ctr, Dept Cardiovasc Surg, Clin Res Inst, Fukuoka, Japan; [Yasaka, Masahiro] Natl Hosp Org Kyushu Med Ctr, Dept Cerebrovasc Dis, Clin Res Inst, Fukuoka, Japan	Tomita, Y (reprint author), Natl Hosp Org Kyushu Med Ctr, Dept Cardiovasc Surg, Chuo Ku, 1-8-1 Jigyo Hama, Fukuoka, Japan.	ytomita@kyumed.jp					Kuroda S, 2001, STROKE, V32, P2110, DOI 10.1161/hs0901.095692; GERRATY RP, 1993, STROKE, V24, P1115; Menke J, 2009, EUR RADIOL, V19, P2204, DOI 10.1007/s00330-009-1403-9; Inoue T, 2008, ACT NEUR S, V103, P79; Nakamizo A, 2009, AM J NEURORADIOL, V30, P900, DOI 10.3174/ajnr.A1468; MATSUDA H, 1995, EUR J NUCL MED, V22, P633, DOI 10.1007/BF01254564; Fujimoto S, 2004, STROKE, V35, P1852, DOI 10.1161/01.STR.0000133131.93900.ff; Rothwell PM, 2003, STROKE, V34, P514, DOI 10.1161/01.STR.0000054671.71777.C7; Likosky DS, 2003, STROKE, V34, P2830, DOI 10.1161/01.STR.0000098650.12386.B3; Arrowsmith JE, 2000, BRIT J ANAESTH, V84, P378; Farrell B, 1998, LANCET, V351, P1379; Mizumura S, 2004, ANN NUCL MED, V18, P13, DOI 10.1007/BF02985609; COYLE KA, 1995, ANN VASC SURG, V9, P21, DOI 10.1007/BF02015313; Silvestrini M, 2000, JAMA-J AM MED ASSOC, V283, P2122, DOI 10.1001/jama.283.16.2122; Powers WJ, 2011, JAMA-J AM MED ASSOC, V306, P1983, DOI 10.1001/jama.2011.1610; BRENER BJ, 1987, J VASC SURG, V5, P269; Mangla R, 2011, RADIOGRAPHICS, V31, P1201, DOI 10.1148/rg.315105014; Rudolph JL, 2009, ULTRASOUND MED BIOL, V35, P1235, DOI 10.1016/j.ultrasmedbio.2009.04.008; Jinnouchi J, 2006, CEREBROVASC DIS, V22, P177, DOI 10.1159/000093452; ERGIN MA, 1994, J THORAC CARDIOV SUR, V107, P788; Hori Ayuko, 2002, Journal of Medical Investigation, V49, P134; Lovrencic-Huzjan A, 2012, STROKE RES TREAT, V2012; Makhan GM, 2006, STROKE, V37, P562	23	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	NOV	2015	48	5					739	746		10.1093/ejcts/ezu502		8	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CW1PG	WOS:000364762900020		
J	Nishigawa, K; Fukui, T; Tabata, M; Takanashi, S				Nishigawa, Kosaku; Fukui, Toshihiro; Tabata, Minoru; Takanashi, Shuichiro			V-composite grafting using the right internal thoracic artery grafts anastomosed to aorto-coronary bypass grafts	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article						Coronary artery bypass grafting; Right internal thoracic artery; Composite graft	CORONARY-ARTERY; SURVIVAL; REVASCULARIZATION; STENOSIS; VESSELS; PATENCY; FLOW	OBJECTIVES: Composite grafting using the right internal thoracic artery (RITA) is occasionally performed when the in situ RITA does not have sufficient length to reach the target vessel. In this study, we assessed the clinical and angiographic outcomes of coronary artery bypass grafting (CABG) with V-composite grafting (defined as a distance between the proximal anastomosis of the RITA and the ascending aorta of <= 1 cm) using the RITA anastomosed to aortocoronary (A-C) bypass grafts. METHODS: Between September 2004 and December 2012, 177 patients underwent CABG with V-composite grafting using the RITA and the A-C bypass graft [radial artery (RA) or saphenous vein graft (SVG)] at our institution. The mean age was 69.2 +/- 8.5 years and 149 (84.2%) were men. The clinical outcomes and patency rates of distal anastomoses of the composite RITA were retrospectively evaluated. RESULTS: Mean distal anastomoses per patient were 4.6 +/- 1.0, and mean distal anastomoses of the RITA per patient were 1.3 +/- 0.5. Inflow conduit of the RITA was the RA in 16 (9.0%) patients and an SVG in 161 (91.0%) patients. The 30-day mortality rate was 1.1% (2/177). The overall patency rate of distal anastomoses of the composite RITA on early (before discharge) and follow-up (at 1 year) angiography was 97.6 and 93.6%, respectively. The inflow conduit (RA or SVG), stenosis grade of target vessel and sequential grafting did not affect the patency rate of the composite RITA. CONCLUSIONS: V-composite grafting using the RITA and the A-C bypass graft provides excellent clinical outcomes with satisfactory early and 1-year patency rates.	[Nishigawa, Kosaku; Fukui, Toshihiro; Tabata, Minoru; Takanashi, Shuichiro] Sakakibara Heart Inst, Dept Cardiovasc Surg, Tokyo, Japan	Nishigawa, K (reprint author), Sakakibara Heart Inst, Dept Cardiovasc Surg, 3-16-1 Asahi Cho, Fuchu, Tokyo 1830003, Japan.	nippie550102@yahoo.co.jp					Fukui T, 2011, ANN THORAC SURG, V91, P445, DOI 10.1016/j.athoracsur.2010.10.002; Pevni D, 2007, J THORAC CARDIOV SUR, V133, P1220, DOI 10.1016/j.jtcvs.2006.07.060; Fukui T, 2007, ANN THORAC SURG, V83, P115, DOI 10.1016/j.athoracsur.2006.08.009; CALAFIORE AM, 1994, ANN THORAC SURG, V58, P185; Endo M, 2001, CIRCULATION, V104, P2164, DOI 10.1161/hc4301.098283; Sakaguchi G, 2002, ANN THORAC SURG, V74, P493, DOI 10.1016/S0003-4975(02)03729-3; Lytle BW, 1999, J THORAC CARDIOV SUR, V117, P855, DOI 10.1016/S0022-5223(99)70365-X; Pevni D, 2001, EUR J CARDIO-THORAC, V20, P299, DOI 10.1016/S1010-7940(01)00832-6; Fukui T, 2010, J THORAC CARDIOV SUR, V139, P868, DOI 10.1016/j.jtcvs.2009.05.033; Gaudino M, 2004, EUR J CARDIO-THORAC, V25, P424, DOI 10.1016/j.ejcts.2003.11.027; Manabe S, 2010, ANN THORAC SURG, V89, P683, DOI 10.1016/j.athoracsur.2009.11.053; Schmidt SE, 1997, ANN THORAC SURG, V64, P9, DOI 10.1016/S0003-4975(97)00473-6; Buxton BF, 2000, EUR J CARDIO-THORAC, V18, P255, DOI 10.1016/S1010-7940(00)00527-3; Taggart DP, 2001, LANCET, V358, P870, DOI 10.1016/S0140-6736(01)06069-X; Cameron A, 1996, NEW ENGL J MED, V334, P216, DOI 10.1056/NEJM199601253340402; Hillis LD, 2011, CIRCULATION, V124, pE652, DOI 10.1161/CIR.0b013e31823c074e	16	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	NOV	2015	48	5					753	757		10.1093/ejcts/ezu525		5	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CW1PG	WOS:000364762900022		
J	Kainuma, S; Mitsuno, M; Toda, K; Funatsu, T; Nakamura, T; Miyagawa, S; Yoshikawa, Y; Fukushima, S; Yoshioka, D; Saito, T; Nishi, H; Takahashi, T; Sakaki, M; Monta, O; Matsue, H; Masai, T; Sakaguchi, T; Yoshitaka, H; Ueno, T; Kuratani, T; Daimon, T; Taniguchi, K; Miyamoto, Y; Sawa, Y				Kainuma, Satoshi; Mitsuno, Masataka; Toda, Koichi; Funatsu, Toshihiro; Nakamura, Teruya; Miyagawa, Shigeru; Yoshikawa, Yasushi; Fukushima, Satsuki; Yoshioka, Daisuke; Saito, Tetsuya; Nishi, Hiroyuki; Takahashi, Toshiki; Sakaki, Masayuki; Monta, Osamu; Matsue, Hajime; Masai, Takafumi; Sakaguchi, Taichi; Yoshitaka, Hidenori; Ueno, Takayoshi; Kuratani, Toru; Daimon, Takashi; Taniguchi, Kazuhiro; Miyamoto, Yuji; Sawa, Yoshiki		Osaka Cardiovasc Surg Res OSCAR Gr	Dilated left atrium as a predictor of late outcome after pulmonary vein isolation concomitant with aortic valve replacement and/or coronary artery bypass grafting	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article						Paroxysmal atrial fibrillation; Pulmonary vein isolation; Left atrial remodelling; Non-mitral valve disease	SURGICAL ABLATION; FIBRILLATION; SURGERY; STROKE; PROGRESSION; SURVIVAL; REGISTRY; RISK	OBJECTIVES: Left atrial (LA) dimension can predict atrial fibrillation (AF) recurrence after catheter-based or surgical ablation. Pulmonary vein isolation (PVI) may be a surgical option during aortic valve replacement (AVR) and/or coronary artery bypass grafting (CABG), though consensus regarding patient selection and late outcome is lacking. METHODS: We studied 160 patients (mean age 70 +/- 9 years) with paroxysmal AF who underwent radiofrequency-based PVI during AVR and/or CABG, and were followed up postoperatively for at least 6 months. Mean preoperative LA dimension was 44 +/- 7 mm. Serial echocardiography was performed to evaluate left ventricular (LV) and LA dimensions, E/e', estimated systolic pulmonary artery (PA) pressure and degree of valvular regurgitation. Follow-up was completed with a mean duration of 47 +/- 25 months. RESULTS: At the latest follow-up, 133 patients (83%) remained in sinus rhythm. Preoperative LA dimension was independently associated with increased risk of AF recurrence at 6 months after surgery [adjusted odds ratio 1.3 per 1-mm increase in LA dimension, 95% confidence interval (CI) 1.1-1.6, P < 0.001]. Receiver-operating characteristic curve analysis demonstrated an optimal cut-off value for preoperative LA dimension of 45 mm to predict sinus rhythm restoration (98% for < 45 mm vs 55% for >= 45 mm, P < 0.001). Patients with LA dimension >= 45 mm had a significantly lower 5-year survival rate (62 +/- 7 vs 82 +/- 7%, P = 0.025) and freedom from adverse events defined as cerebral infarction/haemorrhage, admission for heart failure, catheter ablation and permanent pacemaker implantation (58 +/- 7 vs 91 +/- 4%, P < 0.001). Multivariate analysis showed that preoperative LA dimension >= 45 mm was independently associated with adverse events (adjusted hazards ratio 2.4, 95% CI 1.2-5.1, P = 0.019). Serial echocardiography demonstrated improvement in LV systolic function irrespective of LA dimension, whereas patients with LA dimension >= 45 mm showed less improvement in LA dimension and systolic PA pressure (interaction effect P < 0.001) and persistent higher E/e' (group effect P < 0.001), along with aggravated tricuspid regurgitation. CONCLUSIONS: In patients with paroxysmal AF related to aortic valve disease and/or coronary artery disease, a dilated left atrium (>= 45 mm) was associated with inferior AF- and event-free survival after PVI, accompanied by persistent abnormalities in cardiac and haemodynamic function. These findings may assist patient selection for PVI during AVR and/or CABG.	[Kainuma, Satoshi; Toda, Koichi; Nakamura, Teruya; Miyagawa, Shigeru; Yoshikawa, Yasushi; Fukushima, Satsuki; Yoshioka, Daisuke; Saito, Tetsuya; Ueno, Takayoshi; Kuratani, Toru; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 5650871, Japan; [Kainuma, Satoshi; Funatsu, Toshihiro; Taniguchi, Kazuhiro] Osaka Rosai Hosp, Japan Labor Hlth & Welf Org, Dept Cardiovasc Surg, Sakai, Osaka, Japan; [Mitsuno, Masataka; Miyamoto, Yuji] Hyogo Coll Med, Dept Cardiovasc Surg, Nishinomiya, Hyogo 6638501, Japan; [Nishi, Hiroyuki; Takahashi, Toshiki] Osaka Police Hosp, Dept Cardiovasc Surg, Osaka, Japan; [Sakaki, Masayuki] Osaka Natl Hosp, Dept Cardiovasc Surg, Osaka, Japan; [Monta, Osamu] Fukui Cardiovasc Ctr, Dept Cardiovasc Surg, Fukui, Japan; [Matsue, Hajime] Rinku Gen Med Ctr, Dept Cardiovasc Surg, Izumisano, Japan; [Masai, Takafumi] Sakurabashi Watanabe Hosp, Dept Cardiovasc Surg, Osaka, Japan; [Sakaguchi, Taichi; Yoshitaka, Hidenori] Sakakibara Heart Inst Okayama, Dept Cardiovasc Surg, Okayama, Japan; [Daimon, Takashi] Hyogo Coll Med, Dept Biostat, Nishinomiya, Hyogo 6638501, Japan	Sawa, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, 2-2-E1 Yamadaoka, Suita, Osaka 5650871, Japan.	yshksw2@gmail.com			Japan Labor Health and Welfare Organization	This research was partially supported by research funds to promote the hospital function of the Japan Labor Health and Welfare Organization.	Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Malaisrie SC, 2012, J HEART VALVE DIS, V21, P350; Ngaage DL, 2007, J THORAC CARDIOV SUR, V133, P182, DOI 10.1016/j.jtcvs.2006.09.021; Quader MA, 2004, ANN THORAC SURG, V77, P1514, DOI 10.1016/j.athoracsur.2003.09.069; Berruezo A, 2007, EUR HEART J, V28, P836, DOI 10.1093/eurheartj/ehm027; Kainuma S, 2011, EUR J CARDIO-THORAC, V40, P61, DOI 10.1016/j.ejcts.2010.11.008; Healey JS, 2005, AM HEART J, V150, P288, DOI 10.1016/j.ahj.2004.09.054; Frustaci A, 1997, CIRCULATION, V96, P1180; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; Schulenberg R, 2010, ANN THORAC SURG, V89, P738, DOI 10.1016/j.athoracsur.2009.12.023; Ngaage DL, 2006, ANN THORAC SURG, V82, P1392, DOI 10.1016/j.athoracsur.2006.04.004; Edgerton JR, 2009, J THORAC CARDIOV SUR, V138, P109, DOI 10.1016/j.jtcvs.2008.09.080; McCarthy PM, 2010, J THORAC CARDIOV SUR, V139, P860, DOI 10.1016/j.jtcvs.2009.12.038; Senoo K, 2014, CIRC J, V78, P1121, DOI 10.1253/circj.CJ-13-1272; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Katz ES, 2000, J AM COLL CARDIOL, V36, P468, DOI 10.1016/S0735-1097(00)00765-8; WOLF PA, 1978, NEUROLOGY, V28, P973; Bagge L, 2009, J THORAC CARDIOV SUR, V137, P1265, DOI 10.1016/j.jtcvs.2008.12.017; Oral H, 2002, CIRCULATION, V105, P1077, DOI 10.1161/hc0902.104712; Kainuma S, 2013, EUR J CARDIO-THORAC, V44, P1013, DOI 10.1093/ejcts/ezt117; Kerr CR, 2005, AM HEART J, V149, P489, DOI 10.1016/j.ahj.2004.09.053; Chugh SS, 2001, J AM COLL CARDIOL, V37, P371, DOI 10.1016/S0735-1097(00)01107-4; Galderisi M, 2013, J AM COLL CARDIOL, V62, P1922; Zaid RR, 2013, EUR HEART J CARDIOVA, V14, P555	24	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	NOV	2015	48	5					765	777		10.1093/ejcts/ezu532		13	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CW1PG	WOS:000364762900024		
J	Fukumoto, Y; Sugimoto, S; Okada, M; Miyoshi, S				Fukumoto, Yuma; Sugimoto, Seiichiro; Okada, Masanori; Miyoshi, Shinichiro			False-positive axillary lymph node on positron emission tomography/computed tomography in a thymoma patient with a tattoo	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Editorial Material						Positron emission tomography; Axillary lymph nodes; Thymoma			[Fukumoto, Yuma; Sugimoto, Seiichiro; Okada, Masanori; Miyoshi, Shinichiro] Okayama Univ Hosp, Dept Gen Thorac Surg, Okayama 7008558, Japan	Sugimoto, S (reprint author), Okayama Univ Hosp, Dept Gen Thorac Surg, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	sugimo-s@cc.okayama-u.ac.jp						0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	NOV	2015	48	5					804	804		10.1093/ejcts/ezv071		1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CW1PG	WOS:000364762900029		
J	Chen, YC; Wang, SY; Chen, QX; Xi, ZL; Wang, CW; Chen, XY; Feng, X; Liang, R; Yang, JJ				Chen, Yichun; Wang, Siyu; Chen, Qixian; Xi, Zhilin; Wang, Chenwan; Chen, Xiyi; Feng, Xin; Liang, Rong; Yang, Jinjun			Modulated crystallization behavior, polymorphic crystalline structure and enzymatic degradation of poly(butylene adipate): Effects of layered metal phosphonate	EUROPEAN POLYMER JOURNAL			English	Article						Poly(butylene adipate); Nucleating agent; Crystallization; Polymorphism; Biodegradation	ZIRCONIUM-PHOSPHATE NANOCOMPOSITES; WALLED CARBON NANOTUBES; NUCLEATING-AGENTS; POLY(TETRAMETHYLENE ADIPATE); POLY(1,4-BUTYLENE ADIPATE); EPITAXIAL CRYSTALLIZATION; SPHERULITE MORPHOLOGY; MELT CRYSTALLIZATION; ALPHA-CYCLODEXTRIN; PHASE-TRANSITION	Layered metal phosphonate, zinc phenylphosphonate (PPZn) was synthesized and used as a model benign nucleating agent for poly(butylene adipate) (PBA) to manipulate the crystallization behavior, polymorphic crystalline structure and biodegradation of PBA. Upon incorporation of PPZn, the crystallization temperature (T-c) and crystallinity of PBA increased. Meanwhile, the crystallization rate and spherulite density of PBA increased in the presence of PPZn, indicating that PPZn has an effective nucleating effect for PBA. PPZn is favorable for the formation of the PBA alpha-modification. 'Furthermore, PPZn would speed up highly the phase transition of PBA from the beta- to alpha-one. PPZn significantly suppressed the biodegradation of PBA. Mechanisms for nucleating, preferential formation of the alpha-modification, accelerated phase transition and decreased degradation rate of PBA in the presence of PPZn have also been proposed. It is considered that layered metal phosphonate material is a new type of benign filler for controlling the polymorphic crystalline structure and biodegradation rate of the polymer, which is expected to further modify the property of the polymer and might widen the applications of biodegradable materials in the environmental and biomedical fields. (C) 2015 Elsevier Ltd. All rights reserved.	[Chen, Yichun; Wang, Siyu; Xi, Zhilin; Wang, Chenwan; Feng, Xin; Liang, Rong; Yang, Jinjun] Tianjin Univ Technol, Sch Environm Sci & Safety Engn, Tianjin 300384, Peoples R China; [Chen, Qixian] Univ Tokyo, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Chen, Xiyi] Dalian Med Univ, Sch Publ Hlth, Dalian 116044, Liaoning Provin, Peoples R China	Yang, JJ (reprint author), Tianjin Univ Technol, Sch Environm Sci & Safety Engn, 391 Binshui Xidao, Tianjin 300384, Peoples R China.	tjyjj_2014@tjut.edu.cn		Yang, Jinjun/0000-0002-9939-151X	National Natural Science Foundation of China [21304070, 51304146]; Program of Study Abroad for Young Scholar - Tianjin Municipal Education Commission (the ninth batch), China; Training Programs of Innovation and Entrepreneurship for Undergraduates in Colleges and Universities of Tianjin, China [X2014015]	This work was supported by the "National Natural Science Foundation of China (Grant Nos. 21304070 & 51304146)", "Program of Study Abroad for Young Scholar sponsored by Tianjin Municipal Education Commission (the ninth batch), China" and "Training Programs of Innovation and Entrepreneurship for Undergraduates in Colleges and Universities of Tianjin, China (Grant No. X2014015)".	Jiang N, 2010, POLYM DEGRAD STABIL, V95, P1045, DOI 10.1016/j.polymdegradstab.2010.03.004; Gan ZH, 2004, BIOMACROMOLECULES, V5, P371, DOI 10.1021/bm0343850; Pan PP, 2009, ACS APPL MATER INTER, V1, P402, DOI 10.1021/am800106f; Yan C, 2008, J PHYS CHEM B, V112, P3311, DOI 10.1021/jp077195i; Jaber M, 2007, SOLID STATE SCI, V9, P144, DOI 10.1016/j.solidstatesciences.2006.11.007; Yang JJ, 2015, IND ENG CHEM RES, V54, P8048, DOI 10.1021/acs.iecr.5b02150; Song YY, 2014, POLYMER, V55, P3054, DOI 10.1016/j.polymer.2014.05.011; Tang YR, 2015, IND ENG CHEM RES, V54, P1832, DOI 10.1021/ie504593z; Sun LY, 2007, CHEM MATER, V19, P1749, DOI 10.1021/cm062993r; Gan ZH, 2005, POLYM DEGRAD STABIL, V87, P191, DOI 10.1016/j.polymdegradstab.2004.08.007; Woo EM, 2006, MACROMOL CHEM PHYSIC, V207, P2232, DOI 10.1002/macp.200600379; Wang LY, 2012, POLYMER, V53, P3815, DOI 10.1016/j.polymer.2012.06.031; FRINK KJ, 1991, INORG CHEM, V30, P1438, DOI 10.1021/ic00007a004; LEGRAS R, 1983, NATURE, V304, P432, DOI 10.1038/304432a0; Zhao YY, 2011, CRYSTENGCOMM, V13, P7129, DOI 10.1039/c1ce05616f; MINKE R, 1980, J MACROMOL SCI PHYS, VB18, P233, DOI 10.1080/00222348008241380; Boo WJ, 2007, COMPOS SCI TECHNOL, V67, P262, DOI 10.1016/j.compscitech.2006.08.012; Nikolic MS, 2001, POLYM DEGRAD STABIL, V74, P263, DOI 10.1016/S0141-3910(01)00156-2; Yang JJ, 2010, MACROMOLECULES, V43, P8610, DOI 10.1021/ma1015566; Sun YJ, 2006, POLYMER, V47, P2455, DOI 10.1016/j.polymer.2006.02.002; Herschke L, 2006, J MATER SCI-MATER M, V17, P95, DOI 10.1007/s10856-006-6333-3; Mathieu C, 2002, J POLYM SCI POL PHYS, V40, P2504, DOI 10.1002/polb.10309; Wang GY, 2014, IND ENG CHEM RES, V53, P1712, DOI 10.1021/ie403778d; Okada K, 2007, POLYMER, V48, P401, DOI 10.1016/j.polymer.2006.10.048; Chen YA, 2014, IND ENG CHEM RES, V53, P16689, DOI 10.1021/ie503303u; Pan PJ, 2009, MACROMOL BIOSCI, V9, P585, DOI 10.1002/mabi.200800294; Yang JJ, 2011, POLYMER, V52, P3460, DOI 10.1016/j.polymer.2011.05.041; Dong T, 2004, MACROMOL BIOSCI, V4, P1084, DOI 10.1002/mabi.20040054; Wu MC, 2005, POLYM INT, V54, P1681, DOI 10.1002/pi.1922; Pan P, 2009, MACROMOLECULES, V42, P3374, DOI 10.1021/ma8024943; Zhao YY, 2012, J NANOSCI NANOTECHNO, V12, P4067, DOI 10.1166/jnn.2012.5876; Yang JJ, 2009, J POLYM SCI POL PHYS, V47, P1997, DOI 10.1002/polb.21798; Pan P, 2009, PROG POLYM SCI, V34, P605, DOI 10.1016/j.progpolymsci.2009.01.003; Bothe M, 2012, MACROMOL CHEM PHYS, V213, P2378, DOI 10.1002/macp.201200096; Liu J, 2011, POLYMER, V52, P4619, DOI 10.1016/j.polymer.2011.08.001; Sun XL, 2011, J PHYS CHEM B, V115, P1950, DOI 10.1021/jp110003m; Brandao LS, 2006, J APPL POLYM SCI, V102, P3868, DOI 10.1002/app.24096; Haubruge HG, 2003, MACROMOLECULES, V36, P4452, DOI 10.1021/ma0341723; Weng MT, 2012, IND ENG CHEM RES, V51, P13862, DOI 10.1021/ie302423n; Kai WH, 2005, J POLYM SCI POL PHYS, V43, P2340, DOI 10.1002/polb.20523; Gan ZH, 2002, MACROMOL CHEM PHYSIC, V203, P2369, DOI 10.1002/macp.200290007; Dong T, 2007, MACROMOLECULES, V40, P8285, DOI 10.1021/ma071776o; Lugito G, 2012, MACROMOL CHEM PHYS, V213, P2228, DOI 10.1002/macp.201200299; Gan ZH, 2004, POLYM DEGRAD STABIL, V83, P289, DOI 10.1016/S0141-3910(03)00274-X; Sun YJ, 2005, MACROMOLECULES, V38, P2739, DOI 10.1021/ma0474269; MINKE R, 1979, J MACROMOL SCI PHYS, VB16, P407, DOI 10.1080/00222347908212305; Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1; Bothe M, 2013, MACROMOL CHEM PHYS, V214, P2683, DOI 10.1002/macp.201300464; ALBERTI G, 1993, ANGEW CHEM INT EDIT, V32, P1357, DOI 10.1002/anie.199313571; Zhang R, 2007, J MATER SCI, V42, P5641, DOI 10.1007/s10853-006-0629-z; Libster D, 2007, POLYM ADVAN TECHNOL, V18, P685, DOI 10.1002/pat.970; Woo EM, 2005, J POLYM SCI POL PHYS, V43, P1662, DOI 10.1002/polb.20470; Keller A, 1998, POLYMER, V39, P4461, DOI 10.1016/S0032-3861(97)10320-2; WRIGHT PA, 1993, J CHEM SOC CHEM COMM, P633, DOI 10.1039/c39930000633; Zhang BL, 1997, J AM CHEM SOC, V119, P2751, DOI 10.1021/ja9634583; Bothe M., 2013, J MATER CHEM A, V1, P14491; Bujoli Bruno, 2005, Chemistry, V11, P1980, DOI 10.1002/chem.200400960; CAO G, 1988, INORG CHEM, V27, P2781, DOI 10.1021/ic00289a008; Gedde U. W., 1995, POLYM PHYS; Huang S, 2014, IND ENG CHEM RES, V53, P15296, DOI 10.1021/ie502794a; Van Krevelen D. W., 1990, PROPERTIES POLYM; HOFFMAN JD, 1962, J RES NBS A PHYS CH, V66, P13, DOI 10.6028/jres.066A.003; Yang J., 2012, J PHYS CHEM B, V116, P1266	63	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0014-3057	1873-1945		EUR POLYM J	Eur. Polym. J.	NOV	2015	72						222	237		10.1016/j.eurpolymj.2015.09.020		16	Polymer Science	Polymer Science	CV4PW	WOS:000364250000020		
J	Gao, BT; Konno, T; Ishihara, K				Gao, Botao; Konno, Tomohiro; Ishihara, Kazuhiko			Cytocompatible and spontaneously forming phospholipid polymer hydrogels	EUROPEAN POLYMER JOURNAL			English	Article						2-Methacryloyloxyethyl phosphorylcholine; (MPC) polymer; Cytocompatibility; Living cell encapsulation; Multifunctional hydrogel layers; Layer-by-layer (LbL) assembly process	LAYER-BY-LAYER; IN-VITRO RELEASE; BIOMEDICAL APPLICATIONS; DRUG-DELIVERY; CELL-CYCLE; TITANIUM-ALLOY; CROSS-LINKING; SURFACE; DEGRADATION; CANCER	Given the importance of regulating living cell functions in three-dimensional (3D) environments, we have designed a cytocompatible and spontaneously forming polymer hydrogel matrix. Water-soluble phospholipid polymers bearing a phenylboronic acid unit, poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate-co-p-vinylphenylboronic acid) (PMBV), and poly(vinyl alcohol) (PVA), are candidate systems for preparing the hydrogel matrices. Aqueous solutions of PMBV and PVA can be used to form hydrogels based on reversible complexation between the phenylboronic acid groups in PMBV and the diol groups in PVA, even under cell culture conditions. Uniform cell encapsulation is easily achieved with hydrogel formation, and cells survived well in the hydrogel. By applying a spinning-assisted layer-by-layer (LbL) process, multilayered PMBV/PVA hydrogels containing living cells can be assembled. This multilayered hydrogel, which mimics the stratified structure of in vivo tissues, allows the layer-specific encapsulation of cells and temporary storage of bioactive molecules. Distance-dependent cell-cell interactions are investigated using the multilayered hydrogel where two cell-laden layers are separated by a finely controlled multilayered hydrogel. In addition, dual-crosslinked multilayered hydrogels are also assembled by alternative depositions of PMBV and photoreactive-PVA solutions, followed by photoirradiation. The dual-crosslinked hydrogel has a lower diffusivity of bioactive molecules than that of single-crosslinked hydrogel and therefore acts as a diffusion-controlling barrier. We demonstrate the utility of this dual-crosslinked hydrogel by examining ways to regulate the diffusion of bioactive molecules in the hydrogel and investigating the diffusion-dependent effects on cell behavior. In conclusion, these hydrogel matrices can provide insights into the regulation of cell behavior in 3D matrices. In turn, our results may contribute to the future design of 3D cell culture systems and tissue regenerated medicine based on cell engineering. (C) 2015 Elsevier Ltd. All rights reserved.	[Gao, Botao; Ishihara, Kazuhiko] Univ Tokyo, Dept Mat Engn, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Konno, Tomohiro; Ishihara, Kazuhiko] Univ Tokyo, Dept Bioengn, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan	Ishihara, K (reprint author), Univ Tokyo, Dept Mat Engn, Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	ishihara@mpc.t.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [2306]; Japan Society for the Promotion of Science (JSPS) [26282135]; Chinese Scholarship Council (CSC)	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Nanomedicine Molecular Science" (No. 2306) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and in part by a Grant-in-Aid for Scientific Research (B) (26282135) from Japan Society for the Promotion of Science (JSPS). One of the authors (B.G.) would like to acknowledge the Chinese Scholarship Council (CSC) for financial support.	Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005; Sung SY, 2008, CANCER RES, V68, P9996, DOI 10.1158/0008-5472.CAN-08-2492; Kimura M, 2005, BIOMATERIALS, V26, P6853, DOI 10.1016/j.biomaterials.2005.05.018; Gao BT, 2014, BIOMATERIALS, V35, P2181, DOI 10.1016/j.biomaterials.2013.11.060; Li ZY, 2012, BIOSENS BIOELECTRON, V34, P191, DOI 10.1016/j.bios.2012.01.042; Zhu L, 2001, CURR OPIN GENET DEV, V11, P91, DOI 10.1016/S0959-437X(00)00162-3; Ishiyama N, 2010, BIOMATERIALS, V31, P4009, DOI 10.1016/j.biomaterials.2010.01.100; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Choi J, 2012, BIOMATERIALS, V33, P954, DOI 10.1016/j.biomaterials.2011.10.006; Dai HJ, 2009, SOFT MATTER, V5, P1987, DOI 10.1039/b821363a; Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804; Lewis AL, 2000, COLLOID SURFACE B, V18, P261, DOI 10.1016/S0927-7765(99)00152-6; Xu Y, 2010, ADV MATER, V22, P3017, DOI 10.1002/adma.201000006; Dai WS, 1999, J MEMBRANE SCI, V156, P67, DOI 10.1016/S0376-7388(98)00330-5; Feder-Mengus C, 2008, TRENDS MOL MED, V14, P333, DOI 10.1016/j.molmed.2008.06.001; Springsteen G, 2002, TETRAHEDRON, V58, P5291, DOI 10.1016/S0040-4020(02)00489-1; Aikawa T, 2012, LANGMUIR, V28, P2145, DOI 10.1021/la2037586; Luhmann T, 2009, MATERIALS, V2, P1058, DOI 10.3390/ma2031058; Yan J, 2004, TETRAHEDRON, V60, P11205, DOI 10.1016/j.tet.2004.08.051; Kimura M, 2004, J BIOMAT SCI-POLYM E, V15, P631, DOI 10.1163/156856204323046898; Ishihara K, 2011, BBA-GEN SUBJECTS, V1810, P268, DOI 10.1016/j.bbagen.2010.04.008; Hunt Nicola C., 2009, Biotechnology Journal, V4, P730, DOI 10.1002/biot.200800292; Iwasaki Y, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/6/064101; Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Suzuki Y, 1998, J BIOMED MATER RES, V39, P317, DOI 10.1002/(SICI)1097-4636(199802)39:2<317::AID-JBM20>3.0.CO;2-8; Ishiyama N, 2011, J BONE JOINT SURG AM, V93A, P142, DOI 10.2106/JBJS.I.01634; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Gao BT, 2013, COLLOID SURFACE B, V108, P345, DOI 10.1016/j.colsurfb.2013.02.022; Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109; Konno T, 2007, BIOMATERIALS, V28, P1770, DOI 10.1016/j.biomaterials.2006.12.017; Jang Y, 2012, MACROMOLECULES, V45, P3542, DOI 10.1021/ma3002615; Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; Cambre JN, 2011, POLYMER, V52, P4631, DOI 10.1016/j.polymer.2011.07.057; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Cho J, 2001, ADV MATER, V13, P1076, DOI 10.1002/1521-4095(200107)13:14<1076::AID-ADMA1076>3.0.CO;2-M; Nam K, 2004, EUR J PHARM SCI, V23, P261, DOI 10.1016/j.ejps.2004.07.012; Choi J, 2009, BIOMATERIALS, V30, P5201, DOI 10.1016/j.biomaterials.2009.06.003; Xu Y, 2010, BIOMATERIALS, V31, P8839, DOI 10.1016/j.biomaterials.2010.07.106; ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355; Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Kuijpers AJ, 2000, J CONTROL RELEASE, V67, P323, DOI 10.1016/S0168-3659(00)00221-2; Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k; Oda H, 2013, BIOMATERIALS, V34, P5891, DOI 10.1016/j.biomaterials.2013.04.015; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Hammond PT, 2012, MATER TODAY, V15, P196, DOI 10.1016/S1369-7021(12)70090-1; Aikawa T, 2013, SOFT MATTER, V9, P4628, DOI 10.1039/c3sm50394a; Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233; Choi JY, 2008, COLLOID SURFACE B, V67, P216, DOI 10.1016/j.colsurfb.2008.08.025; JAMEELA SR, 1995, BIOMATERIALS, V16, P769, DOI 10.1016/0142-9612(95)99639-4; Hiemstra C, 2007, MACROMOLECULES, V40, P1165, DOI 10.1021/ma062468d; Nam K, 2005, POLYMER, V46, P4704, DOI 10.1016/j.polymer.2005.03.087; Chen WX, 2014, J BIOMAT SCI-POLYM E, V25, P1629, DOI 10.1080/09205063.2014.936925; Choi J, 2014, BIOMATER BIOMED ENG, V1, P1, DOI 10.12989/bme.2014.1.1.001; Choi J, 2009, CURR APPL PHYS, V9, P259; Fan CJ, 2015, MACROMOL BIOSCI, V15, P535, DOI 10.1002/mabi.201400453; Garcia JPD, 2014, POLYMERS-BASEL, V6, P39, DOI 10.3390/polym6010039; Gribova V, 2012, CHEM MATER, V24, P854, DOI 10.1021/cm2032459; Ishihara K, 2014, PHOSPHORUS BASED POL, P68; Ishihara K., 2000, SCI TECHNOL ADV MAT, V1, P131, DOI 10.1016/S1468-6996(00)00012-7; Lewis AL, 2012, BIOMIMETIC BIORESPON, P95; Lin Xiaojie, 2012, Biomaterials, V33, P8221, DOI 10.1016/j.biomaterials.2012.08.035; Liu YH, 2014, J BIOMAT SCI-POLYM E, V25, P474, DOI 10.1080/09205063.2013.873282; Shukla A, 2014, WIRES NANOMED NANOBI, V6, P411, DOI 10.1002/wnan.1269; van de Wetering P, 2005, J CONTROL RELEASE, V102, P619, DOI 10.1016/j.jconrel.2004.10.029	68	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0014-3057	1873-1945		EUR POLYM J	Eur. Polym. J.	NOV	2015	72						577	589		10.1016/j.eurpolymj.2015.03.030		13	Polymer Science	Polymer Science	CV4PW	WOS:000364250000045		
J	Nakamae, H; Koh, H; Katayama, T; Nishimoto, M; Hayashi, Y; Nakashima, Y; Nakane, T; Nakamae, M; Hirose, A; Hino, M				Nakamae, Hirohisa; Koh, Hideo; Katayama, Takako; Nishimoto, Mitsutaka; Hayashi, Yoshiki; Nakashima, Yasuhiro; Nakane, Takahiko; Nakamae, Mika; Hirose, Asao; Hino, Masayuki			HLA haploidentical peripheral blood stem cell transplantation using reduced dose of posttransplantation cyclophosphamide for poor-prognosis or refractory leukemia and myelodysplastic syndrome	EXPERIMENTAL HEMATOLOGY			English	Article							BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; HIGH-RISK; HEMATOLOGIC MALIGNANCIES; PBSC TRANSPLANTATION; CLINICAL-OUTCOMES; GRAFT COMPOSITION; PHASE-II; DONOR; ENGRAFTMENT	Nonmyeloablative, human leukocyte antigen (HLA) haploidentical, T-cell-replete bone marrow transplantation followed by high-dose posttransplantation cyclophosphamide (PT/Cy) has recently been developed. This transplantation milieu has resulted in favorable outcomes with low transplantation-related mortality, owing to a low incidence of graft-versus-host disease (GVHD), without increased infectious complications. However, the high relapse rate remains a major concern. We therefore performed a prospective pilot study of HLA haploidentical peripheral blood stem cell transplantation (PBSCT) with intensified conditioning, followed by two lower doses of PT/Cy. A total of 20 patients with refractory or poor-prognosis myelodysplastic syndrome (MDS) and leukemia were enrolled in the study. A trend toward a lower incidence of grade III-IV acute GVHD at day 100 in the group receiving 25 mg/kg x 2 doses of PT/Cy, compared with the group receiving 25 mg/kg of PT/Cy (9.1% vs. 33%, p = 0.20), was noted. However, the cumulative incidence of chronic GVHD was low, at 10% irrespective of PT/Cy dose. The number of infused CD34(+) cells significantly correlated with the grade of acute GVHD (p = 0.004). In addition, the occurrence of BK virus hemorrhagic cystitis was significantly more common in the double-dose PT/Cy group (25% vs. 0%, p = 0.043), especially when combined with busulfan. The probability of overall survival at 1 year in the double-dose group tended to be better compared with that in the single-dose group (64% vs. 44%, respectively; p = 0.20). In conclusion, HLA haploidentical, T-cell-replete PBSCT with 25 mg/kg x 2 doses of PT/Cy might be a feasible option for treating high-risk leukemia and MDS. Copyright (C) 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.	[Nakamae, Hirohisa; Koh, Hideo; Katayama, Takako; Nishimoto, Mitsutaka; Hayashi, Yoshiki; Nakashima, Yasuhiro; Nakane, Takahiko; Nakamae, Mika; Hirose, Asao; Hino, Masayuki] Osaka City Univ, Grad Sch Med, Dept Hematol, Osaka 5458585, Japan	Nakamae, H (reprint author), Osaka City Univ, Grad Sch Med, Dept Hematol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	hirohisa@msic.med.osaka-cu.ac.jp			Japan Society for the Promotion of Science KAKENHI Grant [23591423]	This pilot study was supported by Japan Society for the Promotion of Science KAKENHI Grant (no. 23591423).	Aimoto M, 2014, INFECTION, V42, P971, DOI 10.1007/s15010-014-0657-6; O'Donnell PV, 2002, BIOL BLOOD MARROW TR, V8, P377, DOI 10.1053/bbmt.2002.v8.pm12171484; Colvin GA, 2009, BIOL BLOOD MARROW TR, V15, P421, DOI 10.1016/j.bbmt.2008.12.503; JADUS MR, 1992, BONE MARROW TRANSPL, V10, P1; McDonald GB, 2006, ALIMENT PHARM THERAP, V24, P441, DOI 10.1111/j.1365-2036.2006.03001.x; Ichihara H, 2011, TRANSPL P, V43, P3927, DOI 10.1016/j.transproceed.2011.08.104; Liu DH, 2011, PEDIATR BLOOD CANCER, V57, P135, DOI 10.1002/pbc.23107; Panse JP, 2005, BRIT J HAEMATOL, V128, P659, DOI 10.1111/j.1365-2141.2005.05363.x; Nakane T, 2011, INT J HEMATOL, V93, P509, DOI 10.1007/s12185-011-0805-z; Kitaya K, 2003, J CLIN ENDOCR METAB, V88, P1809, DOI 10.1210/jc.2002-020980; Hayashi Y, 2012, LEUKEMIA LYMPHOMA, V53, P1084, DOI 10.3109/10428194.2011.647017; Baron F, 2005, LEUKEMIA, V19, P822, DOI 10.1038/sj.leu.2403718; Luznik L, 2008, BIOL BLOOD MARROW TR, V14, P641, DOI 10.1016/j.bbmt.2008.03.005; Luznik L, 2010, CURR OPIN HEMATOL, V17, P493, DOI 10.1097/MOH.0b013e32833eaf1b; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Wang Y, 2013, CANCER-AM CANCER SOC, V119, P978, DOI 10.1002/cncr.27761; Dhedin N, 2012, BONE MARROW TRANSPL, V47, P1564, DOI 10.1038/bmt.2012.75; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Luznik L, 2012, SEMIN ONCOL, V39, P683, DOI 10.1053/j.seminoncol.2012.09.005; Pulsipher MA, 2009, BLOOD, V114, P2606, DOI 10.1182/blood-2009-03-208355; Aversa F, 2005, J CLIN ONCOL, V23, P3447, DOI 10.1200/JCO.2005.09.117; Grosso D, 2011, BLOOD, V118, P4732, DOI 10.1182/blood-2011-07-365338; Spitzer TR, 2001, BONE MARROW TRANSPL, V27, P893, DOI 10.1038/sj.bmt.1703015; Brunstein CG, 2011, BLOOD, V118, P282, DOI 10.1182/blood-2011-03-344853; Kawamura K, 2014, INT J INFECT DIS, V19, P26, DOI 10.1016/j.ijid.2013.09.020; Luo XL, 2004, CELL MOL IMMUNOL, V1, P199; Solomon SR, 2012, BIOL BLOOD MARROW TR, V18, P1859, DOI 10.1016/j.bbmt.2012.06.019	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	NOV	2015	43	11					921	929		10.1016/j.exphem.2015.07.006		9	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CV9OV	WOS:000364617400001		
J	Nakamura, D; Yoshimitsu, M; Kuroki, A; Hachiman, M; Kamada, Y; Ezinne, CC; Arai, A; Inoue, H; Hamada, H; Hayashida, M; Suzuki, S; Fujino, S; Arima, N; Arima, M; Tabuchi, T; Okada, S; Arima, N				Nakamura, Daisuke; Yoshimitsu, Makoto; Kuroki, Ayako; Hachiman, Miho; Kamada, Yuhei; Ezinne, Chibueze C.; Arai, Akihiko; Inoue, Hirosaka; Hamada, Heiichirou; Hayashida, Maiko; Suzuki, Shinsuke; Fujino, Satoshi; Arima, Naosuke; Arima, Mamiko; Tabuchi, Tomohisa; Okada, Seiji; Arima, Naomichi			A new ATL xenograft model and evaluation of pyrrolidine dithiocarbamate as a potential ATL therapeutic agent	EXPERIMENTAL HEMATOLOGY			English	Article							T-CELL LEUKEMIA; LEUKEMIA/LYMPHOMA; TRANSPLANTATION; LYMPHOMA; CHOP; INDUCTION; APOPTOSIS; MICE	Adult T-cell leukemia/lymphoma (ATL) is caused by human T-lymphotrophic virus type 1 infection and is one of the most refractory malignant T-cell lymphomas. Improvement of ATL therapy options requires the establishment of appropriate ATL animal models. In this study, we successfully generated an ATL mouse model by xenotransplantation of primary peripheral blood mononuclear cells (PBMCs) isolated from ATL patients (ATL cells) into non-obese diabetic/severe combined immunodeficiency/Jak3-null mice (NOJ mice). To generate the model, the ATL S1T cell line was subcutaneously injected into mice. Primary ATL cells were then transplanted subcutaneously, intraperitoneally, or intravenously. ATL cells infiltrated multiple organs, and elevated human soluble interleukin 2 receptor (IL-2R) levels were detected in peripheral blood. Injection of one million primary ATL cells was needed for successful engraftment into host mice. Thawed cells, frozen long-term in liquid nitrogen, could also be transplanted; however, more cells were required to achieve similar results. The median mouse survival time was proportional to the number of cells injected. Successful secondary transplantation of ATL cells from one NOJ mouse into another was achieved and confirmed by T-cell receptor analysis. Finally, we examined the effects of the antioxide pyrrolidine dithiocarbamate (PDTC) as an antitumor agent in vivo. PDTC administration inhibited the increase of soluble IL-2R and improved mouse survival, suggesting that this compound has potential as an anti-ATL agent. We demonstrated that ATL cells could be stably xenotransplanted into NOJ mice using primary cells. This model will be useful in the establishment of novel therapies to treat ATL. Copyright (C) 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.	[Nakamura, Daisuke; Yoshimitsu, Makoto; Kuroki, Ayako; Hachiman, Miho; Kamada, Yuhei; Ezinne, Chibueze C.; Arai, Akihiko; Suzuki, Shinsuke; Arima, Naomichi] Kagoshima Univ, Grad Sch Med & Dent Sci, Ctr Chron Viral Dis, Div Hematol & Immunol, Kagoshima 8908544, Japan; [Nakamura, Daisuke; Yoshimitsu, Makoto; Kamada, Yuhei; Arai, Akihiko; Inoue, Hirosaka; Hamada, Heiichirou; Hayashida, Maiko; Fujino, Satoshi; Arima, Naosuke; Arima, Mamiko; Tabuchi, Tomohisa; Arima, Naomichi] Kagoshima Univ Hosp, Dept Hematol & Immunol, Kagoshima, Japan; [Okada, Seiji] Kumamoto Univ, Ctr AIDS Res, Div Hematopoiesis, Kumamoto, Japan	Yoshimitsu, M (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Ctr Chron Viral Dis, Div Hematol & Immunol, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	myoshimi@m.kufm.kagoshima-u.ac.jp			Frontier Science Research Center, Kagoshima University; Special Expense of National University Operating Grants; Japan Society for the Promotion of Science KAKENHI [25461427]	The authors thank all the staff members of the Division of Laboratory Animal Sciences, Natural Science of Center for Research and Education, Kagoshima University, who performed animal care. This study was supported by a grant from the Frontier Science Research Center, Kagoshima University, and Special Expense of National University Operating Grants (granted from 2013 to 2017). This work was further supported by a Japan Society for the Promotion of Science KAKENHI Grant-in-Aid for Scientific Research (C) (25461427) to Dr. M. Yoshimitsu.	Chinery R, 1997, NAT MED, V3, P1233, DOI 10.1038/nm1197-1233; Kawano N, 2005, LEUKEMIA, V19, P1384, DOI 10.1038/sj.leu.2403829; KONDO A, 1993, BLOOD, V82, P2501; Kantarjian HM, 2011, LANCET ONCOL, V12, P841, DOI 10.1016/S1470-2045(11)70201-7; Tsukasaki K, 2007, J CLIN ONCOL, V25, P5458, DOI 10.1200/JCO.2007.11.9958; TAKEMOTO S, 1994, BLOOD, V84, P3080; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; White Y, 2011, ANTICANCER RES, V31, P4251; ARIMA N, 1991, J VIROL, V65, P6892; Okada S, 2008, INT J HEMATOL, V88, P476, DOI 10.1007/s12185-008-0215-z; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Utsunomiya A, 2001, BONE MARROW TRANSPL, V27, P15, DOI 10.1038/sj.bmt.1702731; Hishizawa M, 2010, BLOOD, V116, P1369, DOI 10.1182/blood-2009-10-247510; Masaki A, 2013, J IMMUNOL, V191, P135, DOI 10.4049/jimmunol.1202692; Phillips KE, 2000, CANCER RES, V60, P6977; Dewan MZ, 2006, BLOOD, V107, P716, DOI 10.1182/blood-2005-02-0735; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Arima N, 2004, EXP HEMATOL, V32, P195, DOI 10.1016/j.exphem.2003.11.008; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Kawada H, 2015, BIOL BLOOD MARROW TR, V21, P696, DOI 10.1016/j.bbmt.2014.12.020	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	NOV	2015	43	11					944	950		10.1016/j.exphem.2015.06.303		7	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CV9OV	WOS:000364617400004		
J	Fujita, N; Ichii, M; Maeda, T; Saitoh, N; Yokota, T; Yamawaki, K; Kakitani, M; Tomizuka, K; Oritani, K; Kanakura, Y				Fujita, Natsuko; Ichii, Michiko; Maeda, Tetsuo; Saitoh, Norimitsu; Yokota, Takafumi; Yamawaki, Kengo; Kakitani, Makoto; Tomizuka, Kazuma; Oritani, Kenji; Kanakura, Yuzuru			Identification of osteoblast stimulating factor 5 as a negative regulator in the B-lymphopoietic niche	EXPERIMENTAL HEMATOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; CARBOXYPEPTIDASE-LIKE PROTEIN; GROWTH-FACTOR-BETA; BONE-MARROW; STEM/PROGENITOR CELLS; SECRETED PROTEINS; DIVERSE FUNCTIONS; DIFFERENTIATION; PLEIOTROPHIN; PROGENITORS	Recent studies have revealed the crucial role of the niche which supports B-lymphocyte differentiation from hematopoietic stem cells. In this study, we aimed to identify a novel regulator of B lymphopoiesis secreted in the specific niche using the signal sequence trap method. Among the identified proteins from MS5 stromal cells, expression of pleiotrophin, placental proliferin 2, and osteoblast stimulating factor 5 (OSF-5) was dominantly high in several stromal cell lines. We found that OSF-5 suppressed early B lymphopoiesis in transgenic mice producing the target protein. The number of pre-B and immature B cells was reduced by more than half compared with control in the transgenic mice. In vitro studies showed that a secreted variant of OSF-5 inhibited the proliferation and colony formation of pre-B cells, whereas cell-intrinsic form had no influence on B lymphopoiesis. The main components of the B-lymphopoietic niche, osteoblasts in mice and mesenchymal cells in humans, are primary producers of OSF-5. These results define a novel mechanism of B lymphopoiesis in bone marrow. In the specific niche, B-lymphocyte differentiation is fine-tuned by negative regulators as well as supportive factors. Copyright (C) 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.	[Fujita, Natsuko; Ichii, Michiko; Maeda, Tetsuo; Saitoh, Norimitsu; Yokota, Takafumi; Oritani, Kenji; Kanakura, Yuzuru] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka 5650871, Japan; [Yamawaki, Kengo] Kyowa Hakko Kirin, Nephrol Res & Dev Unit, Div Res & Dev, Nephrol Res Labs, Tokyo, Japan; [Kakitani, Makoto] Kyowa Hakko Kirin, Bio Proc Res & Dev Labs, Prod Div, Gunma, Japan; [Tomizuka, Kazuma] Kyowa Hakko Kirin, Div Res & Dev, Res Funct Unit, Innovat Technol Labs, Tokyo, Japan	Oritani, K (reprint author), Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	oritani@bldon.med.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; New Energy and Industrial Technology Development Organization (NEDO)	This work was supported by Ministry of Education, Culture, Sports, Science and Technology of Japan and the New Energy and Industrial Technology Development Organization (NEDO). We thank Dr. Paul Kincade for many thoughtful suggestions on the manuscript and Dr. T. Sakai (Orthopedic surgery, Osaka University) for providing human samples.	Tumelty KE, 2014, J BIOL CHEM, V289, P2526, DOI 10.1074/jbc.M113.502617; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Bogachev O, 2011, MOL MED, V17, P1056, DOI 10.2119/molmed.2011.00141; Ichii M, 2010, IMMUNOL REV, V237, P10, DOI 10.1111/j.1600-065X.2010.00933.x; Himburg HA, 2012, CELL REP, V2, P964, DOI 10.1016/j.celrep.2012.09.002; Guezguez B, 2013, CELL STEM CELL, V13, P175, DOI 10.1016/j.stem.2013.06.015; Schissel SL, 2009, AM J PATHOL, V174, P818, DOI 10.2353/ajpath.2009.080856; Corbacho AM, 2002, J ENDOCRINOL, V173, P219, DOI 10.1677/joe.0.1730219; Yokota T, 2008, J IMMUNOL, V181, P6061; Corfe SA, 2012, SEMIN IMMUNOL, V24, P198, DOI 10.1016/j.smim.2012.02.001; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Oritani K, 1996, J CELL BIOL, V134, P771, DOI 10.1083/jcb.134.3.771; Zhang QZ, 2012, CURR OPIN IMMUNOL, V24, P196, DOI 10.1016/j.coi.2011.12.007; Ichii M, 2008, EXP HEMATOL, V36, P587, DOI 10.1016/j.exphem.2007.12.013; Yokota T, 2013, INT J HEMATOL, V98, P382, DOI 10.1007/s12185-013-1424-7; Tare RS, 2002, J BONE MINER RES, V17, P2009, DOI 10.1359/jbmr.2002.17.11.2009; Satoh Y, 2013, IMMUNITY, V38, P1105, DOI 10.1016/j.immuni.2013.05.014; Ramirez J, 2010, CURR OPIN IMMUNOL, V22, P177, DOI 10.1016/j.coi.2010.02.003; Nakamori Y, 2012, BRIT J HAEMATOL, V157, P674, DOI 10.1111/j.1365-2141.2012.09109.x; Ichii M, 2012, BLOOD, V119, P1683, DOI 10.1182/blood-2011-07-369199; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Deuel TF, 2002, ARCH BIOCHEM BIOPHYS, V397, P162, DOI 10.1006/abbi.2001.2705; Kaneko S, 2010, CURR OPIN HEMATOL, V17, P271, DOI 10.1097/MOH.0b013e32833a25ee; Gagnon A, 2005, EXP CELL RES, V308, P265, DOI 10.1016/j.yexcr.2005.04.031; Istvanffy R, 2011, BLOOD, V118, P2712, DOI 10.1182/blood-2010-05-287235; HE GP, 1995, NATURE, V378, P92, DOI 10.1038/378092a0; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Majdalawieh A, 2007, MOL BIOL CELL, V18, P930, DOI 10.1091/mbc.E06-03-0217; Choong ML, 2003, FEBS LETT, V550, P155, DOI 10.1016/S0014-5793(03)00844-5; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Corselli M, 2013, BLOOD, V121, P2891, DOI 10.1182/blood-2012-08-451864; Panaroni C, 2013, CALCIFIED TISSUE INT, V93, P261, DOI 10.1007/s00223-013-9753-3; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Dolence JJ, 2014, EXP HEMATOL, V42, P380, DOI 10.1016/j.exphem.2014.01.001; Layne MD, 2001, MOL CELL BIOL, V21, P5256, DOI 10.1128/MCB.21.15.5256-5261.2001; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Baba Y, 2005, IMMUNITY, V23, P599, DOI 10.1016/j.immuni.2005.10.009; Holloway RW, 2012, J BIOL CHEM, V287, P39171, DOI 10.1074/jbc.M112.404293; Kikuchi K, 2006, P NATL ACAD SCI USA, V103, P17852, DOI 10.1073/pnas.0603368103; Manilay JO, 2014, TRENDS MOL MED, V20, P405, DOI 10.1016/j.molmed.2014.03.003; Kakitani M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni083; Krevvata M, 2014, BLOOD, V124, P2834, DOI 10.1182/blood-2013-07-517219; Montecino-Rodriguez E, 2012, IMMUNITY, V36, P13, DOI 10.1016/j.immuni.2011.11.017; Oritani K, 1997, BLOOD, V119, P1683; Prieyl J A, 1996, Proc Natl Acad Sci U S A, V93, P10348	45	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	NOV	2015	43	11					963	973		10.1016/j.exphem.2015.07.002		11	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	CV9OV	WOS:000364617400006		
J	Yamamoto, Y; Yokoi, N; Ogata, M; Shiraishi, A; Yamaguchi, M; Uno, T; Inagaki, K; Hayashi, K; Kinoshita, S; Ohashi, Y				Yamamoto, Yasuaki; Yokoi, Norihiko; Ogata, Miki; Shiraishi, Atsushi; Yamaguchi, Masahiko; Uno, Toshihiko; Inagaki, Kayoko; Hayashi, Kozaburo; Kinoshita, Shigeru; Ohashi, Yuichi			Correlation Between Recurrent Subconjunctival Hemorrhages and Conjunctivochalasis by Clinical Profile and Successful Surgical Outcome	Eye & Contact Lens-Science and Clinical Practice			English	Article						Recurrent subconjunctival hemorrhages; Conjunctivochalasis surgery; Correlation	IMPACT	Objective: To characterize the clinical profile of patients with recurrent subconjunctival hemorrhages (SCHs) and evaluate the effect of conjunctivochalasis (CCh) surgery on disease recurrences. Methods: Three hundred and sixty-two patients with SCHs (mean age, 56.416.0 years) were enrolled in this multicenter epidemiologic study. The severity of CCh, lifestyle at the time of SCH onset, and the frequency of previous SCHs were compared. Thirty-eight patients with 2 or more episodes of SCHs (mean age, 68.28.9 years) underwent surgery for CCh. The effectiveness of surgery was evaluated by comparing the frequency of SCH preoperatively and postoperatively. Results: Patients with three or more recurrent SCHs showed a significantly (P=0.003) higher grade of CCh and tended to be engaged in activities that require visual concentration, such as watching a visual display terminal, knitting, reading, and driving. More than 80% of eyes that underwent surgery to CCh showed no recurrence of the hemorrhages, and the frequency of SCH significantly (P<0.0001) decreased postoperatively. Conclusions: Moderate or severe CCh and activities that may cause dry eye can be considered to be risk factors for recurrent SCHs. Surgery to treat CCh is a useful option for patients with frequent recurrences of SCHs.	[Yamamoto, Yasuaki; Ogata, Miki; Shiraishi, Atsushi; Yamaguchi, Masahiko; Uno, Toshihiko; Hayashi, Kozaburo; Ohashi, Yuichi] Ehime Univ, Grad Sch Med, Dept Ophthalmol, Toon, Ehime 7910295, Japan; [Yokoi, Norihiko; Inagaki, Kayoko; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan	Yamamoto, Y (reprint author), Ehime Univ, Grad Sch Med, Dept Ophthalmol, Toon, Ehime 7910295, Japan.	yyasuaki@m.ehime-u.ac.jp					Sodhi PK, 2003, JPN J OPHTHALMOL, V47, P316, DOI 10.1016/S0021-5155(03)00017-0; PITTS JF, 1992, BRIT J OPHTHALMOL, V76, P297, DOI 10.1136/bjo.76.5.297; Meller D, 1998, SURV OPHTHALMOL, V43, P225, DOI 10.1016/S0039-6257(98)00037-X; Mimura T, 2009, OPHTHALMOLOGY, V116, P1880, DOI 10.1016/j.ophtha.2009.03.021; Miljanovic B, 2007, AM J OPHTHALMOL, V143, P409, DOI 10.1016/j.ajo.2006.11.060; Incorvaia C, 2002, AM J OPHTHALMOL, V134, P927, DOI 10.1016/S0002-9394(02)01812-3; TSUBOTA K, 1993, NEW ENGL J MED, V328, P584, DOI 10.1056/NEJM199302253280817; FUKUYAMA J, 1990, OPHTHALMOLOGICA, V200, P63; Yokoi N, 2005, CORNEA, V24, pS24, DOI 10.1097/01.ico.0000178740.14212.1a; Di Pascuale MA, 2004, BRIT J OPHTHALMOL, V88, P388, DOI 10.1136/bjo.2003.025460; Uchino M, 2008, OPHTHALMOLOGY, V115, P1982, DOI 10.1016/j.ophtha.2008.06.022; Asplund R, 2004, Can J Urol, V11, P2322; Duke-Elder S., 1965, SYSTEM OPHTHALMOLOGY, V2, P547; Duke-Elder S., 1965, SYSTEM OPHTHALMOLOGY, V8, P33; Höh H, 1995, Ophthalmologe, V92, P802; Hughes WL, 1942, AM J OPHTHALMOL, V25, P48; Mimura T, 2009, OPHTHALMOLOGICA, V224, P133; Nakamura S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011119; Wilson R J, 1986, J Am Optom Assoc, V57, P376; Yokoi Norihiko, 2008, Dev Ophthalmol, V41, P138, DOI 10.1159/000131086	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1542-2321	1542-233X		EYE CONTACT LENS	Eye Contact Lens-Sci. Clin. Pra.	NOV	2015	41	6					367	372		10.1097/ICL.0000000000000139		6	Ophthalmology	Ophthalmology	CV6LF	WOS:000364381000008		
J	Orban, T; Johnson, WM; Dong, ZQ; Maeda, T; Maeda, A; Sakai, T; Tsuneoka, H; Mieyal, JJ; Palczewski, K				Orban, Tivadar; Johnson, William M.; Dong, Zhiqian; Maeda, Tadao; Maeda, Akiko; Sakai, Tsutomu; Tsuneoka, Hiroshi; Mieyal, John J.; Palczewski, Krzysztof			Serum levels of lipid metabolites in age-related macular degeneration	FASEB JOURNAL			English	Article						docosahexaenoic acid; arachidonic acid; risk evaluation; serum; mouse model	OPTICAL COHERENCE TOMOGRAPHY; OPERATING CHARACTERISTIC CURVES; RETINAL DEGENERATION; GEOGRAPHIC ATROPHY; ANIMAL-MODELS; MOUSE RETINA; COGNITIVE DECLINE; DARK-ADAPTATION; AGING BRAIN; BIOMARKERS	Age-related macular degeneration (AMD) is a neurodegenerative disease that causes adult-onset blindness. There are 2 forms of this progressive disease: wet and dry. Currently there is no cure for AMD, but several treatment options have started to emergemaking early detection critical for therapeutic success. Analysis of the eyes of Abca4(-/-) Rdh8(-/-) mice that display light-induced retinal degeneration indicates that 11-cis-retinal and docosahexaenoic acid (DHA) levels were significantly decreased as compared with the eyes of control dark-adapted C57BL/6J mice. In addition, exposure to intense light correlated with higher levels of prostaglandin G2 in the eyes of Abca4(-/-) Rdh8(-/-) mice. Intense light exposure also loweredDHA levels in the eyes of wild-type C57BL/6J mice without discernible retinal degeneration. Analysis of human serumfrom patients with AMD recapitulated these dysregulated DHA levels and revealed dysregulation of arachidonic acid (AA) levels as well (similar to 32% increase in patients with AMDcomparedwith average levels in healthy individuals). From these observations, we then built a statistical model that included levels of DHA and AA from human serum. This model had a 74% probability of correctly identifying patients with AMD from controls. Addition of a genetic analysis for one of the most prevalent amino acid substitutions in the age-related maculopathy susceptibility 2 gene linked to AMD, Ala(69) -> Ser, did not improve the statisticalmodel. Thus, we have characterized a reliablemethod with the potential to detect AMDwithout a genetic component, paving the way for a larger-scale clinical evaluation. Our studies on mouse models along with the analysis of human serum suggest that our small molecule-based model may serve as an effective tool to estimate the risk of developing AMD.	[Orban, Tivadar; Johnson, William M.; Maeda, Akiko; Mieyal, John J.; Palczewski, Krzysztof] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Maeda, Tadao; Maeda, Akiko] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Sch Med, Cleveland, OH 44106 USA; [Dong, Zhiqian] Polgenix Inc, Cleveland, OH USA; [Sakai, Tsutomu; Tsuneoka, Hiroshi] Jikei Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Mieyal, John J.] Louis Stokes Vet Affairs Med Res Ctr, Cleveland, OH USA	Palczewski, K (reprint author), Case Western Reserve Univ, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu			U.S. National Institutes of Health, National Eye Institute [EY009339, EY021126]; Foundation Fighting Blindness; Arnold and Mabel Beckman Foundation	The authors thank Drs. Leslie T. Webster, Jr., Daniel Figeys, and members of the K.P. laboratory for helpful comments on this manuscript; and Drs. Philip D. Kiser, Marcin Golczak, and Yaroslav Tsybovsky (all from Case Western Reserve University) for support and advice during this study. This work was supported by funding from the U.S. National Institutes of Health, National Eye Institute Grants EY009339 and EY021126 (to K.P.), the Foundation Fighting Blindness, and the Arnold and Mabel Beckman Foundation. K.P. is a John H. Hord Professor of Pharmacology. The authors declare no conflicts of interest.	Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Dimitrov PN, 2012, INVEST OPHTH VIS SCI, V53, P5213, DOI 10.1167/iovs.11-8958; Patti GJ, 2013, ANAL CHEM, V85, P798, DOI 10.1021/ac3029745; Heimann H, 2013, EYE, V27, P208, DOI 10.1038/eye.2012.251; Drexler W, 2008, PROG RETIN EYE RES, V27, P45, DOI 10.1016/j.preteyeres.2007.07.005; Kohno H, 2013, J BIOL CHEM, V288, P15326, DOI 10.1074/jbc.M112.448712; Fletcher EL, 2011, PROG MOL BIOL TRANSL, V100, P211, DOI 10.1016/B978-0-12-384878-9.00006-6; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041; Costa RA, 2006, PROG RETIN EYE RES, V25, P325, DOI 10.1016/j.preteyeres.2006.03.001; Schuman SG, 2009, OPHTHALMOLOGY, V116, P488, DOI 10.1016/j.ophtha.2008.10.006; Palczewska G, 2014, P NATL ACAD SCI USA, V111, pE5445, DOI 10.1073/pnas.1410162111; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Nassar K, 2015, GRAEF ARCH CLIN EXP, V253, P699, DOI 10.1007/s00417-014-2738-8; Kim HJ, 2014, INVEST OPHTH VIS SCI, V55, P7166, DOI 10.1167/iovs.14-15168; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Grund B, 2010, CURR OPIN HIV AIDS, V5, P473, DOI 10.1097/COH.0b013e32833ed742; McMahon A, 2007, FEBS LETT, V581, P5459, DOI 10.1016/j.febslet.2007.10.050; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; DeAngelis MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P49, DOI 10.1001/archopht.125.1.49; Vine AK, 2005, OPHTHALMOLOGY, V112, P2076, DOI 10.1016/j.ophtha.2005.07.004; Gu JY, 2009, MOL CELL PROTEOMICS, V8, P1338, DOI 10.1074/mcp.M800453-MCP200; Maeda A, 2014, P NATL ACAD SCI USA, V111, pE1428, DOI 10.1073/pnas.1317986111; ZWEIG MH, 1993, CLIN CHEM, V39, P561; Marnett LJ, 1999, J BIOL CHEM, V274, P22903, DOI 10.1074/jbc.274.33.22903; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407; Kohno H, 2014, J IMMUNOL, V192, P3816, DOI 10.4049/jimmunol.1301738; Nussenblatt RB, 2014, AM J OPHTHALMOL, V158, P5, DOI 10.1016/j.ajo.2014.03.014; van Velthoven MEJ, 2007, PROG RETIN EYE RES, V26, P57, DOI 10.1016/j.preteyeres.2006.10.002; Guymer RH, 2011, INVEST OPHTH VIS SCI, V52, P4639, DOI 10.1167/iovs.10-7120; Palczewska G, 2014, INVEST OPHTH VIS SCI, V55, P4438, DOI 10.1167/iovs.14-14395; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Grimm C, 2004, J NEUROSCI, V24, P5651, DOI 10.1523/JNEUROSCI.1288-04.2004; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; Merle BMJ, 2014, INVEST OPHTH VIS SCI, V55, P2010, DOI 10.1167/iovs.14-13916; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; Gabriele ML, 2010, PROG RETIN EYE RES, V29, P556, DOI 10.1016/j.preteyeres.2010.05.005; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Dimitrov PN, 2011, INVEST OPHTH VIS SCI, V52, P9457, DOI 10.1167/iovs.10-7043; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Pennesi ME, 2012, MOL ASPECTS MED, V33, P487, DOI 10.1016/j.mam.2012.06.003; Ni JQ, 2009, MOL CELL PROTEOMICS, V8, P1921, DOI 10.1074/mcp.M900127-MCP200; GELFANT S, 1972, SCIENCE, V178, P357, DOI 10.1126/science.178.4059.357; Gaffney AJ, 2013, DOC OPHTHALMOL, V127, P191, DOI 10.1007/s10633-013-9400-3; Carroll J, 2013, CURR EYE RES, V38, P709, DOI 10.3109/02713683.2013.784792; Agbaga MP, 2010, J LIPID RES, V51, P1624, DOI 10.1194/jlr.R005025; Yoshida T, 2007, MOL VIS, V13, P545; Holz FG, 2014, OPHTHALMOLOGY, V121, P1079, DOI 10.1016/j.ophtha.2013.11.023; Owsley C, 2000, INVEST OPHTH VIS SCI, V41, P267; Chader GJ, 2002, VISION RES, V42, P393, DOI 10.1016/S0042-6989(01)00212-7; Chen Y, 2013, J CLIN INVEST, V123, P5119, DOI 10.1172/JCI69076; Palczewska G, 2014, NAT MED, V20, P785, DOI 10.1038/nm.3590; Morgan J, 2005, EXP EYE RES, V80, P297, DOI 10.1016/j.exer.2004.12.010; McMahon A, 2007, MOL VIS, V13, P258; Guarente L, 1997, SCIENCE, V275, P943, DOI 10.1126/science.275.5302.943; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Ayyagari R, 2001, Ophthalmic Genet, V22, P233, DOI 10.1076/opge.22.4.233.2219; de Ruijter W., 2009, BMJ-BRIT MED J, V338, P1; Gutchess A, 2014, SCIENCE, V346, P579, DOI 10.1126/science.1254604; Hunter Jennifer J, 2010, Biomed Opt Express, V2, P139, DOI 10.1364/BOE.2.000139; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Keles Sadullah, 2014, Clin Ophthalmol, V8, P1573, DOI 10.2147/OPTH.S66160; Lindenberger U, 2014, SCIENCE, V346, P572, DOI 10.1126/science.1254403; Maeda A., 2013, DRUG DISCOV TODAY DI, V10, pe163; Owsley C, 2014, INVEST OPHTH VIS SCI, V55, P4776, DOI 10.1167/iovs.14-14502; Schmitz-Valckenberg S, 2009, INVEST OPHTH VIS SCI, V50, P3915, DOI 10.1167/iovs.08-2484; Shafto MA, 2014, SCIENCE, V346, P583, DOI 10.1126/science.1254404	71	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4579	4588		10.1096/fj.15-275289		10	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	WOS:000364514700017		
J	Sako, K; Falcus, S				Sako, Katsura; Falcus, Sarah			dementia, care and time in post-war Japan: The Twilight Years, Memories of Tomorrow and Pecoross' Mother and Her Days	FEMINIST REVIEW			English	Article						dementia; care; Japan; film; fiction; comic	POLITICS	As the number of people affected by dementia increases rapidly, dementia has been transformed into an epidemic which endangers global health and wealth, and many populations are now living in what Jain terms a time of prognosis, in fear of the disease. Through its strong association with ageing and memory loss, dementia is conceived of as a linear decline into loss of self and death, and those with dementia as other. More significantly, imagined as a threat that signifies both a loss of able-bodied workforce and a large population dependent on care and support, dementia inevitably feeds into the 'crisis-of-care' narrative that is prominent in many ageing societies. With one of the fastest ageing populations in the world, and an extremely low birth rate, the dementia prognosis is particularly acute in Japan and dementia is strongly linked to the idea of a 'care crisis'. This situation has produced an increasing number of cultural representations of dementia and care and this paper considers three of these cultural texts, all rooted in the historical and cultural contexts in which they were produced: the novel The Twilight Years; the film Memories of Tomorrow; and the comic book Pecoross' Mother and Her Days. The analysis concentrates upon their representations of care, seeing this as a space where the ethical relationship between self and other can be negotiated and where time with dementia can be imagined and re-imagined. The analysis of these texts from a feminist ethics perspective demonstrates the potential of popular and creative representations to interrogate and potentially expand the meanings of dementia, ageing and living in prognosis.	[Sako, Katsura] Keio Univ, English, Tokyo 108, Japan; [Falcus, Sarah] Univ Huddersfield, English Literature, Huddersfield HD1 3DH, W Yorkshire, England	Sako, K (reprint author), Keio Univ, English, Tokyo 108, Japan.				JSPS KAKENHI [25770115]	The research undertaken by Katsura Sako towards this co-authored work was supported by JSPS KAKENHI (grant number 25770115).	Adkins L., 2009, SOCIOLOGICAL RES ONL, V14, P8; Alzheimers Disease International (ADI), 2013, POLICY BRIEF HEADS G; Bastian M, 2011, FEMINIST REV, P151, DOI 10.1057/fr.2010.34; Kittay EF, 2005, J POLIT PHILOS, V13, P443, DOI 10.1111/j.1467-9760.2005.00232.x; Basting AD, 2003, J AGING STUD, V17, P87, DOI 10.1016/S0890-4065(02)00092-0; Jain SL, 2007, REPRESENTATIONS, P77, DOI 10.1525/rep.2007.98.77; DONOW HS, 1990, GERONTOLOGIST, V30, P486; Adam B, 2002, FEMINIST REV, P3; Morhardt D, 2013, GENERATIONS, V37, P37; LOUGHMAN C, 1991, WORLD LITERATURE TOD, V65, P49, DOI 10.2307/40146119; Berlant L, 2007, CRIT INQUIRY, V33, P754, DOI 10.1086/521568; Chivers S., 2011, SILVERING SCREENS OL; Cosslett T., 2000, FEMINISM AUTOBIOGRAP; Coulman F., 2007, POPULATION DECLINE A; Gilleard C., 2000, CULTURES AGEING SELF; Grosz E, 2004, NICK TIME POLITICS E; Hana ichimonme, 1985, HANA ICHIMONME; Hayashi M, 2011, HIST POLICY; Hughes JC, 2013, DEMENTIA-LONDON, V12, P348, DOI 10.1177/1471301213479597; Jennings B., 2010, COGNITIVE DISABILITY, P170; Katz S., 2012, OCCASION INTERDISCIP, V4, P1; Kingston J., 2011, JAPAN TRANSFORMATION; Kontos P, 2013, DEMENTIA-LONDON, V12, P288, DOI 10.1177/1471301213479787; [Labour and Welfare Ministry of Health], 2014, MIN HLTH LAB WELF SE; Long SO, 2000, SOCIAL SCI JAPAN J, V3, P21, DOI 10.1093/ssjj/3.1.21; Mainichi ga arutsuhaima, 2012, MAINICHI GA ARUTSUHA; Memories of Tomorrow, 2006, MEMORIES OF TOMORROW; Mobu N., 2004, KAIGO NYMON; Motion Pictures Producers Association of Japan, 2007, MOV BOX OFF GROSS RE; Okano Y., 2013, PECOROSS MOTHER HER; Pilling D., 2014, FINANCIAL TIMES; Population Reference Bureau (PRB), 2013, PRB 2013 WORLD POP D; Puar Jasbir K., 2009, WOMEN PERFORMANCE J, V19, P161, DOI DOI 10.1080/07407700903034147; Sae S., 1995, KORAKU; Sasaki A., 2008, KAIGO SHOSETSU NO FU; Shinoda S., 2014, CHOJO TACHI; Sugimoto Y., 2010, INTRO JAPANESE SOC; Tahara M., 1984, THE TWILIGHT YEARS; Traphagan J.W., 2000, TAMING OBLIVION AGIN; Wagahaha no ki, 2012, WAGAHAHA NO KI; Wartenberg T.E., 2012, ART COMICS PHILOS AP, P87; Wolk D., 2007, READING COMICS GRAPH; Woodward K., 2012, OCCASION INTERDISCIP, V4, P1	43	0	0	PALGRAVE MACMILLAN LTD	BASINGSTOKE	BRUNEL RD BLDG, HOUNDMILLS, BASINGSTOKE RG21 6XS, HANTS, ENGLAND	0141-7789	1466-4380		FEMINIST REV	Fem. Rev.	NOV	2015		111					88	108		10.1057/fr.2015.36		21	Women's Studies	Women's Studies	CW1CX	WOS:000364728300007		
J	Shiraishi, K; Oku, M; Uchida, D; Yurimoto, H; Sakai, Y				Shiraishi, Kosuke; Oku, Masahide; Uchida, Daichi; Yurimoto, Hiroya; Sakai, Yasuyoshi			Regulation of nitrate and methylamine metabolism by multiple nitrogen sources in the methylotrophic yeast Candida boidinii	FEMS YEAST RESEARCH			English	Article						nitrate reductase; amine oxidase; peroxisome; autophagy; nitrogen metabolism	ZN(II)(2)CYS(6) TRANSCRIPTIONAL FACTOR; HANSENULA-POLYMORPHA; GENE; ASSIMILATION; REDUCTASE; CLONING; PEROXISOMES; ACTIVATION; PROTEINS; MUTANTS	The methylotrophic yeast Candida boidinii, which is capable of growth on methanol as a sole carbon source, can proliferate on the leaf surface of Arabidopsis thaliana. Previously, we demonstrated that adaptation to a change in the major available nitrogen source from nitrate to methylamine during the host plant aging was crucial for yeast survival on the leaf environment. In this report, we investigated the regulatory profile of nitrate and methylamine metabolism in the presence of multiple nitrogen sources in C. boidinii. The transcript level of nitrate reductase (Ynr1) gene was induced by nitrate and nitrite, and was not repressed by the coexistence with other nitrogen sources. In contrast, the transcript level of amine oxidase (Amo1) gene, which was induced by methylamine, was significantly repressed by the coexistence with ammonium or glutamine. In addition, we investigated the intracellular dynamics of Ynr1 during the nitrogen source shift from nitrate to other compounds. Under these tested conditions, Ynr1 was effectively transported to the vacuole via selective autophagy only during the shift from nitrate to methylamine. Moreover, Ynr1 was subject to degradation after the shift from nitrate to nitrate plus methylamine medium even though nitrate was still available. These regulatory profiles may reflect life style of nitrogen utilization in this yeast living in the phyllosphere.	[Shiraishi, Kosuke; Oku, Masahide; Uchida, Daichi; Yurimoto, Hiroya; Sakai, Yasuyoshi] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan; [Sakai, Yasuyoshi] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Res Unit Physiol Chem, Kyoto 6068502, Japan; [Sakai, Yasuyoshi] Japan Sci & Technol Agcy, Adv Low Carbon Technol Res & Dev Program, Chiyoda Ku, Tokyo, Japan	Sakai, Y (reprint author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan.	ysakai@kais.kyoto-u.ac.jp			Japan Society for the Promotion of Science [26111511, 25281063, 26850064]; Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan	This research was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas (26111511 to Y.S.), a Grant-in-Aid for Scientific Research (B) (25281063 to H.Y.), and a Grant-in-Aid for Exploratory Research (B) (26850064 to M.O.) from the Japan Society for the Promotion of Science. The work was also supported in part by the Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency. This study was partly supported by the program for leading graduate schools (all-round model) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to K.S.).	Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; HIPKIN CR, 1993, BIOCHEM J, V295, P611; Barea JM, 2005, J EXP BOT, V56, P1761, DOI 10.1093/jxb/eri197; Pignocchi C, 1998, MICROBIOL-UK, V144, P2323; ZWART K, 1980, ARCH MICROBIOL, V126, P117, DOI 10.1007/BF00511216; FABER KN, 1994, P NATL ACAD SCI USA, V91, P12985, DOI 10.1073/pnas.91.26.12985; ZWART KB, 1983, A VAN LEEUW J MICROB, V49, P369; TANI Y, 1985, J FERMENT TECHNOL, V63, P443; SAKAI Y, 1992, J BACTERIOL, V174, P5988; Avila J, 1998, BIOCHEM J, V335, P647; Brito N, 1996, BIOCHEM J, V317, P89; SAKAI Y, 1991, J BACTERIOL, V173, P7458; GONZALEZ C, 1992, J GEN MICROBIOL, V138, P1445; Garcia-Lugo P, 2000, YEAST, V16, P1099, DOI 10.1002/1097-0061(20000915)16:12<1099::AID-YEA596>3.0.CO;2-S; Siverio JM, 2002, FEMS MICROBIOL REV, V26, P277, DOI 10.1111/j.1574-6976.2002.tb00615.x; Pita WD, 2011, ANTON LEEUW INT J G, V100, P99, DOI 10.1007/s10482-011-9568-z; Bustin SA, 2012, MYCOSES, V55, P30; Ruiz-Rueda O, 2009, FEMS MICROBIOL ECOL, V67, P308, DOI 10.1111/j.1574-6941.2008.00615.x; Avila J, 2002, YEAST, V19, P537, DOI 10.1002/yea.847; Suzuki K, 2013, CELL DEATH DIFFER, V20, P43, DOI 10.1038/cdd.2012.73; Sakai Y, 1998, YEAST, V14, P1175, DOI 10.1002/(SICI)1097-0061(19980930)14:13<1175::AID-YEA319>3.3.CO;2-Z; Barnett J., 2000, YEASTS CHARACTERISTI; Kawaguchi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025257; Kumar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048982; Lodish H, 2008, MOL CELL BIOL; Shiraishi K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09719; Stevenson FJ, 1999, CYCLES SOILS CARBON	27	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1567-1356	1567-1364		FEMS YEAST RES	FEMS Yeast Res.	NOV	2015	15	7							fov084	10.1093/femsyr/fov084		9	Biotechnology & Applied Microbiology; Microbiology; Mycology	Biotechnology & Applied Microbiology; Microbiology; Mycology	CW1PY	WOS:000364765000017		
J	Irzmanska, E; Dutkiewicz, J				Irzmanska, Emilia; Dutkiewicz, Jacek			Preliminary Evaluation of Airlaid Nonwovens with Superabsorbent for Use in Protective Footwear: Tests Involving a Thermal Foot Model and Climatic Chamber	FIBRES & TEXTILES IN EASTERN EUROPE			English	Article						nonwovens; superabsorbent; protective footwear; insoles	MICROCLIMATE; COMFORT; FIBERS; IMPACT	The paper presents preliminary results of simulation studies evaluating moisture absorption from the air that indicate the possibility of applying a superabsorbent polymer (SAP) in the construction of protective footwear insoles. The performance of different types of non-wovens was tested in terms of moisture absorption from air of high relative humidity in a climatic chamber and on a thermal foot model. The tests simulated the temperature and humidity conditions that occur inside all-rubber protective footwear. It was found that insoles containing SAP dehumidified the air more effectively than either insoles not containing SAP or traditional wool felt insoles. The tests showed a new application potential of absorbent materials in protective footwear with a view to improving hygienic comfort during use.	[Irzmanska, Emilia] Cent Inst Labour Protect, Natl Res Inst, Tokyo, Japan; [Dutkiewicz, Jacek] Univ Bielsko Biala, Bielsko Biala, Poland	Irzmanska, E (reprint author), Cent Inst Labour Protect, Natl Res Inst, Tokyo, Japan.	emirz@ciop.lodz.pl			National Science Centre [N N404 068240, 0682/B/P01/2011/40]; Ministry of Science and Higher Education/The National Centre for Research and Development	The publication draws on results obtained as part of a research task implemented under statutory activity of CIOP-PIB (2010-2012) and research grant No. N N404 068240 (contract number 0682/B/P01/2011/40) financed by the National Science Centre in the years 2011-2013 at the CIOP-PIB.; The publication was based on the results of Phase II of the National Programme "Safety and working conditions improvement", funded in the years 2011-2013 in the area of research and development works by the Ministry of Science and Higher Education/The National Centre for Research and Development. The Programme coordinator: Central Institute for Labour Protection - National Research Institute	Kabiri K, 2011, POLYM COMPOSITE, V32, P277, DOI 10.1002/pc.21046; Bartkowiak G, 2010, FIBRES TEXT EAST EUR, V18, P82; Zohuriaan-Mehr MJ, 2008, IRAN POLYM J, V17, P451; Das A, 2008, J APPL POLYM SCI, V107, P1466, DOI 10.1002/app.26936; Kokabi M, 2007, EUR POLYM J, V43, P773, DOI 10.1016/j.eurpolymj.2006.11.030; AKBARKHANZADEH F, 1995, APPL ERGON, V26, P195, DOI 10.1016/0003-6870(95)00017-7; Bartkowiak G, 2011, WOODHEAD PUBL SER TE, P505; Bartkowiak G, 2006, FIBRES TEXT EAST EUR, V14, P57; Irzmanska E, 2014, INT J IND ERGONOM, V44, P706, DOI 10.1016/j.ergon.2014.07.006; HOLE LG, 1973, J SOC COSMET CHEM, V24, P43; Irzmanska E, 2012, FIBRES TEXT EAST EUR, V20, P119; Irzmanska E, 2015, APPL ERGON, V47, P34, DOI 10.1016/j.apergo.2014.08.013; Bartkowiak G, 2002, FIBRES TEXT EAST EUR, V1, P57; Beres J, 1992, CHEMIK, V3, P59; Dutkiewicz J, 2000, France, Patent No. [WO2000041882 A1, 2000041882]; Dutkiewicz JK, 2001, USA, Patent No. [6,329,565 B1, 6329565]; Glados S, 1998, WIAD CHEM, V52, P101; Irzmanska E, 2014, FIBRES TEXT EAST EUR, V22, P89; Irzmanska E, 2014, AUTEX RES J, V14, P89, DOI 10.2478/aut-2014-0005; Irzmanska E, 2014, TEXT RES J, V84, P728, DOI 10.1177/0040517513507362; Nowicka C., 1994, PRACE I WLOKIENNICTW, VXLVI, P59; Nowicka C, 2003, FIBRES TEXT EAST EUR, V11, P46; Sadikoglu TG, 2005, FIBRES TEXT EAST EUR, V13, P54; Steplewski W, 2006, FIBRES TEXT EAST EUR, V14, P25; Wawro D, 2002, FIBRES TEXT EAST EUR, V10, P23; Wawro D, 2006, FIBRES TEXT EAST EUR, V14, P97	26	0	0	INST CHEMICAL FIBRES	LODZ	UL M SKLODOWSKIEJ-CURIE 19/27, 90-570 LODZ, POLAND	1230-3666			FIBRES TEXT EAST EUR	Fibres Text. East. Eur.	NOV-DEC	2015	23	6					138	142		10.5604/12303666.1167432		5	Materials Science, Textiles	Materials Science	CW0WW	WOS:000364711700018		
J	Asakawa, T; Muraki, H; Watamura, S				Asakawa, Tsuguhiko; Muraki, Hisayoshi; Watamura, Satoshi			Gravity theory on Poisson manifold with R-flux	FORTSCHRITTE DER PHYSIK-PROGRESS OF PHYSICS			English	Article						Gravity; Poisson Geometry; Non-geometries	DOUBLE FIELD-THEORY; LIE BIALGEBROIDS; QUANTIZATION; GEOMETRY	A novel gravity theory based on Poisson Generalized Geometry is investigated. A gravity theory on a Poisson manifold equipped with a Riemannian metric is constructed from a contravariant version of the Levi-Civita connection, which is based on the Lie algebroid of a Poisson manifold. Then, we show that in Poisson Generalized Geometry the R-fluxes are consistently coupled with such a gravity. An R-flux appears as a torsion of the corresponding connection in a similar way as an H-flux which appears as a torsion of the connection formulated in the standard Generalized Geometry. We give an analogue of the Einstein-Hilbert action coupled with an R-flux, and show that it is invariant under both beta-diffeomorphisms and beta-gauge transformations.	[Asakawa, Tsuguhiko] Maebashi Inst Technol, Fac Engn, Dept Integrated Design Engn, Maebashi, Gumma 3710816, Japan; [Muraki, Hisayoshi] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan; [Watamura, Satoshi] Tohoku Univ, Grad Sch Sci, Dept Phys, Particle Theory & Cosmol Grp,Aoba Ku, Sendai, Miyagi 9808578, Japan	Muraki, H (reprint author), Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan.	asakawa@maebashi-it.ac.jp; hmuraki@het.ph.tsukuba.ac.jp			Tohoku University Institute for International Advanced Research and Education	Authors would like to thank the members of the particle theory and cosmology group, in particular U. Carow-Watamura for helpful comments and discussions. They would also like to thank David Andriot for valuable comments and suggestions. H. M. is supported in part by the Tohoku University Institute for International Advanced Research and Education.	Andriot D, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2014)059; Andriot D., 2013, J HIGH ENERGY PHYS, V1306, P021; Andriot D., 2015, JHEP, V1504, P006; Andriot D., ARXIV13030251HEPTH; Andriot D., 2013, J HIGH ENERGY PHYS, V1312, P083; Severa P, 2001, PROG THEOR PHYS SUPP, P145; Kimura T, 2015, NUCL PHYS B, V893, P1, DOI 10.1016/j.nuclphysb.2015.01.023; Weinstein A, 1997, J GEOM PHYS, V23, P379, DOI 10.1016/S0393-0440(97)80011-3; Steinacker H, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/13/133001; Hitchin N, 2003, Q J MATH, V54, P281, DOI 10.1093/qmath/hag025; de Boer J, 2013, PHYS REP, V532, P65, DOI 10.1016/j.physrep.2013.07.003; Aldazabal G, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/16/163001; Roytenberg D, 2002, LETT MATH PHYS, V61, P123, DOI 10.1023/A:1020708131005; Kikuchi T, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.046001; Aschieri P, 2005, CLASSICAL QUANT GRAV, V22, P3511, DOI 10.1088/0264-9381/22/17/011; Asakawa T, 2014, INT J MOD PHYS A, V29, DOI 10.1142/S0217751X14500894; Fernandes RL, 2000, J DIFFER GEOM, V54, P303; Asakawa T, 2015, INT J MOD PHYS A, V30, DOI 10.1142/S0217751X15500979; Cattaneo AS, 2000, COMMUN MATH PHYS, V212, P591, DOI 10.1007/s002200000229; Yang HS, 2009, INT J MOD PHYS A, V24, P4473, DOI 10.1142/S0217751X0904587X; Liu ZJ, 1997, J DIFFER GEOM, V45, P547; Kontsevich M, 2003, LETT MATH PHYS, V66, P157, DOI 10.1023/B:MATH.0000027508.00421.bf; BHASKARA KH, 1988, B LOND MATH SOC, V20, P68, DOI 10.1112/blms/20.1.68; Andriot D, 2012, FORTSCHR PHYS, V60, P1150, DOI 10.1002/prop.201200085; Andriot D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.261602; Hohm O, 2013, FORTSCHR PHYS, V61, P926, DOI 10.1002/prop.201300024; Asakawa T., ARXIV150305720HEPTH; Asakawa T., 2012, J HIGH ENERGY PHYS, V1210, P064; Baraglia D., 2007, THESIS U ADELAIDE; Blumenhagen R., 2013, J HIGH ENERGY PHYS, V1302, P122; Boucetta M., 2004, DIFFER GEOM APPL, V20, P279, DOI 10.1016/j.difgeo.2003.10.013; Boucetta M, 2003, CR MATH, V336, P423, DOI 10.1016/S1631-073X(03)00079-7; Boucetta M, 2001, CR ACAD SCI I-MATH, V333, P763, DOI 10.1016/S0764-4442(01)02132-2; Bruce A. J., ARXIV150607738MATHDG; Carroll S. M., ARXIVGRQC9712019; Chatzistavrakidis A, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.066004; da Silva A. C., 1999, GEOMETRIC MODELS NON; Dabholkar A., 2006, JHEP, V0605, P009; Gualtieri M., MATH0401221; Gualtieri M., ARXIVMATH07102719; Gualtieri M., MATH0703298; Hawkins E, 2004, COMMUN MATH PHYS, V246, P211, DOI 10.1007/s00220-004-1036-4; Hitchin N., ARXIV10080973MATHDG; Hull C., 2009, J HIGH ENERGY PHYS, V0909, P014; Hull C., 2009, JHEP, V0909, P090; Hull CM, 2005, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2005/10/065; Kimura T., 2014, J HIGH ENERGY PHYS, V1407, P127; Kimura T., 2015, JHEP, V1503, P076; KOSMANNSCHWARZBACH Y, 1990, ANN I H POINCARE-PHY, V53, P35; Kosmann-Schwarzbach Y, 2008, SYMMETRY INTEGR GEOM, V4, DOI 10.3842/SIGMA.2008.005; Koszul J. L., 1985, ASTERISQUE, P257; Okada T, 2015, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2015)131; Park M., ARXIV150505169HEPTH; Roytenberg D., 1999, THESIS BERKELEY; Sakatani Y, 2015, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2015)135; Shelton J, 2005, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2005/10/085; Steinacker H., 2007, JHEP, V0712, P049; Zwiebach B., 2012, LECT NOTE PHYS, V851, P265	58	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	0015-8208	1521-3978		FORTSCHR PHYS	Fortschritte Phys.-Prog. Phys.	NOV	2015	63	11-12					683	704		10.1002/prop.201500049		22	Physics, Multidisciplinary	Physics	CV5VP	WOS:000364339700002		
J	Suzuki, T; Yamamoto, M				Suzuki, Takafumi; Yamamoto, Masayuki			Molecular basis of the Keap1-Nrf2 system	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Nrf2; Keap1; Stress response; Carcinogenesis; Chemical inducers; Free radicals	HIGH-FAT DIET; CONSTITUTIVE NRF2 ACTIVATION; TRANSCRIPTION FACTOR NRF2; OXIDATIVE STRESS; BARDOXOLONE METHYL; LUNG-CANCER; INCREASED SUSCEPTIBILITY; SELECTIVE AUTOPHAGY; INSULIN-RESISTANCE; DIABETES-MELLITUS	Nrf2 (NF-E2-related factor 2) is a master regulator of cellular responses against environmental stresses. Nrf2 induces the expression of detoxification and antioxidant enzymes, and Keap1 (Kelch-like ECH-associated protein 1), an adaptor subunit of Cullin 3-based E3 ubiquitin ligase, regulates Nrf2 activity. Keap1 also acts as a sensor for oxidative and electrophilic stresses. Keap1 retains multiple sensor cysteine residues that detect various stress stimuli. Increasing attention has been paid to the roles that Nrf2 plays in the protection of our bodies against drug toxicity and stress-induced diseases. On the other hand, Nrf2 is found to promote both oncogenesis and cancer cell resistance against chemotherapeutic drugs. Thus, although Nrf2 acts to protect our body from deleterious stresses, cancer cells hijack the Nrf2 activity to support their malignant growth. Nrf2 has emerged as a new therapeutic target, and both inducers and inhibitors of Nrf2 are awaited. Studies challenging the molecular basis of the Keap1-Nrf2 system functions are now critically important to improve translational studies of the system. Indeed, recent studies identified cross talk between Nrf2 and other signaling pathways, which provides new insights into the mechanisms by which the Keap1-Nrf2 system serves as a potent regulator of our health and disease. (C) 2015 Published by Elsevier Inc.	[Suzuki, Takafumi; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 9808575, Japan	Yamamoto, M (reprint author), Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 9808575, Japan.	masiyamamoto@med.tohoku.ac.jp			MEXT/JSPS KAKENHI [24249015, 26460354, 25112502, 2611010]; CREST, JST; P-DIRECT, MEXT; Naito Foundation; Takeda Science Foundation	This work was supported in part by MEXT/JSPS KAKENHI (24249015 to M.Y. and 26460354, 25112502, and 2611010 to T.S.), CREST, JST (to M.Y.), P-DIRECT, MEXT) (to T.S. and M.Y.), the Naito Foundation (to M.Y.), and the Takeda Science Foundation (to M.Y.).	Hiramoto K, 2014, CANCER PREV RES, V7, P835, DOI 10.1158/1940-6207.CAPR-14-0094; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Satoh H, 2010, CARCINOGENESIS, V31, P1833, DOI 10.1093/carcin/bgq105; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Lewis KN, 2015, P NATL ACAD SCI USA, V112, P3722, DOI 10.1073/pnas.1417566112; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Shibata T, 2008, GASTROENTEROLOGY, V135, P1358, DOI 10.1053/j.gastro.2008.06.082; Hast BE, 2014, CANCER RES, V74, P808, DOI 10.1158/0008-5472.CAN-13-1655; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Zhang YKJ, 2012, TOXICOL APPL PHARM, V264, P305, DOI 10.1016/j.taap.2012.09.014; Dinkova-Kostova AT, 2012, TRENDS MOL MED, V18, P337, DOI 10.1016/j.molmed.2012.04.003; Deeb D, 2011, CARCINOGENESIS, V32, P757, DOI 10.1093/carcin/bgr030; Khor TO, 2008, CANCER PREV RES, V1, P187, DOI 10.1158/1940-6207.CAPR-08-0028; Taguchi K, 2012, P NATL ACAD SCI USA, V109, P13561, DOI 10.1073/pnas.1121572109; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Marcotte D, 2013, BIOORGAN MED CHEM, V21, P4011, DOI 10.1016/j.bmc.2013.04.019; Tran K, 2012, CANCER PREV RES, V5, P726, DOI 10.1158/1940-6207.CAPR-11-0404; Itoh K, 1999, FREE RADICAL RES, V31, P319, DOI 10.1080/10715769900300881; Hong DS, 2012, CLIN CANCER RES, V18, P3396, DOI 10.1158/1078-0432.CCR-11-2703; Kitamura Y, 2007, CANCER SCI, V98, P19, DOI 10.1111/j.1349-7006.2006.00352.x; Adam J, 2011, CANCER CELL, V20, P524, DOI 10.1016/j.ccr.2011.09.006; Saha PK, 2010, J BIOL CHEM, V285, P40581, DOI 10.1074/jbc.M110.176545; Ooi A, 2011, CANCER CELL, V20, P511, DOI 10.1016/j.ccr.2011.08.024; Meher AK, 2012, FREE RADICAL BIO MED, V52, P1708, DOI 10.1016/j.freeradbiomed.2012.02.022; Suzuki T, 2013, MOL CELL BIOL, V33, P2402, DOI 10.1128/MCB.00065-13; Gao L, 2007, J BIOL CHEM, V282, P2529, DOI 10.1074/jbc.M607622200; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Muscarella LA, 2011, EPIGENETICS-US, V6, P710, DOI 10.4161/epi.6.6.15773; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Marzec JM, 2007, FASEB J, V21, P2237, DOI 10.1096/fj.06-7759com; Morrow CS, 1998, J BIOL CHEM, V273, P20114, DOI 10.1074/jbc.273.32.20114; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Satoh H, 2013, CANCER RES, V73, P4158, DOI 10.1158/0008-5472.CAN-12-4499; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Meakin PJ, 2014, MOL CELL BIOL, V34, P3305, DOI [10.1128/MCB.00677-14, 10.1128/MCB.00677-1]; Fukutomi T, 2014, MOL CELL BIOL, V34, P832, DOI 10.1128/MCB.01191-13; Baird L, 2013, P NATL ACAD SCI USA, V110, P15259, DOI 10.1073/pnas.1305687110; Uruno A, 2013, MOL CELL BIOL, V33, P2996, DOI 10.1128/MCB.00225-13; Iida K, 2004, CANCER RES, V64, P6424, DOI 10.1158/0008-5472.CAN-04-1906; Yagishita Y, 2014, DIABETES, V63, P605, DOI 10.2337/db13-0909; Liby KT, 2012, PHARMACOL REV, V64, P972, DOI 10.1124/pr.111.004846; Chowdhry S, 2013, ONCOGENE, V32, P3765, DOI 10.1038/onc.2012.388; Takaya K, 2012, FREE RADICAL BIO MED, V53, P817, DOI 10.1016/j.freeradbiomed.2012.06.023; Xu CJ, 2006, CANCER RES, V66, P8293, DOI 10.1158/0008-5472.CAN-06-0300; de Zeeuw D, 2013, NEW ENGL J MED, V369, P2492, DOI 10.1056/NEJMoa1306033; Kanojia D, 2006, ORAL ONCOL, V42, P655, DOI 10.1016/j.oraloncology.2005.10.013; Ohkoshi A, 2013, CANCER PREV RES, V6, P149, DOI 10.1158/1940-6207.CAPR-12-0401-T; Taguchi K, 2014, MOL CELL BIOL, V34, P900, DOI 10.1128/MCB.01384-13; Ogura T, 2010, P NATL ACAD SCI USA, V107, P2842, DOI 10.1073/pnas.0914036107; Hu LQ, 2013, BIOORG MED CHEM LETT, V23, P3039, DOI 10.1016/j.bmcl.2013.03.013; Xu J, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-54; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Nagaraj S, 2010, CLIN CANCER RES, V16, P1812, DOI 10.1158/1078-0432.CCR-09-3272; Slocum SL, 2011, ARCH TOXICOL, V85, P273, DOI 10.1007/s00204-011-0675-4; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Uruno A, 2015, ARCH BIOCHEM BIOPHYS, V566, P76, DOI 10.1016/j.abb.2014.12.012; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Kim YR, 2010, J PATHOL, V220, P446, DOI 10.1002/path.2653; Taguchi K, 2010, MOL CELL BIOL, V30, P3016, DOI 10.1128/MCB.01591-09; Rachakonda G, 2008, CHEM RES TOXICOL, V21, P705, DOI 10.1021/tx700302s; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Yamamoto T, 2004, BIOCHEM BIOPH RES CO, V321, P72, DOI 10.1016/j.bbrc.2004.06.112; Bauer AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026590; Becks L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-540; Dinkova-Kostova AT, 2008, MOL NUTR FOOD RES, V52, pS128, DOI 10.1002/mnfr.200700195; Furusawa Y, 2014, GENES CELLS, V19, P864, DOI 10.1111/gtc.12186; Gao Xiaohua, 2011, Cancers (Basel), V3, P3353, DOI 10.3390/cancers3033353; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Okano Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073794; Rojo AI, 2014, ANTIOXID REDOX SIGN, V21, P2498, DOI 10.1089/ars.2014.5843; Wang YY, 2014, DRUG DES DEV THER, V8, P2075, DOI 10.2147/DDDT.S68872	83	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	NOV	2015	88		B				93	100		10.1016/j.freeradbiomed.2015.06.006		8	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CV0TN	WOS:000363966300002		
J	Murakami, S; Motohashi, H				Murakami, Shohei; Motohashi, Hozumi			Roles of Nrf2 in cell proliferation and differentiation	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Keap1-Nrf2 system; Cell proliferation; Differentiation; Stem cells	HEMATOPOIETIC STEM-CELLS; SMALL MAF PROTEINS; TRANSCRIPTION FACTOR NF-E2; YA-SUBUNIT GENE; REACTIVE OXYGEN; OXIDATIVE STRESS; SELF-RENEWAL; OSTEOCLAST DIFFERENTIATION; RESPONSIVE ELEMENT; KEAP1-NRF2 SYSTEM	The Keap1-Nrf2 system plays pivotal roles in defense mechanisms by regulating cellular redox homeostasis. Nrf2 is an inducible transcription factor that activates a battery of genes encoding antioxidant proteins and phase II enzymes in response to oxidative stress and electrophilic xenobiotics. The activity of Nrf2 is regulated by Keap1, which promotes the ubiquitination and subsequent degradation of Nrf2 under normal conditions and releases the inhibited Nrf2 activity upon exposure to the stresses. Though an impressive contribution of the Keap1-Nrf2 system to the protection from exogenous and endogenous electrophilic insults has been well established, a line of evidence has suggested that the Keap1-Nrf2 system has various novel functions, particularly in cell proliferation and differentiation. Because the proliferation and differentiation of diverse cell types are often influenced and modulated by the cellular redox balance, Nrf2 has been considered to control these cellular processes by regulating the cellular levels of reactive oxygen species (ROS). In addition, analyses of the genome-wide distribution of Nrf2 have identified new sets of Nrf2 target genes whose products are involved in cell proliferation and differentiation but not necessarily in the regulation of oxidative stress. Considering the most characteristic features of Nrf2 as an inducible transcription factor, a newly emerged concept proposes that the Keap1-Nrf2 system translates environmental stresses into regulatory network signals in cell fate determination. In this review, we introduce the contribution of Nrf2 to lineage-specific differentiation, maintenance and differentiation of stem cells, and proliferation of normal and cancer cells, and we discuss how the response to fluctuating environments modulates cell behavior through the Keap1-Nrf2 system. (C) 2015 Published by Elsevier Inc.	[Murakami, Shohei; Motohashi, Hozumi] Tohoku Univ, Inst Dev Aging & Canc, Dept Gene Express Regulat, Aoba Ku, Sendai, Miyagi 9808575, Japan	Motohashi, H (reprint author), Tohoku Univ, Inst Dev Aging & Canc, Dept Gene Express Regulat, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	hozumim@idac.tohoku.ac.jp			JSPS KAKENHI [24390075, 15108999]; MEXT KAKENHI [23116002]; Takeda Scientific Foundation; Core Research for Evolutional Science and Technology from the JST; GSK Japan Research Grant	This work was supported by JSPS KAKENHI Grant Numbers 24390075 (HM), 15108999 (SM), MEXT KAKENHI Grant Number 23116002 (HM), the Takeda Scientific Foundation (HM), the Core Research for Evolutional Science and Technology from the JST (HM) and the GSK Japan Research Grant (SM).	Agarwal Ashok, 2014, World J Mens Health, V32, P1, DOI 10.5534/wjmh.2014.32.1.1; Al-Sawaf O, 2014, J PATHOL, V234, P538, DOI 10.1002/path.4418; ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; Lean JM, 2003, J CLIN INVEST, V112, P915, DOI 10.1172/JCI200318859; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Kuroha T, 1998, J BIOCHEM-TOKYO, V123, P376; Brigelius-Flohe R, 2011, ANTIOXID REDOX SIGN, V15, P2335, DOI 10.1089/ars.2010.3534; Lewis KN, 2015, P NATL ACAD SCI USA, V112, P3722, DOI 10.1073/pnas.1417566112; Kimura M, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706863200; Hochmuth CE, 2011, CELL STEM CELL, V8, P188, DOI 10.1016/j.stem.2010.12.006; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Motohashi H, 2006, MOL CELL BIOL, V26, P4652, DOI 10.1128/MCB.02196-05; Paek J, 2012, CELL METAB, V16, P526, DOI 10.1016/j.cmet.2012.09.007; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Motohashi H, 2010, BLOOD, V115, P677, DOI 10.1182/blood-2009-05-223107; Cho HY, 2012, ANTIOXID REDOX SIGN, V17, P1066, DOI 10.1089/ars.2011.4288; Hinoi E, 2006, J BIOL CHEM, V281, P18015, DOI 10.1074/jbc.M600603200; Fisher D, 2012, J CELL SCI, V125, P4703, DOI 10.1242/jcs.106351; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Katsuoka F, 2003, MOL CELL BIOL, V23, P1163, DOI 10.1128/MCB.23.4.1163-1174.2003; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908; Persano L, 2013, BIOCHEM PHARMACOL, V85, P612, DOI 10.1016/j.bcp.2012.10.001; Xue P, 2013, DIABETES, V62, P845, DOI 10.2337/db12-0584; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Lefebvre B, 2010, J CLIN INVEST, V120, P1454, DOI 10.1172/JCI38606; Shirasaki K, 2014, HEPATOLOGY, V59, P2371, DOI 10.1002/hep.27020; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Fujita R, 2013, MOL CELL BIOL, V33, P2659, DOI 10.1128/MCB.01274-12; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Zhao F, 2009, FREE RADICAL BIO MED, V47, P867, DOI 10.1016/j.freeradbiomed.2009.06.029; Suzuki T, 2013, MOL CELL BIOL, V33, P2402, DOI 10.1128/MCB.00065-13; Hinoi E, 2007, BONE, V40, P337, DOI 10.1016/j.bone.2006.08.016; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; Ye ZW, 2015, BBA-GEN SUBJECTS, V1850, P1607, DOI 10.1016/j.bbagen.2014.11.010; Kondo H, 2010, J APPL PHYSIOL, V108, P152, DOI 10.1152/japplphysiol.00294.2009; Wang K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.50; Jia D, 2011, RADIAT RES, V176, P624, DOI 10.1667/RR2505.1; Shin S, 2007, MOL CELL BIOL, V27, P7188, DOI 10.1128/MCB.00915-07; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Nakamura BN, 2010, FREE RADICAL BIO MED, V49, P1368, DOI 10.1016/j.freeradbiomed.2010.07.019; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Pi JB, 2010, J BIOL CHEM, V285, P9292, DOI 10.1074/jbc.M109.093955; Myant KB, 2013, CELL STEM CELL, V12, P761, DOI 10.1016/j.stem.2013.04.006; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; KATAOKA K, 1995, MOL CELL BIOL, V15, P2180; ITOH K, 1995, MOL CELL BIOL, V15, P4184; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Hyeon S, 2013, FREE RADICAL BIO MED, V65, P789, DOI 10.1016/j.freeradbiomed.2013.08.005; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Motohashi H, 2000, CELL, V103, P865, DOI 10.1016/S0092-8674(00)00190-2; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Yu BL, 2012, J MOL MED, V90, P1333, DOI 10.1007/s00109-012-0914-z; Park CK, 2014, BONE, V63, P36, DOI 10.1016/j.bone.2014.01.025; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Uruno A, 2013, MOL CELL BIOL, V33, P2996, DOI 10.1128/MCB.00225-13; Kanamori M, 2015, NEURO-ONCOLOGY, V17, P555, DOI 10.1093/neuonc/nou282; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Paul MK, 2014, CELL STEM CELL, V15, P199, DOI 10.1016/j.stem.2014.05.009; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Yagishita Y, 2014, DIABETES, V63, P605, DOI 10.2337/db13-0909; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Hirotsu Y, 2012, NUCLEIC ACIDS RES, V40, P10228, DOI 10.1093/nar/gks827; Hegab AE, 2011, STEM CELLS, V29, P1283, DOI 10.1002/stem.680; Zhu JH, 2014, ONCOL LETT, V7, P693, DOI 10.3892/ol.2013.1760; FRILING RS, 1990, P NATL ACAD SCI USA, V87, P6258, DOI 10.1073/pnas.87.16.6258; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Xu JL, 2012, DIABETES, V61, P3208, DOI 10.2337/db11-1716; Merchant AA, 2011, BLOOD, V118, P6572, DOI 10.1182/blood-2011-05-355362; Taguchi K, 2014, MOL CELL BIOL, V34, P900, DOI 10.1128/MCB.01384-13; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Karkkainen V, 2014, STEM CELLS, V32, P1904, DOI 10.1002/stem.1666; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Rana T, 2012, FREE RADICAL BIO MED, V53, P2298, DOI 10.1016/j.freeradbiomed.2012.10.536; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Motohashi H, 2011, MOL CELL BIOL, V31, P151, DOI 10.1128/MCB.00798-10; McCrann DJ, 2009, BLOOD, V114, P1243, DOI 10.1182/blood-2008-12-195883; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; Hou YY, 2012, FREE RADICAL BIO MED, V52, P462, DOI 10.1016/j.freeradbiomed.2011.10.453; Lee JM, 2004, P NATL ACAD SCI USA, V101, P9751, DOI 10.1073/pnas.0403620101; Huebner AJ, 2012, DEV CELL, V23, P1238, DOI 10.1016/j.devcel.2012.11.002; Bobilev I, 2011, CANCER BIOL THER, V11, P317, DOI 10.4161/cbt.11.3.14098; Kim JH, 2014, J CLIN INVEST, V124, P730, DOI 10.1172/JCI70812; Holmstrom KM, 2013, BIOL OPEN, V2, P761, DOI 10.1242/bio.20134853; Kanzaki H, 2013, J BIOL CHEM, V288, P23009, DOI 10.1074/jbc.M113.478545; Inoue D, 2012, CANCER SCI, V103, P760, DOI 10.1111/j.1349-7006.2012.02216.x; Kawatani Y, 2011, BLOOD, V117, P986, DOI 10.1182/blood-2010-05-285817; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Ewald CY, 2015, NATURE, V519, P97, DOI 10.1038/nature14021; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Muto A, 1998, EMBO J, V17, P5734, DOI 10.1093/emboj/17.19.5734; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Yamamoto T, 2006, GENES CELLS, V11, P575, DOI 10.1111/j.1365-2443.2006.00965.x; Itoh K, 2015, J CLIN BIOCHEM NUTR, V56, P91, DOI 10.3164/jcbn.14-134; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Beyer TA, 2008, EMBO J, V27, P212, DOI 10.1038/sj.emboj.7601950; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Rojo AI, 2012, FREE RADICAL BIO MED, V52, P473, DOI 10.1016/j.freeradbiomed.2011.11.003; Takayama M, 2010, MOL CELL BIOL, V30, P2668, DOI 10.1128/MCB.01304-09; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Drevet JR, 2006, MOL CELL ENDOCRINOL, V250, P70, DOI 10.1016/j.mce.2005.12.027; Tsai JJ, 2013, NAT CELL BIOL, V15, P309, DOI 10.1038/ncb2699; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Reddy NM, 2008, ONCOGENE, V27, P5821, DOI 10.1038/onc.2008.188; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; Bishop A.N., 2007, NATURE, V447, P545; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P2383, DOI 10.1093/nar/22.12.2383; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Del Vecchio CA, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001945; Forman HJ, 2015, FREE RADICAL BIO MED, V78, P233, DOI 10.1016/j.freeradbiomed.2014.10.504; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Itoh-Nakadai A, 2014, NAT IMMUNOL, V15, P1171, DOI 10.1038/ni.3024; Jang JW, 2014, STEM CELLS, V32, P2616, DOI 10.1002/stem.1764; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Murakami S, 2014, GENES CELLS, V19, P239, DOI 10.1111/gtc.12126; Onodera Y, 2014, ENDOCR-RELAT CANCER, V21, P241, DOI 10.1530/ERC-13-0234; Singer E, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.566; Singh A K, 2013, RES REV J ECOLOGY EN, V1, P1; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Tsujita T, 2014, MOL CELL BIOL, V34, P3800, DOI 10.1128/MCB.00110-14; Wakabayashi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000762; Zhu JH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-380; Zou YH, 2015, AM J PHYSIOL-GASTR L, V308, pG262, DOI 10.1152/ajpgi.00332.2014	151	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	NOV	2015	88		B				168	178		10.1016/j.freeradbiomed.2015.06.030		11	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CV0TN	WOS:000363966300007		
J	Ishii, T				Ishii, Tetsuro			Close teamwork between Nrf2 and peroxiredoxins 1 and 6 for the regulation of prostaglandin D-2 and E-2 production in macrophages in acute inflammation	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Nrf2; Peroxiredoxin; 15d-PGJ(2); Prostaglandin; Lipocalin-type prostaglandin D synthase; Toll like receptor 4; NE-kappa B; NADPH oxidase 2; Lipopolysaccharide; S-glutathionylation; Polyphenols; Free radicals		Inflammation is a complex biological self-defense reaction triggered by tissue damage or infection by pathogens. Acute inflammation is regulated by the time- and cell type-dependent production of cytokines and small signaling molecules including reactive oxygen species and prostaglandins. Recent studies have unveiled the important role of the transcription factor Nrf2 in the regulation of prostaglandin production through transcriptional regulation of peroxiredoxins 1 and 6 (Prx1 and Prx6) and lipocalin-type prostaglandin D synthase (L-PGDS). Prx1 and Prx6 are multifunctional proteins important for cell protection against oxidative stress, but also work together to facilitate production of prostaglanclins E-2 and D-2 (PGE(2) and PGD(2)). Prxl secreted from cells under mild oxidative stress binds Toll-like receptor 4 and induces NF-kappa B activation, important for the expression of cyclooxygenase-2 and microsomal PGE synthase-1 (mPGES-1) expression. The activated MAPKs p38 and ERK phosphorylate Prx6, leading to NADPH oxidase-2 activation, which contributes to production of PGD2 by hematopoietic prostaglandin D synthase (H-PGDS). PGD(2) and its end product 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) activate Nrf2 thereby forming a positive feedback loop for further production of PGD2 by L-PGDS. Maintenance of cellular glutathione levels is an important role of Nrf2 not only for cell protection but also for the synthesis of prostaglandins, as mPGES-1 and H-PGDS require glutathione for their activities. This review is aimed at describing the functions of Prxl and Prx6 in the regulation of PGD2 and PGE2 production in acute inflammation in macrophages and the importance of 15d-PGJ2 as an intrinsic Nrf2 activator. (C) 2015 Elsevier Inc. All rights reserved.	Univ Tsukuba, Ibaraki 3058575, Japan	Ishii, T (reprint author), Univ Tsukuba, Ibaraki 3058575, Japan.	ishiitetsuro305@gmail.com						0	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	NOV	2015	88		B				189	198		10.1016/j.freeradbiomed.2015.04.034		10	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CV0TN	WOS:000363966300009		
J	Mimura, J; Itoh, K				Mimura, Junsei; Itoh, Ken			Role of Nrf2 in the pathogenesis of atherosclerosis	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Atherosclerosis; Nrf2; Oxidative stress; Inflammation; Oxidized LDL; Lipid metabolism; Endothelial cell; Smooth muscle cell; Macrophage; CD36	E-DEFICIENT MICE; LOW-DENSITY-LIPOPROTEIN; SMOOTH-MUSCLE-CELL; TRANSCRIPTION FACTOR NRF2; MACROPHAGE SCAVENGER RECEPTORS; ANTIOXIDANT RESPONSE ELEMENTS; MONOCYTE-DERIVED MACROPHAGES; DIET-INDUCED OBESITY; HIGH-FAT DIET; APOLIPOPROTEIN-E	Atherosclerosis is a chronic inflammatory disease of the vascular arterial walls. A number of studies have revealed the biological and genetic bases of atherosclerosis, and over 100 genes influence atherosclerosis development. Nrf2 plays an important role in oxidative stress response and drug metabolism, but the Nrf2 signaling pathway is closely associated with atherosclerosis development. During atherosclerosis progression, Nrf2 signaling modulates many physiological and pathophysiological processes, such as lipid homeostasis regulation, foam cell formation, macrophage polarization, redox regulation and inflammation. Interestingly, Nrf2 exhibits both pro- and anti-atherogenic effects in experimental animal models. These observations make the Nrf2 pathway a promising target to prevent atherosclerosis. (C) 2015 Published by Elsevier Inc.	[Mimura, Junsei; Itoh, Ken] Hirosaki Univ, Dept Stress Response Sci, Grad Sch Med, Hirosaki, Aomori 0368562, Japan	Mimura, J (reprint author), Hirosaki Univ, Dept Stress Response Sci, Grad Sch Med, Hirosaki, Aomori 0368562, Japan.	jmimura@hirosaki-u.ac.jp			MEXT, Japan [26111010]	We thank Drs. Atsushi Maruyama and Hiromi Yamazaki for their helpful advice and discussion. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Oxygen Biology: a new criterion for integrated understanding of life" (to K.I., No.26111010) of MEXT, Japan.	Ho FM, 2007, BIOCHEM PHARMACOL, V74, P298, DOI 10.1016/j.bcp.2007.04.008; Boyle JJ, 2009, AM J PATHOL, V174, P1097, DOI 10.2353/ajpath.2009.080431; Torzewski M, 2007, ARTERIOSCL THROM VAS, V27, P850, DOI 10.1161/01.ATV.0000258809.47285.07; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141; Touyz RM, 2004, HISTOCHEM CELL BIOL, V122, P339, DOI 10.1007/s00418-004-0696-7; Freigang S, 2011, EUR J IMMUNOL, V41, P2040, DOI 10.1002/eji.201041316; Duckers HJ, 2001, NAT MED, V7, P693, DOI 10.1038/89068; Griendling KK, 1998, J LAB CLIN MED, V132, P9, DOI 10.1016/S0022-2143(98)90019-1; Boyle JJ, 2012, CIRC RES, V110, P20, DOI 10.1161/CIRCRESAHA.111.247577; Zhang HP, 2013, ARCH MED RES, V44, P13, DOI 10.1016/j.arcmed.2012.12.001; Hur KY, 2010, ATHEROSCLEROSIS, V211, P69, DOI 10.1016/j.atherosclerosis.2010.01.035; Chen XL, 2006, AM J PHYSIOL-HEART C, V290, pH1862, DOI 10.1152/ajpheart.00651.2005; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Leemans JC, 2011, IMMUNOL REV, V243, P152, DOI 10.1111/j.1600-065X.2011.01043.x; Maor I, 2000, BIOCHEM BIOPH RES CO, V269, P775, DOI 10.1006/bbrc.2000.2359; Oury C, 2014, CELL MOL IMMUNOL, V11, P8, DOI 10.1038/cmi.2013.48; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Bonomini F, 2008, HISTOL HISTOPATHOL, V23, P381; De Nardo D, 2011, TRENDS IMMUNOL, V32, P373, DOI 10.1016/j.it.2011.05.004; Zipper LM, 2003, TOXICOL SCI, V73, P124, DOI 10.1093/toxsci/kfg083; Gui T, 2012, MEDIAT INFLAMM, DOI 10.1155/2012/693083; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Kitteringham NR, 2010, J PROTEOMICS, V73, P1612, DOI 10.1016/j.jprot.2010.03.018; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; Yet SF, 2003, FASEB J, V17, P1759, DOI 10.1096/fj.03-0187fje; Dai G, 2007, CIRC RES, V101, P723, DOI 10.1161/CIRCRESAHA.107.152942; Gleissner CA, 2010, CIRC RES, V106, P203, DOI 10.1161/CIRCRESAHA.109.199505; Ruotsalainen AK, 2013, CARDIOVASC RES, V98, P107, DOI 10.1093/cvr/cvt008; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Xue P, 2013, DIABETES, V62, P845, DOI 10.2337/db12-0584; Kong ANT, 2001, DRUG METAB REV, V33, P255, DOI 10.1081/DMR-120000652; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Howden R, 2013, OXID MED CELL LONGEV, DOI 10.1155/2013/104308; Zhang YKJ, 2010, TOXICOL APPL PHARM, V245, P326, DOI 10.1016/j.taap.2010.03.016; Orozco LD, 2007, CIRC RES, V100, P1703, DOI 10.1161/CIRCRESAHA.107.151720; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI14006; Li JQ, 2009, EXPERT OPIN THER TAR, V13, P785, DOI 10.1517/14728220903025762; Rosenblat Mira, 2007, Atherosclerosis, V195, pe61, DOI 10.1016/j.atherosclerosis.2007.05.012; Karasawa T, 2011, ARTERIOSCL THROM VAS, V31, P1788, DOI 10.1161/ATVBAHA.110.219659; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Wei YH, 2013, P NATL ACAD SCI USA, V110, pE3910, DOI 10.1073/pnas.1309276110; Juan SH, 2001, CIRCULATION, V104, P1519, DOI 10.1161/hc3801.095663; Shin S, 2007, MOL CELL BIOL, V27, P7188, DOI 10.1128/MCB.00915-07; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Pi JB, 2010, J BIOL CHEM, V285, P9292, DOI 10.1074/jbc.M109.093955; Hybertson BM, 2011, MOL ASPECTS MED, V32, P234, DOI 10.1016/j.mam.2011.10.006; Victor VM, 2009, CURR PHARM DESIGN, V15, P2988; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Marzec JM, 2007, FASEB J, V21, P2237, DOI 10.1096/fj.06-7759com; Vinchi F, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00094; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022; Harada N, 2012, FREE RADICAL BIO MED, V53, P2256, DOI 10.1016/j.freeradbiomed.2012.10.001; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Tanaka Y, 2008, J PHARMACOL EXP THER, V325, P655, DOI 10.1124/jpet.107.135822; Dornas WC, 2010, ARQ BRAS CARDIOL, V95, P272, DOI 10.1590/S0066-782X2010001200020; HAYEK T, 1994, BIOCHEM BIOPH RES CO, V201, P1567, DOI 10.1006/bbrc.1994.1883; Ranalletta M, 2006, ARTERIOSCL THROM VAS, V26, P2308, DOI 10.1161/01.ATV.0000242275.92915.43; Pae HO, 2006, ATHEROSCLEROSIS, V187, P274, DOI 10.1016/j.atherosclerosis.2005.09.010; Jawien J, 2004, J PHYSIOL PHARMACOL, V55, P503; Fan JL, 2015, PHARMACOL THERAPEUT, V146, P104, DOI 10.1016/j.pharmthera.2014.09.009; Biswas SK, 2005, BIOCHEM BIOPH RES CO, V338, P1368, DOI 10.1016/j.bbrc.2005.10.098; Rosenblat M, 2002, ATHEROSCLEROSIS, V163, P17, DOI 10.1016/S0021-9150(01)00744-4; De Paoli F, 2014, CIRC J, V78, P1775, DOI 10.1253/circj.CJ-14-0621; Chen XL, 2009, INFLAMM RES, V58, P513, DOI 10.1007/s00011-009-0017-7; Tang XW, 2011, FREE RADICAL BIO MED, V50, P1599, DOI 10.1016/j.freeradbiomed.2011.03.008; Lewis P, 2007, CIRCULATION, V115, P2178, DOI 10.1161/CIRCULATIONAHA.106.664250; Zhang ZY, 2015, SPECTROSC SPECT ANAL, V35, P1, DOI 10.3964/j.issn.1000-0593(2015)01-0001-04; Sanan DA, 1998, P NATL ACAD SCI USA, V95, P4544, DOI 10.1073/pnas.95.8.4544; Harada N, 2011, ARCH BIOCHEM BIOPHYS, V508, P101, DOI 10.1016/j.abb.2011.02.001; Ding Y, 2014, INT J CARDIOL, V175, P508, DOI 10.1016/j.ijcard.2014.06.045; Lin W, 2008, BIOCHEM PHARMACOL, V76, P967, DOI 10.1016/j.bcp.2008.07.036; Bories G, 2013, CIRC RES, V113, P1196, DOI 10.1161/CIRCRESAHA.113.301656; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; Kim MJ, 2013, ENDOCR J, V60, P1171; Chowdhry S, 2013, ONCOGENE, V32, P3765, DOI 10.1038/onc.2012.388; Zghonda N, 2011, BIOSCI BIOTECH BIOCH, V75, P1259, DOI 10.1271/bbb.110022; Callegari A, 2011, ARTERIOSCL THROM VAS, V31, P2473, DOI 10.1161/ATVBAHA.111.229765; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Wang XJ, 2007, P NATL ACAD SCI USA, V104, P19589, DOI 10.1073/pnas.0709483104; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Collins AR, 2012, ARTERIOSCL THROM VAS, V32, P2839, DOI 10.1161/ATVBAHA.112.300345; de Villiers WJS, 1999, J LEUKOCYTE BIOL, V66, P740; Leitinger N, 2013, ARTERIOSCL THROM VAS, V33, P1120, DOI 10.1161/ATVBAHA.112.300173; Zhao CC, 2014, J BIOL CHEM, V289, P17020, DOI 10.1074/jbc.M114.563114; Xu JL, 2012, DIABETES, V61, P3208, DOI 10.2337/db11-1716; Barajas B, 2011, ARTERIOSCL THROM VAS, V31, P58, DOI 10.1161/ATVBAHA.110.210906; Takabe W, 2011, ANTIOXID REDOX SIGN, V15, P1415, DOI 10.1089/ars.2010.3433; Lee TS, 1999, CIRCULATION, V99, P1222; Xu J, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-54; Sawada H, 2012, ATHEROSCLEROSIS, V225, P83, DOI 10.1016/j.atherosclerosis.2012.08.023; Kim SY, 2009, CIRC RES, V104, P842, DOI 10.1161/CIRCRESAHA.108.189837; Cho SS, 1999, FREE RADICAL BIO MED, V26, P589, DOI 10.1016/S0891-5849(98)00232-9; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Boyle JJ, 1999, INT J EXP PATHOL, V80, P197, DOI 10.1046/j.1365-2613.1999.00125.x; Warabi E, 2007, FREE RADICAL BIO MED, V42, P260, DOI 10.1016/j.freeradbiomed.2006.10.043; Kondo T, 2009, J ATHEROSCLER THROMB, V16, P532; Takahashi T, 2009, BIOCHEM BIOPH RES CO, V382, P549, DOI 10.1016/j.bbrc.2009.03.059; Zheng F, 2014, MEDIAT INFLAMM, DOI 10.1155/2014/507208; Schneider KS, 2013, ADV NUTR, V4, P62, DOI 10.3945/an.112.003103; Hou YY, 2012, FREE RADICAL BIO MED, V52, P462, DOI 10.1016/j.freeradbiomed.2011.10.453; Kuhn AM, 2011, FREE RADICAL BIO MED, V50, P1382, DOI 10.1016/j.freeradbiomed.2011.02.036; Mo CF, 2014, ANTIOXID REDOX SIGN, V20, P574, DOI 10.1089/ars.2012.5116; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Cairo G, 2011, TRENDS IMMUNOL, V32, P241, DOI 10.1016/j.it.2011.03.007; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Qiao M, 2007, ARTERIOSCL THROM VAS, V27, P1375, DOI 10.1161/ATVBAHA.107.142109; Ashino T, 2013, ARTERIOSCL THROM VAS, V33, P760, DOI 10.1161/ATVBAHA.112.300614; Valcarcel-Ares MN, 2012, J GERONTOL A-BIOL, V67, P821, DOI 10.1093/gerona/glr229; Levonen AL, 2007, ARTERIOSCL THROM VAS, V27, P741, DOI 10.1161/01.ATV.0000258868.80079.4d; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Hsieh CY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-12; Kisucka J, 2008, CIRC RES, V103, P598, DOI 10.1161/CIRCRESAHA.108.174870; Ishii T, 2004, CIRC RES, V94, P609, DOI 10.1161/01.RES.0000119171.44657.45; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Kuchibhotla S, 2008, CARDIOVASC RES, V78, P185, DOI 10.1093/cvr/cvm093; Hosoya T, 2005, J BIOL CHEM, V280, P27244, DOI 10.1074/jbc.M502551200; Sugimoto R, 2010, J CELL MOL MED, V14, P1546, DOI 10.1111/j.1582-4934.2009.00914.x; Kong XN, 2010, J IMMUNOL, V185, P569, DOI 10.4049/jimmunol.0902315; Park JG, 2011, CIRC RES, V109, P739, DOI 10.1161/CIRCRESAHA.111.245530; Huang JS, 2010, AM J PHYSIOL-GASTR L, V299, pG1211, DOI 10.1152/ajpgi.00322.2010; Magesh S, 2012, MED RES REV, V32, P687, DOI 10.1002/med.21257; Bea F, 2003, CIRC RES, V92, P386, DOI 10.1161/01.RES.0000059561.65545.16; SMITH C, 1992, BIOCHEM J, V286, P901; Cheng C, 2009, CIRCULATION, V119, P3017, DOI 10.1161/CIRCULATIONAHA.108.808618; Collins AR, 2009, CIRC RES, V104, pe42, DOI 10.1161/CIRCRESAHA.108.188771; Cheng C, 2012, ARTERIOSCL THROM VAS, V32, P1289, DOI 10.1161/ATVBAHA.112.245530; Maruyama A, 2008, ARCH BIOCHEM BIOPHYS, V477, P139, DOI 10.1016/j.abb.2008.06.004; Zipper LM, 2000, BIOCHEM BIOPH RES CO, V278, P484, DOI 10.1006/bbrc.2000.3830; Chen JS, 2011, ATHEROSCLEROSIS, V214, P301, DOI 10.1016/j.atherosclerosis.2010.11.010; Finn AV, 2012, J AM COLL CARDIOL, V59, P166, DOI 10.1016/j.jacc.2011.10.852; Figarska SM, 2014, PHYSIOL GENOMICS, V46, P411, DOI 10.1152/physiolgenomics.00178.2013; Mann Giovanni E., 2007, Shengli Xuebao, V59, P117; Gleissner CA, 2010, J IMMUNOL, V184, P4810, DOI 10.4049/jimmunol.0901368; Recalcati S, 2010, EUR J IMMUNOL, V40, P824, DOI 10.1002/eji.200939889; Baldan A., 2006, THROMB VASC BIOL, V26, P2301; Colin S, 2014, IMMUNOL REV, V262, P153, DOI 10.1111/imr.12218; Gupte A.A., 2013, CURR DIABETES REP, V13, P367; Hernandez-Trujillo Y, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-3; Hsieh HJ, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-3; Kapourchali Fatemeh Ramezani, 2014, World J Clin Cases, V2, P126, DOI 10.12998/wjcc.v2.i5.126; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Kim J, 2010, MUTAT RES-FUND MOL M, V690, P12, DOI [10.1016/j.mrfmmm.2009.09.007, 10.1016/j.mrfmmm.2010.09.007]; Kumar H, 2014, NAT PROD REP, V31, P109, DOI 10.1039/c3np70065h; Kwak MK, 2004, MUTAT RES-FUND MOL M, V555, P133, DOI 10.1016/j.mrfmmm.2004.06.041; Lusis Aldons J, 2004, Annu Rev Genomics Hum Genet, V5, P189, DOI 10.1146/annurev.genom.5.061903.175930; Menu P, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.18; Mudau M, 2012, CARDIOVASC J AFR, V23, DOI 10.5830/CVJA-2011-068; Niture SK, 2011, J BIOL CHEM, V286, P28821, DOI 10.1074/jbc.M111.255042; Rafieian-Kopaei Mahmoud, 2014, Int J Prev Med, V5, P927; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Roberts A, 1976, Adv Exp Med Biol, V67, P313; Rudijanto Achmad, 2007, Acta Med Indones, V39, P86; Seo H.-A., 2013, OXID MED CELL LONGEV, V184598, P2013; Siedlinski M, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-73; Sullivan JL, 2009, BBA-GEN SUBJECTS, V1790, P718, DOI 10.1016/j.bbagen.2008.06.005; Sussan TE, 2008, PLOS ONE, V3, pe3791, DOI DOI 10.1371/J0URNAL.P0NE.0003791); Van Berkel TJC, 2000, ANN NY ACAD SCI, V902, P113; Van Berkel T.J., 2000, ANN NY ACAD SCI, V902, P126; Whitman Stewart C, 2004, Clin Biochem Rev, V25, P81; Xu JL, 2015, OBESITY, V23, P335, DOI 10.1002/oby.20929; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	166	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	NOV	2015	88		B				221	232		10.1016/j.freeradbiomed.2015.06.019		12	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CV0TN	WOS:000363966300013		
J	Li, TC; Villarrubia, G; Sun, SD; Corchado, JM; Bajo, J				Li, Tian-cheng; Villarrubia, Gabriel; Sun, Shu-dong; Corchado, Juan M.; Bajo, Javier			Resampling methods for particle filtering: identical distribution, a new method, and comparable study	FRONTIERS OF INFORMATION TECHNOLOGY & ELECTRONIC ENGINEERING			English	Article						Particle filter; Resampling; Kullback-Leibler divergence; Kolmogorov-Smirnov statistic	SEQUENTIAL MONTE-CARLO; ONLINE INFERENCE; CONVERGENCE; TRACKING; STABILITY; MODELS; IMPOVERISHMENT; ALGORITHMS; FRAMEWORK	Resampling is a critical procedure that is of both theoretical and practical significance for efficient implementation of the particle filter. To gain an insight of the resampling process and the filter, this paper contributes in three further respects as a sequel to the tutorial (Li et al., 2015). First, identical distribution (ID) is established as a general principle for the resampling design, which requires the distribution of particles before and after resampling to be statistically identical. Three consistent metrics including the (symmetrical) Kullback-Leibler divergence, Kolmogorov-Smirnov statistic, and the sampling variance are introduced for assessment of the ID attribute of resampling, and a corresponding, qualitative ID analysis of representative resampling methods is given. Second, a novel resampling scheme that obtains the optimal ID attribute in the sense of minimum sampling variance is proposed. Third, more than a dozen typical resampling methods are compared via simulations in terms of sample size variation, sampling variance, computing speed, and estimation accuracy. These form a more comprehensive understanding of the algorithm, providing solid guidelines for either selection of existing resampling methods or new implementations.	[Li, Tian-cheng; Villarrubia, Gabriel; Corchado, Juan M.] Univ Salamanca, BISITE Grp, Fac Sci, E-37008 Salamanca, Spain; [Li, Tian-cheng; Sun, Shu-dong] Northwestern Polytech Univ, Sch Mech Engn, Xian 710072, Peoples R China; [Bajo, Javier] Tech Univ Madrid, Dept Artificial Intelligence, Madrid 28040, Spain; [Corchado, Juan M.] Osaka Inst Technol, Asahi Ku, Omiya, Osaka 5358585, Japan	Li, TC (reprint author), Univ Salamanca, BISITE Grp, Fac Sci, C Espejo S-N, E-37008 Salamanca, Spain.	t.c.li@usal.es			National Natural Science Foundation of China [51475383]; European Commission MSCA-RISE [641794]; Excellent Doctorate Foundation of Northwestern Polytechnical University; University of Salamanca	Project supported by the National Natural Science Foundation of China (No. 51475383), European Commission MSCA-RISE-2014 (No. 641794), the Excellent Doctorate Foundation of Northwestern Polytechnical University, and the Postdoctoral Fellowship of the University of Salamanca	Adiprawita W., 2011, P INT C EL ENG INF, P1, DOI [10.1109/ICEEI.2011.6021733, DOI 10.1109/ICEEI.2011.6021733]; Djuric PM, 2010, IEEE T SIGNAL PROCES, V58, P5069, DOI 10.1109/TSP.2010.2053707; KONG A, 1994, J AM STAT ASSOC, V89, P278, DOI 10.2307/2291224; Li TC, 2012, SIGNAL PROCESS, V92, P1637, DOI 10.1016/j.sigpro.2011.12.019; Li TC, 2016, SIGNAL PROCESS, V119, P115, DOI 10.1016/j.sigpro.2015.07.013; Crisan D, 2002, IEEE T SIGNAL PROCES, V50, P736, DOI 10.1109/78.984773; Gustafsson F, 2010, IEEE AERO EL SYS MAG, V25, P53, DOI 10.1109/MAES.2010.5546308; Whiteley N, 2013, ANN APPL PROBAB, V23, P2500, DOI 10.1214/12-AAP909; Hu XL, 2011, IEEE T SIGNAL PROCES, V59, P3424, DOI 10.1109/TSP.2011.2135349; Perez CJ, 2005, COMMUN STAT-SIMUL C, V34, P97, DOI 10.1081/SAC-200047112; Li TC, 2014, EXPERT SYST APPL, V41, P3944, DOI 10.1016/j.eswa.2013.12.031; Stano PM, 2013, AUTOMATICA, V49, P147, DOI 10.1016/j.automatica.2012.10.006; [Anonymous], 2003, ACOUST SPEECH SIG PR; Djuric PM, 2003, IEEE SIGNAL PROC MAG, V20, P19, DOI 10.1109/MSP.2003.1236770; Fearnhead P, 2003, J R STAT SOC B, V65, P887, DOI 10.1111/1467-9868.00421; Fox D, 2003, INT J ROBOT RES, V22, P985, DOI 10.1177/0278364903022012001; Beskos A, 2014, ANN APPL PROBAB, V24, P1396, DOI 10.1214/13-AAP951; Chen YG, 2005, J ROY STAT SOC B, V67, P199, DOI 10.1111/j.1467-9868.2005.00497.x; Hong SH, 2010, CIRC SYST SIGNAL PR, V29, P155, DOI 10.1007/s00034-009-9117-4; Arulampalam MS, 2002, IEEE T SIGNAL PROCES, V50, P174, DOI 10.1109/78.978374; Wang YF, 2013, J INVERSE ILL-POSE P, V21, P1, DOI 10.1515/jip-2012-0030; Liu JS, 1998, J AM STAT ASSOC, V93, P1032, DOI 10.2307/2669847; Mbalawata IS, 2016, SIGNAL PROCESS, V118, P133, DOI 10.1016/j.sigpro.2015.06.018; Godsill SJ, 2007, P IEEE, V95, P925, DOI 10.1109/JPROC.2007.894708; Kwak N, 2008, ROBOTICA, V26, P205, DOI 10.1017/S0263574707003773; Crisan D, 1999, PROBAB THEORY REL, V115, P549, DOI 10.1007/s004400050249; Sutharsan S, 2012, IEEE T AERO ELEC SYS, V48, P1601, DOI 10.1109/TAES.2012.6178081; Das SK, 2013, 2013 8TH INTERNATIONAL WORKSHOP ON SYSTEMS, SIGNAL PROCESSING AND THEIR APPLICATIONS (WOSSPA), P384, DOI 10.1109/WoSSPA.2013.6602396; Li TC, 2015, IEEE SIGNAL PROC MAG, V32, P70, DOI 10.1109/MSP.2014.2330626; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Cappe O, 2007, P IEEE, V95, P899, DOI 10.1109/JPROC.2007.893250; Douc R, 2014, ANN APPL PROBAB, V24, P1767, DOI 10.1214/13-AAP962; Morelande MR, 2011, INT CONF ACOUST SPEE, P3984; Bashi A., 2003, P 2003 INT C INF FUS, P1164, DOI DOI 10.1109/ICIF.2003.177369; Choe GM, 2014, J ZHEJIANG U-SCI C, V15, P861, DOI 10.1631/jzus.C1400006; Choe G, 2015, IET COMPUT VIS, V9, P184, DOI 10.1049/iet-cvi.2014.0106; Crisan D., 1998, RELATED FIELDS, V5, P293; Del Moral P., 2012, FDN TRENDS MACHINE L, V3, P225; Douc R., 2005, Proceedings of the 4th International Symposium on Image and Signal Processing and Analysis (IEEE Cat. No. 05EX1094); Doucet A., 2001, SEQUENTIAL MONTE CAR, DOI [10.1007/978-1-4757-3437-9, DOI 10.1007/978-1-4757-3437-9]; Efron B., 2015, INT ENCY SOCIAL BEHA, P492, DOI [10.1016/B978-0-08-097086-8.42165-3, DOI 10.1016/B978-0-08-097086-8.42165-3]; Fearnhead P, 2007, J ROY STAT SOC B, V69, P589, DOI 10.1111/j.1467-9868.2007.00601.x; GORDON NJ, 1993, IEE PROC-F, V140, P107; Hol J.D., 2006, P NONL STAT SIGN PRO, P79, DOI 10.1109/NSSPW.2006.4378824; Kalman R. E., 1960, J BASIC ENG, V82, P35, DOI DOI 10.1115/1.3662552; Kitagawa G., 1996, J COMPUTATIONAL GRAP, V5, P1, DOI DOI 10.2307/1390750; Lang H., 2015, P 6 INT S AMB INT, P45, DOI [10.1007/978-3-319-19695-4_5, DOI 10.1007/978-3-319-19695-4_5]; LENSTRA HW, 1983, MATH OPER RES, V8, P538, DOI 10.1287/moor.8.4.538; Li T., 2013, P 2013 IEEE EL DISTR, P1, DOI 10.1049/ic.2013.0002; Li Tian-Cheng, 2010, Acta Automatica Sinica, V36, DOI 10.3724/SP.J.1004.2010.01279; Li T., 2013, ELECTRON LETT, V46, P740, DOI [10.1049/e1.2013.0233, DOI 10.1049/E1.2013.0233]; Liu JS, 2001, STAT ENG IN, P225; Miguez J., 2004, EURASIP J APPL SIG P, V15, P2278, DOI DOI 10.1155/S1110865704406039; Murray L., 2012, ARXIV12026163V1; Nielsen F., 2010, ARXIV10094004; Robert CP, 2004, MONTE CARLO STAT MET, DOI [10.1007/978-1-4757-4145-2, DOI 10.1007/978-1-4757-4145-2]; RUBIN DB, 1987, J AM STAT ASSOC, V82, P543, DOI 10.2307/2289460; Sileshi B.G., 2013, P C DES ARCH SIGN IM, P319; Simonetto A., 2009, P 1 IFAC WORKSH EST, P138, DOI 10.3182/20090924-3-IT-4005.00024; Topsoe F, 2000, IEEE T INFORM THEORY, V46, P1602, DOI 10.1109/18.850703; Zhi R., 2014, ADV MAT RES, V951, P202, DOI [10.4028/www.scientific.net/AMR.951.202, DOI 10.4028/WWW.SCIENTIFIC.NET/AMR.951.202]	61	0	0	ZHEJIANG UNIV	HANGZHOU	EDITORIAL BOARD, 20 YUGU RD, HANGZHOU, 310027, PEOPLES R CHINA	2095-9184	2095-9230		FRONT INFORM TECH EL	Front. Inform. Technol. Elect. Eng.	NOV	2015	16	11					969	984		10.1631/FITEE.1500199		16	Computer Science, Information Systems; Computer Science, Software Engineering; Engineering, Electrical & Electronic	Computer Science; Engineering	CV8VD	WOS:000364565200006		
J	Furuta, T; Komeda, N; Asano, K; Uehara, K; Gamuyao, R; Angeles-Shim, RB; Nagai, K; Doi, K; Wang, DR; Yasui, H; Yoshimura, A; Wu, JZ; McCouch, SR; Ashikari, M				Furuta, Tomoyuki; Komeda, Norio; Asano, Kenji; Uehara, Kanako; Gamuyao, Rico; Angeles-Shim, Rosalyn B.; Nagai, Keisuke; Doi, Kazuyuki; Wang, Diane R.; Yasui, Hideshi; Yoshimura, Atsushi; Wu, Jianzhong; McCouch, Susan R.; Ashikari, Motoyuki			Convergent Loss of Awn in Two Cultivated Rice Species Oryza sativa and Oryza glaberrima Is Caused by Mutations in Different Loci	G3-GENES GENOMES GENETICS			English	Article						awn; domestication; Asian rice; African rice; CSSLs	SUBSTITUTION LINES CSSLS; WHEAT AWNS; ORIGIN; RUFIPOGON; GENOME; GENE; DNA; TRANSFORMATION; AGROBACTERIUM; DOMESTICATION	A long awn is one of the distinct morphological features of wild rice species. This organ is thought to aid in seed dispersal and prevent predation by animals. Most cultivated varieties of Oryza sativa and Oryza glaberrima, however, have lost the ability to form long awns. The causal genetic factors responsible for the loss of awn in these two rice species remain largely unknown. Here, we evaluated three sets of chromosome segment substitution lines (CSSLs) in a common O. sativa genetic background (cv. Koshihikari) that harbor genomic fragments from Oryza nivara, Oryza rufipogon, and Oryza glaberrima donors. Phenotypic analyses of these libraries revealed the existence of three genes, Regulator of Awn Elongation 1 (RAE1), RAE2, and RAE3, involved in the loss of long awns in cultivated rice. Donor segments at two of these genes, RAE1 and RAE2, induced long awn formation in the CSSLs whereas an O. sativa segment at RAE3 induced long awn formation in O. glaberrima. These results suggest that the two cultivated rice species, O. sativa and O. glaberrima, have taken independent paths to become awnless.	[Furuta, Tomoyuki; Komeda, Norio; Asano, Kenji; Uehara, Kanako; Gamuyao, Rico; Angeles-Shim, Rosalyn B.; Nagai, Keisuke; Doi, Kazuyuki; Ashikari, Motoyuki] Nagoya Univ, Biosci & Biotechnol Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Wang, Diane R.; McCouch, Susan R.] Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA; [Yasui, Hideshi; Yoshimura, Atsushi] Kyushu Univ, Plant Breeding Lab, Higashi Ku, Fukuoka 8128581, Japan; [Wu, Jianzhong] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan	McCouch, SR (reprint author), Cornell Univ, Dept Genet & Plant Breeding, 162 Emerson Hall, Ithaca, NY 14853 USA.	srm4@cornell.edu; ashi@agr.nagoya-u.ac.jp			Program for the Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Ministry of Education, Culture, Sports, Science [22119007]; Japan Science and Technology (JST) Agency-Japan International Cooperation Agency within framework of the Science and Technology Research Partnership for Sustainable Development (SATREPS); Core Research for Evolutional Science and Technology, JST; National Science Foundation (USA) through a graduate research fellowship; Plant Genome Research Program Grant [1026555]	This work was supported mainly by the Program for the Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, and in part by Grants in Aid for Scientific Research 22119007 from the Ministry of Education, Culture, Sports, Science, by the Japan Science and Technology (JST) Agency-Japan International Cooperation Agency within the framework of the Science and Technology Research Partnership for Sustainable Development (SATREPS), by the Core Research for Evolutional Science and Technology, JST, and by the National Science Foundation (USA) through a graduate research fellowship (to D.W.) and a Plant Genome Research Program Grant (#1026555).	Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Toriba T, 2014, PLANT J, V77, P616, DOI 10.1111/tpj.12411; Luo JH, 2013, PLANT CELL, V25, P3360, DOI 10.1105/tpc.113.113589; Fuller DQ, 2010, ARCHAEOL ANTHROP SCI, V2, P115, DOI 10.1007/s12520-010-0035-y; Elbaum R, 2007, SCIENCE, V316, P884, DOI 10.1126/science.1140097; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li ZM, 2011, THEOR APPL GENET, V123, P21, DOI 10.1007/s00122-011-1563-2; KJACK JL, 1974, CROP SCI, V14, P243; Shim RA, 2010, BREEDING SCI, V60, P613, DOI 10.1270/jsbbs.60.613; Gross BL, 2010, J EVOLUTION BIOL, V23, P2747, DOI 10.1111/j.1420-9101.2010.02125.x; Sanyal A, 2010, MOL BIOL EVOL, V27, P2487, DOI 10.1093/molbev/msq133; Furuta T, 2014, BREEDING SCI, V63, P468, DOI 10.1270/jsbbs.63.468; Hattori Y, 2007, BREEDING SCI, V57, P305, DOI 10.1270/jsbbs.57.305; Liu YG, 1999, P NATL ACAD SCI USA, V96, P6535, DOI 10.1073/pnas.96.11.6535; TAKAHASHI R, 1955, ADV GENET, V7, P227, DOI 10.1016/S0065-2660(08)60097-8; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; Wang MH, 2014, NAT GENET, V46, P982, DOI 10.1038/ng.3044; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Linares OF, 2002, P NATL ACAD SCI USA, V99, P16360, DOI 10.1073/pnas.252604599; HOOD EE, 1986, J BACTERIOL, V168, P1291; Elbaum R, 2008, J STRUCT BIOL, V164, P101, DOI 10.1016/j.jsb.2008.06.008; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; Tanabata T, 2012, PLANT PHYSIOL, V160, P1871, DOI 10.1104/pp.112.205120; GRUNDBACHER FJ, 1963, BOT REV, V29, P366, DOI 10.1007/BF02860824; Lorieux M, 2000, THEOR APPL GENET, V100, P593, DOI 10.1007/s001229900061; Yoshimura A, 2010, BREEDING SCI, V60, P597, DOI 10.1270/jsbbs.60.597; Cheng CY, 2003, MOL BIOL EVOL, V20, P67, DOI 10.1093/molbev/msg004; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Xiong LX, 1999, THEOR APPL GENET, V98, P243, DOI 10.1007/s001220051064; Chang T. T., 1977, Meeting on African rice species, 25-26 January 1977., P67; Dahlgren R, 1985, FAMILIES MONOCOTYLED; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Sato S, 1996, BREEDING SCI, V46, P321; TAKAHASHI N, 1986, Reports of the Institute for Agricultural Research Tohoku University, V35, P21; Tatsumi J., 1972, NIPPON SAKUMOTSU GAK, V56, P11; Tsudamori M., 1933, NISSAKUKI, V5, P380; Yamanaka S, 2003, GENET RESOUR CROP EV, V50, P529, DOI 10.1023/A:1023926802198	37	0	0	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	2160-1836			G3-GENES GENOM GENET	G3-Genes Genomes Genet.	NOV	2015	5	11					2267	2274		10.1534/g3.115.020834		8	Genetics & Heredity	Genetics & Heredity	CW0BA	WOS:000364652700005		
J	So, R; Hirota, T; Yamamoto, Y; Hishimoto, A; Correll, CU				So, Ryuhei; Hirota, Tomoya; Yamamoto, Yuki; Hishimoto, Akitoyo; Correll, Christoph U.			Lack of cardinal symptoms of meningitis in a hospitalized patient with chronic schizophrenia: lessons to be learned	GENERAL HOSPITAL PSYCHIATRY			English	Editorial Material						Acute Disorder; Internal Medicine; Neuropsychiatry; Schizophrenia; Meningitis	ADULTS; PAIN	Objective: There are prior reports describing a diagnostic delay in medical emergencies in patients with schizophrenia. To our knowledge, this is the first case report demonstrating the risk of diagnostic delay of acute meningitis due to reduced pain perception as well as other factors related to schizophrenia and its treatment. Method: We report a case of meningitis in a patient suffering from chronic schizophrenia and poor treatment response despite high doses of antipsychotics. Potential difficulties and pitfalls when suspecting or diagnosing meningitis as a physical comorbidity in patients with schizophrenia are discussed. Results: A 33-year-old man with chronic and treatment-resistant schizophrenia developed acute meningitis. The definite diagnosis was delayed because the cardinal symptoms other than fever were not clearly elicited by physical examination. The characteristic symptoms of meningitis were concealed by reduced pain perception, rigidity due to the administration of antipsychotics, disorganized thinking and potentially diminished communication with health care professionals as commonly seen in patients with schizophrenia. Conclusion: Meningitis should not be dismissed as a possibility in patients with fever of unknown origin just because a patient with schizophrenia does not present with cardinal features of meningitis other than fever. (c) 2015 Elsevier Inc. All rights reserved.	[So, Ryuhei] Okayama Psychiat Med Ctr, Dept Psychiat, Okayama, Japan; [Hirota, Tomoya] Univ Calif San Francisco, Dept Psychiat, Div Child & Adolescent Psychiat, San Francisco, CA USA; [Yamamoto, Yuki] Kurashiki Cent Hosp, Dept Infect Control & Prevent, Dept Clin Lab Medecine, Okayama, Japan; [Hishimoto, Akitoyo] Kobe Univ, Dept Psychiat, Grad Sch Med, Kobe, Hyogo 657, Japan; [Correll, Christoph U.] North Shore LIJ Hlth Syst, Div Psychiat Res, Zucker Hillside Hosp, Glen Oaks, NY USA	So, R (reprint author), 3-16 Shikatahonmachi,Kita Ward, Okayama 7000915, Japan.	nexttext@gmail.com; tomoya.hirota@ucsf.edu; yy14429@kchnet.or.jp; hishipon@med.kobe-u.ac.jp; ccorrell@lij.edu					De Hert M, 2007, PSYCHIAT RES, V152, P165, DOI 10.1016/j.psychres.2006.07.012; Engels G, 2014, J PAIN, V15, P457, DOI 10.1016/j.jpain.2013.11.005; Thomas KE, 2002, CLIN INFECT DIS, V35, P46, DOI 10.1086/340979; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Metersky ML, 1997, CLIN INFECT DIS, V25, P285, DOI 10.1086/514531; Murakami H, 2010, LANCET, V375, P864, DOI 10.1016/S0140-6736(09)62061-4; De Hert M, 2011, WORLD PSYCHIATRY, V10, P52; Gabriel A, 1997, CAN J PSYCHIAT, V42, P864; Retamero C, 2012, GEN HOSP PSYCHIAT, V34; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0163-8343	1873-7714		GEN HOSP PSYCHIAT	Gen. Hosp. Psych.	NOV-DEC	2015	37	6							UNSP 621.e3	10.1016/j.genhosppsych.2015.07.011		2	Psychiatry	Psychiatry	CV8AK	WOS:000364498700025		
J	Akai, R; Hosoda, A; Yoshino, M; Iwawaki, T				Akai, Ryoko; Hosoda, Akira; Yoshino, Mayuko; Iwawaki, Takao			Constitutive role of GADD34 and CReP in cancellation of phospho-eIF2-alpha dependent translational attenuation and insulin biosynthesis in pancreatic beta cells	GENES TO CELLS			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; GLUCOSE-REGULATED PROTEINS; ER STRESS; MAMMALIAN-CELLS; MESSENGER-RNA; DIABETES-MELLITUS; IRE1; SURVIVAL; TRANSCRIPTION	Insulin biosynthesis has been well characterized with respect to transcriptional and post-translational regulation. However, the relationship between translational regulation of insulin and protein quality control in the endoplasmic reticulum (ER) remains to be clarified. Here we carried out forced expression of insulin in non-insulin-producing cells and compared activation level of ER stress-responsive molecules between insulin-producing cells and non-insulin-producing cells under normal culture condition or ER stress condition. Forced expression of insulin in non-insulin-producing cells caused severe ER stress with striking translational attenuation through phosphorylation of eIF2 by activation of protein kinase RNA-like endoplasmic reticulum kinase (PERK), resulting in inhibition of insulin production at the protein level. We also found that GADD34 and CReP are highly expressed in the cells that endogenously produce insulin and that eIF2 shows constitutively low phosphorylation level in these cells although PERK is constitutively activated under both normal culture conditions and physiological conditions in the same cells. Inhibition of eIF2 phosphatase further decreased insulin level in pancreatic cells. These findings suggest that eIF2 phosphorylation level is kept low by GADD34- and/or CReP-regulated phosphatases in pancreatic cells and that cancellation of phospho-eIF2-dependent translational inhibition by the molecular mechanism contributes to mass production of insulin in pancreatic beta cells.	[Akai, Ryoko; Yoshino, Mayuko; Iwawaki, Takao] Gunma Univ, Grad Sch Med, Educ & Res Support Ctr, Iwawaki Lab, Maebashi, Gunma 3718511, Japan; [Akai, Ryoko; Hosoda, Akira; Iwawaki, Takao] RIKEN, Adv Sci Inst, Iwawaki Initiat Res Unit, Wako, Saitama 3510198, Japan	Iwawaki, T (reprint author), Gunma Univ, Grad Sch Med, Educ & Res Support Ctr, Iwawaki Lab, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	iwawaki@gunma-u.ac.jp			RIKEN; tenure-track program in Gunma Univ.; MEXT [24390049]	We thank M. Tokuda for technical assistance. We are also grateful for the support of BSI's Research Resources Center (RIKEN) and the Biosignal Genome Resource Center (Gunma University) in performing the DNA sequencing analysis, grateful to the Radioisotope Experiment Center (RIKEN) and the Radioisotope Research Center (Gunma University) in experiments with radioisotopes, and the Laboratory for Analytical Instruments (Gunma University) in analysis with an IP laser scanner. This work was supported by grants from RIKEN (to T.I.), JST (to T.I.), the tenure-track program in Gunma Univ. (to T.I.) and MEXT (No. 24390049 to T.I.).	KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Van Lommel L, 2006, DIABETES, V55, P3214, DOI 10.2337/db06-0774; Kulkarni RN, 2004, INT J BIOCHEM CELL B, V36, P365, DOI 10.1016/j.biocel.2003.08.010; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Wek RC, 2006, BIOCHEM SOC T, V34, P7; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; SCHUIT FC, 1991, BIOCHEM BIOPH RES CO, V178, P1182, DOI 10.1016/0006-291X(91)91017-7; Shi YG, 1998, MOL CELL BIOL, V18, P7499; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086; Iwawaki T, 2001, NAT CELL BIOL, V3, P158, DOI 10.1038/35055065; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Yagishita Y, 2014, DIABETES, V63, P605, DOI 10.2337/db13-0909; SCHUIT FC, 1988, P NATL ACAD SCI USA, V85, P3865, DOI 10.1073/pnas.85.11.3865; Yamaguchi S, 2008, CELL METAB, V7, P269, DOI 10.1016/j.cmet.2008.01.008; Harding HP, 1999, NATURE, V397, P271; Davidson HW, 2004, CELL BIOCHEM BIOPHYS, P143; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; ELAYAT AA, 1995, J ANAT, V186, P629; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; Iwawaki T, 2013, SEMIN IMMUNOPATHOL, V35, P333, DOI 10.1007/s00281-013-0369-5; Nadanaka S, 2007, MOL CELL BIOL, V27, P1027, DOI 10.1128/MCB.00408-06; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Kimata Y, 2011, CURR OPIN CELL BIOL, V23, P135, DOI 10.1016/j.ceb.2010.10.008; Iwawaki T, 2006, BIOCHEM BIOPH RES CO, V350, P709, DOI 10.1016/j.bbrc.2006.09.100; Delepine M, 2000, NAT GENET, V25, P406; Connor JH, 2001, MOL CELL BIOL, V21, P6841, DOI 10.1128/MCB.21.20.6841-6850.2001; BAETENS D, 1979, SCIENCE, V206, P1323, DOI 10.1126/science.390711; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; PERMUTT MA, 1972, J BIOL CHEM, V247, P1194; Hinnebusch Alan G., 1994, Seminars in Cell Biology, V5, P417, DOI 10.1006/scel.1994.1049; Iwawaki T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013052; Oikawa D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051290	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	NOV	2015	20	11					871	886		10.1111/gtc.12279		16	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CV8FY	WOS:000364517800001		
J	Ishida, K; Miyauchi, K; Kimura, Y; Mito, M; Okada, S; Suzuki, T; Nakagawa, S				Ishida, Kentaro; Miyauchi, Kenjyo; Kimura, Yuko; Mito, Mari; Okada, Shunpei; Suzuki, Tsutomu; Nakagawa, Shinichi			Regulation of gene expression via retrotransposon insertions and the noncoding RNA 4.5S RNA(H)	GENES TO CELLS			English	Article							NUCLEAR RETENTION; TRANSPOSABLE ELEMENTS; MESSENGER-RNAS; POLYMERASE-II; EDITING SITES; HEAT-SHOCK; CELLS; MOUSE; TRANSCRIPTION; EVOLUTION	Short interspersed elements (SINEs) comprise a significant portion of mammalian genomes and regulate gene expression through a variety of mechanisms. Here, we show that Myodonta clade-specific 4.5S RNA(H) (4.5SH), an abundant nuclear noncoding RNA that is highly homologous to the retrotransposon SINE B1, controls the expression of reporter gene that contains the antisense insertion of SINE B1 via nuclear retention. The depletion of endogenous 4.5SH with antisense oligonucleotides neutralizes the nuclear retention and changes the subcellular distribution of the reporter transcripts containing the antisense SINE B1 insertion. Importantly, endogenous transcripts with antisense SINE B1 were increased in the cytoplasm after knockdown of 4.5SH, leading to a decrease in cellular growth. We propose a tentative hypothesis that the amplification of the 4.5SH cluster in specific rodent species might delineate their evolutionary direction via the regulation of genes containing the antisense insertion of SINE B1.	[Ishida, Kentaro; Kimura, Yuko; Mito, Mari; Nakagawa, Shinichi] RIKEN, Adv Res Inst, RNA Biol Lab, Wako, Saitama 3510198, Japan; [Miyauchi, Kenjyo; Okada, Shunpei; Suzuki, Tsutomu] Univ Tokyo, Dept Chem Biotechnol, Grad Sch Engn, Bunkyo Ku, Tokyo 113, Japan	Nakagawa, S (reprint author), RIKEN, Adv Res Inst, RNA Biol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	nakagawas@riken.jp	Nakagawa, Shinichi/I-4192-2014		Japan Science and Technology Agency; Ministry of Education, Science, Sports and Culture of Japan (MEXT); Japan Society for the Promotion of Science	We thank Drs Yutaka Hirose and for their discussions and thoughtful comments as well as Ms Kaori Yanaka and Ms Chieko Nashiki for their technical assistance. This work was supported by a PRESTO project grant from the Japan Science and Technology Agency, Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Science, Sports and Culture of Japan (MEXT) and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	Gong CG, 2013, NAT STRUCT MOL BIOL, V20, P1214, DOI 10.1038/nsmb.2664; SCHOENIGER LO, 1986, MOL CELL BIOL, V6, P1508; Sakurai M, 2010, NAT CHEM BIOL, V6, P733, DOI [10.1038/nchembio.434, 10.1038/.NCHEMBIO.434]; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Espinoza CA, 2004, NAT STRUCT MOL BIOL, V11, P822, DOI 10.1038/nsmb812; Hirose Y, 2008, BIOCHEM BIOPH RES CO, V365, P62, DOI 10.1016/j.bbrc.2007.10.117; Mariner PD, 2008, MOL CELL, V29, P499, DOI 10.1016/j.molcel.2007.12.013; Bohne A, 2008, CHROMOSOME RES, V16, P203, DOI 10.1007/s10577-007-1202-6; Ip JY, 2012, DEV GROWTH DIFFER, V54, P44, DOI 10.1111/j.1440-169X.2011.01303.x; LEINWAND LA, 1982, MOL CELL BIOL, V2, P1320; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; Taniguchi-Ikeda M, 2011, NATURE, V478, P127, DOI 10.1038/nature10456; Ferrigno O, 2001, NAT GENET, V28, P77, DOI 10.1038/88306; Allen TA, 2004, NAT STRUCT MOL BIOL, V11, P816, DOI 10.1038/nsmb813; Lunyak VV, 2007, SCIENCE, V317, P248, DOI 10.1126/science.1140871; Parrott AM, 2007, NUCLEIC ACIDS RES, V35, P6249, DOI 10.1093/nar/gkm668; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Gogvadze E, 2009, CELL MOL LIFE SCI, V66, P3727, DOI 10.1007/s00018-009-0107-2; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; HARADA F, 1986, NUCLEIC ACIDS RES, V14, P1629, DOI 10.1093/nar/14.4.1629; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Sakurai M, 2011, METHODS MOL BIOL, V718, P89, DOI 10.1007/978-1-61779-018-8_5; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Ishizuka A, 2014, GENES CELLS, V19, P704, DOI 10.1111/gtc.12169; JELINEK W, 1978, CELL, V15, P205, DOI 10.1016/0092-8674(78)90095-8; HARADA F, 1980, NUCLEIC ACIDS RES, V8, P1273, DOI 10.1093/nar/8.6.1273; LABUDA D, 1994, J MOL EVOL, V39, P506; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Jarosz DF, 2010, SCIENCE, V330, P1820, DOI 10.1126/science.1195487; Kramerov DA, 2005, INT REV CYTOL, V247, P165, DOI 10.1016/S0074-7696(05)47004-7; Sone M, 2007, J CELL SCI, V120, P2498, DOI 10.1242/jcs.009357; HARADA F, 1979, NUCLEIC ACIDS RES, V7, P909, DOI 10.1093/nar/7.4.909; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Gogolevskaya IK, 2005, MOL BIOL EVOL, V22, P1546, DOI 10.1093/molbev/msi140; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Hu SB, 2015, GENE DEV, V29, P630, DOI 10.1101/gad.257048.114; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Thompson JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0203S00	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	NOV	2015	20	11					887	901		10.1111/gtc.12280		15	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CV8FY	WOS:000364517800002		
J	Shimaji, K; Konishi, T; Tanaka, S; Yoshida, H; Kato, Y; Ohkawa, Y; Sato, T; Suyama, M; Kimura, H; Yamaguchi, M				Shimaji, Kouhei; Konishi, Takahiro; Tanaka, Shintaro; Yoshida, Hideki; Kato, Yasuko; Ohkawa, Yasuyuki; Sato, Tetsuya; Suyama, Mikita; Kimura, Hiroshi; Yamaguchi, Masamitsu			Genomewide identification of target genes of histone methyltransferase dG9a during Drosophila embryogenesis	GENES TO CELLS			English	Article							DEVELOPMENTAL CONTROL; ZYGOTIC GENOME; LYSINE 9; IN-VIVO; G9A; METHYLATION; H3; NUCLEAR; EMBRYO; CHROMATIN	Post-translational modification of the histone plays important roles in epigenetic regulation of various biological processes. Among the identified histone methyltransferases (HMTases), G9a is a histone H3 Lys 9 (H3K9)-specific example active in euchromatic regions. Drosophila G9a (dG9a) has been reported to feature H3K9 dimethylation activity invivo. Here, we show that the time required for hatching of a homozygous dG9a null mutant and heteroallelic combination of dG9a null mutants is delayed, suggesting that dG9a is at least partially responsible for progression of embryogenesis. Immunocytochemical analyses of the wild-type and the dG9a null mutant flies indicated that dG9a localizes in cytoplasm up to nuclear division cycle 7 where it is likely responsible for di-methylation of nucleosome-free H3K9. From cycles 8-11, dG9a moves into the nucleus and is responsible for di-methylating H3K9 in nucleosomes. RNA-sequence analysis utilizing early wild-type and dG9a mutant embryos showed that dG9a down-regulates expression of genes responsible for embryogenesis. RNA fluorescent insitu hybridization analysis further showed temporal and spatial expression patterns of these mRNAs did not significantly change in the dG9a mutant. These results indicate that dG9a controls transcription levels of some zygotic genes without changing temporal and spatial expression patterns of the transcripts of these genes.	[Shimaji, Kouhei; Konishi, Takahiro; Tanaka, Shintaro; Yoshida, Hideki; Kato, Yasuko; Yamaguchi, Masamitsu] Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan; [Shimaji, Kouhei; Konishi, Takahiro; Tanaka, Shintaro; Yoshida, Hideki; Kato, Yasuko; Yamaguchi, Masamitsu] Kyoto Inst Technol, Insect Biomed Res Ctr, Sakyo Ku, Kyoto 6068585, Japan; [Ohkawa, Yasuyuki] Kyushu Univ, Fac Med, Dept Adv Med Initiat, Fukuoka 8128582, Japan; [Sato, Tetsuya; Suyama, Mikita] Kyushu Univ, Med Inst Bioregulat, Div Bioinformat, Fukuoka 8128582, Japan; [Kimura, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Yamaguchi, M (reprint author), Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan.	myamaguc@kit.ac.jp			Ministry of Education, Science, Sports and Culture of Japan; JST; JSPS Core-to-Core Program, Asia-Africa Science Platforms, JSPS KAKENHI [15J0948B]	We thank Dr P. Spierer for kindly providing the w dG9a<SUP>RG5</SUP> fly and Dr M. Moore for advice in English usage. We acknowledge all members of the Chromosome Engineering Laboratory for helpful discussion and advice. This work was partly carried out in the Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University. This study was partially supported by Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan, JST and the JSPS Core-to-Core Program, Asia-Africa Science Platforms, JSPS KAKENHI Grant Number 15J0948B.	Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Bittencourt D, 2012, P NATL ACAD SCI USA, V109, P19673, DOI 10.1073/pnas.1211803109; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad989402; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Bashirullah A, 1999, EMBO J, V18, P2610, DOI 10.1093/emboj/18.9.2610; Myant K, 2011, GENOME RES, V21, P83, DOI 10.1101/gr.108498.110; Kato Y, 2008, GENES CELLS, V13, P703, DOI 10.1111/j.1365-2443.2008.01199.x; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Schotta G, 2003, GENETICA, V117, P149, DOI 10.1023/A:1022923508198; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; ZALOKAR M, 1976, DEV BIOL, V49, P425, DOI 10.1016/0012-1606(76)90185-8; YAMAGUCHI M, 1992, CELL STRUCT FUNCT, V17, P105; FORBES AJ, 1993, DEVELOPMENT, P115; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Ebert A, 2004, GENE DEV, V18, P2973, DOI 10.1101/gad.323004; Mis J, 2006, MOL GENET GENOMICS, V275, P513, DOI 10.1007/s00438-006-0116-x; Kuhfittig S, 2001, GENETICS, V157, P1227; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Lee DY, 2006, J BIOL CHEM, V281, P8476, DOI 10.1074/jbc.M511093200; Kato Y, 2011, CELL STRUCT FUNCT, V36, P121; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Rudolph T, 2007, MOL CELL, V26, P103, DOI 10.1016/j.molcel.2007.02.025; Ganguly A, 2005, DEVELOPMENT, V132, P3419, DOI 10.1242/dev.01903; Seum C, 2007, GENETICS, V177, P1955, DOI 10.1534/genetics.107.078220; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Ushijima Y, 2012, CHROMOSOME RES, V20, P319, DOI 10.1007/s10577-012-9276-1; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Lanzotti DJ, 2002, MOL CELL BIOL, V22, P2267, DOI 10.1128/MCB.22.7.2267-2282.2002; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Stabell M, 2006, NUCLEIC ACIDS RES, V34, P4609, DOI 10.1093/nar/gkl640; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Pilot F, 2006, DEVELOPMENT, V133, P711, DOI 10.1242/dev.02251; Wagschal A, 2008, MOL CELL BIOL, V28, P1104, DOI 10.1128/MCB.01111-07; Lee KS, 2010, INSECT MOL BIOL, V19, P131, DOI 10.1111/j.1365-2583.2009.00955.x; Ashburner M., 1989, DROSOPHILA LAB HDB; De Renzis S, 2007, PLOS BIOL, V5, P1036, DOI 10.1371/journal.pbio.0050117; Dennis Glynn Jr, 2003, Genome Biol, V4, pP3, DOI 10.1186/gb-2003-4-5-p3; FOE VE, 1983, J CELL SCI, V61, P31; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kramer JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000569; Lecuyer E., 2008, CSH PROTOC, V28; Seum C, 2007, PLOS GENET, V3, P709, DOI 10.1371/journal.pgen.0030076	47	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	NOV	2015	20	11					902	914		10.1111/gtc.12281		13	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CV8FY	WOS:000364517800003		
J	Shimada, T; Takada, H; Yamamoto, K; Ishihama, A				Shimada, Tomohiro; Takada, Hiraku; Yamamoto, Kaneyoshi; Ishihama, Akira			Expanded roles of two-component response regulator OmpR in Escherichia coli: genomic SELEX search for novel regulation targets	GENES TO CELLS			English	Article							SIGNAL-TRANSDUCTION SYSTEMS; BARA SENSOR KINASE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; IN-VITRO; ACETYL PHOSPHATE; TRANSPORT SYSTEM; RNA-POLYMERASE; SIGMA-FACTORS; PHOSPHORYLATION	The two-component system (TCS) is a sophisticated bacterial signal transduction system for regulation of genome transcription in response to environmental conditions. The EnvZ-OmpR system is one of the well-characterized TCS of Escherichia coli, responding to changes in environmental osmolality. Regulation has largely focused on the differential expression of two porins, OmpF and OmpC, which transport small molecules across the outer membrane. Recently, it has become apparent that OmpR serves a more global regulatory role and regulates additional targets. To identify the entire set of regulatory targets of OmpR, we performed the genomic SELEX screening of OmpR-binding sites along the E.coli genome. As a result, more than 30 novel genes have been identified to be under the direct control of OmpR. One abundant group includes the genes encoding a variety of membrane-associated transporters that mediate uptake or efflux of small molecules, while another group encodes a set of transcription regulators, raising a concept that OmpR is poised to control a diverse set of responses by altering downstream transcriptional regulators.	[Shimada, Tomohiro; Takada, Hiraku; Yamamoto, Kaneyoshi; Ishihama, Akira] Hosei Univ, Micronano Technol Res Ctr, Tokyo 1848584, Japan; [Shimada, Tomohiro] Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan; [Yamamoto, Kaneyoshi; Ishihama, Akira] Hosei Univ, Dept Frontier Biosci, Tokyo 1848584, Japan	Ishihama, A (reprint author), Hosei Univ, Micronano Technol Res Ctr, Tokyo 1848584, Japan.	aishiham@hosei.ac.jp			MEXT [(A) (21241047), (B) (18310133), (C) (25430173), (B) (24710214), S0801037]; Research Fund from IFO (Institute for Fermentation, Osaka); MEXT Cooperative Research Program of Network Joint Research Center for Materials and Devices	We thank Dr Linda J. Kenney for valuable comments throughout this research and critical reading of the manuscript. We also thank Kayoko Yamada and Ayako Kori for purification of His-tagged OmpR proteins. This work was supported by MEXT Grants-in-Aid for Scientific Research (A) (21241047), (B) (18310133) and (C) (25430173) to AI, MEXT Grant-in-Aid for Young Scientists (B) (24710214) to TS, Research Fund from IFO (Institute for Fermentation, Osaka) to TS, a support from the MEXT Cooperative Research Program of Network Joint Research Center for Materials and Devices to TS and AI, and the MEXT-Supported Program for the Strategic Research Foundation at Private Universities 208-2012 (S0801037) to Hosei University.	Azam TA, 1999, J BACTERIOL, V181, P6361; Yoshida T, 2006, J BIOL CHEM, V281, P17114, DOI 10.1074/jbc.M602112200; Flores-Valdez MA, 2014, MICROBIOL-SGM, V160, P733, DOI 10.1099/mic.0.071381-0; Feng XH, 2003, MOL MICROBIOL, V48, P1131, DOI 10.1046/j.1365-2958.2003.03502.x; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; Randall LP, 2002, RES VET SCI, V72, P87, DOI 10.1053/rvsc.2001.0537; IGO MM, 1988, J BACTERIOL, V170, P5971; FORST S, 1988, J BACTERIOL, V170, P5080; Ogasawara H, 2007, J BACTERIOL, V189, P5534, DOI 10.1128/JB.00229-07; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Ishihama A, 2010, FEMS MICROBIOL REV, V34, P628, DOI 10.1111/j.1574-6976.2010.00227.x; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Prohinar P, 2002, MOL MICROBIOL, V43, P1493, DOI 10.1046/j.1365-2958.2002.02804.x; PRATT LA, 1995, MOL MICROBIOL, V17, P565, DOI 10.1111/j.1365-2958.1995.mmi_17030565.x; Pratt LA, 1996, MOL MICROBIOL, V20, P911, DOI 10.1111/j.1365-2958.1996.tb02532.x; FORST S, 1988, ANNU REV CELL BIOL, V4, P21, DOI 10.1146/annurev.cb.04.110188.000321; Mattison K, 2002, J BIOL CHEM, V277, P11143, DOI 10.1074/jbc.M111128200; ENZ S, 1995, GENE, V163, P13, DOI 10.1016/0378-1119(95)00380-O; Braun V, 2003, CURR OPIN MICROBIOL, V6, P173, DOI 10.1016/S1369-5274(03)00022-5; INOUYE M, 1972, J BIOL CHEM, V247, P8154; Rhee JE, 2008, J BIOL CHEM, V283, P8664, DOI 10.1074/jbc.M705550200; Wang LC, 2012, EMBO J, V31, P2648, DOI 10.1038/emboj.2012.99; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; DELGADO J, 1993, MOL MICROBIOL, V10, P1037, DOI 10.1111/j.1365-2958.1993.tb00974.x; Mondragon V, 2006, J BACTERIOL, V188, P8303, DOI 10.1128/JB.01052-06; IGARASHI K, 1991, P NATL ACAD SCI USA, V88, P8958, DOI 10.1073/pnas.88.20.8958; Pernestig AK, 2001, J BIOL CHEM, V276, P225; Bang IS, 2002, MOL MICROBIOL, V44, P1235, DOI 10.1046/j.1365-2958.2002.02937.x; Ogasawara H, 2010, MICROBIOL-SGM, V156, P2470, DOI 10.1099/mic.0.039131-0; Ishihama A, 2014, J BACTERIOL, V196, P2718, DOI 10.1128/JB.01579-14; CHATFIELD SN, 1991, INFECT IMMUN, V59, P449; Shimada T, 2008, NUCLEIC ACIDS RES, V36, P3950, DOI 10.1093/nar/gkn339; Ma D, 1996, MOL MICROBIOL, V19, P101, DOI 10.1046/j.1365-2958.1996.357881.x; RAMPERSAUD A, 1994, J BIOL CHEM, V269, P12559; Chavez RG, 2010, J BACTERIOL, V192, P2009, DOI 10.1128/JB.01685-09; KENNEY LJ, 1995, P NATL ACAD SCI USA, V92, P8866, DOI 10.1073/pnas.92.19.8866; Matsubara M, 1999, BIOSCI BIOTECH BIOCH, V63, P408, DOI 10.1271/bbb.63.408; MAEDA S, 1990, J BACTERIOL, V172, P501; HARLOCKER SL, 1995, J BIOL CHEM, V270, P26849; Oshima T, 2002, MOL MICROBIOL, V46, P281, DOI 10.1046/j.1365-2958.2002.03170.x; Shimada T, 2005, GENES CELLS, V10, P907, DOI 10.1111/j.1365-2443.2005.00868.x; Jishage M, 1997, J BACTERIOL, V179, P959; SLAUCH JM, 1989, J MOL BIOL, V210, P281, DOI 10.1016/0022-2836(89)90330-6; FORST S, 1989, P NATL ACAD SCI USA, V86, P6052, DOI 10.1073/pnas.86.16.6052; OCHS M, 1995, MOL MICROBIOL, V15, P119, DOI 10.1111/j.1365-2958.1995.tb02226.x; Cowles CE, 2011, MOL MICROBIOL, V79, P1168, DOI 10.1111/j.1365-2958.2011.07539.x; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Ishihama A, 2012, P JPN ACAD B-PHYS, V88, P485, DOI 10.2183/pjab.88.485; Bernstein HD, 2011, MOL MICROBIOL, V79, P1128, DOI 10.1111/j.1365-2958.2011.07538.x; SHIN S, 1995, J BACTERIOL, V177, P4696; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stincone A, 2011, NUCLEIC ACIDS RES, V39, P7512, DOI 10.1093/nar/gkr338; Ames SK, 1999, P NATL ACAD SCI USA, V96, P11792, DOI 10.1073/pnas.96.21.11792; Huang KJ, 1996, J MOL BIOL, V262, P615, DOI 10.1006/jmbi.1996.0540; Liu XQ, 2001, MICROBIOL-SGM, V147, P2981; Braun V, 2005, FEMS MICROBIOL REV, V29, P673, DOI 10.1016/j.femsre.2004.10.001; Hirakawa H, 2003, J BACTERIOL, V185, P1851, DOI 10.1128/JB.185.6.1851-1856.2003; BRAUN V, 1969, EUR J BIOCHEM, V10, P426, DOI 10.1111/j.1432-1033.1969.tb00707.x; Capra EJ, 2012, ANNU REV MICROBIOL, V66, P325, DOI 10.1146/annurev-micro-092611-150039; Kinoshita E, 2009, PROTEOMICS, V9, P4098, DOI 10.1002/pmic.200900020; MIZUNO T, 1990, MOL MICROBIOL, V4, P1077, DOI 10.1111/j.1365-2958.1990.tb00681.x; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; Prigent-Combaret C, 2001, J BACTERIOL, V183, P7213, DOI 10.1128/JB.183.24.7213-7223.2001; Head CG, 1998, J MOL BIOL, V281, P857, DOI 10.1006/jmbi.1998.1985; Cook H, 2013, ENVIRON MICROBIOL, V15, P3121, DOI 10.1111/1462-2920.12236; Baba Tomoya, 2006, Mol Syst Biol, V2; Cameron ADS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002615; De la Cruz MA, 2010, J MOL MICROB BIOTECH, V18, P24, DOI 10.1159/000274309; Hoch J. A., 1995, 2 COMPONENT SIGNAL T; Ishihama A., 2009, ECOSALESCHERICHIA CO; Millar J. H., 1972, EXPT MOL GENETICS CO; Mizuno T, 1997, DNA Res, V4, P161, DOI 10.1093/dnares/4.2.161; Quinn HJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004215; Shimada T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090447; Shimada T., 2011, MOL MICROBIOL, V82, P376; Shimada T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020081; Siebenlist K. R., 1980, CELL, V20, P269; VansHove B., 1990, J BACTERIOL, V172, P6749	78	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	NOV	2015	20	11					915	931		10.1111/gtc.12282		17	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CV8FY	WOS:000364517800004		
J	Miwa, T; Takasaki, T; Inoue, K; Sakamoto, H				Miwa, Takashi; Takasaki, Teruaki; Inoue, Kunio; Sakamoto, Hiroshi			Restricted distribution of mrg-1 mRNA in C.elegans primordial germ cells through germ granule-independent regulation	GENES TO CELLS			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; GENE-EXPRESSION; POLYCOMB GROUP; LINE; PROTEIN; COMPLEX; PIE-1; SEGREGATION; REPRESSION	The chromodomain protein MRG-1 is an essential maternal factor for proper germline development that protects germ cells from cell death in C.elegans. Unlike germ granules, which are exclusively segregated to the germline blastomeres at each cell division from the first cleavage of the embryo, MRG-1 is abundant in all cells in early embryos and is then gradually restricted to the primordial germ cells (PGCs) by the morphogenesis stage. Here, we show that this characteristic spatiotemporal expression pattern is dictated by the mrg-1 3'UTR and is differentially regulated at the RNA level between germline and somatic cells. Asymmetric segregation of germ granules is not necessary to localize MRG-1 to the PGCs. We found that MES-4, an essential chromatin regulator in germ cells, also accumulates in the PGCs in a germ granule-independent manner. We propose that C.elegans PGCs have a novel mechanism to accumulate at least some chromatin-associated proteins that are essential for germline immortality.	[Miwa, Takashi; Takasaki, Teruaki; Inoue, Kunio; Sakamoto, Hiroshi] Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 657, Japan	Takasaki, T (reprint author), Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 657, Japan.	takasaki@port.kobe-u.ac.jp			JSPS KAKENHI [24770211, 23510234, 26290062]	We thank Aya Sato (Kyoto U.) for technical advice on the MosSCI method, Susan Strom (UCSC) for antibodies, and the Caenorhabditis Genetics Center for reagents. This work was supported by JSPS KAKENHI Grant Number 24770211 to T.T. and 23510234, 26290062 to H.S.	Fujita M, 2002, MECH DEVELOP, V114, P61, DOI 10.1016/S0925-4773(02)00058-8; Tenenhaus C, 2001, GENE DEV, V15, P1031, DOI 10.1101/gad.876201; Korf I, 1998, DEVELOPMENT, V125, P2469; CAPOWSKI EE, 1991, GENETICS, V129, P1061; DeRenzo C, 2003, NATURE, V424, P685, DOI 10.1038/nature01887; Tani S, 2013, EVOL DEV, V15, P293, DOI 10.1111/ede.12039; Subramaniam K, 1999, DEVELOPMENT, V126, P4861; Fong YY, 2002, SCIENCE, V296, P2235, DOI 10.1126/science.1070790; Bender LB, 2004, CURR BIOL, V14, P1639, DOI 10.1016/j.cub.2004.08.062; STROME S, 1982, P NATL ACAD SCI-BIOL, V79, P1558, DOI 10.1073/pnas.79.5.1558; D'Agostino I, 2006, DEV BIOL, V292, P244, DOI 10.1016/j.ydbio.2005.11.046; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Merritt C, 2008, CURR BIOL, V18, P1476, DOI 10.1016/j.cub.2008.08.013; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Shiimori M, 2013, MOL CELL BIOL, V33, P444, DOI 10.1128/MCB.01298-12; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; DENIS H, 1993, TRENDS GENET, V9, P7, DOI 10.1016/0168-9525(93)90065-P; Unhavaithaya Y, 2002, CELL, V111, P991, DOI 10.1016/S0092-8674(02)01202-3; Shin TH, 2003, CURR OPIN GENET DEV, V13, P455, DOI 10.1016/S0959-437X(03)00109-6; Takasaki T, 2007, DEVELOPMENT, V134, P757, DOI 10.1242/dev.02771; Gaydos LJ, 2014, SCIENCE, V345, P1515, DOI 10.1126/science.1255023; Updike D, 2010, J ANDROL, V31, P53, DOI 10.2164/jandrol.109.008292; Tenenhaus C, 1998, DEV BIOL, V200, P212, DOI 10.1006/dbio.1998.8940; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Holdeman R, 1998, DEVELOPMENT, V125, P2457; Gallo CM, 2010, SCIENCE, V330, P1685, DOI 10.1126/science.1193697; Daniels BR, 2009, J CELL BIOL, V184, P473, DOI 10.1083/jcb.200809077; Xu L, 2001, GENETICS, V159, P1007; Wang JT, 2013, ADV EXP MED BIOL, V757, P17, DOI 10.1007/978-1-4614-4015-4_2; BRENNER S, 1974, GENETICS, V77, P71; Cui MX, 2006, PLOS GENET, V2, P719, DOI 10.1371/journal.pgen.0020074; Furuhashi H, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-15; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Rechtsteiner A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001091; STROME S, 1986, J EMBRYOL EXP MORPH, V97, P15	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	NOV	2015	20	11					932	942		10.1111/gtc.12285		11	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CV8FY	WOS:000364517800005		
J	Yama, K; Matsumoto, Y; Murakami, Y; Seno, S; Matsuda, H; Gotoh, K; Motooka, D; Nakamura, S; Ying, BW; Yomo, T				Yama, Kazuma; Matsumoto, Yuki; Murakami, Yoshie; Seno, Shigeto; Matsuda, Hideo; Gotoh, Kazuyoshi; Motooka, Daisuke; Nakamura, Shota; Ying, Bei-Wen; Yomo, Tetsuya			Functional specialization in regulation and quality control in thermal adaptive evolution	GENES TO CELLS			English	Article							TRANSCRIPTION FACTOR SIGMA(32); HEAT-SHOCK RESPONSE; ESCHERICHIA-COLI; MOLECULAR CHAPERONES; GENE-EXPRESSION; PROTEIN; GENOME; DNAK; ADAPTATION; BACTERIA	Distinctive survival strategies, specialized in regulation and in quality control, were observed in thermal adaptive evolution with a laboratory Escherichia coli strain. The two specialists carried a single mutation either within rpoH or upstream of groESL, which led to the activated global regulation by sigma factor 32 or an increased amount of GroEL/ES chaperonins, respectively. Although both specialists succeeded in thermal adaptation, the common winner of the evolution was the specialist in quality control, that is, the strategy of chaperonin-mediated protein folding. To understand this evolutionary consequence, multilevel analyses of cellular status, for example, transcriptome, protein and growth fitness, were carried out. The specialist in quality control showed less change in transcriptional reorganization responding to temperature increase, which was consistent with the finding of that the two specialists showed the biased expression of molecular chaperones. Such repressed changes in gene expression seemed to be advantageous for long-term sustainability because a specific increase in chaperonins not only facilitated the folding of essential gene products but also saved cost in gene expression compared with the overall transcriptional increase induced by rpoH regulation. Functional specialization offered two strategies for successful thermal adaptation, whereas the evolutionary advantageous was more at the points of cost-saving in gene expression and the essentiality in protein folding.	[Yama, Kazuma; Murakami, Yoshie; Seno, Shigeto; Matsuda, Hideo; Yomo, Tetsuya] Osaka Univ, Grad Sch Informat Sci & Technol, Osaka 5650871, Japan; [Matsumoto, Yuki; Ying, Bei-Wen] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki 3058572, Japan; [Gotoh, Kazuyoshi; Motooka, Daisuke; Nakamura, Shota] Osaka Univ, Microbial Dis Res Inst, Osaka 5650871, Japan; [Yomo, Tetsuya] Osaka Univ, Grad Sch Frontier Biosci, Osaka 5650871, Japan; [Yomo, Tetsuya] Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Tokyo 1020076, Japan	Yomo, T (reprint author), Osaka Univ, Grad Sch Informat Sci & Technol, Osaka 5650871, Japan.	yomo@ist.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23241061]; Institute for Fermentation, Osaka, Japan	This work was supported by Grants-in-Aid for Scientific Research (A) 23241061 (to TY) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and in part by the research grant of the Institute for Fermentation, Osaka, Japan (to BWY).	Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; YURA T, 1993, ANNU REV MICROBIOL, V47, P321, DOI 10.1146/annurev.micro.47.1.321; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; GAMER J, 1992, CELL, V69, P833, DOI 10.1016/0092-8674(92)90294-M; Morita M, 1999, J BACTERIOL, V181, P401; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Yura T, 1999, CURR OPIN MICROBIOL, V2, P153, DOI 10.1016/S1369-5274(99)80027-7; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Bogumil D, 2012, BIOCHEMISTRY-US, V51, P9941, DOI 10.1021/bi3013643; Furusawa C, 2009, BIOINFORMATICS, V25, P36, DOI 10.1093/bioinformatics/btn570; Hashimoto M, 2005, MOL MICROBIOL, V55, P137, DOI 10.1111/j.1365-2958.2004.04386.x; Makino Y, 1997, J BIOL CHEM, V272, P12468, DOI 10.1074/jbc.272.19.12468; Ying BW, 2014, MOL BIOSYST, V10, P375, DOI 10.1039/c3mb70254e; Fujiwara K, 2010, EMBO J, V29, P1552, DOI 10.1038/emboj.2010.52; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Niwa T, 2009, P NATL ACAD SCI USA, V106, P4201, DOI 10.1073/pnas.0811922106; Guisbert E, 2008, MICROBIOL MOL BIOL R, V72, P545, DOI 10.1128/MMBR.00007-08; Rueffler C, 2012, P NATL ACAD SCI USA, V109, pE326, DOI 10.1073/pnas.1110521109; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Gamer J, 1996, EMBO J, V15, P607; Morita MT, 1999, GENE DEV, V13, P655, DOI 10.1101/gad.13.6.655; Ihaka R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Kishimoto T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001164; Matsumoto Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-808; Mogk A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004366; Murakami Y, 2015, NUCLEIC ACIDS RES, V43, P1304, DOI 10.1093/nar/gku1366; Salgado H, 2012, NUCLEIC ACIDS RES, V41, pD203, DOI [10.1093/nar/gks1201, DOI 10.1093/NAR/GKS1201]; Suzuki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019534; Szekely P, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003163; Ying BW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-25	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	NOV	2015	20	11					943	955		10.1111/gtc.12298		13	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CV8FY	WOS:000364517800006		
J	Badaluddin, NA; Kitakawa, M				Badaluddin, Noor Afiza; Kitakawa, Madoka			Escherichia coli inner membrane protein YciB interacts with ZipA that is important for cell division	GENES TO CELLS			English	Article							PEPTIDOGLYCAN SYNTHESIS; SEPTAL RING; FTSZ; COMPONENT; DIVISOME; MACHINERY; DYNAMICS; BACTERIA; MUTATION; GENES	Escherichia coli propagates by undergoing cycles of lateral elongation, septum formation, and cell fission at the mid-cell. A large number of genes involved in these processes have been identified, but it is likely that others remain. A deletion mutant of yciB (yciB) is shorter in the cell length compared to wild type and, in contrast, over-expression of yciB causes elongation of the cell. Furthermore, the septum localization of ZipA, an essential protein of cell division, is disturbed in a yciB mutant. Purified YciB protein directly interacted with ZipA, which might indicate that YciB is involved in the cell envelope synthesis directed by ZipA in a PBP3-independent manner.	[Badaluddin, Noor Afiza; Kitakawa, Madoka] Kobe Univ, Fac Sci, Dept Biol, Nada Ku, Kobe, Hyogo 6578501, Japan	Kitakawa, M (reprint author), Kobe Univ, Fac Sci, Dept Biol, Nada Ku, Rokko 1-1, Kobe, Hyogo 6578501, Japan.	madoka@kobe-u.ac.jp			Ministry of Education, Malaysia	We are grateful to Prof. de Boer for kindly providing us strains (P773, P774, P789) and valuable suggestions. NAB was supported by IPTA Academic Training Scheme Scholarship from the Ministry of Education, Malaysia.	Margolin W, 2000, FEMS MICROBIOL REV, V24, P531, DOI 10.1016/S0168-6445(00)00038-3; Potluri LP, 2012, J BACTERIOL, V194, P5334, DOI 10.1128/JB.00859-12; Hale CA, 1999, J BACTERIOL, V181, P167; Rico AI, 2013, J BIOL CHEM, V288, P20830, DOI 10.1074/jbc.R113.479519; Varma A, 2007, J BACTERIOL, V189, P5692, DOI 10.1128/JB.00455-07; Boyd D, 2000, J BACTERIOL, V182, P842, DOI 10.1128/JB.182.3.842-847.2000; Sikdar R, 2013, J BACTERIOL, V195, P12, DOI 10.1128/JB.00762-12; Fenton AK, 2013, EMBO J, V32, P1953, DOI 10.1038/emboj.2013.129; Natale P, 2013, ENVIRON MICROBIOL, V15, P3169, DOI 10.1111/1462-2920.12227; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; WIENTJES FB, 1989, J BACTERIOL, V171, P3412; Sun Q, 1998, J BACTERIOL, V180, P2050; Chien AC, 2012, CURR BIOL, V22, pR340, DOI 10.1016/j.cub.2012.02.032; DAVIS BD, 1950, J BACTERIOL, V60, P17; Karimova G, 2012, J BACTERIOL, V194, P5576, DOI 10.1128/JB.00774-12; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.3344.3351.2003; Niba ETE, 2010, FEMS MICROBIOL LETT, V309, P35, DOI 10.1111/j.1574-6968.2010.02014.x; Niba ETE, 2007, DNA RES, V14, P237, DOI 10.1093/dnares/dsm024; Tsukanov R, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/6/066003; Geissler B, 2003, P NATL ACAD SCI USA, V100, P4197, DOI 10.1073/pnas.0635003100; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; Karimova G, 2009, J BACTERIOL, V191, P333, DOI 10.1128/JB.00331-08; Niu LL, 2008, BIOPHYS J, V95, P2009, DOI 10.1529/biophysj.108.128751; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Baba Tomoya, 2006, Mol Syst Biol, V2; Doerrler W. T., 2012, J BACTERIOL, V195, P3; El-Hajj Z. W., 2015, FRONT MICROBIOL, V21, P309; Hill NS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003663; Li G., 2012, ISRN MOL BIOL, V2012; Li G., 2012, THESIS; Mac Síomóin R A, 1996, Mol Microbiol, V19, P599, DOI 10.1046/j.1365-2958.1996.405941.x; Margolin W., 2009, CURR BIOL, V19, P812; Robert L., 2015, FRONT MICROBIOL, V29, P515; Sambrook J., 2001, MOL CLONING LAB MANU; Shiomi D, 2013, MICROBIOLOGYOPEN, V2, P798, DOI 10.1002/mbo3.116; Sternberg F., 2005, J BIOL CHEM, V280, P34409; van der Ploeg R, 2013, MOL MICROBIOL, V87, P1074, DOI 10.1111/mmi.12150	40	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	NOV	2015	20	11					956	965		10.1111/gtc.12299		10	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CV8FY	WOS:000364517800007		
J	Usami, K; Matsumoto, R; Kobayashi, K; Hitomi, T; Shimotake, A; Kikuchi, T; Matsuhashi, M; Kunieda, T; Mikuni, N; Miyamoto, S; Fukuyama, H; Takahashi, R; Ikeda, A				Usami, Kiyohide; Matsumoto, Riki; Kobayashi, Katsuya; Hitomi, Takefumi; Shimotake, Akihiro; Kikuchi, Takayuki; Matsuhashi, Masao; Kunieda, Takeharu; Mikuni, Nobuhiro; Miyamoto, Susumu; Fukuyama, Hidenao; Takahashi, Ryosuke; Ikeda, Akio			Sleep modulates cortical connectivity and excitability in humans: Direct evidence from neural activity induced by single-pulse electrical stimulation	HUMAN BRAIN MAPPING			English	Article						CCEP; consciousness; frontal lobe epilepsy; high-gamma activity; sleep; non-REM	CORTICOCORTICAL EVOKED-POTENTIALS; INFERIOR FRONTAL GYRUS; EYE-MOVEMENT SLEEP; HUMAN BRAIN; IN-VIVO; GAMMA-OSCILLATIONS; REM-SLEEP; FUNCTIONAL CONNECTIVITY; SLOW WAVES; EPILEPSY	Sleep-induced changes in human brain connectivity/excitability and their physiologic basis remain unclear, especially in the frontal lobe. We investigated sleep-induced connectivity and excitability changes in 11 patients who underwent chronic implantation of subdural electrodes for epilepsy surgery. Single-pulse electrical stimuli were directly injected to a part of the cortices, and cortico-cortical evoked potentials (CCEPs) and CCEP-related high-gamma activities (HGA: 100-200 Hz) were recorded from adjacent and remote cortices as proxies of effective connectivity and induced neuronal activity, respectively. HGA power during the initial CCEP component (N1) correlated with the N1 size itself across all states investigated. The degree of cortical connectivity and excitability changed during sleep depending on sleep stage, approximately showing dichotomy of awake vs. non-rapid eye movement (REM) [NREM] sleep. On the other hand, REM sleep partly had properties of both awake and NREM sleep, placing itself in the intermediate state between them. Compared with the awake state, single-pulse stimulation especially during NREM sleep induced increased connectivity (N1 size) and neuronal excitability (HGA increase at N1), which was immediately followed by intense inhibition (HGA decrease). The HGA decrease was temporally followed by the N2 peak (the second CCEP component), and then by HGA re-increase during sleep across all lobes. This HGA rebound or re-increase of neuronal synchrony was largest in the frontal lobe compared with the other lobes. These properties of sleep-induced changes of the cortex may be related to unconsciousness during sleep and frequent nocturnal seizures in frontal lobe epilepsy. Hum Brain Mapp, 2015. (c) 2015 Wiley Periodicals, Inc.	[Usami, Kiyohide; Kobayashi, Katsuya; Shimotake, Akihiro; Takahashi, Ryosuke] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto 6068507, Japan; [Matsumoto, Riki; Ikeda, Akio] Kyoto Univ, Grad Sch Med, Dept Epilepsy Movement Disorders & Physiol, Kyoto 6068507, Japan; [Hitomi, Takefumi] Kyoto Univ, Grad Sch Med, Dept Clin Lab Med, Kyoto 6068507, Japan; [Hitomi, Takefumi] Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto 6068507, Japan; [Kikuchi, Takayuki; Kunieda, Takeharu; Miyamoto, Susumu] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068507, Japan; [Matsuhashi, Masao; Fukuyama, Hidenao] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto 6068507, Japan; [Mikuni, Nobuhiro] Sapporo Med Univ, Sch Med, Dept Neurosurg, Sapporo, Hokkaido 0608543, Japan	Matsumoto, R (reprint author), Kyoto Univ, Grad Sch Med, Dept Epilepsy Movement Disorders & Physiol, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	matsumot@kuhp.kyoto-u.ac.jp; akio@kuhp.kyoto-u.ac.jp			Kyoto University Foundation; MEXT/JSPS KAKENHI [26560465, 15K10361, 26282218, 15H05874, 15H01664]; Japan Epilepsy Research Foundation	Contract grant sponsor: Kyoto University Foundation; Contract grant sponsor: MEXT/JSPS KAKENHI; Contract grant numbers: 26560465, 15K10361, 26282218, 15H05874, 15H01664; Contract grant sponsor: Japan Epilepsy Research Foundation	Destexhe A, 1998, J NEUROPHYSIOL, V79, P999; Riedner BA, 2007, SLEEP, V30, P1643; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Matsumoto R, 2007, BRAIN, V130, P181, DOI 10.1093/brain/awl257; Alarcon G, 2012, CLIN NEUROPHYSIOL, V123, P1736, DOI 10.1016/j.clinph.2012.02.062; Braun AR, 1998, SCIENCE, V279, P91, DOI 10.1126/science.279.5347.91; Shouse MN, 1996, J CLIN NEUROPHYSIOL, V13, P32, DOI 10.1097/00004691-199601000-00004; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Ray S, 2008, J NEUROSCI, V28, P7334, DOI 10.1523/JNEUROSCI.1588-08.2008; Keller CJ, 2011, P NATL ACAD SCI USA, V108, P10308, DOI 10.1073/pnas.1019750108; Yamao Y, 2014, HUM BRAIN MAPP, V35, P4345, DOI 10.1002/hbm.22479; Massimini M, 2010, COGN NEUROSCI, V1, P176, DOI 10.1080/17588921003731578; Bergmann TO, 2012, J NEUROSCI, V32, P243, DOI 10.1523/JNEUROSCI.4792-11.2012; Viswanathan A, 2007, NAT NEUROSCI, V10, P1308, DOI 10.1038/nn1977; Jimenez-Jimenez D, 2015, CORTEX, V65, P208, DOI 10.1016/j.cortex.2015.01.011; Matsumoto R, 2012, HUM BRAIN MAPP, V33, P2856, DOI 10.1002/hbm.21407; Greenlee JDW, 2004, J NEUROPHYSIOL, V92, P1153, DOI 10.1152/jn.00609.2003; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Matsumoto R, 2004, BRAIN, V127, P2316, DOI 10.1093/brain/awh246; Matsumoto R, 2011, NEUROPSYCHOLOGIA, V49, P1350, DOI 10.1016/j.neuropsychologia.2011.01.023; Takahara M, 2002, PSYCHIAT CLIN NEUROS, V56, P257, DOI 10.1046/j.1440-1819.2002.00999.x; Keller CJ, 2014, J NEUROSCI, V34, P9152, DOI 10.1523/JNEUROSCI.4289-13.2014; Tononi G, 2008, BIOL BULL-US, V215, P216; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Koike T, 2011, NEUROSCI RES, V69, P322, DOI 10.1016/j.neures.2010.12.018; Linden H, 2010, J COMPUT NEUROSCI, V29, P423, DOI 10.1007/s10827-010-0245-4; Pigorini A, 2015, NEUROIMAGE, V112, P105, DOI 10.1016/j.neuroimage.2015.02.056; Ray S, 2008, CLIN NEUROPHYSIOL, V119, P116, DOI 10.1016/j.clinph.2007.09.136; Crespel A, 1998, EPILEPSIA, V39, P150, DOI 10.1111/j.1528-1157.1998.tb01352.x; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; STERIADE M, 1995, J NEUROSCI, V15, P623; Iwasaki M, 2010, EPILEPTIC DISORD, V12, P292, DOI 10.1684/epd.2010.0334; LI CL, 1962, J CELL COMPAR PHYSL, V60, P1, DOI 10.1002/jcp.1030600102; Matsumoto R, 2005, EPILEPSIA, V46, P1744, DOI 10.1111/j.1528-1167.2005.00284.x; Herman ST, 2001, NEUROLOGY, V56, P1453; Marini C, 2007, BIOCHEM PHARMACOL, V74, P1308, DOI 10.1016/j.bcp.2007.06.030; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; Wehrle R, 2007, EUR J NEUROSCI, V25, P863, DOI 10.1111/j.1460-9568.2007.05314.x; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Derry CP, 2013, EPILEPSY BEHAV, V26, P394, DOI 10.1016/j.yebeh.2012.10.033; Kubota Y, 2013, CLIN NEUROPHYSIOL, V124, P1547, DOI 10.1016/j.clinph.2013.01.024; Ray S, 2008, J NEUROSCI, V28, P11526, DOI 10.1523/JNEUROSCI.2848-08.2008; Swann NC, 2012, NEUROIMAGE, V59, P2860, DOI 10.1016/j.neuroimage.2011.09.049; Lacruz ME, 2007, EUR J NEUROSCI, V26, P1357, DOI 10.1111/j.1460-9568.2007.05730.x; Changeux JP, 1996, RES PER NEUROSCI, P125; David Olivier, 2010, Front Syst Neurosci, V4, P148, DOI 10.3389/fnsys.2010.00148; Kobayashi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130461; Rechtschaffen A., 1968, MANUAL STANDARDIZED; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588	53	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	NOV	2015	36	11					4714	4729		10.1002/hbm.22948		16	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CV4EQ	WOS:000364219500034		
J	Majima, T; Funahashi, Y; Takai, S; Goins, WF; Gotoh, M; Tyagi, P; Glorioso, JC; Yoshimura, N				Majima, Tsuyoshi; Funahashi, Yasuhito; Takai, Shun; Goins, William F.; Gotoh, Momokazu; Tyagi, Pradeep; Glorioso, Joseph C.; Yoshimura, Naoki			Herpes Simplex Virus Vector-Mediated Gene Delivery of Poreless TRPV1 Channels Reduces Bladder Overactivity and Nociception in Rats	HUMAN GENE THERAPY			English	Article							PAIN SYNDROME/INTERSTITIAL CYSTITIS; LOWER URINARY-TRACT; FOS-LIKE PROTEIN; INTERSTITIAL CYSTITIS; SPINAL-CORD; INTRAVESICAL INSTILLATION; INCREASED EXCITABILITY; EXPRESSION; NEURONS; THERAPY	Increased afferent excitability has been proposed as an important pathophysiology of interstitial cystitis/bladder pain syndrome (IC/BPS) and overactive bladder (OAB). In this study, we investigated whether herpes simplex virus (HSV) vectors encoding poreless TRPV1, in which the segment in C terminus of TRPV1 receptor is deleted, suppress bladder overactivity and pain behavior using a rat model of chemical cystitis. Replication-defective HSV vectors encoding poreless TRPV1 were injected into the bladder wall of adult female Sprague-Dawley rats. Additionally, recombinant HSV virus (vHG) vectors were injected as control. Cystometry (CMG) under urethane anesthesia was performed 1 week after viral injection to evaluate bladder overactivity induced by resiniferatoxin (RTx, a TRPV1 agonist). RTx-induced nociceptive behavior such as licking (lower abdominal licking) and freezing (motionless head-turning) was observed 2 weeks after viral injection. GFP expression in L4/L6/S1 dorsal root ganglia and the bladder as well as c-Fos-positive cells in the L6 spinal cord dorsal horn were also evaluated 2 weeks after viral injection. In CMG, the poreless TRPV1 vector-treated group showed a significantly smaller reduction in intercontraction intervals and voided volume after RTx infusion than the vHG-treated control group. The number of the RTx-induced freezing events was significantly decreased in the poreless TRPV1 group than in the vHG group, whereas there was no significant difference of the number of RTx-induced licking events between groups. The number of c-Fos-positive cells in the DCM and SPN regions of the L6 spinal dorsal horn was significantly smaller in the poreless TRPV1 group than in the vHG group. Our results indicated that HSV vector-mediated gene delivery of poreless TRPV1 had a therapeutic effect on TRPV1-mediated bladder overactivity and pain behavior. Thus, the HSV vector-mediated gene therapy targeting TRPV1 receptors could be a novel modality for the treatment of OAB and/or hypersensitive bladder disorders such as IC/BPS.	[Majima, Tsuyoshi; Takai, Shun; Tyagi, Pradeep; Yoshimura, Naoki] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA 15213 USA; [Goins, William F.; Glorioso, Joseph C.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [Majima, Tsuyoshi; Funahashi, Yasuhito; Takai, Shun; Gotoh, Momokazu] Nagoya Univ, Grad Sch Med, Dept Urol, Nagoya, Aichi 4648601, Japan	Yoshimura, N (reprint author), Univ Pittsburgh, Sch Med, Dept Urol, Suite 700,3471 Fifth Ave, Pittsburgh, PA 15213 USA.	nyos@pitt.edu			NIH [DK088836, P01 DK044935]; DOD [W81XWH-12-1-0565]	Our research was funded by NIH DK088836, P01 DK044935, and DOD W81XWH-12-1-0565.	Fink DJ, 2011, ANN NEUROL, V70, P207, DOI 10.1002/ana.22446; Hayashi Y, 2009, AM J PHYSIOL-REG I, V296, pR1661, DOI 10.1152/ajpregu.91054.2008; LECCI A, 1994, LIFE SCI, V55, P429, DOI 10.1016/0024-3205(94)90054-X; MENETREY D, 1989, J COMP NEUROL, V285, P177, DOI 10.1002/cne.902850203; Srinivasan R, 2007, NAT METHODS, V4, P733, DOI 10.1038/NMETH1077; Moutzouris DA, 2009, CLIN J AM SOC NEPHRO, V4, P1844, DOI 10.2215/CJN.02000309; OCHS RL, 1994, J UROLOGY, V151, P587; Charrua A, 2007, J UROLOGY, V177, P1537, DOI 10.1016/j.juro.2006.11.046; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Funahashi Y, 2013, J UROLOGY, V189, P366, DOI 10.1016/j.juro.2012.08.192; Gardella B, 2008, EUR UROL, V54, P1145, DOI 10.1016/j.eururo.2008.01.079; LILLY JD, 1990, SURG GYNECOL OBSTET, V171, P493; Homma Y, 2013, J UROLOGY, V190, P1925, DOI 10.1016/j.juro.2013.05.049; Yoshimura N, 1999, J NEUROSCI, V19, P4644; Slobodov G, 2004, J UROLOGY, V171, P1554, DOI 10.1097/01.ju.0000118938.09119.a5; Akkaraju GR, 1999, J GENE MED, V1, P280, DOI 10.1002/(SICI)1521-2254(199907/08)1:4<280::AID-JGM45>3.0.CO;2-L; Goss JR, 2009, GENE THER, V16, P493, DOI 10.1038/gt.2009.24; Tripp DA, 2012, EUR UROL, V62, P1188, DOI 10.1016/j.eururo.2012.05.023; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Goins WF, 2014, METHODS MOL BIOL, V1144, P63, DOI 10.1007/978-1-4939-0428-0_5; Saitoh C, 2008, J UROLOGY, V179, P359, DOI 10.1016/j.juro.2007.08.090; Yokoyama H, 2013, HUM GENE THER, V24, P170, DOI 10.1089/hum.2011.180; Keay S, 1997, J UROLOGY, V157, P1083, DOI 10.1016/S0022-5347(01)65146-2; Krisky DM, 1998, GENE THER, V5, P1517, DOI 10.1038/sj.gt.3300755; Chancellor MB, 2004, UROLOGY, V63, P85, DOI 10.1016/j.urology.2003.10.034; Homma Y, 2014, INT J UROL, V21, P43, DOI 10.1111/iju.12314; MELLERICK DM, 1987, VIROLOGY, V158, P265, DOI 10.1016/0042-6822(87)90198-X; Yoshimura N, 1998, NEUROSCIENCE, V83, P633; BIRDER LA, 1992, J NEUROSCI, V12, P4878; Yoshimura N, 2014, INT J UROL, V21, P18, DOI 10.1111/iju.12308; Nickel JC, 2010, J UROLOGY, V183, P167, DOI 10.1016/j.juro.2009.08.133; BULLITT E, 1990, J COMP NEUROL, V296, P517, DOI 10.1002/cne.902960402; Goss James R, 2007, Expert Rev Neurother, V7, P487, DOI 10.1586/14737175.7.5.487; de Groat WC, 2015, COMPR PHYSIOL, V5, P327, DOI 10.1002/cphy.c130056; Hao S, 2006, MOL PAIN, V2, P1; Szallasi A, 2012, EXPERT OPIN INV DRUG, V21, P1351, DOI 10.1517/13543784.2012.704021	36	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	NOV 1	2015	26	11					734	742		10.1089/hum.2015.026		9	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	CV6SQ	WOS:000364401200003		
J	Azmahani, A; Nakamura, Y; Ozawa, Y; McNamara, KM; Fujimura, T; Haga, T; Hashimoto, A; Aiba, S; Sasano, H				Azmahani, Abdullah; Nakamura, Yasuhiro; Ozawa, Yohei; McNamara, Keely M.; Fujimura, Taku; Haga, Takahiro; Hashimoto, Akira; Aiba, Setsuya; Sasano, Hironobu			Androgen receptor, androgen-producing enzymes and their transcription factors in extramammary Paget disease	HUMAN PATHOLOGY			English	Article						Extramammary Paget's disease; Immunohistochemistry; Androgen receptor; Androgen-producing enzymes; Transcription factor	PROSTATE-CANCER; BETA-CATENIN; ESTROGEN-RECEPTORS; BREAST-CANCER; FACTOR FOXP1; EXPRESSION; PATHWAY; CELLS; TUMOR; P53	Extramammary Paget disease (EMPD) has been known to frequently express androgen receptor (AR). Therefore, androgens could play roles in the biological behavior of Paget cells. 5 alpha-Reductase (5 alpha-red) types 1 and 2 and 17 beta-hydroxysteroid dehydrogenase type 5 (17 beta-HSD5) are pivotal in situ regulators of androgen production in androgen-responsive tissues including androgen-dependent neoplasms. Therefore, in this study, we immunolocalized AR, androgen-producing enzymes, and their transcription factors to assess the state of in situ androgen production and actions and its correlation of invasiveness in EMPD. We studied 51 cases of EMPD with known clinicopathological status. AR, 5 alpha-red1, 17 beta-HSD5, and beta-catenin immunoreactivity was evaluated by using the modified H-score method while cyclin D1, p53, forkhead box protein P1, and a proliferation marker, Ki-67, were quantified using labeling index. The mean scores of AR, 5 alpha-red1, and 17 beta-HSD5 in invasive EMPD were all significantly higher than noninvasive EMPD (P<.0001). Ki-67 labeling index as well as the cyclin D1 score was also significantly higher in invasive than noninvasive lesions of EMPD. These results demonstrated that androgen receptor and androgen-producing enzymes were both associated with cell cycle regulation and subsequently the invasiveness of EMPD lesions and could also indicate those above as potential markers of invasive potentials in EMPD. (C) 2015 Elsevier Inc. All rights reserved.	[Azmahani, Abdullah; Nakamura, Yasuhiro; Ozawa, Yohei; McNamara, Keely M.; Sasano, Hironobu] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 9808575, Japan; [Azmahani, Abdullah] Univ Sultan Zainal Abidin, Fac Hlth Sci, Kuala Terengganu 21300, Terengganu, Malaysia; [Ozawa, Yohei] Tohoku Univ, Grad Sch Med, Div Adv Surg Sci & Technol, Sendai, Miyagi 9808574, Japan; [Fujimura, Taku; Haga, Takahiro; Hashimoto, Akira; Aiba, Setsuya] Tohoku Univ, Grad Sch Med, Dept Dermatol, Sendai, Miyagi 9808574, Japan	Nakamura, Y (reprint author), Tohoku Univ, Dept Pathol, Sch Med, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	yasu-naka@patholo2.med.tohoku.ac.jp			Malaysian Government (SLAI)	The first author receives scholarship support from the Malaysian Government (SLAI) throughout the study period.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Petre-Draviam CE, 2005, ONCOGENE, V24, P431, DOI 10.1038/sj.onc.1208200; Kim JC, 1999, J KOREAN MED SCI, V14, P223; Nakamura Y, 2006, ANTICANCER RES, V26, P1935; Takayama K, 2008, BIOCHEM BIOPH RES CO, V374, P388, DOI 10.1016/j.bbrc.2008.07.056; Kasashima S, 2010, BRIT J DERMATOL, V162, P1098, DOI 10.1111/j.1365-2133.2009.09603.x; Fox SB, 2004, CLIN CANCER RES, V10, P3521, DOI 10.1158/1078-0432.CCR-03-0461; Hikita T, 2012, INT J SURG PATHOL, V20, P441, DOI 10.1177/1066896912444159; Culig Z, 2004, J STEROID BIOCHEM, V92, P265, DOI 10.1016/j.jsbmb.2004.10.003; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; NISHI M, 1992, J NATL CANCER I, V84, P519, DOI 10.1093/jnci/84.7.519; Hu ZH, 2015, BIOCHIMIE, V109, P42, DOI 10.1016/j.biochi.2014.12.001; PETERS G, 1995, BREAST CANCER RES TR, V33, P125, DOI 10.1007/BF00682720; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200; Lanzino M, 2010, NUCLEIC ACIDS RES, V38, P5351, DOI 10.1093/nar/gkq278; Aoyagi S, 2008, J DERMATOL SCI, V50, P177, DOI 10.1016/j.jdermsci.2007.12.002; Banham AH, 2001, CANCER RES, V61, P8820; Azmahani A, 2014, J STEROID BIOCHEM, V144, P268, DOI 10.1016/j.jsbmb.2014.07.010; Nakamura Y, 2013, PROSTATE, V73, P590, DOI 10.1002/pros.22599; Alimirah F, 2007, NEOPLASIA, V9, P1152, DOI 10.1593/neo.07769; Yoneyama K, 2005, BRIT J DERMATOL, V153, P853, DOI 10.1111/j.1365-2133.2005.06865.x; Chen S, 2008, CLIN EXP DERMATOL, V33, P634, DOI 10.1111/j.1365-2230.2008.02851.x; de Leon ED, 2000, AM J CLIN PATHOL, V113, P572; Ellis PE, 2008, MODERN PATHOL, V21, P1192, DOI 10.1038/modpathol.2008.50; Kang ZH, 2013, INT J CANCER, V132, P824, DOI 10.1002/ijc.27738; Fujimura T, 2013, CLIN DEV IMMUNOL, P1; Polakis P, 1999, CURR OPIN GENE DEV, V9, P5; Vogelstein B, 2010, NAT ED, V3, P6	29	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0046-8177	1532-8392		HUM PATHOL	Hum. Pathol.	NOV	2015	46	11					1662	1669		10.1016/j.humpath.2015.07.007		8	Pathology	Pathology	CV6DJ	WOS:000364360600012		
J	Terasaki, M; Terasaki, Y; Yoneyama, K; Kuwahara, N; Wakamatsu, K; Nagahama, K; Kunugi, S; Takeshita, T; Shimizu, A				Terasaki, Mika; Terasaki, Yasuhiro; Yoneyama, Koichi; Kuwahara, Naomi; Wakamatsu, Kyoko; Nagahama, Kiyotaka; Kunugi, Shinobu; Takeshita, Toshiyuki; Shimizu, Akira			Uterine leiomyosarcoma with osteoclast-like giant cells associated with high expression of receptor activator of nuclear factor kappa B ligand	HUMAN PATHOLOGY			English	Article						Leiomyosarcoma; Osteoclast-like giant cells; Receptor activator of nuclear factor kappa B ligand; RANKL; Leiomyoma; Uterus; Immunohistochemistry	ANAPLASTIC THYROID-CARCINOMA; HEPATOCELLULAR-CARCINOMA; UTERUS; DIFFERENTIATION; TUMOR; OSTEOSARCOMA; DENOSUMAB; PANCREAS; RANKL	The occurrence of osteoclast-like giant cells (OLGCs) in uterine leiomyosarcomas (LMSs) is a rare phenomenon. The nature of OLGCs and the significance of their accumulation in these tumors are poorly understood. Recent studies revealed that the formation of osteoclasts requires a specific cytokine, receptor activator of nuclear factor kappa B ligand (RANKL), in bone. In this study, we investigated the expression of RANKL in 2 cases of uterine LMS with OLGCs by means of immunohistochemistry and compared the extent of RANKL expression with that in conventional uterine LMSs and leiomyomas by using real-time reverse-transcription quantitative polymerase chain reaction. Our cases of uterine LMS with OLGCs showed markedly high expression of RANKL messenger RNA with clear RANKL immunoreactivity compared with messenger RNA expression and immunoreactivity of conventional uterine LMSs and leiomyomas. These findings suggest that the tumors producing RANKL may account for accumulation of OLGCs in tumor tissue because of RANKL-related osteoclastogenesis. (C) 2015 Elsevier Inc. All rights reserved.	[Terasaki, Mika; Terasaki, Yasuhiro; Kuwahara, Naomi; Wakamatsu, Kyoko; Nagahama, Kiyotaka; Kunugi, Shinobu; Shimizu, Akira] Nippon Med Sch, Dept Analyt Human Pathol, Tokyo 1138602, Japan; [Yoneyama, Koichi; Takeshita, Toshiyuki] Nippon Med Sch, Dept Obstet & Gynecol, Tokyo 1138602, Japan	Terasaki, M (reprint author), Nippon Med Sch, Dept Analyt Human Pathol, Bunkyo Ku, 1-25-16 Nezu, Tokyo 1130031, Japan.	mterasaki@nms.ac.jp					Singhal A, 2010, HEPATOB PANCREAT DIS, V9, P433; Molberg KH, 1998, CANCER, V82, P1279, DOI 10.1002/(SICI)1097-0142(19980401)82:7<1279::AID-CNCR10>3.0.CO;2-3; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; Gaumann A, 2001, PATHOL RES PRACT, V197, P257, DOI 10.1078/0344-0338-00044; Aru A, 2001, ACTA OBSTET GYN SCAN, V80, P371, DOI 10.1034/j.1600-0412.2001.080004371.x; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; PILON VA, 1986, GYNECOL ONCOL, V23, P381, DOI 10.1016/0090-8258(86)90142-3; Bago-Horvath Z, 2014, PATHOLOGY, V46, P411, DOI 10.1097/PAT.0000000000000116; Rosenkrantz AB, 2011, UROLOGY, V78, P1310, DOI 10.1016/j.urology.2011.01.046; CHEN KK, 1995, AM J SURG PATHOL, V19, P487, DOI 10.1097/00000478-199504000-00017; GAFFEY MJ, 1991, AM J SURG PATHOL, V15, P160, DOI 10.1097/00000478-199102000-00009; KUWANO H, 1984, CANCER, V54, P837, DOI 10.1002/1097-0142(19840901)54:5<837::AID-CNCR2820540513>3.0.CO;2-8; Ikeda T, 2003, PATHOL INT, V53, P450, DOI 10.1046/j.1440-1827.2003.01503.x; HOLLAND R, 1984, CANCER, V53, P1963, DOI 10.1002/1097-0142(19840501)53:9<1963::AID-CNCR2820530927>3.0.CO;2-N; Taylor R, 2011, J PATHOL, V225, P195, DOI 10.1002/path.2869; Stopeck AT, 2010, J CLIN ONCOL, V28, P5132, DOI 10.1200/JCO.2010.29.7101; Sukpan Kornkanok, 2010, Journal of the Medical Association of Thailand, V93, P510; Patai K, 2006, GYNECOL ONCOL, V102, P403, DOI 10.1016/j.ygyno.2006.02.030; DARBY AJ, 1975, CANCER, V36, P495, DOI 10.1002/1097-0142(197508)36:2<495::AID-CNCR2820360228>3.0.CO;2-I; MARSHALL RJ, 1986, INT J GYNECOL PATHOL, V5, P260, DOI 10.1097/00004347-198609000-00008; Watanabe K, 1996, PATHOL INT, V46, P656, DOI 10.1111/j.1440-1827.1996.tb03668.x; Tran TA, 2012, INT J GYNECOL PATHOL, V31, P453, DOI 10.1097/PGP.0b013e318246977d; Miyamoto N, 2002, INT IMMUNOPHARMACOL, V2, P25, DOI 10.1016/S1567-5769(01)00134-5; Fizazi K, 2011, LANCET, V377, P813, DOI 10.1016/S0140-6736(10)62344-6; [Anonymous], 2014, ONCOLOGY; Huang L, 2003, J CLIN PATHOL-MOL PA, V56, P116; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; van Meurs HS, 2012, ANN DIAGN PATHOL, V16, P67, DOI 10.1016/j.anndiagpath.2010.11.010; SIEINSKI W, 1990, CANCER, V65, P1838, DOI 10.1002/1097-0142(19900415)65:8<1838::AID-CNCR2820650829>3.0.CO;2-1; Gibbons CLMH, 2010, VIRCHOWS ARCH, V456, P317, DOI 10.1007/s00428-010-0882-z; Ben Salah Ramy, 2012, Tunis Med, V90, P896; Kurman RJ, 2014, WHO CLASSIFICATION T, P139; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Zaloudek CJ, 2011, BLAUSTEINS PATHOLOGY, P471	34	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0046-8177	1532-8392		HUM PATHOL	Hum. Pathol.	NOV	2015	46	11					1679	1684		10.1016/j.humpath.2015.04.018		6	Pathology	Pathology	CV6DJ	WOS:000364360600014		
J	Adachi, K; Miki, Y; Saito, R; Hata, S; Yamauchi, M; Mikami, Y; Okada, Y; Seyama, K; Kondo, T; Sasano, H				Adachi, Koko; Miki, Yasuhiro; Saito, Ryoko; Hata, Shuko; Yamauchi, Masanori; Mikami, Yoshiki; Okada, Yoshinori; Seyama, Kuniaki; Kondo, Takashi; Sasano, Hironobu			Intracrine steroid production and mammalian target of rapamycin pathways in pulmonary lymphangioleiomyomatosis	HUMAN PATHOLOGY			English	Article						Aromatase; Bcl-2; Estrogen; mTOR; Pulmonary lymphangioleiomyomatosis	HIERARCHICAL-CLUSTERING ANALYSIS; TUBEROUS SCLEROSIS COMPLEX; SMOOTH-MUSCLE-CELLS; MATRIX METALLOPROTEINASES; SIGNALING PATHWAYS; BREAST-CARCINOMA; ESTROGEN; SIROLIMUS; MTOR; LAM	Lymphangioleiomyomatosis (LAM) is a rare, potentially fatal disease primarily affecting young women. Estrogens enhance cell proliferation and progression of the tumor. Clinical trials using molecularly targeted agents such as endocrine manipulation and mammalian target of rapamycin (mTOR) inhibitors are in progress, but the status of these molecules, including aromatase and mTOR, has not been explored in LAM tissue. We first examined immunoreactivity for sex steroid receptors (estrogen receptor [ER] alpha, ER beta, progesterone receptor, androgen receptor), sex steroid synthesizing enzymes (aromatase, steroid sulfatase, 17 beta-hydroxysteroid dehydrogenase 1, 5 alpha-reductases), apoptotic suppression factor (Bcl-2), and factors involved in the mTOR signaling pathway in 30 pulmonary LAM tissues Immunoreactivity for ER alpha, ER beta, progesterone receptor, aromatase, and Bcl-2 was significantly more abundant in epithelioid cells, whereas the status of androgen receptor, 5 alpha-reductases, and phospho-mTOR signaling was not different in epithelioid and spindle-shaped LAM cells. We further examined the correlation among H scores of these markers using hierarchical clustering analysis. The results indicated that LAM tumors can be further classified into "aromatase" and "mTOR" groups on the basis of the patterns of immunoreactivity, and the 2 types could benefit from different modes of therapy. (C) 2015 Elsevier Inc. All rights reserved.	[Adachi, Koko; Miki, Yasuhiro; Saito, Ryoko; Hata, Shuko; Sasano, Hironobu] Tohoku Univ, Dept Pathol, Grad Sch Med, Sendai, Miyagi 9808575, Japan; [Adachi, Koko; Yamauchi, Masanori] Tohoku Univ, Dept Anesthesiol, Grad Sch Med, Sendai, Miyagi 9808575, Japan; [Mikami, Yoshiki] Kyoto Univ Hosp, Dept Diagnost Pathol, Kyoto 6068507, Japan; [Okada, Yoshinori; Kondo, Takashi] Tohoku Univ, Dept Thorac Surg, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Seyama, Kuniaki] Juntendo Univ, Fac Med, Dept Resp Med, Tokyo 1138431, Japan	Sasano, H (reprint author), Tohoku Univ, Dept Pathol, Grad Sch Med, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	hsasano@patholo2.med.tohoku.ac.jp					Chen J, 2002, BIOCHEM PHARMACOL, V64, P1071, DOI 10.1016/S0006-2952(02)01263-7; Hayashi T, 1997, HUM PATHOL, V28, P1071, DOI 10.1016/S0046-8177(97)90061-7; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Casanova A, 2011, ARCH BRONCONEUMOL, V47, P470, DOI 10.1016/j.arbres.2011.01.014; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; Mita MM, 2003, CANCER BIOL THER, V2, pS169; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; KITAICHI M, 1995, AM J RESP CRIT CARE, V151, P527; Suzuki T, 2003, J STEROID BIOCHEM, V86, P449, DOI 10.1016/S0960-0760(03)00356-X; Casanova A, 2011, ARCH BRONCONEUMOL, V47, P579, DOI 10.1016/j.arbres.2011.06.008; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Taveira-DaSilva AM, 2004, CHEST, V126, P1867, DOI 10.1378/chest.126.6.1867; Mavroudi M, 2013, J THORAC DIS, V5, P74, DOI 10.3978/j.issn.2072-1439.2013.01.03; Iida S, 2010, CANCER SCI, V101, P2278, DOI 10.1111/j.1349-7006.2010.01657.x; Matsui K, 2000, AM J RESP CRIT CARE, V161, P1002; Yu J, 2004, AM J PHYSIOL-LUNG C, V286, pL694, DOI 10.1152/ajplung.00204.2003; Yu JJ, 2009, P NATL ACAD SCI USA, V106, P2635, DOI 10.1073/pnas.0810790106; Miki Y, 2007, CANCER RES, V67, P3945, DOI 10.1158/0008-5472.CAN-06-3105; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Matsui K, 2000, ARCH PATHOL LAB MED, V124, P267; Krymskaya Vera P, 2008, Proc Am Thorac Soc, V5, P119, DOI 10.1513/pats.200705-061VS; Yu J, 2001, AM J RESP CRIT CARE, V164, P1537; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Strizheva GD, 2001, AM J RESP CRIT CARE, V163, P253; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Hammes SR, 2013, HORM CANCER-US, V4, P70, DOI 10.1007/s12672-012-0128-4; Makretsov NA, 2004, CLIN CANCER RES, V10, P6143, DOI 10.1158/1078-0432.CCR-04-0429; Kumaki F, 2002, AM J RESP CRIT CARE, V166, P187, DOI 10.1164/rccm.2105045; Yu J, 2010, LYMPHAT RES BIOL, V8, P43, DOI 10.1089/lrb.2009.0020; Henske EP, 2012, J CLIN INVEST, V122, P3807, DOI 10.1172/JCI58709; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Davies DM, 2011, CLIN CANCER RES, V17, P4071, DOI 10.1158/1078-0432.CCR-11-0445; Carvalho JC, 2009, CANCER, V115, P4186, DOI 10.1002/cncr.24486; Usuki Jiro, 1998, Archives of Pathology and Laboratory Medicine, V122, P895; Zhu MJ, 2007, FASEB J, V21, P895	35	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0046-8177	1532-8392		HUM PATHOL	Hum. Pathol.	NOV	2015	46	11					1685	1693		10.1016/j.humpath.2015.02.019		9	Pathology	Pathology	CV6DJ	WOS:000364360600015		
J	Nishijima, T; Yamamoto, H; Nakano, T; Nakashima, T; Taguchi, K; Masuda, M; Motoshita, J; Komune, S; Oda, Y				Nishijima, Toshimitsu; Yamamoto, Hidetaka; Nakano, Takafumi; Nakashima, Torahiko; Taguchi, Ken-ichi; Masuda, Muneyuki; Motoshita, Jun-ichi; Komune, Shizuo; Oda, Yoshinao			Dual gain of HER2 and EGFR gene copy numbers impacts the prognosis of carcinoma ex pleomorphic adenoma	HUMAN PATHOLOGY			English	Article						Salivary gland tumor; Carcinoma ex pleomorphic adenoma; Chromogenic in situ hybridization; HER2; EGFR	SALIVARY DUCT CARCINOMA; EPIDERMAL-GROWTH-FACTOR; IN-SITU HYBRIDIZATION; GLAND CARCINOMAS; BREAST-CANCER; FACTOR RECEPTOR; PAROTID-GLAND; PHASE-II; EXPRESSION; THERAPY	We investigated the potential roles of HER2 and EGFR and evaluated their prognostic significance in carcinoma ex pleomorphic adenoma (CXPA). We analyzed HER2 and EGFR overexpression status using immunohistochemistry (IHC) and gene copy number gain by chromogenic in situ hybridization (CISH) in 50 cases of CXPA (40 ductal-type and 10 myoepithelial-type CXPAs). Salivary duct carcinoma was the most common histologic subtype of malignant component (n = 21). Immunohistochemistty positivity and chromogenic in situ hybridization positivity were closely correlated in both HER2 and EGFR. HER2 CISH positivity (mostly gene amplification) and EGFR CISH positivity (mostly gene high polysomy) were present in 19 (40%) and 21 (44%) cases, respectively, and were each significantly correlated with poor outcome (P = .0009 and P = .0032, respectively). Dual gain of HER2 and EGFR gene copy numbers was present in 11 cases (23%) and was the most aggressive genotype. HER2 CISH positivity was more frequently present in ductal-type CXPAs (47%) than in myoepithelial-type CXPAs (10%), whereas the prevalence of EGFR CISH positivity was similar in both histologic subtypes (42% and 50%, respectively). Our results suggest that HER2 and EGFR gene copy number gains may play an important role in the progression of CXPA, in particular ductal-type CXPAs. HER2 CISH-positive/EGFR CISH-positive tumors may be the most aggressive subgroup in CXPA. The molecular subclassification of CXPA based on the HER2 and EGFR status may be helpful for prognostic prediction and decisions regarding the choice of therapeutic strategy. (C) 2015 Elsevier Inc. All rights reserved.	[Nishijima, Toshimitsu; Yamamoto, Hidetaka; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 8128582, Japan; [Nakano, Takafumi] Hamanomachi Hosp, Dept Otorhinolaryngol, Fukuoka 8108539, Japan; [Nakashima, Torahiko; Komune, Shizuo] Kyushu Univ, Grad Sch Med Sci, Dept Otorhinolaryngol, Fukuoka 8218582, Japan; [Taguchi, Ken-ichi] Kyushu Natl Canc Ctr, Dept Pathol, Fukuoka 8111347, Japan; [Masuda, Muneyuki] Kyushu Natl Canc Ctr, Dept Head & Neck Surg, Fukuoka 8111347, Japan; [Motoshita, Jun-ichi] Hamanomachi Hosp, Dept Pathol, Fukuoka 8108539, Japan	Oda, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Higashi Ku, Maidashi3-1-1, Fukuoka 8128582, Japan.	oda@surgpath.med.kyushu-u.ac.jp			Japan Society for the Promotion of Science, Tokyo, Japan [25293088, 102-0083]	Yoshinao Oda is supported by a Grant-in-Aid for Scientific Research (B) (25293088) from the Japan Society for the Promotion of Science, Tokyo 102-0083, Japan.	Zandi R, 2007, CELL SIGNAL, V19, P2013, DOI 10.1016/j.cellsig.2007.06.023; Weiler C, 2011, HISTOPATHOLOGY, V59, P741, DOI 10.1111/j.1365-2559.2011.03937.x; Locati LD, 2009, ORAL ONCOL, V45, P574, DOI 10.1016/j.oraloncology.2008.07.010; GNEPP DR, 1993, PATHOL ANNU, V28, P279; Fischer I, 2008, DIAGN MOL PATHOL, V17, P227, DOI 10.1097/PDM.0b013e3181642230; Nakano T, 2013, HISTOPATHOLOGY, V63, P378, DOI 10.1111/his.12183; Altemani A, 2005, HISTOPATHOLOGY, V46, P635, DOI 10.1111/j.1365-2559.2005.02157.x; Katori H, 2007, ACTA OTO-LARYNGOL, V127, P1207, DOI 10.1080/00016480701230894; Jaehne M, 2005, CANCER, V103, P2526, DOI 10.1002/cncr.21116; Lewis JE, 2001, HUM PATHOL, V32, P596, DOI 10.1053/hupa.2001.25000; Ettl T, 2012, HUM PATHOL, V43, P921, DOI 10.1016/j.humpath.2011.08.006; Stintzing S, 2013, INT J CANCER, V132, P236, DOI 10.1002/ijc.27654; Lambros MBK, 2007, HUM PATHOL, V38, P1105, DOI 10.1016/j.humpath.2007.04.011; Nabili V, 2007, HEAD NECK-J SCI SPEC, V29, P907, DOI 10.1002/hed.20614; Suzuki S, 2012, VIRCHOWS ARCH, V461, P271, DOI 10.1007/s00428-012-1282-3; Glisson B, 2004, CLIN CANCER RES, V10, P944, DOI 10.1158/1078-0432.CCR-03-0253; Hashimoto K, 2011, AM J SURG PATHOL, V35, P346, DOI 10.1097/PAS.0b013e31820832a6; Matsubayashi S, 2007, EUR ARCH OTO-RHINO-L, V264, P789, DOI 10.1007/s00405-007-0256-6; Brandwein M, 1996, ORAL SURG ORAL MED O, V81, P655, DOI 10.1016/S1079-2104(96)80071-0; Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Prat A, 2008, HEAD NECK-J SCI SPEC, V30, P680, DOI 10.1002/hed.20714; Felix A, 1996, HUM PATHOL, V27, P561, DOI 10.1016/S0046-8177(96)90162-8; Haddad R, 2003, ORAL ONCOL, V39, P724, DOI 10.1016/S1368-8375(03)00097-6; Ihrler S, 2007, HISTOPATHOLOGY, V51, P362, DOI 10.1111/j.1365-2559.2007.02736.x; Falchook GS, 2014, HEAD NECK-J SCI SPEC, V36, pE25, DOI 10.1002/hed.23429; Di Palma S, 2005, HISTOPATHOLOGY, V46, P144, DOI 10.1111/j.1365-2559.2005.02058.x; Nashed M, 2009, J LARYNGOL OTOL, V123, P250, DOI 10.1017/S0022215108002314; Lennerz JK, 2011, J CLIN ONCOL, V29, P4803, DOI 10.1200/JCO.2011.35.4928; Lee JS, 2014, J ORAL MAXIL SURG, V72, P1023, DOI 10.1016/j.joms.2013.11.014; Williams MD, 2010, CLIN CANCER RES, V16, P2266, DOI 10.1158/1078-0432.CCR-09-0238; Skalova A, 2003, HISTOPATHOLOGY, V42, P348, DOI 10.1046/j.1365-2559.2003.01600.x; Chan JKC, 2013, DIAGNOSTIC HISTOPATH, V1, P270; Gnepp DR, 2005, WHO CLASSIFICATION T, P242; Hashimoto K, 2012, HISTOPATHOLOGY, V60, P131; Kadowaki Shigenori, 2013, Case Rep Oncol, V6, P450, DOI 10.1159/000355219; Nagatsuma AK, 2015, GASTRIC CANCER, V18, P227, DOI 10.1007/s10120-014-0360-4; Roskoski J., 2014, PHARM RES, V79, P34	38	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0046-8177	1532-8392		HUM PATHOL	Hum. Pathol.	NOV	2015	46	11					1730	1743		10.1016/j.humpath.2015.07.014		14	Pathology	Pathology	CV6DJ	WOS:000364360600020		
J	Suzuki, H				Suzuki, Hiromichi			Importance of follow-up after delivery in women who experience hypertensive disorders during pregnancy	HYPERTENSION RESEARCH			English	Editorial Material							BLOOD-PRESSURE; CARDIOVASCULAR RISK; HOME; PREECLAMPSIA; SOCIETY; ASSOCIATION; GUIDELINES		Saitama Med Univ, Musashino Tokusyukai Hosp, Dept Nephrol, Moroyama, Saitama, Japan	Suzuki, H (reprint author), Saitama Med Univ, Musashino Tokusyukai Hosp, Dept Nephrol, 38 Morohongo, Moroyama, Saitama, Japan.	iromichi@saitama-med.ac.jp					Metoki H, 2012, CLIN EXP HYPERTENS, V34, P290, DOI 10.3109/10641963.2012.681086; Pickering TG, 2008, HYPERTENSION, V52, P10, DOI 10.1161/HYPERTENSIONAHA.107.189010; Imai Y, 2012, HYPERTENS RES, V35, P777, DOI 10.1038/hr.2012.56; McDonald SD, 2008, AM HEART J, V156, P918, DOI 10.1016/j.ahj.2008.06.042; Ostlund E, 2013, HYPERTENS RES, V36, P1081, DOI 10.1038/hr.2013.81; Parati G, 2010, J HUM HYPERTENS, V24, P779, DOI 10.1038/jhh.2010.54; Ishikuro M, 2013, AM J HYPERTENS, V26, P141, DOI 10.1093/ajh/hps002; Walker BR, 1998, BRIT MED J, V316, P834; Ferreira I, 2009, J HYPERTENS, V27, P1955, DOI 10.1097/HJH.0b013e328331b8c6; Oglaend B, 2009, J HYPERTENS, V27, P2051, DOI 10.1097/HJH.0b013e328330052a; Waugh J, 2003, HYPERTENS PREGNANCY, V22, P93, DOI 10.1081/PRG-120017007; Vatten LJ, 2003, OBSTET GYNECOL, V101, P529, DOI 10.1016/S0029-7844(02)02718-7; Taittonen L, 1996, PEDIATR RES, V40, P627, DOI 10.1203/00006450-199610000-00019; Hosaka M, 2015, HYPERTENS RES, V38, P776, DOI 10.1038/hr.2015.63	14	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	NOV	2015	38	11					709	710		10.1038/hr.2015.83		2	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CV9CE	WOS:000364584100001		
J	Mogi, M; Horiuchi, M				Mogi, Masaki; Horiuchi, Masatsugu			Does chronic hypertension prevent cancer progression?	HYPERTENSION RESEARCH			English	Editorial Material							ANGIOGENESIS; THERAPY; EXPRESSION; DISEASE; GLIOMA; RATS; KDR		[Mogi, Masaki; Horiuchi, Masatsugu] Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Tohon, Ehime, Japan	Mogi, M (reprint author), Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Tohon, Ehime, Japan.	mmogi@m.ehime-u.ac.jp					Tuettenberg J, 2006, CRIT REV ONCOL HEMAT, V59, P181, DOI 10.1016/j.critrevonc.2006.01.004; Lombardi G, 2013, ANTI-CANCER DRUG, V24, P90, DOI 10.1097/CAD.0b013e32835aa5fd; Hainsworth AH, 2008, J CEREBR BLOOD F MET, V28, P1877, DOI 10.1038/jcbfm.2008.91; Narayana A, 2009, J NEUROSURG, V110, P173, DOI 10.3171/2008.4.17492; Hirashima C, 2014, HYPERTENS RES, V37, P76, DOI 10.1038/hr.2013.88; Wang H, 2004, BIOCHEM BIOPH RES CO, V315, P363, DOI 10.1016/j.bbrc.2004.01.059; O'Rourke MF, 2005, HYPERTENSION, V46, P200, DOI 10.1161/01.HYP.0000168052.00426.65; Jesmin S, 2005, MOL CELL BIOCHEM, V272, P63, DOI 10.1007/s11010-005-7635-3; Letourneur A, 2015, HYPERTENS RES, V38, P723, DOI 10.1038/hr.2015.66; Omote Y, 2014, J NEUROSCI RES, V92, P369, DOI 10.1002/jnr.23327	10	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	NOV	2015	38	11					711	712		10.1038/hr.2015.87		2	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CV9CE	WOS:000364584100002		
J	Kabutoya, T; Kario, K				Kabutoya, Tomoyuki; Kario, Kazuomi			Depression in hypertension and blood pressure variability over shorter time periods	HYPERTENSION RESEARCH			English	Editorial Material							TO-VISIT VARIABILITY; CORONARY-ARTERY CALCIFICATION; SHORT-SLEEP DURATION; CARDIOVASCULAR EVENTS; HOME; PREDICTOR; SYMPTOMS; DISEASE; ASSOCIATION; POPULATION		[Kabutoya, Tomoyuki; Kario, Kazuomi] Jichi Med Univ, Dept Med, Div Cardiovasc Med, Sch Med, Jichi, Tochigi, Japan	Kabutoya, T (reprint author), Jichi Med Univ, Dept Med, Div Cardiovasc Med, Sch Med, 3311-1 Shimotsuke, Jichi, Tochigi, Japan.	kkario@jichi.ac.jp					Paciencia I, 2013, HYPERTENS RES, V36, P747, DOI 10.1038/hr.2013.36; Kikuya M, 2008, HYPERTENSION, V52, P1045, DOI 10.1161/HYPERTENSIONAHA.107.104620; Hanninen MRA, 2011, J HYPERTENS, V29, P1880, DOI 10.1097/HJH.0b013e32834a98ba; Kamezaki F, 2013, HYPERTENS RES, V36, P398, DOI 10.1038/hr.2012.197; Niu K, 2008, HYPERTENS RES, V31, P409, DOI 10.1291/hypres.31.409; Eguchi K, 2008, ARCH INTERN MED, V168, P2225, DOI 10.1001/archinte.168.20.2225; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; Shah MT, 2013, AM J HYPERTENS, V26, P1413, DOI 10.1093/ajh/hpt135; Nagai M, 2014, ATHEROSCLEROSIS, V233, P19, DOI 10.1016/j.atherosclerosis.2013.11.071; Licht CMM, 2009, HYPERTENSION, V53, P631, DOI 10.1161/HYPERTENSIONAHA.108.126698; Lenoir H, 2008, J HYPERTENS, V26, P1765, DOI 10.1097/HJH.0b013e3283088d1f; Yokota K, 2013, HYPERTENS RES, V36, P151, DOI 10.1038/hr.2012.145; Stergiou GS, 2014, HYPERTENS RES, V37, P565, DOI 10.1038/hr.2014.2; Diaz KM, 2014, HYPERTENSION, V64, P965, DOI 10.1161/HYPERTENSIONAHA.114.03903; King CR, 2008, JAMA-J AM MED ASSOC, V300, P2859, DOI 10.1001/jama.2008.867; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Katz DA, 1998, ARCH INTERN MED, V158, P1099, DOI 10.1001/archinte.158.10.1099; Kario K, 2015, HYPERTENSION, V65, P1163, DOI 10.1161/HYPERTENSIONAHA.115.04800; Hamer M, 2007, BIOL PSYCHOL, V74, P20, DOI 10.1016/j.biopsycho.2006.06.003; Kuo PL, 2011, J HYPERTENS, V29, P2084, DOI 10.1097/HJH.0b013e32834b59ad; Kario K, 2013, HYPERTENS RES, V36, P478, DOI 10.1038/hr.2013.19; Axon RN, 2010, AM J HYPERTENS, V23, P30, DOI 10.1038/ajh.2009.199; Okada H, 2013, HYPERTENS RES, V36, P996, DOI 10.1038/hr.2013.66; Kayano H, 2015, HYPERTENS RES, V38, P751, DOI 10.1038/hr.2015.75; WassertheilSmoller S, 1996, ARCH INTERN MED, V156, P553, DOI 10.1001/archinte.156.5.553	25	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	NOV	2015	38	11					713	715		10.1038/hr.2015.92		3	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CV9CE	WOS:000364584100003		
J	Ikeda, Y; Hamano, H; Satoh, A; Horinouchi, Y; Izawa-Ishizawa, Y; Kihira, Y; Ishizawa, K; Aihara, K; Tsuchiya, K; Tamaki, T				Ikeda, Yasumasa; Hamano, Hirofumi; Satoh, Akiho; Horinouchi, Yuya; Izawa-Ishizawa, Yuki; Kihira, Yoshitaka; Ishizawa, Keisuke; Aihara, Ken-ichi; Tsuchiya, Koichiro; Tamaki, Toshiaki			Bilirubin exerts pro-angiogenic property through Akt-eNOS-dependent pathway	HYPERTENSION RESEARCH			English	Article						angiogenesis; bilirubin; endothelial cells; eNOS	NITRIC-OXIDE SYNTHASE; FLOW-MEDIATED VASODILATION; CORONARY-ARTERY-DISEASE; PROTEIN-KINASE AKT; INDUCED OBESE MICE; SERUM BILIRUBIN; ENDOTHELIAL-CELLS; ANGIOTENSIN-II; ISCHEMIA; HYPERTENSION	Low serum bilirubin levels are associated with the risk of cardiovascular diseases including peripheral artery disease. Bilirubin is known to exert its property such as antioxidant effect or the enhancement of flow-mediated vasodilation, however, bilirubin action on angiogenesis remains unclear. To investigate the molecular mechanism of bilirubin on angiogenic effect, we first employed C57BL/6J mice with unilateral hindlimb ischemia surgery and divided the mice into two groups (vehicle-treated group and bilirubin-treated group). The analysis of laser speckle blood flow demonstrated the enhancement of blood flow recovery in response to ischemia of mice with bilirubin treatment. The density of capillaries was significantly higher in ischemic-adductor muscles of bilirubin-treated mice. The phosphorylated levels of endothelial nitric oxide synthase (eNOS) and Akt were increased in ischemic skeletal muscles of mice with bilirubin treatment compared with vehicle treatment. In in vitro experiments by using human aortic endothelial cells, bilirubin augmented eNOS and Akt phosphorylation, cell proliferation, cell migration and tube formation. These bilirubin actions on endothelial cell activation were inhibited by LY294002, a phosphatidylinositol 3-kinase inhibitor. In conclusion, bilirubin promotes angiogenesis through endothelial cells activation via Akt-eNOS-dependent manner.	[Ikeda, Yasumasa; Hamano, Hirofumi; Horinouchi, Yuya; Izawa-Ishizawa, Yuki; Kihira, Yoshitaka; Tamaki, Toshiaki] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Pharmacol, Tokushima 7708503, Japan; [Hamano, Hirofumi; Horinouchi, Yuya; Ishizawa, Keisuke] Tokushima Univ Hosp, Dept Pharm, Tokushima, Japan; [Satoh, Akiho; Tsuchiya, Koichiro] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Med Pharmacol, Tokushima 7708503, Japan; [Ishizawa, Keisuke] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Clin Pharm, Tokushima 7708503, Japan; [Aihara, Ken-ichi] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Hematol Endocrinol & Metab, Tokushima 7708503, Japan	Ikeda, Y (reprint author), Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Pharmacol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	yasuike@tokushima-u.ac.jp			JSPS KAKENHI Grant [24591203]	This work is supported in part by JSPS KAKENHI Grant (No 24591203 to YI). We appreciate the excellent technical assistance by Mr Hiroaki Watanabe, Department of Medical Pharmacology, and Mr Yusuke Kanai, Department of Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School.	Kureishi Y, 2000, NAT MED, V6, P1004; Tanaka M, 2014, ATHEROSCLEROSIS, V234, P421, DOI 10.1016/j.atherosclerosis.2014.03.015; Davis PA, 2013, HYPERTENS RES, V36, P873, DOI 10.1038/hr.2013.48; Vera T, 2009, AM J PHYSIOL-REG I, V297, pR738, DOI 10.1152/ajpregu.90889.2008; Pattillo CB, 2011, FREE RADICAL BIO MED, V50, P262, DOI 10.1016/j.freeradbiomed.2010.10.714; Ollinger R, 2005, CIRCULATION, V112, P1030, DOI 10.1161/CIRCULATIONAHA.104.528802; Dekker D, 2011, ARTERIOSCL THROM VAS, V31, P458, DOI 10.1161/ATVBAHA.110.211789; Dimmeler S, 1999, NATURE, V399, P601; Kimm H, 2009, STROKE, V40, P3422, DOI 10.1161/STROKEAHA.109.560649; Fulton D, 1999, NATURE, V399, P597; Murohara T, 1999, ARTERIOSCL THROM VAS, V19, P1156; Gullu H, 2005, ARTERIOSCL THROM VAS, V25, P2289, DOI 10.1161/01.ATV.0000185806.61430.7c; Fujii M, 2010, KIDNEY INT, V78, P905, DOI 10.1038/ki.2010.265; Maruhashi T, 2013, ARTERIOSCL THROM VAS, V33, P1401, DOI 10.1161/ATVBAHA.112.300934; Hopkins PN, 1996, ARTERIOSCL THROM VAS, V16, P250; Higashi Y, 2012, HYPERTENS RES, V35, P1039, DOI 10.1038/hr.2012.138; Perlstein TS, 2008, AM J MED, V121, P781, DOI 10.1016/j.amjmed.2008.03.045; El-Azab MF, 2012, EUR J PHARMACOL, V690, P31, DOI 10.1016/j.ejphar.2012.06.002; Vitek L, 2002, ATHEROSCLEROSIS, V160, P449, DOI 10.1016/S0021-9150(01)00601-3; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Erdogan D, 2006, ATHEROSCLEROSIS, V184, P431, DOI 10.1016/j.atherosclerosis.2005.05.01; Ikeda N, 2011, DIABETOLOGIA, V54, P2183, DOI 10.1007/s00125-011-2197-2; SCHWERTNER HA, 1994, CLIN CHEM, V40, P18; Wegiel B, 2009, J BIOL CHEM, V284, P21369, DOI 10.1074/jbc.M109.027433; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Fukui M, 2008, KIDNEY INT, V74, P1197, DOI 10.1038/ki.2008.398; Li RY, 2014, ARTERIOSCL THROM VAS, V34, P946, DOI 10.1161/ATVBAHA.113.303003; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Abbasi A, 2015, DIABETES, V64, P1459, DOI 10.2337/db14-0228; Galasso G, 2006, CIRC RES, V98, P254, DOI 10.1161/01.RES.0000200740.57764.52; Haddad P, 2009, ARTERIOSCL THROM VAS, V29, P1522, DOI 10.1161/ATVBAHA.109.191437; Dennery PA, 2001, NEW ENGL J MED, V344, P581; Polytarchou C, 2005, EUR J PHARMACOL, V510, P31, DOI 10.1016/j.ejphar.2005.01.004; Dong HS, 2014, ENDOCRINOLOGY, V155, P818, DOI 10.1210/en.2013-1667; Pflueger A, 2005, AM J PHYSIOL-RENAL, V288, pF552, DOI 10.1152/ajprenal.00278.2004; Perlstein TS, 2008, ARTERIOSCL THROM VAS, V28, P166, DOI 10.1161/ATVBAHA.107.153262; Riphagen IJ, 2014, DIABETES, V63, P2845, DOI 10.2337/db13-1652; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Ikeda Y, 2013, J CARDIOVASC PHARM, V61, P423, DOI 10.1097/FJC.0b013e318287d526; Chen LL, 2007, CARDIOVASC PATHOL, V16, P221, DOI 10.1016/j.carpath.2007.02.007; OWENS D, 1975, J MED GENET, V12, P152, DOI 10.1136/jmg.12.2.152; Ikeda Y, 2011, ATHEROSCLEROSIS, V215, P339, DOI 10.1016/j.atherosclerosis.2011.01.009; Kito T, 2012, AM J HYPERTENS, V25, P401, DOI 10.1038/ajh.2011.239; Ishizaka N, 2001, Stroke, V32, P580; Liu J., 2014, ABSTR APPL ANAL, V2014, P1	46	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	NOV	2015	38	11					733	740		10.1038/hr.2015.74		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CV9CE	WOS:000364584100006		
J	Takeshita, Y; Watanabe, S; Hattori, T; Nagasawa, K; Matsuura, N; Takahashi, K; Murohara, T; Nagata, K				Takeshita, Yuuri; Watanabe, Shogo; Hattori, Takuya; Nagasawa, Kai; Matsuura, Natsumi; Takahashi, Keiji; Murohara, Toyoaki; Nagata, Kohzo			Blockade of glucocorticoid receptors with RU486 attenuates cardiac damage and adipose tissue inflammation in a rat model of metabolic syndrome	HYPERTENSION RESEARCH			English	Article						adipose tissue; cardiac remodeling; glucocorticoid receptor; glucose metabolism; metabolic syndrome	11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; MINERALOCORTICOID RECEPTOR; DIASTOLIC DYSFUNCTION; HYPERTENSIVE-RATS; CARDIOMYOCYTE HYPERTROPHY; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; OXIDATIVE STRESS; HEART-FAILURE; ANIMAL-MODEL	Glucocorticoids are stress hormones that modulate metabolic, inflammatory and cardiovascular processes. We recently characterized DahlS. Z-Leprfa/Leprfa (DS/obese) rats, derived from a cross between Dahl salt-sensitive (DS) and Zucker rats, as a new animal model of metabolic syndrome (MetS). We have now investigated the effects of glucocorticoid receptor (GR) blockade on cardiac and adipose tissue pathology and gene expression, as well as on glucose metabolism in this model. DS/obese rats were treated with the GR blocker RU486 (2 mg kg(-1) per day, subcutaneous) for 4 weeks beginning at 9 weeks of age. Age-matched homozygous lean (DahlS. Z-Lepr(+)/Lepr(+), or DS/lean) littermates of DS/obese rats served as controls. Treatment of DS/obese rats with RU486 attenuated left ventricular (LV) fibrosis and diastolic dysfunction, as well as cardiac oxidative stress and inflammation, without affecting hypertension or LV hypertrophy. Administration of RU486 to DS/obese rats also inhibited the upregulation of GR and 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) expression at the mRNA and protein levels in the heart; it attenuated adiposity and adipose tissue inflammation, as well as the upregulation of GR and 11 beta-HSD1 mRNA and protein expression in adipose tissue; it ameliorated fasting hyperinsulinemia as well as insulin resistance and glucose intolerance. Our results thus implicate the glucocorticoid-GR axis in the pathophysiology of MetS, and they suggest that GR blockade has therapeutic potential for the treatment of this condition.	[Takeshita, Yuuri; Watanabe, Shogo; Hattori, Takuya; Nagasawa, Kai; Matsuura, Natsumi; Takahashi, Keiji; Nagata, Kohzo] Nagoya Univ, Grad Sch Med, Dept Pathophysiol Lab Sci, Nagoya, Aichi 4618673, Japan; [Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4618673, Japan	Nagata, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Pathophysiol Lab Sci, Higashi Ku, 1-1-20 Daikominami, Nagoya, Aichi 4618673, Japan.	nagata@met.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014		Ministry of Education, Culture, Sports, Science, and Technology of Japan [24590690]	We thank Dr Hiromi Ito and Sae Ohura for technical assistance. This work was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (no. 24590690 to KN).	Kuwahara F, 2004, HYPERTENSION, V43, P739, DOI 10.1161/01.HYP.0000118584.33350.7d; Seckl JR, 2001, ENDOCRINOLOGY, V142, P1371, DOI 10.1210/en.142.4.1371; Kayes-Wandover KM, 2000, J CLIN ENDOCR METAB, V85, P2519, DOI 10.1210/jc.85.7.2519; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Li M, 1999, J HYPERTENS, V17, P419, DOI 10.1097/00004872-199917030-00016; Masuzaki H, 2003, J CLIN INVEST, V112, P83, DOI 10.1172/JCI200317845; Boustany CM, 2004, AM J PHYSIOL-REG I, V287, pR943, DOI 10.1152/ajpregu.00265.2004; Ren RQ, 2012, ENDOCRINOLOGY, V153, P5346, DOI 10.1210/en.2012-1563; Nakagami H, 2014, HYPERTENS RES, V37, P629, DOI 10.1038/hr.2014.53; Cole TJ, 2006, BIOTECHNOL ANN REV, V12, P269, DOI 10.1016/S1387-2656(06)12008-6; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; HAUNER H, 1989, J CLIN INVEST, V84, P1663, DOI 10.1172/JCI114345; Murase T, 2012, HYPERTENS RES, V35, P186, DOI 10.1038/hr.2011.157; MCDONNELL DP, 1994, J STEROID BIOCHEM, V48, P425, DOI 10.1016/0960-0760(94)90190-2; Lister K, 2006, CARDIOVASC RES, V70, P555, DOI 10.1016/j.cardiores.2006.02.010; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Paneni F, 2013, HYPERTENS RES, V36, P36, DOI 10.1038/hr.2012.137; Yamada T, 2009, EUR J PHARMACOL, V615, P163, DOI 10.1016/j.ejphar.2009.05.028; Matsui H, 2008, HYPERTENSION, V52, P287, DOI 10.1161/HYPERTENSIONAHA.108.111815; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI200421625]; Clapham JC, 1997, J PHARMACOL EXP THER, V282, P1503; Whitworth JA, 2000, HYPERTENSION, V36, P912; Rose AJ, 2010, J STEROID BIOCHEM, V122, P10, DOI 10.1016/j.jsbmb.2010.02.010; Funder JW, 2009, HYPERTENSION, V53, P286, DOI 10.1161/HYPERTENSIONAHA.108.119966; Staab CA, 2010, J STEROID BIOCHEM, V119, P56, DOI 10.1016/j.jsbmb.2009.12.013; Whitehurst RM, 1999, J MOL CELL CARDIOL, V31, P1551, DOI 10.1006/jmcc.1999.0990; Rose AJ, 2013, MOL CELL ENDOCRINOL, V380, P65, DOI 10.1016/j.mce.2013.03.007; Rickard AJ, 2006, ENDOCRINOLOGY, V147, P5901, DOI 10.1210/en.2006-0658; Wilckens T, 1997, IMMUNOL TODAY, V18, P418, DOI 10.1016/S0167-5699(97)01111-0; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; LANGLEY SC, 1990, AM J PHYSIOL, V259, pR539; Hoppmann J, 2010, J ENDOCRINOL, V204, P153, DOI 10.1677/JOE-09-0292; Guder G, 2007, CIRCULATION, V115, P1754, DOI 10.1161/CIRCULATIONAHA.106.653964; CZERWINSKIHELMS SM, 1987, BIOCHEM BIOPH RES CO, V142, P322, DOI 10.1016/0006-291X(87)90276-2; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Caprio M, 2007, FASEB J, V21, P2185, DOI 10.1096/fj.06-7970com; Funder JW, 2005, HEART FAIL REV, V10, P15, DOI 10.1007/s10741-005-2344-2; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Nagata K, 2002, HYPERTENSION, V40, P168, DOI 10.1161/01.HYP.0000026668.50222.1E; Nagata K, 2006, HYPERTENSION, V47, P656, DOI 10.1161/01.HYP.000206772.78696.67; Sainte-Marie Y, 2007, FASEB J, V21, P3133, DOI 10.1096/fj.07-8357com; Ohtake M, 2014, NAGOYA J MED SCI, V76, P59; Muiesan ML, 2003, J AM COLL CARDIOL, V41, P2275, DOI 10.1016/S0735-1097(03)00493-5; Sheppard KE, 2002, ENDOCRINOLOGY, V143, P198, DOI 10.1210/en.143.1.198; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Walker BR, 2007, EUR J ENDOCRINOL, V157, P545, DOI 10.1530/EJE-07-0455; Kotsis V, 2010, HYPERTENS RES, V33, P386, DOI 10.1038/hr.2010.9; Vandevyver S, 2013, ENDOCRINOLOGY, V154, P993, DOI 10.1210/en.2012-2045; Hattori T, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2010.1; MARIN P, 1992, METABOLISM, V41, P882, DOI 10.1016/0026-0495(92)90171-6; Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883; Navarro G, 2015, OBESITY, V23, P713, DOI 10.1002/oby.21033; OKADA S, 1992, AM J PHYSIOL, V262, pR1106; Takahashi K, 2015, NAGOYA J MED SCI, V77, P275	54	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	NOV	2015	38	11					741	750		10.1038/hr.2015.77		10	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CV9CE	WOS:000364584100007		
J	Kayano, H; Koba, S; Matsui, T; Fukuoka, H; Kaneko, K; Shoji, M; Toshida, T; Watanabe, N; Geshi, E; Kobayashi, Y				Kayano, Hiroyuki; Koba, Shinji; Matsui, Taiju; Fukuoka, Hiroto; Kaneko, Kyouichi; Shoji, Makoto; Toshida, Tsutomu; Watanabe, Norikazu; Geshi, Eiichi; Kobayashi, Youichi			Impact of depression on masked hypertension and variability in home blood pressure in treated hypertensive patients	HYPERTENSION RESEARCH			English	Article						blood pressure variability; depression; gender; home blood pressure; masked hypertension	RISK-FACTOR; WHITE-COAT; UNCONTROLLED HYPERTENSION; PROGNOSTIC-SIGNIFICANCE; CARDIOVASCULAR EVENTS; NEGATIVE AFFECT; SLEEP DURATION; OLDER-PEOPLE; HEART-RATE; FOLLOW-UP	This study was conducted to determine the effects of depression and/or insomnia on masked hypertension (MHT) compared with other types of HT and on variability in home-measured blood pressure (HBP) and clinic BP (CBP). Three hundred and twentyeight hypertensives (132 women) aged 68 +/- 10 years were classified into four BP types: controlled HT (CHT), white-coat HT, MHT and sustained HT (SHT), based on CBP (140/90mmHg) and morning HBP (135/85mmHg) measurements. A score of. 16 on the Center for Epidemiologic Studies Depression Scale (CES-D) was defined as depression. The mean values and s.d. of BP were calculated from measurements taken during the 14 consecutive days just before the CES-D evaluation. Compared with the CHT group, the risk of depression was 2.77-fold higher in the SHT group and even higher in the MHT group (7.02-fold). The association between depression and MHT was augmented in the presence of insomnia and was somewhat stronger in women. A HBP variability index defined as s.d./mean BPs in both morning and night time was significantly higher in MHT than in the other BP types, whereas that of CBP was not. Both morning and night-time HBP variability were significantly higher in depressive patients than in non-depressives. These suggest that depression is associated with MHT and that increases both morning and night-time HBP variability but not CBP variability. Physicians should be mindful of mental stresses such as depression in their hypertensive patients when forming strategies to control BP over the diurnal cycle.	[Kayano, Hiroyuki; Koba, Shinji; Matsui, Taiju; Fukuoka, Hiroto; Kaneko, Kyouichi; Shoji, Makoto; Toshida, Tsutomu; Watanabe, Norikazu; Kobayashi, Youichi] Showa Univ, Sch Med, Dept Med, Div Cardiol, Tokyo 142, Japan; [Geshi, Eiichi] Showa Univ, Sch Nursing & Rehabil Sci, Dept Internal Med, Yokohama, Kanagawa, Japan	Kayano, H (reprint author), Showa Univ, Sch Med, Dept Med, Div Cardiol, 1-5-8 Hatanodai Shinagawa Ku, Tokyo 142, Japan.	h-kayano@med.showa-u.ac.jp					Almas A, 2014, J MENT HEALTH, V23, P292, DOI 10.3109/09638237.2014.924047; Davidson K, 2000, ARCH INTERN MED, V160, P1495, DOI 10.1001/archinte.160.10.1495; Paciencia I, 2013, HYPERTENS RES, V36, P747, DOI 10.1038/hr.2013.36; Patten SB, 2009, PSYCHOSOM MED, V71, P273, DOI 10.1097/PSY.0b013e3181988e5f; Kikuya M, 2008, HYPERTENSION, V52, P1045, DOI 10.1161/HYPERTENSIONAHA.107.104620; Pickering TG, 2007, HYPERTENS RES, V30, P479, DOI 10.1291/hypres.30.479; Loredo JS, 2004, SLEEP, V27, P1097; Johansson JK, 2011, J HYPERTENS, V29, P1897, DOI 10.1097/HJH.0b013e32834abccd; Imai Y, 2013, HYPERTENS RES, V36, P661, DOI 10.1038/hr.2013.38; Fagard RH, 2007, J HYPERTENS, V25, P2193; Sunbul M, 2014, CLIN EXP HYPERTENS, V36, P354, DOI 10.3109/10641963.2013.827701; Stergiou GS, 2007, AM J HYPERTENS, V20, P616, DOI 10.1016/j.amjhyper.2006.12.013; [Anonymous], 2014, HYPERTENS RES, V37, P253; SCHULBERG HC, 1985, ARCH GEN PSYCHIAT, V42, P1164; Bobrie G, 2004, JAMA-J AM MED ASSOC, V291, P1342, DOI 10.1001/jama.291.11.1342; Rubio-Guerra AF, 2013, EXP CLIN CARDIOL, V18, P10; Shah MT, 2013, AM J HYPERTENS, V26, P1413, DOI 10.1093/ajh/hpt135; Cohen HW, 2001, PSYCHOSOM MED, V63, P203; Mena L, 2005, J HYPERTENS, V23, P505, DOI 10.1097/01.hjh.0000160205.81652.5a; Jokisalo E, 2003, BLOOD PRESSURE, V12, P49, DOI 10.1080/08037050310000463; Delaney JAC, 2010, HYPERTENSION, V55, P408, DOI 10.1161/HYPERTENSIONAHA.109.139824; Kayano H, 2012, CIRC J, V76, P1670, DOI 10.1253/circj.CJ-11-1085; Mancia G, 2007, J HYPERTENS, V25, P1105, DOI 10.1097/HJH.0b013e3281fc975a; Licht CMM, 2009, HYPERTENSION, V53, P631, DOI 10.1161/HYPERTENSIONAHA.108.126698; Sekizuka H, 2010, J CARDIOL, V55, P92, DOI 10.1016/j.jjcc.2009.10.002; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Matthews KA, 2008, AM J HYPERTENS, V21, P826, DOI 10.1038/ajh.2008.183; MacDonald MB, 1999, CAN MED ASSOC J, V161, P265; BARRETTCONNOR E, 1994, BRIT MED J, V308, P446; Wada K, 2007, AM J IND MED, V50, P8, DOI 10.1002/ajim.20403; Chen RL, 2005, ARCH INTERN MED, V165, P2019, DOI 10.1001/archinte.165.17.2019; Eguchi K, 2012, AM J HYPERTENS, V25, P962, DOI 10.1038/ajh.2012.75; Angeli F, 2010, AM J HYPERTENS, V23, P941, DOI 10.1038/ajh.2010.112; Kario K, 2001, HYPERTENSION, V38, P997, DOI 10.1161/hy1101.095009; Stroup-Benham CA, 2000, J AM GERIATR SOC, V48, P250; Chen HF, 2013, BLOOD PRESSURE, V22, P101, DOI 10.3109/08037051.2012.733508; Konstantopoulou AS, 2010, J HUM HYPERTENS, V24, P151, DOI 10.1038/jhh.2009.55; Shimizu M, 2006, CURR HYPERTENS REP, V8, P363, DOI 10.1007/s11906-006-0079-7; Jorm AF, 2001, BRIT J PSYCHIAT, V178, P553, DOI 10.1192/bjp.178.6.553; Tikhonoff V, 2014, J HYPERTENS, V32, P1590, DOI 10.1097/HJH.0000000000000244; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Hanninen MRA, 2012, J HYPERTENS, V30, P705, DOI 10.1097/HJH.0b013e328350a69b; Lies A, 1996, Z KARDIOL, V85, P140; Meng L, 2012, J HYPERTENS, V30, P842, DOI 10.1097/HJH.0b013e32835080b7; Jonas BS, 1997, ARCH FAM MED, V6, P43, DOI 10.1001/archfami.6.1.43; Yamashita T, 1998, AM J CARDIOL, V82, P1364, DOI 10.1016/S0002-9149(98)00642-0; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Roset AM, 2010, J AM COLL CARDIOL, V56, P38; Satoh H, 2015, HYPERTENS RES, V38, P84, DOI 10.1038/hr.2014.137; Symonides B, 2014, BLOOD PRESSURE, V23, P323, DOI 10.3109/08037051.2014.901006; Teramoto Tamio, 2013, J Atheroscler Thromb, V20, P517; Terracciano A, 2014, J HYPERTENS, V32, P1987, DOI 10.1097/HJH.0000000000000289	55	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	NOV	2015	38	11					751	757		10.1038/hr.2015.75		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CV9CE	WOS:000364584100008		
J	Chida, R; Hisauchi, I; Toyoda, S; Kikuchi, M; Komatsu, T; Hori, Y; Nakahara, S; Sakai, Y; Inoue, T; Taguchi, I				Chida, Ryuji; Hisauchi, Itaru; Toyoda, Shigeru; Kikuchi, Migaku; Komatsu, Takaaki; Hori, Yuichi; Nakahara, Shiro; Sakai, Yoshihiko; Inoue, Teruo; Taguchi, Isao			Impact of irbesartan, an angiotensin receptor blocker, on uric acid level and oxidative stress in high-risk hypertension patients	HYPERTENSION RESEARCH			English	Article						angiotensin receptor blocker; irbesartan; oxidative stress; uric acid	CARDIOVASCULAR RISK; LOSARTAN; CAPACITY; OUTCOMES; THERAPY; MEN; ATHEROSCLEROSIS; HYPERURICEMIA; NEPHROPATHY; ASSOCIATION	Hyperuricemia is a known cardiovascular risk factor. The angiotensin II receptor blocker (ARB) losartan is known to decrease serum uric acid (UA) level. A recent in vitro study demonstrated a strong interaction between irbesartan and UA transporters that exceeded that of losartan. The purpose of the present study was to evaluate the hypouricemic effect of irbesartan in a clinical setting. A total of 40 high-risk hypertensive outpatients with coronary artery disease, cerebrovascular disease and/or diabetes complications who were taking ARBs other than irbesartan and losartan were enrolled in this study. After a 4-week control period, the patients' prescribed ARBs were exchanged for an equivalent dose of irbesartan. We assessed blood pressure, heart rate, serum UA level, parameters of lipid and glucose metabolism, cardiac and renal function and inflammatory and oxidative stress markers in blood samples taken immediately before the initiation of irbesartan treatment and again after 12 weeks of treatment. All 40 recruited patients were followed (31 men and 9 women, mean age: 68 years) without any dropouts. During the 12 weeks of irbesartan treatment, no significant changes in blood pressure, heart rate, parameters of lipid or glucose metabolism or other biomarkers of cardiac function, renal function, or inflammation were observed. However, UA level (5.9 +/- 1.6 to 5.5 +/- 1.6 mg ml(-1), P=0.028) and the oxidative stress marker derivative reactive oxygen metabolites (dROMs) (354 +/- 83 to 310 +/- 65 U. CARR, P<0.001) were significantly lower at 12 weeks of treatment compared with before treatment. These results suggest that irbesartan has beneficial effects on hyperuricemia and oxidative stress.	[Chida, Ryuji; Hisauchi, Itaru; Komatsu, Takaaki; Hori, Yuichi; Nakahara, Shiro; Sakai, Yoshihiko; Taguchi, Isao] Dokkyo Med Univ, Koshigaya Hosp, Dept Cardiol, Koshigaya, Saitama 3438555, Japan; [Toyoda, Shigeru; Kikuchi, Migaku; Inoue, Teruo] Dokkyo Med Univ, Dept Cardiovasc Med, Dokkyo, Tochigi, Japan	Taguchi, I (reprint author), Dokkyo Med Univ, Koshigaya Hosp, Dept Cardiol, 2-1-50 Minami Koshigaya, Koshigaya, Saitama 3438555, Japan.	taguchi@dokkyomed.ac.jp					Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Nyyssonen K, 1997, ATHEROSCLEROSIS, V130, P223, DOI 10.1016/S0021-9150(96)06064-9; Nindita Y, 2010, ARZNEIMITTEL-FORSCH, V60, P186, DOI 10.1055/s-0031-1296271; Matsuo K, 2009, J CARDIOL, V53, P232, DOI 10.1016/j.jjcc.2008.11.010; Bhole V, 2010, AM J MED, V123, P957, DOI 10.1016/j.amjmed.2010.03.027; Evans JL, 2005, ANTIOXID REDOX SIGN, V7, P1040, DOI 10.1089/ars.2005.7.1040; Nieto FJ, 2000, ATHEROSCLEROSIS, V148, P131, DOI 10.1016/S0021-9150(99)00214-2; Cavalleri A, 2004, INT J BIOL MARKER, V19, P250; Waring WS, 2003, CLIN SCI, V105, P425, DOI 10.1042/CS20030149; Miao Y, 2011, HYPERTENSION, V58, P2, DOI 10.1161/HYPERTENSIONAHA.111.171488; Tsukimori K, 2008, AM J HYPERTENS, V21, P1343, DOI 10.1038/ajh.2008.289; Cornelli U, 2001, J NUTR, V131, P3208; Ishizaka N, 2005, ARTERIOSCL THROM VAS, V25, P1038, DOI 10.1161/01.ATV.0000161274.87407.26; Lin KC, 2000, J RHEUMATOL, V27, P1501; Bellomo G, 2010, AM J KIDNEY DIS, V56, P264, DOI 10.1053/j.ajkd.2010.01.019; Elliott WJ, 2001, CLIN THER, V23, P1166, DOI 10.1016/S0149-2918(01)80099-0; Manolis AJ, 2000, CLIN THER, V22, P1186, DOI 10.1016/S0149-2918(00)83062-3; Nakamura M, 2010, J PHARMACOL SCI, V114, P115, DOI 10.1254/jphs.10064SC; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Hoieggen A, 2004, KIDNEY INT, V65, P1041, DOI 10.1111/j.1523-1755.2004.00484.x; Kehrer JP, 2000, TOXICOLOGY, V149, P43, DOI 10.1016/S0300-483X(00)00231-6; Takagi H, 2013, HYPERTENS RES, V36, P368, DOI 10.1038/hr.2012.196; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; Wen CP, 2010, AM J KIDNEY DIS, V56, P273, DOI 10.1053/j.ajkd.2010.01.024; MESSERLI FH, 1980, ANN INTERN MED, V93, P817; Sundstrom J, 2005, HYPERTENSION, V45, P28, DOI 10.1161/01.HYP.0000150784.92944.9a; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Wurzner G, 2001, J HYPERTENS, V19, P1855, DOI 10.1097/00004872-200110000-00021; Chiarelli F, 2005, DIABETES CARE, V28, P1690, DOI 10.2337/diacare.28.7.1690; Conen D, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-9; Fauvel JP, 1996, J CARDIOVASC PHARM, V28, P259, DOI 10.1097/00005344-199608000-00012; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Hamada T, 2008, AM J HYPERTENS, V21, P1157, DOI 10.1038/ajh.2008.245; Burnier M, 1996, EXP NEPHROL, V4, P41; Cearone MR, 1999, INT ANGIOL, V18, P127; Hovind P, 2009, DIABETES, V8, P1668; Kim EJ, 2014, HYPERTENS RES, V37, P50, DOI 10.1038/hr.2013.112; Node K, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-5; Rifai N, 1999, CLIN CHEM, V45, P2136; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Taguchi I, 2013, HYPERTENS RES, V26, P608	41	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	NOV	2015	38	11					765	769		10.1038/hr.2015.82		5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CV9CE	WOS:000364584100010		
J	Ishikuro, M; Obara, T; Metoki, H; Ohkubo, T; Iwama, N; Katagiri, M; Nishigori, H; Narikawa, Y; Yagihashi, K; Kikuya, M; Yaegashi, N; Hoshi, K; Suzuki, M; Kuriyama, S; Imai, Y				Ishikuro, Mami; Obara, Taku; Metoki, Hirohito; Ohkubo, Takayoshi; Iwama, Noriyuki; Katagiri, Mikiko; Nishigori, Hidekazu; Narikawa, Yoko; Yagihashi, Katsuyo; Kikuya, Masahiro; Yaegashi, Nobuo; Hoshi, Kazuhiko; Suzuki, Masakuni; Kuriyama, Shinichi; Imai, Yutaka			Parity as a factor affecting the white-coat effect in pregnant women: the BOSHI study	HYPERTENSION RESEARCH			English	Article						home blood pressure; pregnancy; white-coat effect	AMBULATORY BLOOD-PRESSURE; BODY-MASS INDEX; TREATED HYPERTENSIVE PATIENTS; MASKED HYPERTENSION; HOME; JAPAN; RISK; PREECLAMPSIA; POPULATION; DIFFERENCE	Parity has previously been reported to affect the difference in blood pressure (BP) measured in the office and at home, also known as the white-coat effect, during pregnancy. The objective of this study was to identify possible factors that cause the white-coat effect during pregnancy, focusing on parity. In total, 530 pregnant women (31.3 +/- 4.7 years old) who delivered at a maternal clinic were eligible for the study. The association between parity and the white-coat effect (clinic BP compared with home BP) was investigated for each trimester of pregnancy by multivariate analysis of covariance adjusted for age, body mass index, family history of hypertension and smoking habits. The magnitudes of the white-coat effect for systolic BP in the first, second and third trimesters were 4.1 +/- 9.8, 3.4 +/- 7.1 and 1.8 +/- 6.0mmHg, respectively and those for diastolic BP were 3.8 +/- 7.4, 1.6 +/- 5.8 and 2.4 +/- 4.9mmHg, respectively. Parity was significantly and negatively associated with the white-coat effect for systolic BP in the first trimester of pregnancy (nulliparous women: 5.07 +/- 0.61mmHg and multiparous women: 2.78 +/- 0.74mmHg, P=0.02) as well as for diastolic BP in the second and third trimesters of pregnancy. Age, body mass index, family history of hypertension and smoking were not significantly associated with the white-coat effect in any trimester of pregnancy. Parity may have an influence on the white-coat effect in pregnancy; however, the observed effect, on average 1-2mmHg, was small.	[Ishikuro, Mami; Obara, Taku; Narikawa, Yoko; Kikuya, Masahiro; Kuriyama, Shinichi] Tohoku Univ, Grad Sch Med, Div Mol Epidemiol, Sendai, Miyagi 9808575, Japan; [Ishikuro, Mami; Obara, Taku; Metoki, Hirohito; Narikawa, Yoko; Kikuya, Masahiro; Kuriyama, Shinichi] Tohoku Med Megabank Org, Sendai, Miyagi, Japan; [Metoki, Hirohito; Iwama, Noriyuki; Katagiri, Mikiko; Nishigori, Hidekazu; Yaegashi, Nobuo] Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 9808575, Japan; [Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan; [Ohkubo, Takayoshi; Imai, Yutaka] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi 9808575, Japan; [Yagihashi, Katsuyo; Hoshi, Kazuhiko; Suzuki, Masakuni] Suzuki Mem Hosp, Iwanuma, Japan; [Kuriyama, Shinichi] Int Res Inst Disaster Sci, Dept Disaster Publ Hlth, Sendai, Miyagi, Japan	Metoki, H (reprint author), Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	hmetoki@med.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [18590587, 18390192, 21390201, 22890017, 23590771, 23659347, 24689061, 25670314]; Ministry of Health, Labour and Welfare, Health and Labour Sciences Research [H21-Junkankitou[Seishuu]-Ippan-004]; Japan Society for the Promotion of Science (JSPS) fellows [19.7152, 20.7198, 20.7477, 20.54043]; Takeda Science Foundation; OTC Self-Medication Promotion Foundation	This work was supported by Grants for Scientific Research (Nos. 18590587, 18390192, 21390201, 22890017, 23590771, 23659347, 24689061 and 25670314) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a Grant-in-Aid (H21-Junkankitou[Seishuu]-Ippan-004) from the Ministry of Health, Labour and Welfare, Health and Labour Sciences Research Grants, Japan, a Grant-in-Aid for the Japan Society for the Promotion of Science (JSPS) fellows (19.7152, 20.7198, 20.7477 and 20.54043), and Grants from the Takeda Science Foundation; and Grants from the OTC Self-Medication Promotion Foundation.	PICKERING TG, 1988, JAMA-J AM MED ASSOC, V259, P225, DOI 10.1001/jama.259.2.225; Owens PE, 1998, J HUM HYPERTENS, V12, P743, DOI 10.1038/sj.jhh.1000721; Metoki H, 2012, CLIN EXP HYPERTENS, V34, P290, DOI 10.3109/10641963.2012.681086; Brown MA, 2011, HYPERTENS PREGNANCY, V30, P188, DOI 10.3109/10641955.2010.507854; Imai Y, 2013, HYPERTENS RES, V36, P661, DOI 10.1038/hr.2013.38; Pickering TG, 2008, HYPERTENSION, V52, P1, DOI 10.1161/HYPERTENSIONAHA.107.189011; Hozawa A, 2001, J HYPERTENS, V19, P13, DOI 10.1097/00004872-200101000-00002; Fukuhara M, 2013, STROKE, V44, P1512, DOI 10.1161/STROKEAHA.111.000704; Pipkin FB, 1998, J HYPERTENS, V16, P221, DOI 10.1097/00004872-199816020-00013; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Metoki H, 2008, J HYPERTENS, V26, P2406, DOI 10.1097/HJH.0b013e32831364a7; Ishikuro M, 2013, AM J HYPERTENS, V26, P141, DOI 10.1093/ajh/hps002; Mallion JM, 2006, J HYPERTENS, V24, P2365, DOI 10.1097/01.hjh.0000251895.55249.82; Fujime M, 2012, HYPERTENS RES, V35, P633, DOI 10.1038/hr.2012.1; Mahendru AA, 2013, HYPERTENS RES, V36, P698, DOI 10.1038/hr.2013.24; Thadhani R, 1999, OBSTET GYNECOL, V94, P543, DOI 10.1016/S0029-7844(99)00400-7; Lindbaek M, 2003, BRIT J GEN PRACT, V53, P790; Bakker R, 2010, J HYPERTENS, V28, P2210, DOI 10.1097/HJH.0b013e32833e2a3d; Horikawa T, 2008, HYPERTENS RES, V31, P1115, DOI 10.1291/hypres.31.1115; Fenwick J, 2009, J CLIN NURS, V18, P667, DOI 10.1111/j.1365-2702.2008.02568.x; Tomoda S, 1996, AM J PERINAT, V13, P73, DOI 10.1055/s-2007-994295; Biswas A, 1997, ACTA OBSTET GYN SCAN, V76, P829, DOI 10.3109/00016349709024360; Yoon HJ, 2012, CLIN EXP HYPERTENS, V34, P555, DOI 10.3109/10641963.2012.681725; Ohkuchi A, 2006, HYPERTENS RES, V29, P161, DOI 10.1291/hypres.29.161; Manios ED, 2008, AM J HYPERTENS, V21, P153, DOI 10.1038/ajh.2007.43; Imai Y, 2003, HYPERTENS RES, V26, P771, DOI 10.1291/hypres.26.771; Pickering T G, 1999, Blood Press Monit, V4, P333, DOI 10.1097/00126097-199912000-00006	27	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	NOV	2015	38	11					770	775		10.1038/hr.2015.97		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CV9CE	WOS:000364584100011		
J	Hosaka, M; Asayama, K; Staessen, JA; Tatsuta, N; Satoh, M; Kikuya, M; Ohkubo, T; Satoh, H; Imai, Y; Nakai, K				Hosaka, Miki; Asayama, Kei; Staessen, Jan A.; Tatsuta, Nozomi; Satoh, Michihiro; Kikuya, Masahiro; Ohkubo, Takayoshi; Satoh, Hiroshi; Imai, Yutaka; Nakai, Kunihiko			Relationship between maternal gestational hypertension and home blood pressure in 7-year-old children and their mothers: Tohoku Study of Child Development	HYPERTENSION RESEARCH			English	Article						child; gestational hypertension; home blood pressure; prospective birth cohort study; self-measurement	BIRTH-WEIGHT; STROKE RISK; PREECLAMPSIA; PREGNANCY; COHORT; ADOLESCENTS; POPULATION; DISORDERS; MORTALITY; DISEASE	Women who had hypertensive disorders in pregnancy have an increased risk of cardiovascular diseases in later life. No studies, however, have investigated whether maternal hypertensive disorders in pregnancy affect self-measured blood pressure at home (HBP) in mothers and their children. We evaluated the association between maternal hypertension during pregnancy and HBP based on the prospective Tohoku Study of Child Development birth cohort study, which was performed in two areas in Japan. We included children in a singleton birth at term (36-42 weeks of gestation) with a birth weight of 42400 g. We collected prenatal care data from the medical charts. Because only two mothers experienced preeclampsia, we defined gestational hypertension (GH) as a hypertensive disorder in pregnancy. Seven years after birth, mothers and their children measured their HBP in the morning for 2 weeks. Of 813 eligible mothers, 28 (3.4%) experienced GH, and those were of a similar age compared with 785 non-GH mothers (37.3 vs. 38.0 years; P=0.41). Women with GH had higher body mass index (BMI) (23.8 vs. 21.4 kgm(-2); P=0.01) and elevated HBP (120.3/76.8 vs. 110.4/68.6mmHg; P<0.0002) 7 years after delivery. However, HBP was similar in children with and without GH mothers (93.5/55.9 vs. 94.1/56.1mmHg, P>0.38). These results were confirmatory in case-control (1: 2) analyses with matching by maternal age, maternal BMI before pregnancy, survey area and parity. In conclusion, maternal GH did not affect HBP in offspring but strongly affected maternal HBP even 7 years after birth.	[Hosaka, Miki; Asayama, Kei; Imai, Yutaka] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi 980, Japan; [Asayama, Kei; Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 1738605, Japan; [Staessen, Jan A.] Univ Leuven, Studies Coordinating Ctr, Res Unit Hypertens & Cardiovasc Epidemiol, KU Leuven Dept Cardiovasc Sci, Leuven, Belgium; [Staessen, Jan A.] Maastricht Univ, VitaK Res & Dev, NL-6200 MD Maastricht, Netherlands; [Tatsuta, Nozomi; Nakai, Kunihiko] Tohoku Univ, Grad Sch Med, Dept Environm Hlth Sci, Sendai, Miyagi 980, Japan; [Tatsuta, Nozomi; Nakai, Kunihiko] Tohoku Univ, Grad Sch Med, Dept Dev & Environm Med, Sendai, Miyagi 980, Japan; [Satoh, Michihiro] Tohoku Univ Hosp, Dept Pharm, Sendai, Miyagi, Japan; [Kikuya, Masahiro] Tohoku Univ, Tohoku Med Megabank Org, Dept Epidemiol & Prevent Med, Sendai, Miyagi 980, Japan; [Satoh, Hiroshi] Tohoku Univ, Sendai, Miyagi 980, Japan	Asayama, K (reprint author), Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	kei@asayama.org			Ministry of Education, Culture, Sports, Science and Technology, Japan [23390171]; Ministry of Health, Labour and Welfare, Japan; Ministry of the Environment, Japan; Grant for Environmental Research Projects from the Sumitomo Foundation;  [25.7756];  [25.9328]	We gratefully acknowledge all the staff members of the Tohoku Study of Child Development for their valuable contributions to data collection and database management. We also thank all the participants in the study. Sources of funding: the study was supported by Grants for Scientific Research (23390171) from the Ministry of Education, Culture, Sports, Science and Technology, Japan; a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) fellows (25.7756 and 25.9328); the Ministry of Health, Labour and Welfare, Japan; the Ministry of the Environment, Japan; and the Grant for Environmental Research Projects from the Sumitomo Foundation.	Mori T, 2014, HYPERTENS RES, V37, P145, DOI 10.1038/hr.2013.131; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Vatten LJ, 2004, BJOG-INT J OBSTET GY, V111, P298, DOI 10.1111/j.1471-0528.2004.00071.x; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)17987-2; Xiong X, 2002, AM J EPIDEMIOL, V155, P203, DOI 10.1093/aje/155.3.203; Stergiou GS, 2011, HYPERTENS RES, V34, P640, DOI 10.1038/hr.2011.10; Imai Y, 2013, HYPERTENS RES, V36, P661, DOI 10.1038/hr.2013.38; Stergiou GS, 2006, BLOOD PRESS MONIT, V11, P229, DOI 10.1097/01.mbp.0000209074.38331.16; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Kollias A, 2012, EUR J PUBLIC HEALTH, V22, P389, DOI 10.1093/eurpub/ckr082; Geelhoed JJM, 2010, CIRCULATION, V122, P1192, DOI 10.1161/CIRCULATIONAHA.110.936674; Ohkubo T, 1997, J HYPERTENS, V15, P357, DOI 10.1097/00004872-199715040-00006; Ostlund E, 2013, HYPERTENS RES, V36, P1081, DOI 10.1038/hr.2013.81; Asayama K, 2012, ACTA CARDIOL, V67, P449, DOI 10.2143/AC.67.4.2170687; Mannisto T, 2013, CIRCULATION, V127, P681, DOI 10.1161/CIRCULATIONAHA.112.128751; Stergiou GS, 2009, HYPERTENS RES, V32, P311, DOI 10.1038/hr.2009.9; Asayama K, 2009, J HYPERTENS, V27, P357, DOI 10.1097/HJH.0b013e32831967ca; Sun SS, 2007, PEDIATRICS, V119, P237, DOI 10.1542/peds.2006-2543; Xiong X, 2000, AM J OBSTET GYNECOL, V183, P148, DOI 10.1016/S0002-9378(00)24793-5; Ohkubo T, 1998, J HYPERTENS, V16, P971, DOI 10.1097/00004872-199816070-00010; Ferrazzani S, 2011, EARLY HUM DEV, V87, P445, DOI 10.1016/j.earlhumdev.2011.03.005; Ferreira I, 2009, J HYPERTENS, V27, P1955, DOI 10.1097/HJH.0b013e328331b8c6; Nakai K, 2004, TOHOKU J EXP MED, V202, P227, DOI 10.1620/tjem.202.227; Ohkubo T, 2004, J HYPERTENS, V22, P1099, DOI 10.1097/01.hjh.0000125406.50839.15; Tenhola S, 2006, PEDIATR RES, V59, P320, DOI 10.1203/01.pdr.0000196734.54473.e3; Wilson BJ, 2003, BRIT MED J, V326, P845, DOI 10.1136/bmj.326.7394.845; Mamun AA, 2012, J HUM HYPERTENS, V26, P288, DOI 10.1038/jhh.2011.35; Fraser A, 2013, HYPERTENSION, V62, P614, DOI 10.1161/HYPERTENSIONAHA.113.01513; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Vatten LJ, 2003, OBSTET GYNECOL, V101, P529, DOI 10.1016/S0029-7844(02)02718-7; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Japan Society for Study of Hypertension In Pregnancy, 2009, GUID 2009 CAR TREATM; Lida Minoru, 2003, J Hum Hypertens, V17, P851; North RA, 1999, BRIT J OBSTET GYNAEC, V106, P767, DOI 10.1111/j.1471-0528.1999.tb08396.x	35	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	NOV	2015	38	11					776	782		10.1038/hr.2015.63		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CV9CE	WOS:000364584100012		
J	Nagai, M; Ohkubo, T; Murakami, Y; Takashima, N; Kadota, A; Miyagawa, N; Saito, Y; Nishi, N; Okuda, N; Kiyohara, Y; Nakagawa, H; Nakamura, Y; Fujiyoshi, A; Abbott, RD; Okamura, T; Okayama, A; Ueshima, H; Miura, K				Nagai, Masato; Ohkubo, Takayoshi; Murakami, Yoshitaka; Takashima, Naoyuki; Kadota, Aya; Miyagawa, Naoko; Saito, Yoshino; Nishi, Nobuo; Okuda, Nagako; Kiyohara, Yutaka; Nakagawa, Hideaki; Nakamura, Yoshikazu; Fujiyoshi, Akira; Abbott, Robert D.; Okamura, Tomonori; Okayama, Akira; Ueshima, Hirotsugu; Miura, Katsuyuki		NIPPON DATA80-90-1010 Res Grp	Secular trends of the impact of overweight and obesity on hypertension in Japan, 1980-2010	HYPERTENSION RESEARCH			English	Article						epidemiology; Japan; obesity; overweight; trend	NATIONAL NUTRITION SURVEY; BODY-MASS INDEX; HIGH BLOOD-PRESSURE; GENERAL-POPULATION; NIPPON DATA90; RISK-FACTORS; 7TH REPORT; DISEASE; PREVENTION; ADULTS	The prevalence of overweight (body mass index (BMI)= 25.0-29.9 kgm(-2)) and obesity (>= 30.0 kgm(-2)) has been increasing over the last several decades in Japan. We examined trends of the impact of overweight and obesity on hypertension (systolic/diastolic blood pressure. 140/90mmHg or antihypertensive drugs use) using four national surveys in Japan, from which the participants were randomly sampled from the entire population. Study participants aged 30-79 years were selected for each survey (10 370 in 1980, 8005 in 1990, 5327 in 2000 and 2547 in 2010). The results showed that the impact of overweight and obesity on hypertension had increased significantly (P=0.040 and 0.006 in men and women, respectively). From 1980 to 2010, the multivariable-adjusted odds ratios for hypertension, comparing overweight and obesity with normal weight (BMI = 18.5-24.9 kgm(-2)), went from 1.94 (95% confidence intervals: 1.64, 2.28) to 2.82 (2.07, 3.83) in men, and from 2.37 (2.05, 2.73) to 3.48 (2.57, 4.72) in women. Most of the association was observed in overweight participants, as only 3% of the Japanese were obese. In addition to the relationship between excessive BMI and other adverse health conditions, the rise in the association with hypertension increases the urgency in addressing weight control. We need to address the overweight and obesity epidemic.	[Nagai, Masato; Ohkubo, Takayoshi; Takashima, Naoyuki; Kadota, Aya; Miyagawa, Naoko; Saito, Yoshino; Fujiyoshi, Akira; Ueshima, Hirotsugu; Miura, Katsuyuki] Shiga Univ Med Sci, Dept Publ Hlth, Otsu, Shiga 52021, Japan; [Nagai, Masato] Fukushima Med Univ, Radiat Med Sci Ctr Fukushima Hlth Management Surv, Fukushima 9601295, Japan; [Nagai, Masato] Fukushima Med Univ, Sch Med, Dept Epidemiol, Fukushima 9601295, Japan; [Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan; [Murakami, Yoshitaka] Toho Univ, Sch Med, Dept Med Stat, Tokyo, Japan; [Kadota, Aya; Abbott, Robert D.; Ueshima, Hirotsugu; Miura, Katsuyuki] Shiga Univ Med Sci, Ctr Epidemiol Res Asia, Otsu, Shiga 52021, Japan; [Nishi, Nobuo] Natl Inst Biomed Innovat, Natl Inst Hlth & Nutr, Ctr Int Collaborat & Partnership, Tokyo, Japan; [Nishi, Nobuo] Natl Inst Hlth, Natl Inst Hlth & Nutr, Ctr Int Collaborat & Partnership, Tokyo 141, Japan; [Nishi, Nobuo] Natl Inst Nutr, Natl Inst Hlth & Nutr, Ctr Int Collaborat & Partnership, Tokyo, Japan; [Okuda, Nagako] Univ Human Arts & Sci, Dept Hlth & Nutr, Saitama, Japan; [Kiyohara, Yutaka] Kyushu Univ, Grad Sch Med Sci, Dept Environm Med, Fukuoka 812, Japan; [Nakagawa, Hideaki] Kanazawa Med Univ, Dept Epidemiol & Publ Hlth, Kanazawa, Ishikawa, Japan; [Nakamura, Yoshikazu] Jichi Med Univ, Dept Publ Hlth, Jichi, Tochigi, Japan; [Okamura, Tomonori] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan; [Okayama, Akira] Res Inst Strategy Prevent, Tokyo, Japan	Nagai, M (reprint author), Fukushima Med Univ, Radiat Med Sci Ctr Fukushima Hlth Management Surv, Hikarigaoka 1, Fukushima 9601295, Japan.	mnagai@fmu.ac.jp			Ministry of Health, Labor and Welfare under the auspices of the Japanese Association for Cerebro-cardiovascular Disease Control; Ministry of Health, Labor and Welfare, and a Health and Labor Sciences Research Grant, Japan [7A-2, H11-Chouju-046, H14-Chouju-003, H17-Chouju-012, H19-Chouju-Ippan-014]; Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus [H22-Jyunkankitou-Seisyu-Sitei-017, H25-Jyunkankitou-Seisyu-Sitei-022]	We thank all the public health centers that cooperated with our study. The members of the NIPPON DATA80/90/2010 Research Group are listed below. This study was supported by a Grant-in-Aid from the Ministry of Health, Labor and Welfare under the auspices of the Japanese Association for Cerebro-cardiovascular Disease Control, a Research Grant for Cardiovascular Diseases (7A-2) from the Ministry of Health, Labor and Welfare, and a Health and Labor Sciences Research Grant, Japan (Comprehensive Research on Aging and Health (H11-Chouju-046, H14-Chouju-003, H17-Chouju-012, H19-Chouju-Ippan-014) and Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus (H22-Jyunkankitou-Seisyu-Sitei-017, H25-Jyunkankitou-Seisyu-Sitei-022)).	Okamura T, 2004, AM HEART J, V147, P1024, DOI 10.1016/j.ahj.2003.12.020; Funatogawa I, 2009, INT J EPIDEMIOL, V38, P83, DOI 10.1093/ije/dyn182; Okamura T, 2003, J INTERN MED, V253, P169, DOI 10.1046/j.1365-2796.2003.01080.x; Ueshima H, 2007, J ATHEROSCLER THROMB, V14, P278; Yoshiike N, 1998, INT J OBESITY, V22, P684, DOI 10.1038/sj.ijo.0800651; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Okuda N, 2010, J EPIDEMIOL, V20, pS506, DOI 10.2188/jea.JE20090218; Ikeda N, 2008, B WORLD HEALTH ORGAN, V86, P978, DOI 10.2471/BLT.07.050195; Miura K, 2013, CIRC J, V77, P2226, DOI 10.1253/circj.CJ-13-0847; Elliott P, 1996, BRIT MED J, V312, P1249; UESHIMA H, 1987, J CHRON DIS, V40, P137, DOI 10.1016/0021-9681(87)90065-8; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nakamura K, 2006, CIRC J, V70, P954, DOI 10.1253/circj.70.954; Staessen JA, 2001, LANCET, V358, P1305, DOI 10.1016/S0140-6736(01)06411-X; Rosengren A, 2009, J INTERN MED, V266, P268, DOI 10.1111/j.1365-2796.2009.02116.x; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Kastarinen MJ, 2000, J HYPERTENS, V18, P255, DOI 10.1097/00004872-200018030-00003; Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560; Kadota A, 2007, DIABETES CARE, V30, P1533, DOI 10.2337/dc06-2074; Nakamura K, 2007, EUR J EPIDEMIOL, V22, P691, DOI 10.1007/s10654-007-9168-4; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Borodulin K, 2014, EUR J PUBLIC HEALTH, V25, P539; Japan Heart Foundation, 2003, 5 NAT SURV CIRC DIS; Ministry of health and Welfare, 1982, NAT NUTR SURV JAP 19; Ministry of Health Labour and Welfare, 2010, NAT HLTH NUTR SURV J; Ministry of Health Labour and Welfare, 2011, NAT HLTH NUTR SURV J; Ueshima H, 2006, CIRC J, V70, P1249; Statistic Bureau Ministry of Internal Affairs and Communications, 2011 POP CENS JAP; Matsuzawa Y, 2002, CIRC J, V66, P987; Ueshima Hirotsugu, 2006, Nihon Rinsho, V64 Suppl 6, P108; Yatsuya Hiroshi, 2011, EPMA J, V2, P65, DOI 10.1007/s13167-011-0071-4; Yoshiike N, 2002, Obes Rev, V3, P183, DOI 10.1046/j.1467-789X.2002.00070.x	32	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	NOV	2015	38	11					790	795		10.1038/hr.2015.81		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CV9CE	WOS:000364584100014		
J	Islam, AKMM; Shiomi, J; Ishihara, T; Onodera, H				Islam, A. K. M. Mahfuzul; Shiomi, Jun; Ishihara, Tohru; Onodera, Hidetoshi			Wide-Supply-Range All-Digital Leakage Variation Sensor for On-Chip Process and Temperature Monitoring	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Article						Leakage current; MOSFET; on-chip sensor; process variation; reconfigurable; ring oscillator; temperature	PROCESS VARIABILITY; RING OSCILLATOR; CIRCUITS; CMOS; VOLTAGE	Variation in process, voltage and temperature is a major obstacle in achieving energy-efficient operation of LSI. This paper proposes an all-digital on-chip circuit to monitor leakage current variations of both of the nMOSFET and pMOSFET independently. As leakage current is highly sensitive to threshold voltage and temperature, the circuit is suitable for tracking process and temperature variation. The circuit uses reconfigurable inhomogeneity to obtain statistical properties from a single monitor instance. A compact reconfigurable inverter topology is proposed to implement the monitor circuit. The compact and digital nature of the inverter enables cell-based design, which will reduce design costs. Measurement results from a 65 nm test chip show the validity of the proposed circuit. For a 124 sample size for both of the nMOSFET and pMOSFET, the monitor area is 4500 mu m(2) and active power consumption is 76 nW at 0.8 V operation. The proposed technique enables area-efficient and low-cost implementation thus can be used in product chips for applications such as dynamic energy and thermal management, testing and post-silicon tuning.	[Islam, A. K. M. Mahfuzul] Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan; [Shiomi, Jun; Ishihara, Tohru; Onodera, Hidetoshi] Kyoto Univ, Dept Commun & Comp Engn, Kyoto 6068501, Japan	Islam, AKMM (reprint author), Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan.	mahfuzul@iis.u-tokyo.ac.jp			JSPS KAKENHI [25280014, 25.6432]	This work was supported in part by JSPS KAKENHI Grant Numbers 25280014 and 25.6432.	Borkar S, 2003, DES AUT CON, P338; Chen P, 2011, IEEE T CIRCUITS-I, V58, P913, DOI 10.1109/TCSI.2010.2090567; Rao R, 2004, IEEE T VLSI SYST, V12, P131, DOI 10.1109/TVLSI.2003.821549; Fujimoto S, 2013, IEEE T SEMICONDUCT M, V26, P296, DOI 10.1109/TSM.2013.2265702; Kim CH, 2006, IEEE T VLSI SYST, V14, P646, DOI 10.1109/TVLSI.2006.878226; Saxena S, 2008, IEEE T ELECTRON DEV, V55, P131, DOI 10.1109/TED.2007.911351; Ituero P, 2008, IEEE SENS J, V8, P2036, DOI 10.1109/JSEN.2008.2007692; Fujii M, 2008, PROC EUR SOLID-STATE, P258, DOI 10.1109/ESSCIRC.2008.4681841; Mukhopadhyay S, 2008, IEEE J SOLID-ST CIRC, V43, P1951, DOI 10.1109/JSSC.2008.2001896; Kim NS, 2003, COMPUTER, V36, P68, DOI 10.1109/MC.2003.1250885; Pang LT, 2009, IEEE J SOLID-ST CIRC, V44, P1655, DOI 10.1109/JSSC.2009.2015789; Souri K, 2013, IEEE J SOLID-ST CIRC, V48, P292, DOI 10.1109/JSSC.2012.2214831; Islam AKMM, 2013, IEEE ASIAN SOLID STA, P125; Ituero P, 2013, IEEE SENS J, V13, P442, DOI 10.1109/JSEN.2012.2227713; Chowdhury G. R., 2012, P IEEE INT S CIRC SY, P1999; Howard J., 2010, IEEE INT SOL STAT CI, V9, P58; Iizuka T, 2012, IEICE T ELECTRON, VE95C, P627, DOI [10.1587/transele.E95.C627, 10.1587/transele.E95.C.627]; Islam A. M., 2014, P IEEE AS SOL STAT C, P45; Islam A. M., 2014, JPN J APPL PHYS, V53; Kim C., 2004, S VLSI CIRC JUN, P250; Klass F., 2008, IEEE INT SOL STAT CI, P408; Kuhn K. J., 2009, IWCE, P1; Lefurgy C. R., 2011, P 44 ANN IEEE ACM IN, P1; Narendra S., 2001, P INT S LOW POW EL D, P195, DOI 10.1145/383082.383132; Roy K, 2003, P IEEE, V91, P305, DOI 10.1109/JPROC.2002.808156; Saneyoshi E., 2008, S VLSI CIRC DIG, P138; Tschanz J., 2007, IEEE INT SOL STAT CI, P292; Tsunomura T., 2008, S VLSI TECHN, P156; Weste Neil, 2011, CMOS VLSI DESIGN CIR	29	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9200	1558-173X		IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	NOV	2015	50	11					2475	2490		10.1109/JSSC.2015.2461598		16	Engineering, Electrical & Electronic	Engineering	CV7MR	WOS:000364458200002		
J	Miura, N; Dosho, S; Tezuka, H; Miki, T; Fujimoto, D; Kiriyama, T; Nagata, M				Miura, Noriyuki; Dosho, Shiro; Tezuka, Hiroyuki; Miki, Takuji; Fujimoto, Daisuke; Kiriyama, Takuya; Nagata, Makoto			A 1 mm Pitch 80 x 80 Channel 322 Hz Frame-Rate Multitouch Distribution Sensor With Two-Step Dual-Mode Capacitance Scan	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Article						Capacitance distribution; high resolution; human interface; multitouch; touch sensor		A 1 mm pitch 80 x 80 channel 322 Hz frame-rate capacitive multitouch distribution sensor has been developed. High-resolution multiple touch points are detected including touch-strength distribution around them. A two-step dual-mode capacitance scan scheme is proposed, where self-and mutual-capacitance measurements are hierarchically performed in two steps to increase the frame scan rate that is otherwise reduced due to high resolution. 160 row-and-column dedicated parallel ADCs further increase the scan rate. A time-domain counter-based slope ADC suppresses power and area penalty for the parallel ADC approach. A signal attenuation due to the sensor capacitance reduction in the high resolution is compensated by thorough noise-reduction techniques in the sensor analog frontend (AFE). A prototype in 0.35 mu m CMOS demonstrates 41 dB signal-to-noise ratio (SNR) with >5x tighter sensor-channel pitch, >10x faster touch-point scan, >10x and >4x higher energy and area efficiency to the state-of-the-art touch distribution sensors.	[Miura, Noriyuki; Kiriyama, Takuya; Nagata, Makoto] Kobe Univ, Grad Sch Syst Informat, Kobe, Hyogo 6578501, Japan; [Dosho, Shiro] Tokyo Inst Technol, Yokohama, Kanagawa 2268503, Japan; [Tezuka, Hiroyuki] Panasonic Semicond Solut, Kyoto 6178520, Japan; [Miki, Takuji] Panasonic AIS Corp Engn Div, Osaka 5718506, Japan; [Fujimoto, Daisuke] Yokohama Natl Univ, Matsumoto Lab, Yokohama, Kanagawa 2408501, Japan	Miura, N (reprint author), Kobe Univ, Grad Sch Syst Informat, Kobe, Hyogo 6578501, Japan.	miura@cs.kobe-u.ac.jp			JSPS [26820128]	This work was supported by JSPS Grants-in-Aid for Scientific Research under Grant 26820128.	Walker G, 2012, J SOC INF DISPLAY, V20, P413, DOI 10.1002/jsid.100; SAKURAI T, 1983, IEEE J SOLID-ST CIRC, V18, P418, DOI 10.1109/JSSC.1983.1051966; Yang JJ, 2013, J GERIATR CARDIOL, V10, P10, DOI [10.3969/j.issn.1671-5411.2013.01.003, 10.3724/SP.J.1263.2012.12191]; Hamaguchi M., 2014, IEEE INT SOL STAT CI, P214, DOI DOI 10.1109/ISSCC.2014.6757405; Kim H.-R., 2010, IEEE INT SOL STAT CI, P114; Kim K.-D., 2012, ISSCC, P116, DOI DOI 10.1109/ISSCC.2012.6176943; Kim K.-D., 2014, S VLSI CIRC, P1; Miura N., 2014, IEEE ISSCC, P216; Shin H., 2013, ISSCC, P388; Shoushun C., 2008, IEEE SENS J, V8, P286, DOI 10.1109/JSEN.2007.912783; Yang J.-H., 2012, SOC INF DISPL S JUN, P1570	11	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9200	1558-173X		IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	NOV	2015	50	11					2741	2749		10.1109/JSSC.2015.2480094		9	Engineering, Electrical & Electronic	Engineering	CV7MR	WOS:000364458200024		
J	Pu, J; Wang, J; Yu, WW; Shen, ZM; Lv, Q; Zeljic, K; Zhang, CC; Sun, BM; Liu, GX; Wang, Z				Pu, Jian; Wang, Jun; Yu, Wenwen; Shen, Zhuangming; Lv, Qian; Zeljic, Kristina; Zhang, Chencheng; Sun, Bomin; Liu, Guoxiang; Wang, Zheng			Discriminative Structured Feature Engineering for Macroscale Brain Connectomes	IEEE TRANSACTIONS ON MEDICAL IMAGING			English	Article						Classification; feature engineering; macroscale brain connectomes; statistical significance	OBSESSIVE-COMPULSIVE DISORDER; RICH-CLUB ORGANIZATION; FEATURE-SELECTION; NETWORKS; HUBS; PREDICTION; KETAMINE; CONNECTIVITY; STABILITY; GRAPHS	Neuroimaging techniques can measure structural and functional brain connectivity with unprecedented detail in vivo. This so-called brain connectome can be represented as high dimensional matrices corresponding to edge weights in graphs. After measuring the matrices of two cohorts (i.e., patients and healthy controls), one is often required to formulate computational network models for effective feature engineering to draw discriminative distinctions between the cohorts, as well as estimate the associated statistical significance. We designed a novel method to reveal the intrinsic features of functional matrices of discriminative power for group comparison. More specifically, by encouraging co-selection of edges connected to the same node, we preserved the discriminative edges to maximum extent. To reduce the false positive rate of the extracted discriminative edges, an optimization procedure was developed to evaluate the significance of these edges and remove trivial ones. We validated the proposed method using both synthetic data and real benchmarks, and compared it to regularized logistic regression, univariate t-test and stability selection. The experimental results clearly showed that the proposed approach outperformed the three competing methods under various settings. In addition to increasing the F-measure of feature selection, our approach captured the endogenous, discriminative connectivity patterns consistent with recent findings in biomedical literature. This data-driven method paves a new avenue of enquiry into the inherent nature of network models for functional brain connectomes.	[Pu, Jian; Yu, Wenwen; Shen, Zhuangming; Lv, Qian; Zeljic, Kristina; Wang, Zheng] Chinese Acad Sci, Inst Neurosci, Key Lab Primate Neurobiol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Wang, Jun] Inst Data Sci & Technol, Alibaba Grp, Seattle, WA 98101 USA; [Zhang, Chencheng; Sun, Bomin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Funct Neurosurg, Shanghai 200025, Peoples R China; [Liu, Guoxiang] Osaka Univ, Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks CiNet, Osaka 5650871, Japan	Wang, Z (reprint author), Chinese Acad Sci, Inst Neurosci, Key Lab Primate Neurobiol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.	jianpu@ion.ac.cn; zheng.wang@ion.ac.cn					Milad MR, 2012, TRENDS COGN SCI, V16, P43, DOI 10.1016/j.tics.2011.11.003; Achard S, 2012, P NATL ACAD SCI USA, V109, P20608, DOI 10.1073/pnas.1208933109; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Sprechmann P, 2011, IEEE T SIGNAL PROCES, V59, P4183, DOI 10.1109/TSP.2011.2157912; Craddock RC, 2013, NAT METHODS, V10, P524, DOI [10.1038/nmeth.2482, 10.1038/NMETH.2482]; Fitzgerald KD, 2005, BIOL PSYCHIAT, V57, P287, DOI 10.1016/j.biopsych.2004.10.038; de Reus MA, 2013, J NEUROSCI, V33, P12929, DOI 10.1523/JNEUROSCI.1448-13.2013; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Castellanos FX, 2013, NEUROIMAGE, V80, P527, DOI 10.1016/j.neuroimage.2013.04.083; Richiardi J, 2013, IEEE SIGNAL PROC MAG, V30, P58, DOI 10.1109/MSP.2012.2233865; Slawski M, 2010, ANN APPL STAT, V4, P1056, DOI 10.1214/09-AOAS302; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Power JD, 2013, NEURON, V79, P798, DOI 10.1016/j.neuron.2013.07.035; Turk-Browne NB, 2013, SCIENCE, V342, P580, DOI 10.1126/science.1238409; van den Heuvel MP, 2014, NEUROPSYCHOL REV, V24, P32, DOI 10.1007/s11065-014-9248-7; Chang YT, 2014, NEUROIMAGE, V91, P99, DOI 10.1016/j.neuroimage.2014.01.010; Rondina JM, 2014, IEEE T MED IMAGING, V33, P85, DOI 10.1109/TMI.2013.2281398; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Grosenick L, 2013, NEUROIMAGE, V72, P304, DOI 10.1016/j.neuroimage.2012.12.062; Meinshausen N, 2010, J R STAT SOC B, V72, P417; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Simon D, 2014, NEUROIMAGE-CLIN, V4, P549, DOI 10.1016/j.nicl.2014.03.011; Musso F, 2011, NEUROIMAGE, V58, P508, DOI 10.1016/j.neuroimage.2011.06.045; van den Heuvel OA, 2004, PSYCHIAT RES-NEUROIM, V132, P225, DOI 10.1016/j.pscychresns.2004.06.007; Niesters M, 2012, ANESTHESIOLOGY, V117, P868, DOI 10.1097/ALN.0b013e31826a0db3; Echtermeyer C., 2011, FRONT NEUROINFORM, V5, P1; Essen D. C. V., 2001, J AM MED INFORM ASSN, V8, P443; Gabrieli JDE, 2015, NEURON, V85, P11, DOI 10.1016/j.neuron.2014.10.047; Grant M., 2014, CVX MATLAB SOFTWARE; Hastie T., 2001, STATISTICS; Javanmard A., 2013, ADV NEURAL INFORM PR, P1187; Javanmard A., 2013, IEEE T INFORM THEORY, V60, P6522; Li F., 2013, HUM BRAIN MAPP, V35, P2643; Lv Q., BIOL PSYCHI IN PRESS; Lv Q., BIOL PSYCHIAT; Meskaldji DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023009; Miao XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025546; Ng A., 2004, P 21 INT C MACH LEAR, P78, DOI DOI 10.1145/1015330.1015435; Rohlfing T., 2012, FRONT NEUROINFORMATI, V6, P1; Rubinov Mikail, 2013, Dialogues Clin Neurosci, V15, P339; Scheidegger M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044799; Sinner B., 2008, V182, P313; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049	50	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0062	1558-254X		IEEE T MED IMAGING	IEEE Trans. Med. Imaging	NOV	2015	34	11					2333	2342		10.1109/TMI.2015.2431294		10	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Engineering, Electrical & Electronic; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	Computer Science; Engineering; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	CV7NP	WOS:000364461000011		
J	Kohyama, TI; Akiyama, T; Nishida, C; Takami, K; Onuma, M; Momose, K; Masuda, R				Kohyama, Tetsuo I.; Akiyama, Takuya; Nishida, Chizuko; Takami, Kazutoshi; Onuma, Manabu; Momose, Kunikazu; Masuda, Ryuichi			Isolation and characterization of major histocompatibility complex class II B genes in cranes	IMMUNOGENETICS			English	Article						Aves; Concerted evolution; Gruiformes; MHC; Trans-species polymorphism	MHC CLASS IIB; POLYMORPHISM; EVOLUTION; SELECTION; HYPOTHESIS; RESISTANCE; PHYLOGENY; DIVERSITY; PASSERINE; SEQUENCES	In this study, we isolated and characterized the major histocompatibility complex (MHC) class II B genes in cranes. Genomic sequences spanning exons 1 to 4 were amplified and determined in 13 crane species and three other species closely related to cranes. In all, 55 unique sequences were identified, and at least two polymorphic MHC class II B loci were found in most species. An analysis of sequence polymorphisms showed the signature of positive selection and recombination. A phylogenetic reconstruction based on exon 2 sequences indicated that trans-species polymorphism has persisted for at least 10 million years, whereas phylogenetic analyses of the sequences flanking exon 2 revealed a pattern of concerted evolution. These results suggest that both balancing selection and recombination play important roles in the crane MHC evolution.	[Kohyama, Tetsuo I.; Akiyama, Takuya; Nishida, Chizuko; Masuda, Ryuichi] Hokkaido Univ, Fac Sci, Dept Nat Hist Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Takami, Kazutoshi] Osaka Municipal Tennoji Zool Gardens, Tennoji Ku, Osaka, Osaka 5430063, Japan; [Onuma, Manabu] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Ecol Genet Anal Sect, Tsukuba, Ibaraki 3058506, Japan; [Momose, Kunikazu] Red Crowned Crane Conservancy, Kushiro, Hokkaido 0850036, Japan	Masuda, R (reprint author), Hokkaido Univ, Fac Sci, Dept Nat Hist Sci, Kita Ku, N10W8, Sapporo, Hokkaido 0600810, Japan.	masudary@mail.sci.hokudai.ac.jp		Kohyama, Tetsuo/0000-0002-4567-2893	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [D-1201]; Akiyama Life Science Foundation	We thank Tama Zoological Park, Hirakawa Zoological Park, Fukuoka Municipal Zoological and Botanical Gardens, Maruyama Zoo, Osaka Municipal Tennoji Zoological Gardens, Sayama Chikozan Park Children's Zoo, Kushiro Zoo, Inokashira Park Zoo, Ueno Zoological Gardens, Nogeyama Zoological Gardens of Yokohama, and Chiba Zoological Park for providing samples, and Dr. Matthew Dick and Masahito T. Kimura for invaluable comments and English editing of the manuscript. This study was supported in part by a grant (D-1201) from the Environment Research and Technology Development Fund of the Ministry of the Environment, Japan, and a research grant from the Akiyama Life Science Foundation.	Alcaide M, 2014, ECOL EVOL, V4, P688, DOI 10.1002/ece3.974; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Ewing B, 1998, GENOME RES, V8, P175; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Scheffler K, 2006, BIOINFORMATICS, V22, P2493, DOI 10.1093/bioinformatics/btl427; Gordon D, 1998, GENOME RES, V8, P195; Krajewski C, 2010, AUK, V127, P440, DOI 10.1525/auk.2009.09045; Martinsohn JT, 1999, IMMUNOGENETICS, V50, P168, DOI 10.1007/s002510050593; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Nishida C, 2013, CYTOGENET GENOME RES, V141, P284, DOI 10.1159/000352067; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Spurgin LG, 2010, P R SOC B, V277, P979, DOI 10.1098/rspb.2009.2084; Alcaide M, 2007, J MOL EVOL, V65, P541, DOI 10.1007/s00239-007-9033-9; Bonneaud C, 2006, EVOLUTION, V60, P383, DOI 10.1554/05-409.1; Burri R, 2014, MOL ECOL RESOUR, V14, P778, DOI 10.1111/1755-0998.12234; Wiuf C, 2004, GENETICS, V168, P2363, DOI 10.1554/genetics.104.029488; FIGUEROA F, 1988, NATURE, V335, P265, DOI 10.1038/335265a0; Fain MG, 2007, MOL PHYLOGENET EVOL, V43, P515, DOI 10.1016/j.ympev.2007.02.015; Lenz TL, 2008, GENE, V427, P117, DOI 10.1016/j.gene.2008.09.013; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Jarvi SI, 1999, J HERED, V90, P152, DOI 10.1093/jhered/90.1.152; Li L, 2011, J MOL EVOL, V72, P474, DOI 10.1007/s00239-011-9446-3; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Ujvari B, 2011, INT J MOL SCI, V12, P5168, DOI 10.3390/ijms12085168; Frankham R., 2010, INTRO CONSERVATION G; IUCN, 2015, IUCN RED LIST THREAT; KLEIN J, 1987, HUM IMMUNOL, V19, P155, DOI 10.1016/0198-8859(87)90066-8; Klein J., 1986, NATURAL HIST MAJOR H; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Meine CD, 1996, CRANES STATUS SURVEY; Nei M, 2000, MOL EVOLUTION PHYLOG; Promerova M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069135; R Core Team, 2015, R LANG ENV STAT COMP; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16	37	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0093-7711	1432-1211		IMMUNOGENETICS	Immunogenetics	NOV	2015	67	11-12					705	710		10.1007/s00251-015-0874-x		6	Genetics & Heredity; Immunology	Genetics & Heredity; Immunology	CV8GJ	WOS:000364519300007		
J	Akutsu, H; Hashimoto, R; Yamada, J; Nakatsuji, S; Nakazawa, Y; Turner, SS				Akutsu, Hiroki; Hashimoto, Ryuichiro; Yamada, Jun-ichi; Nakatsuji, Shin'ichi; Nakazawa, Yasuhiro; Turner, Scott S.			Structures and properties of new ferrocene-based paramagnetic anion octamethylferrocenedisulfonate and its ITF salt	INORGANIC CHEMISTRY COMMUNICATIONS			English	Article						Ferrocene; Tetrathiafulvalene; Crystal structure; Charge-transfer salt; Organic conductors	CHARGE-TRANSFER SALT; MOLECULAR CONDUCTORS	The structure and properties of a new ferrocene-based disulfonate anion, octamethylferrocenedisulfonate (Fe(C-5(CH3)(4)(SO3))(2)), obtained as tetraphenylphosphonium (PPh4) salts, are described. Recrystallisation gave two types of salts, yellow crystals and green powder. The former composition was found to be (PPh4)(2)[Fe(C-5(CH3)(4)(SO3))(2)], where Fe(Cs(CH3)4(SO3))(2) is dianionic. The green powder was determined to be (PPM[Fe(C-5(CH3)(4)(SO3))(2)].0.4H2O, in which the iron complex is monoanionic despite it having two anionic sulfo groups. The ferrocenyl part has a charge of +1 and temperature-dependent magnetic susceptibility indicates that the green salt is paramagnetic. Metathesis of either PPh4 salts with (TTF)(3)(BF4)(2) (TTF = tetrathiafulvalene) gave the same compound, (TTF)[Fe(C-5(CH3)(4)(SO3))(2)].0.4H(2)O, in which the anion is paramagnetic. This is the first TTF-type salt that contains a non-diamagnetic ferfocenyl-based counter-ion. The structure and properties of the TTF salt are reported. (C) 2015 Elsevier B.V. All rights reserved.	[Akutsu, Hiroki; Nakazawa, Yasuhiro] Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 5600043, Japan; [Akutsu, Hiroki; Hashimoto, Ryuichiro; Yamada, Jun-ichi; Nakatsuji, Shin'ichi] Univ Hyogo, Grad Sch Mat Sci, Kamigori, Hyogo 6781297, Japan; [Turner, Scott S.] Univ Surrey, Dept Chem, Guildford GU2 7XH, Surrey, England	Akutsu, H (reprint author), Osaka Univ, Grad Sch Sci, Dept Chem, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan.						Clemente DA, 1996, J MATER CHEM, V6, P941, DOI 10.1039/jm9960600941; Furuta K, 2005, SYNTHETIC MET, V152, P381, DOI 10.1016/j.synthmet.2005.07.113; Coronado E, 2004, CHEM REV, V104, P5419, DOI 10.1021/cr030641n; Furuta K, 2006, J MATER CHEM, V16, P1504, DOI 10.1039/b601614f; Kobayashi H, 2004, CHEM REV, V104, P5265, DOI 10.1021/cr030657d; Akutsu H, 2013, DALTON T, V42, P16351, DOI 10.1039/c3dt52346b; Akutsu H, 2007, INORG CHEM, V46, P8472, DOI 10.1021/ic701392z; MILLER JS, 1988, CHEM REV, V88, P201, DOI 10.1021/cr00083a010; Kanbayashi N, 2012, INORG CHEM COMMUN, V21, P122, DOI 10.1016/j.inoche.2012.04.028; Fourmigue M, 2009, TOP ORGANOMETAL CHEM, V27, P161, DOI 10.1007/978-3-642-00408-7_7; Mochida T, 2014, EUR J INORG CHEM, P3920, DOI 10.1002/ejic.201400093; Saito G, 2014, EUR J INORG CHEM, P3785, DOI 10.1002/ejic.201402628; El-Wareth A, 2005, TETRAHEDRON, V61, P3889, DOI 10.1016/j.tet.2005.02.028; Togni A., 1995, FERROCENES HOMOGENOU; Zanello P., 2003, FERROCENES INORGANIC	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1387-7003	1879-0259		INORG CHEM COMMUN	Inorg. Chem. Commun.	NOV	2015	61						41	47		10.1016/j.inoche.2015.08.018		7	Chemistry, Inorganic & Nuclear	Chemistry	CV9NK	WOS:000364613700011		
J	Sekine, K; Kumazawa, T; Tanabe, Y				Sekine, Kiyoto; Kumazawa, Takeshi; Tanabe, Yasuhiro			Influence of Joining Interlayer on Impact Damage to Laminated Boron Carbide Ceramics	INTERNATIONAL JOURNAL OF APPLIED CERAMIC TECHNOLOGY			English	Article							MECHANICAL-PROPERTIES; FRACTURE; B4C; TEMPERATURE; PENETRATION; COMPOSITES; TOUGHNESS; CRACK; AL	Impact damage of laminated B4C ceramic samples was investigated using four types of aluminum sheets without holes and with 25 4-, 8-, and 25-mm-diameter holes at joining ratios of 100, 94, 76, and 45%. Four 1-mm-thick B4C ceramics plates were laminated using three aluminum sheets of the same type and joined at 700 degrees C in vacuum. In impact damage tests using spherical SUJ-2 projectile with a diameter of 4mm with a velocity of approximately 300ms(-1), bulk B4C showed a large conical crack and significant fractures; the conical crack in the laminated samples was smaller than that of the bulk B4C. However, the conical cracks of the laminated B4C with the joining ratio 45 to 96% were of the same size, irrespective of the joining ratios. The total load and induced pressure area on the rear side of laminated samples were smaller than that observed for bulk B4C, and total load and induced pressure area were similar for laminated samples with high and low joining ratios. The maximum pressure on the rear face of laminated B4C samples was higher than that observed for bulk B4C and increased with decreasing joining ratio of laminate interlayer.	[Sekine, Kiyoto] Mino Ceram Co Ltd, NC Dept, Handa, Aichi 4750027, Japan; [Sekine, Kiyoto; Tanabe, Yasuhiro] Nagoya Univ, Nagoya, Aichi 4648603, Japan; [Kumazawa, Takeshi] Mino Ceram Co Ltd, NC Dept, Nagoya, Aichi 4500003, Japan	Sekine, K (reprint author), Mino Ceram Co Ltd, NC Dept, Handa, Aichi 4750027, Japan.	sekine@mino-ceramic.co.jp					Viala JC, 1997, J MATER SCI, V32, P4559, DOI 10.1023/A:1018625402103; Orlovskaya N, 2005, J MATER SCI, V40, P5483, DOI 10.1007/s10853-005-1923-x; Sekine K, 2012, J CERAM SOC JPN, V120, P393, DOI 10.2109/jcersj2.120.393; SHOCKEY DA, 1990, INT J IMPACT ENG, V9, P263, DOI 10.1016/0734-743X(90)90002-D; WILKINS ML, 1978, INT J ENG SCI, V16, P793, DOI 10.1016/0020-7225(78)90066-6; Sekine K, 2012, J CERAM SOC JPN, V120, P207, DOI 10.2109/jcersj2.120.207; Tariolle S, 2005, J EUR CERAM SOC, V25, P3639, DOI 10.1016/j.jeurceramsoc.2004.09.014; Holmquist TJ, 2006, J APPL PHYS, V100, DOI 10.1063/1.2362979; Mashhadi M, 2009, CERAM INT, V35, P831, DOI 10.1016/j.ceramint.2008.03.003; Yamada M, 2010, J CERAM SOC JPN, V118, P903, DOI 10.2109/jcersj2.118.903; Dariel MP, 2012, ADV APPL CERAM, V111, P301, DOI 10.1179/1743676111Y.0000000078; Zhuang SM, 2003, J MECH PHYS SOLIDS, V51, P245, DOI 10.1016/S0022-5096(02)00100-X; FURLONG JR, 1994, J APPL PHYS, V76, P25, DOI 10.1063/1.357138; Kumazawa T, 2008, J CERAM SOC JPN, V116, P1319, DOI 10.2109/jcersj2.116.1319; Schwetz KA, 1997, J SOLID STATE CHEM, V133, P68, DOI 10.1006/jssc.1997.7316; Sigl LS, 1998, J EUR CERAM SOC, V18, P1521, DOI 10.1016/S0955-2219(98)00071-5; Lee H, 2002, J AM CERAM SOC, V85, P1291; Tanabe Y, 2005, J CERAM SOC JPN, V113, P198, DOI 10.2109/jcersj.113.198; Miyazaki H, 2010, J EUR CERAM SOC, V30, P999, DOI 10.1016/j.jeurceramsoc.2009.10.015; Zhang Y, 2006, J APPL PHYS, V100, DOI 10.1063/1.2399334; Radovitzky R, 2011, COMPUT METHOD APPL M, V200, P326, DOI 10.1016/j.cma.2010.08.014; SCHWETZ KA, 1981, J LESS-COMMON MET, V82, P37, DOI 10.1016/0022-5088(81)90195-8; Blanks KS, 1998, J EUR CERAM SOC, V18, P1945, DOI 10.1016/S0955-2219(98)00134-4; Lin QL, 2009, SCRIPTA MATER, V60, P960, DOI 10.1016/j.scriptamat.2009.02.024; Hayun S, 2009, J EUR CERAM SOC, V29, P3395, DOI 10.1016/j.jeurceramsoc.2009.07.007; Yadav S, 2003, INT J IMPACT ENG, V28, P557, DOI 10.1016/S0734-743X(02)00122-7; Gonzalez L. V., 2010, INT J APPL CERAM TEC, V7, P643; LaSalvia J. C., 2009, CERAM ENG SCI P, V30, P45; Sekine K., 2012, CERAM ENG SCI P, V33, P105; Thevenot F., 1990, Journal of the European Ceramic Society, V6, DOI 10.1016/0955-2219(90)90048-K	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1546-542X	1744-7402		INT J APPL CERAM TEC	Int. J. Appl. Ceram. Technol.	NOV-DEC	2015	12	6					1217	1229		10.1111/ijac.12342		13	Materials Science, Ceramics	Materials Science	CW0VV	WOS:000364708800013		
J	Huang, FX; Liu, J; Maruoka, N; Kitamura, S; Ishikawa, A				Huang, Fuxiang; Liu, Jiang; Maruoka, Nobuhiro; Kitamura, Shin-ya; Ishikawa, Akira			Dissolution Rates of Solid Oxides into Molten Slags	INTERNATIONAL JOURNAL OF APPLIED CERAMIC TECHNOLOGY			English	Article								To reduce refractory damage during steelmaking, precise control of slag composition is important. Usually, the formation and decomposition rates of interfacial layer are considered to be rate-controlling steps. The influence of the interfacial layer on the dissolution rate was investigated. The reagents were mixed and sintered to make an oxide that simulated the interfacial layer. The sample was added to molten slag stirred by Ar gas, and the dissolution rate was determined from the change in slag composition. The results revealed the importance of the effects of the density and composition of the interfacial layer on the dissolution rate.	[Huang, Fuxiang; Liu, Jiang] Univ Sci & Technol, Sch Met & Ecol Engn, Beijing 100083, Peoples R China; [Maruoka, Nobuhiro; Kitamura, Shin-ya] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan; [Ishikawa, Akira] Tohoku Univ, Grad Sch Engn, Dept Met, Sendai, Miyagi 9808577, Japan	Huang, FX (reprint author), Univ Sci & Technol, Sch Met & Ecol Engn, Beijing 100083, Peoples R China.	kitamura@tagen.tohoku.ac.jp			Technical Association of Refractories, Japan; JFE 21st Century Foundation	The authors appreciate financial support from the Technical Association of Refractories, Japan and the JFE 21st Century Foundation.	Satyoko Y, 1999, BRIT CERAM T, V98, P261, DOI 10.1179/096797899680552; Yang J, 2007, ISIJ INT, V47, P1401, DOI 10.2355/isijinternational.47.1401; Maruoka N, 2013, HIGH TEMP MAT PR-ISR, V32, P15, DOI 10.1515/htmp-2012-0049; Huang F., J TECHN ASS IN PRESS; Ito S., 2008, NIPPON STEEL TECHNIC, V98, P63; Lee W. E., 2004, P 7 INT C MOLT SLAGS; Maruoka N., 2013, P 5 BAOST BIENN AC C; Maruoka N., 2011, P 12 UN INT TECHN C; Umakoshi M., 1981, TETSU TO HAGANE, V67, P1726	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1546-542X	1744-7402		INT J APPL CERAM TEC	Int. J. Appl. Ceram. Technol.	NOV-DEC	2015	12	6					1239	1244		10.1111/ijac.12334		6	Materials Science, Ceramics	Materials Science	CW0VV	WOS:000364708800015		
J	Shimada, H; Hirano, S; Sinotoh, H; Ota, T; Tanaka, N; Sato, K; Yamada, M; Fukushi, K; Irie, T; Zhang, MR; Higuchi, M; Kuwabara, S; Suhara, T				Shimada, H.; Hirano, S.; Sinotoh, H.; Ota, T.; Tanaka, N.; Sato, K.; Yamada, M.; Fukushi, K.; Irie, T.; Zhang, M. R.; Higuchi, M.; Kuwabara, S.; Suhara, T.			Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [C-11]MP4A PET study	INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY			English	Article						dementia with Lewy bodies; Alzheimer's disease; differential diagnosis; positron emission tomography; [C-11]MP4A; acetylcholinesterase activity	POSITRON-EMISSION-TOMOGRAPHY; PARKINSONS-DISEASE; BODY DISEASE; GLUCOSE-METABOLISM; TAU PATHOLOGY; DIAGNOSIS; BETA; RADIOACTIVITY; RADIOLIGAND; IMPAIRMENT	Objective: To investigate the diagnostic performance of brain acetylcholinesterase (AChE) activity measurement using N-[C-11]-methyl-4-piperidyl acetate (MP4A) and PET in patients with dementia with Lewy bodies (DLB) and Alzheimer's disease (AD). Methods: Participants were 14 DLB patients, 25 AD patients and 18 age-matched healthy controls (HC). All subjects underwent PET scans and MP4A to measure regional brain AChE activity. We performed anatomical standardization of each brain image, and k(3) values, an index of AChE activity, in each voxel were estimated by nonlinear least squares analysis. Volumes of interest (VOIs) were identified on parametric k(3) images in frontal, temporal, parietal and occipital cortices, and in anterior and posterior cingulate gyri (ACG and PCG). In each VOI, the differential diagnostic performance between AD and DLB of k(3) values was assessed by area under the curve (AUC) of the receiver-operating characteristic. Voxel-based statistical analyses were also performed. Results: Mean cortical AChE activities in AD patients (-8.2% compared with normal mean) and DLB patients (-27.8%) were lower than HCs (p<0.05, p<0.001, respectively). There was a significant difference in mean cortical AChE activities between AD and DLB patients (p<0.001). All regional brain AChE activities of defined VOIs except ACG were able to well discriminate DLB from AD, and notably performance was the most significant in PCG (AUC=0.989, 95% CI: 0.965-1.000). Conclusions: Brain cholinergic deficit is consistently prominent in DLB compared with AD. PET measurement of brain AChE activity may be useful for the differential diagnosis between DLB and AD. Copyright (C) 2015 John Wiley & Sons, Ltd.	[Shimada, H.; Hirano, S.; Sinotoh, H.; Ota, T.; Tanaka, N.; Sato, K.; Yamada, M.; Higuchi, M.; Suhara, T.] Natl Inst Radiol Sci, Mol Imaging Ctr, Mol Neuroimaging Program, Chiba, Chiba 260, Japan; [Hirano, S.; Kuwabara, S.] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Chiba, Japan; [Sinotoh, H.] Neurol Chiba Clin, Chiba, Chiba, Japan; [Ota, T.] Juntendo Univ, Sch Med, Dept Psychiat, Bunkyo Ku, Tokyo 113, Japan; [Sato, K.] Teikyo Univ, Chiba Med Ctr, Dept Psychiat, Ichihara, Chiba, Japan; [Yamada, M.] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Chiyoda Ku, Tokyo, Japan; [Fukushi, K.; Irie, T.; Zhang, M. R.] Natl Inst Radiol Sci, Mol Imaging Ctr, Mol Probe Program, Chiba, Chiba 260, Japan	Suhara, T (reprint author), Natl Inst Radiol Sci, Mol Imaging Ctr, Mol Neuroimaging Program, Chiba, Chiba 260, Japan.	suhara@nirs.go.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [22790836]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Health, Labour and Welfare [22790836]	A part of this work was supported by 'Japan Advanced Molecular Imaging Program (J-AMP)', and Grant-in-Aid for Young Scientists (B) (22790836) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and a Grant-in-Aid for Comprehensive Research on Dementia (No. 22790836) from the Ministry of Health, Labour and Welfare.	Kuhl DE, 1999, NEUROLOGY, V52, P691; Yoshita M, 2006, NEUROLOGY, V66, P1850, DOI 10.1212/01.wnl.0000219640.59984.a7; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; Kono AK, 2007, EUR J NUCL MED MOL I, V34, P1490, DOI 10.1007/s00259-007-0380-y; Shimizu S, 2008, ANN NUCL MED, V22, P911, DOI 10.1007/s12149-008-0193-5; MCKHANN G, 1984, NEUROLOGY, V34, P939; Okamura N, 2013, J NUCL MED, V54, P1420, DOI 10.2967/jnumed.112.117341; Jureus A, 2010, J NEUROCHEM, V114, P784, DOI 10.1111/j.1471-4159.2010.06812.x; Graff-Radford J, 2012, BRAIN, V135, P2470, DOI 10.1093/brain/aws173; Shinotoh H, 1999, ANN NEUROL, V46, P62; Tsuboi Y, 2005, PARKINSONISM RELAT D, V11, pS47, DOI 10.1016/j.parkreldis.2004.10.014; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Kikuchi T, 2005, J MED CHEM, V48, P2577, DOI 10.1021/jm049100w; PERRY EK, 1994, NEUROREPORT, V5, P747, DOI 10.1097/00001756-199403000-00002; Williams SS, 2009, J NEUROL NEUROSUR PS, V80, P667, DOI 10.1136/jnnp.2008.155895; Dotigny F, 2008, NEUROSCIENCE, V154, P1607, DOI 10.1016/j.neuroscience.2008.04.030; Andersson M, 2008, DEMENT GERIATR COGN, V26, P284, DOI 10.1159/000160962; Meyer JH, 1999, NEUROIMAGE, V9, P545, DOI 10.1006/nimg.1999.0431; Imamura T, 1997, NEUROSCI LETT, V235, P49, DOI 10.1016/S0304-3940(97)00713-1; Shimada H, 2009, NEUROLOGY, V73, P273, DOI 10.1212/WNL.0b013e3181ab2b58; Barker WW, 2002, ALZ DIS ASSOC DIS, V16, P203, DOI 10.1097/00002093-200210000-00001; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Nelson PT, 2010, J NEUROL, V257, P359, DOI 10.1007/s00415-009-5324-y; Choi SR, 2009, J NUCL MED, V50, P1887, DOI 10.2967/jnumed.109.065284; Hilker R, 2005, NEUROLOGY, V65, P1716, DOI 10.1212/01.wnl.0000191154.78131.f6; Rowe CC, 2008, LANCET NEUROL, V7, P129, DOI 10.1016/S1474-4422(08)70001-2; Vandenberghe R, 2010, ANN NEUROL, V68, P319, DOI 10.1002/ana.22068; Colloby SJ, 2004, NEUROIMAGE, V23, P956, DOI 10.1016/j.neuroimage.2004.06.045; Bohnen NI, 2003, ARCH NEUROL-CHICAGO, V60, P1745, DOI 10.1001/archneur.60.12.1745; Ishii K, 2009, EUR J NUCL MED MOL I, V36, P831, DOI 10.1007/s00259-008-1051-3; Tiraboschi P, 2002, ARCH GEN PSYCHIAT, V59, P946, DOI 10.1001/archpsyc.59.10.946; Kikuchi T, 2010, SYNAPSE, V64, P209, DOI 10.1002/syn.20720; Shinotoh H, 2000, ANN NEUROL, V48, P194, DOI 10.1002/1531-8249(200008)48:2<194::AID-ANA9>3.0.CO;2-X; Namba H, 1999, EUR J NUCL MED, V26, P135, DOI 10.1007/s002590050369; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; Gomperts SN, 2008, NEUROLOGY, V71, P903, DOI 10.1212/01.wnl.0000326146.60732.d6; Herholz K, 2000, J NEURAL TRANSM, V107, P1457, DOI 10.1007/s007020070009; Mori E, 2012, ANN NEUROL, V72, P41, DOI 10.1002/ana.23557; Maetzler W, 2009, NEUROBIOL DIS, V34, P107, DOI 10.1016/j.nbd.2008.12.008; Namba H, 2002, METHODS, V27, P242, DOI 10.1016/S1046-2023(02)00081-6; Namba H, 1998, LANCET, V351, P881, DOI 10.1016/S0140-6736(05)70293-2; Nagatsuka S, 2001, J CEREBR BLOOD F MET, V21, P1354; Zaccai J, 2005, AGE AGEING, V34, P561, DOI 10.1093/ageing/afi190; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; Mizukami K, 2009, ANN NEUROL, V65, P614, DOI 10.1002/ana.21613; Knopman DS, 2001, NEUROLOGY, V56, P1143; Shimada H, 2013, MOVEMENT DISORD, V28, P169, DOI 10.1002/mds.25286; Fahn S., 1987, RECENT DEV PARKINSON, P153; Farina Elisabetta, 2009, Acta Biomed, V80, P57; [Anonymous], 1975, J PSYCHIATR RES, DOI DOI 10.1016/0022-3956(75)90026-6; Kantarci K, 2007, BRIT J RADIOL, V80, pS146, DOI 10.1259/bjr/60346217; Koeppe RA, 2008, ALZHEIMERS DEMENT, V4, pS67, DOI 10.1016/j.jalz.2007.11.016; Nedelska Z, 2015, NEUROBIOL AGING, V36, P452, DOI 10.1016/j.neurobiolaging.2014.07.005	53	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-6230	1099-1166		INT J GERIATR PSYCH	Int. J. Geriatr. Psychiatr.	NOV	2015	30	11					1105	1113		10.1002/gps.4338		9	Geriatrics & Gerontology; Gerontology; Psychiatry	Geriatrics & Gerontology; Psychiatry	CW1XE	WOS:000364784400001		
J	Ikebe, T; Sasaki, H; Saburi, Y; Ogata, M				Ikebe, Taichi; Sasaki, Hitohiro; Saburi, Yoshio; Ogata, Masao			Bilateral psoas muscle lymphoma: an unusual presentation of EBV-positive diffuse large B-cell lymphoma of the elderly	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Editorial Material									[Ikebe, Taichi; Sasaki, Hitohiro; Saburi, Yoshio] Oita Prefectural Hosp, Dept Hematol, Oita 8708511, Japan; [Ogata, Masao] Oita Univ, Fac Med, Dept Med Oncol & Hematol, Oita 87011, Japan	Ikebe, T (reprint author), Oita Prefectural Hosp, Dept Hematol, 477 Bunyou, Oita 8708511, Japan.	tikebe@oita-u.ac.jp; h-sasaki@oita-u.ac.jp; saburi@oitakenbyo.jp; mogata@oita-u.ac.jp					Surov A, 2014, CLIN IMAG, V38, P594, DOI 10.1016/j.clinimag.2014.03.006; TRAVIS WD, 1987, AM J SURG PATHOL, V11, P359, DOI 10.1097/00000478-198705000-00004; Derenzini E, 2013, CL LYMPH MYELOM LEUK, V13, P258, DOI 10.1016/j.clml.2012.10.003; Komatsuda M, 1981, Rinsho Ketsueki, V22, P891	4	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	NOV	2015	102	5					509	510		10.1007/s12185-015-1876-z		2	Hematology	Hematology	CW0VC	WOS:000364706700001		
J	Chiba, S				Chiba, Shigeru			Guest editorial: pre-leukemia/pre-lymphoma-what is old, what is new?	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Editorial Material							T-CELL LYMPHOMA; MUTATIONS; TET2		Univ Tsukuba, Dept Hematol, Fac Med, Tsukuba, Ibaraki, Japan	Chiba, S (reprint author), Univ Tsukuba, Dept Hematol, Fac Med, Tsukuba, Ibaraki, Japan.	schiba-tky@umin.net					Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Kikushige Y, 2011, CANCER CELL, V20, P246, DOI 10.1016/j.ccr.2011.06.029; Couronne L, 2012, NEW ENGL J MED, V366, P95, DOI 10.1056/NEJMc1111708; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Damm F, 2014, CANCER DISCOV, V4, P1088, DOI 10.1158/2159-8290.CD-14-0104; HAMILTONPATERSON JL, 1949, ACTA HAEMATOL-BASEL, V2, P309; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872	8	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	NOV	2015	102	5					511	512		10.1007/s12185-015-1879-9		2	Hematology	Hematology	CW0VC	WOS:000364706700002		
J	Sakata-Yanagimoto, M				Sakata-Yanagimoto, Mamiko			Multistep tumorigenesis in peripheral T cell lymphoma	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						TET2; RHOA; AITL; PTCL	ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLONAL HEMATOPOIESIS; TET2 MUTATIONS; MYELODYSPLASTIC SYNDROMES; INACTIVATION PATTERNS; EPIGENETIC REGULATORS; DRIVER MUTATIONS; DNMT3A MUTATIONS	Peripheral T cell lymphomas (PTCL) are classified as mature T cell neoplasms. However, several new findings support the notion that premalignant cells arise in the immature stage of hematopoietic differentiation, and subsequently evolve into full-blown T-lineage tumor cells. Acquisition of (Ten-Eleven Translocation 2) TET2 mutations may be an important event for the establishment of premalignant cells. In PTCL harboring features of follicular helper T cells, tumor-specific G17V RHOA mutations co-occur with premalignant TET2 mutations. The G17V (ras homolog family member A) RHOA mutations may play important roles in clonal evolution of premalignant cells into tumor cells. Indeed, multistep tumorigenesis is thought to be essential for pathogenesis of PTCL.	Univ Tsukuba, Dept Hematol, Fac Med, Tsukuba, Ibaraki 3058575, Japan	Sakata-Yanagimoto, M (reprint author), Univ Tsukuba, Dept Hematol, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	sakatama-tky@umin.net					Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Naoe T, 2013, INT J HEMATOL, V97, P165, DOI 10.1007/s12185-013-1257-4; Rohde M, 2014, GENE CHROMOSOME CANC, V53, P911, DOI 10.1002/gcc.22202; Lemonnier F, 2012, BLOOD, V120, P1466, DOI 10.1182/blood-2012-02-408542; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Busque L, 1996, BLOOD, V88, P59; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Nischal S, 2013, CANCER RES, V73, P1076, DOI 10.1158/0008-5472.CAN-12-0735; Yoo HY, 2014, NAT GENET, V46, P371, DOI 10.1038/ng.2916; Couronne L, 2012, NEW ENGL J MED, V366, P95, DOI 10.1056/NEJMc1111708; Gale RE, 1997, BRIT J HAEMATOL, V98, P512, DOI 10.1046/j.1365-2141.1997.2573078.x; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Cleverley SC, 2000, ONCOGENE, V19, P13, DOI 10.1038/sj.onc.1203259; Itzykson R, 2013, J CLIN ONCOL, V31, P2428, DOI 10.1200/JCO.2012.47.3314; Shide K, 2012, LEUKEMIA, V26, P2216, DOI 10.1038/leu.2012.94; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Nakao M, 1996, LEUKEMIA, V10, P1911; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; HIRAI H, 1987, NATURE, V327, P430, DOI 10.1038/327430a0; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Cairns RA, 2012, BLOOD, V119, P1901, DOI 10.1182/blood-2011-11-391748; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Yamazaki J, 2013, INT J HEMATOL, V97, P175, DOI 10.1007/s12185-012-1197-4; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Kakiuchi M, 2014, NAT GENET, V46, P583, DOI 10.1038/ng.2984; Yamazaki J, 2012, EPIGENETICS-US, V7, P201, DOI 10.4161/epi.7.2.19015; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Jan M., 2012, SCI TRANSL MED, V4; Kunimoto H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00273; Perez C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031605; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872; Stein E, 2014, 2014 AACR ANN M APR; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733	53	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	NOV	2015	102	5					523	527		10.1007/s12185-015-1738-8		5	Hematology	Hematology	CW0VC	WOS:000364706700004		
J	Kikushige, Y; Miyamoto, T				Kikushige, Yoshikane; Miyamoto, Toshihiro			Pre-malignant lymphoid cells arise from hematopoietic stem/progenitor cells in chronic lymphocytic leukemia	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Hematopoietic stem cell; Chronic lymphocytic leukemia; Pre-leukemia/pre-lymphoma	ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; RECURRENT MUTATIONS; ANTIGEN RECEPTORS; TUMOR-SUPPRESSOR; DNMT3A MUTATIONS; STEM-CELLS; GENES; PATHOGENESIS; FREQUENT	Human malignancies progress through a multistep process that includes the development of critical somatic mutations over the clinical course. Recent novel findings have indicated that hematopoietic stem cells (HSCs), which have the potential to self-renew and differentiate into multilineage hematopoietic cells, are an important cellular target for the accumulation of critical somatic mutations in hematological malignancies and play a central role in myeloid malignancy development. In contrast to myeloid malignancies, mature lymphoid malignancies, such as chronic lymphocytic leukemia (CLL), are thought to originate directly from differentiated mature lymphocytes; however, recent compelling data have shown that primitive HSCs and hematopoietic progenitor cells contribute to the pathogenesis of mature lymphoid malignancies. Several representative mutations of hematological malignancies have been identified within the HSCs of CLL and lymphoma patients, indicating that the self-renewing long-lived fraction of HSCs can serve as a reservoir for the development of oncogenic events. Novel mice models have been established as human mature lymphoma models, in which specific oncogenic events target the HSCs and immature progenitor cells. These data collectively suggest that HSCs can be the cellular target involved in the accumulation of oncogenic events in the pathogenesis of mature lymphoid and myeloid malignancies.	[Kikushige, Yoshikane; Miyamoto, Toshihiro] Kyushu Univ, Grad Sch Med, Dept Med & Biosyst Sci, Higashi Ku, Fukuoka 8128582, Japan; [Kikushige, Yoshikane] Japan Soc Promot Sci, Tokyo, Japan	Miyamoto, T (reprint author), Kyushu Univ, Grad Sch Med, Dept Med & Biosyst Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	toshmiya@intmed1.med.kyushu-u.ac.jp			ministry of education, culture, sports, science and technology of Japan; KANAE foundation	We thank the members of the SyStemAge project for the helpful discussion. This study was supported in part by a Grant-in-Aid from the ministry of education, culture, sports, science and technology of Japan (to Y.K.) and a Grant-in-Aid from KANAE foundation (to Y.K.). This study was also supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas "Stem Cell Aging and Disease" from ministry of education, culture, sports, science and technology of Japan (to T.M.).	Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Ghiotto F, 2004, J CLIN INVEST, V113, P1008, DOI 10.1172/JCI200419399; Dagklis A, 2009, BLOOD, V114, P26, DOI 10.1182/blood-2008-09-176933; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Lemonnier F, 2012, BLOOD, V120, P1466, DOI 10.1182/blood-2012-02-408542; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Rawstron AC, 2008, NEW ENGL J MED, V359, P575, DOI 10.1056/NEJMoa075290; Marti GE, 2005, BRIT J HAEMATOL, V130, P325, DOI 10.1111/j.1365-2141.2005.05550.x; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Kikushige Y, 2011, CANCER CELL, V20, P246, DOI 10.1016/j.ccr.2011.06.029; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Nieto WG, 2009, BLOOD, V114, P33, DOI 10.1182/blood-2009-01-197368; Stevenson FK, 2004, BLOOD, V103, P4389, DOI 10.1182/blood-2003-12-4312; Couronne L, 2012, NEW ENGL J MED, V366, P95, DOI 10.1056/NEJMc1111708; Shanafelt TD, 2009, J CLIN ONCOL, V27, P3959, DOI 10.1200/JCO.2008.21.2704; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Widhopf GF, 2004, BLOOD, V104, P2499, DOI 10.1182/blood-2004-03-0818; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Messmer BT, 2004, J EXP MED, V200, P519, DOI 10.1084/jem.20040544; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Weigert O, 2012, BLOOD, V120, P2553, DOI 10.1182/blood-2012-05-414995; Cairns RA, 2012, BLOOD, V119, P1901, DOI 10.1182/blood-2011-11-391748; BROKER BM, 1988, J AUTOIMMUN, V1, P469, DOI 10.1016/0896-8411(88)90068-6; Caligaris-Cappio F, 2008, J CLIN ONCOL, V26, P4497, DOI 10.1200/JCO.2007.15.4393; Landgren O, 2009, NEW ENGL J MED, V360, P659, DOI 10.1056/NEJMoa0806122; Oricchio E, 2011, CELL, V147, P554, DOI 10.1016/j.cell.2011.09.035; Tobin G, 2004, BLOOD, V104, P2879, DOI 10.1182/blood-2004-01-0132; STHOEGER ZM, 1989, J EXP MED, V169, P255, DOI 10.1084/jem.169.1.255; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Miyamoto T, 1996, BLOOD, V87, P4789; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Herve M, 2005, J CLIN INVEST, V115, P1636, DOI 10.1172/JCI24387; Marti G, 2007, BRIT J HAEMATOL, V139, P701, DOI 10.1111/j.1365-2141.2007.06865.x; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Lanasa MC, 2010, LEUKEMIA, V24, P133, DOI 10.1038/leu.2009.192; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Seifert M, 2012, J EXP MED, V209, P2183, DOI 10.1084/jem.20120833; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Sanchez ML, 2003, BLOOD, V102, P2994, DOI 10.1182/blood-2003-01-0045; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Vicente-Duenas C, 2012, P NATL ACAD SCI USA, V109, P10534, DOI 10.1073/pnas.1204127109; Hamblin TJ, 1999, BLOOD, V94, P1848; Okosun J, 2014, NAT GENET, V46, P176, DOI 10.1038/ng.2856; Vicente-Duenas C, 2012, EMBO J, V31, P3704, DOI 10.1038/emboj.2012.227; BORCHE L, 1990, BLOOD, V76, P562; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Chung SS, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008004; Damm F, 2014, CANCER DISCOV, V4, P1088, DOI 10.1158/2159-8290.CD-14-0104; Green MR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4904; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Kikushige Y, 2014, INT J HEMATOL, V100, P335, DOI 10.1007/s12185-014-1651-6; Romero-Camarero I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2334; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872; Shim YK, 2014, BLOOD, V123, P1319, DOI 10.1182/blood-2013-08-523704; Shima T, 2014, EXP HEMATOL; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Zenz T, 2011, NAT REV CANCER, V10, P37	65	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	NOV	2015	102	5					528	535		10.1007/s12185-015-1740-1		8	Hematology	Hematology	CW0VC	WOS:000364706700005		
J	Yamaguchi, H; Sakaguchi, H; Yoshida, K; Yabe, M; Yabe, H; Okuno, Y; Muramatsu, H; Takahashi, Y; Yui, S; Shiraishi, Y; Chiba, K; Tanaka, H; Miyano, S; Inokuchi, K; Ito, E; Ogawa, S; Kojima, S				Yamaguchi, Hiroki; Sakaguchi, Hirotoshi; Yoshida, Kenichi; Yabe, Miharu; Yabe, Hiromasa; Okuno, Yusuke; Muramatsu, Hideki; Takahashi, Yoshiyuki; Yui, Shunsuke; Shiraishi, Yuichi; Chiba, Kenichi; Tanaka, Hiroko; Miyano, Satoru; Inokuchi, Koiti; Ito, Etsuro; Ogawa, Seishi; Kojima, Seiji			Clinical and genetic features of dyskeratosis congenita, cryptic dyskeratosis congenita, and Hoyeraal-Hreidarsson syndrome in Japan	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Bone marrow failure; Dyskeratosis congenita; Hoyeraal-Hreidarsson syndrome; Cryptic dyskeratosis congenita; Genetic feature	BONE-MARROW FAILURE; TELOMERASE REVERSE-TRANSCRIPTASE; APLASTIC-ANEMIA; MUTATIONS; COMPONENT; RNA; RTEL1; TINF2; IDENTIFICATION; DISORDERS	Dyskeratosis congenita (DKC) is an inherited bone marrow failure (BMF) syndrome typified by reticulated skin pigmentation, nail dystrophy, and mucosal leukoplakia. Hoyeraal-Hreidarsson syndrome (HHS) is considered to be a severe form of DKC. Unconventional forms of DKC, which develop slowly in adulthood but without the physical anomalies characteristic of DKC (cryptic DKC), have been reported. Clinical and genetic features of DKC have been investigated in Caucasian, Black, and Hispanic populations, but not in Asian populations. The present study aimed to determine the clinical and genetic features of DKC, HHS, and cryptic DKC among Japanese patients. We analyzed 16 patients diagnosed with DKC, three patients with HHS, and 15 patients with cryptic DKC. We found that platelet count was significantly more depressed than neutrophil count or hemoglobin value in DKC patients, and identified DKC patients with large deletions in the telomerase reverse transcriptase and cryptic DKC patients with RTEL1 mutations on both alleles. This led to some patients previously considered to have unclassifiable BMF being diagnosed with cDKC through identification of new gene mutations. It thus seems important from a clinical viewpoint to re-examine the clinical characteristics, frequency of genetic mutations, and treatment efficacy in DKC, HHS, and cDKC.	[Yamaguchi, Hiroki; Yui, Shunsuke; Inokuchi, Koiti] Nippon Med Sch, Dept Hematol, Bunkyo Ku, Tokyo 1138603, Japan; [Sakaguchi, Hirotoshi; Okuno, Yusuke; Muramatsu, Hideki; Takahashi, Yoshiyuki; Kojima, Seiji] Nagoya Univ, Grad Sch Med, Dept Pediat, Showa Ku, Nagoya, Aichi 4668560, Japan; [Yoshida, Kenichi; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Sakyou Ku, Kyoto 6068501, Japan; [Yabe, Miharu; Yabe, Hiromasa] Tokai Univ, Sch Med, Dept Cell Transplantat & Regenerat Med, Isehara, Kanagawa 2591193, Japan; [Shiraishi, Yuichi; Chiba, Kenichi] Univ Tokyo, Inst Med Sci, Lab DNA Informat Anal,Human Genome Ctr, Minato Ku, Tokyo 1088639, Japan; [Tanaka, Hiroko; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Lab Sequence Anal,Human Genome Ctr, Minato Ku, Tokyo 1088639, Japan; [Ito, Etsuro] Hirosaki Univ, Grad Sch Med, Dept Pediat, Hirosaki, Aomori 0368563, Japan	Yamaguchi, H (reprint author), Nippon Med Sch, Dept Hematol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	y-hiroki@fd6.so-net.ne.jp					Ballew BJ, 2013, HUM GENET, V132, P473, DOI 10.1007/s00439-013-1265-8; Zhong F, 2011, GENE DEV, V25, P11, DOI 10.1101/gad.2006411; Yamaguchi Hiroki, 2007, Journal of Nippon Medical School, V74, P202, DOI 10.1272/jnms.74.202; Yoshida K, 2013, NAT GENET, V45, P1293, DOI 10.1038/ng.2759; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Ballew BJ, 2013, EXPERT REV HEMATOL, V6, P327, DOI [10.1586/ehm.13.23, 10.1586/EHM.13.23]; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335; Sakaguchi H, 2013, INT J HEMATOL, V97, P20, DOI 10.1007/s12185-012-1249-9; Le Guen T, 2013, HUM MOL GENET, V22, P3239, DOI 10.1093/hmg/ddt178; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Liang J, 2006, HAEMATOL-HEMATOL J, V91, P656; Kunishima S, 2013, AM J HUM GENET, V92, P431, DOI 10.1016/j.ajhg.2013.01.015; Walne AJ, 2008, BLOOD, V112, P3594, DOI 10.1182/blood-2008-05-153445; Fogarty PF, 2003, LANCET, V362, P1628, DOI 10.1016/S0140-6736(03)14797-6; Vulliamy TJ, 2005, BLOOD CELL MOL DIS, V34, P257, DOI 10.1016/j.bcmd.2004.12.008; Marrone A, 2007, BLOOD, V110, P4198, DOI 10.1182/blood-2006-12-062851; Calado RT, 2008, BLOOD, V111, P4446, DOI 10.1182/blood-2007-08-019729; Takeuchi J, 2008, BLOOD CELL MOL DIS, V40, P185, DOI 10.1016/j.bcmd.2007.08.002; Knight SW, 1999, AM J HUM GENET, V65, P50, DOI 10.1086/302446; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Walne AJ, 2013, AM J HUM GENET, V92, P448, DOI 10.1016/j.ajhg.2013.02.001; Yamaguchi H, 2010, BRIT J HAEMATOL, V150, P725, DOI 10.1111/j.1365-2141.2010.08278.x; Savage SA, 2008, AM J HUM GENET, V82, P501, DOI 10.1016/j.ajhg.2007.10.004; Vulliamy T, 2008, P NATL ACAD SCI USA, V105, P8073, DOI 10.1073/pnas.0800042105; Ruggero D, 2003, SCIENCE, V299, P259, DOI 10.1126/science.1079447; Walne AJ, 2009, BRIT J HAEMATOL, V145, P164, DOI 10.1111/j.1365-2141.2009.07598.x; Walne AJ, 2007, HUM MOL GENET, V16, P1619, DOI 10.1093/hmg/ddm111; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373	28	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	NOV	2015	102	5					544	552		10.1007/s12185-015-1861-6		9	Hematology	Hematology	CW0VC	WOS:000364706700007		
J	Mizuno, S; Hanamura, I; Ota, A; Karnan, S; Narita, T; Ri, M; Mizutani, M; Goto, M; Gotou, M; Tsunekawa, N; Shikami, M; Iida, S; Hosokawa, Y; Miwa, H; Ueda, R; Nitta, M; Takami, A				Mizuno, Shohei; Hanamura, Ichiro; Ota, Akinobu; Karnan, Sivasundaram; Narita, Tomoko; Ri, Masaki; Mizutani, Motonori; Goto, Mineaki; Gotou, Mayuko; Tsunekawa, Norikazu; Shikami, Masato; Iida, Shinsuke; Hosokawa, Yoshitaka; Miwa, Hiroshi; Ueda, Ryuzo; Nitta, Masakazu; Takami, Akiyoshi			Overexpression of salivary-type amylase reduces the sensitivity to bortezomib in multiple myeloma cells	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Myeloma; Amylase; Transfectant; Bortezomib; Lenalidomide	CANCER; LINES; PLASMACYTOMA; EXPRESSION; KINASE	Amylase-producing myeloma exhibits refractoriness to chemotherapy and a dismal prognosis. In this study, we established a human myeloma cell line, 8226/AMY1, in which a lentivirally transfected AMY1 gene was stably expressed and explored its biological characteristics. 8226/AMY1 showed a survival advantage over mock control when treated with dexamethasone, bortezomib, and lenalidomide in vitro partly through inhibition of apoptosis induced by these reagents. In a xenograft murine model, 8226/AMY1 showed rapid tumor growth and reduced sensitivity to bortezomib compared with mock. A microarray gene expression analysis identified TCL1A, which functions as a coactivator of the cell survival kinase Akt, differentially up-regulated in 8226/AMY1. The expression of phosphorylated Akt was increased in the 8226/AMY1 cells following bortezomib treatment, but not in the mock cells. In addition, treatment with perifosine, an inhibitor of Akt phosphorylation, enhanced the anti-myeloma effect of bortezomib in the 8226/AMY1 cells. Our data suggest that amylase-producing myeloma reduced the sensitivity to bortezomib in vitro and in vivo, and the up-regulation of TCL1A may influence the drug susceptibility of 8226/AMY1 via the phosphorylation of Akt. These findings provide clues for developing treatment approaches for not only amylase-producing myeloma, but also relapsed and refractory myelomas.	[Mizuno, Shohei; Hanamura, Ichiro; Mizutani, Motonori; Goto, Mineaki; Gotou, Mayuko; Tsunekawa, Norikazu; Nitta, Masakazu; Takami, Akiyoshi] Aichi Med Univ, Div Hematol, Dept Internal Med, Nagakute, Aichi 4801195, Japan; [Ota, Akinobu; Karnan, Sivasundaram; Hosokawa, Yoshitaka] Aichi Med Univ, Dept Biochem, Nagakute, Aichi 4801195, Japan; [Narita, Tomoko; Ri, Masaki; Iida, Shinsuke] Nagoya City Univ, Grad Sch Med Sci, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Shikami, Masato] Daiyukai Gen Hosp, Dept Hematol, Ichinomiya, Aichi, Japan; [Miwa, Hiroshi] Toyama Hosp, Dept Internal Med, Tsu, Mie, Japan; [Ueda, Ryuzo] Aichi Med Univ, Dept Tumor Immunol, Nagakute, Aichi 4801195, Japan	Hanamura, I (reprint author), Aichi Med Univ, Div Hematol, Dept Internal Med, 1,1 Karimata, Nagakute, Aichi 4801195, Japan.	hanamura@aichi-med-u.ac.jp			Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports and Technology of Japan; SENSHIN Medical Research Foundation (Osaka, Japan); Aichi Cancer Research Foundation (Nagoya, Japan); 24th General Assembly of the Japanese Association of Medical Sciences (Nagoya, Japan)	The authors would like to thank Ms. A. Nakamura for her valuable secretarial assistance and Brian Quinn for his editorial assistance. This study was supported by grants from the Ministry of Health, Labour and Welfare of Japan, the Ministry of Education, Culture, Sports and Technology of Japan, the SENSHIN Medical Research Foundation (Osaka, Japan), the Aichi Cancer Research Foundation (Nagoya, Japan), and the 24th General Assembly of the Japanese Association of Medical Sciences (Nagoya, Japan). The funders played no role in the study design, data collection and analysis, the decision to publish or the preparation of the manuscript.	Hsu JH, 2001, BLOOD, V98, P2853, DOI 10.1182/blood.V98.9.2853; Richardson PG, 2011, J CLIN ONCOL, V29, P4243, DOI 10.1200/JCO.2010.33.9788; MATSUZAKI H, 1989, BLOOD, V74, P889; TAGAWA S, 1990, LEUKEMIA, V4, P600; FUJII H, 1991, ARCH PATHOL LAB MED, V115, P952; HATA H, 1990, JPN J CLIN ONCOL, V20, P246; Tsunekawa-Imai N, 2013, LEUKEMIA RES, V37, P1132, DOI 10.1016/j.leukres.2013.05.017; Pinelli M, 2006, LEUKEMIA LYMPHOMA, V47, P151, DOI 10.1080/10428190500262144; Weng JS, 2012, BLOOD, V120, P1613, DOI 10.1182/blood-2011-09-382838; Ri M, 2010, LEUKEMIA, V24, P1506, DOI 10.1038/leu.2010.137; Morishita Y, 2000, CLIN CHEM, V46, P928; Aggarwal M, 2009, MODERN PATHOL, V22, P206, DOI 10.1038/modpathol.2008.148; Watanabe R, 2013, INT J HEMATOL, V97, P333, DOI 10.1007/s12185-013-1294-z; HATA H, 1988, CANCER, V62, P1511, DOI 10.1002/1097-0142(19881015)62:8<1511::AID-CNCR2820620811>3.0.CO;2-L; Sakai M, 2005, ANN THORAC SURG, V79, P1409, DOI 10.1016/j.athoracsur.2003.10.069; Mitsiades N, 2002, P NATL ACAD SCI USA, V99, P14374, DOI 10.1073/pnas.202445099; HIGASHIYAMA M, 1991, J CLIN PATHOL, V44, P144, DOI 10.1136/jcp.44.2.144; Moriyama T, 2008, CLIN CHIM ACTA, V391, P106, DOI 10.1016/j.cca.2008.01.025; Sosnoff DR, 2013, J CLIN ONCOL, V31, pE309, DOI 10.1200/JCO.2012.46.4677; Gotou M, 2012, GENE CHROMOSOME CANC, V51, P42, DOI 10.1002/gcc.20929; Ludwig H, 2014, ONCOLOGIST, V19, P829, DOI 10.1634/theoncologist.2014-0042; Chinen Y, 2014, CANCER RES, V74, P7418, DOI 10.1158/0008-5472.CAN-14-1420; Harborne SL, 2009, BMJ CASE REP, DOI [10.1136/bcr.08.2008.0639, DOI 10.1136/BCR.08.2008.0639]; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Ok SJ, 2014, ANN LAB MED, V34, P463, DOI 10.3343/alm.2014.34.6.463	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	NOV	2015	102	5					569	578		10.1007/s12185-015-1859-0		10	Hematology	Hematology	CW0VC	WOS:000364706700010		
J	Hirase, S; Hasegawa, D; Takahashi, H; Moriwaki, K; Saito, A; Kozaki, A; Ishida, T; Yanai, T; Kawasaki, K; Yamamoto, N; Kubokawa, I; Mori, T; Hayakawa, A; Nishimura, N; Nishio, H; Iijima, K; Kosaka, Y				Hirase, Satoshi; Hasegawa, Daiichiro; Takahashi, Hironobu; Moriwaki, Kensuke; Saito, Atsuro; Kozaki, Aiko; Ishida, Toshiaki; Yanai, Tomoko; Kawasaki, Keiichiro; Yamamoto, Nobuyuki; Kubokawa, Ikuko; Mori, Takeshi; Hayakawa, Akira; Nishimura, Noriyuki; Nishio, Hisahide; Iijima, Kazumoto; Kosaka, Yoshiyuki			Absolute lymphocyte count at the end of induction therapy is a prognostic factor in childhood acute lymphoblastic leukemia	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Acute lymphoblastic leukemia; Absolute lymphocyte count; Childhood	STEM-CELL TRANSPLANTATION; MINIMAL RESIDUAL DISEASE; REMISSION INDUCTION; SURVIVAL; RECOVERY; IMPACT; TRIAL; JAPAN	Recent studies have reported that the absolute lymphocyte count (ALC) during induction therapy is predictive of treatment outcome in de novo acute lymphoblastic leukemia (ALL); however, the significance of ALC on outcomes remains controversial. In the present study, we assessed the significance of ALC at day 29 (ALC-29), the end of induction therapy, on outcomes in our Japanese cohort. The outcomes of 141 patients aged a parts per thousand currency sign18 years with newly diagnosed ALL who were enrolled on the JACLS ALL-02 at our hospitals were analyzed in terms of ALC-29. Patients with ALC-29 a parts per thousand yen750/mu L (n = 81) had a superior 5-year EFS (95.2 +/- A 2.7 vs 84.3 +/- A 4.8 %, P = 0.016) and OS (100 vs 87.0 +/- A 4.7 %, P = 0.0062). A multivariate analysis identified ALC-29 a parts per thousand yen750/mu L as a significant predictor of improved EFS and OS after controlling for confounding factors. A multiple linear regression model revealed a significant inverse relationship between the percentage of blasts in bone marrow on day 15 and ALC-29 (P = 0.005). These results indicate that ALC is a simple prognostic factor in childhood ALL, and, thus, has the potential to refine current risk algorithms.	[Hirase, Satoshi; Yamamoto, Nobuyuki; Kubokawa, Ikuko; Mori, Takeshi; Hayakawa, Akira; Nishimura, Noriyuki; Iijima, Kazumoto] Kobe Univ, Grad Sch Med, Dept Pediat, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Hasegawa, Daiichiro; Saito, Atsuro; Kozaki, Aiko; Ishida, Toshiaki; Yanai, Tomoko; Kawasaki, Keiichiro; Kosaka, Yoshiyuki] Kobe Childrens Hosp, Dept Hematol & Oncol, Kobe, Hyogo 6540081, Japan; [Takahashi, Hironobu] Himeji Red Cross Hosp, Dept Pediat, Himeji, Hyogo 6708540, Japan; [Moriwaki, Kensuke] Kobe Pharmaceut Univ, Dept Med Stat, Kobe, Hyogo 6588558, Japan; [Nishimura, Noriyuki; Nishio, Hisahide] Kobe Univ, Dept Epidemiol, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan	Hasegawa, D (reprint author), Kobe Childrens Hosp, Dept Hematol & Oncol, 1-1-1 Takakuradai, Kobe, Hyogo 6540081, Japan.	hasegawa_kch@hp.pref.hyogo.jp					Porrata LF, 2002, LEUKEMIA, V16, P1311, DOI 10.1038/sj.leu.2402503; Alkayed K, 2012, PEDIATR BLOOD CANCER, V59, P351, DOI 10.1002/pbc.24120; Hasegawa D, 2011, BLOOD, V118, P653; Rubnitz JE, 2013, CANCER-AM CANCER SOC, V119, P2061, DOI 10.1002/cncr.28026; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Stow P, 2010, BLOOD, V115, P4657, DOI 10.1182/blood-2009-11-253435; Ishaqi MK, 2008, BONE MARROW TRANSPL, V41, P245, DOI 10.1038/sj.bmt.1705891; Sun D, 2012, AM J HEMATOL, V87, P957, DOI 10.1002/ajh.23279; Rabin KR, 2012, PEDIATR BLOOD CANCER, V59, P468, DOI 10.1002/pbc.23395; Shen HQ, 2013, LEUKEMIA RES, V37, P671, DOI 10.1016/j.leukres.2013.02.002; Schultz KR, 2007, BLOOD, V109, P926, DOI 10.1182/blood-2006-01-024729; Chang YJ, 2011, AM J HEMATOL, V86, P227, DOI 10.1002/ajh.21921; Asai D, 2013, CANCER MED-US, V2, P412, DOI 10.1002/cam4.87; De Angulo G, 2008, CANCER, V112, P407, DOI 10.1002/cncr.23168; Moricke A, 2008, BLOOD, V111, P4477, DOI 10.1182/blood-2007-09-112920; Cox DR, 1972, J R STAT SOC, V34, P248; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Patel B, 2010, BRIT J HAEMATOL, V148, P80, DOI 10.1111/j.1365-2141.2009.07941.x; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001	19	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	NOV	2015	102	5					594	601		10.1007/s12185-015-1875-0		8	Hematology	Hematology	CW0VC	WOS:000364706700013		
J	Tomizawa, D; Kato, M; Takahashi, H; Fujimura, J; Inukai, T; Fukushima, T; Kiyokawa, N; Koh, K; Manabe, A; Ohara, A				Tomizawa, Daisuke; Kato, Motohiro; Takahashi, Hiroyuki; Fujimura, Junya; Inukai, Takeshi; Fukushima, Takashi; Kiyokawa, Nobutaka; Koh, Katsuyoshi; Manabe, Atsushi; Ohara, Akira			Favorable outcome in non-infant children with MLL-AF4-positive acute lymphoblastic leukemia: a report from the Tokyo Children's Cancer Study Group	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Acute lymphoblastic leukemia; MLL; Children; Hematopoietic stem cell transplantation	MLL GENE-REARRANGEMENT; RANDOMIZED-TRIAL; CHILDHOOD; RISK; CHEMOTHERAPY; PREDNISOLONE; PROTOCOL; THERAPY; ENZYMES; L99-15	Unlike acute lymphoblastic leukemia (ALL) in infants, MLL gene rearrangement (MLL-r) is rare in ALL children (>= 1 year old). The outcome and optimal treatment options for MLL-r ALL remain controversial. Among the 1827 children enrolled in the Tokyo Children's Cancer Study Group ALL studies L95-14, L99-15, L99-1502, L04-16, and L07-1602 (1995-2009), 25 MLL-r ALL patients (1.3 %) were identified. Their median age and leukocyte count at diagnosis was 2 years old (range 1-15 years) and 27,690/mu L (range 1800-1,113,000/mu L), respectively. All but one patient achieved complete remission (CR) after induction therapy, and 19 underwent allogeneic hematopoietic stem cell transplantation (HSCT) in first CR according to the protocol. The 5-year event-free survival (EFS) and overall survival (OS) rate were 60.0 % [standard error (SE), 9.7 %] and 64.0 % (SE 9.6 %), respectively. Notably, 9/12 cases with MLL-AF4-positive ALL are alive in continuous CR with a 75.0 % (SE 12.5 %) EFS rate. The causes of treatment failure were as follows: one induction failure, five relapses, and five transplant-related deaths. With intensive chemotherapy and allogeneic HSCT, favorable outcome of children (>= 1 year old) with MLL-AF4-positive ALL was observed. However, considering the risk of acute and late toxicities associated with HSCT, its indication should be restricted.	[Tomizawa, Daisuke] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Div Leukemia & Lymphoma, Setagaya Ku, Tokyo 1578535, Japan; [Kato, Motohiro] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Div Transplantat & Cell Therapy, Tokyo, Japan; [Takahashi, Hiroyuki; Ohara, Akira] Toho Univ, Dept Pediat, Tokyo, Japan; [Fujimura, Junya] Juntendo Univ, Sch Med, Dept Pediat & Adolescent Med, Tokyo 113, Japan; [Inukai, Takeshi] Yamanashi Univ, Dept Pediat, Kofu, Yamanashi 400, Japan; [Fukushima, Takashi] Univ Tsukuba, Dept Pediat, Tsukuba, Ibaraki, Japan; [Kiyokawa, Nobutaka] Natl Ctr Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Tokyo, Japan; [Koh, Katsuyoshi] Saitama Childrens Med Ctr, Dept Hematol Oncol, Saitama, Japan; [Manabe, Atsushi] St Lukes Int Hosp, Dept Pediat, Tokyo, Japan	Tomizawa, D (reprint author), Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Div Leukemia & Lymphoma, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	tomizawa-d@ncchd.go.jp			 [27-4]	The authors thank all the investigators, coworkers, and members of participating hospitals in the TCCSG, and especially to Ms. Kaori Itagaki of TCCSG central office for her devotion to the group including data management. The authors also thank Dr. Julian Tang of the Department of Education for Clinical Research, National Center for Child Health and Development, for critical comments and editorial assistance. This work was supported in part by a Grant for the National Center for Child Health and Development (27-4).	Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Schrappe M, 2000, BLOOD, V95, P3310; Stumpel DJPM, 2009, BLOOD, V114, P5490, DOI 10.1182/blood-2009-06-227660; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Vu LP, 2013, INT J HEMATOL, V97, P198, DOI 10.1007/s12185-012-1247-y; Igarashi S, 2005, J CLIN ONCOL, V23, P6489, DOI 10.1200/JCO.2005.01.982; Jansen MWJC, 2007, LEUKEMIA, V21, P633, DOI 10.1038/sj.leu.2404578; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Hasegawa D, 2012, PEDIATR BLOOD CANCER, V58, P23, DOI 10.1002/pbc.22965; Kato M, 2014, BRIT J HAEMATOL, V164, P376, DOI 10.1111/bjh.12632; Stam RW, 2003, BLOOD, V101, P1270, DOI 10.1182/blood-2002-05-1600; Manabe A, 2008, HAEMATOL-HEMATOL J, V93, P1155, DOI 10.3324/haematol.12365; Tomizawa D, 2007, LEUKEMIA, V21, P2258, DOI 10.1038/sj.leu.2404903; van Dongen JJM, 1998, LANCET, V352, P1731, DOI 10.1016/S0140-6736(98)04058-6; Tsuchida M, 2010, LEUKEMIA, V24, P383, DOI 10.1038/leu.2009.260; Pieters R, 1998, LEUKEMIA, V12, P1344, DOI 10.1038/sj.leu.2401129; Koh K, 2015, LEUKEMIA, V29, P290, DOI 10.1038/leu.2014.172; Moricke A, 2008, BLOOD, V111, P4477, DOI 10.1182/blood-2007-09-112920; Pieters R, 2007, LANCET, V370, P240, DOI 10.1016/S0140-6736(07)61126-X; Pui CH, 2003, LEUKEMIA, V17, P700, DOI 10.1038/sj.leu.2402883; Conter V, 2014, BLOOD, V123, P1470, DOI 10.1182/blood-2013-10-532598; Pui CH, 2002, LANCET, V359, P1909, DOI 10.1016/S0140-6736(02)08782-2; Dreyer ZE, 2015, PEDIATR BLOOD CANCER, V62, P419, DOI 10.1002/pbc.25322	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	NOV	2015	102	5					602	610		10.1007/s12185-015-1869-y		9	Hematology	Hematology	CW0VC	WOS:000364706700014		
J	Watanabe, E; Nishikawa, T; Ikawa, K; Yamaguchi, H; Abematsu, T; Nakagawa, S; Kurauchi, K; Kodama, Y; Tanabe, T; Shinkoda, Y; Matsumoto, K; Okamoto, Y; Takeda, Y; Kawano, Y				Watanabe, Erika; Nishikawa, Takuro; Ikawa, Kazuro; Yamaguchi, Hiroki; Abematsu, Takanari; Nakagawa, Shunsuke; Kurauchi, Koichiro; Kodama, Yuichi; Tanabe, Takayuki; Shinkoda, Yuichi; Matsumoto, Kazuaki; Okamoto, Yasuhiro; Takeda, Yasuo; Kawano, Yoshifumi			Trough level monitoring of intravenous busulfan to estimate the area under the plasma drug concentration-time curve in pediatric hematopoietic stem cell transplant recipients	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Busulfan; Children; Limited sampling strategy; Pharmacokinetics; Hematopoietic stem cell transplantation	LIQUID-CHROMATOGRAPHY; PHARMACOKINETICS; PERFORMANCE; CHILDREN	Optimizing systemic busulfan exposure, the area under the concentration-time curve (AUC), improves the outcomes for hematopoietic stem cell transplantation (HSCT). The AUC is conventionally calculated using six plasma concentrations (AUC(0-a)) drawn after the first of 16 intravenous busulfan doses given as a 2-h infusion every 6 h. The aim of the present study was to develop limited sampling strategies using three or fewer busulfan concentrations to reliably calculate AUC(0-a) in patients undergoing HSCT. We investigated the pharmacokinetics of busulfan 46 times in 29 pediatric patients receiving intravenous busulfan. Limited sampling strategies using one, two, or three plasma busulfan concentrations were developed by multiple linear regression that showed excellent agreement with AUC(0-a). In single-point sampling strategies, the AUC(0-a) predicted based on C-6 (trough level: busulfan plasma concentration 6 h after the start of the infusion) was significantly correlated with, and not statistically different from, actual values as follows: AUC(0-a) = 2556.5 C-6 + 320.9 (r (2) = 0.929, P < 0.0001, mean bias 0.282 %, precision 7.91 %). In contrast, the predicted AUCs derived from the other sampling single points did not meet the criteria. The trough level well correlated with actual AUC(0-a), suggesting that this time-point is acceptable for busulfan monitoring.	[Watanabe, Erika; Matsumoto, Kazuaki; Takeda, Yasuo] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Clin Pharm & Pharmacol, Kagoshima 8908520, Japan; [Nishikawa, Takuro; Abematsu, Takanari; Nakagawa, Shunsuke; Kurauchi, Koichiro; Kodama, Yuichi; Tanabe, Takayuki; Okamoto, Yasuhiro; Kawano, Yoshifumi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pediat, Kagoshima 8908520, Japan; [Ikawa, Kazuro] Hiroshima Univ, Dept Clin Pharmacotherapy, Hiroshima, Japan; [Yamaguchi, Hiroki] Nippon Med Sch, Dept Hematol, Tokyo 113, Japan; [Shinkoda, Yuichi] Kagoshima City Hosp, Dept Pediat, Kagoshima, Japan	Nishikawa, T (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pediat, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	adu44150@ams.odn.ne.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26870460]	This work was supported in part by funds for Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant Number #26870460 to TN).	YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P547, DOI 10.1007/BF01062109; Okamoto Y, 2014, PEDIATR TRANSPLANT, V18, P294, DOI 10.1111/petr.12236; Spasojevic I, 2012, CANCER INVEST, V30, P679, DOI 10.3109/07357907.2012.726386; Nguyen L, 2004, BONE MARROW TRANSPL, V33, P979, DOI 10.1038/sj.bmt.1704446; Nagasawa M, 2010, INT J HEMATOL, V91, P728, DOI 10.1007/s12185-010-0572-2; Zao JH, 2015, BIOL BLOOD MARROW TR, V21, P1471, DOI 10.1016/j.bbmt.2015.05.006; Nguyen L, 2006, CANCER CHEMOTH PHARM, V57, P191, DOI 10.1007/s00280-005-0029-0; Nishikawa T, 2010, BONE MARROW TRANSPL, V45, P602, DOI 10.1038/bmt.2009.195; Takamatsu Y, 2007, INT J HEMATOL, V86, P261, DOI 10.1532/IJH97.07013; Dupuis LL, 2008, BIOL BLOOD MARROW TR, V14, P576, DOI 10.1016/j.bbmt.2008.03.002; Hoy Sheridan M, 2007, Paediatr Drugs, V9, P271, DOI 10.2165/00148581-200709040-00008; Sato M, 2015, INT J HEMATOL, V101, P497, DOI 10.1007/s12185-015-1756-6; Beri R, 2010, BONE MARROW TRANSPL, V45, P249, DOI 10.1038/bmt.2009.133; Xie HG, 2001, ANNU REV PHARMACOL, V41, P815, DOI 10.1146/annurev.pharmtox.41.1.815; Michel G, 2012, PEDIATR BLOOD CANCER, V58, P90, DOI 10.1002/pbc.22959; HENNER WD, 1987, J CHROMATOGR-BIOMED, V416, P426, DOI 10.1016/0378-4347(87)80531-5; SLATTERY JT, 1995, BONE MARROW TRANSPL, V16, P31; Dix SP, 1996, BONE MARROW TRANSPL, V17, P225; Russell JA, 2008, CURR PHARM DESIGN, V14, P1936, DOI 10.2174/138161208785061382; Bredeson C, 2013, BLOOD, V122, P3871, DOI 10.1182/blood-2013-08-519009	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	NOV	2015	102	5					611	616		10.1007/s12185-015-1853-6		6	Hematology	Hematology	CW0VC	WOS:000364706700015		
J	Shiseki, M; Masuda, A; Yoshinaga, K; Mori, N; Okada, M; Motoji, T; Tanaka, J				Shiseki, Masayuki; Masuda, Akihiro; Yoshinaga, Kentaro; Mori, Naoki; Okada, Michiko; Motoji, Toshiko; Tanaka, Junji			Identification of the SOX5 gene as a novel IGH-involved translocation partner in BCL2-negative follicular lymphoma with t(12;14)(p12.2;q32)	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						SOX5; Follicular lymphoma; BCL2; IGH	EXPRESSION PROFILES; PROGRESSION; ABNORMALITIES; MICROARRAY; CLONING	Chromosome translocations involving the immunoglobulin heavy chain (IGH) gene locus at chromosome region 14q32 are often observed in B-cell lymphoid neoplasms. Of these, t(14;18)(q32;q21) results in juxtaposition of the IGH gene on chromosome 14 and the BCL2 gene on chromosome 18, leading to the overexpression of BCL2 anti-apoptotic protein, which plays a critical role in the development of follicular lymphoma (FL). However, BCL2 overexpression is not observed in approximately 10 % of FL, and the molecular pathogenesis of BCL2-negative FL has not been elucidated. Here, we identify the SRY-related high-morbidity-group (HMG) box 5 (SOX5) gene on chromosome 12p12 as a novel IGH-involved translocation partner in the case of BCL2-negative follicular lymphoma (FL) with a complex karyotype including t(12;14)(p12.2;q32) by long-distance inverse PCR. As a result of this translocation, the SOX5 gene is juxtaposed to the enhancer of the IGH gene; SOX5 overexpression in neoplastic cells was demonstrated by immunohistochemistry. The results of the present study suggest a role for SOX5 in the molecular pathogenesis of FL.	[Shiseki, Masayuki; Yoshinaga, Kentaro; Mori, Naoki; Okada, Michiko; Motoji, Toshiko; Tanaka, Junji] Tokyo Womens Med Univ Hosp, Dept Hematol, Shinjuku Ku, Tokyo 1628666, Japan; [Masuda, Akihiro] Tokyo Womens Med Univ Hosp, Dept Surg Pathol, Tokyo 1628666, Japan	Shiseki, M (reprint author), Tokyo Womens Med Univ Hosp, Dept Hematol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	shisekim@dh.twmu.ac.jp					Shiseki M, 2007, LEUKEMIA LYMPHOMA, V48, P2141, DOI 10.1080/10428190701615900; Ehrhardt GRA, 2008, J EXP MED, V205, P1807, DOI 10.1084/jem.20072682; Ueda R, 2007, INT J CANCER, V120, P1704, DOI 10.1002/ijc.22472; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Ma S, 2009, INT J CANCER, V124, P2323, DOI 10.1002/ijc.24243; Huang DY, 2008, J PATHOL, V214, P445, DOI 10.1002/path.2299; Storlazzi CT, 2007, LEUKEMIA, V21, P2221, DOI 10.1038/sj.leu.2404784; Willis TG, 1997, BLOOD, V90, P2456; Wunderle VM, 1996, GENOMICS, V36, P354, DOI 10.1006/geno.1996.0474; Karube K, 2007, BLOOD, V109, P3076, DOI 10.1182/blood-2006-09-045989; Okada M, 2012, CANCER GENET-NY, V205, P18, DOI 10.1016/j.cancergen.2011.12.002; Zafarana G, 2002, CANCER RES, V62, P1822; Charles ED, 2011, BLOOD, V117, P5425, DOI 10.1182/blood-2010-10-312942; Leich E, 2009, BLOOD, V114, P826, DOI 10.1182/blood-2009-01-198580; Cheung KJJ, 2010, GENE CHROMOSOME CANC, V49, P669, DOI 10.1002/gcc.20780; Leich E, 2011, BLOOD, V118, P5550, DOI 10.1182/blood-2011-06-361972; Zha HB, 2004, LAB INVEST, V84, P235, DOI 10.1038/labinvest.3700051; Harris ML, 2011, PIGM CELL MELANOMA R, V23, P496; Moore CR, 2015, J CANC SCI THER, V7, P67; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Skinnider BF, 1999, HUM PATHOL, V30, P803, DOI 10.1016/S0046-8177(99)90141-7	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	NOV	2015	102	5					633	638		10.1007/s12185-015-1823-z		6	Hematology	Hematology	CW0VC	WOS:000364706700018		
J	Pilster, U; Bohmelt, T; Tago, A				Pilster, Ulrich; Boehmelt, Tobias; Tago, Atsushi			Political Leadership Changes and the Withdrawal from Military Coalition Operations, 1946-2001	International Studies Perspectives			English	Article						military coalitions; military interventions; political leaders; leadership turnover; troop withdrawal	AMERICAN OPINION; CAUSAL INFERENCE; BELIEF SYSTEMS; FOREIGN-POLICY; WAR; INTERVENTION; INSTITUTIONS; DURATION; FORCE; STATES	Several studies have claimed that changes in the political leadership of a country affect foreign policy decision making. The following paper systematically tests this in the context of states' participation in military coalition operations. By building on previous theoretical models, the authors argue that new leaders may differ from their predecessors in that the former (i) have dissimilar preferences with regard to the involvement in military interventions, (ii) evaluate relevant information differently, and (iii) are less likely to be entrapped in intervention policies. Ultimately, the net effect of these factors should make it more likely that political leadership turnovers are associated with premature withdrawals from ongoing military coalitions. The theory is tested by quantitative analyses of newly collected data on military coalition operations in 1946-2001 and a qualitative case study. The authors find strong and robust support for their argument.	[Pilster, Ulrich; Boehmelt, Tobias] Univ Essex, Colchester CO4 3SQ, Essex, England; [Boehmelt, Tobias] Swiss Fed Inst Technol, Zurich, Switzerland; [Tago, Atsushi] Kobe Univ, Kobe, Hyogo, Japan	Pilster, U (reprint author), Univ Essex, Colchester CO4 3SQ, Essex, England.				Suntory Foundation; Nomura Foundation	We thank Xun Cao, Erik Gartzke, and Kristian Skrede Gleditsch for constructive comments on a previous version of the manuscript. Three anonymous reviewers and the journal's editor, Robert Patman, also provided helpful suggestions. The data and replication syntax can be obtained from the authors upon request. We thank the Suntory Foundation and the Nomura Foundation for their generous financial support.	Flores AQ, 2012, INT STUD QUART, V56, P809, DOI 10.1111/j.1468-2478.2012.00735.x; Saunders EN, 2009, INT SECURITY, V34, P119, DOI 10.1162/isec.2009.34.2.119; Stanley EA, 2009, INT SECURITY, V34, P42, DOI 10.1162/isec.2009.34.1.42; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Yi KJ, 2002, PAC HIST REV, V71, P633, DOI 10.1525/phr.2002.71.4.633; VANDERKROEF JM, 1969, PAC AFF, V42, P311, DOI 10.2307/2753901; Eichenberg RC, 2005, INT SECURITY, V30, P140, DOI 10.1162/0162288054894616; Jervis R, 2006, POLIT PSYCHOL, V27, P641, DOI 10.1111/j.1467-9221.2006.00527.x; HERMANN MG, 1980, INT STUD QUART, V24, P7, DOI 10.2307/2600126; Croco SE, 2011, AM POLIT SCI REV, V105, P457, DOI 10.1017/S0003055411000219; LEVY JS, 1994, INT ORGAN, V48, P279; Gandhi J, 2007, COMP POLIT STUD, V40, P1279, DOI 10.1177/00101414007305817; GEORGE AL, 1969, INT STUD QUART, V13, P190, DOI 10.2307/3013944; Diamond A, 2013, REV ECON STAT, V95, P932; Weeks JL, 2008, INT ORGAN, V62, P35, DOI 10.1017/S0020818308080028; Leeds BA, 2003, INT ORGAN, V57, P801, DOI 10.1017/S0020818303574057; Peksen D, 2012, POLIT RES QUART, V65, P558, DOI 10.1177/1065912911417831; Bennett DS, 1996, AM POLIT SCI REV, V90, P239, DOI 10.2307/2082882; LEE CJ, 1973, ASIAN SURV, V13, P94, DOI 10.1525/as.1973.13.1.01p02947; Pilster U, 2011, INT INTERACT, V37, P55, DOI 10.1080/03050629.2011.546259; Jones BF, 2009, AM ECON J-MACROECON, V1, P55, DOI 10.1257/mac.1.2.55; RUSSETT B, 1976, POLIT SCI QUART, V91, P411, DOI 10.2307/2148934; Baumann Robert A., 1993, INT MILITARY INTERVE; Belkin Aaron, 2005, UNITED WE STAND DIVI; Bennett Andrew, 1999, CONDEMNED REPETITION; Mesquita BB, 2003, LOGIC OF POLITICAL SURVIVAL, P1; Buhaug Halvard, 2007, GLOBAL TRENDS ARMED; Chiozza G, 2003, J CONFLICT RESOLUT, V47, P251, DOI 10.1177/0022002703252364; Collins James L., 1985, ALLIED PARTICIPATION; David Singer J., 1987, INT INTERACT, V14, P115, DOI DOI 10.1080/03050628808434695; Downs George W., 1992, FOREIGN MILITARY INT; Fearon James D, 2008, OXFORD HDB POLITICAL; Gerring John, 2008, OXFORD HDB POLITICAL; Gibler DM, 2008, J CONFLICT RESOLUT, V52, P426, DOI 10.1177/0022002707310003; Gilligan MJ, 2008, Q J POLIT SCI, V3, P89, DOI 10.1561/100.00007051; Gartzke E, 2004, AM J POLIT SCI, V48, P775, DOI 10.2307/1519933; Goemans Hein, 2000, WAR PUNISHMENT CAUSE; Goemans HE, 2009, J PEACE RES, V46, P269, DOI 10.1177/0022343308100719; Gelpi C, 2001, J CONFLICT RESOLUT, V45, P794, DOI 10.1177/0022002701045006005; Han Yong-Sup, 2002, SUNSHINE KOREA S KOR; Jaggers Keith, 2004, POLITY 4 PROJECT POL; JENTLESON BW, 1992, INT STUD QUART, V36, P49, DOI 10.2307/2600916; Jervis R., 1976, PERCEPTION MISPERCEP; Kisangani N. F. Emizet, 2000, ARMED FORCES SOC, V26, P203; Pickering J, 2009, J PEACE RES, V46, P589, DOI 10.1177/0022343309334634; Sullivan PL, 2009, J PEACE RES, V46, P707, DOI 10.1177/0022343309336796; Kreps Sarah E., 2009, POLITICAL SCI Q, V123, P573; Kreps Sarah E, 2011, COALITIONS CONVENIEN; Leeds BA, 2009, AM J POLIT SCI, V53, P461, DOI 10.1111/j.1540-5907.2009.00381.x; Levy Jack S, 2003, OXFORD HDB POLITICAL; Kinne BJ, 2013, J CONFLICT RESOLUT, V57, P359, DOI 10.1177/0022002712446124; Morey Daniel S., 2011, MILITARY COALITIONS; Morgan SL, 2007, ANAL METHOD SOC RES, P1, DOI 10.1017/CBO9780511804564; Regan Patrick M., 2002, CIVIL WARS FOREIGN P; Regan PM, 2009, CONFLICT MANAG PEACE, V26, P286, DOI 10.1177/0738894209104556; Renshon J, 2008, J CONFLICT RESOLUT, V52, P820, DOI 10.1177/0022002708323669; Stanley EA, 2009, J CONFLICT RESOLUT, V53, P651, DOI 10.1177/0022002709343194; Sekhon Jasjeet S., 2007, J STAT SOFTW, V42, P1; McGillivray F, 2004, J CONFLICT RESOLUT, V48, P154, DOI 10.1177/0022002703262858; Koch MT, 2010, J POLIT, V72, P616, DOI 10.1017/S0022381610000058; Sullivan PL, 2008, CONFLICT MANAG PEACE, V25, P112, DOI 10.1080/07388940802007223; Sullivan PL, 2008, CONFLICT MANAG PEACE, V25, P49, DOI 10.1080/07388940701860383; Tago A, 2007, INT RELAT ASIA-PAC, V7, P179, DOI 10.1093/irap/lcl001; Tago A, 2008, INT RELAT ASIA-PAC, V8, P379, DOI 10.1093/irap/lcn010; Tago A, 2005, J PEACE RES, V42, P585, DOI 10.1177/0022343305056235; Tago A, 2009, J PEACE RES, V46, P219, DOI 10.1177/0022343308100716; Thomas Neal, 1996, BIOMETRICS, V52, P149; Tierney D, 2011, EUR J INT RELAT, V17, P655, DOI 10.1177/1354066110372433; Vertzberger Yaacov, 1998, RISK TAKING DECISION; Vucetic Srdjan, 2011, EUROPEAN J INT RELAT, V17, P127; Walker Stephen, 2010, INT STUDIES ENCY; WALKER SG, 1983, INT STUD QUART, V27, P179, DOI 10.2307/2600545; Young Michael D., 1998, MERSHON INT STUDIES, V42, P63, DOI 10.2307/254444	73	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1528-3577	1528-3585		INT STUD PERSPECT	Int. Stud. Perspect.	NOV	2015	16	4					463	483		10.1111/insp.12058		21	International Relations	International Relations	CV5WS	WOS:000364342700006		
J	Inoue, I; Tono, K; Joti, Y; Kameshima, T; Ogawa, K; Shinohara, Y; Amemiya, Y; Yabashi, M				Inoue, Ichiro; Tono, Kensuke; Joti, Yasumasa; Kameshima, Takashi; Ogawa, Kanade; Shinohara, Yuya; Amemiya, Yoshiyuki; Yabashi, Makina			Characterizing transverse coherence of an ultra-intense focused X-ray free-electron laser by an extended Young's experiment	IUCrJ			English	Article						X-ray free-electron lasers; transverse coherence; beam diagnostics	SINGLE; PULSES; RADIATION; DYNAMICS; FRINGES; LENGTH	Characterization of transverse coherence is one of the most critical themes for advanced X-ray sources and their applications in many fields of science. However, for hard X-ray free-electron laser (XFEL) sources there is very little knowledge available on their transverse coherence characteristics, despite their extreme importance. This is because the unique characteristics of the sources, such as the ultra-intense nature of XFEL radiation and the shot-by-shot fluctuations in the intensity distribution, make it difficult to apply conventional techniques. Here, an extended Young's interference experiment using a stream of bimodal gold particles is shown to achieve a direct measurement of the modulus of the complex degree of coherence of XFEL pulses. The use of interference patterns from two differently sized particles enables analysis of the transverse coherence on a single-shot basis without a priori knowledge of the instantaneous intensity ratio at the particles. For a focused X-ray spot as small as 1.8 mu m (horizontal) x 1.3 mu m (vertical) with an ultrahigh intensity that exceeds 10(18) W cm(-2) from the SPring-8 Angstrom Compact free-electron LAser (SACLA), the coherence lengths were estimated to be 1.7 +/- 0.2 mu m (horizontal) and 1.3 +/- 0.1 mu m (vertical). The ratios between the coherence lengths and the focused beam sizes are almost the same in the horizontal and vertical directions, indicating that the transverse coherence properties of unfocused XFEL pulses are isotropic. The experiment presented here enables measurements free from radiation damage and will be readily applicable to the analysis of the transverse coherence of ultra-intense nanometre-sized focused XFEL beams.	[Inoue, Ichiro; Shinohara, Yuya; Amemiya, Yoshiyuki] Univ Tokyo, Dept Adv Mat Sci, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan; [Inoue, Ichiro; Ogawa, Kanade; Yabashi, Makina] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan; [Tono, Kensuke; Joti, Yasumasa; Kameshima, Takashi] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan	Inoue, I (reprint author), Univ Tokyo, Dept Adv Mat Sci, Grad Sch Frontier Sci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778561, Japan.	inoue@x-ray.k.u-tokyo.ac.jp; yabashi@spring8.or.jp			Japan Society for the Promotion of Science (JSPS); SACLA graduate-course student programme	The authors acknowledge Drs Y. Inubushi, K. Tamasaku, T. Tanaka and H. Tanaka for their valuable advice and extensive discussions. One of the authors (II) acknowledges support from the Japan Society for the Promotion of Science (JSPS) through a Research Fellowship for Young Scientists, and the SACLA graduate-course student programme.	Suzuki Y, 2004, REV SCI INSTRUM, V75, P1026, DOI 10.1063/1.1651640; Yabashi M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.140801; Lin JJA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.074801; Kameshima T, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4867668; McNeil BWJ, 2010, NAT PHOTONICS, V4, P814, DOI 10.1038/nphoton.2010.239; Loh ND, 2013, OPT EXPRESS, V21, P12385, DOI 10.1364/OE.21.012385; Pfeiffer F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.164801; Clark JN, 2013, SCIENCE, V341, P56, DOI 10.1126/science.1236034; Saldin EL, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/035010; Song C, 2014, J APPL CRYSTALLOGR, V47, P188, DOI 10.1107/S1600576713029944; Yumoto H, 2013, NAT PHOTONICS, V7, P43, DOI [10.1038/nphoton.2012.306, 10.1038/NPHOTON.2012.306]; Alaimo MD, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.194805; Snigirev A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.064801; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; Falus P, 2006, J SYNCHROTRON RADIAT, V13, P253, DOI 10.1107/S0909049506006789; Tamasaku K, 2014, NAT PHOTONICS, V8, P313, DOI [10.1038/nphoton.2014.10, 10.1038/NPHOTON.2014.10]; Kohn V, 2000, PHYS REV LETT, V85, P2745, DOI 10.1103/PhysRevLett.85.2745; Leitenberger W, 2001, OPT COMMUN, V191, P91, DOI 10.1016/S0030-4018(01)01104-X; Saldin EL, 2008, OPT COMMUN, V281, P1179, DOI 10.1016/j.optcom.2007.10.044; Ishikawa T, 2012, NAT PHOTONICS, V6, P540, DOI 10.1038/nphoton.2012.141; Shwartz S, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.163901; Vinko SM, 2012, NATURE, V482, P59, DOI 10.1038/nature10746; Seibert MM, 2011, NATURE, V470, P78, DOI 10.1038/nature09748; Singer A, 2012, OPT EXPRESS, V20, P17480, DOI 10.1364/OE.20.017480; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/nphoton.2010.176, 10.1038/NPHOTON.2010.176]; Tono K, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/8/083035; Gutt C, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.024801; Chapman HN, 2010, NAT PHOTONICS, V4, P833, DOI 10.1038/nphoton.2010.240; Glover TE, 2012, NATURE, V488, P603, DOI 10.1038/nature11340; Lee S, 2013, OPT EXPRESS, V21, P24647, DOI 10.1364/OE.21.024647; Gaffney KJ, 2007, SCIENCE, V316, P1444, DOI 10.1126/science.1135923; ISHIKAWA T, 1988, ACTA CRYSTALLOGR A, V44, P496, DOI 10.1107/S010876738800234X; Lehmkuhler F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05234; Mandel L., 1995, OPTICAL COHERENCE QU; Mimura H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4539; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Skopintsev P, 2014, J SYNCHROTRON RADIAT, V21, P722, DOI 10.1107/S1600577514006857; Tamasaku K, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.043001; Vartanyants IA, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.144801	39	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	2052-2525			IUCRJ	IUCrJ	NOV	2015	2		6				620	626		10.1107/S2052252515015523		7	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CV6XS	WOS:000364415900006		
J	Choi, S; Kurosaki, K; Harnwunggmoung, A; Miyazaki, Y; Ohishi, Y; Muta, H; Yamanaka, S				Choi, Seongho; Kurosaki, Ken; Harnwunggmoung, Adul; Miyazaki, Yoshinobu; Ohishi, Yuji; Muta, Hiroaki; Yamanaka, Shinsuke			Enhancement of thermoelectric properties of CoSb3 skutterudite by addition of Ga and In	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							MULTIPLE-FILLED SKUTTERUDITES; SEVERE PLASTIC-DEFORMATION; LOW-THERMAL-CONDUCTIVITY; PERFORMANCE; CO4SB12; BEHAVIOR; MERIT	Filled skutterudites are known as excellent thermoelectric (TE) materials. The voids in the structure of skutterudites such as cobalt antimonide (CoSb3) can be filled or partially filled with a variety of different atoms. In the present study, we tried to fill both gallium (Ga) and indium (In) into the voids of CoSb3. The polycrystalline samples with nominal compositions of Ga0.2InxCo4Sb12 (x = 0.15, 0.20, 0.25, and 0.30) were prepared and their TE properties were examined from room temperature to 773 K. Ga and In added to CoSb3 partly filled the voids and most of the residual precipitated as nanoparticles at the grain boundaries. A tiny amount of Ga substituted for Sb at the Sb site of CoSb3, while it was more likely for In to fill the voids than Ga. All the samples exhibited negative values for the Seebeck coefficient. The lattice thermal conductivity was reduced effectively by the co-addition of Ga and In without degrading the power factor. The maximum dimensionless figure of merit (ZT) value of 0.95 at 725K was obtained for the sample with the nominal composition Ga0.2In0.3Co4Sb12. (C) 2015 The Japan Society of Applied Physics	[Choi, Seongho; Kurosaki, Ken; Miyazaki, Yoshinobu; Ohishi, Yuji; Muta, Hiroaki; Yamanaka, Shinsuke] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Harnwunggmoung, Adul] Rajamangala Univ Technol, Fac Sci & Technol, Thermoelect & Nanotechnol Res Ctr, Suvarnabhumi 11000, Thailand; [Yamanaka, Shinsuke] Univ Fukui, Res Inst Nucl Engn, Tsuruga, Fukui 9140055, Japan	Choi, S (reprint author), Osaka Univ, Grad Sch Engn, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kurosaki@see.eng.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [25289220]; ALCA (Advanced Low Carbon Technology Research and Development Program) of the Japan Science and Technology Agency; Program for Creating Future Wisdom, Osaka University	This work was supported in part by a Grant-in-Aid for Scientific Research (No. 25289220) from the Ministry of Education, Culture, Sports, Science and Technology and by the ALCA (Advanced Low Carbon Technology Research and Development Program) of the Japan Science and Technology Agency. Additional support was kindly provided in 2014 by the Program for Creating Future Wisdom, Osaka University.	Harnwunggmoung A, 2012, J APPL PHYS, V112, DOI 10.1063/1.4748340; Xiong Z, 2010, ACTA MATER, V58, P3995, DOI 10.1016/j.actamat.2010.03.025; Shi X, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2920210; Wan CL, 2010, MATERIALS, V3, P2606, DOI 10.3390/ma3042606; Mallik RC, 2009, J ELECTRON MATER, V38, P1337, DOI 10.1007/s11664-009-0663-0; Shi X, 2011, J AM CHEM SOC, V133, P7837, DOI 10.1021/ja111199y; Shi X, 2011, J MATER RES, V26, P1745, DOI 10.1557/jmr.2011.84; Su XL, 2012, J MATER CHEM, V22, P15628, DOI 10.1039/c2jm31677c; Li GH, 2013, J ELECTRON MATER, V42, P1463, DOI 10.1007/s11664-012-2290-4; Heremans JP, 2008, SCIENCE, V321, P554, DOI 10.1126/science.1159725; Pei YZ, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3182800; Rogl G, 2012, ACTA MATER, V60, P2146, DOI 10.1016/j.actamat.2011.12.023; Salvador JR, 2010, J APPL PHYS, V107, DOI 10.1063/1.3296186; Xi LL, 2015, ACTA MATER, V85, P112, DOI 10.1016/j.actamat.2014.11.022; Li H, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3099804; Chen LD, 2001, J APPL PHYS, V90, P1864, DOI 10.1063/1.1388162; Kurosaki K, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2009828; Rogl G, 2014, ACTA MATER, V76, P434, DOI 10.1016/j.actamat.2014.05.051; Harnwunggmoung A, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3430739; Harnwunggmoung A, 2011, J APPL PHYS, V110, DOI 10.1063/1.3606417; Grytsiv A, 2013, J ELECTRON MATER, V42, P2940, DOI 10.1007/s11664-013-2679-8; Shi X, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.185503; Zhao XY, 2006, J APPL PHYS, V99, DOI 10.1063/1.2172705; Izumi F, 2007, SOL ST PHEN, V130, P15; Eilertsen J, 2012, ACTA MATER, V60, P2178, DOI 10.1016/j.actamat.2011.12.028; Rogl G, 2013, ACTA MATER, V61, P6778, DOI 10.1016/j.actamat.2013.07.052; Pei YZ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2397538; Yang J, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2737422; He T, 2006, CHEM MATER, V18, P759, DOI 10.1021/cm052055b; BUCHER G, 1986, MONATSH CHEM, V117, P1367, DOI 10.1007/BF00810746; Qiu YT, 2013, ADV FUNCT MATER, V23, P3194, DOI 10.1002/adfm.201202571; Shi X, 2009, J ELECTRON MATER, V38, P930, DOI 10.1007/s11664-008-0650-x; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; Downie RA, 2014, MATERIALS, V7, P7093, DOI 10.3390/ma7107093; Harnwunggmoung A., 2011, THESIS OSAKA U OSAKA; Harnwunggmoung A., 2012, P POWD MET WORLD C E; Kurosaki Ken, 2014, Front Chem, V2, P84, DOI 10.3389/fchem.2014.00084; Sales BC, 1996, SCIENCE, V272, P1325, DOI 10.1126/science.272.5266.1325; Tritt TM, 2006, MRS BULL, V31, P188, DOI 10.1557/mrs2006.44; Zhao WY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7197	40	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							111801	10.7567/JJAP.54.111801		5	Physics, Applied	Physics	CV5CC	WOS:000364283000010		
J	Fujii, S; Kozawa, T; Okamoto, K; Santillan, JJ; Itani, T				Fujii, Shinya; Kozawa, Takahiro; Okamoto, Kazumasa; Santillan, Julius Joseph; Itani, Toshiro			Shot noise limit of sensitivity of chemically amplified resists used for extreme ultraviolet lithography	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ACID GENERATION EFFICIENCY; AMPLIFICATION	With the improvement of resolution, the shot noise effect becomes a serious concern in the lithography used for high-volume production of semiconductor devices. In this study, the shot noise limit of the sensitivity of chemically amplified resists was investigated from the viewpoint of sensitivity enhancement, assuming extreme ultraviolet lithography. The latent images of line-and-space patterns with 11 nm half-pitch were calculated using a Monte Carlo method. The effect of secondary electron blur was eliminated to clarify the shot noise limit of line edge roughness (LER). When the requirement for line width roughness (LWR) was assumed to be 10% critical dimension (CD), the shot noise limit of sensitivity was > 100 mJ cm(-2). For the 20% CD LWR, the shot noise limits of sensitivity for the 10, 20, and 30 wt% acid generator concentrations were 20, 9, and 7 mJ cm(-2), respectively. (C) 2015 The Japan Society of Applied Physics	[Fujii, Shinya; Kozawa, Takahiro] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; [Okamoto, Kazumasa] Hokkaido Univ, Fac Grad Sch Engn, Div Quantum Sci & Engn, Sapporo, Hokkaido 0608628, Japan; [Santillan, Julius Joseph; Itani, Toshiro] EUVL Infrastruct Dev Ctr Inc EIDEC, Tsukuba, Ibaraki 3058569, Japan	Fujii, S (reprint author), Hokkaido Univ, Grad Sch Engn, Div Quantum Sci & Engn, Sapporo, Hokkaido 0608628, Japan.	kozawa@sanken.osaka-u.ac.jp			New Energy and Industrial Technology Development Organization (NEDO)	This work was partially supported by the New Energy and Industrial Technology Development Organization (NEDO).	Kozawa T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.066504; Kozawa T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.067012; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.126501; Natsuda K, 2007, JPN J APPL PHYS 1, V46, P7285, DOI 10.1143/JJAP.46.7285; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.076503; Kozawa T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.026502; Fukuyama T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.065004; Ito H, 2005, ADV POLYM SCI, V172, P37, DOI 10.1007/b97574; KINOSHITA H, 1989, J VAC SCI TECHNOL B, V7, P1648, DOI 10.1116/1.584507; Kozawa T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.116505; Fujii S, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.086502; Kozawa T, 2013, J PHOTOPOLYM SCI TEC, V26, P643; Kozawa T, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.036501; Kozawa T, 2006, J VAC SCI TECHNOL B, V24, pL27, DOI 10.1116/1.2393297; Kozawa T, 2008, J APPL PHYS, V103, DOI 10.1063/1.2909275; Itani T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.010002; Hirose R, 2007, JPN J APPL PHYS 2, V46, pL979, DOI 10.1143/JJAP.46.L979; Itani T, 2009, J VAC SCI TECHNOL B, V27, P2986, DOI 10.1116/1.3258151; Natsuda K, 2006, JPN J APPL PHYS 2, V45, pL1256, DOI 10.1143/JJAP.45.L1256; Kozawa T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.030001; Kozawa T, 2007, J VAC SCI TECHNOL B, V25, P2481, DOI 10.1116/1.2794063; ITO H, 1983, POLYM ENG SCI, V23, P1012, DOI 10.1002/pen.760231807; Gallatin GM, 2012, PROC SPIE, V8322, DOI 10.1117/12.917006; Gao WM, 2012, PROC SPIE, V8322, DOI 10.1117/12.917804; Kozawa T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.086504; Kozawa T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.076502; Mack CA, 2012, PROC SPIE, V8325, DOI 10.1117/12.916195; Peeters R., 2014, EUV S; Petrillo K, 2012, PROC SPIE, V8322, DOI 10.1117/12.925442; Shite H, 2012, PROC SPIE, V8322, DOI 10.1117/12.916388; Smith MD, 2013, PROC SPIE, V8682, DOI 10.1117/12.2011701; Yen A., 2015, P SPIE IN PRESS	32	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							116501	10.7567/JJAP.54.116501		7	Physics, Applied	Physics	CV5CC	WOS:000364283000026		
J	Hachisu, H; Ido, T				Hachisu, Hidekazu; Ido, Tetsuya			Intermittent optical frequency measurements to reduce the dead time uncertainty of frequency link	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SR LATTICE CLOCK; ABSOLUTE FREQUENCY; BASE-LINE; ATOMS; CANCELLATION; TRANSITION; ACCURACY	The absolute frequency of the Sr-87 lattice clock transition was evaluated with an uncertainty of 1.1 x 10(-15) using a frequency link to the international atomic time (TAI). The frequency uncertainty of a hydrogen maser used as a transfer oscillator was reduced by homogeneously distributed intermittent measurement over a five-day grid of TAI. Three sets of four or five days measurements as well as systematic uncertainty of the clock at 8.6 x 10(-17) have resulted in an absolute frequency of Sr-87 S-1(0)-P-3(0) clock transition to be 429 228 004 229 872.85 (47) Hz. (C) 2015 The Japan Society of Applied Physics	[Hachisu, Hidekazu; Ido, Tetsuya] Natl Inst Informat & Commun Technol, Space Time Stand Lab, Koganei, Tokyo 1848795, Japan	Hachisu, H (reprint author), Natl Inst Informat & Commun Technol, Space Time Stand Lab, 4-2-1 Nukuikitamachi, Koganei, Tokyo 1848795, Japan.	hachisu@nict.go.jp; ido@nict.go.jp					Lodewyck J, 2012, IEEE T ULTRASON FERR, V59, P411, DOI 10.1109/TUFFC.2012.2209; Middelmann T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.263004; Panfilo G, 2010, METROLOGIA, V47, P552, DOI 10.1088/0026-1394/47/5/005; Bloom BJ, 2014, NATURE, V506, P71, DOI 10.1038/nature12941; Hachisu H, 2014, OPT LETT, V39, P4072, DOI 10.1364/OL.39.004072; Takamoto M, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.104302; Park CY, 2013, METROLOGIA, V50, P119, DOI 10.1088/0026-1394/50/2/119; Santra R, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.042510; Baillard X, 2008, EUR PHYS J D, V48, P11, DOI 10.1140/epjd/e2007-00330-3; Yu DH, 2007, METROLOGIA, V44, P91, DOI 10.1088/0026-1394/44/1/014; Ludlow AD, 2008, SCIENCE, V319, P1805, DOI 10.1126/science.1153341; Yamaguchi A, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.022701; Safronova MS, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.012509; Campbell GK, 2008, METROLOGIA, V45, P539, DOI 10.1088/0026-1394/45/5/008; Kohno T, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.072501; Matsubara K, 2012, OPT EXPRESS, V20, P22034, DOI 10.1364/OE.20.022034; Nicholson TL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7896; Komar P, 2014, NAT PHYS, V10, P582, DOI [10.1038/nphys3000, 10.1038/NPHYS3000]; Westergaard PG, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.210801; Madej AA, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.203002; Hong FL, 2009, OPT LETT, V34, P692, DOI 10.1364/OL.34.000692; Nakagawa F, 2005, IEEE T INSTRUM MEAS, V54, P829, DOI 10.1109/TIM.2004.843382; Fujieda M, 2014, METROLOGIA, V51, P253, DOI 10.1088/0026-1394/51/3/253; Baillard X, 2007, OPT LETT, V32, P1812, DOI 10.1364/OL.32.001812; Thorpe MJ, 2010, OPT EXPRESS, V18, P18744, DOI 10.1364/OE.18.018744; Akamatsu D, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.012401; Bondarescu R, 2012, GEOPHYS J INT, V191, P78, DOI 10.1111/j.1365-246X.2012.05636.x; Derevianko A, 2014, NAT PHYS, V10, P933, DOI 10.1038/NPHYS3137; Godun RM, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.210801; Greenhall C. A., 2002, P 34 ANN PREC TIM TI, P481; Huang Y, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.030503; KASDIN NJ, 1992, PROCEEDINGS OF THE 1992 IEEE FREQUENCY CONTROL SYMPOSIUM, P274, DOI 10.1109/FREQ.1992.270003; Le Targat R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3109; Ushijima I, 2015, NAT PHOTONICS, V9, P185, DOI 10.1038/NPHOTON.2015.5	34	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							112401	10.7567/JJAP.54.112401		7	Physics, Applied	Physics	CV5CC	WOS:000364283000015		
J	Hashimura, K; Ishii, K; Awazu, K				Hashimura, Keisuke; Ishii, Katsunori; Awazu, Kunio			Selective removal of atherosclerotic plaque with a quantum cascade laser in the 5.7 mu m wavelength range	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							FREE-ELECTRON LASER; TISSUE ABLATION; CHOLESTEROL ESTERS; ANGIOPLASTY	Atherosclerotic plaques consist mainly of cholesteryl esters, and the C=O stretching vibration mode of cholesteryl esters strongly absorbs radiation at a wavelength of 5.75 mu m. For clinical application of less-invasive laser angioplasty with 5.75 mu m, a compact laser is required. Quantum cascade lasers (QCLs) are semiconductor lasers that can emit radiation in the mid-IR range. In this study, the potential of the QCL for less-invasive laser angioplasty was evaluated. At the average power density of 180W/cm(2), the atherosclerotic aorta was ablated for the irradiation time of 1 s or more, whereas the normal aorta was ablated for more than 10 s. This demonstrates that selective ablation of the atherosclerotic aorta was achieved. However, strong coagulation and carbonization were observed. For reducing thermal effects, improving the pulse structure is required. In conclusion, the QCL achieved the selective ablation of the atherosclerotic lesions, which indicates the potential of the QCL. (C) 2015 The Japan Society of Applied Physics	[Hashimura, Keisuke; Ishii, Katsunori; Awazu, Kunio] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Hashimura, Keisuke] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan; [Awazu, Kunio] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Awazu, Kunio] Osaka Univ, Global Ctr Med Engn & Informat, Suita, Osaka 5650871, Japan	Hashimura, K (reprint author), Osaka Univ, Grad Sch Engn, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	awazu@see.eng.osaka-u.ac.jp			JSPS KAKENHI Grant [24241209]	This work was supported in part by JSPS KAKENHI Grant Number 24241209 and a Grant-in-Aid for JSPS Fellows. The authors would like to express their special appreciations to Hamamatsu Photonics K.K., for technical cooperation of the QCL, and Dr. Masashi Shiomi, Institute for Experimental Animals, Kobe University Graduate School of Medicine, for providing the WHHLMI rabbits.	Mackanos MA, 2007, LASER SURG MED, V39, P230, DOI 10.1002/lsm.20461; Ishii K, 2008, P SOC PHOTO-OPT INS, V6854, P85418, DOI 10.1117/12.764442; Edwards GS, 2007, OPT LETT, V32, P1426, DOI 10.1364/OL.32.001426; GRUNDFEST WS, 1985, J AM COLL CARDIOL, V5, P929; Awazu K, 1998, LASER SURG MED, V23, P233, DOI 10.1002/(SICI)1096-9101(1998)23:4<233::AID-LSM6>3.0.CO;2-0; Hashimura K, 2014, J INNOV OPT HEAL SCI, V7, DOI 10.1142/S1793545814500291; ABELA GS, 1982, AM J CARDIOL, V50, P1199, DOI 10.1016/0002-9149(82)90448-9; Kozub J, 2011, BIOMED OPT EXPRESS, V2, P1275, DOI 10.1364/BOE.2.001275; Shiomi M, 2003, ARTERIOSCL THROM VAS, V23, P1239, DOI 10.1161/01.ATV.0000075947.28567.50; Bai Y, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3586773; Fukami Y, 2003, JPN J APPL PHYS 1, V42, P3716, DOI 10.1143/JJAP.42.3716; Andreev YM, 2013, QUANTUM ELECTRON+, V43, P139, DOI 10.1070/QE2013v043n02ABEH014978; Niccoli G, 2011, J INTERV CARDIOL, V24, P514, DOI 10.1111/j.1540-8183.2011.00657.x; Koster R, 1999, J AM COLL CARDIOL, V34, P25, DOI 10.1016/S0735-1097(99)00167-9; Badr Salem, 2013, Cardiovasc Revasc Med, V14, P93, DOI 10.1016/j.carrev.2012.12.008; FAIST J, 1994, SCIENCE, V264, P553, DOI 10.1126/science.264.5158.553; Hashimura K., 2012, ADV BIOMED ENG, V1, P74; Ito T, 1994, J Atheroscler Thromb, V1, P45; Valvano JW, 2011, OPTICAL THERMAL RESPONSE OF LASER-IRRADIATED TISSUE, SECOND EDITION, P455, DOI 10.1007/978-90-481-8831-4_12	19	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							112701	10.7567/JJAP.54.112701		6	Physics, Applied	Physics	CV5CC	WOS:000364283000017		
J	Hatakeyama, T; Sometani, M; Fukuda, K; Okumura, H; Kimoto, T				Hatakeyama, Tetsuo; Sometani, Mitsuru; Fukuda, Kenji; Okumura, Hajime; Kimoto, Tsunenobu			Characterization of traps in SiC/SiO2 interfaces close to the conduction band by deep-level transient spectroscopy	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							FIELD-EFFECT TRANSISTORS; INVERSION CHANNEL MOBILITY; DYNAMICAL SIMULATION; OXIDATION PROCESS; OXIDE; FACE; RELIABILITY; NITRIDATION; CARBIDE; MOSFETS	The effects of the oxidation atmosphere and crystal faces on the traps in SiC/SiO2 interfaces close to the conduction band were investigated by deep-level transient spectroscopy. It was found that a high density of traps was observed around the energy of 0.16 eV from the edge of the conduction band in interfaces oxidized in a N2O atmosphere on the Si-face (O1 traps) and C-face (C1 traps). From the comparison of their energies, it was concluded that the O1 traps and C1 traps had the same origin. We also found that C1 traps were eliminated only on the C-face by wet oxidation. The simulation using the obtained energy and density of C1 traps in the interface oxidized in a N2O atmosphere on the C-face showed that the trapping of electrons in C1 was predominant just after the onset of the formation of an inversion layer, where the total electron density generated by the gate voltage was less than 7 x 10(11) cm(-2). (C) 2015 The Japan Society of Applied Physics	[Hatakeyama, Tetsuo; Sometani, Mitsuru; Fukuda, Kenji; Okumura, Hajime] Natl Inst Adv Ind Sci & Technol, Adv Power Elect Ctr, Tsukuba, Ibaraki 3058568, Japan; [Hatakeyama, Tetsuo] Toshiba Co Ltd, Corp R&D Ctr, Kawasaki, Kanagawa 2128582, Japan; [Kimoto, Tsunenobu] Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6158510, Japan	Hatakeyama, T (reprint author), Natl Inst Adv Ind Sci & Technol, Adv Power Elect Ctr, Tsukuba, Ibaraki 3058568, Japan.	tetsuo-hatakeyama@aist.go.jp					WEISS S, 1988, SOLID STATE ELECTRON, V31, P1733, DOI 10.1016/0038-1101(88)90071-8; Afanas'ev VV, 1997, PHYS STATUS SOLIDI A, V162, P321, DOI 10.1002/1521-396X(199707)162:1<321::AID-PSSA321>3.0.CO;2-F; Fukuda K, 2004, APPL PHYS LETT, V84, P2088, DOI 10.1063/1.1682680; Ohnuma T, 2007, MATER SCI FORUM, V556-557, P615; PALMOUR JW, 1993, PHYSICA B, V185, P461, DOI 10.1016/0921-4526(93)90278-E; Basile AF, 2011, J APPL PHYS, V109, DOI 10.1063/1.3552303; Song Y, 2004, J APPL PHYS, V95, P4953, DOI 10.1063/1.1690097; Tilak V, 2009, PHYS STATUS SOLIDI A, V206, P2391, DOI 10.1002/pssa.200925164; Ohnuma T, 2009, MATER SCI FORUM, V600-603, P591, DOI 10.4028/www.scientific.net/MSF.600-603.591; Hatakeyama T, 2005, MATER SCI FORUM, V483, P829; Dhar S, 2010, J APPL PHYS, V108, DOI 10.1063/1.3484043; Rozen J, 2009, J APPL PHYS, V105, DOI 10.1063/1.3131845; Chung GY, 2001, IEEE ELECTR DEVICE L, V22, P176, DOI 10.1109/55.915604; Hatakeyama T, 2013, MATER SCI FORUM, V740-742, P477, DOI 10.4028/www.scientific.net/MSF.740-742.477; Chokawa K, 2013, MATER SCI FORUM, V740-742, P469, DOI 10.4028/www.scientific.net/MSF.740-742.469; Rozen J, 2010, MATER SCI FORUM, V645-648, P693, DOI 10.4028/www.scientific.net/MSF.645-648.693; Cooper JA, 1997, PHYS STATUS SOLIDI A, V162, P305, DOI 10.1002/1521-396X(199707)162:1<305::AID-PSSA305>3.0.CO;2-7; Haney SK, 2013, MATER SCI FORUM, V740-742, P707, DOI 10.4028/www.scientific.net/MSF.740-742.707; Shen X, 2013, J APPL PHYS, V114, DOI 10.1063/1.4815962; Jamet P, 2001, J APPL PHYS, V90, P5058, DOI 10.1063/1.1412579; Deak P, 2007, J PHYS D APPL PHYS, V40, P6242, DOI 10.1088/0022-3727/40/20/S09; Devynck F, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.235320; Devynck F, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.195319; Suzuki T, 2009, MATER SCI FORUM, V615-617, P557; Saks NS, 2000, APPL PHYS LETT, V77, P3281, DOI 10.1063/1.1326046; Suzuki T, 2009, MATER SCI FORUM, V600-603, P791, DOI 10.4028/www.scientific.net/MSF.600-603.791; Baliga BJ, 2005, SILICON RF POWER MOSFETS, P1, DOI 10.1142/9789812569325; Devynck F., 2008, THESIS SWISS FEDERAL; Nicollian E., 2002, MOS METAL OXIDE SEMI; Weiss S., 1991, THESIS U KASSEL; Yoshioka H, 2012, J APPL PHYS, V111, DOI 10.1063/1.3673572	31	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							111301	10.7567/JJAP.54.111301		7	Physics, Applied	Physics	CV5CC	WOS:000364283000004		
J	Iwaya, M; Yamamoto, T; Iida, D; Kondo, Y; Sowa, M; Matsubara, H; Ishihara, K; Takeuchi, T; Kamiyama, S; Akasaki, I				Iwaya, Motoaki; Yamamoto, Taiji; Iida, Daisuke; Kondo, Yasunari; Sowa, Mihoko; Matsubara, Hiroyuki; Ishihara, Koji; Takeuchi, Tetsuya; Kamiyama, Satoshi; Akasaki, Isamu			Relationship between misfit-dislocation formation and initial threading-dislocation density in GaInN/GaN heterostructures	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							INGAN EPILAYERS; GROWTH; RELAXATION; ALLOYS; STRAIN	The dependence of the critical thickness for the introduction of misfit dislocations in a GaInN/GaN heterostructure system on the dislocation density in the underlying GaN layer was investigated using in situ X-ray diffraction (XRD), ex situ scanning electron microscopy, and transmission electron microscopy analyses. The critical thickness for the introduction of misfit dislocations in the GaInN layer was found to significantly depend on the dislocation density in the underlying GaN layer. Notably, on the basis of the in situ XRD results, a reliable critical thickness for obtaining misfit-dislocation-free growth was determined. (C) 2015 The Japan Society of Applied Physics	[Iwaya, Motoaki; Yamamoto, Taiji; Iida, Daisuke; Kondo, Yasunari; Sowa, Mihoko; Matsubara, Hiroyuki; Ishihara, Koji; Takeuchi, Tetsuya; Kamiyama, Satoshi; Akasaki, Isamu] Meijo Univ, Fac Sci & Technol, Nagoya, Aichi 4688502, Japan; [Akasaki, Isamu] Nagoya Univ, Akasaki Res Ctr, Nagoya, Aichi 4648603, Japan	Iwaya, M (reprint author), Meijo Univ, Fac Sci & Technol, Nagoya, Aichi 4688502, Japan.				Program for the Strategic Research Foundation at Private Universities - Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT [25000011, 15H02019]	This study was partially supported by the Program for the Strategic Research Foundation at Private Universities (2012-2016) supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), the MEXT Grant-in-Aid for Specially Promoted Research Grant No. 25000011, and the MEXT Grant-in-Aid for Scientific Research A Grant No. 15H02019.	Ponce FA, 2003, PHYS STATUS SOLIDI B, V240, P273, DOI 10.1002/pssb.200303527; PEOPLE R, 1985, APPL PHYS LETT, V47, P322, DOI 10.1063/1.96206; Mori M, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.082301; Sugiyama T, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.015701; MATTHEWS JW, 1976, THIN SOLID FILMS, V33, P253, DOI 10.1016/0040-6090(76)90085-7; Srinivasan S, 2003, APPL PHYS LETT, V83, P5187, DOI 10.1063/1.1633029; Kuwahara Y, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.111001; Holec D, 2008, J APPL PHYS, V104, DOI 10.1063/1.3033553; Wu J, 2003, J APPL PHYS, V94, P6477, DOI 10.1063/1.1618353; Akasaki I, 1997, JPN J APPL PHYS 1, V36, P5393, DOI 10.1143/JJAP.36.5393; Yamamoto T, 2014, J CRYST GROWTH, V393, P108, DOI 10.1016/j.jcrysgro.2013.11.072; FISCHER A, 1994, PHYS REV LETT, V73, P2712, DOI 10.1103/PhysRevLett.73.2712; Liu R, 2006, JPN J APPL PHYS 2, V45, pL549, DOI 10.1143/JJAP.45.L5491; Iida D, 2013, PHYS STATUS SOLIDI-R, V7, P211, DOI 10.1002/pssr.201307023; El-Masry N. A., 1996, APPL PHYS LETT, V68, P3269; Hiramatsu K., 1997, MRS INTERNET J N S R, V2, pe6; Kawaguchi Y., 1996, MRS P, V449, P89; Vos A., 1992, ENDOREVERSIBLE THERM, P29	18	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							115501	10.7567/JJAP.54.115501		4	Physics, Applied	Physics	CV5CC	WOS:000364283000022		
J	Kamoi, S; Kim, JG; Hasuike, N; Kisoda, K; Harima, H				Kamoi, Susumu; Kim, Jung Gon; Hasuike, Noriyuki; Kisoda, Kenji; Harima, Hiroshi			Spectroscopic characterization of nitrogen- and boron-doped graphene layers	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							RAMAN-SCATTERING; MONOLAYER GRAPHENE; CHARGE-TRANSFER; LARGE-AREA; TRANSISTOR; GRAPHITE; DOPANTS; GROWTH; FILMS	Nitrogen- and boron-doped graphene layers were grown on copper substrates by alcoholic chemical vapor deposition and characterized by Raman spectroscopy, X-ray photoelectron spectroscopy (XPS), and electrical transport measurements. The growth of high-quality monolayer graphene was confirmed by micro-Raman spectroscopy. The G and 2D peaks showed systematic frequency shift and broadening with the impurity concentration. The G peaks showed Fano-like asymmetric line shapes. These behaviors suggested the generation of free carriers by doping. XPS and electrical transport measurements also supported the systematic incorporation of impurities in graphene layers. (C) 2015 The Japan Society of Applied Physics	[Kamoi, Susumu; Kim, Jung Gon; Hasuike, Noriyuki; Harima, Hiroshi] Kyoto Inst Technol, Dept Elect, Kyoto 6068585, Japan; [Kisoda, Kenji] Wakayama Univ, Dept Phys, Wakayama 6408510, Japan	Kamoi, S (reprint author), Kyoto Prefectural Technol Ctr, Kyoto 6008813, Japan.	s.kamoi@mtc.pref.kyoto.lg.jp					Panchokarla LS, 2009, ADV MATER, V21, P4726, DOI 10.1002/adma.200901285; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Rao AM, 1997, NATURE, V388, P257; PIETRONERO L, 1981, PHYS REV LETT, V47, P593, DOI 10.1103/PhysRevLett.47.593; Lin YC, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3368697; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Dankerl M, 2010, ADV FUNCT MATER, V20, P3117, DOI 10.1002/adfm.201000724; Lazzeri M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.266407; Li XS, 2009, NANO LETT, V9, P4268, DOI 10.1021/nl902515k; Thomsen C, 2000, PHYS REV LETT, V85, P5214, DOI 10.1103/PhysRevLett.85.5214; Schiros T, 2012, NANO LETT, V12, P4025, DOI 10.1021/nl301409h; Reina A, 2009, NANO LETT, V9, P30, DOI 10.1021/nl801827v; Tang YB, 2012, ACS NANO, V6, P1970, DOI 10.1021/nn3005262; Kuzmenko AB, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.116804; Das A, 2008, NAT NANOTECHNOL, V3, P210, DOI 10.1038/nnano.2008.67; Liu HT, 2011, J MATER CHEM, V21, P3335, DOI 10.1039/c0jm02922j; Jin Z, 2011, ACS NANO, V5, P4112, DOI 10.1021/nn200766e; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Heersche HB, 2007, NATURE, V446, P56, DOI 10.1038/nature05555; Mafra DL, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.233407; Usachov D, 2011, NANO LETT, V11, P5401, DOI 10.1021/nl2031037; Zhao LY, 2011, SCIENCE, V333, P999, DOI 10.1126/science.1208759; Yan J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.166802; Lherbier A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.036808; Imamura I., 2011, J PHYS CHEM C, V115, P10000	26	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							115101	10.7567/JJAP.54.115101		5	Physics, Applied	Physics	CV5CC	WOS:000364283000021		
J	Kanatsu, Y; Sato, M				Kanatsu, Youhei; Sato, Masahide			Removal of defects in a colloidal crystal grown in an inverted pyramidal container by changing the external force	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							HARD; CRYSTALLIZATION; SIMULATION; PARTICLES; LIQUIDS	Keeping the formation of colloidal crystals by sedimentation in mind, we carry out Brownian dynamics simulations and study the crystallization of colloidal particles in an inverted pyramidal container. When an external force is added, the sedimentation of particles occurs and the particle density increases in the low region of the inverted pyramidal container. The crystallization of particles occurs and the face-centered cubic structure is formed in the container. When the force is large, the particles with the hexagonal close-packed structure are formed. Disordered particles are also formed and act as defects in bulk. After the sedimentation finishes, we decrease the force transiently. The defects in bulk are removed from the bulk. (C) 2015 The Japan Society of Applied Physics	[Kanatsu, Youhei] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Sato, Masahide] Kanazawa Univ, Informat Media Ctr, Kanazawa, Ishikawa 9201192, Japan	Kanatsu, Y (reprint author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan.		Sato, Masahide/I-4275-2013	Sato, Masahide/0000-0001-8298-9016	JSPS KAKENHI Grant [26103515, 26390054]	This work was supported by JSPS KAKENHI Grant Numbers 26103515 and 26390054. M.S. benefited from the Joint Research Program of the Institute of Low Temperature Science, Hokkaido University.	TENWOLDE PR, 1995, PHYS REV LETT, V75, P2714, DOI 10.1103/PhysRevLett.75.2714; Matsuo S, 2003, APPL PHYS LETT, V82, P4283, DOI 10.1063/1.1583138; Miguez H, 1997, LANGMUIR, V13, P6009, DOI 10.1021/la970589o; Desgranges C, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.054201; Sato M, 2014, J CRYST GROWTH, V401, P87, DOI 10.1016/j.jcrysgro.2014.01.074; Lechner W, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2977970; Marechal M, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3609103; STEINHARDT PJ, 1983, PHYS REV B, V28, P784, DOI 10.1103/PhysRevB.28.784; PUSEY PN, 1989, PHYS REV LETT, V63, P2753, DOI 10.1103/PhysRevLett.63.2753; Blanco A, 2000, NATURE, V405, P437; Mori A, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2193149; Panaitescu A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.108001; Suzuki Y, 2011, J CRYST GROWTH, V318, P780, DOI 10.1016/j.jcrysgro.2010.11.036; Zhu JX, 1997, NATURE, V387, P883; ERMAK DL, 1975, J CHEM PHYS, V62, P4189, DOI 10.1063/1.430300; WEEKS JD, 1971, J CHEM PHYS, V54, P5237, DOI 10.1063/1.1674820; Woodcock LV, 1997, NATURE, V385, P141, DOI 10.1038/385141a0; Kanatsu Y, 2015, J PHYS SOC JPN, V84, DOI 10.7566/JPSJ.84.044601; Fujine M, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.032404; Fujine M, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.042401; Rintoul MD, 1996, J CHEM PHYS, V105, P9258, DOI 10.1063/1.473004; Sato M, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.032403; Sato M, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.084804	23	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							110301	10.7567/JJAP.54.110301		4	Physics, Applied	Physics	CV5CC	WOS:000364283000001		
J	Kikuchi, M; Shinmura, Y; Kaji, T; Kono, T; Yoshida, Y; Hiramoto, M				Kikuchi, Mitsuru; Shinmura, Yusuke; Kaji, Toshihiko; Kono, Takahiro; Yoshida, Yuji; Hiramoto, Masahiro			Enhancing the photocurrent in high-photovoltage organic solar cells by doping	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							POWER CONVERSION EFFICIENCY; OPEN-CIRCUIT VOLTAGE; FILMS; OLIGOTHIOPHENE; INTERLAYER; PIGMENTS	We obtained a 50% improvement in photocurrent with a photovoltage of 1.0V by impurity doping organic photoactive codeposited films consisting of fullerene and a novel organic semiconductor. A reduced cell resistance and the formation of band bending were revealed to be the main reasons for the doping-induced improvement in photocurrent. A conversion efficiency of 3.8% was observed. (C) 2015 The Japan Society of Applied Physics	[Kikuchi, Mitsuru; Shinmura, Yusuke; Kaji, Toshihiko; Hiramoto, Masahiro] Inst Mol Sci, Okazaki, Aichi 4448787, Japan; [Kono, Takahiro; Yoshida, Yuji] Natl Inst Adv Ind Sci & Technol, Res Ctr Photovolta Technol, Tsukuba, Ibaraki 3058565, Japan; [Kikuchi, Mitsuru; Shinmura, Yusuke; Kaji, Toshihiko; Kono, Takahiro; Yoshida, Yuji; Hiramoto, Masahiro] CREST, JST, Chiyoda Ku, Tokyo 1020075, Japan	Kikuchi, M (reprint author), Inst Mol Sci, Okazaki, Aichi 4448787, Japan.	kikuchi@ims.ac.jp; hiramoto@ims.ac.jp			Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Agency (JST)	Financial support from Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Agency (JST) is gratefully acknowledged.	Ishiyama N, 2013, ORG ELECTRON, V14, P1793, DOI 10.1016/j.orgel.2013.04.003; Kubo M, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4847296; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; Chen CC, 2014, ADV MATER, V26, P5670, DOI 10.1002/adma.201402072; Lin YZ, 2012, CHEM SOC REV, V41, P4245, DOI 10.1039/c2cs15313k; Sakai J, 2009, SOL ENERG MAT SOL C, V93, P1149, DOI 10.1016/j.solmat.2009.02.007; TANG CW, 1986, APPL PHYS LETT, V48, P183, DOI 10.1063/1.96937; Wang SY, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3152011; Kubo M, 2013, MOL CRYST LIQ CRYST, V581, P13, DOI 10.1080/15421406.2013.808137; Shibata Y, 2013, ORG ELECTRON, V14, P1073, DOI 10.1016/j.orgel.2013.01.015; Peng YL, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4894089; Mutolo KL, 2006, J AM CHEM SOC, V128, P8108, DOI 10.1021/ja061655o; HIRAMOTO M, 1992, J APPL PHYS, V72, P3781, DOI 10.1063/1.352274; Shinmura Y, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.071601; WAGNER HJ, 1982, J MATER SCI, V17, P2781, DOI 10.1007/BF00644652; Haddock JN, 2005, ORG ELECTRON, V6, P182, DOI 10.1016/j.orgel.2005.06.002; Brabec CJ, 2001, ADV FUNCT MATER, V11, P374, DOI 10.1002/1616-3028(200110)11:5<374::AID-ADFM374>3.3.CO;2-N; Sakai J, 2008, ORG ELECTRON, V9, P582, DOI 10.1016/j.orgel.2008.03.008; Ishiyama N, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4769455; Kubo M, 2011, AIP ADV, V1, DOI 10.1063/1.3647994; HIRAMOTO M, 1991, APPL PHYS LETT, V58, P1062, DOI 10.1063/1.104423; Forrest, 2009, APPL PHYS LETT, V94; Hoppe H, 2004, J MATER RES, V19, P1924, DOI 10.1557/JMR.2004.0252; Kono T., 2013, J MAT SCI; Kubo M, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3556312; Liu YS, 2013, SCI REP-UK, V3, DOI 10.1038/srep03356; Hiramoto Masahiro, 2014, Electronics, V3, DOI 10.3390/electronics3020351; Spanggaard H, 2004, SOL ENERG MAT SOL C, V83, P125, DOI 10.1016/j.solmat.2004.02.021; Sun S.-S., 2005, ORGANIC PHOTOVOLTAIC, P239	29	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							111601	10.7567/JJAP.54.111601		5	Physics, Applied	Physics	CV5CC	WOS:000364283000009		
J	Kikuchi, R; Tsuda, K; Bassem, MM; Ueda, Y				Kikuchi, Ryo; Tsuda, Kenichiro; Bassem, Mohamed Mehdi; Ueda, Yuki			Measurement of performance of thermoacoustic heat pump in a-3 to 160 degrees C temperature range	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ELECTRICITY GENERATOR; POWER	A thermoacoustic heat pump was constructed and tested. It was composed of a looped tube, a straight tube, and a regenerator. The looped tube contained the regenerator and was connected to the straight tube. The tubes were filled with nitrogen. When an acoustic wave was input to the tubes, a temperature difference formed along the regenerator. Our experiments showed that this heat pump could work as both a cooler and a heater. This heat pump achieved -39 degrees C as a cooler and 270 degrees C as a heater. Using antifreeze liquid and oil as heat media, the cooling and heating performance of the heat pump was measured within the temperature range from -3 to 160 degrees C. (C) 2015 The Japan Society of Applied Physics	[Kikuchi, Ryo; Tsuda, Kenichiro; Ueda, Yuki] Tokyo Univ Agr & Technol, Koganei, Tokyo 1848588, Japan; [Bassem, Mohamed Mehdi] Res & Technol Ctr Energy, Borj Cedria Technopk, Tunisia	Kikuchi, R (reprint author), Tokyo Univ Agr & Technol, Koganei, Tokyo 1848588, Japan.	uedayuki@cc.tuat.ac.jp	Ueda, Yuki/E-4530-2010		JSPS KAKENHI Grant [23760181]	This work was supported by JSPS KAKENHI Grant Number 23760181.	Ueda Y, 2010, J APPL PHYS, V107, DOI 10.1063/1.3294616; FUSCO AM, 1992, J ACOUST SOC AM, V91, P2229, DOI 10.1121/1.403656; Yu ZB, 2012, APPL ENERG, V99, P135, DOI 10.1016/j.apenergy.2012.04.046; Swift GW, 1999, J ACOUST SOC AM, V105, P711, DOI 10.1121/1.426262; Bassem MM, 2011, INT J REFRIG, V34, P1125, DOI 10.1016/j.ijrefrig.2011.02.003; Ueda Y, 2009, J ACOUST SOC AM, V125, P780, DOI 10.1121/1.3056552; Backhaus S, 1999, NATURE, V399, P335, DOI 10.1038/20624; Luo EC, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2176855; Wu ZH, 2012, SOL ENERGY, V86, P2376, DOI 10.1016/j.solener.2012.05.010; Wu ZH, 2014, APPL ENERG, V124, P140, DOI 10.1016/j.apenergy.2014.02.063; Bassem MM, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.107301; MATSUBARA Y, 1994, CRYOGENICS, V34, P259, DOI 10.1016/0011-2275(94)90104-X; Sun DM, 2013, APPL ENERG, V106, P377, DOI 10.1016/j.apenergy.2013.01.051; de Blok K., 2012, P INT I AC VIBR ICSV, p[S29, 103]; Poese M. E., 2004, THESIS PENNSYLVANIA; Swift G. W., 2002, THERMOACOUSTICS UNIF; Tijani H., 2012, P INT I AC VIBR ICSV; Tijani H., 2008, CRYOGENICS, V48, P77; Tominaga A., 1998, NETSU ONKYO KOGAKU N; Vanapalli S., 2010, P FEDSM2010	20	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							117101	10.7567/JJAP.54.117101		4	Physics, Applied	Physics	CV5CC	WOS:000364283000029		
J	Kozawa, T; Santillan, JJ; Itani, T				Kozawa, Takahiro; Santillan, Julius Joseph; Itani, Toshiro			Quencher diffusion in chemically amplified poly(4-hydroxystyrene-co-t-butyl methacrylate) resist	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							LITHOGRAPHY; EXPOSURE	Understanding of resist fundamentals is important for the efficient development of resist materials. In this study, we investigated the quencher diffusion in a chemically amplified resist consisting of poly(4-hydroxystyrene-co-t-butyl methacrylate), triphenylsulfonium nonafluorobutanesulfonate (an acid generator), and tri-n-octylamine (a quencher). The dose-pitch matrices of line width and line edge roughness were analyzed on the basis of the sensitization and reaction mechanisms of chemically amplified extreme ultraviolet resists. The ratio of the diffusion constant of tri-n-octylamine to that of nonafluorobutanesulfonic acid was estimated to be 1.2 +/- 0.7. (C) 2015 The Japan Society of Applied Physics	[Kozawa, Takahiro] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; [Santillan, Julius Joseph; Itani, Toshiro] EUVL Infrastruct Dev Ctr Inc EIDEC, Tsukuba, Ibaraki 3058569, Japan	Kozawa, T (reprint author), Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan.	kozawa@sanken.osaka-u.ac.jp			New Energy and Industrial Technology Development Organization (NEDO)	This work was partially supported by the New Energy and Industrial Technology Development Organization (NEDO).	Tsubaki H, 2015, J PHOTOPOLYM SCI TEC, V28, P489; Kozawa T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.066504; Hirose R, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.027004; Kimoto T, 2015, J PHOTOPOLYM SCI TEC, V28, P519; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.126501; Natsuda K, 2007, JPN J APPL PHYS 1, V46, P7285, DOI 10.1143/JJAP.46.7285; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.076503; NAKAMURA J, 1991, JPN J APPL PHYS 1, V30, P2619, DOI 10.1143/JJAP.30.2619; Kozawa T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.026502; Ito H, 2005, ADV POLYM SCI, V172, P37, DOI 10.1007/b97574; Kozawa T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.116505; Mori I, 2008, P SOC PHOTO-OPT INS, V6921, P92102, DOI 10.1117/12.772625; Yamamoto H, 2004, JPN J APPL PHYS 2, V43, pL848, DOI 10.1143/JJAP.43.L848; Uzawa S, 2007, P SOC PHOTO-OPT INS, V6517, P51708, DOI 10.1117/12.711650; Hinsberg WD, 2001, IBM J RES DEV, V45, P667; Kozawa T, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.036501; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.030209; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.076505; Itani T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.010002; Natsuda K, 2006, JPN J APPL PHYS 2, V45, pL1256, DOI 10.1143/JJAP.45.L1256; Kozawa T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.030001; Hirose R, 2008, JPN J APPL PHYS, V47, P7125, DOI 10.1143/JJAP.47.7125; Tawarayama K, 2008, JPN J APPL PHYS, V47, P4866, DOI 10.1143/JJAP.47.4866; Kozawa T, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.016502; Fukuda H, 2001, P SOC PHOTO-OPT INS, V4346, P319, DOI 10.1117/12.435732	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							118002	10.7567/JJAP.54.118002		3	Physics, Applied	Physics	CV5CC	WOS:000364283000032		
J	Lee, H; Hayashi, N; Mizuno, Y; Nakamura, K				Lee, Heeyoung; Hayashi, Neisei; Mizuno, Yosuke; Nakamura, Kentaro			Refractive index sensing using V-shaped polymer optical fibers	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							TRANSMISSION; TAPERS; SENSOR; LIGHT	Although polymer optical fiber (POF) tapers with high flexibility have been used to measure the refractive indices (RIs) of liquids, their fabrication have caused some inconvenience including the need to use external heat sources or chemicals. Here, as an alternative, we develop a simple, secure, and low-cost method of measuring RIs of liquids using V-shaped bent POFs. When the bending angle is 120 degrees (experimentally optimized), with increasing RI, the transmitted power increases almost linearly with a dependence coefficient of approximately 210 dB/RI unit. (C) 2015 The Japan Society of Applied Physics	[Lee, Heeyoung; Hayashi, Neisei; Mizuno, Yosuke; Nakamura, Kentaro] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan	Lee, H (reprint author), Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan.	hylee@sonic.pi.titech.ac.jp; knakamur@sonic.pi.titech.ac.jp			JSPS KAKENHI [25709032, 26630180, 25007652]; Iwatani Naoji Foundation; SCAT Foundation; Konica Minolta Science and Technology Foundation	This work was supported by JSPS KAKENHI Grant Numbers 25709032, 26630180, and 25007652, and by research grants from the Iwatani Naoji Foundation, the SCAT Foundation, and the Konica Minolta Science and Technology Foundation.	Mizuno Y, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4863413; Patrick HJ, 1998, J LIGHTWAVE TECHNOL, V16, P1606, DOI 10.1109/50.712243; Mizuno Y, 2013, OPT LETT, V38, P1467, DOI 10.1364/OL.38.001467; TAKEO T, 1982, JPN J APPL PHYS 1, V21, P1509, DOI 10.1143/JJAP.21.1509; Ujihara H, 2015, APPL PHYS EXPRESS, V8, DOI 10.7567/APEX.8.072501; HARRIS AJ, 1986, J LIGHTWAVE TECHNOL, V4, P34, DOI 10.1109/JLT.1986.1074626; Jeong Y, 2009, CURR APPL PHYS, V9, pE273, DOI 10.1016/j.cap.2009.07.013; Koike Y, 2009, NPG ASIA MATER, V1, P22, DOI 10.1038/asiamat.2009.2; ANDO S, 1994, CHEMTECH, V24, P20; Leung A, 2006, BIOSENS BIOELECTRON, V21, P2202, DOI 10.1016/j.bios.2005.11.022; Hayashi N, 2014, J APPL PHYS, V115, DOI 10.1063/1.4875102; Wong YM, 2003, J OPT A-PURE APPL OP, V5, pS51, DOI 10.1088/1464-4258/5/4/354; Mizuno Y, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3463038; Feng DJ, 2014, APPL OPTICS, V53, P2007, DOI 10.1364/AO.53.002007; Guo SP, 2003, OPT EXPRESS, V11, P215; Jasim AA, 2014, SENSOR ACTUAT A-PHYS, V219, P94, DOI 10.1016/j.sna.2014.07.018; Lide D. R., 2004, HDB CHEM PHYS, P2004; Tian ZB, 2008, IEEE PHOTONIC TECH L, V20, P626, DOI 10.1109/LPT.2008.919507	18	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							118001	10.7567/JJAP.54.118001		2	Physics, Applied	Physics	CV5CC	WOS:000364283000031		
J	Okada, M; Matsui, S				Okada, Makoto; Matsui, Shinji			High-resolution line and space pattern fabrication by electron beam lithography using NEB-22 resist	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							COLD DEVELOPMENT; POLY(METHYLMETHACRYLATE)	Electron beam lithography (EBL) is one of the useful techniques for fabricating nanostructure. Hydrogen silsesquioxane and calixarene are known as effective EB resists for preparing a fine negative-tone pattern by EBL. However, they have exceedingly low sensitivity. NEB-22 is a chemically amplified EB resist having high sensitivity and high contrast. We demonstrated EBL using a diluted NEB-22 to fabricate a high-resolution line-and-space pattern. As a result, 40-nm-line and 60-nm-space pattern was successfully fabricated. (C) 2015 The Japan Society of Applied Physics	[Okada, Makoto; Matsui, Shinji] Univ Hyogo, LASTI, Kamigori, Hyogo 6781205, Japan	Okada, M (reprint author), Univ Hyogo, LASTI, Kamigori, Hyogo 6781205, Japan.	m.okada@lasti.u-hyogo.ac.jp			Adaptable & Seamless Technology Transfer Program through Target-driven R&D (A-STEP) - Japan Science and Technology Agency [AS2615023M]	This work was partially supported by Adaptable & Seamless Technology Transfer Program through Target-driven R&D (A-STEP) (Research No. AS2615023M) funded by Japan Science and Technology Agency. The authors would like to thank Masayuki Abe, Naoto Ito, Mitsuo Oshikata, Tsuneharu Tanaka, Kenji Okuno, and Toru Kimura from Asahi Kasei Corporation for their support.	Fujita J, 1996, APPL PHYS LETT, V68, P1297, DOI 10.1063/1.115958; Namatsu H, 1998, J VAC SCI TECHNOL B, V16, P69, DOI 10.1116/1.589837; Ocola LE, 2006, J VAC SCI TECHNOL B, V24, P3061, DOI 10.1116/1.2366698; Nakajima K, 1997, JPN J APPL PHYS 1, V36, P7535, DOI 10.1143/JJAP.36.7535; Hu WC, 2004, J VAC SCI TECHNOL B, V22, P1711, DOI 10.1116/1.1763897; NISHIDA T, 1992, JPN J APPL PHYS 1, V31, P4508, DOI 10.1143/JJAP.31.4508; Okada M, 2010, J VAC SCI TECHNOL B, V28, P740, DOI 10.1116/1.3449270; Ocola LE, 1999, J VAC SCI TECHNOL B, V17, P3164, DOI 10.1116/1.590973; Ocola LE, 1998, J VAC SCI TECHNOL B, V16, P3705, DOI 10.1116/1.590394; Bilenberg B, 2006, J VAC SCI TECHNOL B, V24, P1776, DOI 10.1116/1.2210002; PFEIFFER HC, 1978, J VAC SCI TECHNOL, V15, P887, DOI 10.1116/1.569621; ITO H, 1983, POLYM ENG SCI, V23, P1012, DOI 10.1002/pen.760231807; Rooks MJ, 2002, J VAC SCI TECHNOL B, V20, P2937, DOI 10.1116/1.1524971; Grigoresecu AE, 2007, P SOC PHOTO-OPT INS, V6519, pA5194, DOI 10.1117/12.725851; Ito H., 1982, S VLSI TECHN, P86; Slot E, 2008, PROC SPIE, V6921, DOI 10.1117/12.771965; Uetani Y., 2000, 20001 R D SUM CHEM C, P4	17	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							118004	10.7567/JJAP.54.118004		2	Physics, Applied	Physics	CV5CC	WOS:000364283000034		
J	Okuno, K				Okuno, Kimio			Observation of carbon growth and interface structures in methanol solution	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							DIAMOND-LIKE CARBON; AMORPHOUS-CARBON; FIELD-EMISSION; FILMS; GAS; DEPOSITION; PLASMA; PHASE	In the deposition of carbon on the surface of a tungsten tip in methanol solution by electrolysis, the growth structure of the carbon films, the interface state, and the dissolution of carbon atoms into the tungsten matrix of the substrate have been investigated with the atomic events by field ion microscopy (FIM). The carbon films preferentially condense on the W{111} plane. The interfacial reaction at the carbon atom-tungsten substrate interface is vigorous and the carbon atoms also readily dissolve into the substrate matrix to form a tungsten-carbon complex. The reaction depth of the deposited carbon depends on the magnitude of electrolytic current and the treatment duration in the methanol solution. In this work, the resolution depth of carbon was found to be approximately 270 atomic layers below the top layer of the tungsten substrate by a field evaporation technique. In the case of a low electrolytic current, the tungsten substrate surface is entirely covered with carbon atoms having a pseudomorphic structure. The field-electron emission characteristics were also evaluated for various coverages of the carbon film formed on the substrate. (C) 2015 The Japan Society of Applied Physics	Nagasaki Inst Appl Sci, Dept Elect & Informat Technol, Nagasaki 8510139, Japan	Okuno, K (reprint author), Nagasaki Inst Appl Sci, Dept Elect & Informat Technol, Nagasaki 8510139, Japan.	OKUNO_Kimio@NiAS.ac.jp					MATSUMOTO S, 1982, J MATER SCI, V17, P3106, DOI 10.1007/BF01203472; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; ROBERTSON J, 1986, ADV PHYS, V35, P317, DOI 10.1080/00018738600101911; NAMBA Y, 1992, J VAC SCI TECHNOL A, V10, P3368, DOI 10.1116/1.577829; KAMO M, 1983, J CRYST GROWTH, V62, P642, DOI 10.1016/0022-0248(83)90411-6; Robertson J, 1997, THIN SOLID FILMS, V296, P61, DOI 10.1016/S0040-6090(96)09381-9; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; JOHNSTON GP, 1994, J APPL PHYS, V76, P5949, DOI 10.1063/1.358373; Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095; Lifshitz Y, 1999, DIAM RELAT MATER, V8, P1659, DOI 10.1016/S0925-9635(99)00087-4; DAVIS RF, 1991, P IEEE, V79, P677, DOI 10.1109/5.90132; HIMPSEL FJ, 1979, PHYS REV B, V20, P624, DOI 10.1103/PhysRevB.20.624; Lifshitz Y, 1996, DIAM RELAT MATER, V5, P388, DOI 10.1016/0925-9635(95)00445-9; ANGUS JC, 1988, SCIENCE, V241, P913, DOI 10.1126/science.241.4868.913; GILDENBLAT GS, 1991, P IEEE, V79, P647, DOI 10.1109/5.90130; Okuno K, 2008, JPN J APPL PHYS, V47, P3584, DOI 10.1143/JJAP.47.3584; Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0; Cui JB, 2001, J APPL PHYS, V89, P3490, DOI 10.1063/1.1350626; Dresselhaus M. S., 1996, SCI FULLERENES CARBO; Field F. E., 1993, PROPERTIES DIAMOND; Good Jr R. H., 1956, HDB DER PHSIK, V21; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Iwata T., 2009, J VAC SOC JPN, V52, P176; Kobashi K., 2005, DIAMOND FILMS; Muller E. W., 1969, FIELD ION MICROSCOPY; Nebel C. E., 2003, SEMICONDUCTORS SEMIM, V76; Okuno K., 2014, J VAC SOC JPN, V57, P185; ROBERTSON J, 1991, PROG SOLID STATE CH, V21, P199, DOI 10.1016/0079-6786(91)90002-H; Robertson J, 2003, IEICE T ELECTRON, VE86C, P787; ROBERTSON J, 1992, SURF COAT TECH, V50, P185, DOI 10.1016/0257-8972(92)90001-Q	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							115502	10.7567/JJAP.54.115502		5	Physics, Applied	Physics	CV5CC	WOS:000364283000023		
J	Onuma, T; Saito, S; Sasaki, K; Masui, T; Yamaguchi, T; Honda, T; Higashiwaki, M				Onuma, Takeyoshi; Saito, Shingo; Sasaki, Kohei; Masui, Tatekazu; Yamaguchi, Tomohiro; Honda, Tohru; Higashiwaki, Masataka			Valence band ordering in beta-Ga2O3 studied by polarized transmittance and reflectance spectroscopy	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SINGLE-CRYSTALS; ABSORPTION; EPITAXY; GROWTH; FILMS	The polarized transmittance and reflectance spectra of beta-Ga2O3 crystals are investigated, and the data are interpreted in terms of the monoclinic crystal band structure. The energies of the absorption edge can be divided into six ranges, and these ranges can be assigned to the transitions from the valence bands to the conduction band minimum according to the selection rules. The indirect bandgap-energy of 4.43 eV is smaller than the direct bandgap-energy of 4.48 eV at RT; and the energy difference of 0.05 eV nearly matches the theoretically calculated values of 0.03-0.04 eV. (C) 2015 The Japan Society of Applied Physics	[Onuma, Takeyoshi; Yamaguchi, Tomohiro; Honda, Tohru] Kogakuin Univ, Dept Appl Phys, Hachioji, Tokyo 1920015, Japan; [Onuma, Takeyoshi; Saito, Shingo; Sasaki, Kohei; Higashiwaki, Masataka] Natl Inst Informat & Commun Technol, Koganei, Tokyo 1848795, Japan; [Sasaki, Kohei; Masui, Tatekazu] Tamura Corp, Sayama, Saitama 3501328, Japan	Onuma, T (reprint author), Kogakuin Univ, Dept Appl Phys, Hachioji, Tokyo 1920015, Japan.	onuma@cc.kogakuin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [25390071, 25289093, 25420341, 25706020]	This work was supported in part by Grants-in-Aid for Scientific Research Nos. 25390071, 25289093, 25420341, and 25706020 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT).	BINET L, 1994, J SOLID STATE CHEM, V113, P420, DOI 10.1006/jssc.1994.1390; He HY, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.195123; Ueda N, 1997, APPL PHYS LETT, V70, P3561, DOI 10.1063/1.119233; Varley JB, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3499306; GELLER S, 1960, J CHEM PHYS, V33, P676, DOI 10.1063/1.1731237; Onuma T, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4816759; Mohamed M, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3521255; Higashiwaki M, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4821858; Yamaguchi K, 2004, SOLID STATE COMMUN, V131, P739, DOI 10.1016/j.ssc.2004.07.030; Shimamura K, 2005, JPN J APPL PHYS 2, V44, pL7, DOI 10.1143/JJAP.44.L7; Oshima T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.011202; PASSLACK M, 1995, J APPL PHYS, V77, P686, DOI 10.1063/1.359055; Ueda N, 1997, APPL PHYS LETT, V71, P933, DOI 10.1063/1.119693; Kokubun Y, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2432946; Orita M, 2000, APPL PHYS LETT, V77, P4166, DOI 10.1063/1.1330559; Peelaers H, 2015, PHYS STATUS SOLIDI B, V252, P828, DOI 10.1002/pssb.201451551; Villora EG, 2004, J CRYST GROWTH, V270, P420, DOI 10.1016/j.jcrysgro.2004.06.027; Higashiwaki M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3674287; Oshima T, 2007, JPN J APPL PHYS 1, V46, P7217, DOI 10.1143/JJAP.46.7217; Cotton F. A., 1971, CHEM APPL GROUP THEO; He HY, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2218046; Klingshirn C. F., 2012, SEMICONDUCTOR OPTICS; MATSUMOT.T, 1974, JPN J APPL PHYS, V13, P1578, DOI 10.1143/JJAP.13.1578; Sasaki K, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.035502; TIPPINS HH, 1965, PHYS REV, V140, pA316, DOI 10.1103/PhysRev.140.A316; Varley JB, 2015, SEMICOND SCI TECH, V30, DOI 10.1088/0268-1242/30/2/024010; Villora E. G., 2006, APPL PHYS LETT, V88	27	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							112601	10.7567/JJAP.54.112601		5	Physics, Applied	Physics	CV5CC	WOS:000364283000016		
J	Ota, M; Yamanoi, K; Kasai, S; Mitani, S; Manago, T				Ota, Masaki; Yamanoi, Kazuto; Kasai, Shinya; Mitani, Seiji; Manago, Takashi			Saturation of attenuation length of spin waves in thick permalloy films	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article								The permalloy (Py) thickness dependence of the magnetostatic spin wave (MSSW) propagation was investigated. Large-group velocity is realized for thick Py films and the MSSW can propagate more than 150 mu m. However, attenuation length hardly changes for samples with a Py thickness of more than 100 nm, despite the increasing group velocity with increasing thickness. The eddy current effect decreases the wave channel thickness and it could cause the damping enhancement due to intralayer spin pumping in thick Py films. (C) 2015 The Japan Society of Applied Physics	[Ota, Masaki; Manago, Takashi] Fukuoka Univ, Dept Appl Phys, Fukuoka 8140180, Japan; [Yamanoi, Kazuto] Kyushu Univ, Dept Phys, Fukuoka 8128581, Japan; [Kasai, Shinya; Mitani, Seiji] NIMS, Tsukuba, Ibaraki 3050047, Japan	Ota, M (reprint author), Fukuoka Univ, Dept Appl Phys, Fukuoka 8140180, Japan.	manago@fukuoka-u.ac.jp			JSPS KAKENHI Grant [24560034, 15K06000]; Central Research Institute of Fukuoka University [127005, 145006]	This work was partly supported by JSPS KAKENHI Grant Numbers 24560034 and 15K06000. This work was partly supported by funds (Nos. 127005 and 145006) from the Central Research Institute of Fukuoka University.	PINCUS P, 1960, PHYS REV, V118, P658, DOI 10.1103/PhysRev.118.658; Maksymov IS, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/49/495001; Sato N, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.063001; Bailleul M, 2001, EUROPHYS LETT, V56, P741, DOI 10.1209/epl/i2001-00583-2; Mukherjee SS, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.224408; Kajiwara Y, 2010, NATURE, V464, P262, DOI 10.1038/nature08876; Kruglyak VV, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/26/264001; Zhang SF, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.086601; KITTEL C, 1950, PHYS REV, V77, P725, DOI 10.1103/PhysRev.77.725.2; Tamaru S, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.104416; Vlaminck V, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.014425; Almeida NS, 1996, PHYS REV B, V53, P12232, DOI 10.1103/PhysRevB.53.12232; Lenk B, 2011, PHYS REP, V507, P107, DOI 10.1016/j.physrep.2011.06.003; Nembach HT, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.117201; Schneider T, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2834714; Kennewell KJ, 2010, J APPL PHYS, V108, DOI 10.1063/1.3488618; Manago T, 2015, J APPL PHYS, V117, DOI 10.1063/1.4914538; Tserkovnyak Y, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.094415; Yamanoi K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.083001	19	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							113001	10.7567/JJAP.54.113001		5	Physics, Applied	Physics	CV5CC	WOS:000364283000018		
J	Park, SJ; Uchida, N; Arimoto, H; Tada, T				Park, Sung Jin; Uchida, Noriyuki; Arimoto, Hiroshi; Tada, Tetsuya			Effects of hydrogenation on electronic properties of P dopant near a Si surface	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ENERGY-LOSS SPECTROSCOPY; TERMINATED SI(100) SURFACES; SINGLE-CRYSTAL SILICON; ATOMIC-HYDROGEN; INFRARED-SPECTROSCOPY; VIBRATIONAL-SPECTRA; INITIAL OXIDATION; SI(111) SURFACES; ACCEPTOR LEVELS; NEUTRALIZATION	We have studied the electronic states of shallow P-doped n-type Si(100) with hydrofluoric acid (HF) treatment using high-resolution electron energy loss spectroscopy (HREELS). Upon HF treatment, HREELS measurements confirmed the formation of hydride on the Si surface. The surface plasmon energy was measured as an indicator of the change in carrier density near the surface region (less than or similar to 12 nm). We observed a blueshift of the plasmon peak after annealing at 300 degrees C, indicating the reactivation of the P dopant atoms neutralized by hydrogen near the Si surface. Further annealing at 600 degrees C removed hydrogen from the Si surface, resulting in surface states due to dangling bonds. The electron transfer towards the surface states induces the reduction in electron density, forming a depletion layer, and band bending. The activation efficiency of the P dopant near the surface was estimated to be 55-59% on the basis of the relationship between surface plasmon energy and carrier density. (C) 2015 The Japan Society of Applied Physics	[Park, Sung Jin; Uchida, Noriyuki; Tada, Tetsuya] Natl Inst Adv Ind Sci & Technol, Nanoelect Res Inst, Tsukuba, Ibaraki 3058562, Japan; [Arimoto, Hiroshi] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan	Park, SJ (reprint author), Natl Inst Adv Ind Sci & Technol, Nanoelect Res Inst, Tsukuba, Ibaraki 3058562, Japan.	s.j.park@bham.ac.uk					HIRASHITA N, 1990, APPL PHYS LETT, V56, P451, DOI 10.1063/1.102762; MIKKELSEN JC, 1985, APPL PHYS LETT, V46, P882, DOI 10.1063/1.95874; BERGMAN K, 1988, PHYS REV B, V37, P2770, DOI 10.1103/PhysRevB.37.2770; JOHNSON NM, 1985, PHYS REV B, V31, P5525, DOI 10.1103/PhysRevB.31.5525; GRAF D, 1990, J APPL PHYS, V68, P5155; SAKURAI T, 1976, PHYS REV B, V14, P1593, DOI 10.1103/PhysRevB.14.1593; Veal TD, 2001, PHYS REV B, V64; IKEDA H, 1995, J APPL PHYS, V77, P5125, DOI 10.1063/1.359323; HUANG LJ, 1992, APPL PHYS LETT, V60, P1108, DOI 10.1063/1.106459; PALMER RE, 1992, REV MOD PHYS, V64, P383, DOI 10.1103/RevModPhys.64.383; VANDERVORST W, 1992, J VAC SCI TECHNOL B, V10, P449, DOI 10.1116/1.586373; EGDELL RG, 1992, SURF SCI, V262, P444, DOI 10.1016/0039-6028(92)90140-2; SCHAEFER JA, 1984, SURF SCI, V140, P207, DOI 10.1016/0039-6028(84)90392-3; YU N, 1993, APPL PHYS LETT, V63, P1125, DOI 10.1063/1.109801; NIWANO M, 1994, J APPL PHYS, V76, P2157, DOI 10.1063/1.357627; Weinelt M, 2005, APPL PHYS A-MATER, V80, P995, DOI 10.1007/s00339-004-3127-7; LUCOVSKY G, 1979, PHYS REV B, V19, P2064, DOI 10.1103/PhysRevB.19.2064; STUCKI F, 1983, SOLID STATE COMMUN, V47, P795, DOI 10.1016/0038-1098(83)90069-8; CHABAL YJ, 1985, PHYS REV LETT, V54, P1055, DOI 10.1103/PhysRevLett.54.1055; Ogawa S, 2005, JPN J APPL PHYS 2, V44, pL1048, DOI 10.1143/JJAP.44.L1048; Park SJ, 2008, SURF SCI, V602, P1492, DOI 10.1016/j.susc.2008.02.012; CHENG CC, 1991, PHYS REV B, V43, P4041, DOI 10.1103/PhysRevB.43.4041; Eggeling J, 1999, J PHYS CHEM B, V103, P9683, DOI 10.1021/jp992217p; PANKOVE JI, 1984, APPL PHYS LETT, V45, P1100, DOI 10.1063/1.95030; JONES TS, 1995, PHYS REV B, V51, P17675, DOI 10.1103/PhysRevB.51.17675; SCHAEFER JA, 1984, J VAC SCI TECHNOL B, V2, P359, DOI 10.1116/1.582824; BURROWS VA, 1988, APPL PHYS LETT, V53, P998, DOI 10.1063/1.100053; MORITA M, 1990, J APPL PHYS, V68, P1272, DOI 10.1063/1.347181; Tautz FS, 1998, J APPL PHYS, V84, P6636, DOI 10.1063/1.369038; THEWALT MLW, 1985, APPL PHYS LETT, V46, P689, DOI 10.1063/1.95531; Ikeda H, 1996, APPL SURF SCI, V104, P354, DOI 10.1016/S0169-4332(96)00170-5; Bell GR, 1997, PHYS REV B, V56, P15995, DOI 10.1103/PhysRevB.56.15995; NARAYANAN EMS, 1988, J APPL PHYS, V63, P2867, DOI 10.1063/1.340943; Angot T, 1996, SURF SCI, V352, P401, DOI 10.1016/0039-6028(95)01169-2; OSHIMA M, 1991, JPN J APPL PHYS 1, V30, P116, DOI 10.1143/JJAP.30.116; HOWARTH LE, 1963, J APPL PHYS, V34, P236, DOI 10.1063/1.1729078; Miyata N, 1997, APPL SURF SCI, V117, P26, DOI 10.1016/S0169-4332(97)80046-3; JONES TS, 1990, J ELECTRON SPECTROSC, V54, P1163, DOI 10.1016/0368-2048(90)80306-U; Piper LFJ, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.195321; CAPIZZI M, 1987, PHYSICA B & C, V146, P19, DOI 10.1016/0378-4363(87)90048-9; Clarysse T, 2004, MAT SCI ENG R, V47, P123, DOI [10.1016/j.mser.2004.12.002, 10.1016/j.mser.2004.012.002]; ESTREICHER SK, 1989, PHYS REV B, V39, P13241, DOI 10.1103/PhysRevB.39.13241; Fisher D. J., 1998, DIFFUSION SILICON 10; Ibach H., 1982, ELECT ENERGY LOSS SP; JOHNSON NM, 1986, PHYS REV LETT, V56, P769, DOI 10.1103/PhysRevLett.56.769; Kittel C., 1991, INTRO SOLID STATE PH; PANKOVE JI, 1983, PHYS REV LETT, V51, P2224, DOI 10.1103/PhysRevLett.51.2224; Seager C. H., 1987, Journal of Materials Research, V2, DOI 10.1557/JMR.1987.0096; Tavendale A. J., 1987, MRS P, V104, P285, DOI 10.1557/PROC-104-285	49	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							111302	10.7567/JJAP.54.111302		6	Physics, Applied	Physics	CV5CC	WOS:000364283000005		
J	Sato, M; Widianto, MYH; Kanatsu, Y				Sato, Masahide; Widianto, Muhammad Yusuf Hakim; Kanatsu, Youhei			Dependence of crystallization of Brownian particles by sedimentation on the force direction	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							HARD-SPHERE CRYSTALS; COLLOIDAL CRYSTALLIZATION; SIMULATIONS; LIQUIDS; GRAVITY	The formation of a large close-packed colloidal crystal with the fcc structure was observed during the sedimentation of colloidal particles in an inverted pyramidal pit [S. Matsuo et al., Appl. Phys. Lett. 82, 4285 (2003)]. Carrying out Brownian dynamics simulations, we confirmed that large grains with the fcc structure are formed when the apex angle of the inverted pyramidal container is suitable and the force direction is parallel to the the center axis [Y. Kanatsu and M. Sato, J. Phys. Soc. Jpn. 84, 044601 (2015)]. To form a high-quality colloidal crystal without defects, it is important to investigate in detail how the quality of a colloidal crystal is affected by the force direction and container shape. In this paper, we focus on the effect of the force direction on crystal quality and investigate how the ratio of the number of the hcp structured particles, N-hcp, to that of fcc structured particles, N-fcc, is affected by the force direction. In our simulation, the ratio of N-fcc to N-hcp is hardly changed when the force direction deviates from the central axis: N-fcc is much larger than N-hcp irrespective of the force direction. Thus, our results show that the crystal structure is insensitive to the force direction in forming a colloidal crystal by sedimentation in an inverted pyramidal container. (C) 2015 The Japan Society of Applied Physics	[Sato, Masahide] Kanazawa Univ, Informat Media Ctr, Kanazawa, Ishikawa 9201192, Japan; [Widianto, Muhammad Yusuf Hakim; Kanatsu, Youhei] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Widianto, Muhammad Yusuf Hakim] Inst Technol Bandung, Phys Earth & Complex Syst, Bandung 40132, Indonesia	Sato, M (reprint author), Kanazawa Univ, Informat Media Ctr, Kanazawa, Ishikawa 9201192, Japan.	sato@cs.s.kanazawa-u.ac.jp	Sato, Masahide/I-4275-2013	Sato, Masahide/0000-0001-8298-9016	JSPS KAKENHI [26103515, 26390054]	This work was supported by JSPS KAKENHI Grants Numbers 26103515 and 26390054. M.S. benefited from the Joint Research Program of the Institute of Low Temperature Science, Hokkaido University.	TENWOLDE PR, 1995, PHYS REV LETT, V75, P2714, DOI 10.1103/PhysRevLett.75.2714; Suzuki Y, 2014, J CRYST GROWTH, V401, P905, DOI 10.1016/j.jcrysgro.2013.11.101; Suzuki Y, 2013, J CRYST GROWTH, V383, P67, DOI 10.1016/j.jcrysgro.2013.08.026; Matsuo S, 2003, APPL PHYS LETT, V82, P4283, DOI 10.1063/1.1583138; Desgranges C, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.054201; Suzuki Y, 2011, J CRYST GROWTH, V322, P109, DOI 10.1016/j.jcrysgro.2011.03.027; Sato M, 2014, J CRYST GROWTH, V401, P87, DOI 10.1016/j.jcrysgro.2014.01.074; Lechner W, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2977970; Marechal M, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3609103; STEINHARDT PJ, 1983, PHYS REV B, V28, P784, DOI 10.1103/PhysRevB.28.784; PUSEY PN, 1989, PHYS REV LETT, V63, P2753, DOI 10.1103/PhysRevLett.63.2753; Blanco A, 2000, NATURE, V405, P437; Yin Y, 2003, LANGMUIR, V19, P622, DOI 10.1021/la026596g; Panaitescu A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.108001; Mori A, 2014, PHYSICA B, V452, P58, DOI 10.1016/j.physb.2014.07.012; Zhu JX, 1997, NATURE, V387, P883; ERMAK DL, 1975, J CHEM PHYS, V62, P4189, DOI 10.1063/1.430300; WEEKS JD, 1971, J CHEM PHYS, V54, P5237, DOI 10.1063/1.1674820; Woodcock LV, 1997, NATURE, V385, P141, DOI 10.1038/385141a0; Kanatsu Y, 2015, J PHYS SOC JPN, V84, DOI 10.7566/JPSJ.84.044601; Blaaderen AV, 1997, NATURE, V385, P321; Fujine M, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.032404; Fujine M, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.042401; Hashimoto K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.030201; Mori A., 2012, WORLD J ENG, V9, P37; Mori A, 2009, PROG THEOR PHYS SUPP, P33, DOI 10.1143/PTPS.178.33; Rintoul MD, 1996, J CHEM PHYS, V105, P9258, DOI 10.1063/1.473004; Sato M, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.032403; Sato M, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.084804	29	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							115503	10.7567/JJAP.54.115503		4	Physics, Applied	Physics	CV5CC	WOS:000364283000024		
J	Tajima, M; Tanaka, K; Dubois, S; Veirman, J; Nakagawa, K; Ogura, A				Tajima, Michio; Tanaka, Koji; Dubois, Sebastien; Veirman, Jordi; Nakagawa, Kei; Ogura, Atsushi			Photoluminescence due to impurity-cluster-bound exciton in highly doped and highly compensated Si	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							PHOTO-LUMINESCENCE; SILICON; PHOSPHORUS; COMPLEXES; SEMICONDUCTORS; ACCEPTORS; SPECTRA; DONORS; BORON; MODEL	We have investigated photoluminescence (PL) at 4.2 K in highly doped and highly compensated Si with donor and acceptor impurities in the intermediate concentration range from 1 x 10(16) to 3 x 10(18)cm(-3). PL spectra were dominated by the radiative recombination of excitons bound by impurity clusters and the donor-acceptor pair emission. The peak position of the exciton emission shifts to the lower energy side monotonically with an increase in the sum of the donor and acceptor concentrations, where the relationship between the position and the concentration is universal regardless of the species of impurities and is valid also for uncompensated Si. This allowed us to suggest that the cluster consists of multiple species of donor and acceptor impurities and that the difference in the species does not cause a detectable variation in the binding energy of an exciton. A possible method for quantifying the donor and acceptor impurities is proposed. (C) 2015 The Japan Society of Applied Physics	[Tajima, Michio; Tanaka, Koji; Nakagawa, Kei; Ogura, Atsushi] Meiji Univ, Kawasaki, Kanagawa 2148571, Japan; [Tajima, Michio; Tanaka, Koji; Nakagawa, Kei] JAXA, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2525210, Japan; [Dubois, Sebastien; Veirman, Jordi] INES, CEA LITEN DTS, F-73375 Le Bourget Du Lac, France	Tajima, M (reprint author), Meiji Univ, Kawasaki, Kanagawa 2148571, Japan.	tajima@meiji.ac.jp			New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry of Japan	The authors would like to thank D. Macdonald of ANU, M. Forster and R. Einhaus of Apollon Solar, S. Binetti of UNIMIB, K. Lauer of CiS, T. Bartel and F. Kirscht of CaliSolar, M. Schubert of Fraunhofer ISE, and K. Kashima and S. Nakagawa of GlobalWafers for supplying some of the samples and for helpful discussion. They also wish to acknowledge two undisclosed Japanese companies for also supplying some of the samples. This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry of Japan.	PARSONS RR, 1979, SOLID STATE COMMUN, V29, P763, DOI 10.1016/0038-1098(79)90156-X; DEAN PJ, 1967, PHYS REV, V161, P711, DOI 10.1103/PhysRev.161.711; VOUK MA, 1977, J LUMIN, V15, P357, DOI 10.1016/0022-2313(77)90036-9; Veirman J, 2011, J APPL PHYS, V109, DOI 10.1063/1.3585800; KOSAI K, 1974, PHYS REV B, V9, P723, DOI 10.1103/PhysRevB.9.723; TAJIMA M, 1978, APPL PHYS LETT, V32, P719, DOI 10.1063/1.89897; Pizzini S, 2010, SOL ENERG MAT SOL C, V94, P1528, DOI 10.1016/j.solmat.2010.01.016; ZIEMELIS UO, 1981, CAN J PHYS, V59, P784; NISHINO T, 1977, J PHYS SOC JPN, V43, P1807, DOI 10.1143/JPSJ.43.1807; JELLISON GE, 1982, J APPL PHYS, V53, P3745, DOI 10.1063/1.331113; Altermatt PP, 2006, J APPL PHYS, V100, DOI 10.1063/1.2386935; Altermatt PP, 2006, J APPL PHYS, V100, DOI 10.1063/1.2386934; [Anonymous], 2004, MF13890704 SEMI; LEVY M, 1994, PHYS REV B, V49, P1677, DOI 10.1103/PhysRevB.49.1677; ENCK RC, 1969, PHYS REV, V177, P1182, DOI 10.1103/PhysRev.177.1182; del Coso G, 2010, SOL ENERG MAT SOL C, V94, P345, DOI 10.1016/j.solmat.2009.10.011; PARSONS RR, 1979, SOLID STATE COMMUN, V29, P1, DOI 10.1016/0038-1098(79)90137-6; [Anonymous], 1996, H0615 JIS; NARITA K, 1979, SOLID STATE COMMUN, V29, P299, DOI 10.1016/0038-1098(79)91061-5; Tajima M, 2011, J APPL PHYS, V110, DOI 10.1063/1.3622560; RIKLUND R, 1982, PHYS REV B, V26, P2168, DOI 10.1103/PhysRevB.26.2168; Tajima M, 2013, J APPL PHYS, V113, DOI 10.1063/1.4812288; HOLCOMB DF, 1969, PHYS REV, V183, P773, DOI 10.1103/PhysRev.183.773; THEWALT MLW, 1977, CAN J PHYS, V55, P1463; THOMAS GA, 1981, PHYS REV B, V23, P5472, DOI 10.1103/PhysRevB.23.5472; SAUER R, 1974, SOLID STATE COMMUN, V14, P481, DOI 10.1016/0038-1098(74)90972-7; SHIRAKI Y, 1979, SOLID STATE COMMUN, V29, P295, DOI 10.1016/0038-1098(79)91060-3; Iwai T, 2011, PHYS STATUS SOLIDI C, V8, DOI 10.1002/pssc.201000273; MOTT N, 1982, P ROY SOC LOND A MAT, V382, P1, DOI 10.1098/rspa.1982.0086; PEARSON GL, 1949, PHYS REV, V75, P865, DOI 10.1103/PhysRev.75.865; Thewalt M. L. W., 1982, MODERN PROBLEMS COND, V2, P393	31	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							111304	10.7567/JJAP.54.111304		5	Physics, Applied	Physics	CV5CC	WOS:000364283000007		
J	Tajima, S; Asahi, R; Isheim, D; Seidman, DN; Itoh, T; Ohishi, KI				Tajima, Shin; Asahi, Ryoji; Isheim, Dieter; Seidman, David N.; Itoh, Tadayoshi; Ohishi, Kei-ichiro			Sodium distribution in solar-grade Cu2ZnSnS4 layers using atom-probe tomographic technique	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							THIN-FILMS; CELLS	To investigate the effect of alkali doping on Cu2ZnSnS4 (CZTS) photovoltaic cells, we studied compositional distributions in CZTS layers using three-dimensional atom-probe tomography. The segregation of Na at a concentration of approximately 1 at.% was observed predominantly at CZTS grain boundaries. The concentration of Na in the interior of the CZTS grains was below the detection limit ( approximately 40 ppm). Na ions may exist as sulfide compounds at CZTS grain boundaries, independent of the presence of oxygen. (C) 2015 The Japan Society of Applied Physics	[Tajima, Shin; Asahi, Ryoji; Itoh, Tadayoshi; Ohishi, Kei-ichiro] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan; [Isheim, Dieter; Seidman, David N.] Northwestern Univ, Evanston, IL 60208 USA	Tajima, S (reprint author), Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan.	e0954@mosk.tytlabs.co.jp					Altamura G., 2013, MRS ONLINE P LIB, V1538, P103; Hellman OC, 2000, MICROSC MICROANAL, V6, P437, DOI 10.1007/s100050010051; Reinhard P, 2013, IEEE J PHOTOVOLT, V3, P572, DOI 10.1109/JPHOTOV.2012.2226869; Repins I, 2012, SOL ENERG MAT SOL C, V101, P154, DOI 10.1016/j.solmat.2012.01.008; Prabhakar T, 2011, SOL ENERG MAT SOL C, V95, P1001, DOI 10.1016/j.solmat.2010.12.012; Sutter-Fella CM, 2014, CHEM MATER, V26, P1420, DOI 10.1021/cm403504u; Johnson M, 2014, ENERG ENVIRON SCI, V7, P1931, DOI 10.1039/c3ee44130j; Schwarz T, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4788815; Cadel E, 2010, ACTA MATER, V58, P2634, DOI 10.1016/j.actamat.2009.12.049; Shin B, 2013, PROG PHOTOVOLTAICS, V21, P72, DOI 10.1002/pip.1174; Tajima S, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4894858; Katagiri H, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.041201; Sardashti K, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201402180; Umehara M, 2015, SOL ENERG MAT SOL C, V134, P1, DOI 10.1016/j.solmat.2014.11.024; Li JV, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4802972; Cojocaru-Miredin O., 2013, JOVE-J VIS EXP, V74, DOI DOI 10.3791/50376; Couzinie-Devy F, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3665948; Fukano T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.062301; Gault B., 2012, SPRINGER SERIES MAT, V160; Gershon T, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201400849; Hiroi Homare, 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy; Ishizuka S, 2009, J APPL PHYS, V106, DOI 10.1063/1.3190528; Nagaoka A, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4871208; ITO K, 1988, JPN J APPL PHYS 1, V27, P2094, DOI 10.1143/JJAP.27.2094; Tajima S, 2015, APPL PHYS EXPRESS, V8, DOI 10.7567/APEX.8.082302	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							112302	10.7567/JJAP.54.112302		5	Physics, Applied	Physics	CV5CC	WOS:000364283000013		
J	Takahashi, N; Kawai, T; Yanase, T; Shimada, T; Nagahama, T				Takahashi, Nozomi; Kawai, Tomohiro; Yanase, Takashi; Shimada, Toshihiro; Nagahama, Taro			Investigation of epitaxial growth and tunnel magnetoresistance effects in magnetic tunnel junctions including spinel ferrite layers	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ROOM-TEMPERATURE; FILMS	The combination of magnetic tunnel junctions (MTJs) and magnetic insulating (MI) layers has attracted much attention because of its potential as novel spintronic devices. To realize such devices, the epitaxial growth and magnetoresistance of MTJs with spinel ferrite were investigated. Nonmagnetic (NM) layers were inserted between the MTJs and MI layers as magnetic decoupling layers, the epitaxial growth of which was important to obtain high-quality epitaxial multilayers. Multilayers of MTJ/NM/MI and MI/NM/MTJ were fabricated and tunnel magnetoresistance (TMR) values of 70 and 50% at room temperature, respectively, were observed. The shape of the magnetoresistance curve depended on the sample structure. (C) 2015 The Japan Society of Applied Physics	[Takahashi, Nozomi; Kawai, Tomohiro] Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido 0608682, Japan; [Yanase, Takashi; Shimada, Toshihiro; Nagahama, Taro] Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 0608628, Japan	Takahashi, N (reprint author), Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido 0608682, Japan.						Margulies DT, 1997, PHYS REV LETT, V79, P5162, DOI 10.1103/PhysRevLett.79.5162; Parkin SSP, 2004, NAT MATER, V3, P862, DOI 10.1038/nmat1256; Xie S, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3006060; LEIBBRANDT GWR, 1993, PHYS REV B, V47, P6630, DOI 10.1103/PhysRevB.47.6630; Uchida K, 2008, NATURE, V455, P778, DOI 10.1038/nature07321; Slonczewski JC, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.054403; Moodera JS, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/16/165202; Bass J, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/18/183201; SIMMONS JG, 1963, J APPL PHYS, V34, P1793, DOI 10.1063/1.1702682; Matsuzaki K, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.073009; Rigato F, 2009, J APPL PHYS, V106, DOI 10.1063/1.3267873; Mizuguchi M, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2213953; Kubota H, 2002, JPN J APPL PHYS 2, V41, pL180, DOI 10.1143/JJAP.41.L180; Serga AA, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/26/264002; Takahashi YK, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3318297; Suzuki Y, 1999, J MAGN MAGN MATER, V191, P1, DOI 10.1016/S0304-8853(98)00364-3; Nagahama T, 2011, THIN SOLID FILMS, V519, P8239, DOI 10.1016/j.tsf.2011.03.104; Nagahama T, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4894575; Yanagihara H, 2011, J APPL PHYS, V109, DOI 10.1063/1.3566079; Yanagihara H, 2014, J APPL PHYS, V115, DOI 10.1063/1.4864048; Yuasa S, 2004, NAT MATER, V3, P868, DOI 10.1038/nmat1257	21	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							118003	10.7567/JJAP.54.118003		3	Physics, Applied	Physics	CV5CC	WOS:000364283000033		
J	Takeuchi, N; Ando, M; Yasuoka, K				Takeuchi, Nozomi; Ando, Mizuki; Yasuoka, Koichi			Investigation of the loss mechanisms of hydroxyl radicals in the decomposition of organic compounds using plasma generated over water	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ADVANCED OXIDATION PROCESSES; NONTHERMAL PLASMA; ELECTRICAL-DISCHARGE; HYDROGEN-PEROXIDE; DEGRADATION; MINERALIZATION; PURIFICATION; COLLISIONS; REACTOR; PHENOL	Many types of plasma processes have been investigated as potential agents for decomposing persistent organic compounds in water using hydroxyl radicals (center dot OH), and a wide range of energy efficiency in the reduction of total organic carbon (TOC) has been observed. In this study, loss mechanisms of center dot OH that limit the energy efficiency were investigated using a plasma generated over an acetic acid solution. Various experiments, including the analysis of the decomposition process, a parametric study, and a numerical simulation, revealed that there are two main loss mechanisms: (i) a self-quenching reaction that generates hydrogen peroxide (H2O2) and (ii) a reaction of center dot OH with H2O2 and hydroperoxyl radicals (HO2 center dot). In the solution, center dot OH reacts with these scavengers rather than target compounds. A pulsed plasma with a low current density, low repetition rate, and short pulse duration can be utilized to achieve high efficiency. (C) 2015 The Japan Society of Applied Physics	[Takeuchi, Nozomi; Ando, Mizuki; Yasuoka, Koichi] Tokyo Inst Technol, Meguro Ku, Tokyo 1528552, Japan	Takeuchi, N (reprint author), Tokyo Inst Technol, Meguro Ku, Tokyo 1528552, Japan.	takeuchi@ee.titech.ac.jp			JSPS KAKENHI Grant [15H05516]	This work was partially supported by JSPS KAKENHI Grant Number 15H05516.	NOVICKI S, 1988, J CHEM PHYS, V89, P7031, DOI 10.1063/1.455330; Lamsal R, 2011, WATER RES, V45, P3263, DOI 10.1016/j.watres.2011.03.038; Kusic H, 2005, J HAZARD MATER, V125, P190, DOI 10.1016/j.jhazmat.2005.05.028; JOSHI AA, 1995, J HAZARD MATER, V41, P3, DOI 10.1016/0304-3894(94)00099-3; Kaneko T, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/12/124011; Njoyim-Tamungang E, 2011, CHEM ENG J, V173, P303, DOI 10.1016/j.cej.2011.07.021; Tochikubo F, 2004, JPN J APPL PHYS 1, V43, P315, DOI 10.1143/JJAP.43.315; Matsui Y, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/3/034015; Kanazawa S, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/3/034010; VENKATADRI R, 1993, HAZARD WASTE HAZARD, V10, P107, DOI 10.1089/hwm.1993.10.107; Katayama H, 2009, IEEE T PLASMA SCI, V37, P897, DOI 10.1109/TPS.2009.2017124; Sannino D, 2011, CATAL TODAY, V161, P255, DOI 10.1016/j.cattod.2010.11.025; Tochikubo F, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.126201; Malik MA, 2001, PLASMA SOURCES SCI T, V10, P82, DOI 10.1088/0963-0252/10/1/311; Tian W, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/16/165201; YAMABE C, 1983, PHYS REV A, V27, P1345, DOI 10.1103/PhysRevA.27.1345; Hamaguchi S, 2013, AIP CONF PROC, V1545, P214, DOI 10.1063/1.4815857; Shimizu T, 2011, J PHOTOPOLYM SCI TEC, V24, P421, DOI 10.2494/photopolymer.24.421; Jardim WF, 1997, WATER RES, V31, P1728, DOI 10.1016/S0043-1354(96)00349-1; Oturan MA, 2008, ELECTROCHIM ACTA, V54, P173, DOI 10.1016/j.electacta.2008.08.012; Leitner NKV, 1996, J PHOTOCH PHOTOBIO A, V99, P137; Polyakov OV, 2003, HIGH ENERG CHEM+, V37, P322, DOI 10.1023/A:1025757014331; Takeuchi N, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/1/015006; Andreozzi R, 1999, CATAL TODAY, V53, P51, DOI 10.1016/S0920-5861(99)00102-9; Yang HM, 2011, J ENVIRON SCI-CHINA, V23, P1044, DOI 10.1016/S1001-0742(10)60512-8; Locke BR, 2006, IND ENG CHEM RES, V45, P882, DOI 10.1021/ie050981u; Magureanu M, 2011, WATER RES, V45, P3407, DOI 10.1016/j.watres.2011.03.057; Hagelaar GJM, 2005, PLASMA SOURCES SCI T, V14, P722, DOI 10.1088/0963-0252/14/4/011; Lukes P, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/1/015019; An GJ, 2011, CHEMOSPHERE, V84, P1296, DOI 10.1016/j.chemosphere.2011.05.007; Bruggeman P., 2009, PLASMA SOURCES SCI T, V18; Chirokov A., 2003, THESIS DREXEL U; Iijima T., 2005, P WORLD OZ C, VIV.2.7; Ishigame H, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.01AF02; LYMBEROPOULOS DP, 1995, J RES NATL INST STAN, V100, P473, DOI 10.6028/jres.100.036; Magee J. L., 1987, RAD CHEM PRINCIPLES, P137; Nishiyama H, 2015, PLASMA CHEM PLASMA P, V35, P339, DOI 10.1007/s11090-014-9607-4; PANDIS SN, 1989, J GEOPHYS RES-ATMOS, V94, P1105, DOI 10.1029/JD094iD01p01105; Shibata T, 2014, PLASMA CHEM PLASMA P, V34, P1331, DOI 10.1007/s11090-014-9575-8; Shirafuji T, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.01AC03; Shirafuji T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.010211; Takeuchi N., 2015, INT J PLASMA ENV SCI, V9, P2; Yamatake A., 2007, INT J PLASMA ENV SCI, V1, P91; Yasuoka K., 2009, INT J PLASMA ENV SCI, V3, P22	44	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							116201	10.7567/JJAP.54.116201		8	Physics, Applied	Physics	CV5CC	WOS:000364283000025		
J	Takiguchi, Y; Miyajima, S				Takiguchi, Yuki; Miyajima, Shinsuke			Device simulation of cuprous oxide heterojunction solar cells	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							THERMAL-OXIDATION; CU2O FILMS; TEMPERATURE; DEPOSITION; DEFECTS; SPECTRA; ELECTRODEPOSITION; SPECTROSCOPY; RESONANCE; EXCITONS	We developed a device simulation model of cuprous oxide (Cu2O)-based heterojunction solar cells. The developed model well reproduces the reported experimental current density-voltage characteristics and the external quantum efficiency results. By using the model, we explored structures for high-efficiency Cu2O-based heterojunction solar cells. It was found that the electron affinity of the buffer layer between transparent conducting oxide and Cu2O significantly affects solar cell performance. Surface recombination on the rear side of the device can be suppressed by employing a highly doped back surface layer. Our device simulation demonstrates a conversion efficiency of 16% without any optical confinement structure. (C) 2015 The Japan Society of Applied Physics	[Takiguchi, Yuki; Miyajima, Shinsuke] Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528550, Japan	Takiguchi, Y (reprint author), Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528550, Japan.	takiguchi.y.ab@m.titech.ac.jp			JSPS KAKENHI [15K14299]	This work was supported by JSPS KAKENHI Grant Number 15K14299. The authors are grateful to Professor Rockett (University of Illinois), Dr. Liu (Nankai University), and Professor Fonash (The Pennsylvania State University) who developed wxAMPS.	KIM SO, 1994, J VAC SCI TECHNOL B, V12, P3006, DOI 10.1116/1.587550; Minami T, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.062301; Duan ZQ, 2012, SOL ENERG MAT SOL C, V96, P292, DOI 10.1016/j.solmat.2011.09.047; RAKHSHANI AE, 1986, SOLID STATE ELECTRON, V29, P7, DOI 10.1016/0038-1101(86)90191-7; PORAT O, 1995, SOLID STATE IONICS, V81, P29, DOI 10.1016/0167-2738(95)00169-7; Malerba C, 2011, SOL ENERG MAT SOL C, V95, P2848, DOI 10.1016/j.solmat.2011.05.047; Ito T, 1997, J PHYS SOC JPN, V66, P2185, DOI 10.1143/JPSJ.66.2185; Izaki M, 2007, J PHYS D APPL PHYS, V40, P3326, DOI 10.1088/0022-3727/40/11/010; Miyajima S, 2006, JPN J APPL PHYS 2, V45, pL432, DOI 10.1143/JJAP.45.L432; SEARS WM, 1983, THIN SOLID FILMS, V103, P303, DOI 10.1016/0040-6090(83)90447-9; OLSEN LC, 1982, SOL CELLS, V7, P247, DOI 10.1016/0379-6787(82)90050-3; ITOH T, 1975, J PHYS SOC JPN, V39, P140, DOI 10.1143/JPSJ.39.140; Minemoto T, 2013, CURR APPL PHYS, V13, P103, DOI 10.1016/j.cap.2012.06.019; Lai BCM, 1999, J ELECTROCHEM SOC, V146, P266, DOI 10.1149/1.1391597; Cui JB, 2010, J PHYS CHEM C, V114, P6408, DOI 10.1021/jp1004314; MARTIN G, 1994, APPL PHYS LETT, V65, P610, DOI 10.1063/1.112247; HODBY JW, 1976, J PHYS C SOLID STATE, V9, P1429, DOI 10.1088/0022-3719/9/8/014; Mittiga A, 2009, THIN SOLID FILMS, V517, P2469, DOI 10.1016/j.tsf.2008.11.054; SCHICK JD, 1972, J ELECTROCHEM SOC, V119, P376, DOI 10.1149/1.2404206; Liu YM, 2012, SOL ENERG MAT SOL C, V98, P124, DOI 10.1016/j.solmat.2011.10.010; GOLTZENE A, 1976, SOLID STATE COMMUN, V18, P1565, DOI 10.1016/0038-1098(76)90394-X; KAGA T, 1991, IEEE T ELECTRON DEV, V38, P255, DOI 10.1109/16.69903; OLSEN LC, 1979, APPL PHYS LETT, V34, P47, DOI 10.1063/1.90593; Brunner D, 1997, J APPL PHYS, V82, P5090, DOI 10.1063/1.366309; BRATTAIN WH, 1951, REV MOD PHYS, V23, P203, DOI 10.1103/RevModPhys.23.203; Lee YS, 2013, J MATER CHEM A, V1, P15416, DOI 10.1039/c3ta13208k; Ishizuka S, 2000, JPN J APPL PHYS 2, V39, pL786, DOI 10.1143/JJAP.39.L786; Zeman M, 1997, SOL ENERG MAT SOL C, V46, P81, DOI 10.1016/S0927-0248(96)00094-3; Minami T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.044101; Pereira L, 2008, THIN SOLID FILMS, V516, P1544, DOI 10.1016/j.tsf.2007.03.088; ITOH T, 1975, J PHYS SOC JPN, V39, P132, DOI 10.1143/JPSJ.39.132; Matsumura H, 1996, JPN J APPL PHYS 1, V35, P5631, DOI 10.1143/JJAP.35.5631; HERION J, 1980, SOL ENERG MATER, V4, P101, DOI 10.1016/0165-1633(80)90022-2; Ishizuka SO, 2001, JPN J APPL PHYS 1, V40, P2765, DOI 10.1143/JJAP.40.2765; Miyajima S, 2011, J APPL PHYS, V109, DOI 10.1063/1.3552888; AOYAMA T, 1989, APPL SURF SCI, V41-2, P584, DOI 10.1016/0169-4332(89)90126-8; Brandt RE, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4905180; Brandt R. E., 2013, P 39 IEEE PHOT SPEC, P846; de Jongh PE, 1999, CHEM MATER, V11, P3512, DOI 10.1021/cm991054e; Gloeckler M, 2005, J APPL PHYS, V98, DOI 10.1063/1.2133906; Gloeckler M, 2003, PROCEEDINGS OF 3RD WORLD CONFERENCE ON PHOTOVOLTAIC ENERGY CONVERSION, VOLS A-C, P491; Ishizuka S., 2004, Physica Status Solidi C, DOI 10.1002/pssc.200304245; Jung YS, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.11RA10; Kramm B, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3685719; Li CC, 2014, J MATER SCI-MATER EL, V25, P1404, DOI 10.1007/s10854-014-1742-4; Meillaud F, 2006, SOL ENERG MAT SOL C, V90, P2952, DOI 10.1016/j.solmat.2006.06.002; Minami T, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4902879; Mittiga A., 2006, P 21 EUR PHOT SOL EN, P219; Miyata T, 2006, P SOC PHOTO-OPT INS, V6037, P3712, DOI 10.1117/12.638649; Mizuno K, 2005, J ELECTROCHEM SOC, V152, pC179, DOI 10.1149/1.1862478; Morales-Guio CG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4059; Munoz-Rojas D, 2012, AIP ADV, V2, DOI 10.1063/1.4771681; Musa AO, 1998, SOL ENERG MAT SOL C, V51, P305, DOI 10.1016/S0927-0248(97)00233-X; Negami T., 2000, P 28 IEEE PHOT SPEC, P634; NOGUET C, 1970, J PHYS-PARIS, V31, P393, DOI 10.1051/jphys:01970003104039300; Nonomura S., 1996, J NONCRYST SOLIDS, V198-200, P174, DOI DOI 10.1016/0022-3093(95)00675-3; Paul GK, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2175492; Ping Z., 2014, J SEMICOND, V35; Raebiger H, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.045209	59	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							112303	10.7567/JJAP.54.112303		6	Physics, Applied	Physics	CV5CC	WOS:000364283000014		
J	Tsunoi, Y; Sato, S; Kawauchi, S; Akutsu, Y; Miyagawa, Y; Araki, K; Shiotani, A; Terakawa, M				Tsunoi, Yasuyuki; Sato, Shunichi; Kawauchi, Satoko; Akutsu, Yusuke; Miyagawa, Yoshihiro; Araki, Koji; Shiotani, Akihiro; Terakawa, Mitsuhiro			Theranostic system for drug delivery and pharmacokinetic imaging based on nanosecond pulsed light-induced photomechanical and photoacoustic effects	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							INDUCED STRESS WAVES; LOADED BUBBLE LIPOSOMES; GENE-TRANSFER; ULTRASOUND; TOMOGRAPHY; AGENTS; NANOPARTICLES; SKIN	For efficient and side effects-free pharmacological treatment, we here propose a theranostic system that enables transvascular drug delivery by photomechanical waves (PMWs) and photoacoustic (PA) imaging of the drug distribution; both functions are based on nanosecond laser pulses and can therefore be integrated in one system. Through optical fibers arranged around an ultrasound sensor, low-energy and high-energy nanosecond light pulses were transmitted respectively for PA imaging and PMW-based drug delivery by temporal switching. With the system, we delivered a test drug (Evans blue) to tumors in mice and visualized distributions of both the blood vessels and drug in the tissue in vivo, showing the validity of the system. (C) 2015 The Japan Society of Applied Physics	[Tsunoi, Yasuyuki; Akutsu, Yusuke; Terakawa, Mitsuhiro] Keio Univ, Sch Integrated Design Engn, Yokohama, Kanagawa 2238522, Japan; [Sato, Shunichi; Kawauchi, Satoko] Natl Def Med Coll, Res Inst, Div Biomed Informat Sci, Tokorozawa, Saitama 3598513, Japan; [Miyagawa, Yoshihiro; Araki, Koji; Shiotani, Akihiro] Natl Def Med Coll, Dept Otolaryngol Head & Neck Surg, Tokorozawa, Saitama 3598513, Japan	Tsunoi, Y (reprint author), Keio Univ, Sch Integrated Design Engn, Yokohama, Kanagawa 2238522, Japan.	shunsato@ndmc.ac.jp			Japan Society for the Promotion of Science (JSPS);  [25460665]	The authors sincerely thank Advantest Corporation for the use of the optical parametric oscillator. This work was partially supported by a Grant-in-Aid for Scientific Research (C), No. 25460665. Y. Tsunoi is grateful for a Grant-in-Aid for Research Fellow of the Japan Society for the Promotion of Science (JSPS).	Ando T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051744; Kurita A, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3628313; Doukas AG, 1996, ULTRASOUND MED BIOL, V22, P151, DOI 10.1016/0301-5629(95)02026-8; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; Beard P, 2011, INTERFACE FOCUS, V1, P602, DOI 10.1098/rsfs.2011.0028; Watanabe R, 2015, PROC SPIE, V9305, DOI 10.1117/12.2078505; Nelson JL, 2002, CANCER RES, V62, P7280; Lee S, 1996, ULTRASOUND MED BIOL, V22, P1285, DOI 10.1016/S0301-5629(96)00149-4; Kodama T, 2000, BIOPHYS J, V79, P1821; Ando T, 2013, APPL PHYS A-MATER, V112, P129, DOI 10.1007/s00339-012-7212-z; Bednarski MD, 1997, RADIOLOGY, V204, P263; Sato S, 2011, OPT LETT, V36, P4545, DOI 10.1364/OL.36.004545; Mulholland SE, 1999, PHARMACEUT RES, V16, P514, DOI 10.1023/A:1018814911497; Ogura M, 2004, LASER SURG MED, V34, P242, DOI 10.1002/lsm.20024; Taurin S, 2012, J CONTROL RELEASE, V164, P265, DOI 10.1016/j.jconrel.2012.07.013; Lutzweiler C, 2014, OPT LETT, V39, P4061, DOI 10.1364/OL.39.004061; Wang JQ, 2010, CURR DRUG METAB, V11, P129; Lee S, 1999, PHARMACEUT RES, V16, P1717, DOI 10.1023/A:1018954015441; Yao JJ, 2013, LASER PHOTONICS REV, V7, P758, DOI 10.1002/lpor.201200060; Tsunoi Y, 2013, BURNS, V39, P1403, DOI 10.1016/j.burns.2013.03.007; Tsunoi Y, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.126701; Satoh Y, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2128432; [Anonymous], 2007, Z136 ANSI; Hu S, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3281673; Xiang LZ, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2437752; Aizawa K, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3253325; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Aizawa K, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3028005; Endo-Takahashi Y, 2013, BIOMATERIALS, V34, P2807, DOI 10.1016/j.biomaterials.2012.12.018; Deán-Ben Xosé Luís, 2013, Photoacoustics, V1, P68, DOI 10.1016/j.pacs.2013.10.002; Dobson J, 2006, DRUG DEVELOP RES, V67, P55, DOI 10.1002/ddr.20067; Endo-Takahashi Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep03883; Garcia PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050482; Geers B, 2012, J CONTROL RELEASE, V164, P248, DOI 10.1016/j.jconrel.2012.08.014; Ho CJH, 2014, SCI REP-UK, V4, DOI 10.1038/srep05342; Li CH, 2009, PHYS MED BIOL, V54, pR59, DOI 10.1088/0031-9155/54/19/R01; Sato S, 2014, J CONTROL RELEASE, V192, P228, DOI 10.1016/j.jconrel.2014.07.048; Shimada T, 2014, PROC SPIE, V8941, DOI 10.1117/12.2039227; Tsunoi Y, 2012, PROC SPIE, V8210, DOI 10.1117/12.907644; Yao Junjie, 2014, Photoacoustics, V2, P87, DOI 10.1016/j.pacs.2014.04.002; Yoon YI, 2014, THERANOSTICS, V4, P1133, DOI 10.7150/thno.9945	41	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							116601	10.7567/JJAP.54.116601		6	Physics, Applied	Physics	CV5CC	WOS:000364283000027		
J	Yamauchi, K; Hagio, T; Mitsuo, T; Iwai, K; Itoh, T				Yamauchi, Kazushige; Hagio, Takeshi; Mitsuo, Tomoya; Iwai, Kazuhiko; Itoh, Takashi			Thermoelectric properties of crystal aligned higher manganese silicide fabricated by solidification under magnetic field	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							C-AXIS; UNIDIRECTIONAL SOLIDIFICATION; ALTERNATING-CURRENT; THERMAL-EXPANSION; MN ALLOYS; ALIGNMENT; ORIENTATION; MICROGRAVITY; PERFORMANCE; PHASE	MnSi1.73 is a promising p-type thermoelectric material for use in the intermediate-temperature region owing to its high oxidation resistance. Its thermoelectric properties are highly dependent on crystallographic direction and control of crystal alignment is thus important for polycrystalline MnSi1.73. On the other hand, solidification under magnetic fields has been reported to directly yield crystal aligned structures in various alloys. Here, a 3 T magnetic field was imposed during solidification of MnSi1.73 for the first time. X-ray diffraction analysis indicated that polycrystalline MnSi1.73 with c-axes aligned perpendicularly to the magnetic field was successfully obtained. The Seebeck coefficient slightly decreased while the electrical conductivity increased more than twofold along the magnetic field direction compared with those of the sample solidified without the magnetic field, which reflected the trend of a single crystal. The power factor reached a maximum of 2.09 x 10(-4) W m(-1) K-2 at 771 K; however, this was about one-fifth of that of a single crystal. Improvement in electrical conductivity by prevention of crack formation shall realize high performance expected from the crystal aligned structure. (C) 2015 The Japan Society of Applied Physics	[Yamauchi, Kazushige; Mitsuo, Tomoya; Itoh, Takashi] Nagoya Univ, Dept Mat Phys & Energy Engn, Nagoya, Aichi 4648603, Japan; [Hagio, Takeshi; Iwai, Kazuhiko] Hokkaido Univ, Dept Engn, Div Mat Sci & Engn, Sapporo, Hokkaido 0608628, Japan	Yamauchi, K (reprint author), Suzuki Motor Corp, Hamamatsu, Shizuoka 4328611, Japan.	shige0228@gmail.com; bb_nba-dreamer1@katch.ne.jp					Morikawa H, 1998, MATER T JIM, V39, P814; Minagawa H, 2001, J MAGN MAGN MATER, V234, P437, DOI 10.1016/S0304-8853(01)00141-X; Mao W, 2012, PROG NAT SCI, V22, P139, DOI 10.1016/j.pnsc.2012.03.008; Chu F, 1999, MAT SCI ENG A-STRUCT, V261, P44, DOI 10.1016/S0921-5093(98)01048-X; Yasuda H, 2003, MATER TRANS, V44, P2550, DOI 10.2320/matertrans.44.2550; Kaga H, 2007, J MATER RES, V22, P2917, DOI 10.1557/JMR.2007.0360; Pierrat P, 1997, J MATER SCI, V32, P3653, DOI 10.1023/A:1018686514939; Horii S, 2009, SCI TECHNOL ADV MAT, V10, DOI 10.1088/1468-6996/10/1/014604; Udono H, 2011, J ELECTRON MATER, V40, P1165, DOI 10.1007/s11664-011-1561-9; Kumagai T, 2005, JPN J APPL PHYS 2, V44, pL1263, DOI 10.1143/JJAP.44.L1263; Luo WH, 2011, INTERMETALLICS, V19, P404, DOI 10.1016/j.intermet.2010.11.008; Aoyama I, 2005, JPN J APPL PHYS 1, V44, P8562, DOI [10.1143/JJAP.44.8562, 10.1143/JJAP.44.85621]; Seo J, 1997, MAT SCI ENG B-SOLID, V49, P247, DOI 10.1016/S0921-5107(97)00123-2; Kuribayashi T, 2006, MATER TRANS, V47, P2387, DOI 10.2320/matertrans.47.2387; Liang BB, 2013, J NANOMATER, DOI 10.1155/2013/210767; [Anonymous], 2009, J THERMOELECTR; LEVINSON LM, 1973, J SOLID STATE CHEM, V6, P126, DOI 10.1016/0022-4596(73)90212-0; XU CH, 1991, PHYS REV B, V43, P5024, DOI 10.1103/PhysRevB.43.5024; Dong GH, 2010, J MATER CHEM, V20, P1976, DOI 10.1039/b915107a; Wang H, 2003, T NONFERR METAL SOC, V13, P1405; ENGSTROM I, 1988, J APPL PHYS, V63, P4476; Iwai K, 2010, ISIJ INT, V50, P1950, DOI 10.2355/isijinternational.50.1950; Legrand BA, 1998, J ALLOY COMPD, V275, P660, DOI 10.1016/S0925-8388(98)00414-9; Horii S, 2003, JPN J APPL PHYS 1, V42, P7018, DOI 10.1143/JJAP.42.7018; Okutani T, 2005, MICROGRAVITY SCI TEC, V16, P84, DOI 10.1007/BF02945953; Hagio T, 2013, MAT SCI ENG C-MATER, V33, P2967, DOI 10.1016/j.msec.2013.03.024; NISHIDA I, 1972, J MATER SCI, V7, P435, DOI 10.1007/BF02403407; Sadia Y, 2013, J NANOMATER, DOI 10.1155/2013/701268; SAVITSKY EM, 1981, J CRYST GROWTH, V52, P519, DOI 10.1016/0022-0248(81)90332-8; Aoyama I, 2005, JPN J APPL PHYS 1, V44, P4275, DOI 10.1143/JJAP.44.4275; Kim DH, 2011, ACTA MATER, V59, P4957, DOI 10.1016/j.actamat.2011.04.040; Usui M, 2007, ISIJ INT, V47, P1613, DOI 10.2355/isijinternational.47.1613; Itoh T., 2010, T JWRI, p[39, 276]; Kaga H, 2006, JPN J APPL PHYS 2, V45, pL1212, DOI 10.1143/JJAP.45.L1212; Li C, 2010, Progress In Electromagnetics Research Letters, V18, DOI 10.2528/PIERL10061301; Nakatsuka Noriaki, 2009, Journal of Physics: Conference Series, V165, DOI 10.1088/1742-6596/165/1/012021; Okutani T, 2009, ANN NY ACAD SCI, V1161, P437, DOI 10.1111/j.1749-6632.2009.04084.x; Okutani T., 2011, J JPN SOC MICROGRAVI, V28, pS57; Ren Z. M., 2005, P JOINT 15 RIG 6 PAM, P253; Yamasaki T., 2012, PAC SCI REV, V14, P275; Yoshikura M, 2010, J JPN SOC POWDER POW, V57, P242	41	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							117102	10.7567/JJAP.54.117102		6	Physics, Applied	Physics	CV5CC	WOS:000364283000030		
J	Yoshidomi, S; Kimura, S; Hasumi, M; Sameshima, T				Yoshidomi, Shinya; Kimura, Shunsuke; Hasumi, Masahiko; Sameshima, Toshiyuki			Indium-gallium-zinc-oxide layer used to increase light transmittance efficiency of adhesive layer for stacked-type multijunction solar cells	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SILICON FILMS; TANDEM; JUNCTION; MULTICRYSTALLINE; TECHNOLOGY; FUTURE	We report the increase in transmittance efficiency of the intermediate layer for multijunction solar cells caused by the indium-gallium-zinc-oxide (IGZO) layer used as the antireflection layer. Si substrates coated with a 200-nm-thick IGZO layer with a refractive index of 1.85 were prepared. The resistivity of the IGZO layer was increased from 0.0069 (as-deposited) to 0.032 Omega cm by heat treatment at 350 degrees C for 1 h to prevent free-carrier optical absorption. Samples with the Si/IGZO/adhesive/IGZO/Si structure were fabricated. The average transmissivity for wavelengths between 1200 and 1600nm was 49%, which was close to 55% of single-crystal silicon substrates. A high effective transmittance efficiency of 89% was experimentally achieved. The numerical calculation showed in an effective transmittance efficiency of 99% for 170-nm-thick antireflection layers with a resistivity of 0.6 Omega cm and a refractive index of 2.1. (C) 2015 The Japan Society of Applied Physics	[Yoshidomi, Shinya; Kimura, Shunsuke; Hasumi, Masahiko; Sameshima, Toshiyuki] Tokyo Univ Agr & Technol, Koganei, Tokyo 1848588, Japan	Yoshidomi, S (reprint author), Tokyo Univ Agr & Technol, Koganei, Tokyo 1848588, Japan.	tsamesim@cc.tuat.ac.jp			New Energy and Industrial Technology Development Organization (NEDO); Ministry of Education, Culture, Sports, Science and Technology of Japan [25420282]; Naito Science and Engineering Foundation; Sameken Co., Ltd.	This work was partly supported by the New Energy and Industrial Technology Development Organization (NEDO), Grant-in-Aid for Scientific Research C (No. 25420282) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, The Naito Science and Engineering Foundation, and Sameken Co., Ltd.	Kamiya T, 2009, J DISP TECHNOL, V5, P273, DOI 10.1109/JDT.2009.2021582; Shah AV, 2004, PROG PHOTOVOLTAICS, V12, P113, DOI 10.1002/pip.533; SUGIURA H, 1988, JPN J APPL PHYS 1, V27, P269, DOI 10.1143/JJAP.27.269; Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090; Carcia PF, 2003, APPL PHYS LETT, V82, P1117, DOI 10.1063/1.1553997; Hadipour A, 2008, ADV FUNCT MATER, V18, P169, DOI 10.1002/adfm.200700517; Heideman RG, 1995, OPT MATER, V4, P741, DOI 10.1016/0925-3467(95)00028-3; Katz EA, 2006, PROG PHOTOVOLTAICS, V14, P297, DOI 10.1002/pip.670; Yamaguchi M, 2006, SOL ENERG MAT SOL C, V90, P3068, DOI 10.1016/j.solmat.2006.06.028; Sameshima T, 1997, JPN J APPL PHYS 2, V36, pL1360; Friedman DJ, 2010, CURR OPIN SOLID ST M, V14, P131, DOI 10.1016/j.cossms.2010.07.001; Sameshima T, 2001, SOL ENERG MAT SOL C, V66, P389, DOI 10.1016/S0927-0248(00)00199-9; Ukawa K, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.076503; Yamaguchi M, 2003, SOL ENERG MAT SOL C, V75, P261, DOI 10.1016/S0927-0248(02)00168-X; Takamoto T, 1997, JPN J APPL PHYS 1, V36, P6215, DOI 10.1143/JJAP.36.6215; Yoshidomi S, 2014, APPL PHYS A-MATER, V116, P2113, DOI 10.1007/s00339-014-8415-2; Schultz O, 2004, PROG PHOTOVOLTAICS, V12, P553, DOI 10.1002/pip.583; Saga T, 2010, NPG ASIA MATER, V2, P96, DOI 10.1038/asiamat.2010.82; King RR, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2734507; Na JH, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2969780; Yamaguchi M, 2008, SOL ENERGY, V82, P173, DOI 10.1016/j.solener.2007.06.011; Walheim S, 1999, SCIENCE, V283, P520, DOI 10.1126/science.283.5401.520; Zhao JH, 1998, APPL PHYS LETT, V73, P1991, DOI 10.1063/1.122345; Ji KH, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3564882; Yamaguchi M, 2005, SOL ENERGY, V79, P78, DOI 10.1016/j.solener.2004.09.018; KARASAWA T, 1993, THIN SOLID FILMS, V223, P135, DOI 10.1016/0040-6090(93)90737-A; OLSON JM, 1990, APPL PHYS LETT, V56, P623, DOI 10.1063/1.102717; Chhajed S, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3050463; Meillaud F, 2006, SOL ENERG MAT SOL C, V90, P2952, DOI 10.1016/j.solmat.2006.06.002; Sameshima T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.052301; TANAKA M, 1992, JPN J APPL PHYS 1, V31, P3518, DOI 10.1143/JJAP.31.3518; Yoshidomi S., 2013, P 6 THIN FILM MAT DE	32	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	NOV	2015	54	11							112301	10.7567/JJAP.54.112301		5	Physics, Applied	Physics	CV5CC	WOS:000364283000012		
J	De Commer, K; Yamashita, M				De Commer, Kenny; Yamashita, Makoto			Tannaka-Krein duality for compact quantum homogeneous spaces II. Classification of quantum homogeneous spaces for quantum SU(2)	JOURNAL FUR DIE REINE UND ANGEWANDTE MATHEMATIK			English	Article							REPRESENTATION CATEGORY; MATRIX PSEUDOGROUPS; ERGODIC ACTIONS; SUBFACTORS; ALGEBRAS; SPHERES; GRAPHS	We apply the Tannaka-Krein duality theory for quantum homogeneous spaces, developed in the first part of this series of papers, to the case of the quantum SU(2) groups. We obtain a classification of their quantum homogeneous spaces in terms of weighted oriented graphs. The equivariant maps between these quantum homogeneous spaces can be characterized by certain quadratic equations associated with the braiding on the representations of SUq(2). We show that, for vertical bar q vertical bar close to 1, all quantum homogeneous spaces are realized by coideals up to strong Morita equivalence.	[De Commer, Kenny] Univ Cergy Pontoise, Dept Math, UMR CNRS 8088, F-95000 Cergy Pontoise, France; [Yamashita, Makoto] Ochanomizu Univ, Dept Math, Bunkyo Ku, Tokyo 1128610, Japan	De Commer, K (reprint author), Univ Cergy Pontoise, Dept Math, UMR CNRS 8088, F-95000 Cergy Pontoise, France.	kenny.de-commer@u-cergy.fr; yamashita.makoto@ocha.ac.jp			Danish National Research Foundation through the Centre for Symmetry and Deformation [DNRF92]	We would again like to thank T. Banica, R. Conti, Y. Kawahigashi, R. Meyer, S. Neshveyev, V. Ostrik, C. Pinzari, N. Snyder, S. Vaes, C. Voigt, and particularly R. Tomatsu, for valuable discussions both on the content and on the presentation of this paper. M.Y. is supported by the Danish National Research Foundation through the Centre for Symmetry and Deformation (DNRF92).	Voigt C, 2011, ADV MATH, V227, P1873, DOI 10.1016/j.aim.2011.04.008; PIMSNER M, 1986, ANN SCI ECOLE NORM S, V19, P57; PRUITT WE, 1964, ANN MATH STAT, V35, P1797, DOI 10.1214/aoms/1177700401; Vaes S, 2005, J FUNCT ANAL, V229, P317, DOI 10.1016/j.jfa.2004.11.016; Banica T, 1999, J REINE ANGEW MATH, V509, P167; Pinzari C, 2007, INT J MATH, V18, P113, DOI 10.1142/S0129167X07003972; Pinzari C, 2010, J GEOM PHYS, V60, P403, DOI 10.1016/j.geomphys.2009.11.007; Banica T, 2007, PUBL RES I MATH SCI, V43, P277, DOI 10.2977/prims/1201011782; Nest R, 2010, J FUNCT ANAL, V258, P1466, DOI 10.1016/j.jfa.2009.10.015; Bichon J, 2003, COMMUN ALGEBRA, V31, P4831, DOI 10.1081/AGB-120023135; Hajac PM, 2003, ALGEBR REPRESENT TH, V6, P169, DOI 10.1023/A:1023288309786; Bichon J, 2006, COMMUN MATH PHYS, V262, P703, DOI 10.1007/s00220-005-1442-2; WORONOWICZ SL, 1988, INVENT MATH, V93, P35, DOI 10.1007/BF01393687; Boca FP, 1995, ASTERISQUE, P93; WORONOWICZ SL, 1987, PUBL RES I MATH SCI, V23, P117, DOI 10.2977/prims/1195176848; Etingof P, 2004, MATH RES LETT, V11, P103; MOHAR B, 1989, B LOND MATH SOC, V21, P209, DOI 10.1112/blms/21.3.209; Tomatsu R, 2008, J FUNCT ANAL, V254, P1, DOI 10.1016/j.jfa.2007.08.013; PODLES P, 1987, LETT MATH PHYS, V14, P193, DOI 10.1007/BF00416848; WASSERMANN A, 1988, INVENT MATH, V93, P309, DOI 10.1007/BF01394336; Banica T, 1996, CR ACAD SCI I-MATH, V322, P241; Blackadar B., 2006, ENCY MATH SCI, V122; De Commer K., 2012, PREPRINT; Evans D. E., 1998, OXFORD MATH MONOGR; Gelaki S., 2012, PREPRINT; Goodman F. M., 1989, MATH SCI RES I PUBL, V14; Hajac PM, 1996, COMMUN MATH PHYS, V182, P579, DOI 10.1007/BF02506418; Ocneanu A., 2002, CONT MATH, V294, P133; Pinzari C., 2008, PREPRINT; Turaev V., 1994, DEGRUYTER STUD MATH, V18; Ueda Y, 2000, INT MATH RES NOTICES, P35; Yamagami S., 2004, PREPRINT	32	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0075-4102	1435-5345		J REINE ANGEW MATH	J. Reine Angew. Math.	NOV	2015	708						143	171		10.1515/crelle-2013-0074		29	Mathematics	Mathematics	CV5LZ	WOS:000364313500007		
J	Noda, S; Suarez-Farinas, M; Ungar, B; Kim, SJ; Strong, CD; Xu, H; Peng, XY; Estrada, YD; Nakajima, S; Honda, T; Shin, JU; Lee, H; Krueger, JG; Lee, KH; Kabashima, K; Guttman-Yassky, E				Noda, Shinji; Suarez-Farinas, Mayte; Ungar, Benjamin; Kim, Soo Jung; Strong, Cristina de Guzman; Xu, Hui; Peng, Xiangyu; Estrada, Yeriel D.; Nakajima, Saeko; Honda, Tetsuya; Shin, Jung U.; Lee, Hemin; Krueger, James G.; Lee, Kwang-Hoon; Kabashima, Kenji; Guttman-Yassky, Emma			The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased T(H)17 polarization	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; T(H)1; T(H)2; T(H)17; T(H)22; acanthosis; parakeratosis; psoriasis; Asian; European American	CHRONIC PLAQUE PSORIASIS; MONOCLONAL-ANTIBODY; TH2 CYTOKINES; TH17 CELLS; T-CELLS; SKIN; DISEASE; MODERATE; MECHANISMS; POPULATION	Background: Atopic dermatitis (AD) shows very high prevalence in Asia, with a large unmet need for effective therapeutics. Direct comparisons between European American (EA) and Asian patients with AD are unavailable, but earlier blood studies detected increased IL-17 1 -producing cell counts in Asian patients with AD. Objective: We sought to characterize the Asian AD skin phenotype and compare it with the EA AD skin phenotype. Methods: We performed genomic profiling (real-time PCR) and immunohistochemistry on lesional and nonlesional biopsy specimens from 52 patients with AD (25 EAs and 27 Asians), 10 patients with psoriasis (all EAs), and 27 healthy subjects (12 EAs and 15 Asians). Results: Although disease severity/SCORAD scores were similar between the AD groups (58.0 vs 56.7, P 5.77), greater acanthosis, higher Ki67 counts, and frequent parakeratosis were characteristics of lesional epidermis from Asian patients with AD (P <.05). Most (24/27) Asian patients had high IgE levels. A principal component analysis using real-time PCR data clustered the Asian AD phenotype between the EA AD and psoriasis phenotypes. T(H)2 skewing characterized both Asian and EA patients with AD but not patients with psoriasis. Significantly higher T(H)17 and T(H)22 (IL17A, IL19, and S100A12 in lesional and IL-22 in nonlesional skin; P <. 05) and lower T(H)1/interferon (CXCL9, CXCL10, MX1, and IFNG in nonlesional skin; P <.05) gene induction typified AD skin in Asian patients. Conclusion: The Asian AD phenotype presents (even in the presence of increased IgE levels) a blended phenotype between that of EA patients with AD and those with psoriasis, including increased hyperplasia, parakeratosis, higher T(H)17 activation, and a strong T(H)2 component. The relative pathogenic contributions of the T(H)17 and T(H)2 axes in creating the Asian AD phenotype need to be tested in future clinical trials with appropriate targeted therapeutics.	[Noda, Shinji; Suarez-Farinas, Mayte; Ungar, Benjamin; Krueger, James G.; Guttman-Yassky, Emma] Rockefeller Univ, Lab Investigat Dermatol, New York, NY 10021 USA; [Suarez-Farinas, Mayte; Ungar, Benjamin; Kim, Soo Jung; Xu, Hui; Peng, Xiangyu; Estrada, Yeriel D.; Guttman-Yassky, Emma] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA; [Suarez-Farinas, Mayte] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA; [Guttman-Yassky, Emma] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA; [Suarez-Farinas, Mayte] Icahn Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, New York, NY USA; [Strong, Cristina de Guzman] Washington Univ, Div Biol & Biomed Sci, St Louis, MO 63130 USA; [Nakajima, Saeko; Honda, Tetsuya; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 6068501, Japan; [Shin, Jung U.; Lee, Hemin; Lee, Kwang-Hoon] Yonsei Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Shin, Jung U.; Lee, Hemin; Lee, Kwang-Hoon] Yonsei Univ, Coll Med, Cutaneous Biol Res Inst, Seoul, South Korea	Guttman-Yassky, E (reprint author), Icahn Sch Med Mt Sinai, Med Ctr, Dept Dermatol, 5 E 98th St, New York, NY 10029 USA.	Emma.Guttman@mountsinai.org			Leo Pharma; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [5UL1RR024143-02]; NIH Roadmap for Medical Research; National Center for Advancing Translational Sciences (NCATS), NIH Clinical and Translational Science Award (CTSA) program [UL1 TR000043]	Supported by a research grant (EGY) from Leo Pharma. S.N., B.U., M.S.-F., and J.G.K. were supported by grant no. 5UL1RR024143-02 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and the NIH Roadmap for Medical Research. S.N. was supported in part by grant no. UL1 TR000043 from the National Center for Advancing Translational Sciences (NCATS), NIH Clinical and Translational Science Award (CTSA) program.	Ahn K, 2014, J ALLERGY CLIN IMMUN, V134, P993, DOI 10.1016/j.jaci.2014.09.023; McLean WHI, 2008, J ALLERGY CLIN IMMUN, V121, P1294, DOI 10.1016/j.jaci.2008.02.039; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Sofen H, 2014, J ALLERGY CLIN IMMUN, V133, P1032, DOI 10.1016/j.jaci.2014.01.025; Lee JS, 2011, CLIN IMMUNOL, V140, P84, DOI 10.1016/j.clim.2011.03.018; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008; Beck LA, 2014, NEW ENGL J MED, V371, P130, DOI 10.1056/NEJMoa1314768; Suarez-Farinas M, 2011, J ALLERGY CLIN IMMUN, V127, P954, DOI 10.1016/j.jaci.2010.12.1124; Guttman-Yassky E, 2007, J ALLERGY CLIN IMMUN, V119, P1210, DOI 10.1016/j.jaci.2007.03.006; Scholz M, 2005, BIOINFORMATICS, V21, P3887, DOI 10.1093/bioinformatics/bti634; Guttman-Yassky E, 2011, J ALLERGY CLIN IMMUN, V127, P1420, DOI 10.1016/j.jaci.2011.01.054; Hao JQ, 2014, INFLAMMATION, V37, P94, DOI 10.1007/s10753-013-9715-y; Silverberg JI, 2013, J ALLERGY CLIN IMMUN, V132, P1132, DOI 10.1016/j.jaci.2013.08.031; Moore MM, 2004, PEDIATRICS, V113, P468, DOI 10.1542/peds.113.3.468; Puya R, 2012, INT J DERMATOL, V51, P115, DOI 10.1111/j.1365-4632.2011.05195.x; Agusti-Mejias A, 2013, ANN DERMATOL, V25, P368, DOI 10.5021/ad.2013.25.3.368; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Saeki H, 2006, J DERMATOL, V33, P817, DOI 10.1111/j.1346-8138.2006.00187.x; Danso MO, 2014, J INVEST DERMATOL, V134, P1941, DOI 10.1038/jid.2014.83; Heratizadeh A, 2011, CURR ALLERGY ASTHM R, V11, P284, DOI 10.1007/s11882-011-0202-y; Margolis JS, 2014, JAMA DERMATOL, V150, P593, DOI 10.1001/jamadermatol.2013.10271; Eyerich S, 2011, NEW ENGL J MED, V365, P231, DOI 10.1056/NEJMoa1104200; Gittler JK, 2012, J ALLERGY CLIN IMMUN, V130, P1344, DOI 10.1016/j.jaci.2012.07.012; Damsker JM, 2010, ANN NY ACAD SCI, V1183, P211, DOI 10.1111/j.1749-6632.2009.05133.x; Sugiura H, 1998, ACTA DERM-VENEREOL, V78, P293; Tintle S, 2011, J ALLERGY CLIN IMMUN, V128, P583, DOI 10.1016/j.jaci.2011.05.042; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Mills KHG, 2008, EUR J IMMUNOL, V38, P2636, DOI 10.1002/eji.200838535; Torrelo A, 2014, J EUR ACAD DERMATOL, V28, P2, DOI 10.1111/jdv.12480; Papp KA, 2012, J INVEST DERMATOL, V132, P2466, DOI 10.1038/jid.2012.163; Bachert C, 2012, J INTERN MED, V272, P133, DOI 10.1111/j.1365-2796.2012.02559.x; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Czarnowicki T, 2015, J ALLERGY CLIN IMMUN, V136, P104, DOI 10.1016/j.jaci.2015.01.020; Guttman-Yassky E, 2008, J IMMUNOL, V181, P7420; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Koga C, 2008, J INVEST DERMATOL, V128, P2625, DOI 10.1038/jid.2008.111; Jiang XD, 2011, AM J RHINOL ALLERGY, V25, pE171, DOI 10.2500/ajra.2011.25.3645; Huang F, 2008, J ALLERGY CLIN IMMUN, V121, P1415, DOI 10.1016/j.jaci.2008.04.016; Khattri S, 2014, J ALLERGY CLIN IMMUN, V133, P1626, DOI 10.1016/j.jaci.2014.03.003; Suarez-Farinas M, 2015, J ALLERGY CLIN IMMUN, V135, P1218, DOI 10.1016/j.jaci.2015.03.003; Sa SM, 2007, J IMMUNOL, V178, P2229; Paust HJ, 2012, KIDNEY INT, V82, P72, DOI 10.1038/ki.2012.101; Suarez-Farinas M, 2013, J ALLERGY CLIN IMMUN, V132, P361, DOI 10.1016/j.jaci.2013.04.046; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Dunbar GC, 2011, J PSYCHOPHARMACOL, V25, P1020, DOI 10.1177/0269881110367727; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Johnson-Huang LM, 2010, J INVEST DERMATOL, V130, P2654, DOI 10.1038/jid.2010.166; Guttman-Yassky E, 2009, J ALLERGY CLIN IMMUN, V124, P1235, DOI 10.1016/j.jaci.2009.09.031; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Brown SJ, 2012, J INVEST DERMATOL, V132, P751, DOI 10.1038/jid.2011.393; Esparza-Gordillo J, 2009, NAT GENET, V41, P596, DOI 10.1038/ng.347; Eichenfield LF, 2014, J AM ACAD DERMATOL, V70, P338, DOI 10.1016/j.jaad.2013.10.010; Alsaad KO, 2005, J CLIN PATHOL, V58, P1233, DOI 10.1136/2005.027151; Kim BE, 2008, CLIN IMMUNOL, V126, P332, DOI 10.1016/j.clim.2007.11.006; Sargen MR, 2014, J INVEST DERMATOL, V134, P51, DOI 10.1038/jid.2013.274; Bhattacharya T, 2014, JAMA DERMATOL, V150, P1232, DOI 10.1001/jamadermatol.2014.1674; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Bin L, 2014, J ALLERGY CLIN IMMUN, V134, P848; Czarnowicki T, 2015, J ALLERGY CLIN IMMUN; Esaki H, 2015, J ALLERGY CLIN IMMUN, V135, P153, DOI 10.1016/j.jaci.2014.10.037; Fernandez-Anton Martinez MC, 2014, ACTA DERMOSIFILIOGR, V105, P312; Flohr C, 2014, ALLERGY, V69, P3, DOI 10.1111/all.12270; Gordon KB, 2014, J AM ACAD DERMATOL, V71, P1176, DOI 10.1016/j.jaad.2014.07.048; Hamilton JD, 2014, J ALLERGY CLIN IMMUN, V134, P1293, DOI 10.1016/j.jaci.2014.10.013; Hanifin Jon M, 2007, Dermatitis, V18, P82, DOI 10.2310/6620.2007.06034; Huang F, 2008, J ALLERGY CLIN IMMUN, V121, pe1; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jolliffe I., 1986, PRINCIPAL COMPONENT; Kim KW, 2015, J ALLERGY CLIN IMMUN; Kubota K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006450; Leung DYM, 2014, J ALLERGY CLIN IMMUN, V134, P769, DOI 10.1016/j.jaci.2014.08.008; Malajian Dana, 2015, Cytokine, V73, P311, DOI 10.1016/j.cyto.2014.11.023; McLean WH, 2008, J ALLERGY CLIN IMMUN, V121, P1295; Nast A, 2015, J INVEST DERMATOL; Noda S, 2015, J ALLERGY CLIN IMMUN, V135, P324, DOI 10.1016/j.jaci.2014.11.015; Noster R, 2014, SCI TRANSL MED, V6, P241, DOI DOI 10.1126/SCITRANSLMED.3008706; Quaranta M, 2014, SCI TRANSL MED, V6, P244, DOI DOI 10.1126/SCITRANSLMED.3008946; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; Samorano LP, 2014, J EUR ACAD DERMATOL; Suarez-Farinas M, 2011, J ALLERGY CLIN IMMUN, V127, pe1; Tintle S, 2011, J ALLERGY CLIN IMMUN, V128, pe1; Tokura Y, 2010, J DERMATOL SCI, V58, P1, DOI 10.1016/j.jdermsci.2010.02.008; Witte E, 2014, J INVEST DERMATOL, V134, P2757, DOI 10.1038/jid.2014.308; Yoshida K, 2014, J ALLERGY CLIN IMMUN, V134, P856, DOI 10.1016/j.jaci.2014.08.001	84	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2015	136	5					1254	1264		10.1016/j.jaci.2015.08.015		11	Allergy; Immunology	Allergy; Immunology	CW1YE	WOS:000364787200014		
J	Holzinger, D; Fassl, SK; de Jager, W; Lohse, P; Rohrig, UF; Gattorno, M; Omenetti, A; Chiesa, S; Schena, F; Austermann, J; Vogl, T; Kuhns, DB; Holland, SM; Rodriguez-Gallego, C; Lopez-Almaraz, R; Arostegui, JI; Colino, E; Roldan, R; Fessatou, S; Isidor, B; Poignant, S; Ito, K; Epple, HJ; Bernstein, JA; Jeng, M; Frankovich, J; Lionetti, G; Church, JA; Ong, PY; LaPlant, M; Abinun, M; Skinner, R; Bigley, V; Sachs, UJ; Hinze, C; Hoppenreijs, E; Ehrchen, J; Foell, D; Chae, JJ; Ombrello, A; Aksentijevich, I; Sunderkoetter, C; Roth, J				Holzinger, Dirk; Fassl, Selina Kathleen; de Jager, Wilco; Lohse, Peter; Roehrig, Ute F.; Gattorno, Marco; Omenetti, Alessia; Chiesa, Sabrina; Schena, Francesca; Austermann, Judith; Vogl, Thomas; Kuhns, Douglas B.; Holland, Steven M.; Rodriguez-Gallego, Carlos; Lopez-Almaraz, Ricardo; Arostegui, Juan I.; Colino, Elena; Roldan, Rosa; Fessatou, Smaragdi; Isidor, Bertrand; Poignant, Sylvaine; Ito, Koichi; Epple, Hans-Joerg; Bernstein, Jonathan A.; Jeng, Michael; Frankovich, Jennifer; Lionetti, Geraldina; Church, Joseph A.; Ong, Peck Y.; LaPlant, Mona; Abinun, Mario; Skinner, Rod; Bigley, Venetia; Sachs, Ulrich J.; Hinze, Claas; Hoppenreijs, Esther; Ehrchen, Jan; Foell, Dirk; Chae, Jae Jin; Ombrello, Amanda; Aksentijevich, Ivona; Sunderkoetter, Cord; Roth, Johannes			Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseases	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Hyperzincemia and hypercalprotectinemia; myeloid-related protein 8/14; calprotectin; S100 proteins; zinc; proline-serine-threonine phosphatase-interacting protein 1; pyogenic arthritis; pyoderma gangrenosum, and acne syndrome; genotype; phenotype; autoinflammation	JUVENILE IDIOPATHIC ARTHRITIS; PAPA SYNDROME; PYODERMA-GANGRENOSUM; ZINC-METABOLISM; RECEPTOR 4; PYOGENIC ARTHRITIS; INTERFERON-GAMMA; GENE-EXPRESSION; IN-VITRO; T-CELLS	Background: Hyperzincemia and hypercalprotectinemia (Hz/Hc) is a distinct autoinflammatory entity involving extremely high serum concentrations of the proinflammatory alarmin myeloid-related protein (MRP) 8/14 (S100A8/S100A9 and calprotectin). Objective: We sought to characterize the genetic cause and clinical spectrum of Hz/Hc. Methods: Proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1) gene sequencing was performed in 14 patients with Hz/Hc, and their clinical phenotype was compared with that of 11 patients with pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome. PSTPIP1-pyrin interactions were analyzed by means of immunoprecipitation and Western blotting. A structural model of the PSTPIP1 dimer was generated. Cytokine profiles were analyzed by using the multiplex immunoassay, and MRP8/14 serum concentrations were analyzed by using an ELISA. Results: Thirteen patients were heterozygous for a missense mutation in the PSTPIP1 gene, resulting in a p.E250K mutation, and 1 carried a mutation resulting in p. E257K. Both mutations substantially alter the electrostatic potential of the PSTPIP1 dimer model in a region critical for protein-protein interaction. Patients with Hz/Hc have extremely high MRP8/14 concentrations (2045 +/- 1300 mu g/mL) compared with those with PAPA syndrome (116 +/- 74 mu g/mL) and have a distinct clinical phenotype. A specific cytokine profile is associated with Hz/Hc. Hz/Hc mutations altered protein binding of PSTPIP1, increasing interaction with pyrin through phosphorylation of PSTPIP1. Conclusion: Mutations resulting in charge reversal in the y-domain of PSTPIP1 (E -> K) and increased interaction with pyrin cause a distinct autoinflammatory disorder defined by clinical and biochemical features not found in patients with PAPA syndrome, indicating a unique genotype-phenotype correlation for mutations in the PSTPIP1 gene. This is the first inborn autoinflammatory syndrome in which inflammation is driven by uncontrolled release of members of the alarmin family.	[Holzinger, Dirk; Fassl, Selina Kathleen; Austermann, Judith; Vogl, Thomas; Roth, Johannes] Univ Munster, Inst Immunol, D-48149 Munster, Germany; [Holzinger, Dirk; Austermann, Judith; Vogl, Thomas; Hinze, Claas; Ehrchen, Jan; Foell, Dirk; Sunderkoetter, Cord; Roth, Johannes] Univ Munster, Univ Hosp Muenster, Interdisciplinary Ctr Clin Res IZKF, D-48149 Munster, Germany; [Holzinger, Dirk; Foell, Dirk] Univ Munster, Univ Childrens Hosp Muenster, Dept Paediat Rheumatol & Immunol, D-48149 Munster, Germany; [de Jager, Wilco; Hinze, Claas] Univ Med Ctr Utrecht, Dept Paediat Immunol, Lab Translat Immunol, Utrecht, Netherlands; [Lohse, Peter] Univ Munich, Dept Clin Chem Grosshadern, D-81377 Munich, Germany; [Roehrig, Ute F.] Swiss Inst Bioinformat, Mol Modeling Grp, Lausanne, Switzerland; [Gattorno, Marco; Omenetti, Alessia; Chiesa, Sabrina; Schena, Francesca] G Gaslini Sci Inst, Div Pediat 2, Genoa, Italy; [Kuhns, Douglas B.] Leidos Biomed Res, Frederick, MD USA; [Holland, Steven M.] NIAID, NIH, Bethesda, MD USA; [Rodriguez-Gallego, Carlos] Hosp Univ Son Espases, Dept Immunol, Palma De Mallorca, Spain; [Lopez-Almaraz, Ricardo] Hosp Univ Canarias, Dept Pediat, San Cristobal la Laguna, Spain; [Arostegui, Juan I.] Hosp Clin IDIBAPS, Dept Immunol CDB, Barcelona, Spain; [Colino, Elena] Complejo Hosp Univ Insular Materno Infant, Dept Paediat, Las Palmas Gran Canaria, Spain; [Roldan, Rosa] Hosp Univ Reina Sofia, Dept Pediat Rheumatol, Cordoba, Spain; [Fessatou, Smaragdi] Univ Athens, Sch Med, ATTIKON Hosp, Dept Pediat 3, GR-10679 Athens, Greece; [Isidor, Bertrand] Ctr Hosp Univ, Serv Genet Med, Nantes, France; [Poignant, Sylvaine] CH Cholet, Serv Pediat, Cholet, France; [Ito, Koichi] Nagoya City Univ, Grad Sch Med Sci, Dept Pediat & Neonatol, Nagoya, Aichi, Japan; [Epple, Hans-Joerg] Charite, Dept Gastroenterol Infect Dis & Rheumatol, D-13353 Berlin, Germany; [Bernstein, Jonathan A.; Jeng, Michael; Frankovich, Jennifer] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Lionetti, Geraldina] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Church, Joseph A.; Ong, Peck Y.] Univ So Calif, Keck Sch Med, Div Clin Immunol & Allergy, Childrens Hosp Los Angeles, Los Angeles, CA 90033 USA; [Church, Joseph A.; Ong, Peck Y.] Univ So Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90033 USA; [LaPlant, Mona] Childrens Hosp & Clin Minnesota, St Paul, MN USA; [Abinun, Mario] Great North Childrens Hosp, Dept Paediat Immunol, Newcastle Upon Tyne, Tyne & Wear, England; [Abinun, Mario] Great North Childrens Hosp, Childrens BMT Unit, Newcastle Upon Tyne, Tyne & Wear, England; [Abinun, Mario] Newcastle Univ, Inst Clin Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Skinner, Rod] Royal Victoria Infirm, Great North Childrens Hosp, Dept Paediat & Adolescent Haematol & Oncol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Skinner, Rod] Royal Victoria Infirm, Great North Childrens Hosp, Childrens BMT Unit, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Skinner, Rod] Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Bigley, Venetia] Newcastle Univ, Sch Med, Human Dendrit Cell Lab, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Sachs, Ulrich J.] Univ Giessen, Inst Clin Immunol & Transfus Med, Giessen, Germany; [Hinze, Claas] Deutsch Zentrum Kinder & Jugendrheumatol, Garmisch Partenkirchen, Germany; [Hoppenreijs, Esther] St Maartens Clin, Dept Paediat Paediat Rheumatol, Nijmegen, Netherlands; [Hoppenreijs, Esther] Radboud Univ Nijmegen, Ctr Med, NL-6525 ED Nijmegen, Netherlands; [Ehrchen, Jan; Sunderkoetter, Cord] Univ Hosp Muenster, Dept Dermatol, Munster, Germany; [Chae, Jae Jin; Ombrello, Amanda; Aksentijevich, Ivona] NHGRI, NIH, Bethesda, MD 20892 USA; [Ehrchen, Jan; Sunderkoetter, Cord] Univ Hosp Muenster, Dept Translat Dermatoinfectiol, Munster, Germany	Roth, J (reprint author), Univ Munster, Inst Immunol, D-48149 Munster, Germany.	rothj@uni-muenster.de		Arostegui, Juan Ignacio/0000-0003-4757-504X	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Instituters of Health, Department of Health and Haman Services; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; "Fondo de Investigaciones Sanitarias,'' Ministerio de Economia y Competitividad [PI06/1031, PI10/01718]; European Regional Development Fund European Social Fund FEDER-FSE; Interdisciplinary Centre for Clinical Research University of Munster; German Research Foundation [SFB1009]; Bundesministerium fur Bildung und Forschung (AID-NET) [01GM08100]	Supported in part by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Instituters of Health, Department of Health and Haman Services (to S.M.H.) and in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract no. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. Also supported by "Fondo de Investigaciones Sanitarias,'' Ministerio de Economia y Competitividad (PI06/1031, PI10/01718), with the funding of European Regional Development Fund European Social Fund FEDER-FSE, the Interdisciplinary Centre for Clinical Research University of Munster, the German Research Foundation (SFB1009), and the Bundesministerium fur Bildung und Forschung (AID-NET, project 01GM08100).	Prasad AS, 1997, P ASSOC AM PHYSICIAN, V109, P68; Sugiura T, 2006, ACTA PAEDIATR, V95, P857, DOI 10.1080/08035250500482255; Besecker BY, 2011, AM J CLIN NUTR, V93, P1356, DOI 10.3945/ajcn.110.008417; Beck FWJ, 2006, NUTRITION, V22, P1045, DOI 10.1016/j.nut.2006.08.001; Shoham NG, 2003, P NATL ACAD SCI USA, V100, P13501, DOI 10.1073/pnas.2135380100; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Yu JW, 2013, J BIOL CHEM, V288, P11378, DOI 10.1074/jbc.M112.448795; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Cortesio CL, 2010, ARTHRITIS RHEUM-US, V62, P2556, DOI 10.1002/art.27521; Lindor NM, 1997, MAYO CLIN PROC, V72, P611; Loser K, 2010, NAT MED, V16, P713, DOI 10.1038/nm.2150; Demidowich AP, 2012, ARTHRITIS RHEUM-US, V64, P2022, DOI 10.1002/art.34332; Hayashi K, 2008, LIFE SCI, V83, P6, DOI 10.1016/j.lfs.2008.04.022; Rammes A, 1997, J BIOL CHEM, V272, P9496; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Wieringa FT, 2004, EUR J CLIN NUTR, V58, P1498, DOI 10.1038/sj.ejcn.1601998; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Holzinger D, 2012, ANN RHEUM DIS, V71, P974, DOI 10.1136/annrheumdis-2011-200598; Schellevis MA, 2011, ANN RHEUM DIS, V70, P1168, DOI 10.1136/ard.2009.126185; Fessatou S, 2005, J PEDIAT HEMATOL ONC, V27, P477, DOI 10.1097/01.mph.0000179958.19524.9c; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Newton RA, 1998, J IMMUNOL, V160, P1427; Bao B, 2011, BIOCHEM BIOPH RES CO, V407, P703, DOI 10.1016/j.bbrc.2011.03.084; Isidor B, 2009, ACTA PAEDIATR, V98, P410, DOI 10.1111/j.1651-2227.2008.01092.x; Frosch M, 2000, ARTHRITIS RHEUM, V43, P628, DOI 10.1002/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X; Lee H, 2012, CLIN EXP RHEUMATOL, V30, P452; Smith EJ, 2010, CURR GENOMICS, V11, P519, DOI 10.2174/138920210793175921; Viemann D, 2005, BLOOD, V105, P2955, DOI 10.1182/blood-2004-07-2520; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Zindl CL, 2013, P NATL ACAD SCI USA, V110, P12768, DOI 10.1073/pnas.1300318110; de Jager W, 2005, J IMMUNOL METHODS, V300, P124, DOI 10.1016/j.jim.2005.03.009; Cooper KM, 2008, MOL BIOL CELL, V19, P3180, DOI 10.1091/mbc.E08-02-0225; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Wittkowski H, 2011, ANN RHEUM DIS, V70, P2075, DOI 10.1136/ard.2011.152496; Reil A, 2013, TRANSFUSION, V53, P2145, DOI 10.1111/trf.12086; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; Tsou TC, 2011, J HAZARD MATER, V196, P335, DOI 10.1016/j.jhazmat.2011.09.035; MADURA JD, 1995, COMPUT PHYS COMMUN, V91, P57, DOI 10.1016/0010-4655(95)00043-F; Marzano AV, 2013, JAMA DERMATOL, V149, P762, DOI 10.1001/jamadermatol.2013.2907; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Sampson B, 2002, LANCET, V360, P1742, DOI 10.1016/S0140-6736(02)11683-7; Yang HL, 2006, J IMMUNOL, V176, P5898; Frosch M, 2009, ARTHRITIS RHEUM, V60, P883, DOI 10.1002/art.24349; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Prasad AS, 2006, TRANSL RES, V148, P325, DOI 10.1016/j.trsl.2006.07.008; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Song XY, 2011, NAT IMMUNOL, V12, P1151, DOI 10.1038/ni.2155; van Lent PLEM, 2008, ANN RHEUM DIS, V67, P1750, DOI 10.1136/ard.2007.077800; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Gaetke LM, 1997, AM J PHYSIOL-ENDOC M, V272, pE952; Hesker PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051105; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Waite AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006147; Wittkowski H, 2008, PEDIAT RHEUMATOL S1, V6, pP208, DOI 10.1186/1546-0096-6-S1-P208	54	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2015	136	5					1337	1345		10.1016/j.jaci.2015.04.016		9	Allergy; Immunology	Allergy; Immunology	CW1YE	WOS:000364787200024		
J	Cuello-Garcia, CA; Brozek, JL; Fiocchi, A; Pawankar, R; Yepes-Nunez, JJ; Terracciano, L; Gandhi, S; Agarwal, A; Zhang, Y; Schunemann, HJ				Cuello-Garcia, Carlos A.; Brozek, Jan L.; Fiocchi, Alessandro; Pawankar, Ruby; Jose Yepes-Nunez, Juan; Terracciano, Luigi; Gandhi, Shreyas; Agarwal, Arnav; Zhang, Yuan; Schuenemann, Holger J.			Recommendations on probiotics in allergy prevention should not be based on pooling data from different strains Reply	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Cuello-Garcia, Carlos A.; Brozek, Jan L.; Jose Yepes-Nunez, Juan; Zhang, Yuan; Schuenemann, Holger J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Cuello-Garcia, Carlos A.] Tecnol Monterrey Sch Med, Monterrey, Mexico; [Brozek, Jan L.; Gandhi, Shreyas; Agarwal, Arnav; Schuenemann, Holger J.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Fiocchi, Alessandro] Pediat Hosp Bambino Gesu, Vatican City, Vatican; [Pawankar, Ruby] Nippon Med Sch, Dept Pediat, Tokyo 113, Japan; [Jose Yepes-Nunez, Juan] Univ Antioquia, Sch Med, Medellin, Colombia; [Terracciano, Luigi] Univ Milan, Sch Med, Melloni Hosp, Dept Child & Maternal Med, Milan, Italy; [Gandhi, Shreyas; Agarwal, Arnav] Univ Toronto, Fac Med, Toronto, ON, Canada	Cuello-Garcia, CA (reprint author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	brozekj@mcmaster.ca					Wickens K, 2008, J ALLERGY CLIN IMMUN, V122, P788, DOI 10.1016/j.jaci.2008.07.011; Fiocchi A, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0055-2; Higgins JP, 2011, COCHRANE COLLABORATI, DOI DOI 10.1136/BMJ.D5928; Szajewska H, 2015, J ALLERGY CLIN IMMUN, V136, P1422, DOI 10.1016/j.jaci.2015.07.022	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2015	136	5					1423	1425		10.1016/j.jaci.2015.07.021		3	Allergy; Immunology	Allergy; Immunology	CW1YE	WOS:000364787200041		
J	Kudo, A; Luce, H; Hashiguchi, H; Wilson, R				Kudo, Atsushi; Luce, Hubert; Hashiguchi, Hiroyuki; Wilson, Richard			Convective Instability Underneath Midlevel Clouds: Comparisons between Numerical Simulations and VHF Radar Observations	JOURNAL OF APPLIED METEOROLOGY AND CLIMATOLOGY			English	Article						Turbulence; Convective-scale processes; Sublimation; Radars; Radar observations	KELVIN-HELMHOLTZ BILLOWS; CLEAR-AIR TURBULENCE; MU RADAR; DOPPLER RADAR; WAVE BREAKING; SYSTEM; STRATOSPHERE; TROPOSPHERE; GENERATION; CIRRUS	Deep turbulent layers can sometimes be observed on the underside of clouds that extend above upper-level frontal zones. In a recent study based on 3D numerical simulations with idealized initial conditions, it was found that midlevel cloud-base turbulence (MCT) can result from Rayleigh-Benard-like convection as a result of cooling by sublimation of precipitating snow into dry and weakly stratified subcloud layers. In the present study, numerically simulated MCT was compared with a turbulent layer detected by the very high-frequency (VHF) middle- and upper-atmosphere (MU) radar during the passage of an upper-level front topped by clouds. The simulations were initialized with thermodynamic parameters derived from simultaneous radiosonde data. It was found that some important features of the simulated MCT (such as the scale of convection and vertical wind velocity perturbations) agreed quantitatively well with those reported in radar observations. Even if the possibility of other generation mechanisms cannot be ruled out, the good agreement strongly suggests that the MU radar actually detected MCT.	[Kudo, Atsushi] Meteorol Res Inst, Tsukuba, Ibaraki 305, Japan; [Kudo, Atsushi] Japan Meteorol Agcy, Tokyo 1008122, Japan; [Luce, Hubert] Toulon Univ, La Garde, France; [Hashiguchi, Hiroyuki] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Japan; [Wilson, Richard] Univ Paris 06, CNRS, Univ Paris 04, INSU, Paris, France; [Wilson, Richard] LATMOS IPSL, Paris, France	Kudo, A (reprint author), Japan Meteorol Agcy, Numer Predict Div, Chiyoda Ku, Tokyo 1008122, Japan.	kudo@met.kishou.go.jp			National Institute of Communications and Technology (NICT); Japan Society for Promotion of Science (JSPS) fellowship	We thank three anonymous reviewers for their constructive comments and suggestions that helped improve the manuscript. Part of this work was carried out at the Research Institute for Sustainable Humanosphere (RISH), Kyoto University, by one of the authors (HL), whose presence at RISH was supported first by the National Institute of Communications and Technology (NICT), later by a Japan Society for the Promotion of Science (JSPS) fellowship, and finally by an appointment as a visiting scientist. The MU radar belongs to and is operated by the RISH.	LARSEN MF, 1985, RADIO SCI, V20, P1223, DOI 10.1029/RS020i006p01223; LUCE H, 1995, RADIO SCI, V30, P1003, DOI 10.1029/95RS00713; Lane TP, 2008, J APPL METEOROL CLIM, V47, P2777, DOI 10.1175/2008JAMC1787.1; Trier SB, 2010, J ATMOS SCI, V67, P2990, DOI 10.1175/2010JAS3531.1; DEARDORFF JW, 1980, BOUND-LAY METEOROL, V18, P495, DOI 10.1007/BF00119502; Luce H, 2006, ANN GEOPHYS-GERMANY, V24, P791; Kudo A, 2013, J APPL METEOROL CLIM, V52, P819, DOI 10.1175/JAMC-D-12-0232.1; Wilson R, 2014, J ATMOS SOL-TERR PHY, V118, P78, DOI 10.1016/j.jastp.2014.01.005; Doyle JD, 2005, J ATMOS SCI, V62, P3106, DOI 10.1175/JAS3528.1; Koch SE, 2005, J ATMOS SCI, V62, P3885, DOI 10.1175/JAS3574.1; Luce H, 2010, MON WEATHER REV, V138, P438, DOI 10.1175/2009MWR2927.1; Lane TP, 2012, B AM METEOROL SOC, V93, P499, DOI 10.1175/BAMS-D-11-00062.1; FUKAO S, 1990, RADIO SCI, V25, P477, DOI 10.1029/RS025i004p00477; SCORER RS, 1949, Q J ROY METEOR SOC, V75, P41, DOI 10.1002/qj.49707532308; Parker MD, 2004, J ATMOS SCI, V61, P1656, DOI 10.1175/1520-0469(2004)061<1656:SCLWLP>2.0.CO;2; Dehghan A, 2011, J ATMOS SOL-TERR PHY, V73, P1052, DOI 10.1016/j.jastp.2010.11.011; Luce H, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050120; THORPE SA, 1977, PHILOS T R SOC A, V286, P125, DOI 10.1098/rsta.1977.0112; Fukao S, 2011, Q J ROY METEOR SOC, V137, P1019, DOI 10.1002/qj.807; HELFAND HM, 1983, J ATMOS SCI, V40, P631, DOI 10.1175/1520-0469(1983)040<0631:AMTDOO>2.0.CO;2; Saito K, 2007, J METEOROL SOC JPN, V85B, P271, DOI 10.2151/jmsj.85B.271; Knox JA, 1997, MON WEATHER REV, V125, P1251, DOI 10.1175/1520-0493(1997)125<1251:PMOCAT>2.0.CO;2; BROWNING KA, 1973, Q J ROY METEOR SOC, V99, P608; MACPHERSON JI, 1977, J APPL METEOROL, V16, P81, DOI 10.1175/1520-0450(1977)016<0081:TCOSCC>2.0.CO;2; Cohn SA, 2011, J APPL METEOROL CLIM, V50, P826, DOI 10.1175/2010JAMC2611.1; Kim JH, 2014, MON WEATHER REV, V142, P2794, DOI 10.1175/MWR-D-14-00008.1; SHAPIRO MA, 1980, J ATMOS SCI, V37, P994, DOI 10.1175/1520-0469(1980)037<0994:TMWTFA>2.0.CO;2; WOODS JD, 1968, J FLUID MECH, V32, P791, DOI 10.1017/S0022112068001035; Asai T., 1972, J METEOROL SOC JAP, V50, P525; Doviak R. J., 1984, DOPPLER RADAR WEATHE; Durran D. R., 1986, MESOSCALE METEOROLOG, P472; Ikawa M., 1991, 28 MRI; Lilly D. K., 1986, MESOSCALE METEOROLOG, P259; MacCready PB, 1964, J APPL METEOROL, V3, P439, DOI 10.1175/1520-0450(1964)003<lessthan>0439:SOGVFA<greaterthan>2.0.CO;2; McCann D. W., 2001, NATL WEA DIG, V25, P3; OTTERSTE.H, 1969, RADIO SCI, V4, P1179, DOI 10.1029/RS004i012p01179; Rottger J., 1990, RADAR METEOROLOGY, P235	37	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	1558-8424	1558-8432		J APPL METEOROL CLIM	J. Appl. Meteorol. Climatol.	NOV	2015	54	11					2217	2227		10.1175/JAMC-D-15-0101.1		11	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CW4MH	WOS:000364965100002		
J	Ju, YI; Sone, T; Ohnaru, K; Tanaka, K; Fukunaga, M				Ju, Yong-In; Sone, Teruki; Ohnaru, Kazuhiro; Tanaka, Kensuke; Fukunaga, Masao			Effect of swimming exercise on three-dimensional trabecular bone microarchitecture in ovariectomized rats	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						non-weight-bearing exercise; muscle contractile forces; trabecular architecture; microcomputed tomography	POSTMENOPAUSAL WOMEN; MINERAL DENSITY; WEIGHT-BEARING; CORTICAL BONE; GROWING-RATS; MECHANICAL-PROPERTIES; TREADMILL EXERCISE; WATER EXERCISE; JUMP EXERCISE; FEMALE RATS	Swimming is generally considered ineffective for increasing bone mass in humans, at least compared with weight-bearing sports. However, swimming exercise has sometimes been shown to have a strong positive effect on bone mass in small animals. This study investigated the effects of swimming on bone mass, strength, and microarchitecture in ovariectomized (OVX) rats. OVX or sham operations were performed on 18-wk-old female Fisher 344 rats. Rats were randomly divided into four groups: sham sedentary (Sham-CON), sham swimming exercised (Sham-SWI), OVX sedentary (OVX-CON), and OVX swimming exercised (OVX-SWI). Rats in exercise groups performed swimming in a water bath for 60 min/day, 5 days/wk, for 12 wk. Bone mineral density (BMD) in right femurs was analyzed using dual-energy X-ray absorptiometry. Three-dimensional trabecular architecture at the distal femoral metaphysis was analyzed using microcomputed tomography (mu CT). Geometrical properties of diaphyseal cortical bone were evaluated in the midfemoral region using mu CT. The biomechanical properties of femurs were analyzed using three-point bending. Femoral BMD was significantly decreased following ovariectomy. This change was suppressed by swimming. Trabecular bone thickness, number, and connectivity were decreased by ovariectomy, whereas structure model index (i.e., ratio of rod-like to plate-like trabeculae) increased. These changes were also suppressed by swimming exercise. Femurs displayed greater cortical width and maximum load in SWI groups than in CON groups. Together, these results demonstrate that swimming exercise drastically alleviated both OVX-induced decreases in bone mass and mechanical strength and the deterioration of trabecular microarchitecture in rat models of osteoporosis.	[Ju, Yong-In] Kawasaki Univ Med Welf, Dept Hlth & Sports Sci, Kurashiki, Okayama 7010193, Japan; [Sone, Teruki; Tanaka, Kensuke] Kawasaki Med Univ, Dept Nucl Med, Kurashiki, Okayama, Japan; [Ohnaru, Kazuhiro] Kawasaki Med Univ, Dept Orthoped Surg, Kurashiki, Okayama, Japan; [Fukunaga, Masao] Kawasaki Med Univ, Kurashiki, Okayama, Japan	Ju, YI (reprint author), Kawasaki Univ Med Welf, Dept Hlth & Sports Sci, 288 Matsushima, Kurashiki, Okayama 7010193, Japan.	jyi.k@mw.kawasaki-m.ac.jp					TURNER RT, 1987, J BONE MINER RES, V2, P115; LEE EJ, 1995, MED SCI SPORT EXER, V27, P1354; Odgaard A, 1997, BONE, V20, P315, DOI 10.1016/S8756-3282(97)00007-0; Kinney JH, 1998, J BONE MINER RES, V13, P839, DOI 10.1359/jbmr.1998.13.5.839; ORWOLL ES, 1989, ARCH INTERN MED, V149, P2197; Balsamo S, 2013, REV BRAS REUMATOL, V53, P193, DOI 10.1590/S0482-50042013000200006; TSUKAHARA N, 1994, J NUTR SCI VITAMINOL, V40, P37; Hart KJ, 2001, J APPL PHYSIOL, V91, P1663; Falcai MJ, 2015, SCAND J MED SCI SPOR, V25, P390, DOI 10.1111/sms.12240; BARENGOLTS EI, 1993, J BONE MINER RES, V8, P937; HAHN M, 1992, BONE, V13, P327, DOI 10.1016/8756-3282(92)90078-B; Ito M, 2002, BONE, V30, P594, DOI 10.1016/S8756-3282(02)00684-1; YEH JK, 1993, J BONE MINER RES, V8, P677; Gruodyte R, 2010, ACTA PAEDIATR, V99, P1879, DOI 10.1111/j.1651-2227.2010.01905.x; Boivin GY, 2000, BONE, V27, P687, DOI 10.1016/S8756-3282(00)00376-8; SWISSASIVAN A, 1992, J BONE MINER RES, V7, P161; SNYDER A, 1992, MECH AGEING DEV, V66, P59, DOI 10.1016/0047-6374(92)90073-M; Barreto TKDP, 2014, REV BRAS REUMATOL, V54, P110, DOI [10.1016/j.rbre.2014.03.005, 10.1016/j.rbr.2014.03.005]; Barou O, 1999, J PHARMACOL EXP THER, V291, P321; Umemura Y, 1997, J BONE MINER RES, V12, P1480, DOI 10.1359/jbmr.1997.12.9.1480; Wolff I, 1999, OSTEOPOROSIS INT, V9, P1, DOI 10.1007/s001980050109; RAAB DM, 1991, J BONE MINER RES, V6, P741; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; KLEEREKOPER M, 1985, CALCIFIED TISSUE INT, V37, P594, DOI 10.1007/BF02554913; Meunier PJ, 1997, BONE, V21, P373, DOI 10.1016/S8756-3282(97)00170-1; Duncan CS, 2002, MED SCI SPORT EXER, V34, P673, DOI 10.1097/00005768-200204000-00018; Kippo K, 1998, J BONE MINER RES, V13, P287, DOI 10.1359/jbmr.1998.13.2.287; Mawatari T, 2000, J BONE MINER RES, V15, P1810, DOI 10.1359/jbmr.2000.15.9.1810; Figard H, 2006, J BONE MINER METAB, V24, P206, DOI 10.1007/s00774-005-0673-9; SWISSASIVAN A, 1990, CALCIFIED TISSUE INT, V47, P173, DOI 10.1007/BF02555984; AXELSON JF, 1987, PHYSIOL BEHAV, V41, P471, DOI 10.1016/0031-9384(87)90083-7; RABIN R, 1993, FASEB J, V7, P396; HARRIGAN TP, 1984, J MATER SCI, V19, P761, DOI 10.1007/BF00540446; McVeigh J, 2010, J SPORT SCI MED, V9, P612; Hoshi A, 1998, BIOMED ENVIRON SCI, V11, P243; KANNUS P, 1994, J BONE MINER RES, V9, P423; Bravo G, 1997, ARCH PHYS MED REHAB, V78, P1375, DOI 10.1016/S0003-9993(97)90313-0; Joo YI, 2003, BONE, V33, P485, DOI 10.1016/S8756-3285(03)00212-6; RAAB DM, 1990, J APPL PHYSIOL, V68, P130; SIMKIN A, 1989, J BIOMECH, V22, P845, DOI 10.1016/0021-9290(89)90068-7; Ju YI, 2008, J APPL PHYSIOL, V104, P1594, DOI 10.1152/japplphysiol.01004.2007; Lane NE, 2003, J BONE MINER RES, V18, P2105, DOI 10.1359/jbmr.2003.18.12.2105; TAAFFE DR, 1995, J BONE MINER RES, V10, P586; Ju YI, 2012, J APPL PHYSIOL, V112, P766, DOI 10.1152/japplphysiol.01219.2011; NYSKA M, 1995, INT J EXP PATHOL, V76, P241; SHEN V, 1995, J CLIN INVEST, V96, P2331, DOI 10.1172/JCI118289; VICO L, 1987, BONE MINER, V2, P383; CHEN MM, 1994, BONE, V15, P313, DOI 10.1016/8756-3282(94)90294-1; Kelley G, 1998, J AM GERIATR SOC, V46, P143; BOURRIN S, 1992, CALCIFIED TISSUE INT, V51, P137, DOI 10.1007/BF00298502; Melton SA, 2004, J STRENGTH COND RES, V18, P508; Buie HR, 2010, MED SCI SPORT EXER, V42, P1834, DOI 10.1249/MSS.0b013e3181dd25d4; CHENG SL, 1995, J BONE MINER RES, V10, P139; FELDKAMP LA, 1989, J BONE MINER RES, V4, P3; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Hildebrand T, 1997, COMPUTER METH BIOMEC, V1, P15, DOI DOI 10.1080/01495739708936692; Hoshi A, 1996, Environ Health Prev Med, V1, P128, DOI 10.1007/BF02931203; Ju YI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107953; Ju YI, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-35; Lashley CJ, 2015, PHYSL REP, V3; MOLSTER AO, 1986, CLIN ORTHOP RELAT R, P278; Park Jonghoon, 2014, J Exerc Nutrition Biochem, V18, P133, DOI 10.5717/jenb.2014.18.2.133	62	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587	1522-1601		J APPL PHYSIOL	J. Appl. Physiol.	NOV 1	2015	119	9					990	997		10.1152/japplphysiol.00147.2015		8	Physiology; Sport Sciences	Physiology; Sport Sciences	CV7TO	WOS:000364478200006		
J	Yoshihara, T; Ichinoseki-Sekine, N; Kakigi, R; Tsuzuki, T; Sugiura, T; Powers, SK; Naito, H				Yoshihara, Toshinori; Ichinoseki-Sekine, Noriko; Kakigi, Ryo; Tsuzuki, Takamasa; Sugiura, Takao; Powers, Scott K.; Naito, Hisashi			Repeated exposure to heat stress results in a diaphragm phenotype that resists ventilator-induced diaphragm dysfunction	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						apoptosis; autophagy; heat stress; respiratory muscle weakness	CONTROLLED MECHANICAL VENTILATION; SKELETAL-MUSCLE ATROPHY; OXIDATIVE STRESS; SHOCK-PROTEIN; DISUSE; HSP70; HEAT-SHOCK-PROTEIN-70; OVEREXPRESSION; APOPTOSIS; AUTOPHAGY	Controlled mechanical ventilation (CMV) is a life-saving intervention for patients in respiratory failure. Unfortunately, prolonged mechanical ventilation (MV) results in diaphragmatic atrophy and contractile dysfunction, both of which are predicted to contribute to problems in weaning patients from the ventilator. Therefore, developing a strategy to protect the diaphragm against ventilator-induced weakness is important. We tested the hypothesis that repeated bouts of heat stress result in diaphragm resistance against CMV-induced atrophy and contractile dysfunction. Male Wistar rats were randomly divided into six experimental groups: 1) control; 2) single bout of whole body heat stress; 3) repeated bouts of whole body heat stress; 4) 12 h CMV; 5) single bout of whole body heat stress 24 h before CMV; and 6) repeated bouts of whole body heat stress 1, 3, and 5 days before 12 h of CMV. Our results revealed that repeated bouts of heat stress resulted in increased levels of heat shock protein 72 in the diaphragm and protection against both CMV-induced diaphragmatic atrophy and contractile dysfunction at submaximal stimulation frequencies. The specific mechanisms responsible for this protection remain unclear: this heat stress-induced protection against CMV-induced diaphragmatic atrophy and weakness may be partially due to reduced diaphragmatic oxidative stress, diminished activation of signal transducer/transcriptional activator-3, lower caspase-3 activation, and decreased autophagy in the diaphragm.	[Yoshihara, Toshinori; Ichinoseki-Sekine, Noriko; Tsuzuki, Takamasa; Naito, Hisashi] Juntendo Univ, Grad Sch Hlth & Sports Sci, Chiba 2701695, Japan; [Yoshihara, Toshinori; Tsuzuki, Takamasa] JSPS, Tokyo, Japan; [Ichinoseki-Sekine, Noriko] Open Univ Japan, Fac Liberal Arts, Chiba, Japan; [Kakigi, Ryo] Juntendo Univ, Fac Med, Tokyo, Japan; [Sugiura, Takao] Yamaguchi Univ, Fac Educ, Yamaguchi, Japan; [Powers, Scott K.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA	Yoshihara, T (reprint author), Juntendo Univ, Sch Hlth & Sports Sci, 1-1 Hirakagakuendai, Chiba 2701695, Japan.	t-yoshih@juntendo.ac.jp			Japan Society for the Promotion of Science (JSPS) [11J11122]; JSPS KAKENHI Grant [23700781]; National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant [RO1 AR-064189]; MEXT	This work was supported by and Japan Society for the Promotion of Science (JSPS) Research Fellowships for Young Scientists Grant no. 11J11122 (T. Yoshihara), JSPS KAKENHI Grant no. 23700781 (N. Ichinoseki-Sekine), and National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant RO1 AR-064189 awarded to Scott K. Powers. This work was also supported by grants from the MEXT-Supported Program for the Strategic Research Foundation at Private Universities.	Miyabara EH, 2012, PFLUG ARCH EUR J PHY, V463, P733, DOI 10.1007/s00424-012-1087-x; Powers SK, 2013, AM J PHYSIOL-REG I, V305, pR464, DOI 10.1152/ajpregu.00231.2013; Nelson WB, 2012, CRIT CARE MED, V40, P1857, DOI 10.1097/CCM.0b013e318246bb5d; Betters JL, 2004, AM J RESP CRIT CARE, V170, P1179, DOI 10.1164/rccm.200407-939OC; Boonyarom O, 2006, ACTA PHYSIOL, V188, P77, DOI 10.1111/j.1748-1716.2006.01613.x; Naito H, 2000, J APPL PHYSIOL, V88, P359; Uehara K, 2004, JPN J PHYSIOL, V54, P263, DOI 10.2170/jjphysiol.54.263; Selsby JT, 2007, J APPL PHYSIOL, V102, P1702, DOI 10.1152/japplphysiol.00722.2006; Vassilakopoulos T, 1996, EUR RESPIR J, V9, P2383, DOI 10.1183/09031936.96.09112383; Hussain SNA, 2010, AM J RESP CRIT CARE, V182, P1377, DOI 10.1164/rccm.201002-0234OC; Radell PJ, 2002, INTENS CARE MED, V28, P358, DOI 10.1007/s00134-002-1207-8; Powers SK, 2011, CRIT CARE MED, V39, P1749, DOI 10.1097/CCM.0b013e3182190b62; Smith IJ, 2014, FASEB J, V28, P2790, DOI 10.1096/fj.13-244210; Selsby JT, 2005, AM J PHYSIOL-REG I, V289, pR134, DOI 10.1152/ajpregu.00497.2004; Whidden MA, 2009, J APPL PHYSIOL, V106, P385, DOI 10.1152/japplphysiol.91106.2008; Lui JCK, 2007, FEBS LETT, V581, P109, DOI 10.1016/j.febslet.2006.11.082; Agten A, 2011, CRIT CARE MED, V39, P777, DOI 10.1097/CCM.0b013e318206cca9; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Sassoon CSH, 2004, AM J RESP CRIT CARE, V170, P626, DOI 10.1164/rccm.200401-042OC; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Anzueto A, 1997, CRIT CARE MED, V25, P1187, DOI 10.1097/00003246-199707000-00021; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Brotto MAP, 2005, EXP PHYSIOL, V90, P417, DOI 10.1113/expphysiol.2004.028316; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Whidden MA, 2010, J APPL PHYSIOL, V108, P1376, DOI 10.1152/japplphysiol.00098.2010; Senf SM, 2010, AM J PHYSIOL-CELL PH, V298, pC38, DOI 10.1152/ajpcell.00315.2009; Mammucari C, 2008, AUTOPHAGY, V4, P524; Bin Aleem Shoaib, 2013, Iran Biomed J, V17, P29; Goto K, 2005, JPN J AEROSP ENV MED, V42, P51; Ichinoseki-Sekine N, 1985, J APPL PHYSIOL, V117, P518; Jaber S, 2011, CRIT CARE, V15, DOI 10.1186/cc10023; Locke M, 1997, Exerc Sport Sci Rev, V25, P105; Oksala NKJ, 2014, REDOX BIOL, V3, P25, DOI 10.1016/j.redox.2014.10.003; Powers Scott K, 2009, Crit Care Med, V37, pS347, DOI 10.1097/CCM.0b013e3181b6e760	35	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587	1522-1601		J APPL PHYSIOL	J. Appl. Physiol.	NOV 1	2015	119	9					1023	1031		10.1152/japplphysiol.00438.2015		9	Physiology; Sport Sciences	Physiology; Sport Sciences	CV7TO	WOS:000364478200010		
J	Matsue, Y; Kagiyama, N; Yoshida, K; Kume, T; Okura, H; Suzuki, M; Matsumura, A; Yoshida, K; Hashimoto, Y				Matsue, Yuya; Kagiyama, Nobuyuki; Yoshida, Kazuki; Kume, Teruyoshi; Okura, Hiroyuki; Suzuki, Makoto; Matsumura, Akihiko; Yoshida, Kiyoshi; Hashimoto, Yuji			Carperitide Is Associated With Increased In-Hospital Mortality in Acute Heart Failure: A Propensity Score-Matched Analysis	JOURNAL OF CARDIAC FAILURE			English	Article						Acute heart failure; vasodilator; prognosis; drug therapy	ATRIAL-NATRIURETIC-PEPTIDE; BLOOD-PRESSURE; RENAL-FUNCTION; RELAX-AHF; EFFICACY; TRIAL; NESIRITIDE; INFUSION; SAFETY	Background: Carperitide (alpha-human A-type natriuretic peptide) has been used for more than one-half of all acute heart failure (AHF) patients in Japan. However, its clinical effectiveness is not well documented. Methods: We retrospectively identified AHF patients presenting with acute onset or worsening of symptoms and admitted to 1 of the 3 participating hospitals. Propensity score matched analysis was performed. The primary end point was in-hospital mortality. Results: Of all of the AHF patients included in this study, 402 (38.7%) were treated with carperitide, and in-hospital mortality rate for the total cohort was 7.6%. We matched 367 pairs of patients treated with and without carperitide according to propensity score. In this matched cohort, treatment with carperitide was associated with in-hospital mortality (odds ratio [OR] 2.13, 95% confidence interval [CI] 1.17-3.85; P = .013). Potentially more harmful effects were observed in elderly patients (OR 2.93, 95% CI 1.54-5.91). Conclusions: Carperitide was significantly associated with increased in-hospital mortality rate in AHF patients. Our results strongly suggest the necessity for well designed randomized clinical trials of carperitide to determine its clinical safety and effectiveness.	[Matsue, Yuya; Suzuki, Makoto; Matsumura, Akihiko; Hashimoto, Yuji] Kameda Med Ctr, Dept Cardiol, Kamogawa, Chiba, Japan; [Kagiyama, Nobuyuki; Yoshida, Kiyoshi] Sakakibara Heart Inst Okayama, Dept Cardiol, Okayama, Japan; [Yoshida, Kazuki] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kume, Teruyoshi] Kawasaki Med Univ, Div Cardiol, Kurashiki, Okayama, Japan; [Okura, Hiroyuki] Nara Med Univ, Dept Internal Med 1, Kashihara, Nara 634, Japan	Matsue, Y (reprint author), Kameda Med Ctr, Dept Cardiol, 929 Higashi Cho, Kamogawa, Chiba, Japan.	yuya8950@gmail.com		Yoshida, Kazuki/0000-0002-2030-3549			Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; Maisel A, 2002, CIRCULATION, V105, P2328, DOI 10.1161/01.CIR.0000019121/91548.C2; Suwa M, 2005, CIRC J, V69, P283, DOI 10.1253/circj.69.283; Sato N, 2013, CIRC J, V77, P944, DOI 10.1253/circj.CJ-13-0187; O'Connor CM, 2011, NEW ENGL J MED, V365, P32, DOI 10.1056/NEJMoa1100171; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Packer M, 2013, JACC-HEART FAIL, V1, P103, DOI 10.1016/j.jchf.2012.12.004; Hata N, 2008, CIRC J, V72, P1787, DOI 10.1253/circj.CJ-08-0130; SAITO Y, 1987, CIRCULATION, V76, P115; Sezai A, 2013, ANN THORAC SURG, V96, P119, DOI 10.1016/j.athoracsur.2013.03.090; Blair JEA, 2011, EUR HEART J, V32, P2563, DOI 10.1093/eurheartj/ehr238; Nomura F, 2008, CIRC J, V72, P1777, DOI 10.1253/circj.CJ-07-0760; Gheorghiade M, 2007, JAMA-J AM MED ASSOC, V297, P1332, DOI 10.1001/jama.297.12.1332; Voors AA, 2011, EUR J HEART FAIL, V13, P961, DOI 10.1093/eurjhf/hfr060; Morikawa S, 2009, J AM COLL CARDIOL, V53, P1040, DOI 10.1016/j.jacc.2008.10.061; Sezai A, 2011, J AM COLL CARDIOL, V58, P897, DOI 10.1016/j.jacc.2011.03.056; Kasama S, 2004, J NUCL MED, V45, P1108; Kobayashi D, 2012, CAN J CARDIOL, V28, P102, DOI 10.1016/j.cjca.2011.04.011; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Chen HH, 2013, JAMA-J AM MED ASSOC, V310, P2533, DOI 10.1001/jama.2013.282190; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; JCS Joint Working Group, 2013, CIRC J, V77, P2157; Patel PA, 2014, CIRC-HEART FAIL, V7, P918, DOI 10.1161/CIRCHEARTFAILURE.113.000872	27	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	NOV	2015	21	11					859	864		10.1016/j.cardfail.2015.05.007		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CV9JK	WOS:000364603300002		
J	Nguyen, TD; Shingu, Y; Amorim, PA; Schwarzer, M; Doenst, T				Nguyen, T. Dung; Shingu, Yasushige; Amorim, Paulo A.; Schwarzer, Michael; Doenst, Torsten			Triheptanoin Alleviates Ventricular Hypertrophy and Improves Myocardial Glucose Oxidation in Rats With Pressure Overload	JOURNAL OF CARDIAC FAILURE			English	Article						Triheptanoin; anaplerosis; cardiac hypertrophy; cardiac metabolism	SYSTOLIC HEART-FAILURE; FATTY-ACID OXIDATION; INSULIN-RESISTANCE; REGULATED ANAPLEROSIS; METABOLISM; FLUX; INEFFICIENCY; CARBOXYLASE; INHIBITION; THERAPY	Objective: Cardiac hypertrophy is characterized by changes in substrate utilization and activity of the Krebs cycle. We assessed the effects of triheptanoin, an odd-chain fat that might support the Krebs cycle, on cardiac metabolism and function in a model of cardiac hypertrophy. Methods and Results: Rats were subjected to aortic banding (AoB) to induce pressure overload (PO). Starting at 1 week after AoB, rats were blindly fed a control diet or a special diet containing triheptanoin at 7% (T7 group) or 30% (T30 group) of total energy value. Six weeks after AoB, echocardiography revealed attenuated hypertrophy and improved diastolic function of the left ventricle. Isolated working heart perfusion showed similar cardiac power, fatty acid oxidation, substrate preference, and insulin response among groups. However, cardiac glucose oxidation (GO) was increased in the T30 group compared with the T7 and control groups. Blood levels of the odd-chain ketone body beta-hydroxypentanoate confirmed adequate bioavailability of triheptanoin. Importantly, they were directly proportional to cardiac GO. Conclusions: Treatment with triheptanoin-enriched diet reduces ventricular hypertrophy and improves diastolic function in rats with PO, which is associated with enhanced cardiac GO. The results suggest targeting supplementation of the Krebs cycle to approach ventricular and metabolic remodeling in cardiac hypertrophy.	[Nguyen, T. Dung; Amorim, Paulo A.; Schwarzer, Michael; Doenst, Torsten] Univ Jena, Dept Cardiothorac Surg, Jena Univ Hosp, D-07747 Jena, Germany; [Shingu, Yasushige] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc & Thorac Surg, Sapporo, Hokkaido, Japan	Doenst, T (reprint author), Univ Jena, Dept Cardiothorac Surg, Erlanger Allee 101, D-07747 Jena, Germany.	doenst@med.uni-jena.de					Zhang LY, 2013, CIRC-HEART FAIL, V6, P1039, DOI 10.1161/CIRCHEARTFAILURE.112.000228; Shingu Y, 2010, EUR J ECHOCARDIOGR, V11, P829, DOI 10.1093/ejechocard/jeq077; Atherton HJ, 2011, CIRCULATION, V123, P2552, DOI 10.1161/CIRCULATIONAHA.110.011387; Roe CR, 2006, J INHERIT METAB DIS, V29, P332, DOI 10.1007/s10545-006-0290-3; Zaha V, 2003, THORAC CARDIOV SURG, V51, P211; Dai DF, 2011, CIRC RES, V108, P837, DOI 10.1161/CIRCRESAHA.110.232306; Chokshi A, 2012, CIRCULATION, V125, P2844, DOI 10.1161/CIRCULATIONAHA.111.060889; Fillmore N, 2013, BBA-MOL CELL RES, V1833, P857, DOI 10.1016/j.bbamcr.2012.08.014; Amorim PA, 2010, J THORAC CARDIOV SUR, V140, P1160, DOI 10.1016/j.jtcvs.2010.08.003; Okere IC, 2006, J APPL PHYSIOL, V100, P76, DOI 10.1152/japplphysiol.00255.2005; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Kolwicz SC, 2012, CIRC RES, V111, P728, DOI 10.1161/CIRCRESAHA.112.268128; Labarthe F, 2008, CARDIOVASC DRUG THER, V22, P97, DOI 10.1007/s10557-008-6084-0; Doenst T, 1999, ANN THORAC SURG, V67, P1682, DOI 10.1016/S0003-4975(99)00326-4; RUSSELL RR, 1991, J CLIN INVEST, V87, P384, DOI 10.1172/JCI115008; Sorokina N, 2007, CIRCULATION, V115, P2033, DOI 10.1161/CIRCULATIONAHA.106.668665; Dai DF, 2011, J AM COLL CARDIOL, V58, P73, DOI 10.1016/j.jacc.2010.12.044; Nguyen TD, 2013, INT J CARDIOL, V168, P4085, DOI 10.1016/j.ijcard.2013.07.018; Taegtmeyer H, 2002, CIRCULATION, V106, P2043, DOI 10.1161/01.CIR.0000036760.42319.3F; Lionetti V, 2011, CARDIOVASC RES, V90, P202, DOI 10.1093/cvr/cvr038; Katz AM, 2000, CIRCULATION, V102, P69; Ussher JR, 2012, CIRC RES, V111, P628, DOI 10.1161/CIRCRESAHA.111.246371; Pound KM, 2009, CIRC RES, V104, P805, DOI 10.1161/CIRCRESAHA.108.189951; Martini WZ, 2003, AM J PHYSIOL-ENDOC M, V284, pE351, DOI 10.1152/ajpendo.00354.2002; Dyck JRB, 2004, CIRC RES, V94, pE78, DOI 10.1161/01.RES.0000129255.19569.8f; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Des Rosiers Christine, 2011, Cardiovasc Res, V90, P210, DOI 10.1093/cvr/cvr055; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Kinman RP, 2006, AM J PHYSIOL-ENDOC M, V291, pE860, DOI 10.1152/ajpendo.00366.2005; KORNBERG HL, 1967, B SOC CHIM BIOL, V49, P1479; Mori J, 2013, AM J PHYSIOL-HEART C, V304, pH1103, DOI 10.1152/ajpheart.00636.2012; Russell RR, 1991, AM J PHYS, V261, pH11756	32	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	NOV	2015	21	11					906	915		10.1016/j.cardfail.2015.07.009		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CV9JK	WOS:000364603300009		
J	Yukiura, H; Kano, K; Kise, R; Inoue, A; Aoki, J				Yukiura, Hiroshi; Kano, Kuniyuki; Kise, Ryoji; Inoue, Asuka; Aoki, Junken			LPP3 localizes LPA(6) signalling to non-contact sites in endothelial cells	JOURNAL OF CELL SCIENCE			English	Article						LPA receptor; LPP3; Endothelial cell; Lysophosphatidic acid	PHOSPHATIDIC-ACID PHOSPHATASE; LYSOPHOSPHATIDIC ACID; BARRIER FUNCTION; RECEPTORS	Lysophosphatidic acid (LPA) is emerging as an angiogenic factor, because knockdown of the enzyme that produces it (autotaxin, also known as ENPP2) and its receptors cause severe developmental vascular defects in both mice and fish. In addition, overexpression of autotaxin in mice causes similar vascular defects, indicating that the extracellular amount of LPA must be tightly regulated. Here, we focused on an LPA-degrading enzyme, lipid phosphate phosphatase 3 (LPP3, also known as PPAP2B), and showed that LPP3 was localized in specific cell-cell contact sites of endothelial cells and suppresses LPA signalling through the LPA6 receptor (also known as LPAR6). In HEK293 cells, overexpression of LPP3 dramatically suppressed activation of LPA6. In human umbilical vein endothelial cells (HUVECs), LPA induced actin stress fibre formation through LPA6, which was substantially upregulated by LPP3 knockdown. LPP3 was localized to cell-cell contact sites and was missing in non-contact sites to which LPA-induced actin stress fibre formation mediated by LPA6 was restricted. Interestingly, the expression of LPP3 in HUVECs was dramatically increased after forskolin treatment in a process involving Notch signalling. These results indicate that LPP3 regulates and localizes LPA signalling in endothelial cells, thereby stabilizing vessels through Notch signalling for proper vasculature.	[Yukiura, Hiroshi; Kano, Kuniyuki; Kise, Ryoji; Inoue, Asuka; Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Inoue, Asuka] Japan Sci & Technol Agcy, PRESTO, Chiyoda Ku, Tokyo 1000004, Japan; [Aoki, Junken] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol AMED CREST, Chiyoda Ku, Tokyo 1000004, Japan	Aoki, J (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	jaoki@m.tohoku.ac.jp			AMED-CREST (Japan Agency for Medical Research and Development, Core Research for Evolutional Science and Technology); Ministry of Science, Sports, and Culture of Japan	This research was supported by grants from AMED-CREST (Japan Agency for Medical Research and Development, Core Research for Evolutional Science and Technology); the Ministry of Science, Sports, and Culture of Japan to J.A. and PRESTO (Japan Science and Technology Agency, Precursory Research for Embryonic Science and Technology) to A. I. Deposited in PMC for immediate release.	STELZNER TJ, 1989, J CELL PHYSIOL, V139, P157, DOI 10.1002/jcp.1041390122; Yukiura H, 2011, J BIOL CHEM, V286, P43972, DOI 10.1074/jbc.M111.301093; Inoue A, 2011, EMBO J, V30, P4248, DOI 10.1038/emboj.2011.296; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Kai M, 1997, J BIOL CHEM, V272, P24572, DOI 10.1074/jbc.272.39.24572; Brindley DN, 2009, J LIPID RES, V50, pS225, DOI 10.1194/jlr.R800055-JLR200; Humtsoe JO, 2005, BIOCHEM BIOPH RES CO, V335, P906, DOI 10.1016/j.bbrc.2005.07.157; Pyne S, 2005, BIOCHEM SOC T, V33, P1370; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Chun J, 2010, PHARMACOL REV, V62, P579, DOI 10.1124/pr.110.003111; Panchatcharam M, 2014, ARTERIOSCL THROM VAS, V34, P837, DOI 10.1161/ATVBAHA.113.302335; Ren YL, 2013, MICROVASC RES, V85, P59, DOI 10.1016/j.mvr.2012.10.004; Humtsoe JO, 2003, EMBO J, V22, P1539, DOI 10.1093/emboj/cdg165; Jiang GW, 2013, BIOORG MED CHEM LETT, V23, P1865, DOI 10.1016/j.bmcl.2013.01.002; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007; Roberts R, 1998, J BIOL CHEM, V273, P22059, DOI 10.1074/jbc.273.34.22059; Jia YJ, 2003, FEBS LETT, V552, P240, DOI 10.1016/S0014-5793(03)00931-1; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Escalante-Alcalde D, 2003, DEVELOPMENT, V130, P4623, DOI 10.1242/dev.00635; McDermot MI, 2006, METHODS, V39, P169, DOI 10.1016/j.ymeth.2006.05.010; Wary Kishore K, 2005, Cell Commun Signal, V3, P9, DOI 10.1186/1478-811X-3-9; Yukiura H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126734	26	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0021-9533	1477-9137		J CELL SCI	J. Cell Sci.	NOV 1	2015	128	21					3871	3877		10.1242/jcs.172098		7	Cell Biology	Cell Biology	CV8IK	WOS:000364526500005		
J	Saitow, M; Kurashige, Y; Yanai, T				Saitow, Masaaki; Kurashige, Yuki; Yanai, Takeshi			Fully Internally Contracted Multireference Configuration Interaction Theory Using Density Matrix Renormalization Group: A Reduced-Scaling Implementation Derived by Computer-Aided Tensor Factorization	JOURNAL OF CHEMICAL THEORY AND COMPUTATION			English	Article							COUPLED-CLUSTER METHOD; SELF-CONSISTENT-FIELD; SIZE-EXTENSIVE MODIFICATION; HIGH-VALENT IRON; MULTICONFIGURATION REFERENCE STATE; DEGENERATE PERTURBATION-THEORY; CYTOCHROME-P450 COMPOUND I; INITIO QUANTUM-CHEMISTRY; MR-AQCC METHOD; AB-INITIO	We present an extended implementation of the multi-reference configuration interaction (MRCI) method combined with the quantum-chemical density matrix renormalization group (DMRG). In the previous study, we introduced the combined theory, referred to as DMRG-MRCI, as a method to calculate high-level dynamic electron correlation on top of the DMRG wave function that accounts for active-space (or strong) correlation using a large number of active orbitals. The DMRG-MRCI method is built on the full internal-contraction scheme for the compact reference treatment and on the cumulant approximation for the treatment of the four-particle rank reduced density matrix (4-RDM). The previous implementation achieved the MRCI calculations with the active space (24e,24o), which are deemed the record largest, whereas the inherent N-act(8) X N complexity of computation was found a hindrance to using further large active space. In this study, an extended optimization of the tensor contractions is developed by explicitly incorporating the rank reduction of the decomposed form of the cumulant-approximated 4-RDM into the factorization. It reduces the computational scaling (to N-act(7) X N) as well as the cache-miss penalty associated with direct evaluation of complex cumulant reconstruction. The present scheme, however, faces the increased complexity of factorization patterns for optimally implementing the tensor contraction terms involving the decomposed 4-RDM objects. We address this complexity using the enhanced symbolic manipulation computer program for deriving and coding programmable equations. The new DMRG-MRCI implementation is applied to the determination of the stability of the iron(IV)-oxo porphyrin relative to the iron(V) electronic isomer (electromer) using the active space (29e,29o) (including four second d-shell orbitals of iron) with triple-zeta-quality atomic orbital basis sets. The DMRG-cu(4)-MRCI+Q model is shown to favor the triradicaloid iron(IV)-oxo state as the lowest energy state and characterize the iron(V) electromer as thermally inaccessible, supporting the earlier experimental and density functional studies. This conflicts with the previous MR. calculations using the restricted active-space second-order perturbation theory (RASPT2) with the similar-size active space (29e,28o) reported by Pierloot et al. (Radon, M.; Broclawik, E.; Pierloot, K. J. Chem. Theory Comput. 2011, 7, 898), showing that the hypothetical iron(V) state indicated by recent laser flash photolysis (LFP) studies is likely thermally accessible because of its underestimated relative energy.	[Saitow, Masaaki; Kurashige, Yuki; Yanai, Takeshi] Grad Univ Adv Studies, Okazaki, Aichi 4448585, Japan; [Kurashige, Yuki; Yanai, Takeshi] Inst Mol Sci, Dept Theoret & Computat Mol Sci, Okazaki, Aichi 4448585, Japan; [Kurashige, Yuki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Saitow, M (reprint author), Grad Univ Adv Studies, Okazaki, Aichi 4448585, Japan.	msaitow514@gmail.com			Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT) [26104538]; Morino Foundation for Molecular Science;  [25288013];  [15H01097];  [25410030]	Y.K. and T.Y. were supported by a Grant-in-Aid for Scientific Research (B) (Grant No. 25288013) and on Innovative Areas "Photosynergetics" (Grant No. 15H01097), and Y.K. also received funding by a Grant-in-Aid for Scientific Research (C) (Grant No. 25410030) and on Innovative Areas "Soft Molecular Systems" (Grant No. 26104538), from the Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT). Y.K. was supported by a grant of the Morino Foundation for Molecular Science.	ANDERSSON K, 1992, J CHEM PHYS, V96, P1218, DOI 10.1063/1.462209; WERNER HJ, 1988, J CHEM PHYS, V89, P5803, DOI 10.1063/1.455556; OLSEN J, 1988, J CHEM PHYS, V89, P2185, DOI 10.1063/1.455063; Kim SH, 2006, J AM CHEM SOC, V128, P5598, DOI 10.1021/ja060776l; Ivanov VV, 2000, J CHEM PHYS, V112, P9258, DOI 10.1063/1.481547; Kurashige Y, 2014, MOL PHYS, V112, P1485, DOI 10.1080/00268976.2013.843730; Harischandra DN, 2009, ORG LETT, V11, P2089, DOI 10.1021/ol900480p; KNOWLES PJ, 1988, CHEM PHYS LETT, V145, P514, DOI 10.1016/0009-2614(88)87412-8; JANSEN G, 1989, PHYS REV A, V39, P6016, DOI 10.1103/PhysRevA.39.6016; Jagau TC, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3370847; Chan GKL, 2004, J CHEM PHYS, V120, P3172, DOI 10.1063/1.1638734; Shamasundar KR, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3256237; NAKANO H, 1993, J CHEM PHYS, V99, P7983, DOI 10.1063/1.465674; Schollwock U, 2005, REV MOD PHYS, V77, P259, DOI 10.1103/RevModPhys.77.259; Verstraete F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.227205; Hanrath M, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3467878; Jagau TC, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4734308; Groves JT, 2006, J INORG BIOCHEM, V100, P434, DOI 10.1016/j.jinorgbio.2006.01.012; Auer AA, 2006, MOL PHYS, V104, P211, DOI 10.1080/00268970500275780; Datta D, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3592494; Chan GKL, 2002, J CHEM PHYS, V116, P4462, DOI 10.1063/1.1449459; WHITE SR, 1992, PHYS REV LETT, V69, P2863, DOI 10.1103/PhysRevLett.69.2863; Celani P, 2000, J CHEM PHYS, V112, P5546, DOI 10.1063/1.481132; Faglioni F, 1999, INT J QUANTUM CHEM, V73, P1, DOI 10.1002/(SICI)1097-461X(1999)73:1<1::AID-QUA1>3.0.CO;2-0; OSTLUND S, 1995, PHYS REV LETT, V75, P3537, DOI 10.1103/PhysRevLett.75.3537; Neuscamman E, 2010, INT REV PHYS CHEM, V29, P231, DOI 10.1080/01442351003620540; Venkatnathan A, 2004, J CHEM PHYS, V120, P1693, DOI 10.1063/1.1635796; Parker SM, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4813827; Radon M, 2011, J CHEM THEORY COMPUT, V7, P898, DOI 10.1021/ct1006168; Walter D, 2001, CHEM PHYS LETT, V346, P177, DOI 10.1016/S0009-2614(01)00966-6; Werner HJ, 2012, WIRES COMPUT MOL SCI, V2, P242, DOI 10.1002/wcms.82; Kurashige Y, 2014, PHYS CHEM CHEM PHYS, V16, P11988, DOI 10.1039/c3cp55225j; Daul S, 2000, INT J QUANTUM CHEM, V79, P331, DOI 10.1002/1097-461X(2000)79:6<331::AID-QUA1>3.3.CO;2-P; JEZIORSKI B, 1981, PHYS REV A, V24, P1668, DOI 10.1103/PhysRevA.24.1668; Szalay PG, 2008, CHEM PHYS, V349, P121, DOI 10.1016/j.chemphys.2008.03.011; Mitrushenkov AO, 2001, J CHEM PHYS, V115, P6815, DOI 10.1063/1.1389475; Marti KH, 2011, PHYS CHEM CHEM PHYS, V13, P6750, DOI 10.1039/c0cp01883j; SZALAY PG, 1993, CHEM PHYS LETT, V214, P481, DOI 10.1016/0009-2614(93)85670-J; MALMQVIST PA, 1990, J PHYS CHEM-US, V94, P5477, DOI 10.1021/j100377a011; Jagau TC, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4734309; Sharma S, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3695642; Neuscamman E, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3125004; Rommer S, 1997, PHYS REV B, V55, P2164, DOI 10.1103/PhysRevB.55.2164; RUEDENBERG K, 1982, CHEM PHYS, V71, P41, DOI 10.1016/0301-0104(82)87004-3; Gdanitz RJ, 2001, INT J QUANTUM CHEM, V85, P281, DOI 10.1002/qua.10019; Pan ZZ, 2006, J INORG BIOCHEM, V100, P524, DOI 10.1016/j.jinorgbio.2005.12.022; Angeli C, 2012, MOL PHYS, V110, P2963, DOI 10.1080/00268976.2012.689872; Forsberg N, 1997, CHEM PHYS LETT, V274, P196, DOI 10.1016/S0009-2614(97)00669-6; Manni GL, 2013, J CHEM THEORY COMPUT, V9, P3375, DOI 10.1021/ct400046n; RUEDENBERG K, 1979, INT J QUANTUM CHEM, V16, P1069, DOI 10.1002/qua.560160511; Parker SM, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4902991; Ma YJ, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4809682; Legeza O, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.125114; Chen H, 2010, J CHEM THEORY COMPUT, V6, P940, DOI 10.1021/ct9006234; Szalay PG, 2012, CHEM REV, V112, P108, DOI 10.1021/cr200137a; Ghigo G, 2004, CHEM PHYS LETT, V396, P142, DOI 10.1016/j.cplett.2004.08.032; Celani P, 2003, J CHEM PHYS, V119, P5044, DOI 10.1063/1.1597672; Nakano H, 2002, J COMPUT CHEM, V23, P1166, DOI 10.1002/jcc.10050; Podewitz M, 2011, FARADAY DISCUSS, V148, P119, DOI 10.1039/c004195e; Cardoen W, 2002, CHEM PHYS LETT, V364, P39, DOI 10.1016/S0009-2614(02)00921-1; WHITE SR, 1993, PHYS REV B, V48, P10345, DOI 10.1103/PhysRevB.48.10345; Shaik S, 2005, CHEM REV, V105, P2279, DOI 10.1021/cr030722j; COLMENERO F, 1993, PHYS REV A, V47, P971, DOI 10.1103/PhysRevA.47.971; Parkhill JA, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3086027; LAIDIG WD, 1987, J CHEM PHYS, V86, P887, DOI 10.1063/1.452291; ANDERSSON K, 1990, J PHYS CHEM-US, V94, P5483, DOI 10.1021/j100377a012; Lischka H, 2001, PHYS CHEM CHEM PHYS, V3, P664, DOI 10.1039/b008063m; Wouters S, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4885815; Cabrero J, 2002, MOL PHYS, V100, P919, DOI 10.1080/00268970110105433; Cullen J, 1996, CHEM PHYS, V202, P217, DOI 10.1016/0301-0104(95)00321-5; Chan GKL, 2008, PROG T CHEM, V18, P49; Evangelista FA, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3559149; Roos BO, 2005, J PHYS CHEM A, V109, P6575, DOI 10.1021/jp0581126; Lan TN, 2014, J CHEM THEORY COMPUT, V10, P1953, DOI 10.1021/ct400978j; Shiozaki T, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3587632; Krisiloff DB, 2012, PHYS CHEM CHEM PHYS, V14, P7710, DOI 10.1039/c2cp23757a; Rassolov VA, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2755738; Ivanic J, 2003, J CHEM PHYS, V119, P9364, DOI 10.1063/1.1615954; GDANITZ RJ, 1988, CHEM PHYS LETT, V143, P413, DOI 10.1016/0009-2614(88)87388-3; HUNT WJ, 1972, J CHEM PHYS, V57, P738, DOI 10.1063/1.1678308; PULAY P, 1984, J CHEM PHYS, V81, P1901, DOI 10.1063/1.447863; Chan GKL, 2003, J CHEM PHYS, V118, P8551, DOI 10.1063/1.1574318; Hanauer M, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4757728; Angeli C, 2001, J CHEM PHYS, V114, P10252, DOI 10.1063/1.1361246; White SR, 1999, J CHEM PHYS, V110, P4127, DOI 10.1063/1.478295; SIEGBAHN PEM, 1992, INT J QUANTUM CHEM, V41, P153, DOI 10.1002/qua.560410114; Malmqvist PA, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2920188; DAVIDSON ER, 1975, J COMPUT PHYS, V17, P87, DOI 10.1016/0021-9991(75)90065-0; LANGHOFF SR, 1974, INT J QUANTUM CHEM, V8, P61, DOI 10.1002/qua.560080106; WERNER HJ, 1982, J CHEM PHYS, V76, P3144, DOI 10.1063/1.443357; de Oliveira FT, 2007, SCIENCE, V315, P835, DOI 10.1126/science.1133417; Weiss R, 2001, J BIOL INORG CHEM, V6, P831, DOI 10.1007/s007750100277; JANSSEN CL, 1991, THEOR CHIM ACTA, V79, P1, DOI 10.1007/BF01113327; HESS BA, 1986, PHYS REV A, V33, P3742, DOI 10.1103/PhysRevA.33.3742; Murakami T, 1998, B CHEM SOC JPN, V71, P1343, DOI 10.1246/bcsj.71.1343; Mahapatra US, 1998, MOL PHYS, V94, P157, DOI 10.1080/002689798168448; Chen H, 2011, J PHYS CHEM B, V115, P1727, DOI 10.1021/jp110016u; ROOS BO, 1980, CHEM PHYS, V48, P157, DOI 10.1016/0301-0104(80)80045-0; Kurashige Y, 2013, NAT CHEM, V5, P660, DOI [10.1038/nchem.1677, 10.1038/NCHEM.1677]; Zgid D, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2883980; COLMENERO F, 1993, PHYS REV A, V47, P979, DOI 10.1103/PhysRevA.47.979; Hanauer M, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3592786; Van Voorhis T, 2002, J CHEM PHYS, V117, P9190, DOI 10.1063/1.1515319; Engels-Putzka A, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3561739; Hirata S, 2003, J PHYS CHEM A, V107, P9887, DOI 10.1021/jp034596z; Wouters S, 2014, COMPUT PHYS COMMUN, V185, P1501, DOI 10.1016/j.cpc.2014.01.019; Chan GKL, 2011, ANNU REV PHYS CHEM, V62, P465, DOI 10.1146/annurev-physchem-032210-103338; Altun A, 2008, J PHYS CHEM A, V112, P12904, DOI 10.1021/jp802092w; Jagau TC, 2012, CHEM PHYS, V401, P73, DOI 10.1016/j.chemphys.2011.10.016; Ghosh D, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2883976; Lee SH, 2007, CHEM-EUR J, V13, P9393, DOI 10.1002/chem.200700513; Hanrath M, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1953407; Kutzelnigg W, 2010, MOL PHYS, V108, P433, DOI 10.1080/00268970903547926; MEYER W, 1976, J CHEM PHYS, V64, P2901, DOI 10.1063/1.432551; Neuscamman E, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4829536; Pan ZZ, 2009, J AM CHEM SOC, V131, P2621, DOI 10.1021/ja807847q; Szalay PG, 2000, PHYS CHEM CHEM PHYS, V2, P2067, DOI 10.1039/b000224k; Neese F, 2003, J CHEM PHYS, V119, P9428, DOI 10.1063/1.1615956; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; MUKHERJEE D, 1977, MOL PHYS, V33, P955, DOI 10.1080/00268977700100871; Zgid D, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2883981; Lan TN, 2015, J CHEM THEORY COMPUT, V11, P73, DOI 10.1021/ct5007778; Hanrath M, 1997, CHEM PHYS, V225, P197, DOI 10.1016/S0301-0104(97)00241-3; Chalupsky J, 2014, J AM CHEM SOC, V136, P15977, DOI 10.1021/ja506934k; Hanauer M, 2012, CHEM PHYS, V401, P50, DOI 10.1016/j.chemphys.2011.09.024; BANERJEE A, 1981, INT J QUANTUM CHEM, V19, P207, DOI 10.1002/qua.560190203; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; BUENKER RJ, 1974, THEOR CHIM ACTA, V35, P33, DOI 10.1007/BF02394557; BUENKER RJ, 1975, THEOR CHIM ACTA, V39, P217, DOI 10.1007/BF00555301; Chan GKL, 2009, ANN REP COMP CHEM, V5, P149, DOI 10.1016/S1574-1400(09)00507-6; DAVIDSON ER, 1977, CHEM PHYS LETT, V52, P403, DOI 10.1016/0009-2614(77)80475-2; DOUGLAS M, 1974, ANN PHYS-NEW YORK, V82, P89, DOI 10.1016/0003-4916(74)90333-9; Evangelista FA, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4718704; FustiMolnar L, 1996, J PHYS CHEM-US, V100, P6288, DOI 10.1021/jp952840j; Gold A, 2000, J PORPHYR PHTHALOCYA, V4, P344, DOI 10.1002/(SICI)1099-1409(200006/07)4:4<344::AID-JPP224>3.3.CO;2-D; Hanauer M, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4718700; Jung C, 2011, BBA-PROTEINS PROTEOM, V1814, P46, DOI 10.1016/j.bbapap.2010.06.007; Kurashige Y, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4900878; Kurashige Y, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3152576; Kurashige Y, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3629454; Kutzelnigg W., 1997, J CHEM PHYS, V107, P432; Lischka H, 2011, WIRES COMPUT MOL SCI, V1, P191, DOI 10.1002/wcms.25; Liu B., 1978, NUMERICAL ALGORITHMS; MacLeod MK, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4907717; Marti KH, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2805383; Meyer W., 1977, METHODS ELECT STRUCT, V3, DOI 10.1007/978-1-4757-0887-5_11; Moritz G, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1824891; Nam W, 2007, ACCOUNTS CHEM RES, V40, P522, DOI 10.1021/ar700027f; Neuscamman E, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3274822; Neuscamman E, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3086932; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Perdew J. P., 1986, J PHYS, V33, P8822; POPLE JA, 1977, INT J QUANTUM CHEM, P149; Roos BO, 1987, ADV CHEM PHYS, V69, P399, DOI 10.1002/9780470142943.ch7; Saitow M., FEMTO INTEGRATED TOO; Saitow M, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4816627; Schollwock U, 2011, ANN PHYS-NEW YORK, V326, P96, DOI 10.1016/j.aop.2010.09.012; Shamasundar KR, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3609809; Sharma S, 2014, NAT CHEM, V6, P927, DOI [10.1038/nchem.2041, 10.1038/NCHEM.2041]; Sharma S., 2015, J CHEM PHYS, V142; Sharma S, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4895977; Shiozaki T, 2015, J CHEM THEORY COMPUT, V11, P4733, DOI 10.1021/acs.jctc.5b00754; Shiozaki T, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3528720; Wouters S, 2014, EUR PHYS J D, V68, DOI 10.1140/epjd/e2014-50500-1; Wouters S, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.075122; YAMAGUCHI K, 1992, J CHEM SOC CHEM COMM, P1721, DOI 10.1039/c39920001721; Yanai T, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2761870; Yanai T, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3275806; Yanai T, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2196410; Zgid D, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2814150	170	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1549-9618	1549-9626		J CHEM THEORY COMPUT	J. Chem. Theory Comput.	NOV	2015	11	11					5120	5131		10.1021/acs.jctc.5b00270		12	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CV9NN	WOS:000364614000008		
J	Harada, R; Kitao, A				Harada, Ryuhei; Kitao, Akio			Nontargeted Parallel Cascade Selection Molecular Dynamics for Enhancing the Conformational Sampling of Proteins	JOURNAL OF CHEMICAL THEORY AND COMPUTATION			English	Article							GLUTAMINE-BINDING-PROTEIN; HISTOGRAM ANALYSIS METHOD; FREE-ENERGY CALCULATIONS; BACTERIOPHAGE-T4 LYSOZYME; COLLECTIVE MOTIONS; FOLDING PROTEINS; TRANSITION; SIMULATION; CHIGNOLIN; SOLVENT	Nontargeted parallel cascade selection molecular dynamics (nt-PaCS-MD) is proposed as an efficient conformational sampling method to enhance the conformational transitions of proteins, which is an extension of the original targeted PaCS-MD (t-PaCS-MD). The original PaCS-MD comprises cycles of (0 selection of initial structures for multiple independent MD simulations toward a predetermined target and (ii) conformational sampling by the independent MDs. In nt-PaCS-MD, structures that significantly deviate from an average are regarded as candidates that have high potential to address other metastable states and are chosen as the initial structures in the selection. To select significantly deviated structures, we examine the root-mean-square deviation (RMSD) of snapshots generated from the average structure based on Gram-Schmidt orthogonalization. nt-PaCS-MD was applied to the folding of the mini-protein chignolin in implicit solvent and to the open closed conformational transitions of T4 lysozyme (T4L) and glutamine binding protein (QBP) in explicit solvent. We show that nt-PaCS-MD can reach chignolin's native state and can also cause the open closed transition of T4L and QBP on a nanosecond time scale, which are very efficient in terms of conformational sampling and comparable to that with t-PaCS-MD.	[Harada, Ryuhei] Univ Tsukuba, Dept Phys, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan; [Harada, Ryuhei] Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki 3058571, Japan; [Kitao, Akio] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Kitao, A (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	kitao@iam.u-tokyo.ac.jp	Kitao, Akio/B-8371-2008	Kitao, Akio/0000-0002-5221-0806	Japan Society for the Promotion of Science (JSPS) Research Fellowship for Young Scientists [15J03797, 26840056, 25104002, 15H04357]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT	This research was supported by a Japan Society for the Promotion of Science (JSPS) Research Fellowship for Young Scientists (no. 15J03797) and a Grant-in-Aid for Young Scientists (B) from JSPS (no. 26840056) to RH., by a Grant-in-Aid in Innovative Areas (no. 25104002) and a Grant-in-Aid for Science Research B (no. 15H04357) to A.K. from JSPS and the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and by Social and Scientific Priority Issues to be tackled using the Post K computer (achievement of a society that provides health and longevity, innovative drug discovery infrastructure through functional control of biomolecular systems) to A.K. from MEXT.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Suenaga A, 2007, CHEM-ASIAN J, V2, P591, DOI 10.1002/asia.200600385; KITAO A, 1991, CHEM PHYS, V158, P447, DOI 10.1016/0301-0104(91)87082-7; Harada R, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4813023; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Sun YJ, 1998, J MOL BIOL, V278, P219, DOI 10.1006/jmbi.1998.1675; TORRIE GM, 1974, CHEM PHYS LETT, V28, P578, DOI 10.1016/0009-2614(74)80109-0; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Harada R, 2011, CHEM PHYS LETT, V516, P113, DOI 10.1016/j.cplett.2011.09.006; Maragliano L, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2212942; Hsiao CD, 1996, J MOL BIOL, V262, P225, DOI 10.1006/jmbi.1996.0509; Harada R, 2012, J CHEM THEORY COMPUT, V8, P290, DOI 10.1021/ct200363h; Prinz JH, 2011, PHYS CHEM CHEM PHYS, V13, P16912, DOI 10.1039/c1cp21258c; Pan AC, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2959573; HAYWARD S, 1993, J MOL BIOL, V234, P1207, DOI 10.1006/jmbi.1993.1671; Leech J, 1996, IEEE COMPUT SCI ENG, V3, P38, DOI 10.1109/99.556511; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Harada R, 2011, J PHYS CHEM B, V115, P8806, DOI 10.1021/jp2008623; Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9; Loeffler HH, 2009, BIOPHYS J, V97, P2541, DOI 10.1016/j.bpj.2009.08.019; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Shea JE, 2001, ANNU REV PHYS CHEM, V52, P499, DOI 10.1146/annurev.physchem.52.1.499; de Groot BL, 1998, PROTEINS, V31, P116, DOI 10.1002/(SICI)1097-0134(19980501)31:2<116::AID-PROT2>3.0.CO;2-K; Isralewitz B, 2001, J MOL GRAPH MODEL, V19, P13, DOI 10.1016/S1093-3263(00)00133-9; SCHLITTER J, 1993, MOL SIMULAT, V10, P291, DOI 10.1080/08927029308022170; Dellago C, 1998, J CHEM PHYS, V108, P1964, DOI 10.1063/1.475562; Dellago C, 2002, ADV CHEM PHYS, V123, P1, DOI 10.1002/0471231509.ch1; ZHANG XJ, 1994, PROTEIN SCI, V3, P1031; FERRENBERG AM, 1989, PHYS REV LETT, V63, P1195, DOI 10.1103/PhysRevLett.63.1195; Kitao A, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3613676; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Lane TJ, 2013, CURR OPIN STRUC BIOL, V23, P58, DOI 10.1016/j.sbi.2012.11.002; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; FRAUENFELDER H, 1988, ANNU REV BIOPHYS BIO, V17, P451; Souaille M, 2001, COMPUT PHYS COMMUN, V135, P40, DOI 10.1016/S0010-4655(00)00215-0; Satoh D, 2006, FEBS LETT, V580, P3422, DOI 10.1016/j.febslet.2006.05.015; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; WEAVER LH, 1987, J MOL BIOL, V193, P189, DOI 10.1016/0022-2836(87)90636-X; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Case D. A., 2010, AMBER 11; Chodera JD, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2714538; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikeguchi M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.078102; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mu Y. G., 2007, J CHEM PHYS, V127, DOI DOI 10.1063/1.2772264; Sakuraba S, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3498745; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409	50	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1549-9618	1549-9626		J CHEM THEORY COMPUT	J. Chem. Theory Comput.	NOV	2015	11	11					5493	5502		10.1021/acs.jctc.5b00723		10	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CV9NN	WOS:000364614000041		
J	Morioka, Y; Engelbrecht, F; Behera, SK				Morioka, Yushi; Engelbrecht, Francois; Behera, Swadhin K.			Potential Sources of Decadal Climate Variability over Southern Africa	JOURNAL OF CLIMATE			English	Article						Geographic location; entity; Africa; Indian Ocean; South Atlantic Ocean; Circulation; Dynamics; Atmosphere-ocean interaction; Models and modeling; General circulation models; Variability; Decadal variability	INDIAN-OCEAN REGION; KUROSHIO EXTENSION; AUSTRAL SUMMER; HEAT-BALANCE; EL-NINO; RAINFALL; OSCILLATION; PACIFIC; ENSO; SYSTEM	Potential sources of decadal climate variability over southern Africa are examined by conducting in-depth analysis of available datasets and coupled general circulation model (CGCM) experiments. The observational data in recent decades show a bidecadal variability noticeable in the southern African rainfall with its positive phase of peak during 1999/2000. It is found that the rainfall variability is related to anomalous moisture advection from the southwestern Indian Ocean, where the anomalous sea level pressure (SLP) develops. The SLP anomaly is accompanied by anomalous sea surface temperature (SST). Both SLP and SST anomalies slowly propagate eastward from the South Atlantic to the southwestern Indian Ocean. The analysis of mixed layer temperature tendency reveals that the SST anomaly in the southwestern Indian Ocean is mainly due to eastward advection of the SST anomaly by the Antarctic Circumpolar Current. The eastward propagation of SLP and SST anomalies are also confirmed in the 270-yr outputs of the CGCM control experiment. However, in a sensitivity experiment where the SST anomalies in the South Atlantic are suppressed by the model climatology, the eastward propagation of the SLP anomaly from the South Atlantic disappears. These results suggest that the local air-sea coupling in the South Atlantic may be important for the eastward propagation of the SLP anomaly from the South Atlantic to the southwestern Indian Ocean. Although remote influences from the tropical Pacific and Antarctica were widely discussed, this study provides new evidence for the potential role of local air-sea coupling in the South Atlantic for the decadal climate variability over southern Africa.	[Morioka, Yushi; Behera, Swadhin K.] Japan Agcy Marine Earth Sci & Technol, Applicat Lab, Yokohama, Kanagawa, Japan; [Engelbrecht, Francois] CSIR, Climate Studies Modelling & Environm Hlth, Nat Resources & Environm, ZA-0001 Pretoria, South Africa	Morioka, Y (reprint author), JAMSTEC, Applicat Lab, Kanazawa Ku, 3173-25 Showamachi, Yokohama, Kanagawa 2360001, Japan.	morioka@jamstec.go.jp			JSPS KAKENHI [15K17768]; Japan Science and Technology Agency/Japan Agency for Medical Research and Development through Science and Technology Research Partnership for Sustainable Development (SATREPS); Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [2-1405]; Applied Centre for Climate and Earth System Studies (ACCESS) in South Africa	The SINTEX-F2 was run on the Earth Simulator at the Japan Agency for Marine-Earth Science and Technology (JAMSTEC). Constructive comments from Drs. Toshio Yamagata, Yukio Masumoto, and Masami Nonaka helped improve the original manuscript. The authors are also grateful to three anonymous reviewers providing helpful comments to revise the manuscript. The present research is supported by JSPS KAKENHI Grant 15K17768, the Japan Science and Technology Agency/Japan Agency for Medical Research and Development through the Science and Technology Research Partnership for Sustainable Development (SATREPS), the Environment Research and Technology Development Fund (2-1405) of the Ministry of the Environment, Japan, and the Applied Centre for Climate and Earth System Studies (ACCESS) in South Africa.	ALLAN RJ, 1995, J CLIMATE, V8, P1853, DOI 10.1175/1520-0442(1995)008<1853:MVITCS>2.0.CO;2; Nakamura H, 2004, J CLIMATE, V17, P1828, DOI 10.1175/1520-0442(2004)017<1828:SVITSH>2.0.CO;2; Engelbrecht FA, 2009, INT J CLIMATOL, V29, P1013, DOI 10.1002/joc.1742; Masson S, 2012, CLIM DYNAM, V39, P681, DOI 10.1007/s00382-011-1247-2; Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Moisan JR, 1998, J PHYS OCEANOGR, V28, P401, DOI 10.1175/1520-0485(1998)028<0401:TSHBOT>2.0.CO;2; JURY MR, 1992, S AFR J SCI, V88, P275; NORTH GR, 1982, MON WEATHER REV, V110, P699, DOI 10.1175/1520-0493(1982)110<0699:SEITEO>2.0.CO;2; Ebita A, 2011, SOLA, V7, P149, DOI 10.2151/sola.2011-038; Colberg F, 2007, J CLIMATE, V20, P1016, DOI 10.1175/JCLI4055.1; Yasuda I, 2000, PROG OCEANOGR, V47, P257, DOI 10.1016/S0079-6611(00)00038-0; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Morioka Y, 2015, J CLIMATE, V28, P678, DOI 10.1175/JCLI-D-14-00133.1; SCHLESINGER ME, 1994, NATURE, V367, P723, DOI 10.1038/367723a0; Reason CJC, 1998, METEOROL ATMOS PHYS, V66, P243, DOI 10.1007/BF01026637; Luo JJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018649; Reason CJC, 1998, INT J CLIMATOL, V18, P391, DOI 10.1002/(SICI)1097-0088(19980330)18:4<391::AID-JOC253>3.0.CO;2-C; Reason CJC, 2001, INT J CLIMATOL, V21, P249; Mo KC, 2001, INT J CLIMATOL, V21, P1211, DOI 10.1002/joc.685; Malherbe J, 2014, CLIM DYNAM, V42, P3121, DOI 10.1007/s00382-013-2027-y; Mason SJ, 1997, PROG PHYS GEOG, V21, P23, DOI 10.1177/030913339702100103; Nakamura M, 2012, J CLIMATE, V25, P1213, DOI [10.1175/JCL1-D-11-00088.1, 10.1175/JCLI-D-11-00088.1]; Cook KH, 2000, J CLIMATE, V13, P3789, DOI 10.1175/1520-0442(2000)013<3789:TSICZA>2.0.CO;2; Thompson DWJ, 2000, J CLIMATE, V13, P1000, DOI 10.1175/1520-0442(2000)013<1000:AMITEC>2.0.CO;2; Venegas SA, 1997, J CLIMATE, V10, P2904, DOI 10.1175/1520-0442(1997)010<2904:AOCVIT>2.0.CO;2; PAULSON CA, 1977, J PHYS OCEANOGR, V7, P952, DOI 10.1175/1520-0485(1977)007<0952:IMITUO>2.0.CO;2; TYSON PD, 1975, Q J ROY METEOR SOC, V101, P817; Power S, 1999, CLIM DYNAM, V15, P319, DOI 10.1007/s003820050284; Malherbe J, 2012, INT J CLIMATOL, V32, P1018, DOI 10.1002/joc.2320; Luo JJ, 2005, J CLIMATE, V18, P2344, DOI 10.1175/JCLI3404.1; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; MASON SJ, 1990, S AFR J SCI, V86, P243; L'Heureux ML, 2006, J CLIMATE, V19, P276, DOI 10.1175/JCLI3617.1; Ratnam JV, 2014, J CLIMATE, V27, P3802, DOI 10.1175/JCLI-D-13-00431.1; Reason CJC, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014663; Fogt RL, 2006, J CLIMATE, V19, P979, DOI 10.1175/JCLI3671.1; QIU B, 1993, J PHYS OCEANOGR, V23, P2027, DOI 10.1175/1520-0485(1993)023<2027:UOHBIT>2.0.CO;2; Pohl B, 2010, J CLIMATE, V23, P238, DOI 10.1175/2009JCLI2443.1; Ashok K, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003798; Balmaseda MA, 2013, Q J ROY METEOR SOC, V139, P1132, DOI 10.1002/qj.2063; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Fichefet T, 1997, J GEOPHYS RES-OCEANS, V102, P12609, DOI 10.1029/97JC00480; Jury MR, 2015, THEOR APPL CLIMATOL, V120, P227, DOI 10.1007/s00704-014-1165-4; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI [10.1175/Bams-83-11-1631, 10.1175/BAMS-83-11-1631]; KRAUS EB, 1967, TELLUS, V19, P98; Madec G., 2008, 27 IPSL, V27; Ngara T., 1983, Zimbabwe Agricultural Journal, V80, P149; NOAA/ESRL/Physical Sciences Division, 2011, ICOADS 1 DEGR REL 2; Reason CJC, 1996, J GEOPHYS RES-OCEANS, V101, P11867, DOI 10.1029/96JC00122; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Roeckner E., 2003, 349 MPI; Schneider U, 2011, GPCC FULL DATA REANA, DOI [10.5676/DWD_GPCC/FD_M_V6_050, DOI 10.5676/DWD_GPCC/FD_M_V6_050, http://dx.doi.org/10.5676/DWD_GPCC/FD_M_V6_050]; Tyson P. D., 1986, CLIMATIC CHANGE VARI; Valcke S., 2004, TRCMGC0468 CERFACS	54	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	NOV	2015	28	22					8695	8709		10.1175/JCLI-D-15-0201.1		15	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CV9TM	WOS:000364629500003		
J	Wang, B; Kajikawa, Y				Wang, Bin; Kajikawa, Yoshiyuki			Reply to "Comments on 'Interdecadal Change of the South China Sea Summer Monsoon Onset'''	JOURNAL OF CLIMATE			English	Editorial Material						Atm; Ocean Structure; Phenomena; Monsoons; Physical Meteorology and Climatology; Climate change; Climate variability	SYNOPTIC-SCALE DISTURBANCES; MADDEN-JULIAN OSCILLATION; INTRASEASONAL OSCILLATIONS; PART I; PACIFIC; MJO; ENERGETICS; CONVECTION		[Wang, Bin] Univ Hawaii, Dept Atmospher Sci, Honolulu, HI 96822 USA; [Wang, Bin] Univ Hawaii, Atmosphere Ocean Res Ctr, Honolulu, HI 96822 USA; [Kajikawa, Yoshiyuki] RIKEN, Adv Inst Computat Sci, Kobe, Hyogo 6500047, Japan	Kajikawa, Y (reprint author), RIKEN, Adv Inst Computat Sci, Chuo Ku, 7-1-26 Minatojima Minami Machi, Kobe, Hyogo 6500047, Japan.	ykaji@riken.jp					Wang B, 2009, DYNAM ATMOS OCEANS, V47, P15, DOI 10.1016/j.dynatmoce.2008.09.004; Hsu PC, 2011, J CLIMATE, V24, P942, DOI 10.1175/2010JCLI3834.1; Wang B, 2004, J CLIMATE, V17, P699, DOI 10.1175/2932.1; Straub KH, 2003, MON WEATHER REV, V131, P945, DOI 10.1175/1520-0493(2003)131<0945:IBTBSI>2.0.CO;2; Xiang BQ, 2013, J CLIMATE, V26, P1993, DOI 10.1175/JCLI-D-12-00445.1; Zhou W, 2005, INT J CLIMATOL, V25, P1585, DOI 10.1002/joc.1209; Kikuchi K, 2009, J CLIMATE, V22, P1340, DOI 10.1175/2008JCLI2368.1; Moncrieff MW, 2004, J ATMOS SCI, V61, P1521, DOI 10.1175/1520-0469(2004)061<1521:AROTLO>2.0.CO;2; Fu XH, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037166; Maloney ED, 2003, J ATMOS SCI, V60, P2153, DOI 10.1175/1520-0469(2003)060<2153:TIOATE>2.0.CO;2; Sobel AH, 2000, GEOPHYS RES LETT, V27, P1739, DOI 10.1029/1999GL011043; Biello JA, 2007, J ATMOS SCI, V64, P1636, DOI 10.1175/JCLI3908.1; Krishnamurti TN, 2003, Q J ROY METEOR SOC, V129, P2559, DOI 10.1256/qj.02.151; Zhou CH, 2010, J CLIMATE, V23, P5738, DOI 10.1175/2010JCLI3468.1; Wang B, 2006, CLIM DYNAM, V27, P661, DOI 10.1007/s00382-006-0163-3; Kikuchi K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019601; Kajikawa Y, 2012, J CLIMATE, V25, P3207, DOI 10.1175/JCLI-D-11-00207.1; Maloney ED, 2001, J ATMOS SCI, V58, P2545, DOI 10.1175/1520-0469(2001)058<2545:TMJOBD>2.0.CO;2; Hsu PC, 2011, J CLIMATE, V24, P927, DOI 10.1175/2010JCLI3833.1; Chen GH, 2015, J CLIMATE, V28, P9029, DOI 10.1175/JCLI-D-14-00732.1; DUCHON CE, 1979, J APPL METEOROL, V18, P1016, DOI 10.1175/1520-0450(1979)018<1016:LFIOAT>2.0.CO;2; LAU KH, 1990, MON WEATHER REV, V118, P1888, DOI 10.1175/1520-0493(1990)118<1888:OSAPCO>2.0.CO;2; MURAKAMI T, 1980, MON WEATHER REV, V108, P205, DOI 10.1175/1520-0493(1980)108<0205:EOFAOS>2.0.CO;2; NAKAZAWA T, 1988, J METEOROL SOC JPN, V66, P823	24	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	NOV	2015	28	22					9036	9039		10.1175/JCLI-D-15-0173.1		4	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CV9TM	WOS:000364629500023		
J	Takeuchi, T; Chen, X; Matsui, R				Takeuchi, T.; Chen, X.; Matsui, R.			Seismic performance of controlled spine frames with energy-dissipating members	JOURNAL OF CONSTRUCTIONAL STEEL RESEARCH			English	Article						Spine system; Steel moment-resisting frame; Seismic performance; Vertical structural irregularity; Incremental dynamic analysis	VALIDATION	Recently, various controlled rocking systems have been proposed in seismic design to prevent damage concentration and to achieve self-centering against a wide range of input ground motion intensities. However, several obstacles must be overcome before these systems can be applied to actual buildings; for example, the requirement for large, self-centering post-tensioned strands and special treatment at uplift column bases must be addressed. This paper proposes a non-uplifting spine frame system with energy-dissipating members without post-tensioned strands, its self-centering function is achieved by envelope elastic-moment frames. The system is applied to an actual building constructed in Japan. Conventional shear damper and uplifting rocking systems with post-tensioned strands developed in prior studies are also applied to the same building structures, and the performances of the three systems, including damage distribution, energy dissipation, self-centering, robustness against severe earthquakes, and irregular stiffness, are compared and discussed through numerical simulations based on practical design criteria. (C) 2015 The Authors. Published by Elsevier Ltd.	[Takeuchi, T.; Chen, X.; Matsui, R.] Tokyo Inst Technol, Dept Architecture & Bldg Engn, Tokyo 1528550, Japan	Takeuchi, T (reprint author), Tokyo Inst Technol, Meguro Ku, M1-29,2-12-1 Ookayama, Tokyo 1528550, Japan.	ttoru@arch.titech.ac.jp; chen.x.ad@m.titech.ac.jp; matsui.r.aa@m.titech.ac.jp					Al-Ali A.A.K., 1998, 130 STANF U JA BLUM; Ikenaga M, 2006, PROC MONOGR ENG WATE, P703; [Anonymous], 2000, FEMA355 EARTHQ ENG R; Chintanapakdee C, 2004, J STRUCT ENG-ASCE, V130, P1177, DOI 10.1061/(ASCE)0733-9445(2004)130:8(1177); Miller DJ, 2012, ENG STRUCT, V40, P288, DOI 10.1016/j.engstruct.2012.02.037; Garlock MM, 2007, J STRUCT ENG-ASCE, V133, P389, DOI 10.1061/(ASCE)0733-9445(2007)133:3(389); Christopoulos C, 2008, J STRUCT ENG-ASCE, V134, P96, DOI 10.1061/(ASCE)0733-9445(2008)134:1(96); Vamvatsikos D, 2002, EARTHQUAKE ENG STRUC, V31, P491, DOI 10.1002/eqe.141; Midorikawa M, 2006, EARTHQ ENG STRUCT D, V35, P1767, DOI 10.1002/eqe.603; Clough R.W., 1977, UCBEERC7722; Deierlein G., 2011, 6 EUR C STEEL COMP S; Eatherton M., 2010, 2010 NASCC STRUCT C, P1523; Eatherton M.R., 2011, EARTHQ SPECTRA, V27, P19; Gunay S., 2009, IMPROVING SEISMIC PE, V2009, P1093; Housner G, 1963, B SEISMOLOGICAL SOC, V53, P403; Janhunen B., 2013, P STRUCT ENG ASS CAL; Ma X., 2010, 2010 NASCC STRUCT C, P1534; Mazzoni S., 2009, OPENSEES VERSION 2 0; Midorigawa M., 2002, P SOC PHOTO-OPT INS, V4696, P265, DOI DOI 10.1117/12.472562; Priestley M., 1978, B NZ NAT SOC EARTHQU, V11, P141; Qu Z., 2012, EARTHQ ENG STRUCT D, V41, P2075; Takamatsu T., 2008, P 14 WORLD C EARTHQ; Takeuchi T., 2003, P STESSA, P55; Takeuchi T., 2011, 6 EUR C STEEL COMP S; Tremblay R., 2008, P 14 WORLD C EARTHQ; Uriz P., 2008, PEER200808 U CAL; Wada A., 2001, 7 INT SEM SEISM IS P	27	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0143-974X	1873-5983		J CONSTR STEEL RES	J. Constr. Steel. Res.	NOV	2015	114						51	65		10.1016/j.jcsr.2015.07.002		15	Construction & Building Technology; Engineering, Civil	Construction & Building Technology; Engineering	CV8BK	WOS:000364501300006		
J	Kamibeppu, K; Murayama, S; Ozono, S; Sakamoto, N; Iwai, T; Asami, K; Maeda, N; Inada, H; Kakee, N; Okamura, J; Horibe, K; Ishida, Y				Kamibeppu, Kiyoko; Murayama, Shiho; Ozono, Shuichi; Sakamoto, Naoko; Iwai, Tsuyako; Asami, Keiko; Maeda, Naoko; Inada, Hiroko; Kakee, Naoko; Okamura, Jun; Horibe, Keizo; Ishida, Yasushi			Predictors of Posttraumatic Stress Symptoms Among Adolescent and Young Adult Survivors of Childhood Cancer: Importance of Monitoring Survivors' Experiences of Family Functioning	JOURNAL OF FAMILY NURSING			English	Article						cancer; family functioning; posttraumatic stress disorders; survivors	SOCIAL SUPPORT QUESTIONNAIRE; DISORDER; PARENTS; MOTHERS; TRAUMA; IMPACT	The purpose of this study was to identify factors associated with posttraumatic stress symptoms (PTSS) among Japanese long-term childhood cancer survivors (CCSs). Subjects comprised 185 adolescent and young adult (AYA) CCSs who completed anonymous self-report questionnaires. Attending physicians also completed an anonymous disease/treatment data sheet. Mean age of survivors was approximately 8 years at diagnosis and 23 years at participation. Multiple regression analysis showed that family functioning, satisfaction with social support, being female, and interactions between family functioning and gender and age at the time of diagnosis were associated with PTSS among survivors. This study revealed family functioning as the most predictive factor of PTSS among AYA CCSs in Japan. Even when the survivor may have unchangeable risk factors, family functioning can potentially moderate the effects on PTSS. Thus, it is crucial for health professionals to carefully monitor and attend to survivors' experiences of family functioning to mitigate PTSS.	[Kamibeppu, Kiyoko; Murayama, Shiho] Univ Tokyo, Grad Sch Med, Dept Family Nursing, Tokyo 1130033, Japan; [Murayama, Shiho] Sophia Univ, Fac Human Sci, Dept Nursing, Tokyo 102, Japan; [Ozono, Shuichi] Kurume Univ, Dept Pediat, Fukuoka, Japan; [Sakamoto, Naoko] Juntendo Univ, Sch Med, Dept Publ Hlth, Tokyo 113, Japan; [Iwai, Tsuyako] Shikoku Med Ctr Children & Adults, Dept Pediat Hematol Oncol, Kagawa, Japan; [Asami, Keiko] Niigata Canc Ctr Hosp, Dept Pediat, Niigata, Japan; [Maeda, Naoko] Natl Hosp Org, Nagoya Med Ctr, Dept Pediat, Nagoya, Japan; [Kakee, Naoko] Natl Res Inst Child Hlth & Dev, Div Bioeth, Tokyo, Japan; [Okamura, Jun] Kyushu Natl Canc Ctr, Inst Clin Res, Fukuoka, Japan; [Ishida, Yasushi] Ehime Prefectural Cent Hosp, Pediat Med Ctr, Ehime, Japan; [Inada, Hiroko] Kurume Univ, Sch Med, Dept Pediat & Child Hlth, Fukuoka, Japan; [Horibe, Keizo] Natl Hosp Org, Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan	Kamibeppu, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Family Nursing, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kkamibeppu-tky@umin.ac.jp			Japanese Ministry of Health, Labour, and Welfare	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was financially supported by Japanese Ministry of Health, Labour, and Welfare: Study of quality of life and prognosis in childhood cancer survivors and establishment of the long-term follow-up system (principal investigator [PI]: Yasushi Ishida) and Study to establish the standard treatment for childhood hematological malignancies (PI: Keizo Horibe).	Aiken L. S., 1991, MULTIPLE REGRESSION; American Psychiatric Association, 2000, QUICK REF DIAGN CRIT; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Taylor N, 2012, EUR J CANCER CARE, V21, P52, DOI 10.1111/j.1365-2354.2011.01281.x; Ganz FD, 2010, ONCOL NURS FORUM, V37, P160, DOI 10.1188/10.ONF.160-167; Stuber ML, 1997, PEDIATRICS, V100, P958, DOI 10.1542/peds.100.6.958; Hobbie WL, 2000, J CLIN ONCOL, V18, P4060; Werba BE, 2007, PEDIATR BLOOD CANCER, V48, P673, DOI 10.1002/pbc.21184; Kamibeppu K, 2010, J CANCER SURVIV, V4, P303, DOI 10.1007/s11764-010-0124-z; Alderfer MA, 2009, J FAM PSYCHOL, V23, P717, DOI 10.1037/a0015996; Furukawa TA, 1999, SOC PSYCH PSYCH EPID, V34, P216, DOI 10.1007/s001270050136; Imber-Black E, 2014, J FAM NURS, V20, P151, DOI 10.1177/1074840714530087; SARASON IG, 1983, J PERS SOC PSYCHOL, V44, P127, DOI 10.1037/0022-3514.44.1.127; Hawkins MM, 2008, PEDIATR BLOOD CANCER, V50, P1018, DOI 10.1002/pbc.21335; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; Langeveld NE, 2004, PEDIATR BLOOD CANCER, V42, P604, DOI 10.1002/pbc.20024; Schwartz L, 2006, J PEDIATR PSYCHOL, V31, P356, DOI 10.1093/jpepsy/jsj018; Ozono S, 2007, SUPPORT CARE CANCER, V15, P309, DOI 10.1007/s00520-006-0139-1; Kazak AE, 1997, J CONSULT CLIN PSYCH, V65, P120; Hayes AF, 2009, BEHAV RES METHODS, V41, P924, DOI 10.3758/BRM.41.3.924; Erickson SJ, 2000, PSYCHOSOMATICS, V41, P339, DOI 10.1176/appi.psy.41.4.339; Rourke MT, 2007, PEDIATR BLOOD CANCER, V49, P177, DOI 10.1002/pbc.20942; Schwartz LA, 2012, J CLIN PSYCHOL MED S, V19, P138, DOI 10.1007/s10880-011-9264-1; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; West CH, 2015, J FAM NURS, V21, P261, DOI 10.1177/1074840715576795; Kazak AE, 2001, J CLIN PSYCHOL MED S, V8, P307, DOI 10.1023/A:1011977031826; Phipps S, 2005, PEDIATR BLOOD CANCER, V45, P952, DOI 10.1002/pbc.20373; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; Olff M, 2007, PSYCHOL BULL, V133, P183, DOI 10.1037/0033-2909.133.2.183; Erickson SJ, 2001, CHILD PSYCHIAT HUM D, V31, P195, DOI 10.1023/A:1026477321319; Children's Oncology Group, 2013, LONG TERM FOLL GUID; Hudson Melissa M, 2004, J Pediatr Oncol Nurs, V21, P170, DOI 10.1177/1043454204264388; Izumi M., 2002, J JPN PEDIAT SOC, V106, P464; Kamibeppu K, 2003, JAPANESE J CHILD ADO, V44, P112; McDonald Catherine C, 2011, J Child Adolesc Psychiatr Nurs, V24, P38, DOI 10.1111/j.1744-6171.2010.00258.x; Meeske K A, 2001, Oncol Nurs Forum, V28, P481; Nagamine T, 1989, COMMUNITY MED, V3, P322; National Center for Child Health Development, 2012, NAT REG TREATM RES P; Nir Y., 1985, POSTTRAUMATIC STRESS, P121; Rourke M., 2005, SURVIVORS CHILDHOOD, P295, DOI 10.1007/3-540-26498-1_19; Rourke M T, 1999, J Pediatr Oncol Nurs, V16, P126, DOI 10.1177/104345429901600303; SMILKSTEIN G, 1978, J FAM PRACTICE, V6, P1231; Stuber ML, 2010, PEDIATRICS, V125, pE1124, DOI 10.1542/peds.2009-2308; Weiss D. S., 2004, ASSESSING PSYCHOL TR, P168, DOI DOI 10.1007/978-0-387-70990-1_10; Weiss Daniel S., 1997, P399; Wright L. M., 2013, NURSES FAMILIES GUID; Wright L.M., 2009, BELIEFS ILLNESS MODE	47	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1074-8407	1552-549X		J FAM NURS	J. Fam. Nurs.	NOV	2015	21	4					529	550		10.1177/1074840715606247		22	Family Studies; Nursing	Family Studies; Nursing	CV9UV	WOS:000364633700003		
J	Sugahara, S; Ueda, Y; Fukuhara, K; Kamamuta, Y; Matsuda, Y; Murata, T; Kuroda, Y; Kabata, K; Ono, M; Igoshi, K; Yasuda, S				Sugahara, Shintaro; Ueda, Yuto; Fukuhara, Kumiko; Kamamuta, Yuki; Matsuda, Yasushi; Murata, Tatsuro; Kuroda, Yasuhiro; Kabata, Kiyotaka; Ono, Masateru; Igoshi, Keiji; Yasuda, Shin			Antioxidant Effects of Herbal Tea Leaves from Yacon (Smallanthus sonchifolius) on Multiple Free Radical and Reducing Power Assays, Especially on Different Superoxide Anion Radical Generation Systems	JOURNAL OF FOOD SCIENCE			English	Article						antioxidant; herbal tea; Smallanthus sonchifolius; superoxide anion radical; yacon	CATION DECOLORIZATION ASSAY; XANTHINE-OXIDASE; REACTIVE OXYGEN; DIABETIC-RATS; PHENOLIC-COMPOUNDS; MEDICINAL-PLANTS; OXIDATIVE STRESS; FRUIT EXTRACTS; MOUSE SKIN; IN-VIVO	Yacon (Smallanthus sonchifolius), a native Andean plant, has been cultivated as a crop and locally used as a traditional folk medicine for the people suffering from diabetes and digestive/renal disorders. However, the medicinal properties of this plant and its processed foods have not been completely established. This study investigates the potent antioxidative effects of herbal tea leaves from yacon in different free radical models and a ferric reducing model. A hot-water extract exhibited the highest yield of total polyphenol and scavenging effect on 1,1-diphenyl-2-picryl hydrazyl (DPPH) radical among four extracts prepared with hot water, methanol, ethanol, and ethylacetate. In addition, a higher reducing power of the hot-water extract was similarly demonstrated among these extracts. Varying concentrations of the hot-water extract resulted in different scavenging activities in four synthetic free radical models: DPPH radical (EC50 28.1 mu g/mL), 2,2-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) cation radical (EC50 23.7 mu g/mL), galvinoxyl radical (EC50 3.06 mu g/mL), and chlorpromazine cation radical (EC50 475 mu g/mL). The yacon tea-leaf extract further demonstrated superoxide anion (O-2(-)) radical scavenging effects in the phenazine methosulfate-NADH-nitroblue tetrazolium (EC50 64.5 mu g/mL) and xanthine oxidase assay systems (EC50 20.7 mu g/mL). Subsequently, incubating human neutrophilic cells in the presence of the tea-leaf extract could suppress the cellular O-2(-) radical generation (IC50 65.7 mu g/mL) in a phorbol 12-myristate 13-acetate-activated cell model. These results support yacon tea leaves may be a good source of natural antioxidants for preventing O-2(-) radical-mediated disorders.	[Sugahara, Shintaro; Ueda, Yuto; Fukuhara, Kumiko; Kamamuta, Yuki; Matsuda, Yasushi; Murata, Tatsuro; Kabata, Kiyotaka; Ono, Masateru; Igoshi, Keiji; Yasuda, Shin] Tokai Univ, Sch Agr, Kawayo, Minamiaso, Kumamoto 8691404, Japan; [Kuroda, Yasuhiro] Tokai Univ, Sch Engn, Hiratsuka, Kanagawa 2591292, Japan; [Sugahara, Shintaro; Ueda, Yuto; Fukuhara, Kumiko; Kamamuta, Yuki; Matsuda, Yasushi; Murata, Tatsuro; Kabata, Kiyotaka; Ono, Masateru; Igoshi, Keiji; Yasuda, Shin] Tokai Univ, Sch Agr, Kumamoto 8691404, Japan; [Kuroda, Yasuhiro] Tokai Univ, Sch Engn, Hiratsuka, Kanagawa 2591292, Japan	Yasuda, S (reprint author), Tokai Univ, Sch Agr, Kumamoto 8691404, Japan.	shin.yasuda@agri.u-tokai.ac.jp			JSPS KAKENHI Grant [23780143, 15K18700]; Research and Study Program/Project of Tokai University Educational System General Research Organization (Kanagawa, Japan); "Center of Community (COC)" program (The Ministry of Education, Culture, Sports, Science, & Technology (MEXT), Japan)	This work was supported in part by Grant-in-Aid for Young Scientists (B) (JSPS KAKENHI Grant Numbers 23780143 and 15K18700), Research and Study Program/Project of Tokai University Educational System General Research Organization (Kanagawa, Japan), and "Center of Community (COC)" program (The Ministry of Education, Culture, Sports, Science, & Technology (MEXT), Japan). No potential conflicts of interest were disclosed.	Przedborski S, 2005, ANTIOXID REDOX SIGN, V7, P685, DOI 10.1089/ars.2005.7.685; Nguyen MTT, 2004, BIOL PHARM BULL, V27, P1414, DOI 10.1248/bpb.27.1414; Genta S, 2009, CLIN NUTR, V28, P182, DOI 10.1016/j.clnu.2009.01.013; Kim YJ, 2004, BIOMACROMOLECULES, V5, P547, DOI 10.1021/bm034392o; Delgado GTC, 2013, PLANT FOOD HUM NUTR, V68, P222, DOI 10.1007/s11130-013-0362-0; Valentova K, 2005, J AGR FOOD CHEM, V53, P5577, DOI 10.1021/jf050403o; Sabu MC, 2002, J ETHNOPHARMACOL, V81, P155, DOI 10.1016/S0378-8741(02)00034-X; Ukeda H, 1999, BIOSCI BIOTECH BIOCH, V63, P485, DOI 10.1271/bbb.63.485; Campos D, 2012, FOOD CHEM, V135, P1592, DOI 10.1016/j.foodchem.2012.05.088; Gulcin I, 2006, TOXICOLOGY, V217, P213, DOI 10.1016/j.tox.2005.09.011; Sueishi Y, 2014, J CLIN BIOCHEM NUTR, V54, P67, DOI 10.3164/jcbn.13-53; Weisburger JH, 2002, EUR J CANCER PREV, V11, pS1; Nishino T, 2008, FEBS J, V275, P3278, DOI 10.1111/j.1742-4658.2008.06489.x; Nagaoka S, 2013, J AGR FOOD CHEM, V61, P10054, DOI 10.1021/jf402811m; Bruck R, 2001, J HEPATOL, V35, P457, DOI 10.1016/S0168-8278(01)00163-5; Tai A, 2012, BIOSCI BIOTECH BIOCH, V76, P314, DOI 10.1271/bbb.110700; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Tai A, 2011, BBA-GEN SUBJECTS, V1810, P170, DOI 10.1016/j.bbagen.2010.11.004; Shi HL, 2001, METHOD ENZYMOL, V335, P157; Gutowski M, 2013, ACTA BIOCHIM POL, V60, P1; UTSUMI T, 1992, ARCH BIOCHEM BIOPHYS, V294, P271, DOI 10.1016/0003-9861(92)90168-V; Fleming I, 2001, CIRC RES, V88, P44; Olszewska MA, 2012, MOLECULES, V17, P3093, DOI 10.3390/molecules17033093; Cosentino F, 1998, J CLIN INVEST, V101, P1530, DOI 10.1172/JCI650; Lin FQ, 2003, BIOSCI BIOTECH BIOCH, V67, P2154, DOI 10.1271/bbb.67.2154; Obata T, 2002, TOXICOL LETT, V132, P83, DOI 10.1016/S0378-4274(02)00076-0; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Havenith RWA, 2008, J PHYS CHEM A, V112, P7734, DOI 10.1021/jp801987d; Aybar MJ, 2001, J ETHNOPHARMACOL, V74, P125, DOI 10.1016/S0378-8741(00)00351-2; Oktay M, 2003, LEBENSM-WISS TECHNOL, V36, P263, DOI 10.1016/S0023-6438(02)00226-8; Oliveira I, 2009, FOOD CHEM TOXICOL, V47, P1507, DOI 10.1016/j.fct.2009.03.042; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; Oliveira GO, 2013, FOOD CHEM TOXICOL, V59, P256, DOI 10.1016/j.fct.2013.05.050; Kim HW, 2002, CANCER LETT, V176, P7, DOI 10.1016/S0304-3835(01)00735-2; Connor M, 2009, BRIT J PHARMACOL, V156, P4, DOI 10.1111/j.1476-5381.2008.00065.x; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Valentova K, 2006, J AGR FOOD CHEM, V54, P1347, DOI 10.1021/jf052645u; Nakamura Y, 1998, CANCER RES, V58, P4832; REINERS JJ, 1989, J INVEST DERMATOL, V93, P132, DOI 10.1111/1523-1747.ep12277382; HARMAN D, 1956, J GERONTOL, V11, P298; Hail N, 2008, FREE RADICAL BIO MED, V45, P97, DOI 10.1016/j.freeradbiomed.2008.04.004; Pellegrini N, 1999, METHOD ENZYMOL, V299, P379; WISWEDEL I, 1989, BIOMED BIOCHIM ACTA, V48, pS73; Desco MC, 2002, DIABETES, V51, P1118, DOI 10.2337/diabetes.51.4.1118; Ferreira ICFR, 2007, FOOD CHEM, V100, P1511, DOI 10.1016/j.foodchem.2005.11.043; Murakami A, 1997, JPN J CANCER RES, V88, P443; Takebayashi J, 2006, BIOL PHARM BULL, V29, P766, DOI 10.1248/bpb.29.766; Droge W, 2002, PHYSIOL REV, V82, P47; Pulido R, 2000, J AGR FOOD CHEM, V48, P3396, DOI 10.1021/jf9913458; KUKREJA RC, 1986, CIRC RES, V59, P612; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Yan XJ, 1999, J AGR FOOD CHEM, V47, P4711, DOI 10.1021/jf981305o; Alam MN, 2013, SAUDI PHARM J, V21, P143, DOI 10.1016/j.jsps.2012.05.002; Prior RL, 2003, J AGR FOOD CHEM, V51, P3273, DOI 10.1021/jf0262256; Watanabe J, 2014, J FOOD SCI, V79, pC1665, DOI 10.1111/1750-3841.12570; Wang BS, 2008, LWT-FOOD SCI TECHNOL, V41, P1122, DOI 10.1016/j.lwt.2007.07.002; Cakmakci S, 2015, INT J FOOD SCI TECH, V50, P472, DOI 10.1111/ijfs.12637; Cantu-Medellin N, 2013, REDOX BIOL, V1, P353, DOI 10.1016/j.redox.2013.05.002; Habib NC, 2011, CHEM-BIOL INTERACT, V194, P31, DOI 10.1016/j.cbi.2011.08.009; Jiwajinda S, 2002, ASIAN PAC J CANCER P, V3, P215; Lim CSH, 2013, LABMEDICINE, V44, P51, DOI 10.1309/LM93W7KTFNPZIXRR; Miftode Alina Monica, 2010, Rev Med Chir Soc Med Nat Iasi, V114, P892; Molyneux P., 2004, SONGKLANAKARIN J SCI, V26, P211; Nagaraja P, 2014, ANAL SCI, V30, P251; Ojansivu L, 2011, TRENDS FOOD SCI TECH, V22, P40, DOI 10.1016/j.tifs.2010.11.005; OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307; PAGANO PJ, 1995, AM J PHYSIOL-HEART C, V268, pH2274; Shintani H, 2013, PHARM ANAL ACTA, V4, P243; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Sugiura M, 2007, B KINKI CHUGOKU SHIK, V6, P1; Thaipong K, 2006, J FOOD COMPOS ANAL, V19, P669, DOI 10.1016/j.jfca.2006.01.003	71	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1147	1750-3841		J FOOD SCI	J. Food Sci.	NOV	2015	80	11					C2420	C2429		10.1111/1750-3841.13092		10	Food Science & Technology	Food Science & Technology	CW1WT	WOS:000364783300013		
J	Kashino, Y; Murota, K; Matsuda, N; Tomotake, M; Hamano, T; Mukai, R; Terao, J				Kashino, Yasuaki; Murota, Kaeko; Matsuda, Namiko; Tomotake, Muneaki; Hamano, Takuya; Mukai, Rie; Terao, Junji			Effect of Processed Onions on the Plasma Concentration of Quercetin in Rats and Humans	JOURNAL OF FOOD SCIENCE			English	Article						bioavailability; food matrix; intestinal absorption; onion quercetin	GLYCOSIDES; BIOAVAILABILITY; METABOLITES; ACCUMULATION; FLAVONOIDS; EXTRACT	Onion is a major dietary source of the bioactive flavonoid, quercetin. Quercetin aglycone (QA) is exclusively distributed in the onion peel, although quercetin-4'-beta-O-glucoside (Q4'G) is present in both the peel and the bulb, and quercetin-3,4'-beta-O-diglucoside (Q3,4'diG) is present only the bulb. The bioavailability of flavonoids from fruits and vegetables is frequently affected by the manufacturing process and related conditions. The present study aimed to estimate the effect of food processing on the bioavailability of onion QA and its glucosides, Q4'G and Q3,4'diG, provided through the consumption of onion products. Rats were fed onion peel and onion bulb products-mixed meal or pure QA/Q4'G+Q3,4'diG-mixed meal at 5 mg QA equivalent/kg body weight. A comparison of the blood plasma concentrations strongly suggested that quercetin glucosides (Q4'G and Q3,4'diG) are superior or at least equal to QA in their bioavailability, when each purified compound is mixed with the meal. The intake of a peel powder-containing meal provided a significantly higher increase of plasma quercetin concentration than the peel extract, bulb powder, bulb extract, and bulb saute containing meals at each period tested. A human ingestion study confirmed the superiority of onion peel powder to onion peel extract. The difference of log P for QA between peel powder and peel extract indicated that a food matrix improves the bioavailability of QA in onion peel products. These results demonstrated that the bioavailability of quercetin provided by not the onion bulb but the onion peel is significantly affected by food processing.	[Kashino, Yasuaki; Murota, Kaeko; Matsuda, Namiko; Mukai, Rie; Terao, Junji] Univ Tokushima, Inst Biomed Sci, Dept Food Sci, Grad Sch, Tokushima 7708503, Japan; [Tomotake, Muneaki] House Wellness Foods Corp, Inst Res & Dev, Yotsukaido, Chiba 2840033, Japan; [Hamano, Takuya] House Foods Grp Inc, Cent Res & Dev Inst, Yotsukaido, Chiba 2840033, Japan	Terao, J (reprint author), Univ Tokushima, Inst Biomed Sci, Dept Food Sci, Grad Sch, Tokushima 7708503, Japan.	terao@tokushima-u.ac.jp			Ministry of Agriculture, Forestry and Fisheries, Japan	This study was partly supported by grants for project research (Research project for new demand creation of agricultural products), the Ministry of Agriculture, Forestry and Fisheries, Japan. There are no conflicts of interest to declare.	HOLLMAN PCH, 1995, AM J CLIN NUTR, V62, P1276; Day AJ, 2000, FEBS LETT, V468, P166, DOI 10.1016/S0014-5793(00)01211-4; Egert S, 2012, BRIT J NUTR, V107, P539, DOI 10.1017/S0007114511003242; Wink M, 1997, ADV BOT RES, V25, P141; Murota K, 2005, FEBS LETT, V579, P5343, DOI 10.1016/j.febslet.2005.08.060; TSUSHIDA T, 1995, J JPN SOC FOOD SCI, V42, P100; Murota K, 2010, ARCH BIOCHEM BIOPHYS, V501, P91, DOI 10.1016/j.abb.2010.06.036; Shi YL, 2015, FOOD FUNCT, V6, P1443, DOI [10.1039/c5fo00155b, 10.1039/C5FO00155B]; Bohn T, 2014, NUTR REV, V72, P429, DOI 10.1111/nure.12114; Piskula MK, 1998, J AGR FOOD CHEM, V46, P4313, DOI 10.1021/jf980117v; Nakayama H, 2013, J AM COLL NUTR, V32, P160, DOI 10.1080/07315724.2013.797858; Wolffram S, 2002, J NUTR, V132, P630; Suleria HAR, 2015, CRIT REV FOOD SCI, V55, P50, DOI 10.1080/10408398.2011.646364; Morand C, 2000, FREE RADICAL RES, V33, P667, DOI 10.1080/10715760000301181; Wiczkowski W, 2008, J NUTR, V138, P885; Griffiths G, 2002, PHYTOTHER RES, V16, P603, DOI 10.1002/ptr.1222; Palafox-Carlos H, 2011, J FOOD SCI, V76, pR6, DOI 10.1111/j.1750-3841.2010.01957.x; Azuma K, 2007, J CLIN BIOCHEM NUTR, V40, P131, DOI 10.3164/jcbn.40.131; Yoshinari O, 2012, NUTRIENTS, V4, P1518, DOI 10.3390/nu4101518; Ishisaka A, 2011, FREE RADICAL BIO MED, V51, P1329, DOI 10.1016/j.freeradbiomed.2011.06.017; Nakamura T, 2014, MOL NUTR FOOD RES, V58, P310, DOI 10.1002/mnfr.201300234; Rothwell JA, 2005, J AGR FOOD CHEM, V53, P4355, DOI 10.1021/jf0483669; Guo Y, 2015, J NUTR BIOCHEM, V26, P201, DOI 10.1016/j.jnutbio.2014.10.008; Murota K, 2003, ARCH BIOCHEM BIOPHYS, V417, P841	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1147	1750-3841		J FOOD SCI	J. Food Sci.	NOV	2015	80	11					H2597	H2602		10.1111/1750-3841.13079		6	Food Science & Technology	Food Science & Technology	CW1WT	WOS:000364783300034		
J	Saito, S; Suzuki, Y; Suzuki, S				Saito, Susumu; Suzuki, Yoshihisa; Suzuki, Shigehiko			Technique of Dorsal Transversely Oriented Transposition Flap for Web Reconstruction in Toe Syndactyly Surgery	Journal of Foot & Ankle Surgery			English	Article						flap; polysyndactyly; surgery; syndactyly; toe	5TH TOE; FOOT; OPERATION	In toe desyndactyly, a dorsal or plantar commissural flap, combined with skin grafts, will ensure an acceptable result. However, the parallel unsightly scars in the longitudinal direction on the dorsum of the toes will sometimes fail to satisfy the patient's and/or the parents' aesthetic expectations. To address this issue, we developed a technique using a transversely oriented transposition flap for web reconstruction, which can spare the dorsal interdigital skin maximally to shift the dorsal scars plantarly such that they become inconspicuous. The design of the flap is simple and uncomplicated surgically. Moreover, the donor site morbidity is minimal, owing to the good healing potential of the transverse scars. This technique could be an alternative in web reconstruction of toe desyndactyly, especially in cases with high cosmetic priority. (C) 2015 by the American College of Foot and Ankle Surgeons. All rights reserved.	[Saito, Susumu; Suzuki, Shigehiko] Kyoto Univ, Dept Plast & Reconstruct Surg, Grad Sch Med, Kyoto 6068507, Japan; [Saito, Susumu; Suzuki, Shigehiko] Kyoto Univ, Fac Med, Kyoto 6068507, Japan; [Suzuki, Yoshihisa] Inst Kitano Hosp, Tazukekofukai Med Res Inst, Dept Plast & Reconstruct Surg, Osaka, Japan	Saito, S (reprint author), Kyoto Univ, Dept Plast & Reconstruct Surg, Grad Sch Med, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	susumus@kuhp.kyoto-u.ac.jp					Hikosaka M, 2009, SCAND J PLAST RECONS, V43, P148, DOI 10.1080/02844310802556968; Park S, 1996, PLAST RECONSTR SURG, V98, P534, DOI 10.1097/00006534-199609000-00029; ONISHI K, 1992, BRIT J PLAST SURG, V45, P554, DOI 10.1016/0007-1226(92)90155-Q; Hayashi A, 2004, PLAST RECONSTR SURG, V114, P433, DOI 10.1097/01.PRS.0000131882.19567.65; ITOH Y, 1995, BRIT J PLAST SURG, V48, P306, DOI 10.1016/0007-1226(95)90069-1; Kawabata H, 2003, SCAND J PLAST RECONS, V37, P150, DOI 10.1080/02844310310007755; Marsh DJ, 2011, J PLAST RECONSTR AES, V64, P535, DOI 10.1016/j.bjps.2010.07.016; Lim Yi-Jia, 2007, J Foot Ankle Surg, V46, P86, DOI 10.1053/j.jfas.2006.11.008; NOGAMI H, 1986, CLIN ORTHOP RELAT R, P261	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1067-2516	1542-2224		J FOOT ANKLE SURG	J. Foot Ankle Surg.	NOV-DEC	2015	54	6					1119	1123		10.1053/j.jfas.2015.03.003		5	Orthopedics; Surgery	Orthopedics; Surgery	CU8WX	WOS:000363825900024		
J	Nagata, N; Niikura, R; Aoki, T; Sakurai, T; Moriyasu, S; Shimbo, T; Sekine, K; Okubo, H; Watanabe, K; Yokoi, C; Yanase, M; Akiyama, J; Uemura, N				Nagata, Naoyoshi; Niikura, Ryota; Aoki, Tomonori; Sakurai, Toshiyuki; Moriyasu, Shiori; Shimbo, Takuro; Sekine, Katsunori; Okubo, Hidetaka; Watanabe, Kazuhiro; Yokoi, Chizu; Yanase, Mikio; Akiyama, Junichi; Uemura, Naomi			Effect of proton-pump inhibitors on the risk of lower gastrointestinal bleeding associated with NSAIDs, aspirin, clopidogrel, and warfarin	JOURNAL OF GASTROENTEROLOGY			English	Article						Lower gastrointestinal tract hemorrhage; Antisecretory drugs; Drug-drug interaction	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LOW-DOSE ASPIRIN; DIVERTICULAR HEMORRHAGE; BACTERIAL OVERGROWTH; ANTIPLATELET THERAPY; OUTCOMES; CYTOCHROME-P450; LANSOPRAZOLE; COLONOSCOPY; PREVENTION	Background We investigated the effects of proton-pump inhibitors (PPIs) on lower gastrointestinal bleeding (LGIB) and of their interactions with nonsteroidal anti-inflammatory drugs (NSAIDs), low-dose aspirin, clopidogrel, and warfarin on LGIB risk. Methods We prospectively studied 355 patients emergently hospitalized for LGIB and 8,221 nonbleeding patients. All patients underwent colonoscopy. Smoking, alcohol drinking, drug exposure, and the Charlson comorbidity index score were assessed before colonoscopy. Adjusted odds ratios (AOR) of LGIB were estimated. Results LGIB was significantly associated with older age, higher comorbidity index, and NSAID, aspirin, clopidogrel, or warfarin use. PPI use was significantly associated with older age, male sex, being a current alcohol drinker, higher comorbidity index, and NSAID, aspirin, clopidogrel, warfarin, acetaminophen, or corticosteroid use. Multivariate analysis adjusted by the confounding factors revealed LGIB was not significantly associated with PPI use (AOR 0.87; 95 % confidence interval 0.68-1.13; p = 0.311), or specifically with omeprazole (AOR 1.18; p = 0.408), esomeprazole (AOR 0.76; p = 0.432), lansoprazole (AOR 0.93; p = 0.669), or rabeprazole (AOR 0.63; p = 0.140). In the interaction model, no significant interactions were observed between PPIs and NSAIDs (AOR 1.40; p = 0.293), aspirin (AOR 1.09; p = 0.767), clopidogrel (AOR 0.99, p = 0.985), or warfarin (AOR 1.52; p = 0.398). Conclusions This large case-control study demonstrated that PPI use did not lead to an increased risk of LGIB, regardless of the type of PPI used. Further, LGIB risk was not affected by PPI use, irrespective of concomitant therapy with NSAIDs, low-dose aspirin, clopidogrel, or warfarin.	[Nagata, Naoyoshi; Niikura, Ryota; Aoki, Tomonori; Sakurai, Toshiyuki; Moriyasu, Shiori; Sekine, Katsunori; Okubo, Hidetaka; Watanabe, Kazuhiro; Yokoi, Chizu; Yanase, Mikio; Akiyama, Junichi] Natl Ctr Global Hlth & Med, Res Inst, Int Clin Res Ctr, Dept Gastroenterol & Hepatol,Shinjuku Ku, Tokyo 1628655, Japan; [Shimbo, Takuro] Natl Ctr Global Hlth & Med, Res Inst, Int Clin Res Ctr, Dept Clin Res & Informat,Shinjuku Ku, Tokyo 1628655, Japan; [Uemura, Naomi] Natl Ctr Global Hlth & Med, Kohnodai Hosp, Dept Gastroenterol & Hepatol, Chiba, Japan	Nagata, N (reprint author), Natl Ctr Global Hlth & Med, Res Inst, Int Clin Res Ctr, Dept Gastroenterol & Hepatol,Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	nnagata_ncgm@yahoo.co.jp					Williams C, 2006, ALIMENT PHARM THERAP, V23, P3, DOI 10.1111/j.1365-2036.2006.02707; Lanas A, 2007, AM J GASTROENTEROL, V102, P507, DOI 10.1111/j.1572-0241.2006.01062.x; Wolfe MM, 2000, GASTROENTEROLOGY, V118, pS9, DOI 10.1016/S0016-5085(00)70004-7; Higuchi K, 2009, J CLIN BIOCHEM NUTR, V45, P125, DOI 10.3164/jcbn.SR09-58; van Boxel OS, 2010, AM J GASTROENTEROL, V105, P2430, DOI 10.1038/ajg.2010.334; HOLT S, 1993, DIGEST DIS SCI, V38, P1619, DOI 10.1007/BF01303169; Zuckerman GR, 1999, GASTROINTEST ENDOSC, V49, P228, DOI 10.1016/S0016-5107(99)70491-8; Chan FKL, 2010, J RHEUMATOL, V37, P167, DOI 10.3899/jrheum.090168; Ishizaki T, 1999, ALIMENT PHARM THERAP, V13, P27; BJARNASON I, 1993, GASTROENTEROLOGY, V104, P1832; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Arroyo RC, 2012, HEART, V98, P718, DOI 10.1136/heartjnl-2012-301632; Strate LL, 2009, GASTROENTEROLOGY, V136, P115, DOI 10.1053/j.gastro.2008.09.025; Keszthelyi D, 2010, ALIMENT PHARM THER, V32, P1124, DOI 10.1111/j.1365-2036.2010.04453.x; Endo H, 2014, GASTROINTEST ENDOSC, V80, P826, DOI 10.1016/j.gie.2014.03.024; Hata M, 2008, THORAC CARDIOV SURG, V56, P274, DOI 10.1055/s-2008-1038378; Strate LL, 2012, DIGEST DIS, V30, P35, DOI 10.1159/000335707; Yoda Y, 2010, J PHYSIOL PHARMACOL, V61, P287; Corleto VD, 2014, CURR OPIN ENDOCRINOL, V21, P3, DOI 10.1097/MED.0000000000000031; Bhatt DL, 2008, J AM COLL CARDIOL, V52, P1502, DOI 10.1016/j.jacc.2008.08.002; Leontiadis GI, 2007, HEALTH TECHNOL ASSES, V11, P1; Watanabe T, 2008, GUT, V57, P181, DOI 10.1136/gut.2007.125963; Hreinsson JP, 2013, EUR J GASTROEN HEPAT, V25, P37, DOI 10.1097/MEG.0b013e32835948e3; Wilcox CM, 1997, DIGEST DIS SCI, V42, P990, DOI 10.1023/A:1018832902287; Lanas A, 2009, AM J GASTROENTEROL, V104, P1633, DOI 10.1038/ajg.2009.164; Lombardo L, 2010, CLIN GASTROENTEROL H, V8, P504, DOI 10.1016/j.cgh.2009.12.022; Chang CH, 2011, GUT, V60, P1372, DOI 10.1136/gut.2010.229906; Kurose K, 2012, DRUG METAB PHARMACOK, V27, P9, DOI 10.2133/dmpk.DMPK-11-RV-111; Nagata N, 2014, GASTROINTEST ENDOSC, V80, P1124, DOI 10.1016/j.gie.2014.06.039; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Pasha SF, 2014, GASTROINTEST ENDOSC, V79, P875, DOI 10.1016/j.gie.2013.10.039; Abraham NS, 2011, CURR OPIN GASTROEN, V27, P558, DOI 10.1097/MOG.0b013e32834a382e; Wallace JL, 2011, GASTROENTEROLOGY, V141, P1314, DOI 10.1053/j.gastro.2011.06.075; Jensen DM, 2000, NEW ENGL J MED, V342, P78, DOI 10.1056/NEJM200001133420202; Lhewa DY, 2012, WORLD J GASTROENTERO, V18, P1185, DOI 10.3748/wjg.v18.i11.1185; Hagiwara Mari, 2004, Journal of Medical Investigation, V51, P43, DOI 10.2152/jmi.51.43; Hata M, 2015, THORAC CARDIOV SURG, V63, P45, DOI 10.1055/s-0034-1383814; Juel J, 2014, CURR VASC PHARMACOL, V12, P751; Lanas A, 2010, RHEUMATOLOGY S2, V49, P3; Gonzalez ELM, 2010, ARTHRITIS RHEUM-US, V62, P1592, DOI 10.1002/art.27412; McCarthy Denis M, 2003, Am J Ther, V10, P330, DOI 10.1097/00045391-200309000-00005; Nagata N, 2014, J GASTROEN HEPATOL, V29, P1786, DOI 10.1111/jgh.12595; Nagata N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081137; Rose S, 2009, INT J BIOSTAT, V5, DOI 10.2202/1557-4679.1127	44	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	NOV	2015	50	11					1079	1086		10.1007/s00535-015-1055-2		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CV8HR	WOS:000364524000001		
J	Nishiyama, S; Oka, S; Tanaka, S; Sagami, S; Nagai, K; Ueno, Y; Arihiro, K; Chayama, K				Nishiyama, Soki; Oka, Shiro; Tanaka, Shinji; Sagami, Shintaro; Nagai, Kenta; Ueno, Yoshitaka; Arihiro, Koji; Chayama, Kazuaki			Clinical usefulness of endocytoscopy in the remission stage of ulcerative colitis: a pilot study	JOURNAL OF GASTROENTEROLOGY			English	Article						Ulcerative colitis; Endocytoscopy; Endocytoscopy system score (ECSS); Magnifying colonoscopy; Relapse	BAND IMAGING COLONOSCOPY; HISTOLOGIC INFLAMMATION; MAGNIFYING COLONOSCOPY; GASTROINTESTINAL-TRACT; COLORECTAL LESIONS; CLASSIFICATION; SEVERITY; FEATURES; DISEASE; PATTERN	Background Histopathology can be used to detect ulcerative colitis (UC) relapse, but diagnosis of the disease activity by histopathology requires multiple biopsies to be taken. Magnifying endocytoscopy provides a method for real-time ultra-magnifying imaging. It was recently reported that the endocytoscopy system score (ECSS) correlates well with the histopathology of UC. Here we evaluated the clinical usefulness of endocytoscopy for accurately monitoring UC during remission. Methods We performed endocytoscopy on 26 patients with UC in remission that had been diagnosed by conventional colonoscopy at our institution between January and April 2013. Endocytoscopy was performed at the area of the rectum where UC had been detected with conventional endoscopy. Biopsies were also taken from the same area and histopathology was evaluated by a single pathologist according to the Matts' grading system. The correlation between the relapse rate of UC and both the ECSS and the Matts' histopathological grade was evaluated. Results The ECSS of the intestinal mucosa in UC showed a correlation with the Matts' histopathological grade (Spearman's |r| = 0.647). The patients were classified into two groups: those with an ECSS of 0-2 (Grade A, 12 cases) and those with an ECSS of 3-6 (Grade B, 10 cases). To date, three Grade B cases have relapsed and no Grade A cases have relapsed. The average post-endocytoscopy surveillance period was 446 +/- A 92 days. Conclusions The ECSS may be a predictive indicator for UC relapse since there was a correlation between the ECSS and the degree of inflammation as determined by histopathology.	[Nishiyama, Soki; Sagami, Shintaro; Nagai, Kenta; Ueno, Yoshitaka; Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed Sci, Gastroenterol & Metab, Hiroshima, Japan; [Oka, Shiro; Tanaka, Shinji] Hiroshima Univ, Grad Sch Biomed Sci, Endoscopy & Med, Hiroshima, Japan; [Arihiro, Koji] Hiroshima Univ Hosp, Dept Pathol, Hiroshima, Japan	Oka, S (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Endoscopy & Med, Hiroshima, Japan.	oka4683@hiroshima-u.ac.jp					Sasajima K, 2006, GASTROINTEST ENDOSC, V63, P1010, DOI 10.1016/j.gie.2006.01.021; Nishio Y, 2006, GUT, V55, P1768, DOI 10.1136/gut.2005.086900; Fujiya M, 2002, GASTROINTEST ENDOSC, V56, P535, DOI 10.1067/mge.2002.127101; Kunihiro M, 2004, INFLAMM BOWEL DIS, V10, P737, DOI 10.1097/00054725-200411000-00007; Lemmens B, 2013, INFLAMM BOWEL DIS, V19, P1194, DOI 10.1097/MIB.0b013e318280e75f; Colombel JF, 2011, GASTROENTEROLOGY, V141, P1194, DOI 10.1053/j.gastro.2011.06.054; Travis SPL, 2012, GUT, V61, P535, DOI 10.1136/gutjnl-2011-300486; Neumann H, 2011, ALIMENT PHARM THER, V33, P1183, DOI 10.1111/j.1365-2036.2011.04647.x; Matsumoto T, 1997, GASTROINTEST ENDOSC, V46, P400, DOI 10.1016/S0016-5107(97)70031-2; Inoue H, 2006, ENDOSCOPY, V38, P891, DOI 10.1055/s-2006-944667; Kudo T, 2009, INT J COLORECTAL DIS, V24, P495, DOI 10.1007/s00384-008-0631-9; Kudo SE, 2011, ENDOSCOPY, V43, P869, DOI 10.1055/s-0030-1256663; Inoue H, 2005, NAT CLIN PRACT GASTR, V2, P31, DOI 10.1038/ncpgasthep0072; Rotondano G, 2010, INT J COLORECTAL DIS, V25, P1111, DOI 10.1007/s00384-010-0969-7; Gupta RB, 2007, GASTROENTEROLOGY, V133, P1099, DOI 10.1053/j.gastro.2007.08.001; Bessho R, 2011, J GASTROENTEROL, V46, P1197, DOI 10.1007/s00535-011-0439-1; RILEY SA, 1991, GUT, V32, P174, DOI 10.1136/gut.32.2.174; Mori Y, 2013, ENDOSCOPY, V45, P98, DOI 10.1055/s-0032-1325932; Inoue H, 2004, DIGEST DIS, V22, P334, DOI 10.1159/000083595; Esaki M, 2011, DIGEST ENDOSC, V23, P140, DOI 10.1111/j.1443-1661.2011.01110.x; Peyrin-Biroulet L, 2011, J CROHNS COLITIS, V5, P477, DOI 10.1016/j.crohns.2011.06.009; Tanaka S, 2002, ONCOL REP, V9, P1005; Li CQ, 2010, AM J GASTROENTEROL, V105, P1391, DOI 10.1038/ajg.2009.664; Hurlstone DP, 2006, ENDOSCOPY, V38, P1213, DOI 10.1055/s-2006-944732; Inoue Haruhiro, 2004, Gastrointest Endosc Clin N Am, V14, P589, DOI 10.1016/j.giec.2004.03.013; Kantsevoy SV, 2009, GASTROINTEST ENDOSC, V70, P197; Nishiyama S, 2014, INFLAMM BOWEL DIS, V20, P508, DOI 10.1097/01.MIB.0000441199.33325.75; Oka Shiro, 2014, Gastrointest Endosc Clin N Am, V24, P405, DOI 10.1016/j.giec.2014.03.011; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Ueno Yoshitaka, 2010, Gastrointest Endosc Clin N Am, V20, P525, DOI 10.1016/j.giec.2010.04.002	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	NOV	2015	50	11					1087	1093		10.1007/s00535-015-1059-y		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CV8HR	WOS:000364524000002		
J	Asano, K; Esaki, M; Umeno, J; Hirano, A; Maehata, Y; Moriyama, T; Nakamura, S; Matsumoto, T; Kitazono, T				Asano, Kouichi; Esaki, Motohiro; Umeno, Junji; Hirano, Atsushi; Maehata, Yuji; Moriyama, Tomohiko; Nakamura, Shotaro; Matsumoto, Takayuki; Kitazono, Takanari			Contribution of susceptibility variants at FCGR2A and 13q12 to the risk of relapse among Japanese patients with ulcerative colitis	JOURNAL OF GASTROENTEROLOGY			English	Article						Ulcerative colitis; Susceptibility variants; FCGR2A; Risk of relapse; Clinical course	INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; GENETIC PREDICTORS; CROHN-DISEASE; POPULATION; POLYMORPHISMS; LOCI; DEFINITIONS; INFLIXIMAB; PHENOTYPE	Background Recent genome-wide association studies have identified nearly 100 susceptibility genes for ulcerative colitis (UC). However, the contribution of susceptibility variants for UC to clinical outcome has scarcely been reported. The aim of this study was to investigate whether UC-associated genetic variants confer a risk of clinical relapse. Methods One hundred and nine consecutive Japanese subjects with quiescent UC were recruited. Four genetic variants of HLA-DRB1*1502, rs6671847 at FCGR2A, rs17085007 at 13q12, and rs2108225 at SLC26A3 were genotyped by Invader assay. The clinical courses were followed after blood sampling, and the risk of relapse according to these genotypes was calculated by Cox proportional hazard model. Results During the mean follow-up period of 35 months (range 1-81 months), 49 of 109 subjects (45 %) relapsed. Carriers of the G allele of rs6671847 showed an increased risk of relapse compared with non-carriers [adjusted hazard ratio (HR), 2.27; 95 % confidence interval (CI), 1.20-4.32; p = 0.01]. Patients with the CT or TT genotypes of rs17085007 also had an increased risk of relapse compared to subjects with the CC genotype (for CT: adjusted HR, 2.16; 95 % CI, 1.10-4.23; p = 0.03; for TT: adjusted HR, 3.25; 95 % CI, 1.18-8.95; p = 0.02). These two risk variants multiplied the risk of relapse by 2.74 times (95 % CI, 1.10-4.23; p = 0.01) in patients with one risk genotype and 5.40 times (95 % CI, 2.06-14.13; p = 0.0006) in patients with both risk genotypes. Conclusions Genetic variants of rs6671847 at FCGR2A and rs17085007 at 13q12 conferred a risk of relapse in patients with UC.	[Asano, Kouichi; Esaki, Motohiro; Umeno, Junji; Hirano, Atsushi; Maehata, Yuji; Moriyama, Tomohiko; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Higashi Ku, Fukuoka 8128582, Japan; [Asano, Kouichi] Kyushu Univ Hosp, Dept Endoscop Diag & Therapeut, Fukuoka 812, Japan; [Hirano, Atsushi] Yamaguchi Red Cross Hosp, Dept Internal Med, Yamaguchi, Japan; [Nakamura, Shotaro] Kyushu Univ, Fac Med Sci, Dept Adv Med Initiat, Fukuoka 8128582, Japan; [Matsumoto, Takayuki] Iwate Med Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Morioka, Iwate 020, Japan	Asano, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	k-asano@intmed2.med.kyushu-u.ac.jp					Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Annese V, 2005, DIS COLON RECTUM, V48, P57, DOI 10.1007/s10350-004-0747-0; Annese V, 2005, DIS COLON RECTUM, V48; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Hoie O, 2007, AM J GASTROENTEROL, V102, P1692, DOI 10.1111/j.1572-0241.2007.01265.x; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Beaugerie L, 2012, WORLD J GASTROENTERO, V18, P3806, DOI 10.3748/wjg.v18.i29.3806; Daniel F, 2007, INFLAMM BOWEL DIS, V13, P19, DOI 10.1002/ibd.20046; Montes A, 2014, PHARMACOGENET GENOM, V24, P238, DOI 10.1097/FPC.0000000000000042; Ng SC, 2012, INFLAMM BOWEL DIS, V18, P1164, DOI 10.1002/ibd.21845; Dignass A, 2012, J CROHNS COLITIS, V6, P965, DOI 10.1016/j.crohns.2012.09.003; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; SCHACHTER H, 1975, GASTROENTEROLOGY, V68, P591; Ferrante M, 2007, INFLAMM BOWEL DIS, V13, P123, DOI 10.1002/ibd.20054; Potocnik U, 2004, GENES IMMUN, V5, P530, DOI 10.1038/sj.gene.6364123; Langholz E, 1996, SCAND J GASTROENTERO, V31, P260, DOI 10.3109/00365529609004876; Bitton A, 2001, GASTROENTEROLOGY, V120, P13, DOI 10.1053/gast.2001.20912; Ahmad T, 2003, TISSUE ANTIGENS, V62, P527, DOI 10.1046/j.1399-0039.2003.00129.x; Solberg IC, 2007, CLIN GASTROENTEROL H, V5, P1430, DOI 10.1016/j.cgh.2007.09.002; Asano K, 2009, NAT GENET, V41, P1325, DOI 10.1038/ng.482; Maher MM, 2009, DIGEST DIS SCI, V54, P2456, DOI 10.1007/s10620-008-0639-6; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Arimura Y, 2014, J GASTROENTEROL, V49, P1217, DOI 10.1007/s00535-013-0866-2; Henriksen M, 2008, GUT, V57, P1518, DOI 10.1136/gut.2007.146357; Canete JD, 2009, ANN RHEUM DIS, V68, P1547, DOI 10.1136/ard.2008.096982; Rosenfeld G, 2012, AM J GASTROENTEROL, V107, P1407, DOI 10.1038/ajg.2012.190; Haritunians T, 2010, INFLAMM BOWEL DIS, V16, P1830, DOI 10.1002/ibd.21293; Zhou BQ, 2013, STAT MED, V32, P3804, DOI 10.1002/sim.5815; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Lappalainen M, 2008, INFLAMM BOWEL DIS, V14, P1118, DOI 10.1002/ibd.20431; Turner D, 2010, GUT, V59, P1207, DOI 10.1136/gut.2010.211755; Jess T, 2007, INFLAMM BOWEL DIS, V13, P481, DOI 10.1002/ibd.20036; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Charbonneau B, 2013, CANCER IMMUNOL IMMUN, V62, P1475, DOI 10.1007/s00262-013-1452-4; Seo M, 1998, AM J GASTROENTEROL, V93, P2124; Billiet Thomas, 2014, Curr Gastroenterol Rep, V16, P416, DOI 10.1007/s11894-014-0416-y; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Weizman Adam V, 2012, Curr Gastroenterol Rep, V14, P139, DOI 10.1007/s11894-012-0248-6	39	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	NOV	2015	50	11					1094	1102		10.1007/s00535-015-1062-3		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CV8HR	WOS:000364524000003		
J	Takahashi, H; Ono, M; Hyogo, H; Tsuji, C; Kitajima, Y; Ono, N; Eguchi, T; Fujimoto, K; Chayama, K; Saibara, T; Anzai, K; Eguchi, Y				Takahashi, Hirokazu; Ono, Masafumi; Hyogo, Hideyuki; Tsuji, Chika; Kitajima, Yoichiro; Ono, Naofumi; Eguchi, Takahisa; Fujimoto, Kazuma; Chayama, Kazuaki; Saibara, Toshiji; Anzai, Keizo; Eguchi, Yuichiro			Biphasic effect of alcohol intake on the development of fatty liver disease	JOURNAL OF GASTROENTEROLOGY			English	Article						Obesity; NAFLD; NASH; Alcoholic; Prevalence; Ultrasonography	SERUM ALANINE AMINOTRANSFERASE; INSULIN SENSITIVITY; RISK-FACTORS; HEPATIC STEATOSIS; ETHANOL; CONSUMPTION; POPULATION; PREVALENCE; OBESITY; WOMEN	Background Fatty liver is an important clinical feature not only in alcoholic and non-alcoholic fatty liver diseases, but in other chronic liver diseases as well. Our aim was to elucidate the effect and relationship between habitual alcohol intake and obesity in the development of fatty liver disease. Methods We enrolled 8,029 subjects undergoing abdominal ultrasonography with general medical examinations, and analyzed the factors associated with fatty liver based on daily alcohol intake, body mass index (BMI), and waist circumference. Results For fatty liver, BMI, waist circumference, total cholesterol, triglycerides, and fasting plasma glucose were significant and independent risk factors. Heavy alcohol intake (50 g/day) was a significant risk factor for fatty liver in women (odds ratio [OR], 3.35). Analysis based on the presence or absence of obesity revealed that moderate alcohol intake was a significant negative risk factor for fatty liver in both male and female obese (BMI a parts per thousand yen25 kg/m(2)) subjects (OR, 0.74 for non-obese and 0.39 for obese patients, respectively). Heavy alcohol intake was also a significant negative risk factor in obese males (0.62). In contrast, heavy alcohol intake was a risk factor in non-obese males (OR, 1.29) and in all females (OR, 2.22 for non-obese and 6.6 for obese patients, respectively). Conclusions The influence of alcohol intake on fatty liver differed depending on the level of alcohol consumption, gender, and the presence of obesity, and showed biphasic effects.	[Takahashi, Hirokazu; Tsuji, Chika; Kitajima, Yoichiro; Fujimoto, Kazuma; Anzai, Keizo] Saga Med Sch, Dept Internal Med, Saga, Japan; [Ono, Masafumi; Saibara, Toshiji] Kochi Med Sch, Dept Gastroenterol & Hepatol, Kochi, Japan; [Hyogo, Hideyuki; Chayama, Kazuaki] Hiroshima Univ Hosp, Dept Gastroenterol & Metab, Minami Ku, Hiroshima 7348551, Japan; [Tsuji, Chika; Kitajima, Yoichiro; Ono, Naofumi; Eguchi, Takahisa] Eguchi Hosp, Gastroenterol Clin, Saga, Japan; [Eguchi, Yuichiro] Saga Med Sch, Div Hepatol, Saga, Japan	Hyogo, H (reprint author), Hiroshima Univ Hosp, Dept Gastroenterol & Metab, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	hidehyogo@hiroshima-u.ac.jp			Ministry of Health, Labour and Welfare of Japan	The authors thank Professor Kyuichi Tanikawa (International Institute for Liver Research) for his excellent advice; the entire medical staff at Eguchi Hospital, Kochi Medical School, and Kawamura Clinic for assistance; and members of the Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD) for their excellent advice. The authors have no conflicts of interest to declare. This work was supported in part by a Grant-in-Aid from the Ministry of Health, Labour and Welfare of Japan (2014 non-numbered). All authors approved the final version of the article and the guarantor of the article is Hideyuki Hyogo. Author contributions are described as follows: (a) substantial contributions to the conception and design; or the acquisition, analysis, or interpretation of the data: MO, HT, TE, CT, YK, and NO; (b) drafting of the article or critical revision for important intellectual content: HT, HH, MO, YE. and KF; (c) final approval of the version to be published: all authors; (d) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the article are appropriately investigated and resolved: HT, HH, MO, and YE.	Guy Jennifer, 2013, Gastroenterol Hepatol (N Y), V9, P633; Miyake T, 2013, J GASTROENTEROL, V48, P413, DOI 10.1007/s00535-012-0650-8; BHAVANI K, 1995, ALCOHOL CLIN EXP RES, V19, P441, DOI 10.1111/j.1530-0277.1995.tb01528.x; Schulze MB, 2005, AM J CLIN NUTR, V82, P675; Furuya DT, 2005, LIFE SCI, V77, P1813, DOI 10.1016/j.lfs.2004.12.046; Bellentani S, 2000, ANN INTERN MED, V132, P112; FREZZA M, 1990, NEW ENGL J MED, V322, P95, DOI 10.1056/NEJM199001113220205; Pendino GM, 2005, HEPATOLOGY, V41, P1151, DOI 10.1002/hep.20689; Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z; Ikejima K, 1998, AM J PHYSIOL-GASTR L, V274, pG669; Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559; Sogabe M, 2012, J GASTROENTEROL, V47, P293, DOI 10.1007/s00535-011-0489-4; XU YY, 1995, BIOCHEM J, V310, P125; O'Shea RS, 2010, AM J GASTROENTEROL, V105, P14, DOI 10.1038/ajg.2009.593; Dunn W, 2008, HEPATOLOGY, V47, P1947, DOI 10.1002/hep.22292; Feng L, 2012, BRIT J NUTR, V107, P850, DOI 10.1017/S0007114511003722; Guarino MP, 2003, AM J PHYSIOL-GASTR L, V284, pG588, DOI 10.1152/ajpgi.00423.2002; Hiramine Y, 2011, J GASTROENTEROL, V46, P519, DOI 10.1007/s00535-010-0336-z; Michitaka K, 2010, J GASTROENTEROL, V45, P86, DOI 10.1007/s00535-009-0128-5; Nishioji K, 2015, J GASTROENTEROL, V50, P95, DOI 10.1007/s00535-014-0948-9; Nolen-Hoeksema S, 2004, CLIN PSYCHOL REV, V24, P981, DOI 10.1016/j.cpr.2004.08.003; Gunji T, 2009, AM J GASTROENTEROL, V104, P2189, DOI 10.1038/ajg.2009.361; YANG CM, 1991, BIOCHEM PHARMACOL, V41, P923, DOI 10.1016/0006-2952(91)90197-D; Lopez-Garcia E, 2013, ATHEROSCLEROSIS, V231, P152, DOI 10.1016/j.atherosclerosis.2013.09.003; Onishi Y, 2003, BIOCHEM BIOPH RES CO, V303, P788, DOI 10.1016/S0006-291X(03)00407-8; Sierksma A, 2004, DIABETES CARE, V27, P184, DOI 10.2337/diacare.27.1.184; Becker U, 1996, HEPATOLOGY, V23, P1025, DOI 10.1002/hep.510230513; BIZZARO N, 1992, ITAL J GASTROENTEROL, V24, P237; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bedogni G, 2007, HEPATOLOGY, V46, P1387, DOI 10.1002/hep.21827; Zhou YJ, 2007, WORLD J GASTROENTERO, V13, P6419, DOI 10.3748/wjg.13.6419; YKIJARVINEN H, 1985, J CLIN ENDOCR METAB, V61, P941; Ruhl CE, 2005, CLIN GASTROENTEROL H, V3, P1260, DOI 10.1016/S1542-3565(05)00743-3; Dixon JB, 2001, GASTROENTEROLOGY, V121, P91, DOI 10.1053/gast.2001.25540; Suzuki A, 2007, AM J GASTROENTEROL, V102, P1912, DOI 10.1111/j.1572-0241.2007.01274.x; Kondili LA, 2005, EUR J GASTROEN HEPAT, V17, P155, DOI 10.1097/00042737-200502000-00005; Feng L, 2008, J ENDOCRINOL, V199, P95, DOI 10.1677/JOE-08-0026; Lieber CS, 1997, GENDER ALCOHOL INDIV, P77; Lindtner C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005123; Maher Jacquelyn J, 2002, Semin Gastrointest Dis, V13, P31; MENDENHA.CL, 1968, AM J DIG DIS, V13, P783, DOI 10.1007/BF02233094; Tanaka K, 2014, HEPATOL RES, V44, P1196, DOI 10.1111/hepr.12293; Matsuzawa Y, 2002, CIRC J, V66, P987; The World Medical Association Inc., 2008, ETH PRINC MED RES IN; YKIJARVINEN H, 1988, AM J PHYSIOL, V254, pE175	45	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	NOV	2015	50	11					1114	1123		10.1007/s00535-015-1058-z		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CV8HR	WOS:000364524000005		
J	Nishio, K; Miyagi, T; Tatsumi, T; Mukai, K; Yokoyama, Y; Yoshioka, T; Sakamori, R; Hikita, H; Kodama, T; Shimizu, S; Shigekawa, M; Nawa, T; Yoshihara, H; Hiramatsu, N; Yamanaka, H; Seino, K; Takehara, T				Nishio, Kumiko; Miyagi, Takuya; Tatsumi, Tomohide; Mukai, Kaori; Yokoyama, Yoshinobu; Yoshioka, Teppei; Sakamori, Ryotaro; Hikita, Hayato; Kodama, Takahiro; Shimizu, Satoshi; Shigekawa, Minoru; Nawa, Takatoshi; Yoshihara, Harumasa; Hiramatsu, Naoki; Yamanaka, Hiroyuki; Seino, Ken-ichiro; Takehara, Tetsuo			Invariant natural killer T cell deficiency leads to the development of spontaneous liver inflammation dependent on gamma delta T cells in mice	JOURNAL OF GASTROENTEROLOGY			English	Article						Autoimmune hepatitis; Invariant natural killer T cells; gamma delta T cells; Interleukin-17	TYPE-1 AUTOIMMUNE HEPATITIS; NKT CELLS; MURINE LIVER; IMMUNOREGULATION; LYMPHOCYTES; TOLERANCE; DISEASE; ORGAN	Immune tolerance is maintained in the liver, and perturbation of tolerance can lead to immune-mediated liver diseases such as autoimmune hepatitis (AIH). Invariant natural killer T (iNKT) cells and gamma delta T cells have been shown to maintain immune homeostasis as regulatory cells and to play pathogenic roles in immune-mediated diseases as effector cells. We hypothesized that iNKT cells and gamma delta T cells are involved in the maintenance of hepatic immune tolerance and immune-mediated liver disease. We measured liver inflammation and the cytokine profiles of liver mononuclear cells in BALB/c wild-type (WT) mice and BALB/c J alpha 18-deficient (KO) mice lacking iNKT cells. We also examined the role of gamma delta T cells in AIH using liver tissue from AIH patients and control subjects. Spontaneous liver inflammation, hepatocyte damage, and anti-nuclear-antibody production occurred in J alpha 18 KO mice but not in WT mice. Furthermore, liver mononuclear cells from J alpha 18 KO mice, but not those from WT mice, produced interleukin-17 (IL-17). gamma delta T cells were the primary producers of the cytokine, and they were more abundant in the livers of J alpha 18 KO mice than in those of WT mice. In J alpha 18 KO mice, the administration of anti-gamma delta T-cell-receptor antibody abolished liver inflammation, hepatocyte damage, and IL-17 production. gamma delta T cells accumulated in the livers of AIH patients but not in those of the control subjects. Our results suggest a protective role for iNKT cells, a pathologic role for gamma delta T cells, and an association between these cells in the pathogenesis of AIH.	[Nishio, Kumiko; Miyagi, Takuya; Tatsumi, Tomohide; Mukai, Kaori; Yokoyama, Yoshinobu; Yoshioka, Teppei; Sakamori, Ryotaro; Hikita, Hayato; Kodama, Takahiro; Shimizu, Satoshi; Shigekawa, Minoru; Nawa, Takatoshi; Hiramatsu, Naoki; Takehara, Tetsuo] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka 5650871, Japan; [Yoshihara, Harumasa] Osaka Rosai Hosp, Osaka, Japan; [Yamanaka, Hiroyuki; Seino, Ken-ichiro] Hokkaido Univ, Inst Med Genet, Div Immunobiol, Sapporo, Hokkaido, Japan	Takehara, T (reprint author), Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	takehara@gh.med.osaka-u.ac.jp					STINISSEN P, 1995, J IMMUNOL, V154, P4883; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Manns MP, 2006, HEPATOLOGY, V43, pS132, DOI 10.1002/hep.21059; Yeoman AD, 2008, HEPATOLOGY, V48, P863, DOI 10.1002/hep.22432; Gardner TR, 2010, AM J PATHOL, V176, P1779, DOI 10.2353/ajpath.2010.090738; Nowak M, 2007, INT REV IMMUNOL, V26, P95, DOI 10.1080/0883018060107195; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Chauhan SK, 2006, CLIN IMMUNOL, V118, P243, DOI 10.1016/j.clim.2005.10.010; Norris S, 1999, HUM IMMUNOL, V60, P20, DOI 10.1016/S0198-8859(98)00098-6; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; Ferri S, 2010, HEPATOLOGY, V52, P999, DOI 10.1002/hep.23792; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; van der Vliet HJJ, 2001, CLIN IMMUNOL, V100, P144, DOI 10.1006/clim.2001.5060; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri.797; Harada M, 2006, J EXP MED, V203, P2929, DOI 10.1084/jem.20062206; Exley MA, 2004, HEPATOLOGY, V40, P1033, DOI 10.1002/hep.20433; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Miyagi T, 2003, INT J CANCER, V106, P81, DOI 10.1002/ijc.11163; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; WEN L, 1992, CLIN EXP IMMUNOL, V89, P78; Miyagi T, 2004, HEPATOLOGY, V40, P1190, DOI 10.1002/hep.20447; Yoshizawa K, 2012, HEPATOLOGY, V56, P668, DOI 10.1002/hep.25658; Girardi M, 2006, J INVEST DERMATOL, V126, P25, DOI 10.1038/sj.jid.5700003; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Bank I, 2003, J LAB CLIN MED, V141, P33, DOI 10.1067/mlc.2003.1; Czaja AJ, 2010, GASTROENTEROLOGY, V139, pe54; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	NOV	2015	50	11					1124	1133		10.1007/s00535-015-1060-5		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CV8HR	WOS:000364524000006		
J	Fujiyoshi, M; Kuno, A; Gotoh, M; Fukai, M; Yokoo, H; Kamachi, H; Kamiyama, T; Korenaga, M; Mizokami, M; Narimatsu, H; Taketomi, A				Fujiyoshi, Masato; Kuno, Atsushi; Gotoh, Masanori; Fukai, Moto; Yokoo, Hideki; Kamachi, Hirofumi; Kamiyama, Toshiya; Korenaga, Masaaki; Mizokami, Masashi; Narimatsu, Hisashi; Taketomi, Akinobu		Hepatitis Glyco-biomarker Study Gr	Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma	JOURNAL OF GASTROENTEROLOGY			English	Article						Biomarker; Wisteria floribunda agglutinin positive Mac-2-binding protein; Hepatocellular carcinoma; Liver fibrosis; Cirrhosis	MAC-2 BINDING-PROTEIN; RING-LIKE STRUCTURES; HEPATITIS; PREDICT; CHOLANGIOCARCINOMA; HEPATECTOMY; RECURRENCE; CIRRHOSIS; RESECTION; RECEPTOR	Wisteria floribunda agglutinin positive Mac-2-binding protein (WFA(+)-M2BP) is a novel serum marker of liver fibrosis identified in glycoproteomic biomarker screening studies, and its clinicopathological characteristics have yet to be elucidated sufficiently for clinical utilization. We retrospectively analyzed the clinicopathology data and serum WFA(+)-M2BP levels in 376 hepatocellular carcinoma patients undergoing liver surgery. WFA(+)-M2BP was quantified in frozen serum samples collected at the time of surgery using the FastLec-Hepa method. Significant independent determinants of serum WFA(+)-M2BP levels included pathological diagnosis of cirrhosis, female gender, hepatitis C virus (HCV) infection, and liver dysfunction characteristics, such as abnormal indocyanine green retention rate at 15 min, platelet counts, albumin levels, alanine aminotransferase levels, and total bilirubin levels. Serum WFA(+)-M2BP levels increased with the pathological fibrosis stage and liver dysfunction severity. HCV infection significantly affected serum WFA(+)-M2BP levels throughout the pathological and functional progression of liver fibrosis, and the effect of gender was significant only in F4 stage patients with severe liver dysfunction. The diagnostic thresholds for cutoff index values for cirrhosis were 1.435 and 4.615 in HCV-negative and HCV-positive patients, respectively. Serum WFA(+)-M2BP levels at the time of operation were a significant predictor of hepatocellular carcinoma recurrence and overall survival in both HCV-negative and HCV-positive patients. Serum WFA(+)-M2BP levels reflected both the pathological and functional progression of liver fibrosis comprehensively and continuously. Elevated WFA(+)-M2BP levels were a significant risk factor for tumor recurrence and decreased overall survival after liver surgery independent of HCV infection.	[Fujiyoshi, Masato; Yokoo, Hideki; Kamachi, Hirofumi; Kamiyama, Toshiya; Taketomi, Akinobu] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 1, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Kuno, Atsushi; Gotoh, Masanori; Narimatsu, Hisashi] Natl Inst Adv Ind Sci & Technol, RCMG, Tsukuba, Ibaraki 3058568, Japan; [Fukai, Moto] Hokkaido Univ, Grad Sch Med, Dept Transplant Surg, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Korenaga, Masaaki; Mizokami, Masashi] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa 2728516, Japan	Taketomi, A (reprint author), Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 1, Kita Ku, Kita 15-jo Nishi 7 Chome, Sapporo, Hokkaido 0608638, Japan.	taketomi@med.hokudai.ac.jp			Ministry of Health, Labour and Welfare, Japan	The authors are grateful for the assistance of the Hepatitis Glyco-biomarker Study Group. This study was supported by a grant-in-aid from the Ministry of Health, Labour and Welfare, Japan.	Abe M, 2015, J GASTROENTEROL, V50, P776, DOI 10.1007/s00535-014-1007-2; Kamiyama T, 2010, J AM COLL SURGEONS, V211, P443, DOI 10.1016/j.jamcollsurg.2010.06.005; Gassmann P, 2010, WORLD J SURG, V34, P2442, DOI 10.1007/s00268-010-0655-5; Ko S, 2002, BRIT J SURG, V89, P57, DOI 10.1046/j.0007-1323.2001.01969.x; Fukushima K, 2014, J GASTROINTEST SURG, V18, P729, DOI 10.1007/s11605-013-2423-y; Taketomi A, 2007, J AM COLL SURGEONS, V204, P580, DOI 10.1016/j.jamcollsurg.2007.01.035; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; KOTHS K, 1993, J BIOL CHEM, V268, P14245; Matsuda A, 2013, J PROTEOMICS, V85, P1, DOI 10.1016/j.jprot.2013.04.017; Artini M, 1996, J HEPATOL, V25, P212, DOI 10.1016/S0168-8278(96)80076-6; Ocho M, 2014, J PROTEOME RES, V13, P1428, DOI 10.1021/pr400986t; Matsuda A, 2010, HEPATOLOGY, V52, P174, DOI 10.1002/hep.23654; Sasaki T, 1998, EMBO J, V17, P1606, DOI 10.1093/emboj/17.6.1606; Toshima T, 2011, J GASTROENTEROL, V46, P705, DOI 10.1007/s00535-010-0365-7; Cheung KJ, 2009, J VIRAL HEPATITIS, V16, P418, DOI 10.1111/j.1365-2893.2009.01083.x; HO MK, 1982, J IMMUNOL, V128, P1221; Toshima T, 2015, J GASTROENTEROL, V50, P76, DOI 10.1007/s00535-014-0946-y; Kuno A, 2013, PROTEOM CLIN APPL, V7, P642, DOI 10.1002/prca.201300010; Muller SA, 1999, J MOL BIOL, V291, P801, DOI 10.1006/jmbi.1999.2996; ULLRICH A, 1994, J BIOL CHEM, V269, P18401; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Ichida F, 1996, INT HEPATOL COMMUN, V6, P112, DOI 10.1016/S0928-4346(96)00325-8; Kamiyama T, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-107; Kuno A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01065; Vergniol J, 1979, GASTROENTEROLOGY, V2011, P1970; Yamasaki K, 2014, HEPATOLOGY, V60, P1563, DOI 10.1002/hep.27305	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	NOV	2015	50	11					1134	1144		10.1007/s00535-015-1063-2		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CV8HR	WOS:000364524000007		
J	Kai, Y; Hikita, H; Tatsumi, T; Nakabori, T; Saito, Y; Morishita, N; Tanaka, S; Nawa, T; Oze, T; Sakamori, R; Yakushijin, T; Hiramatsu, N; Suemizu, H; Takehara, T				Kai, Yugo; Hikita, Hayato; Tatsumi, Tomohide; Nakabori, Tasuku; Saito, Yoshinobu; Morishita, Naoki; Tanaka, Satoshi; Nawa, Takatoshi; Oze, Tsugiko; Sakamori, Ryotaro; Yakushijin, Takayuki; Hiramatsu, Naoki; Suemizu, Hiroshi; Takehara, Tetsuo			Emergence of hepatitis C virus NS5A L31V plus Y93H variant upon treatment failure of daclatasvir and asunaprevir is relatively resistant to ledipasvir and NS5B polymerase nucleotide inhibitor GS-558093 in human hepatocyte chimeric mice	JOURNAL OF GASTROENTEROLOGY			English	Article						Resistance-associated variants (RAVs); Asunaprevir/daclatasvir; Ledipasvir/sofosbuvir	GENOTYPE 1 INFECTION; DIRECT-ACTING ANTIVIRALS; SOFOSBUVIR; REPLICATION; PHASE-3; TRIAL	Background Resistance-associated variants (RAVs) emerge at multiple positions spanning hepatitis C virus (HCV) NS3/4A and NS5A regions upon failure of asunaprevir/daclatasvir combination therapy. It has not been determined whether the emergence of such RAVs have an impact on re-treatment by a combination of ledipasvir and sofosbuvir, a potent regimen for HCV genotype 1 infection. Methods TK-NOG human hepatocyte chimeric mice were inoculated with sera from a patient with treatment failure of asunaprevir/daclatasvir therapy. Results They developed persistent HCV infection with triple variants of NS3/4A D168V, NS5A L31V plus Y93H. Administration of ledipasvir/GS-558093 (a NS5B nucleotide analog) in these mice failed to achieve end-of-treatment response or sustained virologic response, which was in sharp contrast to the results in mice with wild-type virus infection. The administration of telaprevir/GS-558093 successfully achieved it in those mice. Treatment failure with asunaprevir/daclatasvir may limit further treatment options. This population may represent a growing unmet medical need.	[Kai, Yugo; Hikita, Hayato; Tatsumi, Tomohide; Nakabori, Tasuku; Saito, Yoshinobu; Morishita, Naoki; Tanaka, Satoshi; Nawa, Takatoshi; Oze, Tsugiko; Sakamori, Ryotaro; Yakushijin, Takayuki; Hiramatsu, Naoki; Takehara, Tetsuo] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka 5650871, Japan; [Suemizu, Hiroshi] Cent Inst Expt Anim, Dept Lab Anim Res, Kawasaki, Kanagawa, Japan	Takehara, T (reprint author), Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takehara@gh.med.osaka-u.ac.jp			Japan Agency for Medical Research and development	This work was partly supported by a Grant-in-Aid for Research on Hepatitis from Japan Agency for Medical Research and development.	Takehara T, 2014, EXPERT REV ANTI-INFE, V12, P909, DOI 10.1586/14787210.2014.925800; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Mizokami M, 2015, LANCET INFECT DIS, V15, P645, DOI 10.1016/S1473-3099(15)70099-X; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Lam AM, 2012, ANTIMICROB AGENTS CH, V56, P3359, DOI 10.1128/AAC.00054-12; Fridell RA, 2011, HEPATOLOGY, V54, P1924, DOI 10.1002/hep.24594; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Karino Y, 2013, J HEPATOL, V58, P646, DOI 10.1016/j.jhep.2012.11.012; Svarovskaia ES, 2014, CLIN INFECT DIS, V59, P1666, DOI 10.1093/cid/ciu697; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Aghemo A, 2013, HEPATOLOGY, V58, P428, DOI 10.1002/hep.26371; Wong KA, 2013, ANTIMICROB AGENTS CH, V57, P6333, DOI 10.1128/AAC.02193-12; Manns M, 2014, LANCET, V384, P1597, DOI 10.1016/S0140-6736(14)61059-X; Hasegawa M, 2011, BIOCHEM BIOPH RES CO, V405, P405, DOI 10.1016/j.bbrc.2011.01.042; Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Friborg J, 2014, INFECT DIS THER, V4, P137; Gane EJ, 2014, GASTROENTEROLOGY, V146, P736, DOI 10.1053/j.gastro.2013.11.007; Lam AM, 2014, ANTIMICROB AGENTS CH, V58, P6861, DOI 10.1128/AAC.03847-14; Poole RM, 2014, DRUGS, V74, P1559, DOI 10.1007/s40265-014-0279-4	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	NOV	2015	50	11					1145	1151		10.1007/s00535-015-1108-6		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CV8HR	WOS:000364524000008		
J	Fujioka, K; Gotoh, H; Noumi, T; Yoshida, A; Noutoshi, Y; Inagaki, Y; Yamamoto, M; Ichinose, Y; Shiraishi, T; Toyoda, K				Fujioka, Kayoko; Gotoh, Haruko; Noumi, Taku; Yoshida, Ami; Noutoshi, Yoshiteru; Inagaki, Yoshishige; Yamamoto, Mikihiro; Ichinose, Yuki; Shiraishi, Tomonori; Toyoda, Kazuhiro			Protection induced by volatile limonene against anthracnose disease in Arabidopsis thaliana	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article						Arabidopsis thaliana; Colletotrichum higginsianum; D-Limonene; Plant defensin (PDF1.2); Systemic resistance; Volatile	DEFENSE RESPONSES; BOTRYTIS-CINEREA; PLANT-GROWTH; C6-ALDEHYDES; RESISTANCE; GENE	d-Limonene induces expression of PDF1.2 gene and resistance against Colletotrichum higginsianum in Arabidopsis ecotype Col-0. The limonene-induced expression of PDF1.2 was diminished in jar1-1 (jasmonate resistant 1-1) plants, indicating that the response of Arabidopsis depends on jasmonic acid (JA)-regulated defense signaling pathway. In fact, systemic induction of PDF1.2 was confirmed when the Arabidopsis plants harboring the PDF1.2 promotor::GUS were exposed to limonene. A similar protective effect was also observed on Japanese mustard spinach (Brassica rapa var. perviridis) challenged with C. higginsianum, suggesting that plants are capable of recognizing gaseous limonene and activate disease resistance.	[Fujioka, Kayoko; Noutoshi, Yoshiteru; Inagaki, Yoshishige; Yamamoto, Mikihiro; Ichinose, Yuki; Shiraishi, Tomonori; Toyoda, Kazuhiro] Okayama Univ, Grad Sch Nat Sci & Technol, Kita Ku, Okayama 7008530, Japan; [Fujioka, Kayoko] Okayama Prefectural Yakage Senior High Sch, Okayama 7141201, Japan	Toyoda, K (reprint author), Okayama Univ, Grad Sch Nat Sci & Technol, Kita Ku, 1-1-1 Tsushima Naka, Okayama 7008530, Japan.	pisatin@cc.okayama-u.ac.jp			Graduate School of Natural Science and Technology, Okayama University, Japan	We gratefully acknowledge Drs. Yoshihiro Narusaka and Mari Narusaka (Research Institute of Biological Sciences Okayama, Okayama, Japan) for their gift of Arabidopsis transgenic seeds harboring the PDF1.2 promotor-GUS (beta-glucuronidase) fusion gene as the reporter gene. This research was in part supported by the Research Grant for Encouragement of Students to KF from the Graduate School of Natural Science and Technology, Okayama University, Japan.	Kishimoto K, 2006, PLANT SCI, V171, P415, DOI 10.1016/j.plantsci.2006.05.004; Kishimoto K, 2008, PHYTOCHEMISTRY, V69, P2127, DOI 10.1016/j.phytochem.2008.04.023; Brown RL, 2003, PLANT PHYSIOL, V132, P1020, DOI 10.1104/pp.102.017814; Narusaka Y, 2009, PLANT BIOTECHNOL, V26, P345, DOI 10.5511/plantbiotechnology.26.345; Kishimoto Kyutaro, 2007, Journal of General Plant Pathology, V73, P35, DOI 10.1007/s10327-006-0314-8; Blom D, 2011, ENVIRON MICROBIOL, V13, P3047, DOI 10.1111/j.1462-2920.2011.02582.x; Toyoda K, 2013, J GEN PLANT PATHOL, V79, P1, DOI 10.1007/s10327-012-0405-7; Kishimoto K, 2005, PLANT CELL PHYSIOL, V46, P1093, DOI 10.1093/pcp/pci122; Sun J, 2007, ALTERN MED REV, V12, P259; Yamasaki Yumiko, 2007, Journal of General Plant Pathology, V73, P168, DOI 10.1007/s10327-007-0013-0; Yamagiwa Y, 2011, J GEN PLANT PATHOL, V77, P336, DOI 10.1007/s10327-011-0340-z; Marques JPR, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plu090; Narusaka M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115864; Naznin HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086882; Singh G, 2002, NAT PROD RAD, V1, P8	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2015	81	6					415	419		10.1007/s10327-015-0621-z		5	Plant Sciences	Plant Sciences	CV8DT	WOS:000364509400001		
J	Uwamori, T; Inoue, K; Kida, C; Morita, Y; Park, P; Nakayashiki, H; Kanematsu, S; Ikeda, K				Uwamori, Takahiro; Inoue, Kanako; Kida, Chiaki; Morita, Yuichi; Park, Pyoyun; Nakayashiki, Hitoshi; Kanematsu, Satoko; Ikeda, Kenichi			Self- and nonself recognition during hyphal interactions in Rosellinia necatrix	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article						Rosellinia necatrix; Hyphal interactions; Vacuole; Anastomosis; Virocontrol; Actin	PROGRAMMED CELL-DEATH; VEGETATIVE INCOMPATIBILITY; HETEROKARYON INCOMPATIBILITY; NEUROSPORA-CRASSA; PATHOGENIC FUNGI; F-ACTIN; DIVERSITY; COMPATIBILITY; CYTOSKELETON; GENETICS	Hyphal interactions of 10 Rosellinia necatrix isolates were analyzed. Most incompatible pairings produced broad melanized barrage lines, with a few exceptions. The variation in barrage lines revealed using light microscopy might result from distinct frequencies of different hyphal interaction types. In incompatible pairings, hyphal anastomosis was rarely observed. Activated-charcoal treatment of oatmeal agar media prevented both incompatible and compatible reactions. FUN-1 staining showed vacuole dysfunction at hyphal interaction sites, and the localization of a Lifeact-GFP mutant revealed that actin dynamics was prominent in compatible pairings. These results suggested that self/nonself recognition commonly proceeded to vacuole dysfunction and that actin dynamics played a critical role in the restoration of vacuole integrity.	[Uwamori, Takahiro; Inoue, Kanako; Kida, Chiaki; Morita, Yuichi; Park, Pyoyun; Nakayashiki, Hitoshi; Ikeda, Kenichi] Kobe Univ, Lab Cell Struct & Funct, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan; [Kanematsu, Satoko] NARO, Plant Pathol Res Team, Natl Inst Fruit Tree Sci, Morioka, Iwate 0200123, Japan	Ikeda, K (reprint author), Kobe Univ, Lab Cell Struct & Funct, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan.	ikeken@phoenix.kobe-u.ac.jp			program for Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry	This research was supported by the program for Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry.	Millard PJ, 1997, APPL ENVIRON MICROB, V63, P2897; Armengol J, 2010, PLANT PATHOL, V59, P179, DOI 10.1111/j.1365-3059.2009.02150.x; Kanematsu S, 2004, PHYTOPATHOLOGY, V94, P561, DOI 10.1094/PHYTO.2004.94.6.561; Marek SM, 2003, FUNGAL GENET BIOL, V40, P126, DOI 10.1016/S1087-1845(03)00086-0; Glass NL, 2006, CURR OPIN MICROBIOL, V9, P553, DOI 10.1016/j.mib.2006.09.001; Hatsugai N, 2006, APOPTOSIS, V11, P905, DOI 10.1007/s10495-006-6601-1; ZAKERI Z, 1995, CELL DEATH DIFFER, V2, P87; AINSWORTH AM, 1986, J GEN MICROBIOL, V132, P191; Giovannetti M, 2003, APPL ENVIRON MICROB, V69, P616, DOI 10.1128/AEM.69.1.616-624.2003; Ranganath RM, 2001, INT REV CYTOL, V202, P159, DOI 10.1016/S0074-7696(01)02005-8; PRASAD I, 1970, GENETICA, V41, P388, DOI 10.1007/BF00958920; Berepiki A, 2010, EUKARYOT CELL, V9, P547, DOI 10.1128/EC.00253-09; ROBERSON RW, 1992, MYCOLOGIA, V84, P41, DOI 10.2307/3760400; Essary BD, 2009, J MICROBIOL METH, V78, P208, DOI 10.1016/j.mimet.2009.05.018; Inoue K, 2011, FUNGAL BIOL-UK, V115, P87, DOI 10.1016/j.funbio.2010.10.009; Perez-Jimenez RM, 2006, J PHYTOPATHOL, V154, P257, DOI 10.1111/j.1439-0434.2006.01101.x; Lopez M, 2008, EUR J PLANT PATHOL, V121, P201, DOI 10.1007/s10658-007-9253-2; Geitmann A, 2000, J MICROSC-OXFORD, V198, P218, DOI 10.1046/j.1365-2818.2000.00702.x; Ikeda K, 2004, MYCOL RES, V108, P626, DOI 10.1017/s0953756204000061; Glass NL, 2000, ANNU REV GENET, V34, P165, DOI 10.1146/annurev.genet.34.1.165; Saupe SJ, 2000, MICROBIOL MOL BIOL R, V64, P489, DOI 10.1128/MMBR.64.3.489-502.2000; CATEN CE, 1972, J GEN MICROBIOL, V72, P221; Hutchison E, 2009, MICROBIOL-SGM, V155, P3957, DOI 10.1099/mic.0.032284-0; Sbrana C, 2007, MYCORRHIZA, V17, P667, DOI 10.1007/s00572-007-0144-3; Read ND, 2009, CURR OPIN MICROBIOL, V12, P608, DOI 10.1016/j.mib.2009.09.008; Ramsdale M, 2008, BBA-MOL CELL RES, V1783, P1369, DOI 10.1016/j.bbamcr.2008.01.021; HYAKUMACHI M, 1987, T BRIT MYCOL SOC, V89, P155; Ghabrial SA, 2009, ANNU REV PHYTOPATHOL, V47, P353, DOI 10.1146/annurev-phyto-080508-081932; KIMURA N, 1993, J BACTERIOL, V175, P4427; Ikeda K, 2011, FUNGAL BIOL-UK, V115, P80, DOI 10.1016/j.funbio.2010.10.008; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; ARAKI T., 1967, Bull. natn. Inst. agric. Sci., Tokyo, V21, P1; Esser K, 2006, THE MYCOTA, P141; Fleissner A, 2009, P NATL ACAD SCI USA, V106, P19393, DOI 10.1073/pnas.0907039106; Ishikawa FH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031175; Perez Jimenez Rosa M., 2002, Mycological Research, V106, P239, DOI 10.1017/S0953756201005500; Pinan-Lucarre Berangere, 2003, Molecular Microbiology, V47, P321, DOI 10.1046/j.1365-2958.2003.03208.x; Van Zandycke SM, 2003, BREWING YEAST FERMEN, P162	38	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2015	81	6					420	428		10.1007/s10327-015-0622-y		9	Plant Sciences	Plant Sciences	CV8DT	WOS:000364509400002		
J	Nekoduka, S; Kobayashi, K; Fuji, S; Okuda, M; Sano, T				Nekoduka, Syuuichi; Kobayashi, Kappei; Fuji, Shin-ichi; Okuda, Mitsuru; Sano, Teruo			Molecular epidemiology of Impatiens necrotic spot virus on greenhouse ornamental plants in a local area of Japan	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article						Haplotype; Impatiens necrotic spot virus; Intergenic region; Nucleocapsid protein; Phylogenetic analysis; Tospovirus	FLUE-CURED TOBACCO; WILT-VIRUS; 1ST REPORT; RECOMBINANT SEQUENCES; POPULATION-GENETICS; NUCLEOTIDE-SEQUENCE; INTERGENIC REGION; COMPUTER-PROGRAM; MOSAIC STRUCTURE; S-RNA	Impatiens necrotic spot virus (INSV), belonging to the genus Tospovirus, causes severe damage to greenhouse ornamental plants. We conducted population genetic analyses of INSV isolated from various greenhouse flowers in Iwate Prefecture as a model to elucidate how the virus invaded and spread within a local area of Japan. Forty-two and 30 sequences of the nucleocapsid protein gene (NG) and intergenic regions (IGR), respectively, of the small RNA of the virus were generated from 42 isolates collected from seven greenhouses in three districts, and then they were divided into 10 NG haplotypes and 13 IGR haplotypes. A combined haplotype analysis for the two loci revealed the presence of 14 NG/IGR haplotypes in the region. Genetic structure of the INSV population based on the NG sequences was differentiated according to districts and greenhouses, and 3 major NG haplotypes were predominant in each district. Genetic analysis based on IGR sequences showed that the population structure in some greenhouses consisted of 1 major IGR haplotype and some minor haplotypes with the same NG haplotype. Phylogenetic analysis based on NG and IGR sequences illustrated that INSV haplotypes were clustered according to geographic origin, including the isolates previously reported in Japan and other countries. Host species did not seem to influence the genetic structure of the INSV population. These results suggest that some founder isolates were introduced individually from other epidemic regions to each district in the region through different routes and then spread within the local areas and greenhouses.	[Nekoduka, Syuuichi] Iwate Agr Res Ctr, Kitakami, Iwate 0240003, Japan; [Kobayashi, Kappei] Iwate Biotechnol Res Ctr, Kitakami, Iwate 0240003, Japan; [Fuji, Shin-ichi] Akita Prefectural Univ, Fac Bioresource Sci, Akita 0100195, Japan; [Okuda, Mitsuru] Natl Agr & Food Res Org, Agr Res Ctr, Tsukuba, Ibaraki 3058666, Japan; [Sano, Teruo] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori 0368561, Japan	Nekoduka, S (reprint author), Hanamaki Agr & Forestry Promot Ctr, 1-41 Kajo Cho, Kitakami, Iwate 0250075, Japan.	s-nekoduka@pref.iwate.jp					Moury B, 2006, ADV VIRUS RES, V67, P49, DOI 10.1016/S0065-3527(06)67002-4; Crosslin JM, 2010, PLANT DIS, V94, P1507, DOI 10.1094/PDIS-07-10-0542; Heinze C, 2001, MICROBIOLOGICA, V24, P175; Jeger MJ, 2006, ADV VIRUS RES, V67, P163, DOI 10.1016/S0065-3527(06)67005-X; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Lee JS, 2011, ARCH VIROL, V156, P725, DOI 10.1007/s00705-011-0935-x; Zhang Q, 2010, PLANT DIS, V94, P915, DOI 10.1094/PDIS-94-7-0915A; Cottam EM, 2006, J VIROL, V80, P11274, DOI 10.1128/JVI.01236-06; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Smith TN, 2006, AUSTRALAS PLANT PATH, V35, P359, DOI 10.1071/AP06031; Okuda M, 2010, J PLANT PATHOL, V92, P357; Pappu HR, 2006, ARCH VIROL, V151, P1015, DOI 10.1007/s00705-005-0681-z; SMITH JM, 1992, J MOL EVOL, V34, P126; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Sivparsad BJ, 2008, AFR J AGR RES, V3, P428; Maejima K, 2011, PHYTOPATHOLOGY, V101, P567, DOI 10.1094/PHYTO-10-10-0280; Kondo T, 2011, J GEN PLANT PATHOL, V77, P263, DOI 10.1007/s10327-011-0317-y; Daughtrey ML, 1997, PLANT DIS, V81, P1220, DOI 10.1094/PDIS.1997.81.11.1220; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Pappu SS, 2000, ARCH VIROL, V145, P1035, DOI 10.1007/s007050050694; TEMPLETON AR, 1992, GENETICS, V132, P619; Pappu H, 1998, VIRUS GENES, V17, P169, DOI 10.1023/A:1008072825152; Milgroom MG, 2003, PLANT DIS, V87, P608, DOI 10.1094/PDIS.2003.87.6.608; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Hassani-Mehraban A, 2005, PHYTOPATHOLOGY, V95, P852, DOI 10.1094/PHYTO-95-0852; DEHAAN P, 1992, FEBS LETT, V306, P27, DOI 10.1016/0014-5793(92)80830-A; Tsompana M, 2005, MOL ECOL, V14, P53, DOI 10.1111/j.1365-294X.2004.02392.x; Yin YY, 2011, J PLANT PATHOL, V93, P66; Ciuffo M, 2009, PLANT DIS, V93, P467, DOI 10.1094/PDIS-93-5-0467; Bulajic A, 2009, PLANT DIS, V93, P976, DOI 10.1094/PDIS-93-10-0976; Ding M, 2011, PLANT DIS, V95, P357, DOI 10.1094/PDIS-09-10-0685; Garcia-Arenal F, 2001, ANNU REV PHYTOPATHOL, V39, P157, DOI 10.1146/annurev.phyto.39.1.157; Bhat AI, 1999, VIRUS RES, V61, P161, DOI 10.1016/S0168-1702(99)00049-0; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Bezerra IC, 1999, PHYTOPATHOLOGY, V89, P823, DOI 10.1094/PHYTO.1999.89.9.823; LAW MD, 1990, J GEN VIROL, V71, P933, DOI 10.1099/0022-1317-71-4-933; Kaye AC, 2011, PHYTOPATHOLOGY, V101, P147, DOI 10.1094/PHYTO-01-10-0035; DEAVILA AC, 1992, J PHYTOPATHOL, V134, P133; Sakurai T, 2004, APPL ENTOMOL ZOOL, V39, P71, DOI 10.1303/aez.2004.71; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Nischwitz C, 2007, J PHYTOPATHOL, V155, P531, DOI 10.1111/j.1439-0434.2007.01272.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tentchev D, 2011, J GEN VIROL, V92, P961, DOI 10.1099/vir.0.029082-0; Doi M, 2003, ANN REP KANTO TOSAN, V50, P83; Fuji S, 2000, ANN REPT PLANT PROT, V51, P122; Goto T, 2001, ANN REPT KANTO TOSAN, V48, P97; Grausgruber-Gröger S., 2012, New Disease Reports, V26, P12, DOI 10.5197/j.2044-0588.2012.026.012; Horita H, 2005, JPN J PHYTOPATHOL, V71, P83; Jensen Sten E., 2000, Integrated Pest Management Reviews, V5, P131, DOI 10.1023/A:1009600426262; Kawashima K, 2001, ANN REP PLANT PROT N, V52, P214; Kurokawa E, 2003, JPN J PHYTOPATHOL, V69, P67; LAW MD, 1991, J GEN VIROL, V72, P2597, DOI 10.1099/0022-1317-72-10-2597; Nekoduka S., 2005, Japanese Journal of Phytopathology, V71, P183; Sako K, 2006, ANN REP KANTO TOSAN, V53, P77; Tanina K., 2001, Japanese Journal of Phytopathology, V67, P42; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	58	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2015	81	6					429	438		10.1007/s10327-015-0615-x		10	Plant Sciences	Plant Sciences	CV8DT	WOS:000364509400003		
J	Kobayashi, YO; Kobayashi, A; Maeda, M; Someya, N; Takenaka, S				Kobayashi, Yuki O.; Kobayashi, Akira; Maeda, Masayuki; Someya, Nobutaka; Takenaka, Shigehito			Biological control of potato scab and antibiosis by antagonistic Streptomyces sp WoRs-501	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article						Potato scab; Biocontrol; Streptomyces sp.; nec1 gene; 16S-23S rDNA ITS region sequence; Antibiotic	COMMON SCAB; DISEASE; LESIONS; BIOCONTROL; AGENT; FIELD; GENE; WILT	Streptomyces sp. isolate WoRs-501 suppressed potato scab caused by S. turgidiscabies and S. scabiei in a field pot trial. An inoculum of 2 x 10(7) colony-forming units (CFU)/g dry soil was sufficient to establish a population with a stable suppressive effect on the disease. In the field, mixing the WoRs-501 inoculum (approximately 10(9) CFU/g dry mass) at a ratio of 1:9 (v/v) with scab-infested field soil at 30 x 30 x 15 cm per plant decreased the disease severity score by 26-54 % in comparison with the untreated control. To understand establishment of WoRs-501 in soil and the mechanism of the suppressive effect of the isolate on potato scab, we analyzed the population dynamics of WoRs-501 and scab pathogen in soil using real-time quantitative competitive quenching probe PCR. In a pot trial using soil that was initially treated with 2 x 10(7) WoRs-501 CFU/g dry soil, the copy number of the WoRs-501 16S-23S rDNA ITS sequence was maintained approximately 10(7) copies/g dry soil during potato cultivation. Treatment with 2 x 10(7) WoRs-501 CFU/g dry soil reduced the copy number of the scab pathogen nec1 gene in infested soil below the detection threshold. Though the copy number of this gene increased gradually during potato cultivation, the nec1 copy number remained at a significantly lower value than in the untreated control. An extract of the WoRs-501 inoculum inhibited mycelial growth of S. turgidiscabies in vitro. Therefore, antibiotics from WoRs-501 decrease scab pathogen populations in soil early in potato cultivation and strongly suppress scab disease.	[Kobayashi, Yuki O.; Kobayashi, Akira; Someya, Nobutaka; Takenaka, Shigehito] Natl Agr & Food Res Org, Hokkaido Agr Res Ctr, Memuro, Hokkaido 0820081, Japan; [Maeda, Masayuki] Niigata Agr Res Inst, Nagaoka, Niigata 9400826, Japan; [Kobayashi, Yuki O.; Kobayashi, Akira] Natl Agr & Food Res Org, Kyushu Okinawa Agr Res Ctr, Miyakonojo, Miyazaki 8850091, Japan; [Someya, Nobutaka] Natl Agr & Food Res Org, Tsukuba, Ibaraki 3058517, Japan; [Takenaka, Shigehito] Natl Agr & Food Res Org, Western Reg Agr Res Ctr, Fukuyama, Hiroshima 7218514, Japan	Kobayashi, YO (reprint author), Natl Agr & Food Res Org, Hokkaido Agr Res Ctr, Memuro, Hokkaido 0820081, Japan.	oodaira@affrc.go.jp			Japanese Ministry of Agriculture, Forestry and Fisheries	This study was supported by funding from the Japanese Ministry of Agriculture, Forestry and Fisheries for the project "Development of New Biorational Techniques for Sustainable Agriculture". The authors thank Dr. F. Tanaka from the Hokkaido Research Organization and Dr. S. Naito for supplying the scab pathogens, Dr. H. Sekiguchi for helpful suggestions, and N. Taira, T. Ashida, S. Souma, A. Shintani, H. Suzuki, and H. Ohnuma for technical assistance.	Arseneault T, 2013, PHYTOPATHOLOGY, V103, P995, DOI 10.1094/PHYTO-01-13-0022-R; Wanner LA, 2014, J APPL MICROBIOL, V116, P123, DOI 10.1111/jam.12336; Soltani N, 2002, CAN J PLANT PATHOL, V24, P332; Wanner LA, 2006, PHYTOPATHOLOGY, V96, P1363, DOI 10.1094/PHYTO-96-1363; Singhai PK, 2011, BIOL CONTROL, V57, P150, DOI 10.1016/j.biocontrol.2011.02.008; Song J, 2004, INT J SYST EVOL MICR, V54, P203, DOI 10.1099/ijs.0.02624-0; McKenna F, 2001, PLANT PATHOL, V50, P666, DOI 10.1046/j.1365-3059.2001.00648.x; Khatri BB, 2011, PLANT PATHOL, V60, P776, DOI 10.1111/j.1365-3059.2011.02435.x; Kobayashi YO, 2012, J GEN PLANT PATHOL, V78, P62, DOI 10.1007/s10327-011-0354-6; LIU DQ, 1995, PHYTOPATHOLOGY, V85, P827, DOI 10.1094/Phyto-85-827; Han JS, 2005, J APPL MICROBIOL, V99, P213, DOI 10.1111/j.1365-2672.2005.02614.x; HAYASHIDA S, 1989, AGR BIOL CHEM TOKYO, V53, P349; Meng QX, 2013, BIOL CONTROL, V67, P373, DOI 10.1016/j.biocontrol.2013.09.009; Loria R, 2006, ANNU REV PHYTOPATHOL, V44, P469, DOI 10.1146/annurev.phyto.44.032905.091147; Takenaka S, 2008, PHYTOPATHOLOGY, V98, P187, DOI 10.1094/PHYTO-98-2-0187; Kobayashi A, 2002, BREEDING SCI, V52, P327, DOI 10.1270/jsbbs.52.327; Miyajima K, 1998, INT J SYST BACTERIOL, V48, P495; Beausejour J, 2003, PLANT SOIL, V256, P463, DOI 10.1023/A:1026177714855; Hiltunen LH, 2009, J APPL MICROBIOL, V106, P199, DOI 10.1111/j.1365-2672.2008.03992.x; Schmiedeknecht G, 1998, Z PFLANZENK PFLANZEN, V105, P376; Koyama O, 2007, MICROBES ENVIRONMENT, V22, P123, DOI 10.1264/jsme2.22.123; Neeno-Eckwall EC, 2001, CAN J MICROBIOL, V47, P332, DOI 10.1139/cjm-47-4-332; Dees MW, 2012, MOL PLANT PATHOL, V13, P174, DOI 10.1111/j.1364-3703.2011.00741.x; St-Onge R, 2008, SYST APPL MICROBIOL, V31, P474, DOI 10.1016/j.syapm.2008.09.002; Hooker WJ, 1981, COMPENDIUM POTATO DI, P33; Kobayashi A, 2005, PLANT PROT, V59, P210; Kobayashi Akira, 2005, Journal of General Plant Pathology, V71, P139, DOI 10.1007/s10327-004-0175-y; Konagai K., 2005, Japanese Journal of Phytopathology, V71, P101; Kondo N, 2001, ANN REP HOKKAIDO DIV, V28, P24; Loria R, 2001, COMPENDIUM POTATO DI, P14; Matsumoto K, 1979, PLANT PROT, V33, P461; Mino K, 2001, B HOKKAIDO PREF AGR, V80, P73; Nakagawa A, 2003, SOIL MICROORGANISMS, V58, P87; Sakuma F, 2002, JPN J PHYTOPATHOL, V68, P103; Shiga H, 2005, PLANT PROT, V59, P215; Souma J, 2002, B HOKKAIDO PREF AGR, V82, P121; Takahashi K, 1997, ANN REPT SOC PLANT P, V48, P59; Tanaka T, 2005, PLANT PROT, V59, P218; TANII A, 1990, BIOLOGICAL CONTROL OF SOIL-BORNE PLANT PATHOGENS, P143; Yokoyama R, 1999, PSJ BIOCONT REP, V6, P73	40	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2015	81	6					439	448		10.1007/s10327-015-0614-y		10	Plant Sciences	Plant Sciences	CV8DT	WOS:000364509400004		
J	Sekiguchi, H; Toda, T; Sato, E; Tomioka, K; Murakami, H; Amemiya, R; Hirako, N; Nakata, M; Hyakumachi, M; Tsushima, S				Sekiguchi, Hiroyuki; Toda, Takeshi; Sato, Erika; Tomioka, Keisuke; Murakami, Hiroharu; Amemiya, Ryota; Hirako, Naoyuki; Nakata, Masato; Hyakumachi, Mitsuro; Tsushima, Seiya			Rhizoctonia blight of turnip green caused by Rhizoctonia solani AG-4 HG-III	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Article						Rhizoctonia blight; Rhizoctonia solani AG-4 HG-III; Turnip green	DAMPING-OFF; LETTUCE	Severe wilt was found on seedlings of turnip green (Brassica rapa L., perviridis group) in Ibaraki Prefecture, Japan, from May to September 2013. A fungus repeatedly isolated from diseased plants was identified as Rhizoctonia solani AG-4 HG-III based on culture morphology, anastomosis and sequencing of the internal transcribed spacer region on ribosomal DNA (rDNA-ITS region). Pathogenicity of this isolate to turnip green was confirmed based on inoculation test. Because Rhizoctonia blight of turnip green by AG-4 HG-III has not been reported so far, we propose including it as one of the pathogens causing this disease.	[Sekiguchi, Hiroyuki; Sato, Erika; Tomioka, Keisuke] Natl Agr & Food Res Org, Western Reg Agr Res Ctr, Fukuyama, Hiroshima 7218514, Japan; [Toda, Takeshi] Akita Prefectural Univ, Fac Bioresource Sci, Akita 0100195, Japan; [Murakami, Hiroharu] Natl Agr & Food Res Org, Tsukuba, Ibaraki 3058517, Japan; [Amemiya, Ryota; Hirako, Naoyuki; Nakata, Masato] Shohachi Tsukuba Co Ltd, Chikusei 3004525, Japan; [Hyakumachi, Mitsuro] Gifu Univ, Fac Appl Biol Sci, Gifu 5011193, Japan; [Tsushima, Seiya] Natl Inst Agroenvironm Sci, Nat Resources Inventory Ctr, Tsukuba, Ibaraki 3058604, Japan	Sekiguchi, H (reprint author), Natl Agr & Food Res Org, Western Reg Agr Res Ctr, Fukuyama, Hiroshima 7218514, Japan.	sekihiro@affrc.go.jp			Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry	This study was supported by the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry.	Yang GH, 2005, J PHYTOPATHOL, V153, P185, DOI 10.1111/j.1439-0434.2005.00938.x; Johnk JS, 2001, PHYTOPATHOLOGY, V91, P821, DOI 10.1094/PHYTO.2001.91.9.821; Kawaradani M., 2007, Japanese Journal of Phytopathology, V73, P21, DOI 10.3186/jjphytopath.73.21; Kuramae EE, 2003, EUR J PLANT PATHOL, V109, P391, DOI 10.1023/A:1023591520981; Hagiwara N., 2008, Japanese Journal of Phytopathology, V74, P162, DOI 10.3186/jjphytopath.74.162; Carling DE, 1996, RHIZOCTONIA SPECIES: TAXONOMY, MOLECULAR BIOLOGY, ECOLOGY, PATHOLOGY AND DISEASE CONTROL, P37; Eimori K, 2005, ANN REP KANTO TOSAN, V52, P35; Horie H, 1990, PLANT PROTECT, V44, P431; Kuninaga S., 2002, Japanese Journal of Phytopathology, V68, P3; Misawa T, 2012, ANN REPT PLANT PROT, V63, P87; Sato K, 1999, ANN REPT PLANT PROT, V50, P232; Sato T, 2014, JARQ-JPN AGR RES Q, V48, P317, DOI 10.6090/jarq.48.317; White T. J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1139/B07-071	13	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2015	81	6					454	456		10.1007/s10327-015-0616-9		3	Plant Sciences	Plant Sciences	CV8DT	WOS:000364509400006		
J	Teraoka, T				Teraoka, Tohru			Molecular aspects of infection in plant-microbe interactions based on the rice-rice blast fungus interaction	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Editorial Material							MAGNAPORTHE-ORYZAE; NUCLEOTIDE-SEQUENCE; VEGETATIVE GROWTH; VIRUS		Tokyo Univ Agr & Technol, Grad Sch Agr, Fuchu, Tokyo 1838509, Japan	Teraoka, T (reprint author), Tokyo Univ Agr & Technol, Grad Sch Agr, Saiwai Cho 3-5-8, Fuchu, Tokyo 1838509, Japan.	teraoka@cc.tuat.ac.jp					Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Urayama S, 2014, VIROLOGY, V448, P265, DOI 10.1016/j.virol.2013.10.022; Maejima K, 2008, ARCH VIROL, V153, P389, DOI 10.1007/s00705-007-1101-3; Yokoi T, 2007, ARCH VIROL, V152, P2265, DOI 10.1007/s00705-007-1045-7; Hyon GS, 2012, J GEN PLANT PATHOL, V78, P237, DOI 10.1007/s10327-012-0386-6; Urayama S, 2015, J GEN PLANT PATHOL, V81, P97, DOI 10.1007/s10327-014-0567-6; Obara N, 2002, BIOSCI BIOTECH BIOCH, V66, P2549, DOI 10.1271/bbb.66.2549; Urayama S, 2010, J GEN VIROL, V91, P3085, DOI 10.1099/vir.0.025411-0; Le MT, 2010, J GEN PLANT PATHOL, V76, P177, DOI 10.1007/s10327-010-0231-8; Urayama S, 2012, J VIROL, V86, P8287, DOI 10.1128/JVI.00871-12; Tosa Y, 2004, PHYTOPATHOLOGY, V94, P454, DOI 10.1094/PHYTO.2004.94.5.454; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Marquez LM, 2007, SCIENCE, V315, P513, DOI 10.1126/science.1136237; Chuma I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002147; Teraoka T, 2000, DEV PLANT PATHOL, V15, P281; YAMASHITA S, 1971, Annals of the Phytopathological Society of Japan, V37, P356	16	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2015	81	6					457	460		10.1007/s10327-015-0629-4		4	Plant Sciences	Plant Sciences	CV8DT	WOS:000364509400007		
J	Kageyama, K				Kageyama, Koji			Studies on the taxonomy and ecology of oomycete pathogens	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Editorial Material							MEDIATED ISOTHERMAL AMPLIFICATION; STRAWBERRY PRODUCTION AREAS; SPECIES-SPECIFIC PRIMERS; REAL-TIME PCR; MULTIPLEX PCR; PHYTOPHTHORA-NICOTIANAE; MOLECULAR PHYLOGENY; PYTHIUM MYRIOTYLUM; P-APHANIDERMATUM; GENUS PYTHIUM		Gifu Univ, River Basin Res Ctr, Gifu 5011193, Japan	Kageyama, K (reprint author), Gifu Univ, River Basin Res Ctr, Gifu 5011193, Japan.	kageyama@green.gifu-u.ac.jp					Rahman MZ, 2014, MYCOSCIENCE, V55, P314, DOI 10.1016/j.myc.2013.11.005; Kageyama K, 2003, J PHYTOPATHOL, V151, P485, DOI 10.1046/j.1439-0434.2003.00757.x; Kageyama K, 1998, PLANT DIS, V82, P218, DOI 10.1094/PDIS.1998.82.2.218; Kageyama K, 1997, PLANT DIS, V81, P1155, DOI 10.1094/PDIS.1997.81.10.1155; Rahman MZ, 2015, MYCOSCIENCE, V56, P419, DOI 10.1016/j.myc.2014.12.006; Li MZ, 2013, MICROBES ENVIRON, V28, P195, DOI 10.1264/jsme2.ME12177; Fukuta S, 2013, EUR J PLANT PATHOL, V136, P689, DOI 10.1007/s10658-013-0198-3; Li MZ, 2011, PLANT DIS, V95, P1270, DOI 10.1094/PDIS-01-11-0076; de Cock AWAM, 2015, PERSOONIA, V34, P25, DOI 10.3767/003158515X685382; Li MZ, 2014, EUR J PLANT PATHOL, V140, P229, DOI 10.1007/s10658-014-0456-z; Ishiguro Y, 2013, J GEN PLANT PATHOL, V79, P350, DOI 10.1007/s10327-013-0466-2; Li MZ, 2010, MICROBIOL RES, V165, P695, DOI 10.1016/j.micres.2009.11.010; Ishiguro Y, 2014, J GEN PLANT PATHOL, V80, P423, DOI 10.1007/s10327-014-0520-8; Levesque CA, 2004, MYCOL RES, V108, P1363, DOI 10.1017/S0953756204001431; Takahashi R, 2014, FEMS MICROBIOL LETT, V355, P28, DOI 10.1111/1574-6968.12453; Rahman MZ, 2014, MYCOL PROG, V13, P759, DOI 10.1007/s11557-014-0959-1; Asano T, 2010, J PHYTOPATHOL, V158, P609, DOI 10.1111/j.1439-0434.2009.01660.x; Rahman MZ, 2014, J GEN PLANT PATHOL, V80, P348, DOI 10.1007/s10327-014-0519-1; Villa NO, 2006, MYCOLOGIA, V98, P410, DOI 10.3852/mycologia.98.3.410; Ishiguro Y, 2014, J GEN PLANT PATHOL, V80, P230, DOI 10.1007/s10327-014-0508-4; Rahman MZ, 2015, MYCOSCIENCE, V56, P443, DOI 10.1016/j.myc.2015.01.002; Fukuta S, 2014, LETT APPL MICROBIOL, V59, P49, DOI 10.1111/lam.12244; Bala K, 2010, PERSOONIA, V24, P136; Feng W, 2015, P 100 ANN M PHYT SOC, P71; Hotta K, 2012, JPN J PHYTOPATHOL, V78, P184; Kageyama Koji, 2002, Journal of General Plant Pathology, V68, P15, DOI 10.1007/PL00013047; KAGEYAMA K, 1983, Annals of the Phytopathological Society of Japan, V49, P148; KAGEYAMA K, 1981, Annals of the Phytopathological Society of Japan, V47, P313; Kageyama K., 1981, Annals of the Phytopathological Society of Japan, V47, P320; KAGEYAMA K, 1982, Annals of the Phytopathological Society of Japan, V48, P308; Kageyama Koji, 2005, Journal of General Plant Pathology, V71, P174, DOI 10.1007/s10327-005-0184-5; KAGEYAMA K, 1982, Annals of the Phytopathological Society of Japan, V48, P333; Matsumoto Chieko, 1999, Mycoscience, V40, P321, DOI 10.1007/BF02463876; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Ribeiro OK, 1996, PHYTOPHTHORA DIS WOR; Suzuki M, 2011, JPN J PHYTOPATHOL, V77, P201; VANDERPLAATSNITERINK AJ, 1981, STUD MYCOL, P1; Yin-Ling Zhou W, 2009, FEMS MICROBIOLOGY LE, V293, P85	38	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2015	81	6					461	465		10.1007/s10327-015-0617-8		5	Plant Sciences	Plant Sciences	CV8DT	WOS:000364509400008		
J	Takenaka, S				Takenaka, Shigehito			Studies on biological control mechanisms of Pythium oligandrum	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Editorial Material							BACTERIAL WILT DISEASE; WALL PROTEIN-FRACTIONS; CELL-WALL; JASMONIC ACID; SUGAR-BEET; INDUCED RESISTANCE; BETA-CYANOALANINE; DEFENSE REACTIONS; TOMATO; BIOCONTROL		NARO Western Reg Agr Res Ctr, Fukuyama, Hiroshima 7218514, Japan	Takenaka, S (reprint author), NARO Western Reg Agr Res Ctr, 6-12-1 Nishifukatsu, Fukuyama, Hiroshima 7218514, Japan.	stake@affrc.go.jp					Takenaka S, 2009, J GEN PLANT PATHOL, V75, P340, DOI 10.1007/s10327-009-0186-9; Takenaka S, 2003, PHYTOPATHOLOGY, V93, P1228, DOI 10.1094/PHYTO.2003.93.10.1228; Masunaka A, 2009, J GEN PLANT PATHOL, V75, P281, DOI 10.1007/s10327-009-0173-1; Hase S., 2012, Japanese Journal of Phytopathology, V78, P309, DOI 10.3186/jjphytopath.78.309; Takenaka S, 2006, MOL PLANT PATHOL, V7, P325, DOI 10.1111/j.1364-3703.2006.00340.x; Takahashi H, 2010, J PHYTOPATHOL, V158, P132, DOI 10.1111/j.1439-0434.2009.01589.x; Takenaka S, 2011, J PLANT PHYSIOL, V168, P1972, DOI 10.1016/j.jplph.2011.05.011; TAKENAKA S, 1994, PHYSIOL MOL PLANT P, V45, P249, DOI 10.1016/S0885-5765(05)80057-8; Masunaka A, 2010, J PHYTOPATHOL, V158, P417, DOI 10.1111/j.1439-0434.2009.01641.x; Hase S, 2008, PLANT PATHOL, V57, P870, DOI 10.1111/j.1365-3059.2008.01858.x; Takahashi H, 2006, PHYTOPATHOLOGY, V96, P908, DOI 10.1094/PHYTO-96-0908; Takenaka S, 2013, JARQ-JPN AGR RES Q, V47, P75; Kawamura Y, 2009, J PHYTOPATHOL, V157, P287, DOI 10.1111/j.1439-0434.2008.01489.x; Hondo D, 2007, MOL PLANT MICROBE IN, V20, P72, DOI 10.1094/MPMI-20-0072; Takenaka S, 2008, PHYTOPATHOLOGY, V98, P187, DOI 10.1094/PHYTO-98-2-0187; Kawamura Y, 2009, PLANT CELL PHYSIOL, V50, P924, DOI 10.1093/pcp/pcp044; Ikeda S, 2012, BIOL CONTROL, V60, P297, DOI 10.1016/j.biocontrol.2011.10.016; Hase S, 2006, PLANT PATHOL, V55, P537, DOI 10.1111/j.1365-3059.2006.01396.x; Hase S., 2013, Japanese Journal of Phytopathology, V79, P1, DOI 10.3186/jjphytopath.79.1; Takenaka S, 2011, PNEUMOLOGIE, V65, P117, DOI DOI 10.1055/s-0030-1270364	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2015	81	6					466	469		10.1007/s10327-015-0620-0		4	Plant Sciences	Plant Sciences	CV8DT	WOS:000364509400009		
J	Tashiro, N				Tashiro, Nobuya			Study on the improvement of fruit tree disease management using evidence-based control	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Editorial Material							EARLY-RIPENING SATSUMA; BENZIMIDAZOLE-RESISTANT; 1ST REPORT; ANTHRACNOSE; GREENHOUSES; EFFICACY; PATHOGEN; MEDICINE; JAPAN; MOLD		Saga Prefectural Upland Farming Res & Extens Ctr, Saga 8470326, Japan	Tashiro, N (reprint author), Saga Prefectural Upland Farming Res & Extens Ctr, Saga 8470326, Japan.	tashiro-nobuya@pref.saga.lg.jp					Altman DG, 2000, STAT CONFIDENCE; Ide Y., 2007, Japanese Journal of Phytopathology, V73, P289, DOI 10.3186/jjphytopath.73.289; Tashiro N, 2012, J GEN PLANT PATHOL, V78, P233, DOI 10.1007/s10327-012-0378-6; Tashiro N., 2008, Japanese Journal of Phytopathology, V74, P297, DOI 10.3186/jjphytopath.74.297; Ide Y., 2008, Japanese Journal of Phytopathology, V74, P13, DOI 10.3186/jjphytopath.74.13; Sackett DL, 1996, BRIT MED J, V312, P71; Tashiro N, 2012, J GEN PLANT PATHOL, V78, P140, DOI 10.1007/s10327-012-0363-0; Tashiro N., 2008, Japanese Journal of Phytopathology, V74, P89, DOI 10.3186/jjphytopath.74.89; [Anonymous], 2011, JPN J PHYTOPATHOL; Tashiro N, 2013, J GEN PLANT PATHOL, V79, P158, DOI 10.1007/s10327-013-0430-1; Tashiro N, 2012, J GEN PLANT PATHOL, V78, P221, DOI 10.1007/s10327-012-0375-9; Borenstein M., 2009, INTRO METAANALYSIS; Etho T, 2002, KYUSHU PL PROT RES, V48, P105; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420; Guyatt GH, 1991, ACP J CLUB; ICMJE, 2014, REC COND REP ED PUBL; Ide Y., 2004, Japanese Journal of Phytopathology, V70, P123; Ide Y., 2004, Japanese Journal of Phytopathology, V70, P1; Inose T, 1964, B SAITAMA AGR EXP ST, V22, P1; Kanadani Gen, 1998, Annals of the Phytopathological Society of Japan, V64, P139; Kuchiki T, 1991, P ASS PL PROT KYUSHU, V37, P75; Kuchiki T, 1992, P ASS PL PROT KYUSHU, V38, P49; Kuramoto T, 1981, B FRUIT TREE RES S B, V8, P69; Mametsuka H., 1990, Proceedings of the Association for Plant Protection of Kyushu, V36, P68; Masui K, 2003, LETS START METAANALY; Miyamoto K, 1983, B WAKAYAMA FRUIT TRE, V7, P51; Morita Y., 1994, B KOCHI AGR RES CTR, V3, P1; Nitta H, 1998, B HIROSHIMA PREFECTU, V66, P7; Sadamatsu M, 1982, P ASS PL PROT KYUSHU, V28, P97; Sadamatsu M., 1990, Proceedings of the Association for Plant Protection of Kyushu, V36, P81; Sadamatsu M, 1985, P ASS PL PROT KYUSHU, V31, P68; Tango T, 2002, INTRO METAANALYSES S; Tashiro N, 1998, B SAGA PREF FRUIT TR, V14, P92; Tashiro N, 2010, 6 WORKSH PSJ RES COM, P18; Tashiro N, 2002, JPN J PHYTOPATHOL, V68, P47; Tashiro N, 2004, B SAGA PREF FRUIT TR, V15, P22; Tashiro N, 2009, JPN J FARM WORK RES, V44, P21; Tashiro N, 2003, JPN J PHYTOPATHOL, V69, P21; Tashiro N, 2007, 3 WORKSH PSJ RES COM, P33; Tashiro N, 1994, 4 S PSJ RES COMM FUN, P31; Tashiro N, 2003, PLANT PROT, V57, P111; Tashiro N, 2014, FIELD GUIDE DIS PEST; Tashiro N, 2010, 20 S PSJ RES COMM FU, P39; Tashiro N, 1998, B SAGA PREF FRUIT TR, V14, P79; Tashiro N, 2005, ENCY CONSERVATION AG, V2, P531; Tashiro N, 1996, B SAGA PREF FRUIT TR, V13, P69; Tashiro N, 2005, PLANT PROT, V59, P69; Tashiro N, 2002, JPN J PHYTOPATHOL, V68, P189; Tashiro N, 2009, PLANT PROT, V63, P212; Tashiro N, 2007, DIS PEST MANAGEMENT; Tashiro N, 2008, 4 WORKSH PSJ RES COM, P44; Tashiro N, 2006, 2 WORKSH PSJ RES COM, P1; Tashiro N, 2003, P 9 FOR MAFF DIS PES, P18; Tashiro N, 1996, B SAGA PREF FRUIT TR, V13, P104	54	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2015	81	6					470	475		10.1007/s10327-015-0623-x		6	Plant Sciences	Plant Sciences	CV8DT	WOS:000364509400010		
J	Enya, J				Enya, Junichiro			Study on the composition of microbial flora on tomato leaves and screening of biological control agents	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Editorial Material							PHYLLOSPHERE		Mikado Kyowa Seed Co Ltd, Chiba 2670056, Japan	Enya, J (reprint author), Mikado Kyowa Seed Co Ltd, Chiba 2670056, Japan.	junichiro.enya@mikadokyowaseed.com					Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Enya J, 2009, J GEN PLANT PATHOL, V75, P76, DOI 10.1007/s10327-008-0134-0; Enya J, 2007, MICROB ECOL, V53, P524, DOI 10.1007/s00248-006-9085-1; Enya J, 2007, J PHYTOPATHOL, V155, P446, DOI 10.1111/j.1439-0434.2007.01256.x; ANDREWS JH, 1992, ANNU REV PHYTOPATHOL, V30, P603, DOI 10.1146/annurev.py.30.090192.003131	5	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2015	81	6					476	477		10.1007/s10327-015-0611-1		2	Plant Sciences	Plant Sciences	CV8DT	WOS:000364509400011		
J	Imazaki, I				Imazaki, Iori			Studies on the mechanisms of pathogenicity in soil-borne plant pathogens	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Editorial Material							FUNGUS FUSARIUM-OXYSPORUM		NARO Tohoku Agr Res Ctr, Morioka, Iwate 0200198, Japan	Imazaki, I (reprint author), NARO Tohoku Agr Res Ctr, Morioka, Iwate 0200198, Japan.	iiori@affrc.go.jp					Imazaki I, 2007, MOL MICROBIOL, V63, P737, DOI 10.1111/j.1365-2958.2006.05554.x; Imazaki I, 2009, J GEN PLANT PATHOL, V75, P213, DOI 10.1007/s10327-009-0166-0; van Overbeek LS, 2004, PHYTOPATHOLOGY, V94, P463, DOI 10.1094/PHYTO.2004.94.5.463; Inoue I, 2002, PLANT CELL, V14, P1869, DOI 10.1105/tpc.002576; Imazaki I, 2010, J GEN PLANT PATHOL, V76, P52, DOI 10.1007/s10327-009-0208-7; Inoue Iori, 2001, Journal of General Plant Pathology, V67, P191, DOI 10.1007/PL00013010	6	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2015	81	6					478	479		10.1007/s10327-015-0610-2		2	Plant Sciences	Plant Sciences	CV8DT	WOS:000364509400012		
J	Momma, N				Momma, Noriaki			Studies on mechanisms of anaerobicity-mediated biological soil disinfestation and its practical application	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Editorial Material									Inst Hort Plant Breeding, Matsudo, Chiba, Japan	Momma, N (reprint author), Inst Hort Plant Breeding, 2-5-1 Kamishiki, Matsudo, Chiba, Japan.	momma@enken.or.jp					[Anonymous], 2000, PSJ SOILBORNE DIS WO; Momma N, 2013, APPL MICROBIOL BIOT, V97, P3801, DOI 10.1007/s00253-013-4826-9; Momma N, 2010, J GEN PLANT PATHOL, V76, P336, DOI 10.1007/s10327-010-0252-3; Momma N., 2005, Soil Microorganisms, V59, P27; Momma N., 2007, Soil Microorganisms, V61, P3; Shennana C, 2014, ACTA HORTIC, V1044, P165	6	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2015	81	6					480	482		10.1007/s10327-015-0612-0		3	Plant Sciences	Plant Sciences	CV8DT	WOS:000364509400013		
J	Tsuchiya, K				Tsuchiya, Kenichi			The 100-year history of the Phytopathological Society of Japan	JOURNAL OF GENERAL PLANT PATHOLOGY			English	Editorial Material									Kyushu Univ, Grad Sch Agr, Fukuoka 8128581, Japan	Tsuchiya, K (reprint author), Kyushu Univ, Grad Sch Agr, Fukuoka 8128581, Japan.	kentsuch@agr.kyushu-u.ac.jp						0	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1345-2630	1610-739X		J GEN PLANT PATHOL	J. Gen. Plant Pathol.	NOV	2015	81	6					483	486		10.1007/s10327-015-0624-9		4	Plant Sciences	Plant Sciences	CV8DT	WOS:000364509400014		
J	Otofuji, Y; Zaman, H; Shogaki, G; Seki, H; Polin, VF; Miura, D; Ahn, HS; Ivanov, Y; Minyuk, P; Zimin, P				Otofuji, Yo-ichiro; Zaman, Haider; Shogaki, Gen; Seki, Hanae; Polin, Vladimir F.; Miura, Daisuke; Ahn, Hyeon-Seon; Ivanov, Yurii; Minyuk, Pore; Zimin, Peter			Paleomagnetism of the Late Cretaceous ignimbrite from the Okhotsk-Chukotka Volcanic Belt, Kolyma-Omolon Composite Terrane: Tectonic implications	JOURNAL OF GEODYNAMICS			English	Article						Tectonics; Paleomagnetism; Late Cretaceous; Eurasia; Okhotsk-Chukotka Volcanic Belt; Kolyma-Omolon-Chukotka Block	PLATE RECONSTRUCTIONS; EURASIAN PLATE; NORTH-ATLANTIC; CANADA BASIN; POLAR WANDER; ARCTIC-OCEAN; FOLD TEST; RUSSIA; GEOCHRONOLOGY; ASIA	New Late Cretaceous paleomagnetic results from the Okhotsk-Chukotka Volcanic Belt in the Kolyma-Omolon Composite Terrane yield stable and consistent remanent directions. The Late Cretaceous (86-81 Ma) ignimbrites from the Kholchan and Ola suites were sampled at 19 sites in the Magadan area (60.4 degrees N, 151.0 degrees E). We isolated the characteristic paleomagnetic directions from 16 sampled sites using an alternating field demagnetization procedure. The primary nature of these directions is ascertained by dual polarities and positive fold tests. A tilt-corrected mean direction (D = 42.8 degrees, I = 84.7 degrees, k = 46.0, alpha(95) = 10.0 degrees) yields a paleomagnetic pole of 66.7 degrees N, 168.5 degrees E (A(95) = 18.8 degrees) which appears almost identical to the 90-67 Ma pole reported from the Lake El'gygytgyn area of the Okhotsk-Chukotka Volcanic Belt (Chukotka Terrane). This consistency suggests that the Kolyma-Omolon Composite Terrane and Chukotka Terrane has acted as a single tectonic unit since 80 Ma without any significant internal deformation. Accordingly, we calculate a combined 80 Ma characteristic paleomagnetic pole (Long. = 164.7 degrees E, Lat. = 68.0 degrees, A(95) = 10.9 degrees, N = 12) for the Kolyma-Omolon-Chukotka Block which falls 16.5-17.5 degrees south of the same age poles from Europe and East Asia. We ascribe this discrepancy in pole positions to tectonic activity in the area and infer a southward displacement of 1640 +/- 1380 km for the Kolyma-Omolon-Chukotka Block with respect to the North American and Eurasian blocks since 80 Ma; more than 260 km of it is attributed to tectonic displacement in the Arctic Ocean due to the opening of the Canadian Basin. (C) 2015 Elsevier Ltd. All rights reserved.	[Otofuji, Yo-ichiro; Shogaki, Gen; Seki, Hanae; Ahn, Hyeon-Seon] Kobe Univ, Fac Sci, Dept Earth & Planetary Sci, Kobe, Hyogo 657, Japan; [Zaman, Haider] Taibah Univ, Fac Sci, Dept Geol, Madinah 41477, Saudi Arabia; [Polin, Vladimir F.] Russian Acad Sci, Far East Geol Inst, Vladivostok 690022, Russia; [Miura, Daisuke] CRIEPI, Abiko Res Lab, Abiko, Chiba 1646, Japan; [Ivanov, Yurii; Minyuk, Pore] Russian Acad Sci, North East Interdisciplinary Sci Res Inst, Magadan, Russia; [Zimin, Peter] Russian Acad Sci, Pacific Oceanol Inst, Vladivostok 690022, Russia	Otofuji, Y (reprint author), Kobe Univ, Fac Sci, Dept Earth & Planetary Sci, Kobe, Hyogo 657, Japan.	otofuji@kobe-u.ac.jp; haider_zaman61@hotmail.com; gen@mbh.nifty.com; hanatarozamurai@gmail.com; vfpolin@mail.ru; dmiura@criepi.denken.or.jp; 101s429s@stu.kobe-u.ac.jp; minyuk@neisri.ru; pal105@neisri.ru; petr.zimin.poi92@mail.ru			'The 21st Century COE Program of Origin and Evolution of Planetary Systems' through Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Toyota Foundation; MEXT [18403012, 22403012]	Comments from Rob Van der Voo, John Geissman, Michel Faure, Biggin Andrew, Eduard Petrovsky and anonymous reviewers have improved this manuscript. We thank Poddelsky Igor for providing declination data from the Magadan Geophysical Observatory (http://geomag.gcras.r). Katsuya P. Fujiwara assisted us in the laboratory measurements. Koji Uno is warmly thanked for his valuable comments. This work is supported by 'The 21st Century COE Program of Origin and Evolution of Planetary Systems' through the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT). In addition, this research is partly supported by the Toyota Foundation and Grant-in aid (Nos. 18403012 and 22403012) from MEXT.	Amato J. M., 2004, OROGENIC CURVATURE I, V383, P1; Gilder S, 2003, EARTH PLANET SC LETT, V206, P587, DOI 10.1016/S0012-821X(02)01074-9; Besse J, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000050; Enkin RJ, 2003, EARTH PLANET SC LETT, V212, P151, DOI 10.1016/S0012-821X(03)00238-3; Belyi VF, 2008, STRATIGR GEO CORREL+, V16, P639, DOI 10.1134/S086959380806004X; Metelkin DV, 2008, DOKL EARTH SCI, V418, P62, DOI 10.1134/S1028334X08010145; PARFENOV LM, 1991, TECTONOPHYSICS, V199, P319, DOI 10.1016/0040-1951(91)90177-T; VANDERVOO R, 1990, TECTONOPHYSICS, V184, P1, DOI 10.1016/0040-1951(90)90116-P; Deenen MHL, 2011, GEOPHYS J INT, V186, P509, DOI 10.1111/j.1365-246X.2011.05050.x; MCFADDEN PL, 1990, GEOPHYS J INT, V103, P163, DOI 10.1111/j.1365-246X.1990.tb01761.x; MCINTOSH WC, 1991, J GEOPHYS RES-SOLID, V96, P13459, DOI 10.1029/91JB00603; PARFENOV LM, 1995, TECTONICS, V14, P342, DOI 10.1029/94TC03088; Grantz A, 1998, GEOL SOC AM BULL, V110, P801, DOI 10.1130/0016-7606(1998)110<0801:PSONRM>2.3.CO;2; MCFADDEN PL, 1988, EARTH PLANET SC LETT, V87, P152, DOI 10.1016/0012-821X(88)90071-4; HAGSTRUM JT, 1989, J GEOPHYS RES-SOLID, V94, P1827, DOI 10.1029/JB094iB02p01827; Plattner C, 2010, GEOPHYS J INT, V183, P1089, DOI 10.1111/j.1365-246X.2010.04803.x; Akinin VV, 2011, PETROLOGY+, V19, P237, DOI 10.1134/S0869591111020020; Cogne JP, 2013, GEOPHYS J INT, V192, P1000, DOI 10.1093/gji/ggs104; SRIVASTAVA SP, 1988, MAR PETROL GEOL, V5, P324, DOI 10.1016/0264-8172(88)90026-8; Alvey A, 2008, EARTH PLANET SC LETT, V274, P310, DOI 10.1016/j.epsl.2008.07.036; Sakhno VG, 2010, DOKL EARTH SCI, V434, P1172, DOI 10.1134/S1028334X10090072; Golonka J, 2007, PALAEOGEOGR PALAEOCL, V244, P297, DOI 10.1016/j.palaeo.2006.06.041; Layer PW, 2001, GEOLOGY, V29, P167, DOI 10.1130/0091-7613(2001)029<0167:TSOTPB>2.0.CO;2; MULLER RD, 1992, J GEOPHYS RES-SOL EA, V97, P3337, DOI 10.1029/91JB02605; LOWRIE W, 1990, GEOPHYS RES LETT, V17, P159, DOI 10.1029/GL017i002p00159; Gaina C, 2002, EARTH PLANET SC LETT, V197, P273, DOI 10.1016/S0012-821X(02)00499-5; Pease V, 2014, TECTONOPHYSICS, V628, P1, DOI 10.1016/j.tecto.2014.05.033; MCELHINNY MW, 1964, GEOPHYS J ROY ASTR S, V8, P338; Oxman VS, 2003, TECTONOPHYSICS, V365, P45, DOI 10.1016/S0040-1951(03)00064-7; KIRSCHVINK JL, 1980, GEOPHYS J ROY ASTR S, V62, P699, DOI 10.1111/j.1365-246X.1980.tb02601.x; Lane LS, 1997, TECTONICS, V16, P363, DOI 10.1029/97TC00432; Lyons JJ, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000521; Tsuneki Y, 2009, GEOPHYS J INT, V178, P1327, DOI 10.1111/j.1365-246X.2009.04222.x; Golonka J, 2003, MAR PETROL GEOL, V20, P211, DOI 10.1016/S0264-8172(03)00043-6; Cogne JP, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000227; [Anonymous], 2002, GEOL SOC AM SPEC PAP; Chapin C.E., 1979, SPEC PAP GEOL SOC AM, V180, P137; Drachev S.D., 2006, P 4 INT C ARC MARG D; Dunlop D. J., 2001, ROCK MAGNETISM FUNDA; FISHER R, 1953, PROC R SOC LON SER-A, V217, P295, DOI 10.1098/rspa.1953.0064; HALLS HC, 1978, PHYS EARTH PLANET IN, V16, P1, DOI 10.1016/0031-9201(78)90095-X; Hourigan J.K., 2004, GEOL SOC AM BULL, V116, P637; Khanchuk A.I., 2006, GEODYNAMICS MAGMATIS, P572; Lawyer L.A., 2002, TECTONIC EVOLUTIN BE, V360, P333; Lawyer L.A., 1990, ARCTIC OCEAN REGIO L, VL, P593; Parfenov LM., 2009, S MUELLER SPECIAL PU, V4, P11; Prokopiev A. V., 2009, S MUELLER SPEC PUBL, V4, P65; Saltus RW, 2011, GEOL SOC MEM, V35, DOI 10.1144/M35.4; Sengor A. M. C., 1996, TECTONIC EVOLUTION A, P486; Sokolov S., 2009, STEPHAN MUELLER SPEC, V4, P201, DOI DOI 10.5194/SMSPS-4-201-2009; Stone D. B., 2009, S MUELLER SPECIAL PU, V4, P243; Tikhomirov PL, 2012, J VOLCANOL GEOTH RES, V221, P14, DOI 10.1016/j.jvolgeores.2011.12.011; Zijderveld J., 1967, METHODS PALEOMAGNETI, P254	53	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0264-3707			J GEODYN	J. Geodyn.	NOV	2015	91						1	12		10.1016/j.jog.2015.03.003		12	Geochemistry & Geophysics	Geochemistry & Geophysics	CV9KK	WOS:000364605900001		
J	Nakanishi, A; Omokawa, S; Iida, A; Kaji, D; Tanaka, Y				Nakanishi, Akito; Omokawa, Shohei; Iida, Akio; Kaji, Daisuke; Tanaka, Yasuhito			Predictors of Proximal Interphalangeal Joint Flexion Contracture After Homodigital Island Flap	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						Homodigital island flap; advancement flap; flexion contracture; proximal interphalangeal joint; predictor	COMMINUTED PERIARTICULAR METACARPAL; OBLIQUE TRIANGULAR FLAP; FINGERTIP RECONSTRUCTION; TITANIUM PLATE; FRACTURES; AMPUTATIONS	Purpose To identify independent predictors of postoperative proximal interphalangeal (PIP) joint contracture after direct-flow homodigital island flap transfer. Methods Forty-four fingertip amputations in 39 patients treated with oblique triangular flaps were evaluated at a minimum of 1 year after surgery. Five variables were examined: patient age, injured finger, mechanism of injury, flap advancement distance, and time required for wound healing. Univariate and multivariate linear regression analyses were performed to identify the extent to which these variables affected the flexion contracture of the PIP joint. Results The average reduction in the passive extension angle of the PIP joint was 16 at final follow-up. Univariate analysis indicated significant correlations of PIP joint flexion contracture with age, injured finger, and time for wound healing, but no significant correlation with the distance the flap was advanced. Multivariate analysis indicated that the age and duration of wound healing were independent predictors of the flexion contracture of the PIP joint. Conclusions Elderly people and cases with delayed wound healing are at risk for postoperative PIP joint contracture after homodigital flap transfer. Intervention with early hand therapy and orthotics may be useful in elderly patients with delayed wound healing. (Copyright (C) 2015 by the American Society for Surgery of the Hand. All rights reserved.)	[Nakanishi, Akito; Kaji, Daisuke] Nara Med Univ, Takita Hosp, Dept Orthopaed Surg, Kashihara, Nara 6348522, Japan; [Omokawa, Shohei] Nara Med Univ, Dept Hand Surg, Kashihara, Nara 6348522, Japan; [Iida, Akio; Tanaka, Yasuhito] Nara Med Univ, Dept Orthopaed Surg, Kashihara, Nara 6348522, Japan	Omokawa, S (reprint author), Nara Med Univ, Dept Hand Surg, Kashihara, Nara 6348522, Japan.	omokawa@gaia.eonet.ne.jp					Adani R, 1997, ANN PLAS SURG, V38, P36, DOI 10.1097/00000637-199701000-00007; Kayalar M, 2011, ACTA ORTHOP TRAUMATO, V45, P175, DOI 10.3944/AOTT.2011.2429; Harden RN, 2007, PAIN MED, V8, P326, DOI 10.1111/j.1526-4637-2006.00169.x; Borman H, 2000, ANN PLAS SURG, V45, P24, DOI 10.1097/00000637-200045010-00005; Omokawa S, 2008, J HAND SURG-AM, V33A, P857, DOI 10.1016/j.jhsa.2008.01.040; Bannasch H, 2010, J TRAUMA, V68, P624, DOI 10.1097/TA.0b013e3181bb8ea0; Braga-Silva J, 2009, PLAST RECONSTR SURG, V124, P2012, DOI 10.1097/PRS.0b013e3181bcf2b9; Shimizu T, 2012, INJURY, V43, P940, DOI 10.1016/j.injury.2012.02.011; Netscher DT, 1999, PLAST RECONSTR SURG, V104, P1705, DOI 10.1097/00006534-199911000-00014; Sano K, 2008, J HAND SURG-AM, V33A, P1088, DOI 10.1016/j.jhsa.2008.02.022; SMITH RJ, 1976, J TRAUMA, V16, P778, DOI 10.1097/00005373-197610000-00004; MELONE CP, 1982, J HAND SURG-AM, V7, P291; Katz RD, 2013, J HAND SURG-AM, V38A, P1226, DOI 10.1016/j.jhsa.2013.03.025; VENKATASWAMI R, 1980, PLAST RECONSTR SURG, V66, P296, DOI 10.1097/00006534-198008000-00026; Hirase Y, 2003, J JPN SOC SURG HAND, V20, P501; Kojima T, 1988, JPN J TRAUMA OCCUP M, V36, P824; Matsui M, 1995, J JPN SOC SURG HAND, V12, P597	17	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023	1531-6564		J HAND SURG-AM	J. Hand Surg.-Am. Vol.	NOV	2015	40	11					2155	2159		10.1016/j.jhsa.2015.08.008		5	Orthopedics; Surgery	Orthopedics; Surgery	CW2EO	WOS:000364804100005		
J	Nishiwaki, M; Welsh, MF; Gammon, B; Ferreira, LM; Johnson, JA; King, GJW				Nishiwaki, Masao; Welsh, Mark F.; Gammon, Braden; Ferreira, Louis M.; Johnson, James A.; King, Graham J. W.			Effect of Volarly Angulated Distal Radius Fractures on Forearm Rotation and Distal Radioulnar Joint Kinematics	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						Distal radioulnar joint; distal radius fracture; kinematics; triangular fibrocartilage complex; volar angulation	CORRECTIVE OSTEOTOMY; MALUNION	Purpose To examine the effect of volar angulation deformities of the distal radius with and without triangular fibrocartilage complex (TFCC) rupture on forearm range of motion and the kinematics of the ulnar head at the distal radioulnar joint (DRUJ) during simulated active forearm rotation. Methods Volar angulation deformities of the distal radius with 10 degrees and 20 degrees angulation from the native orientation were created in 8 cadaveric specimens using an adjustable apparatus. Active supination and pronation were performed using a forearm motion simulator. Pronation and supination range of motion was quantified with each deformity. In addition, changes in the dorsovolar position of the ulnar head relative to the radius were calculated after simulating each distal radial deformity. Testing was performed with the TFCC intact and sectioned. Results Volar angulation deformities of 20 degrees decreased the supination range with preservation of pronation. There was no effect of TFCC status on the range of forearm rotation. With the TFCC intact, volar angulation deformities translated the ulna slightly dorsally in pronation and volarly in supination. After sectioning the TFCC, volar angulation deformities of 10 degrees and 20 degrees translated. the ulna dorsally throughout forearm rotation. Conclusions Volar angulation deformities reduce supination range and alter the DRUJ kinematics. The increased tension in the intact TFCC caused by volar angulation deformities likely prevented the expected dorsovolar displacement at the DRUJ and restricted supination. Dividing the TFCC released the constraining effect on the DRUJ and allowed the ulna to translate dorsally. However, supination remained limited, presumably because of impediment from the dorsally subluxated ulna. (Copyright (C) 2015 by the American Society for Surgery of the Hand. All rights reserved.)	[Nishiwaki, Masao] Kawasaki Municipal Hosp, Dept Onhopaed Surg, Kawasaki, Kanagawa 2100013, Japan; [Welsh, Mark F.; Ferreira, Louis M.; Johnson, James A.; King, Graham J. W.] St Josephs Hlth Care London, Hand & Upper Limb Ctr, London, ON, Canada; [Gammon, Braden] Univ Ottawa, Div Orthopaed Surg, Ottawa, ON, Canada	Nishiwaki, M (reprint author), Kawasaki Municipal Hosp, Dept Onhopaed Surg, Kawasaki Ku, 12-1 Shinkawadori, Kawasaki, Kanagawa 2100013, Japan.	nishiwa41@gmail.com			Canadian Institutes for Health Research [R0598A13]	This study was supported by Canadian Institutes for Health Research (R0598A13).	Gordon KD, 2003, J HAND SURG-AM, V28A, P943, DOI 10.1016/S0363-5023(03)00487-8; Fraser GS, 2009, J HAND SURG-AM, V34A, P838, DOI 10.1016/j.jhsa.2009.02.011; Shea K, 1997, J BONE JOINT SURG AM, V79A, P1816; Sato K, 2009, J HAND SURG-AM, V34A, P27, DOI 10.1016/j.jhsa.2008.09.018; POGUE DJ, 1990, J HAND SURG-AM, V15A, P721, DOI 10.1016/0363-5023(90)90143-F; Ishii S, 1998, J HAND SURG-AM, V23A, P909, DOI 10.1016/S0363-5023(98)80172-X; Nishiwaki M, 2014, J HAND SURG-AM, V39, P656, DOI 10.1016/j.jhsa.2014.01.013; Linder L, 1996, ACTA ORTHOP SCAND, V67, P179, DOI 10.3109/17453679608994667; Thivaios GC, 2003, J ORTHOP TRAUMA, V17, P326, DOI 10.1097/00005131-200305000-00002; Bessho Y, 2015, J HAND SURG EUR	10	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023	1531-6564		J HAND SURG-AM	J. Hand Surg.-Am. Vol.	NOV	2015	40	11					2236	2242		10.1016/j.jhsa.2015.07.034		7	Orthopedics; Surgery	Orthopedics; Surgery	CW2EO	WOS:000364804100018		
J	Takada, N; Takatsu, H; Miyano, R; Nakayama, K; Shin, HW				Takada, Naoto; Takatsu, Hiroyuki; Miyano, Rie; Nakayama, Kazuhisa; Shin, Hye-Won			ATP11C mutation is responsible for the defect in phosphatidylserine uptake in UPS-1 cells	JOURNAL OF LIPID RESEARCH			English	Article						uptake of fluorescent phosphatidylserine analogs; adenosine triphosphatases; membrane bilayer; phospholipid; plasma membrane; flippase	PHOSPHOLIPID FLIPPASE; PLASMA-MEMBRANE; SUBCELLULAR-LOCALIZATION; CDC50 PROTEINS; TRANSPORT; EXPRESSION; ATP8B1; MANNER	Type IV P-type ATPases (P4-ATPases) translocate phospholipids from the exoplasmic to the cytoplasmic leaflets of cellular membranes. We and others previously showed that ATP11C, a member of the P4-ATPases, translocates phosphatidylserine (PS) at the plasma membrane. Twenty years ago, the UPS-1 (uptake of fluorescent PS analogs) cell line was isolated from mutagenized Chinese hamster ovary (CHO)-K1 cells with a defect in nonendocytic uptake of nitrobenzoxadiazole PS. Due to its defect in PS uptake, the UPS-1 cell line has been used in an assay for PS-flipping activity; however, the gene(s) responsible for the defect have not been identified to date. Here, we found that the mRNA level of ATP11C was dramatically reduced in UPS-1 cells relative to parental CHO-K1 cells. By contrast, the level of ATP11A, another PS-flipping P4-ATPase at the plasma membrane, or CDC50A, which is essential for delivery of most P4-ATPases to the plasma membrane, was not affected in UPS-1 cells. Importantly, we identified a nonsense mutation in the ATP11C gene in UPS-1 cells, indicating that the intact ATP11C protein is not expressed. Moreover, exogenous expression of ATP11C can restore PS uptake in UPS-1 cells. These results indicate that lack of the functional ATP11C protein is responsible for the defect in PS uptake in UPS-1 cells and ATP11C is crucial for PS flipping in CHO-K1 cells.	[Takada, Naoto; Takatsu, Hiroyuki; Miyano, Rie; Nakayama, Kazuhisa; Shin, Hye-Won] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan	Shin, HW (reprint author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan.	shin@pharm.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Inamori Foundation; Research Foundation for Pharmaceutical Sciences	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Takeda Science Foundation; the Inamori Foundation; and the Research Foundation for Pharmaceutical Sciences.	Williamson P, 2002, BBA-MOL CELL BIOL L, V1585, P53, DOI 10.1016/S1388-1981(02)00324-4; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; Shin HW, 2005, J CELL SCI, V118, P4039, DOI 10.1242/jcs.02524; Shin HW, 2005, METHOD ENZYMOL, V404, P206, DOI 10.1016/S0076-6879(05)04020-6; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Yabas M, 2014, J BIOL CHEM, V289, P19531, DOI 10.1074/jbc.C114.570267; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; Siggs OM, 2011, NAT IMMUNOL, V12, P434, DOI 10.1038/ni.2012; Bryde S, 2010, J BIOL CHEM, V285, P40562, DOI 10.1074/jbc.M110.139543; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Zwaal RFA, 1997, BLOOD, V89, P1121; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Naito T, 2015, J BIOL CHEM, V290, P15004, DOI 10.1074/jbc.M115.655191; Wurm FM, 2011, NAT BIOTECHNOL, V29, P718, DOI 10.1038/nbt.1943; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; Graham TR, 2004, TRENDS CELL BIOL, V14, P670, DOI 10.1016/j.tcb.2004.10.008; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; HANADA K, 1995, J CELL BIOL, V128, P793, DOI 10.1083/jcb.128.5.793; Takatsu H, 2014, J BIOL CHEM, V289, P33543, DOI 10.1074/jbc.M114.593012; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Miyato Y, 2001, FEBS LETT, V504, P73, DOI 10.1016/S0014-5793(01)02771-5; Folmer DE, 2009, HEPATOLOGY, V50, P1597, DOI 10.1002/hep.23158; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Zhu XJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002853	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0022-2275	1539-7262		J LIPID RES	J. Lipid Res.	NOV	2015	56	11					2151	2157		10.1194/jlr.M062547		7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CW2XL	WOS:000364856300014		
J	Saito, Y; Shichiri, M; Hamajima, T; Ishida, N; Mita, Y; Nakao, S; Hagihara, Y; Yoshida, Y; Takahashi, K; Niki, E; Noguchi, N				Saito, Yoshiro; Shichiri, Mototada; Hamajima, Takashi; Ishida, Noriko; Mita, Yuichiro; Nakao, Shohei; Hagihara, Yoshihisa; Yoshida, Yasukazu; Takahashi, Kazuhiko; Niki, Etsuo; Noguchi, Noriko			Enhancement of lipid peroxidation and its amelioration by vitamin E in a subject with mutations in the SBP2 gene	JOURNAL OF LIPID RESEARCH			English	Article						selenocysteine insertion sequence-binding protein 2; selenoprotein; antioxidative defense; free radical; cholesterol; oxysterol; oxidized lipids	CELL-DEATH; GLUTATHIONE-PEROXIDASE; MONOCLONAL-ANTIBODIES; SELENIUM DEFICIENCY; OMEGA-HYDROXYLASE; BINDING PROTEIN-2; OXIDATIVE STRESS; SELENOPROTEIN-P; OXIDIZED DJ-1; HUMAN HEALTH	Selenocysteine (Sec) insertion sequence-binding protein 2 (SBP2) is essential for the biosynthesis of Sec-containing proteins, termed selenoproteins. Subjects with mutations in the SBP2 gene have decreased levels of several selenoproteins, resulting in a complex phenotype. Selenoproteins play a significant role in antioxidative defense, and deficiencies in these proteins can lead to increased oxidative stress. However, lipid peroxidation and the effects of antioxidants in subjects with SBP2 gene mutations have not been studied. In the present study, we evaluated the lipid peroxidation products in the blood of a subject (the proband) with mutations in the SBP2 gene. We found that the proband had higher levels of free radical-mediated lipid peroxidation products, such as 7-hydroxycholesterol, than the control subjects. Treatment of the proband with vitamin E (-tocopherol acetate, 100 mg/day), a lipid-soluble antioxidant, for 2 years reduced lipid peroxidation product levels to those of control subjects. Withdrawal of vitamin E treatment for 7 months resulted in an increase in lipid peroxidation products. Collectively, these results clearly indicate that free radical-mediated oxidative stress is increased in the subject with SBP2 gene mutations and that vitamin E treatment effectively inhibits the generation of lipid peroxidation products.	[Saito, Yoshiro; Mita, Yuichiro; Nakao, Shohei; Noguchi, Noriko] Doshisha Univ, Dept Med Life Syst, Fac Life & Med Sci, Syst Life Sci Lab, Kyoto 6100394, Japan; [Shichiri, Mototada; Ishida, Noriko; Hagihara, Yoshihisa; Yoshida, Yasukazu; Niki, Etsuo] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Ikeda, Osaka 5638577, Japan; [Hamajima, Takashi] Aichi Childrens Hlth & Med Ctr, Dept Pediat Endocrinol & Metab, Obu, Aichi 4748710, Japan; [Takahashi, Kazuhiko] Hokkaido Pharmaceut Univ, Dept Nutr Biochem, Otaru, Hokkaido 0470264, Japan	Saito, Y (reprint author), Doshisha Univ, Dept Med Life Syst, Fac Life & Med Sci, Syst Life Sci Lab, Kyoto 6100394, Japan.	ysaito@mail.doshisha.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [25292078]; Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This work was supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 25292078 and Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities. No potential conflicts of interest relevant to this article were reported.	Sontag TJ, 2007, J LIPID RES, V48, P1090, DOI 10.1194/jlr.M600514-JLR200; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Saito Y, 2003, J BIOL CHEM, V278, P39428, DOI 10.1074/jbc.M305542200; Labunskyy VM, 2014, PHYSIOL REV, V94, P739, DOI 10.1152/physrev.00039.2013; Hosomi A, 1997, FEBS LETT, V409, P105, DOI 10.1016/S0014-5793(97)00499-7; Imai H, 2010, J CLIN BIOCHEM NUTR, V46, P1, DOI 10.3164/jcbn.09-94R; Saito Y, 2007, FEBS LETT, V581, P4349, DOI 10.1016/j.febslet.2007.08.010; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1301/nr.2004.jun.S3-S12; Niki E, 2012, ANN NUTR METAB, V61, P207, DOI 10.1159/000343106; Schomburg L, 2008, MOL NUTR FOOD RES, V52, P1235, DOI 10.1002/mnfr.200700465; Saito Y, 2014, BIOCHEM BIOPH RES CO, V446, P741, DOI 10.1016/j.bbrc.2013.12.083; Liu W, 2010, CHEM RES TOXICOL, V23, P986, DOI 10.1021/tx1000943; Saito Y, 2014, J NEUROPATH EXP NEUR, V73, P714, DOI 10.1097/NEN.0000000000000087; Dale DC, 2008, BLOOD, V112, P935, DOI 10.1182/blood-2007-12-077917; Copeland PR, 1999, J BIOL CHEM, V274, P25447, DOI 10.1074/jbc.274.36.25447; Milne GL, 2008, J BIOL CHEM, V283, P15533, DOI 10.1074/jbc.R700047200; HOGAN JS, 1990, J DAIRY SCI, V73, P2372; Hamajima T, 2012, EUR J ENDOCRINOL, V166, P757, DOI 10.1530/EJE-11-0812; Di Cosmo C, 2009, J CLIN ENDOCR METAB, V94, P4003, DOI 10.1210/jc.2009-0686; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Pratt DA, 2011, ACCOUNTS CHEM RES, V44, P458, DOI 10.1021/ar200024c; Yoshida Y, 2003, CHEM PHYS LIPIDS, V123, P63, DOI 10.1016/S0009-3084(02)00164-0; Yoshida Y, 2013, J CLIN BIOCHEM NUTR, V52, P9, DOI 10.3164/jcbn.12-112; Steinbrenner H, 2009, BBA-GEN SUBJECTS, V1790, P1478, DOI 10.1016/j.bbagen.2009.02.014; Salonen RM, 2003, CIRCULATION, V107, P947, DOI 10.1161/01.CIR.0000050626.25057.51; Saito Y, 2010, FREE RADICAL BIO MED, V49, P1542, DOI 10.1016/j.freeradbiomed.2010.08.016; Beck MA, 2007, J NUTR, V137, P1338; Saito Y, 2009, NEUROSCI LETT, V465, P1, DOI 10.1016/j.neulet.2009.08.074; Parker RS, 2004, ANN NY ACAD SCI, V1031, P13, DOI 10.1196/annals.1331.002; Traber MG, 2013, J LIPID RES, V54, P2295, DOI 10.1194/jlr.R032946; Wortmann M, 2013, CIRC RES, V113, P408, DOI 10.1161/CIRCRESAHA.113.279984; Niki E, 2009, FREE RADICAL BIO MED, V47, P469, DOI 10.1016/j.freeradbiomed.2009.05.032; THOMAS JP, 1990, BIOCHIM BIOPHYS ACTA, V1045, P252, DOI 10.1016/0005-2760(90)90128-K; Dumitrescu AM, 2005, NAT GENET, V37, P1247, DOI 10.1038/ng1654; Milne GL, 2011, CHEM REV, V111, P5973, DOI 10.1021/cr200160h; DIMITROV NV, 1991, AM J CLIN NUTR, V53, P723; Yoshida Y, 2008, J OLEO SCI, V57, P407, DOI 10.5650/jos.57.407; Niki E, 2005, BIOCHEM BIOPH RES CO, V338, P668, DOI 10.1016/j.bbrc.2005.08.072; Schoenmakers E, 2010, J CLIN INVEST, V120, P4220, DOI 10.1172/JCI43653; Hill KE, 2001, J NUTR, V131, P1798; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; LEE BJ, 1989, J BIOL CHEM, V264, P9724; Takebe G, 2002, J BIOL CHEM, V277, P41254, DOI 10.1074/jbc.M202773200; YAMAMOTO Y, 1995, CLIN CHIM ACTA, V236, P93, DOI 10.1016/0009-8981(95)06041-4; Saito Y, 2001, J HEALTH SCI, V47, P346, DOI 10.1248/jhs.47.346; Ogawa Y, 2008, FREE RADICAL RES, V42, P674, DOI 10.1080/10715760802277396; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; BURTON GW, 1990, ANNU REV NUTR, V10, P357, DOI 10.1146/annurev.nutr.10.1.357; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Traber MG, 1999, ANNU REV NUTR, V19, P343, DOI 10.1146/annurev.nutr.19.1.343; Kono N, 2013, SCIENCE, V340, P1106, DOI 10.1126/science.1233508; Behrman R. E., 2003, NELSONS TXB PEDIAT; Niki E, 2014, FREE RADICAL BIO MED, V66, P3, DOI 10.1016/j.freeradbiomed.2013.03.022; Wang XH, 2006, P NATL ACAD SCI USA, V103, P3604, DOI 10.1073/pnas.0510962103	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0022-2275	1539-7262		J LIPID RES	J. Lipid Res.	NOV	2015	56	11					2172	2182		10.1194/jlr.M059105		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CW2XL	WOS:000364856300016		
J	Kakuda, M; Matsuzaki, S; Kobayashi, E; Yoshino, K; Morii, E; Kimura, T				Kakuda, Mamoru; Matsuzaki, Shinya; Kobayashi, Eiji; Yoshino, Kiyoshi; Morii, Eiichi; Kimura, Tadashi			A Case of Extragonadal Teratoma in the Pouch of Douglas and Literature Review	Journal of Minimally Invasive Gynecology			English	Review						Auto-amputation; Douglas; Extragonadal teratoma; Fallopian tube; Parasitic	MATURE CYSTIC TERATOMA; PARASITIC DERMOID CYST; PRIMORDIAL GERM-CELLS; SINGLE-SITE SURGERY; OF-THE-LITERATURE; UTEROSACRAL LIGAMENT; SUPERNUMERARY OVARY; MANAGEMENT; DIAGNOSIS	Mature cystic teratoma is a germ cell tumor of the ovaries and is often observed in clinical practice. However, extragonadal teratomas are rare tumors and have been reported outside the ovaries, (e.g., in the greater omentum). The mechanism underlying the development of extragonadal teratomas remains unknown. We encountered a case of extragonadal teratoma in the pouch of Douglas that appeared to be a parasitic dermoid cyst. From our experience and the literature review, we discuss the potential mechanism leading to the development of extragonadal teratomas. A 41-year-old nonpregnant woman was referred to our department due to myoma and anemia. A 4-cm asymptomatic mass in the pouch of Douglas was observed, and the patient was diagnosed with ovarian mature cystic teratoma. She underwent laparoscopic surgery, and intraoperative findings revealed that the fallopian tube was injured and torn, and a residual small ovary was observed in the left side of the ovary. A tumor measuring approximately 4 cm observed in the pouch of Douglas was extracted without rupturing. The tumor was diagnosed as a parasitic dermoid cyst by macroscopic and histopathological findings. Auto-amputation could be the underlying mechanism that leads to an isolated parasitic dermoid cyst in the pouch of Douglas. (C) 2015 AAGL. All rights reserved.	[Kakuda, Mamoru; Matsuzaki, Shinya; Kobayashi, Eiji; Yoshino, Kiyoshi; Kimura, Tadashi] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka 5650871, Japan; [Morii, Eiichi] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan	Matsuzaki, S (reprint author), Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	zacky@gyne.med.osaka-u.ac.jp					ALPERN HD, 1990, J REPROD MED, V35, P283; Gatcombe HG, 2004, J SURG ONCOL, V86, P107, DOI 10.1002/jso.20043; FUJIMOTO T, 1977, ANAT REC, V188, P315, DOI 10.1002/ar.1091880305; Ushakov FB, 1998, EUR J OBSTET GYN R B, V81, P77, DOI 10.1016/S0301-2115(98)00144-4; Turhan NO, 2000, EUR J OBSTET GYN R B, V93, P213, DOI 10.1016/S0301-2115(00)00284-0; Takeda A, 2005, J MINIM INVAS GYN L, V12, P34, DOI 10.1016/j.jmig.2004.12.015; Koo YJ, 2012, TAIWAN J OBSTET GYNE, V51, P86, DOI 10.1016/j.tjog.2012.01.017; Duwe BV, 2005, CHEST, V128, P2893, DOI 10.1378/chest.128.4.2893; PETERSON WF, 1955, AM J OBSTET GYNECOL, V70, P368; Khoo CK, 2008, J MINIM INVAS GYN, V15, P761, DOI 10.1016/j.jmig.2008.07.014; Stany MP, 2008, OBSTET GYN CLIN N AM, V35, P271, DOI 10.1016/j.ogc.2008.03.004; Sinha R, 2009, J MINIM INVAS GYN, V16, P789, DOI 10.1016/j.jmig.2009.08.003; HELLER DS, 1989, ARCH PATHOL LAB MED, V113, P802; Eda M, 2012, PATHOL INT, V62, P771, DOI 10.1111/pin.12002; Takeda A, 2012, J MINIM INVAS GYN, V19, P647, DOI 10.1016/j.jmig.2012.03.024; WHARTON LR, 1959, AM J OBSTET GYNECOL, V78, P1101; Liu JH, 2011, OBSTET GYNECOL, V117, P1413, DOI 10.1097/AOG.0b013e31821c62b6; LEFKOWITCH JH, 1978, AM J OBSTET GYNECOL, V131, P818; Moawad NS, 2008, J MINIM INVAS GYN, V15, P523, DOI 10.1016/j.jmig.2008.04.017; Matsushita H, 2009, J REPROD MED, V54, P709; Kusaka M, 2007, J OBSTET GYNAECOL RE, V33, P368, DOI 10.1111/j.1447-0756.2007.00538.x; Kobayashi Y, 2006, INT J GYNECOL OBSTET, V92, P81, DOI 10.1016/j.ijgo.2005.07.018; Mollgard K, 2010, MOL HUM REPROD, V16, P621, DOI 10.1093/molehr/gaq052; Bambao Clarissa, 2010, J Obstet Gynaecol Can, V32, P821; Bartlett Ciprian E, 2009, J Med Case Rep, V3, P63, DOI 10.1186/1752-1947-3-63; Chen HJ, 2004, TAIWAN J OBSTET GYNE, V43, P226; Farghaly SA, 2014, CLIN EXP OBSTET GYN, V41, P609; Hegde P, 2014, J OBSTET GYNAECOL RE, V40, P618, DOI 10.1111/jog.12198; Makni Amin, 2013, Tunis Med, V91, P473; Peitsidou A, 2009, FERTIL STERIL, V91; Tokunaga M, 2012, Asian J Endosc Surg, V5, P31, DOI 10.1111/j.1758-5910.2011.00107.x	31	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1553-4650	1553-4669		J MINIM INVAS GYN	J. Mimim. Invasive Gynecol.	NOV-DEC	2015	22	7					1311	1317		10.1016/j.jmig.2015.07.008		7	Obstetrics & Gynecology	Obstetrics & Gynecology	CV7GB	WOS:000364439300033		
J	Nash, O; Omotuyi, O; Lee, J; Kwon, BM; Ogbadu, L				Nash, Oyekanmi; Omotuyi, Olaposi; Lee, Joonku; Kwon, Byoung-Mog; Ogbadu, Lucy			Artocarpus altilis CG-901 alters critical nodes in the JH1-kinase domain of Janus kinase 2 affecting upstream JAK/STAT3 signaling	JOURNAL OF MOLECULAR MODELING			English	Article						Artocarpus altilis; Anticancer; STAT3; Janus kinase; Geranyl dihydrochalcone; Critical nodes	MOLECULAR-DYNAMICS; SOFTWARE NEWS; FORCE-FIELD; ACTIVATION; CANCER; INHIBITORS; INTERFACE; PATHWAY; PHOSPHORYLATION; SUPPRESSION	As a key step in achieving low-cost, easily accessible anti-cancer therapy for low-and middle-income countries, we recently established the scientific basis for the folkloric use of Artocarpus altilis for the treatment of cancer by investigating the geranyl dihydrochalcone (CG-901) content and its interference with signal transducer and activator of transcription 3 (STAT3) phosphorylation and blockage of further downstream signaling. In the current study, the CG-901 upstream target was queried by chemical fingerprinting similarity assessment, semi-empirical (PM6ESCF) QMMM and molecular dynamics (MD) simulation. Moderate (similar to 0.4) to high (similar to 0.7) Tanimoto scores were found when the CG-901 scaffold was compared to ligands co-crystallized with Janus kinases (JAK) 1-3. High negative energy values were obtained when the CG-901 was treated semi-empirically (PM6ESCF) within the classical field of JAK (1-3). Multiple nanosecond MD simulations showed that CG-901 did not cause any large structural perturbations in the nucleotide-binding, activation and catalytic loops within the kinase (JH1) domain of JAK (1-3); however, it reduced the energy required to attain metastability along the path to energy minima conformation. In comparison to JAK1 and Apo-state JAK2, JAK2-bound CG-901 exhibited a highly re-organized key intra-domain protein network; indicating atomic level interference with inter-residue communication. In conclusion, CG-901 isolated from A. altilis represents a broad-spectrum JAK inhibitor, which may underlie the mechanism of STAT3 phosphorylation blockage.	[Nash, Oyekanmi; Ogbadu, Lucy] Natl Biotechnol Dev Agcy, Ctr Genom Res & Innovat, Abuja, Nigeria; [Omotuyi, Olaposi] Adekunle Ajasin Univ, Ctr Biocomp, Akungba Akoko, Nigeria; [Omotuyi, Olaposi] Nagasaki Univ, Dept Pharmacol & Therapeut Innovat, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Lee, Joonku] Korea Res Inst Biosci & Biotechnol, Int Biol Mat Res Ctr, Taejon, South Korea; [Kwon, Byoung-Mog] Univ Sci & Technol, Lab Chem Biol & Genom, Korea Res Inst Biosci & Biotechnol, Taejon, South Korea; [Nash, Oyekanmi] Univ Ibadan, Coll Med, Inst Adv Med Res & Training, Ibadan, Nigeria; [Nash, Oyekanmi; Omotuyi, Olaposi] Natl Biotechnol Dev Agcy NABDA, Bioinformat Network Node H3Africa, Abuja, Nigeria	Omotuyi, O (reprint author), Adekunle Ajasin Univ, Ctr Biocomp, Akungba Akoko, Nigeria.	omotuyi@nagasaki-u.ac.jp			H3Africa Bioinformatics Network (H3ABioNet) - NIH Common Fund Award/NHGRI [U41HG006941]	This work was partly supported by the H3Africa Bioinformatics Network (H3ABioNet) grant funded by NIH Common Fund Award/NHGRI (Grant Number U41HG006941).	Alicea-Velazquez NL, 2011, CURR DRUG TARGETS, V12, P546; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Koukos PI, 2013, J COMPUT CHEM, V34, P2310, DOI 10.1002/jcc.23381; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Duan JX, 2010, J MOL GRAPH MODEL, V29, P157, DOI 10.1016/j.jmgm.2010.05.008; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; West K, 2009, CURR OPIN INVEST DR, V10, P491; Lucet IS, 2006, BLOOD, V107, P176, DOI 10.1182/blood-2005-06-2413; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Jeon YJ, 2015, PHYTOTHER RES, V29, P749, DOI 10.1002/ptr.5311; Rathore RS, 2013, CURR PHARM DESIGN, V19, P4674; Heifets A, 2010, J MOL GRAPH MODEL, V29, P93, DOI 10.1016/j.jmgm.2010.05.005; Kumar N, 2007, J BIOL CHEM, V282, P30341, DOI 10.1074/jbc.C600319200; Hurley CA, 2013, BIOORG MED CHEM LETT, V23, P3592, DOI 10.1016/j.bmcl.2013.04.018; Li T, 2010, J MOL MODEL, V16, P49, DOI 10.1007/s00894-009-0519-9; Wang TS, 2009, J MED CHEM, V52, P7938, DOI 10.1021/jm901383u; Park ES, 2000, MOL ENDOCRINOL, V14, P662, DOI 10.1210/me.14.5.662; Lin Q, 2005, AM J PATHOL, V167, P969, DOI 10.1016/S0002-9440(10)61187-X; Brasca MG, 2015, BIOORGAN MED CHEM, V23, P2387, DOI 10.1016/j.bmc.2015.03.059; Andre N, 2013, LANCET ONCOL, V14, pE239, DOI 10.1016/S1470-2045(13)70056-1; Stritzker J, 2013, P NATL ACAD SCI USA, V110, P8325, DOI 10.1073/pnas.1305832110; Van Gunsteren WF, 1988, MOL SIMULAT, V1, P173, DOI 10.1080/08927028808080941; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Florova P, 2010, J CHEM THEORY COMPUT, V6, P3569, DOI 10.1021/ct1003687; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Feng J, 1997, MOL CELL BIOL, V17, P2497; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Chen YW, 2015, BLOOD, V125, P1589, DOI 10.1182/blood-2014-07-588970; Antonysamy S, 2009, BIOORG MED CHEM LETT, V19, P279, DOI 10.1016/j.bmcl.2008.08.064; Gotz AW, 2014, J COMPUT CHEM, V35, P95, DOI 10.1002/jcc.23444; Yoshikawa H, 2001, NAT GENET, V28, P29, DOI 10.1038/ng0501-29; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Leow CCY, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.1; Duan JF, 2014, J NANOMATER, V2014, P1; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P; Jatiani Shashidhar S, 2010, Genes Cancer, V1, P331, DOI 10.1177/1947601910371337; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Looyenga BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030820; Luqmani YA, 2005, MED PRIN PRACT, V14, P35, DOI 10.1159/000086183; Molecular Operating Environment (MOE), 2015, MOL OP ENV MOE; Omotuyi OI, 2015, SCI REP-UK, V5, DOI 10.1038/srep13343; Pinz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090275; Tulunay A, 2015, GENES IMMUN, V16, P176, DOI 10.1038/gene.2014.80; Wolfram Research, 2014, MATHEMATICA VOL VERS	49	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1610-2940	0948-5023		J MOL MODEL	J. Mol. Model.	NOV	2015	21	11							280	10.1007/s00894-015-2821-z		11	Biochemistry & Molecular Biology; Biophysics; Chemistry, Multidisciplinary; Computer Science, Interdisciplinary Applications	Biochemistry & Molecular Biology; Biophysics; Chemistry; Computer Science	CV8IQ	WOS:000364527300002		
J	Wakamatsu, K; Tabuchi, K; Ojika, M; Zucca, FA; Zecca, L; Ito, S				Wakamatsu, Kazumasa; Tabuchi, Keisuke; Ojika, Makoto; Zucca, Fabio A.; Zecca, Luigi; Ito, Shosuke			Norepinephrine and its metabolites are involved in the synthesis of neuromelanin derived from the locus coeruleus	JOURNAL OF NEUROCHEMISTRY			English	Article						HCl hydrolysis; locus coeruleus; neuromelanin; Parkinson's disease; substantia nigra	PARKINSONS-DISEASE; OXIDATION CHEMISTRY; SUBSTANTIA-NIGRA; HUMAN-BRAIN; CATECHOLAMINERGIC NEURONS; LIQUID-CHROMATOGRAPHY; PHEOMELANIN; MELANIN; EUMELANIN; COERULEUS	In order to elucidate the chemical structure of black to brown pigments, neuromelanins (NMs), in the substantia nigra (SN) and the locus coeruleus (LC) in the central nervous system of humans and other mammalian species during aging, chemical degradative methods are powerful tools. HPLC analysis after hydroiodic acid hydrolysis detected aminohydroxyphenylethylamines, aminohydroxyphenylacetic acids, and aminohydroxyethylbenzenes, which confirmed that SN-NM and LC-NM contain melanin derived not only from dopamine and norepinephrine (NE) but also from several other catecholic metabolites, such as 3,4-dihydroxyphenylalanine, 3,4-dihydroxyphenylacetic acid, 3,4-dihydroxymandelic acid, 3,4-dihydroxyphenylethanol, and 3,4-dihydroxyphenylethylene glycol, in addition to the corresponding Cys-derivatives in varying degrees. However, hydroiodic acid hydrolysis showed that LC-NM produced the same degradation products as were detected in SN-NM. Thus, we needed to develop a new chemical detection method to validate the existence of NE in LC-NM. In the present study, we report that HCl hydrolysis of LC-NM in the presence of thioglycolic acid yields new products arising from substitution of the hydroxyl group by thioglycolic acid at the benzyl position of NE and cysteinyl-NE. This is the first chemical evidence showing that NE and cysteinyl-NE are incorporated into LC-NM.	[Wakamatsu, Kazumasa; Tabuchi, Keisuke; Ito, Shosuke] Fujita Hlth Univ, Sch Hlth Sci, Dept Chem, Toyoake, Aichi 4701192, Japan; [Ojika, Makoto] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan; [Zucca, Fabio A.; Zecca, Luigi] Natl Res Council Italy, Inst Biomed Technol, Milan, Italy	Wakamatsu, K (reprint author), Fujita Hlth Univ, Sch Hlth Sci, Dept Chem, Toyoake, Aichi 4701192, Japan.	kwaka@fujita-hu.ac.jp	Zucca, Fabio/O-4368-2015; 	Zucca, Fabio/0000-0003-1230-1129; Wakamatsu, Kazumasa/0000-0003-1748-9001	Japan Society for the Promotion of Science (JSPS) [21500358, 24500450]; Lombardy Region-CNR an MbMM Project [18089/RCC]; Italian Ministry of Education, University, and Research (MIUR)-Research Projects of National Interest (PRIN) [prot. 2010M2JARJ]	This work was supported by grants from the Japan Society for the Promotion of Science (JSPS) (No. 21500358, No. 24500450) given to KW and SI. FAZ and LZ were supported by a Lombardy Region-CNR 2013-2015 Framework Agreement, an MbMM Project (18089/RCC) and by Italian Ministry of Education, University, and Research (MIUR)-Research Projects of National Interest (PRIN) 2010-2011 prot. 2010M2JARJ. The authors also thank the Section of Legal Medicine and Insurances, Department of Biomedical Sciences for Health at the University of Milano for providing brain tissue samples. The authors declare no conflict of interest.	Wakamatsu K, 2003, J NEUROCHEM, V86, P1015, DOI 10.1046/j.1471-4159.2003.01917.x; Zecca L, 2002, FEBS LETT, V510, P216, DOI 10.1016/S0014-5793(01)03269-0; ZHANG F, 1993, BIOORG CHEM, V21, P392, DOI 10.1006/bioo.1993.1033; Zecca L, 2004, P NATL ACAD SCI USA, V101, P9843, DOI 10.1073/pnas.0403495101; Manini P, 2007, CHEM RES TOXICOL, V20, P1549, DOI 10.1021/tx700254q; GRAHAM DG, 1979, ARCH PATHOL LAB MED, V103, P359; WAKAMATSU K, 1994, CLIN CHEM, V40, P495; MANN DMA, 1983, MECH AGEING DEV, V21, P193, DOI 10.1016/0047-6374(83)90074-X; ITO S, 1985, ANAL BIOCHEM, V144, P527, DOI 10.1016/0003-2697(85)90150-2; Ito S, 2011, PIGM CELL MELANOMA R, V24, P605, DOI 10.1111/j.1755-148X.2011.00864.x; Sulzer D, 2000, P NATL ACAD SCI USA, V97, P11869, DOI 10.1073/pnas.97.22.11869; Xin WK, 2000, CHEM RES TOXICOL, V13, P749, DOI 10.1021/tx990170t; Murakami K, 2007, BLOOD PURIFICAT, V25, P483, DOI 10.1159/000112516; SAPER CB, 1982, BRAIN, V105, P87, DOI 10.1093/brain/105.1.87; Sulzer D, 2008, J NEUROCHEM, V106, P24, DOI 10.1111/j.1471-4159.2008.05385.x; MANN DMA, 1974, BRAIN, V97, P489, DOI 10.1093/brain/97.1.489; ITO S, 1989, PIGM CELL RES, V2, P53, DOI 10.1111/j.1600-0749.1989.tb00158.x; BOGERTS B, 1981, J COMP NEUROL, V197, P63, DOI 10.1002/cne.901970106; Vauzour D, 2008, ARCH BIOCHEM BIOPHYS, V476, P145, DOI 10.1016/j.abb.2008.03.011; Napolitano A, 2011, CURR MED CHEM, V18, P1832; Zecca L, 2006, NEUROLOGY, V67, pS8; GIESEG SP, 1993, BIOCHEMISTRY-US, V32, P4780, DOI 10.1021/bi00069a012; Segura-Aguilar J, 2014, J NEUROCHEM, V129, P898, DOI 10.1111/jnc.12686; Wakamatsu K, 2002, PIGM CELL RES, V15, P225, DOI 10.1034/j.1600-0749.2002.02009.x; Zarow C, 2003, ARCH NEUROL-CHICAGO, V60, P337, DOI 10.1001/archneur.60.3.337; d'Ischia M, 2013, PIGM CELL MELANOMA R, V26, P616, DOI 10.1111/pcmr.12121; Gesi M, 2000, NEUROSCI BIOBEHAV R, V24, P655, DOI 10.1016/S0149-7634(00)00028-2; Ito S, 2008, PHOTOCHEM PHOTOBIOL, V84, P582, DOI 10.1111/j.1751-1097.2007.00238.x; Land EJ, 2000, PIGM CELL RES, V13, P273, DOI 10.1034/j.1600-0749.2000.130409.x; Zecca L, 2000, J NEUROCHEM, V74, P1758, DOI 10.1046/j.1471-4159.2000.0741758.x; Zecca L, 2008, P NATL ACAD SCI USA, V105, P17567, DOI 10.1073/pnas.0808768105; Wakamatsu K, 2014, MOLECULES, V19, P8039, DOI 10.3390/molecules19068039; ROSENGREN E, 1985, J NEURAL TRANSM, V63, P247, DOI 10.1007/BF01252029; Zecca L, 2003, TRENDS NEUROSCI, V26, P578, DOI 10.1016/j.tins.2003.08.009; Greco G, 2009, PIGM CELL MELANOMA R, V22, P319, DOI 10.1111/j.1755-148X.2009.00561.x; Ito S, 2003, PIGM CELL RES, V16, P523, DOI 10.1034/j.1600-0749.2003.00072.x; ITO S, 1986, J CHROMATOGR, V375, P134, DOI 10.1016/S0378-4347(00)83700-7; PAULUS W, 1991, J NEUROPATH EXP NEUR, V50, P743, DOI 10.1097/00005072-199111000-00006; Shen XM, 2001, TETRAHEDRON, V57, P393, DOI 10.1016/S0040-4020(00)00953-4; Cebrian C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4633; Engelen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048490; Marsden C D, 1983, J Neural Transm Suppl, V19, P121; Segura-Aguilar J, 2001, Neurotox Res, V3, P157; Wakamatsu K., 2012, PIGM CELL MELANOMA R, V25, P793	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	NOV	2015	135	4					768	776		10.1111/jnc.13237		9	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CV9ZV	WOS:000364649300013		
J	Nakagawa, A; Ogawa, Y; Amano, K; Ishii, Y; Tahara, S; Horiguchi, K; Kawamata, T; Yano, S; Arafune, T; Washio, T; Kuratsu, J; Saeki, N; Okada, Y; Teramoto, A; Tominaga, T				Nakagawa, Atsuhiro; Ogawa, Yoshikazu; Amano, Kosaku; Ishii, Yudo; Tahara, Shigeshi; Horiguchi, Kentaro; Kawamata, Takakazu; Yano, Shigetoshi; Arafune, Tatsuhiko; Washio, Toshikatsu; Kuratsu, Jun-ichi; Saeki, Naokatsu; Okada, Yoshikazu; Teramoto, Akira; Tominaga, Teiji			Pulsed Laser-induced Liquid Jet System for Treatment of Sellar and Parasellar Tumors: Safety Evaluation	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						functional preservation; maximal lesion removal; minimally invasive surgery; medical engineering; water jet	HOLMIUM-YAG LASER; WATERJET DISSECTION; TRANSSPHENOIDAL SURGERY; SURGICAL EXPERIENCE; IMPAIRING VESSELS; DEVICE; BRAIN; RESECTION; LIVER; KNIFE	ObjectiveThe pulsed laser-induced liquid jet (LILJ) system is an emerging surgical instrument intended to assist both maximal removal of the lesion and functional maintenance through preservation of fine vessels and minimal damage to the surrounding tissue. The system ejects the minimum required amount of pulsed water through a handy bayonet-shaped catheter. We have already shown a significant increase in removal rate, in addition to a noteworthy reduction of intraoperative blood loss and procedure time in the treatment of large pituitary and skull base tumors in a single-institution series. The present study evaluated the safety of the system in multiple institutions. MethodsThe study included 46 patients, 29 men and 17 women (mean age: 59.1 years) who underwent microsurgical/endoscopic resection of lesions in or in the vicinity of the pituitary fossa through the transsphenoidal approach between October 2011 and June 2012 at six institutions. The histologic diagnoses were pituitary adenoma (31 cases), meningioma (4), craniopharyngioma (3), cavernous angioma (2), and Rathke cyst cleft (1). Lesion volume ranged from 2.0 to 30.4 cm(3) (mean: 3.7 cm(3)). Cavernous sinus invasion was observed in 11 cases and suprasellar extension in 29 cases. ResultsPreservation of intralesional arteries (diameter: 150 mu m) was achieved in all situations in>80% of cases. Intended surgical steps were achieved except for some restrictions in motion due to the use of an optical quartz fiber. No complications occurred directly related to the use of the device. ConclusionsThe LILJ system can be used for safe removal of lesions in or in the vicinity of the pituitary fossa.	[Nakagawa, Atsuhiro; Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi 9808574, Japan; [Ogawa, Yoshikazu] Kohnan Hosp, Dept Neurosurg, Sendai, Miyagi, Japan; [Amano, Kosaku; Kawamata, Takakazu; Okada, Yoshikazu] Tokyo Womans Med Univ, Dept Neurosurg, Tokyo, Japan; [Ishii, Yudo; Tahara, Shigeshi; Teramoto, Akira] Nippon Med Sch, Dept Neurosurg, Tokyo 113, Japan; [Horiguchi, Kentaro; Saeki, Naokatsu] Chiba Univ, Dept Neurosurg, Chiba, Japan; [Yano, Shigetoshi] Kumamoto Univ, Grad Sch, Dept Neurosurg, Kumamoto, Japan; [Arafune, Tatsuhiko] Univ Tokyo, Dept Bioengn, Tokyo, Japan; [Washio, Toshikatsu] Natl Inst Adv Ind & Sci Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan; [Kuratsu, Jun-ichi] Kumamoto Univ, Fac Life Sci Res, Grad Sch, Dept Neurosurg, Kumamoto, Japan	Ogawa, Y (reprint author), Tohoku Univ, Dept Neurosurg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	yogawa@kohnan-sendai.or.jp			Japanese Ministry of Economy, Trade, and Industry	The laser and optical quartz fibers used in the present study were manufactured by Sparkling Photon., Inc., which has served as a partner industry to conduct the "Program to support collaboration between hospitals and businesses for development and improvement of medical equipment and devices to solve unmet medical needs" (supplementary budget, 2010FY ZEN 219 to A.N., Y.O., T.A., T.W., and T.T.) supported by the Japanese Ministry of Economy, Trade, and Industry. The authors otherwise report no conflict of interest concerning the materials or methods used in this study or the findings specified in this article.	Hirano T, 2003, ACTA NEUROCHIR, V145, P401, DOI 10.1007/s00701-003-0010-9; Oertel J, 2003, NEUROSURG REV, V26, P168, DOI 10.1007/s10143-002-0244-7; Aroussi AA, 2006, ANN THORAC SURG, V81, P1911, DOI 10.1016/j.athoracsur.2005.02.070; Tschan C, 2009, J NEUROSURG, V110, P656, DOI 10.3171/2008.5.17561; Nakagawa A, 2004, J NEUROSURG, V101, P145, DOI 10.3171/jns.2004.101.1.0145; Passacantilli E, 2012, PHOTOMED LASER SURG, V30, P286, DOI 10.1089/pho.2011.3137; Cappabianca P, 2001, ACTA NEUROCHIR, V143, P95, DOI 10.1007/s007010170144; Hirano T, 2003, MINIM INVAS NEUROSUR, V46, P121, DOI 10.1055/s-2003-39339; Ohki T, 2004, LASER SURG MED, V34, P227, DOI 10.1002/lsm.20021; Oertel J, 2006, J NEUROSURG, V105, P928, DOI 10.3171/jns.2006.105.6.928; TURNER RJ, 1992, J REPROD MED, V37, P607; Rau HG, 2008, HPB, V10, P275, DOI 10.1080/13651820802167706; Killory BD, 2010, NEUROSURGERY, V66, P1187, DOI 10.1227/01.NEU.0000369195.17553.F3; Ogawa Y, 2011, ACTA NEUROCHIR, V153, P823, DOI 10.1007/s00701-010-0925-x; Hirano T, 2001, LASER SURG MED, V29, P360, DOI 10.1002/lsm.1129; Kroh M, 2008, SURG ENDOSC, V22, P2498, DOI 10.1007/s00464-008-9804-4; Ogawa Y, 2013, ACTA NEUROCHIR, V155, P1879, DOI 10.1007/s00701-013-1817-7; Seki S, 1998, J TRAUMA, V45, P1079, DOI 10.1097/00005373-199812000-00019; Dusick JR, 2007, NEUROSURGERY, V60, P322, DOI 10.1227/01.NEU.0000255408.84269.A8; Oertel J, 2004, J NEUROSURG, V100, P498, DOI 10.3171/jns.2004.100.3.0498; Nakagawa A, 2002, LASER SURG MED, V31, P129, DOI 10.1002/lsm.10055; Tschan CA, 2009, ACTA NEUROCHIR, V151, P1473, DOI 10.1007/s00701-009-0333-2; PAPACHRISTOU DN, 1982, BRIT J SURG, V69, P93, DOI 10.1002/bjs.1800690212; Couldwell WT, 2004, NEUROSURGERY, V55, P539, DOI 10.1227/01.NEU.0000134287.19377.A2; F Esposito, 2007, NEUROSURGERY, V60, P328, DOI DOI 10.1227/01.NEU.0000255408.84269.A8; Carrabba Giorgio, 2008, Neurosurgery, V63, pE178, DOI 10.1227/01.NEU.0000335087.85470.18; G Carrabba, 2008, NEUROSURGERY, V63, pE179; Gasiński Mateusz, 2009, Otolaryngol Pol, V63, P47, DOI 10.1016/S0030-6657(09)70188-X; GOEL A, 1995, BRIT J NEUROSURG, V9, P37; J Oertel, 2003, NEUROSURGERY, V52, P159; Oertel J, 2003, NEUROSURGERY, V52, P153, DOI 10.1227/01.NEU.0000039020.36409.8F; Laws E R Jr, 1976, Clin Neurosurg, V23, P401; Laws E R Jr, 1999, Pituitary, V2, P163; Miller JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P871, DOI 10.1001/archopht.121.6.871; Nakagawa A, 2008, NEUROL SURG TOKYO, V36, P1005; Rhoton AL, 2002, NEUROSURGERY, V51, pS335, DOI 10.1227/01.NEU.0000028680.51299.00; Ridderheim P A, 1987, ACTA NEUROCHIR WIEN, V89, P84; Sato C, 2013, DIGEST ENDOSC, V25, P255, DOI 10.1111/j.1443-1661.2012.01375.x; Seto T, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3587069; T Hirano, 2003, ACTA NEUROCHIR WIEN, V145, P406; Terzis A J, 1989, Br J Neurosurg, V3, P361, DOI 10.3109/02688698909002816	41	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	NOV	2015	76	6					473	482		10.1055/s-0034-1396436		10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CV5TI	WOS:000364333700007		
J	Nakatogawa, H; Tanaka, T; Inenaga, C; Fujimoto, A; Yamamoto, T				Nakatogawa, Hirokazu; Tanaka, Tokutaro; Inenaga, Chikanori; Fujimoto, Ayataka; Yamamoto, Takamichi			Endoscopic Removal of Neonatal Acute Epidural Hematoma via Strip-Bending Osteoplastic Craniotomy. Technical Note	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						acute epidural hematoma; neonate; neuroendoscope; delivery trauma; strip-bending osteoplastic craniotomy	GUIDED NEEDLE ASPIRATION; EXTRADURAL HEMORRHAGE; SKULL FRACTURES; NEWBORN-INFANTS; CEPHALHEMATOMA; CHILDREN; SURGERY; TRAUMA; BIRTH	We present a rare case of an acute epidural hematoma extending through a skull fracture into a cephalohematoma in a neonate. The epidural hematoma was caused by a fall after delivery. The neonate remained neurologically asymptomatic. A computed tomography scan 12 days after delivery showed the large-volume epidural hematoma with midline shift. We performed a strip-bending osteoplastic craniotomy and removed the epidural hematoma and external cephalohematoma under neuroendoscopic control. This is the first reported case of an acute epidural hematoma in a neonate treated successfully neuroendoscopically via a strip-bending craniotomy.	[Nakatogawa, Hirokazu; Tanaka, Tokutaro; Inenaga, Chikanori; Fujimoto, Ayataka; Yamamoto, Takamichi] Seirei Hamamatsu Gen Hosp, Dept Neurosurg, Hamamatsu, Shizuoka 4308558, Japan	Nakatogawa, H (reprint author), Seirei Hamamatsu Gen Hosp, Dept Neurosurg, Naka Ku, 2-12-12 Sumiyoshi, Hamamatsu, Shizuoka 4308558, Japan.	hiro-nakato@sis.seirei.or.jp					Andoh Y, 1988, NERV SYST CHILD KOBE, V13, P177; ESPARZA J, 1982, SURG NEUROL, V17, P341, DOI 10.1016/0090-3019(82)90305-6; AOKI N, 1983, NEUROSURGERY, V13, P55; TAKAGI T, 1978, CHILD BRAIN, V4, P306; Noguchi M, 2010, CHILD NERV SYST, V26, P713, DOI 10.1007/s00381-009-1072-7; Vachharajani A, 2002, AM J PERINAT, V19, P401, DOI 10.1055/s-2002-36837; Akiyama Y, 2001, CHILD NERV SYST, V17, P290, DOI 10.1007/s003810000408; Huang APH, 2012, J TRAUMA ACUTE CARE, V73, P774, DOI 10.1097/TA.0b013e31824a7974; CAMPBELL JB, 1951, SURG GYNECOL OBSTET, V92, P257; NATELSON SE, 1973, PEDIATRICS, V51, P169; Smets KJ, 2010, EUR J PEDIATR, V169, P617, DOI 10.1007/s00431-009-1071-4; MERRY GS, 1979, J NEUROSURG, V51, P713, DOI 10.3171/jns.1979.51.5.0713; Ohshima T, 2012, NEUROL MED-CHIR, V52, P829; Ballance C A, 1922, LANCET, V203, P1109; HARWOODN.DC, 1971, RADIOLOGY, V101, P151; Hayashi T, 1982, NERV SYST CHILD, V7, P167; Ishikawa S, 2007, NEUROL SURG TOKYO, V35, P175; Lieu A S, 1996, J MED SCI, V12, P434; Makiyama Y, 1991, NERV SYST CHILD, V16, P443; OATEY PE, 1983, MED J AUSTRALIA, V2, P176; Heyman R, 2005, NEUROSURGERY, V57, P924, DOI 10.1227/01.NEU.0000180026.73246.bf; Scheibl A, 2012, J PEDIATR SURG, V47, pE19, DOI 10.1016/j.jpedsurg.2011.10.078; TADA M, 1986, Hokkaido Journal of Medical Science, V61, P244; WAKAI S, 1990, Dokkyo Journal of Medical Sciences, V17, P57; Wakayama A, 1991, NIHON KYUKYU IGAKUKA, V2, P723; Yamamoto Tetsuya, 1995, Neurologia Medico-Chirurgica, V35, P749, DOI 10.2176/nmc.35.749; Yamanouchi Y, 1999, NERV SYST CHILD, V24, P298; ZELSON C, 1974, J PEDIATR-US, V85, P371, DOI 10.1016/S0022-3476(74)80118-6	28	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	NOV	2015	76	6					495	498		10.1055/s-0035-1551822		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CV5TI	WOS:000364333700009		
J	Natelson, BH; Vu, D; Mao, XL; Weiduschat, N; Togo, F; Lange, G; Blate, M; Kang, GX; Coplan, JD; Shungu, DC				Natelson, Benjamin H.; Vu, Diana; Mao, Xiangling; Weiduschat, Nora; Togo, Fumiharu; Lange, Gudrun; Blate, Michelle; Kang, Guoxin; Coplan, Jeremy D.; Shungu, Dikoma C.			Effect of Milnacipran Treatment on Ventricular Lactate in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial	JOURNAL OF PAIN			English	Article						Widespread pain; serotonin-norepinephrine reuptake inhibitor; brain function; magnetic resonance spectroscopy	CHRONIC-FATIGUE-SYNDROME; CEREBROSPINAL-FLUID; CHRONIC PAIN; DISORDER; NEUROINFLAMMATION; MICROGLIA; BRAIN; GLIA	Milnacipran, a serotonin/norepinephrine reuptake inhibitor, has been approved by the US Food and Drug Administration for the treatment of fibromyalgia (FM). This report presents the results of a randomized, double-blind, placebo-controlled trial of milnacipran conducted to test the hypotheses that a) similar to patients with chronic fatigue syndrome, patients with FM have increased ventricular lactate levels at baseline; b) 8 weeks of treatment with milnacipran will lower ventricular lactate levels compared with baseline levels and with ventricular lactate levels after placebo; and c) treatment with milnacipran will improve attention and executive function in the Attention Network Test compared with placebo. In addition, we examined the results for potential associations between ventricular lactate and pain. Baseline ventricular lactate measured by proton magnetic resonance spectroscopic imaging was found to be higher in patients with FM than in healthy controls (F-1,F-37 = 22.11, P<.0001, partial eta(2) = .37). Milnacipran reduced pain in patients with FM relative to placebo but had no effect on cognitive processing. At the end of the study, ventricular lactate levels in the rnilnacipran-treated group had decreased significantly compared with baseline and after placebo (F-1,F-18 = 8.18, P =.01, partial eta(2) =.31). A significantly larger proportion of patients treated with milnacipran showed decreases in both ventricular lactate and pain than those treated with placebo (P =.03). These results suggest that proton magnetic resonance spectroscopic imaging measurements of lactate may serve as a potential biomarker for a therapeutic response in FM and that milnacipran may act, at least in part, by targeting the brain response to glial activation and neuroinflammation. Perspective: Patients treated with milnacipran showed decreases in both pain and ventricular lactate levels compared with those treated with placebo, but, even after treatment, levels of ventricular lactate remained higher than in controls. The hypothesized mechanism for these decreases is via drug-induced reductions of a central inflammatory state. (c) 2015 by the American Pain Society	[Natelson, Benjamin H.; Vu, Diana; Lange, Gudrun; Blate, Michelle] Mt Sinai Beth Israel, Dept Neurol, New York, NY USA; [Mao, Xiangling; Weiduschat, Nora; Kang, Guoxin; Shungu, Dikoma C.] Cornell Univ, Dept Radiol, Weill Med Coll, New York, NY 10021 USA; [Togo, Fumiharu] Univ Tokyo, Grad Sch Educ, Educ Physiol Lab, Tokyo, Japan; [Coplan, Jeremy D.] Suny Downstate Med Ctr, Dept Psychiat & Behav Sci, Brooklyn, NY 11203 USA	Natelson, BH (reprint author), Suite 4K,10 Union Sq East, New York, NY 10003 USA.	bnatelson@bethisraelny.org			Pfizer Pharmaceuticals; GSK; Corcept; Neurocrine; Forest Laboratories Investigator-initiated grant; National Institutes of Mental Health (NIMH) [R01 MH100005]	J.D.C. has been a speaker for Pfizer, Forest, Bristol Myers Squibb, Glaxo Smith Kline, Eli Lilly, and Sunovion. He has received grants from Pfizer Pharmaceuticals, GSK, Corcept, and Neurocrine. There were no other conflicts of interest in doing this research. This work was supported by a Forest Laboratories Investigator-initiated grant to B.H.N., and, in part, by National Institutes of Mental Health (NIMH) grant R01 MH100005 to D.C.S. The sources of funding had no involvement in any of the aspects of running this study, analyzing the data, or preparing this manuscript.	Kaufmann P, 2004, NEUROLOGY, V62, P1297; COHEN J, 1973, EDUC PSYCHOL MEAS, V33, P107, DOI 10.1177/001316447303300111; Gimeno-Bayon J, 2014, J NEUROSCI RES, V92, P723, DOI 10.1002/jnr.23356; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Shungu DC, 2012, NMR BIOMED, V25, P1073, DOI 10.1002/nbm.2772; SEIDENBERG M, 1994, J CLIN EXP NEUROPSYC, V16, P93, DOI 10.1080/01688639408402620; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Kadetoff D, 2012, J NEUROIMMUNOL, V242, P33, DOI 10.1016/j.jneuroim.2011.10.013; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; White KP, 1999, J RHEUMATOL, V26, P1570; DUYN JH, 1993, RADIOLOGY, V188, P277; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Murrough JW, 2010, NMR BIOMED, V23, P643, DOI 10.1002/nbm.1512; Tynan RJ, 2012, BRAIN BEHAV IMMUN, V26, P469, DOI 10.1016/j.bbi.2011.12.011; Jason LA, 1999, ARCH INTERN MED, V159, P2129, DOI 10.1001/archinte.159.18.2129; Mathew SJ, 2009, NMR BIOMED, V22, P251, DOI 10.1002/nbm.1315; WALZ W, 1988, NEUROSCI LETT, V86, P296, DOI 10.1016/0304-3940(88)90499-5; Weiduschat N, 2014, NEUROLOGY, V82, P798, DOI [10.1212/WNL.0000000000000169, 10.1212/WNL.0000000000000173]; Kosek E, 1996, PAIN, V68, P375, DOI 10.1016/S0304-3959(96)03188-0; Vollmar P, 2008, INT J NEUROPSYCHOPH, V11, P111, DOI 10.1017/S1461145707007729; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Okifuji A, 1997, J RHEUMATOL, V24, P377; Nakatomi Y, 2014, J NUCL MED, V55, P945, DOI 10.2967/jnumed.113.131045; Ciccone DS, 2003, PSYCHOSOM MED, V65, P268, DOI 10.1097/01.PSY.0000033125.08272.A9; First MB, 1994, MANUAL STRUCTURED CL; FUKUDA K, 1994, ANN INTERN MED, V121, P953; Lutz NW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000595; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Togo F, 2013, J NEUROPSYCHOL, V9, P1; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147	30	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1526-5900			J PAIN	J. Pain	NOV	2015	16	11					1211	1219		10.1016/j.jpain.2015.08.004		9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CV9MX	WOS:000364612400014		
J	Otsuki, S; Iwamoto, S; Azuma, E; Nashida, Y; Akachi, S; Taniguchi, K; Higashigawa, M; Komada, Y				Otsuki, Shoichiro; Iwamoto, Shotaro; Azuma, Eiichi; Nashida, Yuji; Akachi, Shigehiro; Taniguchi, Kiyosu; Higashigawa, Masamune; Komada, Yoshihiro			Hemophagocytic Lymphohistiocytosis Due to Rickettsia Japonica in a 3-Month-old Infant	JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY			English	Letter							JAPANESE SPOTTED-FEVER		[Otsuki, Shoichiro; Iwamoto, Shotaro; Azuma, Eiichi; Komada, Yoshihiro] Mie Univ, Sch Med, Dept Pediat, Tsu, Mie, Japan; [Nashida, Yuji; Higashigawa, Masamune] Ise Red Cross Hosp, Dept Pediat, Tsu, Mie, Japan; [Akachi, Shigehiro] Mie Prefecture Hlth & Environm Res Inst, Tsu, Mie, Japan; [Taniguchi, Kiyosu] Mie Natl Hosp, Dept Clin Res, Tsu, Mie, Japan	Otsuki, S (reprint author), Mie Univ, Sch Med, Dept Pediat, Tsu, Mie, Japan.						Mahara F, 1997, EMERG INFECT DIS, V3, P105; Hinson A, 2015, J PEDIAT HEMATOL ONC, V37, P300, DOI 10.1097/MPH.0000000000000234; Kondo M, 2010, INT J DERMATOL, V49, P430, DOI 10.1111/j.1365-4632.2010.04359.x; Tai K, 2014, J CLIN MICROBIOL, V52, P1938, DOI 10.1128/JCM.03238-13; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; Cascio A, 2011, J MED MICROBIOL, V60, P537, DOI 10.1099/jmm.0.025833-0; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Imashuku S, 2005, EUR J PEDIATR, V164, P315, DOI 10.1007/s00431-005-1636-9; Koh KN, 2015, EUR J HAEMATOL, V94, P51, DOI 10.1111/ejh.12399; Nashida Yuji, 2011, Kansenshogaku Zasshi, V85, P638	10	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1077-4114	1536-3678		J PEDIAT HEMATOL ONC	J. Pediatr. Hematol. Oncol.	NOV	2015	37	8					627	628				2	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	CV5SA	WOS:000364330200011		
J	Hasegawa, J; Arakaki, T; Ichizuka, K; Sekizawa, A				Hasegawa, Junichi; Arakaki, Tatsuya; Ichizuka, Kiyotake; Sekizawa, Akihiko			Management of vasa previa during pregnancy	JOURNAL OF PERINATAL MEDICINE			English	Article						Cesarean section; nonreassuring fetal status; tocholysis; vasa previa; velamentous cord insertion		In order to prevent fetal mortality due to vasa previa, it is neceesary to obtain an antenatal diagnosis and perform elective cesarean section prior to membrane rupture. Under present circumstances, management strategies for vasa previa depend on each institutional policy. In our institution, patients are not routinely admitted, although precise outpatient management, including confirming the presence of uterine contractions and monitoring the cervical length, fetal growth and fetal heart rate, is provided for pregnant females with vasa previa. In the present report, we reviewed 21 cases of vasa previa managed at our hospital. Some 71% (15/21) of them were required inpatient management due to its complications, resulting in emergency delivery in about half of them. Therefore, our results suggest that only carefully selected asymptomatic patients may be successfully managed as outpatients.	[Hasegawa, Junichi] Showa Univ, Sch Med, Dept Obstet & Gynecol, Shinagawa Ku, Tokyo 1428666, Japan; [Arakaki, Tatsuya; Ichizuka, Kiyotake; Sekizawa, Akihiko] Showa Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 1428666, Japan	Hasegawa, J (reprint author), Showa Univ, Sch Med, Dept Obstet & Gynecol, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428666, Japan.	hasejun@oak.dti.ne.jp					Hasegawa J, 2012, J MATERN-FETAL NEO M, V25, P2795, DOI 10.3109/14767058.2012.712570; Oyelese Y, 2006, OBSTET GYNECOL, V107, P927, DOI 10.1097/01.AOG.0000207559.15715.98; Oyelese Y, 2004, OBSTET GYNECOL, V103, P937, DOI 10.1097/01.AOG.0000123245.48645.98; Gagnon Robert, 2009, J Obstet Gynaecol Can, V31, P748	4	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0300-5577	1619-3997		J PERINAT MED	J. Perinat. Med.	NOV	2015	43	6					783	784		10.1515/jpm-2014-0047		2	Obstetrics & Gynecology; Pediatrics	Obstetrics & Gynecology; Pediatrics	CV9AM	WOS:000364579700021		
J	Hasegawa, J; Sekizawa, A; Ishiwata, I; Ikeda, T; Kinoshita, K				Hasegawa, Junichi; Sekizawa, Akihiko; Ishiwata, Isamu; Ikeda, Tomoaki; Kinoshita, Katsuyuki			Uterine rupture after the uterine fundal pressure maneuver	JOURNAL OF PERINATAL MEDICINE			English	Article						Amniotic fluid embolism; maternal death; postpartum bleeding; uterine fundal pressure; uterine rupture	AMNIOTIC-FLUID EMBOLISM; UNSCARRED UTERUS; 2ND-STAGE; LABOR	Objective: To clarify the incidence of uterine fundal pressure at delivery and its effect on uterine rupture. Study design: A questionnaire was sent to 2518 institutions in Japan. We received a response from 1430. Results: Of reporting institutions, 89.4% used fundal pressure in at least some of their deliveries. Among the 347,771 women who delivered vaginally in this study, 38,973 (11.2%) were delivered with the assistance of fundal pressure. There were six cases of uterine rupture associated with uterine fundal pressure, with one case resulting in maternal death secondary to amniotic fluid embolism. Conclusion: Since uterine fundal pressure may potentially cause serious injury to either the mother and/or neonates, the indications for application need to be clearly elucidated, and obstetric care providers also need comprehensive education and training.	[Hasegawa, Junichi] Showa Univ, Sch Med, Dept Obstet & Gynecol, Shinagawa Ku, Tokyo 1428666, Japan; [Sekizawa, Akihiko] Showa Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 1428666, Japan; [Ishiwata, Isamu] Ishiwata Obstet & Gynecol Hosp, Ibaraki, Japan; [Ikeda, Tomoaki] Mie Univ, Sch Med, Dept Obstet & Gynecol, Tsu, Mie, Japan; [Kinoshita, Katsuyuki] Seijo Kinoshita Hosp, Tokyo, Japan	Hasegawa, J (reprint author), Showa Univ, Sch Med, Dept Obstet & Gynecol, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428666, Japan.	hasejun@oak.dti.ne.jp					Matsuo K, 2009, ARCH GYNECOL OBSTET, V280, P781, DOI 10.1007/s00404-009-1015-2; Kramer MS, 2013, PAEDIATR PERINAT EP, V27, P436, DOI 10.1111/ppe.12066; HOGBERG U, 1985, GYNECOL OBSTET INVES, V20, P130; Pan HS, 2002, J REPROD MED, V47, P1044; Moiety FMS, 2014, J OBSTET GYNAECOL RE, V40, P946, DOI 10.1111/jog.12284; Catanzarite V, 2006, OBSTET GYNECOL, V108, P723, DOI 10.1097/01.AOG.0000215559.21051.dc; Api O, 2009, ACTA OBSTET GYN SCAN, V88, P320, DOI 10.1080/00016340902730326; Clark SL, 2014, OBSTET GYNECOL, V123, P337, DOI 10.1097/AOG.0000000000000107; Kurdoglu Mertihan, 2009, Cases J, V2, P7966, DOI 10.1186/1757-1626-2-7966; Matsubara S, 2012, RURAL REMOTE HEALTH, V12; Simpson K R, 2001, MCN Am J Matern Child Nurs, V26, P64, DOI 10.1097/00005721-200103000-00004; Wei Shen-Chuan, 2006, Taiwan J Obstet Gynecol, V45, P170	12	1	1	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0300-5577	1619-3997		J PERINAT MED	J. Perinat. Med.	NOV	2015	43	6					785	788		10.1515/jpm-2014-0284		4	Obstetrics & Gynecology; Pediatrics	Obstetrics & Gynecology; Pediatrics	CV9AM	WOS:000364579700022		
J	Katsura, S; Oka, E; Sato, K				Katsura, Shota; Oka, Eitarou; Sato, Kanako			Formation Mechanism of Barrier Layer in the Subtropical Pacific	JOURNAL OF PHYSICAL OCEANOGRAPHY			English	Article							WESTERN EQUATORIAL PACIFIC; SEA-SURFACE SALINITY; MIXED-LAYER; INTERANNUAL VARIABILITY; TROPICAL WATER; NORTH PACIFIC; TOGA DECADE; PART II; OCEAN; ARGO	Seasonal and interannual variations of the barrier layer (BL) and its formation mechanism in the subtropical North and South Pacific were investigated by using raw and gridded Argo profiling float data and various surface flux data in 2003-12 and hydrographic section data from the World Ocean Circulation Experiment Hydrographic Programme. BLs detected by raw Argo profiles, which existed within the sea surface salinity (SSS) front located on the equator side of SSS maxima, were thickest and most frequent in winter and had a temporal scale shorter than 10 days, indicating their transient nature. Surface and subsurface processes for the BL formation suggested by previous studies were evaluated. Poleward Ekman advection of fresher water was dominant as the surface freshening process but cannot explain the observed seasonal variations of the BL. Subsurface equatorward intrusion of high-salinity tropical water was too deep to produce salinity stratification within isothermal layers. These results strongly suggest that BLs in the subtropical Pacific are formed mainly through tilting of the SSS front due to the poleward Ekman flow near the sea surface and the equatorward geostrophic flow in the subsurface. This idea is supported by the dominant contribution of the meridional SSS gradient to the meridional sea surface density gradient within the SSS front and the correspondence between the seasonal variations of the BL and isothermal layer depth. On an interannual time scale, the winter BL thickness in the North and South Pacific was related to the Pacific decadal oscillation and the El Nino-Southern Oscillation, respectively, through the intensity of trade winds controlling isothermal layer depth.	[Katsura, Shota; Oka, Eitarou] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Sato, Kanako] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan	Katsura, S (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778564, Japan.	katsura@aori.u-tokyo.ac.jp			Japan Society for the Promotion of Science (KAKENHI) [15J05210, 25287118]; Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [22106007, 25121502]	The authors are thankful for comments from Frederick M. Bingham, Meghan F. Cronin, Shinya Kouketsu, Ichiro Yasuda, Yutaka Yoshikawa, participants at the "Research Meetings on Air-Sea Interaction" in 2013 held as a part of the Collaborative Research Program of Hydrospheric Atmospheric Research Center, Nagoya University, and two anonymous reviewers. They also thank Kana Nakamoto for her assistance in preparing Argo float data. SK is a research fellow of the Japan Society for the Promotion of Science and supported by the Japan Society for the Promotion of Science (KAKENHI; Grant Number 15J05210). EO is supported by the Japan Society for Promotion of Science (KAKENHI; Grant-in-Aid for Scientific Research (B), 25287118) and the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT; Grant-in-Aid for Scientific Research on Innovative Areas under Grants 22106007 and 25121502). The Argo float data used in this study were collected and made freely available by the International Argo Project and the national programs that contribute to it (http://www.argo.ucsd.edu; http://www.jcommops.org/argo). Argo is a pilot program of the Global Ocean Observing System.	AKIMA H, 1970, J ACM, V17, P589, DOI 10.1145/321607.321609; Ando K, 1997, J GEOPHYS RES-OCEANS, V102, P23063, DOI 10.1029/97JC01443; Bingham FM, 2010, OCEAN SCI, V6, P775, DOI 10.5194/os-6-775-2010; Oka E, 2007, J OCEANOGR, V63, P293, DOI 10.1007/s10872-007-0029-2; Cronin MF, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001171; Qu TD, 2014, J GEOPHYS RES-OCEANS, V119, P15, DOI 10.1002/2013JC009375; Vialard J, 1998, J PHYS OCEANOGR, V28, P1089, DOI 10.1175/1520-0485(1998)028<1089:AOSFTT>2.0.CO;2; Vialard J, 1998, J PHYS OCEANOGR, V28, P1071, DOI 10.1175/1520-0485(1998)028<1071:AOSFTT>2.0.CO;2; Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Katsura S, 2013, J PHYS OCEANOGR, V43, P2400, DOI 10.1175/JPO-D-13-031.1; Balaguru K, 2012, P NATL ACAD SCI USA, V109, P14343, DOI 10.1073/pnas.1201364109; LUKAS R, 1991, J GEOPHYS RES-OCEANS, V96, P3343; Roemmich D, 2004, MAR TECHNOL SOC J, V38, P21; Sato K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018590; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Delcroix T, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000862; SPRINTALL J, 1994, J GEOPHYS RES-OCEANS, V99, P963, DOI 10.1029/93JC02809; Ren L, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2009JC005307; Mignot J, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003954; Masson S, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001807; SPRINTALL J, 1992, J GEOPHYS RES-OCEANS, V97, P7305, DOI 10.1029/92JC00407; Zhang LL, 2014, GEOPHYS RES LETT, V41, P2441, DOI 10.1002/2014GL059490; Wang WM, 2000, J PHYS OCEANOGR, V30, P2989, DOI 10.1175/1520-0485(2001)031<2989:TSLHBI>2.0.CO;2; Kistler R, 2001, B AM METEOROL SOC, V82, P247, DOI 10.1175/1520-0477(2001)082<0247:TNNYRM>2.3.CO;2; Mignot J, 2009, OCEAN SCI, V5, P379; Huffman GJ, 1997, B AM METEOROL SOC, V78, P5, DOI 10.1175/1520-0477(1997)078<0005:TGPCPG>2.0.CO;2; Mignot J, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007435; Bosc C, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005187; Carton JA, 2008, J CLIMATE, V21, P1029, DOI 10.1175/2007JCLI1798.1; Maes C, 2011, SOLA, V7, P97, DOI 10.2151/sola.2011-025; Bingham FM, 2012, OCEAN SCI, V8, P915, DOI 10.5194/os-8-915-2012; Sato K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025631; Yu LS, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006937; Conkright M. E., 2002, WORLD OCEAN ATLAS 20; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; Montegut CD, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003953; Fisher R., 1950, STAT METHODS RES WOR; GODFREY JS, 1989, J GEOPHYS RES-OCEANS, V94, P8007, DOI 10.1029/JC094iC06p08007; Hosoda S., 2008, JAMSTEC REP RES DEV, V8, P47, DOI DOI 10.5918/JAMSTECR.8.47; Shuto K., 1996, J OCEANOGR, V52, P575, DOI DOI 10.1007/BF02238322; Tippins D., 2003, OCEAN DYNAM, V53, P332, DOI [10.1007/s10236-003-0056-5, DOI 10.1007/S10236-003-0056-5]; Wong A., 2014, ARGO QUALITY CONTROL, DOI 10.13155/33951	42	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-3670	1520-0485		J PHYS OCEANOGR	J. Phys. Oceanogr.	NOV	2015	45	11					2790	2805		10.1175/JPO-D-15-0028.1		16	Oceanography	Oceanography	CV6WI	WOS:000364412100006		
J	Takatani, S; Otani, K; Kanazawa, M; Takahashi, T; Motose, H				Takatani, Shogo; Otani, Kento; Kanazawa, Mai; Takahashi, Taku; Motose, Hiroyasu			Structure, function, and evolution of plant NIMA-related kinases: implication for phosphorylation-dependent microtubule regulation	JOURNAL OF PLANT RESEARCH			English	Article						NIMA-related kinase; Phosphorylation; Tubulin; Microtubule; Cell expansion; Cell division	TOBACCO BY-2 CELLS; PREPROPHASE BAND FORMATION; HANDED HELICAL GROWTH; GAMMA-TUBULIN; CORTICAL MICROTUBULES; ARABIDOPSIS-THALIANA; PROTEIN-KINASE; ABSCISIC-ACID; POSTTRANSLATIONAL MODIFICATIONS; CYTOKINETIC PHRAGMOPLAST	Microtubules are highly dynamic structures that control the spatiotemporal pattern of cell growth and division. Microtubule dynamics are regulated by reversible protein phosphorylation involving both protein kinases and phosphatases. Never in mitosis A (NIMA)-related kinases (NEKs) are a family of serine/threonine kinases that regulate microtubule-related mitotic events in fungi and animal cells (e.g. centrosome separation and spindle formation). Although plants contain multiple members of the NEK family, their functions remain elusive. Recent studies revealed that NEK6 of Arabidopsis thaliana regulates cell expansion and morphogenesis through beta-tubulin phosphorylation and microtubule destabilization. In addition, plant NEK members participate in organ development and stress responses. The present phylogenetic analysis indicates that plant NEK genes are diverged from a single NEK6-like gene, which may share a common ancestor with other kinases involved in the control of microtubule organization. On the contrary, another mitotic kinase, polo-like kinase, might have been lost during the evolution of land plants. We propose that plant NEK members have acquired novel functions to regulate cell growth, microtubule organization, and stress responses.	[Takatani, Shogo; Otani, Kento; Takahashi, Taku; Motose, Hiroyasu] Okayama Univ, Grad Sch Nat Sci & Technol, Div Biosci, Okayama 7008530, Japan; [Kanazawa, Mai; Takahashi, Taku; Motose, Hiroyasu] Okayama Univ, Fac Sci, Dept Biol, Okayama 7008530, Japan	Motose, H (reprint author), Okayama Univ, Grad Sch Nat Sci & Technol, Div Biosci, Tsushimanaka 3-1-1, Okayama 7008530, Japan.	motose@cc.okayama-u.ac.jp	TAKAHASHI, Taku/B-1462-2011		Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan [22770043, 23119513, 25119715, 25440137, 26113516]; Ryobi Teien Memory Foundation	We are most grateful to the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan for Grants in Aid for Scientific Research (22770043, 23119513, 25119715, 25440137 and 26113516) and to the Ryobi Teien Memory Foundation for the grant. It is also a pleasure to thank Prof. Hirokazu Tsukaya for critical reading of our manuscript and Dr. Kimitsune Ishizaki and Prof. Takayuki Kohchi for the sequence information of MpNEK1.	Agueci F, 2011, PLANT MOL BIOL REP, V30, P339; Alvarado-Kristensson M, 2009, NAT CELL BIOL, V11, P1081, DOI 10.1038/ncb1921; Yoon GM, 2013, PLANT CELL, V25, P1016, DOI 10.1105/tpc.113.110106; Kirik V, 2007, J CELL SCI, V120, P4416, DOI 10.1242/jcs.024950; Baskin TI, 1997, PLANT PHYSIOL, V113, P493, DOI 10.1104/pp.113.2.493; Wright AJ, 2009, PLANT CELL, V21, P234, DOI 10.1105/tpc.108.062810; Jones MA, 2006, PLANT J, V45, P83, DOI 10.1111/j.1365-313X.2005.02609.x; Hardham AR, 2013, PLANT J, V75, P278, DOI 10.1111/tpj.12171; Bringmann M, 2012, TRENDS PLANT SCI, V17, P666, DOI 10.1016/j.tplants.2012.06.003; ISHIDA K, 1992, INT J PLANT SCI, V153, P155, DOI 10.1086/297017; Fujita M, 2011, PLANT J, V66, P915, DOI 10.1111/j.1365-313X.2011.04552.x; Ambrose JC, 2007, PLANT CELL, V19, P2763, DOI 10.1105/tpc.107.053777; Kosetsu K, 2010, PLANT CELL, V22, P3778, DOI 10.1105/tpc.110.077164; Kurihara D, 2006, PLANT J, V48, P572, DOI 10.1111/j.1365-313X.2006.02893.x; Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; Kurihara D, 2008, PLANT CELL PHYSIOL, V49, P1256, DOI 10.1093/pcp/pcn098; Binarova P, 2006, PLANT CELL, V18, P1199, DOI 10.1105/tpc.105.038364; Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Naoi K, 2004, PLANT CELL, V16, P1841, DOI 10.1105/tpc.021865; Uyttewaal M, 2012, CELL, V149, P439, DOI 10.1016/j.cell.2012.02.048; Webb M, 2002, DEVELOPMENT, V129, P123; Azimzadeh J, 2008, PLANT CELL, V20, P2146, DOI 10.1105/tpc.107.056812; Fujita M, 2012, PROTOPLASMA, V249, pS59, DOI 10.1007/s00709-011-0332-z; TRAAS J, 1995, NATURE, V375, P676, DOI 10.1038/375676a0; Hames RS, 2001, EMBO J, V20, P7117, DOI 10.1093/emboj/20.24.7117; Da Silva EAA, 2008, ANN BOT-LONDON, V102, P425, DOI 10.1093/aob/mcn112; Beck M, 2010, PLANT CELL, V22, P755, DOI 10.1105/tpc.109.071746; Ning YS, 2011, PLANT PHYSIOL, V157, P242, DOI 10.1104/pp.111.180893; Abe T, 2005, PLANT J, V43, P191, DOI 10.1111/j.1365-313X.2005.02442.x; Rellos P, 2007, J BIOL CHEM, V282, P6833, DOI 10.1074/jbc.M609721200; TORRESRUIZ RA, 1994, DEVELOPMENT, V120, P2967; Takahashi Y, 2010, PLANT CELL PHYSIOL, V51, P1766, DOI 10.1093/pcp/pcq135; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Abe T, 2004, PLANT CELL PHYSIOL, V45, P211, DOI 10.1093/pcp/pch026; Kong ZS, 2010, PLANT CELL, V22, P191, DOI 10.1105/tpc.109.071191; OSMANI SA, 1987, J CELL BIOL, V104, P1495, DOI 10.1083/jcb.104.6.1495; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; Fujii S, 2009, PLANT CELL PHYSIOL, V50, P828, DOI 10.1093/pcp/pcp026; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Murata T, 2005, NAT CELL BIOL, V7, P961, DOI 10.1038/ncb1306; Suttangkakul A, 2011, PLANT CELL, V23, P3761, DOI 10.1105/tpc.111.090993; Kawabe A, 2005, PLANT MOL BIOL, V58, P1, DOI 10.1007/s11103-005-3454-x; Bertran MT, 2011, EMBO J, V30, P2634, DOI 10.1038/emboj.2011.179; Oda Y, 2010, CURR BIOL, V20, P1197, DOI 10.1016/j.cub.2010.05.038; Berger F, 2011, ANNU REV PLANT BIOL, V62, P461, DOI 10.1146/annurev-arplant-042110-103824; Sassi M, 2014, CURR BIOL, V24, P2335, DOI 10.1016/j.cub.2014.08.036; Pnueli L, 2001, PLANT CELL, V13, P2687, DOI 10.1105/tpc.13.12.2687; Sakai T, 2008, PLANT J, V53, P157, DOI 10.1111/j.1365-313X.2007.03327.x; Kawamura E, 2008, J CELL SCI, V121, P4114, DOI 10.1242/jcs.039065; Quarmby LM, 2005, J CELL SCI, V118, P5161, DOI 10.1242/jcs.02681; Camilleri C, 2002, PLANT CELL, V14, P833, DOI 10.1105/tpc.010402; Fu Y, 2005, CELL, V120, P687, DOI 10.1016/j.cell.2004.12.026; Walia A, 2009, PLANT J, V59, P565, DOI 10.1111/j.1365-313X.2009.03895.x; Zhang B, 2011, PLANT J, V68, P830, DOI 10.1111/j.1365-313X.2011.04733.x; Barisic M, 2015, SCIENCE, V348, P799, DOI 10.1126/science.aaa5175; Verhey KJ, 2007, CELL CYCLE, V6, P2152; Keck JM, 2011, SCIENCE, V332, P1557, DOI 10.1126/science.1205193; Demidov D, 2005, PLANT CELL, V17, P836, DOI 10.1105/tpc.104.029710; Bichet A, 2001, PLANT J, V25, P137, DOI 10.1046/j.1365-313x.2001.00946.x; OSMANI SA, 1988, CELL, V53, P237, DOI 10.1016/0092-8674(88)90385-6; Notaguchi M, 2009, J PLANT RES, V122, P201, DOI 10.1007/s10265-008-0209-1; Zeng CJT, 2009, PLANT CELL, V21, P1129, DOI 10.1105/tpc.109.065953; Taoka K, 2011, NATURE, V476, P332, DOI 10.1038/nature10272; Twell D, 2002, NAT CELL BIOL, V4, P711, DOI 10.1038/ncb844; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; Vigneault F, 2007, PLANT J, V51, P575, DOI 10.1111/j.1365-313X.2007.03161.x; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; SHIBAOKA H, 1994, ANNU REV PLANT PHYS, V45, P527, DOI 10.1146/annurev.pp.45.060194.002523; Bouquin T, 2003, J CELL SCI, V116, P791, DOI 10.1242/jcs.00274; Shimamura M, 2004, PLANT CELL, V16, P45, DOI 10.1105/tpc.016501; Rapley J, 2005, MOL CELL BIOL, V25, P1309, DOI 10.1128/MCB.25.4.1309-1324.2005; Whittington AT, 2001, NATURE, V411, P610, DOI 10.1038/35079128; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Wasteneys GO, 2009, TRENDS CELL BIOL, V19, P62, DOI 10.1016/j.tcb.2008.11.004; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; Notaguchi M, 2008, PLANT CELL PHYSIOL, V49, P1645, DOI 10.1093/pcp/pcn154; Demidov D, 2009, PLANT J, V59, P221, DOI 10.1111/j.1365-313X.2009.03861.x; Shaw SL, 2003, SCIENCE, V300, P1715, DOI 10.1126/science.1083529; Vogel J, 2001, DEV CELL, V1, P621, DOI 10.1016/S1534-5807(01)00073-9; Ben-Nissan G, 2008, PLANT PHYSIOL, V148, P1897, DOI 10.1104/pp.108.129346; Kawamura E, 2006, PLANT PHYSIOL, V140, P102, DOI 10.1104/pp.105.069989; Lindeboom JJ, 2013, SCIENCE, V342, P1202, DOI 10.1126/science.1245533; Oda Y, 2013, PLANT CELL, V25, P4439, DOI 10.1105/tpc.113.117853; Kirik A, 2012, PLANT CELL, V24, P1158, DOI 10.1105/tpc.111.094367; Shoji T, 2006, PLANT CELL PHYSIOL, V47, P1158, DOI 10.1093/pcp/pcj090; LIU B, 1994, PLANT CELL, V6, P303, DOI 10.1105/tpc.6.2.303; SAKIYAMASOGO M, 1993, PLANT CELL PHYSIOL, V34, P431; Baskin TI, 2001, PROTOPLASMA, V215, P150, DOI 10.1007/BF01280311; Lee YRJ, 2007, PLANT CELL, V19, P2595, DOI 10.1105/tpc.107.050716; Burk DH, 2002, PLANT CELL, V14, P2145, DOI 10.1105/tpc.003947; Nakamura M, 2010, NAT CELL BIOL, V12, P1064, DOI 10.1038/ncb2110; Thitamadee S, 2002, NATURE, V417, P193, DOI 10.1038/417193a; Krupnova T, 2009, CURR BIOL, V19, P518, DOI 10.1016/j.cub.2009.02.021; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; Nakamura M, 2012, PLANT J, V71, P216, DOI 10.1111/j.1365-313X.2012.04988.x; Melixetian M, 2009, NAT CELL BIOL, V11, P1247, DOI 10.1038/ncb1969; Fourest-Lieuvin A, 2006, MOL BIOL CELL, V17, P1041, DOI 10.1091/mbc.E05-07-0621; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Richards MW, 2009, MOL CELL, V36, P560, DOI 10.1016/j.molcel.2009.09.038; Hotta T, 2012, PLANT CELL, V24, P1494, DOI 10.1105/tpc.112.096610; Nick P, 2013, PLANT J, V75, P309, DOI 10.1111/tpj.12102; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Fu Y, 2009, CURR BIOL, V19, P1827, DOI 10.1016/j.cub.2009.08.052; Moritz M, 2000, NAT CELL BIOL, V2, P365, DOI 10.1038/35014058; Kim S, 2004, PLANT PHYSIOL, V136, P3639, DOI 10.1104/pp.104.049189; Ho CMK, 2011, PLANT CELL, V23, P2606, DOI 10.1105/tpc.111.086892; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Sdelci S, 2012, CURR BIOL, V22, P1516, DOI 10.1016/j.cub.2012.06.027; Oh SA, 2005, CURR BIOL, V15, P2107, DOI 10.1016/j.cub.2005.10.044; Sasabe M, 2006, GENE DEV, V20, P1004, DOI 10.1101/gad.1408106; Strompen G, 2002, CURR BIOL, V12, P153, DOI 10.1016/S0960-9822(01)00655-8; Hamada T, 2004, PLANT CELL PHYSIOL, V45, P1233, DOI 10.1093/pcp/pch145; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Roig J, 2002, GENE DEV, V16, P1640, DOI 10.1101/gad.972202; Ban Y, 2013, PLANT CELL PHYSIOL, V54, P848, DOI 10.1093/pcp/pct065; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Ambrose C, 2013, DEV CELL, V24, P649, DOI 10.1016/j.devcel.2013.02.007; Nishihama R, 2002, CELL, V109, P87, DOI 10.1016/S0092-8674(02)00691-8; Hames RS, 2005, MOL BIOL CELL, V16, P1711, DOI 10.1091/mcb.E04-08-0688; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; Lin DS, 2013, CURR BIOL, V23, P290, DOI 10.1016/j.cub.2013.01.022; Wang C, 2007, PLANT CELL PHYSIOL, V48, P1534, DOI 10.1093/pcp/pcm123; Lee SJ, 2010, MOL CELLS, V29, P559, DOI 10.1007/s10059-010-0070-7; Cloutier M, 2005, FEBS LETT, V579, P4659, DOI 10.1016/j.febslet.2005.07.036; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Nishihama R, 2001, GENE DEV, V15, P352, DOI 10.1101/gad.863701; Mardin BR, 2011, CURR BIOL, V21, P1145, DOI 10.1016/j.cub.2011.05.047; Wang SH, 2011, PLANT CELL, V23, P3412, DOI 10.1105/tpc.111.089920; Noguchi K, 2002, J BIOL CHEM, V277, P39655, DOI 10.1074/jbc.M204599200; Oda Y, 2012, SCIENCE, V337, P1333, DOI 10.1126/science.1222597; Nakamura M, 2004, PLANT CELL PHYSIOL, V45, P1330, DOI 10.1093/pcp/pch300; Murata T, 2007, J PLANT RES, V120, P73, DOI 10.1007/s10265-006-0054-z; Fujita S, 2013, CURR BIOL, V23, P1969, DOI 10.1016/j.cub.2013.08.006; SAKIYAMA M, 1990, PROTOPLASMA, V157, P165, DOI 10.1007/BF01322649; Blume Y, 2008, PLANTA, V229, P143, DOI 10.1007/s00425-008-0816-z; GREEN PB, 1962, SCIENCE, V138, P1404, DOI 10.1126/science.138.3548.1404; Loughlin R, 2011, CELL, V147, P1397, DOI 10.1016/j.cell.2011.11.014; Kumagai F, 2003, EUR J CELL BIOL, V82, P43, DOI 10.1078/0171-9335-00292; Soyano T, 2003, GENE DEV, V17, P1055, DOI 10.1101/gad.1071103; Nakamura M, 2009, J CELL SCI, V122, P2208, DOI 10.1242/jcs.044131; Mahjoub MR, 2002, J CELL SCI, V115, P1759; Sasabe M, 2011, P NATL ACAD SCI USA, V108, P17844, DOI 10.1073/pnas.1110174108; Sugimoto K, 2003, PLANT CELL, V15, P1414, DOI 10.1105/tpc.011593; O'Connell MJ, 2003, TRENDS CELL BIOL, V13, P221, DOI 10.1016/S0962-8924(03)00056-4; Drevensek S, 2012, PLANT CELL, V24, P178, DOI 10.1105/tpc.111.089748; Noguchi K, 2004, J BIOL CHEM, V279, P32716, DOI 10.1074/jbc.M404104200; Pastuglia M, 2006, PLANT CELL, V18, P1412, DOI 10.1105/039644; Oh SA, 2012, PLANT J, V72, P308, DOI 10.1111/j.1365-313X.2012.05077.x; Motose H, 2011, PLANT J, V67, P993, DOI 10.1111/j.1365-313X.2011.04652.x; Bradley BA, 2005, J CELL SCI, V118, P3317, DOI 10.1242/jcs.02455; Ishida T, 2007, J PLANT RES, V120, P61, DOI 10.1007/s10265-006-0039-y; Eng RC, 2014, PLANT CELL, V26, P3372, DOI 10.1105/tpc.114.126789; Fry AM, 2012, J CELL SCI, V125, P1; Gifford E. M., 1989, MORPHOLOGY EVOLUTION; Grallert A, 2002, EMBO J, V21, P3096, DOI 10.1093/emboj/cdf294; Hamada T, 2014, INT REV CEL MOL BIO, V312, P1, DOI 10.1016/B978-0-12-800178-3.00001-4; Heisler MG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000516; Hori K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4978; Ikeno S, 1897, ANN BOT, V11, P344; Ishida T, 2007, P NATL ACAD SCI USA, V104, P8544, DOI 10.1073/pnas.0701224104; Kohoutova L, 2015, NEW PHYTOL, V207, P1061, DOI 10.1111/nph.13501; LEDBETTER MC, 1963, J CELL BIOL, V19, P239, DOI 10.1083/jcb.19.1.239; Lei L, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00090; Lin TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019700; Mihara M, 2009, NUCLEIC ACIDS RES, V38, pD835; Motose Hiroyasu, 2012, Plant Signal Behav, V7, P1552, DOI 10.4161/psb.22412; Motose H, 2008, PLANT J, V58, P829; Murata T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2967; O'Regan L, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-25; Parker JDK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001076; SAMMAK PJ, 1988, NATURE, V332, P724, DOI 10.1038/332724a0; Sasabe Michiko, 2011, Plant Signal Behav, V6, P743; Sedbrook JC, 2008, TRENDS PLANT SCI, V13, P303, DOI 10.1016/j.tplants.2008.04.002; Spinner L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2831; Takatani S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11364; Wasteneys GO, 2002, J CELL SCI, V115, P1345; Wehenkel A, 2014, NAT CELL BIOL, V16, P303, DOI 10.1038/ncb2938; Yang G, 2007, PLOS ONE, V10, pe1074	180	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	NOV	2015	128	6					875	891		10.1007/s10265-015-0751-6		17	Plant Sciences	Plant Sciences	CV8EB	WOS:000364511100001		
J	Sakata, Y; Itami, J; Isagi, Y; Ohgushi, T				Sakata, Yuzu; Itami, Joanne; Isagi, Yuji; Ohgushi, Takayuki			Multiple and mass introductions from limited origins: genetic diversity and structure of Solidago altissima in the native and invaded range	JOURNAL OF PLANT RESEARCH			English	Article						Genetic diversity; Invasion history; Microsatellite; Phylogeography; Population genetics; Solidago altissima	MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; PHYLOGENETIC TREES; PLANT INVASIONS; EVOLUTIONARY GENETICS; INTEGRATED SOFTWARE; BIOLOGICAL-CONTROL; DNA; DIFFERENTIATION; EUROPE	Understanding the origins and diversity of invasive species can reveal introduction and invasion pathways, and inform an effective management of invasive species. Tall goldenrod, Solidago altissima, is a herbaceous perennial plant native to North America and it has become a widespread invasive weed in East Asian countries. We used microsatellite and chloroplast DNA markers to obtain information on neutral processes and on genetic diversity in native and invaded populations of S. altissima and to infer how it invaded and spread in Japan. We found that introduced (n = 12) and native (n = 20) populations had similar levels of genetic diversity at nuclear SSR loci. Genetic structure analysis indicated that at least two independent colonization events gave rise to current S. altissima populations in Japan. The majority (68 %) of the Japanese S. altissima were genetically similar and likely shared a common origin from a single or a small number of populations from the southern USA populations, while the populations in Hokkaido were suggested to arise from a different source. Our results suggest that multiple and mass introductions have contributed to the persistence and rapid adaptation of S. altissima promoting its widespread establishment throughout Japan.	[Sakata, Yuzu; Ohgushi, Takayuki] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan; [Itami, Joanne] Univ Minnesota, Dept Biol, Duluth, MN 55812 USA; [Isagi, Yuji] Kyoto Univ, Div Forest & Biomat Sci, Lab Forest Biol, Grad Sch Agr, Kyoto 6068502, Japan	Sakata, Y (reprint author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan.	sakata@ecology.kyoto-u.ac.jp			Japan Society for the Promotion of Science [20004]; National Science Foundation [DEB 0949280]	We thank H. Choi, M. Ikemoto, K. Shiojiri, A. Uesugi, W. Licht, C. Hafdahl, C. Sacchi, J. Cronin, and K. Dixon for their great help in collecting plant materials. We are indebted to T. Craig for help with site selection for plant sampling and manuscript revision. We are grateful to M. Yamasaki for assistance with figure preparation and S. Sakaguchi for insightful comments on data analysis and manuscript improvement. We thank the two reviewers for invaluable comments and suggestions. This work was partly supported by JSPS Core-to-Core Program (No. 20004) from Japan Society for the Promotion of Science and the National Science Foundation grant (DEB 0949280).	Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; MOODY ME, 1993, GENETICS, V134, P649; [Anonymous], 2006, MOL ECOL NOTES, DOI DOI 10.1111/J.1471-8286.2005.01155.X; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Weber E, 2005, FLORA, V200, P109, DOI 10.1016/j.flora.2004.09.001; Peirson JA, 2013, J BIOGEOGR, V40, P1887, DOI 10.1111/jbi.12136; Weber E, 1997, NORD J BOT, V17, P631, DOI 10.1111/j.1756-1051.1997.tb00359.x; Takezaki N, 1996, GENETICS, V144, P389; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Handley LJL, 2011, BIOCONTROL, V56, P409, DOI 10.1007/s10526-011-9386-2; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Pritchard JK, 2000, GENETICS, V155, P945; Halverson K, 2008, AM J BOT, V95, P50, DOI 10.3732/ajb.95.1.50; Henry P, 2009, MOL ECOL, V18, P2819, DOI 10.1111/j.1365-294X.2009.04237.x; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; [Anonymous], 2012, CONSERV GENET RESOUR, DOI DOI 10.1007/S12686-011-9548-7; Weber E, 1998, AM J BOT, V85, P1110, DOI 10.2307/2446344; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Hornoy B, 2013, HEREDITY, V111, P355, DOI 10.1038/hdy.2013.53; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.01018.x; Fitzpatrick BM, 2012, BIOL INVASIONS, V14, P245, DOI 10.1007/s10530-011-0064-1; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Yuan YG, 2013, J PLANT ECOL, V6, P253, DOI 10.1093/jpe/rts033; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lambrinos JG, 2004, ECOLOGY, V85, P2061, DOI 10.1890/03-8013; Garcia-Rossi D, 2003, ECOL APPL, V13, P1640, DOI 10.1890/01-5301; Dybdahl MF, 2011, BIOL INVASIONS, V13, P1663, DOI 10.1007/s10530-010-9923-4; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Sakata Y, 2013, J PLANT INTERACT, V8, P216, DOI 10.1080/17429145.2013.779036; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Meyer AH, 1999, J ECOL, V87, P42, DOI 10.1046/j.1365-2745.1999.00317.x; Ito I, 1998, ANN BOT-LONDON, V82, P625, DOI 10.1006/anbo.1998.0722; MELVILLE MR, 1982, CAN J BOT, V60, P976; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Twyford AD, 2012, HEREDITY, V108, P179, DOI 10.1038/hdy.2011.68; te Beest M, 2012, ANN BOT-LONDON, V109, P19, DOI 10.1093/aob/mcr277; Kelager A, 2013, BIOL INVASIONS, V15, P1125, DOI 10.1007/s10530-012-0356-0; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LYNCH M, 1990, MOL BIOL EVOL, V7, P478; Roderick GK, 2003, NAT REV GENET, V4, P889, DOI 10.1038/nrg1201; Schlaepfer DR, 2008, MOL ECOL, V17, P5245, DOI 10.1111/j.1365-294X.2008.03980.x; Vallejo-Marin M, 2013, HEREDITY, V110, P111, DOI 10.1038/hdy.2012.91; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; Kil JH, 2004, WEED TECHNOL, V18, P1493, DOI 10.1614/0890-037X(2004)018[1493:DONAPI]2.0.CO;2; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Excoffier L, 2005, EVOL BIOINFORM, V1, P47; Falush D, 2003, GENETICS, V164, P1567; Clark LV, 2011, MOL ECOL RESOUR, V11, P562, DOI 10.1111/j.1755-0998.2011.02985.x; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Okada M, 2007, MOL ECOL, V16, P4956, DOI 10.1111/j.1365-294X.2007.03568.x; Jaramillo-Correa JP, 2009, CAN J FOREST RES, V39, P286, DOI 10.1139/X08-181; Laureto PJ, 2011, SYST BOT, V36, P209, DOI 10.1600/036364411X553289; ASAI Y, 1970, Journal of Japanese Botany, V45, P82; Drummond A.J., 2011, GENEIOUS VERSION 5 4; EXCOFFIER L, 1992, GENETICS, V131, P479; Fukuda I, 1982, SCI REP TOKYO WOMANS, V32, P675; Gaudeul M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017658; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; HARPENDING HC, 1994, HUM BIOL, V66, P591; HUANG H., 2004, GUANGXI SCI, V11, P69; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Li HL, 1978, FLORA TAIWAN, V4, P768; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; Milligan B. G., 1992, Molecular genetic analysis of populations: a practical approach., P59; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; R Development Core Team, 2013, R 3 0 1 R PROJ STAT; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Sakata Y, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200313; Sakata Y, 2014, ECOLOGY, V95, P2569; SEMPLE J. C., 2015, PHYTONEURON, V10, P1; Semple JC, 2006, FLORA N AM, V20, P107; Shimizu T, 2003, NATURALIZED PLANTS J; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.2307/2408641; Yu XQ, 2014, BIOL INVASIONS, V16, P2351, DOI 10.1007/s10530-014-0669-2	86	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	NOV	2015	128	6					909	921		10.1007/s10265-015-0753-4		13	Plant Sciences	Plant Sciences	CV8EB	WOS:000364511100003		
J	Yamada, N; Tanaka, A; Horiguchi, T				Yamada, Norico; Tanaka, Ayumi; Horiguchi, Takeo			Pigment compositions are linked to the habitat types in dinoflagellates	JOURNAL OF PLANT RESEARCH			English	Article						Benthic; Diatom; Dinoflagellate; HPLC; Planktonic; Pigment	SP-NOV DINOPHYCEAE; DIATOM ENDOSYMBIONT; MARINE-PHYTOPLANKTON; PERIDINIUM-BALTICUM; SERIAL REPLACEMENT; CHLOROPHYLL-A; PYRRHOPHYTA; ISLAND; GYMNODINIALES; PHYLOGENY	Compared to planktonic species, there is little known about the ecology, physiology, and existence of benthic dinoflagellates living in sandy beach or seafloor environments. In a previous study, we discovered 13(2),17(3)-cyclopheophorbide a enol (cPPB-aE) from sand-dwelling benthic dinoflagellates. This enol had never been detected in phytoplankton despite the fact that it is a chlorophyll a catabolite. We speculated from this discovery that habitat selection might be linked to pigment compositions in dinoflagellates. To test the hypothesis of habitat selection linking to pigment compositions, we conducted extensive analysis of pigments with high performance liquid chromatography (HPLC) for 40 species using 45 strains of dinoflagellates including three habitat types; sand-dwelling benthic forms, tidal pool inhabitants and planktonic species. The 40 dinoflagellates are also able to be distinguished into two types based on their chloroplast origins; red alga-derived secondary chloroplasts and diatom-derived tertiary ones. By plotting the pigments profiles onto three habitats, we noticed that twelve pigments including cPPB-aE were found to occur only in benthic sand-dwelling species of red alga-derived type. The similar tendency was also observed in dinoflagellates with diatom-derived chloroplasts, i.e. additional sixteen pigments including chl c (3) were found only in sand-dwelling forms. This is the first report of the occurrence of chl c (3) in dinoflagellates with diatom-derived chloroplasts. These results clarify that far greater diversity of pigments are produced by the dinoflagellates living in sand regardless of chloroplast types relative to those of planktonic and tidal pool forms. Dinoflagellates seem to produce a part of their pigments in response to their habitats.	[Yamada, Norico; Horiguchi, Takeo] Hokkaido Univ, Grad Sch Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan; [Tanaka, Ayumi] Hokkaido Univ, Inst Low Temp Sci, JST CREST, Sapporo, Hokkaido 0600819, Japan; [Horiguchi, Takeo] Hokkaido Univ, Fac Sci, Dept Biol Sci, Sapporo, Hokkaido 0600810, Japan	Horiguchi, T (reprint author), Hokkaido Univ, Grad Sch Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan.	horig@mail.sci.hokudai.ac.jp			Japan Society for the Promotion of Science (JSPS) [24370034, 322]; Japan Science and Technology Agency	We gratefully acknowledge Ms. Junko Kishimoto for technical assistance with the HPLC analyses. We also appreciate to Ms. Saeka Takabayashi for cluster analyses of detected pigments. Our thanks go to Dr. Stuart D. Sym for reading the manuscript and collecting No. 39 and 40 of Durinskia sp. We also thank to Dr. Ryuta Terada and Captain M. Uchiyama and the crew of T/S Nanseimaru, Faculty of Fisheries, Kagoshima University, for their kind help in collecting the underwater samples. This work was partly supported by the Grant-in-Aid by the Japan Society for the Promotion of Science (JSPS) (No. 24370034). Eleven of the strains used in this study were collected during the field trips for the project entitled 'Biodiversity and evolution of algae in the Indo-Pacific: a Japan/South Africa comparison' (Strategic International Research Cooperative Program) supported by Japan Science and Technology Agency. This research was also supported by JSPS Research Fellowships for young scientists (No. 322).	RILEY JP, 1967, J MAR BIOL ASSOC UK, V47, P351; Zhang ZD, 1999, NATURE, V400, P155; Faust MA, 2008, J PHYCOL, V44, P232, DOI 10.1111/j.1529-8817.2007.00450.x; Ito H, 2014, PLANT CELL PHYSIOL, V55, P593, DOI 10.1093/pcp/pct203; JEFFREY SW, 1975, J PHYCOL, V11, P374, DOI 10.1111/j.0022-3646.1975.00374.x; Ma LF, 1999, PHYTOCHEMISTRY, V50, P195, DOI 10.1016/S0031-9422(98)00584-6; Carreto JI, 2001, MAR ECOL PROG SER, V223, P49, DOI 10.3354/meps223049; Louda JW, 2000, ORG GEOCHEM, V31, P1561; Zapata M, 2012, MAR ECOL PROG SER, V465, P33, DOI 10.3354/meps09879; Yamada N, 2014, J PHYCOL, V50, P101, DOI 10.1111/jpy.12135; Tamura M, 2005, J PHYCOL, V41, P658, DOI 10.1111/j.1529-8817.2005.00085.x; Fraga S, 2011, HARMFUL ALGAE, V11, P10, DOI 10.1016/j.hal.2011.06.013; WATANABE MM, 1990, J PHYCOL, V26, P741, DOI 10.1111/j.0022-3646.1990.00741.x; Green BR, 2011, PHOTOSYNTH RES, V107, P103, DOI 10.1007/s11120-010-9584-2; Parsons ML, 2007, HARMFUL ALGAE, V6, P658, DOI 10.1016/j.hal.2007.01.001; HORIGUCHI T, 1987, PHYCOLOGIA, V26, P478, DOI 10.2216/i0031-8884-26-4-478.1; Taylor FJR, 2008, BIODIVERS CONSERV, V17, P407, DOI 10.1007/s10531-007-9258-3; Tengs T, 2000, MOL BIOL EVOL, V17, P718; Beale SI, 1999, PHOTOSYNTH RES, V60, P43, DOI 10.1023/A:1006297731456; Matsumoto T, 2012, J PLANT RES, V125, P705, DOI 10.1007/s10265-012-0486-6; WITHERS NW, 1977, J PHYCOL, V13, P354, DOI 10.1111/j.0022-3646.1977.00354.x; Horiguchi T, 2006, PHYCOL RES, V54, P193, DOI 10.1111/j.1440-1835.2006.00426.x; HORIGUCHI T, 1988, BOT MAG TOKYO, V101, P255, DOI 10.1007/BF02488603; Takano Y, 2008, PHYCOLOGIA, V47, P41, DOI 10.2216/07-36.1; Murray S, 2002, EUR J PHYCOL, V37, P279, DOI 10.1017/S0967026202003591; Yamada N, 2013, J PHYCOL, V49, P555, DOI 10.1111/jpy.12064; Pienaar RN, 2007, J PLANT RES, V120, P247, DOI 10.1007/s10265-006-0047-y; MANDELLI EF, 1968, J PHYCOL, V4, P347, DOI 10.1111/j.1529-8817.1968.tb04706.x; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229; Chesnick JM, 1997, J EUKARYOT MICROBIOL, V44, P314, DOI 10.1111/j.1550-7408.1997.tb05672.x; Hoppenrath M, 2007, PHYCOL RES, V55, P159, DOI 10.1111/j.1440-1835.2007.00459.x; Zapata M, 2000, MAR ECOL PROG SER, V195, P29, DOI 10.3354/meps195029; Wakahama T, 2012, ACTA BIOCHIM POL, V59, P155; Zhang Q, 2011, EUR J PROTISTOL, V47, P149, DOI 10.1016/j.ejop.2011.03.001; Choi S.S., 2010, J SYST CYBERN INF, V8, P43; Herdman EC, 1922, T LIVERPOOL BIOL SOC, V36, P15; Hoppenrath M, 2014, MARINE BENTHIC DINOF; Imanian B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010711; KIMURA B, 1985, Japanese Journal of Limnology, V46, P315; Saburova N, 2009, BIO RISK, V3, P97; Sokal RR, 1958, KANSAS U SCI B, V38, P1409; Zhang Q, 2014, ALGOL STUD, V146, P119	42	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	NOV	2015	128	6					923	932		10.1007/s10265-015-0745-4		10	Plant Sciences	Plant Sciences	CV8EB	WOS:000364511100004		
J	Takahashi, Y; Takakura, K; Kawata, M				Takahashi, Yuma; Takakura, Koh-ichi; Kawata, Masakado			Flower color polymorphism maintained by overdominant selection in Sisyrinchium sp.	JOURNAL OF PLANT RESEARCH			English	Article						Color polymorphism; Heterozygote advantage; Reward-bearing flowers; Overdominant selection; Sisyrinchium	FREQUENCY-DEPENDENT SELECTION; GLORY IPOMOEA-PURPUREA; SOUTHERN BRAZIL; IRIDACEAE; EVOLUTION; MAINTENANCE; HETEROGENEITY; PATTERNS	Negative frequency-dependent selection derived from positive frequency-dependent foraging is the best-known selection force maintaining genetic polymorphism within a population. However, in flowering plants, positive frequency-dependent foraging by pollinators is expected to accelerate the loss of low-frequency morphs by conferring a fitness advantage to the common morph, leading to monomorphism. In Japan, a non-native species, Sisyrinchium sp., exhibits conspicuous flower color polymorphism within a population comprising both purple morphs (homozygous recessive) and white morphs (heterozygous or homozygous dominant). Here we quantified genotype-specific reproductive success in order to reveal the contribution of overdominant selection on the maintenance of flower color polymorphism in this species. In artificial pollination experiments using individuals with identified genotypes, female reproductive success was higher in the heterozygote than in either homozygote. The frequency of purple morphs in natural populations (ca. 31 %) is similar to the frequency predicted by overdominant selection (25 %). Our results suggest that overdominant selection contributes to the maintenance of color morphs in the natural population of this species.	[Takahashi, Yuma] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 9808578, Japan; [Takahashi, Yuma; Kawata, Masakado] Tohoku Univ, Grad Sch Life Sci, Div Ecol & Evolutionary Biol, Sendai, Miyagi 9808578, Japan; [Takakura, Koh-ichi] Univ Shiga Prefecture, Sch Environm Sci, Shiga 5228533, Japan	Takahashi, Y (reprint author), Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	takahashi.yum@gmail.com; takakura.k@ses.usp.ac.jp; kawata@m.tohoku.ac.jp			JSPS KAKENHI Grant [26650154]	This study was partly supported by JSPS KAKENHI Grant No. 26650154.	Yeaman S, 2010, EVOLUTION, V64, P3398, DOI 10.1111/j.1558-5646.2010.01075.x; Salzmann CC, 2007, PLANT SYST EVOL, V267, P37, DOI 10.1007/s00606-007-0560-z; Dormont L, 2010, NEW PHYTOL, V185, P300, DOI 10.1111/j.1469-8137.2009.03052.x; RAUSHER MD, 1993, GENETICS, V134, P1237; Eckhart VM, 2006, OIKOS, V112, P412, DOI 10.1111/j.0030-1299.2006.14289.x; Mojonnier LE, 1997, EVOLUTION, V51, P608, DOI 10.2307/2411133; STEPHENSON AG, 1981, ANNU REV ECOL SYST, V12, P253, DOI 10.1146/annurev.es.12.110181.001345; Zufall RA, 2003, J HERED, V94, P442, DOI 10.1093/jhered/esg098; von Wettberg EJ, 2010, EVOL ECOL RES, V12, P457; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Schemske DW, 2007, EVOLUTION, V61, P2528, DOI 10.1111/j.1558-5646.2007.00219.x; Paulsen S, 2000, J HERED, V91, P491, DOI 10.1093/jhered/91.6.491; Gigord LDB, 2001, P NATL ACAD SCI USA, V98, P6253, DOI 10.1073/pnas.111162598; Majetic CJ, 2008, ANN BOT-LONDON, V102, P911, DOI 10.1093/aob/mcn181; Takahashi Y, 2010, EVOLUTION, V64, P3620, DOI 10.1111/j.1558-5646.2010.01083.x; Smithson A, 1997, EVOLUTION, V51, P715, DOI 10.2307/2411148; Silva D. P., 2013, Journal of Pollination Ecology, V11, P27; Tacuatia LO, 2012, GENET MOL BIOL, V35, P99, DOI 10.1590/S1415-47572012005000012; WEISS MR, 1995, AM J BOT, V82, P167, DOI 10.2307/2445525; Parra-Tabla V, 1998, FUNCT ECOL, V12, P591, DOI 10.1046/j.1365-2435.1998.00229.x; Ashman TL, 2006, HEREDITY, V96, P343, DOI 10.1038/sj.hdy.6800815; Streisfeld MA, 2005, EVOLUTION, V59, P2548; Chauveau O, 2011, ANN BOT-LONDON, V107, P1287, DOI 10.1093/aob/mcr080; Tacuatia LO, 2012, BOT J LINN SOC, V169, P350, DOI 10.1111/j.1095-8339.2012.01229.x; Coe EH, 1988, CORN CORN IMPROVEMEN, P81; DEMPSTER ER, 1955, COLD SPRING HARB SYM, V20, P25; FORD EB, 1945, BIOL REV, V20, P73, DOI 10.1111/j.1469-185X.1945.tb00315.x; Hellens RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013230; Makino T, 1956, ILLUSTRATED FLORA JA; Maynard-Smith J, 1982, EVOLUTION THEORY GAM; Norton NA, 2015, EVOLUTION, V69, P1191, DOI 10.1111/evo.12659; R Core Team, 2014, R LANG ENV STAT COMP; Yamaguchi H., 1987, Weed Research, Japan, V32, P38	33	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	NOV	2015	128	6					933	939		10.1007/s10265-015-0750-7		7	Plant Sciences	Plant Sciences	CV8EB	WOS:000364511100005		
J	Mizuno, S; Sonoda, M; Tamura, Y; Nishino, E; Suzuki, H; Sato, T; Oizumi, T				Mizuno, Shinji; Sonoda, Masatoshi; Tamura, Yayoi; Nishino, Eisho; Suzuki, Hideyuki; Sato, Takahide; Oizumi, Toshikatsu			Chiba Tendril-Less locus determines tendril organ identity in melon (Cucumis melo L.) and potentially encodes a tendril-specific TCP homolog	JOURNAL OF PLANT RESEARCH			English	Article						Cucumis melo L.; Genetic mapping; Tendril; TCP transcription factor	TRANSCRIPTION FACTORS; DNA-BINDING; CUCURBITACEAE; EVOLUTIONARY; ARABIDOPSIS; CURVATURE; GENOME; FAMILY	Tendrils are filamentous plant organs that coil on contact with an object, thereby providing mechanical support for climbing to reach more sunlight. Plant tendrils are considered to be modified structure of leaves, stems, or inflorescence, but the origin of cucurbit tendrils is still argued because of the complexity in the axillary organ patterning. We carried out morphological and genetic analyses of the Chiba Tendril-Less (ctl) melon (Cucumis melo) mutant, and found strong evidence that the melon tendril is a modified organ derived from a stem-leaf complex of a lateral shoot. Heterozygous (CTL/ctl) plants showed traits intermediate between tendril and shoot, and ontogenies of wild-type tendrils and mutant modified shoots coincided. We identified the CTL locus in a 200-kb region in melon linkage group IX. A single base deletion in a melon TCP transcription factor gene (CmTCP1) was detected in the mutant ctl sequence, and the expression of CmTCP1 was specifically high in wild-type tendrils. Phylogenetic analysis demonstrated the novelty of the CmTCP1 protein and the unique molecular evolution of its orthologs in the Cucurbitaceae. Our results move us closer to answering the long-standing question of which organ was modified to become the cucurbit tendril, and suggest a novel function of the TCP transcription factor in plant development.	[Mizuno, Shinji; Oizumi, Toshikatsu] Chiba Prefectural Agr & Forestry Res Ctr, Southern Prefectural Hort Inst, Tateyama, Chiba 2940014, Japan; [Sonoda, Masatoshi; Nishino, Eisho; Sato, Takahide] Chiba Univ, Grad Sch Hort, Chiba 2718510, Japan; [Tamura, Yayoi] Chiba Univ, Fac Hort, Chiba 2718510, Japan; [Suzuki, Hideyuki] Kazusa DNA Res Inst, Kisarazu, Chiba 2920812, Japan; [Oizumi, Toshikatsu] Inst Hort Plant Breeding, Matsudo, Chiba 2702221, Japan	Mizuno, S (reprint author), Chiba Prefectural Agr & Forestry Res Ctr, Southern Prefectural Hort Inst, 1762 Yamamoto, Tateyama, Chiba 2940014, Japan.	mizuno.shinji@nihon-u.ac.jp					Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; Aguilar-Martinez JA, 2007, PLANT CELL, V19, P458, DOI 10.1105/tpc.106.048934; Hofer J, 2009, PLANT CELL, V21, P420, DOI 10.1105/tpc.108.064071; Gerrath JM, 2008, AM J BOT, V95, P773, DOI 10.3732/ajb.2007362; Dastur RH, 1931, ANN BOT-LONDON, V45, P279; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Boss PK, 2002, NATURE, V416, P847, DOI 10.1038/416847a; SRINIVASAN C, 1979, PLANTA, V145, P187, DOI 10.1007/BF00388716; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Ori N, 2007, NAT GENET, V39, P787, DOI 10.1038/ng2036; Martin-Trillo M, 2010, TRENDS PLANT SCI, V15, P31, DOI 10.1016/j.tplants.2009.11.003; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Fernandez-Silva I, 2008, THEOR APPL GENET, V118, P139, DOI 10.1007/s00122-008-0883-3; Hirabayashi Tetsuo, 2007, Horticultural Research (Japan), V6, P313, DOI 10.2503/hrj.6.313; Monna L, 2002, DNA RES, V9, P11, DOI 10.1093/dnares/9.1.11; JAFFE MJ, 1968, ANN REV PLANT PHYSIO, V19, P417, DOI 10.1146/annurev.pp.19.060168.002221; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Kosugi S, 2002, PLANT J, V30, P337, DOI 10.1046/j.1365-313X.2002.01294.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Ameha M, 1998, J HORTIC SCI BIOTECH, V73, P159; Aggarwal P, 2010, PLANT CELL, V22, P1174, DOI 10.1105/tpc.109.066647; Gerbode SJ, 2012, SCIENCE, V337, P1087, DOI 10.1126/science.1223304; Bell A, 1991, PLANT FORM ILLUSTRAT; Darwin C, 1865, J LINN SOC LOND, V9, P1; HAGERUP O., 1930, DANSK BOT ARK, V6, P1; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087197; Kumazawa M, 1964, PHYTOMORPHOLOGY, V14, P287; Kwack Soo Nyeon, 1995, Journal of the Korean Society for Horticultural Science, V36, P780; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lin D, 1992, CUCURBIT GENET COOP, V15, P74; Loy B, 2012, CUCURBIT GENET COOP, V35-36, P31; Oizumi T, 2005, B CHIBA AGR RES CTR, V4, P69; Rhodes BB, 1999, CUCURBIT GENET COOP, V22, P28; Rowe JT, 1965, P AM SOC HORTIC SCI, V86, P436; SENS ARM A PRIYADARSAN, 1955, PROC NATL FAST SCI INDIA B BIOL SCI, V21, P162; Troll W, 1939, VERGLEICHENDE MORP 2	39	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	NOV	2015	128	6					941	951		10.1007/s10265-015-0747-2		11	Plant Sciences	Plant Sciences	CV8EB	WOS:000364511100006		
J	Shinohara, N; Kakegawa, K; Fukuda, H				Shinohara, Naoki; Kakegawa, Koichi; Fukuda, Hiroo			Monoclonal antibody-based analysis of cell wall remodeling during xylogenesis	JOURNAL OF PLANT RESEARCH			English	Article						Arabinogalactan protein; Cell wall; Germin-like protein; Pectic galactan; Monoclonal antibody; Xylogenesis	GERMIN-LIKE PROTEIN; TRACHEARY ELEMENT DIFFERENTIATION; SUPEROXIDE-DISMUTASE ACTIVITY; PHAGE DISPLAY SUBTRACTION; ZINNIA-ELEGANS; SIDE-CHAINS; ARABINOGALACTAN PROTEINS; RHAMNOGALACTURONAN-I; ARABIDOPSIS-THALIANA; SEQUENCE ALIGNMENT	Xylogenesis, a process by which woody tissues are formed, entails qualitative and quantitative changes in the cell wall. However, the molecular events that underlie these changes are not completely understood. Previously, we have isolated two monoclonal antibodies, referred to as XD3 and XD27, by subtractive screening of a phage-display library of antibodies raised against a wall fraction of Zinnia elegans xylogenic culture cells. Here we report the biochemical and immunohistochemical characterization of those antibodies. The antibody XD3 recognized (1 -> 4)-beta-d-galactan in pectin fraction. During xylogenesis, the XD3 epitope was localized to the primary wall of tracheary-element precursor cells, which undergo substantial cell elongation, and was absent from mature tracheary elements. XD27 recognized an arabinogalactan protein that was bound strongly to a germin-like protein. The XD27 epitope was localized to pre-lignified secondary walls of tracheary elements. Thus these cell-wall-directed monoclonal antibodies revealed two molecular events during xylogenesis. The biological significance of these events is discussed in relation to current views of the plant cell wall.	[Shinohara, Naoki; Fukuda, Hiroo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Hongo, Tokyo 1130033, Japan; [Kakegawa, Koichi] Forestry & Forest Prod Res Inst, Dept Biomass Chem, Tsukuba, Ibaraki 3058687, Japan	Shinohara, N (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Hongo, Tokyo 1130033, Japan.	naoki-s@yd5.so-net.ne.jp			Ministry of Education, Science, Sports and Culture of Japan (NC-CARP project); Japan Society for the Promotion of Science [23227001]	We thank Tadashi Ishii for help with sugar-linkage analysis; Jin Nakashima for help with cell sectioning; Kuninori Iwamoto for searching ZeGLP1 cDNA sequence; and Maaike de Jong for critical reading of the manuscript. This work was supported partly by Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan (NC-CARP project) and from the Japan Society for the Promotion of Science (23227001) to HF.	Liwanag AJM, 2012, PLANT CELL, V24, P5024, DOI 10.1105/tpc.112.106625; Ogawa K, 1997, PLANT CELL PHYSIOL, V38, P1118; Ryser U, 2004, J CELL SCI, V117, P1179, DOI 10.1242/jcs.00966; FUKUDA H, 1980, PLANT PHYSIOL, V65, P57, DOI 10.1104/pp.65.1.57; Bernier F, 2001, PLANT PHYSIOL BIOCH, V39, P545, DOI 10.1016/S0981-9428(01)01285-2; KNOX JP, 1991, PLANT J, V1, P317, DOI 10.1046/j.1365-313X.1991.t01-9-00999.x; SOJAR HT, 1987, METHOD ENZYMOL, V138, P341; McCartney L, 2003, PLANT J, V33, P447, DOI 10.1046/j.1365-313X.2003.01640.x; Park YB, 2012, PLANT PHYSIOL, V158, P1933, DOI 10.1104/pp.111.192880; Stacey NJ, 1995, PLANT J, V8, P891; LANE BG, 1993, J BIOL CHEM, V268, P12239; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Ohdaira Y, 2002, PLANTA, V215, P177, DOI 10.1007/s00425-001-0731-z; Woo EJ, 2000, NAT STRUCT BIOL, V7, P1036; Nakata M, 2004, PLANT MOL BIOL, V56, P381, DOI 10.1007/s11103-004-3475-x; Motose H, 2004, NATURE, V429, P873, DOI 10.1038/nature02619; Schier R, 1996, J MOL BIOL, V263, P551, DOI 10.1006/jmbi.1996.0598; BARR DP, 1994, ARCH BIOCHEM BIOPHYS, V311, P378, DOI 10.1006/abbi.1994.1251; Shinohara N, 2002, J IMMUNOL METHODS, V264, P187, DOI 10.1016/S0022-1759(02)00088-1; Chen Y, 1999, J MOL BIOL, V293, P865, DOI 10.1006/jmbi.1999.3192; Nakashima J, 2004, PLANTA, V218, P729, DOI 10.1007/s00425-003-1167-4; SCHINDLER T, 1995, PLANT J, V7, P25, DOI 10.1046/j.1365-313X.1995.07010025.x; Dean GH, 2007, PLANT CELL, V19, P4007, DOI 10.1105/tpc.107.050609; HORNICK CL, 1972, IMMUNOCHEMISTRY, V9, P325, DOI 10.1016/0019-2791(72)90096-1; HURKMAN WJ, 1994, PLANT PHYSIOL, V104, P803, DOI 10.1104/pp.104.2.803; Pattathil S, 2010, PLANT PHYSIOL, V153, P514, DOI 10.1104/pp.109.151985; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; WOODWARD MP, 1985, J IMMUNOL METHODS, V78, P143, DOI 10.1016/0022-1759(85)90337-0; McCartney L, 2000, PLANT J, V22, P105, DOI 10.1046/j.1365-313x.2000.00719.x; Dunwell JM, 2008, CRIT REV PLANT SCI, V27, P342, DOI 10.1080/07352680802333938; Yamahara T, 1999, J BIOL CHEM, V274, P33274, DOI 10.1074/jbc.274.47.33274; Jones L, 1997, PLANT PHYSIOL, V113, P1405; Ohmiya A, 2002, PLANT SCI, V163, P683, DOI 10.1016/S0168-9452(02)00231-5; JARVIS MC, 1981, PLANTA, V152, P93, DOI 10.1007/BF00391179; Ulvskov P, 2005, PLANTA, V220, P609, DOI 10.1007/s00425-004-1373-8; LANE BG, 1992, EUR J BIOCHEM, V209, P961, DOI 10.1111/j.1432-1033.1992.tb17369.x; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Lane BG, 2000, BIOCHEM J, V349, P309, DOI 10.1042/0264-6021:3490309; Dyson RJ, 2012, J THEOR BIOL, V307, P125, DOI 10.1016/j.jtbi.2012.04.035; Zykwinska AW, 2005, PLANT PHYSIOL, V139, P397, DOI 10.1104/pp.105.065912; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; Davidson RM, 2009, PLANT SCI, V177, P499, DOI 10.1016/j.plantsci.2009.08.012; Shinohara N, 2000, P NATL ACAD SCI USA, V97, P2585, DOI 10.1073/pnas.050582197; Badjic JD, 2005, ACCOUNTS CHEM RES, V38, P723, DOI 10.1021/ar040223k; Carter C, 2000, J BIOL CHEM, V275, P36726, DOI 10.1074/jbc.M006461200; Zhong RQ, 2000, PLANT PHYSIOL, V123, P59, DOI 10.1104/pp.123.1.59; Chaffey N, 2002, PHYSIOL PLANTARUM, V114, P594, DOI 10.1034/j.1399-3054.2002.1140413.x; Randall RC, 1989, FOOD HYDROCOLLOID, V3, P65; PASSIOURA JB, 1992, AUST J PLANT PHYSIOL, V19, P565; Knox JP, 2008, CURR OPIN PLANT BIOL, V11, P308, DOI 10.1016/j.pbi.2008.03.001; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Macquet A, 2007, PLANT CELL, V19, P3990, DOI 10.1105/tpc.107.050179; Ohmiya A, 1998, PLANT CELL PHYSIOL, V39, P492; Gucciardo S, 2007, J EXP BOT, V58, P1161, DOI 10.1093/jxb/erl282; Willats WGT, 1999, PLANT J, V20, P619, DOI 10.1046/j.1365-313X.1999.00629.x; Godfrey D, 2007, MOL PLANT MICROBE IN, V20, P1112, DOI 10.1094/MPMI-20-9-1112; Zykwinska A, 2007, J EXP BOT, V58, P1795, DOI 10.1093/jxb/erm037; Michalak M, 2012, ENZYME MICROB TECH, V50, P121, DOI 10.1016/j.enzmictec.2011.11.001; DOLAN L, 1995, NEW PHYTOL, V131, P121, DOI 10.1111/j.1469-8137.1995.tb03061.x; HIRST EL, 1947, J CHEM SOC, P1225, DOI 10.1039/jr9470001225; Kabat E. A., 1976, STRUCTURAL CONCEPTS; Kishi-Kaboshi M, 2014, PLANT PHYSIOL BIOCH, V85, P1, DOI 10.1016/j.plaphy.2014.10.005; Larson PR, 1994, SPRINGER SERIES WOOD; YORK WS, 1986, METHOD ENZYMOL, V118, P3	66	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0918-9440	1618-0860		J PLANT RES	J. Plant Res.	NOV	2015	128	6					975	986		10.1007/s10265-015-0758-z		12	Plant Sciences	Plant Sciences	CV8EB	WOS:000364511100008		
J	Yoshioka, N				Yoshioka, Nobutaka			Selective orbicularis neuromyectomy for postparetic periocular synkinesis	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article						Synkinesis; Facial paralysis; Neuromyectomy; Surgical treatment	FACIAL-SYNKINESIS; BOTULINUM TOXIN	Background: Facial synkinesis is a distressing consequence of incomplete recovery from facial paralysis. The author presents selective orbicularis neuromyectomy as an alternative surgical treatment for periocular synkinesis. Methods: Eleven patients (eight women and three men; mean age: 67 years; range: 50-77 years) with postparetic facial synkinesis underwent selective orbicularis neuromyectomy at our hospital between March 2010 and December 2013. All 11 patients exhibited ocular hypertonicity and synkinetic eye closure during voluntary oral movements. The causes of the subjects' facial palsy were as follows: Bell's palsy, seven cases; Hunt's syndrome, two cases; and brain tumor resection, two cases. The patients' preoperative and postoperative facial function levels were evaluated using the Sunnybrook scale. Results: The mean duration of the follow-up period was 37 months (range: 12-57 months). During follow-up, all 11 patients showed decreasing ocular hypertonicity and less marked synkinetic ocular movements. The subjects' mean synkinesis score fell by 4.5 points (48%). One patient demonstrated lower lid ectropion at 1 postoperative month, which was repaired secondarily. No other postoperative complications occurred. Conclusions: Selective orbicularis neuromyectomy is simple and effective for patients who exhibit periocular synkinesis after facial paralysis, and it should be considered as an alternative treatment for periocular synkinesis. (C) 2015 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Yoshioka, Nobutaka] Tominaga Hosp, Dept Craniofacial Surg & Plast Surg, Osaka 5560017, Japan	Yoshioka, N (reprint author), Tominaga Hosp, Dept Craniofacial Surg & Plast Surg, Naniwa Ku, 1-4-48 Minatomachi, Osaka 5560017, Japan.	Yoshioka0225@aol.com					GUERRISSI JO, 1991, PLAST RECONSTR SURG, V87, P459, DOI 10.1097/00006534-199103000-00010; Beurskens CHG, 2010, OTOL NEUROTOL, V31, P671, DOI 10.1097/MAO.0b013e3181d8d84d; Choi KH, 2013, J PLAST RECONSTR AES, V66, P1058, DOI 10.1016/j.bjps.2013.04.012; Terzis JK, 2012, PLAST RECONSTR SURG, V129, P925, DOI 10.1097/PRS.0b013e318230e758; Zhang B, 2010, J RECONSTR MICROSURG, V26, P375, DOI 10.1055/s-0030-1249603; Lowe JB, 2005, PLAST RECONSTR SURG, V116, P1743, DOI 10.1097/01.prs.00000186532.29557.96; Henstrom DK, 2011, ARCH FACIAL PLAST S, V13, P239, DOI 10.1001/archfacial.2011.43; Nemoto Y, 2001, JPN J OPHTHALMOL, V45, P445, DOI 10.1016/S0021-5155(01)00381-1; Filipo R, 2012, LARYNGOSCOPE, V122, P266, DOI 10.1002/lary.22404; Azuma T, 2012, OTOLARYNG HEAD NECK, V146, P40, DOI 10.1177/0194599811424125; Hohman MH, 2013, LARYNGOSCOPE, V123, P1385, DOI 10.1002/lary.23873; Husseman J, 2008, FACIAL PLAST SURG, V24, P242, DOI 10.1055/s-2008-1075840	12	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	NOV	2015	68	11					1510	1515		10.1016/j.bjps.2015.06.015		6	Surgery	Surgery	CV8LD	WOS:000364536800010		
J	Uda, H; Tomioka, YK; Sarukawa, S; Sunaga, A; Sugawara, Y				Uda, Hirokazu; Tomioka, Yoko Katsuragi; Sarukawa, Syunji; Sunaga, Ataru; Sugawara, Yasusih			Comparison of abdominal wall morbidity between medial and lateral row-based deep inferior epigastric perforator flap	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article						Deep inferior epigastric perforator flap; Abdominal morbidity; Flexor trunk muscle ability; Isokinetic dynamometer; Medial row perforator; Lateral row perforator	DONOR-SITE COMPLICATIONS; DIEP FLAP; BREAST RECONSTRUCTION; RECTUS-ABDOMINIS; AVOIDING DENERVATION; FREE TRAM; MUSCLE STRENGTH; HARVEST; OUTCOMES; TRUNK	Introduction: Although deep inferior epigastric perforator (DIEP) flap is associated with decreased abdominal morbidity, motor nerve damage during flap elevation cannot be ignored. We compared abdominal morbidity after elevation of DIEP flap with lateral row perforators (L-DIEP) and medial row perforators (M-DIEP) to determine the perforators associated with less abdominal morbidity. Methods: Women who underwent breast reconstruction with DIEP flaps (n = 49) were included in this study. Among them, M-DIEP and L-DIEP were harvested in 27 and 22 patients, respectively. Pre-and postoperative trunk flexor muscle ability (at 3 and 6 months after surgery) was measured prospectively in all patients using an isokinetic dynamometer. The patients were also investigated for postoperative pain, stiffness, activity, bulging, and lumbago. Results: At 3 months after surgery, a significant decrease in trunk flexor muscle ability was observed in the patients of the L-DIEP group, but they recovered well after further 3 months. However, the recovery tended to be weak. Similar results were obtained with respect to pain, stiffness, activity, bulging, and lumbago between the two groups at 6 months after surgery. Conclusions: Dominant perforators for DIEP flap elevation should be chosen by considering flap viability. However, surgeons should be aware that elevation with L-DIEP is associated with a high risk of nerve injury, and may in turn result in short-term decreases in trunk flexor muscle ability. Therefore, precautionary methods should be taken by the surgeons to preserve the motor nerve with atraumatic dissection, especially during elevation with L-DIEP. (C) 2015 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Uda, Hirokazu; Tomioka, Yoko Katsuragi; Sarukawa, Syunji; Sunaga, Ataru; Sugawara, Yasusih] Jichi Med Univ, Dept Plast Surg, Shimotuke, Tochigi 3290498, Japan	Uda, H (reprint author), Jichi Med Univ, Dept Plast Surg, 3311-1 Yakushiji, Shimotuke, Tochigi 3290498, Japan.	udaarare@jichi.ac.jp					Garvey PB, 2011, PLAST RECONSTR SURG, V127, P2198, DOI 10.1097/PRS.0b013e3182131caf; Rozen WM, 2008, PLAST RECONSTR SURG, V122, P710, DOI 10.1097/PRS.0b013e318180ed8b; Bajaj AK, 2006, PLAST RECONSTR SURG, V117, P737, DOI 10.1097/01.prs.000020062.97265.fb; Futter CM, 2003, BRIT J PLAST SURG, V56, P674, DOI 10.1016/s0007-1226(03)00362-X; Rozen WM, 2009, PLAST RECONSTR SURG, V124, P519, DOI 10.1097/PRS.0b013e3181addbee; Man LX, 2009, PLAST RECONSTR SURG, V124, P752, DOI 10.1097/PRS.0b013e31818b7533; Wong C, 2010, PLAST RECONSTR SURG, V125, P772, DOI 10.1097/PRS.0b013e3181cb63e0; Iwai K, 2008, J STRENGTH COND RES, V22, P350, DOI 10.1519/JSC.0b013e3181635d25; den Hartog D, 2010, HERNIA, V14, P243, DOI 10.1007/s10029-010-0627-6; Bottero L, 2004, PLAST RECONSTR SURG, V113, P156, DOI 10.1097/01.PRS.0000095941.86060.8E; Munhoz AM, 2004, PLAST RECONSTR SURG, V113, P517, DOI 10.1097/01.PRS.0000100812.37842.A8; Gill PS, 2004, PLAST RECONSTR SURG, V113, P1153, DOI 10.1097/01.PRS.0000110328.47206.50; Vega SJ, 2006, ANN PLAS SURG, V56, P487, DOI 10.1097/01.sap.0000205236.88313.10; Clavero JA, 2008, AM J ROENTGENOL, V191, P670, DOI 10.2214/AJR.07.2515; Nahabedian MY, 2005, PLAST RECONSTR SURG, V115, P436, DOI 10.1097/01.PRS.0000149404.57087.8E; Futter CM, 2000, BRIT J PLAST SURG, V53, P578, DOI 10.1054/bjps.2000.3427; Rozen WM, 2008, PLAST RECONSTR SURG, V122, P1321, DOI 10.1097/PRS.0b013e3181881e18; Blondeel N, 1997, Br J Plast Surg, V50, P322; Ho CW, 2005, SPINE, V30, pE528, DOI 10.1097/01.brs.0000179307.34310.7d	19	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	NOV	2015	68	11					1550	1555		10.1016/j.bjps.2015.06.028		6	Surgery	Surgery	CV8LD	WOS:000364536800016		
J	Hayashi, N; Yamamoto, T; Hayashi, A; Yoshimatsu, H				Hayashi, Nobuko; Yamamoto, Takumi; Hayashi, Akitatsu; Yoshimatsu, Hidehiko			Correlation between indocyanine green (ICG) patterns and real-time elastography images in lower extremity lymphedema patients	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article						Lymphedema; Cancer; Elastography; Indocyanine green; Lymphography; Ultrasonography	DERMAL BACKFLOW PATTERNS; LYMPHATICOVENULAR ANASTOMOSIS; LYMPHOGRAPHY FINDINGS; SYSTEM; DIAGNOSIS; LESIONS; LYMPHOSCINTIGRAPHY; SUPERMICROSURGERY; ULTRASOUND; EXPERIENCE	Background/aim: Indocyanine green (ICG) lymphography is becoming a popular modality, but unfortunately it is not available in all institutions. Elastography is a relatively new ultrasonographic technique to evaluate tissue elasticity, which visualizes fluid retention as a red region in lymphedema patients. The aim of this study was to evaluate the correlation between elastography and ICG lymphology. Methods: Thirty-six legs in 18 patients with secondary lower extremity lymphedema (LEL) and 20 legs in 10 healthy volunteers were examined using elastography. Thirty-six legs in 18 secondary LEL patients were examined using ICG lymphography. Elastography was performed on both legs at the following three sites: medial thigh (MT), medial leg (ML), and anterior ankle (AA). The area of the red region in the subcutaneous tissue demonstrated by elastography was calculated using Image software. ICG lymphography findings were classified into the following four patterns: linear (ICG1), splash (ICG2), stardust (ICG3), and diffuse (ICG4) patterns. Results: As ICG pattern progressed, the red region area was likely to increase. There was a correlation between ICG patterns and red region area according to the severity at bilateral MT (r(s) = 0.665), ML (r(s) = 0.623), and AA (r(s) = 0.668). Significant difference was demonstrated among group means of the red region area by analysis of variance (healthy vs. ICG1 vs. ICG2 vs. ICG3 vs. ICG 4: 14.4 perpendicular to 5.7 vs. 15.1 perpendicular to 10.3 vs. 25.2 perpendicular to 6.2 vs. 30.8 perpendicular to 9.4 vs. 35.0 perpendicular to 2.8; P < 0.001). Conclusions: The area of the red region in the subcutaneous tissue shown using elastography, which represents fluid, increases with the aggravation of lymphedema demonstrated by ICG patterns. As elastography is performed by ultrasonography, which is available in most institutions, elastography could be a useful alternative evaluation for lymphedema severity when ICG lymphography is not available. (C) 2015 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Hayashi, Nobuko; Yamamoto, Takumi; Hayashi, Akitatsu; Yoshimatsu, Hidehiko] Tokyo Univ Hosp, Dept Plast & Reconstruct Surg, Tokyo 113, Japan	Hayashi, N (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	k-nobunobu@hotmail.co.jp					Yamamoto T, 2011, J PLAST RECONSTR AES, V64, P1541, DOI 10.1016/j.bjps.2011.05.025; PANI SP, 1995, LYMPHOLOGY, V28, P57; Ying L, 2012, EUR RADIOL, V22, P2798, DOI 10.1007/s00330-012-2540-0; Wojcinski S, 2010, ULTRASCHALL MED, V31, P484, DOI 10.1055/s-0029-1245282; Srinivasan S, 2004, ULTRASOUND MED BIOL, V30, P1185, DOI 10.1016/j.ultrasmedbio.2004.07.013; Karges JR, 2003, PHYS THER, V83, P134; Lyshchik A, 2007, RADIOLOGY, V243, P258, DOI 10.1148/radiol.2431052032; Pallwein L, 2007, BJU INT, V100, P42, DOI 10.1111/j.1464-410X.2007.06851.x; Adriaenssens N, 2012, RADIOL ONCOL, V46, P284, DOI 10.2478/v10019-012-0033-z; Jiang ZH, 2014, J PLAST RECONSTR AES, V67, pE173, DOI 10.1016/j.bjps.2014.02.018; Ogata F, 2007, ANN PLAS SURG, V58, P652, DOI 10.1097/01.sap.0000250896.42800.a2; Mihara M, 2011, CLIN RADIOL, V66, P715, DOI 10.1016/j.crad.2011.03.004; Yamamoto T, 2014, ANN PLAS SURG, V72, P67, DOI 10.1097/SAP.0b013e3182605580; Kerchner K, 2008, J AM ACAD DERMATOL, V59, P324, DOI 10.1016/j.jaad.2008.04.013; Naouri M, 2010, BRIT J DERMATOL, V163, P296, DOI 10.1111/j.1365-2133.2010.09810.x; Janssen J, 2007, GASTROINTEST ENDOSC, V65, P971, DOI 10.1016/j.gie.2006.12.057; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, P941, DOI 10.1097/PRS.0b013e3182268cd9; Astrom KGO, 2001, ACTA RADIOL, V42, P409, DOI 10.1080/028418501127346909; Thomas A, 2006, ULTRASOUND OBST GYN, V28, P335, DOI 10.1002/uog.2823; Yuan ZB, 2006, ANN NUCL MED, V20, P341, DOI 10.1007/BF02987244; Warren AG, 2007, ANN PLAS SURG, V59, P464, DOI 10.1097/01.sap.0000257149.42922.7e; Aigner F, 2010, J ENDOUROL, V24, P685, DOI 10.1089/end.2009.0640; Yamamoto T, 2014, VASC ENDOVASC SURG, V48, P139, DOI 10.1177/1538574413510979; Infante JR, 2012, REV ESP MED NUCL IMA, V31, P237, DOI 10.1016/j.remn.2011.11.011; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1979, DOI 10.1097/PRS.0b013e31820cf5df; Baulieu F, 2013, LYMPHOLOGY, V46, P106; Fujihara Y, 2011, MEDIX, V55, P40; Matsumura T, 2004, MEDIX, V41, P30; Suehiro K, 2014, ANN PLAST SURG, V73, P706; Waki K, 2007, P ISICE 1 INT S INF, P449; Yamamoto T, 2014, MICROSURG, V34, P23, DOI 10.1002/micr.22115; Yamamoto T, 2015, J PLAST RECONSTR AES, V68, P136, DOI 10.1016/j.bjps.2014.08.014; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, p314e; Yamamoto T, 2014, ANN PLAST SURG, V3, P706; Yamamoto T, 2013, ANN PLAS SURG, V71, P591, DOI 10.1097/SAP.0b013e318255168a; Yamamoto T, 2013, J VASC SURG VENOUS L, V1, P400; Yamamoto T, 2015, EUR J VASC ENDOVASC, V49, P95, DOI 10.1016/j.ejvs.2014.10.023	37	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	NOV	2015	68	11					1592	1599		10.1016/j.bjps.2015.06.027		8	Surgery	Surgery	CV8LD	WOS:000364536800022		
J	Hamamoto, Y; Nagasao, T; Kogure, T; Tamai, M; Tanaka, Y				Hamamoto, Yusuke; Nagasao, Tomohisa; Kogure, Tetsukuni; Tamai, Motoki; Tanaka, Yoshio			The Double-Tongue Method: A new reconstruction technique for oral floor reconstruction after total glossectomy	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Letter							FUNCTIONAL RECONSTRUCTION; FLAP		[Hamamoto, Yusuke; Nagasao, Tomohisa; Kogure, Tetsukuni; Tamai, Motoki; Tanaka, Yoshio] Kagawa Univ, Sch Med, Dept Plast Reconstruct & Aesthet Surg, Takamatsu, Kagawa 17501, Japan	Hamamoto, Y (reprint author), Kagawa Univ, Sch Med, Dept Plast Reconstruct & Aesthet Surg, Miki Cho Ikenobe, Takamatsu, Kagawa 17501, Japan.	nagasao@med.kagawa-u.ac.jp					Sakuraba M, 2009, J PLAST RECONSTR AES, V62, P795, DOI 10.1016/j.bjps.2007.09.056; Haddock NT, 2008, J RECONSTR MICROSURG, V24, P343, DOI 10.1055/s-2008-1080537; Kiyokawa K, 1999, PLAST RECONSTR SURG, V104, P2015, DOI 10.1097/00006534-199912000-00011	3	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	NOV	2015	68	11					1624	1626		10.1016/j.bjps.2015.07.023		4	Surgery	Surgery	CV8LD	WOS:000364536800029		
J	Ito, T; Saito, T; Ishiura, R; Yamamoto, T				Ito, Taichi; Saito, Takafumi; Ishiura, Ryohei; Yamamoto, Takumi			Diagnosis of trauma-induced lymphedema using indocyanine green lymphography	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Letter							DERMAL BACKFLOW PATTERNS; EXTREMITY LYMPHEDEMA		[Ito, Taichi; Saito, Takafumi; Ishiura, Ryohei; Yamamoto, Takumi] Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo 1138655, Japan	Ito, T (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tyamamoto-tky@umin.ac.jp					Yamamoto T, 2011, PLAST RECONSTR SURG, V128, P941, DOI 10.1097/PRS.0b013e3182268cd9; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1979, DOI 10.1097/PRS.0b013e31820cf5df; Yamamoto T, 2014, J PLAST RECONSTR AES, V67, P1573, DOI 10.1016/j.bjps.2014.06.007; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, p314e; Yamamoto T, 2015, EUR J VASC ENDOVASC, V49, P95, DOI 10.1016/j.ejvs.2014.10.023	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	NOV	2015	68	11					E177	E178		10.1016/j.bjps.2015.07.013		2	Surgery	Surgery	CV8LD	WOS:000364536800004		
J	Yoshimura, Y; Okumoto, T; Iijima, Y; Inoue, Y				Yoshimura, Y.; Okumoto, T.; Iijima, Y.; Inoue, Y.			Reduced nasal growth after primary nasal repair combined with cleft lip surgery	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article						Cleft lip; Nasal repair; Nasal growth; Lateral cephalogram	NOSE; EXPERIENCE	Nasal growth after cleft lip surgery with or without primary nasal repair was evaluated using lateral cephalograms. In 14 patients who underwent simultaneous nasal repair with primary cleft lip repair and 12 patients without simultaneous nasal repair, lateral cephalograms were obtained at 5 and 10 years of age. Lateral cephalograms of normal Japanese children were used as a control. At 5 years of age, there were significant differences in the nasal height and columellar angle among the three groups. Children without simultaneous nasal repair had shorter noses with more upward tilt of the columella compared with the controls, while children with simultaneous nasal repair had much shorter noses and more upward tilt than those without repair. At 10 years of age, the children without simultaneous nasal repair showed no differences from the control group, while those with simultaneous repair still had shorter noses and more upward tilt of the columella. These findings suggest that performing nasal repair at the same time as primary cleft lip surgery has an adverse influence on the subsequent growth of the nose. (C) 2015 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Yoshimura, Y.; Okumoto, T.; Iijima, Y.; Inoue, Y.] Fujita Hlth Univ, Sch Med, Dept Plast & Reconstruct Surg, Toyoake, Aichi 4701192, Japan	Yoshimura, Y (reprint author), Fujita Hlth Univ, Sch Med, Dept Plast & Reconstruct Surg, 1-98 Dengakugakubo Kutsukake, Toyoake, Aichi 4701192, Japan.	yohkoy@fujita-hu.ac.jp					Nakajima T, 2008, J PLAST RECONSTR AES, V61, P870, DOI 10.1016/j.bjps.2007.06.003; SALYER KE, 1986, PLAST RECONSTR SURG, V77, P558, DOI 10.1097/00006534-198604000-00006; BOOCHAI K, 1987, PLAST RECONSTR SURG, V80, P185, DOI 10.1097/00006534-198708000-00005; SUGIHARA T, 1993, CLEFT PALATE-CRAN J, V30, P231, DOI 10.1597/1545-1569(1993)030<0231:PCOTUC>2.3.CO;2; NAKAJIMA T, 1993, BRIT J PLAST SURG, V46, P616, DOI 10.1016/0007-1226(93)90117-T; MCCOMB H, 1985, PLAST RECONSTR SURG, V75, P791, DOI 10.1097/00006534-198506000-00003; McComb HK, 1996, CLEFT PALATE-CRAN J, V33, P23, DOI 10.1597/1545-1569(1996)033<0023:PROTUC>2.3.CO;2; Pigott PW, 1985, CLEFT PALATE-CRAN J, V33, P30; Yamada T, 2002, J JPN PLAST RECONSTR, V22, P102; Yamada T, 2005, J JPN PLAST RECONSTR, V25, P96	10	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	NOV	2015	68	11					E159	E166		10.1016/j.bjps.2015.06.014		8	Surgery	Surgery	CV8LD	WOS:000364536800001		
J	Tsuchiya, T; Osaki, T; Minamino, N; Sasaki, K				Tsuchiya, Takashi; Osaki, Tsukasa; Minamino, Naoto; Sasaki, Kazuki			Peptidomics for Studying Limited Proteolysis	JOURNAL OF PROTEOME RESEARCH			English	Article						adrenomedullin; cardiac fibroblasts; ectodomain shedding; endogenous peptide; peptidomics; limited proteolysis; peptide profiling; regulated intramembrane proteolysis; secretome; membrane stubs	GROWTH-FACTOR-BETA; INTRAMEMBRANE PROTEOLYSIS; CARDIAC FIBROBLASTS; SIGNALING PATHWAYS; BIOACTIVE PEPTIDES; ENDOTHELIAL-CELLS; PRECURSOR PROTEIN; CLEAVAGE; IDENTIFICATION; SURFACE	Limited proteolysis is a pivotal mechanism regulating protein functions. Identifying physiologically or pathophysiologically relevant cleavage sites helps to develop molecular tools that can be used for diagnostics or therapeutics. During proteolysis of secretory and membrane proteins, part of the cleaved protein is liberated and destined to undergo degradation but should retain original cleavage sites created by proteolytic enzymes. We profiled endogenous peptides accumulated for 4 h in media conditioned by primary cultured rat cardiac fibroblasts. A total of 3916 redundant peptide sequences from 94 secretory proteins and membrane proteins served to identify limited cleavage sites, both annotated and unannotated, for signal peptide or propeptide removal, peptide hormone processing, ectodomain shedding, and regulated intramembrane proteolysis. Incorrectly predicted signal cleavage sites are found in typical proteins such as extracellular matrix proteins and the peptide hormone precursor adrenomedullin ADM. The revealed signal peptide cleavage site for ADM was experimentally verified by identifying the major molecular form of flanking proadrenomedullin N-terminal peptide. We suggest that profiling of endogenous peptides, like transcriptome sequence reads, makes sense in regular cells such as fibroblasts and that peptidomics provides insight into proteolysis-regulated protein functions.	[Tsuchiya, Takashi; Osaki, Tsukasa; Minamino, Naoto; Sasaki, Kazuki] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pharmacol, Osaka 5658565, Japan	Sasaki, K (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Mol Pharmacol, Osaka 5658565, Japan.	ksasaki@ncvc.go.jp			JSPS KAICENHI [25461402]; Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO), Japan	We thank Masako Matsubara (National Cerebral and Cardiovascular Center) for creating peptide maps. This study was supported in part by JSPS KAICENHI Grant No. 25461402 and the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO), Japan.	Abonnenc M, 2013, CIRC RES, V113, P1138, DOI 10.1161/CIRCRESAHA.113.302400; Brown KJ, 2012, EXPERT REV PROTEOMIC, V9, P337, DOI [10.1586/epr.12.21, 10.1586/EPR.12.21]; SUGA S, 1992, J CLIN INVEST, V90, P1145, DOI 10.1172/JCI115933; Wilkinson L, 2003, J BIOL CHEM, V278, P34181, DOI 10.1074/jbc.M301247200; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Greening DW, 2013, BBA-PROTEINS PROTEOM, V1834, P2396, DOI 10.1016/j.bbapap.2013.05.006; Nakayama K, 1997, BIOCHEM J, V327, P625; Wang ZH, 2005, BIOCHEMISTRY-US, V44, P12355, DOI 10.1021/bi050620i; Horiuchi K, 2007, J IMMUNOL, V179, P6715; Yamaguchi H, 2007, J BIOL CHEM, V282, P26354, DOI 10.1074/jbc.M701665200; FOLZ RJ, 1988, J BIOL CHEM, V263, P2070; Sasaki K, 2009, MOL CELL PROTEOMICS, V8, P1638, DOI 10.1074/mcp.M900044-MCP200; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Yin P, 2012, J PROTEOME RES, V11, P3965, DOI 10.1021/pr201066t; Araki Y, 2004, J BIOL CHEM, V279, P24343, DOI 10.1074/jbc.M401925200; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V194, P720, DOI 10.1006/bbrc.1993.1881; Lal M, 2011, PHYSIOLOGY, V26, P34, DOI 10.1152/physiol.00028.2010; BOUJRAD N, 1995, SCIENCE, V268, P1609, DOI 10.1126/science.7777858; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Osaki T, 2011, J PROTEOME RES, V10, P1870, DOI 10.1021/pr101114a; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Ikeda Y, 2004, P NATL ACAD SCI USA, V101, P10732, DOI 10.1073/pnas.0404117101; Sasaki K, 2013, MOL CELL PROTEOMICS, V12, P700, DOI 10.1074/mcp.M112.017400; Xia WM, 2003, J CELL SCI, V116, P2839, DOI 10.1242/jcs.00651; Yonezawa T, 2003, GLIA, V44, P190, DOI 10.1002/glia.10279; Impens F, 2010, PROTEOMICS, V10, P1284, DOI 10.1002/pmic.200900418; Fears CY, 2006, J BIOL CHEM, V281, P14533, DOI 10.1074/jbc.C600075200; SAKATA J, 1993, BIOCHEM BIOPH RES CO, V195, P921, DOI 10.1006/bbrc.1993.2132; Scott IC, 2000, J BIOL CHEM, V275, P30504, DOI 10.1074/jbc.M004846200; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Sasaki K, 2010, J PROTEOME RES, V9, P5047, DOI 10.1021/pr1003455; Tokudome T, 2004, ENDOCRINOLOGY, V145, P2458, DOI 10.1210/en.2003-1322; Matsuda S, 2005, J BIOL CHEM, V280, P28912, DOI 10.1074/jbc.C500217200; Fricker LD, 2012, J PROTEOME RES, V11, P1981, DOI 10.1021/pr2012076; Frye BC, 2009, EMBO REP, V10, P783, DOI 10.1038/embor.2009.81; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; NEURATH H, 1989, TRENDS BIOCHEM SCI, V14, P268, DOI 10.1016/0968-0004(89)90061-3; Kim YG, 2012, P NATL ACAD SCI USA, V109, P8523, DOI 10.1073/pnas.1203195109; Heijne G., 1983, EUR J BIOCHEM, V133, P17, DOI 10.1111/j.1432-1033.1983.tb07424.x; Lyons P. J., 2011, CURR PROTOCOLS PROTE, V65; Maruta C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043058; Rogers LD, 2013, MOL CELL PROTEOMICS, V12, P3532, DOI 10.1074/mcp.M113.031310; Shigyo M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12055; Kim SH, 1999, NAT NEUROSCI, V2, P984	45	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	NOV	2015	14	11					4921	4931		10.1021/acs.jproteome.5b00820		11	Biochemical Research Methods	Biochemistry & Molecular Biology	CV7EL	WOS:000364435100043		
J	Rapsey, CM; Lim, CCW; Al-Hamzawi, A; Alonso, J; Bruffaerts, R; Caldas-De-Almeida, JM; Florescu, S; de Girolamo, G; Hu, CY; Kessler, RC; Kovess-Masfety, V; Levinson, D; Medina-Mora, ME; Murphy, S; Ono, Y; Piazza, M; Posada-Villa, J; ten Have, M; Wojtyniak, B; Scott, KM				Rapsey, Charlene M.; Lim, Carmen C. W.; Al-Hamzawi, Ali; Alonso, Jordi; Bruffaerts, Ronny; Caldas-de-Almeida, J. M.; Florescu, Silvia; de Girolamo, Giovanni; Hu, Chiyi; Kessler, Ronald C.; Kovess-Masfety, Viviane; Levinson, Daphna; Elena Medina-Mora, Maria; Murphy, Sam; Ono, Yutaka; Piazza, Maria; Posada-Villa, Jose; ten Have, Margreet; Wojtyniak, Bogdan; Scott, Kate M.			Associations between DSM-IV mental disorders and subsequent COPD diagnosis	JOURNAL OF PSYCHOSOMATIC RESEARCH			English	Article						Alcohol abuse; Anxiety disorders; Comorbidity; COPD; Depression	OBSTRUCTIVE PULMONARY-DISEASE; CHRONIC PHYSICAL CONDITIONS; HEALTH SURVEYS; DEPRESSION; ANXIETY; ONSET; PREVALENCE; DEPENDENCE; ALCOHOL; VERSION	Objectives: COPD and mental disorder comorbidity is commonly reported, although findings are limited by substantive weaknesses. Moreover, few studies investigate mental disorder as a risk for COPD onset. This research aims to investigate associations between current (12-month) DSM-IV mental disorders and COPD, associations between temporally prior mental disorders and subsequent COPD diagnosis, and cumulative effect of multiple mental disorders. Methods: Data were collected using population surveys of 19 countries (n = 52,095). COPD diagnosis was assessed by self-report of physician's diagnosis. The World Mental Health-Composite International Diagnostic Interview (WMH-CIDI) was used to retrospectively assess lifetime prevalence and age at onset of 16 DSM-IV disorders. Adjusting for age, gender, smoking, education, and country, survival analysis estimated associations between first onset of mental disorder and subsequent COPD diagnosis. Results: COPD and several mental disorders were concurrently associated across the 12-month period (ORs 1.5-3.8). When examining associations between temporally prior disorders and COPD, all but two mental disorders were associated with COPD diagnosis (ORs 1.7-3.5). After comorbidity adjustment, depression, generalized anxiety disorder, and alcohol abuse were significantly associated with COPD (ORs 1.6-1.8). There was a substantive cumulative risk of COPD diagnosis following multiple mental disorders experienced over the lifetime. Conclusions: Mental disorder prevalence is higher in those with COPD than those without COPD. Over time, mental disorders are associated with subsequent diagnosis of COPD; further, the risk is cumulative for multiple diagnoses. Attention should be given to the role of mental disorders in the pathogenesis of COPD using prospective study designs. (C) 2015 Elsevier Inc All rights reserved.	[Rapsey, Charlene M.; Lim, Carmen C. W.; Scott, Kate M.] Univ Otago, Dept Psychol Med, Dunedin, New Zealand; [Al-Hamzawi, Ali] Al Qadisiya Univ, Coll Med, Diwania Governorate, Iraq; [Alonso, Jordi] UPF Pompeu Fabra Univ, IMIM Inst Hosp del Mar Invest Med, CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Bruffaerts, Ronny] Univ Leuven, Univ Psychiat Ctr, Louvain, Belgium; [Caldas-de-Almeida, J. M.] Univ Nova Lisboa, Chron Dis Res Ctr CEDOC, P-1200 Lisbon, Portugal; [Caldas-de-Almeida, J. M.] Univ Nova Lisboa, Fac Ciencias Med, Dept Mental Hlth, P-1200 Lisbon, Portugal; [Florescu, Silvia] Natl Sch Publ Hlth Management & Profess Dev, Bucharest, Romania; [Florescu, Silvia; Wojtyniak, Bogdan] Natl Inst Hyg, Natl Inst Publ Hlth, Ctr Monitoring & Anal Populat Hlth, Warsaw, Poland; [de Girolamo, Giovanni] IRCCS Ctr S Giovanni Dio Fatebenefratelli, Brescia, Italy; [Hu, Chiyi] Shenzhen Insitute Mental Hlth, Shenzhen, Peoples R China; [Hu, Chiyi] Shenzhen Kanging Hosp, Shenzhen, Peoples R China; [Kessler, Ronald C.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Kovess-Masfety, Viviane] Paris Descartes Univ, Ecole Hautes Etud Sante Publ EHESP, EA 4057, Paris, France; [Levinson, Daphna] Minist Hlth Israel, Mental Hlth Serv, Jerusalem, Israel; [Elena Medina-Mora, Maria] Natl Inst Psychiat Ramon Fuente, Mexico City, DF, Mexico; [Murphy, Sam] Univ Ulster, Sch Psychol, Coleraine BT52 1SA, Londonderry, North Ireland; [Ono, Yutaka] Natl Ctr Neurol & Psychiat, Ctr Cognit Behav Therapy & Res, Tokyo, Japan; [Piazza, Maria] Peruvian Natl Inst Hlth, Unit Anal & Generat Evidence Publ Hlth, Lima, Peru; [Posada-Villa, Jose] Colegio Mayor Cundinamarca Univ, Bogota, Colombia; [ten Have, Margreet] Netherlands Inst Mental Hlth & Addict, Trimbos Inst, Amsterdam, Netherlands	Rapsey, CM (reprint author), Univ Otago, Dept Psychol Med, POB 913, Dunedin, New Zealand.	charlene.rapsey@otago.ac.nz			National Institute of Mental Health (NIMH) [R01 MH070884]; John D. and Catherine T. MacArthur Foundation; Pfizer Foundation; US Public Health Service [R13-MH066849, R01-MH069864, R01 DA016558]; Fogarty International Center [FIRCA R03-TW006481]; Pan American Health Organization; Eli Lilly and Company; Ortho-McNeil Pharmaceutical; GlaxoSmithKline; Bristol-Myers Squibb; Ministry of Social Protection; European Commission [QLG5-1999-01042, SANCO 2004123, EAHC 20081308]; Piedmont Region (Italy); Fondo de Investigacion Sanitaria; Instituto de Salud Carlos III, Spain [FIS 00/0028]; Ministerio de Ciencia y Tecnologia, Spain [SAF 2000-158-CE]; Departament de Salut; Generalitat de Catalunya, Spain; Instituto de Salud Carlos III [CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP]; Japanese Fund through United Nations Development Group Iraq Trust Fund (UNDGITF); European Fund through United Nations Development Group Iraq Trust Fund (UNDGITF); Ministry of Health; Israel National Institute for Health Policy and Health Services Research; National Insurance Institute of Israel; Grant for Research on Psychiatric and Neurological Diseases and Mental Health from the Japan Ministry of Health, Labor and Welfare [H13-SHOGAI-023,, H14-TOKUBETSU-026, H16-KOKORO-013]; National Institute of Psychiatry Ramon de la Fuente [INPRFMDIES 4280]; National Council on Science and Technology [CONACyT-G30544- H]; New Zealand Ministry of Health; Alcohol Advisory Council; Health Research Council [HRC 11/200]; Health & Social Care Research & Development Division of the Public Health Agency; Shenzhen Bureau of Health; Shenzhen Bureau of Science, Technology, and Information; National Institute of Health of the Ministry of Health of Peru; Norwegian Financial Mechanism; European Economic Area Mechanism; Polish Ministry of Health; Champalimaud Foundation; Gulbenkian Foundation; Foundation for Science and Technology (FCT); Ministry of Public Health	The World Health Organization World Mental Health (WMH) Survey Initiative is supported by the National Institute of Mental Health (NIMH; R01 MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical, GlaxoSmithKline, and Bristol-Myers Squibb. We thank the staff of the WMH Data Collection and Data Analysis Coordination Centers for assistance with instrumentation, fieldwork, and consultation on data analysis. The Colombian National Study of Mental Health (NSMH) is supported by the Ministry of Social Protection. The ESEMeD project is funded by the European Commission (Contracts QLG5-1999-01042; SANCO 2004123, and EAHC 20081308), the Piedmont Region (Italy)), Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain (FIS 00/0028), Ministerio de Ciencia y Tecnologia, Spain (SAF 2000-158-CE), Departament de Salut, Generalitat de Catalunya, Spain, Instituto de Salud Carlos III (CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP), and other local agencies and by an unrestricted educational grant from GlaxoSmithKline. Implementation of the Iraq Mental Health Survey (IMHS) and data entry were carried out by the staff of the Iraqi MOH and MOP with direct support from the Iraqi IMHS team with funding from both the Japanese and European Funds through United Nations Development Group Iraq Trust Fund (UNDGITF). The Israel National Health Survey is funded by the Ministry of Health with support from the Israel National Institute for Health Policy and Health Services Research and the National Insurance Institute of Israel. The World Mental Health Japan (WMHJ) Survey is supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013) from the Japan Ministry of Health, Labor and Welfare. The Mexican National Comorbidity Survey (MNCS) is supported by The National Institute of Psychiatry Ramon de la Fuente (INPRFMDIES 4280) and by the National Council on Science and Technology (CONACyT-G30544- H), with supplemental support from the PanAmerican Health Organization (PAHO). Te Rau Hinengaro: The New Zealand Mental Health Survey (NZMHS) is supported by the New Zealand Ministry of Health, Alcohol Advisory Council, and the Health Research Council (HRC 11/200). The Northern Ireland Study of Mental Health was funded by the Health & Social Care Research & Development Division of the Public Health Agency. The Chinese World Mental Health Survey Initiative is supported by the Pfizer Foundation. The Shenzhen Mental Health Survey is supported by the Shenzhen Bureau of Health and the Shenzhen Bureau of Science, Technology, and Information. The Peruvian World Mental Health Study was funded by the National Institute of Health of the Ministry of Health of Peru. The Polish project Epidemiology of Mental Health and Access to Care -EZOP Poland was carried out by the Institute of Psychiatry and Neurology in Warsaw in consortium with Department of Psychiatry Medical University in Wroclaw and National Institute of Public Health National Institute of Hygiene in Warsaw and in partnership with Psykiatrist Institut Vinderen - Universitet, Oslo. The project was funded by the Norwegian Financial Mechanism and the European Economic Area Mechanism as well as Polish Ministry of Health.; No support from pharmaceutical industry neither other commercial sources was received. The Portuguese Mental Health Study was carried out by the Department of Mental Health, Faculty of Medical Sciences, NOVA University of Lisbon, with collaboration of the Portuguese Catholic University, and was funded by Champalimaud Foundation, Gulbenkian Foundation, Foundation for Science and Technology (FCT) and Ministry of Health. The Romania WMH study projects "Policies in Mental Health Area" and "National Study regarding Mental Health and Services Use" were carried out by National School of Public Health & Health Services Management (former National Institute for Research & Development in Health, present National School of Public Health Management & Professional Development, Bucharest), with technical support of Metro Media Transilvania, the National Institute of Statistics National Centre for Training in Statistics, SC. Cheyenne Services SRL, Statistics Netherlands and were funded by Ministry of Public Health (former Ministry of Health) with supplemental support of Eli Lilly Romania SRL.	Bednarek M, 2008, THORAX, V63, P402, DOI 10.1136/thx.2007.085456; SINGER JD, 1993, J EDUC STAT, V18, P155, DOI 10.3102/10769986018002155; SIMON GE, 1995, EPIDEMIOL REV, V17, P221; Atlantis E, 2013, CHEST, V144, P766, DOI 10.1378/chest.12-1911; Smagula SF, 2014, J PSYCHOSOM RES, V76, P368, DOI 10.1016/j.jpsychores.2014.02.005; Kosacz Nicole M., 2012, Morbidity and Mortality Weekly Report, V61, P938; Kolk AMM, 2002, J PSYCHOSOM RES, V52, P35, DOI 10.1016/S0022-3999(01)00307-5; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; Scott KM, 2007, GEN HOSP PSYCHIAT, V29, P123, DOI 10.1016/j.genhosppsych.2006.12.006; Hynninen KMJ, 2005, J PSYCHOSOM RES, V59, P429, DOI 10.1016/j.jpsychores.2005.04.007; Takao A, 1998, J ALLERGY CLIN IMMUN, V101, P576; Bierut LJ, 2011, NEURON, V69, P618, DOI 10.1016/j.neuron.2011.02.015; Scott KM, 2010, PSYCHOSOM MED, V72, P712, DOI 10.1097/PSY.0b013e3181e3333d; Sisson JH, 2007, ALCOHOL, V41, P293, DOI 10.1016/j.alcohol.2007.06.003; Scott KM, 2011, ARCH GEN PSYCHIAT, V68, P838, DOI 10.1001/archgenpsychiatry.2011.77; Goodwin RD, 2012, NICOTINE TOB RES, V14, P176, DOI 10.1093/ntr/ntr165; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Irwin MR, 2007, BRAIN BEHAV IMMUN, V21, P374, DOI 10.1016/j.bbi.2007.01.010; Willgoss TG, 2013, RESP CARE, V58, P858, DOI 10.4187/respcare.01862; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Scott KM, 2012, BRIT J PSYCHIAT, V200, P469, DOI 10.1192/bjp.bp.111.103267; Patten SB, 2008, GEN HOSP PSYCHIAT, V30, P407, DOI [10.1016/j.genhosppsych.2008.05.001, 10.1016/j.genhosppsych.2008.05.00l]; Decramer M, 2008, COPD, V5, P235, DOI 10.1080/15412550802237531; Scott KM, 2013, INT J CARDIOL, V168, P5293, DOI 10.1016/j.ijcard.2013.08.012; Ng TP, 2009, RESP MED, V103, P895, DOI 10.1016/j.rmed.2008.12.010; Eisner MD, 2010, THORAX, V65, P229, DOI 10.1136/thx.2009.126201; Efron B., 1988, J AM STAT ASSOC, V83, P413; Kessler Ronald C, 2008, WHO WORLD MENTAL HLT; Ochi M., 2014, BMC PUBLIC HLTH, P14; Ohayon M.M., 2014, J PSYCHIATR RES, V54, P79; Salvi SS, LANCET, V374, P733; Scott K.M., 2009, GLOBAL PERSPECTIVES; Shah B. V., 1998, ENCY BIOSTATISTICS, P2276; Statistics NCfH, 1994, VIT HLTH STAT, V2, P1; SUDAAN, 1999, SOFTW STAT AN CORR D; Vassend O, 1999, J Health Psychol, V4, P465, DOI 10.1177/135910539900400402	36	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3999	1879-1360		J PSYCHOSOM RES	J. Psychosomat. Res.	NOV	2015	79	5					333	339		10.1016/j.jpsychores.2015.08.005		7	Psychiatry	Psychiatry	CV6BJ	WOS:000364355400001		
J	Chiang, KC; Yen, CL; Yeh, CN; Hsu, JT; Chen, LW; Kuo, SF; Wang, SY; Sun, CC; Kittaka, A; Cheng, TC; Yeh, TS; Hsu, SY; Juang, HH				Chiang, Kun-Chun; Yen, Cho-Li; Yeh, Chun-Nan; Hsu, Jun-Te; Chen, Li-Wei; Kuo, Sheng-Fong; Wang, Shang-Yu; Sun, Chi-Chin; Kittaka, Atsushi; Cheng, Tai C.; Yeh, Ta-Sen; Hsu, Shu-Yuan; Juang, Horng-Heng			Hepatocellular carcinoma cells express 25(OH)D-1 alpha-hydroxylase and are able to convert 25(OH)D to 1 alpha,25(OH)(2)D, leading to the 25(OH)D-induced growth inhibition	JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						HCC; HepG2; CYP27B1; CYP24A1; 25-Hydroxyvitamin D; Gene therapy	VITAMIN-D-RECEPTOR; CIRCULATING 25-HYDROXYVITAMIN D; PANCREATIC-CANCER; D ANALOG; RISK; MART-10; D-3; DISEASE; HEALTH; POTENT	Hepatocellular carcinoma (HCC) is the most diagnosed liver cancer without effective treatments available for advanced HCC. Vitamin D is getting popular due to its anti-cancer characteristics. However, the clinical application of 1 alpha,25(OH)(2)D, the active form of vitamin, is hampered by its hypercalcemia side effect. 1 alpha,25(OH)(2)D is converted from 25(OH)D, the index of serum vitamin D status, by CYP27B1, which is originally found in kidneys but recently detected in non-renal tissues. 25(OH)D has been shown to repress some cancers expressing CYP27B1 due to the local conversion of 25(OH)D to 1 alpha,25(OH)2D, which works in a intra-, auto-, or paracrine manner and thus minimizes the risk of hypercalcemia. In this study, we found CYP27B1 expression in human hepatocyte, HCC, and HepG2 cells. As we treated HepG2 cells with 25(OH)D, the 1 alpha,25(OH)2D target gene CYP24A1 expression was increased and was further upregulated as CYP27B1 transfection or downregulated as CYP27B1 knockdown. Other 1 alpha,25(OH)(2)D target genes in HepG2 cells, p21 and p27 were also stimulated by 25(OH)D after CYP27B1 transfection. Further, 25(OH)D could inhibit HepG2 cells growth, which was potentiated by CYP27B1 transfection. Collectively, we showed for the first time that HCC expressed CYP27B1 and was able to covert 25(OH)D to 1 alpha,25(OH)2D in vitro, thus responsive to 25(OH)D treatment. Our data justifies the application of 25(OH) D and CYP27B1 gene transfection therapy in further HCC treatment studies. (C) 2015 Elsevier Ltd. All rights reserved.	[Chiang, Kun-Chun] Chang Gung Univ, Chang Gung Mem Hosp, Dept Gen Surg, Keelung 204, Taiwan; [Yen, Cho-Li; Chen, Li-Wei] Chang Gang Univ, Chang Gung Mem Hosp, Dept Gastroenterol, Keelung 204, Taiwan; [Yeh, Chun-Nan; Hsu, Jun-Te; Wang, Shang-Yu; Yeh, Ta-Sen] Chang Gung Univ, Chang Gung Mem Hosp, Dept Gen Surg, Taoyuan 333, Taiwan; [Kuo, Sheng-Fong] Chang Gung Univ, Chang Gung Mem Hosp, Dept Endocrinol & Metab, Keelung, Taiwan; [Sun, Chi-Chin] Chang Gung Univ, Chang Gung Mem Hosp, Dept Ophthalmol, Keelung, Taiwan; [Kittaka, Atsushi] Teikyo Univ, Fac Pharmaceut Sci, Tokyo, Japan; [Cheng, Tai C.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Hsu, Shu-Yuan; Juang, Horng-Heng] Chang Gung Univ, Coll Med, Dept Anat, Taoyuan 333, Taiwan	Hsu, SY (reprint author), Chang Gung Univ, Dept Anat, 259 Wen Hua 1st Rd, Taoyuan 333, Taiwan.	hhj143@mail.cgu.edu.tw			 [CMRPG2A0321];  [2A0322];  [2A0323]	This work was supported by CMRPG2A0321, 2A0322, 2A0323 to Kun-Chun Chiang.	Chu PGG, 2002, AM J SURG PATHOL, V26, P978, DOI 10.1097/01.PAS.0000020482.56467.09; HUGHES MR, 1976, J CLIN INVEST, V58, P61, DOI 10.1172/JCI108459; Chiang KC, 2011, STEROIDS, V76, P1513, DOI 10.1016/j.steroids.2011.08.006; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Dusso A, 2011, BEST PRACT RES CL EN, V25, P647, DOI 10.1016/j.beem.2011.05.005; Hewison M, 2012, CLIN ENDOCRINOL, V76, P315, DOI 10.1111/j.1365-2265.2011.04261.x; Lee JE, 2011, CANCER PREV RES, V4, P735, DOI 10.1158/1940-6207.CAPR-10-0289; Wolpin BM, 2012, CANCER EPIDEM BIOMAR, V21, P82, DOI 10.1158/1055-9965.EPI-11-0836; White JH, 2012, ARCH BIOCHEM BIOPHYS, V523, P58, DOI 10.1016/j.abb.2011.11.006; Chiang KC, 2014, J STEROID BIOCHEM, V139, P54, DOI 10.1016/j.jsbmb.2013.10.005; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; Kawahara MK, 2008, LIFE SCI, V82, P677, DOI 10.1016/j.lfs.2007.12.027; Wagner D, 2013, J CLIN ENDOCR METAB, V98, P1498, DOI 10.1210/jc.2012-4019; Hewison M, 2007, J STEROID BIOCHEM, V103, P316, DOI 10.1016/j.jsbmb.2006.12.078; Hobaus J, 2013, ANTI-CANCER AGENT ME, V13, P20; Norman AW, 2006, ENDOCRINOLOGY, V147, P5542, DOI 10.1210/en.2006-0946; Chiang KC, 2013, J STEROID BIOCHEM, V138, P427, DOI 10.1016/j.jsbmb.2013.09.002; Flanagan JN, 2006, ANTICANCER RES, V26, P2567; Chiang KC, 2013, ANTI-CANCER AGENT ME, V13, P126; Gallicchio L, 2010, AM J EPIDEMIOL, V172, P10, DOI 10.1093/aje/kwq116; McCarthy K, 2009, ANTICANCER RES, V29, P155; Adams JS, 2012, ARCH BIOCHEM BIOPHYS, V523, P95, DOI 10.1016/j.abb.2012.02.016; Bauer SR, 2013, MEDICINE, V92, P123, DOI 10.1097/MD.0b013e3182943bc2; Pike JW, 2010, ENDOCRIN METAB CLIN, V39, P255, DOI 10.1016/j.ecl.2010.02.007; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Cytochromes S. I., 2011, BIOCHIM BIOPHYS ACTA, V1814, P186; PILLAI S, 1988, Skin Pharmacology, V1, P149; Stolzenberg-Solomon RZ, 2010, AM J EPIDEMIOL, V172, P81, DOI 10.1093/aje/kwq120	29	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0760			J STEROID BIOCHEM	J. Steroid Biochem. Mol. Biol.	NOV	2015	154						47	52		10.1016/j.jsbmb.2015.06.008		6	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CV4QI	WOS:000364251200006		
J	Zschockelt, L; Amelkina, O; Koster, S; Painer, J; Okuyama, MW; Serra, R; Vargas, A; Jewgenow, K; Braun, BC				Zschockelt, Lina; Amelkina, Olga; Koster, Stefanie; Painer, Johanna; Okuyama, Minami W.; Serra, Rodrigo; Vargas, Astrid; Jewgenow, Katarina; Braun, Beate C.			Comparative analysis of intraluteal steroidogenic enzymes emphasises the functionality of fresh and persistent corpora lutea during pro-and metoestrus in the lynx	JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						Lynx lynx; Lynx pardinus; Persistent corpus luteum; Proestrus; Metestrus; Steroid Biogenesis	IBERIAN LYNX; EURASIAN LYNX; DOMESTIC CAT; DENOVO SYNTHESIS; OVARIAN ACTIVITY; FELIS-CATUS; LIFE-CYCLE; PROGESTERONE; PREGNANCY; HORMONE	European lynx species demonstrate an atypical ovarian cycle compared to other felids. The physiological persistence of corpora lutea (CLs), reflected in constantly elevated progesterone (P4) concentrations in serum, is thought to ensure a seasonal monooestrus. Moreover, the coexistence of CLs from a recent ovulation (freshCLs) and persistent CLs from previous years (perCLs) on the same ovary has been proven. We assume that perCLs in lynxes occur due to fundamentally different mechanisms of luteal regression. Our study presents a detailed analysis of steroidogenic enzymes and steroids in fresh and perCLs obtained from Iberian lynxes during metoestrus, and in perCLs obtained from Eurasian lynxes during prooestrus. By quantitative PCR we measured relative mRNA amounts of steroidogenic acute regulatory protein (STAR), cytochrome P450 oxidases (CYPs), hydroxysteroid dehydrogenases (HSDs) and a steroid reductase (SRD). Protein expression in CLs was investigated for CYP11A1, CYP17A1, CYP19A1 and HSD3B. Additionally, the intraluteal and serum steroid content was determined. During metoestrus, mRNA amounts of STAR, CYP11A1, CYP19A1, HSD17B7 and SRD5A1 were significantly higher in perCLs compared to freshCLs. Protein of CYP11A1 was detected independently of the CL age in metoestrus, but expression was less evident in prooestrous perCLs. The protein signal of CYP17A1 was strong in freshCLs and perCLs of metoestrus, but weak at prooestrus. The presence of CYP19A1 protein was confirmed in each stage of the CL. These findings contribute to the hypothesis that CLs from previous years might support freshly developed CLs for pregnancy maintenance. However, initiation of ovulation might require a functional down-regulation of perCLs prior to breeding. It is noteworthy that the HSD3B1 mRNA amount was significantly elevated in fresh compared to perCLs (metoestrus). Accordingly, HSD3B protein was substantially present in freshCLs, whereas signals were literally absent in all perCLs. Elevated expression of HSD3B coincided with high intraluteal oestrogen concentrations in freshCLs; however, the enzyme pattern was less concordant with intraluteal P4 and androgen concentrations. Serum P4 concentrations of Iberian lynxes were constant between prooestrus and prolonged dioestrus. Moreover, constantly high serum oestrogen concentrations were measured during pro-, met- and prolonged dioestrus. The physiology of exceptionally high serum oestrogen concentrations outside the breeding season of lynxes merits further investigation. In conclusion our study supports the concept that the unique reproductive strategy of lynxes is directly linked to sustained intraluteal steroid biogenesis in persistent CLs. (C) 2015 Elsevier Ltd. All rights reserved.	[Zschockelt, Lina; Amelkina, Olga; Koster, Stefanie; Painer, Johanna; Jewgenow, Katarina; Braun, Beate C.] Leibniz Inst Zoo & Wildlife Res, Dept Reprod Biol, D-10324 Berlin, Germany; [Okuyama, Minami W.] Hokkaido Univ, Grad Sch Vet Med, Lab Wildlife Biol & Med, Sapporo, Hokkaido 0600818, Japan; [Serra, Rodrigo] Natl Ctr Capt Breeding Iberian Lynx, P-8375082 Messines, Portugal; [Vargas, Astrid] El Acebuche Iberian Lynx Capt Breeding Ctr, Matalascarias 21760, Huelva, Spain	Zschockelt, L (reprint author), Leibniz Inst Zoo & Wildlife Res, Dept Reprod Biol, PF700430, D-10324 Berlin, Germany.	zschockelt@izw-berlin.de; amelkina@izw-berlin.de; stefanie.koster88@gmail.com; painer@izw-berlin.de; okuyama.M@vetmed.hokudai.ac.jp; rodserra@gmail.com; astridvgu@me.com; jewgenow@izw-berlin.de; braun@izw-berlin.de			German Research Foundation [DFG Je 163/11-1]; Federal Ministry of Education and Research [BMBF 033L046]; German Academic Exchange Service [DAAD A/10/86242]	We thank Mareen Albrecht, Sandra Augustin, Saskia Hertwig, Sigrid Holz and Katrin Paschmionka for technical assistance. Provision of in-house steroid EIA by Dr Martin Dehnhard is gratefully acknowledged. The authors thank Prof Toshio Tsubota for provision and Dr Nobuhiro Harada (CYP19A1) and Dr Shiro Kominami (CYP11A1, CYP17A1) for production of antibodies. Iberian lynx samples were provided by the Environmental Council of the Government of Andalusia and Iberian lynx conservation breeding programme. We thank the Statens Naturoppsyn (Norway) and Dr Johan Schulze for help to obtain access to Norwegian Eurasian lynx samples. This work was supported by the German Research Foundation (DFG Je 163/11-1), the Federal Ministry of Education and Research (BMBF 033L046) and the German Academic Exchange Service (DAAD A/10/86242). We thank Dr Barry Bavister for English editing of the manuscript.	Dehnhard M, 2010, GEN COMP ENDOCR, V167, P287, DOI 10.1016/j.ygcen.2010.03.023; HALES DB, 1987, J BIOL CHEM, V262, P11200; Axner E, 2013, THERIOGENOLOGY, V80, P839, DOI 10.1016/j.theriogenology.2013.06.015; Ghayee HK, 2007, REV ENDOCR METAB DIS, V8, P289, DOI 10.1007/s11154-007-9052-2; Auchus RJ, 2004, TRENDS ENDOCRIN MET, V15, P432, DOI 10.1016/j.tem.2004.09.004; Amelkina O, 2015, THERIOGENOLOGY, V83, P711, DOI 10.1016/j.theriogenology.2014.11.008; CROWE DM, 1975, J MAMMAL, V56, P177, DOI 10.2307/1379615; ANAKWE OO, 1987, MOL ENDOCRINOL, V1, P595; SEAL US, 1985, BIOL REPROD, V32, P361, DOI 10.1095/biolreprod32.2.361; BROWN JL, 1994, BIOL REPROD, V51, P776, DOI 10.1095/biolreprod51.4.776; Jewgenow K, 2014, REPROD BIOL, V14, P83, DOI 10.1016/j.repbio.2014.03.002; Goritz F, 2009, REPROD DOMEST ANIM, V44, P87, DOI 10.1111/j.1439-0531.2009.01380.x; SHILLE VM, 1979, BIOL REPROD, V21, P1217, DOI 10.1095/biolreprod21.5.1217; Minjarez D, 2001, BIOL REPROD, V65, P1378, DOI 10.1095/biolreprod65.5.1378; BONNEY RC, 1981, J REPROD FERTIL, V63, P523; Magoffin DA, 2005, INT J BIOCHEM CELL B, V37, P1344, DOI 10.1016/j.biocel.2005.01.016; Palomares F, 2005, BIOL CONSERV, V122, P53, DOI 10.1016/j.biocon.2004.06.020; Braun BC, 2009, THERIOGENOLOGY, V71, P754, DOI 10.1016/j.theriogenology.2008.09.054; Miller Walter L., 2008, V13, P1, DOI 10.1159/000134751; WILDT DE, 1981, BIOL REPROD, V25, P15, DOI 10.1095/biolreprod25.1.15; DAWSON AB, 1946, ANAT REC, V95, P29, DOI 10.1002/ar.1090950105; Lin L, 2007, J CLIN ENDOCR METAB, V92, P982, DOI 10.1210/jc.2006-1181; PAAPE SR, 1975, BIOL REPROD, V13, P470, DOI 10.1095/biolreprod13.4.470; Fanson KV, 2010, GEN COMP ENDOCR, V169, P217, DOI 10.1016/j.ygcen.2010.09.003; Brown JL, 2011, ANIM REPROD SCI, V124, P155, DOI 10.1016/j.anireprosci.2010.08.024; Finkenwirth C, 2010, THERIOGENOLOGY, V73, P530, DOI 10.1016/j.theriogenology.2009.10.008; Braun BC, 2012, J STEROID BIOCHEM, V132, P295, DOI 10.1016/j.jsbmb.2012.07.005; Meyer HHD, 1997, BERL MUNCH TIERARZTL, V110, P143; Hachen A, 2012, THERIOGENOLOGY, V77, P539, DOI 10.1016/j.theriogenology.2011.08.029; REYNOLDS LP, 1983, J REPROD FERTIL, V69, P703; PARKER GR, 1983, CAN J ZOOL, V61, P1771; Carnaby K, 2012, REPRODUCTION, V144, P477, DOI 10.1530/REP-12-0166; Braun BC, 2012, REPRODUCTION, V143, P399, DOI 10.1530/REP-11-0316; Zschockelt L, 2014, J STEROID BIOCHEM, V144, P373, DOI 10.1016/j.jsbmb.2014.08.010; Dehnhard M, 2008, REPROD DOMEST ANIM, V43, P74, DOI 10.1111/j.1439-0531.2008.01145.x; Vargas A., 2008, International Zoo Yearbook, V42, P190, DOI 10.1111/j.1748-1090.2007.00036.x; Jewgenow K, 2012, REPROD DOMEST ANIM, V47, P25, DOI 10.1111/rda.12033; Jewgenow K, 2006, GEN COMP ENDOCR, V149, P151, DOI 10.1016/j.ygcen.2006.05.015; VERHAGE HG, 1976, BIOL REPROD, V14, P579, DOI 10.1095/biolreprod14.5.579; Voigt CC, 2004, GEN COMP ENDOCR, V135, P100, DOI 10.1016/j.ygcen.2003.08.005; Azzouni F., 2012, ADV UROL, V2012, DOI DOI 10.1155/2012/530121; Bowen-Shauver Jennifer M, 2003, Reprod Biol Endocrinol, V1, P28, DOI 10.1186/1477-7827-1-28; Clark B.J., 1994, J BIOL CHEM, V28, P314; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; IUCN, 2015, IUCN RED LIST THREAT; Keyes P L, 1979, Adv Exp Med Biol, V112, P447; Kvam T, 1991, MAMM BIOL, V56, P146; Painer J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090469; Pelican K.M., 2006, IBERIAN LYNX EXSITU, P113; Siemieniuch MJ, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-89; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vargas A., 2009, IBERIAN LYNX EX SITU; Woshner VM, 2001, PROCEEDINGS OF THE FIFTY-FIFTH ANNUAL CONFERENCE OF THE SOUTHEASTERN ASSOCIATION OF FISH AND WILDLIFE AGENCIES, P427	53	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0760			J STEROID BIOCHEM	J. Steroid Biochem. Mol. Biol.	NOV	2015	154						75	84		10.1016/j.jsbmb.2015.07.001		10	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CV4QI	WOS:000364251200010		
J	Oka, K; Hoang, A; Okada, D; Iguchi, T; Baker, ME; Katsu, Y				Oka, Kaori; Hoang, Andree; Okada, Daijiro; Iguchi, Taisen; Baker, Michael E.; Katsu, Yoshinao			Allosteric role of the amino-terminal A/B domain on corticosteroid transactivation of gar and human glucocorticoid receptors	JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						Glucocorticoid Receptor; Evolution; Gar; Intrinsically Disordered Domain; Allosteric regulation of gene transcription	TRANSCRIPTIONAL ACTIVATION FUNCTIONS; MINERALOCORTICOID RECEPTOR; TELEOST FISH; MOLECULAR-CLONING; LIGAND SPECIFICITY; HORMONE-RECEPTORS; ESTROGEN-RECEPTOR; DISORDERED AF1; 3D MODELS; EVOLUTION	We studied the role of the A/B domain at the amino terminus of gar (Atractosterus tropicus) and human glucocorticoid receptors (GRs) on transcriptional activation by various glucocorticoids. In transient transfection assays, dexamethasone [DEX] and cortisol had a lower half-maximal response (EC50) for transcriptional activation of full length gar GR than of human GR. Both GRs had similar responses to corticosterone, while 11-deoxycortisol had a lower EC50 for gar GR than for human GR. In contrast, constructs of gar GR and human GR consisting of their hinge (D domain), ligand binding domain (LBD) (E domain) fused to a GAL4 DNA-binding domain (DBD) had a higher EC50 (weaker response) for all glucocorticoids. To study the role of the A/B domain, which contains an intrinsically disordered region, we investigated steroid activation of chimeric gar GR and human GR, in which their A/B domains were exchanged. Replacement of human A/B domains with the gar A/B domains yielded a chimeric GR with a lower EC50 for DEX and cortisol, while the EC50 increased for these steroids for the human A/B-gar C/E chimera, indicating that gar A/B domains contributes to the lower EC50 of gar GR for glucocorticoids. Our data suggests that allosteric signaling between the A/B domains and LBD influences transcriptional activation of human and gar GR by different steroids, and this allosteric mechanism evolved over 400 million years before gar and mammals separated from a common ancestor. (C) 2015 Elsevier Ltd. All rights reserved.	[Oka, Kaori; Okada, Daijiro; Katsu, Yoshinao] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan; [Hoang, Andree] Univ Calif San Diego, Dept Biol, San Diego, CA 92103 USA; [Iguchi, Taisen] Natl Inst Basic Biol, Okazaki, Japan; [Baker, Michael E.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Katsu, Yoshinao] Hokkaido Univ, Dept Biol Sci, Sapporo, Hokkaido, Japan	Baker, ME (reprint author), Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.	mbaker@ucsd.edu; ykatsu@sci.hokudai.ac.jp			Japan Society for the Promotion of Science (JSPS); National Institute for Basic Biology Cooperative Research Program [11-322, 12-326]; Ministry of Education, Culture, Sports, Science and Technology of Japan [23570067, 26440159]	K.O. was supported by the Japan Society for the Promotion of Science (JSPS) Research Fellowships for Young Scientists. This work was carried out under the auspices of the National Institute for Basic Biology Cooperative Research Program (11-322 and 12-326 to Y. K) and supported in part by Grants-in-Aid for Scientific Research 23570067 and 26440159 (YK) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Christopoulos A, 2014, PHARMACOL REV, V66, P918, DOI 10.1124/pr.114.008862; Rogerson FM, 2003, MOL CELL ENDOCRINOL, V200, P45, DOI 10.1016/S0303-7207(02)00413-6; Kumar R, 2010, ARCH BIOCHEM BIOPHYS, V496, P140, DOI 10.1016/j.abb.2010.02.010; BOCQUEL MT, 1989, NUCLEIC ACIDS RES, V17, P2581, DOI 10.1093/nar/17.7.2581; TORA L, 1988, NATURE, V333, P185, DOI 10.1038/333185a0; Greenwood AK, 2003, ENDOCRINOLOGY, V144, P4226, DOI 10.1210/en.2003-0566; Huang PX, 2010, ANNU REV PHYSIOL, V72, P247, DOI 10.1146/annurev-physiol-021909-135917; Sladek FM, 2011, MOL CELL ENDOCRINOL, V334, P3, DOI 10.1016/j.mce.2010.06.018; Baker ME, 2011, STEROIDS, V76, P169, DOI 10.1016/j.steroids.2010.10.008; Kumar R, 2012, MOL CELL ENDOCRINOL, V348, P450, DOI 10.1016/j.mce.2011.03.024; Khan SH, 2012, J BIOL CHEM, V287, P44546, DOI 10.1074/jbc.M112.411330; DUCOURET B, 1995, ENDOCRINOLOGY, V136, P3774, DOI 10.1210/en.136.9.3774; Baker ME, 2011, STEROIDS, V76, P1451, DOI 10.1016/j.steroids.2011.07.015; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Sturm A, 2010, J MOL ENDOCRINOL, V45, P391, DOI 10.1677/JME-09-0152; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Kumar R, 2009, STEROIDS, V74, P877, DOI 10.1016/j.steroids.2009.07.012; Becker H, 2008, ENDOCRINOLOGY, V149, P4567, DOI 10.1210/en.2007-1683; Markov GV, 2009, P NATL ACAD SCI USA, V106, P11913, DOI 10.1073/pnas.0812138106; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Baker ME, 2015, J STEROID BIOCHEM, V151, P12, DOI 10.1016/j.jsbmb.2014.10.020; Katsu Y, 2006, MOL CELL ENDOCRINOL, V257-8, P84, DOI 10.1016/j.mce.2006.07.001; Rose AJ, 2013, MOL CELL ENDOCRINOL, V380, P65, DOI 10.1016/j.mce.2013.03.007; Katsu Y, 2008, ENDOCRINOLOGY, V149, P6300, DOI 10.1210/en.2008-0670; Pippal JB, 2009, MOL ENDOCRINOL, V23, P1360, DOI 10.1210/me.2009-0032; Almlof T, 1997, MOL CELL BIOL, V17, P934; Simons SS, 2013, MOL CELL ENDOCRINOL, V376, P81, DOI 10.1016/j.mce.2013.06.007; Chapman K, 2013, PHYSIOL REV, V93, P1139, DOI 10.1152/physrev.00020.2012; Bertrand S, 2011, MOL CELL ENDOCRINOL, V334, P67, DOI 10.1016/j.mce.2010.06.017; RUPPRECHT R, 1993, MOL ENDOCRINOL, V7, P597, DOI 10.1210/me.7.4.597; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Katsu Y, 2010, ENDOCRINOLOGY, V151, P639, DOI 10.1210/en.2009-0766; Stolte EH, 2008, J ENDOCRINOL, V198, P403, DOI 10.1677/JOE-08-0100; Fuller PJ, 2012, J ENDOCRINOL, V213, P15, DOI 10.1530/JOE-11-0372; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Olefsky JM, 2001, J BIOL CHEM, V276, P36863, DOI 10.1074/jbc.R100047200; Bury NR, 2003, J MOL ENDOCRINOL, V31, P141, DOI 10.1677/jme.0.0310141; GODOWSKI PJ, 1987, NATURE, V325, P365, DOI 10.1038/325365a0; LimTio SS, 1997, ENDOCRINOLOGY, V138, P2537, DOI 10.1210/en.138.6.2537; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; Bury NR, 2007, GEN COMP ENDOCR, V153, P47, DOI 10.1016/j.ygcen.2007.03.009; Oka K, 2013, MOL CELL ENDOCRINOL, V365, P153, DOI 10.1016/j.mce.2012.10.014; Li J, 2012, J BIOL CHEM, V287, P26777, DOI 10.1074/jbc.M112.355651; Pippal JB, 2011, MOL CELL ENDOCRINOL, V332, P58, DOI 10.1016/j.mce.2010.09.014; Changeux JP, 2013, NAT REV MOL CELL BIO, V14, P819, DOI 10.1038/nrm3695; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Lou XH, 2014, NAT STRUCT MOL BIOL, V21, P277, DOI 10.1038/nsmb.2778; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; MIESFELD R, 1987, SCIENCE, V236, P423, DOI 10.1126/science.3563519; Baker ME, 2011, MOL CELL ENDOCRINOL, V334, P14, DOI 10.1016/j.mce.2010.07.013; Schaaf MJM, 2008, ENDOCRINOLOGY, V149, P1591, DOI 10.1210/en.2007-1364; Rastinejad F, 2015, TRENDS BIOCHEM SCI, V40, P16, DOI 10.1016/j.tibs.2014.10.011; DAHLMANWRIGHT K, 1995, P NATL ACAD SCI USA, V92, P1699, DOI 10.1073/pnas.92.5.1699; Baker ME, 2013, J STEROID BIOCHEM, V137, P57, DOI 10.1016/j.jsbmb.2013.07.009; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Arterbery AS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-14; Baker M.E., 2014, ENDOCRINE DISRUPTORS, V2; Baker ME, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-24; Bridgham J.T., 2010, PLOS BIOL, V8; Li Y, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-137; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Rastinejad F, 2013, J MOL ENDOCRINOL, V51, pT1, DOI 10.1530/JME-13-0173	63	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0760			J STEROID BIOCHEM	J. Steroid Biochem. Mol. Biol.	NOV	2015	154						112	119		10.1016/j.jsbmb.2015.07.025		8	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CV4QI	WOS:000364251200014		
J	Saito-Kanatani, M; Urano, T; Hiroi, H; Momoeda, M; Ito, M; Fujii, T; Inoue, S				Saito-Kanatani, Mayuko; Urano, Tomohiko; Hiroi, Hisahiko; Momoeda, Mikio; Ito, Masanori; Fujii, Tomoyuki; Inoue, Satoshi			Identification of TRIM22 as a progesterone-responsive gene in Ishikawa endometrial cancer cells	JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						TRIM22; Progesterone receptor; Uterine cells	TRIPARTITE-MOTIF; BREAST-CANCER; REPRODUCTIVE FUNCTIONS; RECEPTOR ISOFORMS; EXPRESSION; VIRUS; P53; PROTEIN; MICE; PROMOTER	Progesterone plays important roles in implantation and maintains pregnancy. It antagonizes estrogen-mediated cell proliferation and promotes differentiation in the uterus. The action of progesterone is mediated by specific receptors, namely, the progesterone receptors (PRs). We generated two Ishikawa cell clones stably expressing PR isoform A (PR-A) and identified progesterone-responsive genes using cDNA microarray analysis. Fifteen genes were identified as progesterone-responsive gene candidates by microarray analysis and their progesterone-responsiveness was shown by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) analysis. Out of these 15 genes, we focused on TRIM22. A database search revealed a progesterone response element (PRE) located from the 25 to -11 bp region upstream of TRIM22 exon 1. This PRE had a 1-bp mismatch in the consensus PRE sequence. A chromatin immunoprecipitation assay revealed that the interaction of PR with the TRIM22 PRE region increased in a hormone-dependent manner. The progesterone-dependent enhancer activity of TRIM22 PRE was demonstrated using a luciferase assay. Based on these results, we propose that TRIM22 is a direct target gene of PR and that it can mediate progesterone actions in uterine cells. (C) 2015 Elsevier Ltd. All rights reserved.	[Saito-Kanatani, Mayuko; Urano, Tomohiko; Inoue, Satoshi] Univ Tokyo, Dept Geriatr Med, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan; [Urano, Tomohiko; Inoue, Satoshi] Univ Tokyo, Dept Antiaging Med, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan; [Saito-Kanatani, Mayuko; Hiroi, Hisahiko; Ito, Masanori; Fujii, Tomoyuki] Univ Tokyo, Dept Obstet & Gynaecol, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan; [Momoeda, Mikio] St Lukes Int Hosp, Dept Integrated Womens Hlth, Chuo Ku, Tokyo 1048560, Japan; [Inoue, Satoshi] Saitama Med Univ, Res Ctr Genom Med, Saitama 3501241, Japan	Inoue, S (reprint author), Univ Tokyo, Dept Antiaging Med, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	INOUE-GER@h.u-tokyo.ac.jp			MEXT; Japan Society for the Promotion of Science; MHLW; Advanced Research for Medical Products Mining Programme of the NIBIO; Takeda Science Foundation	This study was supported by Cell Innovation Program and Support Project of Strategic Research Center in Private Universities from the MEXT, grants from the Japan Society for the Promotion of Science, grants-in-aid from the MHLW and the Advanced Research for Medical Products Mining Programme of the NIBIO and a grant from the Takeda Science Foundation. The authors thank Drs. Takashi Oishi, Noriko Sasaki, Ed Sakamoto, Yumi Hosokawa, Ryo Tsutsumi, Fumiko Zenri, Minako Koizumi, Hanako Nakae, Tetsu Yano and Yuji Taketani.	Aietro P. Di, 2013, J VIROL, V87, P4523; Lee WL, 2014, J CHIN MED ASSOC, V77, P221, DOI 10.1016/j.jcma.2014.02.007; Horie-Inoue K, 2013, J BIOCHEM, V154, P309, DOI 10.1093/jb/mvt076; Suzuki T, 2005, CLIN CANCER RES, V11, P6148, DOI 10.1158/1078-0432.CCR-05-0040; Hirota Y, 2010, J CLIN INVEST, V120, P803, DOI 10.1172/JCI40051; Conneely OM, 2001, MOL CELL ENDOCRINOL, V179, P97, DOI 10.1016/S0303-7207(01)00465-8; Vicent GP, 2010, J BIOL CHEM, V285, P2622, DOI 10.1074/jbc.M109.060848; Gao JG, 2000, MOL ENDOCRINOL, V14, P1954, DOI 10.1210/me.14.12.1954; Ito M, 2012, J MOL ENDOCRINOL, V49, P193, DOI 10.1530/JME-12-0112; Sun Y, 2013, BIOCHEM BIOPH RES CO, V441, P600, DOI 10.1016/j.bbrc.2013.10.110; Coit P, 2013, J AUTOIMMUN, V43, P78, DOI 10.1016/j.jaut.2013.04.003; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; TISSOT C, 1995, J BIOL CHEM, V270, P14891; Liu J, 2012, AM J PATHOL, V180, P839, DOI [10.1016/j.ajpath.2011.10.020, 10.1016/j.aj.path.2011.10.020]; Doll A, 2008, J STEROID BIOCHEM, V108, P221, DOI 10.1016/j.jsbmb.2007.09.020; Gonzalez-Rodilla I, 2011, ANTICANCER RES, V31, P4191; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Mulac-Jericevic B, 2000, SCIENCE, V289, P1751, DOI 10.1126/science.289.5485.1751; Endo H, 2012, J BIOCHEM, V151, P139, DOI 10.1093/jb/mvr128; Smith S, 2014, ARTHRITIS RHEUMATOL, V66, P163, DOI 10.1002/art.38187; Tsuchiya S, 2003, GENES CELLS, V8, P747, DOI 10.1046/j.1365-2443.2003.00672.x; Zhu LJ, 1998, ENDOCRINOLOGY, V139, P3923, DOI 10.1210/en.139.9.3923; Gao B, 2009, HEPATOLOGY, V50, P424, DOI 10.1002/hep.23011; Wan C, 2014, AM J REPROD IMMUNOL, V71, P165, DOI 10.1111/aji.12168; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Ghizzoni L, 1997, ENDOCRINOLOGY, V138, P4806, DOI 10.1210/en.138.11.4806; Hubler TR, 2003, ENDOCRINOLOGY, V144, P2380, DOI 10.1210/en.2003-0092; Obad S, 2004, ONCOGENE, V23, P4050, DOI 10.1038/sj.onc.1207524; Zirn B, 2006, INT J CANCER, V118, P1954, DOI 10.1002/ijc.21564; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Eldin P, 2009, J GEN VIROL, V90, P536, DOI 10.1099/vir.0.006288-0; Cobos J., 2012, SCI REP, V2, P763; Folkers ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014697; Hattlmann CJ., 2012, MOL BIOL INT, V2012, DOI DOI 10.1155/2012/153415; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Patel B, 2015, HUM REPROD UPDATE, V21, P155, DOI 10.1093/humupd/dmu056; Sivaramakrishnan G., 2009, EXP CELL RES, V315, P1521	37	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0760			J STEROID BIOCHEM	J. Steroid Biochem. Mol. Biol.	NOV	2015	154						217	225		10.1016/j.jsbmb.2015.08.024		9	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CV4QI	WOS:000364251200025		
J	Yamaguchi, T; Takizawa, K; Shibata, K				Yamaguchi, Taichi; Takizawa, Kazuki; Shibata, Keisuke			ACUTE EFFECT OF DYNAMIC STRETCHING ON ENDURANCE RUNNING PERFORMANCE IN WELL-TRAINED MALE RUNNERS	JOURNAL OF STRENGTH AND CONDITIONING RESEARCH			English	Article						warm-up; middle- or long-distance running; running economy	LEG EXTENSION; ENERGY-COST; EFFECT SIZE; DISTANCE; ECONOMY; POWER; DETERMINANTS; STATISTICS; EXERCISE; COACHES	Yamaguchi, T, Takizawa, K, and Shibata, K. Acute effect of dynamic stretching on endurance running performance in well-trained male runners. J Strength Cond Res 29(11): 3045-3052, 2015The purpose of this study was to clarify the acute effect of dynamic stretching (DS) on relative high-intensity endurance running performance. The endurance running performances of 7 well-trained middle- or long-distance male runners were assessed on a treadmill after 2 types of pretreatment. The pretreatments were nonstretching (NS) and DS treatment. In the DS treatment, DS was performed as 1 set of 10 repetitions as quickly as possible for the 5 muscle groups in lower extremities. The endurance running performances were evaluated by time to exhaustion (TTE) and total running distance (TRD) during running at a velocity equivalent to 90% maximal oxygen uptake (Vo(2)max) in each subject. The oxygen uptake (Vo(2)) during running was measured as an index of running economy (RE). The TTE (928.6 +/- 215.0 seconds) after DS treatment was significantly (p < 0.01) more prolonged compared with that (785.3 +/- 206.2 seconds) after NS. The TRD (4,301.2 +/- 893.8 m) after DS treatment was also significantly (p < 0.01) longer than that (3,616.9 +/- 783.3 m) after NS. The changes in the Vo(2) during running, however, did not significantly (p > 0.05) differ between the pretreatments. The results demonstrated that the DS treatment improved the endurance performance of running at a velocity equivalent to 90% Vo(2)max in well-trained male runners, although it did not change the RE. This running velocity is equivalent to that for a 3,000- or 5,000-m race. Our finding suggests that performing DS during warm-up before a race is effective for improving performance.	[Yamaguchi, Taichi] Rakuno Gakuen Univ, Coll Agr Food & Environm Sci, Dept Foods Sci & Human Wellness, Lab Food Ecol & Sports Sci, Ebetsu, Hokkaido, Japan; [Takizawa, Kazuki] Hokkaido Univ, Ctr Res & Dev Higher Educ, Res Div Lifelong Learning, Sapporo, Hokkaido, Japan; [Shibata, Keisuke] Hokkaido Univ, Grad Sch Educ, Sapporo, Hokkaido, Japan	Yamaguchi, T (reprint author), Rakuno Gakuen Univ, Coll Agr Food & Environm Sci, Dept Foods Sci & Human Wellness, Lab Food Ecol & Sports Sci, Ebetsu, Hokkaido, Japan.	taichi@rakuno.ac.jp			JSPS KAKENHI [24700655]	Supported by JSPS KAKENHI Grant number 24700655.	Hayes PR, 2007, J STRENGTH COND RES, V21, P1227; Fletcher IM, 2004, J STRENGTH COND RES, V18, P885; Kallerud H, 2013, SPORTS MED, V43, P733, DOI 10.1007/s40279-013-0053-x; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Midgley AW, 2007, SPORTS MED, V37, P857; Wilson JM, 2010, J STRENGTH COND RES, V24, P2274, DOI 10.1519/JSC.0b013e3181b22ad6; Spurrs RW, 2003, EUR J APPL PHYSIOL, V89, P1, DOI 10.1007/s00421-002-0741-y; Peck E, 2014, CURR SPORT MED REP, V13, P179, DOI 10.1249/JSR.0000000000000052; Yamaguchi T, 2005, J STRENGTH COND RES, V19, P677; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Judge LW, 2013, J STRENGTH COND RES, V27, P2456, DOI 10.1519/JSC.0b013e318257703c; Sekir U, 2010, SCAND J MED SCI SPOR, V20, P268, DOI 10.1111/j.1600-0838.2009.00923.x; SHELLOCK FG, 1985, SPORTS MED, V2, P267, DOI 10.2165/00007256-198502040-00004; Nummela AT, 2006, EUR J APPL PHYSIOL, V97, P1, DOI 10.1007/s00421-006-0147-3; Yamaguchi T, 2007, J STRENGTH COND RES, V21, P1238; Kay AD, 2012, MED SCI SPORT EXER, V44, P154, DOI 10.1249/MSS.0b013e318225cb27; Saunders PU, 2004, SPORTS MED, V34, P465, DOI 10.2165/00007256-200434070-00005; Zourdos MC, 2012, J STRENGTH COND RES, V26, P335, DOI 10.1519/JSC.0b013e318225bbae; Behm DG, 2011, EUR J APPL PHYSIOL, V111, P2633, DOI 10.1007/s00421-011-1879-2; Joyner MJ, 2008, J PHYSIOL-LONDON, V586, P35, DOI 10.1113/jphysiol.2007.143834; Hudgins B, 2013, J STRENGTH COND RES, V27, P563, DOI 10.1519/JSC.0b013e31827e136f; Simic L, 2013, SCAND J MED SCI SPOR, V23, P131, DOI 10.1111/j.1600-0838.2012.01444.x; Damasceno MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099238; Kline R. B., 2004, SIGNIFICANCE TESTING; Lowery RP, 2014, J STRENGTH COND RES, V28, P161, DOI 10.1519/JSC.0b013e3182956461; Paavolainen LM, 1999, MED SCI SPORT EXER, V31, P124, DOI 10.1097/00005768-199901000-00020; Takizawa K, 2014, P MOV HLTH EX C 2014, P9; Takizawa K, MOV HLTH EX IN PRESS; Yamaguchi T, 2014, J PHYS FITNESS SPORT, V3, P121	29	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1064-8011	1533-4287		J STRENGTH COND RES	J. Strength Cond. Res.	NOV	2015	29	11					3045	3052		10.1519/JSC.0000000000000969		8	Sport Sciences	Sport Sciences	CV4JF	WOS:000364232300006		
J	Miyaguchi, K; Demura, S; Omoya, M				Miyaguchi, Kazuyoshi; Demura, Shinichi; Omoya, Masashi			RELATIONSHIP BETWEEN JUMP ROPE DOUBLE UNDERS AND SPRINT PERFORMANCE IN ELEMENTARY SCHOOLCHILDREN	JOURNAL OF STRENGTH AND CONDITIONING RESEARCH			English	Article						stretch-shortening cycle; sprint ability; rebound jumping; Myotest; reactivity index	STRETCH-SHORTENING CYCLE; LEG STRENGTH; STIFFNESS; FORCE; POWER; EXERCISES; VELOCITY; FEMALES; MALES; TIME	Miyaguchi, K, Demura, S, and Omoya, M. Relationship between jump rope double unders and sprint performance in elementary schoolchildren. J Strength Cond Res 29(11): 3229-3233, 2015According to dynamic analyses of muscle contraction, jump rope is a typical stretch-shortening cycle (SSC) movement. It has been reported that the relationship with SSC is higher in double unders than in single unders (basic jumps); however, the relationship between jump rope and sprint performances has not been extensively studied. To clarify this relationship in elementary schoolchildren, we compared the sprint speed and SSC ability of children who were grouped according to gender and ability. The subjects were 143 elementary fifth and sixth graders (78 boys, 65 girls). The consecutive maximal number of double unders, reactivity index (index of SSC ability) by Myotest, and 20-m sprint time were measured. According to the mean of jump rope records, the children were divided into a superior ability group (more than average + 0.5 SD) and an inferior ability group (less than average - 0.5 SD) for each gender. In both genders, a significant difference was found in the 20-m sprint time between the inferior and superior ability groups. The times for the superior ability groups (boys, 3.75 +/- 0.23 seconds; girls, 4.02 +/- 0.24 seconds) were excellent compared with the inferior ability groups (boys, 4.17 +/- 0.32 seconds; girls, 4.23 +/- 0.21 seconds). This effect size was higher in boys (1.44) than in girls (0.93). The reactivity index in the superior ability group was excellent compared with that in the inferior ability group. In conclusion, children who perform better in double unders are also faster during a 20-m sprint run. This tendency may be higher in boys. Classic jump rope training, such as double unders, should be effective as elementary plyometrics for improving the sprint ability of children.	[Miyaguchi, Kazuyoshi] Ishikawa Prefectural Univ, Nonoichi, Ishikawa, Japan; [Demura, Shinichi] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Omoya, Masashi] Kanazawa Univ, Human & Socioenvironm Studies, Grad Sch, Kanazawa, Ishikawa, Japan	Miyaguchi, K (reprint author), Ishikawa Prefectural Univ, Nonoichi, Ishikawa, Japan.	kazu1060@lapis.plala.or.jp					MERO A, 1994, J APPL BIOMECH, V10, P1; NORMAN RW, 1979, ACTA PHYSIOL SCAND, V106, P241, DOI 10.1111/j.1748-1716.1979.tb06394.x; JONES DM, 1962, RES QUART, V33, P236; Miyaguchi K, 2009, J STRENGTH COND RES, V23, P231, DOI 10.1519/JSC.0b013e3181876a38; JETTE M, 1979, J SPORT MED PHYS FIT, V19, P33; MERO A, 1986, EUR J APPL PHYSIOL O, V55, P553, DOI 10.1007/BF00421652; Miyaguchi K, 2014, J STRENGTH COND RES, V28, P700, DOI 10.1519/JSC.0b013e3182a0c9a5; Chelly SM, 2001, MED SCI SPORT EXER, V33, P326; AURA O, 1986, EUR J APPL PHYSIOL O, V55, P37, DOI 10.1007/BF00422890; TOWN GP, 1980, MED SCI SPORT EXER, V12, P295; Viitasalo JT, 1997, J APPL BIOMECH, V13, P254; Blackburn JT, 2006, CLIN BIOMECH, V21, P159, DOI 10.1016/j.clinbiomech.2005.08.012; MERO A, 1990, EUR J APPL PHYSIOL O, V61, P73, DOI 10.1007/BF00236697; Bret C, 2002, J SPORT MED PHYS FIT, V42, P274; COLLIANDER EB, 1989, EUR J APPL PHYSIOL O, V59, P227, DOI 10.1007/BF02386192; COSTILL DL, 1968, RES QUART, V39, P785; Endo T, 2007, JPN SOC PHYS EDUC, V52, P149; Ito H, 1984, B FACULTY ED SHIZUOK, V35, P67; Kato E, 2005, INT J SPORT HLTH SCI, V3, P218, DOI 10.5432/ijshs.3.218; Kitagawa J, 1987, B ANN FITNESS SPORTS, V2, P61; Komi P V, 1984, Exerc Sport Sci Rev, V12, P81; Locatelli E, 1996, N STUD ATHLETICS, V11, P121; MERO A, 1988, RES Q EXERCISE SPORT, V59, P94; Yamaguchi H, 2000, KAWASAKI MED WELFARE, V10, P329; Yoon S, 1999, JAPAN J PHYS ED HLTH, V44, P510	25	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1064-8011	1533-4287		J STRENGTH COND RES	J. Strength Cond. Res.	NOV	2015	29	11					3229	3233		10.1519/JSC.0000000000000543		5	Sport Sciences	Sport Sciences	CV4JF	WOS:000364232300030		
J	Yamaji, A				Yamaji, Atsushi			N How tightly does calcite e-twin constrain stress? (vol 72, pg 83, 2015)	JOURNAL OF STRUCTURAL GEOLOGY			English	Correction									Kyoto Univ, Grad Sch Sci, Div Earth & Planetary Sci, Kyoto 6068502, Japan	Yamaji, A (reprint author), Kyoto Univ, Grad Sch Sci, Div Earth & Planetary Sci, Kyoto 6068502, Japan.						Yamaji A, 2015, J STRUCT GEOL, V72, P83, DOI 10.1016/j.jsg.2015.01.008	1	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0191-8141			J STRUCT GEOL	J. Struct. Geol.	NOV	2015	80						1	1		10.1016/j.jsg.2015.08.004		1	Geosciences, Multidisciplinary	Geology	CV4NZ	WOS:000364245100001		
J	Yamaji, A				Yamaji, Atsushi			Generalized Hough transform for the stress inversion of calcite twin data	JOURNAL OF STRUCTURAL GEOLOGY			English	Article						Stress space; Inverse method; Sampling bias; Paleostress	FAULT-SLIP DATA; TENSOR INVERSION; STRIATED FAULTS; PALEOSTRESS; POLYCRYSTALS; SPACE	Since the mechanical twinning along calcite e-planes has a critical resolved shear stress, not only principal stress axes but also differential stress can be determined from the orientations of twin lamellae. Based on the five-dimensional stress space that fulfills the principle of coordinate invariance, it is shown in this article that the inversion of twin and untwin data is comparable with fitting a spherical cap to data points on a unit sphere in the space. The principal stress orientations and stress ratio are indicated by the center of the cap, whereas differential stress is denoted by the size of the cap. Based on this geometrical interpretation, the generalized Hough transform was applied to the inversion of the data in this study. The new method is demonstrated to be robust to sampling bias, variability in the critical resolved shear stress. The determination of differential stress was difficult when the differential stress to be detected was 10 times larger than the critical resolved shear stress. Stresses were separated by the method from heterogeneous data successfully as long as the spherical caps corresponding to the stresses to be detected had no or a small intersection. (C) 2015 Elsevier Ltd. All rights reserved.	Kyoto Univ, Grad Sch Sci, Div Earth & Planetary Sci, Kyoto 6068502, Japan	Yamaji, A (reprint author), Kyoto Univ, Grad Sch Sci, Div Earth & Planetary Sci, Kyoto 6068502, Japan.	yamaji@kueps.kyoto-u.ac.jp			JSPS [15H02141]	The author gratefully acknowledges the helpful comments by Prof. O. Lacombe and Dr. K. Amrouch to early versions of the manuscript, which greatly improved the manuscript. Thanks are also due to Prof. T. Takeshita for his kind editorial support. This work was supported financially by JSPS (15H02141).	Amrouch K, 2010, TECTONICS, V29, DOI 10.1029/2009TC002525; Amrouch K, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048649; Angelier J., 1977, B SOC GEOL FR, V19, P1309; TAKESHITA T, 1987, J GEOPHYS RES-SOLID, V92, P12917, DOI 10.1029/JB092iB12p12917; Sato K, 2006, J STRUCT GEOL, V28, P957, DOI 10.1016/j.jsg.2006.03.004; Nemcok M, 1999, J STRUCT GEOL, V21, P597, DOI 10.1016/S0191-8141(99)00053-X; TERZAGHI RD, 1965, GEOTECHNIQUE, V15, P287; Orife T, 2003, J STRUCT GEOL, V25, P949, DOI 10.1016/S0191-8141(02)00120-7; Yamaji A, 2006, GEOPHYS J INT, V167, P933, DOI 10.1111/j.1365-246X.2006.03188.x; Yamaji A, 2000, J STRUCT GEOL, V22, P441, DOI 10.1016/S0191-8141(99)00163-7; LAURENT P, 1990, TECTONICS, V9, P379, DOI 10.1029/TC009i003p00379; LAURENT P, 1981, TECTONOPHYSICS, V78, P651, DOI 10.1016/0040-1951(81)90034-2; Yamaji A, 2012, COMPUT GEOSCI-UK, V38, P164, DOI 10.1016/j.cageo.2011.04.016; TOURNERET C, 1990, TECTONOPHYSICS, V180, P287, DOI 10.1016/0040-1951(90)90314-X; Beaudoin N, 2012, TECTONOPHYSICS, V576, P20, DOI 10.1016/j.tecto.2012.03.036; Fry N, 2001, J STRUCT GEOL, V23, P1, DOI 10.1016/S0191-8141(00)00136-X; Gagala L, 2009, INT J EARTH SCI, V98, P461, DOI 10.1007/s00531-007-0262-3; Bullard D.H., 1981, PATTERN RECOGN, V13, P111; DAVIES ER, 1987, PATTERN RECOGN LETT, V6, P1, DOI 10.1016/0167-8655(87)90042-0; Etchecopar A., 1984, THESIS U MONTPELLIER; Hill R., 1950, MATH THEORY PLASTICI; Jaya A., 2014, J STRUCT GEOL, V55, P34; Lacombe O, 2010, OIL GAS SCI TECHNOL, V65, P809, DOI 10.2516/ogst/2009088; Meyer C. D., 2000, MATRIX ANAL APPL LIN; Pfiffner O.A., 1987, ANN TECTONICAE, V1, P48; Press W. H., 2007, NUMERICAL RECIPES AR; Rakhamanov D.E.A., 1994, MATH RES LETT, V1, P647; Ottosen NS, 2005, MECHANICS OF CONSTITUTIVE MODELING, P1; Shakarchi R., 1998, PROBLEMS SOLUTIONS U; Tan P. N., 2006, INTRO DATA MINING; Yamaji A., 2007, INTRO TECTONOPHYSICS; Yamaji A, 2015, J STRUCT GEOL, V72, P83, DOI 10.1016/j.jsg.2015.01.008	32	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0191-8141			J STRUCT GEOL	J. Struct. Geol.	NOV	2015	80						2	15		10.1016/j.jsg.2015.08.001		14	Geosciences, Multidisciplinary	Geology	CV4NZ	WOS:000364245100002		
J	Mateen, T; Yamamoto, H; Rehman, HU; Terabayashi, M				Mateen, Tayyaba; Yamamoto, Hiroshi; Rehman, Hafiz Ur; Terabayashi, Masaru			Ductility contrast induced by silicification in pelitic schist of the Ryoke metamorphic belt, Japan	JOURNAL OF STRUCTURAL GEOLOGY			English	Article						Ryoke metamorphic belt; Pelitic schist; Silicification; Quartz veins; Bright spot	SOUTHWEST JAPAN; FABRIC DEVELOPMENT; PREFERRED ORIENTATIONS; TEMPERATURE CONDITIONS; SEISMIC PROPERTIES; SUBDUCTION ZONE; POISSONS RATIO; YANAI DISTRICT; BRIGHT SPOTS; MIDDLE CRUST	Contrasting ductility is recognized in the rocks of Cretaceous Ryoke metamorphic belt in Iwakuni area, southwest Japan. Pelitic schist is ubiquitous in the region and differences in mineral assemblages mark increase in metamorphic grade. The area has been graded as chlorite-biotite zone in the north progressing into biotite- and muscovite-cordierite zones in the south. Pelitic schist near the boundary between the biotite- and muscovite-cordierite zones has undergone partial silicification to form whitish silicified schist layers which contain two types of quartz veins: those parallel to foliation in the host rock are called schistosity-concordant veins, and those inclined to host rock foliation, schistosity-discordant veins. In this study we examined the quartz structure in the silicified schist and in both types of veins to understand the ductility contrast induced by the silicification process. Crystallographic orientations of quartz in the veins and silicified schist rocks were studied using the Scanning Electron Microscopy (SEM) based Electron Back Scatter Diffraction (EBSD) technique. Quartz c-axis orientations in the silicified schist are nearly random, demonstrating an absence of post-silicification ductile deformation. Quartz grains in the schistosity-concordant veins have preferred c-axis orientations perpendicular to the schistosity indicating ductile shortening. In contrast, schistosity-discordant veins display distinct quartz c-axis fabric than that found in the schistosity-concordant veins. This is because the two types of host rocks exhibit a difference in ductility during deformation. The presence of deformed quartz veins in the undeformed silicified schist indicates transformation of the ductile pelitic schist into the brittle silicified schist at mid-crustal levels where these rocks originate, hence forming contrasting rock layers. Schistosity-concordant veins in the biotite-rich pelitic schist deformed with its host rock in a ductile manner while the schistosity-discordant veins in the neighboring silicified schist were left intact. Silicification of the pelitic schist may have been caused by the silica-rich geofluids produced by subsurface processes. Geofluids responsible for the occurrence of such mechanically contrasting layers mark an increase in seismic reflectivity at mid-crustal depths and may be potential reflectors of seismic waves giving rise to the so-called "bright spots". (C) 2015 Elsevier Ltd. All rights reserved.	[Mateen, Tayyaba; Yamamoto, Hiroshi; Rehman, Hafiz Ur] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 8900065, Japan; [Terabayashi, Masaru] Kagawa Univ, Dept Safety Syst Construct Engn, Takamatsu, Kagawa 7610396, Japan	Mateen, T (reprint author), Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 8900065, Japan.	k9977115@kadai.jp; hyam@sci.kagoshim-u.ac.jp; hafiz@sci.kagoshima-u.ac.jp; tera@eng.kagawa-u.ac.jp		Mateen, Tayyaba/0000-0002-4660-2387	KAKENHI [22540472]	The authors thank Y. Oozono and K. Ohkura of the Natural Science Center for Research and Education, Kagoshima University, for his help with the EBSD and EPMA-CL analyses. The authors are indebted to L F. G. Morales and an anonymous reviewer for their critical comments. This study was supported in part by KAKENHI (No. 22540472).	Mateen T, 2013, J MINER PETROL SCI, V108, P278, DOI 10.2465/jmps.130118b; TULLIS J, 1973, GEOL SOC AM BULL, V84, P297, DOI 10.1130/0016-7606(1973)84<297:MAPOOE>2.0.CO;2; Breeding CM, 2002, GEOLOGY, V30, P499, DOI 10.1130/0091-7613(2002)030<0499:SDFAQV>2.0.CO;2; Sibson RH, 2009, TECTONOPHYSICS, V473, P404, DOI 10.1016/j.tecto.2009.03.016; DEVOOGD B, 1986, GEOLOGY, V14, P64, DOI 10.1130/0091-7613(1986)14<64:DVBSAM>2.0.CO;2; Ito K, 1999, TECTONOPHYSICS, V306, P423, DOI 10.1016/S0040-1951(99)00069-4; Lloyd GE, 2009, EARTH PLANET SC LETT, V288, P320, DOI 10.1016/j.epsl.2009.09.035; Hasegawa A, 2000, TECTONOPHYSICS, V319, P225, DOI 10.1016/S0040-1951(99)00296-6; OKUDAIRA T, 1995, TECTONOPHYSICS, V250, P31, DOI 10.1016/0040-1951(95)00039-4; Ward D, 2012, GEOPHYS J INT, V190, P1123, DOI 10.1111/j.1365-246X.2012.05528.x; Matsumoto Y, 2010, ISL ARC, V19, P30, DOI 10.1111/j.1440-1738.2009.00695.x; Hippertt J, 1996, J STRUCT GEOL, V18, P1345, DOI 10.1016/S0191-8141(96)00047-8; Fagereng A, 2014, TECTONOPHYSICS, V612, P147, DOI 10.1016/j.tecto.2013.12.002; Barth NC, 2010, GEOL SOC SPEC PUBL, V335, P663, DOI 10.1144/SP335.27; IKEDA T, 1993, LITHOS, V30, P109, DOI 10.1016/0024-4937(93)90010-A; Terabayashi M, 2010, ISL ARC, V19, P17, DOI 10.1111/j.1440-1738.2009.00701.x; Price NA, 2012, TECTONOPHYSICS, V518, P63, DOI 10.1016/j.tecto.2011.11.011; WHITE RS, 1977, EARTH PLANET SC LETT, V37, P29, DOI 10.1016/0012-821X(77)90143-1; Makovsky Y, 1999, J GEOPHYS RES-SOL EA, V104, P10795, DOI 10.1029/1998JB900074; Umino N, 2002, EARTH PLANETS SPACE, V54, P1021; BEBOUT GE, 1989, GEOLOGY, V17, P976, DOI 10.1130/0091-7613(1989)017<0976:FFAMIA>2.3.CO;2; Ikeda T, 2004, CONTRIB MINERAL PETR, V146, P577, DOI 10.1007/s00410-003-0521-7; MAINPRICE D, 1994, SURV GEOPHYS, V15, P575, DOI 10.1007/BF00690175; Law RD, 2004, J GEOL SOC LONDON, V161, P305, DOI 10.1144/0016-764903-047; TULLIS J, 1977, TECTONOPHYSICS, V39, P87, DOI 10.1016/0040-1951(77)90090-7; LISTER GS, 1979, J STRUCT GEOL, V1, P283, DOI 10.1016/0191-8141(79)90003-8; Zhao DP, 1996, SCIENCE, V274, P1891, DOI 10.1126/science.274.5294.1891; LISTER GS, 1980, J STRUCT GEOL, V2, P355, DOI 10.1016/0191-8141(80)90023-1; Lloyd GE, 2005, GEOL SOC SPEC PUBL, V240, P75, DOI 10.1144/GSL.SP.2005.240.01.07; Lagoeiro L, 2010, J STRUCT GEOL, V32, P595, DOI 10.1016/j.jsg.2010.03.007; Toy VG, 2008, J STRUCT GEOL, V30, P602, DOI 10.1016/j.jsg.2008.01.001; Brown M, 1998, J METAMORPH GEOL, V16, P3, DOI 10.1111/j.1525-1314.1998.00061.x; Morales LFG, 2014, TECTONOPHYSICS, V636, P52, DOI 10.1016/j.tecto.2014.08.011; CHIGIRA M, 1994, J GEOPHYS RES-SOL EA, V99, P15539, DOI 10.1029/94JB01175; Christensen NI, 1996, J GEOPHYS RES-SOL EA, V101, P3139, DOI 10.1029/95JB03446; Kirschner D., 1990, J STRUCT GEOL, V13, P105; Lee J., 1987, GEOLOGICAL SOC SPECI, V28, P267, DOI 10.1144/GSL.SP.1987.028.01.18; Okudaira T., 1993, MEMOIRS GEOLOGICAL S, V42, P91; Passchier C.W., 2005, MICROTECTONICS, P366; Pratt T.L., 1991, REFLECTION POLARITY; Prior D, 2009, ELECT BACKSCATTER DI, P345, DOI 10.1007/978-0-387-88136-2_26; Schmid S.M., 1986, GEOPHYS MONOGR AM GE, V36, P263, DOI DOI 10.1029/GM036P0263; Yamamoto H, 2004, J GEOLOGICAL SOC JAP, V110, P119	43	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0191-8141			J STRUCT GEOL	J. Struct. Geol.	NOV	2015	80						38	46		10.1016/j.jsg.2015.08.009		9	Geosciences, Multidisciplinary	Geology	CV4NZ	WOS:000364245100005		
J	Wang, HX; Yoda, Y; Ogata, H; Tanaka, Y; Lubitz, W				Wang, Hongxin; Yoda, Yoshitaka; Ogata, Hideaki; Tanaka, Yoshihito; Lubitz, Wolfgang			A strenuous experimental journey searching for spectroscopic evidence of a bridging nickel-iron-hydride in [NiFe] hydrogenase	JOURNAL OF SYNCHROTRON RADIATION			English	Article						nuclear resonance vibrational spectroscopy; NRVS; ultra-weak signal; [NiFe] hydrogenase; Ni-R; Ni-H-Fe wag mode; iron hydride	RESONANCE VIBRATIONAL SPECTROSCOPY; NORMAL-MODE ANALYSIS; ACTIVE-SITE; ELECTRONIC-STRUCTURE; SCATTERING BEAMLINE; RAMAN-SPECTROSCOPY; ENDOR SPECTROSCOPY; LONG UNDULATOR; SPRING-8; ENZYMES	Direct spectroscopic evidence for a hydride bridge in the Ni-R form of [NiFe] hydrogenase has been obtained using iron-specific nuclear resonance vibrational spectroscopy (NRVS). The Ni-H-Fe wag mode at 675 cm(-1) is the first spectroscopic evidence for a bridging hydride in Ni-R as well as the first iron-hydride-related NRVS feature observed for a biological system. Although density function theory (DFT) calculation assisted the determination of the Ni-R structure, it did not predict the Ni-H-Fe wag mode at similar to 675 cm(-1) before NRVS. Instead, the observed Ni-H-Fe mode provided a critical reference for the DFT calculations. While the overall science about Ni-R is presented and discussed elsewhere, this article focuses on the long and strenuous experimental journey to search for and experimentally identify the Ni-H-Fe wag mode in a Ni-R sample. As a methodology, the results presented here will go beyond Ni-R and hydrogenase research and will also be of interest to other scientists who use synchrotron radiation for measuring dilute samples or weak spectroscopic features.	[Wang, Hongxin] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Wang, Hongxin] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Yoda, Yoshitaka; Tanaka, Yoshihito] SPring 8 JASRI, Res & Utilizat Div, Sayo, Hyogo 6795198, Japan; [Ogata, Hideaki; Lubitz, Wolfgang] Max Planck Inst Chem Energy Convers, D-45470 Mulheim, Germany; [Tanaka, Yoshihito] Univ Hyogo, Grad Sch Mat Sci, Kamigori, Hyogo 6781297, Japan	Wang, HX (reprint author), Univ Calif Davis, Dept Chem, 1 Cyclotron Rd, Davis, CA 95616 USA.	hxwang2@lbl.gov	Ogata, Hideaki/J-4975-2013		NIH [GM-65440]; DOE Office of Biological and Environmental Research; BMBF [03SF0355C]; EU/Energy Network project SOLAR-H2 (FP7) [212508]; DFG - Cluster of Excellence RESOLV [EXC1069]; Max Planck Society; JASRI [2012A0032-2013B0032, 2014B1032]; RIKEN [20120107, 20130022]	This work was funded by NIH (GM-65440) and DOE Office of Biological and Environmental Research (both to Professor Stephen P. Cramer at UC Davis). We also thank Professor Cramer for his overall support to this research. The work was also supported by BMBF (03SF0355C), EU/Energy Network project SOLAR-H2 (FP7 contract 212508), DFG-funded Cluster of Excellence RESOLV (EXC1069) and Max Planck Society (HO and WL). Use of SPring-8 is supported by JASRI (via proposals 2012A0032-2013B0032 and 2014B1032) and RIKEN (via proposals 20120107 and 20130022).	Dole F, 1997, BIOCHEMISTRY-US, V36, P7847, DOI 10.1021/bi963171i; Barilone JL, 2015, PHYS CHEM CHEM PHYS, V17, P16204, DOI 10.1039/c5cp01322d; Wang HX, 2000, J AM CHEM SOC, V122, P10544, DOI 10.1021/ja000945g; Kim JYH, 2013, KOREAN J CHEM ENG, V30, P1, DOI 10.1007/s11814-012-0208-8; Wang HX, 2001, J ELECTRON SPECTROSC, V114, P855, DOI 10.1016/S0368-2048(00)00370-4; Hara T, 2002, REV SCI INSTRUM, V73, P1125, DOI 10.1063/1.1445866; Jugder BE, 2013, RSC ADV, V3, P8142, DOI 10.1039/c3ra22668a; Wang HX, 2014, METHODS MOL BIOL, V1122, P125, DOI 10.1007/978-1-62703-794-5_9; Tard C, 2009, CHEM REV, V109, P2245, DOI 10.1021/cr800542q; Armstrong FA, 2009, CHEM SOC REV, V38, P36, DOI 10.1039/b801144n; Ogata H, 2015, NATURE, V520, P571, DOI 10.1038/nature14110; Fritsch J, 2013, NAT REV MICROBIOL, V11, P106, DOI 10.1038/nrmicro2940; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Inada T, 2013, PHYS LETT B, V722, P301, DOI 10.1016/j.physletb.2013.04.033; Wang H, 2001, J ELECTRON SPECTROSC, V114, P865, DOI 10.1016/S0368-2048(00)00375-3; Gu WW, 2003, J INORG BIOCHEM, V93, P41, DOI 10.1016/S0162-0134(02)00494-4; Wang HX, 2012, J SYNCHROTRON RADIAT, V19, P257, DOI 10.1107/S0909049512001380; Yang JY, 2011, MRS BULL, V36, P39, DOI 10.1557/mrs.2010.8; Xiao YM, 2005, J AM CHEM SOC, V127, P14596, DOI 10.1021/ja042960h; Armstrong FA, 2009, PHOTOSYNTH RES, V102, P541, DOI 10.1007/s11120-009-9428-0; Bergmann U, 2003, J AM CHEM SOC, V125, P4016, DOI 10.1021/ja028767+; STURHAHN W, 1995, PHYS REV LETT, V74, P3832, DOI 10.1103/PhysRevLett.74.3832; Yoda Y, 2012, HYPERFINE INTERACT, V206, P83, DOI 10.1007/s10751-011-0532-0; Amara P, 1999, J AM CHEM SOC, V121, P4468, DOI 10.1021/ja983971b; Lauterbach L, 2015, CHEM SCI, V6, P1055, DOI 10.1039/c4sc02982h; Ogata H, 2005, STRUCTURE, V13, P1635, DOI 10.1016/j.str.2005.07.018; Guiral M, 2006, INT J HYDROGEN ENERG, V31, P1424, DOI 10.1016/j.ijhydene.2006.06.007; Tinberg CE, 2010, J AM CHEM SOC, V132, P18168, DOI 10.1021/ja106290p; Jayapal P, 2008, PHYS CHEM CHEM PHYS, V10, P1734, DOI 10.1039/b719980e; Evans RM, 2013, J AM CHEM SOC, V135, P2694, DOI 10.1021/ja311055d; Smith MC, 2005, INORG CHEM, V44, P5562, DOI 10.1021/ic0482584; Matsumoto T, 2013, CHEMCATCHEM, V5, P1368, DOI 10.1002/cctc.201200595; Lubitz W, 2014, CHEM REV, V114, P4081, DOI 10.1021/cr4005814; Shafaat HS, 2012, INORG CHEM, V51, P11787, DOI 10.1021/ic3017276; Kamali S, 2013, ANGEW CHEM INT EDIT, V52, P724, DOI 10.1002/anie.201204616; Do LH, 2011, CHEM COMMUN, V47, P10945, DOI 10.1039/c1cc13836g; Brecht M, 2003, J AM CHEM SOC, V125, P13075, DOI 10.1021/ja036624x; Dong WB, 2013, INFRARED PHYS TECHN, V56, P51, DOI 10.1016/j.infrared.2012.10.003; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; Simmons TR, 2013, ANGEW CHEM INT EDIT, V52, P6143, DOI 10.1002/anie.201302908; Yoda Y, 2001, NUCL INSTRUM METH A, V467, P715, DOI 10.1016/S0168-9002(01)00474-0; Foerster S, 2003, J AM CHEM SOC, V125, P83, DOI 10.1021/ja027522u; Pelmenschikov V, 2011, FARADAY DISCUSS, V148, P409, DOI 10.1039/c004367m; Wang HX, 2013, J SYNCHROTRON RADIAT, V20, P683, DOI 10.1107/S0909049513021201; SETO M, 1995, PHYS REV LETT, V74, P3828, DOI 10.1103/PhysRevLett.74.3828; Barton BE, 2009, J AM CHEM SOC, V131, P6942, DOI 10.1021/ja902570u; Schilter D, 2012, INORG CHEM, V51, P2338, DOI 10.1021/ic202329y; Yabashi M, 2001, NUCL INSTRUM METH A, V467, P678, DOI 10.1016/S0168-9002(01)00444-2; Takahashi S, 2001, NUCL INSTRUM METH A, V467, P758, DOI 10.1016/S0168-9002(01)00488-0; Shafaat HS, 2013, BBA-BIOENERGETICS, V1827, P986, DOI 10.1016/j.bbabio.2013.01.015; Heinekey DM, 2009, J ORGANOMET CHEM, V694, P2671, DOI 10.1016/j.jorganchem.2009.03.047; Mertens R, 2004, CURR OPIN BIOTECH, V15, P343, DOI 10.1016/j.copbio.2004.06.010; Cammack, 2001, HYDROGEN FUEL LEARNI; Cramer S. P., 2007, HYPERFINE INTERACT, V170, P47, DOI 10.1007/s10751-006-9473-4; Crossland J. L., 2009, DALTON T, V2009, P9253; Gastel M. van, 2005, J BIOL INORG CHEM, V11, P41; Goto S., 2000, SPRING 8 ANN REPORT, P30; Lubitz W., 2013, ENCY BIOL CHEM, P562; Ogata H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8890; Tanaka Y, 2011, Journal of Physics: Conference Series, V278, DOI 10.1088/1742-6596/278/1/012018; Volbeda A, 2015, J BIOL INORG CHEM, V20, P11, DOI 10.1007/s00775-014-1203-9	61	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	1600-5775			J SYNCHROTRON RADIAT	J. Synchrot. Radiat.	NOV	2015	22		6				1334	1344		10.1107/S1600577515017816		11	Instruments & Instrumentation; Optics; Physics, Applied	Instruments & Instrumentation; Optics; Physics	CV6ZV	WOS:000364422100002		
J	Toyoshima, A; Kikuchi, T; Tanaka, H; Mase, K; Amemiya, K				Toyoshima, Akio; Kikuchi, Takashi; Tanaka, Hirokazu; Mase, Kazuhiko; Amemiya, Kenta			In situ removal of carbon contamination from a chromium-coated mirror: ideal optics to suppress higher-order harmonics in the carbon K-edge region	JOURNAL OF SYNCHROTRON RADIATION			English	Article						carbon contamination; in situ carbon removal; chromium-coated optics; carbon K-edge; higher-order harmonics	BEAMLINE; CONSTRUCTION; ULTRAVIOLET; FILTER	Carbon-free chromium-coated optics are ideal in the carbon K-edge region (280-330 eV) because the reflectivity of first-order light is larger than that of gold-coated optics while the second-order harmonics (560-660 eV) are significantly suppressed by chromium L-edge and oxygen K-edge absorption. Here, chromium-, gold- and nickel-coated mirrors have been adopted in the vacuum ultraviolet and soft X-ray branch beamline BL-13B at the Photon Factory in Tsukuba, Japan. Carbon contamination on the chromium- coated mirror was almost completely removed by exposure to oxygen at a pressure of 8 x 10(-2) Pa for 1 h under irradiation of non-monochromated synchrotron radiation. The pressure in the chamber recovered to the order of 10(-7) Pa within a few hours. The reflectivity of the chromium- coated mirror of the second-order harmonics in the carbon K-edge region (560-660 eV) was found to be a factor of 0.1-0.48 smaller than that of the gold-coated mirror.	[Toyoshima, Akio; Kikuchi, Takashi; Tanaka, Hirokazu; Mase, Kazuhiko; Amemiya, Kenta] KEK, Inst Mat Struct Sci, Tsukuba, Ibaraki 3050801, Japan; [Mase, Kazuhiko; Amemiya, Kenta] SOKENDAI Grad Univ Adv Studies, Dept Mat Struct Sci, Tsukuba, Ibaraki 3050801, Japan	Mase, K (reprint author), KEK, Inst Mat Struct Sci, 1-1 Oho, Tsukuba, Ibaraki 3050801, Japan.	mase@post.kek.jp					SUITS AG, 1995, REV SCI INSTRUM, V66, P4841, DOI 10.1063/1.1146161; YAMADA R, 1982, J NUCL MATER, V111, P744, DOI 10.1016/0022-3115(82)90299-9; WAKI I, 1989, REV SCI INSTRUM, V60, P2072, DOI 10.1063/1.1140829; Amemiya K, 2004, J SYNCHROTRON RADIAT, V11, P171, DOI 10.1107/S0909049503023598; Toyoshima A, 2012, J SYNCHROTRON RADIAT, V19, P722, DOI 10.1107/S0909049512024971; SASAKI S, 1989, REV SCI INSTRUM, V60, P1859, DOI 10.1063/1.1140923; ROSENBERG RA, 1986, PHYS REV B, V33, P4034, DOI 10.1103/PhysRevB.33.4034; Mase K, 2010, AIP CONF PROC, V1234, P709, DOI 10.1063/1.3463308; Mase Kazuhiko, 2010, Journal of the Vacuum Society of Japan, V53, DOI 10.3131/jvsj2.53.454; POWELL FR, 1990, OPT ENG, V29, P614, DOI 10.1117/12.55641; Samson J. A., 2000, VACUUM ULTRAVIOLET S; Tanaka Hirokazu, 2011, Journal of the Vacuum Society of Japan, V54, DOI 10.3131/jvsj2.54.481; Toyoshima A, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/15/152019; Toyoshima Akio, 2011, Journal of the Vacuum Society of Japan, V54, DOI 10.3131/jvsj2.54.580	14	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	1600-5775			J SYNCHROTRON RADIAT	J. Synchrot. Radiat.	NOV	2015	22		6				1359	1363		10.1107/S1600577515015040		5	Instruments & Instrumentation; Optics; Physics, Applied	Instruments & Instrumentation; Optics; Physics	CV6ZV	WOS:000364422100005		
J	Makizako, H; Shimada, H; Tsutsumimoto, K; Lee, S; Doi, T; Nakakubo, S; Hotta, R; Suzuki, T				Makizako, Hyuma; Shimada, Hiroyuki; Tsutsumimoto, Kota; Lee, Sanyoon; Doi, Takehiko; Nakakubo, Sho; Hotta, Ryo; Suzuki, Takao			Social Frailty in Community-Dwelling Older Adults as a Risk Factor for Disability	Journal of the American Medical Directors Association			English	Article						Frailty; disability; long-term care; social activity; social role; social relationship	TERM-CARE INSURANCE; ELDERLY-PEOPLE; HEALTH-CARE; JAPAN; POPULATION; WOMEN; PREVALENCE; MORTALITY; DEMENTIA; NETWORK	Objective: To determine social frailty status using simple questions and to examine the association between social frailty and disability onset among community-dwelling older adults. Design: Prospective cohort study. Setting: Japanese community. Participants: A total of 4304 adults age >= 65 years living in the community participated in a baseline assessment from 2011 to 2012. They were followed monthly for incident certification of care needs during the 2 years after the baseline assessment. Measurements: Care-needs certification in the national long-term care insurance system of Japan; a self-reported questionnaire including 7 items to define social frailty status, adjustment for several potential confounders such as demographic characteristics; and Kaplan-Meier survival curves for disability incidence by social frailty. Results: During the 2 years, 144 participants (3.3%) were certified as requiring long-term care insurance in accordance with incident disability. Five of the 7 items in the self-reported questionnaire were significantly associated with disability incidence. In the adjusted model including potential covariates, participants who were defined as having social frailty (=2/5) (hazard ratio 1.66, 95% confidence interval 1.00-2.74) and prefrailty (=1/5) (hazard ratio 1.53, 95% confidence interval 1.02-2.531), based on 5 items at the baseline assessment, had an increased risk of disability compared with nonfrail participants (=0/5). Conclusions: Social frailty, assessed using simple questions regarding living alone, going out less frequently compared with the prior year, visiting friends sometimes, feeling helpful to friends or family, and talking with someone every day, has a strong impact on the risk of future disability among community-dwelling older people. (C) 2015 AMDA - The Society for Post-Acute and Long-Term Care Medicine.	[Makizako, Hyuma; Shimada, Hiroyuki; Tsutsumimoto, Kota; Lee, Sanyoon; Doi, Takehiko; Nakakubo, Sho; Hotta, Ryo] Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Dept Prevent Gerontol, Obu, Aichi 4748511, Japan; [Suzuki, Takao] Oberlin Univ, Res Inst Aging & Dev, Tokyo, Japan	Makizako, H (reprint author), Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Dept Prevent Gerontol, 7-430 Morioka Machi, Obu, Aichi 4748511, Japan.	makizako@ncgg.go.jp			Japanese Ministry of Health, Labor, and Welfare [B-3]; National Center for Geriatrics and Gerontology (Research Funding for Longevity Sciences) [22-16]; Japan Society for the Promotion of Science [26702033]	This work was supported by the Japanese Ministry of Health, Labor, and Welfare (Project for optimizing long-term care) [grant number B-3]; and the National Center for Geriatrics and Gerontology (Research Funding for Longevity Sciences) [grant number 22-16]. This study was also supported in part by a grant-in-aid for young scientists (A) (26702033) from the Japan Society for the Promotion of Science.	Garre-Olmo J, 2013, AGE AGEING, V42, P46, DOI 10.1093/ageing/afs047; Bergman H, 2007, J GERONTOL A-BIOL, V62, P731; Ensrud KE, 2008, ARCH INTERN MED, V168, P382, DOI 10.1001/archinternmed.2007.113; Shimada H, 2015, J AM MED DIR ASSOC, V16, P690, DOI 10.1016/j.jamda.2015.03.019; Fujiwara Y, 2003, ARCH GERONTOL GERIAT, V36, P141, DOI 10.1016/S0167-4943(02)00081-X; Campbell JC, 2000, HEALTH AFFAIR, V19, P26, DOI 10.1377/hlthaff.19.3.26; Shimada H, 2013, J AM MED DIR ASSOC, V14, P518, DOI 10.1016/j.jamda.2013.03.010; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146; Buchman AS, 2009, ARCH INTERN MED, V169, P1139, DOI 10.1001/archinternmed.2009.135; Fratiglioni L, 2000, LANCET, V355, P1315, DOI 10.1016/S0140-6736(00)02113-9; Zunzunegui MV, 2003, J GERONTOL B-PSYCHOL, V58, pS93; Fujita K, 2006, J EPIDEMIOL, V16, P261, DOI 10.2188/jea.16.261; Levers MJ, 2006, J ADV NURS, V56, P282, DOI 10.1111/j.1365-2648.2006.04021.x; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; Lund R, 2010, AGE AGEING, V39, P319, DOI 10.1093/ageing/afq020; Avlund K, 2004, ARCH GERONTOL GERIAT, V38, P85, DOI 10.1016/j.archger.2003.08.003; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Gobbens RJJ, 2012, GERONTOLOGIST, V52, P619, DOI 10.1093/geront/gnr135; Fukutomi E, 2015, GERIATR GERONTOL INT, V15, P864, DOI 10.1111/ggi.12360; Tsutsui T, 2005, J AM GERIATR SOC, V53, P522, DOI 10.1111/j.1532-5415.2005.53175.x; Tamiya N, 2011, LANCET, V378, P1183, DOI 10.1016/S0140-6736(11)61176-8; Rockwood K, 1999, LANCET, V353, P205, DOI 10.1016/S0140-6736(98)04402-X; Gruenewald TL, 2007, J GERONTOL B-PSYCHOL, V62, pP28; Crooks VC, 2008, AM J PUBLIC HEALTH, V98, P1221, DOI 10.2105/AJPH.2007.115923; [Anonymous], 1975, J PSYCHIATR RES, DOI DOI 10.1016/0022-3956(75)90026-6; Hogan David B, 2003, Aging Clin Exp Res, V15, P1; Leon CF, 2014, J GERONTOL B-PSYCHOL, V69, P287; Vermeulen J, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-33	28	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1525-8610	1538-9375		J AM MED DIR ASSOC	J. Am. Med. Dir. Assoc.	NOV 1	2015	16	11								10.1016/j.jamda.2015.08.023		5	Geriatrics & Gerontology	Geriatrics & Gerontology	CV7DO	WOS:000364432800023		
J	Yamada, M; Arai, H				Yamada, Minoru; Arai, Hidenori			Predictive Value of Frailty Scores for Healthy Life Expectancy in Community-Dwelling Older Japanese Adults	Journal of the American Medical Directors Association			English	Article						Frailty; long-term care insurance; older adults	ELDERLY-PEOPLE; ASSOCIATION; PREVALENCE; DISABILITY; PHENOTYPE; INDEX	Objective: Frailty is one of many serious problems in countries with aging populations, such as Japan. The aim of this study was to examine whether higher scores on the newly developed self-report questionnaire for frailty are associated with adults being certified as needing care under the new long-term care insurance (LTCI) service requirement, over 2 years in community-dwelling older Japanese adults. Design: A prospective cohort study. Setting and Participants: We analyzed the cohort data for older adults (65 years and older) from a prospective study. We followed 5852 older individuals for 2 years and analyzed the association between higher frailty scores at baseline and new LTCI service requirement certifications. Outcome: The outcome was new certifications for LTCI services in a 2-year period. Measurements: We developed the 5-item frailty screening index, which included nutrition/shrinking, physical function, physical activity, forgetfulness, and emotions/exhaustion. Results: The prevalence values for frailty and prefrailty using our frailty screening index were 12.5% and 54.1%, respectively. During the 2-year follow-up period, 2.3% died and 8.5% individuals became newly certified as needing LTCI services. Prefrail older adults (adjusted hazard ratio: 8.4 [95% CI 5.0-14.2]) and frail older adults (adjusted hazard ratio: 22.7 [95% CI 13.3-38.8]) had a significantly higher risk of needing LTCI services than robust older adults as determined by multivariate analyses. Conclusion: The newly developed 5-item self-report questionnaire for frailty can predict disability in older Japanese adults. (C) 2015 AMDA - The Society for Post-Acute and Long-Term Care Medicine.	[Yamada, Minoru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Bunkyo Ku, Tokyo 1120012, Japan; [Arai, Hidenori] Natl Ctr Geriatr & Gerontol, Obu, Aichi, Japan	Yamada, M (reprint author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Bunkyo Ku, 3-29-1 Otsuka, Tokyo 1120012, Japan.	m-yamada@human.tsukuba.ac.jp			Ministry of Health, Labour, and Welfare, Japan [H24-Tyojyu-001]	This work was funded by Grants-in-Aid for Comprehensive Research on Aging and Health, from the Ministry of Health, Labour, and Welfare, Japan (H24-Tyojyu-001).	Subra J, 2012, J NUTR HEALTH AGING, V16, P714, DOI 10.1007/s12603-012-0391-7; Cawthon PM, 2007, J AM GERIATR SOC, V55, P1216, DOI 10.1111/j.1532-5415.2007.01259.x; Graham JE, 2009, GERONTOLOGY, V55, P644, DOI 10.1159/000235653; Shimada H, 2013, J AM MED DIR ASSOC, V14, P518, DOI 10.1016/j.jamda.2013.03.010; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Morley JE, 2012, J NUTR HEALTH AGING, V16, P601, DOI 10.1007/s12603-012-0084-2; Woo J, 2015, J AM MED DIR ASSOC, V16, P412, DOI 10.1016/j.jamda.2015.01.087; Malmstrom TK, 2014, J AM GERIATR SOC, V62, P721, DOI 10.1111/jgs.12735; Tsutsui T, 2005, J AM GERIATR SOC, V53, P522, DOI 10.1111/j.1532-5415.2005.53175.x; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Rockwood K, 1999, LANCET, V353, P205, DOI 10.1016/S0140-6736(98)04402-X; Wong CH, 2010, AGING CLIN EXP RES, V22, P54, DOI 10.3275/6675; Arai H, 2015, GERIATR GERONTOL INT, V15, P518, DOI 10.1111/ggi.12397; Blodgett J, 2015, ARCH GERONTOL GERIAT, V60, P464, DOI 10.1016/j.archger.2015.01.016; Nishiguchi S, 2015, J AM MED DIR ASSOC, V16, P120, DOI 10.1016/j.jamda.2014.07.010; Vermeulen J, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-33; Wade D T, 1988, Int Disabil Stud, V10, P64	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1525-8610	1538-9375		J AM MED DIR ASSOC	J. Am. Med. Dir. Assoc.	NOV 1	2015	16	11								10.1016/j.jamda.2015.08.001		5	Geriatrics & Gerontology	Geriatrics & Gerontology	CV7DO	WOS:000364432800020		
J	Obase, K; Weinert, L; Hollatz, A; Farooqui, F; Roberts, JD; Minhaj, MM; Tung, A; Chaney, M; Ota, T; Balkhy, HH; Jeevanandam, V; Saito, K; Yoshida, K; Mor-Avi, V; Lang, RM				Obase, Kikuko; Weinert, Lynn; Hollatz, Andrew; Farooqui, Farhan; Roberts, Joseph D.; Minhaj, Mohammed M.; Tung, Avery; Chaney, Mark; Ota, Takeyoshi; Balkhy, Husam H.; Jeevanandam, Valluvan; Saito, Ken; Yoshida, Kiyoshi; Mor-Avi, Victor; Lang, Roberto M.			Leaflet-Chordal Relations in Patients with Primary and Secondary Mitral Regurgitation	JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY			English	Article						Functional mitral regurgitation; Degenerative mitral regurgitation; Chordae tendineae; 3D transesophageal echocardiography	3-DIMENSIONAL ECHOCARDIOGRAPHY; PAPILLARY-MUSCLES; VALVE REPAIR; ADAPTATION; REPLACEMENT; TENDINEAE; PROLAPSE	Background: The strategy for mitral valve (MV) repair has recently focused on the restoration of the submitral apparatus. However, the relationship between geometric changes of the submitral apparatus and the mitral leaflets has not been systematically investigated. The aim of this study was to determine the relationships among chordal length (CL) and LV size and leaflet surface area (LSA) in normal subjects, patients with primary (degenerative) mitral regurgitation (PMR), and patients with functional (secondary) mitral regurgitation (FMR). Methods: A total of 72 patients who underwent three-dimensional transesophageal echocardiography, including: 27 with PMR with isolated P2 flail leaflet, 25 with FMR with greater than mild mitral regurgitation, and 20 with normal mitral valves. LSA was quantified at midsystole from full-volume midesophageal views. CL was calculated by averaging the lengths of eight primary chords from transgastric full-volume data sets using multiplanar reconstruction. Results: Both CL and LSA in the PMR group were significantly longer compared with the FMR and normal control groups. No difference in CL was noted between patients with FMR and normal subjects. In all three groups, CL and LSA did not correlate with LV systolic or diastolic dimensions. Although CL did not correlate with LSA in the FMR group, a moderate correlation (R = 0.62) was observed in the PMR group. Conclusions: In patients with FMR with greater than mild mitral regurgitation, the chords retain normal length, despite LSA and LV enlargement. In patients with PMR with flail P2 scallops, CL elongation of primary chords is associated with larger LSA but not with LV dimensions. This information may have implications for clinical strategies for mitral valve repair surgery, including the submitral approach and percutaneous procedures.	[Obase, Kikuko; Weinert, Lynn; Mor-Avi, Victor; Lang, Roberto M.] Univ Chicago, Cardiol Sect, Dept Med, Chicago, IL 60637 USA; [Hollatz, Andrew; Farooqui, Farhan; Roberts, Joseph D.; Minhaj, Mohammed M.; Tung, Avery; Chaney, Mark] Univ Chicago, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA; [Ota, Takeyoshi; Balkhy, Husam H.; Jeevanandam, Valluvan] Univ Chicago, Cardiovasc Surg, Chicago, IL 60637 USA; [Obase, Kikuko; Saito, Ken; Yoshida, Kiyoshi] Kawasaki Med Univ, Dept Cardiol, Kurashiki, Okayama, Japan	Lang, RM (reprint author), Univ Chicago, Med Ctr, Dept Med, Noninvas Cardiac Imaging Lab,Sect Cardiol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	rlang@medicine.bsd.uchicago.edu					Kron IL, 2002, ANN THORAC SURG, V74, P600, DOI 10.1016/S0003-4975(02)03749-9; Fornes P, 1999, CARDIOVASC PATHOL, V8, P81, DOI 10.1016/S1054-8807(98)00021-0; Dal-Bianco JP, 2009, CIRCULATION, V120, P334, DOI 10.1161/CIRCULATIONAHA.108.846782; Gunnal SA, 2013, SINGAP MED J, V54, P44, DOI 10.11622/smedj.2013011; Grande-Allen KJ, 2005, J THORAC CARDIOV SUR, V130, P783, DOI 10.1016/j.jtcvs.2005.04.019; Mohty D, 2001, CIRCULATION, V104, pI1; LAM JHC, 1970, CIRCULATION, V41, P449; Calafiore AM, 2001, ANN THORAC SURG, V71, P1146, DOI 10.1016/S0003-4975(00)02650-3; Adams DH, 2010, EUR HEART J, V31, P1958, DOI 10.1093/eurheartj/ehq222; VICTOR S, 1995, J CARDIAC SURG, V10, P597, DOI 10.1111/j.1540-8191.1995.tb00642.x; PERIER P, 1984, CIRCULATION, V70, P187; Perier P, 2008, ANN THORAC SURG, V86, P718, DOI 10.1016/j.athoracsur.2008.05.015; Sonne C, 2009, EUR J ECHOCARDIOGR, V10, P287, DOI 10.1093/ejechocard/jen237; Messas E, 2001, CIRCULATION, V104, P1958, DOI 10.1161/hc4201.097135; Rama A, 2007, ANN THORAC SURG, V84, P2130, DOI 10.1016/j.athoracsur.2007.04.056; Nishimura RA, 2014, CIRCULATION, V129, P2440, DOI 10.1161/CIR.0000000000000029; BARLOW JB, 1985, AM J CARDIOL, V55, P501, DOI 10.1016/0002-9149(85)90402-3; Beaudoin J, 2013, CIRC-CARDIOVASC IMAG, V6, P784, DOI 10.1161/CIRCIMAGING.113.000561; Anyanwu Ani C, 2007, Semin Thorac Cardiovasc Surg, V19, P90, DOI 10.1053/j.semtcvs.2007.04.002; Chaput M, 2008, CIRCULATION, V118, P845, DOI 10.1161/CIRCULATIONAHA.107.749440; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Obase K, 2015, J AM SOC ECHOCARDIOG, V28, P449, DOI 10.1016/j.echo.2015.01.015	22	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0894-7317			J AM SOC ECHOCARDIOG	J. Am. Soc. Echocardiogr.	NOV	2015	28	11					1302	1308		10.1016/j.echo.2015.08.009		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CV7DY	WOS:000364433800006		
J	Ogawa, A; Anzou, H; Yamamoto, S; Shimagaki, M				Ogawa, Akira; Anzou, Hideki; Yamamoto, So; Shimagaki, Mituru			Contributions of the Secondary Jet to the Maximum Tangential Velocity and to the Collection Efficiency of the Fixed Guide Vane Type Axial Flow Cyclone Dust Collector	JOURNAL OF THERMAL SCIENCE			English	Article						Axial Flow Cyclone Dust Collector; Maximum Tangential Velocity; Cut-Size; Particle Size Distribution; Collection Efficiency; Reynolds number; Centrifugal Effect		In order to control the maximum tangential velocity V-theta m(m/s) of the turbulent rotational air flow and the collection efficiency eta(c) (%) using the fly ash of the mean diameter X-R50=5.57 A mu m, two secondary jet nozzles were installed to the body of the axial flow cyclone dust collector with the body diameter D-1=99mm. Then in order to estimate V-theta m (m/s), the conservation theory of the angular momentum flux with Ogawa combined vortex model was applied. The comparisons of the estimated results of V-theta m(m/s) with the measured results by the cylindrical Pitot-tube were shown in good agreement. And also the estimated collection efficiencies eta(cth) (%) basing upon the cut-size Xc (A mu m) which was calculated by using the estimated V-theta m(m/s) and also the particle size distribution R(Xp) were shown a little higher values than the experimental results due to the re-entrainment of the collected dust. The best method for adjustment of eta(c) (%) related to the contribution of the secondary jet flow is principally to apply the centrifugal effect Phi(c) (1). Above stated results are described in detail.		Ogawa, A (reprint author), 110-0011 Minowa 2-14-7,Taitou Ku, Tokyo, Japan.						Bohnet M., 1986, ZYKLONABSCHEIDER ZUM; Maslob B. E., 1970, ENG PHYS J, V18, p[59, 63]; Moore D. F., 1959, THESIS; Ogawa A., 1999, J THERM SCI, V8; Ogawa A., 1984, SEPARATION PARTICLES, VII; Ogawa A., 1997, APPL MECHANICSREVIEW, V50; Ogawa A., 2006, J THERM SCI, V15, pP240; Ogawa A., 1992, VORTEXFLOW, pP129; Ogawa Y. Fujita, 1984, J COLL ENG NIHON U A, VA-25, pP31; STORCH OTAKAR, 1979, IND SEPARATORS GAS C; Tuzson J., 1959, THESIS	11	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1003-2169	1993-033X		J THERM SCI	J. Therm. Sci.	NOV	2015	24	6					503	509	1003-2169(2015)06-0503-07	10.1007/s11630-015-0815-x		7	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	CW0VI	WOS:000364707400001		
J	Mahlangu, JN; Weldingh, KN; Lentz, SR; Kaicker, S; Karim, FA; Matsushita, T; Recht, M; Tomczak, W; Windyga, J; Ehrenforth, S; Knobe, K				Mahlangu, J. N.; Weldingh, K. N.; Lentz, S. R.; Kaicker, S.; Karim, F. A.; Matsushita, T.; Recht, M.; Tomczak, W.; Windyga, J.; Ehrenforth, S.; Knobe, K.		Adept 2 Investigators	Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity	JOURNAL OF THROMBOSIS AND HAEMOSTASIS			English	Article						antibodies; antibody formation; hemophilia; immunoglobulin isotypes; recombinant factor VIIa; vatreptacog alfa	COAGULATION-FACTOR VIIA; SEVERE HEMOPHILIA-A; INHIBITOR RISK; HOME TREATMENT; DOUBLE-BLIND; EFFICACY; SAFETY; MULTICENTER; RESPONSES; RFVIIA	Background: Vatreptacog alfa, a recombinant human factor VIIa (rFVIIa) analog developed to improve the treatment of bleeds in hemophilia patients with inhibitors, differs from native FVIIa by three amino acid substitutions. In a randomized, double-blind, crossover, confirmatory phase III trial (adep (TM) 2), 8/72 (11%) hemophilia A or B patients with inhibitors treated for acute bleeds developed anti-drug antibodies (ADAs) to vatreptacog alfa. Objectives: To characterize the formation of anti-vatreptacog alfa ADAs in hemophilia patients with inhibitors. Methods/patients: This was a post hoc analysis of adept (TM) 2. Immunoglobulin isotype determination, specificity analysis of rFVIIa cross-reactive antibodies, epitope mapping of rFVIIa single mutant analogs and pharmacokinetic (PK) profiling were performed to characterize the ADAs. Results: Immunoglobulin isotyping indicated that the ADAs were of the immunoglobulin G subtype. In epitope mapping, none of the rFVIIa single mutant analogs (V158D, E296V or M298Q) contained the complete antibody epitope, confirming that the antibodies were specific for vatreptacog alfa. In two patients, for whom PK profiling was performed both before and after the development of ADAs, vatreptacog alfa showed a prolonged elimination phase following ADA development. During the follow-up evaluation, the rFVIIa cross-reactivity disappeared after the last vatreptacog alfa exposure, despite continued exposure to rFVIIa as part of standard care. Conclusions: Results from the vatreptacog alfa phase III trial demonstrate that the specific changes made, albeit relatively small, to the FVIIa molecule alter its clinical immunogenicity.	[Mahlangu, J. N.] Univ Witwatersrand, Fac Hlth Sci, Haemophilia Comprehens Care Ctr, Johannesburg, South Africa; [Mahlangu, J. N.] Natl Hlth Lab Serv, Johannesburg, South Africa; [Weldingh, K. N.; Lentz, S. R.; Ehrenforth, S.; Knobe, K.] Novo Nordisk AS, Bagsvaerd, Denmark; [Lentz, S. R.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Kaicker, S.] Maimonides Hosp, New York, NY USA; [Karim, F. A.] Natl Blood Ctr, Haemophilia Ctr, Kuala Lumpur, Malaysia; [Matsushita, T.] Nagoya Univ Hosp, Dept Transfus Med, Nagoya, Aichi, Japan; [Recht, M.] Oregon Hlth & Sci Univ, Hemophilia Ctr, Portland, OR 97201 USA; [Tomczak, W.] Med Univ Lublin, Dept Hematooncol & Bone Marrow Transplantat, Lublin, Poland; [Windyga, J.] Inst Hematol & Transfus Med, Dept Disorders Haemostasis & Internal Med, Warsaw, Poland	Mahlangu, JN (reprint author), Univ Witwatersrand, Fac Hlth Sci, Haemophilia Comprehens Care Ctr, 7 York Rd, Johannesburg, South Africa.	johnny.mahlangu@nhls.ac.za			Novo Nordisk	The authors would like to thank C. Buoen Stenmo for conducting and evaluating the PK assessment, M. Ribel Chehade for study coordination, K. Lambert for valuable input in collecting, analyzing and evaluating the HLA data, and E. Persson for providing FFR-FVIIa and the single mutant analogs. Editorial assistance to the authors during the preparation of this manuscript was provided by S. Eastwood (medical writer, PAREXEL) and was financially supported by Novo Nordisk in compliance with international guidelines for good publication practice. The authors also wish to acknowledge the following adept (TM) 2 Principal Investigators: Japan, M. Taki; Poland, M. Gorska-Kosicka; Russian Federation, T. Andreeva; Taiwan, W. Tsay; Turkey, A. Kupesiz; UK, S. Rangarajan; USA, K. Saxena, J. Barrett, A. Stopeck, J. Lin and A. Sori.	Mahlangu JN, 2012, J THROMB HAEMOST, V10, P773, DOI 10.1111/j.1538-7836.2012.04667.x; Brophy DF, 2010, BLOOD COAGUL FIBRIN, V21, P539, DOI 10.1097/MBC.0b013e32833b63e9; Shankar G, 2007, NAT BIOTECHNOL, V25, P555, DOI 10.1038/nbt1303; Tiede A, 2011, J THROMB HAEMOST, V9, P1191, DOI 10.1111/j.1538-7836.2011.04293.x; Ludlam CA, 2003, BRIT J HAEMATOL, V120, P808, DOI 10.1046/j.1365-2141.2003.04173.x; Astermark J, 2007, BLOOD, V109, P546, DOI 10.1182/blood-2006-04-017988; Pavlova A, 2009, J THROMB HAEMOST, V7, P2006, DOI 10.1111/j.1538-7836.2009.03636.x; Persson E, 2001, P NATL ACAD SCI USA, V98, P13583, DOI 10.1073/pnas.241339498; Schwarz J, 2013, HAEMOPHILIA, V19, P113, DOI 10.1111/hae.12004; Sauna ZE, 2012, J THROMB HAEMOST, V10, P1961, DOI 10.1111/j.1538-7836.2012.04830.x; Brinks V, 2013, PHARM RES-DORDR, V30, P1719, DOI 10.1007/s11095-013-1062-z; Ponce R, 2009, REGUL TOXICOL PHARM, V54, P164, DOI 10.1016/j.yrtph.2009.03.012; Young G, 2008, HAEMOPHILIA, V14, P287, DOI 10.1111/j.1365-2516.2007.01601.x; Moss J, 2009, J THROMB HAEMOST, V7, P299, DOI 10.1111/j.1538-7836.2008.03253.x; Persson E, 2012, SEMIN THROMB HEMOST, V38, P274, DOI 10.1055/s-0032-1302442; Kavakli K, 2006, THROMB HAEMOSTASIS, V95, P600, DOI 10.1160/TH05-07-0510; Rand KD, 2008, J BIOL CHEM, V283, P13378, DOI 10.1074/jbc.M709716200; Ghosh S, 2007, J THROMB HAEMOST, V5, P336, DOI 10.1111/j.1538-7836.2007.02308.x; Lentz SR, 2014, J THROMB HAEMOST, V12, P1244, DOI 10.1111/jth.12634; Sorensen BB, 1997, J BIOL CHEM, V272, P11863, DOI 10.1074/jbc.272.18.11863; Sommer C, 2007, THROMB HAEMOSTASIS, V98, P721, DOI 10.1160/TH07-05-0349; Abshire T, 2004, J THROMB HAEMOST, V2, P899, DOI 10.1111/j.1538-7836.2004.00759.x; Whelan SFJ, 2013, BLOOD, V121, P1039, DOI 10.1182/blood-2012-07-444877; Parameswaran R, 2005, HAEMOPHILIA, V11, P100, DOI 10.1111/j.1365-2516.2005.01075.x; de vansWeert M, 2008, IMMUNOGENICITY BIOPH; desPaula EV, 2012, J THROMB HAEMOST, V10, P81; Shepherd AJ, 2015, BRIT J HAEMATOL, V168, P413, DOI 10.1111/bjh.13131; Zollner S, 2014, J THROMB HAEMOST, V12, P220, DOI 10.1111/jth.12477	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1538-7933	1538-7836		J THROMB HAEMOST	J. Thromb. Haemost.	NOV	2015	13	11					1989	1998		10.1111/jth.13141		10	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CW1VB	WOS:000364778700007		
J	Deforche, L; Roose, E; Vandenbulcke, A; Vandeputte, N; Feys, HB; Springer, TA; Mi, LZ; Muia, J; Sadler, JE; Soejima, K; Rottensteiner, H; Deckmyn, H; De Meyer, SF; Vanhoorelbeke, K				Deforche, L.; Roose, E.; Vandenbulcke, A.; Vandeputte, N.; Feys, H. B.; Springer, T. A.; Mi, L. Z.; Muia, J.; Sadler, J. E.; Soejima, K.; Rottensteiner, H.; Deckmyn, H.; De Meyer, S. F.; Vanhoorelbeke, K.			Linker regions and flexibility around the metalloprotease domain account for conformational activation of ADAMTS-13	JOURNAL OF THROMBOSIS AND HAEMOSTASIS			English	Article						ADAMTS-13 protein; human; allosteric regulation; autoantibodies; protein conformation; von Willebrand factor	VON-WILLEBRAND-FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA; CRYSTAL-STRUCTURES; ENDOTHELIAL-CELLS; CATALYTIC DOMAIN; INDUCED CLEAVAGE; SHEAR-STRESS; VWF; PROTEIN; FLOW	Background: Recently, conformational activation of ADAMTS-13 was identified. This mechanism showed the evolution from a condensed conformation, in which the proximal MDTCS and distal T2-CUB2 domains are in close contact with each other, to an activated, open structure due to binding with von Willebrand factor (VWF). Objectives: Identification of cryptic epitope/exosite exposure after conformational activation and of sites of flexibility in ADAMTS-13. Methods: The activating effect of 25 anti-T2-CUB2 antibodies was studied in the FRETS-VWF73 and the vortex assay. Cryptic epitope/exosite exposure was determined with ELISA and VWF binding assay. The molecular basis for flexibility was hypothesized through rapid automatic detection and alignment of repeats (RADAR) analysis, tested with ELISA using deletion variants and visualized using electron microscopy. Results: Eleven activating anti-ADAMTS-13 antibodies, directed against the T5-CUB2 domains, were identified in the FRETS-VWF73 assay. RADAR analysis identified three linker regions in the distal domains. Interestingly, identification of an antibody recognizing a cryptic epitope in the metalloprotease domain confirmed the contribution of these linker regions to conformational activation of the enzyme. The proof of flexibility around both the T2 and metalloprotease domains, as shown by by electron microscopy, further supported this contribution. In addition, cryptic epitope exposure was identified in the distal domains, because activating anti-T2-CUB2 antibodies increased the binding to folded VWF up to similar to 3-fold. Conclusion: Conformational activation of ADAMTS-13 leads to cryptic epitope/exosite exposure in both proximal and distal domains, subsequently inducing increased activity. Furthermore, three linker regions in the distal domains are responsible for flexibility and enable the interaction between the proximal and the T8-CUB2 domains.	[Deforche, L.; Roose, E.; Vandenbulcke, A.; Vandeputte, N.; Deckmyn, H.; De Meyer, S. F.; Vanhoorelbeke, K.] KU Leuven Kulak, IRF Life Sci, Lab Thrombosis Res, B-8500 Kortrijk, Belgium; [Feys, H. B.] Belgian Red Cross Flanders, Transfus Res Ctr, Ghent, Belgium; [Springer, T. A.; Mi, L. Z.] Harvard Univ, Sch Med, Program Cellular & Mol Med, Boston Childrens Hosp, Boston, MA USA; [Springer, T. A.; Mi, L. Z.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Muia, J.; Sadler, J. E.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Muia, J.; Sadler, J. E.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Soejima, K.] Chemoserotherapeut Res Inst, Kikuchi, Kumamoto, Japan; [Rottensteiner, H.] Baxter Innovat GmbH, Vienna, Austria	Vanhoorelbeke, K (reprint author), KU Leuven Kulak, IRF Life Sci, Lab Thrombosis Res, Etienne Sabbelaan 53, B-8500 Kortrijk, Belgium.	karen.vanhoorelbeke@kuleuven-kulak.be			Agency for Innovation by Science and Technology (IWT, ) Flanders, Belgium [IWT-SB/111507]; 'Fonds voor Wetenschappelijk Onderzoek' (FWO, ) Flanders, Belgium [G.0548.11]; National Institutes of Health [R01 HL72917, R01 HL89746, U54 HL112303, T32 HL007088]	This work was funded by a PhD grant from the Agency for Innovation by Science and Technology (IWT, ) Flanders, Belgium (IWT-SB/111507, awarded to L. Deforche), and a grant from the 'Fonds voor Wetenschappelijk Onderzoek' (FWO, ) Flanders, Belgium (G.0548.11, awarded to K. Vanhoorelbeke). This work was also supported by National Institutes of Health grants (grants.nih.gov/) R01 HL72917, R01 HL89746, U54 HL112303 and T32 HL007088 (awarded to J. E. Sadler). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank I. Pareyn for the development of the mAbs.	Wu T, 2010, BLOOD, V115, P370, DOI 10.1182/blood-2009-03-210369; Cauwenberghs N, 2000, ARTERIOSCL THROM VAS, V20, P1347; Anderson PJ, 2006, J BIOL CHEM, V281, P850, DOI 10.1074/jbc.M504540200; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Han Y, 2011, TRANSFUSION, V51, P1580, DOI 10.1111/j.1537-2995.2010.03020.x; Muia J, 2014, P NATL ACAD SCI USA, V111, P18584, DOI 10.1073/pnas.1413282112; Tao ZY, 2005, BLOOD, V106, P141, DOI 10.1182/blood-2004-11-4188; Sadler JE, 2008, BLOOD, V112, P11, DOI 10.1182/blood-2008-02-078170; Ying JY, 2010, BIOPHYS J, V98, P1685, DOI 10.1016/j.bpj.2009.12.4324; McKinnon TAJ, 2008, BLOOD, V111, P3042, DOI 10.1182/blood-2007-06-095042; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; Kokame K, 2005, BRIT J HAEMATOL, V129, P93, DOI 10.1111/j.1365-2141.2005.05420.x; Uemura M, 2005, BLOOD, V106, P922, DOI 10.1182/blood-2005-01-0152; Shim K, 2008, BLOOD, V111, P651, DOI 10.1182/blood-2007-05-093021; Crawley JTB, 2011, BLOOD, V118, P3212, DOI 10.1182/blood-2011-02-306597; Shieh HS, 2008, J BIOL CHEM, V283, P1501, DOI 10.1074/jbc.M705879200; South K, 2014, P NATL ACAD SCI USA, V111, P18578, DOI 10.1073/pnas.1411979112; Mi LZ, 2011, NAT STRUCT MOL BIOL, V18, P984, DOI 10.1038/nsmb.2092; SPORN LA, 1985, J CLIN INVEST, V76, P1102, DOI 10.1172/JCI112064; SADLER JE, 1991, J BIOL CHEM, V266, P22777; WAGNER DD, 1982, J CELL BIOL, V95, P355, DOI 10.1083/jcb.95.1.355; TSAI HM, 1994, BLOOD, V83, P2171; Zheng XL, 2001, J BIOL CHEM, V276, P41059, DOI 10.1074/jbc.C100515200; Mosyak L, 2008, PROTEIN SCI, V17, P16, DOI 10.1110/ps.073287008; Feys HB, 2010, BLOOD, V116, P2005, DOI 10.1182/blood-2010-04-280479; Gao WQ, 2006, P NATL ACAD SCI USA, V103, P19099, DOI 10.1073/pnas.0607264104; Akiyama M, 2009, P NATL ACAD SCI USA, V106, P19274, DOI 10.1073/pnas.0909755106; Soejima K, 2006, J BIOCHEM, V139, P147, DOI 10.1093/jb/mvj013; Zhang P, 2007, BLOOD, V110, P1887, DOI 10.1182/blood-2007-04-083329; Turner N, 2009, J THROMB HAEMOST, V7, P229, DOI 10.1111/j.1538-7836.2008.03209.x; Feys HB, 2006, J THROMB HAEMOST, V4, P955, DOI 10.1111/j.1538-7836.2006.01833.x; Zhou YF, 2011, EMBO J, V30, P4098, DOI 10.1038/emboj.2011.297; Ai JH, 2005, J BIOL CHEM, V280, P29428, DOI 10.1074/jbc.M505513200; Calzada MJ, 2008, MATRIX BIOL, V27, P339, DOI 10.1016/j.matbio.2007.12.002; Igari A, 2012, THROMB RES, V130, pE79, DOI 10.1016/j.thromres.2012.06.006; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905; Feys HB, 2009, J THROMB HAEMOST, V7, P2088, DOI 10.1111/j.1538-7836.2009.03620.x; Zanardelli S, 2009, BLOOD, V114, P2819, DOI 10.1182/blood-2009-05-224915; Gerhardt S, 2007, J MOL BIOL, V373, P891, DOI 10.1016/j.jmb.2007.07.047; Feys HB, 2010, J THROMB HAEMOST, V8, P2053, DOI 10.1111/j.1538-7836.2010.03942.x; DesCeunynck K, 2011, J BIOL CHEM, V286, P36361; DesMeyer SF, 2008, ARTERIOSCLER THROMB, V28, P1621; DisStasio E, 2008, BIOPHYS J, V95, P2450; Zhu J, 2014, BLOOD AM SOC HEMATOL, V124, P107	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1538-7933	1538-7836		J THROMB HAEMOST	J. Thromb. Haemost.	NOV	2015	13	11					2063	2075		10.1111/jth.13149		13	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CW1VB	WOS:000364778700015		
J	Nakajima, R; Kobayashi, T; Moriya, N; Mizutani, M; Kan, K; Nozaki, T; Saitoh, K; Yamato, M; Okano, T; Takeda, S				Nakajima, Ryota; Kobayashi, Toyoshige; Moriya, Noboru; Mizutani, Manabu; Kan, Kazutoshi; Nozaki, Takayuki; Saitoh, Kazuo; Yamato, Masayuki; Okano, Teruo; Takeda, Shizu			A novel closed cell culture device for fabrication of corneal epithelial cell sheets	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						closed cell culture; culture device; automated culture system; epithelial cell; cell sheet; stratified epithelium	ENDOSCOPIC SUBMUCOSAL DISSECTION; STEM-CELLS; REGENERATIVE MEDICINE; OCULAR SURFACE; TISSUE; RECONSTRUCTION; SYSTEM; TRANSPLANTATION; DIFFERENTIATION; VALIDATION	Automation technology for cell sheet-based tissue engineering would need to optimize the cell sheet fabrication process, stabilize cell sheet quality and reduce biological contamination risks. Biological contamination must be avoided in clinical settings. A closed culture system provides a solution for this. In the present study, we developed a closed culture device called a cell cartridge, to be used in a closed cell-culture system for fabricating corneal epithelial cell sheets. Rabbit limbal epithelial cells were cultured on the surface of a porous membrane with 3T3 feeder cells, which are separate from the epithelial cells in the cell cartridges and in the cell-culture inserts as a control. To fabricate the stratified cell sheets, five different thicknesses of the membranes which were welded to the cell cartridge, were examined. Multilayered corneal epithelial cell sheets were fabricated in cell cartridges that were welded to a 25 mu m-thick gas-permeable membrane, which was similar to the results with the cell-culture inserts. However, stratification of corneal epithelial cell sheets did not occur with cell cartridges that were welded to 100-300 mu m-thick gas-permeable membranes. The fabricated cell sheets were evaluated by histological analyses to examine the expression of corneal epithelial-specific markers. Immunohistochemical analyses showed that a putative stem cell marker, p63, a corneal epithelial differentiation maker, CK3, and a barrier function marker, Claudin-1, were expressed in the appropriate position in the cell sheets. These results suggest that the cell cartridge is effective for fabricating corneal epithelial cell sheets. Copyright (C) 2012 John Wiley & Sons, Ltd.	[Nakajima, Ryota; Kobayashi, Toyoshige; Moriya, Noboru; Kan, Kazutoshi; Nozaki, Takayuki; Saitoh, Kazuo; Takeda, Shizu] Hitachi Ltd, Cent Res Lab, Saitama 3500395, Japan; [Mizutani, Manabu] CellSeed Inc, Shinjuku Ku, Tokyo 1620056, Japan; [Yamato, Masayuki; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Shinjuku Ku, Tokyo 1628666, Japan	Takeda, S (reprint author), Hitachi Ltd, Cent Res Lab, 2520 Hatoyama, Saitama 3500395, Japan.	shizu.takeda.me@hitachi.com			Formation of Innovation Centre for Fusion of Advanced Technologies through the Special Coordination Funds for Promoting Science and Technology, 'Cell Sheet Tissue Engineering Center (CSTEC)'.	The authors thank Ms Y. Kondo and Mr K. Mori (Hitachi Ltd) for their technical assistance. We also wish to thank Mr T. Kashiwagi and Mr K. Kusama (Emerson Japan Ltd) for their technical advice on ultrasound welding and Mr Y. Tanaka (Tammy Co., Ltd) for technical advice on injection molding. We are grateful for the helpful suggestions given by Ms A. Hisada and all of our laboratory team (Hitachi Ltd). Finally, we express our gratitude to Dr H. Koizumi, Dr H. Takeda and Dr M. Sakairi (Hitachi Ltd) for their valuable comments. This work was supported in part by the Formation of Innovation Centre for Fusion of Advanced Technologies through the Special Coordination Funds for Promoting Science and Technology, 'Cell Sheet Tissue Engineering Center (CSTEC)', from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. This research was presented in part as an abstract at the Annual Meeting of the Tissue Engineering and Regenerative Medicine International Society (TERMIS), December 2011, Houston, TX, USA.	Nozaki T, 2008, J TISSUE ENG REGEN M, V2, P190, DOI 10.1002/term.80; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; Kato R, 2010, TISSUE ENG PART C-ME, V16, P947, DOI 10.1089/ten.TEC.2009.0305; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Murakami D, 2006, BIOMATERIALS, V27, P5518, DOI 10.1016/j.biomaterials.2006.05.042; Yang J, 2007, BIOMATERIALS, V28, P5033, DOI 10.1016/j.biomaterials.2007.07.052; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Miyashita H, 2007, INVEST OPHTH VIS SCI, V48, P3586, DOI 10.1167/iovs.07-0077; Oie Y, 2010, BRIT J OPHTHALMOL, V94, P1244, DOI 10.1136/bjo.2009.175042; Miyashita H, 2008, TISSUE ENG PT A, V14, P1275, DOI 10.1089/tea.2007.0212; Ngo MA, 2007, J INVEST DERMATOL, V127, P354, DOI 10.1038/sj.jid.5700522; Takagi R, 2011, PATHOBIOLOGY, V78, P311, DOI 10.1159/000322575; Rama P, 2001, TRANSPLANTATION, V72, P1478, DOI 10.1097/00007890-200111150-00002; Kino-Oka M, 2009, J BIOSCI BIOENG, V108, P267, DOI 10.1016/j.jbiosc.2009.04.007; Priya SG, 2008, TISSUE ENG PT B-REV, V14, P105, DOI 10.1089/teb.2007.0318; Ban Y, 2003, EXP EYE RES, V76, P663, DOI 10.1016/S0014-4835(03)00054-X; Watanabe R, 2011, TISSUE ENG PT A, V17, P2213, DOI [10.1089/ten.TEA.2010.0568, 10.1089/ten.tea.2010.0568]; Ohki T, 2006, GUT, V55, P1704, DOI 10.1136/gut.2005.088518; Ohki T, 2012, GASTROENTEROLOGY, V143, P582, DOI 10.1053/j.gastro.2012.04.050; Hayashi R, 2010, TISSUE ENG PART C-ME, V16, P553, DOI 10.1089/ten.TEC.2009.0277; Watanabe S, 2005, J BIOSCI BIOENG, V100, P105, DOI 10.1263/jbb.100.105; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Hayashida Y, 2005, INVEST OPHTH VIS SCI, V46, P1632, DOI 10.1167/iovs.04-0813; Murakami Daisuke, 2006, J Artif Organs, V9, P185, DOI 10.1007/s10047-006-0342-3	25	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	NOV	2015	9	11					1259	1267		10.1002/term.1639		9	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Cell Biology; Biotechnology & Applied Microbiology; Engineering	CV8GQ	WOS:000364520300006		
J	Wang, XG; Suzawa, T; Miyauchi, T; Zhao, BH; Yasuhara, R; Anada, T; Nakamura, M; Suzuki, O; Kamijo, R				Wang, Xiaogu; Suzawa, Tetsuo; Miyauchi, Tomohiko; Zhao, Baohong; Yasuhara, Rika; Anada, Takahisa; Nakamura, Masanori; Suzuki, Osamu; Kamijo, Ryutaro			Synthetic octacalcium phosphate-enhanced reparative dentine formation via induction of odontoblast differentiation	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						octacalcium phosphate (OCP); biomineralization; reparative dentine; dental pulp; Runx2; odontoblasts; dentine sialophosphoprotein	BONE-FORMATION; HYDROXYAPATITE; CELLS; OSTEOBLASTS; EXPRESSION; MATRIX; RUNX2; RAT; SIALOPHOSPHOPROTEIN; MINERALIZATION	Synthetic octacalcium phosphate (OCP) has been suggested to be a useful biomaterial for the regeneration of hard tissues, including bone. However, it remains unknown whether OCP induces dentine formation by dental pulp. We investigated biomineralization of dental pulp exposed to synthetic OCP in vitro and in vivo. When dental pulp was exposed directly to OCP, rapid formation of reparative dentine (RD) was induced and expression of dentine sialoprotein synthesis was observed in dental pulp adjacent to newly synthesized RD. OCP inhibited the proliferation of rat pulp cells and also promoted their odontoblastic differentiation in vitro, as alkaline phosphatase activity, mineralization of pulp cells and the expression level of dentine sialophosphoprotein were enhanced. Direct contact between OCP and pulp cells is required for OCP to exhibit its effects in vitro. The expression level of Runx2, a transcription factor whose downregulation is closely related to odontoblast differentiation, was downregulated in pulp cells cultured with OCP. Structural changes of OCP during culture were determined by Fourier transform infrared spectroscopy. OCP tended to be converted to carbonate hydroxyapatite after incubation with or without pulp cells, which may be analogous to biological apatite crystals. Taken together, our data suggest that synthetic OCP supports RD formation by dental pulp and downregulation of Runx2 may be involved in that stimulatory activity. Furthermore, OCP-apatite conversion is involved in this stimulatory capacity of OCP. Copyright (C) 2013 John Wiley & Sons, Ltd.	[Wang, Xiaogu; Suzawa, Tetsuo; Miyauchi, Tomohiko; Zhao, Baohong; Yasuhara, Rika; Kamijo, Ryutaro] Showa Univ, Sch Dent, Dept Biochem, Tokyo 1428555, Japan; [Anada, Takahisa; Suzuki, Osamu] Tohoku Univ, Grad Sch Dent, Div Craniofacial Funct Engn, Sendai, Miyagi 980, Japan; [Nakamura, Masanori] Showa Univ, Sch Dent, Dept Oral Anat & Dev Biol, Tokyo 142, Japan	Suzawa, T (reprint author), Showa Univ, Sch Dent, Dept Biochem, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	suzawa@dent.showa-u.ac.jp; suzuki-o@m.tohoku.ac.jp			Project to Establish a Strategic Research Centre for Innovative Dentistry by the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science; MEXT [17076001, 23106010]	We are grateful for the kind support and advice of Dr Toshihisa Komori, Department of Cell Biology, Unit of Basic Medical Sciences, Graduate School of Biomedical Sciences, Nagasaki University. This study was supported by: the Project to Establish a Strategic Research Centre for Innovative Dentistry by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), 2010-2014; Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science; and a Grant-in-Aid for Scientific Research on Priority Areas (No. 17076001, 23106010) from MEXT.	FOWLER BO, 1966, ARCH ORAL BIOL, V11, P477, DOI 10.1016/0003-9969(66)90154-3; CHICKERUR NS, 1980, CALCIFIED TISSUE INT, V32, P55, DOI 10.1007/BF02408521; YAMAMURA T, 1985, J DENT RES, V64, P530; Miyazaki T, 2008, ARCH HISTOL CYTOL, V71, P131, DOI 10.1679/aohc.71.131; Pashley DH, 1996, CRIT REV ORAL BIOL M, V7, P104; LUMSDEN AGS, 1988, DEVELOPMENT, V103, P155; Tohda H, 1997, J ELECTRON MICROSC, V46, P97; BURNELL JM, 1980, CALCIFIED TISSUE INT, V31, P13, DOI 10.1007/BF02407162; Crane NJ, 2006, BONE, V39, P434, DOI 10.1016/j.bone.2006.02.059; Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972; Chen S, 2005, J BIOL CHEM, V280, P29717, DOI 10.1074/jbc.M502929200; NAKASHIMA M, 1992, ARCH ORAL BIOL, V37, P231, DOI 10.1016/0003-9969(92)90093-N; KIM HM, 1995, J BONE MINER RES, V10, P1589; BROWN WE, 1962, NATURE, V196, P1050, DOI 10.1038/1961050a0; Papagerakis P, 2002, BONE, V30, P377, DOI 10.1016/S8756-3282(01)00683-4; Iijima M, 2006, EUR J ORAL SCI, V114, P304, DOI 10.1111/j.1600-0722.2006.00324.x; Bodier-Houlle P, 1998, ACTA CRYSTALLOGR D, V54, P1377, DOI 10.1107/S0907444998005769; GLIMCHER MJ, 1984, PHILOS T ROY SOC B, V304, P479, DOI 10.1098/rstb.1984.0041; Suzuki O, 2006, J BIOMED MATER RES B, V77B, P201, DOI 10.1002/jbm.b.30407; Suzuki O, 2008, CURR MED CHEM, V15, P305, DOI 10.2174/092986708783497283; SUZUKI O, 1991, TOHOKU J EXP MED, V164, P37, DOI 10.1620/tjem.164.37; Imaizumi H, 2006, CALCIFIED TISSUE INT, V78, P45, DOI 10.1007/s00223-005-0170-0; Anada T, 2008, TISSUE ENG PT A, V14, P965, DOI 10.1089/tea.2007.0339; MacDougall M, 1997, J BIOL CHEM, V272, P835; Rey C, 2009, OSTEOPOROSIS INT, V20, P1013, DOI 10.1007/s00198-009-0860-y; Suzuki O, 2006, BIOMATERIALS, V27, P2671, DOI 10.1016/j.boimaterials.2005.12.004; Mahamid J, 2010, P NATL ACAD SCI USA, V107, P6316, DOI 10.1073/pnas.0914218107; Chen S, 2009, J DENT RES, V88, P904, DOI 10.1177/0022034509342873; Xiao ZS, 1998, GENE, V214, P187, DOI 10.1016/S0378-1119(98)00227-3; Sena M, 2004, ORAL SURG ORAL MED O, V97, P749, DOI 10.1016/j.tripleo.2003.10.029; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; SMITH AJ, 1994, ARCH ORAL BIOL, V39, P13, DOI 10.1016/0003-9969(94)90029-9; Papaccio G, 2006, J CELL PHYSIOL, V208, P319, DOI 10.1002/jcp.20667; Takami M, 2009, TISSUE ENG PT A, V15, P3991, DOI 10.1089/ten.TEA.2009.0065; AOBA T, 1990, CALCIFIED TISSUE INT, V47, P356, DOI 10.1007/BF02555887; Kamakura S, 1996, ARCH ORAL BIOL, V41, P1029, DOI 10.1016/S0003-9969(96)00080-5; Barrere F, 1999, BONE, V25, P107; Gaikwad J S, 2001, Adv Dent Res, V15, P19; Nelson DG, 1989, ANAT REC, V224, P256	39	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	NOV	2015	9	11					1310	1320		10.1002/term.1669		11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Cell Biology; Biotechnology & Applied Microbiology; Engineering	CV8GQ	WOS:000364520300011		
J	Muraoka, I; Takatsuki, M; Sakai, Y; Tomonaga, T; Soyama, A; Hidaka, M; Hishikawa, Y; Koji, T; Utoh, R; Ohashi, K; Okano, T; Kanematsu, T; Eguchi, S				Muraoka, Izumi; Takatsuki, Mitsuhisa; Sakai, Yusuke; Tomonaga, Tetsuo; Soyama, Akihiko; Hidaka, Masaaki; Hishikawa, Yoshitaka; Koji, Takehiko; Utoh, Rie; Ohashi, Kazuo; Okano, Teruo; Kanematsu, Takashi; Eguchi, Susumu			Transplanted fibroblast cell sheets promote migration of hepatic progenitor cells in the incised host liver in allogeneic rat model	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						cell sheet; temperature-responsive dishes; dermal fibroblast; hepatic progenitor cell; liver regeneration; tissue engineering; nude rats; allogeneic rat model	HEPATOCELLULAR-CARCINOMA; MONOCLONAL-ANTIBODIES; IMPAIRED MYOCARDIUM; HEPATOCYTES; LINEAGES; RECONSTRUCTION; REGENERATION; EXPRESSION	Cell sheet engineering has been noted as a new and valuable approach in the tissue-engineering field. The objective of this study was to explore a procedure to induce hepatic progenitor cells and biliary duct structures in the liver. Sprague-Dawley rat dermal fibroblast (DF) sheets were transplanted into the incised surface of the liver of F344 nude rats. In the control group, an incision was made without transplantation of the DF sheets. Bile duct (BD)-like structures and immature hepatocyte-like cells were observed in the DF sheet transplant sites. These BD-like structures were cytokeratin-8-positive, while the hepatocyte-like cells were both OV-6-positive and -fetoprotein-positive as well. The proliferation and differentiation of liver progenitor cells were not influenced by hepatectomy. We also transplanted DF sheets transfected with a plasmid encoding the enhanced yellow fluorescent protein target to mitochondria (pEYFP-Mito) by electroporation, and found that the new structures were pEYFP-Mito-negative. We observed new BD-like structures and immature hepatocytes after transplantation of DF sheets onto incised liver surfaces, and clarified that the origin of these BD-like structures and hepatocyte-like cells was the recipient liver. The present study described an aspect of the hepatic differentiation process induced at the site of liver injury. Copyright (C) 2013 John Wiley & Sons, Ltd.	[Muraoka, Izumi; Takatsuki, Mitsuhisa; Sakai, Yusuke; Tomonaga, Tetsuo; Soyama, Akihiko; Hidaka, Masaaki; Kanematsu, Takashi; Eguchi, Susumu] Nagasaki Univ, Dept Surg, Grad Sch Biomed Sci, Nagasaki 8528501, Japan; [Hishikawa, Yoshitaka; Koji, Takehiko] Nagasaki Univ, Dept Histol & Cell Biol, Grad Sch Biomed Sci, Nagasaki 8528501, Japan; [Utoh, Rie; Ohashi, Kazuo; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Hishikawa, Yoshitaka] Miyazaki Univ, Fac Med, Dept Anat, Div Mol & Cellular Biol, Miyazaki, Japan	Eguchi, S (reprint author), Nagasaki Univ, Dept Surg, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	sueguchi@nagasaki-u.ac.jp			Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology of Japan	The present study was supported in part by Special Coordination Funds for Promoting Science and Technology (to K.O. and T.O.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Mitaka T, 1999, HEPATOLOGY, V29, P111, DOI 10.1002/hep.510290103; SELL S, 1989, AM J PATHOL, V134, P1347; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Pinney E, 2000, J CELL PHYSIOL, V183, P74, DOI 10.1002/(SICI)1097-4652(200004)183:1<74::AID-JCP9>3.0.CO;2-G; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; MARCEAU N, 1994, GUT, V35, P294, DOI 10.1136/gut.35.3.294; Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576; Gu K, 2011, MOL BIOL REP, V38, P1687, DOI 10.1007/s11033-010-0281-1; DUNSFORD HA, 1989, CANCER RES, V49, P4887; SHIOJIRI N, 1994, CELL TISSUE RES, V278, P117, DOI 10.1007/BF00305783; Memon IA, 2005, J THORAC CARDIOV SUR, V130, P1333, DOI 10.1016/j.jtcvs.2005.07.023; Miyagawa S, 2010, TRANSPLANTATION, V90, P364, DOI 10.1097/TP.0b013e3181e6f201; Ohashi K, 2001, J MOL MED-JMM, V79, P617; DUNSFORD HA, 1989, CANCER RES, V49, P4894; Zhou HC, 2007, HEPATOLOGY, V45, P716, DOI 10.1002/hep.21557; Crosby HA, 1998, AM J PATHOL, V152, P771; Kobayashi H, 2008, J ARTIF ORGANS, V11, P141, DOI 10.1007/s10047-008-0421-8; Nagase K, 2009, J R SOC INTERFACE, V6, pS293, DOI 10.1098/rsif.2008.0499.focus; Takagi R, 2010, GASTROINTEST ENDOSC, V72, P1253, DOI 10.1016/j.gie.2010.08.007; CASCIO S, 1991, DEVELOPMENT, V113, P217; Mansbridge JN, 1999, DIABETES OBES METAB, V1, P265, DOI 10.1046/j.1463-1326.1999.00032.x; Tamaru N, 2004, LAB INVEST, V84, P1460, DOI 10.1038/labinvest.3700166; Behbahan IS, 2011, STEM CELL REV REP, V7, P748, DOI 10.1007/s12015-010-9216-4; Chen Y, 2012, HEPATOLOGY; Coleman W, 1998, LIVER GROWTH REPAIR, P50; Melo José Ulisses de Souza, 2010, Rev Col Bras Cir, V37, P351, DOI 10.1590/S0100-69912010000500008; Ohashi K, 2011, CELL TRANSPLANT, V21, P429; Ohki M, 2006, GUT, V55, P1704; Puppi J, 2011, CELL TRANSPL	30	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	NOV	2015	9	11					E108	E115		10.1002/term.1718		8	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Cell Biology; Biotechnology & Applied Microbiology; Engineering	CV8GQ	WOS:000364520300021		
J	Negishi, J; Funamoto, S; Kimura, T; Nam, K; Higami, T; Kishida, A				Negishi, Jun; Funamoto, Seiichi; Kimura, Tsuyoshi; Nam, Kwangoo; Higami, Tetsuya; Kishida, Akio			Porcine radial artery decellularization by high hydrostatic pressure	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						tissue engineering; decellularization; small-diameter vessel; high pressure; radial artery; xenotransplantaion	BLOOD-VESSELS; GRAFTS; CORONARY; RECONSTRUCTION; SCAFFOLDS; XENOGRAFT; COLLAGEN; PATENCY; DEVICE; REPAIR	Many types of decellularized tissues have been studied and some have been commercially used in clinics. In this study, small-diameter vascular grafts were made using HHP to decellularize porcine radial arteries. One decellularization method, high hydrostatic pressure (HHP), has been used to prepare the decellularized porcine tissues. Low-temperature treatment was effective in preserving collagen and collagen structures in decellularized porcine carotid arteries. The collagen and elastin structures and mechanical properties of HHP-decellularized radial arteries were similar to those of untreated radial arteries. Xenogeneic transplantation (into rats) was performed using HHP-decellularized radial arteries and an untreated porcine radial artery. Two weeks after transplantation into rat carotid arteries, the HHP-decellularized radial arteries were patent and without thrombosis. In addition, the luminal surface of each decellularized artery was covered by recipient endothelial cells and the arterial medium was fully infiltrated with recipient cells. Copyright (C) 2012 John Wiley & Sons, Ltd.	[Negishi, Jun; Funamoto, Seiichi; Kimura, Tsuyoshi; Nam, Kwangoo; Kishida, Akio] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Div Biofunct Mol, Tokyo 1010062, Japan; [Funamoto, Seiichi; Kimura, Tsuyoshi; Nam, Kwangoo; Kishida, Akio] Japan Sci & Technol Agcy CREST, Saitama, Japan; [Higami, Tetsuya] Sapporo Med Univ, Sch Med, Dept Thorac & Cardiovasc Surg, Sapporo, Hokkaido, Japan	Kishida, A (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Div Biofunct Mol, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.	kishida.fm@tmd.ac.jp			Research on Human Genome, Tissue Engineering from the Ministry of Health, Labour and Welfare; Core Research of Evolutional Science and Technology from the Japan Science and Technology Agency (JST-CREST)	This work was supported in part by Research on Human Genome, Tissue Engineering from the Ministry of Health, Labour and Welfare, and by the Core Research of Evolutional Science and Technology from the Japan Science and Technology Agency (JST-CREST).	WHITTEMORE AD, 1989, J VASC SURG, V10, P299; Liu SQ, 2004, BIOMATERIALS, V25, P1869, DOI 10.1016/j.biomaterials.2003.08.044; Negishi J, 2011, J ARTIF ORGANS, V14, P223, DOI 10.1007/s10047-011-0570-z; Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4; Kural MH, 2012, J BIOMECH, V45, P790, DOI 10.1016/j.jbiomech.2011.11.019; Zeng W, 2012, BIOMATERIALS, V33, P473, DOI 10.1016/j.biomaterials.2011.09.066; Sarkar S, 2006, EUR J VASC ENDOVASC, V31, P627, DOI 10.1016/j.ejvs.2006.01.006; CHARD RB, 1987, J THORAC CARDIOV SUR, V94, P132; Hashimoto Y, 2010, BIOMATERIALS, V31, P3941, DOI 10.1016/j.biomaterials.2010.01.122; Konertz W, 2005, J HEART VALVE DIS, V14, P78; Funamoto S, 2010, BIOMATERIALS, V31, P3590, DOI 10.1016/j.biomaterials.2010.01.073; GULATI AK, 1988, J NEUROSURG, V68, P117, DOI 10.3171/jns.1988.68.1.0117; Greenwald SE, 2000, J PATHOL, V190, P292, DOI 10.1002/(SICI)1096-9896(200002)190:3<292::AID-PATH528>3.0.CO;2-S; Griese DP, 2003, CIRCULATION, V108, P2710, DOI 10.1161/01.CIR.0000096490.16596.A6; FISCHER GM, 1966, CIRC RES, V19, P394; McCann ME, 2005, ANESTH ANALG, V101, P978, DOI 10.1213/01.ane.0000171231.29328.9f; Sasaki S, 2009, MOL VIS, V15, P2022; Conklin BS, 2002, MED ENG PHYS, V24, P173, DOI 10.1016/S1350-4533(02)00010-3; JACKSON DW, 1987, AM J SPORT MED, V15, P528, DOI 10.1177/036354658701500602; REUL GJ, 1985, TEX HEART I J, V12, P211; Cooley DA, 1998, CIRCULATION, V97, P2384; Quinn RW, 2011, ANN THORAC SURG, V92, P131, DOI 10.1016/j.athoracsur.2011.03.039; Nakayama Y, 2004, CELL TRANSPLANT, V13, P439, DOI 10.3727/000000004783983828; Pankajakshan D, 2010, CAN J PHYSIOL PHARM, V88, P855, DOI [10.1139/y10-073, 10.1139/Y10-073]; Boonyaratanakornkit BB, 2002, BIOCHIM BIOPHYS ACTA, V25, P235; Chlupac J, 2009, PHYSIOL RES, V2, P119; KARGES DAVID E., 1963, CLIN ORTHOP RELAT RES, V29, P230; L'Heureux N, 2006, NAT MED, V12, P361; Obermiller FJ, 2004, MED SCI MONITOR, V10, P1; Talman Eric A., 1995, Annals of Thoracic Surgery, V60, P369; Weston MW, 1996, J BIOMECH, V29, P187, DOI 10.1016/0021-9290(95)00028-3	31	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	NOV	2015	9	11					E144	E151		10.1002/term.1662		8	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Cell Biology; Biotechnology & Applied Microbiology; Engineering	CV8GQ	WOS:000364520300025		
J	Iguchi, T; Hiraki, T; Ishii, H; Gobara, H; Fujiwara, H; Matsui, Y; Kanazawa, S				Iguchi, Toshihiro; Hiraki, Takao; Ishii, Hiroaki; Gobara, Hideo; Fujiwara, Hiroyasu; Matsui, Yusuke; Kanazawa, Susumu			Transosseous Route for CT Fluoroscopy-Guided Radiofrequency Ablation of Lung Tumors	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article							PERCUTANEOUS RADIOFREQUENCY; TRANSSTERNAL APPROACH; MICROWAVE ABLATION; LOCAL PROGRESSION; RIB FRACTURES; NEEDLE-BIOPSY; RISK-FACTORS; EXPERIENCE; LESIONS; EFFICACY	Purpose: To retrospectively evaluate radiofrequency (RF) ablation of lung tumors performed via the transosseous approach. Materials and Methods: Twelve lung tumors (mean diameter, 1.0 cm; range, 0.4-1.6 cm) in 12 patients were treated by RF ablation via a transscapular and/or transrib route with the use of a bone biopsy needle under computed tomographic fluoroscopy guidance. Therapeutic outcomes evaluated included feasibility, safety, and local efficacy. Complications were assessed based on the National Cancer Institute Common Terminology Criteria for Adverse Events, version 4.0. Results: The transosseous route was successfully employed in all patients, and the electrode was successfully advanced into all tumors with this approach. The mean distance of penetrated bone was 0.57 cm (range, 0.19-1.16 cm). Complications occurred in eight RF ablation sessions, including six grade 1 events (two cases of pneumothorax and one case each of asymptomatic rib fracture 6 mo after treatment, neuralgia, pulmonary hemorrhage, and hemothorax), two grade 2 events (pneumonia and high fever), and one grade 3 event (pneumothorax requiring pleurodesis). No adverse events of-grade >= 4 occurred. The mean and median tumor follow-up periods were 19.5 and 15.2 mo (range, 3.0-41.5 mo). Local progression occurred in two cases at 3 and 12 mo after treatment and Was successfully treated with a: second RF ablation procedure. The technique efficacy rates were 91.7% at 6 mo, 81.5% at 1 y, and 81.5% at 2 y. Conclusions: The transosseous approach was feasible in computed tomographic fluoroscopy guided RF ablation of select lung tumors when no other option was available.	[Iguchi, Toshihiro; Hiraki, Takao; Ishii, Hiroaki; Gobara, Hideo; Fujiwara, Hiroyasu; Matsui, Yusuke; Kanazawa, Susumu] Okayama Univ, Sch Med, Dept Radiol, Kita Ku, Okayama 7008558, Japan	Iguchi, T (reprint author), Okayama Univ, Sch Med, Dept Radiol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	iguchi@ba2.so-net.ne.jp					Ahmed M, 2014, J VASC INTERV RADIOL, V25, P1691, DOI 10.1016/j.jvir.2014.08.027; Richardson CM, 2002, BRIT J RADIOL, V75, P731; Zhu JC, 2008, ANN SURG ONCOL, V15, P1765, DOI 10.1245/s10434-008-9848-7; de Baere T, 2006, RADIOLOGY, V240, P587, DOI 10.1148/radiol.2402050807; Yamakado K, 2013, RADIOLOGY, V269, P946, DOI 10.1148/radiol.13131612; Lencioni R, 2008, LANCET ONCOL, V9, P621, DOI 10.1016/S1470-2045(08)70155-4; Gupta S, 2002, RADIOLOGY, V222, P57; Hiraki T, 2011, ACTA MED OKAYAMA, V65, P287; Sano Y, 2007, CANCER, V109, P1397, DOI 10.1002/cncr.22541; Simon CJ, 2007, RADIOLOGY, V243, P268, DOI 10.1148/radiol.2431060088; Tomiyama N, 2006, EUR J RADIOL, V59, P60, DOI 10.1016/j.ejrad.2006.02.001; Rossi UG, 2011, CARDIOVASC INTER RAD, V34, P184, DOI 10.1007/s00270-010-9816-z; Kashima M, 2011, AM J ROENTGENOL, V197, pW576, DOI 10.2214/AJR.11.6408; Okuma T, 2010, CARDIOVASC INTER RAD, V33, P787, DOI 10.1007/s00270-009-9770-9; Alexander ES, 2013, RADIOLOGY, V266, P971, DOI 10.1148/radiol.12120933; Hiraki T, 2006, CANCER, V107, P2873, DOI 10.1002/cncr.22333; Suzuki T, 2010, ACTA RADIOL, V51, P389, DOI 10.3109/02841851003662798; de Baere T, 2011, CARDIOVASC INTER RAD, V34, P241, DOI 10.1007/s00270-010-9860-8; Hiraki T, 2009, CHEST, V136, P1612, DOI 10.1378/chest.09-0370; Hiraki T, 2010, EUR J RADIOL, V74, P136, DOI 10.1016/j.ejrad.2009.01.026; Iguchi T, 2006, J VASC INTERV RADIOL, V17, P184, DOI 10.1016/S1051-0443(07)60895-1; Lee EW, 2009, CARDIOVASC INTER RAD, V32, P833, DOI 10.1007/s00270-009-9513-y; Astrom KGO, 1996, RADIOLOGY, V199, P564	23	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1051-0443	1535-7732		J VASC INTERV RADIOL	J. Vasc. Interv. Radiol.	NOV	2015	26	11					1694	1698		10.1016/j.jvir.2015.08.012		5	Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular Disease	Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System & Cardiology	CV9PQ	WOS:000364619500016		
J	Kumasaka, S; Miyazaki, M; Tsushima, Y				Kumasaka, Soma; Miyazaki, Masaya; Tsushima, Yoshito			CT-Guided Percutaneous Cryoablation of an Aggressive Osteoblastoma: A Case Report	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY			English	Letter									[Kumasaka, Soma] Gunma Univ Hosp, Dept Intervent Radiol, Maebashi, Gumma 3718511, Japan; Gunma Univ Hosp, Clin Ultrasound Ctr, Maebashi, Gumma 3718511, Japan	Kumasaka, S (reprint author), Gunma Univ Hosp, Dept Intervent Radiol, 3-39-15 Showa Machi, Maebashi, Gumma 3718511, Japan.						Weber MA, 2015, SKELETAL RADIOL, V44, P981, DOI 10.1007/s00256-015-2139-z; Gordon SC, 2001, ORAL SURG ORAL MED O, V91, P570, DOI 10.1067/moe.2001.113349; MCLEOD RA, 1976, AM J ROENTGENOL, V126, P321; Kurup AN, 2014, J VASC INTERV RADIOL, V25, P1657, DOI 10.1016/j.jvir.2014.08.006	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1051-0443	1535-7732		J VASC INTERV RADIOL	J. Vasc. Interv. Radiol.	NOV	2015	26	11					1746	1748		10.1016/j.jvir.2015.08.002		3	Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular Disease	Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System & Cardiology	CV9PQ	WOS:000364619500026		
J	Osuga, T; Nakamura, K; Morita, T; Lim, SY; Nisa, K; Yokoyama, N; Sasaki, N; Morishita, K; Ohta, H; Takiguchi, M				Osuga, T.; Nakamura, K.; Morita, T.; Lim, S. Y.; Nisa, K.; Yokoyama, N.; Sasaki, N.; Morishita, K.; Ohta, H.; Takiguchi, M.			Vitamin D Status in Different Stages of Disease Severity in Dogs with Chronic Valvular Heart Disease	JOURNAL OF VETERINARY INTERNAL MEDICINE			English	Article						25-Hydroxyvitamin D; Cardiac remodeling; Dog; Echocardiography	MITRAL-VALVE DISEASE; D SUPPLEMENTATION; D DEFICIENCY; FAILURE; ECHOCARDIOGRAPHY; FIBROSIS; SURVIVAL	BackgroundIn humans with heart disease, vitamin D deficiency is associated with disease progression and a poor prognosis. A recent study showed that serum 25-hydroxyvitamin D [25(OH)D] concentration, the hallmark of vitamin D status, was lower in dogs with heart failure than in normal dogs, and a low concentration was associated with poor outcome in dogs with heart failure. ObjectivesTo elucidate the vitamin D status of dogs with chronic valvular heart disease (CVHD) at different stages of disease severity. AnimalsForty-three client-owned dogs with CVHD. MethodsIn this cross-sectional study, dogs were divided into 3 groups (14 dogs in Stage B1, 17 dogs in Stage B2, and 12 dogs in Stage C/D) according to ACVIM guidelines. Dogs underwent clinical examination including echocardiography. Serum 25(OH)D concentrations were measured in each dog. ResultsSerum 25(OH)D concentration was significantly lower in Stage B2 (median, 33.2nmol/L; range, 4.9-171.7nmol/L) and C/D (13.1nmol/L; 4.9-58.1nmol/L) than in Stage B1 (52.5nmol/L; 33.5-178.0nmol/L) and was not significantly different between Stage B2 and Stage C/D. Among clinical variables, there were significant negative correlations between 25(OH)D concentration and both left atrial-to-aortic root ratio and left ventricular end-diastolic diameter normalized for body weight. Conclusions and Clinical ImportanceThese results indicate that vitamin D status is associated with the degree of cardiac remodeling, and the serum 25(OH)D concentration begins to decrease before the onset of heart failure in dogs with CVHD.	[Osuga, T.; Morita, T.; Lim, S. Y.; Nisa, K.; Yokoyama, N.; Sasaki, N.; Ohta, H.; Takiguchi, M.] Hokkaido Univ, Grad Sch Vet Med, Dept Vet Clin Sci, Lab Vet Internal Med, Sapporo, Hokkaido 0600818, Japan; [Nakamura, K.; Morishita, K.] Hokkaido Univ, Vet Teaching Hosp, Grad Sch Vet Med, Sapporo, Hokkaido 0600818, Japan	Takiguchi, M (reprint author), Hokkaido Univ, Grad Sch Vet Med, Dept Vet Clin Sci, Lab Vet Internal Med, Sapporo, Hokkaido 0600818, Japan.	mtaki@vetmed.hokudai.ac.jp			Japan Society for the Promotion of Science [23580436, 25850203, 13J01112]; Japanese Society of Veterinary Clinical Nutrition	This study was supported in part by the Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Nos. 23580436, 25850203, and 13J01112) and the Scholarship Program 2013 of the Japanese Society of Veterinary Clinical Nutrition.	Moonarmart W, 2010, J SMALL ANIM PRACT, V51, P84, DOI 10.1111/j.1748-5827.2009.00889.x; Dalbeni A, 2014, NUTR METAB CARDIOVAS, V24, P861, DOI 10.1016/j.numecd.2014.02.015; Zittermann A, 2003, J AM COLL CARDIOL, V41, P105, DOI 10.1016/S0735-1097(02)02624-4; Meems LMG, 2012, J STEROID BIOCHEM, V132, P282, DOI 10.1016/j.jsbmb.2012.06.004; Kraus MS, 2014, J VET INTERN MED, V28, P109, DOI 10.1111/jvim.12239; SIMPSON RU, 1988, CELL CALCIUM, V9, P285, DOI 10.1016/0143-4160(88)90009-7; Lee JS, 2009, J VET INTERN MED, V23, P832, DOI 10.1111/j.1939-1676.2009.0332.x; Falk T, 2013, J VET INTERN MED, V27, P500, DOI 10.1111/jvim.12075; Agborsangaya C, 2010, NUTR CANCER, V62, P51, DOI 10.1080/01635580903191460; Fall T, 2012, EUR J HEART FAIL, V14, P985, DOI 10.1093/eurjhf/hfs091; Gotsman I, 2012, EUR J HEART FAIL, V14, P357, DOI 10.1093/eurjhf/hfr175; Meyer J, 2013, AM J VET RES, V74, P1223, DOI 10.2460/ajvr.74.9.1223; Green JJ, 2006, J MOL CELL CARDIOL, V41, P350, DOI 10.1016/j.yjmcc.2006.05.019; Cornell CC, 2004, J VET INTERN MED, V18, P311, DOI 10.1892/0891-6640(2004)18<311:ASOMCM>2.0.CO;2; Zois NE, 2012, J VET INTERN MED, V26, P1309, DOI 10.1111/j.1939-1676.2012.01017.x; Borgarelli M, 2008, J VET INTERN MED, V22, P120, DOI 10.1111/j.1939-1676.2007.0008.x; Atkins C, 2009, J VET INTERN MED, V23, P1142, DOI 10.1111/j.1939-1676.2009.0392.x; Shedeed SA, 2012, PEDIATR CARDIOL, V33, P713, DOI 10.1007/s00246-012-0199-6; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Mawby DI, 2004, J AM ANIM HOSP ASSOC, V40, P109; Rishniw M, 2000, J VET INTERN MED, V14, P429, DOI 10.1892/0891-6640(2000)014<0429:EOFEMO>2.3.CO;2; Weber KT, 2009, CARDIOVASC RES, V81, P500, DOI 10.1093/cvr/cvn261; Nakamura K, 2014, J VET INTERN MED, V28, P1746, DOI 10.1111/jvim.12441; Witham Miles D, 2011, Curr Heart Fail Rep, V8, P123, DOI 10.1007/s11897-011-0048-6; Wesselowski S, 2014, J VET INTERN MED, V28, P1527, DOI 10.1111/jvim.12410	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0891-6640	1939-1676		J VET INTERN MED	J. Vet. Intern. Med.	NOV-DEC	2015	29	6					1518	1523		10.1111/jvim.13606		6	Veterinary Sciences	Veterinary Sciences	CW0UL	WOS:000364704900011		
J	Fujiwara-Igarashi, A; Igarashi, H; Hasegawa, D; Fujita, M				Fujiwara-Igarashi, A.; Igarashi, H.; Hasegawa, D.; Fujita, M.			Efficacy and Complications of Palliative Irradiation in Three Scottish Fold Cats with Osteochondrodysplasia	JOURNAL OF VETERINARY INTERNAL MEDICINE			English	Article						Feline; Genetics; Palliative therapy; Radiotherapy			[Fujiwara-Igarashi, A.; Hasegawa, D.; Fujita, M.] Nippon Vet & Life Sci Univ, Dept Clin Vet Med, Div Therapeut Sci 1, Musashino, Tokyo 1800023, Japan; [Igarashi, H.] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Internal Med, Bunkyo Ku, Tokyo, Japan	Fujiwara-Igarashi, A (reprint author), Nippon Vet & Life Sci Univ, Dept Clin Vet Med, Div Therapeut Sci 1, 1-7-1 Kyonancho, Musashino, Tokyo 1800023, Japan.	afjig@nvlu.ac.jp					Tuncbilek E, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-20; Chang J, 2007, J VET SCI, V8, P307; Hautmann MG, 2014, STRAHLENTHER ONKOL, V190, P298, DOI 10.1007/s00066-013-0462-7; Kataoka T, 2013, J RADIAT RES, V54, P587, DOI 10.1093/jrr/rrs141; MATHEWS KG, 1995, J AM ANIM HOSP ASSOC, V31, P280; Malik R, 1999, AUST VET J, V77, P85, DOI 10.1111/j.1751-0813.1999.tb11672.x; EMAMI B, 1991, INT J RADIAT ONCOL, V21, P109; Takanosu M, 2008, J SMALL ANIM PRACT, V49, P197, DOI 10.1111/j.1748-5827.2008.00561.x; Arenas M, 2012, STRAHLENTHER ONKOL, V188, P975, DOI 10.1007/s00066-012-0170-8; Hubler M, 2004, VET RADIOL ULTRASOUN, V45, P582, DOI 10.1111/j.1740-8261.2004.04101.x; Bomford CK, 2003, WALTER MILLERS TXB R, P307; Frey B, 2015, CANC LETT IN PRESS; Gandolfi B, 2015, PLANT ANIMAL GENOME, P151; Koca T, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-21; Malik R, 2001, J Feline Med Surg, V3, P109, DOI 10.1053/jfms.2001.0121; Niewald M, 2008, RADIAT ONCOL, V3, DOI 10.1186/1748-717X-3-27; Pederson NC, 1991, FELINE HUSBANDRY DIS, P75; Rödel Franz, 2012, Front Oncol, V2, P120, DOI 10.3389/fonc.2012.00120; Tsang Annetta K L, 2013, Spec Care Dentist, V33, P248, DOI 10.1111/scd.12018; Wastlhuber J, 1991, FELINE HUSBANDRY DIS, P12	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0891-6640	1939-1676		J VET INTERN MED	J. Vet. Intern. Med.	NOV-DEC	2015	29	6					1643	1647		10.1111/jvim.13614		5	Veterinary Sciences	Veterinary Sciences	CW0UL	WOS:000364704900030		
J	Liu, ZQ; Ishihara, T				Liu, Zhenqing; Ishihara, Takeshi			A study of tornado induced mean aerodynamic forces on a gable-roofed building by the large eddy simulations	JOURNAL OF WIND ENGINEERING AND INDUSTRIAL AERODYNAMICS			English	Article						Tornado-like vortex; Building model; Aerodynamic forces; Force coefficients; LES	LOW-RISE BUILDINGS; NUMERICAL-SIMULATION; SWIRL RATIO; WIND LOADS; OUTFLOW BOUNDARY; MODEL; VORTICES; VORTEX; PREDICTION; EVOLUTION	A tornado simulator was built and tornado-induced mean aerodynamic forces on a gable-roofed building were numerically studied. Simulated mean flow fields and mean forces acting on a building model showed satisfactory agreement with those from experiments verifying the accuracy of the tornado simulator. Around the world experimental tornado simulators are very limited which makes estimating tornado induced forces much difficult. Therefore, examining whether or not there are any relationships between tornado induced forces and straight-line wind induced forces is the target of this study. After checking mean wind profiles below the height of building in tornado flow fields, a kind of spiral was found. This spiral is unique compared with profiles in traditional wind tunnel. Therefore a concept of volume averaged velocity was proposed and found to be the linkage between tornado induced mean forces and straight-line wind induced mean forces, i.e. removing tornado induced atmospheric pressures, the building in tornado experiences similar responses with those in wind tunnel if the direction of volume averaged velocity is same. Based on this finding, a method estimating the tornado-induced mean aerodynamic forces using the straight-line wind tunnel is proposed and the results transformed from the data base of the straight-line wind tunnel show satisfactory agreement with those directly calculated in the tornado simulator. (C) 2015 Elsevier Ltd. All rights reserved.	[Liu, Zhenqing] Huazhong Univ Sci & Technol, Sch Civil Engn & Mech, Wuhan, Hubei, Peoples R China; [Ishihara, Takeshi] Univ Tokyo, Sch Engn, Dept Civil Engn, Tokyo, Japan	Liu, ZQ (reprint author), Huazhong Univ Sci & Technol, Sch Civil Engn & Mech, Wuhan, Hubei, Peoples R China.	liuzhenqing1984@hotmail.com					Alrasheedi N.H., 2011, P ASME EARL CAR TECH; Yang ZF, 2011, J FLUID STRUCT, V27, P471, DOI 10.1016/j.jfluidstructs.2011.02.011; Tamura Y, 2001, J WIND ENG IND AEROD, V89, P1635, DOI 10.1016/S0167-6105(01)00153-2; HOXEY RP, 1993, J WIND ENG IND AEROD, V50, P203, DOI 10.1016/0167-6105(93)90075-Y; Lee BD, 1997, J ATMOS SCI, V54, P2387, DOI 10.1175/1520-0469(1997)054<2387:TNSONT>2.0.CO;2; Yang W, 2008, J WIND ENG IND AEROD, V96, P2080, DOI 10.1016/j.jweia.2008.02.014; Oka S, 2009, J WIND ENG IND AEROD, V97, P548, DOI 10.1016/j.jweia.2009.08.006; Tamura T, 2008, J WIND ENG IND AEROD, V96, P1974, DOI 10.1016/j.jweia.2008.02.020; Wurman J, 2005, MON WEATHER REV, V133, P97, DOI 10.1175/MWR-2856.1; MONJI N, 1985, J METEOROL SOC JPN, V63, P703; Tamura T, 1997, J WIND ENG IND AEROD, V67-8, P671, DOI 10.1016/S0167-6105(97)00109-8; Maruyama T, 2011, J WIND ENG IND AEROD, V99, P249, DOI 10.1016/j.jweia.2011.01.016; CHURCH CR, 1979, J ATMOS SCI, V36, P1755, DOI 10.1175/1520-0469(1979)036<1755:COTLVA>2.0.CO;2; JISCHKE MC, 1983, J WIND ENG IND AEROD, V13, P371, DOI 10.1016/0167-6105(83)90157-5; Haan FL, 2010, J STRUCT ENG-ASCE, V136, P106, DOI 10.1061/(ASCE)ST.1943-541X.0000093; Lee BD, 1997, J ATMOS SCI, V54, P32, DOI 10.1175/1520-0469(1997)054<0032:TNSONS>2.0.CO;2; Hu H, 2011, EXP FLUIDS, V51, P835, DOI 10.1007/s00348-011-1102-6; Hangan H, 2008, WIND STRUCT, V11, P291; Mishra AR, 2008, J WIND ENG IND AEROD, V96, P1258, DOI 10.1016/j.jweia.2008.02.027; Doswell CA, 2012, WEATHER, V67, P88, DOI 10.1002/wea.1902; Yang ZF, 2010, J VISUAL-JAPAN, V13, P285, DOI 10.1007/s12650-010-0052-z; Ishihara T, 2011, J WIND ENG IND AEROD, V99, P239, DOI 10.1016/j.jweia.2011.01.014; Kopp GA, 2006, J STRUCT ENG-ASCE, V132, P909, DOI 10.1061/(ASCE)0733-9445(2006)132:6(909); Lewellen DC, 2000, J ATMOS SCI, V57, P527, DOI 10.1175/1520-0469(2000)057<0527:TIOALS>2.0.CO;2; Blocken B, 2007, J WIND ENG IND AEROD, V95, P941, DOI 10.1016/j.jweia.2007.01.013; Haan FL, 2008, ENG STRUCT, V30, P1146, DOI 10.1016/j.engstruct.2007.07.0; Rajasekharan SG, 2013, J WIND ENG IND AEROD, V112, P52, DOI 10.1016/j.jweia.2012.11.005; MOCHIDA A, 1993, J WIND ENG IND AEROD, V46-7, P455, DOI 10.1016/0167-6105(93)90312-C; Ishihara T, 2014, WIND STRUCT, V19, P89; Kikitsu H., 2012, P 2012 ANN M JAP SOC; Matsui M., 2009, P EACWE; Peric M., 2002, COMPUTATIONAL METHOD; Pierre L.M.S., 2005, J WIND ENG IND AEROD, V93, P31, DOI DOI 10.1016/J.JWEIA.2004.07.007; Rajasekharan S.G., 2013, J WIND ENG IND AEROD, V122, P113; Refan M., 2014, THESIS W U; Rotz J., 1974, TORNADO EXTREME WIND; Tad P.H., 2010, J WIND ENG IND AEROD, V98, P936; WARD NB, 1972, J ATMOS SCI, V29, P1194, DOI 10.1175/1520-0469(1972)029<1194:TEOCFO>2.0.CO;2; Wilson T., 1977, TORNADO STRUCTURE IN	39	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-6105	1872-8197		J WIND ENG IND AEROD	J. Wind Eng. Ind. Aerodyn.	NOV	2015	146						39	50		10.1016/j.jweia.2015.08.002		12	Engineering, Civil; Mechanics	Engineering; Mechanics	CV4QQ	WOS:000364252000004		
J	Kim, YC; Tamura, Y; Yoon, SW				Kim, Yong Chul; Tamura, Yukio; Yoon, Sung-won			Proximity effect on low-rise building surrounded by similar-sized buildings	JOURNAL OF WIND ENGINEERING AND INDUSTRIAL AERODYNAMICS			English	Article						Sheltering effect; Pressure coefficient; Local pressure coefficient; Surface roughness element; Upstream distance; Area density; Building distance	AYLESBURY COMPARATIVE EXPERIMENT; OF-THE-ART; WIND LOADS; PRESSURE DISTRIBUTION; SURFACE PRESSURES; BOUNDARY-LAYERS; TUNNEL; MODELS; FORCES; FIELD	Wind pressures on a low-rise building in a large group were measured to investigate the proximity effects of surrounding buildings. Five area densities and a long upstream distance were considered under a suburban flow. Results show that variations of pressure coefficients within one area density are relatively small, and that local pressure coefficients increase significantly because of a rapid decrease in local velocity pressures at the model position. Focusing on the peak pressure coefficients, sensitivity study of area density and building distance were conducted for two area densities. The effect of an upstream building is the largest, and the effect of modified arrangement of all buildings is similar to that of the upstream building. The effects of side and downstream buildings are smaller than that of area density. (C) 2015 Elsevier Ltd. All rights reserved.	[Kim, Yong Chul] Tokyo Polytech Univ, Atsugi, Kanagawa, Japan; [Tamura, Yukio] Beijing Jiaotong Univ, Beijing, Peoples R China; [Yoon, Sung-won] Seoul Natl Univ Sci & Technol, Seoul, South Korea	Kim, YC (reprint author), Tokyo Polytech Univ, Atsugi, Kanagawa, Japan.	gentle95@gmail.com			Ministry of Education, Culture, Sports, Science and Technology, Japan through the Global Center of Excellence Program [H13]; Ministry of Education, Culture, Sports, Science and Technology, Japan, through 111 Project [B13002]; 1000 Foreign Talent Program in China	This study was funded by the Ministry of Education, Culture, Sports, Science and Technology, Japan, through the Global Center of Excellence Program, 2008-2012 (H13), and 111 Project (B13002) and 1000 Foreign Talent Program in China. The authors gratefully acknowledge their support.	Chang CH, 2003, J WIND ENG IND AEROD, V91, P1039, DOI 10.1016/S0167-6105(03)00051-5; Khanduri AC, 1998, ENG STRUCT, V20, P617, DOI 10.1016/S0141-0296(97)00066-7; LEE BE, 1977, J FLUID ENG-T ASME, V99, P503; Richardson GM, 1997, J WIND ENG IND AEROD, V72, P187, DOI 10.1016/S0167-6105(97)00274-2; SURRY D, 1995, J WIND ENG IND AEROD, V58, P113, DOI 10.1016/0167-6105(95)00016-K; Holscher N, 1998, J WIND ENG IND AEROD, V74-6, P599, DOI 10.1016/S0167-6105(98)00054-3; Young MA, 1998, J WIND ENG IND AEROD, V77-8, P233, DOI 10.1016/S0167-6105(98)00146-9; COOK NJ, 1982, J WIND ENG IND AEROD, V9, P295, DOI 10.1016/0167-6105(82)90021-6; Kiefer H, 1998, J WIND ENG IND AEROD, V74-6, P619, DOI 10.1016/S0167-6105(98)00056-7; Kose DA, 2010, J WIND ENG IND AEROD, V98, P628, DOI 10.1016/j.jweia.2010.06.004; SILL BL, 1990, J WIND ENG IND AEROD, V36, P1289; LEVITAN ML, 1991, J WIND ENG IND AEROD, V38, P227, DOI 10.1016/0167-6105(91)90043-V; FANG C, 1995, J WIND ENG IND AEROD, V56, P87, DOI 10.1016/0167-6105(94)00008-2; MURAKAMI S, 1993, J WIND ENG IND AEROD, V46-7, P21, DOI 10.1016/0167-6105(93)90112-2; HUNT A, 1982, J WIND ENG IND AEROD, V10, P137, DOI 10.1016/0167-6105(82)90061-7; Kim YC, 2013, J WIND ENG IND AEROD, V112, P58, DOI 10.1016/j.jweia.2012.11.003; Kim YC, 2012, ENG STRUCT, V35, P18, DOI 10.1016/j.engstruct.2011.10.024; Jia YQ, 1998, J WIND ENG IND AEROD, V77-8, P491, DOI 10.1016/S0167-6105(98)00167-6; STATHOPOULOS T, 1984, ENG STRUCT, V6, P119, DOI 10.1016/0141-0296(84)90005-1; HUSSAIN M, 1980, J WIND ENG IND AEROD, V6, P207, DOI 10.1016/0167-6105(80)90002-1; SILL BL, 1990, J WIND ENG IND AEROD, V36, P1047; HO TCE, 1991, J WIND ENG IND AEROD, V38, P297, DOI 10.1016/0167-6105(91)90049-3; FANG C, 1992, J WIND ENG IND AEROD, V41, P449, DOI 10.1016/0167-6105(92)90444-F; PETERKA JA, 1976, J STRUCT DIV-ASCE, V102, P533; SILL BL, 1989, J WIND ENG IND AEROD, V32, P285, DOI 10.1016/0167-6105(89)90004-4; Kim Y. C., 2013, J STRUCT ENG, V137, P275; Kim Y.C., 2014, J STRUCT ENG, V140; Sill B.L., 1992, J WIND ENG IND AEROD, V41-44, P1553; Wang K., 2006, STRUCTURES C, P1; Zisis I., 2010, P 7 AS PAC C WIND EN	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-6105	1872-8197		J WIND ENG IND AEROD	J. Wind Eng. Ind. Aerodyn.	NOV	2015	146						150	162		10.1016/j.jweia.2015.08.011		13	Engineering, Civil; Mechanics	Engineering; Mechanics	CV4QQ	WOS:000364252000014		
J	Mizuno, T; Kojima, Y				Mizuno, T.; Kojima, Y.			A blindsnake that decapitates its termite prey	JOURNAL OF ZOOLOGY			English	Article						Indotyphlops braminus; Typhlopidae; predatory behavior; manipulating prey	DIETARY HABITS; TYPHLOPID SNAKES; GARTER SNAKES; DEFENSE; PREDATORS; IDENTIFICATION; TETRODOTOXIN; ISOPTERA; SOLDIERS; HISTORY	Almost all snakes swallow their prey whole. However, a few species are known as exceptions. Two species of Asian crab-eating snakes tear off crab legs and ingest them one at a time to eat prey that is otherwise too large. Two species of leptotyphlopid blindsnakes break off the head of termites or suck abdominal contents of termites, discarding remains of termites. Here, we show that a typhlopid blindsnake Indotyphlops braminus decapitates its termite prey and consumes only the thorax and abdomen. In our feeding trials, I.braminus decapitated a median of 47% of termites they eat, while swallowing the remaining termites whole. Decapitation did not affect ingestion speed, and therefore, it is unlikely that decapitation assists for fast ingestion. Ingested termite heads often remain undigested in the feces, implying that the decapitation functions to remove an indigestible part of termites. Decapitation might also be related to circumvention of chemical defenses of termites because termite heads often contain toxic compounds. These observations showed unusual feeding behavior used by a basal snake, which could be associated with removal of indigestible and/or toxic parts of prey items.	[Mizuno, T.] Kyoto Inst Technol, Appl Entomol Lab, Ctr Bioresources Field Sci, Kyoto 606, Japan; [Kojima, Y.] Kyoto Univ, Grad Sch Sci, Dept Zool, Kyoto, Japan	Mizuno, T (reprint author), Saga Ippongi Cho 1, Kyoto 6168354, Japan.	takafumi.takafumizuno@gmail.com					AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; PRESTWICH GD, 1977, J CHEM ECOL, V3, P579, DOI 10.1007/BF00989078; Avila RW, 2006, HERPETOL J, V16, P403; OLSON DH, 1989, COPEIA, P391, DOI 10.2307/1445435; Williams BL, 2012, CHEMOECOLOGY, V22, P179, DOI 10.1007/s00049-011-0093-3; WEBB JK, 1993, COPEIA, P762; Jayne BC, 2002, NATURE, V418, P143, DOI 10.1038/418143a; HINES AH, 1982, ECOLOGY, V63, P1547, DOI 10.2307/1938879; Fellers Gary M., 2007, Herpetological Review, V38, P317; Webb JK, 2001, J HERPETOL, V35, P558, DOI 10.2307/1565893; PRESTWICH GD, 1979, J CHEM ECOL, V5, P459, DOI 10.1007/BF00987930; Torres JA, 2000, INSECT SOC, V47, P1, DOI 10.1007/s000400050001; Masuoka Y, 2013, ARTHROPOD STRUCT DEV, V42, P469, DOI 10.1016/j.asd.2013.08.003; HELFMAN GS, 1986, COPEIA, P679, DOI 10.2307/1444949; Webb JK, 2000, J ZOOL, V250, P321, DOI 10.1111/j.1469-7998.2000.tb00776.x; SHINE R, 1985, COPEIA, P1067; SMITH CC, 1972, ECOLOGY, V53, P82, DOI 10.2307/1935712; Kley NJ, 2001, AM ZOOL, V41, P1321, DOI 10.1668/0003-1569(2001)041[1321:PTMIBA]2.0.CO;2; BRODIE ED, 1990, EVOLUTION, V44, P651; Rey PJ, 1996, J AVIAN BIOL, V27, P327, DOI 10.2307/3677264; Mochida Koji, 2007, Mammal Study, V32, P135, DOI 10.3106/1348-6160(2007)32[135:CTTMPT]2.0.CO;2; Voris HK, 2002, J NAT HIST, V36, P1621, DOI 10.1080/00222930110062642; CHUAH CH, 1983, J CHEM ECOL, V9, P347, DOI 10.1007/BF00988454; SCHEFFRAHN RH, 1983, J CHEM ECOL, V9, P1293, DOI 10.1007/BF00994798; SHINE R, 1990, J HERPETOL, V24, P357, DOI 10.2307/1565050; Bates D., 2014, LME4 LINEAR MIXED EF; Cundall David, 2000, P293, DOI 10.1016/B978-012632590-4/50010-1; Hedges S. Blair, 2014, Caribbean Herpetology, V49, P1; Morimoto K., 1965, J SOC MATER SCI JPN, V14, P634; PUNZO F, 1974, Journal of Herpetology, V8, P153, DOI 10.2307/1562811; R Development Core Team, 2014, R LANG ENV STAT COMP; REID JACK R., 1963, HERPETOLOGICA, V19, P141; SMITH HOBART M., 1957, HERPETOLOGICA, V13, P102; Vidal Nicolas, 2009, P390; Vitt L.J., 2014, HERPETOLOGY INTRO BI	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-8369	1469-7998		J ZOOL	J. Zool.	NOV	2015	297	3					220	224		10.1111/jzo.12268		5	Zoology	Zoology	CV9YE	WOS:000364643900007		
J	Kusunoki, Y; Matsui, I; Hamano, T; Shimomura, A; Mori, D; Yonemoto, S; Takabatake, Y; Tsubakihara, Y; St-Arnaud, R; Isaka, Y; Rakugi, H				Kusunoki, Yasuo; Matsui, Isao; Hamano, Takayuki; Shimomura, Akihiro; Mori, Daisuke; Yonemoto, Sayoko; Takabatake, Yoshitsugu; Tsubakihara, Yoshiharu; St-Arnaud, Rene; Isaka, Yoshitaka; Rakugi, Hiromi			Excess 25-hydroxyvitamin D3 exacerbates tubulointerstitial injury in mice by modulating macrophage phenotype	KIDNEY INTERNATIONAL			English	Article						fibrosis; macrophages; oxidative stress	VITAMIN-D-RECEPTOR; RENAL INTERSTITIAL FIBROSIS; RANDOMIZED CONTROLLED-TRIAL; TGF-BETA; OBSTRUCTIVE NEPHROPATHY; KIDNEY-DISEASE; ACTIVATION; MORTALITY; ANALOG; MODEL	Vitamin D hydroxylated at carbon 25 (25(OH)D) is generally recognized as a precursor of active vitamin D. Despite its low affinity for the vitamin D receptor (VDR), both deficient and excessive 25(OH)D levels are associated with poor clinical outcomes. Here we studied direct effects of 25(OH)D-3 on the kidney using 25(OH)D-1 alpha-hydroxylase (CYP27B1) knockout mice. The effects of 25(OH)D-3 on unilateral ureteral obstruction were analyzed as proximal tubular cells and macrophages are two major cell types that take up 25(OH)D and contribute to the pathogenesis of kidney injury. Excess 25(OH)D-3 in obstructed mice worsened oxidative stress and tubulointerstitial fibrosis, whereas moderate levels of 25(OH)D-3 had no effects. The exacerbating effects of excess 25(OH)D-3 were abolished in CYP27B1/VDR double-knockout mice and in macrophage-depleted CYP27B1 knockout mice. Excess 25(OH)D-3 upregulated both M1 marker (TNF-alpha) and M2 marker (TGF-beta 1) levels of kidney-infiltrating macrophages. In vitro analyses verified that excess 25(OH)D-3 directly upregulated TNF-alpha and TGF-beta 1 in cultured macrophages but not in tubular cells. TNF-alpha and 25(OH)D-3 cooperatively induced oxidative stress by upregulating iNOS in tubular cells. Aggravated tubulointerstitial fibrosis in mice with excess 25(OH)D-3 indicated that macrophage-derived TGF-beta 1 also had a key role in the pathogenesis of surplus 25(OH)D-3. Thus, excess 25(OH)D-3 worsens tubulointerstitial injury by modulating macrophage phenotype.	[Kusunoki, Yasuo; Matsui, Isao; Shimomura, Akihiro; Mori, Daisuke; Yonemoto, Sayoko; Takabatake, Yoshitsugu; Isaka, Yoshitaka; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka 5650871, Japan; [Hamano, Takayuki; Tsubakihara, Yoshiharu] Osaka Univ, Grad Sch Med, Dept Comprehens Kidney Dis Res, Suita, Osaka 5650871, Japan; [St-Arnaud, Rene] Shriners Hosp Children, Res Unit, Montreal, PQ, Canada; [St-Arnaud, Rene] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [St-Arnaud, Rene] McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada; [St-Arnaud, Rene] McGill Univ, Dept Med, Montreal, PQ, Canada	Isaka, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	isaka@kid.med.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [26461227]; Kidney Foundation, Japan [JKFB14-23]	We thank Naoko Horimoto for her technical assistance. We are also grateful to the Center of Medical Research and Education, Osaka University Graduate School of Medicine, for technical support. This research was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (no. 26461227 to IM) and The Kidney Foundation, Japan (JKFB14-23 to IM). TH and YT are members of a department that has received donations from Chugai Pharmaceutical, Chugai, Japan.	Glendenning P, 2012, J BONE MINER RES, V27, P170, DOI 10.1002/jbmr.524; Dardenne O, 2001, ENDOCRINOLOGY, V142, P3135, DOI 10.1210/en.142.7.3135; Ito I, 2013, J CLIN INVEST, V123, P4579, DOI 10.1172/JCI67804; Li HM, 2005, J EXP MED, V201, P1169, DOI 10.1081/jem.20011111; Ravani P, 2009, KIDNEY INT, V75, P88, DOI 10.1038/ki.2008.501; WECKSLER WR, 1978, J STEROID BIOCHEM, V9, P929, DOI 10.1016/0022-4731(78)90053-5; Morris HA, 2014, ANN LAB MED, V34, P181, DOI 10.3343/alm.2014.34.3.181; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; KREAM BE, 1977, ARCH BIOCHEM BIOPHYS, V179, P462, DOI 10.1016/0003-9861(77)90134-5; Inoue K, 2012, LAB INVEST, V92, P1686, DOI 10.1038/labinvest.2012.107; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Namba T, 2014, J AM SOC NEPHROL, V25, P2254, DOI 10.1681/ASN.2013090986; RIZZOLI R, 1994, BONE, V15, P193, DOI 10.1016/8756-3282(94)90707-2; Vieth R, 2007, J BONE MINER RES, V22, pV64, DOI [10.1359/jbmr.07s221, 10.1359/JBMR.07S221]; Smith H, 2007, RHEUMATOLOGY, V46, P1852, DOI 10.1093/rheumatology/kem240; Melamed ML, 2009, J AM SOC NEPHROL, V20, P2631, DOI 10.1681/ASN.2009030283; Rowling MJ, 2007, J NUTR, V137, P2608; Kitamoto K, 2009, J PHARMACOL SCI, V111, P285, DOI 10.1254/jphs.09227FP; Dusso AS, 2011, KIDNEY INT SUPPL, V1, P136, DOI 10.1038/kisup.2011.30; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Michaelsson K, 2010, AM J CLIN NUTR, V92, P841, DOI 10.3945/ajcn.2010.29749; Kimura T, 2011, J AM SOC NEPHROL, V22, P902, DOI 10.1681/ASN.2010070705; Wagner D, 2009, CLIN BIOCHEM, V42, P1549, DOI 10.1016/j.clinbiochem.2009.07.013; Gurlek A, 2002, ENDOCR REV, V23, P763, DOI 10.1210/er.2001-0044; HUGHES MR, 1977, ENDOCRINOLOGY, V100, P799; Massague J, 2012, FEBS LETT, V586, P1953, DOI 10.1016/j.febslet.2012.03.023; Jones G, 1998, PHYSIOL REV, V78, P1193; Takeyama KI, 1999, MOL CELL BIOL, V19, P1049; Hamano T, 2013, KIDNEY INT SUPPL, V3, P469, DOI 10.1038/kisup.2013.97; Nakano C, 2012, CLIN J AM SOC NEPHRO, V7, P810, DOI 10.2215/CJN.08680811; Matsui I, 2009, NEPHROL DIAL TRANSPL, V24, P2354, DOI 10.1093/ndt/gfp117; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; de Zeeuw D, 2010, LANCET, V376, P1543, DOI 10.1016/S0140-6736(10)61032-X; Chen YZ, 2013, J IMMUNOL, V190, P3687, DOI 10.4049/jimmunol.1203273; Ferre S, 2012, KIDNEY INT, V82, P1157, DOI 10.1038/ki.2012.179; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Nakano Y, 2006, J MED CHEM, V49, P2398, DOI 10.1021/jm050738x; Wang HL, 2009, J INVEST DERMATOL, V129, P1100, DOI 10.1038/jid.2009.43; Zhang Y, 2012, J IMMUNOL, V188, P2127, DOI 10.4049/jimmunol.1102412; de Boer IH, 2007, AM J KIDNEY DIS, V50, P69, DOI 10.1053/j.ajkd.2007.04.015; Sempos CT, 2013, J CLIN ENDOCR METAB, V98, P3001, DOI 10.1210/jc.2013-1333; DeLuca HF, 2009, GASTROENTEROLOGY, V137, pS79, DOI 10.1053/j.gastro.2009.07.075; DeLuca Hector F, 2004, Am J Clin Nutr, V80, p1689S; Eddy AA, 2014, KIDNEY INT SUPPL, V4, P2, DOI 10.1038/kisup.2014.2; Jones G, 2008, AM J CLIN NUTR, V88, P5825; Martinez I, 1996, NEPHROL DIAL TRANSPL, V11, P22; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; SHEPARD RM, 1980, ARCH BIOCHEM BIOPHYS, V202, P43, DOI 10.1016/0003-9861(80)90404-X; Tan XY, 2006, J AM SOC NEPHROL, V17, P3382, DOI 10.1681/ASN.2006050520	56	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	NOV	2015	88	5					1013	1029		10.1038/ki.2015.210		17	Urology & Nephrology	Urology & Nephrology	CW2CR	WOS:000364799200015		
J	Chen, JD; Huang, DC; Rubera, I; Futami, K; Wang, PF; Zickert, P; Khoo, SK; Dykema, K; Zhao, P; Petillo, D; Cao, B; Zhang, ZF; Si, SH; Schoen, SR; Yang, XMJ; Zhou, M; Xiao, GQ; Wu, G; Nordenskjold, M; Tauc, M; Williams, BO; Furge, KA; Teh, B				Chen, Jindong; Huang, Dachuan; Rubera, Isabelle; Futami, Kunihiko; Wang, Pengfei; Zickert, Peter; Khoo, Sok-Kean; Dykema, Karl; Zhao, Ping; Petillo, David; Cao, Brian; Zhang, Zhongfa; Si, Shuhui; Schoen, Susan R.; Yang, Ximing J.; Zhou, Ming; Xiao, Guang-Qian; Wu, Guan; Nordenskjold, Magnus; Tauc, Michel; Williams, Bart O.; Furge, Kyle A.; Teh, Bin Lean			Disruption of tubular FIcn expression as a mouse model for renal tumor induction	KIDNEY INTERNATIONAL			English	Article						BHD; FLCN; gene targeting; kidney cancer; mouse model; mTOR; RCC; TGF-beta	HOGG-DUBE-SYNDROME; TGF-BETA; CELL CARCINOMA; CONDITIONAL INACTIVATION; EMBRYONIC LETHALITY; POLYCYSTIC KIDNEYS; CYST DEVELOPMENT; MTOR ACTIVATION; BHD GENE; CANCER	The study of kidney cancer pathogenesis and its treatment has been limited by the scarcity of genetically defined animal models. The FLCN gene that codes for the protein folliculin, mutated in Birt-Hogg-Dube syndrome, presents a new target for mouse modeling of kidney cancer. Here we developed a kidney-specific knockout model by disrupting the mouse Flcn in the proximal tubules, thus avoiding homozygous embryonic lethality or neonatal mortality, and eliminating the requirement of loss of heterozygosity for tumorigenesis. This knockout develops renal cysts and early onset (6 months) of multiple histological subtypes of renal neoplasms featuring high tumor penetrance. Although the majority of the tumors were chromophobe renal cell carcinomas in affected mice under 1 year of age, papillary renal cell carcinomas predominated in the kidneys of older knockout mice. This renal neoplasia from cystic hyperplasia at 4 months to high-grade renal tumors by 16 months represented the progression of tumorigenesis. The mTOR and TGF-beta signalings were upregulated in Flcn-deficient tumors, and these two activated pathways may synergetically cause renal tumorigenesis. Treatment of knockout mice with the mTOR inhibitor rapamycin for 10 months led to the suppression of tumor growth. Thus, our model recapitulates human Birt Hogg Dube kidney tumorigenesis, provides a valuable tool for further study of Flcn-deficient renal tumorigenesis, and tests. new drugs/approaches to their treatment.	[Chen, Jindong; Wang, Pengfei; Si, Shuhui; Schoen, Susan R.; Wu, Guan] Univ Rochester, Med Ctr, Dept Urol, Kidney Canc Res Lab, Rochester, NY 14642 USA; [Chen, Jindong] Zunyi Med Univ, Dept Cell Biol & Genet, Zunyi, Peoples R China; [Huang, Dachuan; Teh, Bin Lean] Natl Canc Ctr, NCCS VARI Translat Canc Res Lab, Singapore 169610, Singapore; [Rubera, Isabelle; Tauc, Michel] Univ Nice Sophia Antipolis, F-06189 Nice, France; [Futami, Kunihiko] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Course Appl Marine Biosci, Tokyo, Japan; [Zickert, Peter] Karolinska Inst, Dept Pathol, Danderyds Hosp, S-10401 Stockholm, Sweden; [Khoo, Sok-Kean] Grand Valley State Univ, Cook DeVos Ctr Hlth Sci, Dept Cell & Mol Biol, Grand Rapids, MI USA; [Dykema, Karl; Petillo, David; Zhang, Zhongfa; Furge, Kyle A.; Teh, Bin Lean] Van Andel Res Inst, Lab Interdisciplinary Renal Oncol, Grand Rapids, MI USA; [Zhao, Ping] Helen DeVos Childrens Hosp, Spectrum Hlth, Grand Rapids, MI USA; [Petillo, David] Ferris State Univ, Coll Hlth Profess, Mol Diagnost Program, Grand Rapids, MI USA; [Cao, Brian] Van Andel Res Inst, Mol Oncol Lab, Grand Rapids, MI USA; [Yang, Ximing J.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Zhou, Ming] NYU, Med Ctr, Dept Pathol, New York, NY 10016 USA; [Xiao, Guang-Qian] Univ Rochester, Med Ctr, Dept Pathol, Rochester, NY 14642 USA; [Nordenskjold, Magnus] Karolinska Inst, Dept Mol Med & Surg, Clin Genet, Stockholm, Sweden; [Nordenskjold, Magnus] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Williams, Bart O.] Van Andel Res Inst, Lab Cell Signaling & Carcinogenesis, Grand Rapids, MI USA	Chen, JD (reprint author), Univ Rochester, Med Ctr, Dept Urol, 601 Elmwood Ave,Box 656, Rochester, NY 14642 USA.	jindong_chen@URMC.rochester.edu; teh.bin.tean@singhealth.com.sg			Van Andel Foundation	We thank the following Van Andel Research Institute core facilities for their services: the gene-targeting core; the vivarium; the analytical, cellular, and molecular microscopy core; and the flow cytometry core. We also thank Dr Bob Sigler and Yun Cao for technical assistance in mouse pathology, David Nadziejka for technical editing, and Sabrina Noyes for her administrative support. This work was supported by the Van Andel Foundation.	Abrahams Neil A, 2003, Ann Diagn Pathol, V7, P296, DOI 10.1016/S1092-9134(03)00072-8; Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Cash TP, 2011, ONCOGENE, V30, P2534, DOI 10.1038/onc.2010.628; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Yu Q, 2000, GENE DEV, V14, P163; Mazal PR, 2005, MODERN PATHOL, V18, P535, DOI 10.1038/modpathol.3800320; Goraksha-Hicks P, 2009, DEV CELL, V17, P6, DOI 10.1016/j.devcel.2009.07.004; BIRT AR, 1977, ARCH DERMATOL, V113, P1674, DOI 10.1001/archderm.113.12.1674; Frew IJ, 2008, EMBO J, V27, P1747, DOI 10.1038/emboj.2008.96; Tardio JC, 2000, HISTOPATHOLOGY, V36, P184; Parada David, 2006, Archivos Espanoles de Urologia, V59, P209; Brunelli M, 2007, MODERN PATHOL, V20, P303, DOI 10.1038/modpathol.3800739; Qian CN, 2005, J BIOL CHEM, V280, P3938, DOI 10.1074/jbc.M410697200; Hartman TR, 2009, ONCOGENE, V28, P1594, DOI 10.1038/onc.2009.14; Albers J, 2013, EMBO MOL MED, V5, P949, DOI 10.1002/emmm.201202231; Qian CN, 2009, CANCER RES, V69, P8256, DOI 10.1158/0008-5472.CAN-09-1689; Khoo SK, 2003, CANCER RES, V63, P4583; Hasumi Y, 2009, P NATL ACAD SCI USA, V106, P18722, DOI 10.1073/pnas.0908853106; Baba M, 2008, J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Carpten JD, 2002, NAT GENET, V32, P676, DOI 10.1038/ng1048; Teh BT, 1996, J CLIN ENDOCR METAB, V81, P4204, DOI 10.1210/jc.81.12.4204; Pollard PJ, 2007, CANCER CELL, V11, P311, DOI 10.1016/j.ccr.2007.02.005; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Furge KA, 2007, CANCER RES, V67, P3171, DOI 10.1158/0008-5472.CAN-06-4571; Pavlovich CP, 2002, AM J SURG PATHOL, V26, P1542, DOI 10.1097/00000478-200212000-00002; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Graveel C, 2004, P NATL ACAD SCI USA, V101, P17198, DOI 10.1073/pnas.0407651101; Wu LY, 2009, DEV CELL, V17, P35, DOI 10.1016/j.devcel.2009.05.010; Hirokawa M, 1998, APMIS, V106, P993; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Kobayashi T, 2001, P NATL ACAD SCI USA, V98, P8762, DOI 10.1073/pnas.151033798; Kleymenova E, 2004, CARCINOGENESIS, V25, P309, DOI 10.1093/carcin/bgh017; Hudon V, 2010, J MED GENET, V47, P182, DOI 10.1136/jmg.2009.072009; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Rubera I, 2004, J AM SOC NEPHROL, V15, P2050, DOI 10.1097/01.ASN.0000133023.89251.01; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Launonen V, 2001, P NATL ACAD SCI USA, V98, P3387, DOI 10.1073/pnas.051633798; Nagashima Y, 2000, PATHOL RES PRACT, V196, P647; Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241; Kiuru M, 2001, AM J PATHOL, V159, P825, DOI 10.1016/S0002-9440(10)61757-9; Akhtar M, 1997, AM J SURG PATHOL, V21, P1188, DOI 10.1097/00000478-199710000-00009; SCHULTZCHERRY S, 1993, J CELL BIOL, V122, P923, DOI 10.1083/jcb.122.4.923; Okimoto K, 2004, P NATL ACAD SCI USA, V101, P2023, DOI 10.1073/pnas.0308071100; Lingaas F, 2003, HUM MOL GENET, V12, P3043, DOI 10.1093/hmg/ddg336; Chen JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003581; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; FRANKSSO.C, 1972, J UROLOGY, V108, P58; Hong SB, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-160; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Pritchett TL, 2014, ONCOGENE, V34, P2631; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545	51	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	NOV	2015	88	5					1057	1069		10.1038/ki.2015.177		13	Urology & Nephrology	Urology & Nephrology	CW2CR	WOS:000364799200018		
J	Nakamura, K; Nakagawa, H; Murakami, Y; Kitamura, A; Kiyama, M; Sakata, K; Tsuji, I; Miura, K; Ueshima, H; Okamura, T				Nakamura, Koshi; Nakagawa, Hideaki; Murakami, Yoshitaka; Kitamura, Akihiko; Kiyama, Masahiko; Sakata, Kiyomi; Tsuji, Ichiro; Miura, Katsuyuki; Ueshima, Hirotsugu; Okamura, Tomonori		EPOCH-JAPAN Res Grp	Smoking increases the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease	KIDNEY INTERNATIONAL			English	Article						cardiovascular diseases; chronic kidney disease; cohort study; mortality; smoking	GLOMERULAR-FILTRATION-RATE; POOLED ANALYSIS; COLLABORATIVE METAANALYSIS; POPULATION COHORTS; BLOOD-PRESSURE; UNITED-STATES; PREVALENCE; IMPACT; JAPAN; CKD	Little is known about the magnitude and nature of the combined effect of chronic kidney disease (CKD) and smoking on cardiovascular diseases. We studied this in a Japanese population using a pooled analysis of 15,468 men and 19,154 women aged 40-89 years enrolled in 8 cohort studies. The risk of mortality from all-causes and cardiovascular disease was compared in 6 gender-specific categories of baseline CKD status (non-CKD or CKD) and smoking habits (lifelong never smoked, former smokers, or currently smoking). CKD was defined as a decreased level of estimated glomerular filtration rate (under 60 ml/min per 1.73 m(2)) and/or dipstick proteinuria. Hazard ratios were estimated for each category, relative to never smokers without CKD. During the follow-up period (mean 14.8 years), there were 6771 deaths, 1975 of which were due to cardiovascular diseases. In both men and women, current or former smokers with CKD had the first or second highest crude mortality rates from all-cause and cardiovascular diseases among the 6 categories. After adjustment for age and other major cardiovascular risk factors, the hazard ratios in male and female current smokers with CKD were 2.26 (95% confidence interval, 1.95-2.63) and 1.78 (1.36 - 2.32) for all-causes, and 2.66 (2.04-3.47) and 1.71 (1.10 - 2.67) for cardiovascular diseases, respectively. Thus, coexistence of CKD and smoking may markedly increase the risk of all-cause and cardiovascular mortality.	[Nakamura, Koshi] Hokkaido Univ, Grad Sch Med, Dept Publ Hlth, Sapporo, Hokkaido 0608638, Japan; [Nakamura, Koshi; Nakagawa, Hideaki] Kanazawa Med Univ, Dept Epidemiol & Publ Hlth, Uchinada, Ishikawa 92002, Japan; [Murakami, Yoshitaka] Toho Univ, Sch Med, Dept Med Stat, Tokyo, Japan; [Kitamura, Akihiko] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Publ Hlth, Suita, Osaka, Japan; [Kiyama, Masahiko] Osaka Ctr Canc & Cardiovasc Dis Prevent, Osaka, Japan; [Sakata, Kiyomi] Iwate Med Univ, Sch Med, Dept Hyg & Prevent Med, Yahaba, Iwate, Japan; [Tsuji, Ichiro] Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol, Sendai, Miyagi 980, Japan; [Miura, Katsuyuki; Ueshima, Hirotsugu] Shiga Univ Med Sci, Ctr Epidemiol Res Asia, Dept Publ Hlth, Otsu, Shiga 52021, Japan; [Okamura, Tomonori] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan	Nakamura, K (reprint author), Hokkaido Univ, Grad Sch Med, Dept Publ Hlth, Kita Ku, Kita 15 Nishi 7, Sapporo, Hokkaido 0608638, Japan.	koshi.nakamura@med.hokudai.ac.jp			Ministry of Health, Labour and Welfare, Health and Labor Sciences research grants, Japan [H17-Kenkou-007, H18-Junkankitou, H19-Junkankitou [Seishuu]-Ippan-012, H20-Junkankitou [Seishuu]-Ippan-013, H23-Junkankitou [Seishuu]-Ippan-005]; Intramural Research Fund [22-4-5]; Comprehensive Research on Cardiovascular and Life-Style Related Diseases [H26-Junkankitou [Seisaku]-Ippan-001]	We are grateful to all the participants in each cohort study. We thank Mrs Toshimi Yoshida (Shiga University of Medical Science) and Mrs Satoko Narikawa (Keio University) for expert clerical assistance. This research was supported by a grant-in-aid from the Ministry of Health, Labour and Welfare, Health and Labor Sciences research grants, Japan (Research on Health Services: H17-Kenkou-007; Comprehensive Research on Cardiovascular Disease and Life-Related Disease: H18-Junkankitou) Seishuu]-Ippan-012; Comprehensive Research on Cardiovascular Disease and Life-Related Disease: H19-Junkankitou [Seishuu]-Ippan-012; Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H20-Junkankitou [Seishuu]-Ippan-013; Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H23-Junkankitou [Seishuu]-Ippan-005), an Intramural Research Fund (22-4-5) for Cardiovascular Diseases of National Cerebral and Cardiovascular Center; and Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H26-Junkankitou [Seisaku]-Ippan-001.	American Diabetes Association, 2014, DIABETES CARE S1, V37, pS14, DOI [DOI 10.2337/DC14-S014, 10.2337/dc14-S014]; Muntner P, 2002, J AM SOC NEPHROL, V13; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Gifford FJ, 2011, QJM-INT J MED, V104, P1045, DOI 10.1093/qjmed/hcr122; Parikh NI, 2008, AM J CARDIOL, V102, P47, DOI 10.1016/j.amjcard.2008.02.095; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Murakami Y, 2008, HYPERTENSION, V51, P1483, DOI 10.1161/HYPERTENSIONAHA.107.102459; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Murakami Y, 2011, PREV MED, V52, P60, DOI 10.1016/j.ypmed.2010.11.009; Kent BD, 2012, AM J NEPHROL, V36, P287, DOI 10.1159/000342207; Iseki K, 2004, AM J KIDNEY DIS, V44, P806, DOI 10.1053/j.ajkd.2004.07.007; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Zhang LX, 2008, AM J KIDNEY DIS, V51, P373, DOI 10.1053/j.ajkd.2007.11.009; Levey AS, 2009, ANN INTERN MED, V150, P604; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; White SL, 2010, AM J KIDNEY DIS, V55, P660, DOI 10.1053/j.ajkd.2009.12.011; Nakamura K, 2009, TOB CONTROL, V18, P345, DOI 10.1136/tc.2008.028795; Katanoda K, 2014, TOB CONTROL, V23, P359, DOI 10.1136/tobaccocontrol-2012-050852; Nakamura K, 2012, CEREBROVASC DIS, V33, P480, DOI 10.1159/000336764; Cheng TYD, 2008, AM J KIDNEY DIS, V52, P1051, DOI 10.1053/j.ajkd.2008.05.030; Betriu A, 2014, NEPHROL DIAL TRANSPL, V29, P1415, DOI 10.1093/ndt/gfu038; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Nagata M, 2013, AM J EPIDEMIOL, V178, P1, DOI 10.1093/aje/kws447; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Ninomiya T, 2008, CIRCULATION, V118, P2694, DOI 10.1161/CIRCULATIONAHA.108.792903; Chan M, 2008, WHO REPORT GLOBAL TO; Health and Welfare Statistics Association, 2014, 2014 2015 KOK EIS NO; Imai Enyu, 2007, Clin Exp Nephrol, V11, P41, DOI 10.1007/s10157-006-0453-4; Imai Enyu, 2007, Clin Exp Nephrol, V11, P156, DOI 10.1007/s10157-007-0463-x; Kitiyakara C, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-1; Kurth T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2392; Nakamura Koshi, 2012, Int J Prev Med, V3, P459; Nakamura Masakazu, 2003, J Atheroscler Thromb, V10, P145; National Cholesterol Education Program (NCEP); Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), 2002, CIRCULATION, V106, P3143, DOI DOI 10.1001/ARCHINTE.1991.00400060019005; The Japanese Society of Nephrology, 2013, EV BAS CLIN PRACT GU; Woodward M, 2005, EPIDEMIOLOGY STUDY D; World Health Organization, 2000, WHO TECHN REP SER, V894	39	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	NOV	2015	88	5					1144	1152		10.1038/ki.2015.212		9	Urology & Nephrology	Urology & Nephrology	CW2CR	WOS:000364799200027		
J	Urena, R; Chiclana, F; Fujita, H; Herrera-Viedma, E				Urena, Raquel; Chiclana, Francisco; Fujita, Hamido; Herrera-Viedma, Enrique			Confidence-consistency driven group decision making approach with incomplete reciprocal intuitionistic preference relations	KNOWLEDGE-BASED SYSTEMS			English	Article						Group decision making; Uncertainty; Incomplete information; Intuitionistic fuzzy preference relations; Asymmetric fuzzy preference relations; Uninorm	AGGREGATION OPERATORS; FUZZY-SETS; RECOGNITION; INFORMATION; VALUES	Intuitionistic preference relations constitute a flexible and simple representation format of experts' preference on a set of alternative options, while at the same time allowing to accommodate degrees of hesitation inherent to all decision making processes. In comparison with fuzzy preference relations, the use of intuitionistic fuzzy preference relations in decision making is limited, which is mainly due to the computational complexity associated to using membership degree, non-membership degree and hesitation degree to model experts' subjective preferences. In this paper, the set of reciprocal intuitionistic fuzzy preference relations and the set of asymmetric fuzzy preference relations are proved to be mathematically isomorphic. This result can be exploited to use methodologies developed for fuzzy preference relations to the case of intuitionistic fuzzy preference relations and, ultimately, to overcome the computation complexity mentioned above and to extend the use of reciprocal intuitionistic fuzzy preference relations in decision making. In particular, in this paper, this isomorphic equivalence is used to address the presence of incomplete reciprocal intuitionistic fuzzy preference relations in decision making by developing a consistency driven estimation procedure via the corresponding equivalent incomplete asymmetric fuzzy preference relation procedure. Additionally, the hesitancy degree of the reciprocal intuitionistic fuzzy preference relation is used to introduce the concept of expert's confidence from which a group decision making procedure, based on a new aggregation operator that takes into account not only the experts' consistency but also their confidence degree towards the opinion provided, is proposed. (C) 2015 Elsevier B.V. All rights reserved.	[Urena, Raquel; Herrera-Viedma, Enrique] Univ Granada, Dept Comp Sci, E-18071 Granada, Spain; [Urena, Raquel; Herrera-Viedma, Enrique] Univ Granada, AI, E-18071 Granada, Spain; [Chiclana, Francisco] De Montfort Univ, Ctr Computat Intelligence, Leicester LE1 9BH, Leics, England; [Fujita, Hamido] Iwate Prefectural Univ, Takizawa, Iwate, Japan; [Herrera-Viedma, Enrique] King Abdulaziz Univ, Dept Elect & Comp Engn, Jeddah 21413, Saudi Arabia	Chiclana, F (reprint author), De Montfort Univ, Ctr Computat Intelligence, Leicester LE1 9BH, Leics, England.	raquel@decsai.ugr.es; chiclana@dmu.ac.uk; issam@iwate-pu.ac.jp; viedma@decsai.ugr.es	Chiclana, Francisco/B-9031-2008	Chiclana, Francisco/0000-0002-3952-4210	Andalusian Excellence research project [TIC-5991]; FEDER funds in the Spanish National research project [TIN2013-40658-P]; University of Granada 's International Office; University of Granada 'Strengthening through Short-Visits' programme	This work has been developed with the financing of the Andalusian Excellence research project TIC-5991 and FEDER funds in the Spanish National research project TIN2013-40658-P, the mobility grant programmme awarded by the University of Granada 's International Office and the University of Granada 'Strengthening through Short-Visits' (Ref. GENIL-SSV 2015) programme.	Xu ZS, 2015, KNOWL-BASED SYST, V80, P131, DOI 10.1016/j.knosys.2014.12.034; Xu ZS, 2008, INFORM SCIENCES, V178, P3775, DOI 10.1016/j.ins.2008.06.008; Chiclana F, 2007, EUR J OPER RES, V182, P383, DOI 10.1016/j.ejor.2006.08.032; Fujita H, 2009, KNOWL-BASED SYST, V22, P216, DOI 10.1016/j.knosys.2008.11.005; Guha D, 2010, APPL SOFT COMPUT, V10, P90, DOI 10.1016/j.asoc.2009.06.009; Yager RR, 2003, FUZZY SET SYST, V137, P59, DOI 10.1016/S0165-0114(02)00432-3; Perez-Asurmendi P, 2014, APPL SOFT COMPUT, V18, P196, DOI 10.1016/j.asoc.2014.01.010; Alonso S, 2009, INT J INF TECH DECIS, V8, P313; Herrera-Viedma E, 2004, EUR J OPER RES, V154, P98, DOI 10.1016/S0377-2217(02)00725-7; Chiclana F, 2009, IEEE T FUZZY SYST, V17, P14, DOI 10.1109/TFUZZ.2008.2008028; Lee LW, 2012, EXPERT SYST APPL, V39, P11666, DOI 10.1016/j.eswa.2012.04.043; Wu J, 2012, EXPERT SYST APPL, V39, P13409, DOI 10.1016/j.eswa.2012.05.062; STEPHENSON GM, 1986, BRIT J SOC PSYCHOL, V25, P341; Fedrizzi M, 2007, EUR J OPER RES, V183, P303, DOI 10.1016/j.ejor.2006.09.065; Szmidt E, 2002, CONTROL CYBERN, V31, P1037; YAGER RR, 1988, IEEE T SYST MAN CYB, V18, P183, DOI 10.1109/21.87068; Alonso S, 2008, INT J INTELL SYST, V23, P155, DOI 10.1002/int.20262; Vlachos IK, 2007, PATTERN RECOGN LETT, V28, P197, DOI 10.1016/j.patrec.2006.07.004; Yager RR, 1996, FUZZY SET SYST, V80, P111, DOI 10.1016/0165-0114(95)00133-6; Xu ZS, 2011, INT J INTELL SYST, V26, P787, DOI 10.1002/int.20494; Herrera-Viedma E, 2007, IEEE T SYST MAN CY B, V37, P176, DOI 10.1109/TSMCB.2006.875872; Ebenbach DH, 2000, ORGAN BEHAV HUM DEC, V81, P1, DOI 10.1006/obhd.1999.2870; Atanassov KT, 2012, STUD FUZZ SOFT COMP, V283, P1, DOI 10.1007/978-3-642-29127-2; Atanassov K, 1986, FUZZY SETS SYST, V110, P87, DOI [DOI 10.1016/S0165-0114(86)80034-3, DOI 10.1016/S0165-0114(86)80034-3]]; Fujita H., 2013, TOPICS INTELLIGENT E, V3, P197; Herrera F., 2000, EUR J OPER RES, V120, P147; HINSZ VB, 1990, J PERS SOC PSYCHOL, V59, P705, DOI 10.1037/0022-3514.59.4.705; Johnson H.H., 1967, EXPERT SYST APPL, P263; Millet I., 1997, J MULTICRITERIA DECI, V6, P41, DOI 10.1002/(SICI)1099-1360(199701)6:1<41::AID-MCDA122>3.0.CO;2-D; Roubens M., 1994, FUZZY PREFERENCE MOD; Saaty T., 1980, ANAL HIERARCHY PROCE; TANINO T, 1984, FUZZY SET SYST, V12, P117, DOI 10.1016/0165-0114(84)90032-0; Urena R, 2015, INFORM SCIENCES, V302, P14, DOI 10.1016/j.ins.2014.12.061; Wu J, 2014, KNOWL-BASED SYST, V71, P187, DOI 10.1016/j.knosys.2014.07.024; ZADEH LA, 1975, INFORM SCIENCES, V8, P199, DOI 10.1016/0020-0255(75)90036-5; Zarnoth P, 1997, J EXP SOC PSYCHOL, V33, P345, DOI 10.1006/jesp.1997.1326	36	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0950-7051	1872-7409		KNOWL-BASED SYST	Knowledge-Based Syst.	NOV	2015	89						86	96		10.1016/j.knosys.2015.06.020		11	Computer Science, Artificial Intelligence	Computer Science	CV4PU	WOS:000364249800005		
J	Gu, J; Li, L; Xu, ZS; Fujita, H				Gu, Jing; Li, Lu; Xu, Zeshui; Fujita, Hamido			Construction of a technology adoption decision-making model and its extension to understanding herd behavior	KNOWLEDGE-BASED SYSTEMS			English	Article						Herd behavior; Information cascade; Observational learning; Sequential decision making; Technology adoption; Waiting strategy	INFORMATIONAL CASCADES; INTERNET; FADS	Decision makers often face challenges during the adoption of technology. Indeed, technology adoption usually occurs sequentially, so observational learning can help the decision makers to reach reasonable decisions. In reality, the decision makers may prefer to adopt a waiting strategy when the situation is equivocal. In this study, we construct a technology adoption model called the G-WB model, where we consider a generalized waiting situation based on the Walden-Browne (WB) model. In our model, herd behavior is a difficult issue, but an information cascade occurs after herding appears. We explore the effect of different parameters on the convergence speed and extend our G-WB model. We also demonstrate that observational learning is a useful strategy during sequential decision making and our model is an optimal version of the WB model, which facilitates a better understanding of herding. (C) 2015 Elsevier B.V. All rights reserved.	[Gu, Jing] Sichuan Univ, Sch Econ, Chengdu 610064, Peoples R China; [Li, Lu] Peking Univ, Sch Math Sci, Beijing 100871, Peoples R China; [Xu, Zeshui] Sichuan Univ, Sch Business, Chengdu 610064, Peoples R China; [Fujita, Hamido] Iwate Prefectural Univ, Fac Software & Informat Sci, Takizawa, Iwate 0200193, Japan	Xu, ZS (reprint author), Sichuan Univ, Sch Business, Chengdu 610064, Peoples R China.	gj0901@scu.edu.cn; xuzeshui@263.net; HFujita-799@acm.org			National Natural Science Foundation of China [71401116, 61273209]; Sichuan university [skgt201501]	This research was funded by the National Natural Science Foundation of China (Nos. 71401116 and 61273209), and Sichuan university (No. skgt201501).	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Smith L, 2000, ECONOMETRICA, V68, P371, DOI 10.1111/1468-0262.00113; BANDURA A, 1978, J COMMUN, V28, P12, DOI 10.1111/j.1460-2466.1978.tb01621.x; Brynjolfsson E, 1996, MANAGE SCI, V42, P541, DOI 10.1287/mnsc.42.4.541; Gale D, 1996, EUR ECON REV, V40, P617, DOI 10.1016/0014-2921(95)00074-7; Celen B, 2004, GAME ECON BEHAV, V47, P72, DOI 10.1016/S0899-8256(03)00179-9; Banerjee A, 2004, GAME ECON BEHAV, V46, P1, DOI 10.1016/S0899-8256(03)00048-4; Duan W, 2009, MIS QUART, V33, P23; Walden E, 2008, ELECTRON COMMER R A, V7, P44, DOI 10.1016/j.elerap.2006.09.001; Walden EA, 2009, J ASSOC INF SYST, V10, P31; Zhang SC, 2010, KNOWL-BASED SYST, V23, P369, DOI 10.1016/j.knosys.2010.01.008; BANERJEE AV, 1992, Q J ECON, V107, P797, DOI 10.2307/2118364; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Brookes F.P., 1975, MYTHICAL MAN MONTH E; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; Doong Shing H., 2011, HAW INT C SYST SCI, P1; Rogers E.M., 1983, DIFFUSION INNOVATION; Samuelson W., 1988, J RISK UNCERTAINTY, V1, P7, DOI DOI 10.1007/BF00055564; Smith L., 2013, WORKING PAPER; Song J., 2003, 9 AM C INF SYST	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0950-7051	1872-7409		KNOWL-BASED SYST	Knowledge-Based Syst.	NOV	2015	89						471	486		10.1016/j.knosys.2015.08.014		16	Computer Science, Artificial Intelligence	Computer Science	CV4PU	WOS:000364249800034		
J	Mookiah, MRK; Acharya, UR; Fujita, H; Koh, JEW; Tan, JH; Chua, CK; Bhandary, SV; Noronha, K; Laude, A; Tong, L				Mookiah, Muthu Rama Krishnan; Acharya, U. Rajendra; Fujita, Hamido; Koh, Joel E. W.; Tan, Jen Hong; Chua, Chua Kuang; Bhandary, Sulatha V.; Noronha, Kevin; Laude, Augustinus; Tong, Louis			Automated detection of age-related macular degeneration using empirical mode decomposition	KNOWLEDGE-BASED SYSTEMS			English	Article						Age-related macular degeneration; Fundus imaging; Empirical mode decomposition; Locality sensitive discriminant analysis; Decision support system	RETINAL FUNDUS IMAGES; EPILEPTIC EEG SIGNALS; DIABETIC-RETINOPATHY; DRUSEN DETECTION; DIAGNOSIS; SEGMENTATION; FEATURES; CLASSIFICATION; IDENTIFICATION; RECOGNITION	Age-related Macular Degeneration (AMD) is the posterior segment eye disease affecting elderly people and may lead to loss of vision. AMD is diagnosed using clinical features like drusen, Geographic Atrophy (GA) and Choroidal NeoVascularization (CNV) present in the fundus image. It is mainly classified into dry and wet type. Dry AMD is most common among elderly people. At present there is no treatment available for dry AMD. Early diagnosis and treatment to the affected eye may reduce the progression of disease. Manual screening of fundus images is time consuming and subjective. Hence in this study we are proposing an Empirical Mode Decomposition (EMD)-based nonlinear feature extraction to characterize and classify normal and AMD fundus images. EMD is performed on 1D Radon Transform (RT) projections to generate different Intrinsic Mode Functions (IMF). Various nonlinear features are extracted from the IMFs. The dimensionality of the extracted features are reduced using Locality Sensitive Discriminant Analysis (LSDA). Then the reduced LSDA features are ranked using minimum Redundancy Maximum Relevance (mRMR), Kullback-Leibler Divergence (KLD) and Chernoff Bound and Bhattacharyya Distance (CBBD) techniques. Ranked LSDA components are sequentially fed to Support Vector Machine (SVM) classifier to discriminate normal and AMD classes. The performance of the current study is experimented using private and two public datasets namely Automated Retinal Image Analysis (ARIA) and STructured Analysis of the Retina (STARE). The 10-fold cross validation approach is used to evaluate the performance of the classifiers and obtained highest average classification accuracy of 100%, sensitivity of 100% and specificity of 100% for STARE dataset using only two ranked LSDA components. Our results reveal that the proposed system can be used as a decision support tool for clinicians for mass AMD screening. (C) 2015 Elsevier B.V. All rights reserved.	[Mookiah, Muthu Rama Krishnan; Acharya, U. Rajendra; Koh, Joel E. W.; Tan, Jen Hong; Chua, Chua Kuang] Ngee Ann Polytech, Dept Elect & Comp Engn, Singapore 599489, Singapore; [Acharya, U. Rajendra] SIM Univ, Sch Sci & Technol, Dept Biomed Engn, Singapore 599491, Singapore; [Acharya, U. Rajendra] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia; [Fujita, Hamido] Iwate Prefectural Univ, Fac Software & Informat Sci, Takizawa, Iwate 0200693, Japan; [Bhandary, Sulatha V.] Kasturba Med Coll & Hosp, Dept Ophthalmol, Manipal 576104, Karnataka, India; [Noronha, Kevin] St Francis Inst Technol, Dept Elect & Telecommun, Bombay 400103, Maharashtra, India; [Laude, Augustinus] Tan Tock Seng Hosp, Natl Healthcare Grp Eye Inst, Singapore 308433, Singapore; [Tong, Louis] Singapore Natl Eye Ctr, Singapore 168751, Singapore; [Tong, Louis] Singapore Eye Res Inst, Ocular Surface Res Grp, Singapore 168751, Singapore; [Tong, Louis] Duke NUS Grad Med Sch, Singapore 169857, Singapore; [Tong, Louis] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117597, Singapore	Mookiah, MRK (reprint author), Ngee Ann Polytech, Dept Elect & Comp Engn, Singapore 599489, Singapore.	mkm2@np.edu.sg			Social Innovation Research Fund (SIRE), Singapore [T1202]	Authors thank Social Innovation Research Fund (SIRE/Project Code: T1202), Singapore for providing grant for this research. Also authors would like to acknowledge Head of Department and all staff members of Department of Ophthalmology, Kasturba Medical College, Manipal, India for sharing the images for this study.	Acharya R. U., 2005, COMPUT METH PROG BIO, V80, P37, DOI DOI 10.1016/J.CMPB.2005.06.011; Pachori RB, 2015, EXPERT SYST APPL, V42, P4567, DOI 10.1016/j.eswa.2015.01.051; Quellec G, 2011, IEEE T MED IMAGING, V30, P523, DOI 10.1109/TMI.2010.2089383; Khushaba RN, 2011, IEEE T BIO-MED ENG, V58, P121, DOI 10.1109/TBME.2010.2077291; Nunes J, 2005, MACH VISION APPL, V16, P177, DOI 10.1007/s00138-004-0170-5; Burlina P, 2011, IEEE ENG MED BIO, P3962, DOI 10.1109/IEMBS.2011.6090984; Haleem MS, 2013, COMPUT MED IMAG GRAP, V37, P581, DOI 10.1016/j.compmedimag.2013.09.005; Acharya UR, 2012, BIOMED SIGNAL PROCES, V7, P401, DOI 10.1016/j.bspc.2011.07.007; Mandic DP, 2013, IEEE SIGNAL PROC MAG, V30, P74, DOI 10.1109/MSP.2013.2267931; Rapantzikos K, 2003, MED IMAGE ANAL, V7, P95, DOI 10.1016/S1361-8415(02)00093-2; Zheng YL, 2012, INVEST OPHTH VIS SCI, V53, P8310, DOI 10.1167/iovs.12-9576; Chua KC, 2010, MED ENG PHYS, V32, P679, DOI 10.1016/j.medengphy.2010.04.009; Cheng J, 2012, IEEE IMAGE PROC, P2805; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Mookiah MRK, 2014, MED BIOL ENG COMPUT, V52, P781, DOI 10.1007/s11517-014-1180-8; Brandon L, 2003, LECT NOTES COMPUT SC, V2878, P618; Acharya UR, 2009, J MECH MED BIOL, V9, P539, DOI 10.1142/S0219519409003152; Chen JK, 2014, ENTROPY-SWITZ, V16, P3009, DOI 10.3390/e16063009; Acharya UR, 2011, INT J NEURAL SYST, V21, P199, DOI 10.1142/S0129065711002808; Chopdar A, 2003, BRIT MED J, V326, P485, DOI 10.1136/bmj.326.7387.485; Bressan M, 2003, IEEE T PATTERN ANAL, V25, P1312, DOI 10.1109/TPAMI.2003.1233904; Niemeijer M, 2007, INVEST OPHTH VIS SCI, V48, P2260, DOI 10.1167/iovs.06-0996; Khandhadia S, 2012, IMMUNOBIOLOGY, V217, P127, DOI 10.1016/j.imbio.2011.07.019; Kose C, 2010, J MED SYST, V34, P1, DOI 10.1007/s10916-008-9210-4; Tanaka T, 2007, IEEE SIGNAL PROC LET, V14, P101, DOI 10.1109/LSP.2006.882107; Pal S, 2012, COMPUT BIOL MED, V42, P83, DOI 10.1016/j.compbiomed.2011.10.012; Agurto C, 2011, INVEST OPHTH VIS SCI, V52, P5862, DOI 10.1167/iovs.10-7075; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903; Gao QX, 2014, NEURAL NETWORKS, V54, P49, DOI 10.1016/j.neunet.2014.02.009; Soliz P, 2008, 2008 IEEE SOUTHWEST SYMPOSIUM ON IMAGE ANALYSIS & INTERPRETATION, P65, DOI 10.1109/SSIAI.2008.4512286; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226; Bartlett H, 2007, SURV OPHTHALMOL, V52, P655, DOI 10.1016/.j.survophthal.2007.08.022; Martis RJ, 2012, INT J NEURAL SYST, V22, DOI 10.1142/S012906571250027X; Kose C, 2008, COMPUT BIOL MED, V38, P611, DOI 10.1016/j.compbiomed.2008.02.008; Mookiah MRK, 2015, COMPUT BIOL MED, V63, P208, DOI 10.1016/j.compbiomed.2015.05.019; Fleureau J, 2011, SIGNAL PROCESS, V91, P2783, DOI 10.1016/j.sigpro.2011.01.018; Liang ZY, 2010, IEEE ENG MED BIO, P4100; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Sharma R, 2015, ENTROPY-SWITZ, V17, P669, DOI 10.3390/e17020669; Hijazi MHA, 2012, KNOWL-BASED SYST, V29, P83, DOI 10.1016/j.knosys.2011.07.002; Ben Sbeh Z, 2001, IEEE T MED IMAGING, V20, P1321, DOI 10.1109/42.974927; Freund DE, 2009, 2009 IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: FROM NANO TO MACRO, VOLS 1 AND 2, P61, DOI 10.1109/ISBI.2009.5192983; Mookiah MRK, 2013, COMPUT BIOL MED, V43, P2136, DOI 10.1016/j.compbiomed.2013.10.007; Barriga E.S., 2009, 22 IEEE INT S COMP B, P1; Bhuiyan A., 2014, J COMPUT SCI SYST BI, V7; Cai D, 2007, P JOINT C ART INT IJ, V20, P708; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Duda R.O., 2007, PATTERN CLASSIFICATI; Hijazi M.H.A., 2015, INT J SIMUL SYST SCI, P57; Hijazi M.H.A., 2010, IEEE INT JOINT C NEU, P3501; Jadhav DV, 2009, NEUROCOMPUTING, V72, P1951, DOI 10.1016/j.neucom.2008.05.001; Molinari F, 2015, COMPUT BIOL MED, V59, P1, DOI 10.1016/j.compbiomed.2015.01.011; Mookiah MRK, 2014, COMPUT BIOL MED, V53, P55, DOI 10.1016/j.compbiomed.2014.07.015; Mora AD, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-59; Nikias C.L., 1993, P 15 ANN INT C IEEE, P319, DOI 10.1109/IEMBS.1993.978564; PIZER SM, 1987, COMPUT VISION GRAPH, V39, P355, DOI 10.1016/S0734-189X(87)80186-X; RADON J, 1986, IEEE T MED IMAGING, V5, P170, DOI 10.1109/TMI.1986.4307775; Santos-Villalobos H., 2011, ANN INT C IEEE ENG M, P6236; Singh Kesar, BOOTSTRAP STAT UNPUB; Towers S., 2002, P ADV STAT TECHN PAR, P107; Vapnik V.N., 1998, STAT LEARNING THEORY, V1; Venturas S., 2005, ALGORITHMS MOL BIOL, V4; Zbilut J. P., 2005, TUTORIALS CONT NONLI, P26	63	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0950-7051	1872-7409		KNOWL-BASED SYST	Knowledge-Based Syst.	NOV	2015	89						654	668		10.1016/j.knosys.2015.09.012		15	Computer Science, Artificial Intelligence	Computer Science	CV4PU	WOS:000364249800047		
J	Molenaar, RJ; Thota, S; Nagata, Y; Patel, B; Clemente, M; Przychodzen, B; Hirsh, C; Viny, AD; Hosano, N; Bleeker, FE; Meggendorfer, M; Alpermann, T; Shiraishi, Y; Chiba, K; Tanaka, H; van Noorden, CJF; Radivoyevitch, T; Carraway, HE; Makishima, H; Miyano, S; Sekeres, MA; Ogawa, S; Haferlach, T; Maciejewski, JP				Molenaar, R. J.; Thota, S.; Nagata, Y.; Patel, B.; Clemente, M.; Przychodzen, B.; Hirsh, C.; Viny, A. D.; Hosano, N.; Bleeker, F. E.; Meggendorfer, M.; Alpermann, T.; Shiraishi, Y.; Chiba, K.; Tanaka, H.; van Noorden, C. J. F.; Radivoyevitch, T.; Carraway, H. E.; Makishima, H.; Miyano, S.; Sekeres, M. A.; Ogawa, S.; Haferlach, T.; Maciejewski, J. P.			Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms	LEUKEMIA			English	Article							ONCOMETABOLITE 2-HYDROXYGLUTARATE; TET2 FUNCTION; MUTANT IDH2; LEUKEMIA; DIFFERENTIATION; INHIBITOR; (R)-2-HYDROXYGLUTARATE; 5-METHYLCYTOSINE; LEUKEMOGENESIS; SUFFICIENT	Mutations in isocitrate dehydrogenase 1/2 (IDH1/2(MT)) are drivers of a variety of myeloid neoplasms. As they yield the same oncometabolite, D-2-hydroxyglutarate, they are often treated as equivalent, and pooled. We studied the validity of this approach and found IDH1/2 mutations in 179 of 2119 myeloid neoplasms (8%). Cross-sectionally, the frequencies of these mutations increased from lower-to higher risk disease, thus suggesting a role in clinical progression. Variant allelic frequencies indicated that IDH1(MT) and IDH2(MT) are ancestral in up to 14/74 (19%) vs 34/99 (34%; P = 0.027) of cases, respectively, illustrating the pathogenic role of these lesions in myeloid neoplasms. IDH1/2(MT) was associated with poor overall survival, particularly in lower risk myelodysplastic syndromes. Ancestral IDH1(MT) cases were associated with a worse prognosis than subclonal IDH1(MT) cases, whereas the position of IDH2(MT) within clonal hierarchy did not impact survival. This may relate to distinct mutational spectra with more DNMT3A and NPM1 mutations associated with IDH1(MT) cases, and more ASXL1, SRSF2, RUNX1, STAG2 mutations associated with IDH2(MT) cases. Our data demonstrate important clinical and biological differences between IDH1(MT) and IDH2(MT) myeloid neoplasms. These mutations should be considered separately as their differences could have implications for diagnosis, prognosis and treatment with IDH1/2(MT) inhibitors of IDH1/2(MT) patients.	[Molenaar, R. J.; Thota, S.; Patel, B.; Clemente, M.; Przychodzen, B.; Hirsh, C.; Hosano, N.; Makishima, H.; Sekeres, M. A.; Maciejewski, J. P.] Cleveland Clin, Taussig Canc Inst, Dept Translat Hematol & Oncol Res, Cleveland, OH 44195 USA; [Molenaar, R. J.; van Noorden, C. J. F.] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [Nagata, Y.; Miyano, S.; Ogawa, S.] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan; [Viny, A. D.] Mem Sloan Kettering Canc Ctr, Dept Med Human Oncol & Pathogenesis, New York, NY 10021 USA; [Bleeker, F. E.] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; [Meggendorfer, M.; Alpermann, T.; Haferlach, T.] Munich Leukemia Labs, Munich, Germany; [Shiraishi, Y.; Chiba, K.] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal, Tokyo, Japan; [Tanaka, H.] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Sequence Anal, Tokyo, Japan; [Radivoyevitch, T.] Cleveland Clin, Lerner Res Inst, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Carraway, H. E.; Sekeres, M. A.] Cleveland Clin, Taussig Canc Inst, Leukemia Program, Cleveland, OH 44106 USA	Maciejewski, JP (reprint author), Cleveland Clin, Taussig Canc Inst, Dept Translat Hematol & Oncol Res, R40,9500 Euclid Ave, Cleveland, OH 44195 USA.	maciejj@ccf.org			National Institutes of Health (Bethesda, MD, USA; NIH) [RO1HL-082983, U54 RR019391, K24 HL-077522]; AA & MDS International Foundation (Rockville, MD, USA); Robert Duggan Charitable Fund (Cleveland, OH, USA); Scott Hamilton CARES grant (Cleveland, OH, USA); AA & MDS International Foundation; Ministry of Health, Labor and Welfare of Japan (Tokyo, Japan) [23249052, 22134006, 21790907]; project for development of innovative research on cancer therapies (p-direct) (Tokyo, Japan); Japan Society for the Promotion of Science (JSPS) through the 'Funding Program for World-Leading Innovative R&D on Science and Technology'; Council for Science and Technology Policy (CSTP) (Tokyo, Japan); Dutch Cancer Society (KWF) [UVA 2014-6839]; AMC PhD Scholarship; American Society of Hematology Research Training award; Damon Runyon Postdoctoral Fellowship [DRG 117-15]; Ministry of Health, Labor and Welfare of Japan [23249052, 22134006, 21790907, 24221011]; Industrial Technology Research Grant Program from NEDO [08C46598a]; Project for Development of Innovative Research on Cancer Therapeutics; Funding Program for World-Leading Innovative R&D on Science and Technology; Edward P Evans AA/MDS foundation	This work was supported by National Institutes of Health (Bethesda, MD, USA; NIH) grants RO1HL-082983 (JPM), U54 RR019391 (JPM), K24 HL-077522 (JPM), a grant from the AA & MDS International Foundation (Rockville, MD, USA; JPM), the Robert Duggan Charitable Fund (Cleveland, OH, USA; JPM) and Scott Hamilton CARES grant (Cleveland, OH, USA; HM), a grant from the AA & MDS International Foundation (HM) and Grant-in-Aids from the Ministry of Health, Labor and Welfare of Japan and KAKENHI (23249052, 22134006 and 21790907) (Tokyo, Japan; SO), project for development of innovative research on cancer therapies (p-direct) (Tokyo, Japan; SO), the Japan Society for the Promotion of Science (JSPS) through the 'Funding Program for World-Leading Innovative R&D on Science and Technology', initiated by the Council for Science and Technology Policy (CSTP) (Tokyo, Japan; SO), the Dutch Cancer Society (KWF; UVA 2014-6839) (CJFvN, RJM and FEB), an AMC PhD Scholarship (RJM), the American Society of Hematology Research Training award for fellows and a Damon Runyon Postdoctoral Fellowship (DRG 117-15, ADV), Grant-in-Aids from the Ministry of Health, Labor and Welfare of Japan and KAKENHI (23249052, 22134006, 24221011 and 21790907; TH), by the Industrial Technology Research Grant Program from NEDO (08C46598a; TH), by Project for Development of Innovative Research on Cancer Therapeutics (P-Direct; TH) and by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST, TH) and Edward P Evans AA/MDS foundation (MAS). The results presented here are partly based upon the data generated by The Cancer Genome Atlas pilot project established by the NCI and NHGRI.	Ledford H, 2014, NATURE, V508, P158, DOI 10.1038/508158a; Stead LF, 2013, HUM MUTAT, V34, P1432, DOI 10.1002/humu.22365; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Kats LM, 2014, CELL STEM CELL, V14, P329, DOI 10.1016/j.stem.2013.12.016; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Ponnaluri VKC, 2013, BIOCHEM BIOPH RES CO, V436, P115, DOI 10.1016/j.bbrc.2013.05.077; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Chen C, 2013, GENE DEV, V27, P1974, DOI 10.1101/gad.226613.113; Makishima H, 2009, J CLIN ONCOL, V27, P6109, DOI 10.1200/JCO.2009.23.7503; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Chaturvedi A, 2013, BLOOD, V122, P2877, DOI 10.1182/blood-2013-03-491571; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Mylonas E, 2014, LEUKEMIA, V28, P1343, DOI 10.1038/leu.2014.18; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Davis MI, 2014, J BIOL CHEM, V289, P13717, DOI 10.1074/jbc.M113.511030; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Losman JA, 2013, SCIENCE, V339, P1621, DOI 10.1126/science.1231677; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Jankowska AM, 2011, BLOOD, V118, P3932, DOI 10.1182/blood-2010-10-311019; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Makishima H, 2013, NAT GENET, V45, P942, DOI 10.1038/ng.2696; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Zhou KG, 2012, LEUKEMIA LYMPHOMA, V53, P2423, DOI 10.3109/10428194.2012.695359; Deng G, 2014, J BIOL CHEM, V290, P762; Johnson BE, 2013, SCIENCE, V343, P189; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Molenaar RJ, 2014, NEURO-ONCOLOGY, V16, P1263, DOI 10.1093/neuonc/nou005; Molenaar RJ, 2014, BBA-REV CANCER, V1846, P326, DOI 10.1016/j.bbcan.2014.05.004; Rampal R, 2014, CELL REP, V9, P1841, DOI 10.1016/j.celrep.2014.11.004	34	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0887-6924	1476-5551		LEUKEMIA	Leukemia	NOV	2015	29	11					2134	2142		10.1038/leu.2015.91		9	Oncology; Hematology	Oncology; Hematology	CV8IR	WOS:000364527400003		
J	Ford, AM; Mansur, MB; Furness, CL; van Delft, FW; Okamura, J; Suzuki, T; Kobayashi, H; Kaneko, Y; Greaves, M				Ford, A. M.; Mansur, M. B.; Furness, C. L.; van Delft, F. W.; Okamura, J.; Suzuki, T.; Kobayashi, H.; Kaneko, Y.; Greaves, M.			Protracted dormancy of pre-leukemic stem cells	LEUKEMIA			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; LATE RECURRENCE; PHILADELPHIA-CHROMOSOME; MONOZYGOTIC TWINS; RELAPSE; CANCER; ORIGINS; LYMPHOPROLIFERATIONS; REARRANGEMENT; MECHANISMS	Cancer stem cells can escape therapeutic killing by adopting a quiescent or dormant state. The reversibility of this condition provides the potential for later recurrence or relapse, potentially many years later. We describe the genomics of a rare case of childhood BCR-ABL1-positive, B-cell precursor acute lymphoblastic leukemia that relapsed, with an acute myeloblastic leukemia immunophenotype, 22 years after the initial diagnosis, sustained remission and presumed cure. The primary and relapsed leukemias shared the identical BCR-ABL1 fusion genomic sequence and two identical immunoglobulin gene rearrangements, indicating that the relapse was a derivative of the founding clone. All other mutational changes (single-nucleotide variant and copy number alterations) were distinct in diagnostic or relapse samples. These data provide unambiguous evidence that leukemia-propagating cells, most probably pre-leukemic stem cells, can remain covert and silent but potentially reactivatable for more than two decades.	[Ford, A. M.; Mansur, M. B.; Furness, C. L.; Greaves, M.] Inst Canc Res, Ctr Evolut & Canc, Sutton SM2 5NG, Surrey, England; [Mansur, M. B.] Inst Nacl Canc, Res Ctr, Paediat Haematol Oncol Program, Rio De Janeiro, Brazil; [van Delft, F. W.] NICR, Newcastle Canc Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Okamura, J.] Kyushu Natl Canc Ctr, Dept Pediat, Minami Ku, Fukuoka, Japan; [Suzuki, T.; Kobayashi, H.; Kaneko, Y.] Saitama Canc Ctr, Dept Hematol, Ina, Saitama, Japan	Greaves, M (reprint author), Inst Canc Res, Ctr Evolut & Canc, Brookes Lawley Bldg,15 Cotswold Rd, Sutton SM2 5NG, Surrey, England.	mel.greaves@icr.ac.uk			Leukaemia and Lymphoma Research; European Hematology Association-EHA Partner Fellowship [2011/01]; Instituto Nacional de Cancer-INCA; Lady Tata Memorial Trust-LTMT International Award for Research in Leukaemia; Kay Kendall Leukaemia Fund (FWvD); Wellcome Trust Strategic Award [105104/Z/14/Z]	This work was supported by Leukaemia and Lymphoma Research (MG, AMF and CF), the European Hematology Association-EHA Partner Fellowship 2011/01, Instituto Nacional de Cancer-INCA and the Lady Tata Memorial Trust-LTMT International Award for Research in Leukaemia (MBM), The Kay Kendall Leukaemia Fund (FWvD) and by a Wellcome Trust Strategic Award (105104/Z/14/Z) (to MG). We thank Dr Brian Walker for help with custom-library preparation and the members of the ICR Tumour Profiling Unit for providing the targeted sequencing data on the diagnostic material.	Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Bateman CM, 2010, BLOOD, V115, P3553, DOI 10.1182/blood-2009-10-251413; Papaemmanuil E, 2014, NAT GENET, V46, P116, DOI 10.1038/ng.2874; Zhang X, 2014, LEUKEMIA, V28, P1751, DOI 10.1038/leu.2014.113; Kodama Y, 2013, BRIT J HAEMATOL, V161, P286, DOI 10.1111/bjh.12212; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; Bessho F, 2013, INT J HEMATOL, V97, P525, DOI 10.1007/s12185-013-1289-9; OKAMURA J, 1988, BLOOD, V72, P1261; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Cazzaniga G, 2011, BLOOD, V118, P5559, DOI 10.1182/blood-2011-07-366542; Sneddon JB, 2007, CELL STEM CELL, V1, P607, DOI 10.1016/j.stem.2007.11.009; Sosa MS, 2014, NAT REV CANCER, V14, P611, DOI 10.1038/nrc3793; Lutz C, 2013, LEUKEMIA, V27, P1204, DOI 10.1038/leu.2012.306; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Ford AM, 2001, BLOOD, V98, P558, DOI 10.1182/blood.V98.3.558; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; CHEN SJ, 1989, NUCLEIC ACIDS RES, V17, P7631, DOI 10.1093/nar/17.19.7631; LEVASSEUR M, 1994, BRIT J HAEMATOL, V87, P437, DOI 10.1111/j.1365-2141.1994.tb04942.x; Frost L, 1997, BRIT J HAEMATOL, V98, P992, DOI 10.1046/j.1365-2141.1997.3103129.x; Langerak AW, 2012, LEUKEMIA, V26, P2159, DOI 10.1038/leu.2012.246; van Delft FW, 2011, BLOOD, V117, P6247, DOI 10.1182/blood-2010-10-314674; Faries MB, 2013, J AM COLL SURGEONS, V217, P27, DOI 10.1016/j.jamcollsurg.2013.03.007; Tsao HS, 1997, CANCER, V79, P2361; MIR R, 1987, CANCER, V60, P2510, DOI 10.1002/1097-0142(19871115)60:10<2510::AID-CNCR2820601027>3.0.CO;2-X; Vora A, 1998, BLOOD, V92, P2334; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Goss PE, 2010, NAT REV CANCER, V10, P871, DOI 10.1038/nrc2933; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Malogolowkin M, 2013, PEDIATR BLOOD CANCER, V60, P1612, DOI 10.1002/pbc.24604; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Pui CH, 2014, LEUKEMIA, V28, P2336, DOI 10.1038/leu.2014.142; Waanders E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002533	36	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0887-6924	1476-5551		LEUKEMIA	Leukemia	NOV	2015	29	11					2202	2207		10.1038/leu.2015.132		6	Oncology; Hematology	Oncology; Hematology	CV8IR	WOS:000364527400010		
J	Morita, K; Masamoto, Y; Kataoka, K; Koya, J; Kagoya, Y; Yashiroda, H; Sato, T; Murata, S; Kurokawa, M				Morita, K.; Masamoto, Y.; Kataoka, K.; Koya, J.; Kagoya, Y.; Yashiroda, H.; Sato, T.; Murata, S.; Kurokawa, M.			BAALC potentiates oncogenic ERK pathway through interactions with MEKK1 and KLF4	LEUKEMIA			English	Article							ACUTE MYELOID-LEUKEMIA; SIGNAL-REGULATED KINASE; KRUPPEL-LIKE FACTOR-4; COLON-CANCER CELLS; GROWTH-FACTOR; SELF-RENEWAL; GROUP-B; EXPRESSION; RESISTANCE; DIFFERENTIATION	Although high brain and acute leukemia, cytoplasmic (BAALC) expression is a well-characterized poor prognostic factor in acute myeloid leukemia (AML), neither the exact mechanisms by which BAALC drives leukemogenesis and drug resistance nor therapeutic approaches against BAALC-high AML have been properly elucidated. In this study, we found that BAALC induced cell-cycle progression of leukemia cells by sustaining extracellular signal-regulated kinase (ERK) activity through an interaction with a scaffold protein MEK kinase-1 (MEKK1), which inhibits the interaction between ERK and MAP kinase phosphatase 3 (MKP3/DUSP6). BAALC conferred chemoresistance in AML cells by upregulating ATP-binding cassette proteins in an ERK-dependent manner, which can be therapeutically targeted by MEK inhibitor. We also demonstrated that BAALC blocks ERK-mediated monocytic differentiation of AML cells by trapping Kruppel-like factor 4 (KLF4) in the cytoplasm and inhibiting its function in the nucleus. Consequently, MEK inhibition therapy synergizes with KLF4 induction and is highly effective against BAALC-high AML cells both in vitro and in vivo. Our data provide a molecular basis for the role of BAALC in regulating proliferation and differentiation of AML cells and highlight the unique dual function of BAALC as an attractive therapeutic target against BAALC-high AML.	[Morita, K.; Masamoto, Y.; Kataoka, K.; Koya, J.; Kagoya, Y.; Sato, T.; Kurokawa, M.] Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Tokyo 1138655, Japan; [Yashiroda, H.; Murata, S.] Univ Tokyo, Grad Sch Med, Lab Prot Metab, Tokyo 1138655, Japan; [Sato, T.] Tokyo Univ Hosp, Dept Transfus Med, Tokyo 113, Japan; [Kurokawa, M.] Tokyo Univ Hosp, Dept Cell Therapy & Transplantat, Tokyo 113, Japan	Kurokawa, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kurokawa-tky@umin.ac.jp					Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-27; Damiani D, 2013, AM J HEMATOL, V88, P848, DOI 10.1002/ajh.23516; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Jin JO, 2010, MOL CARCINOGEN, V49, P771, DOI 10.1002/mc.20654; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; El Azreq MA, 2012, MOL BIOL CELL, V23, P3473, DOI 10.1091/mbc.E12-02-0132; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Yoshimi A, 2011, BLOOD, V117, P3617, DOI 10.1182/blood-2009-12-261602; Towatari M, 1997, LEUKEMIA, V11, P479, DOI 10.1038/sj.leu.2400617; Jain N, 2014, CLIN CANCER RES, V20, P490, DOI 10.1158/1078-0432.CCR-13-1311; Deschenes-Simard X, 2013, GENE DEV, V27, P900, DOI 10.1101/gad.203984.112; Santamaria C, 2010, ANN HEMATOL, V89, P453, DOI 10.1007/s00277-009-0864-x; Nakamura Y, 2005, ONCOGENE, V24, P7592, DOI 10.1038/sj.onc.1208899; Kim MO, 2012, NAT STRUCT MOL BIOL, V19, P283, DOI 10.1038/nsmb.2217; Miranda MB, 2002, LEUKEMIA, V16, P683, DOI 10.1038/sj/leu/2402400; Kim Y, 2003, BIOCHEMISTRY-US, V42, P15197, DOI 10.1021/bi035346b; Baldus CD, 2003, BLOOD, V102, P1613, DOI 10.1182/blood-2003-02-0359; Langer C, 2008, BLOOD, V111, P5371, DOI 10.1182/blood-2007-11-124958; Abrams SL, 2010, CELL CYCLE, V9, P1781; Chang G, 2003, FEBS LETT, V555, P102, DOI 10.1016/S0014-5793(03)01085-8; Lai JK, 2012, J CELL SCI, V125, P4853, DOI 10.1242/jcs.108910; Shen HL, 2011, EXP HEMATOL, V39, P558, DOI 10.1016/j.exphem.2011.01.013; Cho SD, 2008, MOL CANCER THER, V7, P2109, DOI 10.1158/1535-7163.MCT-07-2311; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Chen ZY, 2005, MOL PHARMACOL, V68, P1203, DOI 10.1124/mol.105.014944; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Eisfeld AK, 2012, BLOOD, V120, P249, DOI 10.1182/blood-2012-02-408492; Imai Y, 2009, CANCER SCI, V100, P1118, DOI 10.1111/j.1349-7006.2009.01154.x; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Baldus CD, 2003, EXP HEMATOL, V31, P1051, DOI 10.1016/j.exphem.2003.08.004; Tanner SM, 2001, P NATL ACAD SCI USA, V98, P13901, DOI 10.1073/pnas.241525498; Heuser M, 2012, LEUKEMIA, V26, P532, DOI 10.1038/leu.2011.228; Karandikar M, 2000, J BIOL CHEM, V275, P40120, DOI 10.1074/jbc.M005926200; Eisfeld AK, 2012, P NATL ACAD SCI USA, V109, P6668, DOI 10.1073/pnas.1203756109; Eisfeld AK, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004762	35	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0887-6924	1476-5551		LEUKEMIA	Leukemia	NOV	2015	29	11					2248	2256		10.1038/leu.2015.137		9	Oncology; Hematology	Oncology; Hematology	CV8IR	WOS:000364527400015		
J	Inoue, D; Nishimura, K; Kozuka-Hata, H; Oyama, M; Kitamura, T				Inoue, D.; Nishimura, K.; Kozuka-Hata, H.; Oyama, M.; Kitamura, T.			The stability of epigenetic factor ASXL1 is regulated through ubiquitination and USP7-mediated deubiquitination	LEUKEMIA			English	Letter							MYELODYSPLASTIC SYNDROMES; MUTATIONS; LANDSCAPE; DISEASE; HAUSP		[Inoue, D.; Nishimura, K.; Kitamura, T.] Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Tokyo, Japan; [Kozuka-Hata, H.; Oyama, M.] Univ Tokyo, Inst Med Sci, Med Prote Lab, Tokyo, Japan	Inoue, D (reprint author), Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Tokyo, Japan.	kitamura@ims.u-tokyo.ac.jp					Inoue D, 2013, J CLIN INVEST, V123, P4627, DOI 10.1172/JCI70739; Thol F, 2011, J CLIN ONCOL, V29, P2499, DOI 10.1200/JCO.2010.33.4938; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Abdel-Wahab O, 2013, J EXP MED, V210, P2641, DOI 10.1084/jem.20131141; Fisher CL, 2010, BLOOD, V115, P38, DOI 10.1182/blood-2009-07-230698; Wang JP, 2014, BLOOD, V123, P541, DOI 10.1182/blood-2013-05-500272; Sanchez-Pulido L, 2012, BIOINFORMATICS, V28, P1953, DOI 10.1093/bioinformatics/bts319; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Maertens GN, 2010, EMBO J, V29, P2553, DOI 10.1038/emboj.2010.129; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Eletr ZM, 2014, BBA-MOL CELL RES, V1843, P114, DOI 10.1016/j.bbamcr.2013.06.027; Chen TC, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2013.74; Cole AJ, 2015, ENDOCR-RELAT CANCER, V22, P19; Huether R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4630	15	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0887-6924	1476-5551		LEUKEMIA	Leukemia	NOV	2015	29	11					2257	2260		10.1038/leu.2015.90		4	Oncology; Hematology	Oncology; Hematology	CV8IR	WOS:000364527400016		
J	Hyun, J; Kimura, Y; Yamane, H				Hyun, Jungyub; Kimura, Yoshiharu; Yamane, Hideki			Competitive Effects of Stereocomplexation and Hyper-Conjugation of Triethoxysilyl-Terminated Poly(D-lactide) in Poly(L-lactide) matrices	MACROMOLECULAR MATERIALS AND ENGINEERING			English	Article						hydrolytic polycondensation; hyper-conjugated polymer; polymer blend; silyl-terminated poly(lactide)s; stereocomplex	ENANTIOMERIC POLY(LACTIC ACID)S; THERMAL-PROPERTIES; POLYMERS; NANOCOMPOSITES; CRYSTALLIZATION; COMPOSITES; MORPHOLOGY; SOLVENT	Triethoxysilyl-terminated poly(d-lactide)s (eSi-PDLA) were successfully prepared by hydrosilylation of allyl-terminated PDLAs (A-PDLA-ac) which were readily prepared by ring-opening polymerization of d-lactide and the following terminal protection by acetylation. Their acid-catalyzed hydrolysis produced hyper-conjugated PDLAs with terminal silanol coupling. Blend PLLA films containing eSi-PDLA (M-n=2.1kDa) in 5-25wt.% were successfully prepared by the solution casting method. The blend films were found to take a nano-porous or micro-phase separation structure, being different from that of the blend PLLA films containing trimethoxysilyl-terminated poly(d-lactide) (mSi-PDLA) which exhibited particle distribution structure. This difference was reasonably attributed to the different rate of hydrolytic polycondensation of the trimethoxy- and triethoxy-silyl terminals. These results revealed that the competing sterecomplexation/ hyper-conjugation/phase separation can afford specific morphologies, allowing fine control of properties.	[Hyun, Jungyub; Kimura, Yoshiharu; Yamane, Hideki] Kyoto Inst Technol, Dept Biobased Mat Sci, Kyoto 6068585, Japan	Kimura, Y (reprint author), Kyoto Inst Technol, Dept Biobased Mat Sci, Kyoto 6068585, Japan.	ykimura@kit.ac.jp					Hyun J, 2015, MACROMOL MATER ENG, V300, P650, DOI 10.1002/mame.201400429; Calder S, 2011, CHEM MATER, V23, P2917, DOI 10.1021/cm200444n; Yan SF, 2007, MATER LETT, V61, P2683, DOI 10.1016/j.matlet.2006.10.023; Kumar AP, 2009, PROG POLYM SCI, V34, P479, DOI 10.1016/j.progpolymsci.2009.01.002; Rasal RM, 2010, PROG POLYM SCI, V35, P338, DOI 10.1016/j.progpolymsci.2009.12.003; Tsuji H, 2005, BIOMACROMOLECULES, V6, P244, DOI 10.1021/bm049552q; ARKLES B, 1992, J ADHES SCI TECHNOL, V6, P193, DOI 10.1163/156856192X00133; ENDO M, 1995, CARBON, V33, P873, DOI 10.1016/0008-6223(95)00016-7; Sodergard A, 2002, PROG POLYM SCI, V27, P1123, DOI 10.1016/S0079-6700(02)00012-6; Murariu M, 2010, POLYM DEGRAD STABIL, V95, P889, DOI 10.1016/j.polymdegradstab.2009.12.019; TSUJI H, 1991, MACROMOLECULES, V24, P5657, DOI 10.1021/ma00020a027; Chakraborty A, 2005, HOLZFORSCHUNG, V59, P102, DOI 10.1515/HF.2005.016; Ohshita J, 1997, MACROMOLECULES, V30, P1540, DOI 10.1021/ma960728t; Wu DF, 2013, IND ENG CHEM RES, V52, P6731, DOI 10.1021/ie4004199; Kuo SW, 2011, PROG POLYM SCI, V36, P1649, DOI 10.1016/j.progpolymsci.2011.05.002; Lu LH, 2003, LANGMUIR, V19, P3074, DOI 10.1021/la026521c; Kimura Y, 2009, POLYM J, V41, P797, DOI 10.1295/polymj.PJ2009154; Tsuji H, 1999, POLYMER, V40, P6699, DOI 10.1016/S0032-3861(99)00004-X; Gamez-Perez J, 2011, EXPRESS POLYM LETT, V5, P82, DOI 10.3144/expresspolymlett.2011.9; DOI Y, 1994, J PESTIC SCI, V19, pS11; Golecki HM, 2014, LANGMUIR, V30, P13369, DOI 10.1021/la5023104; Kimura Y., 2013, HDB R D INFORM JAPAN; Oliveira J, 2014, J ENG FIBER FABR, V9, P117; Ray SS, 2003, PROG POLYM SCI, V28, P1539, DOI 10.1016/j.progpolymsci.2003.08.002	24	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1438-7492	1439-2054		MACROMOL MATER ENG	Macromol. Mater. Eng.	NOV	2015	300	11					1123	1132		10.1002/mame.201500157		10	Materials Science, Multidisciplinary; Polymer Science	Materials Science; Polymer Science	CV5PF	WOS:000364322500011		
J	Kudo, S; Nagasaki, Y				Kudo, Shinpei; Nagasaki, Yukio			Facile and Quantitative Synthesis of a Poly(ethylene glycol)-b-Poly(L-arginine) Block Copolymer and Its Use for the Preparation of Polyion Complex Micelles with Polyanions for Biomedical Applications	MACROMOLECULAR RAPID COMMUNICATIONS			English	Article						alpha-amino acid N-carboxyanhydride (NCA); guanidinylation; poly(ethylene glycol) (PEG); polyion complex micelle (PIC micelle); poly-L-arginine	NITRIC-OXIDE; INTRACELLULAR DELIVERY; STABILITY; AMINES; LENGTH; CORE	Though L-arginine-containing polymers show versatile biological functions, a precisely controlled synthesis of poly(ethylene glycol)-b-poly(L-arginine) (PEG-b-PArg) block copolymers has not been reported. Here, an effective method for the synthesis of PEG-b-PArg block copolymers is developed. In order to obtain PEG-b-PArg, a two-step reaction, i.e., synthesis of PEG-b-poly(L-ornithine) is employed, followed by guanidinylation with N,N'-bis(tert-butoxycarbonyl)-1H-pyrazole-1-carboxamidine. This procedure quantitatively converts amino groups to guanidium groups at the side chains of peptide segments under mild conditions. Polyion complex (PIC) micelles are prepared by mixing the positively charged PEG-b-PArg with negatively charged homo-polyelectrolytes such as hyaluronic acid (HA) or chondroitin sulfate C (CS). PIC micelles prepared with CS show a higher stability than those prepared with HA, probably due to strong interactions between guanidium cations in PEG-b-PArg and carboxylate/sulfate in CS. Thus, PIC micelles containing PArg are a potentially effective arginine carrier for the development of in vivo therapeutic applications for various diseases related to nitric oxide, which is generated from inducible nitric oxide synthase in macrophages using L-arginine as a substrate.	[Kudo, Shinpei; Nagasaki, Yukio] Univ Tsukuba, Inst Mat Sci, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan; [Nagasaki, Yukio] Univ Tsukuba, Grad Sch Comprehens Human Sci, Masters Sch Med Sci, Tsukuba, Ibaraki 3058573, Japan	Nagasaki, Y (reprint author), Univ Tsukuba, Inst Mat Sci, Grad Sch Pure & Appl Sci, Tennoudai 1-1-1, Tsukuba, Ibaraki 3058573, Japan.	yukio@nagalabo.jp			World Premier International Research Center Initiative (WPI Initiative) on Materials Nanoarchitronics of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan;  [25220203]	A part of this work was supported by Grant-in-Aid for Scientific Research S (25220203) and the World Premier International Research Center Initiative (WPI Initiative) on Materials Nanoarchitronics of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The authors were grateful to Dr. Takehiko Ishii of NanoCarrier Co., Ltd. (Chiba, Tokyo) for his advice and discussion about NCA synthesis.	Luedtke NW, 2000, J AM CHEM SOC, V122, P12035, DOI 10.1021/ja002421m; Mochida Y, 2014, ACS NANO, V8, P6724, DOI 10.1021/nn500498t; Futaki S, 2006, BIOPOLYMERS, V84, P241, DOI 10.1002/hip.20421; Tomita S, 2011, BIOPOLYMERS, V95, P695, DOI 10.1002/bip.21637; Matsumoto S, 2009, BIOMACROMOLECULES, V10, P119, DOI 10.1021/bm800985e; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Feichtinger K, 1998, J ORG CHEM, V63, P3804, DOI 10.1021/jo980425s; Andersson T, 2003, J POLYM SCI POL CHEM, V41, P1904, DOI 10.1002/pola.10742; TSUCHIDA E, 1974, MAKROMOL CHEM, V175, P593; Deng C, 2014, PROG POLYM SCI, V39, P330, DOI 10.1016/j.progpolymsci.2013.10.008; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Thomas DD, 2004, P NATL ACAD SCI USA, V101, P8894, DOI 10.1073/pnas.0400453101; Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004; Li M, 2015, ANGEW CHEM INT EDIT, V54, P2941, DOI 10.1002/anie.201410429; Ieda N, 2014, J AM CHEM SOC, V136, P7085, DOI 10.1021/ja5020053; Harada A, 2003, MACROMOLECULES, V36, P4995, DOI 10.1021/ma025737i; Dufresne MH, 2004, PHARM RES, V21, P160, DOI 10.1023/B:PHAM.0000012164.60867.c6; Dautzenberg H, 2002, MACROMOL CHEM PHYS, V203, P2095, DOI 10.1002/1521-3935(200210)203:14<2095::AID-MACP2095>3.0.CO;2-9; Kanayama N, 2010, CHEM LETT, V39, P1008, DOI 10.1246/cl.2010.1008; CALNAN BJ, 1991, SCIENCE, V252, P1167, DOI 10.1126/science.252.5009.1167; BERNATOWICZ MS, 1992, J ORG CHEM, V57, P2497, DOI 10.1021/jo00034a059; Holowka EP, 2007, NAT MATER, V6, P52, DOI 10.1038/nmat1794; Castillo-Melendez JA, 2004, SYNTHESIS-STUTTGART, P1655, DOI 10.1055/s-2004-829130; Kudo S., UNPUB; Okuno K., 2010, ANGEW CHEM INT EDIT, V49, P3030; Tanford C., 1980, HYDROPHOBIC EFFECT F; Van Holde K. E., 1971, PHYS BIOCH; Wu G., 1998, BIOCH J, V336	28	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1022-1336	1521-3927		MACROMOL RAPID COMM	Macromol. Rapid Commun.	NOV	2015	36	21			SI		1916	1922		10.1002/marc.201500224		7	Polymer Science	Polymer Science	CV5WA	WOS:000364340800009		
J	Sriyudthsak, K; Uno, H; Gunawan, R; Shiraishi, F				Sriyudthsak, Kansuporn; Uno, Harumi; Gunawan, Rudiyanto; Shiraishi, Fumihide			Using dynamic sensitivities to characterize metabolic reaction systems	MATHEMATICAL BIOSCIENCES			English	Article						Aromatic amino acid synthetic system; Bottleneck ranking indicator; Dynamic sensitivities; Metabolic reaction network	TAYLOR-SERIES METHOD; TRICARBOXYLIC-ACID CYCLE; DICTYOSTELIUM-DISCOIDEUM; STEADY-STATE; BOTTLENECK ENZYMES; MODEL; PATHWAY; FLUX; COMPUTATION; INDICATORS	Metabolite concentrations in cells are governed by enzyme kinetics in the metabolic reaction system. One can analyze how these concentrations depend on system variables such as enzyme activities by computing system sensitivities, which generally vary with time. Dynamic sensitivities, i.e., time-varying sensitivities, reflect the time-dependent response of the metabolic reaction network to perturbations. Unfortunately, dynamic sensitivity profiles are not commonly used in the analysis of metabolic reaction systems. In the present study, we demonstrate the use of dynamic logarithmic gains, i.e., normalized time-varying sensitivities, to gain insights into the dynamic behavior of metabolic networks. A biosynthetic reaction model of aromatic amino acids proposed by other researchers is used as a case study. The model system is analyzed using the dynamic logarithmic gains in parallel with simulations of the time-transient behavior of metabolite concentrations and metabolic fluxes. The result indicates that the influences of independent variables are most pronounced just after perturbations and the effects of perturbations on metabolite concentration at early times can be larger than those at steady state. These findings suggest that it is important to perform dynamic sensitivity analysis in addition to steady-state analysis. Furthermore, the rankings of the bottleneck ranking indicators, defined as the product of dynamic logarithmic gain and metabolite concentration, for three desired amino acids reveal that the degree of bottleneck for each enzyme changes with time. In conclusion, the dynamic logarithmic gains are not only useful for analyzing metabolic reaction systems but also can offer additional insights on the transient behavior of the system over steady state sensitivities, leading to a proper design of metabolic systems. (C) 2015 The Authors. Published by Elsevier Inc.	[Sriyudthsak, Kansuporn; Uno, Harumi; Shiraishi, Fumihide] Kyushu Univ, Sect Bioproc Design, Dept Biosci & Biotechnol, Grad Sch Bioresource & Bioenvironm Sci,Higashi Ku, Fukuoka 8208581, Japan; [Sriyudthsak, Kansuporn] RIKEN Ctr Sustainable & Resource Sci, Yokohama, Kanagawa 2300045, Japan; [Gunawan, Rudiyanto] ETH, Inst Chem & Bioengn, CH-8093 Zurich, Switzerland	Shiraishi, F (reprint author), Kyushu Univ, Sect Bioproc Design, Dept Biosci & Biotechnol, Grad Sch Bioresource & Bioenvironm Sci,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8208581, Japan.	fumishira@brs.kyushu-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [25119719]; RIKEN Incentive Research Grant	This work was supported by a research fellow grant from the Japan Society for the Promotion of Science KAKENHI Grant #25119719 to FS and RIKEN Incentive Research Grant to KS.	HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Sriyudthsak K, 2010, IND ENG CHEM RES, V49, P9738, DOI 10.1021/ie100911h; GALAZZO JL, 1990, ENZYME MICROB TECH, V12, P162, DOI 10.1016/0141-0229(90)90033-M; Voit EO, 2003, J THEOR BIOL, V223, P55, DOI 10.1016/S0022-5193(03)00072-9; SHIRAISHI F, 1992, J BIOL CHEM, V267, P22919; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P365, DOI 10.1016/S0022-5193(69)80026-3; SIMPSON TW, 1995, BIOCHEM SOC T, V23, P381; Mulukutla BC, 2012, METAB ENG, V14, P138, DOI 10.1016/j.ymben.2011.12.006; SHIRAISHI F, 1993, J BIOL CHEM, V268, P16917; Mauch K, 1997, CHEM ENG SCI, V52, P2589, DOI 10.1016/S0009-2509(97)00075-4; Shiraishi F, 2007, MATH BIOSCI, V208, P590, DOI 10.1016/j.mbs.2006.11.007; Pascoe DE, 2007, BIOTECHNOL BIOENG, V98, P391, DOI 10.1002/bit.21460; HESS B, 1971, ANNU REV BIOCHEM, V40, P237, DOI 10.1146/annurev.bi.40.070171.001321; Shiraishi F, 2006, J THEOR BIOL, V239, P398, DOI 10.1016/j.jtbi.2005.08.021; Becker J, 2005, APPL ENVIRON MICROB, V71, P8587, DOI 10.1128/AEM.71.12.8587-8596.2005; Stephanopoulos G, 1997, CHEM ENG SCI, V52, P2607, DOI 10.1016/S0009-2509(97)00077-8; Shiraishi F, 2002, APPL MATH COMPUT, V127, P103, DOI 10.1016/S0096-3003(01)00007-8; SHIRAISHI F, 1992, J BIOL CHEM, V267, P22926; Perumal TM, 2014, IND ENG CHEM RES, V53, P9149, DOI 10.1021/ie403277d; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P370, DOI 10.1016/S0022-5193(69)80027-5; RABITZ H, 1983, ANNU REV PHYS CHEM, V34, P419, DOI 10.1146/annurev.pc.34.100183.002223; Perumal TM, 2009, J THEOR BIOL, V261, P248, DOI 10.1016/j.jtbi.2009.07.037; SHIRAISHI F, 1995, J CHEM ENG JPN, V28, P306, DOI 10.1252/jcej.28.306; GALAZZO J, 1991, ENZYME MICROB TECH, V13, P363; Shiraishi F, 2011, MATH BIOSCI, V233, P59, DOI 10.1016/j.mbs.2011.06.004; Shiraishi F, 2009, MATH BIOSCI, V222, P73, DOI 10.1016/j.mbs.2009.09.001; Gunawan R, 2006, BIOPHYS J, V91, P2131, DOI 10.1529/biophysj.105.078006; Miyakawa H, 1999, BIOCHEM ENG J, V3, P91, DOI 10.1016/S1369-703X(99)00007-8; Shiraishi F, 2012, ASIA-PAC J CHEM ENG, V7, pS32, DOI 10.1002/apj.630; Sriyudthsak K, 2010, MATH BIOSCI, V228, P1, DOI 10.1016/j.mbs.2010.08.001; Shiraishi F, 2005, J THEOR BIOL, V234, P79, DOI 10.1016/j.jtbi.2004.11.015; Ma NN, 2009, BIOTECHNOL PROGR, V25, P1353, DOI 10.1002/btpr.238; Zi Z, 2011, IET SYST BIOL, V5, P336, DOI 10.1049/iet-syb.2011.0015; Shiraishi F, 2001, CHEM ENG J, V83, P175, DOI 10.1016/S1385-8947(00)00252-7; Sriyudthsak K, 2010, J BIOTECHNOL, V149, P191, DOI 10.1016/j.jbiotec.2010.01.015; Sriyudthsak K, 2010, IND ENG CHEM RES, V49, P2122, DOI 10.1021/ie901531d; Hirayama H., 2002, JSIAM, V12, P1; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Perumal TM, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-41; Savageau M. A., 1976, BIOCH SYSTEMS ANAL S; Shiraishi F., 2010, IND ENG CHEM RES, V48, P415; Stephanopoulos G. N., 1998, METABOLIC ENG PRINCI; Varma A., 1999, PARAMETRIC SENSITIVI; Voit E. O., 2000, COMPUTATIONAL ANAL B	44	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0025-5564	1879-3134		MATH BIOSCI	Math. Biosci.	NOV	2015	269						153	163		10.1016/j.mbs.2015.09.002		11	Biology; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology	CV7FG	WOS:000364437200015		
J	Shioura, A; Shakhlevich, NV; Strusevich, VA				Shioura, Akiyoshi; Shakhlevich, Natalia V.; Strusevich, Vitaly A.			Decomposition algorithms for submodular optimization with applications to parallel machine scheduling with controllable processing times	MATHEMATICAL PROGRAMMING			English	Article						Submodular optimization; Parallel machine scheduling; Controllable processing times; Decomposition		In this paper we present a decomposition algorithm for maximizing a linear function over a submodular polyhedron intersected with a box. Apart from this contribution to submodular optimization, our results extend the toolkit available in deterministic machine scheduling with controllable processing times. We demonstrate how this method can be applied to developing fast algorithms for minimizing total compression cost for preemptive schedules on parallel machines with respect to given release dates and a common deadline. Obtained scheduling algorithms are faster and easier to justify than those previously known in the scheduling literature.	[Shioura, Akiyoshi] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan; [Shakhlevich, Natalia V.] Univ Leeds, Sch Comp, Leeds LS2 9JT, W Yorkshire, England; [Strusevich, Vitaly A.] Univ Greenwich, Old Royal Naval Coll, Dept Math Sci, London SE10 9LS, England	Strusevich, VA (reprint author), Univ Greenwich, Old Royal Naval Coll, Dept Math Sci, Pk Row, London SE10 9LS, England.	shioura@dais.is.tohoku.ac.jp; N.Shakhlevich@leeds.ac.uk; sv02@gre.ac.uk			EPSRC [EP/J019755/1]; Humboldt Research Fellowship of the Alexander von Humboldt Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [24500002, 25106503]	This research was supported by the EPSRC funded project EP/J019755/1 "Submodular Optimisation Techniques for Scheduling with Controllable Parameters". The first author was partially supported by the Humboldt Research Fellowship of the Alexander von Humboldt Foundation and by Grant-in-Aid of the Ministry of Education, Culture, Sports, Science and Technology of Japan, grants 24500002 and 25106503.	Jansen K, 2004, COMPUT OPER RES, V31, P1565, DOI 10.1016/S0305-0548(03)00101-1; GROENEVELT H, 1991, EUR J OPER RES, V54, P227, DOI 10.1016/0377-2217(91)90300-K; FUJISHIGE S, 1980, MATH OPER RES, V5, P186, DOI 10.1287/moor.5.2.186; Shabtay D, 2007, DISCRETE APPL MATH, V155, P1643, DOI 10.1016/j.dam.2007.02.003; CHEN YL, 1994, EUR J OPER RES, V74, P111, DOI 10.1016/0377-2217(94)90208-9; Shakhlevich NV, 2008, LECT NOTES COMPUT SC, V5193, P756, DOI 10.1007/978-3-540-87744-8_63; SAHNI S, 1979, OPER RES, V27, P925, DOI 10.1287/opre.27.5.925; Shakhlevich NV, 2008, ALGORITHMICA, V51, P451, DOI 10.1007/S00453-007-9091-9; NOWICKI E, 1995, DISCRETE APPL MATH, V63, P237, DOI 10.1016/0166-218X(94)00071-5; McCormick ST, 1999, OPER RES, V47, P744, DOI 10.1287/opre.47.5.744; Shakhlevich NV, 2009, INT J FOUND COMPUT S, V20, P247, DOI 10.1142/S0129054109006541; SAHNI S, 1980, J ACM, V27, P550, DOI 10.1145/322203.322214; Shioura A, 2013, SIAM J DISCRETE MATH, V27, P186, DOI 10.1137/110843836; Janiak A, 1996, EUR J OPER RES, V94, P284, DOI 10.1016/0377-2217(96)00129-4; NOWICKI E, 1990, DISCRETE APPL MATH, V26, P271, DOI 10.1016/0166-218X(90)90105-L; Shakhlevich NV, 2005, J SCHED, V8, P233, DOI 10.1007/s10951-005-6813-1; Brucker P., 2007, SCHEDULING ALGORITHM; Fujishige S, 2005, ANN DISCR MATH, V58, P1; GONZALEZ T, 1978, J ACM, V25, P92, DOI 10.1145/322047.322055; Iwata S, 2001, J ACM, V48, P761, DOI 10.1145/502090.502096; Katoh N., 1998, HDB COMBINATORIAL OP, V2, P159; Lawler E.L., 1993, HDB OPERATIONS RES M, V4, P445; Leung J. Y.-T., 2004, HDB SCHEDULING ALGOR, P34; McNaughton R., 1959, MANAGE SCI, V12, P1; Nemhauser G.L., 1988, INTEGER COMBINATORIA; Schrijver A., 2003, COMBINATORIAL OPTIMI; Schrijver A, 2000, J COMB THEORY B, V80, P346, DOI 10.1006/jctb.2000.1989	27	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5610	1436-4646		MATH PROGRAM	Math. Program.	NOV	2015	153	2					495	534		10.1007/s10107-014-0814-9		40	Computer Science, Software Engineering; Operations Research & Management Science; Mathematics, Applied	Computer Science; Operations Research & Management Science; Mathematics	CV5SB	WOS:000364330300009		
J	Morimoto-Yamashita, Y; Kawakami, Y; Tatsuyama, S; Miyashita, K; Emoto, M; Kikuchi, K; Kawahara, K; Tokuda, M				Morimoto-Yamashita, Yoko; Kawakami, Yoshiko; Tatsuyama, Syoko; Miyashita, Keiko; Emoto, Makiko; Kikuchi, Kiyoshi; Kawahara, Ko-ichi; Tokuda, Masayuki			A natural therapeutic approach for the treatment of periodontitis by MK615	MEDICAL HYPOTHESES			English	Article							PRO-INFLAMMATORY CYTOKINE; PRUNUS-MUME-SIEB.; CELLS IN-VITRO; BACTEROIDES-GINGIVALIS; RAW264.7 CELLS; DISEASE; CANCER; MAPK; LIPOPOLYSACCHARIDE; INHIBITION	Periodontitis is a chronic inflammatory disease that affects the tooth-supporting tissues. Gingival fibroblasts are the most abundant cells in periodontal tissues and they participate actively in the host inflammatory response to periodontal pathogens that is known to mediate local tissue destruction in periodontitis. The Japanese apricot, known as Ume in Japanese, has been a traditional Japanese medicine for centuries and is a familiar and commonly consumed food. The health benefits of Ume are widely recognized and have been confirmed in recent studies showing that MK615, an extract of compounds from Ume, has strong anticancer and anti-inflammatory effects. However, the potential role of MK615 in oral health is unknown. We hypothesized that the anti-inflammatory activities of MK615 could be exploited to inhibit the effects of lipopolysaccharide (LPS) produced by periodontal bacterial pathogens, such as Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis. Here, we show that LPS-induced interleukin (IL)-6 and IL-8 production by gingival fibroblasts was dose-dependently inhibited by MK615. As a potent inhibitor of the inflammatory responses induced by periodontal pathogens, MK615 merits further testing as a therapeutic agent in inflammatory diseases such as periodontitis. (C) 2015 Published by Elsevier Ltd.	[Morimoto-Yamashita, Yoko; Kawakami, Yoshiko; Tatsuyama, Syoko; Miyashita, Keiko; Emoto, Makiko; Tokuda, Masayuki] Kagoshima Univ, Dept Restorat Dent & Endodontol, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan; [Kikuchi, Kiyoshi] Kurume Univ, Dept Physiol, Sch Med, Fukuoka, Japan; [Kawahara, Ko-ichi] Osaka Inst Technol, Osaka 535, Japan	Tokuda, M (reprint author), Kagoshima Univ, Dept Restorat Dent & Endodontol, Grad Sch Med & Dent Sci, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	mas-tok@dent.kagoshima-u.ac.jp			JSPS KAKENHI [24593161]	This study was supported in part by JSPS KAKENHI Grant Number 24593161.	Seymour GJ, 2007, CLIN MICROBIOL INFEC, V13, P3, DOI 10.1111/j.1469-0691.2007.01798.x; Okada T, 2008, WORLD J GASTROENTERO, V14, P1378, DOI 10.3748/wjg.14.1378; BIRKEDALHANSEN H, 1993, J PERIODONTAL RES, V28, P500, DOI 10.1111/j.1600-0765.1993.tb02113.x; Genco CA, 1998, TRENDS MICROBIOL, V6, P444, DOI 10.1016/S0966-842X(98)01363-8; Morimoto Y, 2009, BIOCHEM BIOPH RES CO, V389, P90, DOI 10.1016/j.bbrc.2009.08.103; Kim J, 2006, ODONTOLOGY, V94, P10, DOI 10.1007/s10266-006-0060-6; Son YH, 2008, J CARDIOVASC PHARM, V51, P71, DOI 10.1097/FJC.0b013e31815bd23d; Nakagawa A, 2007, BREAST J, V13, P44, DOI 10.1111/j.1524-4741.2006.00361.x; Bodet C, 2008, J PERIODONTAL RES, V43, P400, DOI 10.1111/j.1600-0765.2007.01055.x; Mori S, 2007, WORLD J GASTROENTERO, V13, P6512, DOI 10.3748/wjg.13.6512; Wang PL, 2003, BIOCHEM BIOPH RES CO, V305, P970, DOI 10.1016/S0006-291X(03)00821-0; Takashiba S, 2003, J PERIODONTOL, V74, P103, DOI 10.1902/jop.2003.74.1.103; Neuder LE, 2009, VET IMMUNOL IMMUNOP, V129, P192, DOI 10.1016/j.vetimm.2008.11.006; Kawahara KI, 2009, INT J MOL MED, V23, P615, DOI 10.3892/ijmm_00000172; Adachi M, 2007, INT J FOOD PROP, V10, P375, DOI 10.1080/10942910600547624; Okada H, 1998, CRIT REV ORAL BIOL M, V9, P248; Henderson B, 1996, MICROBIOL REV, V60, P316; Bodet C, 2008, CRIT REV FOOD SCI, V48, P672, DOI 10.1080/10408390701636211; MAKIMURA M, 1993, J PERIODONTOL, V64, P630; Meyer MS, 2008, CANCER CAUSE CONTROL, V19, P895, DOI 10.1007/s10552-008-9163-4; Bodet C, 2006, J DENT RES, V85, P235; HOLT SC, 1988, SCIENCE, V239, P55, DOI 10.1126/science.3336774; Morimoto-Yamashita Y, 2011, MED HYPOTHESES, V77, P258, DOI 10.1016/j.mehy.2011.04.027; SLOTS J, 1988, J CLIN PERIODONTOL, V15, P85, DOI 10.1111/j.1600-051X.1988.tb00999.x	24	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	NOV	2015	85	5					618	621		10.1016/j.mehy.2015.07.028		4	Medicine, Research & Experimental	Research & Experimental Medicine	CV9MO	WOS:000364611500020		
J	Sugano, Y; Mizuta, M; Takao, S; Shirato, H; Sutherland, KL; Date, H				Sugano, Yasutaka; Mizuta, Masahiro; Takao, Seishin; Shirato, Hiroki; Sutherland, Kenneth L.; Date, Hiroyuki			Optimization of the fractionated irradiation scheme considering physical doses to tumor and organ at risk based on dose-volume histograms	MEDICAL PHYSICS			English	Article						fractionated radiotherapy; linear-quadratic (LQ) model; universal survival curve (USC); repopulation of tumor cells; dose-volume histogram (DVH)	UNIVERSAL SURVIVAL-CURVE; LINEAR-QUADRATIC MODEL; ACCELERATED RADIOTHERAPY CHART; CELL LUNG-CANCER; RADIATION-THERAPY; CONTROL PROBABILITY; PROSTATE-CANCER; BREAST-CANCER; TOXICITY; TRIAL	Purpose: Radiotherapy of solid tumors has been performed with various fractionation regimens such as multi- and hypofractionations. However, the ability to optimize the fractionation regimen considering the physical dose distribution remains insufficient. This study aims to optimize the fractionation regimen, in which the authors propose a graphical method for selecting the optimal number of fractions (n) and dose per fraction (d) based on dose-volume histograms for tumor and normal tissues of organs around the tumor. Methods: Modified linear-quadratic models were employed to estimate the radiation effects on the tumor and an organ at risk (OAR), where the repopulation of the tumor cells and the linearity of the dose-response curve in the high dose range of the surviving fraction were considered. The minimization problem for the damage effect on the OAR was solved under the constraint that the radiation effect on the tumor is fixed by a graphical method. Here, the damage effect on the OAR was estimated based on the dose-volume histogram. Results: It was found that the optimization of fractionation scheme incorporating the dose-volume histogram is possible by employing appropriate cell surviving models. The graphical method considering the repopulation of tumor cells and a rectilinear response in the high dose range enables them to derive the optimal number of fractions and dose per fraction. For example, in the treatment of prostate cancer, the optimal fractionation was suggested to lie in the range of 8-32 fractions with a daily dose of 2.2-6.3 Gy. Conclusions: It is possible to optimize the number of fractions and dose per fraction based on the physical dose distribution (i.e., dose-volume histogram) by the graphical method considering the effects on tumor and OARs around the tumor. This method may stipulate a new guideline to optimize the fractionation regimen for physics-guided fractionation. (C) 2015 American Association of Physicists in Medicine.	[Sugano, Yasutaka] Hokkaido Univ, Grad Sch Hlth Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Mizuta, Masahiro] Hokkaido Univ, Informat Initiat Ctr, Lab Adv Data Sci, Kita Ku, Sapporo, Hokkaido 0600811, Japan; [Takao, Seishin; Shirato, Hiroki; Sutherland, Kenneth L.] Hokkaido Univ, Grad Sch Med, Dept Radiat Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Date, Hiroyuki] Hokkaido Univ, Fac Hlth Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Date, H (reprint author), Hokkaido Univ, Fac Hlth Sci, Kita Ku, Kita 12,Nishi 5, Sapporo, Hokkaido 0600812, Japan.	date@hs.hokudai.ac.jp			JSPS KAKENHI [25540008]	This work was supported by JSPS KAKENHI Grant No. 25540008. Any actual or potential conflicts of interest do not exist for all authors.	Aluwini S, 2015, LANCET ONCOL, V16, P274, DOI 10.1016/S1470-2045(14)70482-6; Yeoh EE, 2011, INT J RADIAT ONCOL, V81, P1271, DOI 10.1016/j.ijrobp.2010.07.1984; Astrahan M, 2008, MED PHYS, V35, P4161, DOI 10.1118/1.2969065; Borst GR, 2010, INT J RADIAT ONCOL, V77, P1596, DOI 10.1016/j.ijrobp.2009.10.015; Lindblom E, 2014, ACTA ONCOL, V53, P1035, DOI 10.3109/0284186X.2014.925582; Unkelbach J, 2013, MED PHYS, V40, DOI 10.1118/1.4816658; Bourhis J, 2006, LANCET, V368, P843, DOI 10.1016/S0140-6736(06)69121-6; Whelan TJ, 2010, NEW ENGL J MED, V362, P513, DOI 10.1056/NEJMoa0906260; Budach W, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-28; Mizuta M, 2012, INT J RADIAT ONCOL, V84, P829, DOI 10.1016/j.ijrobp.2012.01.004; Stavreva N, 2010, ACTA ONCOL, V49, P1324, DOI 10.3109/0284186X.2010.517782; Saunders M, 1999, RADIOTHER ONCOL, V52, P137, DOI 10.1016/S0167-8140(99)00087-0; Mizuta M, 2012, MED PHYS, V39, P6791, DOI 10.1118/1.4757580; Vogelius IS, 2010, ACTA ONCOL, V49, P1052, DOI 10.3109/0284186X.2010.498835; DISCHE S, 1990, INT J RADIAT ONCOL, V19, P1317; Flanz J, 2013, SEMIN RADIAT ONCOL, V23, P142, DOI 10.1016/j.semradonc.2012.11.006; Park C, 2008, INT J RADIAT ONCOL, V70, P847, DOI 10.1016/j.ijrobp.2007.10.059; Hijal T, 2010, CURR ONCOL, V17, P22; SAUNDERS MI, 1986, BRIT J RADIOL, V59, P523; Guckenberger M, 2013, RADIOTHER ONCOL, V109, P13, DOI 10.1016/j.radonc.2013.09.005; Kirkpatrick JP, 2008, SEMIN RADIAT ONCOL, V18, P240, DOI 10.1016/j.semradonc.2008.04.005; Monroe AT, 2005, INT J RADIAT ONCOL, V61, P856, DOI 10.1016/j.ijrobp.2004.07.664; Unkelbach J, 2013, PHYS MED BIOL, V58, P159, DOI 10.1088/0031-9155/58/1/159; Yang Y, 2005, MED PHYS, V32, P3666, DOI 10.1118/1.2126167; Wennberg B, 2013, ACTA ONCOL, V52, P902, DOI 10.3109/0284186X.2012.728292; Nagata Y, 2011, INT J RADIAT ONCOL, V79, P660, DOI 10.1016/j.ijrobp.2010.10.004; Wennberg BM, 2011, ACTA ONCOL, V50, P518, DOI 10.3109/0284186X.2010.543695; Timmerman R, 2006, J CLIN ONCOL, V24, P4833, DOI 10.1200/JCO.2006.07.5937; Onishi H, 2011, INT J RADIAT ONCOL, V81, P1352, DOI 10.1016/j.ijrobp.2009.07.1751; Keller H, 2013, MED PHYS, V40, DOI 10.1118/1.4812884; Arcangeli G, 2011, INT J RADIAT ONCOL, V79, P1013, DOI 10.1016/j.ijrobp.2009.12.045; Date Hiroyuki, 2014, Radiol Phys Technol, V7, P148, DOI 10.1007/s12194-013-0244-z; Withers HR, 1975, ADV RADIAT BIOL, V5, P241	33	0	0	AMER ASSOC PHYSICISTS MEDICINE AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0094-2405			MED PHYS	Med. Phys.	NOV	2015	42	11					6203	6210		10.1118/1.4931969		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CV6SY	WOS:000364402100009		
J	Yamamoto, S; Toshito, T; Okumura, S; Komori, M				Yamamoto, Seiichi; Toshito, Toshiyuki; Okumura, Satoshi; Komori, Masataka			Luminescence imaging of water during proton-beam irradiation for range estimation	MEDICAL PHYSICS			English	Article						luminescence; imaging; water; proton; range	POSITRON-EMISSION; THERAPY; VERIFICATION; SYSTEM; RADIOTHERAPY; PHYSICS; PET; OUTPUT; CAMERA	Purpose: Proton therapy has the ability to selectively deliver a dose to the target tumor, so the dose distribution should be accurately measured by a precise and efficient method. The authors found that luminescence was emitted from water during proton irradiation and conjectured that this phenomenon could be used for estimating the dose distribution. Methods: To achieve more accurate dose distribution, the authors set water phantoms on a table with a spot scanning proton therapy system and measured the luminescence images of these phantoms with a high-sensitivity, cooled charge coupled device camera during proton-beam irradiation. The authors imaged the phantoms of pure water, fluorescein solution, and an acrylic block. Results: The luminescence images of water phantoms taken during proton-beam irradiation showed clear Bragg peaks, and the measured proton ranges from the images were almost the same as those obtained with an ionization chamber. Furthermore, the image of the pure-water phantom showed almost the same distribution as the tap-water phantom, indicating that the luminescence image was not related to impurities in the water. The luminescence image of the fluorescein solution had similar to 3 times higher intensity than water, with the same proton range as that of water. The luminescence image of the acrylic phantom had a 14.5% shorter proton range than that of water; the proton range in the acrylic phantom generally matched the calculated value. The luminescence images of the tap-water phantom during proton irradiation could be obtained in less than 2 s. Conclusions: Luminescence imaging during proton-beam irradiation is promising as an effective method for range estimation in proton therapy. (C) 2015 American Association of Physicists in Medicine.	[Yamamoto, Seiichi; Okumura, Satoshi; Komori, Masataka] Nagoya Univ, Radiol & Med Lab Sci, Grad Sch Med, Nagoya, Aichi 4618673, Japan; [Toshito, Toshiyuki] Nagoya City West Med Ctr, Nagoya Proton Therapy Ctr, Dept Proton Therapy Phys, Nagoya, Aichi 4628508, Japan	Yamamoto, S (reprint author), Nagoya Univ, Radiol & Med Lab Sci, Grad Sch Med, Nagoya, Aichi 4618673, Japan.	s-yama@met.nagoya-u.ac.jp					Ammar C, 2014, PHYS MED BIOL, V59, P7229, DOI 10.1088/0031-9155/59/23/7229; Oelfke U, 1996, PHYS MED BIOL, V41, P177, DOI 10.1088/0031-9155/41/1/013; Jakel O, 2009, RADIAT PROT DOSIM, V137, P156, DOI 10.1093/rpd/ncp192; Nishio T, 2006, MED PHYS, V33, P4190, DOI 10.1118/1.2361079; BENNETT GW, 1978, SCIENCE, V200, P1151, DOI 10.1126/science.200.4346.1151; Glaser AK, 2013, PHYS MED BIOL, V58, P601, DOI 10.1088/0031-9155/58/3/601; Knopf A, 2009, PHYS MED BIOL, V54, P4477, DOI 10.1088/0031-9155/54/14/008; Henry T, 2015, MED PHYS, V42, P3581, DOI 10.1118/1.4925478; Newhauser WD, 2015, PHYS MED BIOL, V60, pR155, DOI 10.1088/0031-9155/60/8/R155; Helo Y, 2014, PHYS MED BIOL, V59, P1963, DOI 10.1088/0031-9155/59/8/1963; Iseki Y, 2003, NUCL INSTRUM METH A, V515, P840, DOI 10.1016/j.nima.2003.07.005; Sun B, 1998, J ELECTROSTAT, V43, P115, DOI 10.1016/S0304-3886(97)00166-6; Smeets J, 2012, PHYS MED BIOL, V57, P3371, DOI 10.1088/0031-9155/57/11/3371; Fahimian B, 2014, MED PHYS, V41, DOI 10.1118/1.4851595; Min CH, 2012, MED PHYS, V39, P2100, DOI 10.1118/1.3694098; Tarasov MD, 2007, INSTRUM EXP TECH+, V50, P761, DOI 10.1134/S0020441207060085; DELGUERRA A, 1994, NUCL INSTRUM METH A, V345, P379, DOI 10.1016/0168-9002(94)91016-2; Parodi K, 2002, PHYS MED BIOL, V47, P21, DOI 10.1088/0031-9155/47/1/302; Hishikawa Y, 2002, INT J RADIAT ONCOL, V53, P1388, DOI 10.1016/S0360-3016(02)02887-0; Inaniwa T, 2005, PHYS MED BIOL, V50, P1131, DOI 10.1088/0031-9155/50/6/007; Attri P, 2015, SCI REP-UK, V5, DOI 10.1038/srep09332; Helo Y, 2014, PHYS MED BIOL, V59, P7107, DOI 10.1088/0031-9155/59/23/7107; Kase Y, 2015, PHYS MED BIOL, V60, P359, DOI 10.1088/0031-9155/60/1/359; Kim M, 2015, MED PHYS, V42, P1071, DOI 10.1118/1.4906131; SITHARAMARO DN, 1963, J PHYS CHEM-US, V67, P2126, DOI 10.1021/j100804a037; Uickenden T I, 1971, Radiat Res, V46, P28; Yamamoto S, 2014, MED PHYS, V41, DOI 10.1118/1.4898592	27	0	0	AMER ASSOC PHYSICISTS MEDICINE AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0094-2405			MED PHYS	Med. Phys.	NOV	2015	42	11					6498	6506		10.1118/1.4932630		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CV6SY	WOS:000364402100035		
J	Sakurai, Y; Tanaka, H; Kondo, N; Kinashi, Y; Suzuki, M; Masunaga, S; Ono, K; Maruhashi, A				Sakurai, Yoshinori; Tanaka, Hiroki; Kondo, Natsuko; Kinashi, Yuko; Suzuki, Minoru; Masunaga, Shinichiro; Ono, Koji; Maruhashi, Akira			Development of a dual phantom technique for measuring the fast neutron component of dose in boron neutron capture therapy	MEDICAL PHYSICS			English	Article						boron neutron capture therapy; fast neutron; dual phantom technique; lithium hydroxide; enriched lithium-6	BNCT FACILITY	Purpose: Research and development of various accelerator-based irradiation systems for boron neutron capture therapy (BNCT) is underway throughout the world. Many of these systems are nearing or have started clinical trials. Before the start of treatment with BNCT, the relative biological effectiveness (RBE) for the fast neutrons (over 10 keV) incident to the irradiation field must be estimated. Measurements of RBE are typically performed by biological experiments with a phantom. Although the dose deposition due to secondary gamma rays is dominant, the relative contributions of thermal neutrons (below 0.5 eV) and fast neutrons are virtually equivalent under typical irradiation conditions in a water and/or acrylic phantom. Uniform contributions to the dose deposited from thermal and fast neutrons are based in part on relatively inaccurate dose information for fast neutrons. This study sought to improve the accuracy in the dose estimation for fast neutrons by using two phantoms made of different materials in which the dose components can be separated according to differences in the interaction cross sections. The development of a "dual phantom technique" for measuring the fast neutron component of dose is reported. Methods: One phantom was filled with pure water. The other phantom was filled with a water solution of lithium hydroxide (LiOH) capitalizing on the absorbing characteristics of lithium-6 (Li-6) for thermal neutrons. Monte Carlo simulations were used to determine the ideal mixing ratio of Li-6 in LiOH solution. Changes in the depth dose distributions for each respective dose component along the central beam axis were used to assess the LiOH concentration at the 0, 0.001, 0.01, 0.1, 1, and 10 wt. % levels. Simulations were also performed with the phantom filled with 10 wt. % (LiOH)-Li-6 solution for 95%-enriched Li-6. A phantom was constructed containing 10 wt. % (LiOH)-Li-6 solution based on the simulation results. Experimental characterization of the depth dose distributions of the neutron and gamma-ray components along the central axis was performed at Heavy Water Neutron Irradiation Facility installed at Kyoto University Reactor using activation foils and thermoluminescent dosimeters, respectively. Results: Simulation results demonstrated that the absorbing effect for thermal neutrons occurred when the LiOH concentration was over 1%. The most effective Li-6 concentration was determined to be enriched (LiOH)-Li-6 with a solubility approaching its upper limit. Experiments confirmed that the thermal neutron flux and secondary gamma-ray dose rate decreased substantially; however, the fast neutron flux and primary gamma-ray dose rate were hardly affected in the 10%-(LiOH)-Li-6 phantom. It was confirmed that the dose contribution of fast neutrons is improved from approximately 10% in the pure water phantom to approximately 50% in the 10%-(LiOH)-Li-6 phantom. Conclusions: The dual phantom technique using the combination of a pure water phantom and a 10%-(LiOH)-Li-6 phantom developed in this work provides an effective method for dose estimation of the fast neutron component in BNCT. Improvement in the accuracy achieved with the proposed technique results in improved RBE estimation for biological experiments and clinical practice. (C) 2015 American Association of Physicists in Medicine.	[Sakurai, Yoshinori; Tanaka, Hiroki; Kondo, Natsuko; Kinashi, Yuko; Suzuki, Minoru; Masunaga, Shinichiro; Ono, Koji; Maruhashi, Akira] Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan	Sakurai, Y (reprint author), Kyoto Univ, Inst Res Reactor, Asashironishi 2-1010, Kumatori, Osaka 5900494, Japan.	yosakura@rri.kyoto-u.ac.jp					Kumada H, 2014, APPL RADIAT ISOTOPES, V88, P211, DOI 10.1016/j.apradiso.2014.02.018; Kreiner AJ, 2014, APPL RADIAT ISOTOPES, V88, P185, DOI 10.1016/j.apradiso.2013.11.064; Sakurai Y, 2000, NUCL INSTRUM METH A, V453, P569, DOI 10.1016/S0168-9002(00)00465-4; CASWELL RS, 1980, RADIAT RES, V83, P217, DOI 10.2307/3575276; Culbertson CN, 2004, APPL RADIAT ISOTOPES, V61, P733, DOI 10.1016/j.apradiso.2004.05.057; Ceballos C, 2011, APPL RADIAT ISOTOPES, V69, P1660, DOI 10.1016/j.apradiso.2011.01.032; Tanaka H, 2009, NUCL INSTRUM METH B, V267, P1970, DOI 10.1016/j.nimb.2009.03.095; Kreiner AJ, 2011, APPL RADIAT ISOTOPES, V69, P1672, DOI 10.1016/j.apradiso.2011.01.040; Shen XZ, 2013, ANN NUCL ENERGY, V62, P195, DOI 10.1016/j.anucene.2013.06.014; Briesmeister J. F., 2000, LA13709M; International Atomic Energy Agency, 2001, IAEATECDOC1223; Locher GL, 1936, AM J ROENTGENOL RADI, V36, P1; Sakurai Y., 2010, P 14 INT C NEUTR CAP, P254; Synder W. S., 1975, REPORT TASK GROUP RE	14	0	0	AMER ASSOC PHYSICISTS MEDICINE AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0094-2405			MED PHYS	Med. Phys.	NOV	2015	42	11					6651	6657		10.1118/1.4934243		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CV6SY	WOS:000364402100051		
J	Sugano, T; Seike, M; Noro, R; Soeno, C; Chiba, M; Zou, FF; Nakamichi, S; Nishijima, N; Matsumoto, M; Miyanaga, A; Kubota, K; Gemma, A				Sugano, Teppei; Seike, Masahiro; Noro, Rintaro; Soeno, Chie; Chiba, Mika; Zou, Fenfei; Nakamichi, Shinji; Nishijima, Nobuhiko; Matsumoto, Masaru; Miyanaga, Akihiko; Kubota, Kaoru; Gemma, Akihiko			Inhibition of ABCB1 Overcomes Cancer Stem Cell-like Properties and Acquired Resistance to MET Inhibitors in Non-Small Cell Lung Cancer	MOLECULAR CANCER THERAPEUTICS			English	Article							P-GLYCOPROTEIN ABCB1; RANDOMIZED PHASE-II; MULTIDRUG-RESISTANCE; GEFITINIB RESISTANCE; EXPRESSION SIGNATURE; ACTIVATING MUTATIONS; GENE AMPLIFICATION; BRAIN ACCUMULATION; KINASE INHIBITORS; PROSTATE-CANCER	Patients with non-small cell lung cancer (NSCLC) EGFR mutations have shown a dramatic response to EGFR inhibitors (EGFR-TKI). EGFR T790M mutation and MET amplification have been recognized as major mechanisms of acquired resistance to EGFR-TKI. Therefore, MET inhibitors have recently been used in NSCLC patients in clinical trials. In this study, we tried to identify the mechanism of acquired resistance to MET inhibitors. We analyzed the antitumor effects of two MET inhibitors, PHA-665752 and crizotinib, in 10 NSCLC cell lines. EBC-1 cells with MET amplification were the only cells that were sensitive to both MET inhibitors. We established PHA-665752-resistant EBC-1 cells, namely EBC-1R cells. Activation of KRAS, EGFR, and FGFR2 signaling was observed in EBC-1R cells by FISH and receptor tyrosine kinase phosphorylation antibody arrays. EBC-1R cells also showed overexpression of ATP-binding cassette subfamily B member 1 (ABCB1) as well as phosphorylation of MET. EBC-1R cells grew as cell spheres that exhibited cancer stem cell-like (CSC) properties and epithelial-mesenchymal transition (EMT). The level of miR138 that targeted ABCB1 was decreased in EBC-1R cells. ABCB1 siRNA and the ABCB1 inhibitor elacridar could reduce sphere numbers and suppress EMT. Elacridar could also reverse resistance to PHA-665752 in EBC-1R cells. Our study demonstrated that ABCB1 overexpression, which was associated with CSC properties and EMT, was involved in the acquired resistance to MET inhibitors. Inhibition of ABCB1 might be a novel therapeutic strategy for NSCLC patients with acquired resistance to MET inhibitors. (C) 2015 AACR.	[Sugano, Teppei; Seike, Masahiro; Noro, Rintaro; Soeno, Chie; Chiba, Mika; Zou, Fenfei; Nakamichi, Shinji; Nishijima, Nobuhiko; Matsumoto, Masaru; Miyanaga, Akihiko; Kubota, Kaoru; Gemma, Akihiko] Nippon Med Sch, Grad Sch Med, Dept Pulm Med & Oncol, Bunkyo Ku, Tokyo 1138603, Japan	Seike, M (reprint author), Nippon Med Sch, Grad Sch Med, Dept Pulm Med & Oncol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	mseike@nms.ac.jp					Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416,9.1.105; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Kuppens IELM, 2007, CLIN CANCER RES, V13, P3276, DOI 10.1158/1078-0432.CCR-06-2414; Spigel DR, 2013, J CLIN ONCOL, V31, P4105, DOI 10.1200/JCO.2012.47.4189; Zhao XH, 2010, LEUKEMIA RES, V34, P1078, DOI 10.1016/j.leukres.2009.10.002; Berns A, 2005, CELL, V121, P811, DOI 10.1016/j.cell.2005.06.004; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Seike M, 2007, J NATL CANCER I, V99, P1257, DOI 10.1093/jnci/djm083; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Liu XQ, 2009, CANCER LETT, V286, P217, DOI 10.1016/j.canlet.2009.05.030; Lagas JS, 2009, CLIN CANCER RES, V15, P2344, DOI 10.1158/1078-0432.CCR-08-2253; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Porter J, 2010, EXPERT OPIN THER PAT, V20, P159, DOI 10.1517/13543770903514137; Planting AST, 2005, CANCER CHEMOTH PHARM, V55, P91, DOI 10.1007/s00280-004-0854-6; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Tang SC, 2012, INT J CANCER, V130, P223, DOI 10.1002/ijc.26000; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Lutterbach B, 2007, CANCER RES, V67, P2081, DOI 10.1158/0008-5472.CAN-06-3495; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Sequist LV, 2011, J CLIN ONCOL, V29, P3307, DOI 10.1200/JCO.2010.34.0570; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Zhu YZ, 2013, MOL CANCER THER, V12, P1829, DOI 10.1158/1535-7163.MCT-13-0208; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Cepero V, 2010, CANCER RES, V70, P7580, DOI 10.1158/0008-5472.CAN-10-0436; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Shimokawa T, 2012, BRIT J CANCER, V106, P867, DOI 10.1038/bjc.2012.7; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Agarwal S, 2010, J PHARMACOL EXP THER, V334, P147, DOI 10.1124/jpet.110.167601; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Katoh M, 2008, INT J ONCOL, V33, P233, DOI 10.3892/ijo_00000001; HYAFIL F, 1993, CANCER RES, V53, P4595; Qi J, 2011, CANCER RES, V71, P1081, DOI 10.1158/0008-5472.CAN-10-1623; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Kitamura K, 2014, MOL CANCER THER, V13, P444, DOI 10.1158/1535-7163.MCT-13-0448; Noro Rintaro, 2015, BMC Cancer, V15, P31, DOI 10.1186/s12885-015-1019-1; O'Neill AJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-126; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984	43	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	NOV	2015	14	11					2433	2440		10.1158/1535-7163.MCT-15-0050		8	Oncology	Oncology	CV9FE	WOS:000364592000003		
J	Davies, BR; Guan, N; Logie, A; Crafter, C; Hanson, L; Jacobs, V; James, N; Dudley, P; Jacques, K; Ladd, B; D'Cruz, CM; Zinda, M; Lindemann, J; Kodaira, M; Tamura, K; Jenkins, EL				Davies, Barry R.; Guan, Nin; Logie, Armelle; Crafter, Claire; Hanson, Lyndsey; Jacobs, Vivien; James, Neil; Dudley, Philippa; Jacques, Kelly; Ladd, Brendon; D'Cruz, Celina M.; Zinda, Michael; Lindemann, Justin; Kodaira, Makoto; Tamura, Kenji; Jenkins, Emma L.			Tumors with AKT1(E17K) Mutations Are Rational Targets for Single Agent or Combination Therapy with AKT Inhibitors	MOLECULAR CANCER THERAPEUTICS			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; BREAST-CANCER; ONCOGENIC MUTATION; E17K MUTATION; PATHWAY; PIK3CA; CARCINOMA; GROWTH; CELLS; MODEL	AKT1(E17K) mutations occur at low frequency in a variety of solid tumors, including those of the breast and urinary bladder. Although this mutation has been shown to transform rodent cells in culture, it was found to be less oncogenic than PIK3CA mutations in breast epithelial cells. Moreover, the therapeutic potential of AKT inhibitors in human tumors with an endogenous AKT1(E17K) mutation is not known. Expression of exogenous copies of AKT1(E17K) in MCF10A breast epithelial cells increased phosphorylation of AKT and its substrates, induced colony formation in soft agar, and formation of lesions in the mammary fat pad of immunodeficient mice. These effects were inhibited by the allosteric and catalytic AKT inhibitors MK-2206 and AZD5363, respectively. Both AKT inhibitors caused highly significant growth inhibition of breast cancer explant models with AKT1E17K mutation. Furthermore, in a phase I clinical study, the catalytic Akt inhibitor AZD5363 induced partial responses in patients with breast and ovarian cancer with tumors containing AKT1(E17K) mutations. In MGH-U3 bladder cancer xenografts, which contain both AKT1(E17K) and FGFR3(Y373C) mutations, AZD5363 monotherapy did not significantly reduce tumor growth, but tumor regression was observed in combination with the FGFR inhibitor AZD4547. The data show that tumors with AKT1(E17K) mutations are rational therapeutic targets for AKT inhibitors, although combinations with other targeted agents may be required where activating oncogenic mutations of other proteins are present in the same tumor. (C) 2015 AACR.	[Davies, Barry R.; Logie, Armelle; Crafter, Claire; Hanson, Lyndsey; Jacobs, Vivien; James, Neil; Dudley, Philippa; Lindemann, Justin] AstraZeneca, Oncol iMED, Macclesfield SK10 4TG, Cheshire, England; [Guan, Nin; Jacques, Kelly; Ladd, Brendon; D'Cruz, Celina M.; Zinda, Michael; Jenkins, Emma L.] Gatehouse Pk, Waltham, MA USA; [Kodaira, Makoto; Tamura, Kenji] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo, Japan	Davies, BR (reprint author), AstraZeneca, Alderley Pk, Macclesfield SK10 4TG, Cheshire, England.	barry.davies@astrazeneca.com					Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Lauring J, 2010, ONCOGENE, V29, P2337, DOI 10.1038/onc.2009.516; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Davies BR, 2012, MOL CANCER THER, V11, P873, DOI 10.1158/1535-7163.MCT-11-0824-T; Cohen Y, 2010, GYNECOL ONCOL, V116, P88, DOI 10.1016/j.ygyno.2009.09.038; Bleeker FE, 2008, ONCOGENE, V27, P5648, DOI 10.1038/onc.2008.170; Flatley E, 2013, HUM PATHOL, V44, P1320, DOI 10.1016/j.humpath.2012.10.018; Beaver JA, 2013, CLIN CANCER RES, V19, P5413, DOI 10.1158/1078-0432.CCR-13-0884; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; MEYSKENS FL, 1984, CANCER RES, V44, P271; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Shoji K, 2009, BRIT J CANCER, V101, P145, DOI 10.1038/sj.bjc.6605109; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Yi KH, 2013, ONCOTARGET, V4, P29; Landgraf KE, 2008, BIOCHEMISTRY-US, V47, P12260, DOI 10.1021/bi801683k; Boormans JL, 2010, BRIT J CANCER, V102, P1491, DOI 10.1038/sj.bjc.6605673; Malanga D, 2008, CELL CYCLE, V7, P665; Askham JM, 2008, ONCOGENE, V27, P5648; Rudolph M, 2014, AACR ANN M SAN DIEG; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Troxell ML, 2010, MODERN PATHOL, V23, P27, DOI 10.1038/modpathol.2009.142	22	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	NOV	2015	14	11					2441	2451		10.1158/1535-7163.MCT-15-0230		11	Oncology	Oncology	CV9FE	WOS:000364592000004		
J	Ye, XS; Fan, L; Van Horn, RD; Nakai, R; Ohta, Y; Akinaga, S; Murakata, C; Yamashita, Y; Yin, TG; Credille, KM; Donoho, GP; Merzoug, FF; Li, H; Aggarwal, A; Blanchard, K; Westin, EH				Ye, Xiang S.; Fan, Li; Van Horn, Robert D.; Nakai, Ryuichiro; Ohta, Yoshihisa; Akinaga, Shiro; Murakata, Chikara; Yamashita, Yoshinori; Yin, Tinggui; Credille, Kelly M.; Donoho, Gregory P.; Merzoug, Farhana F.; Li, Heng; Aggarwal, Amit; Blanchard, Kerry; Westin, Eric H.			A Novel Eg5 Inhibitor (LY2523355) Causes Mitotic Arrest and Apoptosis in Cancer Cells and Shows Potent Antitumor Activity in Xenograft Tumor Models	MOLECULAR CANCER THERAPEUTICS			English	Article							SPINDLE ASSEMBLY CHECKPOINT; SMALL-MOLECULE INHIBITOR; KINESIN EG5; IN-VITRO; CENTROSOME SEPARATION; MOTOR PROTEIN; MICROTUBULES; SLIPPAGE; PHOSPHORYLATION; ACTIVATION	Intervention of cancer cell mitosis by antitubulin drugs is among the most effective cancer chemotherapies. However, antitubulin drugs have dose-limiting side effects due to important functions of microtubules in resting normal cells and are often rendered ineffective by rapid emergence of resistance. Antimitotic agents with different mechanisms of action and improved safety profiles are needed as new treatment options. Mitosis-specific kinesin Eg5 represents an attractive anticancer target for discovering such new antimitotic agents, because Eg5 is essential only in mitotic progression and has no roles in resting, nondividing cells. Here, we show that a novel selective Eg5 inhibitor, LY2523355, has broad target-mediated anticancer activity in vitro and in vivo. LY2523355 arrests cancer cells at mitosis and causes rapid cell death that requires sustained spindle-assembly checkpoint (SAC) activation with a required threshold concentration. In vivo efficacy of LY2523355 is highly dose/schedule-dependent, achieving complete remission in a number of xenograft tumor models, including patient-derived xenograft (PDX) tumor models. We further establish that histone-H3 phosphorylation of tumor and proliferating skin cells is a promising pharmacodynamic biomarker for in vivo anticancer activity of LY2523355. (C) 2015 AACR.	[Ye, Xiang S.; Fan, Li; Van Horn, Robert D.; Yin, Tinggui; Credille, Kelly M.; Donoho, Gregory P.; Merzoug, Farhana F.; Li, Heng; Aggarwal, Amit; Blanchard, Kerry; Westin, Eric H.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Nakai, Ryuichiro; Yamashita, Yoshinori] Kyowa Hakko Kirin Co Ltd, Drug Discovery Res Labs, Shizuoka, Japan; [Ohta, Yoshihisa; Murakata, Chikara] Kyowa Hakko Kirin Co Ltd, Med Chem Res Labs, Shizuoka, Japan; [Akinaga, Shiro] Kyowa Hakko Kirin Co Ltd, Dev Div, Clin Dev Dept 1, Shizuoka, Japan	Ye, XS (reprint author), Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA.	Ye_Xiang_S@lilly.com					Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Nakai R, 2009, CANCER RES, V69, P3901, DOI 10.1158/0008-5472.CAN-08-4373; Castillo A, 2007, CANCER RES, V67, P10138, DOI 10.1158/0008-5472.CAN-07-0326; Liu M, 2008, BIOCHEM PHARMACOL, V76, P169, DOI 10.1016/j.bcp.2008.04.018; Kim AJ, 2000, J CELL SCI, V113, P3681; Van Horn RD, 2010, J BIOL CHEM, V285, P21849, DOI 10.1074/jbc.M110.141010; Huszar D, 2009, CANCER METAST REV, V28, P197, DOI 10.1007/s10555-009-9185-8; Brito DA, 2008, J CELL BIOL, V182, P623, DOI 10.1083/jcb.200805072; Yan YW, 2004, J MOL BIOL, V335, P547, DOI 10.1016/j.jmb.2003.10.074; Kashina AS, 1997, BBA-MOL CELL RES, V1357, P257, DOI 10.1016/S0167-4889(97)00037-2; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Sakowicz R, 2004, CANCER RES, V64, P3276, DOI 10.1158/0008-5472.CAN-03-3839; Riffell JL, 2009, CELL CYCLE, V8, P3025; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; SAWIN KE, 1995, P NATL ACAD SCI USA, V92, P4289, DOI 10.1073/pnas.92.10.4289; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Lestini BJ, 2009, CANCER BIOL THER, V8, P1587, DOI 10.4161/cbt.8.16.8964; Liu M, 2010, J PATHOL, V221, P221, DOI 10.1002/path.2706; Tunquist BJ, 2010, MOL CANCER THER, V9, P2046, DOI 10.1158/1535-7163.MCT-10-0033; Jackson JR, 2007, NAT REV CANCER, V7, P107, DOI 10.1038/nrc2049; Marcus AI, 2005, J BIOL CHEM, V280, P11569, DOI 10.1074/jbc.M413471200; Blangy A, 1995, CELL, V83, P1159; Tao WK, 2005, CANCER CELL, V8, P49, DOI 10.1016/j.ccr.2005.06.003; Orr GA, 2003, ONCOGENE, V22, P7280, DOI 10.1038/sj.onc.1206934; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Tanenbaum ME, 2010, DEV CELL, V19, P797, DOI 10.1016/j.devcel.2010.11.011; Uzbekov R, 1999, MICROSC RES TECHNIQ, V45, P31, DOI 10.1002/(SICI)1097-0029(19990401)45:1<31::AID-JEMT3>3.0.CO;2-K; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Fiebig HH, 2004, EUR J CANCER, V40, P802, DOI 10.1016/j.ejca.2004.01.009; Bekier ME, 2009, MOL CANCER THER, V8, P1646, DOI 10.1158/1535-7163.MCT-08-1084; Rudolph D, 2009, CLIN CANCER RES, V15, P3094, DOI 10.1158/1078-0432.CCR-08-2445; Dagenbach EM, 2004, J CELL SCI, V117, P3, DOI 10.1242/jcs.00875; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Terrano DT, 2010, MOL CELL BIOL, V30, P640, DOI 10.1128/MCB.00882-09; Dalton WB, 2009, FUTURE ONCOL, V5, P1363, DOI [10.2217/fon.09.118, 10.2217/FON.09.118]; Cahu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003936; Gil T, 2010, J CLIN ONCOL S, V28, p15s; Lobert S, 1997, Crit Care Nurse, V17, P71	43	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	NOV	2015	14	11					2463	2472		10.1158/1535-7163.MCT-15-0241		10	Oncology	Oncology	CV9FE	WOS:000364592000006		
J	Smith, AM; Harrison, JS; Grube, CD; Sheppe, AEF; Sahara, N; Ishii, R; Nureki, O; Roy, H				Smith, Angela M.; Harrison, Jesse S.; Grube, Christopher D.; Sheppe, Austin E. F.; Sahara, Nahoko; Ishii, Ryohei; Nureki, Osamu; Roy, Herve			tRNA-dependent alanylation of diacylglycerol and phosphatidylglycerol in Corynebacterium glutamicum	MOLECULAR MICROBIOLOGY			English	Article							ANTIMICROBIAL PEPTIDE RESISTANCE; STAPHYLOCOCCUS-AUREUS; LYSYL-PHOSPHATIDYLGLYCEROL; PSEUDOMONAS-AERUGINOSA; LISTERIA-MONOCYTOGENES; ANTIBIOTIC-RESISTANCE; LIPID HOMEOSTASIS; IONIC PROPERTIES; MEMBRANE-LIPIDS; PHOSPHOLIPIDS	Aminoacyl-phosphatidylglycerol synthases (aaPGSs) are membrane proteins that utilize aminoacylated tRNAs to modify membrane lipids with amino acids. Aminoacylation of membrane lipids alters the biochemical properties of the cytoplasmic membrane and enables bacteria to adapt to changes in environmental conditions. aaPGSs utilize alanine, lysine and arginine as modifying amino acids, and the primary lipid recipients have heretofore been defined as phosphatidylglycerol (PG) and cardiolipin. Here we identify a new pathway for lipid aminoacylation, conserved in many Actinobacteria, which results in formation of Ala-PG and a novel alanylated lipid, Alanyl-diacylglycerol (Ala-DAG). Ala-DAG formation in Corynebacterium glutamicum is dependent on the activity of an aaPGS homolog, whereas formation of Ala-PG requires the same enzyme acting in concert with a putative esterase encoded upstream. The presence of alanylated lipids is sufficient to enhance the bacterial fitness of C.glutamicum cultured in the presence of certain antimicrobial agents, and elucidation of this system expands the known repertoire of membrane lipids acting as substrates for amino acid modification in bacterial cells.	[Smith, Angela M.; Harrison, Jesse S.; Grube, Christopher D.; Sheppe, Austin E. F.; Roy, Herve] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32826 USA; [Sahara, Nahoko; Ishii, Ryohei; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; [Sahara, Nahoko; Ishii, Ryohei; Nureki, Osamu] RIKEN, Adv Sci Inst, Wako, Saitama 3510198, Japan	Roy, H (reprint author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32826 USA.	herve.roy@ucf.edu			National Institute of General Medical Sciences [109404]; CRIF from National Science Foundation [0541761]	This work was supported by National Institute of General Medical Sciences Grant 109404. Mass spectrometry analyses were performed by the University of Florida Department of Chemistry Mass Spectrometry Services (Gainesville, FL) and supported by CRIF grant 0541761 from the National Science Foundation.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; HAEST CWM, 1972, BIOCHIM BIOPHYS ACTA, V255, P720, DOI 10.1016/0005-2736(72)90385-9; Kahm M, 2010, J STAT SOFTW, V33, P1; Samant S, 2009, J BACTERIOL, V191, P1311, DOI 10.1128/JB.01345-08; Komatsuzawa H, 2001, FEMS MICROBIOL LETT, V203, P49, DOI 10.1111/j.1574-6968.2001.tb10819.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; TOCANNE JF, 1974, CHEM PHYS LIPIDS, V12, P201, DOI 10.1016/0009-3084(74)90075-9; Arendt W, 2012, J BACTERIOL, V194, P1401, DOI 10.1128/JB.06576-11; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Roy H, 2008, METHODS, V44, P164, DOI 10.1016/j.ymeth.2007.09.002; Lausberg F, 2012, PLASMID, V68, P142, DOI 10.1016/j.plasmid.2012.05.001; FOLCH J, 1957, J BIOL CHEM, V226, P497; DITTMER JC, 1964, J LIPID RES, V5, P126; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Ernst CM, 2011, MOL MICROBIOL, V80, P290, DOI 10.1111/j.1365-2958.2011.07576.x; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; SACRE MM, 1977, CHEM PHYS LIPIDS, V20, P305, DOI 10.1016/0009-3084(77)90071-8; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Klein S, 2009, MOL MICROBIOL, V71, P551, DOI 10.1111/j.1365-2958.2008.06562.x; Roy H, 2009, J BIOL CHEM, V284, P29677, DOI 10.1074/jbc.M109.046367; Slavetinsky CJ, 2012, ANTIMICROB AGENTS CH, V56, P3492, DOI 10.1128/AAC.00370-12; Roy H, 2008, P NATL ACAD SCI USA, V105, P4667, DOI 10.1073/pnas.0800006105; Thedieck K, 2006, MOL MICROBIOL, V62, P1325, DOI 10.1111/j.1365-2958.2006.05452.x; Garg RP, 2008, P NATL ACAD SCI USA, V105, P6543, DOI 10.1073/pnas.0708957105; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Roy H, 2009, IUBMB LIFE, V61, P940, DOI 10.1002/iub.240; Hachmann AB, 2009, ANTIMICROB AGENTS CH, V53, P1598, DOI 10.1128/AAC.01329-08; Dare K, 2014, VIRULENCE, V5, P534, DOI 10.4161/viru.28359; Sohlenkamp C, 2007, MOL PLANT MICROBE IN, V20, P1421, DOI 10.1094/MPMI-20-11-1421; Jiang Y, 2011, CHEMBIOCHEM, V12, P768, DOI 10.1002/cbic.201000693; Zavaleta-Pastor M, 2010, P NATL ACAD SCI USA, V107, P302, DOI 10.1073/pnas.0912930107; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Walkiewicz K, 2012, P NATL ACAD SCI USA, V109, P21408, DOI 10.1073/pnas.1209335110; Smith AM, 2013, J BIOL CHEM, V288, P22768, DOI 10.1074/jbc.M113.484402; Arendt W, 2013, J BIOL CHEM, V288, P24717, DOI 10.1074/jbc.M113.482935; Lopez-Lara IM, 2003, MOL PLANT MICROBE IN, V16, P567, DOI 10.1094/MPMI.2003.16.7.567; FINKELSTEIN A, 1976, J GEN PHYSIOL, V68, P127, DOI 10.1085/jgp.68.2.127; Ernst CM, 2015, MBIO, V6, DOI 10.1128/mBio.02340-14; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; RUBIN HE, 1982, J DAIRY SCI, V65, P197; Christie W.W., 2010, LIPID ANAL ISOLATION; Crellin P. K., 2013, LIPID METABOLISM, V6, P119; Ernst CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000660; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Maloney E, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00019; Maloney E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000534; Ming L., 2010, BIOINF BIOM ENG ICEB, P1	49	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0950-382X	1365-2958		MOL MICROBIOL	Mol. Microbiol.	NOV	2015	98	4					681	693		10.1111/mmi.13150		13	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	CV8KP	WOS:000364534200007		
J	Nishiyama, K; Nakazato, A; Ueno, S; Seto, Y; Kakuda, T; Takai, S; Yamamoto, Y; Mukai, T				Nishiyama, Keita; Nakazato, Akiko; Ueno, Shintaro; Seto, Yasuyuki; Kakuda, Tsutomu; Takai, Shinji; Yamamoto, Yuji; Mukai, Takao			Cell surface-associated aggregation-promoting factor from Lactobacillus gasseriSBT2055 facilitates host colonization and competitive exclusion of Campylobacter jejuni	MOLECULAR MICROBIOLOGY			English	Article							LACTOBACILLUS-GASSERI SBT2055; EXTRACELLULAR-MATRIX COMPONENTS; FIBRONECTIN-BINDING PROTEINS; ESCHERICHIA-COLI O157-H7; EPITHELIAL-CELLS; INTEGRIN BETA1; ADIPOCYTE SIZE; HIGH-FREQUENCY; CRISPATUS; ADHERENCE	Campylobacter jejuni, one of the most common causes of gastroenteritis worldwide, is transmitted to humans through poultry. We previously reported that Lactobacillus gasseriSBT2055 (LG2055) reduced C. jejuni infection in human epithelial cells in vitro and inhibited pathogen colonization of chickens in vivo. This suggested that the LG2055 adhesion and/or co-aggregation phenotype mediated by cell-surface aggregation-promoting factors (APFs) may be important for the competitive exclusion of C. jejuni. Here, we show that cell surface-associated APF1 promoted LG2055 self-aggregation and adhesion to human epithelial cells and exhibited high affinity for the extracellular matrix component fibronectin. These effects were absent in the apf1 knockout mutant, indicating the role of APF1 in LG2055-mediated inhibition of C. jejuni in epithelial cells and chicken colonization. Similar to APF1, APF2 promoted the co-aggregation of LG2055 and C. jejuni but did not inhibit C. jejuni infection. Our data suggest a pivotal role for APF1 in mediating the interaction of LG2055 with human intestinal cells and in inhibiting C. jejuni colonization of the gastrointestinal tract. We thus provide new insight into the health-promoting effects of probiotics and mechanisms of competitive exclusion in poultry. Further research is needed to determine whether the probiotic strains reach the epithelial surface.	[Nishiyama, Keita; Nakazato, Akiko; Ueno, Shintaro; Yamamoto, Yuji; Mukai, Takao] Kitasato Univ, Sch Vet Med, Dept Anim Sci, Towada, Aomori 0348628, Japan; [Seto, Yasuyuki] Megmilk Snow Brand Co Ltd, Milk Sci Res Inst, Kawagoe, Saitama 3501165, Japan; [Kakuda, Tsutomu; Takai, Shinji] Kitasato Univ, Sch Vet Med, Fac Vet Med, Towada, Aomori 0348628, Japan	Mukai, T (reprint author), Kitasato Univ, Sch Vet Med, Dept Anim Sci, Towada, Aomori 0348628, Japan.	mukai@vmas.kitasato-u.ac.jp			Japan Society for the Promotion of Science [19580315, 21580334, 20229917]; Megmilk Snow Brand Co., Ltd.	We thank Aya Takamine, Ayuha Niwano, Ryo Ito and Yuki Motomura (Kitasato University) for technical assistance with the chicken colonization assay. This work was supported in part by a Grant-in-Aid for Scientific Research C (19580315; 21580334; 20229917) from the Japan Society for the Promotion of Science. This work was also funded by Megmilk Snow Brand Co., Ltd.	Dasti JI, 2010, INT J MED MICROBIOL, V300, P205, DOI 10.1016/j.ijmm.2009.07.002; Harper S, 2011, METHODS MOL BIOL, V681, P259, DOI 10.1007/978-1-60761-913-0_14; Callaway T. R., 2008, Animal Health Research Reviews, V9, P217, DOI 10.1017/S1466252308001540; Fujiwara S, 2001, J APPL MICROBIOL, V90, P343, DOI 10.1046/j.1365-2672.2001.01251.x; Matsui H, 2015, HELICOBACTER, V20, P291, DOI 10.1111/hel.12203; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; Bergonzelli GE, 2006, INFECT IMMUN, V74, P425, DOI 10.1128/IAI.74.1.425-434.2006; Collado MC, 2007, FOOD RES INT, V40, P629, DOI 10.1016/j.foodres.2006.11.007; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micnif.2006.03.011; KUUSELA P, 1989, BIOCHIM BIOPHYS ACTA, V993, P297, DOI 10.1016/0304-4165(89)90180-3; BISWAS I, 1993, J BACTERIOL, V175, P3628; Zhang GD, 2007, J FOOD PROTECT, V70, P867; Preidis GA, 2011, GASTROENTEROLOGY, V140, P8, DOI 10.1053/j.gastro.2010.11.010; Alemka A, 2010, INFECT IMMUN, V78, P2812, DOI 10.1128/IAI.01249-09; Spurbeck RR, 2010, INFECT IMMUN, V78, P3103, DOI 10.1128/IAI.01200-09; Schar-Zammaretti P, 2005, APPL ENVIRON MICROB, V71, P8165, DOI 10.1128/AEM.71.12.8165-8173.2005; Allos BM, 2001, CLIN INFECT DIS, V32, P1201; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Schachtsiek M, 2004, APPL ENVIRON MICROB, V70, P7078, DOI 10.1128/AEM.70.12.7078-7085.2004; Wine E, 2009, FEMS MICROBIOL LETT, V300, P146, DOI 10.1111/j.1574-6968.2009.01781.x; Marcotte H, 2004, J APPL MICROBIOL, V97, P749, DOI 10.1111/j.1365-2672.2004.02364.x; Friedman CR, 2004, CLIN INFECT DIS, V38, pS285, DOI 10.1086/381598; WEI MQ, 1995, J MICROBIOL METH, V21, P97, DOI 10.1016/0167-7012(94)00038-9; Kainulainen V, 2012, J BACTERIOL, V194, P2509, DOI 10.1128/JB.06704-11; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Jankovic I, 2003, J BACTERIOL, V185, P3288, DOI 10.1128/JB.185.11.3288.3296.2003; Monteville MR, 2003, MICROBIOL-SGM, V149, P153, DOI 10.1099/mic.0.25820-0; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Hevia A, 2013, APPL ENVIRON MICROB, V79, P6059, DOI 10.1128/AEM.01657-13; Chagnot C, 2012, CELL MICROBIOL, V14, P1687, DOI 10.1111/cmi.12002; Ziprin RL, 1999, AVIAN DIS, V43, P586, DOI 10.2307/1592660; Boonaert CJP, 2000, APPL ENVIRON MICROB, V66, P2548, DOI 10.1128/AEM.66.6.2548-2554.2000; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Morishita TY, 1997, AVIAN DIS, V41, P850, DOI 10.2307/1592338; RENIERO R, 1992, J GEN MICROBIOL, V138, P763; KMET V, 1995, LETT APPL MICROBIOL, V21, P351, DOI 10.1111/j.1472-765X.1995.tb01079.x; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119; Goh YJ, 2010, APPL ENVIRON MICROB, V76, P5005, DOI 10.1128/AEM.00030-10; Stern NJ, 2006, ANTIMICROB AGENTS CH, V50, P3111, DOI 10.1128/AAC.00259-06; Eucker TP, 2012, CELL MICROBIOL, V14, P226, DOI 10.1111/j.1462-5822.2011.01714.x; Sato M, 2008, BRIT J NUTR, V99, P1013, DOI 10.1017/S0007114507839006; SIMON D, 1988, BIOCHIMIE, V70, P559, DOI 10.1016/0300-9084(88)90093-4; Chen XY, 2007, INT J FOOD MICROBIOL, V115, P307, DOI 10.1016/j.ijfoodmicro.2006.11.007; Miyoshi M, 2014, EUR J NUTR, V53, P599, DOI 10.1007/s00394-013-0568-9; Svetoch EA, 2011, APPL ENVIRON MICROB, V77, P2749, DOI 10.1128/AEM.02481-10; Turner MS, 2004, APPL ENVIRON MICROB, V70, P3673, DOI 10.1128/aem.70.6.3673-3680.2004; Hamad EM, 2009, BRIT J NUTR, V101, P716, DOI 10.1017/S0007114508043808; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; Konkel ME, 2010, J BACTERIOL, V192, P68, DOI 10.1128/JB.00969-09; Antikainen J, 2002, MOL MICROBIOL, V46, P381, DOI 10.1046/j.1365-2958.2002.03180.x; Thorns CJ, 2000, REV SCI TECH OIE, V19, P226; BREITWIESER A, 1992, J BACTERIOL, V174, P8008; NURMI E, 1973, NATURE, V241, P210, DOI 10.1038/241210a0; Johnson-Henry KC, 2007, CELL MICROBIOL, V9, P356, DOI 10.1111/j.1462-5822.2006.00791.x; Robinson CJ, 2010, MICROBIOL MOL BIOL R, V74, P453, DOI 10.1128/MMBR.00014-10; Ventura M, 2002, APPL ENVIRON MICROB, V68, P6172, DOI 10.1128/AEM.68.12.6172-6181.2002; Cesena C, 2001, J DAIRY SCI, V84, P1001; Boehm M, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00017; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Collado MC, 2007, EUR FOOD RES TECHNOL, V226, P1065; Day CJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00009; desLeeuw E., 2006, FEMS MICROBIOL LETT, V260, P210; European Food Safety Authority (EFSA), 2014, COMM ENS EUR FOOD IS; Frese SA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004057; Krause-Gruszczynska M, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-32; Miljkovic M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126387; Nakayama Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04638; Neal-McKinney JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043928; Nishiyama K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108827; Nishiyama K., 2014, BIOSCI BIOTECH BIOCH, V29, P1; Croinin TO, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00025; Schroder W, 1997, FEMS MICROBIOL LETT, V150, P141, DOI 10.1016/S0378-1097(97)00111-0; Willis W. L., 2005, POULTRY SCI, V87, P606	73	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0950-382X	1365-2958		MOL MICROBIOL	Mol. Microbiol.	NOV	2015	98	4					712	726		10.1111/mmi.13153		15	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	CV8KP	WOS:000364534200009		
J	Tomioka, K; Izhizaka, F; Fukui, T				Tomioka, Katsuhiro; Izhizaka, Fumiya; Fukui, Takashi			Selective-Area Growth of InAs Nanowires on Ge and Vertical Transistor Application	NANO LETTERS			English	Article						III-V; nanowire; heteroepitaxy; transistor; selective-area epitaxy; nanowires; transistors; heterogeneous integration	FIELD-EFFECT TRANSISTORS; SURFACE	III-V compound semiconductor and Ge are promising channel materials for future low-power and high-performance integrated circuits. A heterogeneous integration of these materials on the same platform, however, raises serious problem owing to a huge mismatch of carrier mobility. We proposed direct integration of perfectly vertically aligned InAs nanowires on Ge as a method for new alternative integrated circuits and demonstrated a high-performance InAs nanowire-vertical surrounding-gate transistor Virtually 100% yield of vertically aligned InAs nanowires was achieved by controlling the initial surface of Ge and high-quality InAs nanowires were obtained regardless of lattice mismatch (6.7%). The transistor performance showed significantly higher conductivity with good gate control compared to Si-based conventional field-effect transistors: the drain current was 0.65 mA/mu m, and the transconductance was 2.2 mS/mu m at drain-source voltage of 0.50 V. These demonstrations are a first step for building alternative integrated circuits using vertical III-V/multigate planar Ge FETs.	[Tomioka, Katsuhiro; Izhizaka, Fumiya; Fukui, Takashi] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 0600814, Japan; [Tomioka, Katsuhiro; Izhizaka, Fumiya; Fukui, Takashi] Hokkaido Univ, Res Ctr Integrated Quantum Elect, Sapporo, Hokkaido 0608628, Japan; [Tomioka, Katsuhiro] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Tomioka, K (reprint author), Hokkaido Univ, Grad Sch Informat Sci & Technol, North 14 West 9, Sapporo, Hokkaido 0600814, Japan.	tomioka@rciqe.hokudai.ac.jp	Fukui, Takashi/A-5261-2012		MEXT; Japan Science and Technology Agency (JST)-PRESTO program	The authors would like to thank Prof. Dr. Tamotsu Hashizume, Prof. Dr. Junichi Motohisa, Dr. Masatoshi Yoshimura, and Dr. Eiji Nakai for their fruitful discussions. This work was financially supported by a Grant-in-Aid for Scientific Research from the MEXT and Japan Science and Technology Agency (JST)-PRESTO program.	SNIDER GL, 1990, J APPL PHYS, V68, P2849, DOI 10.1063/1.346443; Ionescu AM, 2011, NATURE, V479, P329, DOI 10.1038/nature10679; Ferain I, 2011, NATURE, V479, P310, DOI 10.1038/nature10676; Tomioka K, 2013, NANO LETT, V13, P5822, DOI 10.1021/nl402447h; Duke CB, 1996, CHEM REV, V96, P1237, DOI 10.1021/cr950212s; Tomioka K, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4865921; del Alamo JA, 2011, NATURE, V479, P317, DOI 10.1038/nature10677; Seabaugh AC, 2010, P IEEE, V98, P2095, DOI 10.1109/JPROC.2010.2070470; ANDERSON RL, 1962, SOLID STATE ELECTRON, V5, P341, DOI 10.1016/0038-1101(62)90115-6; Gu JJJ, 2013, IEEE ELECTR DEVICE L, V34, P608, DOI 10.1109/LED.2013.2248114; Galindo PL, 2007, ULTRAMICROSCOPY, V107, P1186, DOI 10.1016/j.ultramic.2007.01.019; Kim S, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.014201; BRINGANS RD, 1985, PHYS REV LETT, V55, P533, DOI 10.1103/PhysRevLett.55.533; Tomioka K, 2007, J CRYST GROWTH, V298, P644, DOI 10.1016/j.jcrysgro.2006.10.183; Riel H, 2014, MRS BULL, V39, P668, DOI 10.1557/mrs.2014.137; Bakkers EPAM, 2004, NAT MATER, V3, P769, DOI 10.1038/nmat1235; Tomioka K, 2012, NATURE, V488, P189, DOI 10.1038/nature11293; Gu J. J., 2011, IEDM, P769; Hudait MK, 2014, SCI REP-UK, V4, DOI 10.1038/srep06964; Lind E, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3449559; Motohisa J, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.11PE07; Nishimura T, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.051301; Peng J. W., 2009, IEDM, P931; Radosavljevic M, 2011, IEDM, P765; van Dal M. J. H., 2012, IEDM, P521	25	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	NOV	2015	15	11					7253	7257		10.1021/acs.nanolett.5b02165		5	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CW1BU	WOS:000364725400013		
J	Ishikawa, F; Akamatsu, Y; Watanabe, K; Uesugi, F; Asahina, S; Jahn, U; Shimomura, S				Ishikawa, Fumitaro; Akamatsu, Yoshihiko; Watanabe, Kentaro; Uesugi, Fumihiko; Asahina, Shunsuke; Jahn, Uwe; Shimomura, Satoshi			Metamorphic GaAs/GaAsBi Heterostructured Nanowires	NANO LETTERS			English	Article						Semiconductor nanowires; GaAsBi; GaAs; roughening; luminescence	MOLECULAR-BEAM EPITAXY; CORE-SHELL NANOWIRES; GAAS NANOWIRES; BULK GAASBI; BAND-GAP; GROWTH; ALLOY; SILICON; PHOTOLUMINESCENCE; ELECTRONICS	GaAs/GaAsBi coaxial multishell nanowires were grown by molecular beam epitaxy. Introducing Bi results in a characteristic nanowire surface morphology with strong roughening. Elemental mappings clearly show the formation of the GaAsBi shell with inhomogeneous Bi distributions within the layer surrounded by the outermost GaAs, having a strong structural disorder at the wire surface. The nanowire exhibits a predominantly ZB structure from the bottom to the middle part. The polytipic WZ structure creates denser twin defects in the upper part than in the bottom and middle parts of the nanowire. We observe room temperature cathodoluminescence from the GaAsBi nanowires with a broad spectral line shape between 1.1 and 1.5 eV, accompanied by multiple peaks. A distinct energy peak at 1.24 eV agrees well with the energy of the reduced GaAsBi alloy band gap by the introduction of 2% Bi. The existence of localized states energetically and spatially dispersed throughout the NW are indicated from the low temperature cathodoluminescence spectra and images, resulting in the observed luminescence spectra characterized by large line widths at low temperatures as well as by the appearance of multiple peaks at high temperatures and for high excitation powers.	[Ishikawa, Fumitaro; Akamatsu, Yoshihiko; Shimomura, Satoshi] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Watanabe, Kentaro] Natl Inst Mat Sci, WPI Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan; [Uesugi, Fumihiko] Natl Inst Mat Sci, Transmiss Elect Microscopy Stn, Tsukuba, Ibaraki 3050044, Japan; [Asahina, Shunsuke] JEOL Ltd, SM Business Unit, Akishima, Tokyo 1968558, Japan; [Jahn, Uwe] Paul Drude Inst Festkorperelekt, D-10117 Berlin, Germany	Ishikawa, F (reprint author), Ehime Univ, Grad Sch Sci & Engn, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	ishikawa@ee.ehime-u.ac.jp	Watanabe, Kentaro/M-4936-2013	Watanabe, Kentaro/0000-0002-9104-7458	Kato Foundation for the Promotion of Science; Murata Science Foundation	The authors greatly acknowledge TEM/EDS study by Y. Nakayama and M. Takeguchi of the National Institute for Materials Science under the Nanotechnology Platform Project operated by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. This work was partly supported by Kato Foundation for the Promotion of Science and Murata Science Foundation.	Ahn N, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.065001; Gudiksen MS, 2002, NATURE, V415, P617, DOI 10.1038/415617a; Kolmakov A, 2004, ANNU REV MATER RES, V34, P151, DOI 10.1146/annurev.matsci.34.040203.112141; Yao J, 2013, NAT NANOTECHNOL, V8, P329, DOI [10.1038/nnano.2013.55, 10.1038/NNANO.2013.55]; Colby R, 2010, NANO LETT, V10, P1568, DOI 10.1021/nl9037455; Imhof S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3374884; Alekseev PA, 2015, NANO LETT, V15, P63, DOI 10.1021/nl502909k; Thelander C, 2006, MATER TODAY, V9, P28, DOI 10.1016/S1369-7021(06)71651-0; Xia XH, 2012, ACS NANO, V6, P5531, DOI 10.1021/nn301454q; Moussa I, 2008, THIN SOLID FILMS, V516, P8372, DOI 10.1016/j.tsf.2008.04.062; Lu XF, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3191675; Yang PD, 2010, NANO LETT, V10, P1529, DOI 10.1021/nl100665r; Paek JH, 2009, PHYS STATUS SOLIDI C, V6, P1436, DOI 10.1002/pssc.200881520; Joyce HJ, 2007, NANO LETT, V7, P921, DOI 10.1021/nl062755v; Tomioka K, 2008, NANO LETT, V8, P3475, DOI 10.1021/nl802398j; Ertekin E, 2005, J APPL PHYS, V97, DOI 10.1063/1.1903106; Takehara Y, 2006, JPN J APPL PHYS 1, V45, P67, DOI 10.1143/JJAP.45.67; Mazur YI, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/6/065306; Dillen DC, 2014, NAT NANOTECHNOL, V9, P116, DOI [10.1038/nnano.2013.301, 10.1038/NNANO.2013.301]; Watanabe K, 2015, ACS NANO, V9, P2989, DOI 10.1021/nn507159u; Bastiman F, 2012, J CRYST GROWTH, V338, P57, DOI 10.1016/j.jcrysgro.2011.07.036; Ozel T, 2013, ADV MATER, V25, P4515, DOI 10.1002/adma.201301367; Kishino K, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/22/225602; Joyce HJ, 2008, ADV FUNCT MATER, V18, P3794, DOI 10.1002/adfm.200800625; Chen R, 2011, NAT PHOTONICS, V5, P170, DOI [10.1038/nphoton.2010.315, 10.1038/NPHOTON.2010.315]; Dimakis E, 2014, NANO LETT, V14, P2604, DOI 10.1021/nl500428v; Pacebutas V, 2012, THIN SOLID FILMS, V520, P6415, DOI 10.1016/j.tsf.2012.06.047; Shakfa MK, 2013, PHYS STATUS SOLIDI C, V10, P1234, DOI 10.1002/pssc.201200738; Somaschini C, 2013, NANO LETT, V13, P3607, DOI 10.1021/nl401404w; LEAMY HJ, 1982, J APPL PHYS, V53, pR51, DOI 10.1063/1.331667; Ptak AJ, 2012, J CRYST GROWTH, V338, P107, DOI 10.1016/j.jcrysgro.2011.10.040; Mieszawska AJ, 2007, SMALL, V3, P722, DOI 10.1002/smll.2006007; Vardar G, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4789369; Martensson T, 2004, NANO LETT, V4, P1987, DOI 10.1021/nl0487267; KANAYA K, 1972, J PHYS D APPL PHYS, V5, P43, DOI 10.1088/0022-3727/5/1/308; Czaban JA, 2009, NANO LETT, V9, P148, DOI 10.1021/nl802700u; SNYDER CW, 1991, PHYS REV LETT, V66, P3032, DOI 10.1103/PhysRevLett.66.3032; Gomathi A, 2005, ADV MATER, V17, P2757, DOI 10.1002/adma.200500539; Francoeur S, 2003, APPL PHYS LETT, V82, P3874, DOI 10.1063/1.1581983; Demichel O, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3519980; Hersee SD, 2006, NANO LETT, V6, P1808, DOI 10.1021/nl060553t; Fluegel B, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.067205; Cullis AG, 1996, J CRYST GROWTH, V158, P15, DOI 10.1016/0022-0248(95)00430-0; Hibi H, 2014, NANO LETT, V14, P7024, DOI 10.1021/nl503385g; Zhuang XJ, 2012, ADV MATER, V24, P13, DOI 10.1002/adma.201103191; Tixier S, 2003, APPL PHYS LETT, V82, P2245, DOI 10.1063/1.1565499; Uesugi F, 2013, ULTRAMICROSCOPY, V135, P80, DOI 10.1016/j.ultramic.2013.07.003; Breuer S, 2011, NANO LETT, V11, P1276, DOI 10.1021/nl104316t; Fitouri H, 2007, J CRYST GROWTH, V300, P347, DOI 10.1016/j.jcrysgro.2006.12.033; Tomioka K, 2012, NATURE, V488, P189, DOI 10.1038/nature11293; Araki Y., 2013, NANOTECHNOLOGY, V24; Bahrami-Yekta V, 2015, SEMICOND SCI TECH, V30, DOI 10.1088/0268-1242/30/9/094007; Brillson LJ, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/18/183001; Broderick CA, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.195301; Cirlin G. E., 2010, PHYS REV B, V82; Jahn U, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.045323; Kudrawiec R, 2014, J APPL PHYS, V116, DOI 10.1063/1.4904740; Luna E, 2015, J APPL PHYS, V117, DOI 10.1063/1.4919896; Mazur YI, 2013, J APPL PHYS, V113, DOI 10.1063/1.4801429; Mazzucato S, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4812660; Mazzucato S, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-19; Plante MC, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/49/495603; Plissard S, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/38/385602; Pursley B, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4781415; Puustinen J, 2013, J APPL PHYS, V114, DOI 10.1063/1.4851036; Sarcan F, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-119; Viturro R. E., 1988, J VAC SCI TECHNOL B, V6, P1397; Warren MV, 2015, J APPL PHYS, V117, DOI 10.1063/1.4906992; Wu MJ, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/20/205605; Yoshimoto M, 2003, JPN J APPL PHYS 2, V42, pL1235, DOI 10.1143/JJAP.42.L1235	70	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	NOV	2015	15	11					7265	7272		10.1021/acs.nanolett.5b02316		8	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CW1BU	WOS:000364725400015		
J	Chandni, U; Watanabe, K; Taniguchi, T; Eisenstein, JP				Chandni, U.; Watanabe, K.; Taniguchi, T.; Eisenstein, J. P.			Evidence for Defect-Mediated Tunneling in Hexagonal Boron Nitride-Based Junctions	NANO LETTERS			English	Article						Tunneling; hexagonal boron nitride (hBN); hBN defects; graphite; coulomb blockade; annealing	2-DIMENSIONAL ELECTRON-SYSTEMS; ATOMIC DEFECTS; HETEROSTRUCTURES; MONOLAYER; FIELD	We investigate electron tunneling through atomically thin layers of hexagonal boron nitride (hBN). Metal (Cr/Au) and semimetal (graphite) counter-electrodes are employed. While the direct tunneling resistance increases nearly exponentially with barrier thickness as expected, the thicker junctions also exhibit clear signatures of Coulomb blockade, including strong suppression of the tunnel current around zero bias and step-like features in the current at larger biases. The voltage separation of these steps suggests that single-electron charging of nanometer-scale defects in the hBN barrier layer are responsible for these signatures. We find that annealing the metal-hBN-metal junctions removes these defects and the Coulomb blockade signatures in the tunneling current.	[Chandni, U.; Eisenstein, J. P.] CALTECH, Dept Phys, Inst Quantum Informat & Matter, Pasadena, CA 91125 USA; [Watanabe, K.; Taniguchi, T.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan	Chandni, U (reprint author), CALTECH, Dept Phys, Inst Quantum Informat & Matter, 1200 East Calif Blvd, Pasadena, CA 91125 USA.	chandniu@caltech.edu			Institute for Quantum Information and Matter, an NSF Physics Frontiers Center; Gordon and Betty Moore Foundation [GBMF1250]	We thank J. Petta, J. Velasco Jr., and D. Wong for useful discussions. Special thanks to G. Rossman for the use of his Raman spectroscopy facility. Atomic force microscopy was done at the Molecular Materials Research Center of the Beckman Institute at the California Institute of Technology. This work was supported by the Institute for Quantum Information and Matter, an NSF Physics Frontiers Center with support of the Gordon and Betty Moore Foundation through Grant No. GBMF1250.	Alem N, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.126102; EISENSTEIN JP, 1991, APPL PHYS LETT, V58, P1497, DOI 10.1063/1.105157; Cretu O, 2014, NANO LETT, V14, P1064, DOI 10.1021/nl404735w; HANNA AE, 1991, PHYS REV B, V44, P5919, DOI 10.1103/PhysRevB.44.5919; Wang J, 2015, J PHYS CHEM A, V119, P3621, DOI 10.1021/acs.jpca.5b01308; EISENSTEIN JP, 1992, PHYS REV LETT, V69, P3804, DOI 10.1103/PhysRevLett.69.3804; Zobelli A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.094104; XU YN, 1991, PHYS REV B, V44, P7787, DOI 10.1103/PhysRevB.44.7787; Watanabe K, 2004, NAT MATER, V3, P404, DOI 10.1038/nmat1134; Gibb AL, 2013, J AM CHEM SOC, V135, P6758, DOI 10.1021/ja400637n; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Jin CH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.195505; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; SIMMONS JG, 1963, J APPL PHYS, V34, P1793, DOI 10.1063/1.1702682; Fallahazad B, 2015, NANO LETT, V15, P428, DOI 10.1021/nl503756y; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Britnell L, 2012, NANO LETT, V12, P1707, DOI 10.1021/nl3002205; Rasool HI, 2015, ADV MATER, V27, P5771, DOI 10.1002/adma.201500231; Taniguchi T, 2007, J CRYST GROWTH, V303, P525, DOI 10.1016/j.jcrysgro.2006.12.061; BROWN KM, 1994, PHYS REV B, V50, P15465, DOI 10.1103/PhysRevB.50.15465; Averin D. V., 1991, MESOSCOPIC PHENOMENA, P169; Britnell L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2817; Ju L, 2014, Nat Nanotechnol, V9, P348, DOI 10.1038/nnano.2014.60; Kouwenhoven L. P., 1997, P NATO ADV STUD I ME, P105; Lee GH, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3662043; Mishchenko A, 2014, NAT NANOTECHNOL, V9, P808, DOI [10.1038/nnano.2014.187, 10.1038/NNANO.2014.187]; Smoliner J, 1996, SEMICOND SCI TECH, V11, P1, DOI 10.1088/0268-1242/11/1/005; Wong D., 2014, ARXIV14121878	28	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	NOV	2015	15	11					7329	7333		10.1021/acs.nanolett.5b02625		5	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CW1BU	WOS:000364725400024		
J	Lin, YC; Teng, PY; Yeh, CH; Koshino, M; Chiu, PW; Suenaga, K				Lin, Yung-Chang; Teng, Po-Yuan; Yeh, Chao-Hui; Koshino, Masanori; Chiu, Po-Wen; Suenaga, Kazu			Structural and Chemical Dynamics of Pyridinic-Nitrogen Defects in Graphene	NANO LETTERS			English	Article						graphene; pyridinic-nitrogen; graphitic-nitrogen; EELS; chemical dynamics	OXYGEN REDUCTION REACTION; ENERGY-LOSS SPECTROSCOPY; WALLED CARBON NANOTUBES; DOPED GRAPHENE; ELECTRON-MICROSCOPY; DOPANTS	High density and controllable nitrogen doping in graphene is a critical issue to realize high performance graphene-based devices. In this paper, we demonstrate an efficient method to selectively produce graphitic-N and pyridinic-N defects in graphene by using the mixture plasma of ozone and nitrogen. The atomic structure, electronic structure, and dynamic behavior of these nitrogen defects are systematically studied at the atomic level by using a scanning transmission electron microscopy. The pyridinic-N exhibits higher chemical activity and tends to trap a series of transition metal atoms (Mg, Al, Ca, Ti, Cr, Mn, and Fe) as individual atoms.	[Lin, Yung-Chang; Koshino, Masanori; Suenaga, Kazu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan; [Teng, Po-Yuan; Yeh, Chao-Hui; Chiu, Po-Wen] Natl Tsing Hua Univ, Dept Elect Engn, Hsinchu 30013, Taiwan	Lin, YC (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan.	yc-lin@aist.go.jp; suenaga-kazu@aist.go.jp	Suenaga, Kazu/E-2339-2014	Suenaga, Kazu/0000-0002-6107-1123	JST Research Acceleration Programme; National Tsing Hua University; Taiwan Ministry of Science and Technology [MOST 103-2628-M-007-004-MY3, MOST 103-2119-M-007-008-MY3, MOST 102-2633-M-007-002]; JSPS KAKENHI [26390004]	Toma Susi and Jani Kotakoski are gratefully acknowledged for the discussion about the N atom dynamics. The authors from AIST acknowledge the support from JST Research Acceleration Programme. P.W.C. appreciates the project support of National Tsing Hua University and of Taiwan Ministry of Science and Technology: MOST 103-2628-M-007-004-MY3; MOST 103-2119-M-007-008-MY3; and MOST 102-2633-M-007-002 (P.W.C.). A financial support by JSPS KAKENHI 26390004 is acknowledged by M.K.	Banhart F, 2011, ACS NANO, V5, P26, DOI 10.1021/nn102598m; Gong KP, 2009, SCIENCE, V323, P760, DOI 10.1126/science.1168049; Lin YC, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3368697; Chen LF, 2012, ACS NANO, V6, P7092, DOI 10.1021/nn302147s; Wang XR, 2009, SCIENCE, V324, P768, DOI 10.1126/science.1170335; Wang Y, 2010, ACS NANO, V4, P1790, DOI 10.1021/nn100315s; Niwa H, 2009, J POWER SOURCES, V187, P93, DOI 10.1016/j.jpowsour.2008.10.064; Meyer JC, 2011, NAT MATER, V10, P209, DOI [10.1038/nmat2941, 10.1038/NMAT2941]; Warner JH, 2014, NANO LETT, V14, P6155, DOI [10.1021/nl5023095, 10.1021/n15023095]; Shao YY, 2010, J MATER CHEM, V20, P7491, DOI 10.1039/c0jm00782j; Ramasse QM, 2013, NANO LETT, V13, P4989, DOI 10.1021/nl304187e; Bangert U, 2013, NANO LETT, V13, P4902, DOI 10.1021/nl402812y; Suenaga K, 2009, NAT CHEM, V1, P415, DOI [10.1038/nchem.282, 10.1038/NCHEM.282]; Wang DW, 2010, ELECTROCHEM COMMUN, V12, P1423, DOI 10.1016/j.elecom.2010.07.037; Nagaiah TC, 2010, ELECTROCHEM COMMUN, V12, P338, DOI 10.1016/j.elecom.2009.12.021; Zhou W, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.206803; Elias AL, 2007, SMALL, V3, P1723, DOI 10.1002/smll.200700331; Luo ZQ, 2011, J MATER CHEM, V21, P8038, DOI 10.1039/c1jm10845j; Fei HL, 2014, ACS NANO, V8, P10837, DOI 10.1021/nn504637y; Pham VD, 2014, ACS NANO, V8, P9403, DOI 10.1021/nn503753e; Susi T, 2012, ACS NANO, V6, P8837, DOI 10.1021/nn303944f; Cho YJ, 2011, J PHYS CHEM C, V115, P9451, DOI 10.1021/jp201485j; Krivanek OL, 2010, NATURE, V464, P571, DOI 10.1038/nature08879; Wang HB, 2012, ACS CATAL, V2, P781, DOI 10.1021/cs200652y; Suenaga K, 2010, NATURE, V468, P1088, DOI 10.1038/nature09664; Rao CV, 2010, J PHYS CHEM LETT, V1, P2622, DOI 10.1021/jz100971v; Reddy ALM, 2010, ACS NANO, V4, P6337, DOI 10.1021/nn101926g; Warner JH, 2014, ACS NANO, V8, P11806, DOI 10.1021/nn5054798; Lin YC, 2012, NANO LETT, V12, P414, DOI 10.1021/nl203733r; Susi T, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.115501; Lin YC, 2011, ACS NANO, V5, P2362, DOI 10.1021/nn200105j; Suenaga K, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.075501; Zhao LY, 2011, SCIENCE, V333, P999, DOI 10.1126/science.1208759; Qu LT, 2010, ACS NANO, V4, P1321, DOI 10.1021/nn901850u; Jeong HM, 2011, NANO LETT, V11, P2472, DOI 10.1021/nl2009058; Carrero-Sanchez JC, 2006, NANO LETT, V6, P1609, DOI 10.1021/nl060548p; Nicholls RJ, 2013, ACS NANO, V7, P7145, DOI 10.1021/nn402489v; Guo BD, 2010, NANO LETT, V10, P4975, DOI 10.1021/nl103079j; Wu ZS, 2011, ACS NANO, V5, P5463, DOI 10.1021/nn2006249; Arenal R, 2014, NANO LETT, V14, P5509, DOI 10.1021/nl501645g; Fujimoto Y, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.245446; Fujimoto Y, 2014, J APPL PHYS, V115, DOI 10.1063/1.4871465; Guo JJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6389; Kondo T, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035436; Lin Y.-C., 2015, PHYS REV LE IN PRESS; Lv R., 2012, SCI REP, V2, P1; Shao YY, 2008, APPL CATAL B-ENVIRON, V79, P89, DOI 10.1016/j.apcatb.2007.09.047	47	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	NOV	2015	15	11					7408	7413		10.1021/acs.nanolett.5b02831		6	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CW1BU	WOS:000364725400036		
J	Kim, Y; Lee, DS; Jung, S; Skakalova, V; Taniguchi, T; Watanabe, K; Kim, JS; Smet, JH				Kim, Youngwook; Lee, Dong Su; Jung, Suyong; Skakalova, Viera; Taniguchi, T.; Watanabe, K.; Kim, Jun Sung; Smet, Jurgen H.			Fractional Quantum Hall States in Bilayer Graphene Probed by Transconductance Fluctuations	NANO LETTERS			English	Article						Bilayer graphene; transconductance fluctuations; fractional quantum Hall states; electron-hole symmetry	BROKEN-SYMMETRY STATES; QUASI-PARTICLES; BERRYS PHASE; LOCALIZATION; CHARGE; EXCITATIONS	We have investigated fractional quantum Hall (QH) states in Bernal-stacked bilayer graphene using trans-conductance fluctuation measurements. A variety of odd-denominator fractional QH states with nu(QH) --> nu(QH) + 2 symmetry, as previously reported, are observed. However, surprising is that also particle-hole symmetric states are clearly resolved in the same measurement set. We attribute their emergence to the reversal of orbital states in the octet level scheme induced by a strong local charge imbalance, which can be captured by the transconductance fluctuations. Also the even-denominator fractional QH state at filling -1/2 is observed. However, contrary to a previous study on a suspended graphene layer [Ki et al. Nano Lett. 2014, 14, 2135], the particle-hole symmetric state at filling 1/2 is detected as well. These observations suggest that the stability of both odd and even denominator fractional QH states is very sensitive to local transverse electric fields in bilayer graphene.	[Kim, Youngwook; Kim, Jun Sung] Pohang Univ Sci & Technol, Dept Phys, Pohang 790784, South Korea; [Kim, Youngwook; Smet, Jurgen H.] Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany; [Lee, Dong Su] KIST Jeonbuk Inst Adv Composite Mat, Jeonbuk 565905, South Korea; [Jung, Suyong] Korea Res Inst Stand & Sci, Ctr Quantum Measurement Sci, Taejon 305340, South Korea; [Skakalova, Viera] Univ Vienna, Fac Phys, A-1090 Vienna, Austria; [Skakalova, Viera] STU Ctr Nanodiagnost, Bratislava 81243, Slovakia; [Taniguchi, T.; Watanabe, K.] Natl Inst Mat Sci, Adv Mat Lab, Tsukuba, Ibaraki 3050044, Japan	Kim, JS (reprint author), Pohang Univ Sci & Technol, Dept Phys, Pohang 790784, South Korea.	js.kim@postech.ac.kr; j.smet@fkf.mpg.de			National Research Foundation (NRF) through SRC [2011-0030785]; Max Planck POSTECH/KOREA Research Initiative [2011-0031558]; IBS [IBSR014- D1-2014-a02]; Korea Institute of Science and Technology (KIST) Institutional Program; NRF through the Fusion Research Program for Green Technologies [NRF-2012M3C1a1048861]; UVP [OPVaV-2011/4.2/01-PN]; DFG [SPP 1459]	We thank D. K Ki, D. Zhang, and F. Paolucci for fruitful discussions and M. Hagel for assistance with sample preparation. This work was supported by the National Research Foundation (NRF) through SRC (Grant 2011-0030785), the Max Planck POSTECH/KOREA Research Initiative (Grant 2011-0031558) programs, and also by IBS (No. IBSR014- D1-2014-a02). The work at KIST was supported by the Korea Institute of Science and Technology (KIST) Institutional Program. The work at KRISS was supported by NRF through the Fusion Research Program for Green Technologies (NRF-2012M3C1a1048861) Program. V.S. acknowledges support of the Project UVP, OPVaV-2011/4.2/01-PN. J.H.S. acknowledges financial support from the graphene flagship and the DFG Priority Program SPP 1459.	Abanin DA, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.115407; LAUGHLIN RB, 1983, PHYS REV LETT, V50, P1395, DOI 10.1103/PhysRevLett.50.1395; TSUI DC, 1982, PHYS REV LETT, V48, P1559, DOI 10.1103/PhysRevLett.48.1559; Feldman BE, 2012, SCIENCE, V337, P1196, DOI 10.1126/science.1224784; Maher P, 2014, SCIENCE, V345, P61, DOI 10.1126/science.1252875; MACDONALD AH, 1986, PHYS REV B, V33, P4009, DOI 10.1103/PhysRevB.33.4009; Feldman BE, 2009, NAT PHYS, V5, P889, DOI 10.1038/NPHYS1406; Tsukazaki A, 2010, NAT MATER, V9, P889, DOI [10.1038/nmat2874, 10.1038/NMAT2874]; Falson J, 2015, NAT PHYS, V11, P347, DOI 10.1038/NPHYS3259; Cote R, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.245307; dePicciotto R, 1997, NATURE, V389, P162, DOI 10.1038/38241; Kou A, 2014, SCIENCE, V345, P55, DOI 10.1126/science.1250270; WILLETT R, 1987, PHYS REV LETT, V59, P1776, DOI 10.1103/PhysRevLett.59.1776; Saminadayar L, 1997, PHYS REV LETT, V79, P2526, DOI 10.1103/PhysRevLett.79.2526; Weitz RT, 2010, SCIENCE, V330, P812, DOI 10.1126/science.1194988; Martin J, 2004, SCIENCE, V305, P980, DOI 10.1126/science.1099950; Snizhko K, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.201415; Ki DK, 2014, NANO LETT, V14, P2135, DOI 10.1021/nl5003922; Lee DS, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.056602; Shibata N, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.104708; Feldman BE, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.076802; Zomer PJ, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3665405; Barlas Y, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.097601; Lee K, 2014, SCIENCE, V345, P58, DOI 10.1126/science.1251003; NELSON SF, 1992, APPL PHYS LETT, V61, P64, DOI 10.1063/1.107670; Novoselov KS, 2006, NAT PHYS, V2, P177, DOI 10.1038/nphys245; SUEN YW, 1992, PHYS REV LETT, V68, P1379, DOI 10.1103/PhysRevLett.68.1379; Scarola VW, 2000, NATURE, V406, P863; Apalkov VM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.036801; Jung SY, 2011, NAT PHYS, V7, P245, DOI 10.1038/NPHYS1866; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; EISENSTEIN JP, 1992, PHYS REV LETT, V68, P1383, DOI 10.1103/PhysRevLett.68.1383; JAIN JK, 1989, PHYS REV LETT, V63, P199, DOI 10.1103/PhysRevLett.63.199; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Reznikov M, 1999, NATURE, V399, P238; Dean CR, 2011, NAT PHYS, V7, P693, DOI [10.1038/nphys2007, 10.1038/NPHYS2007]; Lai K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.156805; Martin J, 2009, NAT PHYS, V5, P669, DOI 10.1038/NPHYS1344; Ilani S, 2004, NATURE, V427, P328, DOI 10.1038/nature02230; Maher P, 2013, NAT PHYS, V9, P154, DOI 10.1038/nphys2528; Zhao Y, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.066801; Kim S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.016803; Venkatachalam V, 2011, NATURE, V469, P185, DOI 10.1038/nature09680; Apalkov VM, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.186803; Papic Z, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.046602	45	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	NOV	2015	15	11					7445	7451		10.1021/acs.nanolett.5b02876		7	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CW1BU	WOS:000364725400041		
J	Nishiyama, Y; Imura, K; Okamoto, H				Nishiyama, Yoshio; Imura, Kohei; Okamoto, Hiromi			Observation of Plasmon Wave Packet Motions via Femtosecond Time-Resolved Near-Field Imaging Techniques	NANO LETTERS			English	Article						Plasmon wave packet; near-field optical microscopy; ultrafast dynamics; nanoscale	SINGLE GOLD NANORODS; OPTICAL MICROSCOPY; SURFACE-PLASMONS; DYNAMICS; ANTENNAS	The generation and dynamics of plasmon wave packets in single gold nanorods were observed at a spatiotemporal scale of 100 nm and 10 fs via time-resolved near-field optical microscopy. Following simultaneous excitation of two plasmon modes of a nanorod with an ultrashort near-field pulse, a decay and revival feature of the time-resolved signal was obtained, which reflected the reciprocating motion of the wave packet. The time-resolved near-field images were also indicative of the wave packet motion. At some period of time after the excitation, the spatial features of the two modes appeared alternately, showing motion of plasmonic wave crests along the rod. The wave packet propagation was clearly demonstrated from this observation with the aid of a simulation model. The present experimental scheme opens the door to coherent control of plasmon-induced optical fields in a nanometer spatial scale and femtosecond temporal scale.	[Nishiyama, Yoshio; Okamoto, Hiromi] Inst Mol Sci, Okazaki, Aichi 4448585, Japan; [Okamoto, Hiromi] Grad Univ Adv Studies, Okazaki, Aichi 4448585, Japan; [Imura, Kohei] Waseda Univ, Sch Adv Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan	Okamoto, H (reprint author), Inst Mol Sci, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	aho@ims.ac.jp			Japan Society for the Promotion of Science [22225002, 25810013, 24350014, 2510971, 15H02161]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [2606, 26107003]	The authors thank Dr. T. Narushima for his assistance in developing the ultrafast SNOM system and Ms. A. Ishikawa (IMS) for the nanostructured sample fabrication. This work was supported by Grants-in-Aid for Scientific Research (Grants 22225002, 25810013, 24350014, 2510971, and 15H02161) from the Japan Society for the Promotion of Science and that for Scientific Research on Innovative Areas "Photosynergetics" (Area No. 2606, Grant 26107003) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Aeschlimann M, 2007, NATURE, V446, P301, DOI 10.1038/nature05595; Imura K, 2004, J PHYS CHEM B, V108, P16344, DOI 10.1021/jp047950h; Anderson A, 2010, NANO LETT, V10, P2519, DOI 10.1021/nl101090s; Zhang SP, 2013, NANOSCALE, V5, P6985, DOI 10.1039/c3nr01219k; Hanke T, 2012, NANO LETT, V12, P992, DOI 10.1021/nl2041047; Damrauer NH, 2002, EUR PHYS J D, V20, P71, DOI 10.1140/epjd/e2002-00101-8; Levin L, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.233003; Schuller JA, 2010, NAT MATER, V9, P193, DOI [10.1038/nmat2630, 10.1038/NMAT2630]; SCHERER NF, 1991, J CHEM PHYS, V95, P1487, DOI 10.1063/1.461064; Gong Y, 2015, NANO LETT, V15, P3472, DOI 10.1021/acs.nanolett.5b00803; Stockman MI, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.067402; Lamprecht B, 1999, APPL PHYS B-LASERS O, V69, P223, DOI 10.1007/s003400050798; Onishi S, 2013, OPT EXPRESS, V21, P26631, DOI 10.1364/OE.21.026631; Imura K, 2005, J PHYS CHEM B, V109, P13214, DOI 10.1021/jp051631o; Berweger S, 2011, NANO LETT, V11, P4309, DOI 10.1021/nl2023299; Aeschlimann M, 2012, IEEE J SEL TOP QUANT, V18, P275, DOI 10.1109/JSTQE.2011.2119470; Verellen N, 2014, NANO LETT, V14, P2322, DOI 10.1021/nl404670x; Nishiyama Y, 2015, J PHYS CHEM C, V119, P16215, DOI 10.1021/acs.jpcc.5b03341; Sonnichsen C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.077402; Stockman MI, 2005, NANO LETT, V5, P2325, DOI 10.1021/nl051895m; Kubo A, 2005, NANO LETT, V5, P1123, DOI 10.1021/nl0506655; Cao L, 2010, NANO LETT, V10, P3389, DOI 10.1021/nl101285t; Bozhevolnyi SI, 2009, PLASMONIC NANOGUIDES AND CIRCUITS, P1; Brinks D, 2013, P NATL ACAD SCI USA, V110, P18386, DOI 10.1073/pnas.1308652110; Crozier KB, 2003, J APPL PHYS, V94, P4632, DOI 10.1063/1.1602956; Imura K, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1873692; Katsuki H, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.013403; Kubo A, 2007, J PHYS B-AT MOL OPT, V40, pS259, DOI 10.1088/0953-4075/40/11/S02; Vala J, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.062316; Wu HJ, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.062002; Zhang LX, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.245442	31	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	NOV	2015	15	11					7657	7665		10.1021/acs.nanolett.5b03610		9	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CW1BU	WOS:000364725400073		
J	Watanabe, A				Watanabe, Akira			Valuation as deletion: inverse in Jemez and Kiowa	NATURAL LANGUAGE & LINGUISTIC THEORY			English	Article						Agreement; Impoverishment; Inverse; Valuation; Jemez; Kiowa	NUMBER; DEMONSTRATIVES; IMPOVERISHMENT; MOVEMENT; SYNTAX	This article proposes a new theory of agreement that carries out valuation by means of deletion. This new theory makes possible unification of inverse in Jemez and Kiowa with the help of an impoverishment operation, improving on Harbour's (2011) original account and reinstating the intuitive notion of inverse. The motivation for the new theory largely comes from examination of morpho-syntactic details in Jemez, which have not received enough theoretical attention before.	Univ Tokyo, Dept English, Bunkyo Ku, Tokyo 1130033, Japan	Watanabe, A (reprint author), Univ Tokyo, Dept English, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	akirawat@l.u-tokyo.ac.jp			Japan Society for the Promotion of Science [22520492]	Part of the materials in this article were presented at GLOW in Asia IX held at Mie University in 2012, and an earlier version of the analysis appeared in the proceedings (Watanabe 2013b). The final analysis was taken up in a lecture series at Kwansei Gakuin University in 2013. In addition to inputs on these occasions, comments from anonymous reviewers helped hammer out the final version. I would also like to thank Ad Neeleman for editorial advice. The research reported in this article was supported by Grant-in-Aid for Scientific Research (C) 22520492 from the Japan Society for the Promotion of Science.	Adger D, 2013, LINGUIST INQ MONOGR, V64, P1; Adger David, 2007, SYNTAX, V10, P2, DOI 10.1111/j.1467-9612.2007.00095.x; Adger David, 2009, MIRRORS MICROPARAMET; Albright Adam, 2012, MORPHOLOGY PHONOLOGY, P236; Bobaljik JD, 2008, LINGUIST REV, V25, P203, DOI 10.1515/TLR.2008.005; Nevins A, 2011, LINGUIST INQ, V42, P413; Watanabe A, 2013, LINGUIST INQ, V44, P469, DOI 10.1162/ling_a_00135; Carstens V, 2005, NAT LANG LINGUIST TH, V23, P219, DOI 10.1007/s11049-004-0996-6; Embick D, 2001, LINGUIST INQ, V32, P555, DOI 10.1162/002438901753373005; Bernstein JB, 1997, LINGUA, V102, P87, DOI 10.1016/S0024-3841(96)00046-0; Kennedy C, 2000, NAT LANG LINGUIST TH, V18, P89, DOI 10.1023/A:1006362716348; Harbour D, 2011, LINGUIST INQ, V42, P561; SHLONSKY U, 1991, LINGUA, V84, P159, DOI 10.1016/0024-3841(91)90069-H; LONGOBARDI G, 1994, LINGUIST INQ, V25, P609; Arregi Karlos, 2012, MORPHOTACTICS BASQUE; Bonet Eulalia, 2012, MORPHOLOGY PHONOLOGY, P195; Bonet Eulalia, 1991, THESIS; Brisson C, 2003, LINGUIST PHILOS, V26, P129, DOI 10.1023/A:1022771705575; Cardinaletti A., 2006, BLACKWELL COMPANION, VV, P23; Chomsky N., 2004, STRUCTURES CARTOGRAP, V3, P104; Chomsky N, 2007, STUD GENERAT GRAMM, V89, P1; Chomsky Noam, 2001, K HALE LIFE LANGUAGE, P1; Cinque G., 2002, FUNCTIONAL STRUCTURE, V1, P15; Embick David, 2010, LOCALISM VERSUS GLOB; Giusti G., 1991, LINGUISTISCHE BERICH, V136, P438; GIUSTI G., 1993, SINTASSI DETERMINANT; Halle Morris, 1993, VIEW BUILDING, V20, P111; Halle Morris, 1997, MIT WORKING PAPERS L, P425; Harbour Daniel, 2007, MORPHOSEMANTIC NUMBE; Harley Heidi, 2008, PHI THEORY PHI FEATU, P251; Hiraiwa Ken, 2005, THESIS; Kayne R. S., 1994, ANTISYMMETRY SYNTAX; Longobardi Giuseppe, 1991, LOGICAL STRUCTURE LI, P149; Noyer Rolf., 1997, FEATURES POSITIONS A; SIGURDSSON HA, 1991, NAT LANG LINGUIST TH, V9, P327, DOI 10.1007/BF00134679; Svenonius Peter, 2008, ADJECTIVES ADVERBS S, P16; Szabolcsi Anna, 2010, QUANTIFICATION; Trommer Jochen, 2012, MORPHOLOGY PHONOLOGY, P121; Trommer Jochen, 2012, MORPHOLOGY PHONOLOGY, P326; Watanabe Akira, 2013, P GLOW AS 9 2012 MAI, P55; Watkins Laurel J., 1984, GRAMMAR KIOWA ASSIST; Wonderly WL, 1954, INT J AM LINGUIST, V20, P1, DOI 10.1086/464244; Yumitani Yukihiro, 1998, THESIS	43	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-806X	1573-0859		NAT LANG LINGUIST TH	Nat. Lang. Linguist. Theory	NOV	2015	33	4					1387	1420		10.1007/s11049-014-9272-6		34	Linguistics; Language & Linguistics	Linguistics	CV8JD	WOS:000364529100010		
J	Adachi, T; Kobayashi, T; Sugihara, E; Yamada, T; Ikuta, K; Pittaluga, S; Saya, H; Amagai, M; Nagao, K				Adachi, Takeya; Kobayashi, Tetsuro; Sugihara, Eiji; Yamada, Taketo; Ikuta, Koichi; Pittaluga, Stefania; Saya, Hideyuki; Amagai, Masayuki; Nagao, Keisuke			Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma	NATURE MEDICINE			English	Article							MYCOSIS-FUNGOIDES; SEZARY-SYNDROME; STEM-CELLS; INFECTION; TISSUE; TUMOR; EXPRESSION; IMMUNITY; SUBSETS; CD4(+)	The skin harbors a variety of resident leukocyte subsets that must be tightly regulated to maintain immune homeostasis. Hair follicles are unique structures in the skin that contribute to skin dendritic cell homeostasis through chemokine production. We demonstrate that CD4(+) and CD8(+) skin-resident memory T cells (T-RM cells), which are responsible for long-term skin immunity, reside predominantly within the hair follicle epithelium of the unperturbed epidermis. T-RM cell tropism for the epidermis and follicles is herein termed epidermotropism. Hair follicle expression of IL-15 was required for CD8(+) T-RM cells, and IL-7 for CD8(+) and CD4(+) T-RM cells, to exert epidermotropism. A lack of either cytokine in the skin led to impaired hapten-induced contact hypersensitivity responses. In a model of cutaneous T cell lymphoma, epidermotropic CD4(+) T-RM lymphoma cell localization depended on the presence of hair follicle-derived IL-7. These findings implicate hair follicle-derived cytokines as regulators of malignant and non-malignant T-RM cell tissue residence, and they suggest that the cytokines may be targeted therapeutically in inflammatory skin diseases and lymphoma.	[Adachi, Takeya; Kobayashi, Tetsuro; Amagai, Masayuki; Nagao, Keisuke] Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Kobayashi, Tetsuro; Nagao, Keisuke] NCI, Dermatol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Sugihara, Eiji; Saya, Hideyuki] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat, Tokyo, Japan; [Yamada, Taketo] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan; [Ikuta, Koichi] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Lab Biol Protect, Kyoto 606, Japan; [Pittaluga, Stefania] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Nagao, K (reprint author), Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan.	keisuke.nagao@nih.gov	Nagao, Keisuke/J-5116-2013	Nagao, Keisuke/0000-0002-7005-3138	Japan Society for the Promotion of Science; Kanae Foundation for the Promotion of Medical Science; Japanese Society for Investigative Dermatology's (JSID's) Fellowship Shiseido Award; NIH NCI Intramural Research Programs	We thank M. Ohyama for helpful discussion on human hair follicles; N. Sakai, K. Eguchi and S. Sato (Keio University School of Medicine) for their technical assistance; H. Kong (National Institutes of Health) for their discussions on human CTCL; Y. Madokoro (Keio University School of Medicine) for human CTCL immunohistochemical staining; T. Kitamura (University of Tokyo) for providing the retroviral vector pMXs-IG and Plat-E cells; J. Takeda (Osaka University) for providing K5-Cre mice; D.H. Kaplan (University of Minnesota) for providing Langerin-DTA mice; and B.E. Clausen (Johannes Gutenberg University of Mainz) for providing Langerin-DTR mice. This work was supported by the Japan Society for the Promotion of Science, The Kanae Foundation for the Promotion of Medical Science, the Japanese Society for Investigative Dermatology's (JSID's) Fellowship Shiseido Award and the NIH NCI Intramural Research Programs.	Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Seneschal J, 2012, IMMUNITY, V36, P873, DOI 10.1016/j.immuni.2012.03.018; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; EDELSON RL, 1980, J AM ACAD DERMATOL, V2, P89; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Shiohara T, 1997, J INVEST DERMATOL, V109, P271, DOI 10.1111/1523-1747.ep12335465; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; van Leeuwen EMM, 2009, CURR OPIN IMMUNOL, V21, P167, DOI 10.1016/j.coi.2009.02.005; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Campbell JJ, 2010, BLOOD, V116, P767, DOI 10.1182/blood-2009-11-251926; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Liang BF, 2012, J IMMUNOL, V189, P4444, DOI 10.4049/jimmunol.1201181; Mizukawa Y, 2002, AM J PATHOL, V161, P1337, DOI 10.1016/S0002-9440(10)64410-0; Kamijo T, 1999, CANCER RES, V59, P2217; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Dorfman DM, 2002, HUM PATHOL, V33, P330, DOI 10.1053/hupa.2002.32215; Yamanaka K, 2006, BLOOD, V107, P2440, DOI 10.1182/blood-2005-03-1139; Sugihara E, 2012, ONCOGENE, V31, P2849, DOI 10.1038/onc.2011.462; Christoph T, 2000, BRIT J DERMATOL, V142, P862, DOI 10.1046/j.1365-2133.2000.03464.x; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Suffia I, 2005, J IMMUNOL, V174, P5444; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Rodriguez RS, 2014, J CLIN INVEST, V124, P1027, DOI 10.1172/JCI72932; Hwang ST, 2008, LANCET, V371, P945, DOI 10.1016/S0140-6736(08)60420-1; Lanzavecchia A, 2005, CURR OPIN IMMUNOL, V17, P326, DOI 10.1016/j.coi.2005.04.010; KANAVAROS P, 1994, PATHOL RES PRACT, V190, P767; Clark RA, 2006, J IMMUNOL, V176, P4431; Bromley SK, 2013, J IMMUNOL, V190, P970, DOI 10.4049/jimmunol.1202805; Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Clark RA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003008; Espinet Blanca, 2013, Methods Mol Biol, V973, P175, DOI 10.1007/978-1-62703-281-0_11	33	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2015	21	11					1272	1279		10.1038/nm.3962		8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CV9QH	WOS:000364621200011		
J	Wong, D; Velasco, J; Ju, L; Lee, J; Kahn, S; Tsai, HZ; Germany, C; Taniguchi, T; Watanabe, K; Zettl, A; Wang, F; Crommie, MF				Wong, Dillon; Velasco, Jairo, Jr.; Ju, Long; Lee, Juwon; Kahn, Salman; Tsai, Hsin-Zon; Germany, Chad; Taniguchi, Takashi; Watanabe, Kenji; Zettl, Alex; Wang, Feng; Crommie, Michael F.			Characterization and manipulation of individual defects in insulating hexagonal boron nitride using scanning tunnelling microscopy	NATURE NANOTECHNOLOGY			English	Article							POINT-DEFECTS; SINGLE-CRYSTALS; GRAPHENE; SPECTROSCOPY; BN; SUBSTRATE; RESONANCE; GAAS; EPR	Defects play a key role in determining the properties and technological applications of nanoscale materials and, because they tend to be highly localized, characterizing them at the singledefect level is of particular importance. Scanning tunnelling microscopy has long been used to image the electronic structure of individual point defects in conductors(1), semiconductors(2-4) and ultrathin films(5-9), but such single-defect electronic characterization remains an elusive goal for intrinsic bulk insulators. Here, we show that individual native defects in an intrinsic bulk hexagonal boron nitride insulator can be characterized and manipulated using a scanning tunnelling microscope. This would typically be impossible due to the lack of a conducting drain path for electrical current. We overcome this problem by using a graphene/boron nitride heterostructure, which exploits the atomically thin nature of graphene to allow the visualization of defect phenomena in the underlying bulk boron nitride. We observe three different defect structures that we attribute to defects within the bulk insulating boron nitride. Using scanning tunnelling spectroscopy we obtain charge and energy-level information for these boron nitride defect structures. We also show that it is possible to manipulate the defects through voltage pulses applied to the scanning tunnelling microscope tip.	[Wong, Dillon; Velasco, Jairo, Jr.; Ju, Long; Lee, Juwon; Kahn, Salman; Tsai, Hsin-Zon; Germany, Chad; Zettl, Alex; Wang, Feng; Crommie, Michael F.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Taniguchi, Takashi; Watanabe, Kenji] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Zettl, Alex; Wang, Feng; Crommie, Michael F.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Zettl, Alex; Wang, Feng; Crommie, Michael F.] Univ Calif Berkeley, Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [Zettl, Alex; Wang, Feng; Crommie, Michael F.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	Crommie, MF (reprint author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	crommie@berkeley.edu			sp<SUP>2</SUP> programme; LBNL Molecular Foundry; Office of Science, Office of Basic Energy Sciences of the US Department of Energy [DE-AC02-05CH11231]; National Science Foundation [CMMI-1235361]; UC President's Postdoctoral Fellowship; Department of Defense (DoD) through the National Defense Science & Engineering Graduate Fellowship (NDSEG) Program; Qualcomm Scholars Research Fellowship	The authors thank P. Jarillo-Herrero, N. Gabor, A. Young, P. Yu and A. Rubio for discussions. This research was supported by the sp<SUP>2</SUP> programme (STM measurement and device fabrication) and the LBNL Molecular Foundry (graphene growth characterization) funded by the Director, Office of Science, Office of Basic Energy Sciences of the US Department of Energy (contract no. DE-AC02-05CH11231). Support was also provided by National Science Foundation award CMMI-1235361 (device characterization, image analysis). J.V.J. acknowledges support from the UC President's Postdoctoral Fellowship. D.W. was supported by the Department of Defense (DoD) through the National Defense Science & Engineering Graduate Fellowship (NDSEG) Program. S.K. acknowledges support from the Qualcomm Scholars Research Fellowship.	Das Sarma S, 2011, REV MOD PHYS, V83, P407, DOI 10.1103/RevModPhys.83.407; Scheffler M, 2012, ACS NANO, V6, P10590, DOI 10.1021/nn303485c; Teichmann K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.076103; Choi T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.035430; AVOURIS P, 1989, APPL PHYS LETT, V55, P1074, DOI 10.1063/1.102457; Wang Y, 2013, SCIENCE, V340, P734, DOI 10.1126/science.1234320; Brar VW, 2011, NAT PHYS, V7, P43, DOI [10.1038/nphys1807, 10.1038/NPHYS1807]; KATZIR A, 1975, PHYS REV B, V11, P2370, DOI 10.1103/PhysRevB.11.2370; Xue JM, 2011, NAT MATER, V10, P282, DOI [10.1038/nmat2968, 10.1038/NMAT2968]; Britnell L, 2013, SCIENCE, V340, P1311, DOI 10.1126/science.1235547; Watanabe K, 2004, NAT MATER, V3, P404, DOI 10.1038/nmat1134; Lee DH, 2010, SCIENCE, V330, P1807, DOI 10.1126/science.1197434; ANDREI EY, 1976, PHYS REV B, V13, P2831, DOI 10.1103/PhysRevB.13.2831; Garleff JK, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075459; ZUNGER A, 1975, PHYS REV B, V11, P2378, DOI 10.1103/PhysRevB.11.2378; Zhang YB, 2008, NAT PHYS, V4, P627, DOI 10.1038/nphys1022; Remes Z, 2005, PHYS STATUS SOLIDI A, V202, P2229, DOI 10.1002/pssa.200561902; Woodside MT, 2002, SCIENCE, V296, P1098, DOI 10.1126/science.1069923; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Repp J, 2004, SCIENCE, V305, P493, DOI 10.1126/science.1099557; Repp J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.225503; Kharche N, 2011, NANO LETT, V11, P5274, DOI 10.1021/nl202725w; FEENSTRA RM, 1993, PHYS REV LETT, V71, P1176, DOI 10.1103/PhysRevLett.71.1176; Pradhan NA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.076801; Attaccalite C, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.144115; Decker R, 2011, NANO LETT, V11, P2291, DOI 10.1021/nl2005115; FANCIULLI M, 1993, PHYSICA B, V185, P228, DOI 10.1016/0921-4526(93)90242-X; Taniguchi T, 2007, J CRYST GROWTH, V303, P525, DOI 10.1016/j.jcrysgro.2006.12.061; Madhavan V, 1998, SCIENCE, V280, P567, DOI 10.1126/science.280.5363.567; Pradhan NA, 2005, J PHYS CHEM B, V109, P8513, DOI 10.1021/jp045289b; Wang Y, 2012, NAT PHYS, V8, P653, DOI 10.1038/NPHYS2379; Ju L, 2014, Nat Nanotechnol, V9, P348, DOI 10.1038/nnano.2014.60; Zomer P. J., 2011, APPL PHYS LETT, V99	33	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1748-3387	1748-3395		NAT NANOTECHNOL	Nat. Nanotechnol.	NOV	2015	10	11					949	U192		10.1038/NNANO.2015.188		6	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	CV8IY	WOS:000364528300011		
J	Veitch, AM; Uedo, N; Yao, K; East, JE				Veitch, Andrew M.; Uedo, Noriya; Yao, Kenshi; East, James E.			Optimizing early upper gastrointestinal cancer detection at endoscopy	NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY			English	Article							SQUAMOUS-CELL CARCINOMA; GRADE INTRAEPITHELIAL NEOPLASIA; RANDOMIZED CONTROLLED-TRIAL; EARLY GASTRIC-CANCER; BARRETTS-ESOPHAGUS; COLORECTAL-CANCER; SCREENING-PROGRAM; WITHDRAWAL TIME; QUALITY-CONTROL; COLONOSCOPY	Survival rates for upper gastrointestinal cancers are poor and oesophageal cancer incidence is increasing. Upper gastrointestinal cancer is also often missed during examinations; a predicament that has not yet been sufficiently addressed. Improvements in the detection of premalignant lesions, early oesophageal and gastric cancers will enable organ-preserving endoscopic therapy, potentially reducing the number of advanced upper gastrointestinal cancers and resulting in improved prognosis. Japan is a world leader in high-quality diagnostic upper gastrointestinal endoscopy and the clinical routine in this country differs substantially from Western practice. In this Perspectives article, we review lessons learnt from Japanese gastroscopy technique, training and screening for risk stratification. We suggest a key performance indicator for upper gastrointestinal endoscopy with a minimum total procedure time of 8min, and examine how quality assurance concepts in bowel cancer screening in the UK could be applied to upper gastrointestinal endoscopy and improve clinical practice.	[Veitch, Andrew M.] New Cross Hosp, Dept Gastroenterol, Wolverhampton WC10 0QP, W Midlands, England; [Uedo, Noriya] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gastrointestinal Oncol, Higashinari Ku, Osaka 5378511, Japan; [Yao, Kenshi] Fukuoka Univ, Dept Endoscopy, Chikushi Hosp, Chikushino City, Fukuoka 8188502, Japan; [East, James E.] John Radcliffe Hosp, Translat Gastroenterol Unit, Oxford OX3 9DU, England	Veitch, AM (reprint author), New Cross Hosp, Dept Gastroenterol, Wednesfield Rd, Wolverhampton WC10 0QP, W Midlands, England.	andrew.veitch@nhs.net			Cosmo Pharmaceuticals	Competing interests; J.E.E. has been an advisory board member and received research support from Cosmo Pharmaceuticals and honoraria for speaking for Abbvie and Olympus. The other authors declare no competing interests.	Voutilainen ME, 2005, EUR J GASTROEN HEPAT, V17, P1345, DOI 10.1097/00042737-200512000-00013; Gavin DR, 2013, GUT, V62, P242, DOI 10.1136/gutjnl-2011-301848; Vradelis S, 2011, POSTGRAD MED J, V87, P335, DOI 10.1136/pgmj.2010.101832; Yalamarthi S, 2004, ENDOSCOPY, V36, P874, DOI 10.1055/s-2004-825853; Kariyawasam VC, 2012, GASTROINTEST ENDOSC, V75, P938, DOI 10.1016/j.gie.2011.12.025; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Levine DS, 2000, AM J GASTROENTEROL, V95, P1152; Fujii T, 1998, GASTROINTEST ENDOSC, V47, P382, DOI 10.1016/S0016-5107(98)70223-8; Watabe H, 2005, GUT, V54, P764, DOI 10.1136/gut.2004.055400; Choi KS, 2011, CANCER SCI, V102, P1559, DOI 10.1111/j.1349-7006.2011.01982.x; Shariff MK, 2012, GASTROINTEST ENDOSC, V75, P954, DOI 10.1016/j.gie.2012.01.029; Hamashima C, 2008, JPN J CLIN ONCOL, V38, P259, DOI 10.1093/jjco/hyn017; Whiting JL, 2002, GUT, V50, P378, DOI 10.1136/gut.50.3.378; Corley DA, 2014, NEW ENGL J MED, V370, P1298, DOI 10.1056/NEJMoa1309086; Muto M, 2002, GASTROINTEST ENDOSC, V56, P517, DOI 10.1067/mge.2002.128104; Muto M, 2010, J CLIN ONCOL, V28, P1566, DOI 10.1200/JCO.2009.25.4680; Rey JF, 2001, ENDOSCOPY, V33, P901; Logan RFA, 2012, GUT, V61, P1439, DOI 10.1136/gutjnl-2011-300843; Khalil Q, 2014, SOUTH MED J, V107, P225, DOI 10.1097/SMJ.0000000000000092; Kodashima S, 2014, DIGEST ENDOSC, V26, P164, DOI 10.1111/den.12108; Fitzgerald RC, 2014, GUT, V63, P7, DOI 10.1136/gutjnl-2013-305372; Raftopoulos SC, 2010, AM J GASTROENTEROL, V105, P1292, DOI 10.1038/ajg.2009.736; Enestvedt BK, 2013, GASTROINTEST ENDOSC, V78, P462, DOI 10.1016/j.gie.2013.03.167; Pech O, 2007, ENDOSCOPY, V39, P588, DOI 10.1055/s-2007-966363; Lee TJW, 2013, ENDOSCOPY, V45, P20, DOI 10.1055/s-0032-1325803; Miki K, 2003, AM J GASTROENTEROL, V98, P735, DOI 10.1016/S0002-9270(03)00128-X; Uedo N, 2011, DIGEST DIS SCI, V56, P926, DOI 10.1007/s10620-011-1603-4; Yoshida N, 2014, DIGEST ENDOSC, V26, P250, DOI 10.1111/den.12127; Evans JA, 2013, GASTROINTEST ENDOSC, V77, P328, DOI 10.1016/j.gie.2012.10.001; Dinis-Ribeiro M, 2012, ENDOSCOPY, V44, P74, DOI 10.1055/s-0031-1291491; Ezoe Y, 2011, GASTROENTEROLOGY, V141, P2017, DOI 10.1053/j.gastro.2011.08.007; Uedo N, 2013, GASTROENTEROL CLIN N, V42, P317, DOI 10.1016/j.gtc.2013.01.007; Evans JA, 2012, GASTROINTEST ENDOSC, V76, P1087, DOI 10.1016/j.gie.2012.08.004; Kaye PV, 2008, AM J GASTROENTEROL, V103, P2883, DOI 10.1111/j.1572-0241.2008.02121.x; Butterly L, 2014, AM J GASTROENTEROL, V109, P417, DOI 10.1038/ajg.2013.442; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Amin A, 2002, J ROY COLL SURG EDIN, V47, P681; Anagnostopoulos GK, 2006, DIS ESOPHAGUS, V19, P84, DOI 10.1111/j.1442-2050.2006.00545.x; Benaglia T, 2013, GASTROENTEROLOGY, V144, P62, DOI 10.1053/j.gastro.2012.09.060; Bhandari P, 2010, SCAND J GASTROENTERO, V45, P357, DOI 10.3109/00365520903483643; INA H, 1994, CANCER, V73, P2038, DOI 10.1002/1097-0142(19940415)73:8<2038::AID-CNCR2820730804>3.0.CO;2-X; Bowles CJA, 2004, GUT, V53, P277, DOI 10.1136/gut.2003.016436; Gupta N, 2012, GASTROINTEST ENDOSC, V76, P531, DOI 10.1016/j.gie.2012.04.470; Cho YS, 2015, DIGEST DIS SCI, V60, P936, DOI 10.1007/s10620-014-3384-z; Bloomfeld RS, 2005, DYSPHAGIA, V20, P278, DOI 10.1007/s00455-005-0025-x; Menon S, 2012, GUT, V61, pA43, DOI 10.1136/gutjnl-2012-302514a.98; Ren W, 2013, WORLD J GASTROENTERO, V19, P2092, DOI 10.3748/wjg.v19.i13.2092; ASGE Committee on Training. Esophagogastroduodenoscopy (EGO), 2004, ES EGD COR CURR; ASGE/ACG Task Force on Quality in Endoscopy, 2015, GASTROINTEST ENDOSC, V81, P1; Early DS, 2012, GASTROINTEST ENDOSC, V75, P1127, DOI 10.1016/j.gie.2012.01.011; Cancer Research UK, 2014, OES CANC STAT; Correa F, 2010, AM J GASTROENTEROL, V105, P493; Ferlay J, 2013, IARC CANCERBASE; Gotoda I, 2010, BRIT J SURG, V97, P868; Hosokawa O, 2007, HEPATO-GASTROENTEROL, V54, P442; JAG, 2010, DOPS GRAD DESCR DIAG; JAG, 2010, FORM DOPS ASS FORM D; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Kadri SR, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4372; lchinose M., 2010, JPN J CLIN EXP MED, V87, P41; Matsui D., 2008, TOHOKU J RADIO TECHN, V17, P114; McLean MIH, 2014, NAT REV GASTRO HEPAT, V11, P664, DOI 10.1038/nrgastro.2014.143; Menon Shyam, 2014, Endosc Int Open, V2, pE46, DOI 10.1055/s-0034-1365524; Morris E. J., GUT; NICE, 2014, DYSP GASTR REFL DIS; Pechz O, 2008, GUT, V57, P1200, DOI 10.1136/gut.2007.142539; Sami S. S., 2014, AM J GASTROENTEROL, V110, P148; Shiozaki H., 1990, CANCER, V66, P2066; Statistics and Information Department. Ministry of Health Labour and Welfare, 2006, NAT REP CANC SCREEN; Suzuki Haruhisa, 2006, Gastric Cancer, V9, P315, DOI 10.1007/s10120-006-0399-y; Teh JL, 2015, CLIN GASTROENTEROL H, V13, P480, DOI 10.1016/j.cgh.2014.07.059; Terasawa T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109783; The Japanese Society of Gastrointestinal Cancer Screening, 2012, THE 2012 REP; Yao K., 2012, DEV E LEARNING SYSTE; Yao K, 2013, ANN GASTROENTEROL, V26, P11	75	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1759-5045	1759-5053		NAT REV GASTRO HEPAT	Nat. Rev. Gastroenterol. Hepatol.	NOV	2015	12	11					660	667		10.1038/nrgastro.2015.128		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CV9OL	WOS:000364616400009		
J	Takenouchi, T				Takenouchi, Takashi			A Novel Parameter Estimation Method for Boltzmann Machines	NEURAL COMPUTATION			English	Article							INFORMATION GEOMETRY; STATISTICAL-MODELS; LIKELIHOOD; DIVERGENCE	We propose a novel estimator for a specific class of probabilistic models on discrete spaces such as the Boltzmann machine. The proposed estimator is derived from minimization of a convex risk function and can be constructed without calculating the normalization constant, whose computational cost is exponential order. We investigate statistical properties of the proposed estimator such as consistency and asymptotic normality in the framework of the estimating function. Small experiments show that the proposed estimator can attain comparable performance to the maximum likelihood expectation at a much lower computational cost and is applicable to high-dimensional data.	Future Univ Hakodate, Hakodate, Hokkaido 0418655, Japan	Takenouchi, T (reprint author), Future Univ Hakodate, Hakodate, Hokkaido 0418655, Japan.	ttakashi@fun.ac.jp			MEXT, Japan [25730018]	This work was supported by grant-in-aid for young scientists (B) 25730018 from MEXT, Japan.	ACKLEY DH, 1985, COGNITIVE SCI, V9, P147; Amari S., 2000, METHODS INFORM GEOME; Banerjee A, 2005, J MACH LEARN RES, V6, P1705; Murata N, 2004, NEURAL COMPUT, V16, P1437, DOI 10.1162/089976604323057452; GODAMBE VP, 1976, BIOMETRIKA, V63, P277, DOI 10.1093/biomet/63.2.277; Neal RM, 2001, STAT COMPUT, V11, P125, DOI 10.1023/A:1008923215028; Hyvarinen A, 2007, COMPUT STAT DATA AN, V51, P2499, DOI 10.1016/j.csda.2006.09.003; AMARI S, 1992, IEEE T NEURAL NETWOR, V3, P260, DOI 10.1109/72.125867; Hyvarinen A, 2006, NEURAL COMPUT, V18, P2283, DOI 10.1162/neco.2006.18.10.2283; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; Amari S, 1997, BERNOULLI, V3, P29, DOI 10.2307/3318651; GODAMBE VP, 1960, ANN MATH STAT, V31, P1208, DOI 10.1214/aoms/1177705693; Dawid A.P., 2012, ANN STAT, V40, P593; Gutmann M., 2012, 12023727 ARXIV; Hinton G. E., 1986, LEARNING RELEARNING; Hyvarinen A, 2005, J MACH LEARN RES, V6, P695; Opper M., 2001, ADV MEAN FIELD METHO; R Core Team, 2014, R LANG ENV STAT COMP; Sejnowski T. J., 1986, C P AM I PHYS; Van der Vaart A.W., 1998, ASYMPTOTIC STAT	20	0	0	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0899-7667	1530-888X		NEURAL COMPUT	Neural Comput.	NOV	2015	27	11					2423	2446		10.1162/NECO_a_00781		24	Computer Science, Artificial Intelligence; Neurosciences	Computer Science; Neurosciences & Neurology	CV6RG	WOS:000364397200005		
J	Zhang, H; Ma, Y; Sugiyama, M				Zhang, Hao; Ma, Yao; Sugiyama, Masashi			Bandit-Based Task Assignment for Heterogeneous Crowdsourcing	NEURAL COMPUTATION			English	Article								We consider a task assignment problem in crowdsourcing, which is aimed at collecting as many reliable labels as possible within a limited budget. A challenge in this scenario is how to cope with the diversity of tasks and the task-dependent reliability of workers; for example, a worker may be good at recognizing the names of sports teams but not be familiar with cosmetics brands. We refer to this practical setting as heterogeneous crowdsourcing. In this letter, we propose a contextual bandit formulation for task assignment in heterogeneous crowdsourcing that is able to deal with the exploration-exploitation trade-off in worker selection. We also theoretically investigate the regret bounds for the proposed method and demonstrate its practical usefulness experimentally.	[Zhang, Hao; Ma, Yao] Tokyo Inst Technol, Dept Comp Sci, Meguro Ku, Tokyo 1528552, Japan; [Sugiyama, Masashi] Univ Tokyo, Dept Complex Sci & Engn, Bunkyo Ku, Tokyo 1130033, Japan	Zhang, H (reprint author), Tokyo Inst Technol, Dept Comp Sci, Meguro Ku, Tokyo 1528552, Japan.	zhang.h.ae@m.titech.ac.jp; mycw45@gmail.com; sugi@k.u-tokyo.ac.jp			MEXT scholarship; CREST program; MEXT KAKENHI [25700022]	H.Z. and Y.M. were supported by the MEXT scholarship and the CREST program. M.S. was supported by MEXT KAKENHI 25700022.	Raykar VC, 2010, J MACH LEARN RES, V11, P1297; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1; Donmez P, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P259; Auer P, 2002, MACH LEARN, V47, P235, DOI 10.1023/A:1013689704352; Arora S., 2012, THEORY COMPUT, V8, P121, DOI DOI 10.4086/TOC.2012.V008A006; Auer P., 2002, SIAM J COMPUT, V32, P48, DOI DOI 10.1137/S0097539701398375; Balzano L., 2010, ARXIV10064046V2; Bubeck S., 2010, THESIS U LILLE; Bubeck Sebastien, 2012, Foundations and Trends in Machine Learning, V5, DOI 10.1561/2200000024; Cesa-Bianchi N., 2006, PREDICTION LEARNING; Chen X, 2013, ICML, V2013, P64; Dawid A. P., 1979, J ROYAL STAT SOC C, V28, P20, DOI [DOI 10.2307/2346806, 10.2307/2346806]; Ertekin S, 2014, DATA MIN KNOWL DISC, V28, P1189, DOI 10.1007/s10618-014-0354-1; Goel G., 2014, P 2 AAAI C HUM COMP; Hazan E., 2011, OPTIMIZATION MACHINE, P287; Ho C., 2012, P 26 C ART INT AAAI, P45; Ho C-J, 2013, P 30 INT C MACH LEAR, P534; Ipeirotis P. G., 2010, P ACM SIGKDD WORKSH, P64, DOI DOI 10.1145/1837885.1837906; Kaelbling L. P., 1990, THESIS STANFORD U; Kajino H., 2012, P AAAI C ART INT, P73; Karger D. R., 2011, ADV NEURAL INFORM PR, V24, P1953; Law E., 2011, HUMAN COMPUTATION; Lewis D. D., 1994, P C RES DEV INF RETR, V17, P3; Liu Q., 2012, ADV NEURAL INFORM PR, V25, P701; Mo K., 2013, P 19 ACM SIGKDD INT, P677; Shai Shalev-Shwartz, 2012, FDN TRENDS MACH LEAR, V4, P107; Slivkins A., 2014, SIGECOM EXCH, V12, P4; Smyth P., 1994, ADV NEURAL INFORM PR, V7, P1085; Snow R, 2008, P C EMP METH NAT LAN, P254, DOI 10.3115/1613715.1613751; Welinder P., 2010, ADV NEURAL INFORM PR, V23, P2424; Welinder P., 2010, WORKSH ADV COMP VIS, P25; Yan Y, 2010, J MAC LEARN RES P TR, V9, P932; Zhou D., 2012, ADV NEURAL INFORM PR, V25, P2204	33	0	0	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0899-7667	1530-888X		NEURAL COMPUT	Neural Comput.	NOV	2015	27	11					2447	2475		10.1162/NECO_a_00782		29	Computer Science, Artificial Intelligence; Neurosciences	Computer Science; Neurosciences & Neurology	CV6RG	WOS:000364397200006		
J	Song, YN; Hakoda, Y				Song, Yongning; Hakoda, Yuji			Lack of Global Precedence and Global-to-Local Interference Without Local Processing Deficit: A Robust Finding in Children With Attention-Deficit/Hyperactivity Disorder Under Different Visual Angles of the Navon Task	NEUROPSYCHOLOGY			English	Article						ADHD; Global-local processing; Navon effect	HYPERACTIVITY DISORDER; HEMISPHERIC-SPECIALIZATION; INFORMATION; DYSFUNCTION; STIMULI; DEPENDS; TELL; ADHD; MRI	Objective: The Navon effect (Navon, 1977) is an automatic tendency to process the global picture prior to local details when processing compound patterns. However, several recent studies have reported that this effect is lacking in attention-deficit/hyperactivity disorder (ADHD). Although previous research has shown that the Navon effect is strongly affected by visual angles, whether this phenomenon will also be observed in ADHD is yet to be understood. We examine the lack of the Navon effect in ADHD under various visual angles to ensure that this phenomenon is not an artifact of saliency. Method: By employing three different visual angles for the local stimuli, global and local processing of Navon-type hierarchical letters was examined in participants with ADHD (n = 15) and a comparison group (n = 17). Results: ADHD participants presented with a lack of the Navon effect without local processing deficit regardless of visual angle, in comparison to non-ADHD participants. Conclusion: A lack of global precedence and global-to-local interference without local processing deficit can be generalized in ADHD. This suggests that people with ADHD experience difficulties in processing the "whole picture," and it also challenges the Diagnostic and Statistical Manual of Mental Disorders (5th ed.; American Psychiatric Association, 2013) criteria of ADHD in which the failure to pay close attention to details was emphasized. Moreover, the current results have important implications for understanding ADHD and could also have significant clinical value.	[Song, Yongning] Minist Educ, Key Lab Brain Funct Genom, Shanghai, Peoples R China; [Song, Yongning] E China Normal Univ, Sch Psychol & Cognit Sci, Key Lab Brain Funct Genom, Shanghai 200062, Peoples R China; [Hakoda, Yuji] Kyoto Womens Univ, Fac Human Dev & Educ, Kyoto, Japan	Song, YN (reprint author), E China Normal Univ, Sch Psychol & Cognit Sci, Shanghai 200062, Peoples R China.	ynsong@psy.ecnu.edu.cn			National Natural Foundation of China [31300839]; Japan Society for the Promotion of Science Postdoctoral Fellowship for Foreign Researchers [P13311]; Shanghai Pujiang Program [12PJC034]; Ministry of Education in China Project of Humanities and Social Sciences [13YJC190020]	We declare that there is no conflict of interest in this article. This work was supported by National Natural Foundation of China Grant 31300839, Grant-in-Aid for Japan Society for the Promotion of Science Postdoctoral Fellowship for Foreign Researchers P13311, Shanghai Pujiang Program 12PJC034, Ministry of Education in China Project of Humanities and Social Sciences Grant 13YJC190020. We thank all the participants in this experiment.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT; MARTIN M, 1979, MEM COGNITION, V7, P476, DOI 10.3758/BF03198264; Song YN, 2012, BRAIN DEV-JPN, V34, P308, DOI 10.1016/j.braindev.2011.07.010; Filipek PA, 1997, NEUROLOGY, V48, P589; ANGOLD A, 1995, PSYCHOL MED, V25, P739; Shedden JM, 2001, PERCEPT PSYCHOPHYS, V63, P241, DOI 10.3758/BF03194465; Volberg G, 2007, EXP PSYCHOL, V54, P83, DOI 10.1027/1618-3169.54.1.83; KINCHLA RA, 1979, PERCEPT PSYCHOPHYS, V25, P225, DOI 10.3758/BF03202991; Vance A, 2007, MOL PSYCHIATR, V12, P826, DOI 10.1038/sj.mp.4001999; Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; Castellanos FX, 1996, ARCH GEN PSYCHIAT, V53, P607; Conners CK, 1998, J CLIN PSYCHIAT, V59, P24; Almeida LG, 2010, J PSYCHIATR RES, V44, P1214, DOI 10.1016/j.jpsychires.2010.04.026; Nigg JT, 2002, J AM ACAD CHILD PSY, V41, P59, DOI 10.1097/00004583-200201000-00012; Song Y, 2011, J ATTEN DISORD, V15, P499, DOI 10.1177/1087054710367607; Waldie KE, 2010, NEUROPSYCHOLOGIA, V48, P3650, DOI 10.1016/j.neuropsychologia.2010.08.023; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Poirel N, 2008, ACTA PSYCHOL, V127, P1, DOI 10.1016/j.actpsy.2006.12.001; Kalanthroff E, 2013, NEUROPSYCHOLOGY, V27, P546, DOI 10.1037/a0033655; Ripoll T, 2005, EXP PSYCHOL, V52, P272, DOI 10.1027/1618-3169.52.4.272; MARTIN M, 1979, NEUROPSYCHOLOGIA, V17, P33, DOI 10.1016/0028-3932(79)90019-8; Yeo RA, 2003, J AM ACAD CHILD PSY, V42, P303, DOI 10.1097/01.CHI.0000037024.34553.1B; Nigg JT, 2005, BIOL PSYCHIAT, V57, P1424, DOI 10.1016/j.biopsych.2004.11.011; CASTELLANOS FX, 1994, AM J PSYCHIAT, V151, P1791; DELIS DC, 1986, NEUROPSYCHOLOGIA, V24, P205, DOI 10.1016/0028-3932(86)90053-9; Navon D, 2003, ACTA PSYCHOL, V114, P273, DOI 10.1016/j.actpsy.2003.06.002; Song YN, 2015, BEHAV BRAIN RES, V290, P187, DOI 10.1016/j.bbr.2015.04.047; Conners C. K., 1995, CONNERS RATING SCALE; [Han Shihui 韩世辉], 2004, [心理学报, Acta Psychological Sinica], V36, P410; KIMCHI R, 1992, PSYCHOL BULL, V112, P24, DOI 10.1037/0033-2909.112.1.24; LAMB MR, 1990, PERCEPT PSYCHOPHYS, V47, P489, DOI 10.3758/BF03208182; Raven J., 1992, STANDARD PROGR MATRI; ROBERTSON LC, 1991, COGNITIVE PSYCHOL, V23, P299, DOI 10.1016/0010-0285(91)90012-D; SERGENT J, 1982, J EXP PSYCHOL HUMAN, V8, P253, DOI 10.1037/0096-1523.8.2.253	34	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	NOV	2015	29	6					888	894		10.1037/neu0000213		7	Psychology, Clinical; Neurosciences; Psychology	Psychology; Neurosciences & Neurology	CV9FF	WOS:000364592100008		
J	Tanaka, K; Chujo, Y				Tanaka, Kazuo; Chujo, Yoshiki			Recent progress of optical functional nanomaterials based on organoboron complexes with beta-diketonate, ketoiminate and diiminate	NPG ASIA MATERIALS			English	Review							AGGREGATION-INDUCED EMISSION; CRYSTALLIZATION-INDUCED EMISSION; INFRARED PHOTOCHROMIC BEHAVIOR; BORON DIFLUORIDE COMPLEXES; FLUORESCENCE PROPERTIES; CONJUGATED POLYMERS; PI-CONJUGATION; FACILE SYNTHESIS; BF2 COMPLEXES; MAIN-CHAIN	The synthesis and application of organoboron complexes are a highly relevant topic owng to their unique characteristics. Based on their emissive properties, these complexes have been used to make novel optical materials and devices; boron beta-diketonate is a simple and robust organoboron complex. From a series of recent studies, unique and versatile optical properties have been reported. In this review, we introduce the results of primarily recent studies on boron diketonate and related compounds containing polymers and particularly explain their optical properties. Initially, the multi-emission of boron diketonate derivatives and its application to biotechnology are explained. Next, the formation of nanostructures and its emission properties are demonstrated. The modulation of optical properties by mechanical stress is also presented. Finally, recent progress in the development of solid-emissive materials are shown with boron diketonates and their derivatives, which have aggregation-induced emission properties. The versatility of boron diketonates as a building block for the preparation of functional optical materials is the focus of this review.	[Tanaka, Kazuo; Chujo, Yoshiki] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Katsura, Kyoto 6158510, Japan	Tanaka, K (reprint author), Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Katsura, Kyoto 6158510, Japan.	kazuo123@chujo.synchem.kyoto-u.ac.jp; chujo@chujo.synchem.kyoto-u.ac.jp					Guieu S, 2015, EUR J ORG CHEM, P3423, DOI 10.1002/ejoc.201500318; Maeda H, 2011, J AM CHEM SOC, V133, P8896, DOI 10.1021/ja203880d; Jiang XX, 2014, MACROMOL CHEM PHYS, V215, P358, DOI 10.1002/macp.201300569; Haketa Y, 2011, CHEM-EUR J, V17, P1485, DOI 10.1002/chem.201002748; Zhang GQ, 2010, J AM CHEM SOC, V132, P2160, DOI 10.1021/ja9097719; Mirochnik AG, 2008, RUSS CHEM B+, V57, P1190; Chujo Y, 2015, B CHEM SOC JPN, V88, P633, DOI 10.1246/bcsj.20150081; Braunschweig H, 2011, CHEM COMMUN, V47, P10903, DOI 10.1039/c1cc13071d; Chow YL, 1996, J PHYS ORG CHEM, V9, P7, DOI 10.1002/(SICI)1099-1395(199601)9:1<7::AID-POC747>3.3.CO;2-8; Wang DJ, 2013, SPECTROCHIM ACTA A, V104, P419, DOI 10.1016/j.saa.2012.11.102; Yoshii R, 2014, J AM CHEM SOC, V136, P18131, DOI 10.1021/ja510985v; Galer P, 2014, J AM CHEM SOC, V136, P7383, DOI 10.1021/ja501977a; Ono K, 2007, TETRAHEDRON, V63, P9354, DOI 10.1016/j.tet.2007.07.004; Fedorenko EV, 2014, DYES PIGMENTS, V109, P181, DOI 10.1016/j.dyepig.2014.04.016; Kubota Y, 2012, ORG LETT, V14, P4682, DOI 10.1021/ol302179r; Poon CT, 2010, J AM CHEM SOC, V132, P13992, DOI 10.1021/ja105537j; Dai CH, 2015, POLYM CHEM-UK, V6, P5070, DOI 10.1039/c5py00733j; Okamoto A, 2005, J AM CHEM SOC, V127, P13128, DOI 10.1021/ja053609e; Wang L, 2015, ADV MATER, V27, P2918, DOI 10.1002/adma.201500589; Wu YP, 2015, ORG BIOMOL CHEM, V13, P5775, DOI 10.1039/c5ob00607d; Zhang XP, 2014, MACROMOL RAPID COMM, V35, P566, DOI 10.1002/marc.201300834; Matsumi N, 1998, J AM CHEM SOC, V120, P5112, DOI 10.1021/ja9741943; Samonina-Kosicka J, 2014, MACROMOLECULES, V47, P3736, DOI 10.1021/ma5006606; Yoshii R, 2014, MACROMOLECULES, V47, P2268, DOI 10.1021/ma500082e; Bando Y, 2013, CHEM-ASIAN J, V8, P2088, DOI 10.1002/asia.201300635; Poon CT, 2013, CHEM-EUR J, V19, P3467, DOI 10.1002/chem.201203105; Tanaka K, 2013, MACROMOLECULES, V46, P2969, DOI 10.1021/ma400368e; Ito F, 2013, RSC ADV, V3, P19785, DOI 10.1039/c3ra43321h; Perumal K, 2012, CHEM-ASIAN J, V7, P2670, DOI 10.1002/asia.201200477; Ulrich G, 2008, ANGEW CHEM INT EDIT, V47, P1184, DOI 10.1002/anie.200702070; Turanova OA, 2006, RUSS J GEN CHEM+, V76, P730, DOI 10.1134/S1070363206050124; Nagai A, 2008, MACROMOLECULES, V41, P8295, DOI 10.1021/ma801690d; Kajiwara Y, 2013, J MATER CHEM C, V1, P4437, DOI 10.1039/c3tc30276h; Yoshii R, 2014, MACROMOL RAPID COMM, V35, P1315, DOI 10.1002/marc.201400198; Xu SP, 2013, INORG CHEM, V52, P3597, DOI 10.1021/ic300077g; Maeda H, 2011, J AM CHEM SOC, V133, P9266, DOI 10.1021/ja203206g; Yoshii R, 2014, CHEM-EUR J, V20, P8320, DOI 10.1002/chem.201402946; Vovna VI, 2013, RUSS J PHYS CHEM A+, V87, P688, DOI 10.1134/S0036024413040304; Pi Y, 2014, SPECTROCHIM ACTA A, V131, P209, DOI 10.1016/j.saa.2014.04.078; Rao YL, 2012, COORDIN CHEM REV, V256, P759, DOI 10.1016/j.ccr.2011.11.009; Yoshii R, 2013, CHEM-EUR J, V19, P4506, DOI 10.1002/chem.201203703; Nagai A, 2008, J ORG CHEM, V73, P8605, DOI 10.1021/jo8017582; Zhang GQ, 2009, NAT MATER, V8, P747, DOI [10.1038/nmat2509, 10.1038/NMAT2509]; Tanaka K, 2012, MACROMOL RAPID COMM, V33, P1235, DOI 10.1002/marc.201200239; Sanchez I, 2010, NEW J CHEM, V34, P2937, DOI 10.1039/c0nj00503g; Maeda H, 2010, CHEM COMMUN, V46, P4559, DOI 10.1039/c0cc00551g; Wang DJ, 2015, OPTOELECTRON ADV MAT, V9, P79; Kumar GR, 2014, DALTON T, V43, P3871, DOI 10.1039/c3dt52768a; DeRosa CA, 2015, MACROMOLECULES, V48, P2967, DOI 10.1021/acs.macromol.5b00394; Cogne-Laage E, 2004, CHEM-EUR J, V10, P1445, DOI 10.1002/chem.200305321; Yoshii R, 2015, CHEM-EUR J, V21, P7231, DOI 10.1002/chem.201500033; Zhang ZQ, 2015, J MATER CHEM C, V3, P4921, DOI 10.1039/c5tc00463b; Hirose A, 2015, POLYM CHEM-UK, V6, P5590, DOI 10.1039/c5py00055f; Sun C, 2011, ORGANOMETALLICS, V30, P5552, DOI 10.1021/om2007979; Turanova OA, 2010, RUSS J GEN CHEM+, V80, P2317, DOI 10.1134/S1070363210110150; Koch M, 2014, ANGEW CHEM INT EDIT, V53, P6378, DOI 10.1002/anie.201402199; Ono K, 2010, CHEM-EUR J, V16, P13539, DOI 10.1002/chem.201001185; Bu JX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4799; Hirose A, 2014, TETRAHEDRON LETT, V55, P6477, DOI 10.1016/j.tetlet.2014.10.012; Liao CW, 2015, CHEM COMMUN, V51, P2656, DOI 10.1039/c4cc08958h; Luo JD, 2001, CHEM COMMUN, P1740, DOI 10.1039/b105159h; Macedo FP, 2008, EUR J INORG CHEM, P3200, DOI 10.1002/ejic.200800243; Palmer GM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3523363; Sanchez I, 2014, J MATER CHEM C, V2, P9653, DOI 10.1039/c4tc01373e; Zhang ZQ, 2014, J MATER CHEM C, V2, P9543, DOI 10.1039/c4tc01639d	65	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1884-4049	1884-4057		NPG ASIA MATER	NPG Asia Mater.	NOV	2015	7								e223	10.1038/am.2015.118		15	Materials Science, Multidisciplinary	Materials Science	CV7YK	WOS:000364493100001		
J	Haba, N; Ishida, H; Takahashi, R; Yamaguchi, Y				Haba, Naoyuki; Ishida, Hiroyuki; Takahashi, Ryo; Yamaguchi, Yuya			Hierarchy problem, gauge coupling unification at the Planck scale, and vacuum stability	NUCLEAR PHYSICS B			English	Article							MINIMAL STANDARD MODEL; DARK-MATTER; COLLISIONS; MECHANISM; SEARCH; QUARK	From the point of view of the gauge hierarchy problem, introducing an intermediate scale in addition to TeV scale and the Planck scale (M-Pl = 2.4 x10(18) GeV) is unfavorable. In that way, a gauge coupling unification (GCU) is expected to be realized at M-P1. We explore possibilities of GCU at M-Pl by adding a few extra particles with TeV scale mass into the standard model (SM). When extra particles are fermions and scalars (only fermions) with the same mass, the GCU at M-Pl can (not) be realized. On the other hand, when extra fermions have different masses, the GCU can be realized around root 8 pi M-Pl without extra scalars. This simple SM extension has two advantages that a vacuum becomes stable up to M-Pl(root 8 pi M-Pl) and a proton lifetime becomes much longer than an experimental bound. (C) 2015 The Authors. Published by Elsevier B.V.	[Haba, Naoyuki; Ishida, Hiroyuki; Takahashi, Ryo; Yamaguchi, Yuya] Shimane Univ, Grad Sch Sci & Engn, Matsue, Shimane 6908504, Japan; [Yamaguchi, Yuya] Hokkaido Univ, Dept Phys, Fac Sci, Sapporo, Hokkaido 0600810, Japan	Yamaguchi, Y (reprint author), Shimane Univ, Grad Sch Sci & Engn, Matsue, Shimane 6908504, Japan.	yy@particle.sci.hokudai.ac.jp			Scientific Grant by the Ministry of Education, Culture, Sports, Science and Technology [24540272]; Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists [24.801, 26.2428]	We thank H. Sugawara and N. Okada for helpful and fruitful discussions which leaded a motivation of this research. We also thank S. Iso and T. Yamashita for helpful discussions and valuable comments. This work is partially supported by Scientific Grant by the Ministry of Education, Culture, Sports, Science and Technology, No. 24540272. The works of R.T. and Y.Y. are supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists (Grants No. 24.801 (R.T.) and No. 26.2428 (Y.Y.)).	Aad G, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP11(2014)104; Alekhin S, 2012, PHYS LETT B, V716, P214, DOI 10.1016/j.physletb.2012.08.024; Haba N, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.036006; Grzadkowski B, 2009, ACTA PHYS POL B, V40, P3007; SLANSKY R, 1981, PHYS REP, V79, P1, DOI 10.1016/0370-1573(81)90092-2; Hamada Y, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.053009; JONES DRT, 1982, PHYS REV D, V25, P581, DOI 10.1103/PhysRevD.25.581; Hamada Y, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.059901; ZEE A, 1979, PHYS REV LETT, V42, P417, DOI 10.1103/PhysRevLett.42.417; FORD C, 1992, NUCL PHYS B, V387, P373, DOI 10.1016/0550-3213(92)90165-8; MCDONALD J, 1994, PHYS REV D, V50, P3637, DOI 10.1103/PhysRevD.50.3637; Jegerlehner F, 2014, ACTA PHYS POL B, V45, P1167, DOI 10.5506/APhysPolB.45.1167; Lindner M, 1996, PHYS LETT B, V383, P405, DOI 10.1016/0370-2693(96)00775-7; Perez-Lorenzana A, 2000, EUROPHYS LETT, V49, P296, DOI 10.1209/epl/i2000-00148-y; Davoudiasl H, 2005, PHYS LETT B, V609, P117, DOI 10.1016/j.physletb.2005.01.026; Robinson SP, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.231601; Haba N, 2014, PHYS LETT B, V734, P220, DOI 10.1016/j.physletb.2014.05.016; Branchina V, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.241801; SILVEIRA V, 1985, PHYS LETT B, V161, P136, DOI 10.1016/0370-2693(85)90624-0; Froggatt CD, 1996, PHYS LETT B, V368, P96, DOI 10.1016/0370-2693(95)01480-2; Ford C, 1997, NUCL PHYS B, V504, P551, DOI 10.1016/S0550-3213(97)00532-4; Masina I, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.093003; Iso S, 2009, PHYS LETT B, V676, P81, DOI 10.1016/j.physletb.2009.04.046; Burgess CP, 2001, NUCL PHYS B, V619, P709, DOI 10.1016/S0550-3213(01)00513-2; Chatrchyan S, 2012, PHYS LETT B, V718, P348, DOI 10.1016/j.physletb.2012.10.070; Gabrielli E, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.015017; Tavares GM, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.015009; Pietrykowski AR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.061801; COLEMAN S, 1973, PHYS REV D, V7, P1888, DOI 10.1103/PhysRevD.7.1888; Barger V, 2007, INT J MOD PHYS A, V22, P6203, DOI 10.1142/S0217751X07038128; ATLAS Collaboration CDF Collaboration CMS Collaboration D0 Collaboration, ARXIV14034427HEPEX A; Baek S., 2013, J HIGH ENERGY PHYS, V1307; Bardeen W. A., FERMILABCONF95391T; Bezrukov F., 2012, J HIGH ENERGY PHYS, V1210, P140; Boucenna SM, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.055023; Branchina V, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.013003; Branchina V., 2014, JHEP, V1409, P182; Buttazzo D., 2013, J HIGH ENERGY PHYS, V1312, P089, DOI DOI 10.1007/JHEP12(2013)089; Carena M., 2012, J HIGH ENERGY PHYS, V50, P152; Chung DJH, 1999, PHYS REV D, V60, DOI 10.1103/PhysRevD.60.063504; Chatrchyan S, 2014, PHYS LETT B, V729, P149, DOI 10.1016/j.physletb.2014.01.006; Degrassi G., 2012, J HIGH ENERGY PHYS, V1208, DOI DOI 10.1007/JHEP08(2012)098; Drozd A., 2014, JHEP, V1411, P130; Drozd A., 2012, J HIGH ENERGY PHYS, V1204, P006; Foot R, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.035006; Giudice G.F., 2005, NUCL PHYS B, V706, P65; Giudice GF, 2004, NUCL PHYS B, V699, P65, DOI 10.1016/j.nuclphysb.2004.08.001; Giudice G.F., 2015, J HIGH ENERGY PHYS, V1502, P137; Grzadkowski B, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.091802; Haba N., 2014, J HIGH ENERGY PHYS, V1404; Haba N., ARXIV14085548HEPPH; Haba N, 2014, EUR PHYS J C, V74, DOI 10.1140/epjc/s10052-013-2696-z; Hahn T., ARXIV14040186HEPPH; Iso S., 2013, PROG THEOR EXP PHYS, V2013; Kadastik M., 2012, J HIGH ENERGY PHYS, V1205, P061; Masina I, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.053001; Spencer-Smith A., ARXIV14051975HEPPH	57	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	NOV	2015	900						244	258		10.1016/j.nuclphysb.2015.09.004		15	Physics, Particles & Fields	Physics	CV5PJ	WOS:000364323000009		
J	Abe, H; Horie, T; Sumita, K				Abe, Hiroyuki; Horie, Tomoharu; Sumita, Keigo			Superfield description of (4+2n)-dimensional SYM theories and their mixtures on magnetized tori	NUCLEAR PHYSICS B			English	Article							EXTRA DIMENSIONS; SUPERSYMMETRY; MODELS; ORBIFOLDS; BRANES	We provide a systematic way of dimensional reduction for (4 + 2n)-dimensional U(N) supersymmetric Yang-Mills (SYM) theories (n = 0, 1, 2, 3) and their mixtures compactified on two-dimensional tori with background magnetic fluxes, which preserve a partial N = 1 supersymmetry out of full N = 2, 3 or 4 in the original SYM theories. It is formulated in an N = 1 superspace respecting the unbroken supersymmetry, and the four-dimensional effective action is written in terms of superfields representing N = 1 vector and chiral multiplets, those arise from the higher-dimensional SYM theories. We also identify the dilaton and geometric moduli dependence of matter Kahler metrics and superpotential couplings as well as of gauge kinetic functions in the effective action. The results would be useful for various phenomenological/cosmological model buildings with SYM theories or D-branes wrapping magnetized tori, especially, with mixture configurations of them with different dimensionalities from each other. (C) 2015 The Authors. Published by Elsevier B.V.	[Abe, Hiroyuki; Horie, Tomoharu; Sumita, Keigo] Waseda Univ, Dept Phys, Tokyo 1698555, Japan	Sumita, K (reprint author), Waseda Univ, Dept Phys, Tokyo 1698555, Japan.	abe@waseda.jp; k.sumita@aoni.waseda.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan [25800158]; MEXT in Japan [25.4968]	H.A. was supported in part by the Grant-in-Aid for Scientific Research No. 25800158 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan. K.S. was supported in part by a Grant-in-Aid for JSPS Fellows No. 25.4968 from the MEXT in Japan.	Abe H, 2009, NUCL PHYS B, V814, P265, DOI 10.1016/j.nuclphysb.2009.02.002; Abe H, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.126006; Abe H, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.126003; Abe H., 2014, J HIGH ENERGY PHYS, V1404; Abe H, 2009, NUCL PHYS B, V820, P317, DOI [10.1016/j.nuclphysb.2009.05.024, 10.1010/j.nuclphysb.2009.05.024]; Abe H., 2014, J HIGH ENERGY PHYS, V1406; Abe H., ARXIV150503729HEPPH; Abe H., 2009, J HIGH ENERGY PHYS, V0906; Abe H., 2013, PROG THEOR EXP PHYS, V2013; Abe H., 2008, JHEP, V0809; Abe H., ARXIV150306770HEPTH; Abe T.H., 2014, J HIGH ENERGY PHYS, V1401; Abe H, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.105006; Abe H, 2006, NUCL PHYS B, V742, P187, DOI 10.1016/j.nuclphysb.2006.02.034; Angelantonj C, 2000, PHYS LETT B, V489, P223, DOI 10.1016/S0370-2693(00)00907-2; Lust D, 2004, NUCL PHYS B, V696, P205, DOI 10.1016/j.nuclphysb.2004.06.052; Blumenhagen R, 2007, PHYS REP, V445, P1, DOI 10.1016/j.physrep.2007.04.003; Abe H, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.046005; Abe H, 2012, NUCL PHYS B, V863, P1, DOI 10.1016/j.nuclphysb.2012.05.012; Choi K, 2005, NUCL PHYS B, V718, P113, DOI 10.1016/j.nuclphysb.2005.04.032; Fujimoto Y, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.086001; Arkani-Hamed N, 2000, PHYS REV D, V61, DOI 10.1103/PhysRevD.61.033005; Abe H, 2013, NUCL PHYS B, V870, P30, DOI 10.1016/j.nuclphysb.2013.01.014; Kachru S, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.046005; ALVAREZGAUME L, 1982, NUCL PHYS B, V207, P96, DOI 10.1016/0550-3213(82)90138-9; Abe H, 2014, NUCL PHYS B, V888, P194, DOI 10.1016/j.nuclphysb.2014.09.016; MARCUS N, 1983, NUCL PHYS B, V224, P159, DOI 10.1016/0550-3213(83)90318-8; Abe H, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.015002; Everett LL, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.101803; Arkani-Hamed N, 2002, J HIGH ENERGY PHYS; Bachas C., ARXIVHEPTH9503030; Blumenhagen R., 2001, FORTSCHR PHYS, V49, P591; Choi K., 2005, J HIGH ENERGY PHYS, V0509; Choi K., 2004, JHEP, V0411, DOI DOI 10.1088/1126-6708/2004/11/076; Choi KS, 2010, EUR PHYS J C, V67, P273, DOI 10.1140/epjc/s10052-010-1275-9; Cremades D, 2004, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2004/05/079; Di P. Vecchia, 2009, JHEP, V0903, P029; DINE M, 1982, PHYS LETT B, V110, P227, DOI 10.1016/0370-2693(82)91241-2; Abe T, 2015, NUCL PHYS B, V894, P374, DOI 10.1016/j.nuclphysb.2015.03.004; Ibanez LE, 2012, STRING THEORY AND PARTICLE PHYSICS: AN INTRODUCTION TO STRING PHENOMENOLOGY, P1; Kobayashi T., 2010, JHEP, V1005, P050; NAPPI CR, 1982, PHYS LETT B, V113, P175, DOI 10.1016/0370-2693(82)90418-X	42	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	NOV	2015	900						331	365		10.1016/j.nuclphysb.2015.09.014		35	Physics, Particles & Fields	Physics	CV5PJ	WOS:000364323000013		
J	Kimura, Y; Suzuki, R				Kimura, Yusuke; Suzuki, Ryo			Negative anomalous dimensions in N=4 SYM	NUCLEAR PHYSICS B			English	Article							YANG-MILLS-THEORY; OPERATOR PRODUCT EXPANSION; 4-POINT FUNCTIONS; ADS/CFT INTEGRABILITY; CORRELATORS; SUPERGRAVITY; EQUATIONS; SYMMETRY	We elucidate aspects of the one-loop anomalous dimension of so(6)-singlet multi-trace operators in N= 4 SU(N-C) SYM at finite N-C. First, we study how 1/N-C corrections lift the large N-C degeneracy of the spectrum, which we call the operator submixing problem. We observe that all large N-C zero modes acquire anomalous dimensions starting at order 1/N-C(2) with a non-positive coefficient and they mix only among the operators with the same number of traces at leading order. Second, we study the lowest one-loop dimension of operators of length equal to 2N(C). The dimension of such operators becomes more negative as N-C increases, which will eventually diverge in the double scaling limit. Third, we examine the structure of level-crossing at finite N-C in view of unitarity. Finally we find out a correspondence between the large N-C zero modes and completely symmetric polynomials of Mandelstam variables. (C) 2015 The Authors. Published by Elsevier B.V.	[Kimura, Yusuke] Okayama Inst Quantum Phys OIQP, Kita Ku, Okayama 7000015, Japan; [Suzuki, Ryo] Univ Oxford, Math Inst, Radcliffe Observ Quarter, Oxford OX2 6GG, England	Suzuki, R (reprint author), Univ Oxford, Math Inst, Radcliffe Observ Quarter, Andrew Wiles Bldg,Woodstock Rd, Oxford OX2 6GG, England.	londonmileend@gmail.com; Ryo.Suzuki@maths.ox.ac.uk					Abbott M.C., 2008, J HIGH ENERGY PHYS, V0806; Alday L.F., 2015, J HIGH ENERGY PHYS, V1506; Alday LF, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2014)007; Alday L.F., 2015, J HIGH ENERGY PHYS, V1502, P101; Andrianopoli L., 2000, ADV THEOR MATH PHYS, V4, P1149; Ishizeki R, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.126006; Bianchi M, 2004, NUCL PHYS B, V685, P65, DOI 10.1016/j.nuclphysb.2004.02-029; Arutyunov G, 2002, NUCL PHYS B, V643, P49, DOI 10.1016/S0550-3213(02)00679-X; von Neumann J, 1929, PHYS Z, V30, P467; Beisert N, 2003, NUCL PHYS B, V664, P131, DOI 10.1016/S0550-3213(03)00406-1; Kimura Y, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.126003; Kruczenski M, 2013, NUCL PHYS B, V875, P213, DOI 10.1016/j.nuclphysb.2013.06.016; D'Hoker E, 2000, NUCL PHYS B, V589, P38, DOI 10.1016/S0550-3213(00)00523-X; Beisert N, 2012, LETT MATH PHYS, V99, P3, DOI 10.1007/s11005-011-0529-2; Bianchi M, 2002, NUCL PHYS B, V646, P69, DOI 10.1016/S0550-3213(02)00817-9; Bianchi M, 2007, NUCL PHYS B, V767, P163, DOI 10.1016/j.nuclphysb.2006.12.005; Kimura Y, 2012, NUCL PHYS B, V865, P568, DOI 10.1016/j.nuclphysb.2012.08.010; Beisert N, 2003, NUCL PHYS B, V650, P125, DOI 10.1016/S0550-3213(02)01025-8; Cornalba L, 2007, NUCL PHYS B, V767, P327, DOI 10.1016/j.nuclphysb.2007.01.007; Eden B, 1999, NUCL PHYS B, V557, P355, DOI 10.1016/S0550-3213(99)00360-0; [Anonymous], 1998, ADV THEOR MATH PHYS, V2, P231; Corley S, 2002, NUCL PHYS B, V641, P131, DOI 10.1016/S0550-3213(02)00573-4; Dolan FA, 2006, ANN PHYS-NEW YORK, V321, P581, DOI 10.1016/j.aop.2005.07.005; Gonzalez-Rey F, 1999, PHYS LETT B, V448, P37, DOI 10.1016/S0370-2693(99)00017-9; Kristjansen C, 2012, LETT MATH PHYS, V99, P349, DOI 10.1007/s11005-011-0514-9; Beisert N, 2003, PHYS LETT B, V558, P229, DOI 10.1016/S0370-2693(03)00269-7; Koch RD, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.106009; [Anonymous], 1985, TEOR MAT FIZ, V63, P347; RESHETIKHIN NYU, 1983, LETT MATH PHYS, V7, P205, DOI 10.1007/BF00400435; Fateev VA, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/30/304011; Arutyunov G, 2003, NUCL PHYS B, V665, P273, DOI 10.1016/S0550-3213(03)00448-6; Arutyunov G, 2001, NUCL PHYS B, V609, P539, DOI 10.1016/S0550-3213(01)00266-8; Lin H, 2015, INT J GEOM METHODS M, V12, DOI 10.1142/S0219887815500474; Arutyunov G, 2003, NUCL PHYS B, V670, P103, DOI 10.1016/j.nuclphysb.2003.07.027; Boels RH, 2013, NUCL PHYS B, V876, P215, DOI 10.1016/j.nuclphysb.2013.08.009; Arutyunov G., 2011, JHEP, V1102, P025; Bajnok Z., 2014, J HIGH ENERGY PHYS, V1403; Balasubramanian V, 2002, J HIGH ENERGY PHYS; Balasubramanian V., 2005, JHEP, V0503; Berenstein D, 2005, J HIGH ENERGY PHYS; Berkovits N, 2008, J HIGH ENERGY PHYS; Bhattacharyya R., 2008, JHEP, V0803; BIANCHI M, 1999, JHEP, V9908, P20; Brown T.W., 2008, JHEP, V0806; Brown T.W., 2010, JHEP, V1005; Brown T.W., 2008, JHEP, V0802; Brown T.W., 2009, JHEP, V0904; Camanho X. O., ARXIV14075597HEPTH; Caputa P., 2010, J HIGH ENERGY PHYS, V1010; Caputa P., 2013, J HIGH ENERGY PHYS, V1306; Carlson W., 2011, JHEP, V1103, P105; Constable NR, 2002, J HIGH ENERGY PHYS; Corley S., 2002, ADV THEOR MATH PHYS, V5, P809; Cornalba L., 2007, J HIGH ENERGY PHYS, V0708; Cornalba L., 2007, J HIGH ENERGY PHYS, V0709; D'Hoker E., ARXIVHEPTH0201253; D'Hoker E, 2003, J HIGH ENERGY PHYS; De Comarmond V., 2011, JHEP, V1102; de Mello Koch R., 2012, J HIGH ENERGY PHYS, V1206; de Mello Koch R., 2007, JHEP, V0709; Koch RD, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP10(2011)009; de Mello Koch Robert, 2012, Physics Letters B, V713, DOI 10.1016/j.physletb.2012.06.057; de Mello Koch R., 2014, J HIGH ENERGY PHYS, V1402, P125; Dolan FA, 2002, NUCL PHYS B, V629, P3, DOI 10.1016/S0550-3213(02)00096-2; Drukker N., 2009, J HIGH ENERGY PHYS, V0904; Fokken J., 2014, J HIGH ENERGY PHYS, V1407, P150; Goncalves V., 2015, J HIGH ENERGY PHYS, V1504, P150; Grignani G., 2005, J HIGH ENERGY PHYS, V0512; Gross D.J., 2003, JHEP, V0305, DOI DOI 10.1088/1126-6708/2003/05/025; Hadasz L., 2010, JHEP, V1001; Hayashi H., 2007, JHEP, V0711; Hegedus A., 2015, J HIGH ENERGY PHYS, V1504, P107; Hofman Diego M, 2007, JHEP-Journal of High Energy Physics, DOI 10.1088/1126-6708/2007/11/063; Kaviraj A., ARXIV150201437HEPTH; Kemp G., 2014, J HIGH ENERGY PHYS, V1408, P137; Kimura Y., 2007, JHEP, V0711; Kimura Y., 2009, JHEP, V0912; Kimura Y, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP05(2010)103; Mack G., 2009, BULG J PHYS, V36, P214; Mack G., ARXIV09072407HEPTH; Makeenko Y, 2000, NATO ADV SCI I C-MAT, V556, P285; Maldacena J, 1999, INT J THEOR PHYS, V38, P1113, DOI 10.1023/A:1026654312961; Maldacena J.M., 1998, J HIGH ENERGY PHYS, V9812; Minahan JA, 2003, J HIGH ENERGY PHYS; Minahan J.A., 2015, J HIGH ENERGY PHYS, V1504, P134; OEIS Foundation Inc, 2011, ON LINE ENCY INTEGER; Okuda T., 2006, JHEP, V0603; Pasukonis J, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP02(2011)078; Penedones J, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2011)025; Poghossian R., 2009, JHEP, V0912; RESHETIKHIN NY, 1985, THEOR MATH PHYS+, V63, P555, DOI 10.1007/BF01017501; Ryzhov A.V., 2001, JHEP, V0111; THOOFT G, 1974, NUCL PHYS B, VB 72, P461; Uruchurtu L.I., 2007, J HIGH ENERGY PHYS, V0709; Vafa C., ARXIV14091603HEPTH; Velizhanin VN, 2009, JETP LETT+, V89, P593, DOI 10.1134/S0021364009120017; Witten E., 1998, J HIGH ENERGY PHYS, V9807	97	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	NOV	2015	900						603	659		10.1016/j.nuclphysb.2015.09.022		57	Physics, Particles & Fields	Physics	CV5PJ	WOS:000364323000025		
J	Toda, Y; Sakamoto, M; Tagaya, A; Takahashi, M; Davis, AJ				Toda, Yumiko; Sakamoto, Masayo; Tagaya, Akira; Takahashi, Mimi; Davis, Anne J.			Patient advocacy: Japanese psychiatric nurses recognizing necessity for intervention	NURSING ETHICS			English	Article						Expert nurse; mental disorders; nursing judgment; patient advocacy; patient's right; psychiatric nursing	MENTAL-HEALTH LAW; OF-THE-LITERATURE; SCHIZOPHRENIA	Background: Advocacy is an important role of psychiatric nurses because their patients are ethically, socially, and legally vulnerable. This study of Japanese expert psychiatric nurses' judgments of interventions for patient advocacy will show effective strategies for ethical nursing practice and their relationship with Japanese culture. Objectives: This article explores Japanese psychiatric nurses' decision to intervene as a patient advocate and examine their ethical, cultural, and social implications. Research design: Using semi-structured interviews verbatim, themes of the problems that required interventions were inductively summarized by a qualitative analysis and their contexts and nursing judgments were examined. Participants and research context: The participants were 21 nurses with 5 or more years of experience in psychiatric nursing. Ethical considerations: The research was approved by Institutional Review Board of research site and study facilities. The participants gave written informed consent. Findings: Analysis of 45 cases showed that nurses decided to intervene when (a) surrounding people's opinions impeded patients' safety, (b) healthcare professionals' policies impeded patients' decision-making, (c) own violent behaviors impeded treatment and welfare services for patients, (d) own or families' low acceptance of illness impeded patients' self-actualization, (e) inappropriate treatment or care impeded patients' liberty, and (f) their families abused patients' property. Discussion: To solve conflicts between patients and their surrounding people, the nurses sought reconciliation between them, which is in accordance with Japanese cultural norms respecting harmony. When necessary, however, they protected patients' rights against cultural norms. Therefore, their judgments cannot be explained by cultural norms alone. Conclusion: The findings indicate that the nurses' judgments were based on respect for patients' rights apart from cultural norms, and they first sought solutions fitting the cultural norms before other solutions. This seems to be an ethical, effective strategy if advocates know the culture in depth.	[Toda, Yumiko] Japanese Red Cross Hiroshima Coll Nursing, Hatsukaichi Shi 7380052, Japan; [Sakamoto, Masayo; Takahashi, Mimi] Kochi Univ, Kochi, Japan; [Tagaya, Akira; Davis, Anne J.] Nagano Coll Nursing, Nagano, Japan; [Davis, Anne J.] Univ Calif San Francisco, San Francisco, CA 94143 USA	Toda, Y (reprint author), Japanese Red Cross Hiroshima Coll Nursing, 1-2 Ajinadai Higashi, Hatsukaichi Shi 7380052, Japan.	yt11147@jrchcn.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [23593443]	This study was supported by the Grant-in-Aid for Scientific Research 2011-2013 (C) from the Ministry of Education, Culture, Sports, Science and Technology (No. 23593443).	Davis AJ, 2003, NURS ETHICS, V10, P404, DOI 10.1191/0969733003ne621oa; MINAMI H, 1985, INT J NURS STUD, V22, P311, DOI 10.1016/0020-7489(85)90050-1; Ertugrul A, 2004, SOC PSYCH PSYCH EPID, V39, P73, DOI 10.1007/s00127-004-0697-9; Jugessur T, 2009, J PSYCHIATR MENT HLT, V16, P187, DOI 10.1111/j.1365-2850.2008.01315.x; Linden M, 2001, SCHIZOPHRENIA BULL, V27, P585; Konishi E, 2009, NURS ETHICS, V16, P625, DOI 10.1177/0969733009106654; Weisstub DN, 2006, INT J LAW PSYCHIAT, V29, P86, DOI 10.1016/j.ijlp.2005.09.002; Asai K, 1998, PSYCHIAT CLIN NEUROS, V52, pS247; ASAI K, 1990, Journal of Korean Medical Science, V5, P117; Higashi Kyoko, 2013, Ther Adv Psychopharmacol, V3, P200, DOI 10.1177/2045125312474019; Ikenaga M, 1994, KANJA NO KENRI, P24; Iwamoto T, 2007, B KUMAMOTO U SCH HLT, V3, P13; Japanese Nursing Association, 2003, COD ETH NURS; Ministry of Health Labor and Welfare, 2012 NEN IR DOT CHOS, P22; Morgan G, 2010, MENTAL HLTH RELIG CU, V13, P625; Ohnishi K, 2011, J JPN HLTH MED ASS, V20, P73; Oya M, 1995, SEISHINKA IRYO HO JI, P34; Rengokai Kanto Bengoshikai, 2002, SEISHIN SHOGAI ARU H, P18; Rowe J, 2012, J PSYCHIATR MENT HLT, V19, P70, DOI 10.1111/j.1365-2850.2011.01756.x; Sawada A, 2001, J NURS SOC TOYAMA ME, V4, P7; Seishin-hoken-fukushi-hakusho Henshu-iinkai, 2013, SEISH HOK FUK HAK 20, P208; Takemura S, 2007, J HUM NURS STUD, V16, P13; Takemura S, 2008, J HUM NURS STUD, V6, P1; Tanaka M, 2009, SEISHIN SHOGAISHA TA; Tanaka M, 2010, J CLIN EXP DENT, V2, P6; Toda Y, 2009, J NURS RES SOC KOCHI, V3, P23; Usami S, 1999, SEISHINKAKANGO JPN J, V26, P33; Weisstub David N, 2003, Seishin Shinkeigaku Zasshi, V105, P881; WING JK, 1962, BRIT J SOC CLIN PSYC, V1, P38	29	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0969-7330	1477-0989		NURS ETHICS	Nurs. Ethics	NOV	2015	22	7					765	777		10.1177/0969733014547971		13	Nursing	Nursing	CV8WP	WOS:000364569200004		
J	Imai, M; Kuwahara, Y; Hirai, M; Nishimura, R; Nishimura, N; Shimizu, Y; Fujii, T; Iwase, S				Imai, Mika; Kuwahara, Yuko; Hirai, Makoto; Nishimura, Rumiko; Nishimura, Naoki; Shimizu, Yuuki; Fujii, Tetsuya; Iwase, Satoshi			Effects of Defecation Strain at Various Bed Reclining Angles on Intrarectal Pressure and Cardiovascular Responses	NURSING RESEARCH			English	Article						blood pressure; defecation; heart rate; intrarectal pressure; nursing care; patient positioning	VALSALVA MANEUVER; POSITION; POSTURE	Background: There is no clear information about the optimal bed reclining angle for promoting efficient and safe defecation in bedfast patients. Objective: The aim of this study was to examine the optimal bed reclining angle for facilitating increases in intrarectal pressure without causing marked cardiovascular changes in order to develop an efficient and safe defecation position for bedfast patients. Methods: Twelve healthy men participated in this study. The subjects were required to strain for 15 seconds at the end stage of inspiration while their bed was reclined at 0 degrees (supine), 15 degrees, 30 degrees, or 60 degrees. During straining, the subjects were asked to maintain (a) an intrarectal pressure of 20 mm Hg or (b) the maximal intrarectal pressure. Intrarectal pressure, blood pressure, heart rate, and abdominal muscle activity (electromyographic activity) were recorded continuously throughout the study period. Results: During straining, intrarectal pressure increased with the reclining angle, and a significant linear correlation was detected between the sine of the reclining angle of the bed and intrarectal pressure ((2) = .57, p < .01). When subjects were straining with the aim of maintaining maximal intrarectal pressure, the extent of the observed changes (delta) in blood pressure and heart rate did not differ significantly across the reclining angles. When subjects were straining with the aim of maintaining an intrarectal pressure of 20 mm Hg, the delta blood pressure decreased as the reclining angle increased 0 degrees: M = 23.7, SD = 15.3 mm Hg, 95% CI [11.9, 35.4]; 15 degrees: M = 25.9, SD = 10.8 mm Hg, 95% CI [17.6, 34.2]; 30 degrees: M = 17.7, SD = 9.4 mm Hg, 95% CI [10.4, 24.9]; 60 degrees: M = 15.5, SD = 9.5 mm Hg, 95% CI [8.1, 22.8]; 15 degrees versus 30 degrees: p < .05; 15 degrees versus 60 degrees: p < .05. The amount of muscle activity observed during straining decreased as the reclining angle increased. Discussion: In bedfast patients, it is suggested that higher reclining angles may enable safer and more efficient defecation, because it decreases the amount of muscle activity required to increase the intrarectal pressure and reduces the potentially deleterious effects of straining on the cardiovascular system to develop an efficient and safe defecation position for bedfast patients.	[Imai, Mika] Nagoya Univ, Sch Hlth Sci, Dept Nursing, Ogaki Womens Coll, Nagoya, Aichi 4648601, Japan; [Imai, Mika; Hirai, Makoto] Nagoya Univ, Sch Hlth Sci, Dept Nursing, Nagoya, Aichi 4648601, Japan; [Kuwahara, Yuko; Nishimura, Rumiko; Nishimura, Naoki; Shimizu, Yuuki; Iwase, Satoshi] Aichi Med Univ, Dept Physiol, Nagakute, Aichi 48011, Japan; [Fujii, Tetsuya] Seirei Christopher Univ, Dept Nursing, Hamamatsu, Shizuoka, Japan	Imai, M (reprint author), Nagoya Univ, Sch Hlth Sci, Dept Nursing, Higashi Ku, 1-1-20 Daiko Minami, Nagoya, Aichi 4648601, Japan.	imai.mika@c.mbox.nagoya-u.ac.jp			Yamaji Fumiko Nursing Research Fund	The authors would like to extend their gratitude to the subjects who participated in this study. The authors also acknowledge that the study was supported by the Yamaji Fumiko Nursing Research Fund.	Vogel ER, 2008, J CLIN NEUROPHYSIOL, V25, P313, DOI 10.1097/WNP.0b013e318182d319; BURKE D, 1977, J PHYSIOL-LONDON, V272, P399; METZGER BL, 1990, NURS RES, V39, P198; TENHARKEL ADJ, 1990, J APPL PHYSIOL, V68, P147; Sakakibara R, 2010, LUTS, V2, P16, DOI 10.1111/j.1757-5672.2009.00057.x; LITTLER WA, 1974, AM HEART J, V88, P205, DOI 10.1016/0002-8703(74)90011-8; Singer W, 2001, CLIN SCI, V100, P433, DOI 10.1042/CS20000208; Barrett K. E., 2012, GANONGS REV MED PHYS, P497; Fukai K., 1995, KANGO KENNKYU, V28, P25; Hirata T., 2004, RINSHO KANGO, V30, P500; Ishii C., 1995, JAPANESE NURSING ASS, V26, P41; Iwase S, 1987, Physiologist, V30, pS62; Kaneko H, 2006, PHY THER SCI, V21, P255; Kawase H, 1986, Kokyu To Junkan, V34, P51; Kera Takeshi, 2005, Journal of Physiological Anthropology and Applied Human Science, V24, P259, DOI 10.2114/jpa.24.259; Kunieda K., 1995, AUTONOMIC TESTING, P170; Kuwahara Y., 2011, JIRITUSHINKEI, V48, P48, DOI [10.1016/j.autneu.2011.08.019, DOI 10.1016/J.AUTNEU.2011.08.019]; Maruta K., 2006, KAWASAKI MED WELFARE, V15, P463; Mikami R., 2014, BASIC NURSING TECHNI, P55; OLSCHEWSKI H, 1990, EUR J APPL PHYSIOL O, V61, P20, DOI 10.1007/BF00236688; Sakakibara R., 2007, AUTONOMIC TESTING, P322; Sannomiya K., 2000, AUTONOMIC TESTING, P106; Shimizu T., 1997, CURRENT SITUATION SU; Takeo K., 2009, TECHNOLOGY NURSING P, P136; Toyoshima H., 1996, 1995 FISCAL GRANTS A, P1; Uchiyama T., 1997, THERAPEUTIC RES, V18, P196; Ujiie S., 2006, BASIC NURSING TECHNI, P397; Westerhof BE, 2006, AM J PHYSIOL-HEART C, V291, pH2864, DOI 10.1152/ajpheart.01024.2005; Yamashina Y., 2011, BIOPHILIA REHABILITA, V7, P1	29	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0029-6562	1538-9847		NURS RES	Nurs. Res.	NOV-DEC	2015	64	6					413	421		10.1097/NNR.0000000000000118		9	Nursing	Nursing	CV6YR	WOS:000364418800002		
J	Toyoshima, J; Nadaoka, K				Toyoshima, Junko; Nadaoka, Kazuo			Importance of environmental briefing and buoyancy control on reducing negative impacts of SCUBA diving on coral reefs	OCEAN & COASTAL MANAGEMENT			English	Article						Tourism management; Scuba diving; Environmental impact; Pre-dive briefing; Environmental education; Neutral buoyancy; Coral reefs	MARINE PROTECTED AREAS; NORTHERN RED-SEA; DIVE BRIEFINGS; ANCHOR DAMAGE; TOURISM; MANAGEMENT; COMMUNITIES; CAPACITY; FLORIDA; GROWTH	Scuba diving is a growing industry as a form of 'nature tourism' allowing enjoyment of the beauty of coral reef ecosystems. However, as the recreational diver population has increased, diving activities in some heavily dived sites have caused negative ecological impacts, with divers unintentionally contacting live corals and causing physical damage. In this research, we investigated the rate of divers' contacts and physical damage by observing divers' underwater behavior in Okinawa, Japan, and tested the effectiveness of pre-dive briefings as a mitigation measure. Of 105 divers observed, 7% contacted the live coral cover and caused skeletal breakage, and 91% made contact at least once but did not cause visible damage. The average contact frequency of the divers during 30 min of dive time was 0.53 times/min. The contact frequency of the divers decreased significantly after they listened to an environmental briefing among the divers who could maintain neutral buoyancy, but not in the divers who could not. This study suggests that buoyancy control training for divers may also be important for coral reef conservation in addition to environmental education. (C) 2015 Elsevier Ltd. All rights reserved.	[Toyoshima, Junko; Nadaoka, Kazuo] Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Dept Mech & Environm Informat, Meguro Ku, Tokyo 1528552, Japan	Toyoshima, J (reprint author), Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Dept Mech & Environm Informat, Meguro Ku, O Okayama 2-12-1-W8-13, Tokyo 1528552, Japan.	jtoyoshima0035@gmail.com; nadaoka@mei.titech.ac			Japan Society for Promotion of Science (JSPS) [24246086, 25257305]; JST/JICA SATREPS	We thank Mr. Kensuke Yokoi for valuable support and advice in planning and conducting the study. We also thank the dive tour operators who participated in this study for their cooperation and contributions. We thank the recreational divers for taking time to answer the questionnaire and for listening to the briefing during their vacation. We appreciate the volunteer divers, Mr. Kentaro Iwai, Mr. Ryutaro Yoshida, and Mr. Kazuya Hirai, for their help in data collection. The map of Okinawa was provided by Dr. Antoine Collin. This study was supported by Grants-in-Aid for Scientific Research (A) (No. 24246086 and 25257305) from the Japan Society for Promotion of Science (JSPS) and JST/JICA SATREPS.	Schleyer MH, 2000, B MAR SCI, V67, P1025; Van Treeck P, 1998, MAR POLLUT BULL, V37, P499; HAWKINS JP, 1993, J APPL ECOL, V30, P25, DOI 10.2307/2404267; DAVIS G E, 1977, Biological Conservation, V11, P29, DOI 10.1016/0006-3207(77)90024-6; Medio D, 1997, BIOL CONSERV, V79, P91, DOI 10.1016/S0006-3207(96)00074-2; Uyarra M, 2009, ENVIRON MANAGE, V43, P1, DOI 10.1007/s00267-008-9198-z; Camp E, 2012, OCEAN COAST MANAGE, V61, P30, DOI 10.1016/j.ocecoaman.2012.02.002; Harriott V, 1997, AMBIO, V26, P173; Dinsdale EA, 2004, ENVIRON MANAGE, V33, P126, DOI 10.1007/s00267-003-3056-9; Zakai D, 2002, BIOL CONSERV, V105, P179, DOI 10.1016/S0006-3207(01)00181-1; Guzner B, 2010, B MAR SCI, V86, P727; Lamb JB, 2014, BIOL CONSERV, V178, P88, DOI 10.1016/j.biocon.2014.06.027; Davenport J, 2006, ESTUAR COAST SHELF S, V67, P280, DOI 10.1016/j.ecss.2005.11.026; Au ACS, 2014, MAR POLLUT BULL, V85, P789, DOI 10.1016/j.marpolbul.2014.01.024; Hodgson G, 1999, MAR POLLUT BULL, V38, P345, DOI 10.1016/S0025-326X(99)00002-8; HAWKINS JP, 1994, AMBIO, V23, P503; Tratalos JA, 2001, BIOL CONSERV, V102, P67, DOI 10.1016/S0006-3207(01)00085-4; HAWKINS JP, 1992, BIOL CONSERV, V62, P171, DOI 10.1016/0006-3207(92)91045-T; Hasler H, 2008, MAR POLLUT BULL, V56, P1788, DOI 10.1016/j.marpolbul.2008.06.002; KAY AM, 1989, ENVIRON MANAGE, V13, P509, DOI 10.1007/BF01867685; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Polak O, 2012, OCEAN COAST MANAGE, V55, P94, DOI 10.1016/j.ocecoaman.2011.10.006; Barker NHL, 2004, BIOL CONSERV, V120, P481, DOI 10.1016/j.biocon.2004.03.021; Epstein N, 1999, CORAL REEFS, V18, P327, DOI 10.1007/s003380050207; RICHMOND RH, 1993, AM ZOOL, V33, P524; NEIL D, 1990, BIOL CONSERV, V52, P221, DOI 10.1016/0006-3207(90)90127-B; Rouphael AB, 2001, BIOL CONSERV, V100, P281, DOI 10.1016/S0006-3207(01)00032-5; WOODLAND D J, 1977, Biological Conservation, V11, P1, DOI 10.1016/0006-3207(77)90020-9; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Krieger JR, 2013, J COAST CONSERV, V17, P179, DOI 10.1007/s11852-012-0229-9; Allison WR, 1996, CORAL REEFS, V15, P215, DOI 10.1007/s003380050045; Worachananant S, 2008, J SUSTAIN TOUR, V16, P645, DOI 10.2167/jost771.0; Chadwick-Furman N.E., 1997, P91; DAVIS D, 1995, OCEAN COAST MANAGE, V26, P19, DOI 10.1016/0964-5691(95)00004-L; Hawkins J.P., 1997, P 8 INT COR REEF S, V2, P1923; Jameson A.S.C., 2007, J SUSTAIN TOUR, V15, P309; Lew AA, 2013, CONTEMP GEOGR LEIS T, V40, P29; Ministry of the Environment and Japanese Coral Reef Society, 2004, COR REEFS JAP; PENDLETON LH, 1994, COAST MANAGE, V22, P399, DOI 10.1080/08920759409362246; Talge H., 1992, P 7 INT COR REEF S G, V2, P1077; Tilmant J.T., 1981, P 4 INT COR REEF S, V1, P187	41	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0964-5691	1873-524X		OCEAN COAST MANAGE	Ocean Coastal Manage.	NOV	2015	116						20	26		10.1016/j.ocecoaman.2015.06.018		7	Oceanography; Water Resources	Oceanography; Water Resources	CV7FB	WOS:000364436700003		
J	Kanno, T; Nariai, Y; Tatsumi, H; Karino, M; Yoshino, A; Sekine, J				Kanno, Takahiro; Nariai, Yoshiki; Tatsumi, Hiroto; Karino, Masaaki; Yoshino, Aya; Sekine, Joji			A modified pectoralis major myocutaneous flap technique with improved vascular supply and an extended rotation arc for oral defects: A case report	Oncology Letters			English	Article						pectoralis major myocutaneous flap; oral cancer; reconstruction; blood supply; rotation arc	RECONSTRUCTION; HEAD; NECK	The pedicled pectoralis major myocutaneous (PMMC) flap is versatile, and is widely used for the treatment of surgical defects following oral cancer resection. Although free-tissue transfer of a vascularized free flap is often preferred, the clinical benefits of the PMMC flap should not be overlooked. The conventional technique of harvesting a PMMC flap involves a single vascular supply from the pectoral branch of the thoracoacromial artery. However, this approach compromises the distal skin island of the flap, and requires an indirect blood supply via communicating vessels, which increases the potential risk of partial distal flap necrosis. When harvesting a PMMC flap for oral and maxillofacial reconstruction, preservation of the lateral thoracic artery and use of the subclavian route are alternatives that ensure sufficient blood supply and an increased rotation arc. Such an approach enables the harvesting of a PMMC flap that can reach the entire oral cavity, including the infraorbital region, palate, middle pterygopalatine fossa and nasopharynx, with no risk of vascular insufficiency to the distal skin island. In conclusion, the technique described in the present study was able to improve the blood supply of the distal PMMC flap and increase its rotation arc.	[Kanno, Takahiro; Nariai, Yoshiki; Tatsumi, Hiroto; Karino, Masaaki; Yoshino, Aya; Sekine, Joji] Shimane Univ, Fac Med, Dept Oral & Maxillofacial Surg, Izumo, Shimane 6938501, Japan	Kanno, T (reprint author), Shimane Univ, Fac Med, Dept Oral & Maxillofacial Surg, 89-1 Enyacho, Izumo, Shimane 6938501, Japan.	tkanno@med.shimane-u.ac.jp			KAKENHI [25870452]	The authors of the present study would like to thank all of the participants. The present study was in part supported by Grant-in-Aid for Scientific Research (KAKENHI) and Young Scientists (B; grant no. 25870452 to Dr Takahiro Kanno).	Yang DP, 2003, J OTOLARYNGOL, V32, P12, DOI 10.2310/7070.2003.35357; Makiguchi T, 2013, J CRANIOFAC SURG, V24, pE179, DOI 10.1097/SCS.0b013e3182801898; Kiyokawa K, 1998, PLAST RECONSTR SURG, V102, P2336, DOI 10.1097/00006534-199812000-00010; Rikimaru H, 2009, PLAST RECONSTR SURG, V123, P1220, DOI 10.1097/PRS.0b013e31819f2967; Rikimaru H, 2005, PLAST RECONSTR SURG, V115, P1342, DOI 10.1097/01.PRS.0000156972.66044.5C; ARIYAN S, 1979, PLAST RECONSTR SURG, V63, P73, DOI 10.1097/00006534-197901000-00012; Jena A, 2014, J ORAL MAXIL SURG, V72, P222, DOI 10.1016/j.joms.2013.06.205; WEI WI, 1984, BRIT J PLAST SURG, V37, P568, DOI 10.1016/0007-1226(84)90151-6; Elazab EEB, 2012, EUR J PLAST SURG, V35, P9; National Comprehensive Cancer Network (NCCN), 2013, CLIN PRACT GUID ONC, P16; Po-Wing YA, 2006, J PLAST RECONSTR AES, V59, P1433	11	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2015	10	5					2739	2742		10.3892/ol.2015.3696		4	Oncology	Oncology	CV5QB	WOS:000364324800009		
J	Maeda, J; Fujii, Y; Fujisawa, H; Hirakawa, H; Cartwright, IM; Uesaka, M; Kitamura, H; Fujimori, A; Kato, TA				Maeda, Junko; Fujii, Yoshihiro; Fujisawa, Hiroshi; Hirakawa, Hirokazu; Cartwright, Ian M.; Uesaka, Mitsuru; Kitamura, Hisashi; Fujimori, Akira; Kato, Takamitsu A.			Hyperthermia-induced radiosensitization in CHO wild-type, NHEJ repair mutant and HR repair mutant following proton and carbon-ion exposure	Oncology Letters			English	Article						hyperthermia; DNA repair; hadron radiation	RAY-SENSITIVE MUTANTS; CHINESE-HAMSTER CELLS; HOMOLOGOUS RECOMBINATION; IONIZING-RADIATION; DNA-PK; KINASE-ACTIVITY; OVARY CELLS; HEAT; LINE; RADIOTHERAPY	The DNA repair mechanisms involved in hyperthermia-induced radiosensitization with proton and carbon ion radiation exposure were investigated in the present study. In a previous study, Chinese hamster ovary (CHO) cells were exposed to low linear energy transfer (LET) photon radiation. These cells can be sensitized by hyperthermia as a result of inhibition of homologous recombination (HR) repair. The present study used wild-type, non-homologous end joining (NHEJ) and HR repair-deficient CHO cells to define the contributions of each repair pathway to cellular lethality following hyperthermia-induced hadron radiation sensitization. The cells were exposed to ionizing radiation, followed by hyperthermia treatment (42.5 degrees C for 1 h). Hyperthermia-induced radiosensitization was determined by the colony formation assay and thermal enhancement ratio. HR repair-deficient cells exhibited no hyper-sensitization to X-rays, protons, or low and high LET carbon ions when combined with hyperthermia. Wild-type and NHEJ repair-deficient cells exhibited significant hyperthermia-induced sensitization to low LET photon and hadron radiation. Hyperthermia-induced sensitization to high LET carbon-ion radiation was less than at low LET radiation. Relative biological effectiveness (RBE) between radiation alone and radiation combined with hyperthermia cell groups was not significantly different in any of the cell lines, with the exception of wild-type cells exposed to high LET radiation, which exhibited a lower RBE in the combined group. The present study investigated additional cell lines to confirm the lower RBE observed in DNA repair-deficient cell lines. These findings suggested that hyperthermia-induced hyper-sensitization to hadron radiation is also dependent on inhibition of HR repair, as was observed with photon radiation in a previous study.	[Maeda, Junko; Cartwright, Ian M.; Kato, Takamitsu A.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Fujii, Yoshihiro] Ibaraki Prefectural Univ Hlth Sci, Dept Radiol Sci, Inashiki, Ibaraki 3000394, Japan; [Fujisawa, Hiroshi; Uesaka, Mitsuru] Univ Tokyo, Sch Engn, Tokyo 1138656, Japan; [Hirakawa, Hirokazu; Fujimori, Akira] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Int Open Lab, Chiba 2638555, Japan; [Kitamura, Hisashi] Natl Inst Radiol Sci, Res Dev & Support Ctr, Chiba 2638555, Japan	Kato, TA (reprint author), Colorado State Univ, Dept Environm & Radiol Hlth Sci, 1618 Campus Delivery, Ft Collins, CO 80523 USA.	takamitsu.kato@colostate.edu			Colorado State University start-up fund; Dr Akiko Ueno Radiobiology research fund; NIRS International Open Laboratory	The authors of the current study appreciate the technical support from the NIRS cyclotron and HIMAC. This study was partially funded by the Colorado State University start-up fund, the Dr Akiko Ueno Radiobiology research fund and the NIRS International Open Laboratory.	JEGGO PA, 1983, MUTAT RES, V112, P313, DOI 10.1016/0167-8817(83)90026-3; Dewey WC, 2009, INT J HYPERTHER, V25, P3, DOI 10.1080/02656730902747919; Tsujii H, 2012, JPN J CLIN ONCOL, V42, P670, DOI 10.1093/jjco/hys104; STACKHOUSE MA, 1993, RADIAT RES, V136, P241, DOI 10.2307/3578617; FULLER LF, 1988, MUTAT RES, V193, P109, DOI 10.1016/0167-8817(88)90041-7; MITCHEL REJ, 1985, RADIAT RES, V104, P234, DOI 10.2307/3576619; Zafar F, 2010, RADIAT RES, V173, P27, DOI 10.1667/RR1910.1; Maeda J, 2014, ONCOL REP, V31, P551, DOI 10.3892/or.2013.2902; GERWECK LE, 1975, RADIAT RES, V64, P611, DOI 10.2307/3574251; Zeng ZC, 2002, WORLD J GASTROENTERO, V8, P797; Tomita M, 2010, J RADIAT RES, V51, P493, DOI 10.1269/jrr.10039; Kinashi Y, 1998, INT J RADIAT ONCOL, V40, P1185, DOI 10.1016/S0360-3016(97)00943-7; Takahashi A, 2001, INT J RADIAT BIOL, V77, P1043, DOI 10.1080/09553000110066095; CHANG PY, 1992, RADIAT RES, V129, P272, DOI 10.2307/3578026; HOLAHAN EV, 1984, RADIAT RES, V97, P108, DOI 10.2307/3576193; Weyrather WK, 1999, INT J RADIAT BIOL, V75, P1357; Genet SC, 2013, J CELL PHYSIOL, V228, P1473, DOI 10.1002/jcp.24302; Umeda N, 2003, INT J RADIAT BIOL, V79, P671, DOI 10.1080/09553000310001596959; LEE YJ, 1987, J CELL PHYSIOL, V132, P1, DOI 10.1002/jcp.1041320102; MITCHEL REJ, 1984, RADIAT RES, V99, P627, DOI 10.2307/3576336; Kamada T, 2002, J CLIN ONCOL, V20, P4466, DOI 10.1200/JCO.2002.10.050; Woudstra EC, 1999, RADIAT RES, V152, P214, DOI 10.2307/3580096; Olsson G, 2004, CYTOGENET GENOME RES, V104, P227, DOI 10.1159/000077494; Takahashi A, 2000, INT J RADIAT ONCOL, V47, P489, DOI 10.1016/S0360-3016(99)00494-0; WHITMORE GF, 1989, INT J RADIAT BIOL, V56, P657, DOI 10.1080/09553008914551881; DEWEY WC, 1970, INT J RADIAT BIOL RE, V18, P91, DOI 10.1080/09553007014550861; Genet SC, 1990, ONCOL REP, V28, P1591; Hinz JM, 2006, NUCLEIC ACIDS RES, V34, P1358, DOI 10.1093/nar/gkl020; Ihara M, 2014, INT J HYPERTHER, V30, P102, DOI 10.3109/02656736.2014.887793; Kato TA, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-116; Lee YJ, 2000, CANCER RES, V47, P5960; Odijk H, 2002, P NATL ACAD SCI USA, V108, P9851	32	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2015	10	5					2828	2834		10.3892/ol.2015.3732		7	Oncology	Oncology	CV5QB	WOS:000364324800024		
J	Fujihara, S; Mori, H; Kobara, H; Nishiyama, N; Ayaki, M; Ohata, R; Ueda, N; Sugimoto, M; Kakehi, Y; Masaki, T				Fujihara, Shintaro; Mori, Hirohito; Kobara, Hideki; Nishiyama, Noriko; Ayaki, Maki; Ohata, Ryo; Ueda, Nobufumi; Sugimoto, Mikio; Kakehi, Yoshiyuki; Masaki, Tsutomu			Uncommon gastrointestinal bleeding during targeted therapy for advanced renal cell carcinoma: A report of four cases	Oncology Letters			English	Article						gastrointestinal bleeding; temsirolimus; sunitinib; sorafenib; targeted therapy; argon plasma coagulation	TEMSIROLIMUS; TRIAL	Clinically available targeted agents to treat advanced renal cell carcinoma (RCC) include sunitinib, sorafenib and temsirolimus. Sorafenib and sunitinib have been associated with bleeding in selected trials, but clinical and endoscopic characteristics of gastrointestinal bleeding are not well described. Herein, we report four cases of advanced RCC in which endoscopic hemostasis effectively resolved high-grade, life-threatening gastrointestinal bleeding that occurred during targeted therapy. Although stomatitis and mucositis have occurred during targeted therapies, life-threatening gastrointestinal bleeding is less common. In these four patients, the origins of gastrointestinal bleeding were identified, and complete endoscopic hemostasis was achieved. Endoscopies revealed variable characteristics including angiodysplasia, multiple gastric ulcers and oozing bleeding of the normal mucosa. Although the most effective diagnostic and treatment strategies are disputed, endoscopic examinations are best performed before starting targeted therapies. Additionally, these patients should be monitored even for rare life-threat-ening events.	[Mori, Hirohito; Kobara, Hideki; Nishiyama, Noriko; Ayaki, Maki; Masaki, Tsutomu] Kagawa Univ, Fac Med, Dept Gastroenterol & Neurol, Kagawa 7610793, Japan; [Ohata, Ryo] Tottori Red Cross Hosp, Dept Urol, Tottori 6808517, Japan; [Ueda, Nobufumi; Sugimoto, Mikio; Kakehi, Yoshiyuki] Kagawa Univ, Fac Med, Dept Urol, Kagawa 7610793, Japan	Masaki, T (reprint author), Kagawa Univ, Fac Med, Dept Gastroenterol & Neurol, 1750-1 Ikenobe, Kagawa 7610793, Japan.	tmasaki@med.kagawa-u.ac.jp					Je YJ, 2009, LANCET ONCOL, V10, P967, DOI 10.1016/S1470-2045(09)70222-0; Eisen T, 2012, JNCI-J NATL CANCER I, V104, P93, DOI 10.1093/jnci/djr511; Rini BI, 2009, J CLIN ONCOL, V27, P3225, DOI 10.1200/JCO.2008.19.9836; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Kirkali Z, 2011, BJU INT, V107, P1722, DOI 10.1111/j.1464-410X.2010.09985.x; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Gore ME, 2009, LANCET ONCOL, V10, P757, DOI 10.1016/S1470-2045(09)70162-7; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Gomez-Fernandez C, 2012, EUR J CANCER, V48, P340, DOI 10.1016/j.ejca.2011.11.028; Fujihara S, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-141; International Agency for Research on Cancer, GLOBOCAN PROJ CANC I; Kamba T, 2000, CELL, V96, P1788; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207	13	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2015	10	5					2895	2898		10.3892/ol.2015.3671		4	Oncology	Oncology	CV5QB	WOS:000364324800034		
J	Inadomi, K; Kumagai, H; Takayoshi, K; Ariyama, H; Kusaba, H; Nishie, A; Yamamoto, H; Takase, K; Tanaka, M; Sagara, K; Okumura, Y; Nio, K; Nakano, M; Arita, S; Oda, Y; Akashi, K; Baba, E				Inadomi, Kyoko; Kumagai, Hozumi; Takayoshi, Kotoe; Ariyama, Hiroshi; Kusaba, Hitoshi; Nishie, Akihiro; Yamamoto, Hidetaka; Takase, Ken; Tanaka, Mamoru; Sagara, Kosuke; Okumura, Yuta; Nio, Kenta; Nakano, Michitaka; Arita, Shuji; Oda, Yoshinao; Akashi, Koichi; Baba, Eishi			Successful combination chemotherapy for metastatic inflammatory myofibroblastic tumor: A case report	Oncology Letters			English	Article						inflammatory pseudotumor; metastatic inflammatory myofibroblastic tumor; chemotherapy; anaplastic lymphoma kinase rearrangement negative	PSEUDOTUMOR; THERAPY; MDM2	A 64-year-old male presented with increased abdominal fullness and fever. Radiological examination revealed moderate ascites, a tumor with a diameter of 12.5 cm in the mesenteric region, as well as multiple tumors in the thoracic and abdominal para-aortic regions and in the left supraclavicular regions. Pathohistological findings of the biopsy specimen revealed atypical spindle cells accompanied by infiltration of lymphocytes. The plasmacytes were positive for CD68, murine double minute 2 and S-100, while they were negative for a-smooth muscle actin, cyclin-dependent kinase 4 and anaplastic lymphoma kinase. Clinically, the patient presented systemic symptoms and laboratory results indicated an elevation in the inflammatory response, while the CT and MRI findings were consistent with an inflammatory myofibroblastic tumor (IMT). Based on the clinical and histological findings, the patient was diagnosed with IMT. In total, 4 cycles of combination chemotherapy with doxorubicin and ifosfamide were administered. Tumor size reduction by 50% was achieved subsequent to the 4th chemotherapy cycle. In conclusion, successful control of this rare metastatic IMT was achieved by systemic chemotherapy.	[Inadomi, Kyoko; Kumagai, Hozumi; Takayoshi, Kotoe; Ariyama, Hiroshi; Kusaba, Hitoshi; Tanaka, Mamoru; Sagara, Kosuke; Okumura, Yuta; Nio, Kenta; Nakano, Michitaka; Arita, Shuji; Akashi, Koichi] Kyushu Univ Hosp, Dept Hematol & Oncol, Fukuoka, Japan; [Nishie, Akihiro] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Fukuoka 8128582, Japan; [Yamamoto, Hidetaka; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 8128582, Japan; [Yamamoto, Hidetaka; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Pathol Sci, Fukuoka 8128582, Japan; [Takase, Ken] Natl Hosp Org, Kyushu Med Ctr, Dept Hematol, Fukuoka 8100065, Japan; [Baba, Eishi] Kyushu Univ, Fac Med Sci, Dept Comprehens Clin Oncol, Fukuoka 8128582, Japan	Baba, E (reprint author), Kyushu Univ, Fac Med Sci, Dept Comprehens Clin Oncol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	e-baba@intmed1.med.kyushu-u.ac.jp					Yamamoto H, 2003, HISTOPATHOLOGY, V42, P431, DOI 10.1046/j.1365-2559.2003.01611.x; MEIS JM, 1991, AM J SURG PATHOL, V15, P1146, DOI 10.1097/00000478-199112000-00005; Mano H, 2012, CANCER DISCOV, V2, P495, DOI 10.1158/2159-8290.CD-12-0009; Bertocchini A, 2011, J PEDIATR SURG, V46, pE17, DOI 10.1016/j.jpedsurg.2011.01.007; Kovach SJ, 2006, J SURG ONCOL, V94, P385, DOI 10.1002/jso.20516; Applebaum H, 2005, J PEDIATR SURG, V40, P999, DOI 10.1016/j.jpedsurg.2005.03.016; Johnson K, 2013, J PEDIAT HEMATOL ONC, V35, P414, DOI 10.1097/MPH.0b013e3182915cef; Gleason BC, 2008, J CLIN PATHOL, V61, P428, DOI 10.1136/jcp.2007.049387; Binh MBN, 2005, AM J SURG PATHOL, V29, P1340, DOI 10.1097/01.pas.0000170343.09562.39; Lucas DR, 2010, AM J SURG PATHOL, V34, P844, DOI 10.1097/PAS.0b013e3181db34d8; Butrynski JE, 2010, NEW ENGL J MED, V363, P1727, DOI 10.1056/NEJMoa1007056; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; COFFIN CM, 1995, AM J SURG PATHOL, V19, P859, DOI 10.1097/00000478-199508000-00001; Lawrence B, 2000, AM J PATHOL, V157, P377, DOI 10.1016/S0002-9440(10)64550-6; ESMO/European Sarcoma Network Working Group, 2014, ANN ONCOL, V25, DOI [10.1093/annonc/mdu254, DOI 10.1093/ANNONC/MDU254]; Kusunoki-Nakamoto F, 2013, INTERNAL MED, V52, P623, DOI 10.2169/internalmedicine.52.8785; National Cancer Institute, 1998, CANC THER EV PROGR C; Przkora R, 2004, EUR J CLIN INVEST, V34, P320, DOI 10.1111/j.1365-2362.2004.01333.x; Trecate G, 2010, PEDIAT BLOOD CANC, V54, P483; US Department of Health and Human Services, 2009, COMM TERM CRIT ADV E	20	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2015	10	5					2981	2985		10.3892/ol.2015.3708		5	Oncology	Oncology	CV5QB	WOS:000364324800050		
J	Hasegawa, S; Nagano, H; Konno, M; Eguchi, H; Tomokuni, A; Tomimaru, Y; Wada, H; Hama, N; Kawamoto, K; Kobayashi, S; Marubashi, S; Nishida, N; Koseki, J; Gotoh, N; Ohno, S; Yabuta, N; Nojima, H; Mori, M; Doki, Y; Ishii, H				Hasegawa, Shinichiro; Nagano, Hiroaki; Konno, Masamitsu; Eguchi, Hidetoshi; Tomokuni, Akira; Tomimaru, Yoshito; Wada, Hiroshi; Hama, Naoki; Kawamoto, Koichi; Kobayashi, Shogo; Marubashi, Shigeru; Nishida, Naohiro; Koseki, Jun; Gotoh, Noriko; Ohno, Shouichi; Yabuta, Norikazu; Nojima, Hiroshi; Mori, Masaki; Doki, Yuichiro; Ishii, Hideshi			Cyclin G2: A novel independent prognostic marker in pancreatic cancer	Oncology Letters			English	Article						immunohistochemical staining; cyclin G2; pancreatic cancer; overall survival	MALIGNANT-TRANSFORMATION; DECREASED EXPRESSION; RANDOMIZED-TRIAL; CARCINOMA; CELL; CHEMOTHERAPY; GEMCITABINE; GENES; CCNG2; CHEMORADIOTHERAPY	Unlike other cyclins that positively regulate the cell cycle, cyclin G2 (CCNG2) regulates cell proliferation as a tumor suppressor gene. A decreased CCNG2 expression serves as a marker for poor prognosis in several types of cancer. The aim of the present study was to clarify the correlation of CCNG2 expression with overall survival and histopathological factors in pancreatic cancer patients. This retrospective analysis included data from 36 consecutive patients who underwent complete surgical resection for pancreatic cancer and did not undergo any preoperative therapies. The association between prognoses and the expression of CCNG2 was assessed using immunohistochemical staining. Multivariate analysis identified that the expression of CCNG2 is an independent prognostic factor. In addition, the Kaplan-Meier curve for overall survival revealed that decreased expression of CCNG2 was a consistent indicator of poor prognosis in pancreatic cancer patients (P=0.0198). A decreased CCNG2 expression significantly correlated with venous invasion in tumor specimens and the tumor invasion depth. In conclusion, CCNG2 expression inversely reflected cancer progression and may be a novel, independent prognostic marker in pancreatic cancer.	[Hasegawa, Shinichiro; Nagano, Hiroaki; Eguchi, Hidetoshi; Tomokuni, Akira; Tomimaru, Yoshito; Wada, Hiroshi; Hama, Naoki; Kawamoto, Koichi; Kobayashi, Shogo; Marubashi, Shigeru; Mori, Masaki; Doki, Yuichiro] Osaka Univ, Dept Gastroenterol Surg, Grad Sch Med, Suita, Osaka 5650871, Japan; [Hasegawa, Shinichiro; Konno, Masamitsu; Nishida, Naohiro; Ishii, Hideshi] Osaka Univ, Dept Frontier Sci Canc & Chemotherapy, Grad Sch Med, Suita, Osaka 5650871, Japan; [Koseki, Jun; Ishii, Hideshi] Osaka Univ, Dept Canc Profiling Discovery, Grad Sch Med, Suita, Osaka 5650871, Japan; [Gotoh, Noriko] Kanazawa Univ, Canc Res Inst, Div Canc Cell Biol, Kanazawa, Ishikawa 9201192, Japan; [Ohno, Shouichi; Yabuta, Norikazu; Nojima, Hiroshi] Osaka Univ, Microbial Dis Res Inst, Dept Mol Genet, Osaka 5650871, Japan	Ishii, H (reprint author), Osaka Univ, Dept Canc Profiling Discovery, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	mmori@gesurg.med.osaka-u.ac.jp; hishii@gesurg.med.osaka-u.ac.jp			Platform for Drug Discovery, Informatics, and Structural Life Science; Ministry of Education, Culture, Sports, Science and Technology [23390199, 25112708, 25134711, 30253420, 26670604]; Third Comprehensive 10-year Strategy for Cancer Control, Ministry of Health, Labor, and Welfare [H23-003]; Kobayashi Cancer Research Foundation; Princess Takamatsu Cancer Research Fund, Japan; National Institute of Biomedical Innovation, Japan	The authors would like to thank the members of our laboratories for their contribution. This study was supported in part by: A Grant-in-Aid for Scientific Research and a grant from the Platform for Drug Discovery, Informatics, and Structural Life Science, from the Ministry of Education, Culture, Sports, Science and Technology (grant nos. 23390199, 25112708, 25134711, 30253420, 26670604; P-Direct); a Grant-in-Aid from the Third Comprehensive 10-year Strategy for Cancer Control, Ministry of Health, Labor, and Welfare (grant no. H23-003); a grant from the Kobayashi Cancer Research Foundation; a grant from the Princess Takamatsu Cancer Research Fund, Japan; and a grant from the National Institute of Biomedical Innovation, Japan.	Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; Kondo M, 1999, CLIN CANCER RES, V5, P4005; Li WJ, 2013, ASIAN PAC J CANCER P, V14, P6165, DOI 10.7314/APJCP.2013.14.10.6165; Cui DW, 2014, TUMOR BIOL, V35, P3017, DOI 10.1007/s13277-013-1389-4; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Ahmed S, 2012, MOL CANCER RES, V10, P636, DOI 10.1158/1541-7786.MCR-11-0502; Cui DW, 2014, TUMOR BIOL, V35, P3177, DOI 10.1007/s13277-013-1415-6; Ito Y, 2003, ANTICANCER RES, V23, P2335; Bates S, 1996, ONCOGENE, V13, P1103; Eguchi H, 2013, HEPATO-GASTROENTEROL, V60, P904, DOI 10.5754/hge12974; Zhao ZY, 2011, BRAIN RES BULL, V86, P189, DOI 10.1016/j.brainresbull.2011.07.010; Sun GG, 2014, TUMOR BIOL, V35, P2631, DOI 10.1007/s13277-013-1346-2; Kim Y, 2004, CANCER RES, V64, P8980, DOI 10.1158/0008-5472.CAN-04-1926; Fu G, 2011, ONCOGENE, V30, P3953, DOI 10.1038/onc.2011.127; Ohigashi H, 2009, ANN SURG, V250, P88, DOI 10.1097/SLA.0b013e3181ad65cc; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Naito Y, 2013, CELL CYCLE, V12, P1773, DOI 10.4161/cc.24878; Sun GG, 2014, TUMOR BIOL, V35, P3339, DOI 10.1007/s13277-013-1440-5; Choi MG, 2009, J SURG RES, V157, P168, DOI 10.1016/j.jss.2008.06.020; Padua MB, 2009, J CELL BIOCHEM, V107, P1182, DOI 10.1002/jcb.22222; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Kasukabe T, 2008, CANCER SCI, V99, P1693, DOI 10.1111/j.1349-7006.2008.00867.x; Evans DB, 2008, J CLIN ONCOL, V26, P3496, DOI 10.1200/JCO.2007.15.8634; Chen JQ, 2014, TUMOUR BIOL; Hasegawa S, 2014, BRIT J CANCER, V111, P1572, DOI 10.1038/bjc.2014.454; Sobin L, 2009, TNM CLASSIFICATION M	26	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2015	10	5					2986	2990		10.3892/ol.2015.3667		5	Oncology	Oncology	CV5QB	WOS:000364324800051		
J	Zhou, Y; Chen, P; Zhong, L				Zhou, Yu; Chen, Ping; Zhong, Liang			Compound gastroenteropancreatic neuroendocrine and gastrointestinal stromal tumors in the stomach: A case report	Oncology Letters			English	Article						gastroenteropancreatic neuroendocrine tumors; gastrointestinal stromal tumors; stomach	OF-FUNCTION MUTATIONS; CARCINOID-TUMORS; EPIDEMIOLOGY; MANAGEMENT; BIOLOGY; GENE	Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) combined with gastrointestinal stromal tumors (GISTs) are rarely observed in the clinic. In the present study, the case of a 56-year-old female diagnosed with compound GEP-NETs and GISTs was reported. The patient initially presented with epigastric discomfort. The pre-operative diagnosis was of GISTs based on the endoscopic and imaging findings. A subtotal gastrectomy and Roux-en-Y reconstruction were successfully performed. The final diagnosis was revised to be compound GEP-NETs and GISTs based on the pathological findings. After 17 months of follow-up examinations using computed tomography and ultrasonography, the patient showed no symptoms or signs of recurrence.	[Zhou, Yu; Chen, Ping; Zhong, Liang] Yangzhou Univ, Subei Peoples Hosp Jiangsu, Clin Med Coll, Dept Gastrointestinal Surg, Yangzhou 225001, Jiangsu, Peoples R China; [Zhong, Liang] Univ Tokyo, Grad Sch Med, Dept Gastrointestinal Surg, Tokyo 1130033, Japan	Chen, P (reprint author), Yangzhou Univ, Subei Peoples Hosp Jiangsu, Clin Med Coll, Dept Gastrointestinal Surg, 98 Nantong West Rd, Yangzhou 225001, Jiangsu, Peoples R China.	chen86ky@126.com; 250537471@qq.com					Modlin IM, 2003, CANCER, V97, P934, DOI 10.1002/cncr.11105; Schimmack S, 2011, LANGENBECK ARCH SURG, V396, P273, DOI 10.1007/s00423-011-0739-1; Modlin IM, 2008, LANCET ONCOL, V9, P61, DOI 10.1016/S1470-2045(07)70410-2; Lawrence B, 2011, ENDOCRIN METAB CLIN, V40, P1, DOI 10.1016/j.ecl.2010.12.005; Robinson TL, 2000, AM J PATHOL, V156, P1157, DOI 10.1016/S0002-9440(10)64984-X; Corless CL, 2004, J CLIN ONCOL, V22, P3813, DOI 10.1200/JCO.2004.05.140; Modlin IM, 2010, MED J AUSTRALIA, V193, P46; Ramage JK, 2012, GUT, V61, P6, DOI 10.1136/gutjnl-2011-300831; Reddy P, 2007, J CLIN PHARM THER, V32, P557, DOI 10.1111/j.1365-2710.2007.00852.x; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Kloppel G, 2009, NEUROENDOCRINOLOGY, V90, P162, DOI 10.1159/000182196; Daniels M, 2011, CANCER LETT, V312, P43, DOI 10.1016/j.canlet.2011.07.029; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Kloppel G, 2005, BEST PRACT RES CL GA, V19, P507, DOI 10.1016/j.bpg.2005.02.010; Rabin I, 2009, ISR MED ASSOC J, V11, P98; Hirota S, 2003, GASTROENTEROLOGY, V125, P660, DOI 10.1016/S001-5085(03)01046-1; Miettinen M, 2011, J SURG ONCOL, V104, P865, DOI 10.1002/jso.21945; Oberg K, 2011, CANCER METAST REV, V30, P3, DOI 10.1007/s10555-011-9292-1; Kang YN, 2010, CANCER RES TREAT, V42, P135, DOI 10.4143/crt.2010.42.3.135; George Suzanne, 2002, Curr Treat Options Oncol, V3, P489, DOI 10.1007/s11864-002-0068-2; Hamilton SR, 2000, PATHOLOGY GENETICS T; National Comprehensive Cancer Network (NCCN), 2009, NCCN CLIN PRACT GUID; Oberg K, 2005, Rocz Akad Med Bialymst, V50, P62	24	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2015	10	5					2996	2998		10.3892/ol.2015.3666		3	Oncology	Oncology	CV5QB	WOS:000364324800053		
J	Motoori, M; Yano, M; Tanaka, K; Kishi, K; Takahashi, H; Inoue, M; Saito, T; Sugimura, K; Fujiwara, Y; Ishikawa, O; Sakon, M				Motoori, Masaaki; Yano, Masahiko; Tanaka, Koji; Kishi, Kentaro; Takahashi, Hidenori; Inoue, Masahiro; Saito, Takuro; Sugimura, Keijiro; Fujiwara, Yoshiyuki; Ishikawa, Osamu; Sakon, Masato			Intraoperative photodynamic diagnosis of lymph node metastasis in esophageal cancer patients using 5-aminolevulinic acid	Oncology Letters			English	Article						aminolevulinic acid; esophageal cancer; intraoperative diagnosis; lymph node metastasis; photodynamic diagnosis	SUPERFICIAL BLADDER-CANCER; PROSPECTIVE TRIAL; GASTRIC-CANCER; THERAPY; DISSECTION; MICROMETASTASIS; RESECTION; SURGERY	Lymph node metastasis is the strongest prognostic factor in esophageal cancer patients who have undergone esophagectomy. The accurate diagnosis of lymph node metastasis is important, but the pre-operative diagnostic accuracy is poor. The intraoperative diagnosis based on histopathological examination of frozen tissue specimens is complicated and time-consuming. Therefore, the establishment of a simple and rapid intraoperative diagnostic method is essential. Exogenous application of 5-aminolevulinic acid ( ALA) causes a selective accumulation of protoporphyrin-IX, which is a fluorescent substrate, in cancer cells. The present study evaluated the feasibility of photodynamic diagnosis using ALA ( ALA-PDD) for lymph node metastasis in esophageal cancer. A total of 292 lymph nodes were analyzed from 8 esophageal squamous cell cancer patients treated with esophagectomy. The patients were administered ALA orally prior to surgery. Excised lymph nodes were cut in half and examined by spectrometer. The diagnostic results of ALA-PDD were compared to those of the histopathological examination. Among the 292 lymph nodes, 19 nodes (6.5%) were histologically metastatic and 21 nodes (7.2%) were PDD-positive. The sensitivity and specificity of ALA-PDD were 84.2% (16/19) and 98.2% (268/273), respectively. The area of cancer nests of the PDD-negative lymph nodes was < 2 mm(2). Metastatic lymph nodes, including cancer nests > 4 mm(2), were correctly diagnosed by ALA-PDD. In conclusion, this study demonstrated that ALA-PDD of lymph node metastasis in patients with esophageal cancer is feasible. Further investigation would make this method a simple and rapid intraoperative diagnostic tool.	[Motoori, Masaaki; Yano, Masahiko; Tanaka, Koji; Kishi, Kentaro; Takahashi, Hidenori; Saito, Takuro; Sugimura, Keijiro; Fujiwara, Yoshiyuki; Ishikawa, Osamu; Sakon, Masato] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka 5378511, Japan; [Inoue, Masahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Osaka 5378511, Japan	Motoori, M (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Higashinari Ku, 1-3-3 Nakamichi, Osaka 5378511, Japan.	m-moto@fg8.so-net.ne.jp					Yoshioka S, 2002, SURGERY, V132, P34, DOI 10.1067/msy.2002.125306; Miyata H, 2006, J SURG ONCOL, V93, P477, DOI 10.1002/jso.20453; Hinnen P, 1998, BRIT J CANCER, V78, P679, DOI 10.1038/bjc.1998.559; Pech O, 2005, GASTROINTEST ENDOSC, V62, P24, DOI 10.1016/S0016-5107(05)00333-0; Rhodes LE, 2004, ARCH DERMATOL, V140, P17, DOI 10.1001/archderm.140.1.17; Kishi K, 2012, J SURG ONCOL, V106, P294, DOI 10.1002/jso.23075; Koizumi N, 2013, ANN SURG ONCOL, V20, P3541, DOI 10.1245/s10434-013-3017-3; Webber J, 1999, ANN SURG, V230, P12, DOI 10.1097/00000658-199907000-00003; AKIYAMA H, 1994, ANN SURG, V220, P364, DOI 10.1097/00000658-199409000-00012; Messmann H, 1999, GASTROINTEST ENDOSC, V49, P97, DOI 10.1016/S0016-5107(99)70453-0; Nishimaki T, 1999, ANN THORAC SURG, V68, P2059, DOI 10.1016/S0003-4975(99)01171-6; Denzinger S, 2007, UROLOGY, V69, P675, DOI 10.1016/j.urology.2006.12.023; Daniltchenko DI, 2005, J UROLOGY, V174, P2129, DOI 10.1097/01.ju.0000181814.73466.14; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Gaullier JM, 1997, CANCER RES, V57, P1481; Wu LF, 2003, WORLD J GASTROENTERO, V9, P219; Braathen LR, 2007, J AM ACAD DERMATOL, V56, P125, DOI 10.1016/j.jaad.2006.06.006; Sobin L, 2009, TNM CLASSIFICATION M	18	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2015	10	5					3035	3039		10.3892/ol.2015.3685		5	Oncology	Oncology	CV5QB	WOS:000364324800060		
J	Kato, D; Chihara, Y; Shirase, T; Takahashi, T; Takahashi, KI; Sakai, N				Kato, Daisuke; Chihara, Yuichi; Shirase, Tomoyuki; Takahashi, Tamaki; Takahashi, Ken-Ichi; Sakai, Naoki			Successful treatment of two consecutive cases of pulmonary pleomorphic carcinoma with platinum chemotherapy	Oncology Letters			English	Article						pulmonary pleomorphic carcinoma; chemotherapy; taxanes	SARCOMATOID CARCINOMA; PALLIATIVE CHEMOTHERAPY; LUNG; CLASSIFICATION; OUTCOMES; TUMORS	Pulmonary pleomorphic carcinoma (PPC) is a rare pulmonary malignant tumor that has a more aggressive clinical course and a poorer prognosis compared with non-small cell lung cancer (NSCLC) due to its resistance to chemotherapy and radiotherapy. In patients with advanced or relapsed PPC, it has been reported that the response rate to chemotherapy regimens known to be effective in patients with NSCLC is only 0-17%. The present study reports the cases of two consecutive patients with advanced PPC who exhibited marked responses to chemotherapy with carboplatin plus paclitaxel chemotherapy and long-term survival without tumor progression. This suggests that carboplatin plus paclitaxel chemotherapy is a good option for the treatment of advanced PPC.	[Kato, Daisuke; Chihara, Yuichi; Takahashi, Tamaki; Takahashi, Ken-Ichi; Sakai, Naoki] Otsu Red Cross Hosp, Resp Dis Ctr, Otsu, Shiga 5208511, Japan; [Shirase, Tomoyuki] Otsu Red Cross Hosp, Dept Pathol, Otsu, Shiga 5208511, Japan	Chihara, Y (reprint author), Otsu Red Cross Hosp, Resp Dis Ctr, 1-1-35 Nagara, Otsu, Shiga 5208511, Japan.	ro3107@kuhp.kyoto-u.ac.jp					Yuki T, 2007, J THORAC CARDIOV SUR, V134, P399, DOI 10.1016/j.jtcvs.2007.04.018; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; SHANNON RL, 1992, CANCER, V69, P2676, DOI 10.1002/1097-0142(19920601)69:11<2676::AID-CNCR2820691109>3.0.CO;2-P; Lee KW, 2011, JPN J CLIN ONCOL, V41, P430, DOI 10.1093/jjco/hyq180; Mochizuki T, 2008, AM J SURG PATHOL, V32, P1727, DOI 10.1097/PAS.0b013e3181804302; Bae HM, 2007, LUNG CANCER, V58, P112, DOI 10.1016/j.lungcan.2007.05.006; Rossi G, 2003, AM J SURG PATHOL, V27, P311, DOI 10.1097/00000478-200303000-00004; Yendamuri S, 2012, SURGERY, V152, P397, DOI 10.1016/j.surg.2012.05.007; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Ito K, 2010, LUNG CANCER, V68, P204, DOI 10.1016/j.lungcan.2009.06.002; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Hong JY, 2009, MED ONCOL, V26, P287, DOI 10.1007/s12032-008-9117-4; FISHBACK NF, 1994, CANCER, V73, P2936, DOI 10.1002/1097-0142(19940615)73:12<2936::AID-CNCR2820731210>3.0.CO;2-U; Kawano R, 2008, JPN J LUNG CANC, V48, P106; Park JS, 2011, ONCOLOGY-BASEL, V81, P206, DOI 10.1159/000333095; Travis WD, 1999, HISTOLOGICAL TYPING	16	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2015	10	5					3040	3042		10.3892/ol.2015.3678		3	Oncology	Oncology	CV5QB	WOS:000364324800061		
J	Yasuda, M; Hatanaka, T; Shirato, H; Nishioka, T				Yasuda, Motoaki; Hatanaka, Tomoyuki; Shirato, Hiroki; Nishioka, Takeshi			Involvement of UTR-dependent gene expression in the maintenance of cancer stem cell like phenotypes	Oncology Letters			English	Article						hypoxia-inducible factor-1 alpha; Ets2; c-fos; repopulation; radio-resistance; untranslated region; cancer stem cell	FRACTIONATED-IRRADIATION; TREATMENT TIME; RADIOTHERAPY; REPOPULATION; METASTASIS; P53	The present study demonstrated the acquisition of additional malignant characteristics in irradiated mouse fibrosarcoma cells compared with the parent cells. Several reporter assays indicated that hypoxia-inducible factor (HIF)-1 alpha, activator protein-1 and Ets-dependent transcription were activated in irradiated cells. The cis-elements in the 5'-untranslated region (UTR) of these transcription factors plays a major role in their expression in surviving irradiated cancer cells. By contrast, there were no evident differences between the 3'-UTR-dependent repression demonstrated by parent cells and irradiated cells. A small population of parental fibrosarcoma cells was also found to exhibit the same enhanced 5'-UTR-dependent HIF-1 alpha expression as that demonstrated by irradiated cells. These observations may indicate that high-dose X-ray irradiation affects the majority of proliferating cancer cells, but not the cancer stem cells (CSCs), and an increased CSC population may explain the progressive phenotypes of the irradiated cells. It appears likely that the transcription factors that maintain stemness are regulated by the same 5'-UTR-dependent mechanism.	[Yasuda, Motoaki; Hatanaka, Tomoyuki] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Pathobiol, Sapporo, Hokkaido 0608586, Japan; [Shirato, Hiroki] Hokkaido Univ, Grad Sch Med, Dept Radiol & Nucl Med, Sapporo, Hokkaido 0608638, Japan; [Nishioka, Takeshi] Hokkaido Univ, Grad Sch Med, Dept Biol Sci, Sapporo, Hokkaido 0600812, Japan	Yasuda, M (reprint author), Hokkaido Univ, Grad Sch Dent Med, Dept Oral Pathobiol, Kita Ku, Kita 13 Nishi 7, Sapporo, Hokkaido 0608586, Japan.	moyasuda@den.hokudai.ac.jp; trout@hs.hokudai.ac.jp			Ministry of Education, Science, and Culture of Japan [B24390285]	This study was supported by a Grant-in-Aid for Scientific Research (grant no. B24390285) provided by the Ministry of Education, Science, and Culture of Japan.	Akita H, 2014, CANCER RES, V74, P5903, DOI 10.1158/0008-5472.CAN-14-0527; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Sales KM, 2007, STEM CELL REV, V3, P249, DOI 10.1007/s12015-007-9002-0; ALLAM A, 1995, INT J RADIAT ONCOL, V32, P105, DOI 10.1016/0360-3016(95)00511-V; MALAISE E, 1966, CR ACAD SCI D NAT, V263, P292; Habelhah H, 1999, ONCOGENE, V18, P1771, DOI 10.1038/sj.onc.1202465; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Munera J, 2011, STEM CELLS, V29, P430, DOI 10.1002/stem.599; WITHERS HR, 1988, ACTA ONCOL, V27, P131; Bonizzi G, 2012, TRENDS MOL MED, V18, P6, DOI 10.1016/j.molmed.2011.08.002; Yasuda M, 2014, BIOCHEM BIOPH RES CO, V447, P638, DOI 10.1016/j.bbrc.2014.04.058; BECKBORNHOLDT HP, 1991, ACTA ONCOL, V30, P57; BEGG AC, 1991, EUR J CANCER, V27, P537, DOI 10.1016/0277-5379(91)90211-U; Aloni-Grinstein R, 2014, FEBS LETT, V588, P2580, DOI 10.1016/j.febslet.2014.02.011; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Nishioka T, 2009, CELL STRUCT FUNCT, V34, P17; Sagar J, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-9; Withers H R, 1988, Front Radiat Ther Oncol, V22, P105	19	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2015	10	5					3171	3176		10.3892/ol.2015.3688		6	Oncology	Oncology	CV5QB	WOS:000364324800082		
J	Yamamoto, N; Kozaki, A; Hartomo, TB; Yanai, T; Hasegawa, D; Kawasaki, K; Kosaka, Y; Matsuo, M; Hirase, S; Mori, T; Hayakawa, A; Iijima, K; Nishio, H; Nishimura, N				Yamamoto, Nobuyuki; Kozaki, Aiko; Hartomo, Tri Budi; Yanai, Tomoko; Hasegawa, Daiichiro; Kawasaki, Keiichiro; Kosaka, Yoshiyuki; Matsuo, Masafumi; Hirase, Satoshi; Mori, Takeshi; Hayakawa, Akira; Iijima, Kazumoto; Nishio, Hisahide; Nishimura, Noriyuki			Differential expression of minimal residual disease markers in peripheral blood and bone marrow samples from high-risk neuroblastoma patients	Oncology Letters			English	Article						neuroblastoma; minimal residual disease; peripheral blood; bone marrow	CIRCULATING TUMOR-CELLS; CANCER-PATIENTS; BIOLOGICAL INSIGHTS; BREAST-CANCER; PCR MARKERS; IDENTIFICATION; CHALLENGES	Neuroblastoma is an aggressive solid tumor that leads to tumor relapse in more than half of high-risk patients. Minimal residual disease (MRD) is primarily responsible for tumor relapses and may be detected in peripheral blood (PB) and bone marrow (BM) samples. To evaluate the disease status and treatment response, a number of MRD detection protocols based on either common or distinct markers for PB and BM samples have been reported. However, the correlation between the expression of MRD markers in PB and BM samples remains elusive in the clinical samples. In the present study, the expression of 11 previously validated MRD markers (CHRNA3, CRMP1, DBH, DCX, DDC, GABRB3, GAP43, ISL1, KIF1A, PHOX2B and TH) was determined in 23 pairs of PB and BM samples collected from seven high-risk neuroblastoma patients at the same time point, and the sample was scored as MRD-positive if one of the MRD markers exceeded the normal range. Although the number of MRD-positive samples was not significantly different between PB and BM samples, the two most sensitive markers for PB samples (CRMP1 and KIF1A) were different from those for BM samples (PHOX2B and DBH). There was no statistically significant correlation between the expression of MRD markers in the PB and BM samples. These results suggest that MRD markers were differentially expressed in PB and BM samples from high-risk neuroblastoma patients.	[Yamamoto, Nobuyuki; Hirase, Satoshi; Mori, Takeshi; Hayakawa, Akira; Iijima, Kazumoto; Nishio, Hisahide; Nishimura, Noriyuki] Kobe Univ, Grad Sch Med, Dept Pediat, Kobe, Hyogo 6500017, Japan; [Kozaki, Aiko; Yanai, Tomoko; Hasegawa, Daiichiro; Kawasaki, Keiichiro; Kosaka, Yoshiyuki] Kobe Childrens Hosp, Dept Hematol & Oncol, Kobe, Hyogo 6540081, Japan; [Hartomo, Tri Budi; Nishio, Hisahide; Nishimura, Noriyuki] Kobe Univ, Grad Sch Med, Dept Epidemiol, Kobe, Hyogo 6500017, Japan; [Matsuo, Masafumi] Kobe Gakuin Univ, Dept Rehabil Med, Kobe, Hyogo 6512180, Japan	Nishimura, N (reprint author), Kobe Univ, Grad Sch Med, Dept Pediat, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	nnishi@med.kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Children's Cancer Association of Japan; Hyogo Science and Technology Association	This study was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and grants from the Children's Cancer Association of Japan and Hyogo Science and Technology Association.	Alix-Panabieres C, 2014, NAT REV CANCER, V14, P623, DOI 10.1038/nrc3820; Vermeulen L, 2012, LANCET ONCOL, V13, pE83, DOI 10.1016/S1470-2045(11)70257-1; Hartomo TB, 2013, ONCOL REP, V29, P1629, DOI 10.3892/or.2013.2286; Yanez Y, 2011, J CANCER RES CLIN, V137, P1263, DOI 10.1007/s00432-011-0997-x; Muller V, 2010, EUR J CANCER, V46, P1189, DOI 10.1016/j.ejca.2010.02.038; Mordant P, 2012, CANCER TREAT REV, V38, P101, DOI 10.1016/j.ctrv.2011.04.014; Viprey VF, 2008, J PATHOL, V216, P245, DOI 10.1002/path.2406; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Stutterheim J, 2012, J MOL DIAGN, V14, P168, DOI 10.1016/j.jmoldx.2011.12.002; Castleberry RP, 1997, EUR J CANCER, V33, P2113, DOI 10.1016/S0959-8049(97)00202-5; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Cheung IY, 2008, CLIN CANCER RES, V14, P7020, DOI 10.1158/1078-0432.CCR-08-0541; Corrias MV, 2012, PEDIATR BLOOD CANCER, V58, P43, DOI 10.1002/pbc.22960; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Hodgkinson CL, 2014, NAT MED, V20, P897, DOI 10.1038/nm.3600; Stutterheim J, 2009, CLIN CHEM, V55, P1316, DOI 10.1373/clinchem.2008.117945; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Stutterheim J, 2011, EUR J CANCER, V47, P1193, DOI 10.1016/j.ejca.2011.02.003; Plaks V, 2013, SCIENCE, V341, P1186, DOI 10.1126/science.1235226; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kang YB, 2013, CANCER CELL, V23, P573, DOI 10.1016/j.ccr.2013.04.017; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Lin H, 2011, CRIT REV ONCOL HEMAT, V77, P2, DOI 10.1016/j.critrevonc.2010.04.008; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577	24	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2015	10	5					3228	3232		10.3892/ol.2015.3710		5	Oncology	Oncology	CV5QB	WOS:000364324800092		
J	Furukawa, M; Toyooka, S; Hayashi, T; Yamamoto, H; Fujimoto, N; Soh, J; Hashida, S; Shien, K; Asano, H; Aoe, K; Okabe, K; Pass, HI; Tsukuda, K; Kishimoto, T; Miyoshi, S				Furukawa, Masashi; Toyooka, Shinichi; Hayashi, Tatsuro; Yamamoto, Hiromasa; Fujimoto, Nobukazu; Soh, Junichi; Hashida, Shinsuke; Shien, Kazuhiko; Asano, Hiroaki; Aoe, Keisuke; Okabe, Kazunori; Pass, Harvey I.; Tsukuda, Kazunori; Kishimoto, Takumi; Miyoshi, Shinichiro			DNA copy number gains in malignant pleural mesothelioma	Oncology Letters			English	Article						malignant pleural mesothelioma; lung adenocarcinoma; copy number; reverse transcription-quantitative polymerase chain reaction	FACTOR RECEPTOR EGFR; LUNG-CANCER; GENE MUTATION; HOMOZYGOUS DELETION; PHASE-II; AMPLIFICATION; GEFITINIB; ADENOCARCINOMA; METHYLATION; CARCINOMAS	Malignant pleural mesothelioma (MPM) is a highly aggressive tumor with an extremely poor prognosis. The incidence of MPM is increasing as a result of widespread exposure to asbestos. The molecular pathogenesis of MPM remains unclear. The present study analyzed the frequency of various genomic copy number gains (CNGs) in MPM using reverse transcription-quantitative polymerase chain reaction. A total of 83 primary MPMs and 53 primary lung adenocarcinomas were analyzed to compare the CNGs of EGFR, KRAS, MET, FGFR1 and SOX2. In MPM, the CNGs of EGFR, KRAS, MET, FGFR1 and SOX2 were detected in 12 (14.5%), 8 (9.6%), 5 (6.0%), 4 (4.8%) and 1 (1.2%) of the samples, respectively. In lung adenocarcinomas, the CNGs of EGFR, KRAS, MET, FGFR1 and SOX2 were detected in 21 (39.6%), 12 (22.6%), 5 (9.4%), 10 (18.9%) and 0 (0.0%) of the samples, respectively. The CNGs of EGFR, KRAS and FGFR1 were significantly less frequent in the MPMs compared with the lung adenocarcinomas (P=0.0018, 0.048 and 0.018, respectively). Overall, the MPMs exhibited these CNGs less frequently compared with the lung adenocarcinomas (P=0.0002). The differences in CNGs between the two tumor types suggested that they are genetically different.	[Furukawa, Masashi; Toyooka, Shinichi; Hayashi, Tatsuro; Yamamoto, Hiromasa; Soh, Junichi; Hashida, Shinsuke; Shien, Kazuhiko; Asano, Hiroaki; Tsukuda, Kazunori; Miyoshi, Shinichiro] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Thorac Breast & Endocrinol Surg, Okayama, Okayama 7008558, Japan; [Toyooka, Shinichi; Hashida, Shinsuke; Shien, Kazuhiko] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Clin Genom Med, Okayama, Okayama 7008558, Japan; [Hayashi, Tatsuro; Yamamoto, Hiromasa; Okabe, Kazunori] Natl Hosp Org Yamaguchi Ube Med Ctr, Dept Thorac Surg, Ube, Yamaguchi 7550241, Japan; [Fujimoto, Nobukazu; Kishimoto, Takumi] Okayama Rosai Hosp, Dept Internal Med, Okayama, Okayama 7028055, Japan; [Aoe, Keisuke] Natl Hosp Org Yamaguchi Ube Med Ctr, Dept Med Oncol, Ube, Yamaguchi 7550241, Japan; [Pass, Harvey I.] NYU, Langone Med Ctr, Dept Cardiothorac Surg, Div Thorac Surg, New York, NY 10016 USA	Miyoshi, S (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Clin Genom Med, Kita Ku, 2-5-1 Shikata, Okayama, Okayama 7008558, Japan.	toyooka@md.okayama-u.ac.jp			Japan Labor Health and Welfare Organization	The authors would like to thank Ms. Fumiko Isobe for providing excellent technical support. The study received Grant-in-Aids for the 13 fields of occupational injuries and illnesses of the Japan Labor Health and Welfare Organization.	Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Betta PG, 2012, ARCH PATHOL LAB MED, V136, P253, DOI 10.5858/arpa.2010-0604-RA; Sasaki H, 2012, EXP THER MED, V3, P44, DOI 10.3892/etm.2011.374; Okuda K, 2008, J CANCER RES CLIN, V134, P1105, DOI 10.1007/s00432-008-0384-4; Fleury-Feith J, 2003, ONCOGENE, V22, P3799, DOI 10.1038/sj.onc.1206593; Velcheti V, 2009, J THORAC ONCOL, V4, P559, DOI 10.1097/JTO.0b013e31819c8661; Kobayashi N, 2008, LUNG CANCER, V62, P120, DOI 10.1016/j.lungcan.2008.02.013; Nemoto H, 2012, CANCER GENET-NY, V205, P594, DOI 10.1016/j.cancergen.2012.08.005; Cortese JF, 2006, INT J CANCER, V118, P521, DOI 10.1002/ijc.21271; Goto Y, 2009, CANCER RES, V69, P9073, DOI 10.1158/0008-5472.CAN-09-1595; Destro A, 2006, LUNG CANCER, V51, P207, DOI 10.1016/j.lungcan.2005.10.016; Toyooka S, 2008, ACTA MED OKAYAMA, V62, P1; Toyooka S, 2001, CANCER RES, V61, P5727; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Chiosea S, 2008, MODERN PATHOL, V21, P742, DOI 10.1038/modpathol.2008.45; Gee GV, 2010, INT J CANCER, V127, P2859, DOI 10.1002/ijc.25285; Kubo T, 2009, INT J CANCER, V124, P1778, DOI 10.1002/ijc.24150; Asano H, 2006, CLIN CANCER RES, V12, P43, DOI 10.1158/1078-0432.CCR-05-0934; Mezzapelle R, 2013, BRIT J CANCER, V108, P1743, DOI 10.1038/bjc.2013.130; Rena O, 2011, J SURG ONCOL, V104, P701, DOI 10.1002/jso.21901; Takeda M, 2012, J CLIN PATHOL, V65, P77, DOI 10.1136/jclinpath-2011-200208; Garland LL, 2007, J CLIN ONCOL, V25, P2406, DOI 10.1200/JCO.2006.09.7634; Jagadeeswaran R, 2006, CANCER RES, V66, P352, DOI 10.1158/0008-5472.CAN-04-4567; SPIRTAS R, 1994, OCCUP ENVIRON MED, V51, P804; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603; Sasaki H, 2011, J THORAC ONCOL, V6, P15, DOI 10.1097/JTO.0b013e31820594f0; Pache JC, 1998, AM J PATHOL, V152, P333; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Bjorkqvist AM, 1998, BRIT J CANCER, V77, P260, DOI 10.1038/bjc.1998.42; Heist RS, 2012, J THORAC ONCOL, V7, P1775, DOI 10.1097/JTO.0b013e31826aed28; Enomoto Y, 2012, PATHOL INT, V62, P226, DOI 10.1111/j.1440-1827.2011.02778.x; Taniguchi T, 2007, CANCER SCI, V98, P438, DOI 10.1111/j.1349-7006.2006.00386.x; Addis B, 2009, HISTOPATHOLOGY, V54, P55, DOI 10.1111/j.1365-2559.2008.03178.x; Papp T, 2001, INT J ONCOL, V18, P425; Govindan R, 2005, CLIN CANCER RES, V11, P2300, DOI 10.1158/1078-0432.CCR-04-1940; Husain AN, 2012, ARCH PATHOL LAB MED, V137, P647; Kohler LH, 2001, VIRCHOWS ARCH, V461, P49; METCALF RA, 1992, CANCER RES, V52, P2610; Soh J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007464; Yuan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009112	41	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2015	10	5					3274	3278		10.3892/ol.2015.3652		5	Oncology	Oncology	CV5QB	WOS:000364324800100		
J	Ohara, M; Akimoto, E; Noma, M; Matsuura, K; Doi, M; Kagawa, N; Itamoto, T				Ohara, Masahiro; Akimoto, Etsushi; Noma, Midori; Matsuura, Kazuo; Doi, Mihoko; Kagawa, Naoki; Itamoto, Toshiyuki			Prognostic impact of progesterone receptor status combined with body mass index in breast cancer patients treated with adjuvant aromatase inhibitor	Oncology Letters			English	Article						breast cancer; body mass index; progesterone receptor; aromatase inhibitor	INTERNATIONAL EXPERT CONSENSUS; PRIMARY THERAPY; ESTROGEN-RECEPTOR; POSTMENOPAUSAL WOMEN; ENDOCRINE THERAPY; HORMONE; HIGHLIGHTS; TAMOXIFEN; TRIAL; ADIPOSITY	Aromatase inhibitors have played a central role in endocrine therapy for the treatment of estrogen receptor (ER)-positive breast cancer in postmenopausal patients. However, prognostic factors for recurrence following such treatment have not been identified. The current study aimed to validate the prognostic value of endocrine-related progesterone receptor (PgR) status combined with body mass index (BMI). Among 659 consecutive patients with primary breast cancer who underwent curative surgery between 2002 and 2012, 184 postmenopausal patients with ER-positive (ER+) and human epidermal growth factor receptor type 2-negative (HER2-) breast cancer who were treated with adjuvant aromatase inhibitor therapy were assessed. The patients were assigned to groups based on BMI, according to the WHO cut-off value: >= 25 kg/m(2) (high, H) or <25 kg/m(2) (low, L). Positive nodal status, negative PgR status, BMI-H and a high Ki-67 labeling index (>= 20%) were found to be significantly associated with a short recurrence-free interval (RFI) upon univariate analysis (P=0.048, 0.007, 0.027, and 0.012, respectively). The patients were further grouped based on their combined PgR/BMI status. The RFI was significantly shorter in the PgR- and/or BMI-H group compared with that of the PgR+/BMI-L group (P=0.012). Multivariate analysis revealed PgR-tumors and/or BMI-H and positive nodal status to be independent prognostic factors (P=0.012 and 0.020, respectively). The present findings indicate that PgR/BMI status may serve as a practical tool in the management of ER+ and HER2-breast cancer in patients treated with adjuvant aromatase inhibitors.	[Ohara, Masahiro; Akimoto, Etsushi; Noma, Midori; Matsuura, Kazuo; Itamoto, Toshiyuki] Hiroshima Prefectural Hosp, Dept Breast Surg, Hiroshima 7348530, Japan; [Doi, Mihoko] Hiroshima Prefectural Hosp, Dept Clin Oncol, Hiroshima 7348530, Japan; [Kagawa, Naoki] Kagawa Breast Clin, Hiroshima 7300029, Japan	Ohara, M (reprint author), Hiroshima Prefectural Hosp, Dept Breast Surg, Minami Ku, 1-5-54 Ujina Kanda, Hiroshima 7348530, Japan.	oharamas@hotmail.com					Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Burstein HJ, 2010, J CLIN ONCOL, V28, P3784, DOI 10.1200/JCO.2009.26.3756; Dowsett M, 2006, ANN ONCOL, V17, P818, DOI 10.1093/annonc/mdl016; Cardoso F, 2012, ANN ONCOL, V23, P11, DOI 10.1093/annonc/mds232; Berclaz G, 2004, ANN ONCOL, V15, P875, DOI 10.1093/annonc/mdh222; HANKINSON SE, 1995, J NATL CANCER I, V87, P1297, DOI 10.1093/jnci/87.17.1297; Sestak I, 2010, J CLIN ONCOL, V28, P3411, DOI 10.1200/JCO.2009.27.2021; Brisken C, 2013, NAT REV CANCER, V13, P385, DOI 10.1038/nrc3518; Lonning PE, 2014, EUR J CANCER, V50, P1055, DOI 10.1016/j.ejca.2014.01.007; Dowsett M, 2008, J CLIN ONCOL, V26, P1059, DOI 10.1200/JCO.2007.12.9437; Folkerd EJ, 2012, J CLIN ONCOL, V30, P2977, DOI 10.1200/JCO.2012.42.0273; Elliott KM, 2014, BRIT J SURG, V101, P939, DOI 10.1002/bjs.9477; Yamashita H, 2011, ANN ONCOL, V22, P1318, DOI 10.1093/annonc/mdq596; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Allred DC, 1998, MODERN PATHOL, V11, P155; McTiernan A, 2003, J CLIN ONCOL, V21, P1961, DOI 10.1200/JCO.2003.07.057; Bartlett JMS, 2011, J CLIN ONCOL, V29, P1531, DOI 10.1200/JCO.2010.30.3677; Iwase H, 2008, BREAST CANCER-TOKYO, V15, P278, DOI 10.1007/s12282-008-0071-y; Sini V, 2014, BRIT J CANCER, V110, P1133, DOI 10.1038/bjc.2014.2; Ewertz M, 2012, J CLIN ONCOL, V30, P3967, DOI 10.1200/JCO.2011.40.8666; Ohara M, 2013, BREAST, V22, P958, DOI 10.1016/j.breast.2013.05.003; ARAFAH BM, 1982, ENDOCRINOLOGY, V111, P584; Viale G, 2011, ANN ONCOL, V22, P2201, DOI 10.1093/annonc/mdq738; Sendur MAN, 2012, BRIT J CANCER, V107, P1815, DOI 10.1038/bjc.2012.473; Goldhirsch A, 2005, ANN ONCOL, V16, P1569, DOI 10.1093/annonc/mdi326; Barba C, 2004, LANCET, V363, P157; Pfeiler G, 2013, BRIT J CANCER, V109, P1522, DOI 10.1038/bjc.2013.499; Mahabir S, 2006, CANCER EPIDEM BIOMAR, V15, P2502, DOI 10.1158/1055-9965.EPI-06-0499; HORWITZ KB, 1978, J BIOL CHEM, V253, P2223; Goodwin PJ, 2013, BREAST S2, V22, pS44; Kai Kazuharu, 2006, Int J Clin Oncol, V11, P426, DOI 10.1007/s10147-006-0601-6; National Comprehensive Cancer Network, NCCN GUID BREAST CAN; Seynaeve C, 2010, CANC RES, V70; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; The Japanese Breast Cancer Society, 2008, GEN RUL CLIN PATH RE	37	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	NOV	2015	10	5					3286	3292		10.3892/ol.2015.3655		7	Oncology	Oncology	CV5QB	WOS:000364324800102		
J	Takahashi, EJ; Fu, YX; Midorikawa, K				Takahashi, Eiji J.; Fu, Yuxi; Midorikawa, Katsumi			Carrier-envelope phase stabilization of a 16 TW, 10 Hz Ti:sapphire laser	OPTICS LETTERS			English	Article							ISOLATED ATTOSECOND PULSES; SHOT-NOISE; AMPLIFIER; PHYSICS	We propose and demonstrate a simple and promising method for stabilizing the carrier-envelope phase (CEP) of a high-energy ultrashort pulse laser operating at a low repetition rate. The method was successfully applied to a Ti:sapphire laser operating at 10 Hz with 400 mJ pulse energy and 25 fs pulse duration (16 TW). The laser system consists of a 1 kHz front-end preamplifier and a 10 Hz back-end power amplifier. By sampling a 500 Hz reference pulse from a 1 kHz seed pulse, the measured single-shot CEP noise of a 10 Hz amplified pulse is stabilized to 670 mrad rms. Our proposed CEP stabilization concept can be applied to single-shot ultrahigh-power lasers, such as a petawatt laser system. (C) 2015 Optical Society of America	[Takahashi, Eiji J.; Fu, Yuxi; Midorikawa, Katsumi] RIKEN, RIKEN Ctr Adv Photon, Extreme Photon Res Grp, Wako, Saitama 3510198, Japan	Takahashi, EJ (reprint author), RIKEN, RIKEN Ctr Adv Photon, Extreme Photon Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	ejtak@riken.jp	Takahashi, Eiji/A-6936-2011		Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [25286074, 26600122]; Advanced Photon Science Alliance Project	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) (Grant-in-Aid for Scientific Research (B): 25286074, Grant-in-Aid for Exploratory Research: 26600122); Advanced Photon Science Alliance Project.	Huang SW, 2011, NAT PHOTONICS, V5, P475, DOI 10.1038/NPHOTON.2011.140; Aoyama M, 2003, OPT LETT, V28, P1594, DOI 10.1364/OL.28.001594; Holzwarth R, 2000, PHYS REV LETT, V85, P2264, DOI 10.1103/PhysRevLett.85.2264; Borot A, 2012, NAT PHYS, V8, P416, DOI [10.1038/nphys2269, 10.1038/NPHYS2269]; Baltuska A, 2003, IEEE J SEL TOP QUANT, V9, P972, DOI 10.1109/JSTQE.2003.819107; Lan PF, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.013418; Koke S, 2010, NAT PHOTONICS, V4, P462, DOI [10.1038/NPHOTON.2010.91, 10.1038/nphoton.2010.91]; Manzoni C, 2015, LASER PHOTONICS REV, V9, P129, DOI 10.1002/lpor.201400181; Liu CP, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/10/105045; Zeng M, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.084801; Gademann G, 2011, OPT EXPRESS, V19, P24922, DOI 10.1364/OE.19.024922; Borchers B, 2014, LASER PHOTONICS REV, V8, P303, DOI 10.1002/lpor.201300163; Wang H, 2009, J PHYS B-AT MOL OPT, V42, DOI 10.1088/0953-4075/42/13/134007; Planchon TA, 2008, OPT EXPRESS, V16, P18557, DOI 10.1364/OE.16.018557; Cerullo G, 2011, LASER PHOTONICS REV, V5, P323, DOI 10.1002/lpor.201000013; Lucking F, 2014, OPT LETT, V39, P3884, DOI 10.1364/OL.39.003884; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; Li CQ, 2006, OPT EXPRESS, V14, P11468, DOI 10.1364/OE.14.011468; Chang Z., 2011, FUNDAMENTALS ATTOSEC; Nerush EN, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.035001; Li C., 2012, SPRINGER P PHYS, V125, P9; Ma GJ, 2015, PHYS PLASMAS, V22, DOI 10.1063/1.4914087; Mackenroth F, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.063903; Lotstedt E, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.093001; Takahashi E J, 2015, IEEE J SEL TOP QUANT, V21; Takahashi EJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3691; Wen M, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.035401; Wheeler JA, 2012, NAT PHOTONICS, V6, P828, DOI [10.1038/nphoton.2012.284, 10.1038/NPHOTON.2012.284]; Wu Y., 2014, C LAS EL OSA OPT SOC	29	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	NOV 1	2015	40	21					4835	4838		10.1364/OL.40.004835		4	Optics	Optics	CV7QH	WOS:000364468600004		
J	Fu, YX; Takahashi, EJ; Midorikawa, K				Fu, Yuxi; Takahashi, Eiji J.; Midorikawa, Katsumi			High-energy infrared femtosecond pulses generated by dual-chirped optical parametric amplification	OPTICS LETTERS			English	Article							1.6 MU-M; NONLINEAR OPTICS; AMPLIFIER; SUB-2-CYCLE; WAVELENGTH; MICROSCOPY; PHYSICS; LIGHT; WATER	We demonstrate high-energy infrared femtosecond pulse generation by a dual-chirped optical parametric amplification (DC-OPA) scheme [Opt. Express 19, 7190 (2011)]. By employing a 100 mJ pump laser, a signal pulse energy exceeding 20 mJ at a wavelength of 1.4 mu m was achieved before dispersion compensation. A total output energy of 33 mJ was recorded. Under a further energy scaling condition, the signal pulse was compressed to an almost transform-limited duration of 27 fs using a fused silica prism compressor. Since the DC-OPA scheme is efficient and energy scalable, design parameters for obtaining 100 mJ level infrared pulses are presented, which are suitable as driver lasers for the energy scaling of high-order harmonic generation with sub-keV photon energy. (C) 2015 Optical Society of America	[Fu, Yuxi; Takahashi, Eiji J.; Midorikawa, Katsumi] RIKEN, Ctr Adv Photon, Attosecond Sci Res Team, Wako, Saitama 3510198, Japan	Fu, YX (reprint author), RIKEN, Ctr Adv Photon, Attosecond Sci Res Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yxfu@riken.jp; ejtak@riken.jp	Takahashi, Eiji/A-6936-2011		Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [25286074, 26600122]; Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) (grant for Extreme Photonics Research, Grant-in-Aid for Scientific Research(B) 25286074, Grant-in-Aid for Exploratory Research 26600122, Advanced Photon Science Alliance Project); Japan Society for the Promotion of Science (JSPS) (Grant-in-Aid for Scientific Research).	Thire N, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4914344; Goulielmakis E, 2008, SCIENCE, V320, P1614, DOI 10.1126/science.1157846; Huang SW, 2011, NAT PHOTONICS, V5, P475, DOI 10.1038/NPHOTON.2011.140; Gu X, 2009, OPT EXPRESS, V17, P62, DOI 10.1364/OE.17.000062; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Rudd JV, 2005, OPT LETT, V30, P1974, DOI 10.1364/OL.30.001974; FEDER R, 1977, SCIENCE, V197, P259, DOI 10.1126/science.406670; Takahashi EJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.253901; Takahashi E, 2002, OPT LETT, V27, P1920, DOI 10.1364/OL.27.001920; Mucke OD, 2009, OPT LETT, V34, P2498, DOI 10.1364/OL.34.002498; Johnson SL, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.037203; Cerullo G, 2003, REV SCI INSTRUM, V74, P1, DOI 10.1063/1.1523642; Sansone G, 2010, NATURE, V465, P763, DOI 10.1038/nature09084; Takahashi EJ, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2960352; TOMIE T, 1991, SCIENCE, V252, P691, DOI 10.1126/science.2024121; Fu YX, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.013802; Schultze M, 2010, SCIENCE, V328, P1658, DOI 10.1126/science.1189401; Zhang QB, 2011, OPT EXPRESS, V19, P7190, DOI 10.1364/OE.19.007190; Vozzi C, 2007, OPT LETT, V32, P2957, DOI 10.1364/OL.32.002957; Schmidt BE, 2012, J PHYS B-AT MOL OPT, V45, DOI 10.1088/0953-4075/45/7/074008; Seres E, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2364126; Schmidt BE, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3359458; Brida D, 2008, OPT LETT, V33, P741, DOI 10.1364/OL.33.000741; Andriukaitis G, 2011, OPT LETT, V36, P2755, DOI 10.1364/OL.36.002755; Ishii N, 2012, OPT LETT, V37, P4182, DOI 10.1364/OL.37.004182; Gordon A, 2005, OPT EXPRESS, V13, P2941, DOI 10.1364/OPEX.13.002941; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; NISOLI M, 1994, OPT LETT, V19, P1973, DOI 10.1364/OL.19.001973; Miao JW, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.088303; Hu SX, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.073004; Ishii N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4331; Schmidt BE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4643; Shan B., 2001, PHYS REV A, V65, DOI DOI 10.1103/PHYSREVA.65.011804; Takahashi EJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3691; Vaupel A, 2014, OPT ENG, V53, DOI 10.1117/1.OE.53.5.051507	35	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	NOV 1	2015	40	21					5082	5085		10.1364/OL.40.005082		4	Optics	Optics	CV7QH	WOS:000364468600066		
J	Takahashi, T; Inoue, A; Yoshimoto, J; Kanamitsu, K; Taki, T; Imada, M; Yamada, M; Ninomiya, S; Toki, T; Terui, K; Ito, E; Shimada, A				Takahashi, Takahide; Inoue, Akira; Yoshimoto, Junko; Kanamitsu, Kiichiro; Taki, Tomohiko; Imada, Masahide; Yamada, Mutsuko; Ninomiya, Shinsuke; Toki, Tsutomu; Terui, Kiminori; Ito, Etsuro; Shimada, Akira			Transient Myeloproliferative Disorder With Partial Trisomy 21	PEDIATRIC BLOOD & CANCER			English	Article						Down syndrome; GATA1; partial trisomy 21; transient myeloproliferative disorder	DOWN-SYNDROME PHENOTYPES; MEGAKARYOBLASTIC LEUKEMIA; CHROMOSOME-21; ARCHITECTURE; MUTATIONS	Myeloid malignancy with Down syndrome (ML-DS) is estimated to have a step-wise leukemogenesis including GATA1 mutation. Trisomy 21 is essential for ML-DS; however, we do not know exactly which gene or genes located on chromosome 21 are necessary for the ML-DS. We report a female infant with transient myeloproliferative disorder (TMD) and partial trisomy 21. SNP array analysis showed 10Mb amplification of 21q22.12-21q22.3, which included DYRK1A, ERG, and ETS but not the RUNX1 gene. With two other reported TMD cases having partial trisomy 21, DYRK1A, ERG, and ETS were the most likely genes involved in collaboration with the GATA1 mutation. (C) 2015 Wiley Periodicals, Inc.	[Takahashi, Takahide; Imada, Masahide] Okayama Univ Hosp, Div Med Support, Okayama 7008558, Japan; [Inoue, Akira] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Yoshimoto, Junko; Kanamitsu, Kiichiro; Yamada, Mutsuko; Shimada, Akira] Okayama Univ Hosp, Dept Pediat, Okayama 7008558, Japan; [Taki, Tomohiko] Kyoto Prefectural Univ Med, Dept Mol Diagnost & Therapeut, Grad Sch Med Sci, Kyoto, Japan; [Ninomiya, Shinsuke] Kurashiki Cent Hosp, Dept Clin Genet, Kurashiki, Okayama, Japan; [Toki, Tsutomu; Terui, Kiminori] Hirosaki Univ, Dept Pediat, Grad Sch Med, Hirosaki, Aomori, Japan	Shimada, A (reprint author), Okayama Univ Hosp, Dept Pediat, Kita Ku, 2-5-1 Shikatacho, Okayama 7008558, Japan.	pajj236e@okayama-u.ac.jp					Yoshida K, 2013, NAT GENET, V45, P1293, DOI 10.1038/ng.2759; Rainis L, 2005, CANCER RES, V65, P7596, DOI 10.1158/0008-5472.CAN-05-0147; Korbel JO, 2009, P NATL ACAD SCI USA, V106, P12031, DOI 10.1073/pnas.0813248106; Levanon D, 2001, GENE, V262, P23, DOI 10.1016/S0378-1119(00)00532-1; Ives JH, 1998, GENE CHROMOSOME CANC, V23, P61, DOI 10.1002/(SICI)1098-2264(199809)23:1<61::AID-GCC9>3.0.CO;2-4; Papoulidis I, 2014, GENE, V536, P441, DOI 10.1016/j.gene.2013.11.078; Kanezaki R, 2010, BLOOD, V116, P4631, DOI 10.1182/blood-2010-05-282426; Malinge S, 2012, J CLIN INVEST, V122, P948, DOI 10.1172/JCI60455; Shapiro BL, 1999, J NEURAL TRANSM-SUPP, P41; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Bourquin JP, 2006, P NATL ACAD SCI USA, V103, P3339, DOI 10.1073/pnas.0511150103; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; Klusmann JH, 2010, GENE DEV, V24, P478, DOI 10.1101/gad.1856210; Kondo Y, 2006, AM J MED GENET A, V140A, P227, DOI 10.1002/ajmg.a.31073; Gamis AS, 2011, BLOOD, V118, P6752, DOI 10.1182/blood-2011-04-350017; Lyle R, 2009, EUR J HUM GENET, V17, P454, DOI 10.1038/ejhg.2008.214; SINET PM, 1994, BIOMED PHARMACOTHER, V48, P247, DOI 10.1016/0753-3322(94)90140-6	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-5009	1545-5017		PEDIATR BLOOD CANCER	Pediatr. Blood Cancer	NOV	2015	62	11					2021	2024		10.1002/pbc.25624		4	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	CV9BA	WOS:000364581100028		
J	Yasutomi, M; Yoshioka, K; Tanizawa, A; Ohshima, Y; Mibayashi, A; Imai, K; Ohara, O				Yasutomi, Motoko; Yoshioka, Kikuko; Tanizawa, Akihiko; Ohshima, Yusei; Mibayashi, Akiko; Imai, Kohsuke; Ohara, Osamu			Successful Myeloablative Bone Marrow Transplantation in an Infant With Wiskott-Aldrich Syndrome and Bacillus Calmette-Guerin Infection	PEDIATRIC BLOOD & CANCER			English	Letter							CELL TRANSPLANTATION; BCG; JAPAN		[Yasutomi, Motoko; Yoshioka, Kikuko; Tanizawa, Akihiko; Ohshima, Yusei] Univ Fukui, Fac Med Sci, Dept Pediat, Fukui 9101193, Japan; [Mibayashi, Akiko] Fukui Aiiku Hosp, Dept Pediat, Fukui, Japan; [Imai, Kohsuke] Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Tokyo, Japan; [Ohara, Osamu] RIKEN Ctr Integrat Med Sci, Lab Integrat Genom, Yokohama, Kanagawa, Japan; [Ohara, Osamu] Kazusa DNA Res Inst, Kisarazu, Chiba, Japan	Yasutomi, M (reprint author), Univ Fukui, Fac Med Sci, Dept Pediat, 23-3 Shimoaizuki, Fukui 9101193, Japan.	yasutomi@u-fukui.ac.jp					Moratto D, 2011, BLOOD, V118, P1675, DOI 10.1182/blood-2010-11-319376; Yamamoto S, 2007, JPN J INFECT DIS, V60, P331; Marciano BE, 2014, J ALLERGY CLIN IMMUN, V133, P1134, DOI 10.1016/j.jaci.2014.02.028; Andreansky S, 2005, EXP HEMATOL, V33, P443, DOI 10.1016/j.exphem.2004.12.006; Bosticardo M, 2009, BLOOD, V113, P6288, DOI 10.1182/blood-2008-12-115253; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Kobayashi R, 2006, BRIT J HAEMATOL, V135, P362, DOI 10.1111/j.1365-2141.2006.06297.x; Aytekin C, 2008, PEDIATR TRANSPLANT, V12, P479, DOI 10.1111/j.1399-3046.2007.00890.x; Bacalhau S, 2011, CASE REP MED, V2011; Wu JF, 2015, J ALLERGY CLIN IMMUN, V135, P209, DOI 10.1016/j.jaci.2014.06.025	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-5009	1545-5017		PEDIATR BLOOD CANCER	Pediatr. Blood Cancer	NOV	2015	62	11					2052	2053		10.1002/pbc.25588		2	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	CV9BA	WOS:000364581100037		
J	Sato, A; Yokoyama, I; Ebina, K				Sato, Akira; Yokoyama, Izumi; Ebina, Keiichi			Angiotensin peptides attenuate platelet-activating factor-induced inflammatory activity in rats	PEPTIDES			English	Article						Angiotensin peptide; Platelet-activating factor; Interaction; Inflammation; Oxidized phospholipid	MICROVASCULAR HYDRAULIC PERMEABILITY; SYNTHETIC BIOTINYLATED PEPTIDE; INDUCED PAW EDEMA; AT(2) RECEPTORS; IN-VIVO; AT(1); MICE; ENDOTHELIN-1; ANAPHYLAXIS; CARRAGEENAN	Angiotensin (Ang) a peptide that is part of the renin-angiotensin system-induces vasoconstriction and a subsequent increase in blood pressure; Ang peptides, especially AngII, can also act as potent pro-inflammatory mediators. Platelet-activating factor (PAF) is a potent phospholipid mediator that is implicated in many inflammatory diseases. In this study, we investigated the effects of Ang peptides (AngII, AngIII, and AngIV) on PAF-induced inflammatory activity. In experiments using a rat hind-paw oedema model, AngII markedly and dose-dependently attenuated the paw oedema induced by PAF. The inhibitory effects of AngIII and AngIV on PAF-induced paw oedema were lower than that of AngII. Two Ang receptors, the ATi and AT2 receptors, did not affect the AngII-mediated attenuation of PAF-induced paw oedema. Moreover, intrinsic tyrosine fluorescence studies demonstrated that AngII, AngIII, and AngIV interact with PAF, and that their affinities were closely correlated with their inhibitory effects on PAF-induced rat paw oedema. Also, AngII interacted with metabolite/precursor of PAF (lyso-PAF), and an oxidized phospholipid, 1-palmitoy1-2-(5'-oxo-valeroy1)-sn-glycero-3-phosphocholine (POVPC), which bears a marked structural resemblance to PAF. Furthermore, POVPC dose-dependently inhibited AngII-mediated attenuation of PAF-induced paw oedema. These results suggest that Ang peptides can attenuate PAF-induced inflammatory activity through binding to PAF and lyso-PAF in rats. Therefore, Ang peptides may be closely involved in the regulation of many inflammatory diseases caused by PAF. (C) 2015 Elsevier Inc. All rights reserved.	[Sato, Akira; Yokoyama, Izumi; Ebina, Keiichi] Iwaki Meisei Univ, Fac Pharm, Iwaki, Fukushima 9708551, Japan	Sato, A (reprint author), Iwaki Meisei Univ, Fac Pharm, 5-5-1 Chuodai Iino, Iwaki, Fukushima 9708551, Japan.	a-sato@iwakimu.ac.jp					ALMERANI SAMA, 1978, J PHYSIOL-LONDON, V278, P471; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; HENRIQUES MGMO, 1992, BRIT J PHARMACOL, V106, P579; NOGUCHI K, 1989, ARCH ORAL BIOL, V34, P37, DOI 10.1016/0003-9969(89)90044-7; vanKats JP, 1997, HYPERTENSION, V30, P42; Ramirez R, 2006, J SURG RES, V134, P259, DOI 10.1016/j.jss.2006.01.017; Wang M, 2014, EUR J PHARMACOL, V731, P38, DOI 10.1016/j.ejphar.2014.03.012; Fabiani ME, 2000, AM J HYPERTENS, V13, P1005, DOI 10.1016/S0895-7061(00)00286-7; Carvalho RF, 2006, EUR J PHARMACOL, V540, P175, DOI 10.1016/j.ejphar.2006.04.014; SHIMAKURA K, 1995, JPN J PHARMACOL, V67, P383, DOI 10.1254/jjp.67.383; Kihara Y, 2008, J IMMUNOL, V181, P5008; Newton CR, 2004, SURGERY, V136, P1054, DOI 10.1016/j.surg.2004.04.031; CHAO W, 1993, BIOCHEM J, V292, P617; Weiss D, 2001, CIRCULATION, V103, P448; de Gasparo M, 2000, PHARMACOL REV, V52, P415; HAYASHI M, 1987, THROMB RES, V48, P299, DOI 10.1016/0049-3848(87)90442-7; Sato A, 2014, DRUG DEVELOP RES, V75, P246, DOI 10.1002/ddr.21178; LIU M, 1994, P NATL ACAD SCI USA, V91, P6035, DOI 10.1073/pnas.91.13.6035; Victorino GP, 2003, J TRAUMA, V55, P527, DOI 10.1097/01.TA.0000028971.15527.5B; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; Necas J, 2013, VET MED-CZECH, V58, P187; WRIGHT JW, 1994, NEUROSCI BIOBEHAV R, V18, P21, DOI 10.1016/0149-7634(94)90034-5; THUMSER AEA, 1994, BIOCHEM J, V301, P801; Bosnyak S, 2011, CLIN SCI, V121, P297, DOI 10.1042/CS20110036; Page TH, 2009, CURR MOL MED, V9, P69; Jones ES, 2008, PHARMACOL THERAPEUT, V120, P292, DOI 10.1016/j.pharmthera.2008.08.009; ROSENFELD ME, 1991, CIRCULATION, V83, P2137; Unger T, 1996, J HYPERTENS, V14, pS95; Newton CR, 2004, J SURG RES, V120, P83, DOI 10.1016/j.jss.2003.12.030; NEUWIRTH R, 1989, CIRC RES, V64, P1224; Leon LJ, 2006, ARCH BIOCHEM BIOPHYS, V452, P38, DOI 10.1016/j.abb.2006.05.009; PRESCOTT SM, 1990, J BIOL CHEM, V265, P17381; Sato A, 2012, EUR J PHARMACOL, V685, P205, DOI 10.1016/j.ejphar.2012.04.025; Ishii I, 1998, J BIOL CHEM, V273, P9878, DOI 10.1074/jbc.273.16.9878; Vadas P, 2013, J ALLERGY CLIN IMMUN, V131, P144, DOI 10.1016/j.jaci.2012.08.016; EVANGELOU AM, 1994, PROSTAG LEUKOTR ESS, V50, P1, DOI 10.1016/0952-3278(94)90101-5; Guimond M. O., 2012, INT J HYPERTENS; Kawajiri M, 2008, Mult Scler, V14, P557, DOI 10.1177/1352458507085760; Kraft C. A., 2009, SCI SIGNAL, V2, P14; Lodewijk J. W., 2002, CAN J CARDIOL, V18, P1331; Perico N., 1997, J AM SOC NEPHROL, V8, P1392; Raghavendra V, 2000, METHOD FIND EXP CLIN, V22, P633, DOI 10.1358/mf.2000.22.8.802275; Sato A, 2013, INFLAMM RES, V62, P417, DOI 10.1007/s00011-013-0594-3; Sternberg D., 1989, NEW ENGL J MED, V320, P915; Touyz R. M., 2002, Brazilian Journal of Medical and Biological Research, V35, P1001, DOI 10.1590/S0100-879X2002000900001; Vadas P, 2008, NEW ENGL J MED, V358, P28, DOI 10.1056/NEJMoa070030; Victorino GP, 2004, J TRAUMA, V56, P379, DOI 10.1097/01.TA.0000042156.89779.6C; Witztum JL, 1993, BRIT HEART J, V69, P12	49	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	NOV	2015	73						60	66		10.1016/j.peptides.2015.09.002		7	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	CW0SZ	WOS:000364701000007		
J	Katsuyama, T; Otsuka, F; Terasaka, T; Inagaki, K; Takano-Narazaki, M; Matsumoto, Y; Sada, KE; Makino, H				Katsuyama, Takayuki; Otsuka, Fumio; Terasaka, Tomohiro; Inagaki, Kenichi; Takano-Narazaki, Mariko; Matsumoto, Yoshinori; Sada, Ken-Ei; Makino, Hirofumi			Regulatory effects of fibroblast growth factor-8 and tumor necrosis factor-alpha on osteoblast marker expression induced by bone morphogenetic protein-2	PEPTIDES			English	Article						Bone morphogenetic protein (BMP); Fibroblast growth factor (FGF)-8; Osteoblast; Osteogenesis; Tumor necrosis factor (TNF)-alpha	RHEUMATOID-ARTHRITIS PATIENTS; FACTOR RECEPTOR; DIFFERENTIATION; CELLS; FIBROBLAST-GROWTH-FACTOR-8; OSTEOARTHRITIS; ESTROGEN; FGF8; ACHONDROPLASIA; METHOTREXATE	BMP induces osteoblast differentiation, whereas a key proinflammatory cytokine, TNF-ce., causes inflammatory bone damage shown in rheumatoid arthritis. FGF molecules are known to be involved in bone homeostasis. However, the effects of FGF-8 on osteoblast differentiation and the interaction between FGF-8, BMPs and TNF-alpha have yet to be clarified. Here we investigated the effects of FGF-8 in relation to TNF-ci actions on BMP-2-induced osteoblast marker expression using myoblast cell line C2C12, osteoblast precursor cell line MC3T3-E1 and rat calvarial osteoblasts. It was revealed that FGF-8 inhibited BMP-2-induced expression of osteoblast differentiation markers, including Runx2, osteocalcin, alkaline phosphatase, type-1 collagen and osterix, in a concentration-dependent manner. The inhibitory effects of FGF-8 on BMP-induced osteoblast differentiation and Smad1/5/8 activation were enhanced in the presence of TNF-alpha. action. FGF-8 also inhibited BMP-2-induced expression of Wnt5a, which activates a non-canonical Wnt signaling pathway. FGF-8 had no significant influence on the expression levels of TNF receptors, while FGF-8 suppressed the expression of inhibitory Smad6 and Smad7, suggesting a possible feedback activity through FGF to BMP receptor (BMPR) signaling. Of note, inhibition of ERK activity and FGF receptor (FGFR)-dependent protein kinase, but not JNK or NF kappa B pathway, suppressed the FGF-8 actions on BMP-induced osteoblast differentiation. FGF-8 was revealed to suppress BMP-induced osteoblast differentiation through the ERK pathway and the effects were enhanced by TNF-alpha. Given the finding that FGF-8 expression was increased in synovial tissues of rheumatoid arthritis, the functional interaction between FGFR and BMPR signaling may be involved in the development process of inflammatory bone damage. (C) 2015 Elsevier Inc. All rights reserved.	[Katsuyama, Takayuki; Terasaka, Tomohiro; Inagaki, Kenichi; Takano-Narazaki, Mariko; Matsumoto, Yoshinori; Sada, Ken-Ei] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Kita Ku, Okayama 7008558, Japan; [Otsuka, Fumio] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gen Med, Kita Ku, Okayama 7008558, Japan; [Makino, Hirofumi] Okayama Univ Hosp, Kita Ku, Okayama 7008558, Japan	Otsuka, F (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gen Med, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	fumiotsu@md.okayama-u.ac.jp			Japan Rheumatism Foundation [24591364]; Foundation for Growth Science; Astellas Foundation for Research on Metabolic Disorders; Japan Foundation for Applied Enzymology (Japan)	This work was supported in part by Grants-in-Aid for Scientific Research (No. 24591364), Japan Rheumatism Foundation, Foundation for Growth Science, Astellas Foundation for Research on Metabolic Disorders, and Japan Foundation for Applied Enzymology (Japan).	Xu JS, 1999, MECH DEVELOP, V83, P165, DOI 10.1016/S0925-4773(99)00034-9; Manabe N, 1999, RHEUMATOLOGY, V38, P714, DOI 10.1093/rheumatology/38.8.714; Pelletier JP, 2001, ARTHRITIS RHEUM, V44, P1237, DOI 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F; Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032; Mukai T, 2007, BIOCHEM BIOPH RES CO, V356, P1004, DOI 10.1016/j.bbrc.2007.03.099; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Takano M, 2012, MOL CELL ENDOCRINOL, V348, P224, DOI 10.1016/j.mce.2011.08.027; Xing LP, 2002, J BONE MINER RES, V17, P1200, DOI 10.1359/jbmr.2002.17.7.1200; Miyoshi T, 2010, MOL CELL ENDOCRINOL, V325, P84, DOI 10.1016/j.mce.2010.04.012; [Anonymous], 2006, THROMB VASC BIOL, DOI DOI 10.1161/01.ATV.0000227689.41288.5E; OHUCHI H, 1994, BIOCHEM BIOPH RES CO, V204, P882, DOI 10.1006/bbrc.1994.2542; Valta MP, 2006, ENDOCRINOLOGY, V147, P2171, DOI 10.1210/en.2005-1502; Mattila MA, 2007, CYTOKINE GROWTH F R, V18, P257, DOI 10.1016/j.cytogfr.2007.04.010; TANAKA A, 1992, P NATL ACAD SCI USA, V89, P8928, DOI 10.1073/pnas.89.19.8928; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Baum R, 2014, CURR OSTEOPOROS REP, V12, P9, DOI 10.1007/s11914-013-0183-y; Blunt AG, 1997, J BIOL CHEM, V272, P3733; Matsumoto Y, 2010, MOL CELL ENDOCRINOL, V325, P118, DOI 10.1016/j.mce.2010.05.004; MELNYK VO, 1990, ARTHRITIS RHEUM, V33, P493, DOI 10.1002/art.1780330405; Matsumoto Y, 2013, STEROIDS, V78, P513, DOI 10.1016/j.steroids.2013.02.011; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Nakamura H, 2005, BRAIN RES REV, V49, P120, DOI 10.1016/j.brainresrev.2004.10.005; Lin JM, 2009, AM J PHYSIOL-ENDOC M, V297, pE142, DOI 10.1152/ajpendo.90743.2008; Warren SM, 2003, NATURE, V422, P625, DOI 10.1038/nature01545; Watanabe Y, 2010, CIRC RES, V106, P495, DOI 10.1161/CIRCRESAHA.109.201665; Otsuka F, 2010, ENDOCR J, V57, P3; Schmal H, 2012, CYTOTHERAPY, V14, P868, DOI 10.3109/14653249.2012.681039; Nemoto E, 2012, BIOCHEM BIOPH RES CO, V422, P627, DOI 10.1016/j.bbrc.2012.05.039; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Sato MM, 2009, GENES CELLS, V14, P141, DOI 10.1111/j.1365-2443.2008.01258.x; Ellman MB, 2013, J CELL BIOCHEM, V114, P735, DOI 10.1002/jcb.24418; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; Masuda H, 2011, MOL CELL ENDOCRINOL, V343, P7, DOI 10.1016/j.mce.2011.05.037; Verschueren PCPM, 2009, ANN RHEUM DIS, V68, P117, DOI 10.1136/ard.2007.080127; Uchii M, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2474; Wang RN, 2014, GENES DIS, V1, P87, DOI DOI 10.1016/J.GENDIS.2014.07.00525401122	37	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	NOV	2015	73						88	94		10.1016/j.peptides.2015.09.007		7	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	CW0SZ	WOS:000364701000010		
J	Wada, Y; Lonnerdal, B				Wada, Yasuaki; Loennerdal, Bo			Bioactive peptides released by in vitro digestion of standard and hydrolyzed infant formulas	PEPTIDES			English	Article						Bioactive peptide; Infant formula; In vitro digestion; Milk protein; Peptidomic technique	ENZYME-INHIBITORY PEPTIDES; INDUSTRIAL HEATING PROCESSES; MILK-PROTEINS; BETA-CASOMORPHIN; TRYPTIC HYDROLYSATE; ACTIVE PEPTIDES; FAT DIGESTION; C-12 PEPTIDE; CASEIN; IDENTIFICATION	Hydrolyzed infant formulas serve as appropriate nutritional sources for infants afflicted with cow's milk allergy, and milk proteins in hydrolyzed formulas are industrially hydrolyzed extensively or partially. To investigate whether industrial hydrolysis may modulate the digestive trajectory of milk proteins, thereby releasing different profiles of bioactive peptides compared with standard formulas, both standard and hydrolyzed formulas were subjected to in vitro digestion and formation of bioactive peptides were compared. One standard, one extensively hydrolyzed, and one partially hydrolyzed infant formula were digested in vitro with pepsin and pancreatin, taking into account the higher gastric pH of infants, and the digesta were subjected to peptidomic analysis. The standard formula released a larger variety of bioactive peptides than from the hydrolyzed formulas, indicating that industrial hydrolysis of milk proteins may generally attenuate their indigenous bioactivities such as antibacterial, immuno-regulatory, and antioxidative activities. Conversely, industrial hydrolysis may facilitate the formation of bioactive peptides from hydrophobic proteins/regions such as p-LG and the "strategic zone" of p-CN, which encrypt bioactive peptides including a dipeptidyl dipeptidase-4-inhibitory, hypocholesterolemic, and opioid peptides. Infants fed hydrolyzed infant formulas may be influenced by milk protein-derived bioactive peptides in a manner different from those fed standard formula. (C) 2015 Elsevier Inc. All rights reserved.	[Wada, Yasuaki; Loennerdal, Bo] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Wada, Yasuaki] Morinaga Milk Ind Co Ltd, Nutr Sci Inst, Zama, Kanagawa 2528583, Japan	Lonnerdal, B (reprint author), Univ Calif Davis, Dept Nutr, One Shields Ave, Davis, CA 95616 USA.	bllonnerdal@ucdavis.edu					FINBERG L, 1989, PEDIATRICS, V83, P1068; Lahov E, 1996, FOOD CHEM TOXICOL, V34, P131, DOI 10.1016/0278-6915(95)00097-6; Pihlanto-Leppala A, 1998, INT DAIRY J, V8, P325, DOI 10.1016/S0958-6946(98)00048-X; Wada Y, 2014, J NUTR BIOCHEM, V25, P503, DOI 10.1016/j.jnutbio.2013.10.012; Sakaguchi M, 2006, EUR J PHARMACOL, V530, P81, DOI 10.1016/j.ejphar.2005.11.014; Bu GH, 2013, DAIRY SCI TECHNOL, V93, P211, DOI 10.1007/s13594-013-0113-x; Cakir-Kiefer C, 2011, J AGR FOOD CHEM, V59, P11956, DOI 10.1021/jf202890e; Martinez-Maqueda D, 2012, J AGR FOOD CHEM, V60, P8600, DOI 10.1021/jf301279k; Regazzo D, 2010, MOL NUTR FOOD RES, V54, P1428, DOI 10.1002/mnfr.200900443; ASANO M, 1992, BIOSCI BIOTECH BIOCH, V56, P976; Wada Y, 2015, J AGR FOOD CHEM, V63, P6787, DOI 10.1021/acs.jafc.5b02189; FitzGerald RJ, 1998, INT DAIRY J, V8, P451, DOI 10.1016/S0958-6946(98)00068-5; Tauzin J, 2002, FEBS LETT, V531, P369, DOI 10.1016/S0014-5793(02)03576-7; Armand M, 1996, PEDIATR RES, V40, P429, DOI 10.1203/00006450-199609000-00011; Quiros A, 2007, INT DAIRY J, V17, P33, DOI 10.1016/j.idairyj.2005.12.011; Power O, 2013, AMINO ACIDS, V44, P797, DOI 10.1007/s00726-012-1393-9; PASI A, 1993, RES COMMUN CHEM PATH, V80, P305; Quiros A, 2008, INT DAIRY J, V18, P279, DOI 10.1016/j.idairyj.2007.09.006; Hayes Maria, 2007, Biotechnology Journal, V2, P435, DOI 10.1002/biot.200700045; SINGH M, 1989, PEDIATR RES, V26, P34, DOI 10.1203/00006450-198907000-00011; MEISEL H, 1989, Z ERNAHRUNGSWISS, V28, P267, DOI 10.1007/BF02019390; Rizzello CG, 2005, J DAIRY SCI, V88, P2348; Pihlanto-Leppala A, 2000, J DAIRY RES, V67, P53, DOI 10.1017/S0022029999003982; Lopez-Exposito I, 2006, J FOOD PROTECT, V69, P2992; Silva SV, 2006, J DAIRY SCI, V89, P3336; FINK CS, 1984, PEDIATR RES, V18, P248, DOI 10.1203/00006450-198403000-00006; Forsyth JS, 2004, ARCH DIS CHILD, V89, pF442, DOI 10.1136/adc.2003.027896; LOUKAS S, 1983, BIOCHEMISTRY-US, V22, P4567, DOI 10.1021/bi00288a034; Townsend RR, 2004, AM J HYPERTENS, V17, P1056, DOI 10.1016/j.amjhyper.2004.06.018; Bourlieu C, 2014, CRIT REV FOOD SCI, V54, P1427, DOI 10.1080/10408398.2011.640757; Sun ZJ, 2003, PEPTIDES, V24, P937, DOI 10.1016/S0196-9781(03)00156-6; Miguel M, 2006, J DAIRY SCI, V89, P3352; YAMAMOTO N, 1994, J DAIRY SCI, V77, P917, DOI 10.3168/jds.S0022-0302(94)77026-0; Hernell O, 2003, AM J CLIN NUTR, V78, P296; Gomez-Ruiz JA, 2007, ELECTROPHORESIS, V28, P4202, DOI 10.1002/elps.200700324; Kost NV, 2009, PEPTIDES, V30, P1854, DOI 10.1016/j.peptides.2009.06.025; Wada Y, 2014, J AGR FOOD CHEM, V62, P4175, DOI 10.1021/jf501617s; Ricci-Cabello I, 2012, NUTR REV, V70, P241, DOI 10.1111/j.1753-4887.2011.00448.x; FREDRIKZON B, 1977, ACTA PAEDIATR SCAND, V66, P479, DOI 10.1111/j.1651-2227.1977.tb07930.x; Lopez-Exposito I, 2007, LAIT, V87, P241, DOI 10.1051/lait:2007019; KARAKI H, 1990, COMP BIOCHEM PHYS C, V96, P367; Simonian HP, 2005, DIGEST DIS SCI, V50, P2276, DOI 10.1007/s10620-005-3048-0; Owen CG, 2002, PEDIATRICS, V110, P597, DOI 10.1542/peds.110.3.597; UMBACH M, 1985, REGUL PEPTIDES, V12, P223, DOI 10.1016/0167-0115(85)90063-1; Cadee JA, 2007, AM J HYPERTENS, V20, P1, DOI 10.1016/j.amjhyper.2006.06.005; Kalantzi L, 2006, PHARM RES-DORDR, V23, P165, DOI 10.1007/s11095-005-8476-1; Nagaoka S, 2001, BIOCHEM BIOPH RES CO, V281, P11, DOI 10.1006/bbrc.2001.4298; Dziuba J, 1999, NAHRUNG, V43, P190, DOI 10.1002/(SICI)1521-3803(19990601)43:3<190::AID-FOOD190>3.3.CO;2-1; Hayes M, 2006, Appl Environ Microbiol, V72, P2260, DOI 10.1128/AEM.72.3.2260-2264.2006; Hernandez-Ledesma B, 2014, INT DAIRY J, V38, P82, DOI 10.1016/j.idairyj.2013.11.004; Juillerat-Jeanneret L., 2011, AGR FOOD CHEM, V59, P370; MIGLIORESAMOUR D, 1988, EXPERIENTIA, V44, P188, DOI 10.1007/BF01941703; Wada Y, 2015, PEDIATR RES, V77, P546, DOI 10.1038/pr.2015.10	53	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	NOV	2015	73						101	105		10.1016/j.peptides.2015.09.005		5	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	CW0SZ	WOS:000364701000012		
J	Mori, J; Kano, Y				Mori, Joji; Kano, Yutaka			A powerful test for Balaam's design	PHARMACEUTICAL STATISTICS			English	Article						Balaam's design; treatment-by-period interaction; best linear unbiased estimator; t-test statistic	PERENNIAL ALLERGIC RHINITIS; DAYTIME SOMNOLENCE; CROSSOVER DESIGNS; SLEEP DISTURBANCE; TRIALS; SYMPTOMS; MODELS; AB/BA	The crossover trial design (AB/BA design) is often used to compare the effects of two treatments in medical science because it performs within-subject comparisons, which increase the precision of a treatment effect (i.e., a between-treatment difference). However, the AB/BA design cannot be applied in the presence of carryover effects and/or treatments-by-period interaction. In such cases, Balaam's design is a more suitable choice. Unlike the AB/BA design, Balaam's design inflates the variance of an estimate of the treatment effect, thereby reducing the statistical power of tests. This is a serious drawback of the design. Although the variance of parameter estimators in Balaam's design has been extensively studied, the estimators of the treatment effect to improve the inference have received little attention. If the estimate of the treatment effect is obtained by solving the mixed model equations, the AA and BB sequences are excluded from the estimation process. In this study, we develop a new estimator of the treatment effect and a new test statistic using the estimator. The aim is to improve the statistical inference in Balaam's design. Simulation studies indicate that the type I error of the proposed test is well controlled, and that the test is more powerful and has more suitable characteristics than other existing tests when interactions are substantial. The proposed test is also applied to analyze a real dataset. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Mori, Joji; Kano, Yutaka] Osaka Univ, Div Math Sci, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan	Mori, J (reprint author), Osaka Univ, Div Math Sci, Grad Sch Engn Sci, 1-3 Machikaneyama Cho, Toyonaka, Osaka 5608531, Japan.	mori@sigmath.es.osaka-u.ac.jp		Mori, Joji/0000-0002-6545-464X			Senn S, 2004, PHARM STAT, V3, P123, DOI 10.1002/pst.106; LASSERRE V, 1991, STAT MED, V10, P909, DOI 10.1002/sim.4780100612; Golden S, 2000, ANN ALLERG ASTHMA IM, V85, P53; Santos CB, 2008, ALLERGY ASTHMA PROC, V29, P140, DOI 10.2500/aap.2008.29.3097; Sardana N, 2010, ALLERGY ASTHMA PROC, V31, P5, DOI 10.2500/aap.2010.31.3308; Chinchilli VM, 1996, STAT MED, V15, P1619, DOI 10.1002/(SICI)1097-0258(19960815)15:15<1619::AID-SIM326>3.0.CO;2-N; Brennan NA, 2008, EYE CONTACT LENS, V34, P317, DOI 10.1097/ICL.0b013e31818b7428; Senn S, 2004, PHARM STAT, V3, P133, DOI 10.1002/pst.111; Gurevich F, 2005, ALLERGY ASTHMA PROC, V26, P268; Satterthwaite FE, 1941, PSYCHOMETRIKA, V6, P309, DOI 10.1007/BF02288586; LASKA EM, 1985, J AM STAT ASSOC, V80, P704, DOI 10.2307/2288488; Craig TJ, 1998, J ALLERGY CLIN IMMUN, V101, P633; HILLS M, 1979, BRIT J CLIN PHARMACO, V8, P7; BALAAM LN, 1968, BIOMETRICS, V24, P61, DOI 10.2307/2528460; CARRIERE KC, 1994, STAT MED, V13, P1063, DOI 10.1002/sim.4780131008; Candel MJJM, 2012, PHARM STAT, V11, P97, DOI 10.1002/pst.502; Brown H, 2006, APPL MIXED MODELS ME; Henderson C, 1984, APPL LINEAR MODELS A; Hunter KR, 1970, LANCET, V295, P1127, DOI 10.1016/S0140-6736(70)91210-9; Kakumanu Sujani S., 2003, Journal of the American Osteopathic Association, V103, P423; Laird MM, 1992, STAT MED, V11, P1967; Littell R. C., 2006, SAS MIXED MODELS; Liu J, 2008, DESIGN ANAL BIOAVAIL; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Senn SS, 2002, CROSS OVER TRIALS CL	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1539-1604	1539-1612		PHARM STAT	Pharm. Stat.	NOV-DEC	2015	14	6					464	470		10.1002/pst.1703		7	Pharmacology & Pharmacy; Statistics & Probability	Pharmacology & Pharmacy; Mathematics	CV9VJ	WOS:000364635200004		
J	Uchino, K; Okamoto, K; Sakai, E; Yoneshima, E; Iwatake, M; Fukuma, Y; Nishishita, K; Tsukuba, T				Uchino, Kaho; Okamoto, Kuniaki; Sakai, Eiko; Yoneshima, Erika; Iwatake, Mayumi; Fukuma, Yutaka; Nishishita, Kazuhisa; Tsukuba, Takayuki			Dual Effects of Liquiritigenin on the Proliferation of Bone Cells: Promotion of Osteoblast Differentiation and Inhibition of Osteoclast Differentiation	PHYTOTHERAPY RESEARCH			English	Article						osteoclasts; osteoblasts; liquiritigenin; differentiation	LINEAGE COMMITMENT; RANKL; BETA; GENISTEIN; AGONIST; MICE	Bone is constantly controlled by a balance between osteoblastic bone formation and osteoclastic bone resorption. Liquiritigenin is a plant-derived flavonoid and has various pharmacological effects, such as antioxidative, antitumor, and antiinflammatory effects. Here, we show that liquiritigenin has dual effects on the proliferation of bone cells, regarding the promotion of osteoblast differentiation and the inhibition of osteoclast differentiation. Liquiritigenin-treated murine osteoblastic MC3T3-E1 cells showed an increased alkaline phosphatase activity and enhanced phosphorylation of Smad1/5 compared with untreated cells. Moreover, liquiritigenin inhibited osteoclast differentiation, its bone-resorption activity through slightly decreased the phosphorylation of extracellular signal-regulated kinase, c-Jun N-terminal kinase, and inhibitor of nuclear factor kappa B; however, the phosphorylation of Akt and p38 slightly increased in bone marrow-derived osteoclasts. The expression levels of the osteoclast marker proteins nuclear factor of activated T-cell cytoplasmic-1, Src, and cathepsin K diminished. These results suggest that liquiritigenin may be useful as a therapeutic and/or preventive agent for osteoporosis or inflammatory bone diseases. Copyright (C) 2015 John Wiley & Sons, Ltd.	[Uchino, Kaho; Okamoto, Kuniaki; Sakai, Eiko; Yoneshima, Erika; Iwatake, Mayumi; Fukuma, Yutaka; Nishishita, Kazuhisa; Tsukuba, Takayuki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Dent Pharmacol, Nagasaki 8528588, Japan	Tsukuba, T (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Dent Pharmacol, Sakamoto 1-7-1, Nagasaki 8528588, Japan.	tsuta@nagasaki-u.ac.jp			JSPS KAKENHI grant [25293383, 26670906, 15H05298, 25462920, 25462892];  [15H00662]	This study was supported in part by JSPS KAKENHI grant numbers 25293383, 26670906, 15H05298 (T.T.), 25462920 (Y. F.), 25462892 (E. S.), and Grant-in-Aid for Encouragement of Scientists Grant Number 15H00662 (M.I.).	Wu J, 2001, J BONE MINER RES, V16, P1829, DOI 10.1359/jbmr.2001.16.10.1829; Kupfer R, 2008, DRUG METAB DISPOS, V36, P2261, DOI 10.1124/dmd.108.021402; Choi EM, 2012, INT IMMUNOPHARMACOL, V12, P139, DOI 10.1016/j.intimp.2011.11.003; Chen XW, 2003, J NUTR BIOCHEM, V14, P342, DOI 10.1016/S0955-2836(03)00056-1; Soltanoff CS, 2009, CRIT REV EUKAR GENE, V19, P1; Zhou M, 2010, PHYTOTHER RES, V24, P827, DOI 10.1002/ptr.3024; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Komori T, 2008, FRONT BIOSCI-LANDMRK, V13, P898, DOI 10.2741/2730; Choi EM, 2014, PHYTOTHER RES, V28, P880, DOI 10.1002/ptr.5071; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Lee JH, 2010, MOL PHARMACOL, V77, P17, DOI 10.1124/mol.109.057877; Bitto A, 2010, CURR MED CHEM, V17, P3007; Chambers TJ, 2000, J PATHOL, V192, P4; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Mersereau JE, 2008, MOL CELL ENDOCRINOL, V283, P49, DOI 10.1016/j.mce.2007.11.020; Sakai E, 2013, J PHARMACOL SCI, V121, P288, DOI 10.1254/jphs.12243FP; Hu JP, 2008, EUR J PHARMACOL, V580, P70, DOI 10.1016/j.ejphar.2007.11.013; Chen JR, 2014, J BONE MINER RES, V29, P1043, DOI 10.1002/jbmr.2034; Kamiya T, 1998, J BIOCHEM-TOKYO, V123, P752; Watanabe T, 2004, J ENDOCRINOL, V180, P193, DOI 10.1677/joe.0.1800193; Sakai E, 2012, J CELL BIOCHEM, V113, P486, DOI 10.1002/jcb.23372; Jiang Y, 2013, FASEB J, V27, P4406, DOI 10.1096/fj.13-234617	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0951-418X	1099-1573		PHYTOTHER RES	Phytother. Res.	NOV	2015	29	11					1714	1721		10.1002/ptr.5416		8	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CW0XJ	WOS:000364713100005		
J	Khalifa, HO; Kamimoto, M; Shimamoto, T; Shimamoto, T				Khalifa, Hazim O.; Kamimoto, Maki; Shimamoto, Toshi; Shimamoto, Tadashi			Antimicrobial Effects of Blueberry, Raspberry, and Strawberry Aqueous Extracts and their Effects on Virulence Gene Expression in Vibrio cholerae	PHYTOTHERAPY RESEARCH			English	Article						natural antimicrobial; berry extracts; pathogenic bacteria; virulence genes	INDUCED FLUID ACCUMULATION; BIOTYPE EL-TOR; ANTIBACTERIAL ACTIVITY; FOODBORNE PATHOGENS; PHENOLIC-COMPOUNDS; PLANT POLYPHENOLS; TOXIN; IDENTIFICATION; BACTERIA; BERRIES	The antimicrobial effects of aqueous extracts of blueberry, raspberry, and strawberry on 13 pathogenic bacteria were evaluated. The minimum inhibitory concentrations and minimum bactericidal concentrations of the extracts were determined before and after neutralization to pH7.03 +/- 0.15. Both Gram-positive and Gram-negative pathogenic bacteria were selectively inhibited by the non-neutralized berries. Blueberry was the best inhibitor, and Vibrio and Listeria were the most sensitive bacteria. After neutralization, blueberry affected only Vibrio and Listeria, whereas the antimicrobial activities of raspberry and strawberry were abolished. The total contents of phenolics, flavonoids, and proanthocyanidins in the extracts were measured with colorimetric methods and were highest in strawberry, followed by raspberry, and then blueberry. We also studied the effects of sub-bactericidal concentrations of the three berry extracts on virulence gene expression in Vibrio cholerae. Real-time quantitative reverse transcription-polymerase chain reaction revealed that the three berry extracts effectively repressed the transcription of the tcpA gene. Raspberry also repressed the transcription of the ctxA gene, whereas blueberry and strawberry did not. However, the three berry extracts did not affect the transcription of toxT. These results suggest that the three berry extracts exert potent antimicrobial effects and inhibit the expression of the virulence factors of V. cholerae. Copyright (C) 2015 John Wiley & Sons, Ltd.	[Khalifa, Hazim O.; Kamimoto, Maki; Shimamoto, Toshi; Shimamoto, Tadashi] Hiroshima Univ, Lab Food Microbiol & Hyg, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan; [Khalifa, Hazim O.] Kafrelsheikh Univ, Dept Pharmacol, Fac Vet Med, Kafr Al Sheikh 33516, Egypt	Shimamoto, T (reprint author), Hiroshima Univ, Lab Food Microbiol & Hyg, Grad Sch Biosphere Sci, 1-4-4 Kagamiyama, Higashihiroshima 7398528, Japan.	tadashis@hiroshima-u.ac.jp					AIBA H, 1981, J BIOL CHEM, V256, P1905; Dey D, 2012, FOOD CHEM TOXICOL, V50, P4302, DOI 10.1016/j.fct.2012.09.001; Nakamura Y, 2003, J HEALTH SCI, V49, P45, DOI 10.1248/jhs.49.45; Taguri T, 2004, BIOL PHARM BULL, V27, P1965, DOI 10.1248/bpb.27.1965; Chatterjee S, 2010, FEMS MICROBIOL LETT, V306, P54, DOI 10.1111/j.1574-6968.2010.01931.x; Chatterjee A, 2007, INFECT IMMUN, V75, P1946, DOI 10.1128/IAI.01435-06; Puupponen-Pimia R, 2001, J APPL MICROBIOL, V90, P494, DOI 10.1046/j.1365-2672.2001.01271.x; Plumed-Ferrer C, 2013, INT J FOOD MICROBIOL, V164, P99, DOI 10.1016/j.ijfoodmicro.2013.04.001; Mwansa JCL, 2007, EPIDEMIOL INFECT, V135, P847, DOI 10.1017/S0950268806007254; Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.047; Henriques AF, 2011, EUR J CLIN MICROBIOL, V30, P167, DOI 10.1007/s10096-010-1065-1; Zhong ZT, 2008, J ANTIMICROB CHEMOTH, V61, P753, DOI 10.1093/jac/dkm540; Huang WY, 2012, J ZHEJIANG UNIV-SC B, V13, P94, DOI 10.1631/jzus.B1100137; Morinaga N, 2005, J BIOL CHEM, V280, P23303, DOI 10.1074/JBC.M502093200; IWANAGA M, 1985, J CLIN MICROBIOL, V22, P405; Lacombe A, 2012, FOOD MICROBIOL, V30, P124, DOI 10.1016/j.fm.2011.10.006; Schuhmacher DA, 1999, J BACTERIOL, V181, P1508; Puupponen-Pimia R, 2005, J APPL MICROBIOL, V98, P991, DOI 10.1111/j.1365-2672.2005.02547.x; MONTIE T, 1995, EUR J CLIN MICROBIOL, V14, P85, DOI 10.1007/BF02111863; Lacombe A, 2010, INT J FOOD MICROBIOL, V139, P102, DOI 10.1016/j.ijfoodmicro.2010.01.035; TODA M, 1992, MICROBIOL IMMUNOL, V36, P999; Saito T, 2002, MICROBIOL IMMUNOL, V46, P249; Wu VCH, 2008, LWT-FOOD SCI TECHNOL, V41, P1834, DOI 10.1016/j.lwt.2008.01.001; Nascimento GGF, 2000, BRAZ J MICROBIOL, V31, P247; Oi H, 2002, P NATL ACAD SCI USA, V99, P3042, DOI 10.1073/pnas.052709499; Brudzynski K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00242; Hooper David C., 1993, P53; Joseph SV, 2014, J AGR FOOD CHEM, V62, P3886, DOI 10.1021/jf4044056; Mikulic-Petkovsek M, 2012, FOOD CHEM, V135, P2138, DOI 10.1016/j.foodchem.2012.06.115; Rojo EL, 2012, FOOD CHEM, V131, P387; Yang ZF, 2013, FITOTERAPIA, V93, P47	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0951-418X	1099-1573		PHYTOTHER RES	Phytother. Res.	NOV	2015	29	11					1791	1797		10.1002/ptr.5436		7	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CW0XJ	WOS:000364713100015		
J	Matsuoka, S				Matsuoka, Shin-ichi			N-Heterocyclic carbene-catalyzed dimerization, cyclotetramerization and polymerization of Michael acceptors	POLYMER JOURNAL			English	Review							TO-TAIL DIMERIZATION; BAYLIS-HILLMAN REACTION; STABLE CARBENE; 1,3-DICARBONYL COMPOUNDS; CONJUGATE-ADDITION; VINYL SULFONES; 1,3,4-TRIPHENYL-4,5-DIHYDRO-1H-1,2,4-TRIAZOL-5-YLIDENE; ORGANOCATALYSTS; UMPOLUNG; BONDS	N-Heterocyclic carbenes (NHCs), which were first isolated in the early 1990s, have received a great deal of scientific attention as ligands for transition metal complexes and organocatalysts for more than a decade. Organocatalysis by NHCs primarily involves the reaction of carbonyl compounds, particularly the umpolung of aldehydes, although we and others have been developing the reactions and the polymerizations of Michael acceptors. This review focuses on the NHC-catalyzed transformations of Michael acceptors that were developed by our research group, including (1) tail-to-tail dimerization of a wide variety of substrates, (2) cyclotetramerization of acrylates, (3) tandem oxa-Michael addition and head-to-tail dimerization of methacrolein and (4) oxa-Michael addition polymerization of hydroxyl-functionalized acrylates. For the former two reactions, the NHCs turn the beta-carbon of the Michael acceptors into nucleophilic sites (umpolung), thereby generating the deoxy-Breslow intermediate and enabling bond formation between the beta-carbon and electrophiles. The latter two reactions are based on the O-C bond formation between alcohols and Michael acceptors, in which the NHC catalysts act as a Lewis base. Thus, the use of NHC catalysts allowed new modes of reactivity of Michael acceptors other than the conventional addition polymerizations.	[Matsuoka, Shin-ichi] Nagoya Inst Technol, Grad Sch Engn, Dept Mat Sci & Engn, Nagoya, Aichi 4668555, Japan	Matsuoka, S (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Mat Sci & Engn, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	matsuoka.shinichi@nitech.ac.jp			Hibi Science Foundation; Toukai Foundation for Technology;  [24750102]	I thank Professor Masato Suzuki and Professor Koji Takagi of the Nagoya Institute of Technology for their helpful discussions. I also acknowledge Mr Atsushi Washio, Mr Yoshiya Ota, Mr Shintaro Shimakawa, Ms Akiho Katada, Mr Yusuke Tochigi, Mr Terumasa Kato, Ms Shoko Namera and Mr Masanori Nakazawa for their experimental contributions. This work was partially supported by Grant-in-Aid for Scientific Research for Young Scientists (B) No. 24750102, the Hibi Science Foundation, and the Toukai Foundation for Technology.	Enders D, 2007, CHEM REV, V107, P5606, DOI 10.1021/cr068372z; Hopkinson MN, 2014, NATURE, V510, P485, DOI 10.1038/nature13384; Matsuoka S, 2011, TETRAHEDRON LETT, V52, P6835, DOI 10.1016/j.tetlet.2011.10.070; Kang Q, 2011, ORG BIOMOL CHEM, V9, P6715, DOI 10.1039/c1ob05429e; Chen XY, 2013, CHEM-EUR J, V19, P4441, DOI 10.1002/chem.201204539; Hong M, 2014, ANGEW CHEM INT EDIT, V53, P11900, DOI 10.1002/anie.201406630; Boddaert T, 2009, ADV SYNTH CATAL, V351, P1744, DOI 10.1002/adsc.200900292; Ryan SJ, 2013, CHEM SOC REV, V42, P4906, DOI 10.1039/c3cs35522e; Fischer C, 2006, J AM CHEM SOC, V128, P1472, DOI 10.1021/ja058222q; Boddaert T, 2011, CHEM-EUR J, V17, P2266, DOI 10.1002/chem.201002538; Chen XY, 2013, ORG BIOMOL CHEM, V11, P7991, DOI 10.1039/c3ob41469h; Matsuoka S, 2015, POLYM CHEM-UK, V6, P294, DOI 10.1039/c4py01184h; Nair V, 2011, CHEM SOC REV, V40, P5336, DOI 10.1039/c1cs15139h; He L, 2007, J ORG CHEM, V72, P7466, DOI 10.1021/jo071247i; Enders D, 1996, LIEBIGS ANN, P2019; Phillips EM, 2010, J AM CHEM SOC, V132, P13179, DOI 10.1021/ja1061196; Kato T, 2014, J ORG CHEM, V79, P4484, DOI 10.1021/jo500514e; Vora HU, 2011, ALDRICHIM ACTA, V44, P3; Enders D, 2003, SYNTHESIS-STUTTGART, P1292; Kato T, 2013, J ORG CHEM, V78, P8739, DOI 10.1021/jo401477b; Kamber NE, 2007, CHEM REV, V107, P5813, DOI 10.1021/cr068415b; Martin CD, 2013, CHEM SCI, V4, P3020, DOI 10.1039/c3sc51174j; Diez-Gonzalez S, 2009, CHEM REV, V109, P3612, DOI 10.1021/cr900074m; Schedler M, 2014, ORG LETT, V16, P3134, DOI 10.1021/ol501256d; Valente C, 2012, ANGEW CHEM INT EDIT, V51, P3314, DOI 10.1002/anie.201106131; Matsuoka S, 2011, ORG LETT, V13, P3722, DOI 10.1021/ol201380m; ENDERS D, 1995, ANGEW CHEM INT EDIT, V34, P1021, DOI 10.1002/anie.199510211; BRESLOW R, 1958, J AM CHEM SOC, V80, P3719, DOI 10.1021/ja01547a064; Atienza RL, 2011, CHEM SCI, V2, P1772, DOI 10.1039/c1sc00194a; Wang YZ, 2014, INORG CHEM, V53, P11815, DOI 10.1021/ic502231m; Biju AT, 2011, ACCOUNTS CHEM RES, V44, P1182, DOI 10.1021/ar2000716; STETTER H, 1976, ANGEW CHEM INT EDIT, V15, P639, DOI 10.1002/anie.197606391; Biju AT, 2011, ANGEW CHEM INT EDIT, V50, P8412, DOI 10.1002/anie.201103555; Enders D, 2004, ACCOUNTS CHEM RES, V37, P534, DOI 10.1021/ar030050j; Matsuoka S, 2013, ORG LETT, V15, P5916, DOI 10.1021/ol4021942; Chen XY, 2013, ORG BIOMOL CHEM, V11, P5722, DOI 10.1039/c3ob40804c; Fevre M, 2013, CHEM SOC REV, V42, P2142, DOI 10.1039/c2cs35383k; Zhang YT, 2012, ANGEW CHEM INT EDIT, V51, P2465, DOI 10.1002/anie.201108019; Ottou WN, 2014, CHEM-EUR J, V20, P3989, DOI 10.1002/chem.201304492; Kiesewetter MK, 2010, MACROMOLECULES, V43, P2093, DOI 10.1021/ma9025948; Marion N, 2007, ANGEW CHEM INT EDIT, V46, P2988, DOI 10.1002/anie.200603380; He L, 2008, SYNTHESIS-STUTTGART, P2825, DOI 10.1055/s-2008-1067216; Matsuoka S, 2012, TETRAHEDRON, V68, P9836, DOI 10.1016/j.tet.2012.08.076; Hans M, 2014, J ORG CHEM, V79, P2758, DOI 10.1021/jo500108a; Atienza RL, 2011, AUST J CHEM, V64, P1158, DOI 10.1071/CH11264; Anthony J., 1991, J AM CHEM SOC, V113, P361; Anthony J., 1999, ACCOUNTS CHEM RES, V32, P913; Anthony J., 1992, J AM CHEM SOC, V114, P5530; He L, 2014, CHEM COMMUN, V50, P3719, DOI 10.1039/c4cc00154k; Matsuoka S, 2015, B CHEM SOC JPN, V88, P1093, DOI 10.1246/bcsj.20150048; Naumann S, 2015, POLYM CHEM-UK, V6, P3185, DOI 10.1039/c5py00145e; Nolan SP, 2014, N-HETEROCYCLIC CARBENES: EFFECTIVE TOOLS FOR ORGANOMETALLIC SYNTHESIS, P1, DOI 10.1002/9783527671229; Ukai T., 1943, J PHARM SOC JPN, V63, P296	53	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	NOV	2015	47	11					713	718		10.1038/pj.2015.59		6	Polymer Science	Polymer Science	CV8XL	WOS:000364571500001		
J	Shundo, A				Shundo, Atsuomi			Dynamic structure and functionalization of polymer interfaces	POLYMER JOURNAL			English	Review							GLASS-TRANSITION TEMPERATURE; SUM-FREQUENCY GENERATION; SURFACE MOLECULAR-MOTION; SENSITIZED SOLAR-CELLS; POLY(METHYL METHACRYLATE); VIBRATIONAL SPECTROSCOPY; AMORPHOUS POLYMERS; POLYSTYRENE FILMS; BLOCK-COPOLYMERS; WATER INTERFACE	The segmental mobility of polymers at an interface in contact with air, a liquid or a solid is considerably different from that in the internal bulk phase. This review summarizes recent studies offering a concept that the polymer interface is a useful medium for the functionalization of solid polymer materials. Time- and space-resolved fluorescence spectroscopy using evanescent wave excitation revealed that the segmental mobility at the surface and the solid interface had a strong impact on the fluorescence properties of a dye well dispersed in a polymer film when the film thickness decreased. Furthermore, using a chiral polymer designed from the concept of a dynamic interface, enantioselective wetting was successfully demonstrated. The contact angle of chiral liquids on the film varied depending on the chirality of the liquid. This wetting resulted from the enantioselective surface reorganization involving local conformational changes of the polymer chains at the liquid interface, as confirmed using sum frequency generation vibrational spectroscopy.	[Shundo, Atsuomi] Kyushu Univ, Dept Appl Chem, Fukuoka 8190395, Japan; [Shundo, Atsuomi] Kyushu Univ, Dept Automot Sci, Fukuoka 8190395, Japan	Shundo, A (reprint author), Kyushu Univ, Dept Appl Chem, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	a-shundo@cstf.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23750086, 25620176]	I deeply thank Professors Keiji Tanaka, Fuyuki Ito and Nobuo Kimizuka and Dr Koichiro Hori, Mrs Yohei Okada and Takuya Ikeda for their assistance and helpful discussions. This research was partly supported by Grant-in-Aid for Young Scientists (B) (No. 23750086) and for Challenging Exploratory Research (No. 25620176) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Bucknall DG, 2004, PROG MATER SCI, V49, P713, DOI 10.1016/S0079-6425(03)00038-0; Tanaka K, 2009, J PHYS CHEM B, V113, P4571, DOI 10.1021/jp810370f; Bliznyuk VN, 2002, MACROMOLECULES, V35, P6613, DOI 10.1021/ma011326a; Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4; Chang BS, 2015, SMALL, V11, P1097, DOI 10.1002/smll.201402038; Na HS, 2000, MOL CRYST LIQ CRYST, V349, P35, DOI 10.1080/10587250008024859; Balazs AC, 2006, SCIENCE, V314, P1107, DOI 10.1126/science.1130557; Horinouchi A, 2012, MACROMOLECULES, V45, P4638, DOI 10.1021/ma3002559; WALLACE WE, 1995, PHYS REV E, V52, pR3329; SENSHU K, 1995, LANGMUIR, V11, P2293, DOI 10.1021/la00006a070; Tanaka K, 1997, MACROMOLECULES, V30, P6626, DOI 10.1021/ma970057e; ZHU XD, 1987, PHYS REV B, V35, P3047, DOI 10.1103/PhysRevB.35.3047; Chen Z, 2007, POLYM INT, V56, P577, DOI 10.1002/pi.2201; Nogueira AF, 2004, COORDIN CHEM REV, V248, P1455, DOI 10.1016/j.ccr.2004.05.018; Shundo A, 2005, J CHROMATOGR A, V1073, P169, DOI 10.1016/j.chroma.2004.08.062; Maeda M, 2004, APPL PHYS LETT, V85, P351, DOI 10.1063/1.1772522; Kajiyama T, 2000, HIGH PERFORM POLYM, V12, P587, DOI 10.1088/0954-0083/12/4/314; Forrest JA, 1996, PHYS REV LETT, V77, P2002, DOI 10.1103/PhysRevLett.77.2002; Fujii Y, 2013, ADV POLYM SCI, V252, P1, DOI 10.1007/12_2012_175; Coleman JN, 2006, CARBON, V44, P1624, DOI 10.1016/j.carbon.2006.02.038; Luzinov I, 2004, PROG POLYM SCI, V29, P635, DOI 10.1016/j.progpolymsci.2004.03.001; Onoda M, 2006, CURR APPL PHYS, V6, P887, DOI 10.1016/j.cap.2005.06.003; SHEN YR, 1989, NATURE, V337, P519, DOI 10.1038/337519a0; Chen CY, 2005, PHYS CHEM CHEM PHYS, V7, P2357, DOI 10.1039/b501910a; Baldan A, 2004, J MATER SCI, V39, P1, DOI 10.1023/B:JMSC.0000007726.58758.e4; Tanaka K, 2008, LANGMUIR, V24, P296, DOI 10.1021/la702132t; Netz RR, 2003, PHYS REP, V380, P1, DOI 10.1016/S0370-1573(03)00118-2; Sun Y, 2006, ANAL CHIM ACTA, V556, P80, DOI 10.1016/j.aca.2005.09.035; Satomi N, 2001, MACROMOLECULES, V34, P8761, DOI 10.1021/ma010126w; Greene NT, 2005, J AM CHEM SOC, V127, P5695, DOI 10.1021/ja0468022; Tanaka K, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2335593; Crenshaw BR, 2005, ADV MATER, V17, P1471, DOI 10.1002/adma.200401688; Pike JK, 1996, CHEM MATER, V8, P856, DOI 10.1021/cm9504596; Okamoto Y, 1998, ANGEW CHEM INT EDIT, V37, P1020, DOI 10.1002/(SICI)1521-3773(19980504)37:8<1020::AID-ANIE1020>3.0.CO;2-5; Zhang W, 2011, MACROMOL CHEM PHYS, V212, P15, DOI 10.1002/macp.201000489; PHILLIPS D, 1984, POLYM PHOTOCHEM, V5, P153, DOI 10.1016/0144-2880(84)90029-0; Shimomura K, 2014, NAT CHEM, V6, P429, DOI [10.1038/nchem.1916, 10.1038/NCHEM.1916]; Ito F, 2010, PHYS CHEM CHEM PHYS, V12, P10923, DOI 10.1039/c003023f; Ngai KL, 1998, J NON-CRYST SOLIDS, V235, P435, DOI 10.1016/S0022-3093(98)00656-5; Ellison CJ, 2003, NAT MATER, V2, P695, DOI 10.1038/nmat980; Miyazaki T, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061803; Li GF, 2004, J AM CHEM SOC, V126, P12198, DOI 10.1021/ja046183x; KOST A, 1993, OPT LETT, V18, P334, DOI 10.1364/OL.18.000334; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Shundo A, 2013, J AM CHEM SOC, V135, P10282, DOI 10.1021/ja404701s; Jintoku H, 2012, CHEM COMMUN, V48, P4881, DOI 10.1039/c2cc31127e; Anthony J, 2011, J OPT SOC AM B, V28, P1013; Rapp M, 2010, J AM CHEM SOC, V132, P18051, DOI 10.1021/ja109598z; Garcia SJ, 2011, PROG ORG COAT, V72, P211, DOI 10.1016/j.porgcoat.2011.06.016; Tateishi Y, 2010, POLYM CHEM-UK, V1, P303, DOI 10.1039/b9py00227h; Shundo A, 2012, MACROMOLECULES, V45, P329, DOI 10.1021/ma201901x; Tanaka K, 1996, MACROMOLECULES, V29, P3040, DOI 10.1021/ma951378y; Tanaka K, 2000, MACROMOLECULES, V33, P7588, DOI 10.1021/ma000406w; ISHIGURE T, 1994, APPL OPTICS, V33, P4261, DOI 10.1364/AO.33.004261; Rangwalla H, 2004, LANGMUIR, V20, P8625, DOI 10.1021/la049073c; Matsuoka H, 2001, MACROMOL RAPID COMM, V22, P51, DOI 10.1002/1521-3927(20010201)22:2<51::AID-MARC51>3.0.CO;2-5; Shundo A, 2013, PHYS CHEM CHEM PHYS, V15, P16574, DOI 10.1039/c3cp52673a; Fujii Y, 2010, J PHYS CHEM B, V114, P3457, DOI 10.1021/jp909373g; desBarrio J., 2009, J MATER CHEM, V19, P4922; Ihara H., 2007, ENCY CHROMATOGRAPHY, P1; Kim JM, 2007, MACROMOL RAPID COMM, V28, P1191, DOI 10.1002/marc.200700043	61	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	NOV	2015	47	11					719	726		10.1038/pj.2015.60		8	Polymer Science	Polymer Science	CV8XL	WOS:000364571500002		
J	Jin, X; Tateyama, S; Kaneko, T				Jin, Xin; Tateyama, Seiji; Kaneko, Tatsuo			Salt-induced reinforcement of anionic bio-polyureas with high transparency	POLYMER JOURNAL			English	Article							LIGNIN	Bio-based polyureas (PUs) are prepared by the polyaddition of a multifunctional bio-photodimer 4,4'-diamino-a-truxillic acid having two amines and two carboxyls with an aromatic isocyanate comonomer. Weight average molecular weights of the PUs range from 2.4 x 10(5) to 2.5 x 10(5) g mol(-1) with a narrow distribution around 1.3. The 10% weight-loss temperature of the PUs ranges from 270 to 280 degrees C, whereas the softening temperature ranges between 180 and 210 degrees C. The PUs are well dissolved in polar organic solvents such as dimethylformamide and the cast film is prepared from these solutions. The films show high transparency and swell in the alkaline solution when the PU carboxyls are anionized. If metal nitrate salts are added to the films, mechanical properties are increased by the double interaction of the metal cation with carboxylate and nitrate with urea, which causes the films to change the color.	[Jin, Xin; Tateyama, Seiji; Kaneko, Tatsuo] Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa 9231211, Japan	Kaneko, T (reprint author), Japan Adv Inst Sci & Technol, Sch Mat Sci, 1-1 Asahidai, Nomi, Ishikawa 9231211, Japan.	kaneko@jaist.ac.jp			Japan Science and Technology Agency, Advanced Low Carbon Technology Research and Development Program, Tokyo, Japan [5170020]	This work was partially supported by Japan Science and Technology Agency, Advanced Low Carbon Technology Research and Development Program, No. 5170020, Tokyo, Japan.	CHOPRA KL, 1983, THIN SOLID FILMS, V102, P1, DOI 10.1016/0040-6090(83)90256-0; Miller SA, 2013, ACS MACRO LETT, V2, P550, DOI 10.1021/mz400207g; Megiatto JD, 2012, BIOMACROMOLECULES, V13, P1652, DOI 10.1021/bm300367b; Arman B, 2012, MACROMOLECULES, V45, P3247, DOI 10.1021/ma3001934; Perez-Casas C, 2008, J ORG CHEM, V73, P2275, DOI 10.1021/jo702458f; Zakzeski J, 2010, CHEM REV, V110, P3552, DOI 10.1021/cr900354u; Kaneko T, 2006, NAT MATER, V5, P966, DOI 10.1038/nmat1778; Suvannasara P, 2014, MACROMOLECULES, V47, P1586, DOI 10.1021/ma402499m; Ferrer A. S., 2010, MACROMOL CHEM PHYS, V211, P1712; Bondy CR, 2004, J AM CHEM SOC, V126, P5030, DOI 10.1021/ja039712q; Mathers R. T., 2011, GREEN POLYM METHODS; Ostroverkhova O, 2013, WOODH PUB SER ELECT, pXXV	12	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	NOV	2015	47	11					727	732		10.1038/pj.2015.58		6	Polymer Science	Polymer Science	CV8XL	WOS:000364571500003		
J	Nakashima, M; Otsura, T; Naito, H; Ohshita, J				Nakashima, Makoto; Otsura, Takanori; Naito, Hiroyoshi; Ohshita, Joji			Synthesis of new D-A polymers containing disilanobithiophene donor and application to bulk heterojunction polymer solar cells	POLYMER JOURNAL			English	Article							PHOTOVOLTAIC PROPERTIES; COPOLYMER; VOLTAGE	New donor-acceptor-conjugated polymers with disilanobithiophene as the donor and dithienylbenzothiadiazole, thienopyrroledione or diketopyrrolopyrrole as the acceptor were synthesized and their optical and electrochemical properties were investigated. The polymers were black solids and showed broad absorption bands in the visible region. The most red-shifted absorption band having a maximum and an edge of 739 nm and 1.4 eV, respectively, was obtained when diketopyrrolopyrrole was used as the acceptor. The absorption bands were shifted to lower energies when the spectra of the polymers were measured as films, likely due to the interchain interaction of the polymers in the films. Cyclic voltammetry studies of the polymer films were also carried out. The highest occupied molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO) energy levels based on the anodic peak onsets and the optical band gaps were -5.1 to -5.5 and -3.5 to -3.7 eV, respectively, depending on the acceptor structures. Bulk heterojunction polymer solar cells that used the present polymers as host material (indium tin oxide (ITO)/poly(3,4-ethylenedioxythiophene) (PEDOT): polystyrene sulfonate (PSS)/disilane-bridged bithiophenepolymer: PC71BM/Ca/Al) were fabricated, and a maximal power conversion efficiency of 2.49% was achieved based on the polymer with bis(hexylthienyl)benzothiadiazole as the acceptor.	[Nakashima, Makoto; Ohshita, Joji] Hiroshima Univ, Grad Sch Engn, Dept Appl Chem, Higashihiroshima, Japan; [Otsura, Takanori; Naito, Hiroyoshi] Osaka Prefecture Univ, Grad Sch Engn, Dept Phys & Elect, Osaka 5998531, Japan	Naito, H (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Dept Phys & Elect, Naka Ku, 1-1 Gakuen cho, Osaka 5998531, Japan.	naito@pe.osakafu-u.ac.jp; jo@hiroshima-u.ac.jp	Ohshita, Joji/C-7576-2011		Ministry of Education, Culture, Sports, Science and Technology, Japan [2401, 26288094]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas 'New Polymeric Materials Based on Element-Blocks (No. 2401)' and that for Scientific Research (B) (No. 26288094) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. We thank also Associate Professor Shin-ichi Kihara of Hiroshima University for assistance in GPC measurement at high temperature.	Hou JH, 2008, J AM CHEM SOC, V130, P16144, DOI 10.1021/ja806687u; Du C, 2013, J POLYM SCI POL CHEM, V51, P383, DOI 10.1002/pola.26396; Ohshita J, 2014, POLYM CHEM-UK, V5, P346, DOI 10.1039/c3py01157g; Yue S, 1996, MACROMOLECULES, V29, P933, DOI 10.1021/ma951008+; Ohshita J, 2013, POLYM J, V45, P979, DOI 10.1038/pj.2013.13; Medlej H, 2013, EUR POLYM J, V49, P4176, DOI 10.1016/j.eurpolymj.2013.09.025; Yue W, 2009, J MATER CHEM, V19, P2199, DOI 10.1039/b818885h; Piliego C, 2010, J AM CHEM SOC, V132, P7595, DOI 10.1021/ja103275u; Kai H, 2008, J ORGANOMET CHEM, V693, P3490, DOI 10.1016/j.jorganchem.2008.08.018; Dou LT, 2013, ADV MATER, V25, P6642, DOI 10.1002/adma.201302563; Chu TY, 2012, ADV FUNCT MATER, V22, P2345, DOI 10.1002/adfm.201102623; Zhou CZ, 2005, POLYMER, V46, P10952, DOI 10.1016/j.polymer.2005.09.030; Pei JN, 2011, NEW J CHEM, V35, P385, DOI 10.1039/c0nj00378f; Ohshita J, 1999, ORGANOMETALLICS, V18, P1453, DOI 10.1021/om980918n; Liao L, 2007, MACROMOLECULES, V40, P9406, DOI 10.1021/ma071825x; Kwak YW, 2006, ORGANOMETALLICS, V25, P48, DOI 10.1021/om050375z; Albrecht S, 2012, J AM CHEM SOC, V134, P14932, DOI 10.1021/ja305039j; Huo LJ, 2009, MACROMOLECULES, V42, P6564, DOI 10.1021/ma9012972; Yamaguchi S, 1998, ORGANOMETALLICS, V17, P4910, DOI 10.1021/om980393z; Clark J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206406; Azoulay D. J., 2013, MACROMOLECULES, V46, P1337; Ohshita J., 2011, ORGANOMETALLICS, V12, P3233; Ohshita J, 2009, MACROMOL CHEM PHYSIC, V210, P1360, DOI 10.1002/macp.200900180; Rasmussen C. S., 2013, PROG POLYM SCI, V38, P1773; Small E. C., 2012, NAT PHOTONICS, V6, P115; Turner T. S., 2011, ADV FUNCT MATER, V21, P4640; Li YF, 2012, ACCOUNTS CHEM RES, V45, P723, DOI 10.1021/ar2002446	27	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	NOV	2015	47	11					733	738		10.1038/pj.2015.61		6	Polymer Science	Polymer Science	CV8XL	WOS:000364571500004		
J	Ma, XF; Usui, R; Kitazawa, Y; Kokubo, H; Watanabe, M				Ma, Xiaofeng; Usui, Ryoji; Kitazawa, Yuzo; Kokubo, Hisashi; Watanabe, Masayoshi			Temperature and light-induced self-assembly changes of a tetra-arm diblock copolymer in an ionic liquid	POLYMER JOURNAL			English	Article							STAR-BLOCK-COPOLYMER; TRIBLOCK COPOLYMER; NEOTERIC SOLVENTS; PHASE-TRANSITION; LINEAR-POLYMERS; LOW-VOLTAGE; BEHAVIOR; GELS; MICELLIZATION; PH	A tetra-arm diblock copolymer ([PEG-b-P(AzoMA-r-NIPAm)](4)) was synthesized by reversible addition-fragmentation chain transfer copolymerization of N-isopropylacrylamide (NIPAm) and 4-phenylazophenyl methacrylate (AzoMA), initiating from the ends of functionalized tetra-arm polyethylene glycol (tetra-PEG). The resulting tetra-arm diblock copolymer consists of two segments: tetra-PEG (the center block; compatible with 1-butyl-3-methylimidazolium hexafluorophosphate ([C(4)mim]PF6)) and P(AzoMA-r-NIPAm) (the end blocks; temperature-and photosensitive compatibility with [C(4)mim] PF6 due to photoresponsive upper critical solution temperature phase behavior). We found that [PEG-b-P(AzoMA-r-NIPAm)](4) underwent high-temperature unimer and low-temperature micelle (upper critical micellization temperature (UCMT)) transitions in [C(4)mim]PF6. The UCMT of the tetra-arm diblock copolymer depended on photoisomerization states of the azobenzene groups within the copolymer. The UCMT of the trans-form polymer in dark conditions was higher than that of the cis-form polymer under UV-light irradiation. We demonstrated photoinduced self-assembly changes of the tetra-arm diblock copolymer in [C(4)mim]PF6 at a 'bistable' temperature. Reversible photoinduced unimer/micelle transitions were also demonstrated.	[Ma, Xiaofeng; Usui, Ryoji; Kitazawa, Yuzo; Kokubo, Hisashi; Watanabe, Masayoshi] Yokohama Natl Univ, Dept Chem & Biotechnol, Yokohama, Kanagawa 2408501, Japan	Watanabe, M (reprint author), Yokohama Natl Univ, Dept Chem & Biotechnol, Hodogaya Ku, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	mwatanabe@ynu.ac.jp			MEXT of Japan; Japan Society for the Promotion of Science [13J00192];  [A-23245046];  [S-15H05758]	This work was financially supported by the Grants-in-Aid for Scientific Research of #A-23245046, #S-15H05758, and the Specially Promoted Research on 'Iontronics' from the MEXT of Japan, and in part from the Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists (No. 13J00192 to YK).	Alexandridis P., 2000, AMPHIPHILIC BLOCK CO, P1; Tokuda H, 2004, J PHYS CHEM B, V108, P16593, DOI 10.1021/jp047480r; Imaizumi S, 2012, MACROMOLECULES, V45, P401, DOI 10.1021/ma2022138; Lee HN, 2010, MACROMOLECULES, V43, P9522, DOI 10.1021/ma1019279; Winterton N, 2006, J MATER CHEM, V16, P4281, DOI 10.1039/b610143g; Tamura S, 2009, MACROMOLECULES, V42, P6239, DOI 10.1021/ma900922d; Plechkova NV, 2008, CHEM SOC REV, V37, P123, DOI 10.1039/b006677j; Shibayama M, 2006, POLYMER, V47, P6446, DOI 10.1016/j.polymer.2006.06.060; Kodama K, 2011, POLYM J, V43, P242, DOI 10.1038/pj.2010.140; Ueki T, 2012, B CHEM SOC JPN, V85, P33, DOI 10.1246/bcsj.20110225; Ueki T, 2009, LANGMUIR, V25, P8845, DOI 10.1021/la901159r; Rodriguez H, 2010, FLUID PHASE EQUILIBR, V294, P7, DOI 10.1016/j.fluid.2009.12.036; BATES FS, 1991, SCIENCE, V251, P898, DOI 10.1126/science.251.4996.898; Wakai C, 2005, J PHYS CHEM B, V109, P17028, DOI 10.1021/jp053946+; Hunger J, 2009, CHEMPHYSCHEM, V10, P723, DOI 10.1002/cphc.200800483; Ueki T, 2011, MACROMOLECULES, V44, P6908, DOI 10.1021/ma2014244; Ueki T, 2007, LANGMUIR, V23, P988, DOI 10.1021/la062986h; Kodama K, 2009, LANGMUIR, V25, P3820, DOI 10.1021/la803945n; Riess G, 2003, PROG POLYM SCI, V28, P1107, DOI 10.1016/S0079-6700(03)00015-7; He E, 2009, LANGMUIR, V25, P4892, DOI 10.1021/la804056p; Kim KH, 2004, MACROMOL CHEM PHYSIC, V205, P1684, DOI 10.1002/macp.200400084; Strandman S, 2007, POLYMER, V48, P7008, DOI 10.1016/j.polymer.2007.10.002; Shimoboji T, 2002, BIOCONJUGATE CHEM, V13, P915, DOI 10.1021/bc010057q; Pereiro AB, 2007, J CHEM THERMODYN, V39, P1168, DOI 10.1016/j.jct.2006.12.005; KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; Ueki T, 2009, MACROMOLECULES, V42, P1315, DOI 10.1021/ma802443b; Seddon KR, 2003, NAT MATER, V2, P363, DOI 10.1038/nmat907; Magee JW, 2005, ACS SYM SER, V901, P160; Jones MC, 2003, BIOCONJUGATE CHEM, V14, P774, DOI 10.1021/bc020041f; Ueki T, 2015, ANGEW CHEM INT EDIT, V54, P3018, DOI 10.1002/anie.201411526; He E, 2007, LANGMUIR, V23, P2382, DOI 10.1021/la062987+; He Y, 2008, MACROMOLECULES, V41, P167, DOI 10.1021/ma702014z; He YY, 2007, CHEM COMMUN, P2732, DOI 10.1039/b704490a; ZHANG LF, 1995, SCIENCE, V268, P1728, DOI 10.1126/science.268.5218.1728; Lee HN, 2011, J PHYS CHEM B, V115, P1971, DOI 10.1021/jp1106058; He YY, 2006, J AM CHEM SOC, V128, P2745, DOI 10.1021/ja058091t; Jeong YI, 1999, INT J PHARM, V188, P49, DOI 10.1016/S0378-5173(99)00202-1; Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t; Moon HC, 2014, J AM CHEM SOC, V136, P3705, DOI 10.1021/ja5002899; Ueki T, 2012, MACROMOLECULES, V45, P7566, DOI 10.1021/ma3016008; Ueki T, 2006, CHEM LETT, V35, P964, DOI 10.1246/cl.2006.964; Cho JH, 2008, NAT MATER, V7, P900, DOI 10.1038/nmat2291; Kitazawa Y, 2012, SOFT MATTER, V8, P8067, DOI 10.1039/c2sm25375e; Lodge TP, 2008, SCIENCE, V321, P50, DOI 10.1126/science.1159652; He YY, 2007, J PHYS CHEM B, V111, P4645, DOI 10.1021/jp064574n; Mori H, 2012, POLYM J, V44, P550, DOI 10.1038/pj.2012.35; Ueki T, 2012, CHEM COMMUN, V48, P5133, DOI 10.1039/c2cc30830d; Yuan WF, 2006, MACROMOLECULES, V39, P1300, DOI 10.1021/ma051989i; Lai JT, 2002, MACROMOLECULES, V35, P6754, DOI 10.1021/ma020362m; Dietz ML, 2005, ACS SYM SER, V902, P2; Lee HN, 2012, MACROMOLECULES, V45, P3627, DOI 10.1021/ma300335p; Brown W., 1993, DYNAMIC LIGHT SCATTE; Deng M., 2004, J POLYM SCI A, V4, P950; Hamley I. W., 2005, BLOCK COPOLYMERS SOL; Holbrey J. D., 2005, ACS SYM SER, V913, P71; Holbrey JD, 1999, CLEAN PRODUCTS PROCE, V1, P223, DOI DOI 10.1007/S100980050036; Luo C., 2008, J APPL POLYM SCI, V4, P2118; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; Ryayev J., 2005, J AM CHEM SOC, V127, P13373; Wasserscheid P, 2000, ANGEW CHEM INT EDIT, V39, P3772, DOI 10.1002/1521-3773(20001103)39:21<3772::AID-ANIE3772>3.0.CO;2-5; Wilkes JS, 2002, GREEN CHEM, V4, P73, DOI 10.1039/b110838g	61	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	NOV	2015	47	11					739	746		10.1038/pj.2015.55		8	Polymer Science	Polymer Science	CV8XL	WOS:000364571500005		
J	Tanaka, K; Naka, K; Miyoshi, E; Narita, A; Chujo, Y				Tanaka, Kazuo; Naka, Kensuke; Miyoshi, Eisuke; Narita, Asako; Chujo, Yoshiki			Control of interparticle spacing in stable aggregates of gold nanoparticles by light irradiation	POLYMER JOURNAL			English	Article							SURFACE-PLASMON RESONANCE; SELF-ASSEMBLED MONOLAYERS; AZOBENZENE; PHOTOREACTIVITY; NANOTECHNOLOGY; CYCLODEXTRIN; GLUTATHIONE; DERIVATIVES; DISULFIDES; REACTIVITY	This study describes the modulation of interparticle distances in aggregates of gold nanoparticles by light irradiation. Stable aggregates of a series of imidazolium-presenting gold nanoparticles were obtained via a photo-responsive mono-carboxylate linker. In the first step, the mono-carboxylate linker attracted the gold nanoparticles to form water-dispersive aggregates of gold nanoparticles with hydrophobic surface properties. By irradiating the aggregates with ultraviolet, the photo-responsive linker was transformed, leading to the generation of another carboxyl group. As a result, the gold nanoparticles were tightly bound via the dicarboxylate linkers. These changes decreased the interparticle distances in the aggregates, as verified by microscopic observations, and can induce significant changes in their optical characteristics. To the best of our knowledge, this is the first example of a light-driven manipulation system for the distribution of nanoparticles in an aggregate.	[Tanaka, Kazuo; Miyoshi, Eisuke; Narita, Asako; Chujo, Yoshiki] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Kyoto 6158510, Japan; [Naka, Kensuke] Kyoto Inst Technol, Grad Sch Sci & Technol, Fac Mol Chem & Engn, Kyoto 606, Japan	Chujo, Y (reprint author), Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan.	chujo@chujo.synchem.kyoto-u.ac.jp			Hosokawa Powder Technology Foundation; Ministry of Education, Culture, Sports, Science, and Technology, Japan [2401, 25102521]	This work was partially supported by Hosokawa Powder Technology Foundation (to KT) and a Grant-in-Aid for Scientific Research on Innovative Areas 'New Polymeric Materials Based on Element-Blocks (No. 2401)' (25102521) from The Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Han L, 2003, CHEM MATER, V15, P29, DOI 10.1021/cm0208051; Pratibha R, 2009, OPT EXPRESS, V17, P19459, DOI 10.1364/OE.17.019459; Shenhar R, 2003, ACCOUNTS CHEM RES, V36, P549, DOI 10.1021/ar020083j; Tanaka K, 2014, ADV POWDER TECHNOL, V25, P101, DOI 10.1016/j.apt.2013.07.002; Ipe BI, 2003, J AM CHEM SOC, V125, P7174, DOI 10.1021/ja0341182; Itoh H, 2004, LANGMUIR, V20, P1972, DOI 10.1021/la0359777; Hu J, 2001, J AM CHEM SOC, V123, P1464, DOI 10.1021/ja003180l; Zhang SZ, 2007, CHEM COMMUN, P1816, DOI 10.1039/b618818d; Zheng WX, 2000, ANAL CHEM, V72, P2190, DOI 10.1021/ac9912909; Sapsford KE, 2013, CHEM REV, V113, P1904, DOI 10.1021/cr300143v; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Lim IIS, 2008, LANGMUIR, V24, P8857, DOI 10.1021/la800970p; Liu QK, 2010, NANO LETT, V10, P1347, DOI 10.1021/nl9042104; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; Kitamura N, 2013, BIOORG MED CHEM LETT, V23, P281, DOI 10.1016/j.bmcl.2012.10.105; Tanaka K, 2013, BIOORGAN MED CHEM, V21, P2715, DOI 10.1016/j.bmc.2013.03.050; WAKSELMAN M, 1990, EUR J MED CHEM, V25, P519, DOI 10.1016/0223-5234(90)90146-T; Carroll JB, 2002, CHEM COMMUN, P1892, DOI 10.1039/b203771h; Akiyama H, 2003, J PHYS CHEM B, V107, P130, DOI 10.1021/jp026103g; Tanaka K, 2014, TETRAHEDRON LETT, V55, P1635, DOI 10.1016/j.tetlet.2014.01.092; Chen JIL, 2010, J AM CHEM SOC, V132, P9600, DOI 10.1021/ja103240g; Zhang J, 2001, CHEM MATER, V13, P2323, DOI 10.1021/cm000752s; Naka K, 2008, POLYM ADVAN TECHNOL, V19, P1421, DOI 10.1002/pat.1218; Narita A, 2009, COLLOID SURFACE A, V336, P46, DOI 10.1016/j.colsurfa.2008.11.013; Okada H, 2014, BIOORGAN MED CHEM, V22, P3435, DOI 10.1016/j.bmc.2014.04.034; Miyoshi E, 2011, COLLOID SURFACE A, V390, P126, DOI 10.1016/j.colsurfa.2011.09.016; Ghosh SK, 2007, CHEM REV, V107, P4797, DOI 10.1021/cr0680282; Kubo S, 2007, NANO LETT, V7, P3418, DOI 10.1021/nl071893x; Sidhaye DS, 2005, LANGMUIR, V21, P7979, DOI 10.1021/la051125q; Sipova H, 2013, ANAL CHIM ACTA, V773, P9, DOI 10.1016/j.aca.2012.12.040; Liu JJ, 2015, RSC ADV, V5, P32846, DOI 10.1039/c5ra04597e; Manna A, 2003, CHEM MATER, V15, P20, DOI 10.1021/cm0207696; Callari F, 2006, CHEM COMMUN, P1009, DOI 10.1039/b517012e; Jeoung E., 2002, J SUPRAMOL CHEM, V2, P53, DOI 10.1016/S1472-7862(02)00078-3; Lim IIS, 2007, LANGMUIR, V23, P826, DOI 10.1021/la062334t; Moreau A., 2012, NATURE, V491, P86; Saha K, 2012, CHEM REV, V112, P2379	37	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	NOV	2015	47	11					747	752		10.1038/pj.2015.56		6	Polymer Science	Polymer Science	CV8XL	WOS:000364571500006		
J	Nagai, D; Nakazato, A; Morinaga, H				Nagai, Daisuke; Nakazato, Akiko; Morinaga, Hisatoyo			Facile and efficient recovery of mercury based on poly(amine-ester)-bearing metal-complexation and acidic aqueous solution-soluble groups	POLYMER JOURNAL			English	Article							ADSORPTION PROPERTIES; CHELATING RESINS; PRECIOUS METALS; HG(II) IONS; REMOVAL; BEADS; CHITOSAN; WATER; ADSORBENTS; PALLADIUM(II)		[Nagai, Daisuke; Nakazato, Akiko] Gunma Univ, Fac Sci & Technol, Div Mol Sci, Kiryu, Gunma 3768515, Japan; [Morinaga, Hisatoyo] Univ Yamanashi, Grad Fac Interdisciplinary Res, Fac Educ & Human Sci, Yamanashi, Japan	Nagai, D (reprint author), Gunma Univ, Fac Sci & Technol, Div Mol Sci, 1-5-1 Tenjin Cho, Kiryu, Gunma 3768515, Japan.	daisukenagai@gunma-u.ac.jp					Koseoglu H, 2009, MINER ENG, V22, P440, DOI 10.1016/j.mineng.2008.11.006; LIU CY, 1990, INORG CHIM ACTA, V172, P151; Vieira RS, 2006, WATER RES, V40, P1726, DOI 10.1016/j.watres.2006.02.027; Ngah WSW, 2011, CARBOHYD POLYM, V83, P1446, DOI 10.1016/j.carbpol.2010.11.004; Denizli A, 2003, REACT FUNCT POLYM, V55, P121, DOI 10.1016/S1381-5148(02)00221-3; Denizli A, 2002, ADSORPT SCI TECHNOL, V20, P607, DOI 10.1260/02636170260504305; Rivas BL, 1998, J APPL POLYM SCI, V67, P1109, DOI 10.1002/(SICI)1097-4628(19980207)67:6<1109::AID-APP19>3.0.CO;2-V; Atia AA, 2003, REACT FUNCT POLYM, V56, P75, DOI 10.1016/S1381-5148(03)00046-4; Denizli A, 2004, IND ENG CHEM RES, V43, P6095, DOI 10.1021/ie030204z; Arpa C, 2002, ADSORPT SCI TECHNOL, V20, P203, DOI 10.1260/026361702760254405; Di Natale F, 2006, J HAZARD MATER, V132, P220, DOI 10.1016/j.jhazmat.2005.09.046; Nagai D, 2013, CHEM COMMUN, V49, P6852, DOI 10.1039/c3cc43256d; Denizli A, 2000, J APPL POLYM SCI, V78, P81, DOI 10.1002/1097-4628(20001003)78:1<81::AID-APP110>3.0.CO;2-J; Adhikari CR, 2008, ENVIRON SCI TECHNOL, V42, P5486, DOI 10.1021/es800155x; Maruyama T, 2007, ENVIRON SCI TECHNOL, V41, P1359, DOI 10.1021/es061664x; Gao C, 2002, J POLYM SCI POL CHEM, V40, P2340, DOI 10.1002/pola.10322; Boening DW, 2000, CHEMOSPHERE, V40, P1335, DOI 10.1016/S0045-6535(99)00283-0; Kesenci K, 2002, EUR POLYM J, V38, P1443, DOI 10.1016/S0014-3057(01)00311-1; Sadyrbaeva TZ, 2006, J MEMBRANE SCI, V275, P195, DOI 10.1016/j.memsci.2005.09.020; Delacour ML, 1999, J APPL POLYM SCI, V73, P899, DOI 10.1002/(SICI)1097-4628(19990808)73:6<899::AID-APP6>3.0.CO;2-O; Hwang DC, 1997, J APPL POLYM SCI, V64, P891, DOI 10.1002/(SICI)1097-4628(19970502)64:5<891::AID-APP9>3.3.CO;2-5; Salih B, 1998, ANAL CHIM ACTA, V371, P177, DOI 10.1016/S0003-2670(98)00354-7; Fujiwara K, 2007, J HAZARD MATER, V146, P39, DOI 10.1016/j.jhazmat.2006.11.049; Wang JSF, 2005, IND ENG CHEM RES, V44, P922, DOI 10.1021/ie040198m; Ravichandran M, 2004, CHEMOSPHERE, V55, P319, DOI 10.1016/j.chemosphere.2003.11.011; Denizli A, 2000, REACT FUNCT POLYM, V44, P235, DOI 10.1016/S1381-5148(99)00099-1; Puanngam M, 2008, J HAZARD MATER, V154, P578, DOI 10.1016/j.jhazmat.2007.10.090; Cestari AR, 1997, J COLLOID INTERF SCI, V195, P338, DOI 10.1006/jcis.1997.5157; LEZZI A, 1994, J POLYM SCI POL CHEM, V32, P1877, DOI 10.1002/pola.1994.080321008; Parajuli D, 2009, BIORESOURCE TECHNOL, V100, P1000, DOI 10.1016/j.biortech.2008.06.058; Binman S, 1997, J APPL POLYM SCI, V63, P625, DOI 10.1002/(SICI)1097-4628(19970131)63:5<625::AID-APP10>3.0.CO;2-T; PACYNA JM, 1991, WATER AIR SOIL POLL, V56, P51, DOI 10.1007/BF00342260; Navarro RR, 1996, WATER RES, V30, P2488, DOI 10.1016/0043-1354(96)00143-1; Li F, 2009, J APPL POLYM SCI, V113, P1604, DOI 10.1002/app.30068; Zhou LM, 2009, J HAZARD MATER, V172, P439, DOI 10.1016/j.jhazmat.2009.07.030; Uludag Y, 1997, J MEMBRANE SCI, V129, P93, DOI 10.1016/S0376-7388(96)00342-0; Macaskie LE, 2007, BIOTECHNOL BIOENG, V96, P631, DOI 10.1002/bit.21108; Jyo A, 1997, J APPL POLYM SCI, V63, P1327; BECKER NSC, 1993, REACT POLYM, V21, P5, DOI 10.1016/0923-1137(93)90049-L; Eang R., 2005, IND ENG CHEM RES, V44, P4221; Forestner U., 1979, METAL POLLUTION AQUA; Nguyen H. T., 2007, SOLVENT EXTR ION EXC, V25, P407; Ringbom A., 1967, COURS CHIMIE ANAL; Shah S., 1996, REACT FUNCT POLYM, V31, P1; Zhao X., 1996, ENVRION SCI TECHNOL, V9, P1384	45	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	NOV	2015	47	11					761	766		10.1038/pj.2015.57		6	Polymer Science	Polymer Science	CV8XL	WOS:000364571500008		
J	Hiroe, A; Shiraishi, M; Mizuno, K; Tsuge, T				Hiroe, Ayaka; Shiraishi, Masaya; Mizuno, Kouhei; Tsuge, Takeharu			Behavior of different polyhydroxyalkanoate synthases in response to the ethanol level in Escherichia coli cultures	POLYMER JOURNAL			English	Article							MOLECULAR-WEIGHT; POLYESTERS		[Hiroe, Ayaka; Shiraishi, Masaya; Tsuge, Takeharu] Tokyo Inst Technol, Dept Innovat & Engn Mat, Yokohama, Kanagawa 2268502, Japan; [Mizuno, Kouhei] Kitakyushu Natl Coll Technol, Dept Mat Sci & Chem Engn, Kitakyushu, Fukuoka, Japan	Hiroe, A (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Innovat & Engn Mat, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	hiroe.a.aa@m.titech.ac.jp; tsuge.t.aa@m.titech.ac.jp			JST, CREST	This work was partially supported by funding from JST, CREST.	Kusaka S, 1998, J MACROMOL SCI PURE, VA35, P319, DOI 10.1080/10601329808001980; Agus J, 2006, POLYM DEGRAD STABIL, V91, P1138, DOI 10.1016/j.polymdegradstab.2005.07.006; Watanabe Y, 2012, J BIOSCI BIOENG, V113, P286, DOI 10.1016/j.jbiosc.2011.10.015; Choi JI, 2004, BIOTECHNOL BIOPROC E, V9, P196; Hiroe A, 2013, J BIOSCI BIOENG, V115, P633, DOI 10.1016/j.jbiosc.2012.12.015; Kato M, 1996, APPL MICROBIOL BIOT, V45, P363; Madden LA, 1999, INT J BIOL MACROMOL, V25, P43, DOI 10.1016/S0141-8130(99)00014-8; Rehm BHA, 2003, BIOCHEM J, V376, P15, DOI 10.1042/BJ20031254; Kusaka S, 1997, APPL MICROBIOL BIOT, V47, P140; Hiroe A, 2013, ACS CHEM BIOL, V8, P2568, DOI 10.1021/cb400465p; Tomizawa S, 2010, APPL MICROBIOL BIOT, V87, P1427, DOI 10.1007/s00253-010-2601-8; Iwata T, 2005, MACROMOL BIOSCI, V5, P689, DOI 10.1002/mabi.200500066; Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6; Akiyama M, 2003, POLYM DEGRAD STABIL, V80, P183, DOI 10.1016/S0141-3910(02)00400-7; Ilham M, 2014, POLYM DEGRAD STABIL, V109, P416, DOI 10.1016/j.polymdegradstab.2014.04.024	15	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	NOV	2015	47	11					767	770		10.1038/pj.2015.53		4	Polymer Science	Polymer Science	CV8XL	WOS:000364571500009		
J	Nakamura, K; Kanna, T; Sakkaravarthi, K				Nakamura, K.; Kanna, T.; Sakkaravarthi, K.			Protocol of networks using energy sharing collisions of bright solitons	PRAMANA-JOURNAL OF PHYSICS			English	Article						Soliton network; coupled nonlinear Schrodinger system; bright soliton; soliton collision	NONLINEAR SCHRODINGER-EQUATION; INTERVAL; LINE	It is well known that solitons in integrable systems recover their original profiles after their mutual collisions. This is not true in the case of optical fibre arrays, governed by a set of integrable coupled nonlinear Schrodinger (CNLS) equations. We consider the Manakov- and mixed-type 'two-component' CNLS systems. The most important characteristics of these systems are: (1) The polarizations of the two-component solitons are changed through their mutual collisions (Manakov system) and (2) the energy (intensity) switching occurs through the head-on collision (mixed system). By placing the above solitons on the primary star graph (PSG), we see that soliton collisions give rise to interesting phase changes in PSG: (a) The transition in PSG from its depolarized state to polarized one; (b) a state with selectively amplified bond is generated on PSG from its homogeneous state. These results will be applicable to network protocols using optical fibre arrays.	[Nakamura, K.] Natl Univ Uzbekistan, Fac Phys, Tashkent 100174, Uzbekistan; [Nakamura, K.] Osaka City Univ, Dept Appl Phys, Osaka 5588585, Japan; [Kanna, T.; Sakkaravarthi, K.] Bishop Heber Coll, Post Grad & Res Dept Phys, Tiruchchirappalli 620017, Tamil Nadu, India	Kanna, T (reprint author), Bishop Heber Coll, Post Grad & Res Dept Phys, Tiruchchirappalli 620017, Tamil Nadu, India.	kanna_phy@bhc.edu.in	Sakkaravarthi, Karuppaiya/L-4486-2013	Sakkaravarthi, Karuppaiya/0000-0002-1864-474X	Council of Scientific and Industrial Research, Government of India	KN is grateful to Prof. M Lakshmanan for invitation to Bharathidasan University in Tiruchirappalli in February 2014, which has made possible the present work. TK and KS thank the Principal and management of Bishop Heber College for constant support and encouragement. KS acknowledges the support of Council of Scientific and Industrial Research, Government of India, in the form of Senior Research Fellowship.	Ablowitz M J, 2004, DISCRETE CONTINUOUS; Kanna T, 2001, PHYS REV LETT, V86, P5043, DOI 10.1103/PhysRevLett.86.5043; Burioni R, 2006, PHYSICA D, V216, P71, DOI 10.1016/j.physd.2005.12.010; Kopidakis G, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.084103; Fokas AS, 2004, J PHYS A-MATH GEN, V37, P6091, DOI 10.1088/0305-4470/37/23/009; Nakamura K, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.026609; Pikovsky AS, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.094101; RAMOS JI, 1994, MATH COMPUT MODEL, V20, P31, DOI 10.1016/0895-7177(94)90030-2; Jakubowski MH, 1998, PHYS REV E, V58, P6752, DOI 10.1103/PhysRevE.58.6752; Sobirov Z, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.066602; Fokas AS, 2005, NONLINEARITY, V18, P1771, DOI 10.1088/0951-7715/18/4/019; Kaminer I, 2009, P ROY SOC A-MATH PHY, V465, P1093, DOI 10.1098/rspa.2008.0401; Radhakrishnan R, 1997, PHYS REV E, V56, P2213, DOI 10.1103/PhysRevE.56.2213; ABLOWITZ MJ, 1975, J MATH PHYS, V16, P1054, DOI 10.1063/1.522659; Kanna T, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.026604; Flach S, 1998, PHYS REP, V295, P181, DOI 10.1016/S0370-1573(97)00068-9; Hirota R., 2004, DIRECT METHOD SOLITO; Kivshar Y. S., 2003, OPTICAL SOLITONS FIB; Mollenauer L F, 2006, SOLITONS OPTICAL FIB; Steiglitz K., 2001, Physical Review E (Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics), V63, DOI 10.1103/PhysRevE.63.016608; Sulem C., 1999, NONLINEAR SCHRODINGE	21	0	0	INDIAN ACAD SCIENCES	BANGALORE	C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA	0304-4289	0973-7111		PRAMANA-J PHYS	Pramana-J. Phys.	NOV	2015	85	5					1009	1021		10.1007/s12043-015-1112-7		13	Physics, Multidisciplinary	Physics	CV8YK	WOS:000364574100017		
J	Kawakatsu, Y; Tanaka, J; Ogawa, K; Ogendo, K; Honda, S				Kawakatsu, Y.; Tanaka, J.; Ogawa, K.; Ogendo, K.; Honda, S.			Effects of three interventions and determinants of full vaccination among children aged 12-59 months in Nyanza province, Kenya	PUBLIC HEALTH			English	Article						Vaccination; Determinant; Mass immunization campaign; Community health worker; Multi-level analysis; Kenya	IMMUNIZATION ACTIVITIES; HEALTH SURVEY; BURKINA-FASO; COVERAGE; MEASLES; COUNTRIES; NIGERIA; KNOWLEDGE; ISTANBUL; SERVICES	Objectives: The purpose of this study is to describe the effects of the three main interventions and identify the individual and community determinants of full vaccination coverage among children aged 12-59 months in Nyanza province, Kenya. Study design: Cross-sectional study. Methods: We utilized three datasets. One is the Nyanza Province County-based Multiple Indicator Cluster Survey 2011. The other two datasets are the lists of community units and health facilities in Nyanza Province, Kenya. A three-level multilevel logistic regression analysis was performed. Results: In the final model, the highest wealth quintile (AOR: 2.49; 95% CI: 1.333-4.642; P = 0.004), the community with high coverage of media devices (AOR: 1.50; 95% CI: 1.029 -2.198; P = 0.035), the participation of mass immunization campaigns (AOR: 1.63; 95% CI: 1.153-2.303; P = 0.006) were the significant determinants of complete child vaccination. Conclusions: In conclusion, further implementation of mass immunization campaigns is the recommended intervention to increase the uptake of required vaccinations among children. In addition, further attention to the poor and the low coverage of media devices is necessary, since they are the most vulnerable population in terms of accessibility of vaccination services. Implementation community based activity, such as community health workers, would have a positive impact on vaccination coverage, if their performance is continuously high. (C) 2015 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.	[Kawakatsu, Y.; Tanaka, J.; Ogawa, K.; Honda, S.] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Ogendo, K.] Minist Hlth, Nairobi, Kenya	Kawakatsu, Y (reprint author), 1-7-1 Sakamoto, Nagasaki, Japan.	y.kawakatsu.0829@gmail.com					Rainey JJ, 2011, VACCINE, V29, P8215, DOI 10.1016/j.vaccine.2011.08.096; Bradsher CA, 2007, PUBLIC HEALTH NURS, V24, P26, DOI 10.1111/j.1525-1446.2006.00604.x; Glenton C, 2011, TROP MED INT HEALTH, V16, P1044, DOI 10.1111/j.1365-3156.2011.02813.x; Lainez YB, 2012, AM J TROP MED HYG, V87, P144, DOI 10.4269/ajtmh.2012.12-0106; Frolich M, 2009, AFR DEV REV, V21, P86, DOI 10.1111/j.1467-8268.2009.00205.x; Clouston S, 2014, VACCINE, V32, P3533, DOI 10.1016/j.vaccine.2014.04.030; Schoeps A, 2013, VACCINE, V32, P96, DOI 10.1016/j.vaccine.2013.10.063; Goodson JL, 2009, VACCINE, V27, P5870, DOI 10.1016/j.vaccine.2009.07.057; Patel AR, 2010, VACCINE, V28, P604, DOI 10.1016/j.vaccine.2009.10.108; Vijayaraghavan M, 2007, HEALTH POLICY, V83, P27, DOI 10.1016/j.healthpol.2006.11.008; Sia D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-416; Fatiregun AA, 2012, VACCINE, V30, P730, DOI 10.1016/j.vaccine.2011.11.082; Mbabazi WB, 2009, HEALTH POLICY PLANN, V24, P261, DOI 10.1093/heapol/czp008; Anand S, 2007, LANCET, V369, P1277, DOI 10.1016/S0140-6736(07)60599-6; Torun SD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-125; Kosnik IG, 2013, VACCINE, V31, P732, DOI 10.1016/j.vaccine.2012.12.005; Kawakatsu Y, 2012, VACCINE, V30, P7588, DOI 10.1016/j.vaccine.2012.10.037; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Topuzoglu A, 2005, PUBLIC HEALTH, V119, P862, DOI 10.1016/j.puhe.2005.01.015; Ozcirpici B, 2006, PUBLIC HEALTH, V120, P145, DOI 10.1016/j.puhe.2005.04.008; Bishai D, 2011, J INFECT DIS, V204, pS107, DOI 10.1093/infdis/jir131; Central Bureau of Statistics (CBS) [Kenya] Ministry of Health (MOH) [Kenya] ORC Macro, 2004, KEN DEM HLTH SURV 20; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Harvey SA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-160; James L, 2009, STRATEGIC PLAN HLTH; Kane SS, 2010, BMC HLTH SERV RES, P10; Lopes SC, 2014, HUM RESOUR HLTH, P12; Macro KNBoSKaI, 2010, KEN DEM HLTH SURV; Miller JS, 2014, HUM RESOUR HLTH, P12; Ministry of health K, MAST HLTH FAC LIST E; Ministry of public health and sanitation AH, 2008, MIN PUBL HLTH SAN ST; Mutua MK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-6; Nairobi Kenya, 2006, TAK KEN ESS PACK HLT; National bureau of statistics K, 2013, NYANZ PROV MULT IND; NCAPD) NCAfPaD (MOH) MoH (CBS) CBoS Macro O, 2005, KEN SERV PROV ASS SU; Odusanya OO, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-381; Olayo Rose W C, 2014, BMC HLTH SERV RES S1, V14; Owais A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-239; Rabe-Hesketh S., 2005, MULTILEVEL LONGITUDI; Rahman SM, 2010, HUM RESOUR HLTH, P8; Rai RK, 2012, WOMEN HEALTH ISS, V22, pE407, DOI 10.1016/j.whi.2012.05.001; Semali IA, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-299; Wakefield MA, LANCET, V376, P1261; WHO Unicef, 2005, GLOB IMM VIS STRAT 2; World Health Organization, 2012, GLOB MEASL RUB STRAT	45	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0033-3506	1476-5616		PUBLIC HEALTH	Public Health	NOV	2015	129	11					1530	1538		10.1016/j.puhe.2015.07.008		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CV8LB	WOS:000364536400017		
J	Kuroda, R				Kuroda, Reiko			A twisting story: how a single gene twists a snail? Mechanogenetics	QUARTERLY REVIEWS OF BIOPHYSICS			English	Review						Chirality chiromorphology; left-right symmetry; breaking developmental biology; snail handedness	LEFT-RIGHT ASYMMETRY; GASTROPOD; MECHANISMS; HANDEDNESS; PATHWAY	Left-right (l-r) symmetry breaking and the establishment of asymmetric animal body plan during embryonic development are fundamental questions in nature. The molecular basis of l-r symmetry breaking of snails is a fascinating topic as it is determined by a maternal single handedness-determining locus at a very early developmental stage. This perspective describes the current state of the art of the chiromorphogenesis, mainly based on our own work, i.e. the first step of l-r symmetry breaking, as proven by our Mechanogenetics, before the start of zygotic gene expression, transfer of chirality information to the cell-fate determining stage, and the expression of nodal at the blastula stage. The Nodal signalling pathway is a common mechanism in vertebrates' chiromorphogenesis in later development. Studies on snails, especially Lymnaea (L.) stagnalis, shall give important insights into the molecular basis of chiromorphogenesis not only in Lophotrochozoa but in vertebrates as well.	[Kuroda, Reiko] Tokyo Univ Sci, Inst Sci & Technol, Noda, Chiba 2788510, Japan	Kuroda, R (reprint author), Tokyo Univ Sci, Res Inst Sci & Technol, Noda, Chiba 2788510, Japan.	rkuroda@rs.tus.acp					Abe M., 2013, 36 ANN M MOL BIOL SO; Coutelis JB, 2014, EMBO REP, V15, P926, DOI 10.15252/embr.201438972; Henry JJ, 2008, DEV BIOL, V313, P181, DOI 10.1016/j.ydbio.2007.10.019; FREEMAN G, 1982, ROUX ARCH DEV BIOL, V191, P69; Blum M, 2014, DEVELOPMENT, V141, P1603, DOI 10.1242/dev.100560; Sturtevant AH, 1923, SCIENCE, V58, P269, DOI 10.1126/science.58.1501.269; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; MESHCHERYAKOV VN, 1975, ROUX ARCH DEV BIOL, V177, P193, DOI 10.1007/BF00848080; Kuroda R, 2014, INTEGR COMP BIOL, V54, P677, DOI 10.1093/icb/icu096; BROWN NA, 1990, DEVELOPMENT, V109, P1; Kuroda R, 2009, NATURE, V462, P790, DOI 10.1038/nature08597; Shibazaki Y, 2004, CURR BIOL, V14, P1462, DOI 10.1016/j.cub.2004.08.018; Hosoiri Y, 2003, DEV GENES EVOL, V213, P193, DOI 10.1007/s00427-003-0315-y; Abe M, 2014, INT J DEV BIOL, V58, P513, DOI 10.1387/ijdb.140087rk; Grande C, 2009, NATURE, V457, P1007, DOI 10.1038/nature07603; Duboc V, 2008, J EXP ZOOL PART B, V310B, P41, DOI 10.1002/jez.b.21121; BOYCOTT A. E., 1930, PHIL TRANS ROY SOC LONDON B, V219, P51; Crampton H. E., 1894, ANN NY ACAD SCI, V8, P167, DOI 10.1111/j.1749-6632.1894.tb55419.x; Lambert JD, 2003, DEV BIOL, V263, P231, DOI 10.1016/j.ydbio.2003.07.006; Liu MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071067; MESHCHERYAKOV V N, 1978, Ontogenez, V9, P567; Meshcheryakov V. N., 1990, ANIMAL SPECIES DEV S, V1, P69, DOI 10.1007/978-1-4613-0503-3; Vandenberg LN, 2013, DEV BIOL, V379, P1, DOI 10.1016/j.ydbio.2013.03.021; Verdonk N.H., 1983, P91	24	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0033-5835	1469-8994		Q REV BIOPHYS	Q. Rev. Biophys.	NOV	2015	48	4					445	452		10.1017/S0033583515000098		8	Biophysics	Biophysics	CW1PS	WOS:000364764300009		
J	Basketter, D; Ashikaga, T; Casati, S; Hubesch, B; Jaworska, J; de Knecht, J; Landsiedel, R; Manou, I; Mehling, A; Petersohn, D; Rorije, E; Rossi, LH; Steiling, W; Teissier, S; Worth, A				Basketter, David; Ashikaga, Takao; Casati, Silvia; Hubesch, Bruno; Jaworska, Joanna; de Knecht, Joop; Landsiedel, Robert; Manou, Irene; Mehling, Annette; Petersohn, Dirk; Rorije, Emiel; Rossi, Laura H.; Steiling, Winfried; Teissier, Silvia; Worth, Andrew			Alternatives for skin sensitisation: Hazard identification and potency categorisation: Report from an EPAA/CEFIC LRI/Cosmetics Europe cross sector workshop, ECHA Helsinki, April 23rd and 24th 2015	REGULATORY TOXICOLOGY AND PHARMACOLOGY			English	Article						Skin sensitisation; In vitro alternatives hazard classification; Integrated testing strategies; Integrated approaches to testing and assessment	NONANIMAL TEST METHODS; LYMPH-NODE ASSAY; TESTING STRATEGIES; RECOMMENDATIONS; CHEMICALS; CELLS	In the two years since the last workshop report, the environment surrounding the prediction of skin sensitisation hazards has experienced major change. Validated non-animal tests are now OECD Test Guidelines. Accordingly, the recent cross sector workshop focused on how to use in vitro data for regulatory decision-making. After a review of general approaches and six case studies, there was broad consensus that a simple, transparent stepwise process involving non-animal methods was an opportunity waiting to be seized. There was also strong feeling the approach should not be so rigidly defined that assay variations/additional tests are locked out. Neither should it preclude more complex integrated approaches being used for other purposes, e.g. potency estimation. All agreed the ultimate goal is a high level of protection of human health. Thus, experience in the population will be the final arbiter of whether toxicological predictions are fit for purpose. Central to this is the reflection that none of the existing animal assays is perfect; the non-animal methods should not be expected to be so either, but by integrated use of methods and all other relevant information, including clinical feedback, we have the opportunity to continue to improve toxicology whilst avoiding animal use. (C) 2015 Elsevier Inc. All rights reserved.	[Basketter, David] DABMEB Consultancy Ltd, Sharnbrook MK44 1PR, Beds, England; [Ashikaga, Takao] Shiseido, Yokohama, Kanagawa, Japan; [Casati, Silvia; Worth, Andrew] EURL ECVAM, Ispra, Italy; [Hubesch, Bruno] CEFIC, Brussels, Belgium; [Hubesch, Bruno] Hubesch Consult BVBA, Sint Pieters Leeuw, Belgium; [Jaworska, Joanna] Procter & Gamble, Strombeek Bever, Belgium; [de Knecht, Joop] OECD, Paris, France; [Landsiedel, Robert] BASF SE, Ludwigshafen, Germany; [Manou, Irene] EPAA, Brussels, Belgium; [Mehling, Annette] BASF Personal Care & Nutr GmbH, Dusseldorf, Germany; [Petersohn, Dirk] Henkel AG & Co KGaA, Dusseldorf, Germany; [Rorije, Emiel] RIVM, Bilthoven, Netherlands; [Rossi, Laura H.] ECHA, Helsinki, Finland; [Steiling, Winfried] Verband Chem Ind eV, VCI, Frankfurt, Germany; [Teissier, Silvia] LOreal, Paris, France	Basketter, D (reprint author), DABMEB Consultancy Ltd, Sharnbrook MK44 1PR, Beds, England.	dabmebconsultancyltd@me.com					Hirota M, 2015, J APPL TOXICOL, V35, P1333, DOI 10.1002/jat.3105; Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013; Cottrez F, 2015, TOXICOL IN VITRO, V29, P787, DOI 10.1016/j.tiv.2015.02.012; Basketter DA, 2009, CONTACT DERMATITIS, V60, P65, DOI 10.1111/j.1600-0536.2008.01444.x; Piroird C, 2015, TOXICOL IN VITRO, V29, P901, DOI 10.1016/j.tiv.2015.03.009; Steiling W, 2001, FOOD CHEM TOXICOL, V39, P293, DOI 10.1016/S0278-6915(00)00147-2; Jaworska J, 2013, J APPL TOXICOL, V33, P1353, DOI 10.1002/jat.2869; Reuter H, 2015, TOXICOL IN VITRO, V29, P976, DOI 10.1016/j.tiv.2015.03.021; Natsch A, 2013, J APPL TOXICOL, V33, P1337, DOI 10.1002/jat.2868; van der Veen JW, 2014, REGUL TOXICOL PHARM, V69, P371, DOI 10.1016/j.yrtph.2014.04.018; Basketter D, 2013, REGUL TOXICOL PHARM, V67, P531, DOI 10.1016/j.yrtph.2013.10.002; Basketter DA, 2014, DERMATITIS, V25, P11, DOI 10.1097/DER.0000000000000003; Basketter DA, 2012, ALTEX-ALTERN ANIM EX, V29, P5; Adler S, 2011, ARCH TOXICOL, V85, P367, DOI 10.1007/s00204-011-0693-2; Del Bufalo A, 2011, TOXICOL APPL PHARM, V256, P35, DOI 10.1016/j.taap.2011.06.025; Dean JH, 2001, REGUL TOXICOL PHARM, V34, P258, DOI 10.1006/rtph.2001.1497; Mehling A, 2012, ARCH TOXICOL, V86, P1273, DOI 10.1007/s00204-012-0867-6; Patlewicz G, 2014, REGUL TOXICOL PHARM, V69, P529, DOI 10.1016/j.yrtph.2014.06.001; EURL ECVAM, 2014, REC KERATINOSENS ASS; EURL ECVAM, 2012, DIR PEPT REACT ASS D; EURL ECVAM, 2015, REC HUM CELL LIN ACT; Gomes C., 2012, COMPSTAT 20 INT C CO, P271; Natsch A, 2015, TOXICOL SCI, V143, P319, DOI 10.1093/toxsci/kfu229; OECD, 2012, SER TEST ASS, V168; OECD, 2015, OECD GUID TEST CHE C; OECD, 2015, SER TEST ASS, V215; Ramirez T, 2014, TOXICOL IN VITRO, V28, P1482, DOI 10.1016/j.tiv.2014.08.002; Reisinger K, 2015, TOXICOL IN VITRO, V29, P259, DOI 10.1016/j.tiv.2014.10.018; Russell W., 1959, PRINCIPLES HUMANE EX; Urbisch D, 2015, REGUL TOXICOL PHARM, V71, P337, DOI 10.1016/j.yrtph.2014.12.008; Vocanson M, 2013, EXP REV DERMATOL, V8, P395; Wong C.L., 2015, FRONT PHARMACOL, V6, P1	32	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0273-2300	1096-0295		REGUL TOXICOL PHARM	Regul. Toxicol. Pharmacol.	NOV	2015	73	2					660	666		10.1016/j.yrtph.2015.10.005		7	Medicine, Legal; Pharmacology & Pharmacy; Toxicology	Legal Medicine; Pharmacology & Pharmacy; Toxicology	CV9OY	WOS:000364617700022		
J	Ortiz, E; Valdes-Galicia, JF; Matsubara, Y; Nagai, Y; Muraki, Y; Hurtado, A; Musalem, O; Garcia, R; Anzorena, MA; Gonzalez, LX; Itow, Y; Sako, T; Lopez, D; Sasai, Y; Munakata, K; Kato, C; Shibata, S; Takamaru, H; Kojima, H; Watanabe, K; Tsuchiya, H; Koi, T				Ortiz, E.; Valdes-Galicia, J. F.; Matsubara, Y.; Nagai, Y.; Muraki, Y.; Hurtado, A.; Musalem, O.; Garcia, R.; Anzorena, M. A.; Gonzalez, L. X.; Itow, Y.; Sako, T.; Lopez, D.; Sasai, Y.; Munakata, K.; Kato, C.; Shibata, S.; Takamaru, H.; Kojima, H.; Watanabe, K.; Tsuchiya, H.; Koi, T.			Observation of Cosmic Ray at the top of the Sierra Negra volcano in Mexico with the SciCRT prototype	REVISTA MEXICANA DE FISICA			English	Article						Cosmic rays; secondary cosmic rays; SciCRT	K2K SCIBAR DETECTOR; SOLAR	We are currently in the process of calibration of a new cosmic ray detector called SciBar Cosmic Ray Telescope (SciCRT) located at the top of the Sierra Negra volcano at 4,600 m.a.s.l., in Eastern Mexico. The SciCRT will work mainly as a Solar Neutron and Muon Telescope, with a high angular resolution (similar to 1 degrees), but it will also serve as a gamma ray and hadron shower detector. The mini-SciCR is a prototype of the SciCRT, it uses the same scintillator bars and recording hardware, the size of the mini-SciCR is 1/1568 compared with the SciCRT. In this paper we will report the main results obtained with the mini-SciCR that was operating at the top of the Sierra Negra volcano from October 2010 to July 2012. Our main aims were to show the appropriate performance of all the detector systems and to develop a tecnique to separate the flux of soft and hard secondary cosmic rays with the help of a Monte Carlo simulation, our energy range of interest is from 100 MeV to a few GeV. Aditionally we will report results with a modification of the detector setup that helped to confirm the correct identification of the particle species.	[Ortiz, E.; Valdes-Galicia, J. F.; Hurtado, A.; Musalem, O.; Garcia, R.; Anzorena, M. A.] Univ Nacl Autonoma Mexico, Mexico City 04510, DF, Mexico; [Matsubara, Y.; Nagai, Y.; Muraki, Y.; Itow, Y.; Sako, T.; Lopez, D.; Sasai, Y.] Nagoya Univ, Solar Terr Environm Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Gonzalez, L. X.] Univ Nacl Autonoma Mexico, Inst Geofis, SCiESMEX, Unidad Michoacan, Morelia 58190, Michoacan, Mexico; [Munakata, K.; Kato, C.] Shinshu Univ, Dept Phys, Matsumoto, Nagano 3908621, Japan; [Shibata, S.; Takamaru, H.] Chubu Univ, Coll Engn, Kasugai, Aichi 4878501, Japan; [Kojima, H.] Aichi Inst Technol, Fac Engn, Toyota 4700392, Japan; [Watanabe, K.] Japan Aerosp Expt Agcy, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Tsuchiya, H.] Japan Atom Energy Agcy, Ibaraki 3191195, Japan; [Koi, T.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA	Ortiz, E (reprint author), Univ Nacl Autonoma Mexico, Mexico City 04510, DF, Mexico.				PAPIIT-UNAM [IN114612];  [CONACyT-180727]	The authors sincerely thank the engineer Miguel Angel Garcia Palacio for his technical support. This work was partially supported by PAPIIT-UNAM IN114612 and CONACyT-180727.	Valdes-Galicia JF, 2009, ADV SPACE RES, V43, P565, DOI 10.1016/j.asr.2008.09.023; Nitta K, 2004, NUCL INSTRUM METH A, V535, P147, DOI 10.1016/j.nima.2004.07.272; Nagai Y, 2014, ASTROPART PHYS, V59, P39, DOI 10.1016/j.astropartphys.2014.04.005; Muraki Y, 2008, ASTROPART PHYS, V29, P229, DOI 10.1016/j.astropartphys.2007.12.007; Yoshida M, 2004, IEEE T NUCL SCI, V51, P3043, DOI 10.1109/TNS.2004.839075; Belov A.V., 2009, IAU S, V257, P439; Grieder P.K.F., 2001, ELSEVIER SCI BV, P1; Hasegawa M., 2006, THESIS KYOTO U, P24; LONGLEY M, 1992, HERMATHENA, P1; Matsubara Y., 2011, 32 INT COSM RAY C, V10, P14; Montgomery D.J.X., 1949, COSMIC RAY PHYS, P186; Nagai Y., 2011, 32 INT COSM RAY C, V10, P2; Valdes-Galicia JF, 2004, NUCL INSTRUM METH A, V535, P656, DOI 10.1016/j.nima.2004.06.148	13	0	0	SOC MEXICANA FISICA	COYOACAN	APARTADO POSTAL 70-348, COYOACAN 04511, MEXICO	0035-001X			REV MEX FIS	Rev. Mex. Fis.	NOV-DEC	2015	61	6					466	474				9	Physics, Multidisciplinary	Physics	CV6CG	WOS:000364357700010		
J	Sahu, KK; Hatakeyama, N; Miyamoto, A				Sahu, Kamlesh Kumar; Hatakeyama, Nozomu; Miyamoto, Akira			Theoretical investigation of the interactions in binding pocket of Reverse Transcriptase	SAUDI JOURNAL OF BIOLOGICAL SCIENCES			English	Article						Quantum chemical molecular dynamics (QCMD) calculation; Reverse Transcriptase; Enzyme; Density function theory; Nevirapine	MOLECULAR-DYNAMICS SIMULATION; GENERALIZED GRADIENT APPROXIMATION; GEOMETRY OPTIMIZATION; INHIBITORS; RT; RESISTANCE; ENERGIES; CATALYST; MUTANT	Interactions in proteins have been studied using several chemical information techniques including quantum chemical methods that are applied to truncated systems composed of the ligand molecule and the surrounding amino acids of the receptor. In this work we adopt an approach to study these interactions accounting for as many as possible explicit solvent molecules and without the need of a fragmented calculation. Furthermore, we embed our quantum chemical calculations within a molecular dynamics framework that enables a fundamentally fast system for quantum molecular dynamic simulations (QCMD). Central to this new system for QCMD is the tight binding QC system, newly developed in our laboratories, and which combined with the MD paradigm results in an ultra accelerated QCMD method for protein ligand interaction evaluations. We have applied our newly developed method to the Nevirapine (NVP) Reverse Transcriptase (RT) system. We show how the proposed method leads us to new findings. The advanced QCMD was applied to a system of RT with NVP and it has led to the knowledge of specific groups and atoms that interact with surrounding amino acids of RT and help in drug binding. The information derived from this calculation may be used in designing drugs for NVP resistant virus strains that have binding capability like NVP. (C) 2015 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license.	[Sahu, Kamlesh Kumar] Univ Alberta, Dept Phys, Edmonton, AB, Canada; [Hatakeyama, Nozomu; Miyamoto, Akira] Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi 980, Japan	Sahu, KK (reprint author), Univ Alberta, Dept Phys, Edmonton, AB, Canada.						Zhou ZG, 2005, J AM CHEM SOC, V127, P17253, DOI 10.1021/ja053973d; DECLERCQ E, 1994, BIOCHEM PHARMACOL, V47, P155, DOI 10.1016/0006-2952(94)90001-9; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; Archer RH, 2001, BIOCHEMISTRY-US, V40, P4087, DOI 10.1021/bi002328a; DeClercq E, 1996, MED RES REV, V16, P125, DOI 10.1002/(SICI)1098-1128(199603)16:2<125::AID-MED1>3.0.CO;2-2; Jung CH, 2003, CATAL TODAY, V87, P43, DOI 10.1016/j.cattod.2003.09.013; Luo Y, 2003, ORGANOMETALLICS, V22, P2181, DOI 10.1021/om030222g; Jonckheere H, 2000, MED RES REV, V20, P129, DOI 10.1002/(SICI)1098-1128(200003)20:2<129::AID-MED2>3.0.CO;2-A; MITSUYA H, 1990, SCIENCE, V249, P1533, DOI 10.1126/science.1699273; Elanany M, 2003, J PHYS CHEM B, V107, P1518, DOI 10.1021/jp026816z; Wang JM, 2001, J AM CHEM SOC, V123, P5221, DOI 10.1021/ja003834q; CALZAFERRI G, 1989, J PHYS CHEM-US, V93, P5366, DOI 10.1021/j100351a013; KATZ RA, 1994, ANNU REV BIOCHEM, V63, P133, DOI 10.1146/annurev.biochem.63.1.133; MASERAS F, 1995, J COMPUT CHEM, V16, P1170, DOI 10.1002/jcc.540160911; Rizzo RC, 2001, J MED CHEM, V44, P145, DOI 10.1021/jm000255n; Elanany M, 2002, STUD SURF SCI CATAL, V142, P1867; Sasata K, 2003, JPN J APPL PHYS 1, V42, P1859, DOI [10.1143/JJAP.42.1859, 10.1142/JJAP.42.1859]; Humbel S, 1996, J CHEM PHYS, V105, P1959, DOI 10.1063/1.472065; Kubo M, 2004, APPL SURF SCI, V223, P188, DOI 10.1016/S0169-4332(03)00912-7; Hannongbua S., 2001, J COMPUT AID MOL DES, V15, P1004; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Svensson M, 1996, J PHYS CHEM-US, V100, P19357, DOI 10.1021/jp962071j; VOSKO SH, 1980, CAN J PHYS, V58, P1200	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1319-562X			SAUDI J BIOL SCI	Saudi J. Biol. Sci.	NOV	2015	22	6			SI		719	724		10.1016/j.sjbs.2014.12.011		6	Biology	Life Sciences & Biomedicine - Other Topics	CV6CI	WOS:000364357900010		
J	Angster, S; Fielding, EJ; Wesnousky, S; Pierce, I; Chamlagain, D; Gautam, D; Upreti, BN; Kumahara, Y; Nakata, T				Angster, Stephen; Fielding, Eric J.; Wesnousky, Steven; Pierce, Ian; Chamlagain, Deepak; Gautam, Dipendra; Upreti, Bishal Nath; Kumahara, Yasuhiro; Nakata, Takashi			Field Reconnaissance after the 25 April 2015 M 7.8 Gorkha Earthquake	SEISMOLOGICAL RESEARCH LETTERS			English	Article							INDUSTRIAL MASONRY CHIMNEYS; DISPLACEMENT; TECTONICS; FOLDS	Fault scarps and uplifted terraces in young alluvium are frequent occurrences along the trace of the northerly dipping Himalayan frontal thrust (HFT). Generally, it was expected that the 25 April 2015 M 7.8 Gorkha earthquake of Nepal would produce fresh scarps along the fault trace. Contrary to expectation, Interferometric Synthetic Aperture Radar and aftershock studies soon indicated the rupture of the HFT was confined to the subsurface, terminating on the order of 50 km north of the trace of the HFT. We undertook a field survey along the trace of the HFT and along faults and lineaments within the Kathmandu Valley eight days after the earthquake. Our field survey confirmed the lack of surface rupture along the HFT and the mapped faults and lineaments in Kathmandu Valley. The only significant ground deformation we observed was limited to an similar to 1-km-long northeast-trending fracture set in the district of Kausaltar within Kathmandu. This feature is interpreted not to be the result of tectonic displacement, but rather a localized extension along a ridge. Our survey also shows the ubiquitous presence of fallen chimneys of brick kilns along the HFT and within the Kathmandu Valley. Measurements of a small subset of fallen chimneys across the region suggest a degree of systematic fall direction of the chimneys when subdivided geographically. Online Material: Color versions of Figures 3 and 4; additional photographs of the Kausaltar fracture.	[Angster, Stephen; Wesnousky, Steven; Pierce, Ian] Univ Nevada, Ctr Neotecton Studies, Reno, NV 89557 USA; [Fielding, Eric J.] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Chamlagain, Deepak] Tribhuvan Univ, Dept Geol, Kathmandu 44618, Nepal; [Gautam, Dipendra] Ctr Disaster & Climate Change Studies, Kathmandu, Nepal; [Upreti, Bishal Nath] NAST, Khumaltar, Lalitpur, Nepal; [Kumahara, Yasuhiro] Hiroshima Univ, Grad Sch Educ, Higashihiroshima 7398524, Japan; [Nakata, Takashi] Hiroshima Univ, Dept Geog, Higashihiroshima 7398526, Japan	Angster, S (reprint author), Univ Nevada, Ctr Neotecton Studies, MS169,1664 North Virginia St, Reno, NV 89557 USA.	sangster@nevada.unr.edu			University of Nevada, Reno (UNR) Mackay Earth Sciences and Engineering Department; National Science Foundation (NSF) [EAR-1345036]; JAXA RA4 project [P1372]; National Aeronautics and Space Administration (NASA) Earth Surface and Interior focus area	Thanks go to the University of Nevada, Reno (UNR) Mackay Earth Sciences and Engineering Department and Graham Kent for funding Pierce and Angster to travel to the epicentral area. The research was supported in part by National Science Foundation (NSF) Grant EAR-1345036. Original Advanced Land Observation Satellite 2 (ALOS-2) data is copyrighted (2015) by Japanese Aerospace Exploration Agency (JAXA) and was provided under JAXA RA4 project P1372. Part of this research was supported by the National Aeronautics and Space Administration (NASA) Earth Surface and Interior focus area and performed at the Jet Propulsion Laboratory, California Institute of Technology, Pasadena, California. We thank Cunren Liang for processing the ALOS-2 wide-swath interferogram and Susan Owen of the Advanced Rapid Imaging and Analysis (ARIA) project for processing the Global Positioning System (GPS) offsets. Raw GPS data were provided by Jean-Phillipe Avouac with the help of UNAVCO and the Nepal Department of Mines and Geology. We also thank Susan Hough, Roger Bilham, and an anonymous reviewer for reviews and comments that were critical for preparing this manuscript.	Pallares FJ, 2006, INT J SOLIDS STRUCT, V43, P2076, DOI [10.1016/j.ijsolstr.2005.06.014, 10.1016/ijsolstr.2005.06.014]; [Anonymous], 2009, ISR J EARTH SCI, DOI DOI 10.1560/IJES.58.3-4.309; BERBERIAN M, 1995, TECTONOPHYSICS, V241, P193, DOI 10.1016/0040-1951(94)00185-C; Wesnousky SG, 2008, B SEISMOL SOC AM, V98, P1609, DOI 10.1785/0120070111; Lave J, 2005, SCIENCE, V307, P1302, DOI 10.1126/science.1104804; Pallares FJ, 2011, CONSTR BUILD MATER, V25, P4351, DOI 10.1016/j.conbuildmat.2011.02.004; YEATS RS, 1991, J STRUCT GEOL, V13, P215, DOI 10.1016/0191-8141(91)90068-T; Sapkota SN, 2013, NAT GEOSCI, V6, P71, DOI [10.1038/ngeo1669, 10.1038/NGEO1669]; Asahi K., 2003, J NEPAL GEOL SOC, V28, P1; Bollinger L, 2014, J GEOPHYS RES-SOL EA, V119, P7123, DOI 10.1002/2014JB010970; Bonapace C., 2003, TRADITIONAL MAT CONS, P1; Fielding E. J., 3 DIMENSIONAL UNPUB; Lindsey EO, 2015, GEOPHYS RES LETT, V42, P6655, DOI 10.1002/2015GL065385; Martin SS, 2015, SEISMOL RES LETT, V86, P1524, DOI 10.1785/0220150138; Nakata T., 1989, SPEC PAP GEOL SOC AM, V232, P243; Nakata T., 1984, J NEPAL GEOL SOC, V4, P177; Noh M., 2015, KATHMANDU AREA PREEV, V2015; Paudyal Y. R., 2012, J ASIAN EARTH SCI, V62, P627; Rosen P. A., 2012, P 9 EUR C SYNTH AP R, P730	19	2	2	SEISMOLOGICAL SOC AMER	ALBANY	400 EVELYN AVE, SUITE 201, ALBANY, CA 94706-1375 USA	0895-0695	1938-2057		SEISMOL RES LETT	Seismol. Res. Lett.	NOV-DEC	2015	86	6					1506	1513		10.1785/0220150135		8	Geochemistry & Geophysics	Geochemistry & Geophysics	CV9MA	WOS:000364610100003		
J	Toda, S; Stein, RS				Toda, Shinji; Stein, Ross S.			2014 M-w 6.0 South Napa Earthquake Triggered Exotic Seismic Clusters near Several Major Faults	SEISMOLOGICAL RESEARCH LETTERS			English	Article							SAN-ANDREAS FAULT; STRESS TRANSFER; CALIFORNIA; PARKFIELD	Online Material: Figures of background seismicity rate and magnitude of completeness, 95% confidence interval on the principal stress orientation and friction coefficient, influence of fault friction on the Coulomb stress imparted to the major mapped active faults, shear-stress changes resolved on the nodal planes of small earthquakes, and observed aftershock rates.	[Toda, Shinji] Tohoku Univ, Int Res Inst Disaster Sci IRIDeS, Aoba Ku, Sendai, Miyagi 9800845, Japan; [Stein, Ross S.] US Geol Survey, Menlo Pk, CA 94025 USA	Toda, S (reprint author), Tohoku Univ, Int Res Inst Disaster Sci IRIDeS, Aoba Ku, 468-1 Aoba, Sendai, Miyagi 9800845, Japan.	toda@irides.tohoku.ac.jp					Kilb D, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000149; Smith DE, 2010, PURE APPL GEOPHYS, V167, P1067, DOI 10.1007/s00024-010-0093-1; Lienkaemper JJ, 2014, B SEISMOL SOC AM, V104, P3094, DOI 10.1785/0120140117; Field EH, 2014, B SEISMOL SOC AM, V104, P1122, DOI 10.1785/0120130164; Toda S, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000172; Townend J, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018918; Hardebeck JL, 2001, J GEOPHYS RES-SOL EA, V106, P21859, DOI 10.1029/2001JB000292; Brocher TM, 2015, SEISMOL RES LETT, V86, P309, DOI 10.1785/0220150004; Stein RS, 1999, NATURE, V402, P605, DOI 10.1038/45144; DIETERICH J, 1994, J GEOPHYS RES-SOL EA, V99, P2601, DOI 10.1029/93JB02581; Wei SJ, 2015, SEISMOL RES LETT, V86, P344, DOI 10.1785/0220140249; Lienkaemper JJ, 2013, B SEISMOL SOC AM, V103, P2386, DOI 10.1785/0120120198; Barnhart WD, 2015, SEISMOL RES LETT, V86, P335, DOI 10.1785/0220140210; Parsons T, 2014, GEOPHYS RES LETT, V41, P8792, DOI 10.1002/2014GL062379; Bakun WH, 2005, NATURE, V437, P969, DOI 10.1038/nature04067; Toda S, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003415; Smith DE, 2011, B SEISMOL SOC AM, V101, P1396, DOI 10.1785/0120100058; Martinez-Garzon P, 2014, SEISMOL RES LETT, V85, P896, DOI 10.1785/0220130189; ANGELIER J, 1984, J GEOPHYS RES, V89, P5835, DOI 10.1029/JB089iB07p05835; Dreger DS, 2015, SEISMOL RES LETT, V86, P327, DOI 10.1785/0220140244; KING GCP, 1994, B SEISMOL SOC AM, V84, P935; Toda S, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002527; Dawson T., 2014, GEER037; Earthquake Engineering Research Institute (EERI), 2014, M 6 0 S NAP EARTHQ A; Felzer K. R, 2013, UNIFORM CALIFORNIA E; Harris RA, 1998, J GEOPHYS RES, V103, P439; Hauksson E, 2002, B SEISMOL SOC AM, V92, P1154, DOI 10.1785/0120000920; OKADA Y, 1992, B SEISMOL SOC AM, V82, P1018; Pollitz F, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003003; Toda S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047834; Wiemer S, 2001, SEISMOL RES LETT, V72, P373, DOI DOI 10.1785/GSSRL.72.3.373	31	0	0	SEISMOLOGICAL SOC AMER	ALBANY	400 EVELYN AVE, SUITE 201, ALBANY, CA 94706-1375 USA	0895-0695	1938-2057		SEISMOL RES LETT	Seismol. Res. Lett.	NOV-DEC	2015	86	6					1593	1602		10.1785/0220150102		10	Geochemistry & Geophysics	Geochemistry & Geophysics	CV9MA	WOS:000364610100013		
J	Nogami, K; Shima, M				Nogami, Keiji; Shima, Midori			Phenotypic Heterogeneity of Hemostasis in Severe Hemophilia	SEMINARS IN THROMBOSIS AND HEMOSTASIS			English	Article						clinical phenotype; severe hemophilia; heterogeneity	THROMBIN GENERATION ASSAY; WAVE-FORM ANALYSIS; FACTOR-VII GENE; CLINICAL PHENOTYPE; HALF-LIFE; FACTOR-IX; MOLECULAR CHARACTERIZATION; MODERATE HEMOPHILIA; BLEEDING PHENOTYPE; PLASMA-LEVELS	A reduction in bleeding pattern and arthropathy appears to be observed in approximately 10% of the patients with severe hemophilia (< 1% clotting factor activity). These patients rarely bleed and do not always need prophylactic therapy of therapeutic products, resulting in the wide range of joint damage seen in patients with severe hemophilia. The cause(s) of this phenotypic heterogeneity has been investigated in many studies till date, but remains to be completely solved. The large heterogeneity of the clinical phenotype in severe hemophilia seems to be multifactorial, including variation in the levels of various procoagulant and anticoagulant factors, the balance between the coagulation and fibrinolysis systems, pharmacokinetics of therapeutic products, environmental factors including lifestyle activity, and the limitation of measurement at lower levels of clotting factors. As an approach toward clarification, studies should be designed to evaluate a homogenous cohort of hemophilic A patients with an intron 22 inversion who produce no factor VIII. In the future, by a combination of the measurement of lower levels of clotting factors and the evaluation of global clotting function, it might be possible to better grasp the potential of hemostatic coagulation in individual hemophilia patients, which should in turn be useful for the prediction of bleeding phenotype and the designation of adequate and long-term hemostatic management throughout their life.	[Nogami, Keiji; Shima, Midori] Nara Med Univ, Dept Pediat, Kashihara, Nara 6348522, Japan	Nogami, K (reprint author), Nara Med Univ, Dept Pediat, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	roc-noga@naramed-u.ac.jp					ALEDORT LM, 1994, J INTERN MED, V236, P391; Verhoef CM, 2001, J RHEUMATOL, V28, P1960; Bolton-Maggs PHB, 2003, LANCET, V361, P1801, DOI 10.1016/S0140-6736(03)13405-8; Yada K, 2013, THROMB HAEMOSTASIS, V109, P1007, DOI 10.1160/TH12-10-0762; FIJNVANDRAAT K, 1995, BRIT J HAEMATOL, V91, P474, DOI 10.1111/j.1365-2141.1995.tb05325.x; van Dijk K, 2005, HAEMOPHILIA, V11, P438, DOI 10.1111/j.1365-2516.2005.01124.x; Van den Berg HM, 2007, J THROMB HAEMOST, V5, P151, DOI 10.1111/j.1538-7836.2007.02503.x; Barnes C, 2007, HAEMOPHILIA, V13, P202, DOI 10.1111/j.1365-2516.2006.01396.x; Plug I, 2004, BLOOD, V104, P3494, DOI 10.1182/blood-2004-05-2008; Fischer K, 2000, THROMB HAEMOSTASIS, V84, P977; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Frere C, 2005, THROMB HAEMOSTASIS, V94, P373, DOI 10.1160/TH04-08-0497; Iacoviello L, 1998, NEW ENGL J MED, V338, P79, DOI 10.1056/NEJM199801083380202; Oldenburg J, 2001, THROMB HAEMOSTASIS, V85, P577; Trossaert M, 2008, J THROMB HAEMOST, V6, P486, DOI 10.1111/j.1538-7836.2007.02861.x; Vlot AJ, 2000, THROMB HAEMOSTASIS, V83, P65; Dargaud Y, 2005, THROMB HAEMOSTASIS, V93, P475, DOI 10.1160/TH04-10-0706; Czepa D, 2013, HAEMOPHILIA, V19, P194, DOI 10.1111/hae.12031; Jayandharan G, 2005, HAEMOPHILIA, V11, P481, DOI 10.1111/j.1365-2516.2005.01121.x; Foley JH, 2012, HAEMOPHILIA, V18, pe316, DOI 10.1111/j.1365-2516.2011.02648.x; Shima M, 2008, HAEMOPHILIA, V14, P83, DOI 10.1111/j.1365-2516.2008.01737.x; van Dijk K, 2005, HAEMATOL-HEMATOL J, V90, P494; Schramm W, 2002, HAEMOPHILIA, V8, P33, DOI 10.1046/j.1365-2516.2002.00580.x; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Matsumoto T, 2006, J THROMB HAEMOST, V4, P377, DOI 10.1111/j.1538-7836.2006.01730.x; Shima M, 2002, THROMB HAEMOSTASIS, V87, P436; GOODEVE AC, 1994, LANCET, V343, P329, DOI 10.1016/S0140-6736(94)91165-7; White GC, 2001, THROMB HAEMOSTASIS, V85, P560; Santagostino E, 2010, J THROMB HAEMOST, V8, P737, DOI 10.1111/j.1538-7836.2010.03767.x; Onwuzurike N, 1996, HAEMOPHILIA, V2, P137; Matsumoto T, 2009, INT J HEMATOL, V90, P576, DOI 10.1007/s12185-009-0450-y; Jayandharan GR, 2008, SEMIN THROMB HEMOST, V34, P128, DOI 10.1055/s-2008-1066024; Grunewald M, 2002, HAEMOPHILIA, V8, P768, DOI 10.1046/j.1365-2516.2002.00686.x; Mosnier LO, 2001, THROMB HAEMOSTASIS, V86, P1035; Nichols WC, 1996, BLOOD, V88, P1183; Jayandharan GR, 2005, THROMB HAEMOSTASIS, V94, P883; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Lee DH, 2000, THROMB HAEMOSTASIS, V83, P387; LJUNG R, 1990, ACTA PAEDIATR SCAND, V79, P196, DOI 10.1111/j.1651-2227.1990.tb11438.x; Ettingshausen CE, 2001, THROMB HAEMOSTASIS, V85, P218; Molho P, 2000, HAEMOPHILIA, V6, P23; van Dijk K, 2007, J THROMB HAEMOST, V5, P1062, DOI 10.1111/j.1538-7836.2007.02447.x; Bertina RM, 2003, PATHOPHYSIOL HAEMO T, V33, P395, DOI 10.1159/000083835; Gilmore R, 2010, HAEMOPHILIA, V16, P671, DOI 10.1111/j.1365-2516.2009.02190.x; Jayandharan GR, 2009, HAEMOPHILIA, V15, P1228, DOI 10.1111/j.1365-2516.2009.02080.x; Harris S, 2006, HAEMOPHILIA, V12, P237, DOI 10.1111/j.1365-2516.2006.01214.x; Hilberg T, 2003, HAEMOPHILIA, V9, P86, DOI 10.1046/j.1365-2516.2003.00679.x; Nowak-Göttl U, 2003, Hamostaseologie, V23, P36; RAINSFOR.SG, 1973, BRIT J HAEMATOL, V24, P539, DOI 10.1111/j.1365-2141.1973.tb01680.x	49	1	1	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0094-6176	1098-9064		SEMIN THROMB HEMOST	Semin. Thromb. Hemost.	NOV	2015	41	8					826	831		10.1055/s-0034-1395349		6	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CV8WW	WOS:000364569900003		
J	Fan, JM; Zhao, ZH; Gong, C; Cheng, B; Xue, YQ; Yin, S				Fan, Jimin; Zhao, Zhihuan; Gong, Chao; Cheng, Bin; Xue, Yongqiang; Yin, Shu			Enhancement of photocatalytic performance of plasmon-assisted metallic ion doped titania	SOLID STATE SCIENCES			English	Article						Metallic ions doping; Surface plasmon resonance; Codoped TiO2; Nanoparticles; Photocatalysis	VISIBLE-LIGHT IRRADIATION; ANTIBACTERIAL ACTIVITY; MICROCYSTIN-LR; RUTILE TIO2; DEGRADATION; AGI/TIO2; ANATASE; NANOCOMPOSITES; NANOTUBES; COMPOSITE	Plasmonic assisted metallic ion doped titania was synthesized successfully by combining the hydrothermal and photoreduction methods. The chromium ion doping resulted to smaller particle size and preferable crystallinity than pure TiO2. Ag@AgI-TiO2-Cr showed the smallest band gap of 1.9 eV, corresponding to the wavelength range until 652 nm. The Ag-AgI plasmonic effect promoted electron transfer and accelerated photocatalytic reaction. Excellent visible light induced MO degradation was effectively realized. The sample Ag@AgI-TiO2-Cr exhibited the best photodegradation activity, which might be related to its smallest band gap, larger specific surface area of 178.3 m(2) g(-1) and the maximum equilibrium adsorption quantity of 18.0 mg/g. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Fan, Jimin; Zhao, Zhihuan; Gong, Chao; Xue, Yongqiang; Yin, Shu] Taiyuan Univ Technol, Coll Chem & Chem Engn, Taiyuan 030024, Shanxi, Peoples R China; [Cheng, Bin] Shanxi Acad Product Qual Supervis & Inspect, Taiyuan 030012, Shanxi, Peoples R China; [Yin, Shu] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Yin, S (reprint author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	zzh1972129@163.com; shuyin@tagen.tohoku.ac.jp			National Natural Science Foundation of China [21373147]; Key Project of Science and Technology of Shanxi [20130313026-5]	This research was partly supported by the National Natural Science Foundation of China (Grant no. 21373147), and by the Key Project of Science and Technology of Shanxi (Grant no. 20130313026-5).	Fan JM, 2015, APPL SURF SCI, V324, P691, DOI 10.1016/j.apsusc.2014.11.018; Yang KS, 2009, J PHYS CHEM C, V113, P2624, DOI 10.1021/jp808483a; Hu C, 2006, ENVIRON SCI TECHNOL, V40, P7903, DOI 10.1021/es061599r; KRAEUTLER B, 1978, J AM CHEM SOC, V100, P5985, DOI 10.1021/ja00487a001; Franch MI, 2005, APPL CATAL B-ENVIRON, V55, P105, DOI 10.1016/j.apcatb.2004.07.006; Li YZ, 2008, LANGMUIR, V24, P8351, DOI 10.1021/la801046u; Amornpitoksuk P, 2014, ADV POWDER TECHNOL, V25, P1026, DOI 10.1016/j.apt.2014.02.001; Liao WJ, 2013, CHEM ENG J, V231, P455, DOI 10.1016/j.cej.2013.07.054; Anpo M, 2003, J CATAL, V216, P505, DOI 10.1016/S0021-9517(02)00104-5; Chang CH, 2006, MATER LETT, V60, P129, DOI 10.1016/j.matlet.2005.08.005; Wang YZ, 2013, J INORG MATER, V28, P117, DOI 10.3724/SP.J.1077.2013.12337; Ishii T, 2004, J PHOTOCH PHOTOBIO A, V163, P181, DOI 10.1016/S1010-6030(03)00442-8; Yang YQ, 2012, J COLLOID INTERF SCI, V376, P217, DOI 10.1016/j.jcis.2012.03.003; Lee JS, 2005, J PHYS CHEM B, V109, P7399, DOI 10.1021/jp044425+; Finazzi E, 2009, J PHYS CHEM C, V113, P3382, DOI 10.1021/jp8111793; Li HX, 2007, J AM CHEM SOC, V129, P4538, DOI 10.1021/ja069113u; Hu C, 2006, J PHYS CHEM B, V110, P4066, DOI 10.1021/jp0564400; Karvinen S, 2003, J MOL STRUC-THEOCHEM, V626, P271, DOI 10.1016/S0166-1280(03)00108-8; Awazu K, 2008, J AM CHEM SOC, V130, P1676, DOI 10.1021/ja076503n; Zhang JZ, 2013, CERAM INT, V39, P1011, DOI 10.1016/j.ceramint.2012.07.021; Choi J, 2010, J PHYS CHEM C, V114, P783, DOI 10.1021/jp908088x; Tian BZ, 2012, CHEM ENG J, V191, P402, DOI 10.1016/j.cej.2012.03.038; Hirakawa T, 2005, J AM CHEM SOC, V127, P3928, DOI 10.1021/ja042925a; Xue B, 2015, ULTRASON SONOCHEM, V22, P1, DOI 10.1016/j.ultsonch.2014.04.021; Sreekantan S, 2014, MAT SCI SEMICON PROC, V26, P620, DOI 10.1016/j.mssp.2014.05.034; Yang KS, 2007, J PHYS CHEM C, V111, P18985, DOI 10.1021/jp0756350; Xin BF, 2008, APPL SURF SCI, V254, P2569, DOI 10.1016/j.apsusc.2007.09.002; Tieng ST, 2011, APPL CATAL A-GEN, V399, P191, DOI 10.1016/j.apcata.2011.03.056; El-Sheikh SM, 2014, J HAZARD MATER, V280, P723, DOI 10.1016/j.jhazmat.2014.08.038; Grabowski P., 2014, PROCEDIA ENG, V98, P86; Katsumata H, 2015, MATER RES BULL, V63, P116, DOI 10.1016/j.materresbull.2014.11.040; Li H. H., 2013, FUNCT MATER LETT, V6, P14; [王欢 Wang Huan], 2013, [化工进展, Chemical Industry and Engineering Progress], V32, P346; Wu JCS, 2004, J PHOTOCH PHOTOBIO A, V163, P509, DOI 10.1016/j.jphotochem.2004.02.007; Yu D. F., 2014, J NANOTECHNOL, V4, P12; Zhao Z. H., 2014, MAT TECHNOL ADV PERF, V29, pA1	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1293-2558	1873-3085		SOLID STATE SCI	Solid State Sci.	NOV	2015	49						47	53		10.1016/j.solidstatesciences.2015.09.011		7	Chemistry, Inorganic & Nuclear; Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	CV8KY	WOS:000364535900007		
J	Li, YQ; Mu, L; Zeng, X; Li, J; Yamato, T				Li Yan-Qin; Mu Lan; Zeng Xi; Li Jun; Yamato, Takehiko			The Thiacalix [4] arene-Coumarin Fluorescence Probe Recognition for Fe3+ and Bovine Hemoglobin	SPECTROSCOPY AND SPECTRAL ANALYSIS			Chinese	Article						Coumarin; Thiacalix[4]arene Derivatives; Fe3+; Bovine Hemoglobin	SENSOR; 1,3-ALTERNATE; IONS	1,3-alternate coumarin substituted thiacalix[4] arene fluorescent probe 1 was synthesised from 1, 3-alternate diethyl thiacalix[4]arene and 7-hydroxycoumarin by-step reactions. In DMSO/H2O (phi, 3/7, pH 7) solution, the strong fluorescence emission and UV absorption of probe 1 can be selectively quenched or significantly enhanced by Fe3+ ion. The probe 1 showed high Fe3+ selective fluorescence quenching or absorption enhancement over commonly coexistent metal ions in neutral aqueous media, and the limit of detections were obtained as low as 10(-8) mol . L-1 of Fe3+ by fluorescence and absorption spectrometry. Spectral titration, isothermal titration calorimetry and mass spectrometry were showed that probe and Fe3+ form 1:1 complexes, the constant up to 10(5) L . mol(-1) and coordinate process was spontaneous by the mole binding free energy and entropy of probe with Fe3+. In addition, the probe can identification bovine hemoglobin (BHb) over other proteins through quenched its fluorescence in DMSO/H2O (phi, 1/9, Tris-HCl, pH 7, 0.1 mol . L-1 NaCl) media. The limit of detection was obtained as 0.12 mu g . mL(-1) of BHb, as well as a linearity of 0.2 similar to 3.0 mu g . mL(-1), indicating the probe of high sensitivity and quantitation range. It can be used as a selective recognition Fe3+ and BHb of thiacalix[4] arene fluorescent probe.	[Li Yan-Qin; Mu Lan; Zeng Xi; Li Jun] Guizhou Univ, Key Lab Macrocycl & Supramol Chem Guizhou Prov, Guiyang 550025, Peoples R China; [Yamato, Takehiko] Saga Univ, Fac Sci & Engn, Dept Appl Chem, Saga 8408502, Japan	Zeng, X (reprint author), Guizhou Univ, Key Lab Macrocycl & Supramol Chem Guizhou Prov, Guiyang 550025, Peoples R China.	821597431@qq.com; sci.Imou@gzu.edu.cn					An JM, 2013, DYES PIGMENTS, V99, P1, DOI 10.1016/j.dyepig.2013.04.018; Ma GB, 1995, ACTA CHIM SINICA, V53, P1193; Zhang CL, 2006, SUPRAMOL CHEM, V18, P483, DOI 10.1080/10610270600703508; Wu CF, 2012, J ORG CHEM, V77, P4261, DOI 10.1021/jo300063u; Praveen L, 2007, INORG CHEM, V46, P6277, DOI 10.1021/ic070259j; Kumar M, 2011, ORG LETT, V13, P366, DOI 10.1021/ol102543e; Miao FJ, 2012, TETRAHEDRON, V68, P2409, DOI 10.1016/j.tet.2012.01.010; Kumar M, 2010, SENSOR ACTUAT B-CHEM, V144, P183, DOI 10.1016/j.snb.2009.10.050; Csokai V, 2008, TETRAHEDRON, V64, P1058, DOI 10.1016/j.tet.2007.06.116; Zhang XH, 2014, DYES PIGMENTS, V100, P232, DOI 10.1016/j.dyepig.2013.09.011; Kumar R, 2013, DALTON T, V42, P8808, DOI 10.1039/c3dt50142f; Kumar M, 2011, ORG BIOMOL CHEM, V9, P8237, DOI 10.1039/c1ob06273e; Iki N, 1998, J CHEM SOC PERK T, V28, P2745; Kaya E N, 2013, SENSOR ACTUAT B-CHEM, V10, P1; Lin WY, 2008, EUR J ORG CHEM, P4981, DOI 10.1002/ejoc.200800667; Lin WY, 2008, EUR J ORG CHEM, P2689, DOI 10.1002/ejoc.200800077; Ni X L, 2011, TETRAHEDRON, V10, P1; Olimpo G B, 2012, TETRAHEDRON LETT, V53, P6598; Zheng X Y, 2010, J INCL PHENOM MACRO, V7, P8502	19	0	0	OFFICE SPECTROSCOPY & SPECTRAL ANALYSIS	BEIJING	NO 76 COLLAGE SOUTH RD BEIJING, BEIJING 100081, PEOPLES R CHINA	1000-0593			SPECTROSC SPECT ANAL	Spectrosc. Spectr. Anal.	NOV	2015	35	11					3111	3116		10.3964/j.issn.1000-0593(2015)11-3111-06		6	Spectroscopy	Spectroscopy	CV8CH	WOS:000364503600028		
J	Tsunoda, N; Inayama, T; Hata, K; Oka, J				Tsunoda, N.; Inayama, T.; Hata, K.; Oka, J.			Vegetable dishes, dairy products and fruits are key items mediating adequate dietary intake for Japanese adults with spinal cord injury	SPINAL CORD			English	Article							RANDOMIZED CONTROLLED-TRIAL; GUIDE SPINNING TOP; CARDIOVASCULAR-DISEASE; FOOD GUIDE; MORTALITY; POPULATION; MEN; INCREASE; WOMEN	Study design: This is a cross-sectional study. Objectives: The objective of this study was to ascertain the essential items mediating adequate dietary intake based on the Japanese Food Guide in common among the transtheoretical model (TTM), self-efficacy (SE) and outcome expectancy (OE). Setting: Members of the organization Spinal Injuries Japan. Methods: We posted a questionnaire survey to 2731 community-dwelling Japanese adults with spinal cord injury (SCI), and responses from 841 individuals were analyzed. Food intake was assessed as the frequency scores of 10 food items eaten in a daily diet in Japan. The correlations between the frequency scores of food intake and TTM, SE and OE were determined by binominal logistic regression analysis. Results: The frequency scores of food intake were significantly associated with 'To eat vegetable dishes (dishes made mainly from vegetables or potatoes) not less than twice a day', 'To eat green/yellow vegetables not less than twice a day', 'To eat dairy products not less than once a day' and 'To eat fruits not less than once a day' in TTM. 'To eat vegetable dishes (dishes made mainly from vegetables or potatoes) not less than twice a day', 'To eat dairy products not less than once a day' and 'To eat fruits not less than once a day' were significantly associated with the frequency scores of food intake in SE. In OE, no differences were shown. Conclusion: This study finds that vegetable dishes, dairy products and fruits are the key items mediating adequate dietary intake. Dietary guidelines promoting the intake of these dishes for SCI individuals are needed.	[Tsunoda, N.] Toyo Univ, Inst Reg Vitalizat Studies, Gunma, Japan; [Tsunoda, N.; Inayama, T.; Hata, K.] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Hlth Promot Sci, Hachioji, Tokyo 1920297, Japan; [Oka, J.] Tokyo Kasei Univ, Fac Home Econ, Tokyo, Japan	Inayama, T (reprint author), Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Hlth Promot Sci, 1-1 Minami Osawa, Hachioji, Tokyo 1920297, Japan.	tinayama@tmu.ac.jp			JSPS KAKENHI Grant [23500962]	We thank all of the SCI individuals who participated in this study. This work was supported by JSPS KAKENHI Grant Number 23500962.	Shimazu T, 2007, INT J EPIDEMIOL, V36, P600, DOI 10.1093/ije/dym005; Norman GJ, 2013, PREV MED, V56, P3, DOI 10.1016/j.ypmed.2012.10.012; Wong S, 2013, J SPINAL CORD MED, V36, P645, DOI 10.1179/2045772313Y.0000000105; Wong S, 2012, SPINAL CORD, V50, P772, DOI 10.1038/sc.2012.43; SHINGU H, 1995, PARAPLEGIA, V33, P183; Tomey KM, 2005, ARCH PHYS MED REHAB, V86, P664, DOI 10.1016/j.apmr.2004.10.023; Yoshiike N, 2007, NUTR REV, V65, P149, DOI 10.1301/nr.2007.apr.149-154; Katoh S, 2014, SPINAL CORD, V52, P264, DOI 10.1038/sc.2014.13; Knight KH, 2011, SPINAL CORD, V49, P381, DOI 10.1038/sc.2010.103; Nagura J, 2009, BRIT J NUTR, V102, P285, DOI 10.1017/S0007114508143586; Garshick E, 2005, SPINAL CORD, V43, P408, DOI 10.1038/sj.sc.3101729; Oba S, 2009, J AM DIET ASSOC, V109, P1540, DOI 10.1016/j.jada.2009.06.367; Bandura A, 1986, SOCIAL FDN THOUGHT A; Edwards PJ, 2009, COCHRANE DB SYST REV, V8, pMR000008, DOI DOI 10.1002/14651858.MR000008.PUB4; Fluss E, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-104; Fulgoni III, 2010, NUTR TODAY, V45, P262; Green LW, 2005, HLTH PROGRAM PLANNIN; Lavelle K, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-113; Lieberman J, 2014, J SPINAL CORD MED, V37, P751, DOI 10.1179/2045772313Y.0000000180; Ministry of Health Labour and Welfare, 2012, BAS DIR COMPR IMPL N; Mizoguchi K., 2004, Japanese Journal of Nutrition and Dietetics, V62, P269; Prochaska JO, 1998, HDB HLTH BEHAV CHANG; Tokudome S, 2000, ASIAN PACIFIC J CANC, V1, P61; Tsurumi K, 2012, JPN J REHABIL MED, V49, P726	24	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	NOV	2015	53	11					786	790		10.1038/sc.2015.78		5	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CW2GC	WOS:000364808100003		
J	Kawamura, T; Miyagawa, S; Fukushima, S; Kashiyama, N; Kawamura, A; Ito, E; Saito, A; Maeda, A; Eguchi, H; Toda, K; Miyagawa, S; Okuyama, H; Sawa, Y				Kawamura, Takuji; Miyagawa, Shigeru; Fukushima, Satsuki; Kashiyama, Noriyuki; Kawamura, Al; Ito, Emiko; Saito, Atsuhiro; Maeda, Akira; Eguchi, Hiroshi; Toda, Koichi; Miyagawa, Shuji; Okuyama, Hiroomi; Sawa, Yoshiki			Structural Changes in N-Glycans on Induced Pluripotent Stem Cells Differentiating Toward Cardiomyocytes	STEM CELLS TRANSLATIONAL MEDICINE			English	Article						Induced pluripotent stem cell; Induced pluripotent stem cell-derived cardiomyocyte; N-Glycan	GLYCOSYLATION; EXPRESSION; ADHESION; SHEETS; HEART	Cell-surface glycans vary widely, depending on cell properties. Previously, we reported that the pattern of N-glycan expression on murine induced pluripotent stem cells (iPSCs) changed toward that of the cardiac tissue during cardiomyogenic differentiation. In this study, N-glycans were isolated from human iPSCs, iPSC-derived cardiomyocytes (iPSC-CMs), and human cardiomyocytes (hCMCs). Their structures were analyzed by a mapping technique based on high-performance liquid chromatography elution positions and matrix-assisted laser desorption/ionization time-of-flight mass-spectrometric data. Of 52 isolated N-glycans,,the structures of 38 were clearly identified. In addition, 11 structures were partially identified because the binding style and fucose binding site at the nonreduced terminal could not be identified. Quantitation of each type of N-glycan, based on the terminal glycosylation process, revealed that the exposed N-acetylglucosamine (GIcNAc) and the nonreduced terminal fucose types decreased, whereas the exposed galactose or the alpha 2-3 NeuAc types increased in the iPSCs during cardiomyogenic differentiation. However, the bisecting GIcNAc and the triantennary structures were found in relative abundance in the iPSC-CMs in comparison with hCMCs or iPSCs. Expression of MGAT3, a glycosyltransferase-encoding gene that produces the bisecting GIcNAc structures, was higher in iPSCs and iPSC-CMs than in hCMCs. These findings will prove useful in understanding the directional precision of cardiomyogenic differentiation in vitro.	[Kawamura, Takuji; Miyagawa, Shigeru; Fukushima, Satsuki; Kashiyama, Noriyuki; Kawamura, Al; Ito, Emiko; Saito, Atsuhiro; Toda, Koichi; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 5650871, Japan; [Maeda, Akira; Eguchi, Hiroshi; Miyagawa, Shuji; Okuyama, Hiroomi] Osaka Univ, Grad Sch Med, Dept Pediat Surg, Suita, Osaka 5650871, Japan	Sawa, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sawa-p@surg1.med.osaka-u.ac.jp			Japan Science and Technology Agency part of the project "Center for the Development of Myocardial Regenerative Treatments Using iPS Cells"	We thank Drs. Shinya Yamanaka, Keisuke Okita, and Yoshinori Yoshida of the Center for iPS Cell Research and Application, Kyoto University, for kindly providing the human iPSCs. This study was supported by the Japan Science and Technology Agency as a part of the project "Center for the Development of Myocardial Regenerative Treatments Using iPS Cells."	Kawamura M, 2013, CIRCULATION, V128, pS87, DOI 10.1161/CIRCULATIONAHA.112.000366; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Takahashi N, 2003, TRENDS GLYCOSCI GLYC, V15, P235; Miyagawa S, 2001, J BIOL CHEM, V276, P39310, DOI 10.1074/jbc.M104359200; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochems.73.011303.074043; Kumar A, 2013, J BIOL CHEM, V288, P28859, DOI 10.1074/jbc.M113.469403; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Anugraham M, 2014, MOL CELL PROTEOMICS, V13, P2213, DOI 10.1074/mcp.M113.037085; Amano M, 2010, MOL CELL PROTEOMICS, V9, P523, DOI 10.1074/mcp.M900559-MCP200; Vagin O, 2008, J BIOL CHEM, V283, P2192, DOI 10.1074/jbc.M704713200; Kawamura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111064; Lu TY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3307; Miyazaki T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2231; Stanley P., 2009, ESSENTIALS GLYCOBIOL; Tano K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110496	17	0	0	ALPHAMED PRESS	DURHAM	318 BLACKWELL ST, STE 260, DURHAM, NC 27701-2884 USA	2157-6564	2157-6580		STEM CELL TRANSL MED	Stem Cells Transl. Med.	NOV	2015	4	11					1258	1264		10.5966/sctm.2015-0029		7	Cell & Tissue Engineering	Cell Biology	CV9NB	WOS:000364612800009		
J	McNamara, KM; Sasano, H				McNamara, Keely May; Sasano, Hironobu			Beyond the C18 frontier: Androgen and glucocorticoid metabolism in breast cancer tissues The role of non-typical steroid hormones in breast cancer development and progression	STEROIDS			English	Review						Androgen; Oestrogen; Glucocorticoids; Steroidogenesis; Breast	RECEPTOR MESSENGER-RNA; DEHYDROGENASE TYPE-II; MAMMARY-TUMOR VIRUS; ESTROGEN-RECEPTOR; CELL-LINES; PROGESTERONE-RECEPTOR; MICROARRAY ANALYSIS; EXPRESSION; INHIBITION; PROLIFERATION	Breast cancer's hormonal dependence is well known and has been so for a long time. However in the last two decades great advances have been made in understanding the local metabolism of steroids within tissue. In the form of aromatase inhibition this is already one of the mainstays of breast cancer therapy. This review aims to summarise briefly what is known in terms of the metabolism of C18 steroids but perhaps more importantly to touch on the new developments regarding the importance of the metabolism of androgens and glucocorticoids in breast tissue. It is our hope that this review should provide the reader with a "birds eye view" of the current state of knowledge regarding localised steroid metabolism in the breast. (C) 2015 Elsevier Inc. All rights reserved.	[McNamara, Keely May; Sasano, Hironobu] Tohoku Univ, Dept Pathol, Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan	McNamara, KM (reprint author), Tohoku Univ, Dept Pathol, Sch Med, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	kmcnamara@patholo2.med.tohoku.ac.jp					GOYA L, 1993, MOL ENDOCRINOL, V7, P1121, DOI 10.1210/me.7.9.1121; Ariazi EA, 2011, P NATL ACAD SCI USA, V108, P18879, DOI 10.1073/pnas.1115188108; Garay JP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3112; HAM J, 1988, NUCLEIC ACIDS RES, V16, P5263, DOI 10.1093/nar/16.12.5263; Hardin C, 2007, WORLD J SURG, V31, P1041, DOI 10.1007/s00268-007-0694-8; Witzel I, 2013, J CANCER RES CLIN, V139, P809, DOI 10.1007/s00432-013-1382-8; Koyama K, 2001, J STEROID BIOCHEM, V76, P153, DOI 10.1016/S0960-0760(00)00157-6; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Zhang Y, 2009, J BIOL CHEM, V284, P24542, DOI 10.1074/jbc.M109.021469; Belova L, 2009, BREAST CANCER RES TR, V116, P441, DOI 10.1007/s10549-008-0136-9; Hickey TE, 2012, MOL ENDOCRINOL, V26, P1252, DOI 10.1210/me.2012-1107; El-Alfy M, 1999, ENDOCRINOLOGY, V140, P1481, DOI 10.1210/en.140.3.1481; Knower KC, 2013, BREAST CANCER RES TR, V142, P211, DOI 10.1007/s10549-013-2716-6; Huang Y, 2000, CANCER RES, V60, P4426; HACKENBERG R, 1992, J STEROID BIOCHEM, V43, P599, DOI 10.1016/0960-0760(92)90284-P; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Byrns MC, 2009, CHEM-BIOL INTERACT, V178, P221, DOI 10.1016/j.cbi.2008.10.024; EIDNE KA, 1987, J CLIN ENDOCR METAB, V64, P425; Szelei J, 1997, ENDOCRINOLOGY, V138, P1406, DOI 10.1210/en.138.4.1406; Burnstein KL, 1995, MOL CELL ENDOCRINOL, V115, P177, DOI 10.1016/0303-7207(95)03688-1; Lipka C, 2004, HORM METAB RES, V36, P437, DOI 10.1055/s-2004-825724; Park S, 2010, ANN ONCOL, V21, P488, DOI 10.1093/annonc/mdp510; Skor MN, 2013, CLIN CANCER RES, V19, P6163, DOI 10.1158/1078-0432.CCR-12-3826; McNamara KM, 2014, ENDOCR-RELAT CANCER, V21, pT161, DOI 10.1530/ERC-14-0243; Ortmann J, 2002, GYNECOL ENDOCRINOL, V16, P113, DOI 10.1080/713603030; McNamara KM, 2013, J STEROID BIOCHEM, V133, P66, DOI 10.1016/j.jsbmb.2012.08.007; LABRIE F, 1991, MOL CELL ENDOCRINOL, V78, pC113, DOI 10.1016/0303-7207(91)90116-A; Ferguson RD, 2013, VITAM HORM, V93, P51, DOI 10.1016/B978-0-12-416673-8.00010-1; Schubert A, 2011, BREAST CANCER RES TR, V130, P783, DOI 10.1007/s10549-011-1358-9; Siraj A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-246; De Amicis F, 2010, BREAST CANCER RES TR, V121, P1, DOI 10.1007/s10549-009-0436-8; Smith RA, 2007, CANCER LETT, V255, P77, DOI 10.1016/j.canlet.2007.03.019; Park S, 2011, ANN ONCOL, V22, P1755, DOI 10.1093/annonc/mdq678; HACKENBERG R, 1993, BREAST CANCER RES TR, V25, P217, DOI 10.1007/BF00689836; Cops EJ, 2008, J STEROID BIOCHEM, V110, P236, DOI 10.1016/j.jsbmb.2007.10.014; Peters AA, 2009, CANCER RES, V69, P6131, DOI 10.1158/0008-5472.CAN-09-0452; Gonzalez-Angulo AM, 2009, CLIN CANCER RES, V15, P2472, DOI 10.1158/1078-0432.CCR-08-1763; Santen RJ, 2009, ENDOCR REV, V30, P343, DOI 10.1210/er.2008-0016; Shibahara Y, 2013, HUM PATHOL, V44, P2338, DOI 10.1016/j.humpath.2013.04.021; Gucalp A, 2013, CLIN CANCER RES, V19, P5505, DOI 10.1158/1078-0432.CCR-12-3327; Niemeier LA, 2010, MODERN PATHOL, V23, P205, DOI 10.1038/modpathol.2009.159; McNamara KM, 2014, BREAST CANCER RES TR, V145, P281, DOI 10.1007/s10549-014-2942-6; Hu R, 2011, CLIN CANCER RES, V17, P1867, DOI 10.1158/1078-0432.CCR-10-2021; Hundertmark S, 1997, J ENDOCRINOL, V155, P171, DOI 10.1677/joe.0.1550171; Feigelson HS, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2114; BIRRELL SN, 1995, J STEROID BIOCHEM, V52, P459, DOI 10.1016/0960-0760(95)00005-K; Vilasco M, 2011, BREAST CANCER RES TR, V130, P1, DOI 10.1007/s10549-011-1689-6; Vilasco M, 2013, BREAST CANCER RES TR, V142, P283, DOI 10.1007/s10549-013-2722-8; Sasano H, 1997, ANTICANCER RES, V17, P2001; Pan D, 2011, CANCER RES, V71, P6360, DOI 10.1158/0008-5472.CAN-11-0362; Wu W, 2004, CANCER RES, V64, P1757, DOI 10.1158/0008-5472.CAN-03-2546; Mikosz CA, 2001, J BIOL CHEM, V276, P16649, DOI 10.1074/jbc.M010842200; Lapointe J, 1999, ENDOCRINOLOGY, V140, P416, DOI 10.1210/en.140.1.416; Conde I, 2008, HISTOL HISTOPATHOL, V23, P77; HACKENBERG R, 1991, CANCER RES, V51, P5722; Sahu B, 2011, EMBO J, V30, P3962, DOI 10.1038/emboj.2011.328; POULIN R, 1988, BREAST CANCER RES TR, V12, P213, DOI 10.1007/BF01805942; Lu L, 2011, PATHOL ONCOL RES, V17, P627, DOI 10.1007/s12253-011-9361-3; Castellano I, 2010, BREAST CANCER RES TR, V124, P607, DOI 10.1007/s10549-010-0761-y; CATO ACB, 1987, EMBO J, V6, P363; Buxant F, 2010, APPL IMMUNOHISTO M M, V18, P254, DOI 10.1097/PAI.0b013e3181c10180; Cimino-Mathews A, 2012, HUM PATHOL, V43, P1003, DOI 10.1016/j.humpath.2011.08.007; Chanplakorn Niramol, 2011, Hormones & Cancer, V2, P73, DOI 10.1007/s12672-010-0062-2; Cochrane DR, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3599; Goldhirsch A., 2013, ANN ONCOL; Honma N., 2012, BREAST CANC; Huang B., 2014, MOL CELL ENDOCRINOL; von Wahlde MK, 2015, GYNECOL ENDOCRINOL, V31, P160, DOI 10.3109/09513590.2014.971235; McNamara K.M., 2014, J STEROID BIOCH MOL; McNamara K.M., 2014, INT J BIOL MARKERS; Nesset K.A., 2014, EPIGENETICS, V9; Odermatt A., 2014, J STEROID BIOCH MOL; Peters KM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-132; Planeix F, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0128-7; Qu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082650; Seitz S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-847; Simpson ER, 2013, J MOL ENDOCRINOL, V51, pT51, DOI 10.1530/JME-13-0217; Vera-Badillo F.E., 2013, J NATL CANC I; Yoda T., 2014, CANC SCI	79	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0039-128X	1878-5867		STEROIDS	Steroids	NOV	2015	103				SI		115	122		10.1016/j.steroids.2015.05.008		8	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CV9LB	WOS:000364607600012		
J	Shigehisa, H				Shigehisa, Hiroki			Functional Group Tolerant Markovnikov-Selective Hydrofunctionalization of Unactivated Olefins Using a Cobalt Complex as Catalyst	SYNLETT			English	Article						alkenes; radicals; carbocation; transition metals; fluorine	NOBEL LECTURE; FLUORINE TRANSFER; MOLECULAR-OXYGEN; CARBON BONDS; ALKENES; HYDROHYDRAZINATION; HYDROAMINATION; METATHESIS; ANALOGS; HYDROFLUORINATION	Recent developments in the Markovnikov-selective hydrofunctionalization of unactivated olefins are presented. Our group found that the use of a cobalt complex, an N-fluoropyridinium salt, and a siloxane facilitates hydrofunctionalization with excellent functional group tolerance. Mechanistically, this catalysis involves both a carbon radical and a carbocationic intermediate.	Musashino Univ, Fac Pharm, Tokyo 2028585, Japan	Shigehisa, H (reprint author), Musashino Univ, Fac Pharm, 1-1-20 Shinmachi Nishitokyo Shi, Tokyo 2028585, Japan.	cgehisa@musashino-u.ac.jp			JSPS KAKENHI [26860017]; Society of Synthetic Organic Chemistry, a Takeda Pharmaceutical Company award; Uehara Memorial Foundation; Musashino University	This work was supported by JSPS KAKENHI Grant No. 26860017, the Society of Synthetic Organic Chemistry, a Takeda Pharmaceutical Company award, the Uehara Memorial Foundation, and Musashino University. The author thanks Tatsuya Aoki, Sumiko Yamaguchi, Azusa Kurashige, Natsumi Koseki, Nao Shimizu, Mayu Fujisawa, and Eriko Nishi for assisting with this work, and Prof. Hiroya for helpful discussions.	Cherney EC, 2014, J AM CHEM SOC, V136, P12592, DOI [10.1021/ja507321j, 10.1021/ja507321J]; Ishikawa H, 2009, J AM CHEM SOC, V131, P4904, DOI 10.1021/ja809842b; Shigehisa H, 2013, ORG LETT, V15, P5158, DOI 10.1021/ol402696h; Nagatomo M, 2014, J AM CHEM SOC, V136, P5916, DOI 10.1021/ja502770n; Crossley SWM, 2014, J AM CHEM SOC, V136, P16788, DOI 10.1021/ja5105602; Waser J, 2006, J AM CHEM SOC, V128, P11693, DOI 10.1021/ja062355+; Shigehisa H, 2013, J AM CHEM SOC, V135, P10306, DOI 10.1021/ja405219f; Barker TJ, 2012, J AM CHEM SOC, V134, P13588, DOI 10.1021/ja3063716; Renata H, 2015, J AM CHEM SOC, V137, P1330, DOI 10.1021/ja512022r; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Kuramochi A, 2005, J AM CHEM SOC, V127, P14200, DOI 10.1021/ja055301t; Nicewicz DA, 2014, SYNLETT, V25, P1191, DOI 10.1055/s-0033-1340738; Rueda-Becerril M, 2012, J AM CHEM SOC, V134, P4026, DOI 10.1021/ja211679v; Shigehisa H, 2014, J AM CHEM SOC, V136, P13534, DOI 10.1021/ja507295u; Gaspar B, 2008, ANGEW CHEM INT EDIT, V47, P5758, DOI 10.1002/anie.200801760; Tokuyasu T, 2002, ORG LETT, V4, P3595, DOI 10.1021/ol0201299; Gaspar B, 2009, J AM CHEM SOC, V131, P13214, DOI 10.1021/ja904856k; Muller TE, 2008, CHEM REV, V108, P3795, DOI 10.1021/cr0306788; Hannedouche J, 2013, CHEM-EUR J, V19, P4972, DOI 10.1002/chem.201203956; Iwasaki K, 2014, J AM CHEM SOC, V136, P1300, DOI 10.1021/ja412342g; Shigehisa H, 2013, ANGEW CHEM INT EDIT, V52, P3646, DOI 10.1002/anie.201210099; Waser J, 2005, J AM CHEM SOC, V127, P8294, DOI 10.1021/ja052164r; MARYANOFF BE, 1989, CHEM REV, V89, P863, DOI 10.1021/cr00094a007; Leggans EK, 2012, ORG LETT, V14, P1428, DOI 10.1021/ol300173v; Waser J, 2005, ORG LETT, V7, P4249, DOI 10.1021/ol0517473; Waser J, 2004, ANGEW CHEM INT EDIT, V43, P4099, DOI 10.1002/anie.200460811; King SM, 2014, J AM CHEM SOC, V136, P6884, DOI 10.1021/ja502885c; O'Hagan D, 2000, NAT PROD REP, V17, P435, DOI 10.1039/a707613d; Waser J, 2004, J AM CHEM SOC, V126, P5676, DOI 10.1021/ja048698u; Shi J, 2011, J AM CHEM SOC, V133, P8014, DOI 10.1021/ja202103e; Hesp KD, 2010, CHEMCATCHEM, V2, P1192, DOI 10.1002/cctc.201000102; Gaspar B, 2007, ANGEW CHEM INT EDIT, V46, P4519, DOI 10.1002/anie.200700575; Denmark SE, 2009, CHEM COMMUN, P20, DOI 10.1039/b809676g; Chauvin Y, 2006, ANGEW CHEM INT EDIT, V45, P3740, DOI 10.1002/anie.200601234; Gaspar B, 2007, SYNTHESIS-STUTTGART, V3839; Grubbs RH, 2006, ANGEW CHEM INT EDIT, V45, P3760, DOI 10.1002/anie.200600680; ISAYAMA S, 1989, CHEM LETT, P1071, DOI 10.1246/cl.1989.1071; Leung JCT, 2012, ANGEW CHEM INT EDIT, V51, P10804, DOI 10.1002/anie.201206352; Lo JCL, 2014, NATURE, V516, P343, DOI 10.1038/nature14006; Schrock RR, 2006, ANGEW CHEM INT EDIT, V45, P3748, DOI 10.1002/anie.200600085	40	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	NOV	2015	26	18					2479	2484		10.1055/s-0035-1560171		6	Chemistry, Organic	Chemistry	CV6SE	WOS:000364399800002		
J	Yanagisawa, A; Kushihara, N; Sugita, T; Horiguchi, M; Ida, K; Yoshida, K				Yanagisawa, Akira; Kushihara, Naoyuki; Sugita, Takuya; Horiguchi, Moe; Ida, Kazuki; Yoshida, Kazuhiro			Catalytic Enantioselective Synthesis of Chiral 3-Amino-2-oxindoles by a Mannich Approach	SYNLETT			English	Article						alkenyl ester; asymmetric catalysis; imine; Mannich-type reaction; tin	ISATIN-DERIVED KETIMINES; N-BOC KETIMINES; VICINAL TETRASUBSTITUTED STEREOCENTERS; ASYMMETRIC-SYNTHESIS; CONSTRUCTION; IMINES; 3-AMINOOXINDOLES; DERIVATIVES; OXINDOLES; AG-041R	A catalytic enantioselective Mannich-type reaction of a cyclohexanone-derived alkenyl trichloroacetate with isatin imines was achieved using an (S)-BINOL-derived chiral tin dibromide possessing a 4-tert-butylphenyl group at 3- and 3-positions as the chiral precatalyst in the presence of sodium methoxide, sodium iodide, and methanol. Optically active 3-alkylated 3-amino-2-oxindoles having up to 90% enantiomeric excess were diastereoselectively obtained in high yields under the influence of the in situ generated chiral tin iodide methoxide.	[Yanagisawa, Akira; Kushihara, Naoyuki; Sugita, Takuya; Horiguchi, Moe; Ida, Kazuki; Yoshida, Kazuhiro] Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, Chiba 2638522, Japan	Yanagisawa, A (reprint author), Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, Chiba 2638522, Japan.	ayanagi@faculty.chiba-u.jp			Iodine Research Project in Chiba University; COE Program in Chiba University	We gratefully acknowledge the financial support from the Iodine Research Project in Chiba University headed by Professor Hideo Togo and the COE Program in Chiba University headed by Professor Takayoshi Arai.	Hara N, 2012, CHEM-EUR J, V18, P9276, DOI 10.1002/chem.201200367; Guo QX, 2012, J ORG CHEM, V77, P3589, DOI 10.1021/jo202585w; LIBMAN J, 1969, TETRAHEDRON, V25, P1679, DOI 10.1016/S0040-4020(01)82741-1; Arai T, 2014, ORG LETT, V16, P2768, DOI 10.1021/ol501085y; Tang ZK, 2014, ORG BIOMOL CHEM, V12, P6085, DOI 10.1039/c4ob01039f; Kitamura H, 2001, EUR J PHARMACOL, V418, P225, DOI 10.1016/S0014-2999(01)00957-8; Li TZ, 2014, J ORG CHEM, V79, P4332, DOI 10.1021/jo500145w; Wang Y, 2014, CHEM-EUR J, V20, P15047, DOI 10.1002/chem.201403868; Yan WJ, 2012, ORG LETT, V14, P2512, DOI 10.1021/ol3007953; Yanagisawa A, 2009, CHEM-EUR J, V15, P11450, DOI 10.1002/chem.200901822; Liu T, 2015, J ORG CHEM, V80, P4950, DOI 10.1021/acs.joc.5b00302; Singh GS, 2012, CHEM REV, V112, P6104, DOI 10.1021/cr300135y; Zhu Y, 2015, TETRAHEDRON, V71, P4090, DOI 10.1016/j.tet.2015.04.114; Izumiseki A, 2009, ORG LETT, V11, P5310, DOI 10.1021/ol9022613; Chauhan P, 2013, TETRAHEDRON-ASYMMETR, V24, P343, DOI 10.1016/j.tetasy.2013.03.002; Zhao JN, 2015, ANGEW CHEM INT EDIT, V54, P241, DOI 10.1002/anie.201408730; Yanagisawa A, 2013, CHEM REC, V13, P117, DOI 10.1002/tcr.201200019; Bai M, 2015, TETRAHEDRON, V71, P949, DOI 10.1016/j.tet.2014.12.074; Wang XB, 2014, EUR J ORG CHEM, P739, DOI 10.1002/ejoc.201301350; Yanagisawa A, 2012, SYNLETT, P1783, DOI 10.1055/s-0032-1316551; Ziarani GM, 2015, TETRAHEDRON-ASYMMETR, V26, P517, DOI 10.1016/j.tetasy.2015.04.011	21	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	NOV	2015	26	18					2541	2546		10.1055/s-0035-1560636		6	Chemistry, Organic	Chemistry	CV6SE	WOS:000364399800012		
J	Okada, T; Matsumuro, H; Kitagawa, S; Iwai, T; Yamazaki, K; Kinoshita, Y; Kimura, Y; Kirihara, M				Okada, Tomohide; Matsumuro, Hiroaki; Kitagawa, Saori; Iwai, Toshiaki; Yamazaki, Kento; Kinoshita, Yukari; Kimura, Yoshikazu; Kirihara, Masayuki			Selective Synthesis of Sulfoxides through Oxidation of Sulfides with Sodium Hypochlorite Pentahydrate Crystals	SYNLETT			English	Article						sodium hypochlorite; sulfoxide; oxidation; catalyst-free	30-PERCENT HYDROGEN-PEROXIDE; EFFICIENT AEROBIC OXIDATION; SOLVENT-FREE CONDITIONS; CATALYZED OXIDATION; CHEMOSELECTIVE OXIDATION; HIGHLY EFFICIENT; NAOCL-CENTER-DOT-5H(2)O CRYSTALS; THIOETHER-OXIDATION; MOLECULAR-OXYGEN; H2O2	Oxidation of sulfides with sodium hypochlorite pentahydrate crystals (1.1 equiv) in an aqueous acetonitrile solution selectively produces the corresponding sulfoxides in high yields. This procedure is catalyst-free and environmentally benign.	[Okada, Tomohide] Nippon Light Met Co Ltd, R&D Dept Chem, Shimizu Ku, Shizuoka 4213203, Japan; [Matsumuro, Hiroaki; Kitagawa, Saori; Iwai, Toshiaki; Yamazaki, Kento; Kinoshita, Yukari; Kirihara, Masayuki] Shizuoka Inst Sci & Technol, Dept Mat & Life Sci, Fukuroi, Shizuoka 4378555, Japan; [Kimura, Yoshikazu] Iharanikkei Chem Ind Co Ltd, Dept Res & Dev, Shimizu Ku, Shizuoka 4213203, Japan	Kirihara, M (reprint author), Shizuoka Inst Sci & Technol, Dept Mat & Life Sci, 2200-2 Toyosawa, Fukuroi, Shizuoka 4378555, Japan.	kirihara@ms.sist.ac.jp					Taketoshi A, 2013, B CHEM SOC JPN, V86, P1412, DOI 10.1246/bcsj.20130075; Tanaka H, 2010, J AM CHEM SOC, V132, P12034, DOI 10.1021/ja104184r; Boring E, 2001, J AM CHEM SOC, V123, P1625, DOI 10.1021/ja0033133; Bayat A, 2014, CATAL COMMUN, V52, P16, DOI 10.1016/j.catcom.2014.03.026; Fukuda N, 2010, J ORG CHEM, V75, P4629, DOI 10.1021/jo100719w; Pourjavadi A, 2015, NEW J CHEM, V39, P1348, DOI 10.1039/c4nj01931h; Yang HJ, 2011, CHEM-EUR J, V17, P5652, DOI 10.1002/chem.201003711; Rostami A, 2015, J MOL CATAL A-CHEM, V398, P170, DOI 10.1016/j.molcata.2014.12.010; Doherty S, 2015, GREEN CHEM, V17, P1559, DOI 10.1039/c4gc01770f; Li XD, 2015, CHINESE CHEM LETT, V26, P539, DOI 10.1016/j.cclet.2014.12.010; Secci F, 2014, NEW J CHEM, V38, P3622, DOI 10.1039/c4nj00530a; FURUKAWA N, 1983, PHOSPHORUS SULFUR, V16, P167, DOI 10.1080/03086648308077765; Chinnusamy T, 2010, CHEMSUSCHEM, V3, P1040, DOI 10.1002/cssc.201000105; Frenzel R, 2015, J MOL CATAL A-CHEM, V403, P27, DOI 10.1016/j.molcata.2015.02.021; Sato K, 2001, TETRAHEDRON, V57, P2469, DOI 10.1016/S0040-4020(01)00068-0; Murahashi S, 2014, CHEM COMMUN, V50, P10295, DOI 10.1039/c4cc05216a; Kirihara M, 2009, TETRAHEDRON LETT, V50, P1180, DOI 10.1016/j.tetlet.2008.12.064; Caupene C, 2005, J ORG CHEM, V70, P2812, DOI 10.1021/jo0478003; Okada T, 2014, SYNLETT, V25, P596, DOI 10.1055/s-0033-1340483; Maayan G, 2006, J AM CHEM SOC, V128, P4968, DOI 10.1021/ja060696h; Gomez MV, 2007, GREEN CHEM, V9, P331, DOI 10.1039/b614847f; Varma RS, 1999, ORG LETT, V1, P189, DOI 10.1021/ol990522n; Zhang H, 2008, SYNTHETIC COMMUN, V38, P4445, DOI 10.1080/00397910802369562; OVERBERGER CG, 1953, J AM CHEM SOC, V75, P4250, DOI 10.1021/ja01113a030; Wu XF, 2012, TETRAHEDRON LETT, V53, P4328, DOI 10.1016/j.tetlet.2012.06.003; DellAnna MM, 1996, J MOL CATAL A-CHEM, V108, P57, DOI 10.1016/1381-1169(95)00302-9; Kaczorowska K, 2005, TETRAHEDRON, V61, P8315, DOI 10.1016/j.tet.2005.05.044; Capozzi MAM, 2000, J ORG CHEM, V65, P2843, DOI 10.1021/jo991912q; [Anonymous], 2012, ALDRICH CHEM HDB FIN; Imada Y, 2003, J AM CHEM SOC, V125, P2868, DOI 10.1021/ja028276p; Motoshima K, 2007, B CHEM SOC JPN, V80, P2229, DOI 10.1246/bcsj.80.2229; LEONARD NJ, 1962, J ORG CHEM, V27, P282, DOI 10.1021/jo01048a504; Rostami A, 2014, CATAL COMMUN, V43, P16, DOI 10.1016/j.catcom.2013.08.025; NAGATA T, 1995, B CHEM SOC JPN, V68, P3241, DOI 10.1246/bcsj.68.3241; KLEMM LH, 1984, J HETEROCYCLIC CHEM, V21, P1293; Sturala J, 2015, J ORG CHEM, V80, P2676, DOI 10.1021/jo502865f; Martin SE, 2001, TETRAHEDRON LETT, V42, P7147, DOI 10.1016/S0040-4039(01)01490-3; Imada Y, 2015, CHEMCATCHEM, V7, P99, DOI 10.1002/cctc.201402619; Tanaka K, 2013, ASIAN J ORG CHEM, V2, P1055, DOI 10.1002/ajoc.201300140; Hussain S, 2012, TETRAHEDRON LETT, V53, P6512, DOI 10.1016/j.tetlet.2012.09.067; GIANNANDREA R, 1994, J MOL CATAL, V94, P27, DOI 10.1016/0304-5102(94)87027-6; Jeon HB, 2014, TETRAHEDRON LETT, V55, P3905, DOI 10.1016/j.tetlet.2014.05.080; Jafari H, 2012, SYNTHETIC COMMUN, V42, P3150, DOI 10.1080/00397911.2011.577924; CARRENO MC, 1995, CHEM REV, V95, P1717, DOI 10.1021/cr00038a002; Menova P, 2013, ADV SYNTH CATAL, V355, P3451, DOI 10.1002/adsc.201300617; Okun NM, 2006, J MOL CATAL A-CHEM, V246, P11, DOI 10.1016/j.molcata.2005.10.006; Xu HJ, 2010, TETRAHEDRON, V66, P8823, DOI 10.1016/j.tet.2010.09.076; Imada Y, 2013, TETRAHEDRON LETT, V54, P621, DOI 10.1016/j.tetlet.2012.11.133; Gogoi P, 2014, TETRAHEDRON LETT, V55, P1028, DOI 10.1016/j.tetlet.2013.12.073; Lang XJ, 2015, CHEM SCI, V6, P5000, DOI 10.1039/c5sc01813g; Nikoorazm M, 2015, APPL ORGANOMET CHEM, V29, P328, DOI 10.1002/aoc.3295; BORDWELL FG, 1957, J AM CHEM SOC, V79, P717, DOI 10.1021/ja01560a059; Prakash GKS, 2014, GREEN CHEM, V16, P3616, DOI 10.1039/c4gc00586d; Imada Y, 2013, SYNLETT, V24, P1679, DOI 10.1055/s-0033-1339276; Okada T, 2015, CHEM LETT, V44, P185, DOI 10.1246/cl.140899; Zhang H, 2012, SYNTHETIC COMMUN, V42, P811, DOI 10.1080/00397911.2010.531439; KICE JL, 1991, J ORG CHEM, V56, P1424, DOI 10.1021/jo00004a017; Lang XJ, 2015, CHEM SCI, V6, P1075, DOI 10.1039/c4sc02891k; Kirihara M, 2009, TETRAHEDRON, V65, P10477, DOI 10.1016/j.tet.2009.10.007; Aldea R, 1995, J ORG CHEM, V60, P8365, DOI 10.1021/jo00131a009; Imada Y, 2014, TETRAHEDRON, V70, P495, DOI 10.1016/j.tet.2013.11.024; Asawa T., 2008, Japanese Patent, Patent No. 4211130; Caccia-Bava A. M., 1950, ANN CHIM, V40, P21; Clifford G., 1982, J ORG CHEM, V47, P3773; Drabowicz J., 1988, CHEM SULPHONE SULPHO; Drabowicz J., 2014, COMPREHENSIVE ORGANI, V6, P131; EDWARDS D, 1954, J CHEM SOC, P3272, DOI 10.1039/jr9540003272; Frenanez I., 2003, CHEM REV, V103, P3651; Ghorbani-Choghamarani A, 2015, CATAL COMMUN, V60, P70, DOI 10.1016/j.catcom.2014.11.007; Hanson P., 2008, ORG BIOMOL CHEM, P745; IMAGAWA K, 1995, CHEM LETT, P335, DOI 10.1246/cl.1995.335; KAGEYAMA T, 1983, SYNTHESIS-STUTTGART, P815; Kamata K, 2009, CHEM COMMUN, P3958, DOI 10.1039/b907952a; Kirihara M, 2010, SYNLETT, P1557, DOI 10.1055/s-0029-1219947; Kirihara M., 2015, YUKI GOSEI KAGAKU KY, V73, P372; Kon Y, 2014, TETRAHEDRON, V70, P7584, DOI 10.1016/j.tet.2014.07.091; Linden AA, 2003, J ORG CHEM, V68, P5890, DOI 10.1021/jo03427z; Nelsen F. S., 2006, J ORG CHEM, V71, P1493; Noguchi T, 2008, CHEM COMMUN, P3040, DOI 10.1039/b802502a; RABAI J, 1990, SYNTHESIS-STUTTGART, P847; Rostami A, 2013, PHOSPHORUS SULFUR, V188, P833, DOI 10.1080/10426507.2012.710681; SIEDLECKA R, 1994, SYNTHESIS-STUTTGART, P401; Yuan Y, 2011, SYNLETT, P559, DOI 10.1055/s-0030-1259516	83	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	NOV	2015	26	18					2547	2552		10.1055/s-0035-1560482		6	Chemistry, Organic	Chemistry	CV6SE	WOS:000364399800013		
J	Tago, N; Masaki, Y; Nagasawa, H; Kanamori, T; Ohkubo, A; Seio, K; Sekine, M				Tago, Nobuhiro; Masaki, Yoshiaki; Nagasawa, Hiroshi; Kanamori, Takashi; Ohkubo, Akihiro; Seio, Kohji; Sekine, Mitsuo			A New Microfluidic Phase-Transfer Reaction Using HPLC Guard Columns as the Reactor for the N-3-Protection of Uridine Derivatives	SYNLETT			English	Article						microfluidic system; phase-transfer reaction; nucleoside chemistry; flow chemistry; HPLC guard column	LIQUID-LIQUID INTERFACE; NUCLEIC-ACID APTAMERS; TRANSFER CATALYSIS; ANTISENSE OLIGONUCLEOTIDES; CONTINUOUS-FLOW; GENERAL-METHOD; SLUG FLOW; MICROCHANNEL; INTENSIFICATION; HYBRIDIZATION	N-3-Acylation of uridine derivatives with acyl chlorides, mediated by a phase-transfer reaction, was studied using a new microfluidic device containing an HPLC guard as an effective reactor. The acylated products were obtained in more than 80% yields in very short reaction times of several seconds.	[Tago, Nobuhiro; Masaki, Yoshiaki; Kanamori, Takashi; Ohkubo, Akihiro; Seio, Kohji; Sekine, Mitsuo] Tokyo Inst Technol, Dept Life Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Nagasawa, Hiroshi] Kankyo Resilience Co Ltd, Hodogaya Ku, Yokohama, Kanagawa 2400067, Japan	Seio, K (reprint author), Tokyo Inst Technol, Dept Life Sci, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	kseio@bio.titech.ac.jp			Japan Society for the Promotion of Science [21106001, 15H01062, 26810086]	This work was supported by the Japan Society for the Promotion of Science grant No. 21106001 and grant No. 15H01062 and grant No. 26810086.	SEELA F, 1979, ANGEW CHEM INT EDIT, V18, P536, DOI 10.1002/anie.197905361; Zhao YC, 2006, AICHE J, V52, P4052, DOI 10.1002/aic.11029; Kobayashi J, 2004, SCIENCE, V304, P1305, DOI 10.1126/science.1096956; BEIJER B, 1994, NUCLEOS NUCLEOT, V13, P1905, DOI 10.1080/15257779408010672; Deleavey GF, 2012, CHEM BIOL, V19, P937, DOI 10.1016/j.chembiol.2012.07.011; ZHOU XX, 1986, TETRAHEDRON, V42, P5149, DOI 10.1016/S0040-4020(01)88067-4; Hammett LP, 1937, J AM CHEM SOC, V59, P96, DOI 10.1021/ja01280a022; Sharma VK, 2014, MEDCHEMCOMM, V5, P1454, DOI 10.1039/c4md00184b; Guillot P, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.066301; Geary RS, 2001, J PHARMACOL EXP THER, V296, P890; Noel T, 2011, ORG LETT, V13, P5180, DOI 10.1021/ol202052q; Navani NK, 2006, CURR OPIN CHEM BIOL, V10, P272, DOI 10.1016/j.cbpa.2006.04.003; Aota A, 2007, ANAL CHEM, V79, P3919, DOI 10.1021/ac070031d; INOUE H, 1987, NUCLEIC ACIDS RES, V15, P6131, DOI 10.1093/nar/15.15.6131; Yamada T, 2011, J ORG CHEM, V76, P3042, DOI 10.1021/jo101963z; Taha T, 2004, CHEM ENG SCI, V59, P1181, DOI 10.1016/j.ces.2003.10.025; Dong HF, 2013, CHEM REV, V113, P6207, DOI 10.1021/cr300362f; Yadav GD, 2003, J MOL CATAL A-CHEM, V192, P41, DOI 10.1016/S1381-1169(02)00419-3; Reichart B, 2013, SYNLETT, V24, P2393, DOI 10.1055/s-0033-1339839; Jovanovic J, 2010, IND ENG CHEM RES, V49, P2681, DOI 10.1021/ie9017918; Ma HT, 2015, CHEM SOC REV, V44, P1240, DOI 10.1039/c4cs00357h; Suga S, 2010, CHEM LETT, V39, P404, DOI 10.1246/cl.2010.404; Opalka SM, 2013, ORG LETT, V15, P996, DOI 10.1021/ol303442m; Saneyoshi H, 2005, J ORG CHEM, V70, P10453, DOI 10.1021/jo05174.1r; SEKINE M, 1989, J ORG CHEM, V54, P2321, DOI 10.1021/jo00271a015; Li JB, 2014, CHEM SOC REV, V43, P506, DOI 10.1039/c3cs60312a; Yan L, 2014, MOL BIOSYST, V10, P970, DOI 10.1039/c3mb70304e; Griffey RH, 1996, J MED CHEM, V39, P5100, DOI 10.1021/jm950937o; Prakash TP, 2003, ORG LETT, V5, P403, DOI 10.1021/ol027131k; Burns JR, 2001, LAB CHIP, V1, P10, DOI 10.1039/b102818a; Oeda Y, 2009, ORG LETT, V11, P5582, DOI 10.1021/ol902142w; Fukuyama T, 2008, SYNLETT, P151, DOI 10.1055/s-2007-1000884; Hisamoto H, 2001, CHEM COMMUN, P2662, DOI 10.1039/b106494k; Markiewicz W. T., 1979, J CHEM RES MINIPRINT, P173; Seela F., 1988, J CHEM SOC P1, V1, P697; Ueno M, 2003, CHEM COMMUN, P936, DOI 10.1039/b301638b; Yamada YMA, 2009, CHEM COMMUN, P5594, DOI 10.1039/b912696a	37	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	NOV	2015	26	18					2578	2582		10.1055/s-0035-1560264		5	Chemistry, Organic	Chemistry	CV6SE	WOS:000364399800020		
J	Amata, A; Chonan, T; Omae, K; Nodera, H; Terada, J; Tatsumi, K				Amata, Atsuko; Chonan, Tatsuya; Omae, Kazuyuki; Nodera, Hiroshi; Terada, Jiro; Tatsumi, Koichiro			High levels of indium exposure relate to progressive emphysematous changes: a 9-year longitudinal surveillance of indium workers	THORAX			English	Article							PULMONARY ALVEOLAR PROTEINOSIS; TIN OXIDE; FACILITY	Background During the last decade it has been clarified that the inhalation of indium compounds can evoke alveolar proteinosis, cholesterol granuloma, pulmonary fibrosis and emphysema. In this study, we aimed to elucidate the characteristics and time course of pulmonary disorders among indium workers using comprehensive pulmonary examinations at an indium-processing factory. Methods Data for 84 male workers who underwent the examinations for nine consecutive years from 2002 to 2010 were analysed regarding their symptoms, serum indium concentration (sIn), serum markers of interstitial pneumonia, pulmonary function test parameters and high-resolution CT (HRCT) findings of the lungs. Results In association with improvements in the work environment and work practice, the sIn levels decreased with significant reductions in the KL-6 and surfactant protein D (SP-D) levels. Regarding the HRCT findings, the interstitial lesions regressed partially, whereas emphysematous lesions increased progressively in the workers with high sIn values. FEV1/FVC decreased with the years and the rate of decrease was significantly greater in those with high sIn. The biological half-life of sIn was estimated to be 8.09 years. Conclusions The present findings suggest that the sIn, SP-D, KL-6 levels and radiological interstitial changes can be reduced in indium workers by alleviating exposure to indium, whereas emphysematous lesions can progress among those with a history of heavy exposure.	[Amata, Atsuko; Chonan, Tatsuya; Nodera, Hiroshi] Nikko Mem Hosp, Dept Med, Hitachi, Ibaraki, Japan; [Amata, Atsuko; Terada, Jiro; Tatsumi, Koichiro] Chiba Univ, Grad Sch Med, Dept Respirol, Chiba, Chiba 2608670, Japan; [Omae, Kazuyuki] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan	Terada, J (reprint author), Chiba Univ, Grad Sch Med, Dept Respirol, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608670, Japan.	jirotera@chiba-u.jp					Homma T, 2003, J OCCUP HEALTH, V45, P137, DOI 10.1539/joh.45.137; Cummings KJ, 2013, AM J IND MED, V56, P300, DOI 10.1002/ajim.22125; Omae K, 2011, INT ARCH OCC ENV HEA, V84, P471, DOI 10.1007/s00420-010-0575-6; Cummings KJ, 2010, AM J RESP CRIT CARE, V181, P458, DOI 10.1164/rccm.200907-1022CR; Homma S, 2005, EUR RESPIR J, V25, P200, DOI 10.1183/09031936.04.10012704; Chonan T, 2007, EUR RESPIR J, V29, P317, DOI 10.1183/09030936.00020306; Nakano M, 2009, J OCCUP HEALTH, V51, P513; Xiao YL, 2010, CHINESE MED J-PEKING, V123, P1347, DOI 10.3760/cmaj.issn.0366-6999.2010.10.023; HONDA Y, 1995, AM J RESP CRIT CARE, V152, P1860; Cummings KJ, 2012, CHEST, V141, P1512, DOI 10.1378/chest.11-1880; Hamaguchi T, 2008, OCCUP ENVIRON MED, V65, P51, DOI 10.1136/oem.2006.029124; KOHNO N, 1989, CHEST, V96, P68, DOI 10.1378/chest.96.1.68; Chonan T, 2010, JAPANESE J CHEST DIS, V69, P851; Nakano M, 2014, CHEST, V146, P1166, DOI 10.1378/chest.13-2484; Nakano M, 2007, OCCUP HLTH J, V30, P25; Taguchi O, 2006, J JPN RESP SOC, V44, P532; Takeuchi K, 2008, RESPIRATION, V27, P599; Tanaka R, 2013, ANN JAPANESE RESP S, V2, P273; The Japanese Respiratory Society, 2009, GUID DIAGN TREATM CO; The Labor Hygiene Section in the Safety Hygiene Department of Ministry of Labour, 1980, HDB EX PNEUM, P40	20	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0040-6376	1468-3296		THORAX	Thorax	NOV	2015	70	11					1040	1046		10.1136/thoraxjnl-2014-206380		7	Respiratory System	Respiratory System	CW0WP	WOS:000364711000005		
J	Segawa, K; Nagata, S				Segawa, Katsumori; Nagata, Shigekazu			An Apoptotic 'Eat Me' Signal: Phosphatidylserine Exposure	TRENDS IN CELL BIOLOGY			English	Review							P-TYPE ATPASES; RESIDENT PERITONEAL-MACROPHAGES; PROTEIN FAMILY-MEMBERS; PROGRAMMED CELL-DEATH; ENVELOPED-VIRUS ENTRY; ARREST-SPECIFIC GENE; RED-BLOOD-CELLS; PHOSPHOLIPID SCRAMBLASE; PLASMA-MEMBRANE; AMINOPHOSPHOLIPID TRANSLOCASE	Apoptosis and the clearance of apoptotic cells are essential processes in animal development and homeostasis. For apoptotic cells to be cleared, they must display an 'eat me' signal, most likely phosphatidylserine (PtdSer) exposure, which prompts phagocytes to engulf the cells. PtdSer, which is recognized by several different systems, is normally confined to the cytoplasmic leaflet of the plasma membrane by a Ilippase'; apoptosis activates a 'scramblase' that quickly exposes PtdSer on the cell surface. The molecules that flip and scramble phospholipids at the plasma membrane have recently been identified. Here we discuss recent findings regarding the molecular mechanisms of apoptotic PtdSer exposure and the clearance of apoptotic cells.	[Segawa, Katsumori; Nagata, Shigekazu] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Biochem & Immunol, Suita, Osaka 5650871, Japan	Nagata, S (reprint author), Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Biochem & Immunol, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	snagata@ifrec.osaka-u.ac.jp			Ministry of Education, Science, Sports, and Culture in Japan	We thank all of the members of our laboratory for discussions and M. Fujii for secretarial assistance. Experiments in our laboratory were supported in part by grants-in-aid from the Ministry of Education, Science, Sports, and Culture in Japan.	Abe K, 2012, P NATL ACAD SCI USA, V109, P18401, DOI 10.1073/pnas.1212294109; Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; Heemskerk JWM, 2002, THROMB HAEMOSTASIS, V88, P186; Nilsson A, 2009, BIOCHEM BIOPH RES CO, V387, P58, DOI 10.1016/j.bbrc.2009.06.121; Sharom FJ, 2011, IUBMB LIFE, V63, P736, DOI 10.1002/iub.515; Wood W, 2000, DEVELOPMENT, V127, P5245; Panatala R, 2015, J CELL SCI, V128, P2021, DOI 10.1242/jcs.102715; ZACHOWSKI A, 1989, NATURE, V340, P75, DOI 10.1038/340075a0; Simhadri VR, 2012, BLOOD, V119, P2799, DOI 10.1182/blood-2011-08-372425; Baldridge RD, 2013, P NATL ACAD SCI USA, V110, pE358, DOI 10.1073/pnas.1216948110; Wong K, 2010, P NATL ACAD SCI USA, V107, P8712, DOI 10.1073/pnas.0910929107; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240; Zhou QS, 2002, BLOOD, V99, P4030, DOI 10.1182/blood-2001-12-0271; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Toda S, 2012, MOL CELL BIOL, V32, P118, DOI 10.1128/MCB.05993-11; Venegas V, 2007, MOL BIOL CELL, V18, P3180, DOI 10.1091/mbc.E07-02-0138; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Martin SJ, 1996, J BIOL CHEM, V271, P28753; Cui P, 2004, EXP CELL RES, V293, P154, DOI 10.1016/j.yexcr.2003.09.023; Ishimoto Y, 2000, J BIOCHEM-TOKYO, V127, P411; He M, 2011, EMBO REP, V12, P358, DOI 10.1038/embor.2011.28; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; DeKruyff RH, 2010, J IMMUNOL, V184, P1918, DOI 10.4049/jimmunol.0903059; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; Tada K, 2003, J IMMUNOL, V171, P5718; Enari M, 1998, NATURE, V391, P43; Krahling S, 1999, CELL DEATH DIFFER, V6, P183, DOI 10.1038/sj.cdd.4400473; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Elward K, 2005, J BIOL CHEM, V280, P36342, DOI 10.1074/jbc.M506579200; Ichimura T, 2008, J CLIN INVEST, V118, P1657, DOI 10.1172/JCI34487; Toyoshima C, 2013, CURR OPIN STRUC BIOL, V23, P507, DOI 10.1016/j.sbi.2013.06.005; FADOK VA, 1992, J IMMUNOL, V148, P2207; Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van den Eijnde SM, 1998, APOPTOSIS, V3, P9, DOI 10.1023/A:1009650917818; Park D, 2009, CURR BIOL, V19, P346, DOI 10.1016/j.cub.2009.01.042; Schoenwaelder SM, 2009, BLOOD, V114, P663, DOI 10.1182/blood-2009-01-200345; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Wolf A, 2007, EMBO REP, V8, P465, DOI 10.1038/sj.embor.7400956; Nakano T, 1997, J BIOL CHEM, V272, P29411, DOI 10.1074/jbc.272.47.29411; Basse F, 1996, J BIOL CHEM, V271, P17205; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Morizono K, 2014, J VIROL, V88, P4275, DOI 10.1128/JVI.03287-13; Flannagan RS, 2014, MOL BIOL CELL, V25, P1511, DOI 10.1091/mbc.E13-04-0212; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Suzuki J, 2014, J BIOL CHEM, V289, P30257, DOI 10.1074/jbc.M114.583419; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Miyasaka K, 2004, EUR J IMMUNOL, V34, P1414, DOI 10.1002/eji.2004249301; Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Park SY, 2009, J CELL SCI, V122, P3365, DOI 10.1242/jcs.049569; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Anderson HA, 2003, NAT IMMUNOL, V4, P87, DOI 10.1038/ni871; Ehlen HWA, 2013, J BONE MINER RES, V28, P246, DOI 10.1002/jbmr.1751; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Brown S, 2002, NATURE, V418, P200, DOI 10.1038/nature00811; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Segawa K, 2011, P NATL ACAD SCI USA, V108, P19246, DOI 10.1073/pnas.1114799108; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Acharya U, 2006, J CELL BIOL, V173, P69, DOI 10.1083/jcb.200506159; Kim S, 2012, MOL CELL BIOL, V32, P2698, DOI 10.1128/MCB.06743-11; deCathelineau AM, 2003, ESSAYS BIOCHEM, V39, P105; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Nakayama M, 2009, BLOOD, V113, P3821, DOI 10.1182/blood-2008-10-185884; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Wiedmer T, 2000, BBA-BIOMEMBRANES, V1467, P244, DOI 10.1016/S0005-2736(00)00236-4; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Moller-Tank S, 2014, VIROLOGY, V468, P565, DOI 10.1016/j.virol.2014.09.009; Saller F, 2009, BLOOD, V114, P2307, DOI 10.1182/blood-2009-03-209031; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Sahu SK, 2007, ARCH BIOCHEM BIOPHYS, V462, P103, DOI 10.1016/j.abb.2007.04.002; Moller-Tank S, 2013, J VIROL, V87, P8327, DOI 10.1128/JVI.01025-13; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Asano K, 2004, J EXP MED, V200, P459, DOI 10.1084/jem.20040342; Bratton DL, 1997, J BIOL CHEM, V272, P26159, DOI 10.1074/jbc.272.42.26159; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Choi SC, 2011, J IMMUNOL, V187, P3483, DOI 10.4049/jimmunol.1101549; Böse Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; Chen Y, 2013, NAT COMMUN, V4, P1; Dransfield I, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.18; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223; Hue Z., 2002, MOL BIOL CELL, V13, P3162; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; Murakami Y, 2014, CELL DEATH DIFFER, V21, P1746, DOI 10.1038/cdd.2014.86; Nishi C, 2014, MOL CELL BIOL, V34, P1512, DOI 10.1128/MCB.01394-13; Rodriguez-Manzanet R, 2008, J IMMUNOL, V180, P4706; Rothlin C.V., 2014, ANNU REV IMMUNOL, V33, P355; Segawa K, 2014, CELL CYCLE, V13, P2990, DOI 10.4161/15384101.2014.962865; TANAKA Y, 1983, J BIOL CHEM, V258, P1335; Yang H., 2014, NAT COMMUN, V6, P1	112	0	0	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0962-8924			TRENDS CELL BIOL	Trends Cell Biol.	NOV	2015	25	11					639	650		10.1016/j.tcb.2015.08.003		12	Cell Biology	Cell Biology	CV9LI	WOS:000364608300004		
J	Iwakawa, HO; Tomari, Y				Iwakawa, Hiro-oki; Tomari, Yukihide			The Functions of MicroRNAs: mRNA Decay and Translational Repression	TRENDS IN CELL BIOLOGY			English	Review							MIRNA-MEDIATED REPRESSION; STEM-CELL PROLIFERATION; GW182 PROTEINS; IN-VITRO; CAENORHABDITIS-ELEGANS; DEADENYLASE COMPLEXES; CCR4-NOT DEADENYLASE; MAMMALIAN MICRORNAS; ARGONAUTE PROTEINS; TARGET RECOGNITION	MicroRNAs (miRNAs) are a class of endogenous small noncoding RNAs, which regulate complementary mRNAs by inducing translational repression and mRNA decay. Although this dual repression system seems to operate in both animals and plants, genetic and biochemical studies suggest that the mechanism underlying the miRNA-mediated silencing is different in the two kingdoms. Here, we review the recent progress in our understanding of how miRNAs mediate translational repression and mRNA decay, and discuss the contributions of the two silencing modes to the overall silencing effect in both kingdoms.	[Iwakawa, Hiro-oki; Tomari, Yukihide] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Iwakawa, Hiro-oki; Tomari, Yukihide] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Bunkyo Ku, Tokyo 1130032, Japan	Tomari, Y (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	tomari@iam.u-tokyo.ac.jp					Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Ye RQ, 2012, MOL CELL, V46, P859, DOI 10.1016/j.molcel.2012.04.013; Kawamata T, 2010, TRENDS BIOCHEM SCI, V35, P368, DOI 10.1016/j.tibs.2010.03.009; Ricci EP, 2013, NUCLEIC ACIDS RES, V41, P586, DOI 10.1093/nar/gks1076; Nishimura T, 2015, CELL REP, V11, P1425, DOI 10.1016/j.celrep.2015.04.065; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Jinek M, 2010, NAT STRUCT MOL BIOL, V17, P238, DOI 10.1038/nsmb.1768; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Rogers K, 2013, PLANT CELL, V25, P2383, DOI 10.1105/tpc.113.113159; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; Lanet E, 2009, PLANT CELL, V21, P1762, DOI 10.1105/tpc.108.063412; Carbonell A, 2012, PLANT CELL, V24, P3613, DOI 10.1105/tpc.112.099945; Iwakawa H, 2013, MOL CELL, V52, P591, DOI 10.1016/j.molcel.2013.10.033; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Brousse C, 2014, NUCLEIC ACIDS RES, V42, P5270, DOI 10.1093/nar/gku157; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.019; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Su H, 2011, MOL CELL, V43, P97, DOI 10.1016/j.molcel.2011.06.013; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Chen CYA, 2009, NAT STRUCT MOL BIOL, V16, P1160, DOI 10.1038/nsmb.1709; Subtelny AO, 2014, NATURE, V508, P66, DOI 10.1038/nature13007; Nishihara T, 2013, NUCLEIC ACIDS RES, V41, P8692, DOI 10.1093/nar/gkt619; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Takimoto K, 2009, RNA, V15, P1078, DOI 10.1261/rna.1363109; Li SQ, 2008, J CELL SCI, V121, P4134, DOI 10.1242/jcs.036905; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Banerjee S, 2009, NEURON, V64, P871, DOI 10.1016/j.neuron.2009.11.023; Braun JE, 2012, NAT STRUCT MOL BIOL, V19, P1324, DOI 10.1038/nsmb.2413; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Xu J, 2006, PLANT CELL, V18, P3386, DOI 10.1105/tpc.106.047605; Zipprich JT, 2009, RNA, V15, P781, DOI 10.1261/rna.1448009; Iki T, 2012, EMBO J, V31, P267, DOI 10.1038/emboj.2011.395; Ambros V, 2011, CURR OPIN GENET DEV, V21, P511, DOI 10.1016/j.gde.2011.04.003; Kozlov G, 2010, J BIOL CHEM, V285, P13599, DOI 10.1074/jbc.M109.089540; Eulalio A, 2009, RNA, V15, P1067, DOI 10.1261/rna.1605509; Li SB, 2013, CELL, V153, P562, DOI 10.1016/j.cell.2013.04.005; Piao XH, 2010, MOL CELL BIOL, V30, P1486, DOI 10.1128/MCB.01481-09; Presnyak V, 2013, BBA-GENE REGUL MECH, V1829, P817, DOI 10.1016/j.bbagrm.2013.03.006; Mathys H, 2014, MOL CELL, V54, P751, DOI 10.1016/j.molcel.2014.03.036; Bethune J, 2012, EMBO REP, V13, P716, DOI 10.1038/embor.2012.82; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Cooke A, 2010, J BIOL CHEM, V285, P28506, DOI 10.1074/jbc.M110.150763; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Iki T, 2010, MOL CELL, V39, P282, DOI 10.1016/j.molcel.2010.05.014; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Bawankar P, 2013, RNA BIOL, V10, P228, DOI 10.4161/rna.23018; Moretti F, 2012, NAT STRUCT MOL BIOL, V19, P603, DOI 10.1038/nsmb.2309; Rehwinkel J, 2006, MOL CELL BIOL, V26, P2965, DOI 10.1128/MCB.26.8.2965-2975.2006; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bouquin T, 2003, J CELL SCI, V116, P791, DOI 10.1242/jcs.00274; Shih JD, 2011, NUCLEIC ACIDS RES, V39, P7740, DOI 10.1093/nar/gkr456; Chekulaeva M, 2009, RNA, V15, P794, DOI 10.1261/rna.1364909; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Kuzuoglu-Ozturk D, 2012, NUCLEIC ACIDS RES, V40, P5651, DOI 10.1093/nar/gks218; Jager E, 2010, RNA BIOL, V7, P381; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Fukaya T, 2012, MOL CELL, V48, P825, DOI 10.1016/j.molcel.2012.09.024; Chang H, 2014, MOL CELL, V53, P1044, DOI 10.1016/j.molcel.2014.02.007; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Christie M, 2013, MOL CELL, V51, P360, DOI 10.1016/j.molcel.2013.07.011; Chekulaeva M, 2010, NUCLEIC ACIDS RES, V38, P6673, DOI 10.1093/nar/gkq501; Wolf J, 2014, EMBO J, V33, P1514, DOI 10.15252/embj.201488373; Schafer IB, 2014, NAT STRUCT MOL BIOL, V21, P591, DOI 10.1038/nsmb.2834; Jonas S, 2014, NAT STRUCT MOL BIOL, V21, P599, DOI 10.1038/nsmb.2837; Liu QH, 2010, ANNU REV BIOCHEM, V79, P295, DOI 10.1146/annurev.biochem.052208.151733; Zekri L, 2013, EMBO J, V32, P1052, DOI 10.1038/emboj.2013.44; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Chekulaeva M, 2011, NAT STRUCT MOL BIOL, V18, P1218, DOI 10.1038/nsmb.2166; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Lian SL, 2009, RNA, V15, P804, DOI 10.1261/rna.1229409; Ibrahim F, 2006, SCIENCE, V314, P1893, DOI 10.1126/science.1135268; Ren GD, 2014, P NATL ACAD SCI USA, V111, P6365, DOI 10.1073/pnas.1405083111; Iwasaki S, 2009, MOL CELL, V34, P58, DOI 10.1016/j.molcel.2009.02.010; Kundu P, 2012, NUCLEIC ACIDS RES, V40, P5088, DOI 10.1093/nar/gks148; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Rouya C, 2014, RNA, V20, P1398, DOI 10.1261/rna.045302.114; Zekri L, 2009, MOL CELL BIOL, V29, P6220, DOI 10.1128/MCB.01081-09; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Fabian MR, 2011, NAT STRUCT MOL BIOL, V18, P1211, DOI 10.1038/nsmb.2149; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Wakiyama M, 2007, GENE DEV, V21, P1857, DOI 10.1101/gad.1566707; Mishima Y, 2012, P NATL ACAD SCI USA, V109, P1104, DOI 10.1073/pnas.1113350109; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Makino S, 2015, J BIOL CHEM, V290, P8331, DOI 10.1074/jbc.M114.615088; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Huntzinger E, 2010, EMBO J, V29, P4146, DOI 10.1038/emboj.2010.274; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Bologna NG, 2014, ANNU REV PLANT BIOL, V65, P473, DOI 10.1146/annurev-arplant-050213-035728; Souret FF, 2004, MOL CELL, V15, P173, DOI 10.1016/j.molcel.2004.06.006; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Chen Y, 2014, MOL CELL, V54, P737, DOI 10.1016/j.molcel.2014.03.034; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Waghray S, 2015, RNA, V21, P1335, DOI 10.1261/rna.051565.115; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Shenoy A, 2014, NAT REV MOL CELL BIO, V15, P565, DOI 10.1038/nrm3854; Liu MJ, 2013, PLANT CELL, V25, P3699, DOI 10.1105/tpc.113.114769; Hu QD, 2012, NAT STRUCT MOL BIOL, V19, P1168, DOI 10.1038/nsmb.2400; Lazzaretti D, 2009, RNA, V15, P1059, DOI 10.1261/rna.1606309; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Fukaya T, 2011, EMBO J, V30, P4998, DOI 10.1038/emboj.2011.426; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Poulsen C, 2013, PLANT CELL, V25, P22, DOI 10.1105/tpc.112.105643; Yao B, 2011, NUCLEIC ACIDS RES, V39, P2534, DOI 10.1093/nar/gkq1099; Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Beilharz TH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006783; Braun JE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012328; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Eichhorn SW, 2014, MOL CELL, V56, P104, DOI 10.1016/j.molcel.2014.08.028; Endo V., 2013, EMBO REP, V14, P652; Fukao A, 2014, MOL CELL, V56, P79, DOI 10.1016/j.molcel.2014.09.005; Fukaya T, 2014, MOL CELL, V56, P67, DOI 10.1016/j.molcel.2014.09.004; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Huntzinger E., 2012, NUCLEIC ACIDS RES, V41, P978, DOI [10.1093/nar/gksl078, DOI 10.1093/NAR/GKS1078]; Ipsaro JJ, 2015, NAT STRUCT MOL BIOL, V22, P20, DOI 10.1038/nsmb.2931; Kamenska A, 2014, NUCLEIC ACIDS RES, V42, P3298, DOI 10.1093/nar/gkt1265; Lim J, 2014, CELL, V159, P1365, DOI 10.1016/j.cell.2014.10.055; Ryu I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055725; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Todesco M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001031	144	0	0	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0962-8924			TRENDS CELL BIOL	Trends Cell Biol.	NOV	2015	25	11					651	665		10.1016/j.tcb.2015.07.011		15	Cell Biology	Cell Biology	CV9LI	WOS:000364608300005		
J	Miyoshi, T; Sakaguchi, H; Katsuragi, S; Ikeda, T; Yoshimatsu, J				Miyoshi, T.; Sakaguchi, H.; Katsuragi, S.; Ikeda, T.; Yoshimatsu, J.			Novel findings of fetal ectopic atrial tachycardia by cardiotocography	ULTRASOUND IN OBSTETRICS & GYNECOLOGY			English	Letter									[Miyoshi, T.; Katsuragi, S.; Yoshimatsu, J.] Natl Cerebral & Cardiovasc Ctr, Dept Perinatol, Suita, Osaka, Japan; [Miyoshi, T.; Katsuragi, S.; Yoshimatsu, J.] Natl Cerebral & Cardiovasc Ctr, Dept Gynecol, Suita, Osaka, Japan; [Sakaguchi, H.] Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiol, Suita, Osaka, Japan; [Ikeda, T.] Mie Univ, Dept Obstet & Gynecol, Tsu, Mie 514, Japan	Miyoshi, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Perinatol, Suita, Osaka, Japan.	gomiyoshi0327@yahoo.co.jp					Matta MJ, 2010, CLIN OBSTET GYNECOL, V53, P899, DOI 10.1097/GRF.0b013e3181fbb747; Wang JN, 2000, J FORMOS MED ASSOC, V99, P766; STEINFELD L, 1986, J AM COLL CARDIOL, V8, P1425; Knudson Joann M., 1994, Obstetrics and Gynecology, V84, P686; Parer JT, 1997, AM J OBSTET GYNECOL, V177, P1385	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7692	1469-0705		ULTRASOUND OBST GYN	Ultrasound Obstet. Gynecol.	NOV	2015	46	5					629	630		10.1002/uog.14797		2	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	CV5MW	WOS:000364315900021		
J	Taga, M; Hoshino, H; Low, S; Imamura, Y; Ito, H; Yokoyama, O; Kobayashi, M				Taga, Minekatsu; Hoshino, Hitomi; Low, Shulin; Imamura, Yoshiaki; Ito, Hideaki; Yokoyama, Osamu; Kobayashi, Motohiro			A potential role for 6-sulfo sialyl Lewis X in metastasis of bladder urothelial carcinoma	UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS			English	Article						Bladder urothelial carcinoma; 6-Sulfo sialyl Lewis X; E-selectin; High endothelial venule; Metastasis; Antitumor immunity	HIGH ENDOTHELIAL VENULES; LYMPH-NODE ADDRESSIN; L-SELECTIN LIGAND; CARBOHYDRATE ANTIGENS; ECTOPIC EXPRESSION; ULCERATIVE-COLITIS; CANCER-CELLS; ADHESION; INDUCTION; VESSELS	Objectives: It is widely accepted that sialyl Lewis X (sLeX) and sialyl Lewis A (sLeA, also known as CA 19-9) glycans expressed on cancer cells function in E-selectin-mediated metastasis. Recently, it was reported that 6-sulfo sLeX glycans detected by the MECA-79 monoclonal antibody are expressed in roughly a quarter of gastric adenocarcinoma cases, and that these cases show a poorer prognosis than MECA-79-negative cases do. The present study was undertaken to assess expression of 6-sulfo sLeX glycans in bladder urothelial carcinoma and evaluate potential clinical implications. Materials and methods: We analyzed 78 specimens representing bladder urothelial carcinoma, as well as 4 bladder urothelial carcinoma cell lines, by immunostaining with a battery of anticarbohydrate antibodies. We also undertook an E-selectin.IgM chimera binding assay to assess E-selectin binding to 6-sulfo sLeX expressed on bladder urothelial carcinoma cells and performed reverse transcription polymerase chain reaction and complementary DNA transfection to determine which N-acetylglucosamine-6-O-sulfotransferases function in 6-sulfo sLeX biosynthesis in those cells. Finally, we performed double-immunofluorescence staining for MECA-79 and either CD3 or CD8 to evaluate potential association between high endothelial venule (HEV)-like vessels and tumor-infiltrating T lymphocytes. Results: 6-Sulfo sLeX glycans were expressed in similar to 20% of bladder urothelial carcinoma cases, particularly in plasmacytoid and micropapillary variants. Positive cells were also bound by E-selectin.IgM chimeras in a calcium-dependent manner. Transcripts encoding N-acetylducosamine-6-O-sulfotransferase-2 were detected preferentially in HT-1197 bladder urothelial carcinoma cells expressing 6-sulfo sLeX, and transfection of the enzyme complementary DNA into HT-1376 cells, which do not express 6-sulfo sLeX glycans, resulted in cell surface expression of 6-sulfo sLeX. Furthermore, 6-sulfo sLeX glycans were expressed in HEV-like vessels induced in and around lymphocyte aggregates formed near carcinoma cell nests. These HEV-like vessel-associated tumor-infiltrating lymphocytes were composed primarily of CD3(+) T cells, with a fraction of CD8(+) cytotoxic T cells. Conclusions: Our findings indicate that 6-sulfo sLeX glycans likely play 2 roles in bladder urothelial carcinoma progression: one in lymphocyte recruitment to enhance antitumor immune responses, and the other in E-selectin-mediated tumor cell adhesion to vascular endothelial cells, which is potentially associated with metastasis. (C) 2015 Elsevier Inc. All rights reserved.	[Taga, Minekatsu; Hoshino, Hitomi; Low, Shulin; Kobayashi, Motohiro] Univ Fukui, Fac Med Sci, Dept Pathol Sci, Div Tumor Pathol, Eiheiji, Japan; [Taga, Minekatsu; Ito, Hideaki; Yokoyama, Osamu] Univ Fukui, Fac Med Sci, Dept Surg, Div Urol, Eiheiji, Japan; [Imamura, Yoshiaki] Univ Fukui Hosp, Div Surg Pathol, Eiheiji, Japan	Kobayashi, M (reprint author), Univ Fukui, Fac Med Sci, Dept Pathol Sci, Div Tumor Pathol, Eiheiji, Japan.	motokoba@u-fukui.ac.jp			Japan Society for the Promotion of Science, Tokyo, Japan [15K19049, 24590410, 15K08343]	This work was supported in part by a Grant-in-Aid for Young Scientists (B) 15K19049 (to and Grants-in-Aid for Scientific Research (C) 24590410 and 15K08343 (both to M.K.) from the Japan Society for the Promotion of Science, Tokyo, Japan.	Kobayashi M, 2009, INFLAMM BOWEL DIS, V15, P697, DOI 10.1002/ibd.20827; Ohmori K, 2000, BIOCHEM BIOPH RES CO, V278, P90, DOI 10.1006/bbrc.2000.3768; Skorstengaard K, 1999, J UROLOGY, V161, P1316, DOI 10.1016/S0022-5347(01)61677-X; Hanley WD, 2005, CANCER RES, V65, P5812, DOI 10.1158/0008-5472.CAN-04-4557; BERG EL, 1991, J BIOL CHEM, V266, P14869; Sato K, 2009, PATHOL RES PRACT, V205, P189, DOI 10.1016/j.prp.2008.09.004; Kobayashi M, 2010, METHOD ENZYMOL, V479, P271, DOI 10.1016/S0076-6879(10)79016-9; TAKADA A, 1993, CANCER RES, V53, P354; MATSUSAKO T, 1991, BIOCHEM BIOPH RES CO, V181, P1218, DOI 10.1016/0006-291X(91)92068-U; Kanoh A, 2006, GLYCOCONJUGATE J, V23, P453, DOI 10.1007/s10719-006-6979-6; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Hindley JP, 2012, CANCER RES, V72, P5473, DOI 10.1158/0008-5472.CAN-12-1912; Martinet L, 2011, CANCER RES, V71, P5678, DOI 10.1158/0008-5472.CAN-11-0431; Krause T, 1999, CLIN EXP METASTAS, V17, P183, DOI 10.1023/A:1006626500852; Kobayashi M, 2011, J PATHOL, V224, P67, DOI 10.1002/path.2851; Kobayashi M, 2004, P NATL ACAD SCI USA, V101, P17807, DOI 10.1073/pnas.0407503101; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; Maruyama M, 2013, PANCREAS, V42, P53, DOI 10.1097/MPA.0b013e318258ce4c; Uchimura K, 2006, TRENDS IMMUNOL, V27, P559, DOI 10.1016/j.it.2006.10.007; Mitoma J, 2009, GLYCOCONJUGATE J, V26, P511, DOI 10.1007/s10719-008-9207-8; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; Suzawa K, 2007, AM J GASTROENTEROL, V102, P1499, DOI 10.1111/j.1572-0241.2007.01189.x; Okayama H, 2011, CANCER SCI, V102, P1088, DOI 10.1111/j.1349-7006.2011.01895.x; Fujii Y, 2000, UROL INT, V64, P129, DOI 10.1159/000030512; Hoshino H, 2011, J HISTOCHEM CYTOCHEM, V59, P572, DOI 10.1369/0022155411404416; Mannori G, 1997, AM J PATHOL, V151, P233; Sakai Y, 2014, ANDROLOGY-US, V2, P282, DOI 10.1111/j.2047-2927.2014.00192.x; Shirure VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044529	28	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1078-1439	1873-2496		UROL ONCOL-SEMIN ORI	Urol. Oncol.-Semin. Orig. Investig.	NOV	2015	33	11							496.e1	10.1016/j.urolonc.2015.05.026		9	Oncology; Urology & Nephrology	Oncology; Urology & Nephrology	CV6TS	WOS:000364404400012		
J	Dohata, A; Chambers, JK; Uchida, K; Nakazono, S; Kinoshita, Y; Nibe, K; Nakayama, H				Dohata, A.; Chambers, J. K.; Uchida, K.; Nakazono, S.; Kinoshita, Y.; Nibe, K.; Nakayama, H.			Clinical and Pathologic Study of Feline Merkel Cell Carcinoma With Immunohistochemical Characterization of Normal and Neoplastic Merkel Cells	VETERINARY PATHOLOGY			English	Article						cat; cytology; immunohistochemistry; lymphoma; neuroendocrine carcinoma; Merkel cell; Merkel cell carcinoma	NEURON-SPECIFIC ENOLASE; NEUROENDOCRINE CARCINOMA; SKIN; TUMORS; FETAL; ANTIBODIES; EXPRESSION; EPIDERMIS; DENSITY; ORIGIN	The authors herein describe the morphologic and immunohistochemical features of normal Merkel cells as well as the clinicopathologic findings of Merkel cell carcinoma in cats. Merkel cells were characterized as vacuolated clear cells and were individually located in the epidermal basal layer of all regions examined. Clusters of Merkel cells were often observed adjacent to the sinus hair of the face and carpus. Immunohistochemically, Merkel cells were positive for cytokeratin (CK) 20, CK18, p63, neuron-specific enolase, synaptophysin, and protein gene product 9.5. Merkel cell carcinoma was detected as a solitary cutaneous mass in 3 aged cats (13 to 16 years old). On cytology, large lymphocyte-like cells were observed in all cases. Histologic examinations of surgically resected tumors revealed nests of round cells separated by various amounts of a fibrous stroma. Tumor cells were commonly immunopositive for CK20, CK18, p63, neuron-specific enolase, and synaptophysin, representing the characteristics of normal Merkel cells.	[Dohata, A.; Chambers, J. K.; Uchida, K.; Nakayama, H.] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pathol, Bunkyo Ku, Tokyo 1138657, Japan; [Nakazono, S.] Bin Anim Clin, Miyazaki, Japan; [Kinoshita, Y.] Iwakuni Hlth & Welf Ctr, Yamaguchi, Japan; [Nibe, K.] Japan Anim Referral Med Ctr, Kanagawa, Japan	Chambers, JK (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pathol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	achamber@mail.ecc.u-tokyo.ac.jp					Hashimoto K, 1998, J CUTAN PATHOL, V25, P572, DOI 10.1111/j.1600-0560.1998.tb01744.x; Asioli S, 2007, CANCER, V110, P640, DOI 10.1002/cncr.22828; zur Hausen A, 2013, CANCER RES, V73, P4982, DOI 10.1158/0008-5472.CAN-13-0616; MOLL R, 1984, DIFFERENTIATION, V28, P136, DOI 10.1111/j.1432-0436.1984.tb00277.x; DALSGAARD CJ, 1989, HISTOCHEMISTRY, V92, P385, DOI 10.1007/BF00492495; KIM DK, 1995, J INVEST DERMATOL, V104, P411, DOI 10.1111/1523-1747.ep12665903; LEBOIT PE, 1992, AM J SURG PATHOL, V16, P584, DOI 10.1097/00000478-199206000-00006; BOOT PM, 1992, AM J DERMATOPATH, V14, P391, DOI 10.1097/00000372-199210000-00003; Halata Z, 2003, ANAT REC PART A, V271A, P225, DOI 10.1002/ar.a.10029; ZACCONE G, 1986, HISTOCHEMISTRY, V85, P29, DOI 10.1007/BF00508650; GAUWEILER B, 1988, NEUROSCI LETT, V89, P121, DOI 10.1016/0304-3940(88)90367-9; LEFF EL, 1985, CANCER, V56, P625, DOI 10.1002/1097-0142(19850801)56:3<625::AID-CNCR2820560332>3.0.CO;2-M; IGGO A, 1969, J PHYSIOL-LONDON, V200, P763; Szeder V, 2003, DEV BIOL, V253, P258, DOI 10.1016/S0012-1606(02)00015-5; Moll I, 2005, EUR J CELL BIOL, V84, P259, DOI 10.1016/j.ejcb.2004.12.023; Bagnasco G, 2003, VET DERMATOL, V14, P111, DOI 10.1046/j.1365-3164.2003.00321.x; Patnaik AK, 2001, VET PATHOL, V38, P553, DOI 10.1354/vp.38-5-553; GU J, 1983, CANCER, V52, P1039, DOI 10.1002/1097-0142(19830915)52:6<1039::AID-CNCR2820520619>3.0.CO;2-O; Jankowski M, 2014, EXP DERMATOL, V23, P792, DOI 10.1111/exd.12490; Goessling W, 2002, J CLIN ONCOL, V20, P588, DOI 10.1200/JCO.20.2.588; Allen PJ, 1999, ANN SURG, V229, P97, DOI 10.1097/00000658-199901000-00013; Ozaki K, 2009, J VET MED SCI, V71, P1093, DOI 10.1292/jvms.71.1093; Acebo E, 2005, J EUR ACAD DERMATOL, V19, P546, DOI 10.1111/j.1468-3083.2005.01224.x; Skelton HG, 1997, J AM ACAD DERMATOL, V37, P734, DOI 10.1016/S0190-9622(97)70110-5; MOLL I, 1995, J INVEST DERMATOL, V104, P910, DOI 10.1111/1523-1747.ep12606183; WHITELEY LO, 1987, VET PATHOL, V24, P570; ROSEN ST, 1987, LAB INVEST, V56, P302; Kohler S, 2006, WHO CLASSIFICATION T, P272; Miller WH, 2013, SMALL ANIMAL DERMATO, P1; Tilling T, 2012, J SKIN CANC	30	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0300-9858	1544-2217		VET PATHOL	Vet. Pathol.	NOV	2015	52	6					1012	1018		10.1177/0300985815570484		7	Pathology; Veterinary Sciences	Pathology; Veterinary Sciences	CW1FF	WOS:000364734300003		
J	Ogawa, M; Uchida, K; Yamato, O; Mizukami, K; Chambers, JK; Nakayama, H				Ogawa, M.; Uchida, K.; Yamato, O.; Mizukami, K.; Chambers, J. K.; Nakayama, H.			Expression of Autophagy-Related Proteins in the Spinal Cord of Pembroke Welsh Corgi Dogs With Canine Degenerative Myelopathy	VETERINARY PATHOLOGY			English	Article						amyotrophic lateral sclerosis; dog; autophagy; apoptosis; neurodegenerative disease; canine degenerative myelopathy	AMYOTROPHIC-LATERAL-SCLEROSIS; MUTANT SOD1; MOUSE MODEL; DISEASE; MUTATION; GENE; NEURODEGENERATION; DYSREGULATION; APOPTOSIS; MICE	Canine degenerative myelopathy (DM) is a progressive neurodegenerative disease frequently found in Pembroke Welsh Corgi (PWC) dogs, and it has clinical and pathologic similarities to human amyotrophic lateral sclerosis. Autophagy is a major intracellular protein degradation system. Abnormalities of autophagy-resulting in cell death through mechanisms called type II programmed cell death-have recently been reported to occur in various neurodegenerative diseases, including amyotrophic lateral sclerosis. Thus, the distribution and expression levels of proteins involved in autophagy were examined in the spinal cords of 8 PWC dogs suffering from DM with superoxide dismutase mutation, 5 non-DM PWC dogs, and 6 Beagle dogs without neurologic signs. There was no significant difference in the ratio of neurons with microtubule-associated protein light chain 3 (LC3)-positive somata relative to those that were LC3 negative among the 3 groups, whereas the number of LC3-positive neurites was significantly increased in DM dogs. Punctate LC3 immunoreactivity did not colocalize with a lysosome marker, LAMP2 (lysosome-associated membrane protein 2). NBR1 (neighbor of BRCA gene 1) was localized mostly in reactive astrocytes, whereas there were p62 (p62/A170/SQSTM1)-positive foci in the neuropil of the spinal cord of DM dogs. Western blotting revealed in DM dogs the decreased expression of Beclin1 and Atg16 L, which are molecules involved in formation of the isolation membrane. These findings suggest that altered autophagosome degradation may result in LC3 and p62 accumulation in the DM spinal cord, whereas the early stage of membrane formation is likely to be downregulated.	[Ogawa, M.; Uchida, K.; Chambers, J. K.; Nakayama, H.] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pathol, Bunkyo Ku, Tokyo 1138657, Japan; [Yamato, O.; Mizukami, K.] Kagoshima Univ, Joint Fac Vet Med, Dept Vet Med, Kagoshima 890, Japan	Uchida, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pathol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	auchidak@mail.ecc.u-tokyo.ac.jp					Chang HS, 2013, J VET MED SCI, V75, P795, DOI 10.1292/jvms.12-0451; Uchiyama Y, 2008, HISTOCHEM CELL BIOL, V129, P407, DOI 10.1007/s00418-008-0406-y; Ogawa M, 2014, VET PATHOL, V51, P591, DOI 10.1177/0300985813495899; Sasaki S, 2011, J NEUROPATH EXP NEUR, V70, P349, DOI 10.1097/NEN.0b013e3182160690; Coates JR, 2007, J VET INTERN MED, V21, P1323, DOI 10.1892/07-059.1; AVERILL DR, 1973, J AM VET MED ASSOC, V162, P1045; Ogawa M, 2011, J VET MED SCI, V73, P1275, DOI 10.1292/jvms.11-0097; Yamazaki M, 2005, NEUROPATHOLOGY, V25, P381, DOI 10.1111/j.1440-1789.2005.00648.x; Morimoto N, 2007, BRAIN RES, V1167, P112, DOI 10.1016/j.brainres.2007.06.045; Zhang XJ, 2011, AUTOPHAGY, V7, P412, DOI 10.4161/auto.7.4.14541; Winslow AR, 2008, BBA-MOL BASIS DIS, V1782, P723, DOI 10.1016/j.bbadis.2008.06.010; Wininger FA, 2011, J VET INTERN MED, V25, P1166, DOI [10.1111/j.1939-1676.2011.0760.x, 10.1111/j.1939-1676.2011.00760.x]; Odagiri S, 2012, ACTA NEUROPATHOL, V124, P173, DOI 10.1007/s00401-012-0975-7; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Rue L, 2013, NEUROBIOL DIS, V52, P219, DOI 10.1016/j.nbd.2012.12.008; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI 10.1073/pnas.0812297106; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; March PA, 2009, VET PATHOL, V46, P241, DOI 10.1354/vp.46-2-241; Gal J, 2009, J NEUROCHEM, V111, P1062, DOI 10.1111/j.1471-4159.2009.06388.x; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Chu CT, 2006, J NEUROPATH EXP NEUR, V65, P423, DOI 10.1097/01.jnen.0000229233.75253.be; Chen S, 2012, BRAIN PATHOL, V22, P110, DOI 10.1111/j.1750-3639.2011.00546.x; Nassif M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-78; [Anonymous], 1993, NATURE, DOI DOI 10.1038/362059A0	26	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0300-9858	1544-2217		VET PATHOL	Vet. Pathol.	NOV	2015	52	6					1099	1107		10.1177/0300985815570070		9	Pathology; Veterinary Sciences	Pathology; Veterinary Sciences	CW1FF	WOS:000364734300015		
J	Mineshige, T; Kamiie, J; Sugahara, G; Yasuno, K; Aihara, N; Kawarai, S; Yamagishi, K; Shirota, M; Shirota, K				Mineshige, T.; Kamiie, J.; Sugahara, G.; Yasuno, K.; Aihara, N.; Kawarai, S.; Yamagishi, K.; Shirota, M.; Shirota, K.			Expression of Periostin in Normal, Atopic, and Nonatopic Chronically Inflamed Canine Skin	VETERINARY PATHOLOGY			English	Article						dog; immunologic/inflammation; immunohistochemistry; in situ hybridization; periostin	ACVD TASK-FORCE; DERMATITIS; DOGS; ASTHMA; CELLS	In humans, periostin plays a critical role in the enhancement and chronicity of allergic skin inflammation; however, whether it is involved in the pathogenesis of canine dermatitis remains unknown. The aim of this study was to examine the expression patterns of periostin in healthy, atopic, and nonatopic chronically inflamed canine skin. Biopsy specimens from 47 dogs with skin disease and normal skin tissue from 5 adult beagles were examined by light microscopy, immunohistochemistry, and in situ hybridization. In normal skin, periostin was localized just beneath the epidermis and around the hair follicles. In chronically inflamed skin, periostin expression was most intense in the dermis with inflammatory cell infiltrates. In contrast, low levels of periostin were detected in acutely inflamed and noninflamed skin. Conversely, all canine atopic dermatitis tissues characteristically showed the most intense expression of periostin in the superficial dermis, particularly at the epidermal-dermal junction. In situ hybridization showed that periostin mRNA was broadly expressed in the basal epidermal keratinocytes, outer root sheath cells, and dermal fibroblasts in normal dog skin. High expression of periostin mRNA was observed in fibroblasts in dog skin with chronically inflamed dermatitis. Moreover, in some chronically inflamed skin specimens, periostin mRNA expression was increased in basal keratinocytes. The severity score of chronic pathologic changes and CD3+ cell number in the dermis were correlated with distribution pattern of periostin in the atopic skin. These data suggest that periostin could play a role in the pathophysiology of chronic dermatitis, including atopic dermatitis, in dogs.	[Mineshige, T.; Kamiie, J.; Sugahara, G.; Yasuno, K.; Aihara, N.; Shirota, K.] Azabu Univ, Lab Vet Pathol, Sagamihara, Kanagawa 2525201, Japan; [Kawarai, S.] Azabu Univ, Vet Teaching Hosp, Sagamihara, Kanagawa 2525201, Japan; [Yamagishi, K.] Hongo Anim Hosp, Nagano, Nagano, Japan; [Shirota, M.] Azabu Univ, Lab Comparat Toxicol, Sagamihara, Kanagawa 2525201, Japan	Shirota, K (reprint author), Azabu Univ, Lab Vet Pathol, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan.	shirota@azabu-u.ac.jp			Azabu University [2014(DV1206)]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The author was supported by the graduate student research project grant 2014(DV1206) awarded by Azabu University.	Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Shiraishi H, 2012, ALLERGOL INT, V61, P563, DOI 10.2332/allergolint.10-OA-0297; Morra L, 2011, VIRCHOWS ARCH, V459, P465, DOI 10.1007/s00428-011-1151-5; Marsella R, 2009, J INVEST DERMATOL, V129, P2351, DOI 10.1038/jid.2009.98; Schlotter YM, 2011, VET IMMUNOL IMMUNOP, V143, P20, DOI 10.1016/j.vetimm.2011.05.025; Olivry T, 2001, VET IMMUNOL IMMUNOP, V81, P305, DOI 10.1016/S0165-2427(01)00305-1; Yamaguchi Y, 2014, ALLERGOL INT, V63, P161, DOI 10.2332/allergolint.13-RAI-0685; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Sinke JD, 1997, VET IMMUNOL IMMUNOP, V57, P13, DOI 10.1016/S0165-2427(96)05763-7; Zhou HM, 2010, J CELL COMMUN SIGNAL, V4, P99, DOI 10.1007/s12079-010-0090-2; Olivry T, 2003, VET DERMATOL, V14, P121, DOI 10.1046/j.1365-3164.2003.00335.x; Gordon ED, 2012, CLIN EXP ALLERGY, V42, P144, DOI 10.1111/j.1365-2222.2011.03840.x; Masuoka M, 2012, J CLIN INVEST, V122, P2590, DOI 10.1172/JCI58978; BRIGGAMAN RA, 1975, J INVEST DERMATOL, V65, P71, DOI 10.1111/1523-1747.ep12598050; Wood SH, 2009, J DERMATOL SCI, V55, P27, DOI 10.1016/j.jdermsci.2009.03.005; Olivry T, 1999, EXP DERMATOL, V8, P204, DOI 10.1111/j.1600-0625.1999.tb00372.x; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Hayashiya S, 2002, J VET MED A, V49, P27, DOI 10.1046/j.1439-0442.2002.00413.x; Hill PB, 2001, VET IMMUNOL IMMUNOP, V81, P187, DOI 10.1016/S0165-2427(01)00310-5; Terada Y, 2011, J DERMATOL, V38, P784, DOI 10.1111/j.1346-8138.2010.01136.x; Gillan L, 2002, CANCER RES, V62, P5358; Klukowska-Rotzler J, 2013, VET DERMATOL, V24, P54, DOI 10.1111/j.1365-3164.2012.01096.x; Nishiyama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018410; Taniguchi K, 2013, J INVEST DERMATOL, V134, P1295	24	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0300-9858	1544-2217		VET PATHOL	Vet. Pathol.	NOV	2015	52	6					1118	1126		10.1177/0300985815574007		9	Pathology; Veterinary Sciences	Pathology; Veterinary Sciences	CW1FF	WOS:000364734300017		
J	Ohfuji, S				Ohfuji, S.			Emphysematous Eosinophilic Lymphangitis in the Ruminal Submucosa of Cattle	VETERINARY PATHOLOGY			English	Article						apoptosis; cattle; emphysema; eosinophil; granuloma; lymphangitis; rumen	INTESTINAL EMPHYSEMA; APOPTOSIS; RESOLUTION; ASTHMA; PHAGOCYTOSIS; INFLAMMATION; ABOMASITIS	Twenty cattle (14 Holstein-Friesian, 3 Japanese Black, 3 Aberdeen Angus) ranging in age from 3 months to 8 years exhibited, at slaughter, emphysematous thickening of the ruminal submucosa owing to the appearance of numerous, contiguous, small gas bubbles. Microscopic changes in the ruminal submucosa consisted of (1) multiple cystic (emphysematous) lymphangiectasis that was frequently lined or occluded by granulomatous inflammatory infiltrates including macrophages, multinucleate giant cells, and eosinophils; (2) intralymphatic phagocytosis by macrophages and giant cells of eosinophils that showed positive labeling with the terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labeling assay; and (3) an inflammatory infiltrate extending from the area of lymphangitis into surrounding tissue, as well as edema, hemorrhage, fibrin exudation, fibroplasia, or capillary proliferation throughout the lesional submucosa. In addition, 15 (75%) of the cattle had globular leukocyte infiltrates in the mucosal epithelia of the rumen.	Diagnost Anim Pathol Off, Dept Histopathol, Sapporo, Hokkaido 0630041, Japan	Ohfuji, S (reprint author), Diagnost Anim Pathol Off, Dept Histopathol, Sapporo, Hokkaido 0630041, Japan.	tksohfuji@juno.ocn.ne.jp					Woolley KL, 1996, AM J RESP CRIT CARE, V154, P237; MEYER RC, 1977, CAN J COMP MED, V41, P302; ELLIS TM, 1983, AUST VET J, V60, P308, DOI 10.1111/j.1751-0813.1983.tb02817.x; Foresi A, 2000, ANN ALLERG ASTHMA IM, V84, P411; Fan GK, 2000, J ALLERGY CLIN IMMUN, V106, P551; Eveleth DF, 1938, AM J HYG, V27, P364; Walsh GM, 2003, J ENDOCRINOL, V178, P37, DOI 10.1677/joe.0.1780037; STERN M, 1992, J IMMUNOL, V148, P3543; Songer JG, 2005, ANAEROBE, V11, P290, DOI 10.1016/j.anaerobe.2004.12.004; Baker IK, 1993, PATHOLOGY DOMESTIC A, V2; Davidsson A, 2000, LARYNGOSCOPE, V110, P111; Garry FB, 1996, LARGE ANIMAL INTERNA, P824; Lawrence JA, 1997, RES VET SCI, V23, P239	13	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0300-9858	1544-2217		VET PATHOL	Vet. Pathol.	NOV	2015	52	6					1163	1166		10.1177/0300985814568684		4	Pathology; Veterinary Sciences	Pathology; Veterinary Sciences	CW1FF	WOS:000364734300023		
J	Yoshimura, H; Kimura-Tsukada, N; Ono, Y; Michishita, M; Ohkusu-Tsukada, K; Matsuda, Y; Ishiwata, T; Takahashi, K				Yoshimura, H.; Kimura-Tsukada, N.; Ono, Y.; Michishita, M.; Ohkusu-Tsukada, K.; Matsuda, Y.; Ishiwata, T.; Takahashi, K.			Characterization of Spontaneous Mammary Tumors in Domestic Djungarian Hamsters (Phodopus sungorus)	VETERINARY PATHOLOGY			English	Article						carcinosarcoma; Djungarian hamster; epithelial-mesenchymal transition; mammary tumor; Phodopus sungorus	RING CELL-CARCINOMA; TUMORIGENESIS; PATHOLOGY; GLAND; MICE; EMT	Mammary tumors that spontaneously occurred in domestic Djungarian hamsters (Phodopus sungorus) were histologically examined. Forty-five mammary tumors included 14 adenomas, 18 adenocarcinomas, 1 lipid-rich carcinoma, 2 adenoacanthomas, 2 malignant adenomyoepitheliomas, 1 benign mixed tumor, and 7 balloon cell carcinosarcomas. The latter 4 types were newly recognized neoplasms in Djungarian hamsters. The relatively high incidence of spontaneous mammary carcinosarcomas in domestic Djungarian hamsters is intriguing. Carcinosarcomas exhibited anomalous histological features made up of a mixture of glandular cells, polygonal cells (including balloon cells), and sarcomatous spindle cells in varying proportions. Transitional features from glandular cells to polygonal cells and subsequently to sarcomatous spindle cells were observed. Using immunohistochemistry, we observed that glandular cells exhibited an epithelial phenotype (cytokeratin(+)/vimentin(-)), spindle cells exhibited a mesenchymal phenotype (cytokeratin(-)/vimentin(+)), and polygonal cells exhibited an intermediate phenotype (cytokeratin(+)/vimentin(+)). Reduction or loss of beta-catenin expression and gain of S100A4 expression were observed in polygonal and spindle cells. The polygonal cell population included a varying number of characteristic cells that were expanded by large intracytoplasmic vacuoles. Electron microscopy revealed that these balloon cells had large cytoplasmic lumens lined by microvilli. These observations suggest that epithelial-mesenchymal transition may account for the pathogenesis of mammary carcinosarcomas in Djungarian hamsters.	[Yoshimura, H.] Nippon Vet & Life Sci Univ, Sch Vet Nursing & Technol, Dept Appl Sci, Div Physiol Pathol, Musashino, Tokyo 1808602, Japan; [Yoshimura, H.; Kimura-Tsukada, N.; Ono, Y.; Michishita, M.; Ohkusu-Tsukada, K.; Takahashi, K.] Nippon Vet & Life Sci Univ, Sch Vet Med, Dept Vet Pathol, Musashino, Tokyo 1808602, Japan; [Matsuda, Y.] Tokyo Metropolitan Geriatr Hosp, Dept Pathol, Tokyo 173, Japan; [Matsuda, Y.] Inst Gerontol, Tokyo, Japan; [Ishiwata, T.] Nippon Med Sch, Grad Sch Med, Dept Integrated Diagnost Pathol, Tokyo 113, Japan	Takahashi, K (reprint author), Nippon Vet & Life Sci Univ, Dept Vet Pathol, 1-7-1 Kyonan Cho, Musashino, Tokyo 1808602, Japan.	kimimasa@nvlu.ac.jp			Japan Society for the Promotion of Science [26870622]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported, in part, by a Grant-in-Aid from Japan Society for the Promotion of Science to Hisashi Yoshimura (No. 26870622).	Kondo H, 2009, J COMP PATHOL, V140, P127, DOI 10.1016/j.jcpa.2008.09.012; Yoshimura H, 2010, J VET DIAGN INVEST, V22, P305; Hes O, 2005, INT J SURG PATHOL, V13, P375, DOI 10.1177/106689690501300415; POGOSIANZ HE, 1975, J NATL CANCER I, V54, P659; Cardiff RD, 2000, ONCOGENE, V19, P968, DOI 10.1038/sj.onc.1203277; WICK MR, 1993, SEMIN DIAGN PATHOL, V10, P118; Urayama F, 2001, J VET MED SCI, V63, P1249, DOI 10.1292/jvms.63.1249; Baba Y, 2003, COMPARATIVE MED, V53, P527; ZARBO RJ, 1986, AM J SURG PATHOL, V10, P741, DOI 10.1097/00000478-198611000-00001; Radaelli E, 2009, VET PATHOL, V46, P736, DOI 10.1354/vp.08-VP-0280-R-FL; WANG ZY, 1992, JPN J CLIN ONCOL, V22, P377; Damonte P, 2007, LAB INVEST, V87, P1218, DOI 10.1038/labinvest.3700683; HEJKA AG, 1989, UROLOGY, V34, P155, DOI 10.1016/0090-4295(89)90253-7; Cardiff RD, 2010, J MAMMARY GLAND BIOL, V15, P225, DOI 10.1007/s10911-010-9184-y; Schneider M, 2008, J MOL MED-JMM, V86, P507, DOI 10.1007/s00109-007-0301-3; Kondo H, 2008, VET PATHOL, V45, P674, DOI 10.1354/vp.45-5-674; Goldschmidt M, 2011, VET PATHOL, V48, P117, DOI 10.1177/0300985810393258; Corrin B, 2004, WHO CLASSIFICATION T, P53; Dunn T, 1959, PHYSIOPATHOLOGY CANC, P38; Fernandez PL, 1996, PATHOLOGY TUMOURS LA, V3, P45; Lakhani SR, 2012, WHO CLASSIFICATION T; Maria JM, 1981, CANCER, V48, P1830; Meyer R, 1920, ZENTRALBL ALLG PATHO, V30, P291; Misdorp W., 1999, HISTOLOGICAL CLASSIF; Rehm S, 1989, MONOGRAPHS PATHOLOGY, P319; Russo J, 1989, MONOGRAPH SERIES PAT, P275; Squartini F, 1994, PATHOLOGY TUMOURS LA, V2, P47; Tsuchiya Shin-ichi, 2005, Medical Molecular Morphology, V38, P216, DOI 10.1007/s00795-005-0300-9; Virchow R, 1864, KRANKHAFTEN GESCHWUL, V2	29	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0300-9858	1544-2217		VET PATHOL	Vet. Pathol.	NOV	2015	52	6					1227	1234		10.1177/0300985815583097		8	Pathology; Veterinary Sciences	Pathology; Veterinary Sciences	CW1FF	WOS:000364734300034		
J	Gao, XF; Gu, YL; Huang, S; Zhen, GY; Deng, GN; Xie, T; Zhao, YC				Gao, Xiaofeng; Gu, Yilu; Huang, Sheng; Zhen, Guangyin; Deng, Guannan; Xie, Tian; Zhao, Youcai			Comparison of alternative remediation technologies for recycled gravel contaminated with heavy metals	WASTE MANAGEMENT & RESEARCH			English	Article						Contaminated recycled gravel; construction and demolition wastes; heavy metals; mobilization; immobilization; glyphosate	UNPAVED RURAL ROADS; ZERO-VALENT IRON; HUMIC-ACID; AQUEOUS-SOLUTION; DEMOLITION WASTE; COPPER-ION; 2 SOILS; GLYPHOSATE; ADSORPTION; COMPLEXES	To evaluate the effects of different remediation methods on heavy metals contaminated recycled gravel, three immobilization agents (monopotassium phosphate, lime, nano-iron) and two mobilization agents (glyphosate, humic acid (HA)) were studied and compared. Results indicated that nano-iron powder was found to be more effective to immobilize Zn, Cu, Pb and Cd. Meanwhile, glyphosate presents a higher mobilization effect than HA with removal rates of about 66.7% for Cd, more than 80% for Cr, Cu and Zn, and the highest removal percentage of 85.9% for Cr. After the mobilization by glyphosate, the leaching rates of Zn, Cu and Cr were about 0.8%, and below 0.2% for Pb and Cd. The leaching rates after nano-iron powder treatment were 1.18% for Zn, 0.96% for Cr, 0.61% for Cu, 0.45% for Pb and Cd not detected. The formation and disappearance of metal (Zn/Cu/Cr/Pb/Cd) compounds were firmly confirmed through X-ray diffraction and scanning electron microscopy analyses on crystalline phases and morphological surface structures.	[Gao, Xiaofeng; Huang, Sheng; Deng, Guannan; Xie, Tian; Zhao, Youcai] Tongji Univ, State Key Lab Pollut Control & Resource Reuse, Sch Environm Sci & Engn, Shanghai 200092, Peoples R China; [Gu, Yilu] Chinese Acad Sci, Inst Hydrobiol, Beijing 100864, Peoples R China; [Zhen, Guangyin] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan	Zhao, YC (reprint author), Tongji Univ, State Key Lab Pollut Control & Resource Reuse, 325 Mingjing Bldg,1239 Siping Rd, Shanghai 200092, Peoples R China.	zhaoyoucai@tongji.edu.cn			Public Interest Program of the Chinese Ministry of Environmental Protection [201309025]; National Natural Science Foundation of China [51278350]	The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: the Public Interest Program of the Chinese Ministry of Environmental Protection (No. 201309025) and the National Natural Science Foundation of China (No. 51278350).	Waychunas GA, 2005, J NANOPART RES, V7, P409, DOI 10.1007/s11051-005-6931-x; Kools SAE, 2005, SOIL BIOL BIOCHEM, V37, P1303, DOI 10.1016/j.soilbio.2004.11.026; Sundaram A, 1997, J ENVIRON SCI HEAL B, V32, P583, DOI 10.1080/03601239709373104; Chen QQ, 2012, J COLLOID INTERF SCI, V367, P241, DOI 10.1016/j.jcis.2011.10.005; Hale B, 2012, J HAZARD MATER, V199, P119, DOI 10.1016/j.jhazmat.2011.10.065; SUBRAMANIAM V, 1988, J AGR FOOD CHEM, V36, P1326, DOI 10.1021/jf00084a050; Abumaizar RJ, 1999, J HAZARD MATER, V70, P71, DOI 10.1016/S0304-3894(99)00149-1; Liu ZQ, 2012, ANAL CHIM ACTA, V745, P78, DOI 10.1016/j.aca.2012.07.033; Kundu S, 2008, J HAZARD MATER, V153, P434, DOI 10.1016/j.jhazmat.2007.08.073; Liu TY, 2013, WATER RES, V47, P6691, DOI 10.1016/j.watres.2013.09.006; Gomez-Ortiz NM, 2014, INT BIODETER BIODEGR, V91, P1, DOI 10.1016/j.ibiod.2014.02.005; Dabinett TR, 2008, PURE APPL CHEM, V80, P1317, DOI 10.1351/pac200880061317; Galvin AP, 2013, CONSTR BUILD MATER, V40, P1207, DOI 10.1016/j.conbuildmat.2011.12.091; Tadesse I, 2006, BIORESOURCE TECHNOL, V97, P529, DOI 10.1016/j.biortech.2005.04.028; Sureshkumar MK, 2013, SEP SCI TECHNOL, V48, P1132, DOI 10.1080/01496395.2012.724500; Xi YF, 2010, MATER RES BULL, V45, P1361, DOI 10.1016/j.materresbull.2010.06.046; Chlopecka A, 1996, ENVIRON SCI TECHNOL, V30, P3294, DOI 10.1021/es960072j; Ponder SM, 2000, ENVIRON SCI TECHNOL, V34, P2564, DOI 10.1021/es9911420; Zhou CF, 2013, ENVIRON POLLUT, V180, P71, DOI 10.1016/j.envpol.2013.05.016; Zhou DM, 2004, CHEMOSPHERE, V57, P1237, DOI 10.1016/j.chemosphere.2004.08.043; De la Rosa JM, 2011, ESTUAR COAST SHELF S, V93, P478, DOI 10.1016/j.ecss.2011.05.029; Sheals J, 2002, ENVIRON SCI TECHNOL, V36, P3090, DOI 10.1021/es010295w; Jimenez JR, 2012, RESOUR CONSERV RECY, V58, P88, DOI 10.1016/j.resconrec.2011.10.012; MCBRIDE MB, 1991, SOIL SCI SOC AM J, V55, P979; Jimenez JR, 2012, CONSTR BUILD MATER, V34, P34, DOI 10.1016/j.conbuildmat.2012.02.042; Ziegler F, 2001, CEMENT CONCRETE RES, V31, P1327, DOI 10.1016/S0008-8846(01)00557-9; Machappa T, 2012, B MATER SCI, V35, P75, DOI 10.1007/s12034-011-0261-7; Wang YJ, 2008, J HAZARD MATER, V151, P179, DOI 10.1016/j.jhazmat.2007.05.060; MCCONNELL JS, 1985, J AGR FOOD CHEM, V33, P1075, DOI 10.1021/jf00066a014; Ulsen C, 2013, WASTE MANAGE, V33, P656, DOI 10.1016/j.wasman.2012.06.018; Wang YJ, 2006, J HAZARD MATER, V137, P76, DOI 10.1016/j.jhazmat.2006.02.032; Gray CW, 2006, ENVIRON POLLUT, V142, P530, DOI 10.1016/j.envpol.2005.10.017; Barja BC, 2001, POLYHEDRON, V20, P1821, DOI 10.1016/S0277-5387(01)00741-0; Bolan NS, 2003, PLANT SOIL, V250, P83, DOI 10.1023/A:1022826014841; Lin JW, 2011, COLLOID SURFACE A, V384, P9, DOI 10.1016/j.colsurfa.2011.02.044; LIVENS FR, 1991, ENVIRON POLLUT, V70, P183, DOI 10.1016/0269-7491(91)90009-L; Maqueda C, 1998, CHEMOSPHERE, V37, P1063, DOI 10.1016/S0045-6535(98)00103-9; El-Eswed B, 2006, J COLLOID INTERF SCI, V299, P497, DOI 10.1016/j.jcis.2006.02.048; Liu JF, 2008, ENVIRON SCI TECHNOL, V42, P6949, DOI 10.1021/es800924c; GLASS RL, 1984, J AGR FOOD CHEM, V32, P1249, DOI 10.1021/jf00126a010; Ulsen C, 2013, CONSTR BUILD MATER, V40, P1168, DOI 10.1016/j.conbuildmat.2012.02.004; Pehlivan E, 2006, ENERG SOURCE PART A, V28, P1099, DOI 10.1080/009083190910451; Wu PX, 2011, GEODERMA, V164, P215, DOI 10.1016/j.geoderma.2011.06.012; Morillo E, 2000, CHEMOSPHERE, V40, P103, DOI 10.1016/S0045-6535(99)00255-6; Trinelli MA, 2013, COLLOID SURFACE B, V105, P251, DOI 10.1016/j.colsurfb.2012.12.047; Bolan N, 2014, J HAZARD MATER, V266, P141, DOI 10.1016/j.jhazmat.2013.12.018; Chui D, 2006, IND TECHNOLOGIC EC, V10, P35; Jalali M, 2009, SOIL SEDIMENT CONTAM, V19, P88; Kobylecka J, 2000, MONATSH CHEM, V131, P1, DOI 10.1007/s007060050001; Krinik N, 2014, SCI TOTAL ENVIRON, V476-477, P20; Li Y, 2010, J HAZARD MATER, V178, P455, DOI 10.1016/j.jhazmat.2010.01.103; Ping L, 2007, CIVIL CONSTRUCTION T, V21, P34; Qingyu X, 2014, ENVIRONMENT, V2, P36; Quan L, 2014, CHINA BUILDING MAT, V1, P74; Woosley RJ, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007599; Xinchuang L, 2013, METALLURGICAL EC MAN, V3, P4; Zhen GY, 2012, CONSTR BUILD MATER, V30, P675, DOI 10.1016/j.conbuildmat.2011.12.049	57	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0734-242X	1096-3669		WASTE MANAGE RES	Waste Manage. Res.	NOV	2015	33	11					1005	1014		10.1177/0734242X15602963		10	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CV6LI	WOS:000364381300007		
J	Akiyama, Y; Suzuki, K; Ochi, S; Miyamoto, S; Mikuni, N				Akiyama, Yukinori; Suzuki, Kengo; Ochi, Satoko; Miyamoto, Susumu; Mikuni, Nobuhiro			Evaluation of Posterior Hippocampal Epileptogenicity During Epilepsy Surgery For Temporal Lobe Cavernoma by the Occipital Approach	WORLD NEUROSURGERY			English	Article						Epilepsy; Hippocampus; Temporal Cavernoma; Transoccipital Approach	NATURAL-HISTORY; SURGICAL-TREATMENT; DUAL PATHOLOGY; PURE LESIONECTOMY; VERBAL MEMORY; MALFORMATIONS; RESECTION; AMYGDALOHIPPOCAMPECTOMY; LOBECTOMY; ANGIOMAS	BACKGROUND: Cavernomas frequently are associated with intractable epilepsy. When cavernomas located in the temporal lobe are associated with intractable epilepsy, the hippocampus also may have an epileptic focus. The objective in the present study was to clarify the importance of evaluation of the posterior hippocampal epileptogenicity during epilepsy surgery for posteromedial temporal lobe cavernoma. CASE DESCRIPTIONS: In this study, we describe 2 rare cases of medically intractable epilepsy in patients with posteromedial temporal lobe cavernomas who underwent surgery via the occipital approach. Using longitudinal insertion of depth electrodes into the hippocampus, we evaluated epileptogenicity in both patients from the cavernoma cavity and its surrounding hemosiderin, as well as from the posterior hippocampus near the cavernoma. We show that the transoccipital approach to the posteromedial temporal lobe is compatible with depth electrode insertion and subdural electrode placement on the temporal lobe, enabling an accurate evaluation of potential epileptogenic zones in the posterior part of the hippocampus. Both patients did not experience any seizures and had no postoperative neurologic deficits, and their cognitive functions were intact. CONCLUSIONS: The transoccipital approach enables the optimization of the extent of posterior hippocampectomy while avoiding unnecessary resection for seizure control. We suggest resecting the posterior part of the hippocampus in addition to the cavernoma and surrounding areas in patients with medically refractory epilepsy due to a posteromedial temporal cavernoma. Tailored systematic resection guided by intraoperative electrocorticography and electroencephalography with a depth electrode was important and necessary in the present cases.	[Akiyama, Yukinori; Suzuki, Kengo; Ochi, Satoko; Mikuni, Nobuhiro] Sapporo Med Univ, Sch Med, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Miyamoto, Susumu] Kyoto Univ, Sch Med, Dept Neurosurg, Kyoto 606, Japan	Mikuni, N (reprint author), Sapporo Med Univ, Sch Med, Dept Neurosurg, Sapporo, Hokkaido, Japan.	mikunin@sapmed.ac.jp					Mikuni N, 2006, EPILEPSY BEHAV, V8, P560, DOI 10.1016/j.yebeh.2006.01.010; Siegel AM, 2000, NEUROSURG REV, V23, P80; Batra S, 2009, NAT REV NEUROL, V5, P659, DOI 10.1038/nrneurol.2009.177; Li LM, 1999, BRAIN, V122, P799, DOI 10.1093/brain/122.5.799; Hori T, 1999, NEUROL MED-CHIR, V39, P214, DOI 10.2176/nmc.39.214; Helmstaedter C, 1998, EPILEPSIA, V39, P399, DOI 10.1111/j.1528-1157.1998.tb01392.x; Vajkoczy P, 1998, J NEUROSURG, V88, P855, DOI 10.3171/jns.1998.88.5.0855; Miyamoto S, 2004, NEUROSURGERY, V54, P1162, DOI 10.1227/01.NEU.0000119234.61432.E8; Chang EF, 2009, NEUROSURGERY, V65, P31, DOI 10.1227/01.NEU.0000346648.03272.07; Casazza M, 1996, NEUROSURGERY, V39, P26, DOI 10.1097/00006123-199607000-00007; Van Roost D, 1998, NEUROSURGERY, V43, P819, DOI 10.1097/00006123-199810000-00058; COHEN DS, 1995, J NEUROSURG, V83, P237, DOI 10.3171/jns.1995.83.2.0237; DELCURLING O, 1991, J NEUROSURG, V75, P702, DOI 10.3171/jns.1991.75.5.0702; Li LM, 1997, NEUROLOGY, V48, P437; Uda T, 2013, J NEUROSURG, V119, P1098, DOI 10.3171/2013.6.JNS13244; Baumann CR, 2005, SEIZURE-EUR J EPILEP, V14, P324, DOI 10.1016/j.seizure.2005.04.004; Shimizu H, 2006, J CLIN NEUROSCI, V13, P322, DOI 10.1016/j.jocn.2005.04.020; Wen HT, 1999, NEUROSURGERY, V45, P549, DOI 10.1097/00006123-199909000-00028; Stavrou I, 2008, NEUROSURGERY, V63, P888, DOI 10.1227/01.NEU.0000327881.72964.6E; LEVESQUE MF, 1991, J NEUROSURG, V75, P364, DOI 10.3171/jns.1991.75.3.0364; ROBINSON JR, 1991, J NEUROSURG, V75, P709, DOI 10.3171/jns.1991.75.5.0709; Ghareeb F, 2012, J NEUROSURG, V116, P1226, DOI 10.3171/2012.1.JNS112120; Park TS, 1996, J NEUROSURG, V85, P1172, DOI 10.3171/jns.1996.85.6.1172; Nunn JA, 1999, BRAIN, V122, P47, DOI 10.1093/brain/122.1.47; POLKEY CE, 1989, J NEUROL NEUROSUR PS, V52, P1050, DOI 10.1136/jnnp.52.9.1050; KATZ A, 1989, EPILEPSIA, V30, P763, DOI 10.1111/j.1528-1157.1989.tb05336.x; Ferroli P, 2006, NEUROL SCI, V26, P390, DOI 10.1007/s10072-006-0521-2; Awad Issam, 2006, Neurosurg Focus, V21, pe7; Gross BA, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.3.FOCUS1165; Kim DS, 1997, SURG NEUROL, V48, P9, DOI 10.1016/S0090-3019(96)00425-9; Kim DS, 1997, SURG NEUROL, V48, P17; Luders Hans O., 1993, P137; Milner B, 1972, Clin Neurosurg, V19, P421	33	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2015	84	5							1494.e1	10.1016/j.wneu.2015.04.047		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CV8KM	WOS:000364533900055		
J	Takano, S; Akutsu, H; Mizumoto, M; Yamamoto, T; Tsuboi, K; Matsumura, A				Takano, Shingo; Akutsu, Hiroyoshi; Mizumoto, Masashi; Yamamoto, Tetsuya; Tsuboi, Koji; Matsumura, Akira			Neuroendoscopy Followed by Radiotherapy in Cystic Craniopharyngiomas-a Long-Term Follow-Up	WORLD NEUROSURGERY			English	Article						Cystic craniopharyngioma; Neuroendoscopy; Stereotactic radiotherapy	GAMMA-KNIFE SURGERY; ENDONASAL ENDOSCOPIC APPROACH; PEDIATRIC CRANIOPHARYNGIOMA; CLINICAL ARTICLE; STEREOTACTIC APPROACH; INTRACRANIAL TUMORS; RADIATION-THERAPY; EXPERIENCE; MANAGEMENT; RESECTION	BACKGROUND: Treatment of cystic craniopharyngiomas is often complicated because of adherence of craniopharyngiomas to adjacent brain structures. A strategy involving neuroendoscopic procedures followed by stereotactic radiotherapy is less invasive, avoiding brain damage. However, long-term follow-up of this strategy has not been investigated in depth. METHODS: Cystic craniopharyngiomas in 9 patients were treated with neuroendoscopic cyst aspiration and fenestration, followed by fractionated stereotactic radiotherapy (FSRT). The neuroendoscopic procedure focused on widening of cyst fenestration and extensive irrigation of the cyst contents. FSRT was performed using 6 fixed beams, an 8-mm margin to cover the gross tumor volume with a 95% isodose line, and a target delivered dose of 50.4 Gy in 28 fractions. RESULTS: The median follow-up period was 72.9 months. Tumor control was achieved in 8 of 9 patients (88.9%). Marked tumor volume reduction was obtained with the neuroendoscopic procedure alone (26.1%) at 6 months (20.4%), 1 year (11.0%), and 2 years (3.1%). One recurrent case showed multilobulated cysts, and a second surgery was required 1 year after the treatment. Clinical symptoms such as headache and visual disruption were rapidly alleviated after the neuroendoscopic procedure. No new visual disturbances, endocrinopathy, or hypothalamic dysfunction was observed during follow up. CONCLUSIONS: Neuroendoscopic cyst aspiration and fenestration followed by FSRT is a less invasive, powerful strategy for treating adult cystic craniopharyngiomas.	[Takano, Shingo; Akutsu, Hiroyoshi; Yamamoto, Tetsuya; Matsumura, Akira] Univ Tsukuba, Fac Med, Dept Neurosurg, Tsukuba, Ibaraki, Japan; [Mizumoto, Masashi; Tsuboi, Koji] Univ Tsukuba, Fac Med, Dept Radiat Oncol, Tsukuba, Ibaraki, Japan	Takano, S (reprint author), Univ Tsukuba, Fac Med, Dept Neurosurg, Tsukuba, Ibaraki, Japan.	shingo4@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24390339]; Japanese Foundation for Research and Promotion of Endoscopy	This work was supported in part by Grants-in-Aid for Scientific Research Grant No. 24390339 (to S.T.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Japanese Foundation for Research and Promotion of Endoscopy (to S.T.).	Moussa AH, 2013, BRIT J NEUROSURG, V27, P370, DOI 10.3109/02688697.2012.741732; Kawamata T, 2010, NEUROSURG REV, V33, P71, DOI 10.1007/s10143-009-0220-6; Fahlbusch R, 1999, J NEUROSURG, V90, P237, DOI 10.3171/jns.1999.90.2.0237; Paraskevopoulos D, 2011, J NEUROSURG-PEDIATR, V8, P279, DOI 10.3171/2011.6.PEDS10501; Mortini P, 2011, J NEUROSURG, V114, P1350, DOI 10.3171/2010.11.JNS10670; Masson-Cote L, 2013, ACTA ONCOL, V52, P153, DOI 10.3109/0284186X.2012.685525; Osuka S, 2007, CHILD NERV SYST, V23, P897, DOI 10.1007/s00381-007-0315-8; Schoenfeld A, 2012, J NEURO-ONCOL, V108, P133, DOI 10.1007/s11060-012-0806-7; Ali ZS, 2013, CHILD NERV SYST, V29, P2065, DOI 10.1007/s00381-013-2153-1; Nakahara Y, 2004, NEUROL MED-CHIR, V44, P408, DOI 10.2176/nmc.44.408; Liu XM, 2012, J NEUROSURG, V117, P45, DOI 10.3171/2012.7.GKS121019; Joki T, 2002, CHILD NERV SYST, V18, P629, DOI 10.1007/s00381-002-0638-4; Stark AM, 2014, J NEUROL SURG PART A, V75, P371, DOI 10.1055/s-0034-1371515; Kobayashi T, 2005, J NEUROSURG, V103, P482; Koutourousiou M, 2013, J NEUROSURG, V119, P1194, DOI 10.3171/2013.6.JNS122259; Reda WAH, 2002, J NEUROSURG, V97, P610; Komotar RJ, 2012, WORLD NEUROSURG, V77, P329, DOI 10.1016/j.wneu.2011.07.011; Park YS, 2011, J NEUROSURG, V114, P1360, DOI 10.3171/2009.9.JNS09301; Delitala A, 2004, CHILD NERV SYST, V20, P858, DOI 10.1007/s00381-004-0943-1; WEINER HL, 1994, NEUROSURGERY, V35, P1001; Pereira AM, 2005, CLIN ENDOCRINOL, V62, P197, DOI 10.1111/j.1365-2265.2004.02196.x; Lo AC, 2014, INT J RADIAT ONCOL, V88, P1011, DOI 10.1016/j.ijrobp.2014.01.019; Nicolato A, 2004, MINIM INVAS NEUROSUR, V47, P32, DOI 10.1055/s-2003-812467; Depreitere B, 2007, J NEUROSURG, V106, P340, DOI 10.3171/ped.2007.106.5.340; Hayashi N, 2011, J NEUROSURG, V115, P1147, DOI 10.3171/2011.7.JNS101976; Sughrue ME, 2011, J NEURO-ONCOL, V101, P463, DOI 10.1007/s11060-010-0265-y; Sato M, 2012, NEUROL MED-CHIR, V52, P832; Karavitaki N, 2005, CLIN ENDOCRINOL, V62, P397, DOI 10.1111/j.1365-2265.2005.02231.x; HOFFMAN HJ, 1977, J NEUROSURG, V47, P218, DOI 10.3171/jns.1977.47.2.0218; Clark AJ, 2012, J NEUROSURG-PEDIATR, V10, P293, DOI 10.3171/2012.7.PEDS11436; Barajas MA, 2002, J NEUROSURG, V97, P607; Barkhoudarian Garni, 2014, World Neurosurg, V82, pS138, DOI 10.1016/j.wneu.2014.07.017; Campbell PG, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.1.FOCUS09292; Cavallo Luigi Maria, 2014, World Neurosurg, V82, pS32, DOI 10.1016/j.wneu.2014.07.023; Esposito F, 2013, WORLD NEUROSURG, V80, P709, DOI 10.1016/j.wneu.2013.05.011; Greenfield BJ, 2015, RADIOTHER ONCOL, V114, P224, DOI 10.1016/j.radonc.2014.11.035; Harrabi SB, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-203; Lee CC, 2014, J NEUROSURG, V121, P167, DOI 10.3171/2014.8.GKS141411; Oka K, 2008, NEUROSURGERY S2, V62; Rahmathulla Gazanfar, 2013, Surg Neurol Int, V4, pS411, DOI 10.4103/2152-7806.121612; Sakamoto Noriaki, 2013, Surg Neurol Int, V4, P19, DOI 10.4103/2152-7806.107546	41	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2015	84	5					1305	+		10.1016/j.wneu.2015.06.022		13	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CV8KM	WOS:000364533900028		
J	Khafagy, E; Iwamae, R; Kamei, N; Takeda-Morishita, M				Khafagy, El-Sayed; Iwamae, Ruisha; Kamei, Noriyasu; Takeda-Morishita, Mariko			Region-Dependent Role of Cell-Penetrating Peptides in Insulin Absorption Across the Rat Small Intestinal Membrane	AAPS JOURNAL			English	Article						absorption enhancement; cell-penetrating peptide; enzymatic degradation; insulin; intestinal membrane	DRUG-DELIVERY; ORAL INSULIN; IN-VIVO; INTERMOLECULAR INTERACTION; MUCOUS/GLYCOCALYX LAYERS; ANTENNAPEDIA HOMEODOMAIN; INTRACELLULAR DELIVERY; FUNCTIONAL PEPTIDES; PROTEASE INHIBITION; CACO-2 MONOLAYER	We have reported that the cell-penetrating peptide (CPP) penetratin acts as a potential absorption enhancer in oral insulin delivery systems and that this action occurs through noncovalent intermolecular interactions. However, the region-dependent role of CPPs in intestinal insulin absorption has not been clarified. To identify the intestinal region where CPPs have the most effect in increasing insulin absorption, the region-dependent action of penetratin was investigated using in situ closed intestinal loops in rats. The order of the insulin area under the insulin concentration-time curve (AUC) increase effect by L-penetratin was ileum>jejunum>duodenum>colon. By contrast, the AUC order after coadministration of insulin with D-penetratin was colon>duodenum >= jejunum and ileum. We also compared the effects of the L-and D-forms of penetratin, R8, and PenetraMax on ileal insulin absorption. Along with the CPPs used in this study, L-and D-PenetraMax produced the largest insulin AUCs. An absorption study using ilea pretreated with CPPs showed that PenetraMax had no irreversible effect on the intestinal epithelial membrane. The degradation of insulin in the presence of CPPs was assessed in rat intestinal enzymatic fluid. The half-life (t(1/2)) of insulin increased from 14.5 to 23.7 and 184.7 min in the presence of L-and D-PenetraMax, respectively. These enzymatic degradation-resistant effects might contribute partly to the increased ileal absorption of insulin induced by D-PenetraMax. In conclusion, this study demonstrated that the ability of the L-and D-forms of penetratin to increase intestinal insulin absorption was maximal in the ileum and the colon, respectively, and that D-PenetraMax is a powerful but transient enhancer of oral insulin absorption.	[Khafagy, El-Sayed; Iwamae, Ruisha; Kamei, Noriyasu; Takeda-Morishita, Mariko] Kobe Gakuin Univ, Fac Pharmaceut Sci, Lab Drug Delivery Syst, Chuo Ku, Kobe, Hyogo 6508586, Japan; [Khafagy, El-Sayed] Suez Canal Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Ismailia 41522, Egypt	Takeda-Morishita, M (reprint author), Kobe Gakuin Univ, Fac Pharmaceut Sci, Lab Drug Delivery Syst, Chuo Ku, 1-1-3 Minatojima, Kobe, Hyogo 6508586, Japan.	mmtakeda@pharm.kobegakuin.ac.jp			JSPS KAKENHI [23590056]; Japan Student Services Organization	This study was supported in part by JSPS KAKENHI Grant Number 23590056. This work was also supported in part by the Japan Student Services Organization.	Khafagy ES, 2009, INT J PHARMACEUT, V381, P49, DOI 10.1016/j.ijpharm.2009.07.022; WINNE D, 1990, J PHARM PHARMACOL, V42, P517; Gupta B, 2005, ADV DRUG DELIVER REV, V57, P637, DOI 10.1016/j.addr.2004.10.007; PAPPENHEIMER JR, 1994, P NATL ACAD SCI USA, V91, P1942, DOI 10.1073/pnas.91.5.1942; Ziegler A, 2007, BIOCHEMISTRY-US, V46, P8138, DOI 10.1021/bi700416h; Larhed AW, 1998, PHARMACEUT RES, V15, P66, DOI 10.1023/A:1011948703571; WARD FW, 1987, LAB ANIM, V21, P216, DOI 10.1258/002367787781268693; BAI JPF, 1994, J PHARM PHARMACOL, V46, P671; Khafagy ES, 2009, J CONTROL RELEASE, V133, P103, DOI 10.1016/j.jconrel.2008.09.076; Khafagy ES, 2010, INT J PHARMACEUT, V388, P209, DOI 10.1016/j.ijpharm.2009.12.060; Ziegler A, 2008, ADV DRUG DELIVER REV, V60, P580, DOI 10.1016/j.addr.2007.10.005; Hawiger J, 1999, CURR OPIN CHEM BIOL, V3, P89, DOI 10.1016/S1367-5931(99)80016-7; Foged C, 2008, EXPERT OPIN DRUG DEL, V5, P105, DOI 10.1517/17425247.5.1.105; Jones AT, 2012, J CONTROL RELEASE, V161, P582, DOI 10.1016/j.jconrel.2012.04.003; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; Khafagy ES, 2007, ADV DRUG DELIVER REV, V59, P1521, DOI 10.1016/j.addr.2007.08.019; Morishita M, 2004, PHARM RES, V21, P309, DOI 10.1023/B:PHAM.0000016244.88820.28; Nielsen EJB, 2014, J CONTROL RELEASE, V189, P19, DOI 10.1016/j.jconrel.2014.06.022; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922; Kamei N, 2013, J PHARM SCI-US, V102, P3998, DOI 10.1002/jps.23708; Morishita M, 2006, DRUG DISCOV TODAY, V11, P905, DOI 10.1016/j.drudis.2006.08.005; Kamei N, 2013, J PHARM SCI-US, V102, P469, DOI 10.1002/jps.23364; Kamei N, 2008, J CONTROL RELEASE, V132, P21, DOI 10.1016/j.jconrel.2008.08.001; Lensink MF, 2005, BIOPHYS J, V88, P939, DOI 10.1529/biophysj.104.052787; Khafagy ES, 2012, ADV DRUG DELIVER REV, V64, P531, DOI 10.1016/j.addr.2011.12.014; Woitiski CB, 2009, EUR J PHARM BIOPHARM, V73, P25, DOI 10.1016/j.ejpb.2009.06.002; Goldberg M, 2003, NAT REV DRUG DISCOV, V2, P289, DOI 10.1038/nrd1067; Derossi D, 1996, J BIOL CHEM, V271, P18188; Foerg C, 2008, J PHARM SCI-US, V97, P144, DOI 10.1002/jps.21117; Khafagy ES, 2010, J CONTROL RELEASE, V143, P302, DOI 10.1016/j.jconrel.2010.01.019; Kamei N, 2015, EUR J PHARM BIOPHARM, V94, P42, DOI 10.1016/j.ejpb.2015.04.030; Aoki Y, 2005, PHARM RES, V22, P1854, DOI 10.1007/s11095-005-6137-z; Sonaje K, 2010, BIOMATERIALS, V31, P3384, DOI 10.1016/j.biomaterials.2010.01.042; Morishita M, 2007, J CONTROL RELEASE, V118, P177, DOI 10.1016/j.jconrel.2006.12.022; McConnell EL, 2008, J PHARM PHARMACOL, V60, P63, DOI 10.1211/jpp.60.1.0008; SCHILLING RJ, 1990, INT J PHARM, V62, P53, DOI 10.1016/0378-5173(90)90030-8; MORISHITA M, 1993, BIOL PHARM BULL, V16, P68; Lin YH, 2008, J CONTROL RELEASE, V132, P141, DOI 10.1016/j.jconrel.2008.08.020; Yamagata T, 2006, J CONTROL RELEASE, V112, P343, DOI 10.1016/j.jconrel.2006.03.005; PANTZAR N, 1993, SCAND J GASTROENTERO, V28, P205, DOI 10.3109/00365529309096073; Iyer H, 2010, DIABETES OBES METAB, V12, P179, DOI 10.1111/j.1463-1326.2009.01150.x; LAYER P, 1990, GASTROENTEROLOGY, V98, P1311; Kamei N, 2008, J CONTROL RELEASE, V131, P94, DOI 10.1016/j.jconrel.2008.07.016; Kamei N, 2009, J CONTROL RELEASE, V136, P179, DOI 10.1016/j.jconrel.2009.02.015; Su FY, 2012, BIOMATERIALS, V33, P2801, DOI 10.1016/j.biomaterials.2011.12.038; Patel LN, 2007, PHARM RES, V24, P1977, DOI 10.1007/s11095-007-9303-7; Polyansky AA, 2009, J PHYS CHEM B, V113, P1107, DOI 10.1021/jp803640e; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545; Tozaki H, 1998, J PHARM PHARMACOL, V50, P913; Mustata G, 2006, CRIT REV THER DRUG, V23, P111; ASADA H, 1994, PHARMACEUT RES, V11, P1115, DOI 10.1023/A:1018928613837; Ermund A, 2013, AM J PHYSIOL-GASTR L, V305, pG341, DOI 10.1152/ajpgi.00046.2013; Khafagy ES, 2013, EUR J PHARM BIOPHARM, V85, P736, DOI 10.1016/j.ejpb.2013.09.014; TANAKA Y, 1995, PHARMACEUT RES, V12, P523, DOI 10.1023/A:1016245711557	55	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1550-7416			AAPS J	AAPS J.	NOV	2015	17	6					1427	1437		10.1208/s12248-015-9804-y		11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CV2RJ	WOS:000364104100011		
J	Oishi-Tomiyasu, R				Oishi-Tomiyasu, Ryoko			Distribution rules of systematic absences on the Conway topograph and their application to powder auto-indexing (vol A69, pg 603, 2013)	ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES			English	Correction									High Energy Accelerator Res Org, Tsukuba, Ibaraki, Japan	Oishi-Tomiyasu, R (reprint author), High Energy Accelerator Res Org, Tsukuba, Ibaraki, Japan.	ryoko.tomiyasu@kek.jp					Oishi-Tomiyasu R, 2013, ACTA CRYSTALLOGR A, V69, P603, DOI 10.1107/S0108767313021740	1	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	2053-2733			ACTA CRYSTALLOGR A	Acta Crystallogr. Sect. A	NOV	2015	71		6				628	628		10.1107/S2053273315015065		1	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	CV4GX	WOS:000364226200008		
J	Ozawa, T; Suzuki, T; Fujita, K				Ozawa, T.; Suzuki, T.; Fujita, K.			Aerodynamic Measurements and Computational Analyses in Hypersonic Rarefied Flows	AIAA JOURNAL			English	Article							VIBRATIONAL RELAXATION; COLLISION INTEGRALS; NITROGEN; MISSION; SCHEME; ENTRY; GASES; MODEL	The Japan Aerospace Exploration Agency (JAXA) recently proposed a landing mission to Mars. To improve the feasibility of the mission, rarefied aerodynamics need to be accurately estimated for a precise determination of its flight path and landing site. This work has investigated rarefied hypersonic aerodynamics experimentally and numerically. A rarefied aerodynamic measurement scheme has been developed by using pendulous models in a hypersonic rarefied wind tunnel at JAXA, and the results have been compared with direct simulation MonteCarlo computations. Consequently, numerically predicted aerodynamic coefficients are consistent with the measured values.	[Ozawa, T.; Suzuki, T.; Fujita, K.] Japan Aerosp Explorat Agcy, Aerosp Res & Dev Directorate, Higashi Ku, Chofu, Tokyo 1828522, Japan	Ozawa, T (reprint author), Japan Aerosp Explorat Agcy, Aerosp Res & Dev Directorate, Higashi Ku, 7-44-1 Jindaiji, Chofu, Tokyo 1828522, Japan.	ozawa.takashi@jaxa.jp; suzuki.toshiyuki@jaxa.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan [25820414]	The research performed at JAXA was partly supported by the Grant-in-Aid for Young Scientists (B) No. 25820414 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan, whose support is gratefully acknowledged.	BORGNAKKE C, 1975, J COMPUT PHYS, V18, P405, DOI 10.1016/0021-9991(75)90094-7; PARKER JG, 1959, PHYS FLUIDS, V2, P449, DOI 10.1063/1.1724417; MILLIKAN RC, 1963, J CHEM PHYS, V39, P3209, DOI 10.1063/1.1734182; EBERHARDT S, 1992, J THERMOPHYS HEAT TR, V6, P208, DOI 10.2514/3.347; VANLEER B, 1979, J COMPUT PHYS, V32, P101, DOI 10.1016/0021-9991(79)90145-1; BOYD ID, 1992, AIAA J, V30, P2453, DOI 10.2514/3.11247; Ozawa T, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2907198; Fujita K, 2004, J SPACECRAFT ROCKETS, V41, P925, DOI 10.2514/1.3588; Park C, 2001, J THERMOPHYS HEAT TR, V15, P76, DOI 10.2514/2.6582; Fujita K, 2006, J THERMOPHYS HEAT TR, V20, P507, DOI 10.2514/1.18187; Ozawa T, 2011, J THERMOPHYS HEAT TR, V25, P341, DOI 10.2514/1.50714; Ozawa T, 2015, REV SCI INSTRUM, V86, DOI 10.1063/1.4905569; Capitelli M, 2000, J THERMOPHYS HEAT TR, V14, P259, DOI 10.2514/2.6517; Levin E, 2004, J THERMOPHYS HEAT TR, V18, P143, DOI 10.2514/1.2552; Fujita K, 2011, AIP CONF PROC, V1333, P407, DOI [10.1063/1.3597961, 10.1063/1.3562682]; Kannenberg KC, 1996, AIAA J, V34, P83, DOI 10.2514/3.13025; Bird G. A., 1994, MOL GAS DYNAMICS DIR, pPk11; Cook G. E., 1960, AERONAUTICAL RES COU, V523; Hedahl M. O., 1995, TM110205 NASA; MAITLAND GC, 1972, J CHEM ENG DATA, V17, P150, DOI 10.1021/je60053a015; Masson D. J., 1960, RM2678 US AIR FORC; Ozawa T., 2012, T JPN SOC AERONAUT S, V10, pPk11; Rogers K. W., 1966, P 4 INT S RAR GAS DY, V2, P151; Wainwright J. B., 1966, 61119 NASA	24	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0001-1452	1533-385X		AIAA J	AIAA J.	NOV	2015	53	11					3327	3337		10.2514/1.J053889		11	Engineering, Aerospace	Engineering	CV4KE	WOS:000364234900015		
J	Nishida, H; Shiraishi, T				Nishida, Hiroyuki; Shiraishi, Tomomi			Experimental Characterization of Dual-Grounded Tri-Electrode Plasma Actuator	AIAA JOURNAL			English	Article							DIELECTRIC BARRIER DISCHARGE; AERODYNAMIC FLOW-CONTROL; SEPARATION CONTROL; OPTIMIZATION; AIRFOIL; AIR		[Nishida, Hiroyuki] Tokyo Univ Agr & Technol, Inst Engn, Tokyo 1848588, Japan; [Shiraishi, Tomomi] Tokyo Univ Agr & Technol, Grad Sch Engn, Tokyo 1848588, Japan	Nishida, H (reprint author), Tokyo Univ Agr & Technol, Inst Engn, Tokyo 1848588, Japan.		Nishida, Hiroyuki/D-1142-2013		Japan Society for the Promotion of Science [24760659]; Foundation for the Promotion of Ion Engineering	This work was partially supported by Grant-in-Aid for Young Scientists (B) 24760659 of Japan Society for the Promotion of Science and the Foundation for the Promotion of Ion Engineering.	Enloe CL, 2004, AIAA J, V42, P595, DOI 10.2514/1.3884; Post ML, 2006, AIAA J, V44, P3125, DOI 10.2514/1.22716; Corke TC, 2007, PROG AEROSP SCI, V43, P193, DOI 10.1016/j.paerosci.2007.06.001; Nishida H, 2014, J APPL PHYS, V115, DOI 10.1063/1.4870384; Abe T, 2008, AIAA J, V46, P2248, DOI 10.2514/1.30985; Font GI, 2007, CONTRIB PLASM PHYS, V47, P103, DOI 10.1002/ctpp.200710015; Pons J, 2005, J PHYS D APPL PHYS, V38, P3635, DOI 10.1088/0022-3727/38/19/012; Post ML, 2004, AIAA J, V42, P2177, DOI 10.2514/1.2929; Roth JR, 2000, AIAA J, V38, P1166, DOI 10.2514/2.1110; Liu F, 2008, AIAA J, V46, P2969, DOI 10.2514/1.39435; Thomas FO, 2009, AIAA J, V47, P2169, DOI 10.2514/1.41588; Thomas FO, 2008, AIAA J, V46, P1921, DOI 10.2514/1.27821; Giepman RHM, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3597652; Moreau E, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/11/115204; Forte M, 2007, EXP FLUIDS, V43, P917, DOI 10.1007/s00348-007-0362-7	15	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0001-1452	1533-385X		AIAA J	AIAA J.	NOV	2015	53	11					3483	+		10.2514/1.J053784		5	Engineering, Aerospace	Engineering	CV4KE	WOS:000364234900027		
J	Kido, J; Matsumoto, T				Kido, Jun; Matsumoto, Tomoaki			Attenuated Allergenic Activity of Ovomucoid After Electrolysis	ALLERGY ASTHMA & IMMUNOLOGY RESEARCH			English	Editorial Material						Electrolysis; hen's egg allergy; ovomucoid	EGG-WHITE; STRUCTURAL-ANALYSIS; ANTIGENICITY; SEQUENCE	Ovomucoid (OMC) is the most prominent allergen causing hen's egg allergy, containing disulfide (S-S) bonds that may be responsible for its allergic action. As S-S bonds may be reduced during electrolysis, this study was undertaken to evaluate modulation of the allergic action of OMC after electrolysis. Electrolysis was carried out for 1% OMC containing 1% sodium chloride for 30 minutes with a voltage difference of 90 V. 0.23 A (30 mA/cm2). Protein assays, amino acid measurement, and mass spectrometry in untreated OMC and OMC on both the anode and cathode sides after electrolysis were performed. Moreover, 21 patients with IgE-mediated hen's egg allergy were evaluated by using the skin prick test (SPT) for untreated OMC and OMC after electrolysis. The allergic action of OMC was reduced after electrolysis on both the anode and cathode sides when evaluated by the SPT. The modifications of OMC on electrolysis caused the loss of 2 distinct peptide fragments (57E-63K and 123H-128R) as seen on matrix-associated laser desorption/ionization time-of-flight mass spectrometry. The total free SH groups in OMC were increased on the cathode side. Although the regions of S-S broken bonds were not determined in this study, the change in S-S bonds in OMC on both the anode and cathode sides may reduce the allergenic activity.	[Kido, Jun; Matsumoto, Tomoaki] Kumamoto Reg Med Ctr, Dept Pediat, Kumamoto, Kumamoto, Japan; [Kido, Jun] Kumamoto Univ, Grad Sch Med Sci, Dept Pediat, Kumamoto, Kumamoto, Japan; [Matsumoto, Tomoaki] Kumamoto Univ Hosp, Dept Child Dev, Kumamoto, Kumamoto, Japan; [Matsumoto, Tomoaki] Aso Spa Hosp, Div Pediat, Aso City, Kumamoto 8692301, Japan	Matsumoto, T (reprint author), Aso Spa Hosp, Div Pediat, 1153-1 Uchinomaki, Aso City, Kumamoto 8692301, Japan.	matsumoto@a.asospahp.jp					Kovacs-Nolan J, 2000, J AGR FOOD CHEM, V48, P6261, DOI 10.1021/jf000358e; Matsumoto T, 2011, PEDIAT ALLERG IMM-UK, V22, P235, DOI 10.1111/j.1399-3038.2010.01069.x; Ebisawa M, 2008, J ALLERGY CLIN IMMUN, V121, pS237, DOI 10.1016/j.jaci.2007.12.936; Urisu A, 1997, J ALLERGY CLIN IMMUN, V100, P171, DOI 10.1016/S0091-6749(97)70220-3; KATO I, 1987, BIOCHEMISTRY-US, V26, P193, DOI 10.1021/bi00375a027; Gevaert K, 1996, ELECTROPHORESIS, V17, P918, DOI 10.1002/elps.1150170513; Kato Y, 2001, J AGR FOOD CHEM, V49, P3661, DOI 10.1021/jf0102766; Mine Y, 2003, BIOCHEM BIOPH RES CO, V302, P133, DOI 10.1016/S0006-291X(03)00117-7; Cooke SK, 1997, J IMMUNOL, V159, P2026; BERNHISELBROADBENT J, 1994, J ALLERGY CLIN IMMUN, V93, P1047, DOI 10.1016/S0091-6749(94)70054-0; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Hosono A, 2004, Japanese patent, Patent No. [P2004-261154A, 2004261154]; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Noda R, 2010, JPN J FOOD ALLERGY, V10, P5	14	0	0	KOREAN ACAD ASTHMA ALLERGY & CLINICAL IMMUNOLOGY	JONGNO-GU	RM 1705, KUMHO BLDG 327-2, CHANGSINDONG, JONGNO-GU, SEOUL 110-540, SOUTH KOREA	2092-7355	2092-7363		ALLERGY ASTHMA IMMUN	Allergy Asthma Immunol. Res.	NOV	2015	7	6					599	604		10.4168/aair.2015.7.6.599		6	Allergy; Immunology	Allergy; Immunology	CU9ZW	WOS:000363907100011		
J	Saito, K; Nakamura, K; Ueta, M; Kurosawa, R; Fujiwara, A; Kobayashi, HH; Nakayama, M; Toko, A; Nagahama, K				Saito, Kaoru; Nakamura, Kazuhiko; Ueta, Mutsuyuki; Kurosawa, Reiko; Fujiwara, Akio; Kobayashi, Hill Hiroki; Nakayama, Masaya; Toko, Ayako; Nagahama, Kazuyo			Utilizing the Cyberforest live sound system with social media to remotely conduct woodland bird censuses in Central Japan	AMBIO			English	Article						Live sound; Archive; Social media; Cyberforest; Audio census; Remote monitoring		We have developed a system that streams and archives live sound from remote areas across Japan via an unmanned automatic camera. The system was used to carry out pilot bird censuses in woodland; this allowed us to examine the use of live sound transmission and the role of social media as a mediator in remote scientific monitoring. The system has been streaming sounds 8 h per day for more than five years. We demonstrated that: (1) the transmission of live sound from a remote woodland could be used effectively to monitor birds in a remote location; (2) the simultaneous involvement of several participants via Internet Relay Chat to listen to live sound transmissions could enhance the accuracy of census data collection; and (3) interactions through Twitter allowed members of the public to engage or help with the remote monitoring of birds and experience inaccessible nature through the use of novel technologies.	[Saito, Kaoru; Nagahama, Kazuyo] Univ Tokyo, Grad Sch Frontier Sci, Dept Nat Environm Studies, Kashiwa, Chiba 2778563, Japan; [Nakamura, Kazuhiko; Kobayashi, Hill Hiroki] Univ Tokyo, Ctr Spatial Informat Sci, Kashiwa, Chiba 2778568, Japan; [Ueta, Mutsuyuki; Kurosawa, Reiko] Japan Bird Res Assoc, Fuchu, Tokyo 1830034, Japan; [Fujiwara, Akio] Univ Tokyo, Fuji Iyashinomori Woodland Study Ctr, Yamanakako, Yamanashi 4010501, Japan; [Nakayama, Masaya] Univ Tokyo, Ctr Informat Technol, Bunkyo Ku, Tokyo, Japan; [Toko, Ayako] Toyo Univ, Dept Reg Dev Studies, Bukyo Ku, Tokyo 11238606, Japan	Saito, K (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Nat Environm Studies, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778563, Japan.	kaoru@nenv.k.u-tokyo.ac.jp; k_nakamura@csis.u-tokyo.ac.jp; mj-ueta@bird-research.jp; kurosawa@bird-research.jp; akio@uf.a.u-tokyo.ac.jp; kobayashi@csis.u-tokyo.ac.jp; nakayama@nc.u-tokyo.ac.jp; toko@toyo.jp; nagahama@nenv.k.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [23601003, 26282203]; Japan Ministry of Internal Affairs and Communications (MIC) Strategic Information and Communications R&D Promotion Program (SCOPE) [142103015]	This work was mainly supported by the Japan Society for the Promotion of Science (JSPS) and the Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grant-in-Aid for Scientific Research (Grant No. 23601003 for fiscal years 2011-2013 and 26282203 for 2014-2016). Additional support was obtained from the Japan Ministry of Internal Affairs and Communications (MIC) Strategic Information and Communications R&D Promotion Program (SCOPE) (Research Grant 142103015). We thank two anonymous referees for their valuable comments on an earlier version of the work. Special thanks go to the editors whose tireless encouragement was instrumental in improving this manuscript considerably.	Ferster CJ, 2013, COMPUT GEOSCI-UK, V51, P339, DOI 10.1016/j.cageo.2012.09.009; Daume S, 2014, FOREST ECOL MANAG, V316, P9, DOI 10.1016/j.foreco.2013.09.004; Joly A, 2014, ECOL INFORM, V23, P22, DOI 10.1016/j.ecoinf.2013.07.006; Buscher B., 2014, NEW MEDIA SOC; Fujiwara A., 1998, LANDSCAPE RES JAPAN, V60, P601; Hirano Toshiaki, 2009, Bird Research, V5, pT1; Oikarinen J., 1993, REQUEST COMMENTS 145; Parr C. S., 2008, INTERNET ENCY ECOLOG; Saito K., 1998, LANDSCAPE RES JAPAN, V60, P607; Saito K., 2006, J LANDSC ARCHIT, V2, P213; Saito K., 2006, B TOKYO U FORESTS, V116, P267; Saito K., 2002, LANDSCAPE RES JAPAN, V65, P689; Saito K., 2004, 115 JAP FOR SOC C; Ueta Mutsuyuki, 2012, Bird Research, V8, pR1; Ueta M., 2014, BIRD RES, V10, pF3; YUI M, 1980, Journal of the Yamashina Institute for Ornithology, V12, P1	16	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0044-7447	1654-7209		AMBIO	Ambio	NOV	2015	44			4	SI		S572	S583		10.1007/s13280-015-0708-y		12	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CU9CJ	WOS:000363840100007		
J	Omori, K; Yanagawa, Y; Inoue, T; Okamoto, K; Ito, H				Omori, Kazuhiko; Yanagawa, Youichi; Inoue, Teruhiro; Okamoto, Ken; Ito, Hiroshi			Pulmonary edema induced after being buried alive	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article								A 32-year-old male worker was working in a food processing plant to scrape off powder that was stuck to the wall of a tank used to store cornstarch. He was buried alive by a large amount of powder that had suddenly peeled off from the wall. He was rescued from under the tank in a state of cardiopulmonary arrest. When a helicopter carrying doctors arrived on the scene, the patient was found to be in a continued state of cardiopulmonary arrest. The doctor secured the airway by creating an incision in the cricothyroid ligament in the field. No cornstarch was observed in the trachea; however, a bloody, foamy fluid was noted flowing out of the intubation tube when chest compression was performed. The patient was transported by helicopter to a near hospital while receiving advanced cardiac life support, and the resuscitation failed to recover spontaneous circulation. The autopsy computed tomography imaging revealed a diffuse ground-glass appearance in both lung fields, suggesting pulmonary edema. Because there have been no reports concerning the immediate occurrence of pulmonary edema after the inhalation of cornstarch of itself, both hypoxia induced by suffocation and hypoxia deteriorated by concomitant pulmonary edema may have resulted in the immediate respiratory arrest observed in this case. This case report adds one more mechanism to the list of processes underlying the occurrence of death from suffocation.	[Omori, Kazuhiko; Yanagawa, Youichi; Inoue, Teruhiro; Okamoto, Ken] Shizuoka Hosp Juntendo Univ, Dept Emergency Med, Izunokuni City, Shizuoka, Japan; [Ito, Hiroshi] Numazu City Hosp, Numazu, Japan	Omori, K (reprint author), Shizuoka Hosp Juntendo Univ, Dept Emergency Med, Izunokuni City, Shizuoka, Japan.	komichiwonasu@hotmail.co.jp					Rassler B, 2007, RESP PHYSIOL NEUROBI, V159, P45, DOI 10.1016/j.resp.2007.05.008; Rubin DM, 2001, PEDIATRICS, V108, P769, DOI 10.1542/peds.108.3.769; Taylor SC, 1999, J BIOL CHEM, V274, P31217, DOI 10.1074/jbc.274.44.31217; Baumann A, 2007, ACTA ANAESTH SCAND, V51, P447, DOI 10.1111/j.1399-6576.2007.01276; Nishi K, 2010, W INDIAN MED J, V59, P124	5	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	NOV	2015	33	11							1711.e1	10.1016/j.ajem.2013.07.010		2	Emergency Medicine	Emergency Medicine	CU9KH	WOS:000363862900043		
J	Akihisa, Y; Hoshijima, H; Maruyama, K; Koyama, Y; Andoh, T				Akihisa, Yuki; Hoshijima, Hiroshi; Maruyama, Koichi; Koyama, Yukihide; Andoh, Tomio			Effects of sniffing position for tracheal intubation: a meta-analysis of randomized controlled trials	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							SIMPLE HEAD EXTENSION; DIRECT LARYNGOSCOPY; ALIGNMENT THEORY; OBESE; VIEW	Background: The purpose of this meta-analysis was to validate the efficacy of the sniffing position in the performance of intubation with direct laryngoscopy. Methods: We searched MEDLINE, the Cochrane Central Register of Controlled Trials, Embase, and Web of Science. Six randomized controlled trials comprising 2759 adult participants were analyzed. The DerSimonian-Laird method was used to calculate pooled relative risk (RR) and the 95% confidence interval (CI) of Cormack-Lehane classification, Intubation Difficulty Scale, success rate of the first intubation, and weighted mean difference of intubation time. Results: Compared with the other head positions, the sniffing position did not improve glottic visualization, success rate of the first intubation, or intubation time. However, the sniffing position was significantly associated with better Intubation Difficulty Scale compared with the simple head extension position. (RR, 1.28; 95% CI, 1.15-1.42; p<0.0001) Conclusions: Although patients do not benefit from the sniffing position in terms of glottic visualization, success rate of the first intubation, or intubation time, the sniffing position can still be recommended as the initial head position for tracheal intubation because the sniffing position provides easier intubation conditions. (C) 2015 Elsevier Inc. All rights reserved.	[Akihisa, Yuki; Maruyama, Koichi; Andoh, Tomio] Teikyo Univ, Univ Hosp Mizonokuchi, Sch Med, Kawasaki, Kanagawa 2138507, Japan; [Hoshijima, Hiroshi] Tohoku Univ, Grad Sch Dent, Div Dento Oral Anesthesiol, Sendai, Miyagi 9808575, Japan; [Koyama, Yukihide] Yokohama City Univ, Grad Sch Med, Dept Anesthesiol & Crit Care Med, Yokohama, Kanagawa 2360004, Japan	Maruyama, K (reprint author), Teikyo Univ, Univ Hosp Mizonokuchi, Dept Anesthesiol, Sch Med,Takatsu Ku, 3-8-3 Mizonokuchi, Kawasaki, Kanagawa 2138507, Japan.	ypegtj25@yahoo.co.jp; hhoshi6@gmail.com; maru555md@yahoo.co.jp; yukihidekoyama1008@gmail.com; psdelico06@yahoo.co.jp					Moher D, 2009, PHYS THER, V89, P873; Adnet F, 2001, ANESTHESIOLOGY, V94, P83, DOI 10.1097/00000542-200101000-00017; Isono S, 2005, ANESTHESIOLOGY, V103, P489, DOI 10.1097/00000542-200509000-00010; Hochman II, 1999, ANN OTO RHINOL LARYN, V108, P715; Collins JS, 2004, OBES SURG, V14, P1171, DOI 10.1381/0960892042386869; Chou HC, 2002, ANESTHESIOLOGY, V97, P753, DOI 10.1097/00000542-200209000-00040; Park SW, 2014, INT J MED SCI, V11, P1258, DOI 10.7150/ijms.8585; Greenland KB, 2010, BRIT J ANAESTH, V104, P268, DOI 10.1093/bja/aep390; Juvin P, 2003, ANESTH ANALG, V97, P595, DOI 10.1213/01.ANE.0000072547.75928.B0; Adnet F, 2001, ANESTHESIOLOGY, V95, P836, DOI 10.1097/00000542-200110000-00009; Adnet F, 1999, ANESTHESIOLOGY, V91, P1964, DOI 10.1097/00000542-199912000-00060; Benumof JL, 2002, ANESTHESIOLOGY, V97, P750, DOI 10.1097/00000542-200209000-00036; Rao SL, 2008, ANESTH ANALG, V107, P1912, DOI 10.1213/ane.0b013e31818556ed; Adnet F, 1997, ANESTHESIOLOGY, V87, P1290, DOI 10.1097/00000542-199712000-00005; Lebowitz PW, 2012, J CLIN ANESTH, V24, P104, DOI 10.1016/j.jclinane.2011.06.015; Elakkumanan LB, 2008, ACTA ANAESTH SCAND, V52, P1031, DOI 10.1111/j.1399-6576.2008.01681.x; CORMACK RS, 1984, ANAESTHESIA, V39, P1105, DOI 10.1111/j.1365-2044.1984.tb08932.x; Lee L, 2008, ANAESTHESIA, V63, P375, DOI 10.1111/j.1365-2044.2008.05492.x; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Levitan R, 2000, CRIT CARE CLIN, V16, P373, DOI 10.1016/S0749-0704(05)70118-4; Shiga T, 2005, ANESTHESIOLOGY, V103, P429, DOI 10.1097/00000542-200508000-00027; HORTON WA, 1989, BRIT J ANAESTH, V62, P6, DOI 10.1093/bja/62.1.6; Park SH, 2010, J ANESTH, V24, P526, DOI 10.1007/s00540-010-0962-x; Takenaka I, 2007, CAN J ANAESTH, V54, P129; Bannister FB, 1944, LANCET, V2, P651; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berry JM, 2007, BENUMOFS AIRWAY MANA, P379, DOI 10.1016/B978-032302233-0.50023-8; Bhattarai B, 2011, Kathmandu Univ Med J (KUMJ), V9, P58; Henderson J., 2010, MILLERS ANESTHESIA, P1573; Hidaka Syozo, 2005, Masui, V54, P370; Higgins JP, COCHRANE HDB SYSTEMA; Magill IW, 1936, AM J SURG, V34, P450, DOI 10.1016/S0002-9610(36)90666-9; Hafiizhoh Nur A. H., 2014, Middle East Journal of Anesthesiology, V22, P399; Prakash S, 2011, ANESTHESIOL RES PRAC, V2011	34	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	NOV	2015	33	11					1606	1611		10.1016/j.ajem.2015.06.049		6	Emergency Medicine	Emergency Medicine	CU9KH	WOS:000363862900013		
J	Kamiya, K; Shimizu, K; Igarashi, A; Miyake, T				Kamiya, Kazutaka; Shimizu, Kimiya; Igarashi, Akihito; Miyake, Toshiyuki			Assessment of Anterior, Posterior, and Total Central Corneal Astigmatism in Eyes With Keratoconus	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article							HIGHER-ORDER ABERRATIONS; CONTACT-LENS; SCHEIMPFLUG PHOTOGRAPHY; REFRACTIVE SURGERY; INTRAOCULAR LENSES; ELEVATION; REPEATABILITY; PENTACAM; PACHYMETRY; AGREEMENT	PURPOSE: To investigate the magnitudes and the axis orientations of anterior, posterior, and total central corneal astigmatism in eyes with keratoconus. DESIGN: Retrospective case series. METHODS: This study comprised 137 eyes of 137 keratoconic patients (97 men and 40 women; mean age +/- standard deviation, 36.9 +/- 12.2 years). The magnitude and the axis orientation of each corneal astigmatism were determined with a rotating Scheimpflug system. RESULTS: The mean magnitudes of anterior, posterior, and total central corneal astigmatism were 3.93 +/- 2.74 diopters (D), 0.93 +/- 0.64 D, and 3.90 +/- 2.75 D, respectively. With-the-rule (WTR), against-the-rule (ATR), and oblique astigmatism of the anterior corneal surface was found in 90 eyes (65.7%), 33 eyes (24.1%), and 14 eyes (10.2%), respectively, whereas the corresponding astigmatism of the posterior corneal surface was found in 14 eyes (10.2%), 15 eyes (10.9%), and 108 eyes (78.8%), respectively. We found a significant correlation between the magnitudes of anterior and posterior corneal astigmatism (Pearson correlation coefficient r = 0.769, P < .001). CONCLUSIONS: The mean magnitudes of anterior and posterior corneal astigmatism were approximately 4 D and 1 D, respectively, in eyes with keratoconus. Approximately 65% and 80% of eyes showed that WTR anterior astigmatism and ATR posterior astigmatism, respectively. The presence of posterior corneal astigmatism is not necessarily negligible for the accurate astigmatic correction of toric intraocular lens implantation or rigid gas-permeable contact lens wear for keratoconus. (C) 2015 by Elsevier Inc. All rights reserved.)	[Kamiya, Kazutaka; Shimizu, Kimiya; Igarashi, Akihito; Miyake, Toshiyuki] Kitasato Univ, Dept Ophthalmol, Sch Med, Sagamihara, Kanagawa 2520374, Japan	Kamiya, K (reprint author), Kitasato Univ, Dept Ophthalmol, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	kamiyak-tky@umin.ac.jp					Alio JL, 2014, BRIT J OPHTHALMOL, V98, P365, DOI 10.1136/bjophthalmol-2013-303765; Kawamorita T, 2009, J CATARACT REFR SURG, V35, P127, DOI 10.1016/j.jcrs.2008.10.019; Marsack JD, 2007, OPTOMETRY VISION SCI, V84, P463, DOI 10.1097/OPX.0b013e31802e64f0; Mihaltz K, 2009, CORNEA, V28, P976, DOI 10.1097/ICO.0b013e31819e34de; Nakagawa T, 2009, INVEST OPHTH VIS SCI, V50, P2660, DOI 10.1167/iovs.08-2754; Koch DD, 2012, J CATARACT REFR SURG, V38, P2080, DOI 10.1016/j.jcrs.2012.08.036; Negishi K, 2007, AM J OPHTHALMOL, V144, P924, DOI 10.1016/j.ajo.2007.08.004; Schlegel Z, 2008, J CATARACT REFR SURG, V34, P789, DOI [10.1016/j.jcrs.2007.12.036, 10.1016/j.icrs.2007.12.036]; Sauder G, 2003, EUR J OPHTHALMOL, V13, P577; Montalban R, 2013, J CATARACT REFR SURG, V39, P211, DOI 10.1016/j.jcrs.2012.10.033; Ho JD, 2010, CORNEA, V29, P632, DOI 10.1097/ICO.0b013e3181c2965f; Shankar H, 2008, J CATARACT REFR SURG, V34, P103, DOI 10.1016/j.jcrs.2007.09.013; Krumeich JH, 2009, J REFRACT SURG, V25, P357; Budak K, 1999, J CATARACT REFR SURG, V25, P1080, DOI 10.1016/S0886-3350(99)00122-4; Pinero DP, 2010, J CATARACT REFR SURG, V36, P814, DOI 10.1016/j.jcrs.2009.11.012; Ishii R, 2012, CORNEA, V31, P253, DOI 10.1097/ICO.0B013E31823D1EE0; Rao SN, 2002, OPHTHALMOLOGY, V109, P1642, DOI 10.1016/S0161-6420(02)01121-1; Tomidokoro A, 2000, OPHTHALMOLOGY, V107, P1328, DOI 10.1016/S0161-6420(00)00159-7; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; de Sanctis U, 2008, OPHTHALMOLOGY, V115, P1534, DOI 10.1016/j.ophtha.2008.02.020; Visser N, 2011, CORNEA, V30, P720, DOI 10.1097/ICO.0b013e31820009d4; Chen MH, 2008, INVEST OPHTH VIS SCI, V49, P5645, DOI 10.1167/iovs.08-1874; Nanavaty MA, 2012, J REFRACT SURG, V28, P884, DOI 10.3928/1081597X-20121106-02; Tsai PS, 2004, J CATARACT REFR SURG, V30, P2290, DOI 10.1016/j.jcrs.2004.05.021; Kamiya K, 2014, BRIT J OPHTHALMOL, V98, P459, DOI 10.1136/bjophthalmol-2013-304132; BLAND JM, 1986, LANCET, V1, P307; Samy El Gendy, 2012, CORNEA, V31, P418	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	NOV	2015	160	5					851	857		10.1016/j.ajo.2015.08.016		7	Ophthalmology	Ophthalmology	CV0CK	WOS:000363914800002		
J	Kawashima, Y; Uji, A; Ooto, S; Hangai, M; Hosoda, Y; Yoshimura, N				Kawashima, Yu; Uji, Akihito; Ooto, Sotaro; Hangai, Masanori; Hosoda, Yoshikatsu; Yoshimura, Nagahisa			Association Between Insufficient Photoreceptor Layer Plugging and Postoperative Visual Outcome in the Surgically Closed Macular Hole	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article							OPTICAL COHERENCE TOMOGRAPHY; INTERNAL LIMITING MEMBRANE; SCANNING LASER OPHTHALMOSCOPY; OUTER SEGMENT; FOVEAL MICROSTRUCTURE; SURGERY; RECOVERY; CLOSURE; ACUITY; EYES	PURPOSE: To investigate whether the photoreceptor layer status of the detached retina, which has the potential to plug the macular hole (MH), can predict postoperative visual acuity (VA). DESIGN: Retrospective, consecutive, observational case series. METHODS: A consecutive series of 48 eyes in 48 patients with surgically closed MHs were recruited into the study. Spectral-domain optical coherence tomography (SD OCT) images were obtained preoperatively and post-operatively. Length gaps between photoreceptor layers and the preoperative diameter of the basal MH in the detached part of the retina was calculated for the photoreceptor outer segment (OS') and the external limiting membrane (ELM). The postoperative photoreceptor layer status at the fovea, including continuity of the ELM line, inner segment ellipsoid line (ISe), and cone outer segment tip (COST) line, was categorized by graders. RESULTS: The preoperative OS gap length and ELM gap length correlated significantly with postoperative VA. A larger OS or ELM gap length was associated with a more severe postoperative photoreceptor layer status. Eyes with a moderately reflective lesion had a significantly longer OS gap length and ELM gap length, significantly worse postoperative VA, and more severe photoreceptor layer status than did eyes without such a moderately reflective lesion. Eyes with a better postoperative COST status had significantly better postoperative VA (P = .0465). CONCLUSIONS: OS and ELM gap length, which represent the degree of insufficiency of MH plugging, was strongly correlated with postoperative VA; moreover, these preoperative parameters were associated with the postoperative photoreceptor layer status, including glial cell proliferation. (C) 2015 by Elsevier Inc. All rights reserved.	[Kawashima, Yu; Uji, Akihito; Ooto, Sotaro; Hosoda, Yoshikatsu; Yoshimura, Nagahisa] Kyoto Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med, Kyoto 6068507, Japan; [Hangai, Masanori] Saitama Med Sch, Dept Ophthalmol, Saitama, Japan	Uji, A (reprint author), Kyoto Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	akihito1@kuhp.kyoto-u.ac.jp			INNOVATIVE TECHNO-HUB FOR INTEGRATED MEDICAL Bio-Imaging of the Project for Developing Innovation Systems (Ministry of Education, Culture, Sports, Science, and Technology [MEXT], Japan); Topcon Corporation, Tokyo, Japan; Nidek, Gamagori, Japan; Canon, Tokyo, Japan	THIS WORK WAS SUPPORTED, IN PART, BY THE INNOVATIVE TECHNO-HUB FOR INTEGRATED MEDICAL Bio-Imaging of the Project for Developing Innovation Systems (Ministry of Education, Culture, Sports, Science, and Technology [MEXT], Japan). Financial disclosures: N. Yoshimura: Topcon Corporation, Tokyo, Japan (Financial Support), Nidek, Gamagori, Japan (Financial Support, Consultant), Canon, Tokyo, Japan (Financial Support, Consultant). The following authors have no financial disclosures: Yu Kawashima, Akihito Uji, Sotaro Ooto, Masanori Hangai, and Yoshikatsu Hosoda. All authors attest that they meet the current ICMJE criteria for authorship.	Itoh Y, 2012, AM J OPHTHALMOL, V153, P111, DOI 10.1016/j.ajo.2011.05.039; Uji A, 2014, INVEST OPHTH VIS SCI, V55, P3361, DOI 10.1167/iovs.14-13948; Oh J, 2010, INVEST OPHTH VIS SCI, V51, P1651, DOI 10.1167/iovs.09-4420; Ooto S, 2012, AM J OPHTHALMOL, V154, P174, DOI 10.1016/j.ajo.2012.01.031; Shimozono M, 2011, GRAEF ARCH CLIN EXP, V249, P1469, DOI 10.1007/s00417-011-1681-1; Oh J, 2013, GRAEF ARCH CLIN EXP, V251, P477, DOI 10.1007/s00417-012-2058-9; Peyman GA, 2000, RETINA-J RET VIT DIS, V20, P554; Kusuhara S, 2004, AM J OPHTHALMOL, V138, P709, DOI 10.1016/j.ajo.2004.04.063; Michalewska Z, 2008, GRAEF ARCH CLIN EXP, V246, P823, DOI 10.1007/s00417-007-0764-5; Wakabayashi T, 2010, OPHTHALMOLOGY, V117, P1815, DOI 10.1016/j.ophtha.2010.01.017; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Villate N, 2005, AM J OPHTHALMOL, V139, P280, DOI 10.1016/j.ajo.2004.09.029; Tranos PG, 2004, AM J OPHTHALMOL, V138, P995, DOI 10.1016/j.ajo.2004.07.049; Chang LK, 2008, RETINA-J RET VIT DIS, V28, P969, DOI 10.1097/IAE.0b013e3181744165; GUYER DR, 1990, OPHTHALMOLOGY, V97, P1045; Haritoglou C, 2006, RETINA-J RET VIT DIS, V26, P618, DOI 10.1097/00006982-200607000-00005; Ko TH, 2006, ARCH OPHTHALMOL-CHIC, V124, P827, DOI 10.1001/archopht.124.6.827; Hangai M, 2007, OPHTHALMOLOGY, V114, P763, DOI 10.1016/j.ophtha.2006.07.055; Ooka E, 2011, AM J OPHTHALMOL, V152, P283, DOI 10.1016/j.ajo.2011.02.001; Kang SW, 2010, AM J OPHTHALMOL, V150, P551, DOI 10.1016/j.ajo.2010.04.030; Kadonosono K, 2000, ARCH OPHTHALMOL-CHIC, V118, P1116; Ruiz-Moreno JM, 2012, GRAEF ARCH CLIN EXP, V250, P1409, DOI 10.1007/s00417-012-1963-2; Matsumiya W, 2013, JPN J OPHTHALMOL, V57, P308, DOI 10.1007/s10384-013-0232-1; Baba T, 2008, RETINA-J RET VIT DIS, V28, P453, DOI 10.1097/IAE.0b013e3181571398; Meng QL, 2011, AM J OPHTHALMOL, V151, P896, DOI 10.1016/j.ajo.2010.11.006; HEE MR, 1995, OPHTHALMOLOGY, V102, P748; JOHNSON RN, 1988, OPHTHALMOLOGY, V95, P917; Byhr E, 1998, ACTA OPHTHALMOL SCAN, V76, P579, DOI 10.1034/j.1600-0420.1998.760513.x; Roorda A, 2002, OPT EXPRESS, V10, P405, DOI 10.1364/OE.10.000405; Sano M, 2009, AM J OPHTHALMOL, V147, P313, DOI 10.1016/j.ajo.2008.08.002; Brooks HL, 2000, OPHTHALMOLOGY, V107, P1939, DOI 10.1016/S0161-6420(00)00331-6; Ullrich S, 2002, BRIT J OPHTHALMOL, V86, P390, DOI 10.1136/bjo.86.4.390; Itoh Y, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.023; KELLY NE, 1991, ARCH OPHTHALMOL-CHIC, V109, P654; Smiddy WE, 2001, OPHTHALMOLOGY, V108, P1471, DOI 10.1016/S0161-6420(00)00645-X	35	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	NOV	2015	160	5					982	989		10.1016/j.ajo.2015.08.015		8	Ophthalmology	Ophthalmology	CV0CK	WOS:000363914800018		
J	Patel, C; Sugimoto, K; Douard, V; Shah, A; Inui, H; Yamanouchi, T; Ferraris, RP				Patel, Chirag; Sugimoto, Keiichiro; Douard, Veronique; Shah, Ami; Inui, Hiroshi; Yamanouchi, Toshikazu; Ferraris, Ronaldo P.			Effect of dietary fructose on portal and systemic serum fructose levels in rats and in KHK-/- and GLUT5(-/-) mice	AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY			English	Article						diabetes; fructosuria; glucose transporter 5; ketohexokinase; metabolic syndrome	ADIPOSE-TISSUE; GLUCOSE-METABOLISM; FRUCTOKINASE; TRANSPORT; INSULIN; EXPRESSION; RESISTANCE; INCREASES; BEVERAGES; DISEASES	Elevated blood fructose concentrations constitute the basis for organ dysfunction in fructose-induced metabolic syndrome. We hypothesized that diet-induced changes in blood fructose concentrations are regulated by ketohexokinase (KHK) and the fructose transporter GLUT5. Portal and systemic fructose concentrations determined by HPLC in wild-type mice fed for 7 days 0% free fructose were <0.07 mM, were independent of time after feeding, were similar to those of GLUT5(-/-), and did not lead to hyperglycemia. Postprandial fructose levels, however, increased markedly in those fed isocaloric 20% fructose, causing significant hyperglycemia. Deletion of KHK prevented fructose-induced hyperglycemia, but caused dramatic hyperfructosemia (> 1 mM) with reversed portal to systemic gradients. Systemic fructose in wild-type and KHK-/- mice changed by 0.34 and 1.8 mM, respectively, for every millimolar increase in portal fructose concentration. Systemic glucose varied strongly with systemic, but not portal, fructose levels in wild-type, and was independent of systemic and portal fructose in KHK-/-, mice. With ad libitum feeding for 12 wk, fructose-induced hyperglycemia in wild-type, but not hyperfructosemia in KHK-/- mice, increased HbA(1c) concentrations. Increasing dietary fructose to 40% intensified the hyperfructosemia of KHK-/- and the fructose-induced hyperglycemia of wild-type mice. Fructose perfusion or feeding in rats also caused duration- and dose-dependent hyperfructosemia and hyperglycemia. Significant levels of blood fructose are maintained independent of dietary fructose, KHK, and GLUT5, probably by endogenous synthesis of fructose. KHK prevents hyperfructosemia and fructose-induced hyperglycemia that would markedly increase HbA(1c) levels. These findings explain the hyperfructosemia of human hereditary fructosuria as well as the hyperglycemia of fructose-induced metabolic syndrome.	[Patel, Chirag; Douard, Veronique; Ferraris, Ronaldo P.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; [Sugimoto, Keiichiro] Nagaoka Perfumery Co Ltd, Res & Dev Ctr, Ibaraki, Osaka, Japan; [Sugimoto, Keiichiro; Inui, Hiroshi] Osaka Prefecture Univ, Ctr Res & Dev Bioresources, Sakai, Osaka 591, Japan; [Inui, Hiroshi] Osaka Prefecture Univ, Coll Hlth & Human Sci, Dept Clin Nutr, Habikino, Osaka, Japan; [Yamanouchi, Toshikazu] Teikyo Univ, Dept Internal Med, Tokyo 173, Japan	Patel, C (reprint author), Rutgers New Jersey Med Sch, 185 S Orange Ave, Newark, NJ 07103 USA.	ferraris@njms.rutgers.edu	Sugimoto, Keiichiro/M-5064-2015	Sugimoto, Keiichiro/0000-0003-2927-1237	National Science Foundation [IOS-1121049, IOS-1456673]; National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK-102934]	This work was supported by National Science Foundation Grants IOS-1121049 and -1456673. R. P. Ferraris also received support from National Institute of Diabetes and Digestive and Kidney Diseases Grant R01-DK-102934.	Bray GA, 2013, DIABETES CARE, V36, P11, DOI 10.2337/dc12-1631; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Barone S, 2009, J BIOL CHEM, V284, P5056, DOI 10.1074/jbc.M808128200; Schalkwijk CG, 2004, DIABETES-METAB RES, V20, P369, DOI 10.1002/dmrr.488; Cozma AI, 2012, DIABETES CARE, V35, P1611, DOI 10.2337/dc12-0073; Douard V, 2010, J AM SOC NEPHROL, V21, P261, DOI 10.1681/ASN.2009080795; Lustig RH, 2013, ADV NUTR, V4, P226, DOI 10.3945/an.112.002998; Laughlin MR, 2014, NUTRIENTS, V6, P3117, DOI 10.3390/nu6083117; Berglund ED, 2008, DIABETES, V57, P1790, DOI 10.2337/db07-1615; Shapiro A, 2008, AM J PHYSIOL-REG I, V295, pR1370, DOI 10.1152/ajpregu.00195.2008; Ishimoto T, 2012, P NATL ACAD SCI USA, V109, P4320, DOI 10.1073/pnas.1119908109; HORWITZ DL, 1975, J CLIN INVEST, V55, P1278, DOI 10.1172/JCI108047; FROESCH ER, 1962, J BIOL CHEM, V237, P3317; Jiang L, 2001, AM J PHYSIOL-GASTR L, V280, pG113; LARON Z, 1961, ARCH DIS CHILD, V36, P273; BLAKELY SR, 1981, J NUTR, V111, P307; Kawasaki T, 2012, ACTA DIABETOL, V49, P119, DOI 10.1007/s00592-010-0179-3; Johnson RJ, 2009, ENDOCR REV, V30, P96, DOI 10.1210/er.2008-0033; Trindade CEP, 2011, EARLY HUM DEV, V87, P193, DOI 10.1016/j.earlhumdev.2010.12.005; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Krauss RM, 2006, AM J CLIN NUTR, V83, P1025; Cui XL, 2004, PHYSIOL GENOMICS, V18, P206, DOI 10.1152/physiolgenomics.00056.2004; Ramasamy R, 2010, CIRC RES, V106, P1449, DOI 10.1161/CIRCRESAHA.109.213447; Wu XD, 2008, BRAIN RES, V1210, P20, DOI 10.1016/j.brainres.2008.02.094; Kawasaki T, 2004, METABOLISM, V53, P583, DOI 10.1016/j.metabol.2003.12.007; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Du L, 2012, MOL ENDOCRINOL, V26, P1773, DOI 10.1210/me.2012-1122; BONTEMPS F, 1978, BIOCHEM J, V174, P603; Douard V, 2013, J PHYSIOL-LONDON, V591, P401, DOI 10.1113/jphysiol.2011.215731; FERRARIS RP, 1990, AM J PHYSIOL, V259, pG822; Sugimoto K, 2010, J CLIN BIOCHEM NUTR, V46, P205, DOI 10.3164/jcbn.09-93; Litherland GJ, 2004, MOL CELL BIOCHEM, V261, P23, DOI 10.1023/B:MCBI.0000028734.77867.d2; Kristiansen S, 1997, AM J PHYSIOL-ENDOC M, V273, pE543; Diggle CP, 2009, J HISTOCHEM CYTOCHEM, V57, P763, DOI 10.1369/jhc.2009.953190; MAGNANI M, 1988, MECH AGEING DEV, V42, P37, DOI 10.1016/0047-6374(88)90061-9; BONTHRON DT, 1994, HUM MOL GENET, V3, P1627, DOI 10.1093/hmg/3.9.1627; Douard V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093611; Gitzelmann R, 1989, METABOLIC BASIS INHE, P399; Lanaspa MA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3434; Lanaspa MA, 2014, J AM SOC NEPHROL, V25, P2526, DOI 10.1681/ASN.2013080901; Marek G, 2015, DIABETES, V64, P508, DOI 10.2337/db14-0411; Marriott BP, 2009, J NUTR, V139, pS1228, DOI 10.3945/jn.108.098277; Mayes PA, 1993, AM J CLIN NUTR S, V58, P754; Patel C, 2015, FASEB J, V29; Patel C, 2015, AM J PHYSIOL-REG I, V309, pR499, DOI 10.1152/ajpregu.00128.2015; Sugimoto K, 2012, DIETARY SUGARS CHEM, P466; Tharabenjasin P, 2014, AM J PHYSIOL-GASTR L, V306, pG1, DOI 10.1152/ajpgi.00263.2013	47	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0193-1857	1522-1547		AM J PHYSIOL-GASTR L	Am. J. Physiol.-Gastroint. Liver Physiol.	NOV 1	2015	309	9					G779	G790		10.1152/ajpgi.00188.2015		12	Gastroenterology & Hepatology; Physiology	Gastroenterology & Hepatology; Physiology	CV2EP	WOS:000364070000008		
J	Matsushima, S; Sadoshima, J				Matsushima, Shouji; Sadoshima, Junichi			The role of sirtuins in cardiac disease	AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY			English	Review						cell death/survival; FoxO; sirtuin-activating compounds	PROMOTES CELL-SURVIVAL; MANGANESE SUPEROXIDE-DISMUTASE; STRESS-RESPONSIVE DEACETYLASE; DEPENDENT HISTONE DEACETYLASE; ISCHEMIA-REPERFUSION INJURY; FOXO TRANSCRIPTION FACTORS; SMALL-MOLECULE ACTIVATORS; PANCREATIC BETA-CELLS; FATTY-ACID OXIDATION; CEREVISIAE LIFE-SPAN	Modification of histones is one of the important mechanisms of epigenetics, in which genetic control is determined by factors other than an individual's DNA sequence. Sirtuin family proteins, which are class III histone deacetylases, were originally identified as gene silencers that affect the mating type of yeast, leading to the name "silent mating-type information regulation 2" (SIR2). They are characterized by their requirement of nicotinamide adenine dinucleotide for their enzyme activity, unlike other classes of histone deacetylases. Sirtuins have been traditionally linked to longevity and the beneficial effects of calorie restriction and DNA damage repair. Recently, sirtuins have been shown to be involved in a wide range of physiological and pathological processes, including aging, energy responses to low calorie availability, and stress resistance, as well as apoptosis and inflammation. Sirtuins can also regulate mitochondrial biogenesis and circadian clocks. Seven sirtuin family proteins (Sirt1-7) have been identified as mammalian SIR2 orthologs, localized in different subcellular compartments, namely, the cytoplasm (Sirt1, 2), the mitochondria (Sirt3, 4, 5), and the nucleus (Sirt1, 2, 6, 7). Sirt1 is evolutionarily close to yeast SIR2 and has been the most intensively investigated in the cardiovascular system. Endogenous Sirt1 plays a pivotal role in mediating the cell death/survival process and has been implicated in the pathogenesis of cardiovascular disease. Downregulation of Sirt2 is protective against ischemic-reperfusion injury. Increased Sirt3 expression has been shown to correlate with longevity in humans. In addition, Sirt3 protects cardiomyocytes from aging and oxidative stress and suppresses cardiac hypertrophy. Sirt6 has also recently been demonstrated to attenuate cardiac hypertrophy, and Sirt7 is known to regulate apoptosis and stress responses in the heart. On the other hand, the roles of Sirt4 and Sirt5 in the heart remain largely uncharacterized.	[Matsushima, Shouji; Sadoshima, Junichi] Rutgers New Jersey Med Sch, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, Newark, NJ 07103 USA; [Matsushima, Shouji] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan	Sadoshima, J (reprint author), Rutgers New Jersey Med Sch, 185 S Orange Ave, Newark, NJ 07103 USA.	sadoshju@njms.rutgers.edu			National Institutes of Health [HL067724, HL091469, HL102738, HL112330, AG023039]; Fondation Leducq Transatlantic Networks of Excellence; American Heart Association	This work was supported in part by National Institutes of Health Grants HL067724, HL091469, HL102738, HL112330, and AG023039 (to J. Sadoshima), the Fondation Leducq Transatlantic Networks of Excellence (to J. Sadoshima), and an American Heart Association postdoctoral fellowship (to S. Matsushima).	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/ju.molcel.2007.01.011; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; Baksi A, 2014, BRIT J CLIN PHARMACO, V78, P69, DOI 10.1111/bcp.12327; Liang QL, 2013, BIOCHEM J, V454, P249, DOI 10.1042/BJ20130414; Hung LM, 2004, FREE RADICAL BIO MED, V36, P774, DOI 10.1016/j.freeradbiomed.2003.12.016; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Ago T, 2010, CIRC RES, V106, P1253, DOI 10.1161/CIRCRESAHA.109.213116; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Mahlknecht U, 2009, BIOCHEM BIOPH RES CO, V382, P685, DOI 10.1016/j.bbrc.2009.03.092; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Sundaresan NR, 2012, NAT MED, V18, P1643, DOI 10.1038/nm.2961; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; PFEFFER MA, 1990, CIRCULATION, V81, P1161; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Xie M, 2014, CIRCULATION, V129, P1139, DOI 10.1161/CIRCULATIONAHA.113.002416; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Kirsh O, 2002, EMBO J, V21, P2682, DOI 10.1093/emboj/21.11.2682; Hsu CP, 2009, CIRC RES, V105, P481, DOI 10.1161/CIRCRESAHA.109.203703; Liu B, 2013, CELL PHYSIOL BIOCHEM, V32, P1050, DOI 10.1159/000354505; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Oka S, 2011, CELL METAB, V14, P598, DOI 10.1016/j.cmet.2011.10.001; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; TAKAHASHI T, 1992, J CLIN INVEST, V89, P939, DOI 10.1172/JCI115675; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Judge S, 2007, AM J PHYSIOL-CELL PH, V292, pC1983, DOI 10.1152/ajpcell.00285.2006; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Thandapilly SJ, 2010, AM J HYPERTENS, V23, P192, DOI 10.1038/ajh.2009.228; Shinmura K, 2008, AM J PHYSIOL-HEART C, V295, pH2348, DOI 10.1152/ajpheart.00602.2008; Nadtochiy SM, 2011, AM J PHYSIOL-HEART C, V301, pH1506, DOI 10.1152/ajpheart.00587.2011; Fukuda S, 2006, CELL BIOCHEM BIOPHYS, V44, P43, DOI 10.1385/CBB:44:1:043; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Buler M, 2014, FASEB J, V28, P3225, DOI 10.1096/fj.13-245241; Shao D, 2012, J MOL CELL CARDIOL, V52, P550, DOI 10.1016/j.yjmcc.2011.09.009; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Shalwala M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086977; Kang YJ, 1996, J BIOL CHEM, V271, P12610; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Ohsawa S, 2006, FEBS LETT, V580, P5875, DOI 10.1016/j.febslet.2006.09.051; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Tanno M, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0273-5; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; DAMMRICH J, 1983, VIRCHOWS ARCH B, V43, P287, DOI 10.1007/BF02932962; Inoue T, 2014, FEBS J, V281, P2623, DOI 10.1111/febs.12810; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Wang YP, 2014, EMBO J, V33, P1304, DOI 10.1002/embj.201387224; Matsushima S, 2006, CIRCULATION, V113, P1779, DOI 10.1161/CIRCULATIONAHA.105.582239; Ramakrishnan G, 2014, J BIOL CHEM, V289, P6054, DOI 10.1074/jbc.M113.537266; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Imai S, 2000, NATURE, V403, P795; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Dominy JE, 2012, MOL CELL, V48, P900, DOI 10.1016/j.molcel.2012.09.030; Sakamoto J, 2004, FEBS LETT, V556, P281, DOI 10.1016/S0014-5793(03)01444-3; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2008.08.011; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Wu YC, 2011, NEUROSIGNALS, V19, P163, DOI 10.1159/000328516; Liu B, 2013, CELL PHYSIOL BIOCHEM, V32, P655, DOI 10.1159/000354469; Masri S, 2014, CELL, V158, P659, DOI 10.1016/j.cell.2014.06.050; Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307; Liu JN, 2013, INT J MOL SCI, V14, P5633, DOI 10.3390/ijms14035633; Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Nadal-Ginard B, 2003, J CLIN INVEST, V111, P1457, DOI 10.1172/JCI200318611; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Porter GA, 2014, AM J PHYSIOL-HEART C, V306, pH1602, DOI 10.1152/ajpheart.00027.2014; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Xu P, 2011, GENE DEV, V25, P310, DOI 10.1101/gad.1984311; Nadtochiy SM, 2011, CARDIOVASC RES, V89, P643, DOI 10.1093/cvr/cvq287; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; RINE J, 1979, GENETICS, V93, P877; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; MAJNO G, 1995, AM J PATHOL, V146, P3; Becatti M, 2012, CELL MOL LIFE SCI, V69, P2245, DOI 10.1007/s00018-012-0925-5; Hsu CP, 2010, CIRCULATION, V122, P2170, DOI 10.1161/CIRCULATIONAHA.110.958033; Loch T, 2009, CARDIOVASC RES, V82, P448, DOI 10.1093/cvr/cvp092; Csiszar A, 2012, J GERONTOL A-BIOL, V67, P811, DOI 10.1093/gerona/glr228; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JC131960; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hamamori Y, 2003, J CLIN INVEST, V112, P824, DOI 10.1172/JC1200319834; Sadoshima J, 2011, AGING-US, V3, P12; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104; Wang P, 2012, AUTOPHAGY, V8, P77, DOI 10.4161/auto.8.1.18274; Zarzuelo MJ, 2013, BIOCHEM PHARMACOL, V85, P1288, DOI 10.1016/j.bcp.2013.02.015; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Kajstura J, 1996, AM J PHYSIOL-HEART C, V271, pH1215; Lynn EG, 2008, FEBS LETT, V582, P2857, DOI 10.1016/j.febslet.2008.07.016; Puca R, 2010, FREE RADICAL BIO MED, V48, P1338, DOI 10.1016/j.freeradbiomed.2010.02.015; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Fujitaka K, 2011, NUTR RES, V31, P842, DOI 10.1016/j.nutres.2011.09.028; Vakhrusheva O, 2008, CIRC RES, V102, P703, DOI 10.1161/CIRCRESAHA.107.164558; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; ARAI M, 1993, CIRC RES, V72, P463; Planavila A, 2011, CARDIOVASC RES, V90, P276, DOI 10.1093/cvr/cvq376; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Hariharan N, 2010, CIRC RES, V107, P1470, DOI 10.1161/CIRCRESAHA.110.227371; Planavila A, 2012, J MOL CELL CARDIOL, V53, P521, DOI 10.1016/j.yjmcc.2012.07.019; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Maejima Y, 2011, J MOL CELL CARDIOL, V50, P408, DOI 10.1016/j.yjmcc.2010.12.018; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Takasaka N, 2014, J IMMUNOL, V192, P958, DOI 10.4049/jimmunol.1302341; Tanno M, 2010, J BIOL CHEM, V285, P8375, DOI 10.1074/jbc.M109.090266; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Yoshizawa T, 2014, CELL METAB, V19, P712, DOI 10.1016/j.cmet.2014.03.006; Mukherjee S, 2010, CAN J PHYSIOL PHARM, V88, P1017, DOI 10.1139/y10-082; Zhang J, 2003, BIOESSAYS, V25, P808, DOI 10.1002/bies.10317; Gertz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049761; Ide T, 2001, CIRC RES, V88, P529; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Luo X, 2014, CELL BIOL INT, DOI [10.1002/cbin.10291, DOI 10.1002/CBIN.10291]; Maizel J, 2014, AM J PHYSIOL-HEART C, V307, pH1691, DOI 10.1152/ajpheart.00281.2014; Maksin-Matveev A, 2015, EXP CELL RES, V330, P81, DOI 10.1016/j.yexcr.2014.07.013; Masri S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005685; Minor RK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00070; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Rimbaud S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026391; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Tong C, 2013, FASEB J, V27, P4332, DOI 10.1096/fj.12-216473; Venkatasubramanian S, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000042; Yamamoto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098972; Zeng H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107011	155	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6135	1522-1539		AM J PHYSIOL-HEART C	Am. J. Physiol.-Heart Circul. Physiol.	NOV 1	2015	309	9					H1375	H1389		10.1152/ajpheart.00053.2015		15	Cardiac & Cardiovascular Systems; Physiology; Peripheral Vascular Disease	Cardiovascular System & Cardiology; Physiology	CV2NH	WOS:000364092900001		
J	Mizuta, K; Zhang, Y; Mizuta, F; Hoshijima, H; Shiga, T; Masaki, E; Emala, CW				Mizuta, Kentaro; Zhang, Yi; Mizuta, Fumiko; Hoshijima, Hiroshi; Shiga, Toshiya; Masaki, Eiji; Emala, Charles W., Sr.			Novel identification of the free fatty acid receptor FFAR1 that promotes contraction in airway smooth muscle	AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY			English	Article						free fatty acid; FFAR1; FFAR4; G(q)-coupled receptor; airway smooth muscle	PROTEIN-COUPLED RECEPTORS; PANCREATIC BETA-CELLS; INSULIN-SECRETION; ACTIN REORGANIZATION; GPR40; CALCIUM; OBESITY; GPR120; ACTIVATION; RELEASE	Obesity is one of the major risk factors for asthma. Previous studies have demonstrated that free fatty acid levels are elevated in the plasma of obese individuals. Medium-and long-chain free fatty acids act as endogenous ligands for the free fatty acid receptors FFAR1/GPR40 and FFAR4/GPR120, which couple to G(q) proteins. We investigated whether FFAR1 and FFAR4 are expressed on airway smooth muscle and whether they activate G(q)-coupled signaling and modulate airway smooth muscle tone. We detected the protein expression of FFAR1 and FFAR4 in freshly dissected native human and guinea pig airway smooth muscle and cultured human airway smooth muscle (HASM) cells by immunoblotting and immunohistochemistry. The long-chain free fatty acids (oleic acid and linoleic acid) and GW9508 (FFAR1/FFAR4 dual agonist) dose-dependently stimulated transient intracellular Ca2+ concentration ([Ca2+](i)) increases and inositol phosphate synthesis in HASM cells. Downregulation of FFAR1 or FFAR4 in HASM cells by small interfering RNA led to a significant inhibition of the long-chain free fatty acids-induced transient [Ca2+](i) increases. Oleic acid, linoleic acid, or GW9508 stimulated stress fiber formation in HASM cells, potentiated acetylcholine-contracted guinea pig tracheal rings, and attenuated the relaxant effect of isoproterenol after an acetylcholine-induced contraction. In contrast, TUG-891 (FFAR4 agonist) did not induce the stress fiber formation or potentiate acetylcholine-induced contraction. These results suggest that FFAR1 is the functionally dominant free fatty acid receptor in both human and guinea pig airway smooth muscle. The free fatty acid sensors expressed on airway smooth muscle could be an important modulator of airway smooth muscle tone.	[Mizuta, Kentaro; Zhang, Yi; Emala, Charles W., Sr.] Columbia Univ, Coll Phys & Surg, Dept Anesthesiol, New York, NY USA; [Mizuta, Kentaro; Mizuta, Fumiko; Hoshijima, Hiroshi; Masaki, Eiji] Tohoku Univ, Grad Sch Dent, Dept Dentooral Anesthesiol, Sendai, Miyagi 9808575, Japan; [Shiga, Toshiya] Int Univ Hlth & Welf, Chemotherapy Res Inst, Kaken Hosp, Dept Anesthesiol, Chiba, Japan	Mizuta, K (reprint author), Tohoku Univ, Grad Sch Dent, Dept Dentooral Anesthesiol, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	mizuta@m.tohoku.ac.jp			National Institute of General Medical Sciences [GM-065281]; Japan Society for the Promotion of Science [24689072, 23792311]; Takeda Science Foundation	This work was supported by National Institute of General Medical Sciences Grant GM-065281 (to C. W. Emala Sr.), Japan Society for the Promotion of Science Grants-in-Aid 24689072 (to K. Mizuta) and 23792311 (to F. Mizuta), and a research grant from Takeda Science Foundation (to K. Mizuta).	Narayanan D, 2012, AM J PHYSIOL-HEART C, V302, pH2190, DOI 10.1152/ajpheart.01146.2011; Ravnskjaer K, 2010, J LIPID RES, V51, P1370, DOI 10.1194/jlr.M001123; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Yonezawa T, 2013, CURR MED CHEM, V20, P3855; FULCERI R, 1994, CELL CALCIUM, V15, P109, DOI 10.1016/0143-4160(94)90049-3; Watson SJ, 2012, MOL PHARMACOL, V81, P631, DOI 10.1124/mol.111.077388; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Del Guerra S, 2010, NUTR METAB CARDIOVAS, V20, P22, DOI 10.1016/j.numecd.2009.02.008; Shore SA, 2010, J APPL PHYSIOL, V108, P735, DOI 10.1152/japplphysiol.00749.2009; Ou HY, 2013, AM J PHYSIOL-ENDOC M, V304, pE668, DOI 10.1152/ajpendo.00419.2012; Mizuta K, 2011, AM J RESP CELL MOL, V45, P1232, DOI 10.1165/rcmb.2011-0088OC; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Yonezawa T, 2004, BIOCHEM BIOPH RES CO, V314, P805, DOI 10.1016/j.bbrc.2003.12.175; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Mizuta K, 2008, AM J PHYSIOL-LUNG C, V294, pL523, DOI 10.1152/ajplung.00328.2007; PESSAH IN, 1991, MOL PHARMACOL, V39, P679; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hara T, 2009, MOL PHARMACOL, V75, P85, DOI 10.1124/mol.108.052225; Ethier MF, 2006, AM J RESP CELL MOL, V35, P496, DOI 10.1165/rcmb.2005-0290OC; POTTER BJ, 1989, ANNU REV NUTR, V9, P253; Fryer AD, 1998, AM J RESP CRIT CARE, V158, pS154; Gras D, 2009, AM J PHYSIOL-LUNG C, V296, pL970, DOI 10.1152/ajplung.90219.2008; Shore SA, 2006, PHARMACOL THERAPEUT, V110, P83, DOI 10.1016/j.pharmthera.2005.10.002; Mizuta K, 2012, AM J PHYSIOL-LUNG C, V302, pL316, DOI 10.1152/ajplung.00130.2011; Schnell S, 2007, MOL CELL ENDOCRINOL, V263, P173, DOI 10.1016/j.mce.2006.09.013; Einstein R, 2008, P NATL ACAD SCI USA, V105, P5230, DOI 10.1073/pnas.0801319105; Jooste E, 2005, ANESTHESIOLOGY, V102, P117, DOI 10.1097/00000542-200501000-00020; Fujiwara K, 2005, AM J PHYSIOL-ENDOC M, V289, pE670, DOI 10.1152/ajpendo.00035.2005; MacMillan D, 2005, J PHYSIOL-LONDON, V569, P533, DOI 10.1113/jphysiol.2005.096529; Feng DD, 2006, ENDOCRINOLOGY, V147, P674, DOI 10.1210/en.2005-0225; Hotta K, 1999, AM J PHYSIOL-LUNG C, V276, pL405; Arteaga-Solis E, 2013, CELL METAB, V17, P35, DOI 10.1016/j.cmet.2012.12.004; MURRAY RK, 1991, J PHYSIOL-LONDON, V435, P123; Thompson MA, 2014, AM J RESP CELL MOL, V51, P68, DOI 10.1165/rcmb.2013-0144OC; Abaraviciene SM, 2013, MOL CELL ENDOCRINOL, V381, P150, DOI 10.1016/j.mce.2013.07.025; Togashi H, 1998, AM J PHYSIOL-LUNG C, V274, pL803; Bergner A, 2002, J GEN PHYSIOL, V119, P187, DOI 10.1085/jgp.119.2.187; SPECTOR AA, 1975, SCIENCE, V190, P490, DOI 10.1126/science.1166323; Nakamoto K, 2012, BRAIN RES, V1432, P74, DOI 10.1016/j.brainres.2011.11.012; Hall IP, 2000, EUR RESPIR J, V15, P1120, DOI 10.1034/j.1399-3003.2000.01523.x; Hardy S, 2005, J BIOL CHEM, V280, P13285, DOI 10.1074/jbc.M410922200; BJORNTOR.P, 1969, ACTA MED SCAND, V185, P351; Cintra DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030571; Dixon Anne E, 2010, Proc Am Thorac Soc, V7, P325, DOI 10.1513/pats.200903-013ST; Hirshman CA, 1999, AM J PHYSIOL-LUNG C, V277, pL653; Zhao YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060255	50	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	1040-0605	1522-1504		AM J PHYSIOL-LUNG C	Am. J. Physiol.-Lung Cell. Mol. Physiol.	NOV 1	2015	309	9					L970	L982		10.1152/ajplung.00041.2015		13	Physiology; Respiratory System	Physiology; Respiratory System	CV2PD	WOS:000364097800005		
J	Yamanaka, Y; Hashimoto, S; Takasu, NN; Tanahashi, Y; Nishide, S; Honma, S; Honma, K				Yamanaka, Yujiro; Hashimoto, Satoko; Takasu, Nana N.; Tanahashi, Yusuke; Nishide, Shin-ya; Honma, Sato; Honma, Ken-ichi			Morning and evening physical exercise differentially regulate the autonomic nervous system during nocturnal sleep in humans	AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY			English	Article						physical exercise; melatonin; body temperature; autonomic nervous system; sleep EEG; heart rate variability	HEART-RATE-VARIABILITY; CIRCADIAN MELATONIN RHYTHM; PHASE DELAYS; WAKE CYCLE; LIGHT; TIME; QUALITY; TEMPERATURE; ENTRAINMENT; SECRETION	Effects of daily physical exercise in the morning or in the evening were examined on circadian rhythms in plasma melatonin and core body temperature of healthy young males who stayed in an experimental facility for 7 days under dim light conditions (< 10 lux). Sleep polysomnogram (PSG) and heart rate variability (HRV) were also measured. Subjects performed 2-h intermittent physical exercise with a bicycle ergometer at ZT3 or at ZT10 for four consecutive days, where zeitgeber time 0 (ZT0) was the time of wake-up. The rising phase of plasma melatonin rhythm was delayed by 1.1 h without exercise. Phase-delay shifts of a similar extent were detected by morning and evening exercise. But the falling phase shifted only after evening exercise by 1.0 h. The sleep PSG did not change after morning exercise, while Stage 1 + 2 sleep significantly decreased by 13.0% without exercise, and RE sleep decreased by 10.5% after evening exercise. The nocturnal decline of rectal temperature was attenuated by evening exercise, but not by morning exercise. HRV during sleep changed differentially. Very low frequency (VLF) waves increased without exercise. VLF, low frequency (LF), and high frequency (HF) waves increased after morning exercise, whereas HR increased after evening exercise. Morning exercise eventually enhanced the parasympathetic activity, as indicated by HRV, while evening exercise activated the sympathetic activity, as indicated by increase in heart rate in the following nocturnal sleep. These findings indicated differential effects of morning and evening exercise on the circadian melatonin rhythm, PSG, and HRV.	[Yamanaka, Yujiro; Nishide, Shin-ya] Hokkaido Univ, Grad Sch Med, Dept Physiol, Sapporo, Hokkaido 0608638, Japan; [Hashimoto, Satoko] Hokkaido Univ, Grad Sch Med, Res Ctr Cooperat Projects, Sapporo, Hokkaido 0608638, Japan; [Takasu, Nana N.] Osaka Univ, Grad Sch Dent, Lab Oral Chronobiol, Osaka, Japan; [Tanahashi, Yusuke] Asahikawa Med Univ, Dept Pediat, Asahikawa, Hokkaido, Japan; [Honma, Sato; Honma, Ken-ichi] Hokkaido Univ, Grad Sch Med, Dept Chronomed, Sapporo, Hokkaido 0608638, Japan	Honma, K (reprint author), Hokkaido Univ, Grad Sch Med, Dept Chronomed, Kita Ku, N15 W7, Sapporo, Hokkaido 0608638, Japan.	kenhonma@med.hokudai.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [17590197, 23390047]	The present study was supported financially in part by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology (no. 17590197 and 23390047).	Gibbons RJ, 1997, CIRCULATION, V96, P345; Leeder J, 2012, J SPORT SCI, V30, P541, DOI 10.1080/02640414.2012.660188; ASCHOFF J, 1983, J THERM BIOL, V8, P143, DOI 10.1016/0306-4565(83)90094-3; HORNE JA, 1976, ELECTROEN CLIN NEURO, V40, P178, DOI 10.1016/0013-4694(76)90162-0; Saito Y, 1996, NEUROSCI LETT, V219, P135, DOI 10.1016/S0304-3940(96)13171-2; FORET J, 1984, EXPERIENTIA, V40, P422, DOI 10.1007/BF01952375; Buxton OM, 2003, AM J PHYSIOL-REG I, V284, pR714, DOI 10.1152/ajpregu.00355.2002; Sawada Y, 1997, MED BIOL ENG COMPUT, V35, P318, DOI 10.1007/BF02534083; Buxton OM, 1997, AM J PHYSIOL-ENDOC M, V273, pE536; Miyazaki T, 2001, AM J PHYSIOL-REG I, V281, pR197; Mishima K, 2001, J CLIN ENDOCR METAB, V86, P129, DOI 10.1210/jc.86.1.129; SHAPIRO CM, 1981, SCIENCE, V214, P1253, DOI 10.1126/science.7302594; Yamanaka Y, 2010, AM J PHYSIOL-REG I, V298, pR681, DOI 10.1152/ajpregu.00345.2009; Klerman EB, 1998, AM J PHYSIOL-REG I, V274, pR991; Krauchi K, 2000, AM J PHYSIOL-REG I, V278, pR741; Camm AJ, 1996, CIRCULATION, V93, P1043; KIM HE, 1994, PHYSIOL BEHAV, V55, P645, DOI 10.1016/0031-9384(94)90039-6; Takasu NN, 2006, AM J PHYSIOL-REG I, V291, pR1799, DOI 10.1152/ajpregu.00211.2006; Sandercock GRH, 2006, SCAND J MED SCI SPOR, V16, P302, DOI 10.1111/j.1600-0838.2006.00556.x; ASCHOFF J, 1971, SCIENCE, V171, P213, DOI 10.1126/science.171.3967.213; LEWY AJ, 1980, SCIENCE, V210, P1267, DOI 10.1126/science.7434030; Barger LK, 2004, AM J PHYSIOL-REG I, V286, pR1077, DOI 10.1152/ajpregu.00397.2003; Saito M, 1995, JPN J PHYSIOL, V45, P961, DOI 10.2170/jjphysiol.45.961; SWAIN DP, 1994, MED SCI SPORT EXER, V26, P112; Hashimoto S, 1997, NEUROSCI LETT, V221, P89, DOI 10.1016/S0304-3940(96)13291-2; Ako M, 2003, PSYCHIAT CLIN NEUROS, V57, P59, DOI 10.1046/j.1440-1819.2003.01080.x; Myllymaki T, 2011, J SLEEP RES, V20, P146, DOI 10.1111/j.1365-2869.2010.00874.x; NIIJIMA A, 1992, J AUTONOM NERV SYST, V40, P155, DOI 10.1016/0165-1838(92)90026-D; BAEKELAN.F, 1966, PERCEPT MOTOR SKILL, V23, P1203; Endo T, 1995, JPN J PHYSL, V49, P425; Hashimoto S, 1994, THESIS NARA WOMENS U; Hashimoto S, 2004, SLEEP BIOL RHYTHMS, V2, P29, DOI 10.1111/j.1479-8425.2003.00078.x; Pollock ML, 1998, MED SCI SPORT EXER, V30, P975, DOI 10.1097/00005768-199806000-00032; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Saini BS, 2013, SIGNAL PROCESS, V7, P16; Shioda K, 2012, J JPN SOC CLIN SPORT, V20, P306; Uchida S, 2012, FRONTIERS NEUROLOGY, V3, P1; Willmans RL, 1974, ELECTROENCEPHALOGRAP; Yamanaka Y, 2014, AM J PHYSIOL-REG I, V307, pR546, DOI 10.1152/ajpregu.00087.2014; Youngstedt SD, 2006, SLEEP BIOL RHYTHMS, V4, P215, DOI DOI 10.1111/J.1479-8425.2006.00235.X	40	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6119	1522-1490		AM J PHYSIOL-REG I	Am. J. Physiol.-Regul. Integr. Comp. Physiol.	NOV 1	2015	309	9					R1112	R1121		10.1152/ajpregu.00127.2015		10	Physiology	Physiology	CV5OI	WOS:000364320000012		
J	Kato, T				Kato, Tadafumi			Searching for the Molecular Basis of Bipolar Disorder	AMERICAN JOURNAL OF PSYCHIATRY			English	Editorial Material							MOOD DISORDERS		RIKEN Brain Sci Inst, Lab Mol Dynam Mental Disorders, Saitama, Japan	Kato, T (reprint author), RIKEN Brain Sci Inst, Lab Mol Dynam Mental Disorders, Saitama, Japan.	kato@brain.riken.jp			Takeda Pharmaceutical	Dr. Kato has received honoraria for consultancy from Dainippon Sumitomo Pharma, Eli Lilly Japan K K., GlaxoSmithKline K.K., Janssen Pharmaceutical K.K, Taisho Toyama Pharmaceutical, and Takeda Pharmaceutical; he has received honoraria for lectures from Agilent Technologies, Astellas Pharma, Eli Lilly Japan K.K., GlaxoSmithKline K.K., Janssen Pharmaceutical K.K., Kyowa Hakko Kirin, Meiji Seika Pharma, Mochida Pharmaceutical, Pfizer Japan, Otsuka Pharmaceutical, Shionogi & Co., Taisho Toyama Pharmaceutical, Wako Pure Chemical Industries, and Yoshitomiyakuhin; he has received honoraria for manuscripts from Eli Lilly Japan K.K., Kyowa Hakko Kirin, and Otsuka Pharmaceutical; and he has received a research grant from Takeda Pharmaceutical. Dr. Freedman has reviewed this editorial and found no evidence from these relationships.	Akula N, 2014, MOL PSYCHIATR, V19, P1179, DOI 10.1038/mp.2013.170; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Elashoff M, 2007, J MOL NEUROSCI, V31, P221, DOI 10.1385/JMN/31:03:221; Kanba S, 2013, PSYCHIAT CLIN NEUROS, V67, P285, DOI 10.1111/pcn.12060; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Cruceanu C, 2015, AM J PSYCHIAT, V172, P1131, DOI 10.1176/appi.ajp.2015.14101279; Kato T, 2015, PSYCHIAT CLIN NEUROS, V69, P65, DOI 10.1111/pcn.12247; Tomita Hiroaki, 2013, Frontiers in Genetics, V4, P297, DOI 10.3389/fgene.2013.00297	8	0	0	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0002-953X	1535-7228		AM J PSYCHIAT	Am. J. Psychiat.	NOV	2015	172	11					1057	1058		10.1176/appi.ajp.2015.15081059		2	Psychiatry	Psychiatry	CV0CJ	WOS:000363914700004		
J	Kunii, Y; Zhang, WY; Xu, Q; Hyde, TM; McFadden, W; Shin, JH; Deep-Soboslay, A; Ye, TZ; Li, C; Kleinman, JE; Wang, KH; Lipska, BK				Kunii, Yasuto; Zhang, Wenyu; Xu, Qing; Hyde, Thomas M.; McFadden, Whitney; Shin, Joo Heon; Deep-Soboslay, Amy; Ye, Tianzhang; Li, Chao; Kleinman, Joel E.; Wang, Kuan Hong; Lipska, Barbara K.			CHRNA7 and CHRFAM7A mRNAs: Co-Localized and Their Expression Levels Altered in the Postmortem Dorsolateral Prefrontal Cortex in Major Psychiatric Disorders	AMERICAN JOURNAL OF PSYCHIATRY			English	Article							RECEPTOR SUBUNIT GENE; NICOTINIC RECEPTORS; BIPOLAR DISORDER; BINDING-SITES; DEPRESSIVE DISORDER; PARTIAL DUPLICATION; ALPHA-BUNGAROTOXIN; FRONTAL-CORTEX; MOUSE-BRAIN; RAT-BRAIN	Objective: CHRNA7, coding alpha-7 nicotinic acetylcholine receptor (alpha 7 nAChR), is involved in cognition through interneuron modulation of dopamine and glutamate signaling. CHRNA7 and its partially duplicated chimeric gene CHRFAM7A have been implicated in schizophrenia through linkage and association studies. Method: Expression of CHRNA7 and CHRFAM7A mRNA was measured in the postmortem prefrontal cortex in more than 700 subjects, including patients with schizophrenia, bipolar disorder, major depression, and normal comparison subjects. The effects of antipsychotics and nicotine, as well as associations of CHRNA7 SNPs with gene expression, were explored. Fluorescent in-situ hybridization was used to examine coexpression of both transcripts in the human cortex. Results: CHRFAM7A expression and CHRFAM7A/CHRNA7 ratios were higher in fetal compared with postnatal life, whereas CHRNA7 expression was relatively stable. CHRFAM7A expression was significantly elevated in all diagnostic groups, while CHRNA7 expression was reduced in the schizophrenia group and increased in the major depression group compared with the comparison group. CHRFAM7A/CHRNA7 ratios were significantly increased in the schizophrenia and bipolar disorder groups compared with the comparison group There was no effect of nicotine or antipsychotics and no association of SNPs in CHRNA7 with expression. CHRNA7 and CHRFAM7A mRNAs were expressed in the same neuronal nuclei of the human neocortex. Conclusions: These data show preferential fetal CHRFAM7A expression in the human prefrontal cortex and suggest abnormalities in the CHRFAM7A/CHRNA7 ratios in schizophrenia and bipolar disorder, due mainly to overexpression of CHRFAM7A. Given that these transcripts are coexpressed in a subset of human cortical neurons and can interact to alter function of nAChRs, these results support the concept of aberrant function of nAChRs in mental illness.	[Lipska, Barbara K.] NIMH, Human Brain Collect Core, Div Intramural Res Programs, NIH, Bethesda, MD 20892 USA; Fukushima Med Univ, Sch Med, Dept Neuropsychiat, Fukushima, Fukushima, Japan; NIMH, Unit Neural Circuits & Adapt Behav, NIH, Bethesda, MD 20892 USA; Lieber Inst Brain Dev, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Lipska, BK (reprint author), NIMH, Human Brain Collect Core, Div Intramural Res Programs, NIH, Bethesda, MD 20892 USA.	lipskab@mail.nih.gov			Intramural Research Program of the National Institute of Mental Health at the National Institutes of Health	Supported by the Intramural Research Program of the National Institute of Mental Health at the National Institutes of Health.	Thomsen MS, 2011, BIPOLAR DISORD, V13, P701, DOI 10.1111/j.1399-5618.2011.00961.x; Conroy WG, 2003, NEURON, V38, P759, DOI 10.1016/S0896-6273(03)00324-6; Utsugisawa K, 1999, NEUROSCI LETT, V270, P145, DOI 10.1016/S0304-3940(99)00473-5; Mexal S, 2010, J MOL NEUROSCI, V40, P185, DOI 10.1007/s12031-009-9233-4; Leonard S, 2002, ARCH GEN PSYCHIAT, V59, P1085, DOI 10.1001/archpsyc.59.12.1085; Quik M, 1996, J NEUROCHEM, V67, P145; Criado M, 2012, J NEUROCHEM, V123, P504, DOI 10.1111/j.1471-4159.2012.07931.x; Wang Y, 2014, J BIOL CHEM, V289, P26451, DOI 10.1074/jbc.M114.582858; Adams CE, 2002, DEV BRAIN RES, V139, P175, DOI 10.1016/S0165-3806(02)00547-3; Mathew SV, 2007, HUM MOL GENET, V16, P2921, DOI 10.1093/hmg/ddm253; Falk Lena, 2003, Brain Res Dev Brain Res, V142, P151; Hyde TM, 2011, J NEUROSCI, V31, P11088, DOI 10.1523/JNEUROSCI.1234-11.2011; Bruin JE, 2010, TOXICOL SCI, V116, P364, DOI 10.1093/toxsci/kfq103; Mexal S, 2005, MOL BRAIN RES, V139, P317, DOI 10.1016/j.molbrainres.2005.06.006; Vazdarjanova A, 2002, J NEUROSCI, V22, P10067; De Luca V, 2004, NEUROPSYCHOPHARMACOL, V29, P1522, DOI 10.1038/sj.npp.1300466; Mousavi M, 2003, NEUROSCIENCE, V122, P515, DOI 10.1016/S0306-4522(03)00460-3; Saccone NL, 2010, GENES BRAIN BEHAV, V9, P741, DOI 10.1111/j.1601-183X.2010.00608.x; Guan ZZ, 1999, NEUROREPORT, V10, P1779, DOI 10.1097/00001756-199906030-00028; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; MARKS MJ, 1986, MOL PHARMACOL, V30, P427; Joo EJ, 2010, PSYCHIAT INVEST, V7, P196, DOI 10.4306/pi.2010.7.3.196; Araud T, 2011, BIOCHEM PHARMACOL, V82, P904, DOI 10.1016/j.bcp.2011.06.018; Sinkus ML, 2009, BRAIN RES, V1291, P1, DOI 10.1016/j.brainres.2009.07.041; Hong CJ, 2004, NEUROSCI LETT, V355, P69, DOI 10.1016/j.neulet.2003.10.043; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; de Lucas-Cerrillo AM, 2011, J BIOL CHEM, V286, P594, DOI 10.1074/jbc.M110.180067; Faraone SV, 2004, HUM HERED, V57, P59, DOI 10.1159/000077543; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Benfante R, 2011, J NEUROIMMUNOL, V230, P74, DOI 10.1016/j.jneuroim.2010.09.008; Stephens SH, 2012, PSYCHIAT GENET, V22, P1, DOI 10.1097/YPG.0b013e32834c0c33; Ye TZ, 2012, BIOL PSYCHIAT, V72, P651, DOI 10.1016/j.biopsych.2012.06.014; Whiteaker P, 1999, EUR J NEUROSCI, V11, P2689, DOI 10.1046/j.1460-9568.1999.00685.x; Hajos M, 2010, CURR PHARM DESIGN, V16, P538; Lai IC, 2001, J AFFECT DISORDERS, V66, P79, DOI 10.1016/S0165-0327(00)00292-5; de Leon J, 2005, SCHIZOPHR RES, V76, P135, DOI 10.1016/j.schres.2005.02.010; Tribollet E, 2004, NEUROSCIENCE, V124, P405, DOI 10.1016/j.neuroscience.2003.09.028; FREEDMAN R, 1995, BIOL PSYCHIAT, V38, P22, DOI 10.1016/0006-3223(94)00252-X; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; Villiger Y, 2002, J NEUROIMMUNOL, V126, P86, DOI 10.1016/S0165-5728(02)00057-7; De Luca V, 2006, ACTA PSYCHIAT SCAND, V114, P211, DOI 10.1111/j.1600-0447.2006.00785.x; Stephens SH, 2009, SCHIZOPHR RES, V109, P102, DOI 10.1016/j.schres.2008.12.017; Toyohara J, 2009, ANN NUCL MED, V23, P301, DOI 10.1007/s12149-009-0240-x; Tao R, 2014, JAMA PSYCHIAT, V71, P1112; Wonnacott S, 1997, TRENDS NEUROSCI, V20, P92, DOI 10.1016/S0166-2236(96)10073-4	45	2	2	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0002-953X	1535-7228		AM J PSYCHIAT	Am. J. Psychiat.	NOV	2015	172	11					1122	1130		10.1176/appi.ajp.2015.14080978		9	Psychiatry	Psychiatry	CV0CJ	WOS:000363914700015		
J	Nakagawa, S; Ozaki, R; Take, Y; Iuchi, R; Mae, T				Nakagawa, Shigeto; Ozaki, Ritsuro; Take, Yasuhiro; Iuchi, Ryo; Mae, Tatsuo			Relationship Between Glenoid Defects and Hill-Sachs Lesions in Shoulders With Traumatic Anterior Instability	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						traumatic anterior shoulder instability; glenoid defect; Hill-Sachs lesion; bipolar lesion; quantitative measurement; 3-dimensional computed tomography	BANKART REPAIR; BONE LOSS; GLENOHUMERAL INSTABILITY; COMPUTED-TOMOGRAPHY; HUMERAL HEAD; FOLLOW-UP; DISLOCATION; PREVALENCE; MANAGEMENT; STABILITY	Background: While the combination of a glenoid defect and a Hill-Sachs lesion in a shoulder with anterior instability has recently been termed a bipolar lesion, their relationship is unclear. Purpose: To investigate the relationship of the glenoid defect and Hill-Sachs lesion and the factors that influence the occurrence of these lesions as well as the recurrence of instability. Study Design: Case-control study; Level of evidence, 3. Methods: The prevalence and size of both lesions were evaluated retrospectively by computed tomography scanning in 153 shoulders before arthroscopic Bankart repair. First, the relationship of lesion prevalence and size was investigated. Then, factors influencing the occurrence of bipolar lesions were assessed. Finally, the influence of these lesions on recurrence of instability was investigated in 103 shoulders followed for a minimum of 2 years. Results: Bipolar lesions, isolated glenoid defects/isolated Hill-Sachs lesions, and no lesion were detected in 86, 45, and 22 shoulders (56.2%, 29.4%, and 14.4%), respectively. As the glenoid defect became larger, the Hill-Sachs lesion also increased in size. However, the size of these lesions showed a weak correlation, and large Hill-Sachs lesions did not always coexist with large glenoid defects. The prevalence of bipolar lesions was 33.3% in shoulders with primary instability and 61.8% in shoulders with recurrent instability. In relation to the total events of dislocations/subluxations, the prevalence was 44.2% in shoulders with 1 to 5 events, 69.0% in shoulders with 6 to 10 events, and 82.8% in shoulders with 11 events. Regarding the type of sport, the prevalence was 58.9% in athletes playing collision sports, 53.3% in athletes playing contact sports, and 29.4% in athletes playing overhead sports. Postoperative recurrence of instability was 0% in shoulders without lesions, 0% with isolated Hill-Sachs lesions, 8.3% with isolated glenoid defects, and 29.4% with bipolar lesions. The presence of a bipolar lesion significantly influenced the recurrence rate, but lesion size did not. Conclusion: The prevalence of bipolar lesions was approximately 60%. As glenoid defects became larger, Hill-Sachs lesions also enlarged, but there was no strong correlation. Bipolar lesions were frequent in patients with recurrent instability, patients with repetitive dislocation/subluxation, and those playing collision/contact sports. Instability showed a high recurrence rate in shoulders with bipolar lesions.	[Nakagawa, Shigeto; Iuchi, Ryo] Yukioka Hosp, Dept Orthopaed Sports Med, Osaka, Osaka 5300021, Japan; [Ozaki, Ritsuro] Toyonaka City Hosp, Dept Orthopaed Surg, Osaka, Japan; [Take, Yasuhiro; Mae, Tatsuo] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Osaka, Japan	Nakagawa, S (reprint author), Yukioka Hosp, Dept Orthopaed Sports Med, 2-2-3 Ukita, Osaka, Osaka 5300021, Japan.	nakagawa@yukioka.or.jp					Sugaya H, 2003, J BONE JOINT SURG AM, V85A, P878; Kurokawa D, 2013, J SHOULDER ELB SURG, V22, P1285, DOI 10.1016/j.jse.2012.12.033; Cho SH, 2011, AM J SPORT MED, V39, P2389, DOI 10.1177/0363546511398644; Griffith JF, 2008, AM J ROENTGENOL, V190, P1247, DOI 10.2214/AJR.07.3009; Burkhart SS, 2000, ARTHROSCOPY, V16, P677, DOI 10.1053/jars.2000.17715; Voos JE, 2010, AM J SPORT MED, V38, P302, DOI 10.1177/0363546509348049; Chuang TY, 2008, ARTHROSCOPY, V24, P376, DOI 10.1016/j.arthro.2007.10.008; Zhu YM, 2011, AM J SPORT MED, V39, P1640, DOI 10.1177/0363546511400018; Sugaya H, 2005, J BONE JOINT SURG AM, V87A, P1752, DOI 10.2106/JBJS.D.02204; Milano G, 2011, AM J SPORT MED, V39, P1870, DOI 10.1177/0363546511411699; Nakagawa S, 2013, AM J SPORT MED, V41, P1380, DOI 10.1177/0363546513483087; Di Giacomo G, 2014, ARTHROSCOPY, V30, P90, DOI 10.1016/j.arthro.2013.10.004; Pagnani MJ, 2008, AM J SPORT MED, V36, P1805, DOI 10.1177/0363546508316284; Provencher MT, 2012, J AM ACAD ORTHOP SUR, V20, P242, DOI 10.5435/JAAOS-20-04-242; Itoi E, 2000, J BONE JOINT SURG AM, V82A, P35; ROWE CR, 1984, J BONE JOINT SURG AM, V66A, P159; Yamamoto N, 2009, AM J SPORT MED, V37, P949, DOI 10.1177/0363546508330139; Yamamoto N, 2007, J SHOULDER ELB SURG, V16, P649, DOI 10.1016/j.jse.2006.12.012; Larrain MV, 2006, ARTHROSCOPY, V22, P1283, DOI 10.1016/j.arthro.2006.07.052; Lo IKY, 2004, ARTHROSCOPY, V20, P169, DOI 10.1016/j.arthro.2003.11.036; Nakagawa S, 2015, AM J SPORT MED, V43, P1438, DOI 10.1177/0363546515571555; Saito H, 2009, ARCH ORTHOP TRAUM SU, V129, P1327, DOI 10.1007/s00402-009-0854-4; CALANDRA J J, 1989, Arthroscopy, V5, P254, DOI 10.1016/0749-8063(89)90138-2; Miniaci A, 2001, J BONE JOINT SURG S1, V83, P19; Nakagawa S, ORTHOP J SPORTS MED, DOI [10. 1177/2325967114529920, DOI 10.1177/2325967114529920]; Ozaki R, 2014, AM J SPORT MED, V42, P2597, DOI 10.1177/0363546514549543; Sachs M.D., 1940, RADIOLOGY, V35, P690, DOI DOI 10.1148/35.6.690; Wolf EM, 2007, ARTHROSCOPY, V23, pe1, DOI 10.1016/j.arthro.2007.03.015	28	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	NOV	2015	43	11					2763	2773		10.1177/0363546515597668		11	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	CV3XF	WOS:000364199100018		
J	Kawasaki, T; Ota, C; Yoneda, T; Maki, N; Urayama, S; Nagao, M; Nagayama, M; Kaketa, T; Takazawa, Y; Kaneko, K				Kawasaki, Takayuki; Ota, Chihiro; Yoneda, Takeshi; Maki, Nobukazu; Urayama, Shingo; Nagao, Masashi; Nagayama, Masataka; Kaketa, Takefumi; Takazawa, Yuji; Kaneko, Kazuo			Incidence of Stingers in Young Rugby Players	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						rugby; stinger; burner; epidemiology; young athlete	FOOTBALL PLAYERS; BURNER SYNDROME; UNION INJURIES; PART 2; EPIDEMIOLOGY; CONCUSSION; SCHOOL; NEURAPRAXIA; STENOSIS; NERVE	Background: A stinger is a type of neurapraxia of the cervical roots or brachial plexus and represents a reversible peripheral nerve injury. The incidence of and major risk factors for stingers among young rugby players remain uninvestigated. Purpose: To investigate the incidence, symptoms, and intrinsic risk factors for stingers in elite rugby union teams of young players. Study Design: Descriptive epidemiology study. Methods: A total of 569 male rugby players, including 358 players from 7 high school teams and 211 players from 2 university teams, were investigated using self-administered preseason and postseason questionnaires. Results: The prevalence of a history of stingers was 33.9% (95% CI, 30.3-37.9), and 20.9% (119/569) of players experienced at least 1 episode of a stinger during the season (34.2 [95% CI, 26.2-42.1] events per 1000 player-hours of match exposure). The reinjury rate for stingers per season was 37.3% (95% CI, 30.4-44.2). Using the multivariate Poisson regression method, a history of stingers in the previous season and the grade and position of the player were found to be risk factors for stingers during the current season. The mean severity of injury was 2.9 days, with 79.3% (191/241) of the players not losing any time from playing after sustaining a stinger injury and 5.8% (14/241) of the players recovering within more than 14 days. The most frequent symptom was numbness in the unilateral upper extremity, and the most severe symptom was weakness of grasping (mean severity, 6 days). A logistic regression analysis indicated that a history of stingers in the previous season and an injury with more than 3 symptoms, especially motor weakness, were correlated with the severity of injury. Conclusion: Young rugby players with a history of stingers have a significantly high rate of repeat injuries. Although nearly 80% of the players experienced only minimal (0-1 day) time loss injuries, neurological deficits sometimes last beyond 1 month. A history of stingers was identified to be the strongest risk factor for injuries and for lasting symptoms. This information may be useful for planning the proper treatment for stingers in young rugby players.	[Kawasaki, Takayuki] Juntendo Univ, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138421, Japan; [Kawasaki, Takayuki; Nagao, Masashi; Nagayama, Masataka; Kaketa, Takefumi; Takazawa, Yuji; Kaneko, Kazuo] Juntendo Univ, Fac Med, Dept Orthopaed Surg, Tokyo 1138421, Japan; [Ota, Chihiro; Yoneda, Takeshi] Keio Univ, Rugby Football Club, Yokohama, Kanagawa 223, Japan; [Maki, Nobukazu] Mejiro Orthopaed & Internal Med Clin, Tokyo, Japan; [Urayama, Shingo] Int Budo Univ, Dept Sports Med, Katsuura, Japan	Kawasaki, T (reprint author), Juntendo Univ, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	k-saki@luck.ocn.ne.jp					Bleakley C, 2011, J ATHL TRAINING, V46, P555; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Brooks JHM, 2005, BRIT J SPORT MED, V39, P767, DOI 10.1136/bjsm.2005.018408; SALLIS RE, 1992, PHYSICIAN SPORTSMED, V20, P47; ROUX CE, 1987, S AFR MED J, V71, P307; NATHAN M, 1983, S AFR MED J, V64, P132; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; ROBERTSON WC, 1979, JAMA-J AM MED ASSOC, V241, P1480, DOI 10.1001/jama.241.14.1480; Castro FP, 2003, CLIN SPORT MED, V22, P483, DOI 10.1016/S0278-5919(02)00094-7; Safran MR, 2004, AM J SPORT MED, V32, P1063, DOI 10.1177/0363546504265193; MEYER SA, 1994, AM J SPORT MED, V22, P158, DOI 10.1177/036354659402200202; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; McIntosh AS, 2010, BRIT J SPORT MED, V44, P188, DOI 10.1136/bjsm.2007.041400; Nicol A, 2011, J PUBLIC HEALTH-UK, V33, P256, DOI 10.1093/pubmed/fdq047; Collins CL, 2008, ARCH PEDIAT ADOL MED, V162, P49, DOI 10.1001/archpediatrics.2007.1; Devereaux M D, 1983, Br J Sports Med, V17, P137; McManus A, 2004, J SCI MED SPORT, V7, P438, DOI 10.1016/S1440-2440(04)80261-5; Bottini E, 2000, BRIT J SPORT MED, V34, P94, DOI 10.1136/bjsm.34.2.94; Rihn JA, 2009, SPORTS MED, V39, P697, DOI 10.2165/11315190-000000000-00000; Brooks JHM, 2008, CLIN SPORT MED, V27, P51, DOI 10.1016/j.csm.2007.09.001; Shannon B, 2002, CLIN SPORT MED, V21, P29, DOI 10.1016/S0278-5919(03)00055-3; Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Charbonneau RME, 2012, CLIN J SPORT MED, V22, P472, DOI 10.1097/JSM.0b013e3182699ed5; DAVIDSON RM, 1987, MED J AUSTRALIA, V147, P119; SPEER KP, 1990, AM J SPORT MED, V18, P591, DOI 10.1177/036354659001800606; Fuller CW, 2011, CLIN J SPORT MED, V21, P356, DOI 10.1097/JSM.0b013e31821f5085; Feinberg Joseph H, 2008, HSS J, V4, P87, DOI 10.1007/s11420-007-9064-1; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Junge A, 2004, BRIT J SPORT MED, V38, P168, DOI 10.1136/bjsm.2002.003020; Kawasaki T, 2014, J SHOULDER ELB SURG, V23, pE293, DOI 10.1016/j.jse.2014.04.009; Lee AJ, 1996, BRIT J SPORT MED, V30, P213; Levitz CL, 1997, AM J SPORT MED, V25, P73, DOI 10.1177/036354659702500114; McIntosh Andrew S, 2005, Med Sport Sci, V49, P120	33	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	NOV	2015	43	11					2809	2815		10.1177/0363546515597678		7	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	CV3XF	WOS:000364199100023		
J	Tanaka, T; Shinya, T; Sato, S; Mitsuhashi, T; Ichimura, K; Soh, J; Toyooka, S; Kaji, M; Miyoshi, S; Kanazawa, S				Tanaka, Takashi; Shinya, Takayoshi; Sato, Shuhei; Mitsuhashi, Toshiharu; Ichimura, Koichi; Soh, Junichi; Toyooka, Shinichi; Kaji, Mitsumasa; Miyoshi, Shinichiro; Kanazawa, Susumu			Predicting pleural invasion using HRCT and F-18-FDG PET/CT in lung adenocarcinoma with pleural contact	ANNALS OF NUCLEAR MEDICINE			English	Article						Lung adenocarcinoma; Visceral pleural invasion; F-18-FDG; PET/CT; HRCT	POSITRON-EMISSION-TOMOGRAPHY; CHEST-WALL INVASION; COMPUTED-TOMOGRAPHY; CANCER PATIENTS; CT; TUMOR	To evaluate the relevance of high-resolution computed tomography (HRCT) findings and fluorine-18-fluorodeoxyglucose (F-18-FDG) uptake for risk stratification of visceral pleural invasion by lung adenocarcinoma. The HRCT findings and F-18-FDG uptake for lung adenocarcinomas with pleural contact on CT were retrospectively analyzed in 208 consecutive patients (94 females and 114 males; median age, 69.0 years) between January 2009 and December 2013, with institutional review board approval. The HRCT findings and maximum standardized uptake value (SUVmax) were recorded for each patient. Multivariate logistic regression was used for statistical analysis, and subgroup analysis stratified for whole tumor size a parts per thousand currency sign3 cm was also performed. Multivariate analysis showed that SUVmax [odds ratio (OR) 1.09, 95 % confidence interval (CI) 1.02-1.16, P = 0.014] and obtuse angle (OR 4.14, 95 % CI 1.97-8.74, P < 0.001) were significant independent predictors for visceral pleural invasion. Receiver operating characteristic (ROC) analysis showed that, compared with the multivariate models [area under the curve (Az) 0.819-0.829], SUVmax alone (Az 0.815) was useful in predicting visceral pleural invasion. In the subgroup analysis, multivariate analysis showed that SUVmax (OR 1.29, 95 % CI 1.12-1.50, P = 0.001) and contact length with the pleura (OR 1.13, 95 % CI 1.05-1.22, P = 0.001) were significant independent predictors for visceral pleural invasion. ROC analysis showed that SUVmax alone (Az 0.844) showed similar diagnostic performance to the multivariate models (Az 0.845-0.857). SUVmax alone and multivariate models including SUVmax are useful for the prediction of visceral pleural invasion by lung adenocarcinoma.	[Tanaka, Takashi; Shinya, Takayoshi; Sato, Shuhei; Kanazawa, Susumu] Okayama Univ Hosp, Dept Radiol, Okayama 7008558, Japan; [Mitsuhashi, Toshiharu] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama 7008558, Japan; [Ichimura, Koichi] Okayama Univ Hosp, Dept Pathol, Okayama 7008558, Japan; [Soh, Junichi; Toyooka, Shinichi; Miyoshi, Shinichiro] Okayama Univ Hosp, Dept Gen Thorac Surg, Okayama 7008558, Japan; [Kaji, Mitsumasa] Okayama Diagnost Imaging Ctr, Okayama 7000913, Japan	Tanaka, T (reprint author), Okayama Univ Hosp, Dept Radiol, 2-5-1 Shikatacho, Okayama 7008558, Japan.	p9r543qa@s.okayama-u.ac.jp					SUZUKI N, 1993, RADIOLOGY, V187, P39; Tamura M, 2011, WORLD J SURG, V35, P2010, DOI 10.1007/s00268-011-1145-0; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Yanagawa M, 2014, RADIOLOGY, V272, P557, DOI 10.1148/radiol.14131903; SHIRAKAWA T, 1994, RADIOLOGY, V192, P809; Tsutani Y, 2012, J THORAC CARDIOV SUR, V144, P1365, DOI 10.1016/j.jtcvs.2012.07.012; Hamasaki M, 2012, VIRCHOWS ARCH, V461, P513, DOI 10.1007/s00428-012-1317-9; Hattori A, 2014, INTERACT CARDIOV TH, V18, P329, DOI 10.1093/icvts/ivt500; Higashi K, 2002, J NUCL MED, V43, P39; Imai K, 2013, RADIOLOGY, V267, P619, DOI 10.1148/radiol.12120864; RATTO GB, 1991, ANN THORAC SURG, V51, P182; Kato T, 2012, LUNG CANCER, V77, P394, DOI 10.1016/j.lungcan.2012.04.002; Akata S, 2008, J MED IMAG RADIAT ON, V52, P36, DOI 10.1111/j.1440-1673.2007.01908.x; GLAZER HS, 1985, RADIOLOGY, V157, P191; Casali C, 2010, LUNG CANCER, V69, P187, DOI 10.1016/j.lungcan.2009.10.015; MURATA K, 1994, RADIOLOGY, V191, P251; Kawaguchi K, 2009, LUNG CANCER, V64, P41, DOI 10.1016/j.lungcan.2008.07.006; Takenaka T, 2012, SURG TODAY, V42, P934, DOI 10.1007/s00595-012-0277-7; WILLIFORD ME, 1983, AM J ROENTGENOL, V140, P909; Tsutani Y, 2013, J THORAC CARDIOV SUR, V146, P580, DOI 10.1016/j.jtcvs.2013.04.032; Domen H, 2013, JPN J CLIN ONCOL, V43, P874, DOI 10.1093/jjco/hyt100; Maeda Ryo, 2009, Interact Cardiovasc Thorac Surg, V9, P79, DOI 10.1510/icvts.2008.201251; Neri S, 2014, ANN SURG; Travis WBE, 2004, INT HIST CLASSIFICAT	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	NOV	2015	29	9					757	765		10.1007/s12149-015-0999-x		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CU9RH	WOS:000363882000001		
J	Nishimatsu, K; Nakamoto, Y; Ishimori, T; Togashi, K				Nishimatsu, Kayo; Nakamoto, Yuji; Ishimori, Takayoshi; Togashi, Kaori			FDG uptake observed around the lumbar spinous process: relevance to Baastrup disease	ANNALS OF NUCLEAR MEDICINE			English	Article						Positron emission tomography; Computed tomography; Spine; Lumbar spinous process; Baastrup disease	POSITRON-EMISSION-TOMOGRAPHY; KISSING SPINE; SOFT-TISSUES; PET/CT	In positron emission tomography (PET) with F-18-fluorodeoxyglucose (FDG), non-tumorous focal uptake is often observed around the lumbar spinous processes (LSPs). Close approximation of LSPs with sclerosis is often seen, which is called Baastrup disease. The aim of this study was to characterize this finding in terms of location and subjects' age and investigate the relation between PET and CT findings. The PET/CT scans of 40 patients each in the fifth, sixth, seventh, eighth, and ninth decades were screened for FDG uptake around the LSPs from L1-2 through L5-S1. Patients with metastasis to the lumbar spine or recent chemotherapy or rheumatoid arthritis-related disease were excluded. Focal uptake greater than blood pool activity was considered positive. Positive uptake was compared among the ages and locations. We also evaluated the relationship between FDG uptake and CT morphology. Overall, focal uptake was observed in 122 LSPs in 71 patients. At least one positive uptake was seen in 9, 21, 15, 12, and 14 of 40 patients (16, 30, 30, 20, and 26 of 200 regions) in each age group of 40s through 80s, respectively (p = 0.12). As for the location, uptake around L1-2, L2-3, L3-4, L4-5, and L5-S1 was observed in 19, 22, 39, 35, and 7 regions, respectively (p < 0.01). There was no statistically significant difference in PET positivity among the five age groups, but positive uptake was predominantly seen in L3-4. Degeneration on CT was apparent in 58, 74, 108, 123, and 144 regions in each age group, respectively (p < 0.01), and in 38, 79, 131, 151, and 108 regions in each location, respectively (p < 0.01). The PET positive ratio was higher in CT positive group than in CT negative group (14 vs. 10 %, p < 0.05), but there was no significant difference of quantitative values (p = 0.10). Of 42 regions in 27 patients who had serial PET/CT scans that were initially PET-positive, 35 regions (83 %) turned negative on a later PET-scan. Focal uptake around the LSPs was commonly seen in the mid-lumbar vertebrae, independent of age, and was not always correlated with morphological changes. This uptake should not be assumed to represent osseous metastasis.	[Nishimatsu, Kayo; Nakamoto, Yuji; Ishimori, Takayoshi; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan	Nakamoto, Y (reprint author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan.	ynakamo1@kuhp.kyoto-u.ac.jp					Aliyev A, 2012, HELL J NUCL MED, V15, P197, DOI 10.1967/s002449910054; Baastrup CL, 1933, ACTA RADIOL, V14, P52, DOI 10.3109/00016923309132353; Ho L, 2009, CLIN NUCL MED, V34, P896, DOI 10.1097/RLU.0b013e3181beceeb; Keorochana G, 2010, EUR SPINE J, V19, P1740, DOI 10.1007/s00586-010-1327-8; Chen CKH, 2004, AM J ROENTGENOL, V182, P191; Aylott CEW, 2012, EUR SPINE J, V21, P1007, DOI 10.1007/s00586-011-2029-6; RESNICK D, 1985, RADIOLOGY, V156, P3; Yamashita H, 2013, JOINT BONE SPINE, V80, P171, DOI 10.1016/j.jbspin.2012.04.006; Kwong Y, 2011, AM J ROENTGENOL, V196, P1156, DOI 10.2214/AJR.10.5719; Zincirkeser S, 2007, J INT MED RES, V35, P231; Hui C, 2007, CLIN RADIOL, V62, P495, DOI 10.1016/j.crad.2006.12.003; SARTORIS DJ, 1985, AM J ROENTGENOL, V145, P1025; Rosen RS, 2006, J NUCL MED, V47, P1274; Stumpe KDM, 2002, AM J ROENTGENOL, V179, P1151; Gorospe L, 2008, CLIN NUCL MED, V33, P133, DOI 10.1097/RLU.0b013e31815ef7ad; Lin E, 2008, SKELETAL RADIOL, V37, P173, DOI 10.1007/s00256-007-0379-2; Jang EC, 2010, EUR SPINE J, V19, pS165, DOI 10.1007/s00586-009-1262-8; BEKS JWF, 1989, ACTA NEUROCHIR, V100, P134, DOI 10.1007/BF01403600; Boellaard R, 2009, J NUCL MED S1, V50, P11, DOI DOI 10.2967/JNUMED.108.057182; Maes R, 2008, SPINE, V33, pE211, DOI 10.1097/BRS.0b013e318169614a	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	NOV	2015	29	9					766	771		10.1007/s12149-015-1003-5		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CU9RH	WOS:000363882000002		
J	Yamada, Y; Nakatani, H; Yanaihara, H; Omote, M				Yamada, Yoshinori; Nakatani, Hiroshi; Yanaihara, Hisashi; Omote, Masahiro			Phase I clinical trial of Tc-99m-etarfolatide, an imaging agent for folate receptor in healthy Japanese adults	ANNALS OF NUCLEAR MEDICINE			English	Article						Tc-99m-etarfolatide; Folate receptor; Companion diagnostics; SPECT; Phase I	ANTITUMOR-ACTIVITY; OVARIAN-CANCER; VINTAFOLIDE; EXPRESSION; CONJUGATE; ALPHA; EC145	Technetium etarfolatide (Tc-99m-EF) is a radioactive diagnostic imaging agent that was developed to assess the expression of folate receptors in tumors. Administering folic acid prior to the administration of Tc-99m-EF has been shown to improve SPECT images. Here, we conducted a phase I clinical trial to assess the safety, pharmacokinetics, and radiation dosimetry of Tc-99m-EF injection following pre-administration of folic acid in healthy Japanese male adults. Six healthy Japanese male adults were enrolled in the study. Folic acid was intravenously administered, followed 1-3 min later by an intravenous injection of Tc-99m-EF (740 MBq +/- A 20 %). Assessments of subjective symptoms and objective findings, electrocardiograms, physical examination, and laboratory tests were performed before and up to 7 days after the injection to assess the safety of Tc-99m-EF. Blood and urine collections and whole-body planar imaging were conducted at various time points up to 24 h after the injection to assess the pharmacokinetics of Tc-99m-EF. The internal radiation dosimetry was calculated based on the pharmacokinetics results using the MIRD method. Five adverse events were observed in three subjects (50 %) after administration of the folic acid and Tc-99m-EF, while these events were mild and non-serious. Of those five events, three were considered to be related to the administered agents. The radioactivity in blood rapidly decreased and showed a biphasic profile. The activity of Tc-99m-EF at 5 min post injection was largest in the bone marrow, followed by the liver and kidneys, and had decreased within 24 h in all organs/tissues without appreciable retention. The pharmacokinetics results suggested that Tc-99m-EF was mainly eliminated by kidney. The results also suggested that when administered at 925 MBq of Tc-99m-EF, which is the maximum dose generally used for clinical trials in other countries, the corresponding effective dose of Tc-99m-EF is equal to or less than those determined for the current radioactive diagnostic imaging agents. The results of this study assessing the safety and radiation dosimetry of Tc-99m-EF with folic acid pre-administration suggested that folic acid and Tc-99m-EF should be appropriate for further studies. No pharmacokinetics concerns were noted.	[Yamada, Yoshinori; Nakatani, Hiroshi] Kitasato Univ, Kitasato Inst Hosp, Biomed Res Ctr, Minato Ku, Tokyo 1088642, Japan; [Yanaihara, Hisashi] Kitasato Univ, Kitasato Inst Hosp, Dept Diagnost Radiol & Intervent, Tokyo 1088642, Japan; [Omote, Masahiro] Nihon Medi Phys Co Ltd, Clin Dev Dept, Tokyo, Japan	Yamada, Y (reprint author), Kitasato Univ, Kitasato Inst Hosp, Biomed Res Ctr, Minato Ku, 5-9-1 Shirokane, Tokyo 1088642, Japan.	yamada-y@insti.kitasato-u.ac.jp; nakatani@insti.kitasato-u.ac.jp; yanaq@insti.kitasato-u.ac.jp; masahiro_omote@nmp.co.jp			Nihon Medi-Physics Co., Ltd (Tokyo, Japan); Pharma International Co., Ltd (Tokyo, Japan)	This study was sponsored by Nihon Medi-Physics Co., Ltd (Tokyo, Japan). Pharma International Co., Ltd (Tokyo, Japan) supported the preparation of the article and the cost of the preparation was borne by Nihon Medi-Physics. Masahiro Omote is an employee of Nihon Medi-Physics.	Naumann RW, 2013, J CLIN ONCOL, V31, P4400, DOI 10.1200/JCO.2013.49.7685; WEITMAN SD, 1994, J NEURO-ONCOL, V21, P107, DOI 10.1007/BF01052894; Morris RT, 2014, ANN ONCOL, V25, P852, DOI 10.1093/annonc/mdu024; Leamon CP, 2007, MOL PHARM, V4, P659, DOI 10.1021/mp070049c; ROSS JF, 1994, CANCER, V73, P2432, DOI 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S; Wu M, 1999, CANCER EPIDEM BIOMAR, V8, P775; Fisher RE, 2008, J NUCL MED, V49, P899, DOI 10.2967/jnumed.107.049478; Reddy JA, 2007, CANCER RES, V67, P4434, DOI 10.1158/0008.CAN-07-0033; Parker N, 2005, ANAL BIOCHEM, V338, P284, DOI 10.1016/j.ab.2004.12.026; Reddy JA, 2006, CANCER CHEMOTH PHARM, V58, P229, DOI 10.1007/s00280-005-0151-z; Bueno R, 2001, J THORAC CARDIOV SUR, V121, P225, DOI 10.1067/mtc.2001.111176; Maurer AH, 2014, J NUCL MED, V55, P701, DOI 10.2967/jnumed.113.133074; Endocyte, STUD EC0225 TREATM R; Endocyte, PHAS II STUD EC17 FO; Endocyte, STUD WOM PLAT RES OV; Endocyte, FOL AC TUB CONJ EC14; Endocyte, 2014, INV BROCH 99MTC ET E; Endocyte, STUD EC0489 TREATM R; Endocyte, PHAS 2 STUD EC145 AL; Endocyte, SAF BIOD TECHN TC 99; Endocyte, SAF EFF FOLATESCAN T; Endocyte, EV BIOD SAF 99MTC ET; ICRP, 1998, ANN ICRP, V80; ICRP, 1992, ANN ICRP, V22; Leamon CP, 2002, BIOCONJUGATE CHEM, V13, P1200, DOI 10.1021/bc0200430; Merck Sharp and Dohme Corp, STUD MK 8109 VINT GI; Merck Sharp and Dohme Corp, STUD VINT MK 8109 EC; Ministry of Health Labour and Welfare, SUMM VIT STAT; Sausville EA, 2011, HARRISONS PRINCIPLES, P705; Toffoli G, 1997, INT J CANCER, V74, P193, DOI 10.1002/(SICI)1097-0215(19970422)74:2<193::AID-IJC10>3.0.CO;2-F	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	NOV	2015	29	9					792	798		10.1007/s12149-015-1006-2		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CU9RH	WOS:000363882000006		
J	Wang, JH; Ma, K; Li, K; Fan, HW				Wang, Jianhua; Ma, Kai; Li, Kang; Fan, Huawei			Deformations of the spin currents by topological screw dislocation and cosmic dispiration	ANNALS OF PHYSICS			English	Article						Topological defect; Cosmic string; Spin Hall effect	GRAVITATIONAL-FIELD; DIRAC OSCILLATOR; LANDAU-LEVELS; DOMAIN-WALLS; STRINGS; TRANSPORT; DEFECTS; ELECTRON; TORSION; SPACE	We study the spin currents induced by topological screw dislocation and cosmic dispiration. By using the extended Drude model, we find that the spin dependent forces are modified by the non-trivial geometry. For the topological screw dislocation, only the direction of spin current is bent by deforming the spin polarization vector. In contrast, the force induced by cosmic dispiration could affect both the direction and magnitude of the spin current. As a consequence, the spin-Hall conductivity does not receive corrections from screw dislocation. (C) 2015 Elsevier Inc. All rights reserved.	[Wang, Jianhua; Ma, Kai] Shaanxi Univ Technol, Sch Phys Sci, Hanzhong 723000, Shaanxi, Peoples R China; [Li, Kang] Hangzhou Normal Univ, Dept Phys, Hangzhou 310036, Zhejiang, Peoples R China; [Fan, Huawei] Shaanxi Normal Univ, Sch Phys & Informat Technol, Xian 710000, Shaanxi, Peoples R China	Ma, K (reprint author), KEK Theory Ctr & Sokendai, Tsukuba, Ibaraki 3050801, Japan.	makainca@gmail.com			China Scholarship Council; Hanjiang Scholar Project of Shaanxi University of Technology; National Natural Science Foundation of China [11147181, 11175053, 11475051]; Scientific Research Project in Shaanxi Province [2009K01-54, 12JK0960]	K.M. is supported by the China Scholarship Council and the Hanjiang Scholar Project of Shaanxi University of Technology. J.H.W. is supported by the National Natural Science Foundation of China under Grant No. 11147181 and the Scientific Research Project in Shaanxi Province under Grant Nos. 2009K01-54 and 12JK0960. K.L. is supported by National Natural Science Foundation of China under Grant Nos. 11175053 and 11475051.	GALTSOV DV, 1993, PHYS REV D, V47, P4273, DOI 10.1103/PhysRevD.47.4273; Wang JH, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.032107; Bakke K, 2009, EUR PHYS J C, V64, P169, DOI 10.1140/epjc/s10052-009-1148-2; Marques GD, 2001, J PHYS A-MATH GEN, V34, P5945, DOI 10.1088/0305-4470/34/30/306; Hirsch JE, 1999, PHYS REV LETT, V83, P1834, DOI 10.1103/PhysRevLett.83.1834; Bakke K, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.024008; Belich H, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.025026; Murakami S, 2003, SCIENCE, V301, P1348, DOI 10.1126/science.1087128; Chowdhury D, 2013, ANN PHYS-NEW YORK, V339, P358, DOI 10.1016/j.aop.2013.09.011; VILENKIN A, 1985, PHYS REP, V121, P263, DOI 10.1016/0370-1573(85)90033-X; FURTADO C, 1994, PHYS LETT A, V195, P90, DOI 10.1016/0375-9601(94)90432-4; Basu B, 2013, ANN PHYS-NEW YORK, V335, P47, DOI 10.1016/j.aop.2013.04.014; Matsuo M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.076601; Chowdhury D, 2013, ANN PHYS-NEW YORK, V329, P166, DOI 10.1016/j.aop.2012.10.008; Chowdhury D, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.125014; HINDMARSH MB, 1995, REP PROG PHYS, V58, P477, DOI 10.1088/0034-4885/58/5/001; Bakke K, 2009, EUR PHYS J C, V60, P501, DOI 10.1140/epjc/s10052-009-0944-z; HISCOCK WA, 1985, PHYS REV D, V31, P3288, DOI 10.1103/PhysRevD.31.3288; Zhang SF, 2000, PHYS REV LETT, V85, P393, DOI 10.1103/PhysRevLett.85.393; BARRIOLA M, 1989, PHYS REV LETT, V63, P341, DOI 10.1103/PhysRevLett.63.341; Mota HF, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.027702; Basu B, 2013, PHYS LETT A, V377, P1661, DOI 10.1016/j.physleta.2013.05.012; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; VILENKIN A, 1983, PHYS LETT B, V133, P177, DOI 10.1016/0370-2693(83)90554-3; Gradhand M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.186403; DYAKONOV MI, 1971, PHYS LETT A, VA 35, P459, DOI 10.1016/0375-9601(71)90196-4; FOLDY LL, 1950, PHYS REV, V78, P29, DOI 10.1103/PhysRev.78.29; Bakke K, 2013, GEN RELAT GRAVIT, V45, P1847, DOI 10.1007/s10714-013-1561-6; KATANAEV MO, 1992, ANN PHYS-NEW YORK, V216, P1, DOI 10.1016/0003-4916(52)90040-7; Katanaev MO, 1999, ANN PHYS-NEW YORK, V271, P203, DOI 10.1006/aphy.1998.5859; Ma K, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.012104; Bakke K, 2013, ANN PHYS-NEW YORK, V336, P489, DOI 10.1016/j.aop.2013.06.007; DYAKONOV MI, 1971, JETP LETT-USSR, V13, P467; Sinova J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126603; Murakami S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.156804; Bakke K, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.064012; Bakke K, 2014, ANN PHYS-NEW YORK, V346, P51, DOI 10.1016/j.aop.2014.04.003; Chowdhury D, 2014, PHYSICA B, V448, P155, DOI [10.1016/j.physb.2014.04.026, 10.1016/.physb.2014.04.026]; Chudnovsky EM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.199704; Chudnovsky EM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.206601; Dayi O.F., 2009, PHYS LETT A, V373, P131; De Lorenci VA, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.085013; De Lorenci VA, 2004, NUCL PHYS B-PROC SUP, V127, P152, DOI 10.1016/j.nuclphysbps.2003.12.028; de Mello ERB, 2004, J HIGH ENERGY PHYS; de Assis JG, 2000, PHYS REV D, V62, DOI 10.1103/PhysRevD.62.045003; Furtado C., 1994, PHYS LETT A, V188, P392; KIBBLE TWB, 1976, J PHYS A-MATH GEN, V9, P1387, DOI 10.1088/0305-4470/9/8/029; Kravchenko VY, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.199703; Liu XJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.026602; Montero M, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.012337; De Lorenci VA, 2003, PHYS REV D, V67, DOI 10.1103/PhysRevD.67.124002; Murakami S, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.235206; Rong SJ, 2012, MOD PHYS LETT A, V27, DOI 10.1142/S0217732312500939; Rong SJ, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/12/121401; Rong SJ, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/4/041402; Shen JQ, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.067501; Shibata J, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.086603; Yang HX, 2008, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2008/08/024	58	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-4916	1096-035X		ANN PHYS-NEW YORK	Ann. Phys.	NOV	2015	362						327	335		10.1016/j.aop.2015.08.004		9	Physics, Multidisciplinary	Physics	CV1DF	WOS:000363992900019		
J	Dempke, WCM; Edvardsen, K; Lu, S; Reinmuth, N; Reck, M; Inoue, A				Dempke, Wolfram C. M.; Edvardsen, Klaus; Lu, Shun; Reinmuth, Niels; Reck, Martin; Inoue, Akira			Brain Metastases in NSCLC - are TKIs Changing the Treatment Strategy?	ANTICANCER RESEARCH			English	Review						NSCLC; brain metastases; tyrosine kinase inhibitors; review	CELL LUNG-CANCER; GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; PHASE-II TRIAL; RADIATION-THERAPY; SYSTEM METASTASES; TARGETED THERAPY; BREAST-CANCER; CRIZOTINIB; GEFITINIB	Non-small-cell lung cancer (NSCLC) ranks as a leading cause of cancer-related death globally. Brain metastases are a frequent complication of NSCLC, with 25-40% of patients developing brain metastases during the course of the disease, often within the first 2 years after diagnosis of the primary tumor. Improvements in neurological symptoms and performance status have been reported with whole-brain radiation therapy (WBRT) in combination with steroid therapy in NSCLC patients. In addition, a survival benefit has been reported for patients with a single brain metastasis treated with stereotactic radiosurgery, while the clinical outcome is improved with surgery followed by WBRT versus WBRT alone. However, due to their poor performance status, many patients with brain metastases are not eligible for surgery or radiosurgery. Furthermore, the role of systemic chemotherapy for the treatment of brain metastases is controversial due to the impenetrable nature of the blood brain barrier (BBB), with reported response rates to chemotherapy ranging from 15-30% (overall survival [OS] 6-8 months). Response rates of brain metastases to EGFR tyrosine kinase inhibitor (TKI) treatment (e.g. gefitinib, erlotinib, afatinib) in patients with NSCLC harboring EGFR mutations reach 60-80%, with a complete response rate as high as 40%. Median OS is 15-20 months, and progression-free survival in the brain reaches 6.6-11.7 months, demonstrating an improved clinical outcome. Metastatic involvement of the CNS appears to be a relatively common complication in patients with ALK-positive NSCLC and the CNS represents a dominant site of progression in ALK-positive patients treated with the ALK TKI crizotinib. In addition, CNS progression on crizotinib contributes substantially to the high levels of morbidity and mortality observed among patients with ALK-rearrangements, a finding that is consistent with low CNS penetration of the drug. Second-generation ALK inhibitors (ceritinib, alectinib) are well-tolerated and demonstrate excellent intracranial activity. The various reports of dramatic and prolonged responses in brain metastases patients treated with EGFR and ALK TKIs suggest that these agents may be a valid treatment option for patients with asymptomatic brain metastases from NSCLC, especially for those with EGFR-activating mutations or harboring ALK rearrangement. However, larger phase III studies are required to fully define the activity of these agents and their place in the therapeutic armamentarium of brain metastases.	[Dempke, Wolfram C. M.; Edvardsen, Klaus] AstraZeneca Global Med Oncol, Cambridge, England; [Dempke, Wolfram C. M.] Ludwig Maximilians Univ Munchen, Univ Hosp Grosshadern, Haematol & Oncol, Munich, Germany; [Lu, Shun] Lung Tumor Clin Med Ctr, Shanghai, Peoples R China; [Reinmuth, Niels; Reck, Martin] Lungen Clin Grosshansdorf, Airway Res Ctr North, Grosshansdorf, Germany; [Inoue, Akira] Tohoku Univ, Sch Med, Sendai, Miyagi 980, Japan	Dempke, WCM (reprint author), AstraZeneca Med Oncol, Haematol & Oncol, DaVinci Bldg,Melbourn Sci Pk, Cambridge 8SG 6HB, England.	wolfram.dempke@astrazeneca.com					Katayama T, 2009, J THORAC ONCOL, V4, P1415, DOI 10.1097/JTO.0b013e3181b62572; Welsh JW, 2013, J CLIN ONCOL, V31, P895, DOI 10.1200/JCO.2011.40.1174; Weber B, 2011, J THORAC ONCOL, V6, P1287, DOI 10.1097/JTO.0b013e318219ab87; Ma SL, 2009, LUNG CANCER, V65, P198, DOI 10.1016/j.lungcan.2008.10.028; Iuchi T, 2013, LUNG CANCER, V82, P282, DOI 10.1016/j.lungcan.2013.08.016; Gadgeel SM, 2014, LANCET ONCOL, V15, P1119, DOI 10.1016/S1470-2045(14)70362-6; Kancha RK, 2009, CLIN CANCER RES, V15, P460, DOI 10.1158/1078-0432.CCR-08-1757; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Costa DB, 2015, J CLIN ONCOL, V33, P1881, DOI 10.1200/JCO.2014.59.0539; Weickhardt AJ, 2012, J THORAC ONCOL, V7, P1807, DOI 10.1097/JTO.0b013e3182745948; Dempke WCM, 2010, LUNG CANCER, V67, P257, DOI 10.1016/j.lungcan.2009.10.012; Fidler IJ, 2002, LANCET ONCOL, V3, P53, DOI 10.1016/S1470-2045(01)00622-2; SHAPIRO WR, 1986, SEMIN ONCOL, V13, P56; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Eichler AF, 2011, NAT REV CLIN ONCOL, V8, P344, DOI 10.1038/nrclinonc.2011.58; Hoffknecht P, 2015, J THORAC ONCOL, V10, P156, DOI 10.1097/JTO.0000000000000380; Deeken JF, 2007, CLIN CANCER RES, V13, P1663, DOI 10.1158/1078-0432.CCR-06-2854; de Ruiter MB, 2011, HUM BRAIN MAPP, V32, P1206, DOI 10.1002/hbm.21102; Zhang JZ, 2014, CANCER LETT, V351, P6, DOI 10.1016/j.canlet.2014.04.019; Andrews DW, 2004, LANCET, V363, P1665, DOI 10.1016/S0140-6736(04)16250-8; Olmez I, 2010, LUNG CANCER, V70, P174, DOI 10.1016/j.lungcan.2010.01.018; Porta R, 2011, EUR RESPIR J, V37, P624, DOI 10.1183/09031936.00195609; Lee E, 2013, J THORAC ONCOL, V8, P1069, DOI 10.1097/JTO.0b013e318294c8e8; Lee DH, 2008, CANCER, V113, P143, DOI 10.1002/cncr.23526; Park SJ, 2012, LUNG CANCER, V77, P556, DOI 10.1016/j.lungcan.2012.05.092; Chua D, 2010, CLIN LUNG CANCER, V11, P176, DOI 10.3816/CLC.2010.n.022; Shaw AT, 2014, NEW ENGL J MED, V370, P1189, DOI 10.1056/NEJMoa1311107; Dempke WCM, 2015, ANTICANCER RES, V35, P2503; Laquintana V, 2009, EXPERT OPIN DRUG DEL, V6, P1017, DOI 10.1517/17425240903167942; Moyer JD, 1997, CANCER RES, V57, P4838; Ceresoli GL, 2004, ANN ONCOL, V15, P1042, DOI 10.1093/annonc/mdh276; Zeng YD, 2012, ASIAN PAC J CANCER P, V13, P909, DOI 10.7314/APJCP.2012.13.3.909; Ruppert AM, 2009, EUR RESPIR J, V33, P436, DOI 10.1183/09031936.00162307; Kerr KM, 2014, J THORAC ONCOL, V9, P593, DOI 10.1097/JTO.0000000000000171; Moscetti L, 2007, CANCER, V109, P274, DOI 10.1002/cncr.22399; Togashi Y, 2012, CANCER CHEMOTH PHARM, V70, P399, DOI 10.1007/s00280-012-1929-4; Nussbaum ES, 1996, CANCER, V78, P1781, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1781::AID-CNCR19>3.0.CO;2-U; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Costa DB, 2011, J CLIN ONCOL, V29, pE443, DOI 10.1200/JCO.2010.34.1313; Kim JE, 2009, LUNG CANCER, V65, P351, DOI 10.1016/j.lungcan.2008.12.011; Zhao J, 2013, CLIN LUNG CANCER, V14, P188, DOI 10.1016/j.cllc.2012.06.004; Ahles TA, 2010, J CLIN ONCOL, V28, P4434, DOI 10.1200/JCO.2009.27.0827; Togashi Y, 2010, J THORAC ONCOL, V5, P950, DOI 10.1097/JTO.0b013e3181e2138b; Postmus PE, 1999, ANN ONCOL, V10, P753, DOI 10.1023/A:1008318515795; Neuhaus T, 2009, BRIT J CANCER, V100, P291, DOI 10.1038/sj.bjc.6604835; D'Antonio C, 2014, THER ADV MED ONCOL, V6, P101, DOI 10.1177/1758834014521110; Deng Y, 2014, MOL CLIN ONCOL, V2, P116, DOI DOI 10.3892/MCO.2013.190; Gandhi L, 2015, J CLIN ONCOL S15S, V33, p426s; Iacono D, 2015, LUNG CANCER, V87, P211, DOI 10.1016/j.lungcan.2014.12.017; Kim DW, 2014, J CLIN ONCOL, V32, p422s; Li S, 2015, CLIN LUNG CANCER, V16, P86, DOI 10.1016/j.cllc.2014.09.011; Li Z, 2011, J CLIN ONCOL S, V29; Loong HH, 2015, FUTURE ONCOL, V5, P735; Maillet D, 2013, J THORAC ONCOL, V8, pE30, DOI 10.1097/JTO.0b013e318288dc2d; Ohara Sayaka, 2014, J Med Case Rep, V8, P64, DOI 10.1186/1752-1947-8-64; Ou SHI, 2015, J CLIN ONCOL S15S, V33, p424s; Rahmathulla G, 2012, J ONCOL, DOI [10.1155/2012/723541, DOI 10.1155/2012/723541]; Santarpia M, 2015, EXPERT REV RESP MED, V9, P255, DOI 10.1586/17476348.2015.1009040; Sequist LV, 2013, J CLIN ONCOL, V27, P3327; Tallet AV, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-77; Tsao MN, 2012, COCHRANE DB SYST REV, V4; Yu HA, 2015, J CLIN ONCOL S15S, V33, p426s; Zhang JX, 2015, CHIN J CANC PREV TRE, V22, P285; Zimmermann S, 2014, CANC TREAT REV, V40, P718	64	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2015	35	11					5797	5806				10	Oncology	Oncology	CU8LT	WOS:000363794900008		
J	Suetsugu, A; Hiroshima, Y; Matsumoto, T; Hasagawa, K; Nakamura, M; Shimizu, M; Saji, S; Moriwaki, H; Bouvet, M; Hoffman, RM				Suetsugu, Atsushi; Hiroshima, Yukihiko; Matsumoto, Takuro; Hasagawa, Kosuke; Nakamura, Miki; Shimizu, Masahito; Saji, Shigetoyo; Moriwaki, Hisataka; Bouvet, Michael; Hoffman, Robert M.			Recruitment of Cancer-Associated Fibroblasts and Blood Vessels by Orthotopic Liver Tumors Imaged in Red Fluorescent Protein (RFP) Transgenic Nude Mice	ANTICANCER RESEARCH			English	Article						Tumor microenvironment; cancer-associated fibroblasts; blood vessels; liver metastasis; RFP; fluorescence; color-coded imaging	PANCREATIC-CANCER; STROMAL FIBROBLASTS; IN-VIVO; MOUSE; MICROENVIRONMENT; CELLS; HOST; PROGRESSION; ANGIOGENESIS; METASTASIS	Background/Aim: The tumor microenvironment (TME) is critical for tumor growth and progression. We report here an imageable model of the TME of orthotopic liver cancer. Materials and Methods: The transgenic red fluorescent protein (RFP)-expressing nude mouse was used as the host. The RFP nude mouse expresses RFP in all organs. Non-colored Huh-7 human hepatoma cells were injected in the spleen of RFP nude mice to establish an orthotopic liver cancer model. TME formation resulting from the orthotopic liver tumor was observed using the Olympus OV100 small animal fluorescence imaging system. Results: Non-colored liver cancer cells formed tumor colonies in the liver 28 days after cell transplantation to the spleen. RFP-expressing host cells and blood vessels were recruited by the liver tumors as visualized by fluorescence imaging. A desmin-and sirus-red-positive area increased around and within the liver tumor over time. Conclusion: These results indicate cancer-associated fibroblasts (CAFs) were recruited by the liver tumors suggesting that CAFs, along with the angiogenic tumor blood vessels, were necessary for liver-tumor growth and could serve as visible therapeutic targets.	[Suetsugu, Atsushi; Matsumoto, Takuro; Hasagawa, Kosuke; Nakamura, Miki; Shimizu, Masahito; Saji, Shigetoyo; Moriwaki, Hisataka] Gifu Univ, Grad Sch Med, Gifu, Japan; [Suetsugu, Atsushi; Hiroshima, Yukihiko; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA; [Suetsugu, Atsushi; Hiroshima, Yukihiko; Bouvet, Michael; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA	Hoffman, RM (reprint author), AntiCancer Inc, 7917 Ostrow St, San Diego, CA 92111 USA.	all@anticancer.com			National Cancer Institute grant [CA132971]	This study was supported in part by National Cancer Institute grant CA132971.	Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Suetsugu A, 2012, J CELL BIOCHEM, V113, P2290, DOI 10.1002/jcb.24099; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Suetsugu A, 2012, ANTICANCER RES, V32, P31; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927; Bouvet M, 2006, CANCER RES, V66, P11293, DOI 10.1158/0008-5472.CAN-06-2662; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; Suetsugu A, 2012, ANTICANCER RES, V32, P3063; Suetsugu A, 2010, J CELL BIOCHEM, V111, P1035, DOI 10.1002/jcb.22792; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Amoh Y, 2005, CANCER RES, V65, P2337, DOI 10.1158/0008-5472.CAN-04-3857; Suetsugu A, 2011, J CELL BIOCHEM, V112, P949, DOI 10.1002/jcb.23011; Suetsugu A, 2012, ANTICANCER RES, V32, P1175; Yang M, 2004, CANCER RES, V64, P8651, DOI 10.1158/0008-5472.CAN-04-3118; Egeblad M, 2008, DIS MODEL MECH, V1, P155, DOI 10.1242/dmm.000596; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Yang M, 2003, P NATL ACAD SCI USA, V100, P14259, DOI 10.1073/pnas.2436101100; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Olumi AF, 1999, CANCER RES, V59, P5002; Suetsugu A, 2015, ANTICANCER RES, V35, P2545; Yang M, 2009, J CELL BIOCHEM, V106, P279, DOI 10.1002/jcb.21999; Amoh Y, 2005, CANCER RES, V65, P5352, DOI 10.1158/0008-5472.CAN-05-0821; Hoffman RM, 2015, LAB INVEST, V95, P432, DOI 10.1038/labinvest.2014.154; Pietras K, 2008, PLOS MED, V5, P123, DOI 10.1371/journal.pmed.0050019	29	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2015	35	11					5821	5825				5	Oncology	Oncology	CU8LT	WOS:000363794900011		
J	Yoshimasu, T; Ohashi, T; Oura, S; Kokawa, Y; Kawago, M; Hirai, Y; Miyasaka, M; Nishiguchi, H; Kawashima, S; Yata, Y; Honda, M; Fujimoto, T; Okamura, Y				Yoshimasu, Tatsuya; Ohashi, Takuya; Oura, Shoji; Kokawa, Yozo; Kawago, Mitsumasa; Hirai, Yoshimitsu; Miyasaka, Miwako; Nishiguchi, Haruka; Kawashima, Sayoko; Yata, Yumi; Honda, Mariko; Fujimoto, Takahiro; Okamura, Yoshitaka			A Theoretical Model for the Hormetic Dose-response Curve for Anticancer Agents	ANTICANCER RESEARCH			English	Article						Hormesis; lung cancer; chemotherapy	LUNG-CANCER; HORMESIS; MECHANISMS; ASSAY; THRESHOLD	In the present article, we quantitatively evaluated the dose-response relationship of hormetic reactions of anticancer agents in vitro. Serial dilutions of gemcitabine, cisplatin, 5-fluorouracil, vinorelbine, and paclitaxel were administered to the A549 non-small-cell lung cancer cell line. The bi-phasic sigmoidal curve with hormetic and cytotoxic effects is given by the formula y=(ab/(1+exp(c*log(x)-d)))/(1+exp(e*log(x)-f)), that was used to perform a non-linear least square regression. The dose-responses of the five anticancer agents were fitted to this equation. Gemcitabine and 5-fluorouracil, which had the lowest ED50 for their hormetic reaction, had the most pronounced promotive effects out of the five anticancer agents tested. The hormetic reaction progressed exponentially with culturing time. Our theoretical model will be useful in predicting how hormetic reactions affect patients with malignant tumors.	[Yoshimasu, Tatsuya; Ohashi, Takuya; Oura, Shoji; Kokawa, Yozo; Kawago, Mitsumasa; Hirai, Yoshimitsu; Miyasaka, Miwako; Nishiguchi, Haruka; Kawashima, Sayoko; Yata, Yumi; Honda, Mariko; Fujimoto, Takahiro; Okamura, Yoshitaka] Wakayama Med Univ, Dept Thorac & Cardiovasc Surg, Wakayama 6418509, Japan	Yoshimasu, T (reprint author), Wakayama Med Univ, Dept Thorac & Cardiovasc Surg, 811-1 Kimiidera, Wakayama 6418509, Japan.	yositatu@wakayama-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [15K10268]	This study was supported in part by a Grant-in-Aid for Scientific Research (15K10268) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Akaike H., 1973, 2 INT S INF THEOR, P267; Szumiel I, 2012, INT J RADIAT BIOL, V88, P619, DOI 10.3109/09553002.2012.699698; Han J, 1995, LECT NOTES COMPUT SC, V930, P195; Nascarella MA, 2009, DOSE-RESPONSE, V7, P160, DOI 10.2203/dose-response.08-025.Nascarella; FURUKAWA T, 1995, CLIN CANCER RES, V1, P305; Yoshimasu T, 2007, J THORAC CARDIOV SUR, V133, P303, DOI 10.1016/j.jtcvs.2006.06.030; Calabrese EJ, 2006, TOXICOL SCI, V94, P368, DOI 10.1093/toxsci/kf1098; Scott BR, 2014, J CELL COMMUN SIGNAL, V8, P341, DOI 10.1007/s12079-014-0250-x; Calabrese EJ, 2005, CRIT REV TOXICOL, V35, P463, DOI 10.1080/10408440591034502; STEBBING ARD, 1982, SCI TOTAL ENVIRON, V22, P213, DOI 10.1016/0048-9697(82)90066-3; Nascarella MA, 2009, REGUL TOXICOL PHARM, V54, P229, DOI 10.1016/j.yrtph.2009.04.005; Southam CM, 1943, PHYTOPATHOLOGY, V33, P517; Kubota T, 1995, CLIN CANCER RES, V1, P1537; Tang FR, 2015, INT J RADIAT BIOL, V91, P13, DOI 10.3109/09553002.2014.937510; Ohashi T, 2015, ANTICANCER RES, V35, P2669	15	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2015	35	11					5851	5855				5	Oncology	Oncology	CU8LT	WOS:000363794900015		
J	Spengler, G; Ocsovszki, I; Tonki, AS; Saijo, R; Watanabe, G; Kawase, M; Molnar, J				Spengler, Gabriella; Ocsovszki, Imre; Toenki, Adam Szabo; Saijo, Ryosuke; Watanabe, Genki; Kawase, Masami; Molnar, Joseph			Fluorinated beta-Diketo Phosphorus Ylides Are Novel Inhibitors of the ABCB1 Efflux Pump of Cancer Cells	ANTICANCER RESEARCH			English	Article						Multidrug resistance; phosphorus ylide; trifluoroacetyl; ABCB1; P-glycoprotein; mouse T-lymphoma	MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; CONVENIENT SYNTHESIS; PHENOTHIAZINES; MODULATORS; REVERSAL; AGENTS	Efflux pump inhibitors are attractive compounds that reverse multidrug resistance (MDR) in cancer cells. In the present study, 10 phosphorus ylides (P-ylides) were compared based on their MDR-reverting activity in human ATP-binding cassette sub-family B member 1 (ABCB1; P-glycoprotein) gene-transfected L5178Y mouse T-lymphoma cells. Among them, three P-ylides, Ph3P=C(COCF3) COPh, Ph3P=C(COC2F5) COPh and Ph3P=C(COC3F7) COPh were identified as selectively modulating the ABCB1 pump. These compounds, with low cytotoxicity against mouse T-lymphoma cells, exhibited more potency than the positive control ABCB1 inhibitor verapamil.	[Spengler, Gabriella; Toenki, Adam Szabo; Molnar, Joseph] Univ Szeged, Fac Med, Dept Med Microbiol & Immunol, Szeged, Hungary; [Ocsovszki, Imre] Univ Szeged, Fac Med, Dept Biochem, Szeged, Hungary; [Saijo, Ryosuke; Watanabe, Genki; Kawase, Masami] Matsuyama Univ, Fac Pharmaceut Sci, Matsuyama, Ehime 7908578, Japan	Kawase, M (reprint author), Matsuyama Univ, Fac Pharmaceut Sci, 4-2 Bunkyo Cho, Matsuyama, Ehime 7908578, Japan.	kawase@cc.matsuyama-u.ac.jp			Szeged Foundation for Cancer Research; European Union; State of Hungary; European Social Fund [TAMOP 4.2.4. A/2-11-1-2012-0001]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences	This research was supported by the Szeged Foundation for Cancer Research, the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4. A/2-11-1-2012-0001 'National Excellence Program'. This article was supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences.	SHEN YC, 1990, TETRAHEDRON LETT, V31, P5925, DOI 10.1016/S0040-4039(00)97995-4; Kawase M, 2002, BIOORGAN MED CHEM, V10, P1051, DOI 10.1016/S0968-0896(01)00363-7; HAMPER BC, 1988, J ORG CHEM, V53, P5558, DOI 10.1021/jo00258a035; XIA ZX, 1984, ACTA CHIM SINICA, V42, P1223; Amaral L, 2007, IN VIVO, V21, P237; Spengler G, 2014, ANTICANCER RES, V34, P1737; Klinkhammer W, 2009, BIOORGAN MED CHEM, V17, P2524, DOI 10.1016/j.bmc.2009.01.072; Molnar J, 2006, CURR PHARM DESIGN, V12, P287, DOI 10.2174/138161206775201893; Colabufo NA, 2010, J MED CHEM, V53, P1883, DOI 10.1021/jm900743c; PASTAN I, 1988, P NATL ACAD SCI USA, V85, P4486, DOI 10.1073/pnas.85.12.4486; Singh S, 2014, J MED CHEM, V57, P4058, DOI 10.1021/jm401966m; Byrne PA, 2013, CHEM SOC REV, V42, P6670, DOI 10.1039/c3cs60105f; Castaneda F, 2007, ACTA CRYSTALLOGR C, V63, pO65, DOI 10.1107/S0108270106051201; Shukla S, 2011, CURR DRUG TARGETS, V12, P621; Robert J, 2003, J MED CHEM, V46, P4805, DOI 10.1021/jm030183a; Zhang L, 2010, CHEMMEDCHEM, V5, P811, DOI 10.1002/cmdc.201000006; WITTIG G, 1953, LIEBIGS ANN CHEM, V580, P44; Jaszczyszyn A, 2012, PHARMACOL REP, V64, P16; El-Batta A, 2007, J ORG CHEM, V72, P5244, DOI 10.1021/jo070665k; Nesmeyanov NA, 1980, IZV AKAD NAUK SSSR S, V12, P2805; Saijo R, 2014, HETEROCYCLES, V89, P2334, DOI 10.3987/COM-14-13075; SHEN YC, 1984, SYNTHESIS-STUTTGART, P35; SHEN YC, 1985, SYNTHESIS-STUTTGART, P159	23	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2015	35	11					5915	5919				5	Oncology	Oncology	CU8LT	WOS:000363794900023		
J	Yamane, T; Asanoma, K; Kobayashi, H; Liu, G; Yagi, H; Ohgami, T; Ichinoe, A; Sonoda, K; Wake, N; Kato, K				Yamane, Takako; Asanoma, Kazuo; Kobayashi, Hiroaki; Liu, Ge; Yagi, Hiroshi; Ohgami, Tatsuhiro; Ichinoe, Akimasa; Sonoda, Kenzo; Wake, Norio; Kato, Kiyoko			Identification of the Critical Site of Calponin 1 for Suppression of Ovarian Cancer Properties	ANTICANCER RESEARCH			English	Article						Calponin 1 (CNN1); F-actin; cell motility; cell invasion	SMOOTH-MUSCLE CALPONIN; PERITONEAL DISSEMINATION; BINDING PROTEINS; BLOOD-VESSELS; TUMOR VESSELS; F-ACTIN; CELLS; EXPRESSION; H1; INHIBITION	Background: Although several studies have demonstrated the tumor suppressive function of CNN1 (calponin 1), no studies have performed a site-specific analysis of CNN1 on tumor cell activities. Materials and Methods: We herein studied the site-specific effects of CNN1 in ovarian cancer cells using full-length CNN1 (fCNN1), three CNN1 repeats (3CNRs), or the first CNN1 repeat (CNR1) expression vectors. Ovarian cancer cells stably expressing each construct were analyzed for in vitro proliferation, cell motility, invasion, and soft agar assays. An in vitro model of pleural dissemination was also established. Results: Cell proliferation, anchorage-independent colony formation, cell motility, and cell invasion were all suppressed in fCNN1, 3CNRs, and CNR1-stably-expressing cells. CNN1 expression in mesothelial cells suppressed cancer cell invasion into a monolayer of mesothelial cells. Conclusion: CNR1 showed similar suppressive effects as fCNN1. Results suggest CNR1 as a potential small synthetic peptide candidate for therapeutic strategies against ovarian cancer.	[Yamane, Takako; Asanoma, Kazuo; Yagi, Hiroshi; Ohgami, Tatsuhiro; Ichinoe, Akimasa; Sonoda, Kenzo; Kato, Kiyoko] Kyushu Univ, Dept Obstet & Gynecol, Fac Med Sci, Fukuoka 8128582, Japan; [Kobayashi, Hiroaki] Kagoshima Univ, Fac Med Sci, Dept Obstet & Gynecol, Kagoshima 890, Japan; [Liu, Ge; Wake, Norio] Kyushu Univ, Res Ctr Environm & Dev Med Sci, Fukuoka 8128582, Japan	Asanoma, K (reprint author), Kyushu Univ, Dept Obstet & Gynecol, Fac Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	asanoma@med.kyushu-u.ac.jp			JSPS KAKENHI [26462529, 23249075, 23390392]	The Authors appreciate the technical support from Dr. Tomoka Takao, Ms. Yoko Miyanari, Ms. Yumi Konno, and the Research Support Center, Graduate School of Medical Science, Kyushu University. They also appreciate Dr. Shun'ichiro Taniguchi at Shinshu University for providing us a pEGFP-fCNN1 plasmid. This work was supported by JSPS KAKENHI Grant Number 26462529, 23249075, 23390392.	MEZGUELDI M, 1995, J BIOL CHEM, V270, P8867; Hashimoto S, 2003, INT J CANCER, V107, P557, DOI 10.1002/ijc.11454; Leinweber B, 1999, BIOPHYS J, V77, P3208; Xu L, 1998, HUM GENE THER, V9, P2699, DOI 10.1089/hum.1998.9.18-2699; Li D, 2013, ONCOGENE, V32, P4950, DOI 10.1038/onc.2012.509; Mino T, 1998, EUR J BIOCHEM, V251, P262, DOI 10.1046/j.1432-1327.1998.2510262.x; Abouzaglou J, 2004, EUR J BIOCHEM, V271, P2615, DOI 10.1111/j.1432-1033.2004.04190.x; Islam AHMM, 2004, J UROLOGY, V171, P1319, DOI 10.1097/01.ju.0000101969.34419.57; Miano JM, 1996, J BIOL CHEM, V271, P7095; Taniguchi S, 2001, CANCER RES, V61, P7627; Takeoka M, 2002, EUR J CANCER, V38, P436, DOI 10.1016/S0959-8049(01)00390-2; MEZGUELDI M, 1992, J BIOL CHEM, V267, P15943; Uyama Y, 1996, BIOCHEM J, V319, P551; Koganehira Y, 2003, BRIT J DERMATOL, V148, P971, DOI 10.1046/j.1365-2133.2003.05238.x; Taniguchi S, 2005, CANCER SCI, V96, P738, DOI 10.1111/j.1349-7006.2005.00118.x; KAKE T, 1995, BIOCHEM J, V312, P587; Sasaki Y, 2002, CANCER, V94, P1777, DOI 10.1002/cncr.10401; Horiuchi A, 1999, MOL HUM REPROD, V5, P139, DOI 10.1093/molehr/5.2.139; Kaneko M, 2002, JPN J CANCER RES, V93, P935; Yanagisawa Y, 2008, EJSO-EUR J SURG ONC, V34, P531, DOI 10.1016/j.ejso.2007.05.010; Samaha FF, 1996, J BIOL CHEM, V271, P395; Ogura T, 2006, CLIN CANCER RES, V12, P5216, DOI 10.1158/1078-0432.CCR-06-0674; WINDER SJ, 1990, J BIOL CHEM, V265, P10148; Sugaya A, 2010, ANTICANCER RES, V30, P1071; WINDER SJ, 1993, CELL SIGNAL, V5, P677, DOI 10.1016/0898-6568(93)90029-L; Ya J, 1997, ANAT REC, V249, P495, DOI 10.1002/(SICI)1097-0185(199712)249:4<495::AID-AR9>3.0.CO;2-Q; Fattoum A, 2003, BIOCHEMISTRY-US, V42, P1274, DOI 10.1021/bi020336g	27	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2015	35	11					5993	5999				7	Oncology	Oncology	CU8LT	WOS:000363794900030		
J	Nakaoka, E; Tanaka, S; Onda, K; Sugiyama, K; Hirano, T				Nakaoka, Eri; Tanaka, Sachiko; Onda, Kenji; Sugiyama, Kentaro; Hirano, Toshihiko			Effects of Vitamin K-3 and K-5 on Daunorubicin-resistant Human T Lymphoblastoid Leukemia Cells	ANTICANCER RESEARCH			English	Article						Vitamin K-3; vitamin K-5; human T-lymphoblastoid leukemia; daunorubicin resistance; P-glycoprotein; apoptosis	COLORECTAL-CANCER; INDUCED APOPTOSIS; P-GLYCOPROTEIN; IN-VIVO; EXPRESSION; MENADIONE; CYCLE; K2; K3	Background/Aim: Anticancer efficacy of vitamin K derivatives on multidrug-resistant cancer cells has been scarcely investigated. Materials and Methods: The effects of vitamins K-3 and K-5 on proliferation of human leukemia MOLT-4 cells and on daunorubicin-resistant MOLT-4/DNR cells were estimated by a WST assay. Apoptotic cells were detected by Annexin V and propidium iodide staining, followed by flow cytometry. Results: Vitamins K-3 and K-5 significantly inhibited proliferation of leukemic cells at 10 and 100 mu M (p<0.05), and these effects were almost equally observed in both MOLT-4 and MOLT/DNR drug-resistant cells. Vitamin K-3 induced cell apoptosis at 10 and 100 mu M in both MOLT-4 and MOLT-4/DNR cells (p<0.05). Vitamin K-5 also increased apoptotic cells, while rather inducing necrotic cell death. Conclusion: Vitamins K-3 and K-5 suppress MOLT-4 and MOLT-4/DNR cell-proliferation partially through induction of apoptosis, and these vitamin derivatives can overcome drug resistance due to P-glycoprotein expression.	[Nakaoka, Eri; Tanaka, Sachiko; Onda, Kenji; Sugiyama, Kentaro; Hirano, Toshihiko] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Clin Pharmacol, Hachioji, Tokyo 1920392, Japan	Hirano, T (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Clin Pharmacol, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	hiranot@toyaku.ac.jp					Liu ZL, 2002, CANCER CHEMOTH PHARM, V49, P391, DOI 10.1007/s00280-001-0411-5; Komura N, 2007, LEUKEMIA RES, V31, P301, DOI 10.1016/j.leukres.2006.07.015; Kanai K, 2010, CANCER SCI, V101, P216, DOI 10.1111/j.1349-7006.2009.01362.x; Kuriyama S, 2005, INT J ONCOL, V27, P505; Leyssens C, 2013, ENDOCR-RELAT CANCER, V20, pR31, DOI 10.1530/ERC-12-0381; Shah M, 2009, PIGM CELL MELANOMA R, V22, P799, DOI 10.1111/j.1755-148X.2009.00628.x; Ishii K, 2010, CANCER INVEST, V28, P220, DOI 10.3109/07357900902744486; Ogawa M, 2007, INT J ONCOL, V31, P323; Nishimaki J, 1999, LEUKEMIA, V13, P1399, DOI 10.1038/sj.leu.2401491; Akiyoshi T, 2009, CANCER CHEMOTH PHARM, V65, P143, DOI 10.1007/s00280-009-1016-7; Chowdhury R, 2009, APOPTOSIS, V14, P108, DOI 10.1007/s10495-008-0284-8; Hatanaka H, 2014, LIFE SCI, V99, P61, DOI 10.1016/j.lfs.2014.01.068; Ishibashi M, 2011, BIOL PHARM BULL, V35, P10; Luqmani YA, 2005, MED PRIN PRACT, V14, P35, DOI 10.1159/000086183; Sakai C, 2014, ANTICANCER RES, V35, P6489; Yokoyama H., 2012, J CANC THER, V3, P521	16	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2015	35	11					6041	6048				8	Oncology	Oncology	CU8LT	WOS:000363794900035		
J	Tokunaga, M; Baron, B; Kitagawa, T; Tokuda, K; Kuramitsu, Y				Tokunaga, Masayuki; Baron, Byron; Kitagawa, Takao; Tokuda, Kazuhiro; Kuramitsu, Yasuhiro			Active Hexose-correlated Compound Down-regulates Heat Shock Factor 1, a Transcription Factor for HSP27, in Gemcitabine-resistant Human Pancreatic Cancer Cells	ANTICANCER RESEARCH			English	Article						HSF1; HMGB1; HSP27; AHCC; pancreatic cancer; gemcitabine	BREAST-CANCER; PROTEIN 27; HSF1; GROWTH; HEAT-SHOCK-PROTEIN-27; EXPRESSION; THERAPY; TUMORS; TRIAL; HELPS	Background: Active hexose-correlated compound (AHCC) is an extract of a basidiomycete mushroom that enhances the therapeutic effects and reduces the side-effects of chemotherapy. Our previous studies demonstrated that heat-shock protein 27 (HSP27) was involved in gemcitabine-resistance of pancreatic cancer cells and it was downregulated by AHCC-treatment. However, how AHCC downregulated HSP27 is unknown. In the present study, we focused on two transcription factors reported to induce HSP27, heat shock factor 1 (HSF1) and high-mobility group box 1 (HMGB1) and investigated the effect of AHCC on their expression. Materials and Methods: KLM1-R cells were treated with AHCC and the protein expression of HSF1 and HMGB1 were analyzed by western blotting. Results: The protein expression of HSF1 in KLM1-R was down-regulated by AHCC treatment. On the other hand, the protein expression of HMGB1 was not reduced in KLM1-R cells after AHCC treatment. Conclusion: The possibility that AHCC down-regulated HSP27 through down-regulation of the HSF1, was herein shown.	Yamaguchi Univ, Grad Sch Med, Dept Biochem, Ube, Yamaguchi 7558505, Japan; Yamaguchi Univ, Grad Sch Med, Dept Funct Prote, Ube, Yamaguchi 7558505, Japan	Kuramitsu, Y (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Biochem & Funct Prote, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	climates@yamaguchi-u.ac.jp					Dudeja V, 2011, AM J PHYSIOL-GASTR L, V300, pG948, DOI 10.1152/ajpgi.00346.2010; Burris HA, 1997, J CLIN ONCOL, V15, P2403; Mori-Iwamoto S, 2008, MOL MED REP, V1, P429; Matsushita K, 1998, ANTI-CANCER DRUG, V9, P343, DOI 10.1097/00001813-199804000-00008; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Tang DL, 2011, CELL METAB, V13, P701, DOI 10.1016/j.cmet.2011.04.008; Xia Y, 2012, CANCER LETT, V318, P145, DOI 10.1016/j.canlet.2011.09.043; Kang R, 2011, AUTOPHAGY, V7, P1256, DOI 10.4161/auto.7.10.16753; Suenaga S, 2014, ANTICANCER RES, V34, P141; Ito N, 2007, J LEUKOCYTE BIOL, V81, P75, DOI 10.1189/jlb.0306169; Mori-Iwamoto S, 2009, PANCREAS, V38, P224, DOI 10.1097/MPA.0b013e3181773970; Nawata J, 2014, ANTICANCER RES, V34, P4807; Kuramitsu Y, 2012, ANTICANCER RES, V32, P2295; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; GHONEUM M, 1995, INT J IMMUNOTHER, V11, P23; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Wolfgang CL, 2013, CA-CANCER J CLIN, V63, P318, DOI 10.3322/caac.21190; Taba K, 2011, CHEMOTHERAPY, V57, P12, DOI 10.1159/000321019; Maehara S, 2004, INT J CANCER, V112, P184, DOI 10.1002/ijc.20304; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; Mori-Iwamoto S, 2007, INT J ONCOL, V31, P1345; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229; Shi X, 2002, ONCOLOGY-BASEL, V62, P354, DOI 10.1159/000065068; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Kang R, 2010, CELL DEATH DIFFER, V17, P666, DOI 10.1038/cdd.2009.149; de Thonel A, 2012, INT J BIOCHEM CELL B, V44, P1593, DOI 10.1016/j.biocel.2012.06.012; Kim HR, 1999, IUBMB LIFE, V48, P429, DOI 10.1080/152165499306829; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; Terakawa N, 2008, NUTR CANCER, V60, P643, DOI 10.1080/01635580801993280; Cox JL, 2013, PLOS ONE, V8; Guettouche Toumy, 2005, BMC Biochem, V6, P4, DOI 10.1186/1471-2091-6-4; Kidd P M, 2000, Altern Med Rev, V5, P4; Kuroda T, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-134; Lowry OH, 1951, RANDAINJ J BLOL CHEM, V193, P265; Nakamoto D, 2012, INT J CLIN MED, V3, P361; Schulz R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.508; Shigama Kota, 2009, J Exp Ther Oncol, V8, P43; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI DOI 10.3322/CAAC.21208	41	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2015	35	11					6063	6067				5	Oncology	Oncology	CU8LT	WOS:000363794900038		
J	Tachibana, T; Suzuki, Y; Fujioka, K; Ikeda, K; Inoue, Y; Tada, Y; Saito, TK; Manome, Y				Tachibana, Toshiaki; Suzuki, Yuta; Fujioka, Kouki; Ikeda, Keiichi; Inoue, Yuriko; Tada, Yoshifumi; Saito, Takashi Kei; Manome, Yoshinobu			Cell Membrane Perforation with Photosensitizer and a Brush-shaped Soft-polymer Sheet Using a Malignant Glioma Cell Line	ANTICANCER RESEARCH			English	Article						Cell stamper; nanoprinting perforator; malignant glioma	NAKED PLASMID DNA; IN-VIVO; TRANSGENE EXPRESSION; ADENOVIRAL VECTOR; TRANSDUCTION; ULTRASOUND; TRANSFECTION; EFFICIENCY; SYSTEM; VITRO	Background: Transduction of foreign molecules into cells is an important technique to investigate the functions of corresponding molecules and/or targets. Recently, a mass-producible nanoprinting perforator was devised enabling for large-scale, high-performance drug or nucleic-acid transfer into cells without cell damage. Since little is known on the performance of the system, we investigated its effects on a malignant glioma cell line. Materials and Methods: Photosensitization was performed by the Cell Stamper CP-01. The malignant U373MG glioma cell line was used for transduction. Results: Photosensitization transduced FITC-conjugated albumin into cells. Trypan blue inclusion test demonstrated membrane disintegration by the procedure and scanning electron microscopy disclosed perforation of the cell membrane. Conclusion: Local oxidation reaction during the nanoprinting caused reversible membrane perforation. Morphological findings from the current study support the above mechanism, therefore the specific printing system might be convenient for transduction of foreign molecules into malignant glioma cells.	[Tachibana, Toshiaki; Fujioka, Kouki; Ikeda, Keiichi; Manome, Yoshinobu] Jikei Univ, Sch Med, Core Res Facil Basic Sci, Mol Cell Biol Div, Tokyo, Japan; [Suzuki, Yuta] Jikei Univ, Sch Med, Dept Neurosurg, Tokyo, Japan; [Inoue, Yuriko] Showa Univ, Sch Med, Dept Anat, Tokyo 142, Japan; [Tada, Yoshifumi] Tohoku Chem Co Ltd, Res Inst Bio Syst Informat, Morioka, Iwate, Japan; [Saito, Takashi Kei] Akita Prefectural Univ, Dept Machine Intelligence & Syst Engn, Yurihonjo City, Akita, Japan	Manome, Y (reprint author), Jikei Univ, Sch Med, Core Res Facil Basic Sci, Div Mol Cell Biol,Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo, Japan.	manome@jikei.ac.jp					Manome Y, 2005, ULTRASOUND MED BIOL, V31, P693, DOI 10.1016/j.ultrasmedbio.2005.01.015; Parr MJ, 1997, NAT MED, V3, P1145, DOI 10.1038/nm1097-1145; Manome Y, 1996, GENE THER, V3, P513; Saito TK, 2002, BIOTECHNOL LETT, V24, P309, DOI 10.1023/A:1014072904009; Manome Y, 2010, ANTICANCER RES, V30, P383; Tachibana K, 1999, LANCET, V353, P1409, DOI 10.1016/S0140-6736(99)01244-1; Wallace M, 2009, MOL THER, V17, P922, DOI 10.1038/mt.2009.27; Saito TK, 2009, 2009 IEEE/NIH LIFE SCIENCE SYSTEMS AND APPLICATIONS WORKSHOP, P5, DOI 10.1109/LISSA.2009.4906695; KURATA S, 1986, EXP CELL RES, V162, P372, DOI 10.1016/0014-4827(86)90342-3; Taniyama Y, 2002, GENE THER, V9, P372, DOI 10.1038/sj/gt/3301678; Saito T, 1998, PHOTOCHEM PHOTOBIOL, V68, P745; Saito TK, 2008, ANAL BIOANAL CHEM, V391, P2513, DOI 10.1007/s00216-008-2226-2; Manome Y, 2000, HUM GENE THER, V11, P1521, DOI 10.1089/10430340050083252; Manome Y, 1998, HUM GENE THER, V9, P1409, DOI 10.1089/hum.1998.9.10-1409; Manome Y, 1996, NAT MED, V2, P567, DOI 10.1038/nm0596-567; Tanaka T, 1997, NAT MED, V3, P437, DOI 10.1038/nm0497-437; Manome Y, 2002, ANTICANCER RES, V22, P2029; Dongwei Z, 2014, DRUG DELIV, V21, P571; Istvan PS, 2003, J PHYS CHEM B, V107, P3862; Jose IS, 2012, CURRENT GENE THER, V12, P116	20	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2015	35	11					6069	6074				6	Oncology	Oncology	CU8LT	WOS:000363794900039		
J	Shiota, M; Takeuchi, A; Sugimoto, M; Dejima, T; Kashiwagi, E; Kiyoshima, K; Inokuchi, J; Tatsugami, K; Yokomizo, A				Shiota, Masaki; Takeuchi, Ario; Sugimoto, Masaaki; Dejima, Takashi; Kashiwagi, Eiji; Kiyoshima, Keijiro; Inokuchi, Junichi; Tatsugami, Katsunori; Yokomizo, Akira			Low Serum Testosterone But Not Obesity Predicts High Gleason Score at Biopsy Diagnosed as Prostate Cancer in Patients with Serum PSA Lower than 20 ng/ml	ANTICANCER RESEARCH			English	Article						Gleason score; prostate cancer; prostate-specific antigen; testosterone	BODY-MASS INDEX; RADICAL PROSTATECTOMY; BIOCHEMICAL RECURRENCE; METABOLIC SYNDROME; RISK-FACTOR; ASSOCIATION; MEN; POPULATION; DISEASE; COHORT	Background/Aim: The impact of testosterone or obesity on the pathological grade of prostate cancer remains controversial. Therefore, in this study, we investigated the relationship of serum testosterone and body mass index (BMI) to Gleason score at biopsy. Patients and Methods: This study included 128 Japanese patients diagnosed with prostate cancer from 2000 through 2012 whose serum testosterone level and BMI were measured before treatment. Associations between clinical parameters, including pre-treatment serum testosterone level and BMI, and Gleason score at biopsy were examined. Results: The median serum testosterone and BMI were 434 ng/dl (interquartile range=362-542 ng/dl) and 23.5 kg/m(2) (interquartile range= 21.7-25.4 kg/m(2)), respectively. Gleason score at biopsy was < 7, 7 and > 7 for 58 patients (45.3%), 52 patients (40.6%) and 18 patients (14.1%), respectively. On univariate analysis, positive finding at digital rectal examination (DRE), high prostate-specific antigen level at diagnosis and low serum testosterone level, but not BMI, were correlated with high Gleason score at biopsy. Multivariate analysis identified positive finding at DRE and low serum testosterone level as significant predictors of a high Gleason score at prostate biopsy. By combining these parameters, the predictive ability of a high Gleason score was improved. Conclusion: This study showed that positive finding at DRE and a low pre-treatment serum testosterone level, but not obesity, may be factors predictive of aggressive prostate cancer, indicating the diagnostic value of serum testosterone, as well as DRE findings, in risk assessment.	[Shiota, Masaki; Takeuchi, Ario; Sugimoto, Masaaki; Dejima, Takashi; Kashiwagi, Eiji; Kiyoshima, Keijiro; Inokuchi, Junichi; Tatsugami, Katsunori; Yokomizo, Akira] Kyushu Univ, Dept Urol, Grad Sch Med Sci, Fukuoka 8128582, Japan	Yokomizo, A (reprint author), Kyushu Univ, Dept Urol, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yokoa@uro.med.kyushu-u.ac.jp			Kakenhi grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [25462484, 26861273]	This work was supported by Kakenhi grants (25462484 and 26861273) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The Authors would also like to thank Edanz Group Japan for editorial assistance.	Crawford ED, 2007, BJU INT, V100, P509, DOI 10.1111/j.1464-410X.2007.07022.x; Nishiyama T, 2006, J UROLOGY, V176, P1387, DOI 10.1016/j.juro.2006.06.066; Vesprini D, 2013, CURR OPIN UROL, V23, P252, DOI 10.1097/MOU.0b013e32835f89b8; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Shiota M, 2014, J SURG ONCOL, V110, P476, DOI 10.1002/jso.23677; Gong ZH, 2007, CANCER, V109, P1192, DOI 10.1002/cncr.22534; Cao Y, 2011, CANCER PREV RES, V4, P486, DOI 10.1158/1940-6207.CAPR-10-0229; Parker AS, 2013, PROSTATE CANCER P D, V16, P352, DOI 10.1038/pcan.2013.27; Khera M, 2014, EUR UROL, V65, P115, DOI 10.1016/j.eururo.2013.08.015; Salonia A, 2012, CLIN CANCER RES, V18, P3648, DOI 10.1158/1078-0432.CCR-11-2799; Thompson J, 2013, BJU INT, V112, P6, DOI 10.1111/bju.12381; Isom-Batz G, 2005, J UROLOGY, V173, P1935, DOI 10.1097/01.ju.0000158040.33531.e7; MacDonald AA, 2010, HUM REPROD UPDATE, V16, P293, DOI 10.1093/humupd/dmp047; Ide H, 2008, ANTICANCER RES, V28, P2487; Klap J, 2015, J UROLOGY, V193, P403, DOI 10.1016/j.juro.2014.07.123; McGrowder DA, 2012, ASIAN PAC J CANCER P, V13, P1, DOI 10.7314/APJCP.2012.13.1.001; Dai B, 2012, BJU INT, V110, pE667, DOI 10.1111/j.1464-410X.2012.11465.x; ROSS RK, 1987, J NATL CANCER I, V78, P869; Morgentaler A, 2009, EUR UROL, V55, P310, DOI 10.1016/j.eururo.2008.09.024; Corcoran NM, 2011, BJU INT, V108, pE202, DOI 10.1111/j.1464-410X.2011.10119.x; Orwoll ES, 2010, J CLIN ENDOCR METAB, V95, pE151, DOI 10.1210/jc.2009-2435; Lane BR, 2008, UROLOGY, V72, P1240, DOI 10.1016/j.urology.2008.06.001; Pfitzenmaier J, 2009, BJU INT, V103, P877, DOI 10.1111/j.1464-410X.2008.08149.x; De Nunzio C, 2013, UROL ONCOL-SEMIN ORI, V31, P997, DOI 10.1016/j.urolonc.2011.08.007; Imamoto T, 2009, PROSTATE CANCER P D, V12, P78, DOI 10.1038/pcan.2008.35; Schatzl G, 2001, PROSTATE, V47, P52; Allott EH, 2013, EUR UROL, V63, P800, DOI 10.1016/j.eururo.2012.11.013; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Jentzmik F, 2014, INT J UROL, V21, P980, DOI 10.1111/iju.12494; Klotz L, 2015, J CLIN ONCOL, V33, P272, DOI 10.1200/JCO.2014.55.1192; Lundon DJ, 2015, WORLD J UROL, V33, P827, DOI 10.1007/s00345-014-1365-7; Miyoshi Y, 2014, BMC CANCER, V14, P111; San Francisco Ignacio F, 2014, BJU Int, V114, P229, DOI 10.1111/bju.12682; Siegel RL, 2015, CA-CANCER J CLIN, V62, P10; Sobin LH, 1997, TNM CLASSIFICATION M, P170; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Zarotsky V, 2014, ANDROLOGY-US, V2, P819, DOI 10.1111/andr.274	37	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2015	35	11					6137	6145				9	Oncology	Oncology	CU8LT	WOS:000363794900048		
J	Nishio, J; Nabeshima, K; Mori, S; Naito, M				Nishio, Jun; Nabeshima, Kazuki; Mori, Shun; Naito, Masatoshi			Translocation (1;5) in a Glomus Tumor	ANTICANCER RESEARCH			English	Article						Glomus tumor; cytogenetics; t(1;5); NOTCH2; MIR143	ANGIOLEIOMYOMA; ABERRATIONS; BENIGN	Glomus tumor is a rare perivascular neoplasm that usually occurs in the distal extremities of young adults. Recent molecular studies have identified microRNA 143-NOTCH fusions or NOTCH1-3 rearrangements in benign and malignant glomus tumors. Herein, we describe the cytogenetic and molecular cytogenetic findings of a glomus tumor arising in the left wrist of a 45-year-old man. Physical examination showed a 1.3-cm, blue-red, tender nodule. Magnetic resonance imaging demonstrated a subcutaneous, well-circumscribed mass with low signal intensity on T1-weighted sequences and high signal intensity on T2-weighted sequences. Contrast-enhanced fat-suppressed T1-weighted sequences showed a homogeneous, strong enhancement. A marginal excision was performed and histopathological examination confirmed the diagnosis of a glomus tumor. Cytogenetic and spectral karyotypic analyses showed a novel rearrangement involving chromosome bands 1p13 and 5q32. There has been no evidence of local recurrence four months after surgery. To the best of our knowledge, this is the first case of sporadic glomus tumor with t(1;5).	[Nishio, Jun; Mori, Shun; Naito, Masatoshi] Fukuoka Univ, Dept Orthopaed Surg, Fac Med, Fukuoka 8140180, Japan; [Nabeshima, Kazuki] Fukuoka Univ, Dept Pathol, Fac Med, Fukuoka 8140180, Japan	Nishio, J (reprint author), Fukuoka Univ, Dept Orthopaed Surg, Fac Med, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	jnishio@cis.fukuoka-u.ac.jp			Foundation for the Promotion of Medical Science; JSPS KAKENHI [25462355]	This study was supported in part by the Foundation for the Promotion of Medical Science and JSPS KAKENHI Grant Number 25462355.	Stewart DR, 2012, GENE CHROMOSOME CANC, V51, P429, DOI 10.1002/gcc.21928; NILBERT M, 1989, CANCER GENET CYTOGEN, V37, P61, DOI 10.1016/0165-4608(89)90075-7; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Welborn J, 2010, CANCER GENET CYTOGEN, V199, P147, DOI 10.1016/j.cancergencyto.2010.01.022; Nishio J, 2004, INT J MOL MED, V13, P13; Sonobe H, 1996, CANCER GENET CYTOGEN, V90, P54, DOI 10.1016/0165-4608(96)00070-2; Nishio J, 2013, IN VIVO, V27, P519; HEIM S, 1986, CANCER GENET CYTOGEN, V20, P325, DOI 10.1016/0165-4608(86)90091-9; Brouillard P, 2002, AM J HUM GENET, V70, P866, DOI 10.1086/339492; Mosquera JM, 2013, GENE CHROMOSOME CANC, V52, P1075, DOI 10.1002/gcc.22102; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Folpe AL, 2001, AM J SURG PATHOL, V25, P1, DOI 10.1097/00000478-200101000-00001; Hennig Y, 1999, CANCER GENET CYTOGEN, V108, P79, DOI 10.1016/S0165-4608(98)00123-X; Folpe AL, 2013, WHO CLASSIFICATION T, P116	14	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2015	35	11					6167	6170				4	Oncology	Oncology	CU8LT	WOS:000363794900053		
J	Yamada, M; Iihara, H; Fujii, H; Ishihara, M; Matsuhashi, N; Takahashi, T; Yoshida, K; Itoh, Y				Yamada, Maya; Iihara, Hirotoshi; Fujii, Hironori; Ishihara, Masashi; Matsuhashi, Nobuhisa; Takahashi, Takao; Yoshida, Kazuhiro; Itoh, Yoshinori			Prophylactic Effect of Oral Minocycline in Combination with Topical Steroid and Skin Care Against Panitumumab-induced Acneiform Rash in Metastatic Colorectal Cancer Patients	ANTICANCER RESEARCH			English	Article						acneiform rash; minocycline; skin care; panitumumab; colorectal cancer; tumor response; time to treatment failure	PHASE-II; OPEN-LABEL; CETUXIMAB; TRIAL; THERAPY; TETRACYCLINES; CHEMOTHERAPY; IRINOTECAN; INHIBITORS; EFFICACY	Background: Although the anti-EGFR monoclonal antibody panitumumab is effective in treating colorectal cancer, the occurrence of severe skin disorders often discontinues therapy. Herein, we investigated by a retrospective chart review the effect of prophylactic oral minocycline in combination with skin treatment using moisturizer on the incidence of skin disorders and tumor response in metastatic colorectal cancer patients who received panitumumab. Patients and Methods: In a total of 55 patients, 38 patients were eligible, consisting the pre-emptive group (N=25) and reactive group (N=13). Acneiform rash and other adverse events were graded according to the CTCAE v4.0. Results: The occurrence of acneiform rash (grade =2) was significantly lower in pre-emptive group than in reactive group (44.0% vs. 84.6%, p=0.04). No significant differences in the occurrence of other adverse events were observed between the two groups. Tumor response was not significantly different between the two groups (36.0% vs. 7.7%, OR, 6.75; 95% confidence interval (CI)=0.75-60.76, p=0.12). Mean time to treatment failure was 149.7 days and 110.2 days in the pre-emptive group and reactive treatment group, respectively (HR=0.58; 95% CI=0.26-1.28, p=0.18). Conclusion: Prophylactic oral minocycline combined with skin care reduced panitumumab-induced acneiform rash without a significant influence on tumor response.	[Yamada, Maya; Iihara, Hirotoshi; Fujii, Hironori; Ishihara, Masashi; Itoh, Yoshinori] Gifu Univ Hosp, Dept Pharm, Gifu 5011194, Japan; [Matsuhashi, Nobuhisa; Takahashi, Takao; Yoshida, Kazuhiro] Gifu Univ, Grad Sch Med, Dept Surg Oncol, Gifu, Japan	Yamada, M (reprint author), Gifu Univ Hosp, Dept Pharm, 1-1 Yanagido, Gifu 5011194, Japan.	maya@gifu-u.ac.jp					Vincenzi B, 2006, BRIT J CANCER, V94, P792, DOI 10.1038/sj.bjc.6603018; Ishikawa C, 2009, ANTIMICROB AGENTS CH, V53, P1760, DOI 10.1128/AAC.01540-08; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Muro K, 2009, JPN J CLIN ONCOL, V39, P321, DOI 10.1093/jjco/hyp016; Scope A, 2007, J CLIN ONCOL, V25, P5390, DOI 10.1200/JCO.2007.12.6987; Lacouture ME, 2010, J CLIN ONCOL, V28, P1351, DOI 10.1200/JCO.2008.21.7828; BARZA M, 1975, ANTIMICROB AGENTS CH, V8, P713; THONG YH, 1979, CLIN EXP IMMUNOL, V35, P443; Boone SL, 2007, ONCOLOGY-BASEL, V72, P152, DOI 10.1159/000112795; Orditura M, 2009, ONCOL REP, V21, P1023, DOI 10.3892/or_00000319; Eilers RE, 2010, JNCI-J NATL CANCER I, V102, P47, DOI 10.1093/jnci/djp439; Sapadin AN, 2006, J AM ACAD DERMATOL, V54, P258, DOI 10.1016/j.jaad.2005.10.004; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; SOTOMAYOR EA, 1992, CANCER CHEMOTH PHARM, V30, P377, DOI 10.1007/BF00689966; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Lenz HJ, 2006, J CLIN ONCOL, V24, P4914, DOI 10.1200/JCO.2006.06.7595; Kobayashi Y, 2015, J STEPP FUTURE ONCOL, V11, P617; Mittmann N, 2011, CURR ONCOL, V18, pE54; Wagner Lynne I, 2007, Oncology (Williston Park), V21, P34	21	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2015	35	11					6175	6181				7	Oncology	Oncology	CU8LT	WOS:000363794900055		
J	Fukuchi, M; Ishiguro, T; Ogata, K; Kimura, A; Kumagai, Y; Ishibashi, K; Ishida, H; Kuwano, H; Mochiki, E				Fukuchi, Minoru; Ishiguro, Toru; Ogata, Kyoichi; Kimura, Akiharu; Kumagai, Youichi; Ishibashi, Keiichiro; Ishida, Hideyuki; Kuwano, Hiroyuki; Mochiki, Erito			Risk Factors for Recurrence After Curative Conversion Surgery for Unresectable Gastric Cancer	ANTICANCER RESEARCH			English	Article						Unresectable gastric cancer; conversion surgery; recurrence	TRIAL; CHEMOTHERAPY; S-1	Aim: To evaluate the recurrence risk after curative conversion surgery following chemotherapy for initially unresectable gastric cancer. Patients and Methods: We retrospectively analyzed clinicopathological and postoperative recurrence-free survival (RFS) data for 34 patients who underwent curative conversion surgery. Results: Recurrence was observed in 17 (50%) patients, with a median time to recurrence of 22 months (range=1-98 months). In nine (53%) patients with recurrence, the pattern was consistent with their initial metastatic disease. According to multivariate Cox regression analysis, initial clinical T4b disease (cT4b; odds ratio=6.44, 95% confidence interval=1.59-23.9; p=0.01) was the only significant independent risk factor affecting RFS. Pathological T4a or T4b disease was recorded in five-out of six (83%) patients with cT4b. Conclusion: Initial cT4b disease appears to predict recurrence in patients with initially unresectable gastric cancer treated with curative conversion surgery. Effective use of additional chemotherapy may be required for patients with this risk factor.	[Fukuchi, Minoru; Ishiguro, Toru; Kumagai, Youichi; Ishibashi, Keiichiro; Ishida, Hideyuki; Mochiki, Erito] Saitama Med Univ, Saitama Med Ctr, Dept Digest Tract & Gen Surg, Kawagoe, Saitama 3508550, Japan; [Ogata, Kyoichi; Kimura, Akiharu; Kuwano, Hiroyuki] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gumma 371, Japan	Fukuchi, M (reprint author), Saitama Med Univ, Saitama Med Ctr, Dept Digest Tract & Gen Surg, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.	mfukuchi@saitama-med.ac.jp					[Anonymous], 2009, COMM TERM CRIT ADV E; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Fukuchi M, 2015, ANTICANCER RES, V35, P505; Fukuchi M, 2015, ANN SURG ONCOL, V22, P3618, DOI 10.1245/s10434-015-4422-6; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Ogata K, 2009, HEPATO-GASTROENTEROL, V56, P1760; Mochiki E, 2012, BRIT J CANCER, V107, P31, DOI 10.1038/bjc.2012.222; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354; Kanda T, 2012, GASTRIC CANCER, V15, P235, DOI 10.1007/s10120-011-0100-y; Nakajima T, 1997, ANN SURG ONCOL, V4, P203, DOI 10.1007/BF02306611; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Suzuki T, 2010, ONCOL LETT, V1, P743, DOI 10.3892/ol_00000130; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Sobin L, 2009, TNM CLASSIFICATION M	14	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2015	35	11					6183	6187				5	Oncology	Oncology	CU8LT	WOS:000363794900056		
J	Matsumoto, H; Okumura, H; Murakami, H; Kubota, H; Higashida, M; Tsuruta, A; Tohyama, K; Hirai, T				Matsumoto, Hideo; Okumura, Hideo; Murakami, Haruaki; Kubota, Hisako; Higashida, Masaharu; Tsuruta, Atsushi; Tohyama, Kaoru; Hirai, Toshihiro			Fluctuation in Plasma 5-Fluorouracil Concentration During Continuous 5-Fluorouracil Infusion for Colorectal Cancer	ANTICANCER RESEARCH			English	Article						Concentration of 5-FU; 5-FU-based chemotherapy; My5-FU (TM) immunoassay; FOLFIRI; FOLFOX	FLUOROURACIL DOSE ADJUSTMENT; MASS-SPECTROMETRY; DIHYDROPYRIMIDINE DEHYDROGENASE; LIQUID-CHROMATOGRAPHY; MULTICENTER TRIAL; DRUG; PHARMACOKINETICS; CHEMOTHERAPY; IMMUNOASSAY; THERAPY	Background/Aim: It is generally believed that the plasma concentration of 5-fluorouracil (5-FU) is constant when 5-FU is continually administered for chemotherapy. The aim of the present study was to verify whether this is true. Patients and Methods: Nine patients with colorectal cancer were enrolled in this study. All patients received chemotherapy; four patients received FOLFIRI (leucovorin, 5-fluorouracil, irinotecan) and five received FOLFOX (leucovorin, 5-fluorouracil, oxaliplatin). 5-FU was administered continuously (2400 mg/m(2)) for 46 h. Serum was collected at 12 points after the start of administration. The concentration of 5-FU was evaluated using a new immunoassay method and gas chromatography-mass spectrometric (GC/MS) method. Results: The concentrations of 5-FU fluctuated dramatically over time, with greater than 3-fold changes in each individual, and the pattern was not constant. Conclusion: Because the serum concentration of 5-FU fluctuates and displays various patterns, the dosage should not be based on body surface area. A new individualized method for determining the 5-FU dosage should be developed.	[Matsumoto, Hideo; Okumura, Hideo; Murakami, Haruaki; Kubota, Hisako; Higashida, Masaharu; Tsuruta, Atsushi; Hirai, Toshihiro] Kawasaki Med Univ, Dept Digest Surg, Kurashiki, Okayama 7010192, Japan; [Tohyama, Kaoru] Kawasaki Med Univ, Dept Lab Med, Kurashiki, Okayama 7010192, Japan	Matsumoto, H (reprint author), Kawasaki Med Univ, Dept Digest Surg, 577 Matsushiama, Kurashiki, Okayama 7010192, Japan.	h-matsu@med.kawasaki-m.ac.jp					Adjei AA, 2002, J CLIN ONCOL, V20, P1683, DOI 10.1200/JCO.20.6.1683; Capitain O, 2012, CLIN COLORECTAL CANC, V11, P263, DOI 10.1016/j.clcc.2012.05.004; Matsushima E, 1997, J CHROMATOGR B, V691, P95, DOI 10.1016/S0378-4347(96)00429-X; Takimoto CH, 1999, CLIN CANCER RES, V5, P1347; Bi DQ, 2000, J CHROMATOGR B, V738, P249, DOI 10.1016/S0378-4347(99)00528-9; Bressolle F, 1999, CANCER CHEMOTH PHARM, V44, P295, DOI 10.1007/s002800050980; Gamelin E, 2008, J CLIN ONCOL, V26, P2099, DOI 10.1200/JCO.2007.13.3934; Levi F, 1997, LANCET, V350, P681, DOI 10.1016/S0140-6736(97)03358-8; Saif MW, 2009, J NATL CANCER I, V101, P1543, DOI 10.1093/jnci/djp328; Kaldate RR, 2012, ONCOLOGIST, V17, P296, DOI 10.1634/theoncologist.2011-0357; Buchel B, 2013, CLIN CHEM LAB MED, V51, P1681, DOI 10.1515/cclm-2012-0641; Gamelin EC, 1996, CANCER, V77, P441, DOI 10.1002/(SICI)1097-0142(19960201)77:3<441::AID-CNCR4>3.0.CO;2-N; LEVI F, 1995, EUR J CANCER, V31A, P1264, DOI 10.1016/0959-8049(95)00242-B; Jiang H, 2002, J CHROMATOGR B, V769, P169, DOI 10.1016/S1570-0232(02)00009-0; HARRIS BE, 1990, CANCER RES, V50, P197; Goel G, 2014, CLIN COLORECTAL CANC, V13, P1, DOI 10.1016/j.clcc.2013.12.001; MILANO G, 1994, J CLIN ONCOL, V12, P1291; Gamelin E, 1998, J CLIN ONCOL, V16, P1470; AU JLS, 1982, CANCER RES, V42, P2930; Patel JN, 2014, ONCOLOGIST, V19, P959, DOI 10.1634/theoncologist.2014-0132; Matsumoto H, 2012, ANTICANCER RES, V32, P5111; Beumer JH, 2009, THER DRUG MONIT, V3, P688; Gamelin E, 2008, ASCO GASTR CANC S, V431; Soh IPT, 2015, J CLIN ONCOL S3, V33	24	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2015	35	11					6193	6199				7	Oncology	Oncology	CU8LT	WOS:000363794900058		
J	Kitagawa, H; Namikawa, T; Munekage, M; Akimori, T; Kobayashi, M; Hanazaki, K				Kitagawa, Hiroyuki; Namikawa, Tsutomu; Munekage, Masaya; Akimori, Toyokazu; Kobayashi, Michiya; Hanazaki, Kazuhiro			Visualization of the Stomach's Arterial Networks During Esophageal Surgery Using the HyperEye Medical System	ANTICANCER RESEARCH			English	Article						Indocyanine green fluorescence; gastric tube; line-marking method; HyperEye medical system	INDOCYANINE GREEN FLUORESCENCE; LAPAROSCOPIC GASTRIC MOBILIZATION; CANCER; OUTCOMES; NODES; LEAK; TUBE	Aim: The present study investigated the visualization of the arterial networks in the stomach (ANS) during gastric tube (GT) creation using indocyanine green fluorescence and the HyperEye Medical System (HEMS), and the feasibility of the HEMS-line-marking method (LMM). Patients and Methods: We reviewed 51 consecutive patients who had undergone esophageal surgery with GT reconstruction. Patients for whom the HEMS was deployed after GT creation to confirm the anastomosed area's blood supply formed the control group (n=28). Patients for whom the HEMS was deployed before GT creation to confirm and mark the ANS border comprised the HEMS-LMM group (n=23). Results: The HEMS-LMM visualized the ANS border, and the leakage rate decreased from 17.9% to 4.4% (p=0.204). Conclusion: The HEMS-LMM is safe and feasible for visualizing the blood supply border of the right gastroepiploic artery and the ANS before GT creation during esophageal surgery, and it might reduce leakage in esophageal surgery.	[Kitagawa, Hiroyuki; Namikawa, Tsutomu; Munekage, Masaya; Hanazaki, Kazuhiro] Kochi Med Sch, Dept Surg, Nankoku, Kochi 7838505, Japan; [Akimori, Toyokazu] Kochi Hata Prefectural Hosp, Dept Surg, Sukumo, Kochi, Japan; [Kobayashi, Michiya] Kochi Med Sch, Dept Human Hlth & Med Sci, Nankoku, Kochi 7838505, Japan	Namikawa, T (reprint author), Kochi Med Sch, Dept Surg, Kohasu Okocho, Nankoku, Kochi 7838505, Japan.	tsutomun@kochi-u.ac.jp					Juloori A, 2014, J THORAC ONCOL, V9, P534, DOI 10.1097/JTO.0000000000000100; Yoshida M, 2012, J GASTROEN HEPATOL, V27, P29, DOI 10.1111/j.1440-1746.2012.07067.x; Yamamoto M, 2011, SURG TODAY, V41, P1467, DOI 10.1007/s00595-010-4553-0; AKIYAMA H, 1978, ANN SURG, V188, P606, DOI 10.1097/00000658-197811000-00004; Dolan JP, 2013, SURG ENDOSC, V27, P4094, DOI 10.1007/s00464-013-3066-5; Yamamoto M, 2012, EUR J VASC ENDOVASC, V43, P426, DOI 10.1016/j.ejvs.2011.12.030; Shimada Y, 2011, ESOPHAGUS-TOKYO, V8, P259, DOI 10.1007/s10388-011-0291-7; Kassis ES, 2013, ANN THORAC SURG, V96, P1919, DOI 10.1016/j.athoracsur.2013.07.119; Buunen M, 2008, DIS ESOPHAGUS, V21, P272, DOI 10.1111/j.1442-2050.2007.00771.x; Page RD, 2013, ANN THORAC SURG, V95, P292, DOI 10.1016/j.athoracsur.2012.09.048; Kitagawa H, 2009, LANGENBECK ARCH SURG, V394, P617, DOI 10.1007/s00423-008-0354-y; Sugie T, 2013, ANN SURG ONCOL, V20, P2213, DOI 10.1245/s10434-013-2890-0; Kitagawa H, 2013, J LAPAROENDOSC ADV S, V23, P452, DOI 10.1089/lap.2012.0377; Handa Takemi, 2010, Gen Thorac Cardiovasc Surg, V58, P68, DOI 10.1007/s11748-009-0536-8; Kumagai Y, 2014, WORLD J SURG, V38, P138, DOI 10.1007/s00268-013-2237-9; Namikawa T, 2014, AM SURGEON, V80, pE359; Rino Y, 2014, BMC MED IMAGING, V14, DOI 10.1186/1471-2342-14-18	17	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2015	35	11					6201	6205				5	Oncology	Oncology	CU8LT	WOS:000363794900059		
J	Ando, K; Oki, E; Saeki, H; Kasagi, Y; Tsuda, Y; Zaitsu, Y; Nakashima, Y; Imamura, Y; Ohgaki, K; Maehara, Y				Ando, Koji; Oki, Eiji; Saeki, Hiroshi; Kasagi, Yuta; Tsuda, Yasuo; Zaitsu, Yoko; Nakashima, Yuichiro; Imamura, Yu; Ohgaki, Kippei; Maehara, Yoshihiko			Number of Lymph Node Metastases May Indicate the Regimen for Adjuvant Chemotherapy in Patients with Stage III Colorectal Cancer	ANTICANCER RESEARCH			English	Article						Colorectal cancer; numbers of metastatic lymph nodes; adjuvant chemotherapy	CAPECITABINE PLUS OXALIPLATIN; RANDOMIZED PHASE-III; COLON-CANCER; INTRAVENOUS FLUOROURACIL; 1ST-LINE TREATMENT; ORAL URACIL; LEUCOVORIN; RATIO; TRIAL; THERAPY	Background: Adjuvant chemotherapy (ACT) may prevent recurrence in patients with stage III colorectal cancer (CRC). However, only 10% of patients benefit from ACT and no effective indicators exist to predict which patients are likely to benefit. The present study validated metastatic lymph node (MLN) number as a new indicator for ACT. Patients and Methods: We retrospectively reviewed 173 patients with stage III CRC, who were classified by Union for International Cancer Control (UICC) stage or N category, and analyzed their overall survival (OS) and disease-free survival (DFS) according to stage, number of MLNs and ACT use. Results: Among 173 patients, we found 65 with only one MLN (N1a). For N1a patients treated with ACT, the 5-year OS rate was 100%; the 3-year DFS rate was 92.7% for those treated with oral ACT. Conclusion: The number of MLNs is a simple indicator for ACT in patients with stage III CRC. For patients with only one MLN, oral chemotherapy is a good option.	[Ando, Koji; Oki, Eiji; Saeki, Hiroshi; Kasagi, Yuta; Tsuda, Yasuo; Zaitsu, Yoko; Nakashima, Yuichiro; Imamura, Yu; Ohgaki, Kippei; Maehara, Yoshihiko] Kyushu Univ, Dept Surg & Sci, Higashi Ku, Fukuoka 8128582, Japan	Ando, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	k-ando@surg2.med.kyushu-u.ac.jp					ANDRE T, 2004, NEW ENGL J MED, V350, P2343, DOI DOI 10.1056/NEJM0A032709; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Park IJ, 2009, J SURG ONCOL, V100, P240, DOI 10.1002/jso.21273; Kobayashi H, 2007, SURGERY, V141, P67, DOI 10.1016/j.surg.2006.07.020; de Gramont A, 2000, J CLIN ONCOL, V18, P2938; Schmoll HJ, 2007, J CLIN ONCOL, V25, P102, DOI 10.1200/JCO.2006.08.1075; Chen SL, 2011, ANN SURG, V253, P82, DOI 10.1097/SLA.0b013e3181ffa780; WOLMARK N, 1988, J NATL CANCER I, V80, P30, DOI 10.1093/jnci/80.1.30; Heinemann V, 2014, LANCET ONCOL, V15, P1065, DOI 10.1016/S1470-2045(14)70330-4; Lu YJ, 2013, WORLD J SURG, V37, P1927, DOI 10.1007/s00268-013-2051-4; Grothey A, 2004, J CLIN ONCOL, V22, P1209, DOI 10.1200/JCO.2004.11.037; Moug SJ, 2014, INT J COLORECTAL DIS, V29, P599, DOI 10.1007/s00384-014-1848-4; WOLMARK N, 1993, J CLIN ONCOL, V11, P1879; Madbouly KM, 2014, AM J SURG, V207, P824, DOI 10.1016/j.amjsurg.2013.07.022; Lembersky BC, 2006, J CLIN ONCOL, V24, P2059, DOI 10.1200/JCO.2005.04.7498; Cassidy J, 2008, J CLIN ONCOL, V26, P2006, DOI 10.1200/JCO.2007.14.9898; Shimada Y, 2014, EUR J CANCER, V50, P2231, DOI 10.1016/j.ejca.2014.05.025; O'Shea A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104991; Schiffmann L, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-79; Sobin L, 2009, TNM CLASSIFICATION M; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262	21	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2015	35	11					6207	6211				5	Oncology	Oncology	CU8LT	WOS:000363794900060		
J	Hayashi, K; Isohashi, F; Ogawa, K; Oikawa, H; Onishi, H; Ito, Y; Takemoto, M; Karasawa, K; Imai, M; Kosaka, Y; Yamazaki, H; Yoshioka, Y; Nemoto, K; Nishimura, Y				Hayashi, Kazuhiko; Isohashi, Fumiaki; Ogawa, Kazuhiko; Oikawa, Hirobumi; Onishi, Hiroshi; Ito, Yoshinori; Takemoto, Mitsuhiro; Karasawa, Katsuyuki; Imai, Michiko; Kosaka, Yasuhiro; Yamazaki, Hideya; Yoshioka, Yasuo; Nemoto, Kenji; Nishimura, Yasumasa		Japanese Radiation Oncology Study	Postoperative External Irradiation of Patients with Primary Biliary Tract Cancer: A Multicenter Retrospective Study	ANTICANCER RESEARCH			English	Article						Postoperative radiotherapy; biliary tract cancer	BILE-DUCT CANCER; IMPROVED SURVIVAL; EXTRAHEPATIC CHOLANGIOCARCINOMA; ADJUVANT RADIOTHERAPY; RECURRENCE; PATTERNS; SURGERY; THERAPY; CHEMORADIOTHERAPY; CHEMORADIATION	Background/Aim: The aim of the present study was to assess clinical outcomes of postoperative radiotherapy for biliary tract cancer patients. Patients and Methods: Clinical results of 187 patients treated with external irradiation in 31 Japanese Institutions between 2000 and 2011 were retrospectively analyzed. The median radiation dose was 50.4 Gy in fractions of 1.8-2 Gy. Results: Two-year actuarial overall survival and locoregional control (LCs) rates were 56% and 68%, respectively. In multivariate analysis, macroscopic residual tumor (R2) and irradiated doses < 54 Gy were significant indicators of poor LC prognosis. For patients with complete resection (R0) or microscopic residual tumor (R1), 2-year LCs were 71% for < 54 Gy and 83% for >= 54 Gy; doses >= 54 Gy were associated with high long-term LCs. There was no significant difference in acute adverse event rates between < 54 Gy and >= 54 Gy. Conclusion: Postoperative irradiation doses of approximately 54 Gy are safe and effective for R0 or R1 resection patients.	[Hayashi, Kazuhiko; Isohashi, Fumiaki; Ogawa, Kazuhiko; Yoshioka, Yasuo] Osaka Univ, Dept Radiat Oncol, Grad Sch Med, Suita, Osaka, Japan; [Oikawa, Hirobumi] Iwate Med Univ, Dept Radiol, Morioka, Iwate, Japan; [Onishi, Hiroshi] Univ Yamanashi, Dept Radiol, Yamanashi, Japan; [Ito, Yoshinori] Natl Canc Ctr, Dept Radiat Oncol, Tokyo, Japan; [Takemoto, Mitsuhiro] Okayama Univ, Dept Radiol, Okayama 7008530, Japan; [Karasawa, Katsuyuki] Tokyo Metropolitan Komagome Hosp, Dept Radiat Oncol, Tokyo, Japan; [Imai, Michiko] Iwata City Hosp, Dept Radiat Oncol, Shizuoka, Japan; [Yamazaki, Hideya] Kyoto Prefectural Univ Med, Dept Radiol, Kyoto, Japan; [Nemoto, Kenji] Yamagata Univ, Dept Radiat Oncol, Yamagata 990, Japan; [Nishimura, Yasumasa] Kinki Univ, Fac Med, Dept Radiat Oncol, Osaka, Japan	Isohashi, F (reprint author), Osaka Univ, Dept Radiat Oncol, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka, Japan.	isohashi@radonc.med.osaka-u.ac.jp					Nordlinger B, 2013, LANCET ONCOL, V14, P1208, DOI 10.1016/S1470-2045(13)70447-9; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Fuller CD, 2009, CANCER-AM CANCER SOC, V115, P5175, DOI 10.1002/cncr.24572; Hughes MA, 2007, INT J RADIAT ONCOL, V68, P178, DOI 10.1016/j.ijrobp.2006.11.048; Shinohara ET, 2009, INT J RADIAT ONCOL, V74, P1191, DOI 10.1016/j.ijrobp.2008.09.017; Matsuda A, 2014, JPN J CLIN ONCOL, V44, P388, DOI 10.1093/jjco/hyu003; Shinohara ET, 2008, INT J RADIAT ONCOL, V72, P1495, DOI 10.1016/j.ijrobp.2008.03.018; Kim TH, 2011, INT J RADIAT ONCOL, V81, pE853, DOI 10.1016/j.ijrobp.2010.12.019; Park JH, 2011, INT J RADIAT ONCOL, V79, P696, DOI 10.1016/j.ijrobp.2009.12.031; Beltran MB, 2012, CANCER TREAT REV, V38, P111, DOI 10.1016/j.ctrv.2011.05.003; Hezel AF, 2008, ONCOLOGIST, V13, P415, DOI 10.1634/theoncologist.2007-0252; Nelson JW, 2009, INT J RADIAT ONCOL, V73, P148, DOI 10.1016/j.ijrobp.2008.07.008; Yoshioka Y, 2014, RADIOTHER ONCOL, V110, P546, DOI 10.1016/j.radonc.2014.01.003; Kim S, 2002, INT J RADIAT ONCOL, V54, P414, DOI 10.1016/S0360-3016(02)02952-8; Jarnagin WR, 2003, CANCER, V98, P1689, DOI 10.1002/cncr.11699; Heron DE, 2003, AM J CLIN ONCOL-CANC, V26, P422; Borghero Y, 2008, ANN SURG ONCOL, V15, P3147, DOI 10.1245/s10434-008-9998-7; Kim JK, 2003, ABDOM IMAGING, V28, P384, DOI 10.1007/s00261-002-0048-9; Koerkamp BG, 2014, J SURG ONCOL, V110, P585, DOI 10.1002/jso.23762; Isohashi F, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-76; Ellison CE, 2002, SURGERY, V132, P563; Nakeeb A, 2002, SURGERY, V132, P555, DOI 10.1067/msy.2002.127555; Oh D, 2007, AM J CLIN ONCOL-CANC, V30, P21, DOI 10.1097/01.coc.0000245467.97180.78	23	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2015	35	11					6231	6237				7	Oncology	Oncology	CU8LT	WOS:000363794900064		
J	Fujimoto, D; Shimizu, R; Kato, R; Sato, Y; Kogo, M; Ito, J; Teraoka, S; Otoshi, T; Nagata, K; Nakagawa, A; Otsuka, K; Katakami, N; Tomii, K				Fujimoto, Daichi; Shimizu, Ryoko; Kato, Ryoji; Sato, Yuki; Kogo, Mariko; Ito, Jiro; Teraoka, Shunsuke; Otoshi, Takehiro; Nagata, Kazuma; Nakagawa, Atsushi; Otsuka, Kojiro; Katakami, Nobuyuki; Tomii, Keisuke			Second-line Chemotherapy for Patients with Small Cell Lung Cancer and Interstitial Lung Disease	ANTICANCER RESEARCH			English	Article						Chemotherapy-related exacerbation; interstitial lung disease; small cell lung cancer; usual interstitial pneumonia	IDIOPATHIC PULMONARY-FIBROSIS; PHASE-III TRIAL; WEEKLY PACLITAXEL; CARBOPLATIN; TOPOTECAN; EFFICACY; PNEUMONIAS; SAFETY; CYCLOPHOSPHAMIDE; EXACERBATION	Background: The safety and efficacy of second-line chemotherapy for treating patients with small cell lung cancer (SCLC) and interstitial lung disease (ILD) have not been elucidated to date. Patients and Methods: Between January 2005 and September 2013, we analyzed 23 patients with SCLC and ILD who received second-line chemotherapy. Pre-existing ILD was diagnosed according to clinical features and pretreatment chest high-resolution computed tomography results. Results: The overall objective response rates and disease control rates were 22% and 52%, respectively. The median respective durations of progression-free survival and overall survival were 2.1 months (95% confidence interval (CI)=2.0-3.0 months) and 7.1 months (95% CI=3.6-11.3 months), respectively. Three patients with unusual interstitial pneumonia pattern (13%) developed chemotherapy-related pneumonitis. Conclusion: Second-line treatment may be an effective and safe option for SCLC patients with ILD after sufficient evaluation of risks and benefits.	[Fujimoto, Daichi; Shimizu, Ryoko; Kato, Ryoji; Sato, Yuki; Kogo, Mariko; Ito, Jiro; Teraoka, Shunsuke; Otoshi, Takehiro; Nagata, Kazuma; Nakagawa, Atsushi; Otsuka, Kojiro; Katakami, Nobuyuki; Tomii, Keisuke] Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo 6500047, Japan	Fujimoto, D (reprint author), Kobe City Med Ctr Gen Hosp, Dept Resp Med, Chuo Ku, 2 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	daichianzen@yahoo.co.jp			Ethics Committee of Kobe City Medical Center General Hospital	This study was supported by internal funding and the Ethics Committee of Kobe City Medical Center General Hospital.	Okuda K, 2012, ANTICANCER RES, V32, P5475; Minegishi Y, 2009, INTERNAL MED, V48, P665, DOI 10.2169/internalmedicine.48.1650; Togashi Y, 2012, CLIN LUNG CANCER, V13, P304, DOI 10.1016/j.cllc.2011.11.001; O'Brien MER, 2006, J CLIN ONCOL, V24, P5441, DOI 10.1200/JCO.2006.06.5821; Raghu G, 2014, LANCET RESP MED, V2, P566, DOI 10.1016/S2213-2600(14)70101-8; Kenmotsu H, 2011, J THORAC ONCOL, V6, P1242, DOI 10.1097/JTO.0b013e318216ee6b; Inoue A, 2008, J CLIN ONCOL, V26, P5401, DOI 10.1200/JCO.2008.18.1974; Mori K, 2007, CANCER CHEMOTH PHARM, V60, P189, DOI 10.1007/s00280-006-0360-0; Ozawa Y, 2009, RESPIROLOGY, V14, P723, DOI 10.1111/j.1440-1843.2009.01547.x; Groen HJM, 1999, J CLIN ONCOL, V17, P927; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; von Pawel J, 2014, J CLIN ONCOL, V32, P4012, DOI 10.1200/JCO.2013.54.5392; Minegishi Y, 2011, LUNG CANCER, V71, P70, DOI 10.1016/j.lungcan.2010.04.014; Berghmans T, 2012, EUR RESPIR J, V39, P9, DOI 10.1183/09031936.00190310; Yamamoto N, 2006, ANTICANCER RES, V26, P777; Jackman DM, 2005, LANCET, V366, P1385, DOI 10.1016/S0140-6736(05)67569-1; von Pawel J, 1999, J CLIN ONCOL, V17, P658; Sverzellati N, 2011, EUR RESPIR J, V38, P392, DOI 10.1183/09031936.00201809; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Mori K, 2006, CANCER CHEMOTH PHARM, V58, P86, DOI 10.1007/s00280-005-0114-4; Isobe K, 2010, RESPIROLOGY, V15, P88, DOI 10.1111/j.1440-1843.2009.01666.x; Minegishi Y, 2011, J THORAC ONCOL, V6, P801, DOI 10.1097/JTO.0b013e3182103d3c; Watanabe N, 2013, RESPIRATION, V85, P326, DOI 10.1159/000342046; Jin GY, 2013, RADIOLOGY, V268, P563, DOI 10.1148/radiol.13120816; Bouros D, 2002, CHEST, V121, P1278, DOI 10.1378/chest.121.4.1278; Kato Motoyasu, 2014, BMC Cancer, V14, P508, DOI 10.1186/1471-2407-14-508; Kenmotsu H, 2015, CANC CHEMOTHER PHARM; Kobayashi Kunihiko, 2002, Int J Clin Oncol, V7, P177, DOI 10.1007/s101470200026; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Shimizu R, 2014, CANCER CHEMOTH PHARM, V74, P1159, DOI 10.1007/s00280-014-2590-x	30	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	NOV	2015	35	11					6261	6266				6	Oncology	Oncology	CU8LT	WOS:000363794900068		
J	Satomura, T; Sakuraba, H; Suye, S; Ohshima, T				Satomura, Takenori; Sakuraba, Haruhiko; Suye, Shin-ichiro; Ohshima, Toshihisa			Dye-linked D-amino acid dehydrogenases: biochemical characteristics and applications in biotechnology	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Review						Dye-linked dehydrogenase; D-Amino acid dehydrogenase; Flavoenzyme; Amino acid catabolism; Electrochemical biosensor	D-PROLINE DEHYDROGENASE; SUCCINATE-DEHYDROGENASE; PSEUDOMONAS-AERUGINOSA; HYDROXYPROLINE METABOLISM; NADH DEHYDROGENASE; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; D-ASPARTATE; PURIFICATION; MEMBRANE	Dye-linked D-amino acid dehydrogenases (Dye-DADHs) catalyze the dehydrogenation of free D-amino acids in the presence of an artificial electron acceptor. Although Dye-DADHs functioning in catabolism of L-alanine and as primary enzymes in electron transport chains are widely distributed in mesophilic Gram-negative bacteria, biochemical and biotechnological information on these enzymes remains scanty. This is in large part due to their instability after isolation. On the other hand, in the last decade, several novel types of Dye-DADH have been found in thermophilic bacteria and hyperthermophilic archaea, where they contribute not only to L-alanine catabolism but also to the catabolism of other amino acids, including D-arginine and L-hydroxyproline. In this minireview, we summarize recent developments in our understanding of the biochemical characteristics of Dye-DADHs and their specific application to electrochemical biosensors.	[Satomura, Takenori; Suye, Shin-ichiro] Univ Fukui, Grad Sch Engn, Dept Appl Chem & Biotechnol, Fukui 9108507, Japan; [Sakuraba, Haruhiko] Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Miki, Kagawa 7610795, Japan; [Suye, Shin-ichiro] Univ Fukui, Grad Sch Engn, Dept Frontier Fiber Technol & Sci, Fukui 9108507, Japan; [Ohshima, Toshihisa] Osaka Inst Technol, Fac Engn, Dept Biomed Engn, Omiya, Ohsaka 5358585, Japan	Satomura, T (reprint author), Univ Fukui, Grad Sch Engn, Dept Appl Chem & Biotechnol, 3-9-1 Bunkyo, Fukui 9108507, Japan.	satomura@u-fukui.ac.jp			JSPS KAKENHI [25870271]	This work was supported by JSPS KAKENHI Grant Number 25870271.	Adams Michael W. W., 1993, V47, P627; He WQ, 2011, J BACTERIOL, V193, P2107, DOI 10.1128/JB.00036-11; Satomura T, 2015, APPL MICROBIOL BIOT, V99, P4265, DOI 10.1007/s00253-014-6263-9; BERGSMA J, 1982, EUR J BIOCHEM, V128, P151; DAVIS KA, 1971, BIOCHEMISTRY-US, V10, P2509; Li C, 2009, P NATL ACAD SCI USA, V106, P906, DOI 10.1073/pnas.0808269106; Patzold R, 2005, J AGR FOOD CHEM, V53, P9722, DOI 10.1021/jf051433u; Tani Y, 2008, ANAL CHIM ACTA, V619, P215, DOI 10.1016/j.aca.2008.04.063; LOBOCKA M, 1994, J BACTERIOL, V176, P1500; Fu GX, 2010, BIOCHEMISTRY-US, V49, P8535, DOI 10.1021/bi1005865; Tani Y, 2009, ANAL SCI, V25, P919; Li CR, 2010, MICROBIOL-SGM, V156, P60, DOI 10.1099/mic.0.033282-0; Furuchi T, 2005, BIOL PHARM BULL, V28, P1566, DOI 10.1248/bpb.28.1566; Satomura T, 2002, J BIOL CHEM, V277, P12861, DOI 10.1074/jbc.M112272200; MONDADORI C, 1989, EXP BRAIN RES, V75, P449; Nagata Y, 2006, LIFE SCI, V78, P1677, DOI 10.1016/j.lfs.2005.08.009; BATER AJ, 1977, ARCH MICROBIOL, V112, P287, DOI 10.1007/BF00413094; YONEYA T, 1961, J BIOL CHEM, V236, P3272; JONES H, 1983, FEBS LETT, V151, P189, DOI 10.1016/0014-5793(83)80066-0; NISIMOTO Y, 1986, J BIOL CHEM, V261, P285; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; RISON RA, 1995, NEUROSCI BIOBEHAV R, V19, P533, DOI 10.1016/0149-7634(95)00017-8; HEDERSTEDT L, 1979, J BACTERIOL, V138, P370; Watanabe S, 2012, J BIOL CHEM, V287, P32674, DOI 10.1074/jbc.M112.374272; MAGOR AM, 1987, BIOCHIMIE, V69, P63, DOI 10.1016/0300-9084(87)90272-0; Hamase K, 2002, J CHROMATOGR B, V781, P73, DOI 10.1016/S1570-0232(02)00690-6; Erbe T, 2000, EUR FOOD RES TECHNOL, V211, P6, DOI 10.1007/s002170050581; Hamase K, 2001, ANAL BIOCHEM, V298, P253, DOI 10.1006/abio.2001.5382; Boulette ML, 2009, J BACTERIOL, V191, P6329, DOI 10.1128/JB.00817-09; Nagata Y, 2007, AMINO ACIDS, V32, P137, DOI 10.1007/s00726-006-0262-9; Frew JE, 1987, ANAL CHEM, V59, p933A; HANSTEIN WG, 1971, BIOCHEMISTRY-US, V10, P2517; OHSHIMA T, 1989, TRENDS BIOTECHNOL, V7, P210, DOI 10.1016/0167-7799(89)90106-6; Olsiewski JP, 1980, J BIOL CHEM, V255, P4487	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	NOV	2015	99	22					9337	9347		10.1007/s00253-015-6944-z		11	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CV0PB	WOS:000363951800002		
J	Taguchi, S; Ooi, T; Mizuno, K; Matsusaki, H				Taguchi, Seiichi; Ooi, Toshihiko; Mizuno, Kouhei; Matsusaki, Hiromi			Advances and needs for endotoxin-free production strains	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Review						Food-grade Gram-positive bacteria; Lipopolysaccharide; Polyhydroxyalkanoates; Bacteriocins; Membrane proteins; Yeasts	LACTIC-ACID BACTERIA; CONTROLLED GENE-EXPRESSION; BACILLUS-CEREUS YB-4; RECOMBINANT LACTOCOCCUS-LACTIS; LACTATE-POLYMERIZING ENZYME; GRAM-POSITIVE BACTERIA; MEDIUM-CHAIN-LENGTH; CORYNEBACTERIUM-GLUTAMICUM; MEMBRANE-PROTEINS; ESCHERICHIA-COLI	The choice of an appropriate microbial host cell and suitable production conditions is crucial for the downstream processing of pharmaceutical- and food-grade products. Although Escherichia coli serves as a highly valuable leading platform for the production of value-added products, like most Gram-negative bacteria, this bacterium contains a potent immunostimulatory lipopolysaccharide (LPS), referred to as an endotoxin. In contrast, Gram-positive bacteria, notably Bacillus, lactic acid bacteria (LAB), Corynebacterium, and yeasts have been extensively used as generally recognized as safe (GRAS) endotoxin-free platforms for the production of a variety of products. This review summarizes the currently available knowledge on the utilization of these representative Gram-positive bacteria for the production of eco- and bio-friendly products, particularly natural polyesters, polyhydroxyalkanoates, bacteriocins, and membrane proteins. The successful case studies presented here serve to inspire the use of these microorganisms as a main-player or by-player depending on their individual properties for the industrial production of these desirable targets.	[Taguchi, Seiichi; Ooi, Toshihiko] Hokkaido Univ, Grad Sch Engn, Div Appl Chem, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Taguchi, Seiichi; Ooi, Toshihiko] JST, CREST, Kawaguchi, Saitama 3320012, Japan; [Mizuno, Kouhei] Kitakyushu Natl Coll Technol, Dept Mat Sci & Chem Engn, Kokuraminami Ku, Kitakyushu, Fukuoka 8020985, Japan; [Matsusaki, Hiromi] Prefectural Univ Kumamoto, Fac Environm & Symbiot Sci, Higashi Ku, Kumamoto 8628502, Japan	Taguchi, S (reprint author), Hokkaido Univ, Grad Sch Engn, Div Appl Chem, Kita Ku, N13-W8, Sapporo, Hokkaido 0608628, Japan.	staguchi@eng.hokudai.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [23310059]; CREST, Japan Science and Technology Agency (JST)	We thank Professor Steinbuchel for inviting us to write this review article. Some of the studies introduced in this review were supported in part by the Japan Society for the Promotion of Science (JSPS) KAKENHI, grant number 23310059 to S. Taguchi and CREST, Japan Science and Technology Agency (JST). American Journal Experts reviewed the manuscript prior to submission.	VANDERHART DL, 1995, MACROMOLECULES, V28, P6394, DOI 10.1021/ma00123a002; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; STEINBUCHEL A, 1992, FEMS MICROBIOL LETT, V103, P217, DOI 10.1111/j.1574-6968.1992.tb05841.x; Chang DE, 1999, APPL ENVIRON MICROB, V65, P1384; Tsuge T, 2004, MACROMOL BIOSCI, V4, P963, DOI 10.1002/mabi.200400075; Westers L, 2004, BBA-MOL CELL RES, V1694, P299, DOI 10.1016/j.bbammcr.2004.02.011; Chanprateep S, 2010, J BIOSCI BIOENG, V110, P621, DOI 10.1016/j.jbiosc.2010.07.014; Nomura CT, 2007, APPL MICROBIOL BIOT, V73, P969, DOI 10.1007/s00253-006-0566-4; Jo SJ, 2009, J BIOSCI BIOENG, V107, P409, DOI 10.1016/j.jbiosc.2008.12.003; SIEGERS K, 1995, APPL ENVIRON MICROB, V61, P1082; NAKAMURA S, 1992, MACROMOLECULES, V25, P4237, DOI 10.1021/ma00043a001; Taguchi S, 2002, J BIOCHEM, V131, P801; Umakoshi M, 2011, J BIOSCI BIOENG, V112, P595, DOI 10.1016/j.jbiosc.2011.08.011; Kricheldorf HR, 2001, CHEMOSPHERE, V43, P49, DOI 10.1016/S0045-6535(00)00323-4; de Vos WM, 1999, INT DAIRY J, V9, P3, DOI 10.1016/S0958-6946(99)00038-2; Tateno T, 2007, APPL MICROBIOL BIOT, V74, P1213, DOI [10.1007/00253-006-0766-y, 10.1007/s00253-006-0766-y]; Vogl T, 2013, CURR OPIN BIOTECH, V24, P1094, DOI 10.1016/j.copbio.2013.02.024; Nes IF, 1996, ANTON LEEUW INT J G, V70, P113, DOI 10.1007/BF00395929; Jo SJ, 2006, J BIOSCI BIOENG, V102, P233, DOI 10.1263/jbb.102.233; Morita M, 2001, J BIOSCI BIOENG, V91, P469, DOI 10.1263/jbb.91.469; Zhou XX, 2006, BIOTECHNOL ADV, V24, P285, DOI 10.1016/j.biotechadv.2005.11.001; KUIPERS OP, 1995, J BIOL CHEM, V270, P27299, DOI 10.1074/jbc.270.45.27299; Mifune J, 2009, APPL ENVIRON MICROB, V75, P4668, DOI 10.1128/AEM.00487-09; Cheigh CI, 2005, BIOTECHNOL LETT, V27, P1641, DOI 10.1007/s10529-005-2721-x; KEMNITZER JE, 1993, MACROMOLECULES, V26, P1221, DOI 10.1021/ma00058a004; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1111/j.1574-6968.1995.tb07528.x; Horn N, 2004, APPL ENVIRON MICROB, V70, P5030, DOI 10.1128/AEM.70.8.5030-5032.2004; Matsumoto K, 2013, CURR OPIN BIOTECH, V24, P1054, DOI 10.1016/j.copbio.2013.02.021; Inoue Y, 1998, J MOL STRUCT, V441, P119, DOI 10.1016/S0022-2860(97)00294-9; Goncalves AM, 2013, J MICROBIOL BIOTECHN, V23, P587, DOI 10.4014/jmb.1210.10063; Poirier Y, 2002, FEMS MICROBIOL LETT, V207, P97, DOI 10.1111/j.1574-6968.2002.tb11035.x; Draper JL, 2012, BIOENGINEERED, V3, P203, DOI 10.4161/bioe.19567; Leuchtenberger W, 2005, APPL MICROBIOL BIOT, V69, P1, DOI 10.1007/s00253-005-0155-y; de Vos WM, 1999, CURR OPIN MICROBIOL, V2, P289, DOI 10.1016/S1369-5274(99)80050-2; Hori K, 2002, APPL MICROBIOL BIOT, V59, P211, DOI 10.1007/s00253-002-0986-8; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662; Liu Q, 2007, J BIOTECHNOL, V132, P273, DOI 10.1016/jjbiotec.2007.03.014; Abee T, 1995, INT J FOOD MICROBIOL, V28, P169, DOI 10.1016/0168-1605(95)00055-0; Schmidt FR, 2004, APPL MICROBIOL BIOT, V65, P363, DOI 10.1007/s00253-004-1656-9; Monne M, 2005, PROTEIN SCI, V14, P3048, DOI 10.1110/ps.051689905; Kok J, 1996, ANTON LEEUW INT J G, V70, P129, DOI 10.1007/BF00395930; Tomizawa S, 2011, BIOMACROMOLECULES, V12, P2660, DOI 10.1021/bm2004687; de Oliveira VC, 2004, APPL ENVIRON MICROB, V70, P5685, DOI 10.1128/AEM.70.9.5685-5687.2004; Matsumoto K, 2011, BIOSCI BIOTECH BIOCH, V75, P364, DOI 10.1271/bbb.100682; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Rehm BHA, 2010, NAT REV MICROBIOL, V8, P578, DOI 10.1038/nrmicro2354; Haddouche R, 2011, APPL MICROBIOL BIOT, V91, P1327, DOI 10.1007/s00253-011-3331-2; Mizuno K, 2010, POLYM DEGRAD STABIL, V95, P1335, DOI 10.1016/j.polymdegradstab.2010.01.033; KUIPERS OP, 1993, EUR J BIOCHEM, V216, P281, DOI 10.1111/j.1432-1033.1993.tb18143.x; INOUE Y, 1992, PROG POLYM SCI, V17, P571, DOI 10.1016/0079-6700(92)90002-G; Zendo T, 2013, BIOSCI BIOTECH BIOCH, V77, P893, DOI 10.1271/bbb.130014; Enouf V, 2001, APPL ENVIRON MICROB, V67, P1423, DOI 10.1128/AEM.67.4.1423-1428.2001; Normi YM, 2005, MACROMOL BIOSCI, V5, P197, DOI 10.1002/mabi.200400181; Manabe K, 2011, APPL ENVIRON MICROB, V77, P8370, DOI 10.1128/AEM.06136-11; Dinjaski N, 2015, NANOMED-NANOTECHNOL, V11, P885, DOI 10.1016/j.nano.2015.01.018; Lee SY, 1999, APPL ENVIRON MICROB, V65, P2762; Mierau I, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-15; Le Loir Y, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-2; Quillaguaman J, 2005, J APPL MICROBIOL, V99, P151, DOI 10.1111/j.1365-2672.2005.02589.x; Jo SJ, 2007, J BIOSCI BIOENG, V104, P457, DOI 10.1263/jbb.104.457; Okino S, 2008, APPL MICROBIOL BIOT, V78, P449, DOI 10.1007/s00253-007-1336-7; Blatteis CM, 2000, CLIN INFECT DIS, V31, pS168, DOI 10.1086/317522; Yamada M, 2009, BIOMACROMOLECULES, V10, P677, DOI 10.1021/bm8013846; Valentin HE, 1999, MACROMOLECULES, V32, P7389, DOI 10.1021/ma9905167; Ivanova G, 2009, MAGN RESON CHEM, V47, P497, DOI 10.1002/mrc.2423; Poirier Y, 2001, APPL ENVIRON MICROB, V67, P5254, DOI 10.1128/AEM.67.11.5254-5260.2001; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Leonard BAB, 1998, INFECT IMMUN, V66, P3841; Zhang B, 2005, ACS SYM SER, V900, P292; Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6; Chien LJ, 2007, APPL MICROBIOL BIOT, V77, P339, DOI 10.1007/s00253-007-1153-z; CHIKINDAS ML, 1995, LETT APPL MICROBIOL, V21, P183, DOI 10.1111/j.1472-765X.1995.tb01037.x; Song YY, 2012, APPL MICROBIOL BIOT, V93, P1917, DOI 10.1007/s00253-011-3718-0; Hedfalk K, 2013, BIOENGINEERED, V4, P363, DOI 10.4161/bioe.23886; Kunji ERS, 2003, BBA-BIOMEMBRANES, V1610, P97, DOI 10.1016/S0005-2736(02)00712-5; Tajima K, 2009, MACROMOLECULES, V42, P1985, DOI 10.1021/ma802579g; VANDEGUCHTE M, 1992, FEMS MICROBIOL LETT, V88, P73, DOI 10.1016/0378-1097(92)90685-H; Mathiesen G, 2004, J APPL MICROBIOL, V96, P819, DOI 10.1111/j.1365-2672.2004.02206.x; Matsumoto K, 2013, APPL MICROBIOL BIOT, V97, P8011, DOI 10.1007/s00253-013-5120-6; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Auras R, 2004, MACROMOL BIOSCI, V4, P835, DOI 10.1002/mabi.200400043; Valappil SP, 2007, ANTON LEEUW INT J G, V91, P1, DOI 10.1007/s10482-006-9095-5; Wyszynska A, 2015, APPL MICROBIOL BIOT, V99, P2967, DOI 10.1007/s00253-015-6498-0; KLAENHAMMER TR, 1993, FEMS MICROBIOL REV, V12, P39, DOI 10.1111/j.1574-6976.1993.tb00012.x; Tokiwa Y, 2006, APPL MICROBIOL BIOT, V72, P244, DOI 10.1007/s00253-006-0488-1; Gerngross TU, 2004, NAT BIOTECHNOL, V22, P1409, DOI 10.1038/nbt1028; ANDERSON AJ, 1990, MICROBIOL REV, V54, P450; Taguchi S, 2004, MACROMOL BIOSCI, V4, P145, DOI 10.1002/mabi.200300111; Taguchi S, 2008, P NATL ACAD SCI USA, V105, P17323, DOI 10.1073/pnas.0805653105; Bunch PK, 1997, MICROBIOL-UK, V143, P187; Hyakutake M, 2015, APPL MICROBIOL BIOT, V99, P4701, DOI 10.1007/s00253-014-6276-4; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21; Kikuchi Y, 2009, APPL ENVIRON MICROB, V75, P603, DOI 10.1128/AEM.01874-08; Toyoda K, 2009, J BACTERIOL, V191, P4251, DOI 10.1128/JB.00303-09; Zhang B, 2006, APPL ENVIRON MICROB, V72, P536, DOI 10.1128/AEM.72.1.536-543.2006; Yamakawa S, 2012, ENZYME MICROB TECH, V50, P343, DOI 10.1016/j.enzmictec.2012.03.005; Kumar P, 2013, BIOTECHNOL ADV, V31, P1543, DOI 10.1016/j.biotechadv.2013.08.007; BYROM D, 1987, TRENDS BIOTECHNOL, V5, P246, DOI 10.1016/0167-7799(87)90100-4; Furrer P, 2007, J MICROBIOL METH, V69, P206, DOI 10.1016/j.mimet.2007.01.002; Song YY, 2013, J BIOSCI BIOENG, V115, P12, DOI 10.1016/j.jbiosc.2012.08.004; DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007; Wallin E, 1998, PROTEIN SCI, V7, P1029; Hamilton SR, 2007, CURR OPIN BIOTECH, V18, P387, DOI 10.1016/j.copblo.2007.09.001; DEVOS WM, 1995, MOL MICROBIOL, V17, P427, DOI 10.1111/j.1365-2958.1995.mmi_17030427.x; Takors R, 2007, J BIOTECHNOL, V129, P181, DOI 10.1016/j.jbiotec.2007.01.031; Haddouche R, 2010, FEMS YEAST RES, V10, P917, DOI 10.1111/j.1567-1364.2010.00670.x; Rusendi D, 1995, BIORESOURCE TECHNOL, V54, P191, DOI 10.1016/0960-8524(95)00124-7; Baeshen NA, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0141-0; Bill RM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00085; Burkovski A, 2015, CORYNEBACTERIUM GLUT; Byrne Bernadette, 2015, Curr Opin Struct Biol, V32, P9, DOI 10.1016/j.sbi.2015.01.005; Doi Y, 1990, MICROBIAL POLYESTERS; Ferrer-Miralles N, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-17; Frelet-Barrand A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008746; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Hyakutake M, 2014, APPL ENVIRON MICROB, V80, P1421, DOI 10.1128/AEM.03576-13; Karlskas IL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091125; Kim H, 2015, FEMS YEAST RES, V15, DOI 10.1111/1567-1364.12195; Kinoshita S, 1957, J GEN APPL MICROBIOL, V3, P193, DOI 10.2323/jgam.3.193; Kleerebezem M, 1999, CELL-CELL SIGNALING IN BACTERIA, P159; Krainer FW, 2013, SCI REP-UK, V3, DOI 10.1038/srep03279; KRAMER R, 1994, FEMS MICROBIOL REV, V13, P75, DOI 10.1111/j.1574-6976.1994.tb00036.x; Lemoigne M., 1926, B SOC CHIM BIOL, V8, P770; Madhavan Nampoothiri K., 2010, BIORESOURCE TECHNOL, V101, P8493; Mamat U, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0241-5; Matsumoto K, 2010, J BIOTECHNOL, V152, P144; Matsumoto K, 2009, APPL MICROBIOL BIOT, V85, P921; Okamura K, 2010, P NATL ACAD SCI USA, V107, P11265; Oliveira AP, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-39; Ozkoc G, 2009, J APPL POLYM SCI, V114, P2481, DOI 10.1002/app.30772; Park S.J., 2011, BIOTECHNOL ADV, V30, P1196; Perez RH, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S3; Singh A, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0222-8; Singh M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-38; Steinbuchel A, 1998, TRENDS BIOTECHNOL, V16, P419, DOI 10.1016/S0167-7799(98)01194-9; Strop T, 2014, BIOCONJUG CHEM, V25, P855; Taguchi K, 2001, BIOPOLYMERS POLYESTE, P217; Taguchi S, 2002, J BIOSCI BIOENG, V94, P478, DOI 10.1263/jbb.94.478; Tanaka K, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-124; Yokoyama K, 2004, APPL MICROBIOL BIOT, V64, P447, DOI 10.1007/s00253-003-1539-5; Yokoyama K, 2000, BIOSCI BIOTECH BIOCH, V64, P1263, DOI 10.1271/bbb.64.1263; Zweers JC, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-10	144	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	NOV	2015	99	22					9349	9360		10.1007/s00253-015-6947-9		12	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CV0PB	WOS:000363951800003		
J	Sun, J; Matsumoto, K; Tabata, Y; Kadoya, R; Ooi, T; Abe, H; Taguchi, S				Sun, Jian; Matsumoto, Ken'ichiro; Tabata, Yuta; Kadoya, Ryosuke; Ooi, Toshihiko; Abe, Hideki; Taguchi, Seiichi			Molecular weight-dependent degradation of D-lactate-containing polyesters by polyhydroxyalkanoate depolymerases from Variovorax sp C34 and Alcaligenes faecalis T1	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Biobased polyester; Polylactic acid; Biodegradation; Biodegradable material; Size-dependent hydrolysis; Monomer sequence specificity	EXTRACELLULAR POLY(3-HYDROXYBUTYRATE) DEPOLYMERASE; ENZYMATIC DEGRADATION; BIODEGRADABILITY; BACTERIUM	Polyhydroxyalkanoate depolymerase derived from Variovorax sp. C34 (PhaZ(Vs)) was identified as the first enzyme that is capable of degrading isotactic P[67 mol% (R)-lactate(LA)-co-(R)-3-hydroxybutyrate(3HB)] [P(d-LA-co-d-3HB)]. This study aimed at analyzing the monomer sequence specificity of PhaZ(Vs) for hydrolyzing P(LA-co-3HB) in comparison with a P(3HB) depolymerase from Alcaligenes faecalis T1 (PhaZ(Af)) that did not degrade the same copolymer. Degradation of P(LA-co-3HB) by action of PhaZ(Vs) generated dimers, 3HB-3HB, 3HB-LA, LA-3HB, and LA-LA, and the monomers, suggesting that PhaZ(Vs) cleaved the linkages between LA and 3HB units and between LA units. To provide a direct evidence for the hydrolysis of these sequences, the synthetic methyl trimers, 3HB-3HB-3HB, LA-LA-3HB, LA-3HB-LA, and 3HB-LA-LA, were treated with the PhaZs. Unexpectedly, not only PhaZ(Vs) but also PhaZ(Af) hydrolyzed all of these substrates, namely PhaZ(Af) also cleaved LA-LA linkage. Considering the fact that both PhaZs did not degrade P[(R)-LA] (PDLA) homopolymer, the cleavage capability of LA-LA linkage by PhaZs was supposed to depend on the length of the LA-clustering region in the polymer chain. To test this hypothesis, PDLA oligomers (6 to 40 mer) were subjected to the PhaZ assay, revealing that there was an inverse relationship between molecular weight of the substrates and their hydrolysis efficiency. Moreover, PhaZ(Vs) exhibited the degrading activity toward significantly longer PDLA oligomers compared to PhaZ(Af). Therefore, the cleaving capability of PhaZs used here toward the d-LA-based polymers containing the LA-clustering region was strongly associated with the substrate length, rather than the monomer sequence specificity of the enzyme.	[Sun, Jian; Matsumoto, Ken'ichiro; Kadoya, Ryosuke; Ooi, Toshihiko; Taguchi, Seiichi] Hokkaido Univ, Grad Sch Engn, Div Biotechnol & Macromol Chem, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Tabata, Yuta; Abe, Hideki] Tokyo Inst Technol, Dept Innovat & Engn Mat, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Tabata, Yuta; Abe, Hideki] RIKEN Ctr Sustainable Resource Sci, Biomass Engn Program Cooperat Div, Bioplast Res Team, Wako, Saitama 3510198, Japan; [Kadoya, Ryosuke; Ooi, Toshihiko; Taguchi, Seiichi] JST, CREST, Kawaguchi, Saitama 3320012, Japan	Taguchi, S (reprint author), Hokkaido Univ, Grad Sch Engn, Div Biotechnol & Macromol Chem, Kita Ku, Sapporo, Hokkaido 0608628, Japan.	staguchi@eng.hokudai.ac.jp			Japan Society for the Promotion of Science (JSPS); Research Foundation of the Institute for Fermentation, Osaka (IFO); JST, CREST; JSPS Kakenhi [26281043]	We thank Dr. Tomohiro Hiraishi, RIKEN, for providing the phaZ<INF>Af</INF> gene. This study was partially supported by the Japan Society for the Promotion of Science (JSPS) (to J.S.); the Research Foundation of the Institute for Fermentation, Osaka (IFO) (to S.T.); JST, CREST (to S.T.); and JSPS Kakenhi Grant Number 26281043 (to K.M.).	JENDROSSEK D, 1995, CAN J MICROBIOL, V41, P160; Kawai F, 2011, POLYM DEGRAD STABIL, V96, P1342, DOI 10.1016/j.polymdegradstab.2011.03.022; Arai Y, 2002, PLANT CELL PHYSIOL, V43, P555, DOI 10.1093/pcp/pcf068; Sun J, 2014, POLYM DEGRAD STABIL, V110, P44, DOI 10.1016/j.polymdegradstab.2014.08.013; KASUYA K, 1994, POLYM DEGRAD STABIL, V45, P379, DOI 10.1016/0141-3910(94)90208-9; Matsumoto K, 2010, APPL MICROBIOL BIOT, V85, P921, DOI 10.1007/s00253-009-2374-0; Matsumoto K, 2013, CURR OPIN BIOTECH, V24, P1054, DOI 10.1016/j.copbio.2013.02.021; Shinozaki Y, 2013, APPL MICROBIOL BIOT, V97, P8591, DOI 10.1007/s00253-012-4673-0; Sznajder A, 2014, APPL ENVIRON MICROB, V80, P4936, DOI 10.1128/AEM.01056-14; Shozui F, 2011, POLYM DEGRAD STABIL, V96, P499, DOI 10.1016/j.polymdegradstab.2011.01.007; Shinozaki Y, 2013, APPL MICROBIOL BIOT, V97, P2951, DOI 10.1007/s00253-012-4188-8; Kasuya KI, 1997, APPL ENVIRON MICROB, V63, P4844; Jendrossek D, 2002, ANNU REV MICROBIOL, V56, P403, DOI 10.1146/annurev.micro.56.012302.160838; Tokiwa Y, 2009, INT J MOL SCI, V10, P3722, DOI 10.3390/ijms10093722; Jendrossek D, 1996, APPL MICROBIOL BIOT, V46, P451; Kobayashi T, 1999, J ENVIRON POLYM DEGR, V7, P9, DOI 10.1023/A:1021885901119; Tabata Y, 2014, MACROMOLECULES, V47, P7354, DOI 10.1021/ma501783f; Tokiwa Y, 2006, APPL MICROBIOL BIOT, V72, P244, DOI 10.1007/s00253-006-0488-1; Taguchi S, 2008, P NATL ACAD SCI USA, V105, P17323, DOI 10.1073/pnas.0805653105; Knoll M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-89; Nampoothiri KM, 2010, BIORESOURCE TECHNOL, V101, P8493, DOI 10.1016/j.biortech.2010.05.092; Nduko JM, 2013, APPL MICROBIOL BIOT, V98, P2453	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	NOV	2015	99	22					9555	9563		10.1007/s00253-015-6756-1		9	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CV0PB	WOS:000363951800020		
J	Hara, KY; Aoki, N; Kobayashi, J; Kiriyama, K; Nishida, K; Araki, M; Kondo, A				Hara, Kiyotaka Y.; Aoki, Naoko; Kobayashi, Jyumpei; Kiriyama, Kentaro; Nishida, Keiji; Araki, Michihiro; Kondo, Akihiko			Improvement of oxidized glutathione fermentation by thiol redox metabolism engineering in Saccharomyces cerevisiae	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Oxidized glutathione; Thiol oxidase; Yeast; Saccharomyces cerevisiae; Metabolic engineering; Cell factory	DISULFIDE BOND FORMATION; ENDOPLASMIC-RETICULUM; YEAST; PROTEIN; CELLS; TRANSFORMATION; HOMEOSTASIS; OXIDATION; PATHWAYS; STRESS	Glutathione is a valuable tripeptide widely used in the pharmaceutical, food, and cosmetic industries. In industrial fermentation, glutathione is currently produced primarily using the yeast Saccharomyces cerevisiae. Intracellular glutathione exists in two forms; the majority is present as reduced glutathione (GSH) and a small amount is present as oxidized glutathione (GSSG). However, GSSG is more stable than GSH and is a more attractive form for the storage of glutathione extracted from yeast cells after fermentation. In this study, intracellular GSSG content was improved by engineering thiol oxidization metabolism in yeast. An engineered strain producing high amounts of glutathione from over-expression of glutathione synthases and lacking glutathione reductase was used as a platform strain. Additional over-expression of thiol oxidase (1.8.3.2) genes ERV1 or ERO1 increased the GSSG content by 2.9-fold and 2.0-fold, respectively, compared with the platform strain, without decreasing cell growth. However, over-expression of thiol oxidase gene ERV2 showed almost no effect on the GSSG content. Interestingly, ERO1 over-expression did not decrease the GSH content, raising the total glutathione content of the cell, but ERV1 over-expression decreased the GSH content, balancing the increase in the GSSG content. Furthermore, the increase in the GSSG content due to ERO1 over-expression was enhanced by additional over-expression of the gene encoding Pdi1, whose reduced form activates Ero1 in the endoplasmic reticulum. These results indicate that engineering the thiol redox metabolism of S. cerevisiae improves GSSG and is critical to increasing the total productivity and stability of glutathione.	[Hara, Kiyotaka Y.; Aoki, Naoko; Kobayashi, Jyumpei; Nishida, Keiji; Araki, Michihiro] Kobe Univ, Org Adv Sci & Technol, Nada Ku, Kobe, Hyogo 6578501, Japan; [Kiriyama, Kentaro; Kondo, Akihiko] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, Kobe, Hyogo 6578501, Japan	Kondo, A (reprint author), Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodaicho, Kobe, Hyogo 6578501, Japan.	akondo@kobe-u.ac.jp					Ishii J, 2009, J BIOCHEM, V145, P701, DOI 10.1093/jb/mvp028; Vartanyan LS, 2000, BIOCHEMISTRY-MOSCOW+, V65, P442; Grant CM, 1996, REDOX REP, V2, P223; FINLEY JW, 1981, J AGR FOOD CHEM, V29, P404, DOI 10.1021/jf00104a045; Lin SK, 2006, J FOOD DRUG ANAL, V14, P141; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Kim S, 2012, J CELL BIOL, V196, P713, DOI 10.1083/jcb.201110090; Pocsi I, 2004, ADV MICROB PHYSIOL, V49, P1, DOI 10.1016/S0065-2911(04)49001-8; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Thorpe C, 2002, ARCH BIOCHEM BIOPHYS, V405, P1; Hara KY, 2012, APPL MICROBIOL BIOT, V94, P1313, DOI 10.1007/s00253-011-3841-y; Gerber J, 2001, J BIOL CHEM, V276, P23486, DOI 10.1074/jbc.M100134200; Sugimura Y, 1998, J NUTR SCI VITAMINOL, V44, P613; Rolseth V, 2002, TOXICOLOGY, V170, P75, DOI 10.1016/S0300-483X(01)00537-6; Li Y, 2004, APPL MICROBIOL BIOT, V66, P233, DOI 10.1007/s00253-004-1751-y; Ray S, 2002, CLIN EXP ALLERGY, V32, P571, DOI 10.1046/j.0954-7894.2002.01294.x; Kiriyama K, 2013, APPL MICROBIOL BIOT, V97, P7399, DOI 10.1007/s00253-013-5074-8; Toledano MB, 2013, ANTIOXID REDOX SIGN, V18, P1699, DOI 10.1089/ars.2012.5033; FLOHE L, 1985, CURR TOP CELL REGUL, V27, P473; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Penninckx MJ, 2002, FEMS YEAST RES, V2, P295, DOI 10.1111/j.1567-1364.2002.tb00098.x; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Droge W, 2000, P NUTR SOC, V59, P595, DOI 10.1017/S0029665100000847; Morgan B, 2013, NAT CHEM BIOL, V9, P119, DOI [10.1038/nchembio.1142, 10.1038/NCHEMBIO.1142]; Hara KY, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0173-5; ITO H, 1983, J BACTERIOL, V153, P163; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Yamada R, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-32; Yoshida K, 2002, JP Patent, Patent No. 2002284664	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	NOV	2015	99	22					9771	9778		10.1007/s00253-015-6847-z		8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CV0PB	WOS:000363951800037		
J	Takata, T; Kondo, N; Sakurai, Y; Tanaka, H; Hasegawa, T; Kume, K; Suzuki, M				Takata, Takushi; Kondo, Natsuko; Sakurai, Yoshinori; Tanaka, Hiroki; Hasegawa, Takashi; Kume, Kyo; Suzuki, Minoru			Localized dose delivering by ion beam irradiation for experimental trial of establishing brain necrosis model	APPLIED RADIATION AND ISOTOPES			English	Article						Brain radiation necrosis; Animal model; Local volume irradiation; Accelerated ion beam; Spread-out Bragg peak	SYSTEM	Localized dose delivery techniques to establish a brain radiation necrosis model are described. An irradiation field was designed by using accelerated protons or helium ions with a spread-out Bragg peak. Measurement of the designed field confirmed that a high dose can be confined to a local volume of an animal brain. The irradiation techniques described here are very useful for establishing a necrosis model without existence of extraneous complications. (C) 2015 Elsevier Ltd. All rights reserved.	[Takata, Takushi; Kondo, Natsuko; Sakurai, Yoshinori; Tanaka, Hiroki; Suzuki, Minoru] Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan; [Takata, Takushi; Kume, Kyo] Wakasa Wan Energy Res Ctr, Tsuruga, Fukui 9140192, Japan; [Hasegawa, Takashi] Hase Tech LLC, Tsuruga, Fukui 9140801, Japan	Takata, T (reprint author), Kyoto Univ, Inst Res Reactor, 2 Asashiro Nishi, Kumatori, Osaka 5900494, Japan.	taku-takata@rakyoto-u.ac.jp			Wakasa Wan Energy Research Center	This work was supported by Collaborative Research Project of the Wakasa Wan Energy Research Center.	Hatori S, 2005, NUCL INSTRUM METH B, V241, P862, DOI 10.1016/j.nimb.2005.07.176; Sato T, 2013, J NUCL SCI TECHNOL, V50, P913, DOI 10.1080/00223131.2013.814553; Miyatake SI, 2009, J NEURO-ONCOL, V91, P199, DOI 10.1007/s11060-008-9699-x; Hashimoto T., 1991, JAP J MAG RES MED, V11, P208; Kondo N., 2015, APPL RADIAT ISOTOPES, V105, P32; Sun Xue-Zhi, 2004, Journal of Medical Investigation, V51, P103, DOI 10.2152/jmi.51.103; Ziegler J. F., 2008, STOPPING RANGE IONS	7	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0969-8043			APPL RADIAT ISOTOPES	Appl. Radiat. Isot.	NOV	2015	105						32	34		10.1016/j.apradiso.2015.07.023		3	Chemistry, Inorganic & Nuclear; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Chemistry; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	CV4RK	WOS:000364254000007		
J	Zhou, Q; Wang, XQ; Tuo, F; Han, YQ; Ikeuchi, Y; Yang, J; Xu, CH; Zhang, J; Li, WH; Zhang, Q; Su, X				Zhou, Qiang; Wang, Xiaoqiang; Tuo, Fei; Han, Yanqing; Ikeuchi, Yoshihiro; Yang, Jia; Xu, Cuihua; Zhang, Jing; Li, Wenhong; Zhang, Qing; Su, Xu			Intercomparison of gamma-spectrometry analysis of radionuclides between China and Japan in 2012-2013	APPLIED RADIATION AND ISOTOPES			English	Article						gamma-spectrometry; Radioactive nuclides; Soil; Rice; Intercomparison		An intercomparison of gamma-spectrometry measurement and analysis was organized by the Japan Chemical Analysis Center (JCAC), the National Institute for Radiological Protection, Chinese Center for Disease Control and Prevention (NIRP, China CDC), and the Radiation Monitoring Technical Center of Ministry of Environmental Protection, Chinese (RMTC). The main objective of this study was to assess the gamma-spectrometry measurement and analysis technology. The JCAC completed the collection and preparation of soil and powdered rice samples. Three laboratories compared the measurement of seven radionuclides that included two samples of Pb-214, Bi-214, (208)-Tl, Ac-228, K-40, Cs-137, and Cs-134 with gamma-spectrometry. During the studies conducted at the laboratory, the calculated value En was found to be the total uncertainty data of the reported activity. Except Cs-134 in powdered rice sample, the calculated Er, between each of the two laboratories was <1. The measurement results are acceptable except Cs-134; therefore, measurement results in the three laboratories were consistent within a certain range except in the case of Cs-134. Although there is a need to improve the accuracy of measurements and analysis of Cs-134, an intercomparison was conducted of the tested levels on radionuclide analyzed in the three laboratories. (C) 2015 Elsevier Ltd. All rights reserved.	[Zhou, Qiang; Tuo, Fei; Han, Yanqing; Xu, Cuihua; Zhang, Jing; Li, Wenhong; Zhang, Qing; Su, Xu] Chinese Ctr Dis Control & Prevent, Natl Inst Radiol Protect, Key Lab Radiol Protect & Nucl Emergency, Beijing 100088, Peoples R China; [Wang, Xiaoqiang] Hosp Occupat Dis Control Shenzhen City, Shenzhen 518001, Peoples R China; [Ikeuchi, Yoshihiro] Japan Chem Anal Ctr, Inage Ku, Chiba 2630002, Japan; [Yang, Jia] Minist Environm Protect, Radiat Monitoring Tech Ctr, Hangzhou 310012, Zhejiang, Peoples R China	Su, X (reprint author), Chinese Ctr Dis Control & Prevent, Natl Inst Radiol Protect, Key Lab Radiol Protect & Nucl Emergency, 2 Xinkang St Deshengmenwai, Beijing 100088, Peoples R China.	suxu@nirp.cn			National Key Technology RD Program [2013BAK03B05]	The authors are grateful to the laboratories participating in this proficiency test. They also thank the staff from section of science and technology of NIRP for supporting this study. This study was financially supported by the National Key Technology R&D Program (No. 2013BAK03B05).	Rodenas J, 2007, NUCL INSTRUM METH A, V580, P303, DOI 10.1016/j.nima.2007.05.162; Tuo F, 2010, APPL RADIAT ISOTOPES, V68, P2335, DOI 10.1016/j.apradiso.2010.04.023; Vidmar T, 2007, APPL RADIAT ISOTOPES, V65, P243, DOI 10.1016/j.apradiso.2006.07.012; Watjen U, 2008, APPL RADIAT ISOTOPES, V66, P742, DOI 10.1016/j.apradiso.2008.02.012; Zhao L, 2012, RADIAT PROT DOSIM, V148, P380, DOI 10.1093/rpd/ncr091; Shakhashiro A, 2009, APPL RADIAT ISOTOPES, V67, P139, DOI 10.1016/j.apradiso.2008.07.014; Korun M, 2004, APPL RADIAT ISOTOPES, V60, P207, DOI 10.1016/j.apradiso.2003.11.018; [Anonymous], 1989, GB 11743-1989, Patent No. 117431989; Su Qiong, 2000, Nuclear Techniques, V23	9	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0969-8043			APPL RADIAT ISOTOPES	Appl. Radiat. Isot.	NOV	2015	105						244	248		10.1016/j.apradiso.2015.08.023		5	Chemistry, Inorganic & Nuclear; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Chemistry; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	CV4RK	WOS:000364254000040		
J	Koi, S; Ikeda, H; Rutishauser, R; Kato, M				Koi, Satoshi; Ikeda, Hajime; Rutishauser, Rolf; Kato, Masahiro			Historical biogeography of river-weeds (Podostemaceae)	AQUATIC BOTANY			English	Article						Colonization; Diversification; Long-distance dispersal; Molecular phylogeny; Paraphyly; Podostemaceae	CLUSIOID CLADE MALPIGHIALES; BODY PLAN EVOLUTION; DEVELOPMENTAL MORPHOLOGY; SUBFAMILY TRISTICHOIDEAE; MOLECULAR SYSTEMATICS; PHYLOGENETIC-RELATIONSHIPS; INDOTRISTICHA-RAMOSISSIMA; GRACILIS PODOSTEMACEAE; FLOWERING PLANTS; ANATOMY	Podostemaceae are unusual aquatic angiosperms growing as haptophytes in extreme habitats, i.e., rapids and waterfalls. They originated with an ecological shift from terrestrial life, followed by dispersal and diversification. It has been argued that the Tristichoideae originated on the Gondwana and diversified on the drifting continents. We aimed to test this hypothesis, focusing on the place of origin and the frequency and direction of dispersal. We used a Maximum Likelihood (ML) analysis of phylogenetic relationships and comparative morphology for Podostemaceae. The results of the ML analysis showed that the family originated and then diverged to subfamilies Podostemoideae and Weddellinoideae in America, while the Tristichoideae most likely originated in Asia. Comparison with the sister family Hypericaceae indicated that Tristichoideae exhibit plesiomorphic states for all the morphological characters but pollen aperture, whereas Podostemoideae have apomorpic states. Under the island biogeography model, an Asian origin of Podostemaceae may be likely. Those American- and Asian-origin scenarios are contradictory and need further study. The biogeography of the major clades was shaped by several intercontinental dispersals followed by diversification in the colonized continents. A few dispersals happened on the continents of Africa, America and Asia, resulting in the dual biogeography of the continents. Repetition of diversification-dispersal-diversification is suggested by paraphyletic parental groups at higher and lower (species) taxonomic levels. (C) 2015 Elsevier B.V. All rights reserved.	[Koi, Satoshi] Osaka City Univ, Fac Sci, Bot Garden, Osaka 5760004, Japan; [Ikeda, Hajime; Kato, Masahiro] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki 3050005, Japan; [Rutishauser, Rolf] Univ Zurich, Botan Garten, CH-8008 Zurich, Switzerland; [Rutishauser, Rolf] Univ Zurich, Inst Systemat Bot, CH-8008 Zurich, Switzerland	Kato, M (reprint author), Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki 3050005, Japan.	sorang@kahaku.go.jp			Japan Society for the Promotion of Science [26870502, 2529091]	We thank N. Katayama, A. K. Pradeep and T. Wongprasert for their help in the field studies, and A. Mesterhazy, L. Amporpan, T. Sano and A. Lin, who provided geological information of western Africa, Thailand, India and China, respectively. T. Sano helped us to identify types of rocks with Podostemaceae collected from Cambodia, China, India, Japan, and Thailand. We also thank D. E. Boufford for his linguistic correcting the manuscript. This study was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 26870502 to S.K. and No. 2529091 to M.K.).	AIST/Geological Survey of Japan, 2015, GEOL MAP NAV; Ameka G.K., 2010, SYSTEMATICS CONSERVA, P585; Radhakrishna T, 2012, GEOL SOC AM BULL, V124, P240, DOI 10.1130/B30288.1; Koi S, 2012, PLANT SYST EVOL, V298, P1755, DOI 10.1007/s00606-012-0676-7; Imaichi R, 2004, BOT J LINN SOC, V144, P289, DOI 10.1111/j.1095-8339.2003.00244.x; Fujinami R, 2013, INT J PLANT SCI, V174, P609, DOI 10.1086/669907; Soltis DE, 1999, MOL PHYLOGENET EVOL, V11, P261, DOI 10.1006/mpev.1998.0577; Ruhfel BR, 2013, INT J PLANT SCI, V174, P910, DOI 10.1086/670668; Koi S, 2006, AM J BOT, V93, P682, DOI 10.3732/ajb.93.5.682; [Anonymous], 2013, GEOLOGIC MAPS S AM C; STUESSY TF, 1990, SYST BOT, V15, P338, DOI 10.2307/2419187; Kita Y, 2004, J BIOGEOGR, V31, P1605, DOI 10.1111/j.1365-2699.2004.01047.x; Koi S, 2012, BOT J LINN SOC, V169, P461, DOI 10.1111/j.1095-8339.2012.01258.x; Koi S, 2009, INT J PLANT SCI, V170, P237, DOI 10.1086/595292; Thiv M, 2009, PLANT SYST EVOL, V283, P57, DOI 10.1007/s00606-009-0214-4; Endress PK, 2013, ANN BOT-LONDON, V111, P969, DOI 10.1093/aob/mct056; VANROYEN P, 1954, ACTA BOT NEERL, V3, P215; Philbrick CT, 2004, SYST BOT, V29, P109, DOI 10.1600/036364404772974022; Philbrick CT, 2009, SYST BOT, V34, P715; Koi S, 2010, AM J BOT, V97, P373, DOI 10.3732/ajb.0900157; JagerZurn I, 1997, AQUAT BOT, V57, P71, DOI 10.1016/S0304-3770(96)01119-9; Imaichi R, 1999, INT J PLANT SCI, V160, P253, DOI 10.1086/314127; Fujinami R, 2009, J PLANT RES, V122, P551, DOI 10.1007/s10265-009-0243-7; Koi S, 2007, ANN BOT-LONDON, V99, P1121, DOI 10.1093/aob/mcm065; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Kelly LJ, 2010, TAXON, V59, P251; Katayama N, 2010, PLANT CELL, V22, P2131, DOI 10.1105/tpc.109.073189; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Karanth KP, 2006, CURR SCI INDIA, V90, P789; Kato Masahiro, 2006, Bulletin of the National Science Museum Series B (Botany), V32, P19; Tippery NP, 2011, SYST BOT, V36, P105, DOI 10.1600/036364411X553180; RUTISHAUSER R, 1991, PLANT SYST EVOL, V178, P195; RUTISHAUSER R, 1995, CAN J BOT, V73, P1305; Ruhfel BR, 2011, AM J BOT, V98, P306, DOI 10.3732/ajb.1000354; Kita Y, 2005, PLANT SYST EVOL, V254, P221, DOI 10.1007/s00606-005-0315-7; [Anonymous], 2013, MAPS MEXICO SURFACE; Furness CA, 2012, INT J PLANT SCI, V173, P1055, DOI 10.1086/667614; Les DH, 2003, INT J PLANT SCI, V164, P917, DOI 10.1086/378650; Werukamkul Petcharat, 2012, APG Acta Phytotaxonomica et Geobotanica, V63, P11; Kita Y, 2001, PLANT BIOLOGY, V3, P156, DOI 10.1055/s-2001-12895; Suzuki K, 2002, ANN BOT-LONDON, V89, P755, DOI 10.1093/aob/mcf109; RIESEBERG LH, 1994, TAXON, V43, P21, DOI 10.2307/1223457; Kato M, 2009, BLUMEA, V54, P198, DOI 10.3767/000651909X476157; Moline P, 2007, INT J PLANT SCI, V168, P159, DOI 10.1086/509607; PHILBRICK CT, 1995, BRITTONIA, V47, P210, DOI 10.2307/2806959; Moline Philip M., 2006, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V126, P427, DOI 10.1127/0006-8152/2006/0126-0427; Wurdack KJ, 2009, AM J BOT, V96, P1551, DOI 10.3732/ajb.0800207; Koi S, 2005, INT J PLANT SCI, V166, P199, DOI 10.1086/427482; Davis CC, 2005, AM NAT, V165, pE36, DOI 10.1086/428296; PHILBRICK CT, 1994, AQUAT BOT, V48, P145; Koi S, 2010, PLANT BIOLOGY, V12, P794, DOI 10.1111/j.1438-8677.2009.00275.x; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Kato M, 2003, AUST SYST BOT, V16, P177, DOI 10.1071/SB02020; Philbrick CT, 2010, ANN MO BOT GARD, V97, P425, DOI 10.3417/2008087; Deckart K, 1998, J VOLCANOL GEOTH RES, V80, P67, DOI 10.1016/S0377-0273(97)00038-3; LEVIN DA, 1993, SYST BOT, V18, P197, DOI 10.2307/2419397; Barton N.H., 1989, P229; Cook C.D.K., 2007, FAMILIES GENERA VASC, V9, P304, DOI 10.1007/978-3-540-32219-1_40; Cook C.D.K., 1996, AQUATIC PLANT BOOK; Cusset C., 1972, ADANSONIA, V2, P557; Cusset G., 1988, ADANSONIA, V165, P223; Du Puy D., 2013, MADAGASCAR SIMPLIFIE; Eames A.J., 1961, MORPHOLOGY ANGIOSPER; Esau K., 1977, ANATOMY SEED PLANTS; Futuyma D. J., 1998, EVOLUTIONARY BIOL; Gottlieb LD, 2003, NEW PHYTOL, V161, P71, DOI [10.1046/j.1469-8137.2003.00922.x, DOI 10.1046/J.1469-8137.2003.00922.X]; Jager-Zum I., 2007, INT J PLANT SCI, V268, P97; Jager-Zurn I., 1998, EXTREME ADAPTATIONS, P129; Kadono Y., 1994, AQUATIC PLANTS JAPAN; Kato M., 2013, ILLUSTRATED BOOK PLA; Kato Masahiro, 2006, APG Acta Phytotaxonomica et Geobotanica, V57, P1; Khanduri P, 2015, PLANT SYST EVOL, V301, P861, DOI 10.1007/s00606-014-1121-x; Landolt E., 1998, EXTREME ADAPTATIONS; Mohan Ram H.Y., 1997, AQUAT BOT, V57, P97; Novelo R.A., 1997, AQUAT BOT, V57, P275; Novelo R.A., 1993, NOVON, V3, P456; Orr H.A., 2004, SPECIATION; Philbrick CT, 2004, SYST BOT MONOGR, V70, P1, DOI 10.2307/25027922; Robson N.K.B, 1981, B BRIT MUS NAT HIST, V8, P55; Royen P., 1951, MEDED BOT MUS HERB R, V107, P1; Royen P. van, 1953, ACTA BOT NEERL, V2, P1; Rutishauser Rolf, 2005, Flora (Jena), V200, P245; Sculthorpe C. D., 1967, BIOL AQUATIC VASCULA; Segev A., 2002, EGU S MUELLER SPECIA, V2, P171; Soltis DE, 2000, BOT J LINN SOC, V133, P381, DOI 10.1006/bojl.2000.0380; Steeves T. A., 1989, PATTERNS PLANT DEV; Stevens PF, 2007, FAMILIES GENERA VASC, V9, P194, DOI 10.1007/978-3-540-32219-1_24; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Xi Z, 2012, P NATL ACAD SCI USA, V109, P17519	89	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3770	1879-1522		AQUAT BOT	Aquat. Bot.	NOV	2015	127						62	69		10.1016/j.aquabot.2015.08.003		8	Plant Sciences; Marine & Freshwater Biology	Plant Sciences; Marine & Freshwater Biology	CV4QD	WOS:000364250700010		
J	Ibrahim, ME; Watanabe, K; Saleh, GM; Ibrahim, WS				Ibrahim, Mohamed El-Ahmady; Watanabe, Koichiro; Saleh, Gehad Mohamed; Ibrahim, Waleed Saad			Abu Rusheid lamprophyre dikes, South Eastern Desert, Egypt: as physical-chemical traps for REEs, Zn, Y, U, Cu, W, and Ag	ARABIAN JOURNAL OF GEOSCIENCES			English	Article						Lamprophyre; Traps; Uranium; Zinc; REEs	CLASSIFICATION; DEPOSITS; ROCKS	Five lamprophyre dikes (L-1-L-5) intruded Abu Rusheid rocks (cataclastics and monzogranite) in the South Eastern Desert of Egypt along shear zones with NNW-SSE and E-W. The two sets of dikes differ in age, mineralization, and geochemical aspect. The NNW-SSE trending dikes (L-1 and L-2) are polymineralized and dislocate the E-W (L-3, L-4, and L-5) trending dikes. These dikes underwent multistage of hydrothermal processes (ferrugination, fluoritization, kaolinitization, and calcification). They are characterized by common box works (physical trap) filled by incoming mineralization, and their feldspars and micas are relatively altered to clay minerals (chemical trap). From the mineralogical point of view, the cataclastic rocks are rich in base metals (pyrite, sphalerite, molybdenite, chalcopyrite, and galena), radioactive minerals (thorite, uranophane, kasolite, uranothorite), and accessories phases (zircon, xenotime, cassiterite, molybdenite, copper, columbite, and fluorite). L-1 and L-2 lamprophyre dikes contain U minerals (uranophane, kasolite, autunite, and torbernite), Mn-franklinite, woodruffite, xenotime, fluorite, silver, copper, and scheelite. L-3 contains Zn and U minerals, whereas L-4 and L-5 contain Zn minerals only. The source magma producing lamprophyre dikes (L-1 to L-4) are peralkaline to alkaline, whereas L-5 lamprophyres are mainly calc-alkaline in character; they were generated from the mantle and had formed in a post-collision tectonic setting with extensive Ti-rich metasomatism. The average I REE pound content in (L-1 and L-2) lamprophyres is 8006 ppm. REE patterns display clear concave upward pattern of W-type tetrad effect in the REE pattern accompanied by enrichment of the HREE over the LREE and marked negative Eu anomaly due to secondary mobilization of REEs.	[Ibrahim, Mohamed El-Ahmady; Saleh, Gehad Mohamed] Nucl Mat Author, Cairo, Egypt; [Watanabe, Koichiro; Ibrahim, Waleed Saad] Kyushu Univ, Fac Engn, Fukuoka 812, Japan	Ibrahim, ME (reprint author), Nucl Mat Author, Cairo, Egypt.	dr_mahmadi@yahoo.com			Japan Society for the Promotion of Science	The authors appreciate the contribution from all members of Abu Rusheid project at NMA, Egypt. This work was financially supported by the Japan Society for the Promotion of Science during the first author's fellowship. The authors would like to express appreciation to Mr. Shinkawa at Mineral Resources Department, Kyushu University, Japan for all assistance during lab. Analyses.	Bau M, 1999, GEOCHIM COSMOCHIM AC, V63, P67, DOI 10.1016/S0016-7037(99)00014-9; Ibrahim ME, 2000, CHEM ERDE-GEOCHEM, V60, P173; ALDERTON DHM, 1980, EARTH PLANET SC LETT, V49, P149, DOI 10.1016/0012-821X(80)90157-0; FOLEY SF, 1987, EARTH-SCI REV, V24, P81, DOI 10.1016/0012-8252(87)90001-8; Large RR, 2001, ECON GEOL BULL SOC, V96, P957, DOI 10.2113/96.5.957; STRECKEISEN A, 1979, GEOLOGY, V7, P331, DOI 10.1130/0091-7613(1979)7<331:CANOVR>2.0.CO;2; Monecke T, 2002, GEOCHIM COSMOCHIM AC, V66, P1185, DOI 10.1016/S0016-7037(01)00849-3; Assaf HS, 2000, JKAW EARTH SCI, V2000, P1; Awad NT, 1994, EGYPT MINERAL, V6, P77; Boynton WV, 1984, RARE EARTH ELEMENT G, P63; Cox K.G., 1979, INTERPRETATION IGNEO; EYAL Y, 1987, ISRAEL J EARTH SCI, V36, P195; Hashad AH, 1959, REPORT PROSPECTION W; Hassan MA, 1964, THESIS CAIRO U, P165; Hassan MA, 1973, ANN GEOL SURV EGYPT, VIII, P207; Ibrahim ME, 2010, J GEOL MIN RES, V2, P74; Ibrahim ME, 2007, 10 INT MIN PETR MET, P56; Ibrahim ME, 2007, 10 INT MIN PETR MET, P41; Ibrahim ME, 2007, 7 INT C GEOCH, P30; Ibrahim ME, 2007, 10 INT MIN PETR MET, P99; Ishikawa Y., 1976, MINING GEOLOGY, V26, P105; Khalel FM, 2005, THESIS AL AZHAR U, V200, P168; Osman RA, 2007, SCI J FS MINOUFIYA U, VXXI, P143; Rock NMS, 1991, LAMPR GLASG LOND, P285; Saleh GM, 1998, THSIS MANSOURA U, P171; Taylor SR, 1981, BASALTIC VOLCANISM T, P193	26	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1866-7511	1866-7538		ARAB J GEOSCI	Arab. J. Geosci.	NOV	2015	8	11					9261	9270		10.1007/s12517-015-1882-8		10	Geosciences, Multidisciplinary	Geology	CU7LJ	WOS:000363719600021		
J	Agheem, MH; Shah, MT; Khan, T; Murata, M; Dars, H; Zafar, M				Agheem, Muhammad Hassan; Shah, Mohammad Tahir; Khan, Tahseenullah; Murata, Mamoru; Dars, Humaira; Zafar, Muhammad			Petrogenetic evolution of pegmatites of the Shigar Valley, Skardu, Gilgit-Baltistan, Pakistan	ARABIAN JOURNAL OF GEOSCIENCES			English	Article						Pegmatites; Shigar Valley; Peraluminous; Syn-collision	ELEMENT GRANITIC PEGMATITES; NORTH-PAKISTAN; COLLISION; ASIA; HIMALAYA; ARC; DISCRIMINATION; LEUKOGRANITES; INDIA; CONSTRAINTS	Pegmatites of granitic composition intrude the Dassu orthogneiss of the Asian plate in the Shigar Valley of Pakistan. On the basis of field and petrographic studies, these pegmatites are distinguished into evolved and simple pegmatites. The evolved pegmatites are further distinguished as muscovite-tourmaline-beryl-garnet and muscovite-tourmaline pegmatites whereas the simple pegmatites as biotite +/- garnet +/- muscovite and muscovite-biotite +/- garnet pegmatites. In the evolved pegmatites, the predominant minerals are albite and muscovite while in the simple pegmatites orthoclase and biotite are distinctive. Both the pegmatite types seem to be associated genetically to one common magma source and the variation within the mineral constituents are due to fractional crystallization. In spider diagrams, all the pegmatite types illustrate similar negative sloping trends from LILEs to HFSEs with depletion in Ba, Sr, and Ti concentration. In simple pegmatites, P is strongly depleted as compared to the evolved pegmatites. REEs illustrate nearly smooth patterns in all the pegmatite types with contrasting negative Eu anomaly signifying plagioclase fractionation. Both the evolved and simple pegmatites contain aluminous mineral assemblages and show mainly peraluminous geochemistry, which suggest their derivation from pelitic rocks of the Asian continental crust in syn-collision tectonic setting, ensued possibly by the collision of the Indian plate with Asian plate.	[Agheem, Muhammad Hassan; Dars, Humaira] Univ Sindh, Ctr Pure & Appl Geol, Jamshoro, Sindh, Pakistan; [Shah, Mohammad Tahir] Univ Peshawar, Natl Ctr Excellence Geol, Peshawar, Pakistan; [Khan, Tahseenullah; Zafar, Muhammad] Bahria Univ, Dept Earth & Environm Sci, Islamabad, Pakistan; [Murata, Mamoru] Naruto Univ Educ, Fac Sci, Dept Geosci, Naruto, Tokushima 7728502, Japan	Agheem, MH (reprint author), Univ Sindh, Ctr Pure & Appl Geol, Jamshoro, Sindh, Pakistan.	mhagheem@yahoo.com			NCE in Geology, University of Peshawar	The first author is thankful to the administration of University of Sindh, Jamshoro, Pakistan for facilitating this study. Thanks are also extended to Director NCE in Geology, University of Peshawar, for the financial grant. The authors are also thankful to the anonymous reviewers who critically reviewed this manuscript and offered fruitful suggestions for its improvement.	Agheem MH, 2011, HIMAL J EARTH SCI U, V44, P1; ZEITLER PK, 1991, TECTONICS, V10, P729, DOI 10.1029/91TC00168; Rolland Y, 2000, TECTONOPHYSICS, V325, P145, DOI 10.1016/S0040-1951(00)00135-9; Searle MP, 1999, TECTONICS, V18, P929, DOI 10.1029/1999TC900042; Nabelek PI, 2004, T ROY SOC EDIN-EARTH, V95, P73; Robles ER, 1999, MINERAL MAG, V63, P535; Baker DR, 1998, CAN MINERAL, V36, P255; STEWART DB, 1978, AM MINERAL, V63, P970; PEARCE JA, 1984, J PETROL, V25, P956; LONDON D, 1986, AM MINERAL, V71, P396; LEFORT P, 1987, TECTONOPHYSICS, V134, P39, DOI 10.1016/0040-1951(87)90248-4; Whitney DL, 2010, AM MINERAL, V95, P185, DOI 10.2138/am.2010.3371; CERNY P, 1991, GEOSCI CAN, V18, P68; JAHNS RH, 1969, ECON GEOL, V64, P843; Rowley DB, 1996, EARTH PLANET SC LETT, V145, P1, DOI 10.1016/S0012-821X(96)00201-4; WINCHESTER JA, 1977, CHEM GEOL, V20, P325, DOI 10.1016/0009-2541(77)90057-2; Rehman HU, 2011, ISL ARC, V20, P308, DOI 10.1111/j.1440-1738.2011.00774.x; Laurs BM, 1998, CAN MINERAL, V36, P1; NAKAMURA N, 1974, GEOCHIM COSMOCHIM AC, V38, P757, DOI 10.1016/0016-7037(74)90149-5; BECK RA, 1995, NATURE, V373, P55, DOI 10.1038/373055a0; CERNY P, 1991, GEOSCI CAN, V18, P49; Fraser JE, 2001, GEOL SOC AM BULL, V113, P1443, DOI 10.1130/0016-7606(2001)113<1443:CODMAM>2.0.CO;2; PETTERSON MG, 1985, EARTH PLANET SC LETT, V74, P45, DOI 10.1016/0012-821X(85)90165-7; GAETANI M, 1990, GEOL SOC AM BULL, V102, P54, DOI 10.1130/0016-7606(1990)102<0054:TNKSOT>2.3.CO;2; Bignold SM, 2003, J GEOL SOC LONDON, V160, P377, DOI 10.1144/0016-764902-068; MOLNAR P, 1975, SCIENCE, V189, P419, DOI 10.1126/science.189.4201.419; Brotzen O, 1959, GEOL FOREN STOCKH FO, V496, P2; Cameron E.M., 1949, EC GEOL MONOGR, V2; Camp KF, 2011, SEARCH DISCOVERY; Cerny P, 1982, MINERALOG ASS CANADA, V8, P405; Cerny P., 1982, MINERALOGICAL ASS CA, V8, P1; Fersman AE, 1930, PEGMATITES ACAD SCI, P3; Gansser A, 1964, GEOLOGY HIMALAYAS; Ginsburg AI, 1979, PRINCIPLES GEOLOGY G; Hanson CR, 1986, BEDROCK GEOLOGY SHIG; Hanson CR, 1989, TECTONICS W HIMALAYA, V232, P202; JAHNS RH, 1953, AM MINERAL, V38, P563; Jahns R.H., 1982, MINERAL ASS CAN SHOR, V8, P293; Jahns RH, 1955, ECON GEOL, P1025; Le Fort P, 2002, GEOLOGICA, V6, P1; London D, 1982, MINERALOGICAL ASS CA, V8, P99; MANIAR PD, 1989, GEOL SOC AM BULL, V101, P635, DOI 10.1130/0016-7606(1989)101<0635:TDOG>2.3.CO;2; Nabelek PI, 1992, CONTRIB MINERAL PETR, V110, P17; Patino DAE, 1999, GEOLOGICAL SOC SPECI, V168, P55; Searle MP, 1991, GEOLOGY TECTONICS KA; Stewart DB, 1963, GEOL SOC AM SPEC PAP, V76, P159; Tahirkheli RAK, 1979, GEODYNAMICS PAKISTAN, P125; Taylor S.R., 1985, CONTINENTAL CRUST IT	48	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1866-7511	1866-7538		ARAB J GEOSCI	Arab. J. Geosci.	NOV	2015	8	11					9877	9886		10.1007/s12517-015-1900-x		10	Geosciences, Multidisciplinary	Geology	CU7LJ	WOS:000363719600066		
J	Fujii, W; Kawahito, Y; Nagahara, H; Kukida, Y; Seno, T; Yamamoto, A; Kohno, M; Oda, R; Taniguchi, D; Fujiwara, H; Ejima, A; Kishida, T; Mazda, O; Ashihara, E				Fujii, Wataru; Kawahito, Yutaka; Nagahara, Hidetake; Kukida, Yuji; Seno, Takahiro; Yamamoto, Aihiro; Kohno, Masataka; Oda, Ryo; Taniguchi, Daigo; Fujiwara, Hiroyoshi; Ejima, Akika; Kishida, Tsunao; Mazda, Osam; Ashihara, Eishi			Monocarboxylate Transporter 4, Associated With the Acidification of Synovial Fluid, Is a Novel Therapeutic Target for Inflammatory Arthritis	ARTHRITIS & RHEUMATOLOGY			English	Article							RHEUMATOID-ARTHRITIS; DISEASE-ACTIVITY; PLASMA-MEMBRANE; LACTATE; HYPOXIA; CELLS; CD147; CLASSIFICATION; FIBROBLASTS; CRITERIA	Objective. Synovial fluid pH is decreased in patients with rheumatoid arthritis (RA); however, the underlying mechanisms are unclear. We undertook this study to examine the mechanism by which synovial fluid pH is regulated and to explore the possibility of a therapeutic strategy by manipulating this mechanism. Methods. We determined the pH and lactate concentration in synovial fluid from 16 RA patients. Cultured synovial fibroblasts (SFs) from the inflamed joints of 9 RA patients (RASFs) were examined for the expression of ion transporters that regulate intracellular and extracellular pH. The ion transporter up-regulated in RASF lines was then suppressed in RASFs by small interfering RNA (siRNA), and the effect of transfection on viability and proliferation was investigated. Finally, we examined the therapeutic effect of electrotransfer of monocarboxylate transporter 4 (MCT4)-specific siRNA into the articular synovium of mice with collagen-induced arthritis (CIA). Results. Synovial fluid pH correlated inversely with both the Disease Activity Score in 28 joints using the C-reactive protein level and the synovial fluid lactate levels. RASFs exhibited up-regulated transcription of MCT4 messenger RNA. MCT4 exported intracellular lactate into the extracellular space. RASFs had significantly higher MCT4 protein levels than did SFs from patients with osteoarthritis. Knockdown of MCT4 induced intrinsic apoptosis of RASFs, thereby inhibiting their proliferation. Moreover, electrotransfer of MCT4-specific siRNA into the articular synovium of mice with CIA significantly reduced the severity of arthritis. Conclusion. RA activity correlated with decreased synovial fluid pH. This may be due to increased MCT4 expression in RASFs. Silencing MCT4 induced apoptosis in RASFs and reduced the severity of CIA, suggesting that MCT4 is a potential therapeutic target for inflammatory arthritis.	[Fujii, Wataru; Kawahito, Yutaka; Nagahara, Hidetake; Kukida, Yuji; Seno, Takahiro; Yamamoto, Aihiro; Kohno, Masataka; Oda, Ryo; Taniguchi, Daigo; Fujiwara, Hiroyoshi; Ejima, Akika; Kishida, Tsunao; Mazda, Osam] Kyoto Prefectural Univ Med, Kyoto 6028566, Japan; [Ashihara, Eishi] Kyoto Pharmaceut Univ, Kyoto 607, Japan	Kawahito, Y (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Inflammat & Immunol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	kawahity@koto.kpu-m.ac.jp; ash@mb.kyoto-phu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [26461436, 23591404]	Supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grants-in-Aid for Scientific Research 26461436 and 23591404 to Dr. Ashihara).	ALTMAN R, 1991, ARTHRITIS RHEUM, V34, P505, DOI 10.1002/art.1780340502; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Sivakumar B, 2008, J HAND SURG-AM, V33A, P49, DOI 10.1016/j.jhsa.2007.09.002; Wada M, 2007, BIOCHEM BIOPH RES CO, V357, P353, DOI 10.1016/j.bbrc.2007.03.190; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Parks SK, 2011, J CELL PHYSIOL, V226, P299, DOI 10.1002/jcp.22400; Okamura K, 2012, RHEUMATOLOGY, V51, P1484, DOI 10.1093/rheumatology/kes064; Gallagher SM, 2007, CANCER RES, V67, P4182, DOI 10.1158/0008-5472.CAN-06-3184; Jia JF, 2009, RHEUMATOLOGY, V48, P721, DOI 10.1093/rheumatology/kep099; Kawahito Y, 2000, J CLIN INVEST, V106, P189, DOI 10.1172/JCI9652; FALCHUK KH, 1970, AM J MED, V49, P223, DOI 10.1016/S0002-9343(70)80078-X; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Pap T, 2000, ARTHRITIS RES, V2, P361, DOI 10.1186/ar113; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Yamamoto A, 2011, IMMUNOL LETT, V135, P144, DOI 10.1016/j.imlet.2010.10.015; Konisti S, 2012, NAT REV RHEUMATOL, V8, P153, DOI 10.1038/nrrheum.2011.205; HENDERSON B, 1979, ANN RHEUM DIS, V38, P63, DOI 10.1136/ard.38.1.63; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; TREUHAFT PS, 1971, ARTHRITIS RHEUM, V14, P475, DOI 10.1002/art.1780140407; Pinheiro C, 2008, VIRCHOWS ARCH, V452, P139, DOI 10.1007/s00428-007-0558-5; Wakabayashi S, 1997, PHYSIOL REV, V77, P51; Distler JHW, 2004, ARTHRITIS RHEUM, V50, P10, DOI 10.1002/art.11425; Muller-Ladner U, 2005, NAT CLIN PRACT RHEUM, V1, P102, DOI 10.1038/ncprheum0047; Solomon DH, 2014, ARTHRITIS RHEUMATOL, V66, P775, DOI 10.1002/art.38323; Furst DE, 2010, SEMIN ARTHRITIS RHEU, V39, P327, DOI 10.1016/j.semarthrit.2008.10.002; Franck P, 1996, J BIOTECHNOL, V46, P187, DOI 10.1016/0168-1656(95)00189-1; Valcarcel-Ares MN, 2014, RHEUMATOLOGY, V53, P1332, DOI 10.1093/rheumatology/keu016; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Hitchon C, 2002, ARTHRITIS RHEUM, V46, P2587, DOI 10.1002/art.10520; GOETZL EJ, 1971, J CLIN INVEST, V50, P1167, DOI 10.1172/JCI106594; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; POOLE RC, 1993, AM J PHYSIOL, V264, pC761; Juel C, 1999, J PHYSIOL-LONDON, V517, P633, DOI 10.1111/j.1469-7793.1999.0633s.x; Kennedy KM, 2010, FUTURE ONCOL, V6, P127, DOI [10.2217/fon.09.145, 10.2217/FON.09.145]; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Muller-Ladner U, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2337; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Vander Heiden MG, 2009, SCIENCE, V324, P1029, DOI DOI 10.1126/SCIENCE.1160809	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	NOV	2015	67	11					2888	2896		10.1002/art.39270		9	Rheumatology	Rheumatology	CU9RC	WOS:000363881400013		
J	Nishizawa, K; Nishizawa, M; Gnanasambandam, R; Sachs, F; Sukharev, SI; Suchyna, TM				Nishizawa, Kazuhisa; Nishizawa, Manami; Gnanasambandam, Radhakrishnan; Sachs, Frederick; Sukharev, Sergei I.; Suchyna, Thomas M.			Effects of Lys to Glu mutations in GsMTx4 on membrane binding, peptide orientation, and self-association propensity, as analyzed by molecular dynamics simulations	BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES			English	Article						Peptide inhibitor; Mechanotransduction; Multiscale simulations; Membrane-active peptide	MECHANOSENSITIVE CHANNELS; PROTEIN SIMULATIONS; FREE-ENERGIES; ION CHANNELS; AMINO-ACIDS; FORCE-FIELD; PRESSURE; BILAYER; TOXINS; SOLVATION	GsMTx4, a gating modifier peptide acting on cationic mechanosensitive channels, has a positive charge (+5 e) due to six Lys residues. The peptide does not have a stereospecific binding site on the channel but acts from the boundary lipids within a Debye length of the pore probably by changing local stress. To gain insight into how these Lys residues interact with membranes, we performed molecular dynamics simulations of Lys to Glu mutants in parallel with our experimental work. In silico, Kl5E had higher affinity for 1-palmitoyl-2-oleoylglycero-3-phosphocholine bilayers than wild-type (WT) peptide or any other mutant tested, and showed deeper penetration than WT, a finding consistent with the experimental data. Experimentally, the inhibitory activities of K15E and K25E were most compromised, whereas K8E and K28E inhibitory activities remained similar to WT peptide. Binding of WT in an interfacial mode did not influence membrane thickness. With interfacial binding, the direction of the dipole moments of K15E and K25E was predicted to differ from WT, whereas those of K8E and K28E oriented similarly to that of WT. These results support a model in which binding of G5MTx4 to the membrane acts like an immersible wedge that serves as a membrane expansion buffer reducing local stress and thus inhibiting channel activity. In simulations, membrane-bound WT attracted other WT peptides to form aggregates. This may account for the positive cooperativity observed in the ion channel experiments. The Lys residues seem to fine-tune the depth of membrane binding, the tilt angle, and the dipole moments. (C) 2015 Elsevier B.V. All rights reserved.	[Nishizawa, Kazuhisa; Nishizawa, Manami] Teikyo Univ, Sch Med Technol, Tokyo 173, Japan; [Gnanasambandam, Radhakrishnan; Sachs, Frederick; Suchyna, Thomas M.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA; [Sukharev, Sergei I.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	Nishizawa, K (reprint author), Teikyo Univ, Sch Med Technol, Tokyo 173, Japan.	kazunet@med.teikyo-u.ac.jp			DoD [DM102091]; NIH [HL054887, R01 GM107652]	This work was funded by a DoD grant, project # DM102091, and NIH HL054887 to Dr. Frederick Sachs, and NIH R01 GM107652 grant to Dr. Sergei Sukharev.	Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Tieleman DP, 2006, J PHYS-CONDENS MAT, V18, pS1221, DOI 10.1088/0953-8984/18/28/S07; Sachs F, 2010, PHYSIOLOGY, V25, P50, DOI 10.1152/physiol.00042.2009; Swartz KJ, 2007, TOXICON, V49, P213, DOI 10.1016/j.toxicon.2006.09.024; Gomis A, 2008, J PHYSIOL-LONDON, V586, P5633, DOI 10.1113/jphysiol.2008.161257; Chen R, 2013, TOXINS, V5, P456, DOI 10.3390/toxins5020456; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; Cordomi A, 2012, J CHEM THEORY COMPUT, V8, P948, DOI 10.1021/ct200491c; Nishizawa M, 2007, BIOPHYS J, V92, P4233, DOI 10.1529/biophysj.106.101071; Berger O, 1997, BIOPHYS J, V72, P2002; Duncan SL, 2008, BIOPHYS J, V94, P2965, DOI 10.1529/biophysj.107.114215; MacCallum JL, 2008, BIOPHYS J, V94, P3393, DOI 10.1529/biophysj.107.112805; Kamaraju K, 2010, BIOPHYS J, V99, P2870, DOI 10.1016/j.bpj.2010.09.022; Neale C, 2013, J CHEM THEORY COMPUT, V9, P3686, DOI 10.1021/ct301005b; Johansson ACV, 2009, P NATL ACAD SCI USA, V106, P15684, DOI 10.1073/pnas.0905394106; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P16586, DOI 10.1073/pnas.0606894103; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Oswald RE, 2002, J BIOL CHEM, V277, P34443, DOI 10.1074/jbc.M202715200; Tarazona P, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4818421; Sandberg L, 2001, J PHYS CHEM B, V105, P273, DOI 10.1021/jp002110y; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Janosi L, 2010, J CHEM THEORY COMPUT, V6, P3267, DOI 10.1021/ct100381g; Nishizawa M, 2013, BIOPHYS J, V104, P1038, DOI 10.1016/j.bpj.2013.01.022; Berendsen H., 1981, INTERMOLECULAR FORCE, V331, P331; Gao B, 2013, BIOSCIENCE REP, V33, P513, DOI 10.1042/BSR20130052; Gnanasambandam R., 2015, GSMTX4 SUPERFI UNPUB; Humphery W., 2010, J MOL GRAPHICS, V14, P33; Hurst A.C., 2009, EUR BIOPHYS J, V38, P15; Lopez CA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002020; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Neale C., 2011, J CHEM THEORY COMPUT, V12, P4175; Nishizawa M, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4891932; Tieleman D. Peter, 2004, BMC Biochemistry, V5, P10, DOI 10.1186/1471-2091-5-10; UniProt, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI DOI 10.1093/NAR/GKQ1020; Yesylevskyy SO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000810	40	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2736	0006-3002		BBA-BIOMEMBRANES	Biochim. Biophys. Acta-Biomembr.	NOV	2015	1848	11	A				2767	2778		10.1016/j.bbamem.2015.09.003		12	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CV4XW	WOS:000364270800001		
J	Nagao, T; Mishima, D; Javkhlantugs, N; Wang, J; Ishioka, D; Yokota, K; Norisada, K; Kawamura, I; Ueda, K; Naito, A				Nagao, Takashi; Mishima, Daisuke; Javkhlantugs, Namsrai; Wang, Jun; Ishioka, Daisuke; Yokota, Kiyonobu; Norisada, Kazushi; Kawamura, Izuru; Ueda, Kazuyoshi; Naito, Akira			Structure and orientation of antibiotic peptide alamethicin in phospholipid bilayers as revealed by chemical shift oscillation analysis of solid state nuclear magnetic resonance and molecular dynamics	BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES			English	Article						Antibiotic peptide; Phospholipid bilayer; Ion-channel; Chemical shift oscillation; Solid state NMR; Molecular dynamics simulation	MODEL ION CHANNELS; LIPID-BILAYERS; MASS-SPECTROMETRY; HIGH-RESOLUTION; CIRCULAR-DICHROISM; BOMBOLITIN II; NMR; SIMULATION; MEMBRANE; N-15	The structure, topology and orientation of membrane-bound antibiotic alamethicin were studied using solid state nuclear magnetic resonance (NMR) spectroscopy. C-13 chemical shift interaction was observed in [1-C-13]-labeled alamethicin. The isotropic chemical shift values indicated that alamethicin forms a helical structure in the entire region. The chemical shift anisotropy of the carbonyl carbon of isotopically labeled alamethicin was also analyzed with the assumption that alamethicin molecules rotate rapidly about the bilayer normal of the phospholipid bilayers. It is considered that the adjacent peptide planes form an angle of 100 degrees or 120 degrees when it forms alpha-helix or 3(10)-helix, respectively. These properties lead to an oscillation of the chemical shift anisotropy with respect to the phase angle of the peptide plane. Anisotropic data were acquired for the 4 and 7 sites of the N- and C-termini, respectively. The results indicated that the helical axes for the N- and C-termini were tilted 17 degrees and 32 degrees to the bilayer normal, respectively. The chemical shift oscillation curves indicate that the N- and C-termini form the alpha-helix and 3(10)-helix, respectively. The C-terminal 3(10)-helix of alamethicin in the bilayer was experimentally observed and the unique bending structure of alamethicin was further confirmed by measuring the internuclear distances of [1-C-13] and [N-15] doubly-labeled alamethicin. Molecular dynamics simulation of alamethicin embedded into dimyristoyl phophatidylcholine (DMPC) bilayers indicates that the helical axes for alpha-helical N- and 3(10)-helical C-termini are tilted 12 degrees and 32 degrees to the bilayer normal, respectively, which is in good agreement with the solid state NMR results. (C) 2015 Elsevier B.V. All rights reserved.	[Nagao, Takashi; Mishima, Daisuke; Javkhlantugs, Namsrai; Wang, Jun; Ishioka, Daisuke; Yokota, Kiyonobu; Norisada, Kazushi; Kawamura, Izuru; Ueda, Kazuyoshi; Naito, Akira] Yokohama Natl Univ, Grad Sch Engn, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Javkhlantugs, Namsrai] Natl Univ Mongolia, Sch Engn & Appl Sci, Ctr Nanosci & Nanotechnol, Ulaanbaatar 14201, Mongol Peo Rep	Naito, A (reprint author), Yokohama Natl Univ, Grad Sch Engn, Hodogaya Ku, Tokiwadai 79-5, Yokohama, Kanagawa 2408501, Japan.	naito@ynu.ac.jp	Kawamura, Izuru/M-4585-2014	Kawamura, Izuru/0000-0002-8163-9695	Ministry of Education, Culture, Sports, Science and Technology of Japan [26102514, 26104513, 15K06963, 15H04336]	This work was supported by Grants-in-Aid for Scientific Research on an Innovative area (26102514 and 26104513), and Grants-in-Aid for Scientific Research (C) (15K06963) and (B) (15H04336) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Dave PC, 2005, BIOPHYS J, V89, P2434, DOI 10.1529/biophysj.105.067678; BALASUBRAMANIAN TM, 1981, J AM CHEM SOC, V103, P6127, DOI 10.1021/ja00410a024; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kira A, 2014, J PHYS CHEM B, V118, P9604, DOI 10.1021/jp505412j; Uezono T, 2005, J MOL STRUCT, V749, P13, DOI 10.1016/j.molstruc.2005.02.037; Bertelsen K, 2009, J AM CHEM SOC, V131, P18335, DOI 10.1021/ja908604u; Toraya S, 2004, BIOPHYS J, V87, P3323, DOI 10.1529/biophysj.104.046102; MEYER CE, 1967, EXPERIENTIA, V23, P85, DOI 10.1007/BF02135929; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Leitgeb B, 2007, CHEM BIODIVERS, V4, P1027, DOI 10.1002/cbdv.200790095; Naito A, 2000, BIOPHYS J, V78, P2405; WOOLLEY GA, 1992, J MEMBRANE BIOL, V129, P109; GULLION T, 1991, J MAGN RESON, V92, P439, DOI 10.1016/0022-2364(91)90286-3; Psurek A, 2006, J PEPT SCI, V12, P279, DOI 10.1002/psc.720; Toraya S, 2010, BIOPHYS J, V99, P3282, DOI 10.1016/j.bpj.2010.09.060; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Wang Y, 2012, BBA-BIOMEMBRANES, V1818, P1402, DOI 10.1016/j.bbamem.2012.02.017; FOX RO, 1982, NATURE, V300, P325, DOI 10.1038/300325a0; New AP, 1996, TETRAHEDRON LETT, V37, P3039, DOI 10.1016/0040-4039(96)00463-7; Bak M, 2001, BIOPHYS J, V81, P1684; FRANKLIN JC, 1994, BIOCHEMISTRY-US, V33, P4036, DOI 10.1021/bi00179a032; ESPOSITO G, 1987, BIOCHEMISTRY-US, V26, P1043, DOI 10.1021/bi00378a010; Naito A, 1996, J PHYS CHEM-US, V100, P14995, DOI 10.1021/jp960179t; Tieleman DP, 2001, BIOPHYS J, V80, P331; Saito H, 2010, PROG NUCL MAG RES SP, V57, P181, DOI 10.1016/j.pnmrs.2010.04.005; Promsri S, 2012, BIOPHYS CHEM, V170, P9, DOI 10.1016/j.bpc.2012.07.002; SAITO H, 1988, BIOPOLYMERS, V27, P1607, DOI 10.1002/bip.360271006; North CL, 1995, BIOPHYS J, V69, P2392; JUNG G, 1975, EUR J BIOCHEM, V54, P395, DOI 10.1111/j.1432-1033.1975.tb04150.x; PANDEY RC, 1977, J AM CHEM SOC, V99, P8469, DOI 10.1021/ja00468a016; Pan JJ, 2009, J MEMBRANE BIOL, V231, P11, DOI 10.1007/s00232-009-9199-8; BANERJEE U, 1983, J MOL BIOL, V165, P757, DOI 10.1016/S0022-2836(83)80279-4; Bechinger B, 2001, BIOCHEMISTRY-US, V40, P9428, DOI 10.1021/bi010162n; MUELLER P, 1968, NATURE, V217, P713, DOI 10.1038/217713a0; Naito A, 2009, SOLID STATE NUCL MAG, V36, P67, DOI 10.1016/j.ssnmr.2009.06.008; Dittmer J, 2009, J PHYS CHEM B, V113, P6928, DOI 10.1021/jp811494p; Tsutsumi A, 2012, BIOPHYS J, V103, P1735, DOI 10.1016/j.bpj.2012.09.010; PAQUET A, 1982, CAN J CHEM, V60, P976, DOI 10.1139/v82-146; Javkhlantugs N, 2011, BIOPHYS J, V101, P1212, DOI 10.1016/j.bpj.2011.07.018; Psurek A, 2005, ELECTROPHORESIS, V26, P4368, DOI 10.1002/elps.200500387; Chan W.C., 2000, BASIC PROCEDURES, P41; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; Khatami MH, 2014, BBA-BIOMEMBRANES, V1838, P2778, DOI 10.1016/j.bbamem.2014.07.013; Nagao T., 1998, PEPT SCI, P341; Sainikov E.S., 2009, BIOPHYS J, V96, P86; Saito H., 1989, ANNU REP NMR SPECTRO, V21, P209, DOI 10.1016/S0066-4103(08)60124-6; SANSOM MSP, 1993, EUR BIOPHYS J BIOPHY, V22, P105; Steve K. H., 1996, BIOPHYS J, V70, P2659; Steve K.H., 1996, BIOPHYS J, V71, P2669; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; YEE AA, 1992, BIOCHEMISTRY-US, V31, P3135, DOI 10.1021/bi00127a014	51	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2736	0006-3002		BBA-BIOMEMBRANES	Biochim. Biophys. Acta-Biomembr.	NOV	2015	1848	11	A				2789	2798		10.1016/j.bbamem.2015.07.019		10	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CV4XW	WOS:000364270800003		
J	Tamura, Y; Miyagawa, H; Yoshida, T; Chuman, H				Tamura, Yunoshin; Miyagawa, Hiroh; Yoshida, Tatsusada; Chuman, Hiroshi			Binding interaction of SGLT with sugar and thiosugar by the molecular dynamics simulation	BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES			English	Article						Luseogliflozin; Co-transporter; Molecular dynamics; Binding free energy; Bennett's acceptance ratio method	CLINICAL-DATA; FORCE-FIELD; FREE-ENERGY; SODIUM; LUSEOGLIFLOZIN; INHIBITORS; PROTEINS; MECHANISM; EFFICIENT; POTENT	The human sodium-glucose co-transporter 2 (h5GLT2) is a transporter responsible for reabsorption of glucose in the proximal convoluted tubule of the kidney. h5GLT2 inhibitors, including luseogliflozin, have been developed as drugs for type 2 diabetes mellitus. Only luseogliflozin contains a thiosugar ring in its chemical structure, while other hSGLT2 inhibitors contain glucose rings. Consequently, we focused on the binding interactions of hSGLT2 with sugars and thiosugars. We first revealed that the binding affinities of thiosugars are stronger than those of sugars through molecular dynamics simulations of Vibrio parahaemolyticus, sodium-galactose cotransporter, and human hSGLT2. We then demonstrated that Na+ dissociates from the protein to the cytoplasmic solution more slowly in the thiosugar system than in the sugar system. These differences between sugars and thiosugars are discussed on the basis of the different binding modes due to the atom at the 5-position of the sugar and thiosugar rings. Finally, as a result of Na+ dissociation, we suggest that the dissociation of thiosugars is slower than that of sugars. (C) 2015 Elsevier B.V. All rights reserved.	[Tamura, Yunoshin; Miyagawa, Hiroh] Taisho Pharmaceut Co Ltd, Chem Labs, Kita Ku, Saitama, Saitama 3319530, Japan; [Yoshida, Tatsusada; Chuman, Hiroshi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Tokushima 7708505, Japan	Chuman, H (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, 1-78 Shomachi, Tokushima 7708505, Japan.	hchuman@tokushima-u.ac.jp					BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; GREGORET LM, 1991, PROTEINS, V9, P99, DOI 10.1002/prot.340090204; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; HIRONO S, 1990, J MOL BIOL, V212, P197, DOI 10.1016/0022-2836(90)90315-D; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Seino Y, 2014, CURR MED RES OPIN, V30, P1245, DOI 10.1185/03007995.2014.912983; BENNETT CH, 1976, J COMPUT PHYS, V22, P245, DOI 10.1016/0021-9991(76)90078-4; Seino Y, 2014, EXPERT OPIN PHARMACO, V15, P2741, DOI 10.1517/14656566.2014.978290; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; [Anonymous], 2008, MOL OP ENV MOE; Kurosaki E, 2013, PHARMACOL THERAPEUT, V139, P51, DOI 10.1016/j.pharmthera.2013.04.003; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Nauck MA, 2014, DRUG DES DEV THER, V8, P1335, DOI 10.2147/DDDT.S50773; Grempler R, 2012, DIABETES OBES METAB, V14, P83, DOI 10.1111/j.1463-1326.2011.01517.x; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Kitao A, 1999, CURR OPIN STRUC BIOL, V9, P164, DOI 10.1016/S0959-440X(99)80023-2; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Kakinuma H, 2010, J MED CHEM, V53, P3247, DOI 10.1021/jm901893x; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Fujita Y, 2014, J DIABETES INVEST, V5, P265, DOI 10.1111/jdi.12214; Turk E, 2000, J BIOL CHEM, V275, P25711, DOI 10.1074/jbc.M003127200; Hummel CS, 2012, AM J PHYSIOL-CELL PH, V302, pC373, DOI 10.1152/ajpcell.00328.2011; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kalra Sanjay, 2014, Diabetes Ther, V5, P355, DOI 10.1007/s13300-014-0089-4; Li J., 2011, BIOCHIM BIOPHYS ACTA, V1818, P263; Markham A, 2014, DRUGS, V74, P945, DOI 10.1007/s40265-014-0230-8; Uchida S, 2015, J PHARMACOL SCI, V128, P54, DOI 10.1016/j.jphs.2015.04.001	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2736	0006-3002		BBA-BIOMEMBRANES	Biochim. Biophys. Acta-Biomembr.	NOV	2015	1848	11	A				2799	2804		10.1016/j.bbamem.2015.08.001		6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CV4XW	WOS:000364270800004		
J	Kazarna, I; Ejima, Y; Endo, Y; Toyama, H; Matsubara, M; Baba, A; Tachi, M				Kazarna, Itsuro; Ejima, Yutaka; Endo, Yasuhiro; Toyama, Hiroaki; Matsubara, Mitsunobu; Baba, Asuka; Tachi, Masahiro			Chlorpromazine-induced changes in membrane micro-architecture inhibit thrombopoiesis in rat megakaryocytes	BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES			English	Article						Chlorpromazine; Megakaryocytes; Membrane capacitance; Thrombopoiesis; Membrane micro-architecture	K+-CHANNEL CURRENTS; PERITONEAL MAST-CELLS; PLASMA-MEMBRANE; MURINE THYMOCYTES; SURFACE DEFORMATION; PLATELET; THROMBOCYTOPENIA; DRUG; THERAPY; RELEASE	Chlorpromazine often causes severe and persistent thrombocytopenia. Several clinical studies have suggested the presence of an as-yet-unknown mechanism in this drug-induced thrombocytopenia, by which the platelet production from megakaryocytes may directly be affected. As we previously demonstrated in rat peritoneal mast cells or adipocytes, chlorpromazine is amphiphilic and preferentially partitioned into the lipid bilayers of the plasma membrane. Therefore, it can induce some structural changes in the megakatyocyte membrane surface and thus affect the process of thrombopoiesis. In the present study, employing the standard patch-clamp whole-cell recording technique, we examined the effects of chlorpromazine on the membrane capacitance and Kv1.3-channel currents in rat megakaryocytes. By electron microscopic imaging of the cellular surface, we also examined the effects of chlorpromazine on the membrane micro-architecture of megakaryocytes. Chlorpromazine markedly decreased the membrane capacitance of megakaryocytes, indicating the decreased number of invaginated plasma membranes, which was not detected by the fluorescent imaging techniques. As shown by electron microscopy, chlorpromazine actually changed the membrane micro-architecture of megakaryocytes, and was likely to halt the process of pro-platelet formation in the cells. This drug persistently decreased the membrane capacitance and almost totally and irreversibly inhibited the Kv1.3-channel currents in megakaryocytes. This study demonstrated for the first time that chlorpromazine is likely to inhibit the process of thrombopoiesis persistently in megakaryocytes, as detected by the long-lasting decrease in the membrane capacitance and the irreversible suppression of the Kv1.3-channel currents. Chlorpromazine-induced changes in the membrane micro-architecture are thought to be responsible for its persistent effects. (C) 2015 Elsevier B.V. All rights reserved.	[Kazarna, Itsuro; Baba, Asuka] Tohoku Univ, Grad Sch Med, Dept Physiol 1, Aoba Ku, Sendai, Miyagi 980, Japan; [Ejima, Yutaka; Endo, Yasuhiro; Toyama, Hiroaki] Tohoku Univ Hosp, Dept Anesthesiol, Tokyo, Japan; [Matsubara, Mitsunobu] Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Anim Res, Div Mol Med, Sendai, Miyagi 980, Japan; [Baba, Asuka; Tachi, Masahiro] Tohoku Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Sendai, Miyagi 980, Japan	Kazarna, I (reprint author), Tohoku Univ, Grad Sch Med, Dept Physiol 1, Aoba Ku, Seiryo cho, Sendai, Miyagi 980, Japan.	kazaitsu@med.tohoku.ac.jp			MEXT KAKENHI Grant [25860155]	We thank Ms. Chika Tazawa and her colleagues at the Biomedical Research Core of Tohoku University Graduate School of Medicine for their technical support. This work was supported by MEXT KAKENHI Grant Number 25860155.	LaPlaca MC, 2009, IEEE ENG MED BIO, P1113, DOI 10.1109/IEMBS.2009.5334457; MUSKIN PR, 1986, GEN HOSP PSYCHIAT, V8, P404, DOI 10.1016/0163-8343(86)90020-4; Chen JY, 2003, BBA-BIOMEMBRANES, V1616, P95, DOI 10.1016/S0005-2736(03)00229-3; Kazama I, 2013, IMMUNOPHARM IMMUNOT, V35, P28, DOI 10.3109/08923973.2012.723011; Baba A, 2015, PHARMACOL REP, V67, P959, DOI 10.1016/j.pharep.2015.01.009; Greeson JN, 2009, BIOPHYS J, V96, P510, DOI 10.1016/j.bpj.2008.09.016; SHAWVER JR, 1960, AM J PSYCHIAT, V116, P845; Eisenberg S, 2008, J BIOL CHEM, V283, P27279, DOI 10.1074/jbc.M804589200; Kazama I, 2012, J PHYSIOL SCI, V62, P267, DOI 10.1007/s12576-012-0195-x; STEIN PB, 1980, CAN J PSYCHIAT, V25, P659; Naziroglu M, 2011, J MEMBRANE BIOL, V241, P51, DOI 10.1007/s00232-011-9356-8; YOUNG A, 1989, BRIT J PSYCHIAT, V154, P710, DOI 10.1192/bjp.154.5.710; Thon JN, 2010, SEMIN HEMATOL, V47, P220, DOI 10.1053/j.seminhematol.2010.03.005; Thon JN, 2010, J CELL BIOL, V191, P861, DOI 10.1083/jcb.201006102; McCloskey C, 2010, J PHYSIOL-LONDON, V588, P1399, DOI 10.1113/jphysiol.2010.188136; BHATTACHARYYA M, 1990, INT J BIOL MACROMOL, V12, P297, DOI 10.1016/0141-8130(90)90017-5; IKEDA M, 1992, J PHYSIOL-LONDON, V447, P711; Kazama I, 2014, MED HYPOTHESES, V82, P196, DOI 10.1016/j.mehy.2013.11.037; LEVEN RM, 1982, J CELL BIOL, V92, P313, DOI 10.1083/jcb.92.2.313; Aster RH, 2009, J THROMB HAEMOST, V7, P911, DOI 10.1111/j.1538-7836.2009.03360.x; Mahaut-Smith MP, 2011, PURINERG SIGNAL, V7, P341, DOI 10.1007/s11302-011-9224-0; Mahaut-Smith MP, 2003, BIOPHYS J, V84, P2646, DOI 10.1016/S0006-3495(03)75070-X; Murdock DR, 2005, BIOPHYS J, V89, P4090, DOI 10.1529/biophysj.105.069872; Kazama I, 2014, CLIN APPL THROMB-HEM, V20, P318, DOI 10.1177/1076029612461845; Fisher JL, 2004, AM J RESP CELL MOL, V31, P200, DOI 10.1165/rcmb.2003-0224OC; NEHER E, 1988, J PHYSIOL-LONDON, V395, P193; Kazama I, 2015, CELL PHYSIOL BIOCHEM, V35, P2371, DOI 10.1159/000374039; Kazama I, 2014, PHARMACOL REP, V66, P712, DOI 10.1016/j.pharep.2014.03.002; Kenney B, 2009, ARCH PATHOL LAB MED, V133, P309, DOI 10.1043/1543-2165-133.2.309; Mahaut-Smith Martyn P, 2004, Methods Mol Biol, V273, P277; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Flaumenhaft R, 2009, BLOOD, V113, P1112, DOI 10.1182/blood-2008-06-163832; MAHAUTSMITH MP, 1995, J PHYSIOL-LONDON, V484, P15; LIEBER MR, 1984, J BIOL CHEM, V259, P9225; Kazama I, 2013, PHARM BIOL, V51, P760, DOI 10.3109/13880209.2013.764539; BALON R, 1987, CAN J PSYCHIAT, V32, P149; YASSA R, 1985, J CLIN PSYCHIAT, V46, P341; JOHNSON HG, 1979, AGENTS ACTIONS, V9, P239, DOI 10.1007/BF01966694; Morris CE, 2001, J MEMBRANE BIOL, V179, P79; ODRISCOLL D, 1991, J CELL SCI, V100, P237; Schulze H, 2006, BLOOD, V107, P3868, DOI 10.1182/blood-2005-07-2755; Kazama I, 2013, CELL PHYSIOL BIOCHEM, V31, P592, DOI 10.1159/000350079; Apodaca G, 2002, AM J PHYSIOL-RENAL, V282, pF179; BHATTACHARYYA M, 1990, BIOCHEM BIOPH RES CO, V167, P1146, DOI 10.1016/0006-291X(90)90643-2; HOLT RJ, 1984, J CLIN PSYCHOPHARM, V4, P130; Kosaki G, 2008, INT J HEMATOL, V88, P255, DOI 10.1007/s12185-008-0147-7; Martins PT, 2012, J AM CHEM SOC, V134, P4184, DOI 10.1021/ja209917q; Patel SR, 2005, J CLIN INVEST, V115, P3348, DOI 10.1172/JCI26891; Taylor KA, 2014, J THROMB HAEMOST, V12, P987, DOI 10.1111/jth.12566; RICH A, 1990, J MEMBRANE BIOL, V113, P211, DOI 10.1007/BF01870073; Baba A, 2015, CELL PHYSIOL BIOCHEM, V35, P386, DOI 10.1159/000369704; CURRY SH, 1971, P ROY SOC MED, V64, P285; George J.N., 2009, HEMATOLOGY AM SOC HE; Kazama Itsuro, 2011, Nephron Extra, V1, P147, DOI 10.1159/000333018; Kazama I, 2015, J PHYSIOL SCI, V65, P25, DOI 10.1007/s12576-014-0331-x; López-Muñoz Francisco, 2005, Ann Clin Psychiatry, V17, P113, DOI 10.1080/10401230591002002; Shetti P.V.A., 2011, J PHARM BIOMED SCI, V09, P1	57	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2736	0006-3002		BBA-BIOMEMBRANES	Biochim. Biophys. Acta-Biomembr.	NOV	2015	1848	11	A				2805	2812		10.1016/j.bbamem.2015.08.013		8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CV4XW	WOS:000364270800005		
J	Matsubara, S				Matsubara, Shigeki			Re: The Hayman uterine compression suture	BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY			English	Letter							INCONTINENCE		Jichi Med Univ, Dept Obstet & Gynecol, Jichi, Japan	Matsubara, S (reprint author), Jichi Med Univ, Dept Obstet & Gynecol, Jichi, Japan.						Press JZ, 2007, BIRTH-ISS PERINAT C, V34, P228, DOI 10.1111/j.1523-536X.2007.00175.x; Volloyhaug I, 2015, BJOG-INT J OBSTET GY, V122, P964, DOI 10.1111/1471-0528.13322	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1470-0328	1471-0528		BJOG-INT J OBSTET GY	BJOG	NOV	2015	122	12					1715	1716		10.1111/1471-0528.13626		2	Obstetrics & Gynecology	Obstetrics & Gynecology	CU7NY	WOS:000363729300058		
J	Mokuyasu, S; Suzuki, Y; Kawahara, E; Seto, T; Tokuda, Y				Mokuyasu, Seiichi; Suzuki, Yasuhiro; Kawahara, Ei; Seto, Takayuki; Tokuda, Yutaka			High-sensitivity cardiac troponin I detection for 2 types of drug-induced cardiotoxicity in patients with breast cancer	BREAST CANCER			English	Article						Cardiotoxicity; High-sensitivity cardiac troponin I; Trastuzumab; Epirubicin	ACUTE MYOCARDIAL-INFARCTION; HEART-FAILURE; MONOCLONAL-ANTIBODY; EARLY-DIAGNOSIS; TRASTUZUMAB; THERAPY; DYSFUNCTION; EPIRUBICIN; CARDIOMYOPATHY; CHEMOTHERAPY	Background Breast cancer treatment with trastuzumab, a monoclonal antibody that targets human epidermal growth factor receptor type 2 (HER2), has largely been successful in improving the prognosis of HER2-positive disease. However, a critical issue associated with trastuzumab treatment is its cardiotoxic adverse effects, including cardiac insufficiency. Methods We measured levels of cardiac troponin I, a marker of myocardial damage, with a highly sensitive method (hs-cTnI) using a fully automated chemiluminescent immunoassay system (ADVIA Centaur(A (R)) XP) in breast cancer patients and examined the relationship between administration of trastuzumab and epirubicin and concentrations of hs-cTnI. Results The coefficient of variation for within-run repeatability was 1.34-5.93 %, using plasma pools and controls of 3 concentrations, and that for between-run reproducibility was 3.99-8.79 %, indicating high precision of the assay. In a dilutional linearity test with highly concentrated specimens, hs-cTnI values could be measured up to 50 ng/mL with linearity. No influence from coexisting substances was observed. The concentration of hs-cTnI was at or above the reference range (0.04 ng/mL) in 9 of 214 total breast cancer cases (4.2 %). The hs-cTnI concentration was at or above the reference range in 4 of 49 cases (8.2 %) that were administered trastuzumab, and in 5 of 165 cases (3.0 %) that were not. Trastuzumab did not cause elevation of hs-cTnI when not administered in combination with epirubicin. Conclusions These results suggest that epirubicin and trastuzumab cause cardiotoxicity through different mechanisms. Epirubicin can cause myocardial necrosis, while trastuzumab can cause cardiomyopathy without myocardial necrosis.	[Mokuyasu, Seiichi] Tokai Univ Hosp, Dept Clin Lab, Isehara, Kanagawa 2591193, Japan; [Mokuyasu, Seiichi; Kawahara, Ei] Kanazawa Univ, Coll Med Pharmaceut & Hlth Sci, Grad Sch Hlth Sci, Kanazawa, Ishikawa 9200942, Japan; [Suzuki, Yasuhiro; Tokuda, Yutaka] Tokai Univ, Sch Med, Dept Breast & Endocrine Surg, Isehara, Kanagawa 2591193, Japan; [Seto, Takayuki] Tokai Univ OISO Hosp, Dept Clin Lab, Naka, Kanagawa 2590198, Japan	Mokuyasu, S (reprint author), Tokai Univ Hosp, Dept Clin Lab, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	mokuyasu@is.icc.u-tokai.ac.jp					Suter TM, 2007, J CLIN ONCOL, V25, P3859, DOI 10.1200/JCO.2006.09.1611; Sato Y, 2008, INT J CARDIOL, V126, P171, DOI 10.1016/j.ijcard.2007.08.053; Yeh ETH, 2009, J AM COLL CARDIOL, V53, P2231, DOI 10.1016/j.jacc.2009.02.050; Fox KF, 2006, BRIT J CANCER, V95, P1454, DOI 10.1038/sj.bjc.6603340; PEREZ DJ, 1991, J CLIN ONCOL, V9, P2148; Lick S, 2000, AM J MED SCI, V320, P135, DOI 10.1097/00000441-200008000-00013; CUMMINS B, 1987, AM HEART J, V113, P1333, DOI 10.1016/0002-8703(87)90645-4; Crone SA, 2002, NAT MED, V8, P459, DOI 10.1038/nm0502-459; Panjrath GS, 2007, NUCL MED COMMUN, V28, P69, DOI 10.1097/MNM.0b013e328025ae04; JAIN KK, 1985, J CLIN ONCOL, V3, P818; Antman EM, 2002, NEW ENGL J MED, V346, P2079, DOI 10.1056/NEJMe020049; Sawaya H, 2011, AM J CARDIOL, V107, P1375, DOI 10.1016/j.amjcard.2011.01.006; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Jensen BV, 2002, ANN ONCOL, V13, P699, DOI 10.1093/annonc/mdf132; Peacock WF, 2008, NEW ENGL J MED, V358, P2117, DOI 10.1056/NEJMoa0706824; Gennari A, 1999, J CLIN ONCOL, V17, P3596; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; Melanson SEF, 2007, AM J CLIN PATHOL, V128, P282, DOI 10.1309/Q9W5HJTT24GQCXXX; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639; Ewer SM, 2008, DRUG SAFETY, V31, P459, DOI 10.2165/00002018-200831060-00002; Goldhirsch A, 2005, ANN ONCOL, V16, P1569, DOI 10.1093/annonc/mdi326; MAIR J, 1995, CLIN CHEM, V41, P1266; Ryberg M, 1998, J CLIN ONCOL, V16, P3502; Seidman A, 2002, J CLIN ONCOL, V20, P1215, DOI 10.1200/JCO.20.5.1215; Dawood S, 2010, J CLIN ONCOL, V28, P92, DOI 10.1200/JCO.2008.19.9844; Horwich TB, 2003, CIRCULATION, V108, P833, DOI 10.1161/01.CIR.0000084543.79097.34; Morrow David A, 2007, Circulation, V115, pe356; Saidi Abdulfattah, 2011, Curr Cardiol Rev, V7, P245; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	NOV	2015	22	6					563	569		10.1007/s12282-014-0520-8		7	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CU9CS	WOS:000363841100001		
J	Otsuka, S; Watanabe, N; Sasaki, Y; Shimojima, R				Otsuka, Shoko; Watanabe, Naoki; Sasaki, Youko; Shimojima, Reiko			Postoperative courses of breast reconstruction using inferior adipofascial tissue repair	BREAST CANCER			English	Article						Breast reconstruction; Inferior adipofascial tissue; Breast cancer	SKIN-SPARING MASTECTOMY; ANTERIOR RECTUS SHEATH; LOCAL RECURRENCE; FAT NECROSIS; FLAP; CANCER	Background Nevertheless in breast conserving surgery, the dissection of inferior part of breast mound will cause severe deformity, which affects the patient's quality of life adversely. We have used an infra-mammary adipofascial tissue to repair the defect, and breast mound could be reconstructed concurrently in primary breast cancer surgery. Patients and surgical procedure From September 2009 to June 2012, we performed the infra-mammary adipofascial tissue repair (IATR) on 25 patients with breast cancer in inferior site of their breast mound. Surgeon makes the skin incision on the infra-mammary line and performs the quadrantectomy as planned. After verifying its negative surgical margin pathologically, we mobilize the adipofascial fat tissue associated with myofascia of the serratus anterior muscle from the infra-mammary area. This tongue-shaped flap is reflected back, and fills the defect of breast mound. We performed routinely examination, mammography, and ultra-sound echogram to the IATR patients who visited our hospital after 1 year from the end of treatment. We, furthermore, performed the QOL questionnaire (QOL-ACD and QOL-ACD-B) to them and retrospectively compared their data to that from the other breast surgery patients. Results All patients with IATR were treated with irradiation, and no image findings of a partial or total necrosis of the flap recognized 1 year after examination. They produced good cosmetic results; however, they could not elevate the QOL score on the whole.	[Otsuka, Shoko; Watanabe, Naoki; Sasaki, Youko; Shimojima, Reiko] Himeji Hosp, Japanese Red Cross Soc, Dept Breast Surg, Himeji, Hyogo 6708540, Japan	Otsuka, S (reprint author), Himeji Hosp, Japanese Red Cross Soc, Dept Breast Surg, 1-12-1 Shimoteno, Himeji, Hyogo 6708540, Japan.	shoko.rug.718@gmail.com	Watanabe, Naoki/L-6185-2014	Watanabe, Naoki/0000-0002-5849-6112			Kijima Y, 2007, AM J SURG, V193, P789, DOI 10.1016/j.amjsurg.2006.06.052; Fersis N, 2004, BREAST, V13, P488, DOI 10.1016/j.breast.2004.06.009; Medina-Franco H, 2002, ANN SURG, V235, P814, DOI 10.1097/00000658-200206000-00008; Ogawa T, 2012, J BREAST CANCER, V15, P468, DOI 10.4048/jbc.2012.15.4.468; Kurihara M, 1999, PSYCHO-ONCOL, V8, P355, DOI 10.1002/(SICI)1099-1611(199907/08)8:4<355::AID-PON401>3.0.CO;2-I; Eidelman Y, 1998, ANN PLAS SURG, V41, P229; Cunnick GH, 2004, AM J SURG, V188, P78, DOI 10.1016/j.amjsurg.2004.02.004; Bilgen IG, 2001, EUR J RADIOL, V39, P92, DOI 10.1016/S0720-048X(00)00303-X; Ogawa T, 2007, AM J SURG, V193, P514, DOI 10.1016/j.amjsurg.2006.07.018; Kijima Y, 2013, SURG TODAY, V43, P456, DOI 10.1007/s00595-012-0390-7; SAKAI S, 1992, ANN PLAS SURG, V29, P173, DOI 10.1097/00000637-199208000-00015; Carlson GW, 2007, J AM COLL SURGEONS, V204, P1074, DOI 10.1016/j.jamcollsurg.2007.01.063; Carlson GW, 2007, J AM COLL SURGEONS, V204; Foundation PHR, 2013, COMPR SUPP PROJ ONC; HOGGE JP, 1995, RADIOGRAPHICS, V15, P1347; Ogawa T, 2014, BREAST CANCER-TOKYO, V21, P635, DOI 10.1007/s12282-011-0285-2; Theriault RL, 2013, BREAST CANC VERSION	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	NOV	2015	22	6					570	577		10.1007/s12282-014-0522-6		8	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CU9CS	WOS:000363841100002		
J	Mizoguchi, T; Kijima, Y; Hirata, M; Kaneko, K; Arima, H; Nakajo, A; Higashi, M; Tabata, K; Koriyama, C; Arigami, T; Uenosono, Y; Okumura, H; Maemura, K; Ishigami, S; Yoshinaka, H; Shinden, Y; Ueno, S; Natsugoe, S				Mizoguchi, Tadao; Kijima, Yuko; Hirata, Munetsugu; Kaneko, Koichi; Arima, Hideo; Nakajo, Akihiro; Higashi, Michiyo; Tabata, Kazuhiro; Koriyama, Chihaya; Arigami, Takaaki; Uenosono, Yoshikazu; Okumura, Hiroshi; Maemura, Kosei; Ishigami, Sumiya; Yoshinaka, Heiji; Shinden, Yoshiaki; Ueno, Shinichi; Natsugoe, Shoji			Histological findings of an autologous dermal fat graft implanted onto the pectoralis major muscle of a rat model	BREAST CANCER			English	Article						Breast cancer; Breast-conserving surgery; Oncoplastic surgery; Free dermal fat graft; Rat model; Cosmesis; VEGF; Apoptosis	APOPTOSIS; SURGERY; PAROTIDECTOMY; SURVIVAL; TRANSPLANTATION; RECONSTRUCTION; TISSUE	Background The aim of this study was to investigate the maintenance of volume as a spacer by comparing vascular supply and apoptosis in an implanted autologous-free dermal fat graft (FDFG) and free fat graft (FFG). An autologous FDFG is a material used in plastic surgery and oncoplastic breast surgery that is ideal for immediate volume replacement after partial mastectomy because of its easy availability and minimal invasion of the donor site; however, immunohistochemical findings and survival procedures have not yet been reported. Methods An experimental protocol using a unique animal model was designed for the present study. The expression of vascular endothelial growth factor (VEGF) was measured in FDFGs and FFGs implanted onto the pectoral major muscle of Wistar rats. Thirty Wistar rats were divided into two groups and postoperatively 1, 2, 4, 8, and 16 weeks (POW1, 2, 4, 8, 16). Six samples from three rats in each group were used as control samples (POW0). Results The thickness of the implanted FDFG was not significantly different from the control sample at POW1, 2, 4, 8, and 16 between FDFG and FFG group; however, the thickness at POW8 and 16 was significantly lesser in the FFG group than in the control samples. The average proportion of fatty tissue to whole tissue ranged from 34.2 to 48.6 % in the FDFG group and from 57.2 to 76.7 % in the FFG group during the observation period; however, there was no significant difference in the proportion of fatty tissue between these two groups. There were no significant differences between the average number of VEGF-positive cells in the FDFG group and the FFG group at POW1, 2, 4, 8, and 16. The average number of TUNEL-positive cells in the early period at POW1 was significantly lower in the FDFG group than in the FFG group. Conclusions This rat model was useful for investigating the mechanisms of angiogenesis, apoptosis, structure maintenance, and fibromatous changes. From the present experimental study, we believe that FDFG is one of the most convenient materials currently available to repair small defects at the time of BCS even in the clinical field.	[Mizoguchi, Tadao; Kijima, Yuko; Hirata, Munetsugu; Kaneko, Koichi; Arima, Hideo; Nakajo, Akihiro; Arigami, Takaaki; Uenosono, Yoshikazu; Okumura, Hiroshi; Maemura, Kosei; Ishigami, Sumiya; Yoshinaka, Heiji; Shinden, Yoshiaki; Ueno, Shinichi; Natsugoe, Shoji] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Digest Surg Breast & Thyroid Surg, Kagoshima 8908520, Japan; [Higashi, Michiyo; Tabata, Kazuhiro] Kagoshima Univ, Grad Sch Med & Dent Sci, Div Human Pathol, Dept Oncol, Kagoshima 8908520, Japan; [Koriyama, Chihaya] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Epidemiol & Prevent Med, Kagoshima 8908520, Japan	Kijima, Y (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Digest Surg Breast & Thyroid Surg, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	ykijima@m3.kufm.kagoshima-u.ac.jp			 [20591551]	We gratefully acknowledge the valuable technical supports by Miss Yuka Nishizono and Miss Mika Tokunaga throughout the course of the current study and during the preparation of this manuscript. This study was supported in part by a Grant-in-Aid for Scientific Research (Grant No. 20591551).	Papineau D, 2003, METABOLISM, V52, P987, DOI 10.1016/S0026-0495(03)00165-3; Karacaoglu E, 2005, ANN PLAS SURG, V55, P63, DOI 10.1097/01.sap.0000168246.75891.62; Shaw GY, 1997, LARYNGOSCOPE, V107, P177, DOI 10.1097/00005537-199702000-00008; HARADA T, 1993, ANN PLAS SURG, V31, P450, DOI 10.1097/00000637-199311000-00012; MIKUS JL, 1995, LARYNGOSCOPE, V105, P17, DOI 10.1288/00005537-199501000-00007; Warr E, 2004, J INSECT PHYSIOL, V50, P1037, DOI 10.1016/j.jinsphys.2004.09.004; MACKAY DR, 1993, ANN PLAS SURG, V31, P42; Yasuhara S, 2006, J BURN CARE RES, V27, P367, DOI 10.1097/01.BCR.0000216777.94365.47; Baran CN, 2002, PLAST RECONSTR SURG, V109, P1646, DOI 10.1097/00006534-200204150-00023; Fraga MFP, 2008, J PLAST RECONSTR AES, V61, P1044, DOI 10.1016/j.bjps.2007.06.034; Chandarana S, 2009, HEAD NECK-J SCI SPEC, V31, P521, DOI 10.1002/hed.20999; BILLINGS E, 1989, PLAST RECONSTR SURG, V83, P368, DOI 10.1097/00006534-198902000-00033; Nishimura T, 2000, LARYNGOSCOPE, V110, P1333, DOI 10.1097/00005537-200008000-00021; Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023; Picht E, 2007, AM J PHYSIOL-CELL PH, V293, pC1073, DOI 10.1152/ajpcell.00586.2006; Lexer E, 1914, ANN SURG, V60, P166, DOI 10.1097/00000658-191408000-00005; Kijima Y, 2012, SURGERY, V151, P444, DOI 10.1016/j.surg.2011.07.031; Lee J, 2012, BREAST, V21, P194, DOI 10.1016/j.breast.2011.09.011; Kijima Y, 2007, J PLAST RECONSTR AES, V60, P495, DOI 10.1016/j.bjps.2006.06.004; DAVIS RE, 1995, ARCH OTOLARYNGOL, V121, P673; BAUER CA, 1995, ANN OTO RHINOL LARYN, V104, P871; Audretsch W, 1994, P 2 EUR C SEN OCT 2, P139; Audretsch W., 1998, PERSPECT PLAST SURG, V11, p71 ; Kadoya T, 2010, J JPN CLIN SURG, V71, P354; Kijima Y, 2011, SURG TODAY, V44, P477; Kijima Y, 2013, INT CANC C J, V2, P101; NOSAN DK, 1991, OTOLARYNG HEAD NECK, V104, P293; Pires FMF, 2010, J PLAST RECONSTR AES, V63, P818; Sawhney C P, 1969, Br J Plast Surg, V22, P169, DOI 10.1016/S0007-1226(69)80061-5	29	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	NOV	2015	22	6					578	585		10.1007/s12282-014-0523-5		8	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CU9CS	WOS:000363841100003		
J	Kuroi, K; Toi, M; Ohno, S; Nakamura, S; Iwata, H; Masuda, N; Sato, N; Tsuda, H; Kurosumi, M; Akiyama, F				Kuroi, Katsumasa; Toi, Masakazu; Ohno, Shinji; Nakamura, Seigo; Iwata, Hiroji; Masuda, Norikazu; Sato, Nobuaki; Tsuda, Hitoshi; Kurosumi, Masafumi; Akiyama, Futoshi			Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG	BREAST CANCER			English	Article						Neoadjuvant chemotherapy; Pathologic response; Subtype; Breast cancer	INTERNATIONAL EXPERT PANEL; PRIMARY SYSTEMIC TREATMENT; CHEMOTHERAPY; THERAPY; DOCETAXEL; SURVIVAL; RECOMMENDATIONS	Background Neoadjuvant chemotherapy (NAC) has been accepted as one of the standard treatments for operable breast cancer. However, the term pathologic complete response (pCR) has not been consistently defined. Methods This study was a pooled analysis of three prospective studies of NAC conducted by JBCRG and was performed to compare the prognostic significance of different definitions of pCR. pCRs were defined as follows: QpCR, few or no remaining invasive cancer cells in the breast; CpCR, ypT0/is; CpCRbn, ypT0/isypN0; SpCR, ypT0; SpCRbn, ypT0ypN0; Grade 2b, only a few remaining cancer cells in the breast. Results A total of 353 patients were included. A Cox proportional hazards model revealed that hazard ratios (HRs) of each pCR were lower than 1; however, pCR was significant for disease-free survival (DFS) and overall survival (OS) only when QpCR, CpCR, and CpCRbn were used (DFS; QpCR, 0.27; CpCR, 0.39; CpCRbn, 0.42, SpCR, 0.57, SpCRbn, 0.68: OS; QpCR, 0.12; CpCR, 0.17; CpCRbn, 0.16; SpCR, 0.30, SpCRbn, 0.45). Grade 2b was also a significant prognostic variable for DFS and OS (HR: DFS, 0.19; OS, 0.15). Neither bone nor brain was the first site of recurrence in patients who achieved pCR, irrespective of the definition of pCR. Triple-negative and Her2-positive tumors tended to recur in soft tissue more frequently than the other subtypes, and luminal tumors had the lowest rate of recurrence in the brain. Conclusions Prognostic significance of pCR varied according to the definition of pCR, and the pattern of recurrence might be different according to pathologic response and subtype.	[Kuroi, Katsumasa] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Surg, Bunkyo Ku, Tokyo 1138677, Japan; [Toi, Masakazu] Kyoto Univ, Grad Sch Med, Dept Surg Breast Surg, Kyoto, Japan; [Ohno, Shinji] Kyusyu Canc Ctr, Clin Inst NHO, Dept Clin Oncol, Fukuoka, Japan; [Nakamura, Seigo] Showa Univ, Sch Med, Dept Surg, Div Breast Surg Oncol, Tokyo 142, Japan; [Nakamura, Seigo] St Lukes Int Hosp, Dept Breast Surg Oncol, Tokyo, Japan; [Iwata, Hiroji] Aichi Canc Ctr Hosp, Dept Breast Oncol, Aichi, Japan; [Masuda, Norikazu] NHO, Dept Surg, Breast Oncol, Osaka, Japan; [Sato, Nobuaki] Niigata Canc Ctr Hosp, Dept Breast Oncol, Niigata, Japan; [Tsuda, Hitoshi] Natl Def Med Coll, Dept Basic Pathol, Saitama, Japan; [Kurosumi, Masafumi] Saitama Canc Ctr, Dept Pathol, Saitama, Japan; [Akiyama, Futoshi] Japanese Fdn Canc Res, Inst Canc, Dept Pathol, Tokyo 170, Japan	Kuroi, K (reprint author), Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Surg, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138677, Japan.	kurochan@dd.iij4u.or.jp			Osaka Cancer Research Foundation [JBCRG-01]; Advanced Clinical Research Organization [JBCRG-02, JBCRG-03]	The JBCRG-01 study was supported by the Osaka Cancer Research Foundation, and Advanced Clinical Research Organization. The JBCRG-02 and JBCRG-03 studies were supported by the Advanced Clinical Research Organization. The authors gratefully thank the patients who participated in the JBCRG-01, JBCRG-02, and JBCRG-03 studies. The authors also thank Ms Kiyomi Kashiwa and Ms Aya Maruyama for their support and data management.	Houssami N, 2012, EUR J CANCER, V48, P3342, DOI 10.1016/j.ejca.2012.05.023; Bear HD, 2006, J CLIN ONCOL, V24, P2019, DOI 10.1200/JCO.2005.04.1665; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Toi M, 2008, BREAST CANCER RES TR, V110, P531, DOI 10.1007/s10549-007-9744-z; Kuroi K, 2005, BIOMED PHARMACOTHER, V59, pS387, DOI 10.1016/S0753-3322(05)80085-X; Symmans WF, 2007, J CLIN ONCOL, V25, P4414, DOI 10.1200/JCO.2007.10.6823; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; Berruti Alfredo, 2011, Journal of the National Cancer Institute Monographs, P147, DOI 10.1093/jncimonographs/lgr037; Gianni L, 2010, LANCET, V375, P377, DOI 10.1016/S0140-6736(09)61964-4; SATALOFF DM, 1995, J AM COLL SURGEONS, V180, P297; Kaufmann M, 2007, ANN ONCOL, V18, P1927, DOI 10.1093/annonc/mdm201; Kaufmann M, 2006, J CLIN ONCOL, V24, P1940, DOI 10.1200/JCO.200502.6187; Shimizu C, 2009, JPN J CLIN ONCOL, V39, P484, DOI 10.1093/jjco/hyp052; Kurosumi M, 2008, BREAST CANCER-TOKYO, V15, P5, DOI 10.1007/s12282-007-0016-x; Iwata H, 2011, JPN J CLIN ONCOL, V41, P867, DOI 10.1093/jjco/hyr081; Caudle AS, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3198; Cortazar P, 2012, CANC RES S, V72, pS1; Kuroi Katsumasa, 2006, Breast Cancer, V13, P38, DOI 10.2325/jbcs.13.38; Kuroi K, 2013, BREAST CANC; Kuroi K, 2013, JPN J BREAST CANC, V28, P585; Nakamura S, 2008, JPN J BREAST CANC, V23, P111; Prowell T, GUIDANCE IN IN PRESS; SINN HP, 1994, GEBURTSH FRAUENHEILK, V54, P552, DOI 10.1055/s-2007-1022338	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	NOV	2015	22	6					586	595		10.1007/s12282-014-0524-4		10	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CU9CS	WOS:000363841100004		
J	Maeda, I; Kanemaki, Y; Tozaki, M; Koizumi, H; Oana, Y; Okanami, Y; Tsuchiya, K; Shimo, A; Kojima, Y; Hayami, R; Nishikawa, T; Kawamoto, H; Yabuki, Y; Tsugawa, K; Takagi, M				Maeda, Ichiro; Kanemaki, Yoshihide; Tozaki, Mitsuhiro; Koizumi, Hirotaka; Oana, Yoshiyasu; Okanami, Yuko; Tsuchiya, Kyoko; Shimo, Arata; Kojima, Yasuyuki; Hayami, Ryousuke; Nishikawa, Toru; Kawamoto, Hisanori; Yabuki, Yukari; Tsugawa, Koichiro; Takagi, Masayuki			Positive predictive value for malignancy of pure flat epithelial atypia diagnosis by percutaneous needle biopsy of the breast: management of FEA in ultrasonography	BREAST CANCER			English	Article						Flat epithelial atypia; Columnar cell hyperplasia; Biopsy; DCIS; Breast	CORE BIOPSY	Background Some reports suggest that the rate of definitive diagnosis of malignant tumors, namely, the final diagnosis being revised to a higher stage, in patients diagnosed as having flat epithelial atypia (FEA) by percutaneous needle biopsy of the breast (PNB) is as low as 0-3 %. However, other reports suggest that the rate is as high as 10 % or more, bringing confusion on this issue. We examined the positive predictive value for malignancy in the patients diagnosed as having pure FEA and the patients' radiolopathological characteristics observed in our hospital. Methods Of the patients who underwent PNB in our facility, those who were diagnosed as having pure FEA were recruited as the subjects of this study. Results Of the 4,197 consecutive patients who underwent PNB, 44 (1.0 %) were diagnosed as having pure FEA following a re-examination. Among 44 cases, 39 cases were selected as the subjects of this study. Among the 39 patients, six patients were diagnosed as having malignant lesions, two of whom had invasive carcinoma of no special type (papillotubular type), one had tubular carcinoma, one had ductal carcinoma in situ (DCIS) of high nuclear grade, one had DCIS of intermediate nuclear grade, and one had DCIS of low nuclear grade. The diameters of 6 malignant lesions were 10-30 mm at ultrasonography (US) examination. Five of the 39 patients had contralateral breast cancer. Conclusion The positive predictive value for malignancy of pure FEA was 15.7 %. The patients with pure FEA may make a follow up without an excisional biopsy when the lesion sizes less than 10 mm on US examination.	[Maeda, Ichiro; Koizumi, Hirotaka; Oana, Yoshiyasu; Okanami, Yuko; Takagi, Masayuki] St Marianna Univ, Sch Med, Dept Pathol, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan; [Maeda, Ichiro; Kanemaki, Yoshihide; Tozaki, Mitsuhiro; Koizumi, Hirotaka; Oana, Yoshiyasu; Okanami, Yuko; Tsuchiya, Kyoko; Shimo, Arata; Kojima, Yasuyuki; Hayami, Ryousuke; Nishikawa, Toru; Kawamoto, Hisanori; Yabuki, Yukari; Tsugawa, Koichiro; Takagi, Masayuki] St Marianna Univ, Sch Med, Dept Breast & Endocrine Surg, Kawasaki, Kanagawa 2168511, Japan; [Kanemaki, Yoshihide] St Marianna Univ, Sch Med, Dept Radiol, Kawasaki, Kanagawa 2168511, Japan; [Tozaki, Mitsuhiro; Tsuchiya, Kyoko; Shimo, Arata; Kojima, Yasuyuki; Hayami, Ryousuke; Nishikawa, Toru; Kawamoto, Hisanori; Yabuki, Yukari; Tsugawa, Koichiro] Kameda Med Ctr, Breast Ctr, Kamogawa, Japan	Maeda, I (reprint author), St Marianna Univ, Sch Med, Dept Pathol, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	ichirou@marianna-u.ac.jp					Biggar MA, 2012, BREAST J, V18, P578, DOI 10.1111/tbj.12039; Verschuur-Maes AHJ, 2011, INT J CANCER, V129, P2674, DOI 10.1002/ijc.25926; Lavoue V, 2011, BREAST CANCER RES TR, V125, P121, DOI 10.1007/s10549-010-1208-1; Ellis IO, 2004, J CLIN PATHOL, V57, P897, DOI 10.1136/jcp.2003.010983; David N, 2006, J RADIOL, V87, P1671, DOI 10.1016/S0221-0363(06)74145-2; Peres A, 2012, BREAST CANCER RES TR, V133, P659, DOI 10.1007/s10549-011-1839-x; Rajan S, 2011, J CLIN PATHOL, V64, P1001, DOI 10.1136/jclinpath-2011-200176; Uzoaru I, 2012, VIRCHOWS ARCH, V461, P419, DOI 10.1007/s00428-012-1312-1; Solorzano S, 2011, AM J ROENTGENOL, V197, P740, DOI 10.2214/AJR.10.5265; Martel M, 2007, VIRCHOWS ARCH, V451, P883, DOI 10.1007/s00428-007-0499-z; Piubello Q, 2009, AM J SURG PATHOL, V33, P1078, DOI 10.1097/PAS.0b013e31819d0a4d; Yamaguchi R, 2012, CANCER SCI, V103, P1580, DOI 10.1111/j.1349-7006.2012.02314.x; Hanby AM, 2012, WHO CLASSIFICATION T, P69372; Maeda I, 2011, JPN J BREAST CANC, V26, P175; Maeda I, 2013, STMARIAN MED J, V41, P211; Schnitt SJ, 2012, WHO CLASSIFICATION T, P69372	16	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	NOV	2015	22	6					634	640		10.1007/s12282-014-0530-6		7	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CU9CS	WOS:000363841100010		
J	Kobayashi, R; Shiraishi, K; Iwase, S; Ohtomo, K; Nakagawa, K				Kobayashi, Reiko; Shiraishi, Kenshiro; Iwase, Satoru; Ohtomo, Kuni; Nakagawa, Keiichi			Omission of axillary lymph node dissection for clinically node negative early-stage breast cancer patients	BREAST CANCER			English	Article						Axillary lymph node dissection; Breast cancer; Sentinel lymph node	TANGENTIAL IRRADIATION TECHNIQUE; SENTINEL-NODE; FOLLOW-UP; BIOPSY; RADIOTHERAPY; TRIAL; CARCINOMA; OUTCOMES; THERAPY; METASTASIS	Background For clinically node negative (N0) breast cancer patients, sentinel node (SN) biopsy (SNB) is a standard technique and complete axillary lymph node dissection (ALND) remains the standard treatment when the SN is positive. However, the American College of Surgeons Oncology Group Z0011 trial and the International Breast Cancer Study Group 23-01 trial showed that SNB without ALND can offer excellent regional control and equal survival compared with ALND for limited macrometastatic and micrometastatic SN involvement, respectively. We retrospectively evaluated axillary control rates in clinically N0 patients who had no axillary surgical treatment. Methods Data on 158 patients who underwent breast-conserving therapy without any axillary surgical procedure between 1994 and 2010 were extracted. The last follow-up was on May 2013, and the overall median follow-up period was 119.0 months. Results Of all 158 patients, 10 (6.3 %) and 3 (1.9 %) developed locoregional and axillary recurrences, respectively. The 10-year locoregional and axillary recurrence rates were 5.8 and 2.1 %, respectively. The 5- and 10-year overall survival rates were 94.0 and 84.8 %, respectively. Cases with axillary recurrence tended to have common risk factors for recurrence. Conclusion Even if SNB and ALND were omitted, local and regional recurrence rates were very low among clinically N0 patients and were at the same levels shown in recent trials. This suggests that at least ALND might be safely avoided in clinically N0 patients without any obvious risk factors regardless of axillary nodal status after SNB.	[Kobayashi, Reiko; Shiraishi, Kenshiro; Ohtomo, Kuni; Nakagawa, Keiichi] Tokyo Univ Hosp, Dept Radiol, Bunkyo Ku, Tokyo 1138655, Japan; [Iwase, Satoru] Univ Tokyo, Res Hosp, Inst Med Sci, Dept Palliat Med,Minato Ku, Tokyo 1088639, Japan	Shiraishi, K (reprint author), Tokyo Univ Hosp, Dept Radiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kshiraishi-tky@umin.ac.jp					Wong JLS, 2008, INT J RADIAT ONCOL, V72, P866, DOI 10.1016/j.ijrobp.2008.01.031; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Posther KE, 2005, ANN SURG, V242, P593, DOI 10.1097/01.sla.0000184210.68646.77; Naik AM, 2004, ANN SURG, V240, P462, DOI 10.1097/01.sla.0000137130.23530.19; Veronesi U, 2010, ANN SURG, V251, P595, DOI 10.1097/SLA.0b013e3181c0e92a; Giuliano AE, 2010, ANN SURG, V252, P426, DOI 10.1097/SLA.0b013e3181f08f32; Galimberti V, 2013, LANCET ONCOL, V14, P297, DOI 10.1016/S1470-2045(13)70035-4; Langer I, 2009, ANN SURG ONCOL, V16, P3366, DOI 10.1245/s10434-009-0660-9; Galimberti V, 2012, BREAST CANCER RES TR, V131, P819, DOI 10.1007/s10549-011-1486-2; Hoebers FJP, 2000, CANCER, V88, P1633, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1633::AID-CNCR18>3.0.CO;2-S; Krag DN, 2010, LANCET ONCOL, V11, P927, DOI 10.1016/S1470-2045(10)70207-2; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; Fujimoto N, 2004, CANCER, V101, P2155, DOI 10.1002/cncr.20650; Veronesi U, 2003, NEW ENGL J MED, V349, P546, DOI 10.1056/NEJMoa012782; Furukawa T, 2000, ANTICANCER RES, V20, P3657; Reznik J, 2005, INT J RADIAT ONCOL, V61, P163, DOI 10.1016/j.ijrobp.2004.04.065; Takeda A, 2000, INT J RADIAT ONCOL, V46, P815, DOI 10.1016/S0360-3016(99)00463-0; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Takeda A, 2004, INT J RADIAT ONCOL, V58, P1280, DOI [10.1016/j.ijrobp.2003.10.010, 10.1016/j.ijrob.2003.10.010]; Louis-Sylvestre C, 2004, J CLIN ONCOL, V22, P97, DOI 10.1200/JCO.2004.12.108; Ohashi T, 2009, INT J RADIAT ONCOL, V73, P80, DOI 10.1016/j.ijrobp.2008.04.003; Gentilini O, 2012, BREAST, V21, P678, DOI 10.1016/j.breast.2012.06.013; Kim T, 2006, CANCER, V106, P4, DOI 10.1002/cncr.21568; Hwang RF, 2007, CANCER, V110, P723, DOI 10.1002/cncr.22847; Sanuki N, 2013, CLIN BREAST CANCER, V13, P69, DOI 10.1016/j.clbc.2012.09.005; Zurrida S, 2002, ANN SURG ONCOL, V9, P156, DOI 10.1245/aso.2002.9.2.156; Pernas S, 2010, ANN SURG ONCOL, V17, P772, DOI 10.1245/s10434-009-0804-y; Krag DN, 2007, LANCET ONCOL, V8, P881, DOI 10.1016/S1470-2045(07)70278-4; CABANES PA, 1992, LANCET, V339, P1245, DOI 10.1016/0140-6736(92)91591-U; Bilimoria KY, 2009, J CLIN ONCOL, V27, P2946, DOI 10.1200/JCO.2008.19.5750; Wernicke AG, 2011, BREAST CANCER RES TR, V125, P893, DOI 10.1007/s10549-010-1167-6; Giuliano AE, 2000, J CLIN ONCOL, V18, P2553; Giuliano AE, 2010, ANN SURG, V252, P432, DOI DOI 10.1097/SLA.0B013E3181F08F32; Naik AM, 2004, ANN SURG, V240, P468; Posther KE, 2005, ANN SURG, V242, P599	35	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	NOV	2015	22	6					657	663		10.1007/s12282-014-0532-4		7	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CU9CS	WOS:000363841100013		
J	Taira, F; Horimoto, Y; Saito, M				Taira, Fumi; Horimoto, Yoshiya; Saito, Mitsue			Tumor lysis syndrome following trastuzumab for breast cancer: a case report and review of the literature	BREAST CANCER			English	Article						Tumor lysis syndrome; Solid tumor; Breast cancer; Trastuzumab; Molecular targeting drug	CELL LUNG-CANCER; SOLID TUMORS; HEPATOCELLULAR-CARCINOMA; TRANSARTERIAL CHEMOEMBOLIZATION; METASTATIC MELANOMA; PATIENT; ADENOCARCINOMA; CHEMOTHERAPY	Tumor lysis syndrome, a complication of anticancer chemotherapy, results from rapid lysis of malignant cells. We report tumor lysis syndrome in a patient treated with trastuzumab for metastatic breast carcinoma. A 69-year-old woman was diagnosed with multiple liver metastases 1 month after mastectomy. As her liver functions had deteriorated, chemotherapeutic agents were contraindicated and she was treated with trastuzumab alone. On day 6 of the first course of trastuzumab, she developed tumor lysis syndrome. As her liver functions showed deterioration due to multiple hepatic metastases, hemodialysis was contraindicated. Acute renal failure worsened and she died 11 days after the administration of trastuzumab.	[Taira, Fumi; Horimoto, Yoshiya; Saito, Mitsue] Juntendo Univ Hosp, Dept Breast Oncol, Bunkyo Ku, Tokyo 1138421, Japan	Taira, F (reprint author), Juntendo Univ Hosp, Dept Breast Oncol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	fmuraka@juntendo.ac.jp					Abboud M, 2009, CASE REP ONCOL, V2, P229; Baeksgaard L, 2003, CANCER CHEMOTH PHARM, V51, P187, DOI 10.1007/s00280-002-0556-x; Shiba H, 2008, CANCER SCI, V99, P2104, DOI 10.1111/j.1349-7006.2008.00958.x; Sewani HH, 2002, MAYO CLIN PROC, V77, P722; Gemici C, 2006, CLIN ONCOL-UK, V18, P773, DOI 10.1016/j.clon.2006.09.005; Kalemkerian GP, 1997, AM J MED, V103, P363, DOI 10.1016/S0002-9343(97)00153-8; Vaisban E, 2003, AM J MED SCI, V325, P38, DOI 10.1097/00000441-200301000-00008; GOLD JE, 1993, AM J HEMATOL, V44, P42, DOI 10.1002/ajh.2830440109; DRAKOS P, 1994, AM J CLIN ONCOL-CANC, V17, P502, DOI 10.1097/00000421-199412000-00010; Rostom AY, 2000, ANN ONCOL, V11, P1349, DOI 10.1023/A:1008347226743; Hiraizumi Y, 2011, J OBSTET GYNAECOL RE, V37, P947, DOI 10.1111/j.1447-0756.2010.01454.x; Ustundag Y, 1997, ANN PHARMACOTHER, V31, P1548; Kallab AM, 2001, MED ONCOL, V18, P149, DOI 10.1385/MO:18:2:149; D'Alessandro V, 2010, TUMORI, V96, P1040; Castro MP, 1999, CANCER, V85, P1055, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1055::AID-CNCR7>3.0.CO;2-3; Michels J, 2010, INVEST NEW DRUG, V28, P690, DOI 10.1007/s10637-009-9275-z; SKLARIN NT, 1995, AM J CLIN ONCOL-CANC, V18, P71, DOI 10.1097/00000421-199502000-00015; Woo IS, 2001, J KOREAN MED SCI, V16, P115; Feld J, 2000, AM J CLIN ONCOL-CANC, V23, P491, DOI 10.1097/00000421-200010000-00012; Kurt M, 2005, MED ONCOL, V22, P203, DOI 10.1385/MO:22:2:203; BILGRAMI SFA, 1993, MED PEDIATR ONCOL, V21, P521, DOI 10.1002/mpo.2950210712; Shiozawa K, 2010, HEPATO-GASTROENTEROL, V57, P688; Hsieh PM, 2009, WORLD J GASTROENTERO, V15, P4726, DOI 10.3748/wjg.15.4726; Kurt M, 2004, ANN PHARMACOTHER, V38, P902, DOI 10.1345/aph.1D164; Lin CJ, 2007, MED ONCOL, V24, P455, DOI 10.1007/s12032-007-0014-z; Nakamura Y, 2009, INT J DERMATOL, V48, P763, DOI 10.1111/j.1365-4632.2009.04087.x; Beriwal S, 2002, AM J CLIN ONCOL-CANC, V25, P474, DOI 10.1097/00000421-200210000-00010; Wright JL, 2005, INT J UROL, V12, P1012, DOI 10.1111/j.1442-2042.2005.01196.x; CECH P, 1986, NEW ENGL J MED, V315, P263; Schuman S, 2010, J REPROD MED, V55, P441; STARK ME, 1987, CANCER, V60, P762, DOI 10.1002/1097-0142(19870815)60:4<762::AID-CNCR2820600409>3.0.CO;2-P; Habib G, 2002, AM J MED SCI, V323, P155, DOI 10.1097/00000441-200203000-00007; BARTON JC, 1989, CANCER, V64, P738, DOI 10.1002/1097-0142(19890801)64:3<738::AID-CNCR2820640328>3.0.CO;2-Z; Oztop I, 2004, TUMORI, V90, P514; Torres CF, 2009, REV ESP ENFERM DIG, V101, P288; Bertrand C, 2008, J CLIN ONCOL, V26, P2767; Mott Frank E, 2005, Support Cancer Ther, V2, P188, DOI 10.3816/SCT.2005.n.012; Pinder Elizabeth M., 2007, Sarcoma, P82012, DOI 10.1155/2007/82012; Qian Ke-Qing, 2009, Int J Gen Med, V2, P1; Yokoi K, 1997, AM J CLIN ONCOL-CANC, V20, P86, DOI 10.1097/00000421-199702000-00020; Zigrossi P, 2001, Ann Ital Med Int, V16, P112	41	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	NOV	2015	22	6					664	668		10.1007/s12282-013-0448-4		5	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CU9CS	WOS:000363841100014		
J	Zhao, YL; Harmatz, JS; Epstein, CR; Nakagawa, Y; Kurosaki, C; Nakamura, T; Kadota, T; Giesing, D; Court, MH; Greenblatt, DJ				Zhao, Yanli; Harmatz, Jerold S.; Epstein, Carol R.; Nakagawa, Yukako; Kurosaki, Chie; Nakamura, Tetsuro; Kadota, Takumi; Giesing, Dennis; Court, Michael H.; Greenblatt, David J.			Favipiravir inhibits acetaminophen sulfate formation but minimally affects systemic pharmacokinetics of acetaminophen	BRITISH JOURNAL OF CLINICAL PHARMACOLOGY			English	Article						acetaminophen; acetaminophen glucuronide; acetaminophen sulfate; drug interactions; favipiravir; paracetamol	PARACETAMOL METABOLISM; ANTIPYRINE OXIDATION; RNA-POLYMERASE; CONJUGATION; LORAZEPAM; T-705; DISPOSITION; MECHANISM; KINETICS; SULT1A3	AimsThe antiviral agent favipiravir is likely to be co-prescribed with acetaminophen (paracetamol). The present study evaluated the possiblility of a pharmacokinetic interaction between favipiravir and acetaminophen, in vitro and in vivo. MethodsThe effect of favipivir on the transformation of acetaminophen to its glucuronide and sulfate metabolites was studied using a pooled human hepatic S9 fraction in vitro. The effect of acute and extended adminstration of favipiravir on the pharmacokinetics of acetaminophen and metabolites was evaluated in human volunteers. ResultsFavipiravir inhibited the in vitro formation of acetaminophen sulfate, but not acetaminophen glucuronide. In human volunteers, both acute (1 day) and extended (6 days) administration of favipiravir slightly but significantly increased (by about 20 %) systemic exposure to acetaminophen (total AUC), whereas C-max was not significantly changed. AUC for acetaminophen glucuronide was increased by 23 to 35 % above control by favipiravir, while AUC for acetaminophen sulfate was reduced by about 20 % compared to control. Urinary excretion of acetaminophen sulfate was likewise reduced to 44 to 65 % of control values during favipiravir co-administration, while excretion of acetaminophen glucuronide increased to 17 to 32 % above control. ConclusionFavipiravir inhibits acetaminophen sulfate formation in vitro and in vivo. However the increase in systemic exposure to acetaminophen due to favipiravir co-administration, though statistically significant, is small in magnitude and unlikely to be of clinical importance.	[Zhao, Yanli; Harmatz, Jerold S.; Greenblatt, David J.] Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, Boston, MA 02111 USA; [Epstein, Carol R.; Giesing, Dennis] MediVector Inc, Cambridge, MA USA; [Nakagawa, Yukako; Kurosaki, Chie; Kadota, Takumi] Toyama Chem Co LTD, Res Labs, Drug Safety Metab & Pharmacokinet Dept, Tokyo, Japan; [Nakamura, Tetsuro] Toyama Chem Co LTD, Clin Pharmacol Grp, Dept Clin Res, Tokyo, Japan; [Court, Michael H.] Washington State Univ, Coll Vet Med, Dept Vet Clin Sci, Pullman, WA 99164 USA	Greenblatt, DJ (reprint author), Tufts Univ, Sch Med, 136 Harrison Ave, Boston, MA 02111 USA.	DJ.Greenblatt@Tufts.edu			MediVector	All authors have completed the Unified Competing Interest form and declare YZ, JSH, MHC and DJG received no support from any organization for the submitted work. Tufts University received support from MediVector. CRH, and DG are employees of MediVector, Inc. YN, CK, TN and TK are employees of Toyama Chemical Co. YZ, JSH, MHC and DJG had no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years. CRH and DG are employees of MediVector, Inc. YN, CK, TN and TK are employees of Toyama Chemical Co. None of the authors has other relationships or activities that could appear to have influenced the submitted work.	Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; Greenblatt DJ, 2010, ENZYME- AND TRANSPORTER-BASED DRUG-DRUG INTERACTIONS: PROGRESS AND FUTURE CHALLENGES, P625, DOI 10.1007/978-1-4419-0840-7_24; Zhao LZ, 2011, DRUG METAB REV, V43, P41, DOI 10.3109/03602532.2010.527984; Nagai M, 2009, BIOL PHARM BULL, V32, P105, DOI 10.1248/bpb.32.105; DIVOLL M, 1982, CLIN PHARMACOL THER, V31, P151; AMEER B, 1983, J PHARM SCI, V72, P955, DOI 10.1002/jps.2600720832; OCHS HR, 1984, PHARMACOLOGY, V28, P188, DOI 10.1159/000137961; DIVOLL M, 1982, J CLIN PHARMACOL, V22, P571; Sangawa H, 2013, ANTIMICROB AGENTS CH, V57, P5202, DOI 10.1128/AAC.00649-13; ABERNETHY DR, 1983, J PHARMACOL EXP THER, V224, P508; BLYDEN GT, 1988, EUR J CLIN PHARMACOL, V35, P413, DOI 10.1007/BF00561374; ABERNETHY DR, 1983, J LAB CLIN MED, V101, P873; Mannery YO, 2010, J PHARMACOL EXP THER, V333, P948, DOI 10.1124/jpet.110.166439; Nishimuta H, 2007, BIOPHARM DRUG DISPOS, V28, P491, DOI 10.1002/bdd.579; Tarbet EB, 2014, ARCH VIROL, V159, P1279, DOI 10.1007/s00705-013-1922-1; Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015; Greenblatt DJ, 2011, J PHARM PHARMACOL, V63, P214, DOI 10.1111/j.2042-7158.2010.01202.x; CRITCHLEY JAJH, 1986, BRIT J CLIN PHARMACO, V22, P649; Eaton EA, 1996, DRUG METAB DISPOS, V24, P232; FORREST JAH, 1982, CLIN PHARMACOKINET, V7, P93; Critchley JAJH, 2005, J CLIN PHARM THER, V30, P179, DOI 10.1111/j.1365-2710.2004.00626.x; ABERNETHY DR, 1982, CLIN PHARMACOL THER, V31, P783; SCAVONE JM, 1990, PHARMACOLOGY, V40, P77, DOI 10.1159/000138644; CLEMENTS JA, 1984, BRIT J CLIN PHARMACO, V18, P481; ABERNETHY DR, 1985, J PHARMACOL EXP THER, V234, P345; AMEER B, 1977, ANN INTERN MED, V87, P202; Furuta Y, 2009, ANTIVIR RES, V82, P95, DOI 10.1016/j.antiviral.2009.02.198; HAYDEN FG, 1992, CURR TOP MICROBIOL, V176, P119; Cheer Susan M, 2002, Am J Respir Med, V1, P147	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0306-5251	1365-2125		BRIT J CLIN PHARMACO	Br. J. Clin. Pharmacol.	NOV	2015	80	5					1076	1085		10.1111/bcp.12644		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CU9UF	WOS:000363890400016		
J	Gotanda, K; Tokumoto, T; Hirota, T; Fukae, M; Ieiri, I				Gotanda, Keisuke; Tokumoto, Tomoko; Hirota, Takeshi; Fukae, Masato; Ieiri, Ichiro			Sulfasalazine disposition in a subject with 376C > T (nonsense mutation) and 421C > A variants in the ABCG2 gene	BRITISH JOURNAL OF CLINICAL PHARMACOLOGY			English	Letter						ABCG2; breast cancer resistance protein; genetic polymorphism; pharmacokinetics; sulfasalazine	POLYMORPHISMS; BCRP; ABSORPTION		[Gotanda, Keisuke; Tokumoto, Tomoko; Hirota, Takeshi; Fukae, Masato; Ieiri, Ichiro] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacokinet, Fukuoka 8128582, Japan	Ieiri, I (reprint author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacokinet, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ieiri-ttr@umin.ac.jp					Ieiri I, 2012, DRUG METAB PHARMACOK, V27, P85, DOI 10.2133/dmpk.DMPK-11-RV-098; Kobayashi D, 2005, DRUG METAB DISPOS, V33, P94, DOI 10.1124/dmd.104.001628; DAS KM, 1979, GASTROENTEROLOGY, V77, P280; Tamura A, 2006, MOL PHARMACOL, V70, P287, DOI 10.1124/mol.106.023556; Zaher H, 2006, MOL PHARMACEUT, V3, P55, DOI 10.1021/mp050113v; Yamasaki Y, 2008, CLIN PHARMACOL THER, V84, P95, DOI 10.1038/sj.clpt.6100459; Matsuo H, 2009, SCI TRANSL MED, V1, p5ra11, DOI DOI 10.1126/SCITR	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0306-5251	1365-2125		BRIT J CLIN PHARMACO	Br. J. Clin. Pharmacol.	NOV	2015	80	5					1236	1237		10.1111/bcp.12654		2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CU9UF	WOS:000363890400033		
J	Kato, S; Tanaka, M; Isonishi, A; Matsumoto, M; Samori, T; Fujimura, Y				Kato, Seiji; Tanaka, Mutsumi; Isonishi, Ayami; Matsumoto, Masanori; Samori, Tomohiro; Fujimura, Yoshihiro			A rapid, fully automated and highly sensitive ADAMTS13 gold particle immunoassay using a routine biochemistry analyser	BRITISH JOURNAL OF HAEMATOLOGY			English	Letter						ADAMTS13; thrombotic thrombocytopenic purpura; thrombotic microangiopathy; assay	THROMBOTIC THROMBOCYTOPENIC PURPURA; VON-WILLEBRAND-FACTOR; ENZYME-IMMUNOASSAY; PLASMA-LEVELS; FRETS-VWF73; SUBSTRATE; ASSAY		[Kato, Seiji; Tanaka, Mutsumi] Alfresa Pharma Corp, Div Diagnost R&D, Osaka, Japan; [Isonishi, Ayami; Matsumoto, Masanori; Fujimura, Yoshihiro] Nara Med Univ, Dept Blood Transfus Med, Nara, Japan; [Samori, Tomohiro] Japan Clin Labs Inc, Div Res, Kyoto, Japan	Kato, S (reprint author), Alfresa Pharma Corp, Div Diagnost R&D, Osaka, Japan.	seiji-katoh@alfresa-pharma.co.jp					Sadler JE, 2008, BLOOD, V112, P11, DOI 10.1182/blood-2008-02-078170; Fujimura Y, 2011, J THROMB HAEMOST, V9, P283, DOI 10.1111/j.1538-7836.2011.04341.x; Kokame K, 2005, BRIT J HAEMATOL, V129, P93, DOI 10.1111/j.1365-2141.2005.05420.x; Kato S, 2006, TRANSFUSION, V46, P1444, DOI 10.1111/j.1537-2995.2006.00914.x; Yagi H, 2007, INT J HEMATOL, V85, P403, DOI 10.1532/IJH97.06210; Lammle B, 2005, J THROMB HAEMOST, V3, P1663, DOI 10.1111/j.1538-7836.2005.01425.x; Hovinga JAK, 2006, J THROMB HAEMOST, V4, P1146; DEROE C, 1987, J HISTOCHEM CYTOCHEM, V35, P1191; Kokame K, 2004, BLOOD, V103, P607, DOI 10.1182/blood-2003-08-2861; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	NOV	2015	171	4					655	658		10.1111/bjh.13425		4	Hematology	Hematology	CV0NL	WOS:000363947300028		
J	Yamamura, H; Morioka, T; Hagawa, N; Yamamoto, T; Mizobata, Y				Yamamura, Hitoshi; Morioka, Takasei; Hagawa, Naohiro; Yamamoto, Tomonori; Mizobata, Yasumitsu			Computed tomographic assessment of airflow obstruction in smoke inhalation injury: Relationship with the development of pneumonia and injury severity	BURNS			English	Article						Smoke inhalation injury; Computed tomography; Bronchial wall thickness; Luminal area; Airflow narrowing; Pneumonia	WALL THICKNESS; FIBEROPTIC BRONCHOSCOPY; LUNG-FUNCTION; ASTHMA	Purpose: The prediction of pulmonary deterioration in patients with smoke inhalation injury is important because this influences the strategy for patient management. We hypothesized that narrowing of the luminal bronchus due to bronchial wall thickening correlates to respiratory deterioration in smoke inhalation injury patients. Methods: In a prospective observational study, all patients were enrolled at a single tertiary trauma and critical care center. In 40 patients, chest computed tomographic images were obtained within a few hours after smoke inhalation injury. We assessed bronchial wall thickness and luminal area % on chest computed tomographic images. Airway wall thickness to total bronchial diameter (T/D) ratio, percentage of luminal area, and clinical indices were compared between patients with smoke inhalation injury and control patients. Results: The T/D ratio of patients with smoke inhalation was significantly higher than that of control patients (p < 0.001), and the luminal area of these patients was significantly smaller than that of control patients (p < 0.001). The number of mechanical ventilation days correlated with the initial infusion volume, T/D ratio, and luminal area %. ROC analysis showed a cut-off value of 0.26 for the T/D ratio, with a sensitivity of 79.0% and specificity of 73.7%, and a value of 23.4% for luminal area %, with a sensitivity of 68.4% and specificity of 84.2%. Conclusions: These data revealed the utility of computed tomography scanning on admission to show that the patients with smoke inhalation injury had airway wall thickening compared to control patients without smoke inhalation injury. Airflow narrowing due to airway wall thickening was related to the development of pneumonia and the number of mechanical ventilation days in patients with smoke inhalation injury. Airflow narrowing is one important factor of respiratory deterioration in smoke inhalation injury. (C) 2015 Elsevier Ltd and ISBI. All rights reserved.	[Yamamura, Hitoshi; Morioka, Takasei; Hagawa, Naohiro; Yamamoto, Tomonori; Mizobata, Yasumitsu] Osaka City Univ, Grad Sch Med, Dept Crit Care Med, Abeno Ku, Osaka, Osaka 5458585, Japan	Yamamura, H (reprint author), Osaka City Univ, Grad Sch Med, Dept Crit Care Med, Abeno Ku, 1-4-3 Asahimachi, Osaka, Osaka 5458585, Japan.	yamamura@med.osaka-cu.ac.jp					Kosciuch J, 2009, J PHYSIOL PHARMACOL, V60, P71; Chae EJ, 2011, ALLERGY ASTHMA IMMUN, V3, P111, DOI 10.4168/aair.2011.3.2.111; [Anonymous], 2003, J TRAUMA; Elliot J, 1998, AM J RESP CRIT CARE, V158, P802; Albright JM, 2012, CRIT CARE MED, V40, P1113, DOI 10.1097/CCM.0b013e3182374a67; Lin CC, 2012, BURNS, V38, P203, DOI 10.1016/j.burns.2011.08.010; Kwon HP, 2014, BURNS, V40, P1308, DOI 10.1016/j.burns.2014.06.007; SHIRANI KZ, 1987, ANN SURG, V205, P82, DOI 10.1097/00000658-198701000-00015; Kim CH, 2014, J THORAC DIS, V6, P617, DOI 10.3978/j.issn.2072-1439.2014.04.11; Kasahara K, 2002, THORAX, V57, P242, DOI 10.1136/thorax.57.3.242; Little SA, 2002, THORAX, V57, P247, DOI 10.1136/thorax.57.3.247; Davis CS, 2013, ANN SURG, V257, P1137, DOI 10.1097/SLA.0b013e318275f424; Park MS, 2003, J TRAUMA, V55, P417, DOI 10.1097/01.TA.0000083609.24440.7F; Herculiani PP, 2009, TOXICOL PATHOL, V37, P324, DOI 10.1177/0192623308330790; Mosier MJ, 2012, J BURN CARE RES, V33, P65, DOI 10.1097/BCR.0b013e318234d92f; Shimazu T, 1996, J APPL PHYSIOL, V81, P2250; Sheppard NN, 2011, BURNS, V37, P1288, DOI 10.1016/j.burns.2011.07.017; Lange M, 2011, EXP LUNG RES, V37, P239, DOI 10.3109/01902148.2010.538133; Awadh N, 1998, THORAX, V53, P248; Oh JS, 2012, J BURN CARE RES, V33, P532, DOI 10.1097/BCR.0b013e318237455f; Bordes J, 2014, BURNS, P562; Jones SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064250; JONES W G, 1988, Current Surgery, V45, P309; Kim V, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-52; Mlcak R., 1997, Journal of Burn Care and Rehabilitation, V18, P531, DOI 10.1097/00004630-199711000-00011; Yamamura H, 2013, CRIT CARE, V17, DOI 10.1186/cc12740	26	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0305-4179	1879-1409		BURNS	Burns	NOV	2015	41	7					1428	1434		10.1016/j.burns.2015.06.008		7	Critical Care Medicine; Dermatology; Surgery	General & Internal Medicine; Dermatology; Surgery	CV4PH	WOS:000364248500006		
J	Islam, MM; Hirotsugu, T; Matsumoto, T; Tanaka, J; Yamato, T				Islam, M. Monarul; Hirotsugu, Tomiyasu; Matsumoto, Taisuke; Tanaka, Junji; Yamato, Takehiko			Synthesis and conformational studies of 9-benzyloxy-18-substituted [3.3]metacyclophanes	CANADIAN JOURNAL OF CHEMISTRY			English	Article						netacyclophanes; conformation; Wolff-Kishner reduction; anti-syn isomerization; Omicron-benzylation	CYCLOPHANES; METACYCLOPHANES; CONVERSION; NMR	A series of syn-[3.3] metacyclophanes (MCPs) containing internal substituted benzyloxy group have been synthesized by the modified TosMIC coupling reaction followed by acid treatment and Wolff-Kishner reduction. anti-Mono- and di-benzyloxy[3.3] MCPs are synthesized by Omicron-benzylation of the corresponding hydroxy[3.3] MCPs, which are obtained by demethylation of methoxy[3.3] MCPs with BBr3 at room temperature. An interesting and intriguing result was obtained when syn- 6,15-di-tert-butyl-9-methoxy-18-methyl[3.3] MCP-2,11-dione was treated with TMSI to afford the formation of a dihydrobenzofuran ring by a nucleophilic intramolecular cyclization reaction. The H-1 NMR and X-ray analysis of 6a confirms that it adopts a syn (chair-chair) conformation in both solution and solid state.	[Islam, M. Monarul; Hirotsugu, Tomiyasu; Yamato, Takehiko] Saga Univ, Fac Sci & Engn, Dept Appl Chem, Saga, Saga 8408502, Japan; [Matsumoto, Taisuke; Tanaka, Junji] Kyushu Univ, Inst Mat Chem & Engn, Kasuga, Fukuoka 8168580, Japan	Yamato, T (reprint author), Saga Univ, Fac Sci & Engn, Dept Appl Chem, Saga, Saga 8408502, Japan.	yamatot@cc.saga-u.ac.jp			OTEC at Saga University	We would like to thank the OTEC at Saga University for financial support. This work was performed under the Cooperative Research Program of Network Joint Research Center for Materials and Devices (Institute for Materials Chemistry and Engineering, Kyushu University).	TASHIRO M, 1981, J ORG CHEM, V46, P4556, DOI 10.1021/jo00335a047; Werz DB, 2008, J ORG CHEM, V73, P8021, DOI 10.1021/jo801378p; SAKO K, 1992, J ORG CHEM, V57, P6536, DOI 10.1021/jo00050a031; Tazoe K, 2012, CAN J CHEM, V90, P222, DOI 10.1139/V11-148; Shibahara M, 2007, J ORG CHEM, V72, P2865, DOI 10.1021/jo062220m; TASHIRO M, 1983, J ORG CHEM, V48, P1461, DOI 10.1021/jo00157a015; Jeppesen JO, 2004, CHEM REV, V104, P5115, DOI 10.1021/cr030630u; Mitchell RH, 2002, J AM CHEM SOC, V124, P2352, DOI 10.1021/ja0173977; Krafft ME, 2001, TETRAHEDRON LETT, V42, P1427, DOI 10.1016/S0040-4039(00)02299-1; SAKO K, 1988, TETRAHEDRON LETT, V29, P6275, DOI 10.1016/S0040-4039(00)82324-2; Yamato T, 2001, NEW J CHEM, V25, P434, DOI 10.1039/b008258i; Shimizu T, 2009, J CHEM RES-S, P60, DOI 10.3184/030823409X401105; Chen PK, 2011, J AM CHEM SOC, V133, P20142, DOI 10.1021/ja209602z; CRAM DJ, 1951, J AM CHEM SOC, V73, P5691, DOI 10.1021/ja01156a059; SEMMELHACK MF, 1985, J AM CHEM SOC, V107, P7508, DOI 10.1021/ja00311a047; Yamato T, 2002, CAN J CHEM, V80, P510, DOI 10.1139/V02-072; VOGTLE F, 1972, ANGEW CHEM INT EDIT, V11, P73, DOI 10.1002/anie.197200731; Diederich F., 1991, CYCLOPHANES, DOI [10.1021/ja209602z, DOI 10.1021/JA209602Z]; Gleiter R., 2004, MODERN CYCLOPHANE CH; Isaji H, 2001, EUR J ORG CHEM, P2487; Osada S, 1995, CHEM LETT, P1103, DOI 10.1246/cl.1995.1103; Osada S., 1993, MEM FS KYUSHU U C, V19, P39; Satou T, 2002, J CHEM SOC PERK T 2, P393, DOI 10.1039/b200402j; Shinmyozu T., 1985, MEM FS KYUSHU U C, V15, P79; SHINMYOZU T, 1976, CHEM LETT, P1405, DOI 10.1246/cl.1976.1405; Shinmyozu T., 1996, LIEBIGS ANN, V2, P205, DOI [10.1002/jlac.199619960209, DOI 10.1002/JLAC.199619960209]; Takemura H, 2004, EUR J ORG CHEM, P2019, DOI 10.1002/ejoc.200300698; Tsuji T., 1999, ADV STRAINED INTERES; Tsuji T., 2004, MODERN CYCLOPHANE CH; Vogtle F., 1993, CYCLOPHANE CHEM SYNT; VOGTLE F, 1973, SYNTHESIS-STUTTGART, P85, DOI 10.1055/s-1973-22137; Vogtle F., 1978, TOP CURR CHEM, V74, P1, DOI [10.1007/BFb0050144, DOI 10.1007/BFB0050144]; Vogtle F., 1972, ANGEW CHEM, V84, P75, DOI [10.1002/ange.19720840302, DOI 10.1002/ANGE.19720840302]	33	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0008-4042	1480-3291		CAN J CHEM	Can. J. Chem.	NOV	2015	93	11					1161	1168		10.1139/cjc-2015-0174		8	Chemistry, Multidisciplinary	Chemistry	CV3KN	WOS:000364158200001		
J	Narimatsu, Y; Kakehi, S; Ito, S; Okazaki, Y; Inagawa, R; Yano, T				Narimatsu, Yoji; Kakehi, Shigeho; Ito, Shin-ichi; Okazaki, Yuji; Inagawa, Ryo; Yano, Toshikazu			Impact of the Great East Japan Earthquake tsunami on growth and survival of Pacific cod (Gadus macrocephalus)	CANADIAN JOURNAL OF FISHERIES AND AQUATIC SCIENCES			English	Article							TEMPORAL-CHANGES; FEEDING-HABITS; MUTSU BAY; LARVAL; SEA; TEMPERATURE; SETTLEMENT; TRANSPORT; PATTERNS; FLOUNDER	A massive tsunami hit the north Pacific coast of Japan on 11 March 2011. We evaluated the effects of the tsunami on the distribution, growth, and survival of young Pacific cod (Gadus macrocephalus) using data from benthic trawl surveys and otolith microstructure analysis. The distribution of Pacific cod juveniles differed between 2011 and 2008-2010. The 2011 year class was smaller in body size than those in 2008-2010. The majority of 2011 year-class juveniles was captured in deeper areas at a smaller body size, whereas those of previous year classes were primarily distributed in shallower water. The peak hatch of the 2011 year-class juveniles was from early to late February, which was several days later than those of the 2008 and 2010 year classes. The 2011 year class grew at the same rate as those from 2008 and 2010 until the day of the tsunami, but had a lower growth rate during the 30 days after the tsunami, resulting in a decrease in fish size at settlement. Growth of the 2011 year class was also inferior soon after the day of the tsunami in almost all groups divided by the hatching period. Growth of juveniles captured in shallower water following the tsunami in 2011 tended to be slower than that of juveniles captured in deeper water. Our results suggest that the tsunami caused a decrease in growth rates for approximately 30 days and a change in the distribution of juvenile fish relative to prior years. The change in distribution was primarily the result of mortality in shallow water caused by physical damage and (or) subsequent decreased growth. Considering these results and the finding that the recruitment level and the recruits per spawning in the 2011 year class were low, the tsunami may have affected the determination of the recruitment level.	[Narimatsu, Yoji; Yano, Toshikazu] Fisheries Res Agcy, Tohoku Natl Fisheries Res Inst, Hachinohe Lab, Hachinohe, Aomori 0310841, Japan; [Kakehi, Shigeho; Okazaki, Yuji] Fisheries Res Agcy, Tohoku Natl Fisheries Res Inst, Shiogama Lab, Shiogama, Miyagi 9850001, Japan; [Ito, Shin-ichi] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Inagawa, Ryo] Hokkaido Res Org, Fisheries Res Dept, Kushiro Fisheries Res Inst, Kushiro, Hokkaido 0850024, Japan	Narimatsu, Y (reprint author), Fisheries Res Agcy, Tohoku Natl Fisheries Res Inst, Hachinohe Lab, Hachinohe, Aomori 0310841, Japan.	nary@affrc.go.jp			Fisheries Agency, the Ministry of Agriculture, Forestry and Fisheries of Japan	We thank the crew of the Wakataka-maru for their assistance in obtaining samples, Yasutoki Shibata for his advice on data analysis, Tsutomu Hattori and Masaki Ito for their useful comments, and the staff of Hachinohe Laboratory, Tohoku National Fisheries Research Institute, for help in preparing the samples. This study was funded by the Fisheries Agency, the Ministry of Agriculture, Forestry and Fisheries of Japan.	Yamashita Y, 1996, FISH OCEANOGR, V5, P194, DOI 10.1111/j.1365-2419.1996.tb00117.x; CAMPANA SE, 1990, CAN J FISH AQUAT SCI, V47, P2219, DOI 10.1139/f90-246; Whanpetch N, 2010, ESTUAR COAST SHELF S, V87, P246, DOI 10.1016/j.ecss.2010.01.001; Narimatsu Y, 2007, FISHERIES SCI, V73, P1257, DOI 10.1111/j.1444-2906.2007.01463.x; Takatsu T, 2002, FISH OCEANOGR, V11, P90, DOI 10.1046/j.1365-2419.2002.00193.x; Morioka T, 2002, NIPPON SUISAN GAKK, V68, P345; TAKATSU T, 1995, FISHERIES SCI, V61, P415; Ito SI, 2004, J OCEANOGR, V60, P425, DOI 10.1023/B:JOCE.0000038059.54334.6b; Undap SL, 2013, ECOTOX ENVIRON SAFE, V96, P75, DOI 10.1016/j.ecoenv.2013.06.019; Takami H, 2013, FISH OCEANOGR, V22, P113, DOI 10.1111/fog.12008; Plaza G, 2010, FISH RES, V103, P48, DOI 10.1016/j.fishres.2010.02.001; Chavanich S, 2005, CORAL REEFS, V24, P535, DOI 10.1007/s00338-005-0016-2; Narimatsu Y, 2010, ICES J MAR SCI, V67, P1659, DOI 10.1093/icesjms/fsq078; Takasuka A, 2003, MAR ECOL PROG SER, V252, P223, DOI 10.3354/meps252223; Danielsen F, 2005, SCIENCE, V310, P643, DOI 10.1126/science.1118387; PONTON D, 1992, MAR ECOL PROG SER, V81, P215, DOI 10.3354/meps081215; Hurst TP, 2010, FISH B-NOAA, V108, P382; Goto K, 2011, MAR GEOL, V290, P46, DOI 10.1016/j.margeo.2011.10.004; Robert D, 2007, MAR ECOL PROG SER, V337, P209, DOI 10.3354/meps337209; Lomovasky BJ, 2011, J SEA RES, V65, P205, DOI 10.1016/j.seares.2010.10.002; CHAMBERS RC, 1987, CAN J FISH AQUAT SCI, V44, P1936, DOI 10.1139/f87-238; Ito S, 2004, FISH OCEANOGR, V13, P1, DOI 10.1111/j.1365-2419.2004.00309.x; Kumaraguru AK, 2005, CURR SCI INDIA, V89, P1729; Ito S, 2010, PROG OCEANOGR, V87, P186, DOI 10.1016/j.pocean.2010.08.004; Campana Steven E., 1992, Canadian Special Publication of Fisheries and Aquatic Sciences, V117, P73; HASHIMOTO R, 1974, Bulletin of Tohoku National Fisheries Research Institute, V33, P51; Houde Edward D., 2009, P91, DOI 10.1002/9781444312133.ch3; Houde E.D., 1987, AM FISH SOC S, V2, P17; Ikehara K., 2011, SEDIMENTOL SOC J; Kakehi S., 2012, COAST ENG, V68, pI_ 951, DOI [10.2208/kaigan.68.I_951, DOI 10.2208/KAIGAN.68.I_951]; Matarese A. C., 1989, NOAA TECHN REPORT NM, V80, P189; Mori N, 2011, GEOPHYS RES LETT, V38, DOI [10.1029/2011GL049210, DOI 10.1029/2011GL049210]; Narimatsu Y., 2013, MARINE FISHERIES STO, P867; PETERSON I, 1984, CAN J FISH AQUAT SCI, V41, P1117, DOI 10.1139/f84-131; Sava E., 2013, NAT HAZARD EARTH SYS, V1, P3073, DOI [10.5194/nhessd-1-3073-2013, DOI 10.5194/NHESSD-1-3073-2013]; Shimizu Y., 1996, B TOHOKU NATL FISH R, V58, P105; Siswanto E., 2012, INT J IMAGE DATA FUS, V3, P191, DOI DOI 10.1080/19479832.2012.674064; Takatsu Tetsuya, 2001, Bulletin of the Japanese Society of Fisheries Oceanography, V65, P6	38	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0706-652X	1205-7533		CAN J FISH AQUAT SCI	Can. J. Fish. Aquat. Sci.	NOV	2015	72	11					1629	1638		10.1139/cjfas-2014-0467		10	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	CV2RL	WOS:000364104300003		
J	Miyashita, M; Ohno, S; Kataoka, A; Tokunaga, E; Masuda, N; Shien, T; Kawabata, K; Takahashi, M				Miyashita, Mika; Ohno, Shinji; Kataoka, Akemi; Tokunaga, Eriko; Masuda, Norikazu; Shien, Tadahiko; Kawabata, Kimiko; Takahashi, Miyako			Unmet Information Needs and Quality of Life in Young Breast Cancer Survivors in Japan	CANCER NURSING			English	Article						Breast cancer; Quality of life; Unmet information needs; Young survivors	SUPPORTIVE CARE NEEDS; WORLD-HEALTH-ORGANIZATION; PSYCHOMETRIC PROPERTIES; ALTERNATIVE MEDICINE; ASSESSMENT WHOQOL; FERTILITY ISSUES; WOMEN; MENOPAUSE; DIAGNOSIS; AGE	Background: Young breast cancer survivors have specific needs related to age. Clarifying the relationships between unmet information needs and quality of life (QOL) in young breast cancer survivors can contribute to constructing a support system to enhance QOL in patients. Objective: This study aimed to identify the unmet information needs and examine the relationships between unmet information needs and QOL in young breast cancer survivors in Japan. Methods: Participants completed an information needs questionnaire containing 26 items, the World Health Organization Quality of Life Instrument-Short Form (WHOQOL-BREF), and a demographic and medical information questionnaire. Results: Fifty participants (30.7%) were unsatisfied with overall communication with medical professionals. The mean scores on all subscales of the WHOQOL-BREF of the participants who were satisfied with overall communication with medical professionals were significantly higher than those of the unsatisfied group. follow-up tests, treatment for recurrence of breast cancer, strategies about communication with medical staff, and nutrition were significantly related with all subscales in the WHOQOL-BREF. Secondary menopause caused by hormonal therapy was significantly related with physical and psychological health. Conclusions: Japanese young breast cancer survivors have unmet information needs, including age-specific issues. These unmet information needs are related to QOL. In particular, overall communication with medical professionals, which is the most unmet information need, is related to QOL. Implications for Practice: Oncology nurses should teach patients communication skills, provide adequate information, and provide education and emotional support to medical professionals to improve QOL in young breast cancer survivors.	[Miyashita, Mika] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Div Nursing Sci, Hiroshima 7348553, Japan; [Ohno, Shinji] Natl Hosp Org, Kyushu Canc Ctr, Clin Canc Inst, Fukuoka, Japan; [Kataoka, Akemi] Toho Univ, Omori Med Ctr, Dept Breast & Endocrine Surg, Tokyo, Japan; [Tokunaga, Eriko] Kyushu Univ, Dept Surg & Sci, Grad Sch Med Sci, Fukuoka, Japan; [Masuda, Norikazu] Natl Hosp Org, Osaka Natl Hosp, Breast Oncol, Dept Surg, Koshigaya, Japan; [Shien, Tadahiko] Okayama Univ Hosp, Dept Breast & Endocrine Surg, Koshigaya, Japan; [Kawabata, Kimiko] Saitama Prefectural Univ, Sch Hlth & Social Serv, Dept Nursing, Koshigaya, Japan; [Takahashi, Miyako] Natl Canc Ctr, Ctr Canc Control & Informat Serv, Canc Survivorship Res Div, Tokyo 104, Japan	Miyashita, M (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Div Nursing Sci, Minami Ku, 1-2-1 Kasumi, Hiroshima 7348553, Japan.	mika-tky@umin.ac.jp			JSPS [20592540]; Japanese Breast Cancer Society	This research was supported by JSPS KAKENHI grant number 20592540 and by research fund from the Japanese Breast Cancer Society.	Tautz E, 2012, EUR J CANCER, V48, P3133, DOI 10.1016/j.ejca.2012.04.021; Yoshida S, 2010, SUPPORT CARE CANCER, V18, P439, DOI 10.1007/s00520-009-0682-7; Partridge AH, 2004, J CLIN ONCOL, V22, P4174, DOI 10.1200/jco.2004.01.159; Kerr J, 2003, ANN ONCOL, V14, P421, DOI 10.1093/annonc/mdg098; Ashing-Giwa KT, 2011, ONCOL NURS FORUM, V38, P279, DOI 10.1188/11.ONF.279-288; Avis NE, 2005, J CLIN ONCOL, V23, P3322, DOI 10.1200/JCO.2005.05.130; Goodwin PJ, 1999, J CLIN ONCOL, V17, P2365; Sanson-Fisher R, 2000, CANCER, V88, P226, DOI 10.1002/(SICI)1097-0142(20000101)88:1<226::AID-CNCR30>3.0.CO;2-P; Hyodo I, 2005, J CLIN ONCOL, V23, P2645; Thewes B, 2005, J CLIN ONCOL, V23, P5155, DOI 10.1200/JCO.2005.07.773; Robinson JD, 2013, J CLIN ONCOL, V31, P351, DOI 10.1200/JCO.2012.44.2699; Fernandes-Taylor S, 2011, PSYCHO-ONCOLOGY, V20, P506, DOI 10.1002/pon.1749; Dunn J, 2000, PSYCHO-ONCOL, V9, P137, DOI 10.1002/(SICI)1099-1611(200003/04)9:2<137::AID-PON442>3.0.CO;2-0; Uchida M, 2011, JPN J CLIN ONCOL, V41, P530, DOI 10.1093/jjco/hyq230; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Boyes A, 2009, J EVAL CLIN PRACT, V15, P602, DOI 10.1111/j.1365-2753.2008.01057.x; Matsuda T, 2011, JPN J CLIN ONCOL, V41, P139, DOI 10.1093/jjco/hyq169; Griggs JJ, 2007, PATIENT EDUC COUNS, V66, P58, DOI 10.1016/j.pec.2006.10.008; Zebrack B, 2009, SUPPORT CARE CANCER, V17, P349, DOI 10.1007/s00520-008-0469-2; Wang XQ, 1999, CANCER NURS, V22, P157, DOI 10.1097/00002820-199904000-00008; Kroenke CH, 2004, J CLIN ONCOL, V22, P1849, DOI 10.1200/JCO.2004.04.173; Bonevski B, 2000, CANCER, V88, P217, DOI 10.1002/(SICI)1097-0142(20000101)88:1<217::AID-CNCR29>3.0.CO;2-Y; Jefford M, 2011, CANCER NURS, V34, pE1, DOI 10.1097/NCC.0b013e3181f22f02; Howard-Anderson J, 2012, JNCI-J NATL CANCER I, V104, P386, DOI 10.1093/jnci/djr541; Rutten LJF, 2005, PATIENT EDUC COUNS, V57, P250, DOI 10.1016/j.pec.2004.06.006; Campbell HS, 2009, CANCER, V115, P3351, DOI 10.1002/cncr.24386; Park BW, 2012, YONSEI MED J, V53, P118, DOI 10.3349/ymj.2012.53.1.118; Hodgkinson K, 2007, PSYCHO-ONCOL, V16, P796, DOI 10.1002/pon.1137; Freedman RA, 2011, BREAST, V20, pS146, DOI 10.1016/S0960-9776(11)70313-7; Karaoz B, 2010, INT J GYNECOL OBSTET, V109, P118, DOI 10.1016/j.ijgo.2009.11.027; Shimizu C, 2013, BREAST CANCER-TOKYO, V20, P230, DOI 10.1007/s12282-011-0328-8; Wenzel LB, 1999, CANCER, V86, P1768, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1768::AID-CNCR19>3.0.CO;2-O; Carey M, 2012, SUPPORT CARE CANCER, V20, P207, DOI 10.1007/s00520-011-1327-1; Moreira H, 2010, PSYCHO-ONCOLOGY, V19, P959, DOI 10.1002/pon.1647; Gould J, 2006, HEALTH EXPECT, V9, P158, DOI 10.1111/j.1369-7625.2006.00383.x; Hyphantis T, 2013, PSYCHO-ONCOLOGY, V22, P2470, DOI 10.1002/pon.3308; Hillyer GC, 2013, BREAST, V22, P548, DOI 10.1016/j.breast.2012.10.001; Hodgkinson K, 2007, J PSYCHOSOC ONCOL, V25, P89, DOI 10.1300/J077v25n04_06; Bilodeau B A, 1996, Oncol Nurs Forum, V23, P691; Camp-Sorrell Dawn, 2009, Semin Oncol Nurs, V25, P251, DOI 10.1016/j.soncn.2009.08.002; Chopra I, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-14; Ferrans CE, 2011, CANC NURSING PRINCIP, P201; Ganz PA, 2008, J CLIN ONCOL, V12, P412; Kataoka A, 2013, BREAST CANC; Lazarus R. S., 1984, STRESS APPRAISAL COP; Roche N, 2006, BREAST, V15, P571; Rosen Allison, 2009, Semin Oncol Nurs, V25, P268, DOI 10.1016/j.soncn.2009.08.004; Rosenberg SM, 2013, J THORAC DIS, V5, pS55, DOI 10.3978/j.issn.2072-1439.2013.06.20; Rowland JH, 2006, J CLIN ONCOL, V24, P101; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Tazaki M, 2007, WHOQOL26 GUIDANCE; KUYKEN W, 1995, SOC SCI MED, V41, P1403; Harper A, 1998, PSYCHOL MED, V28, P551; WHOQOL Group, 1998, SOC SCI MED, V46, P1569, DOI [10.1016/S0277-9536(98)00009-4, DOI 10.1016/S0277-9536(98)00009-4]	54	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0162-220X	1538-9804		CANCER NURS	Cancer Nurs.	NOV-DEC	2015	38	6					E1	E11		10.1097/NCC.0000000000000201		11	Oncology; Nursing	Oncology; Nursing	CV3XP	WOS:000364200200001		
J	Ushikoshi, H; Okada, H; Morishita, K; Imai, H; Tomita, H; Nawa, T; Suzuki, K; Ikeshoji, H; Kato, H; Yoshida, T; Yoshida, S; Shirai, K; Toyoda, I; Hara, A; Ogura, S				Ushikoshi, Hiroaki; Okada, Hideshi; Morishita, Kentaro; Imai, Hajime; Tomita, Hiroyuki; Nawa, Takahide; Suzuki, Kodai; Ikeshoji, Haruka; Kato, Hisaaki; Yoshida, Takahiro; Yoshida, Shozo; Shirai, Kunihiro; Toyoda, Izumi; Hara, Akira; Ogura, Shinji			An autopsy report of acute myocardial infarction with hypertrophic obstructive cardiomyopathy-like heart	CARDIOVASCULAR PATHOLOGY			English	Article						Acute myocardial infarction; Hypertrophic obstructive cardiomyopathy; Autopsy		An 84-year-old woman, who was followed up as hypertrophic obstructive cardiomyopathy (HOCM) in a local hospital, was transferred to our center because of anterior chest pain and diagnosed with acute myocardial infarction (MI). Coronary angiography showed total occlusion of the mid-left anterior descending, and flow was restored after endovascular thrombectomy. An autopsy was performed after she died on hospital day 6. At autopsy, there was no significant stenosis in this vessel and the absence of plaque rupture was confirmed. Likewise, it was unclear asymmetric hypertrophy at autopsy, it could not deny that a sigmoid deformity of the basal septum occurs in elderly patients and can mimic the asymmetric septal hypertrophy of hypertrophic cardiomyopathy. MI was thought to be caused by coronary spasm or squeezing in HOCM-like heart. Therefore, it may be necessary antithrombosis therapy in HOCM-like patients with no history of paroxysmal atrial fibrillation. (C) 2015 Elsevier Inc. All rights reserved.	[Ushikoshi, Hiroaki; Okada, Hideshi; Morishita, Kentaro; Imai, Hajime; Suzuki, Kodai; Ikeshoji, Haruka; Kato, Hisaaki; Yoshida, Takahiro; Yoshida, Shozo; Shirai, Kunihiro; Toyoda, Izumi; Ogura, Shinji] Gifu Univ, Grad Sch Med, Dept Emergency & Disaster Med, Gifu 5011194, Japan; [Tomita, Hiroyuki; Hara, Akira] Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu 5011194, Japan; [Nawa, Takahide] Gifu Univ, Grad Sch Med, Dept Cardiol, Gifu 5011194, Japan	Okada, H (reprint author), Gifu Univ, Grad Sch Med, Dept Emergency & Disaster Med, 1-1 Yanagido, Gifu 5011194, Japan.	hideshi@gifu-u.ac.jp					Sato Y, 2007, TEX HEART I J, V34, P475; Chockalingam A, 2007, CIRCULATION, V116, pE110, DOI 10.1161/CIRCULATIONAHA.107.711697	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1054-8807	1879-1336		CARDIOVASC PATHOL	Cardiovasc. Pathol.	NOV-DEC	2015	24	6					405	407		10.1016/j.carpath.2015.07.004		3	Cardiac & Cardiovascular Systems; Pathology	Cardiovascular System & Cardiology; Pathology	CV3QN	WOS:000364173800012		
J	Iwasaki, S; Suzuki, A; Fujisawa, T; Sato, T; Shirai, S; Kamigaki, M; Otsuka, N; Tomaru, U; Ishizu, A				Iwasaki, Sari; Suzuki, Akira; Fujisawa, Takashi; Sato, Taiju; Shirai, Shinya; Kamigaki, Mitsunori; Otsuka, Noriyuki; Tomaru, Utano; Ishizu, Akihiro			Fatal cardiac small-vessel involvement in ANCA-associated vasculitis: an autopsy case report	CARDIOVASCULAR PATHOLOGY			English	Article						ANCA-associated vasculitis; Cardiac small-vessel involvement; Sudden death; Autopsy	GRANULOMATOSIS; POLYANGIITIS	An 80-year-old Japanese man, who had fever and generalized fatigue not improved by antibiotics, was admitted to our hospital. Laboratory data indicative of renal dysfunction and antineutrophil cytoplasmic antibody (ANCA) in the serum led to the consideration of ANCA-associated vasculitis as a differential diagnosis. However, before the diagnostic confirmation, he was found dead on the bed. Autopsy revealed necrotizing crescentic glomerulonephritis in the kidneys. In addition, necrotizing granulomatous vasculitis with infiltration of multinucleated giant cells and neutrophils but not eosinophils was present in multiple organs. The direct cause of death was presumed as cardiac arrest by lethal arrhythmia because vasculitic lesions were distributed widely in the cardiac walls, acute congestion was observed in the systemic organs, and other causes of death were ruled out. This report presents the unusual manifestation of cardiac small-vessel involvement in ANCA-associated vasculitis related to sudden death. (C) 2015 Elsevier Inc. All rights reserved.	[Iwasaki, Sari; Suzuki, Akira; Fujisawa, Takashi] KKR Sapporo Med Ctr, Dept Pathol, Sapporo, Hokkaido, Japan; [Sato, Taiju; Shirai, Shinya; Kamigaki, Mitsunori] KKR Sapporo Med Ctr, Dept Cardiol, Sapporo, Hokkaido, Japan; [Otsuka, Noriyuki; Tomaru, Utano] Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido 0600812, Japan; [Ishizu, Akihiro] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido 0600812, Japan	Ishizu, A (reprint author), Hokkaido Univ, Fac Hlth Sci, Kita Ku, Kita 12,Nishi 5, Sapporo, Hokkaido 0600812, Japan.	aishizu@med.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26293082]; Ministry of Health, Labour and Welfare of Japan	This study was supported by the grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan, 26293082 (A.I.), and the grant for Research on Rare and Intractable Diseases, intractable vasculitis (A.I.), from the Ministry of Health, Labour and Welfare of Japan.	GOODFIELD NER, 1995, BRIT HEART J, V73, P110; [Anonymous], 2014, MEDICINE BALTIMORE, V93, pe226; Timlin H, 2015, SEMIN ARTHRITIS RHEU, V45, P67, DOI 10.1016/j.semarthrit.2015.02.005; Norita K, 2012, VIRCHOWS ARCH, V460, P309, DOI 10.1007/s00428-011-1173-z; Vinit J, 2010, EUR J INTERN MED, V21, P341, DOI 10.1016/j.ejim.2010.05.004; Villiger PM, 2010, AUTOIMMUN REV, V9, P812, DOI 10.1016/j.autrev.2010.07.009; Hemmett J, 2015, LANCET, V385, P480, DOI 10.1016/S0140-6736(14)62352-7; Sada KE, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4550	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1054-8807	1879-1336		CARDIOVASC PATHOL	Cardiovasc. Pathol.	NOV-DEC	2015	24	6					408	410		10.1016/j.carpath.2015.07.005		3	Cardiac & Cardiovascular Systems; Pathology	Cardiovascular System & Cardiology; Pathology	CV3QN	WOS:000364173800013		
J	Tanimoto, J				Tanimoto, Jun			Considering individual satisfaction levels enhances cooperation in a spatial prisoner's dilemma game	CHAOS SOLITONS & FRACTALS			English	Article								Based on the observance in human society, the satisfaction level of an individual as a result of an obtained payoff depends on personal tendency to some extent; we establish a new model for spatial prisoner's dilemma games. We describe individual satisfaction as a stochastically deviated value around each of the four payoffs stipulated by a payoff matrix, which is maintained throughout the life of a certain agent. When strategy updating, an agent who refers to his own satisfaction level cannot see neighbors' satisfaction levels but can only observe neighbors' accumulated payoffs. By varying the update rule and underlying topology, we perform numerical simulations that reveal cooperation is significantly enhanced by this change. We argue that this enhancement of cooperation is analogous to a stochastic resonance effect, like the payoff noise effects Perc (2006). (C) 2015 Elsevier Ltd. All rights reserved.	Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan	Tanimoto, J (reprint author), Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan.				JSPS [25560165]; Tateishi Science and Technology Foundation	We gratefully acknowledge the support for this study provided by a Grant-in-Aid for Scientific Research by JSPS, awarded to Professor Tanimoto (#25560165), and by the Tateishi Science and Technology Foundation.	Tanimoto J, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041130; Perc M, 2006, EUROPHYS LETT, V75, P841, DOI 10.1209/epl/i2006-10217-3; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/022; Perc M, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.022101; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Tanimoto J, 2007, BIOSYSTEMS, V90, P105, DOI 10.1016/j.biosystems.2006.07.005; Nowak AM, 2006, EVOLUTIONARY DYNAMIC; Ogasawara T, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/12/P12024; Shigaki K, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.031141; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Tanimoto J, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/05/P05003; Tanimoto J, 2014, PHYS REV E, V90, P8	15	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0779	1873-2887		CHAOS SOLITON FRACT	Chaos Solitons Fractals	NOV	2015	80				SI		24	30		10.1016/j.chaos.2015.02.025		7	Mathematics, Interdisciplinary Applications; Physics, Multidisciplinary; Physics, Mathematical	Mathematics; Physics	CV4XB	WOS:000364268700004		
J	Tanimoto, J				Tanimoto, Jun			Correlated asynchronous behavior updating with a mixed strategy system in spatial prisoner's dilemma games enhances cooperation	CHAOS SOLITONS & FRACTALS			English	Article								A new model of mixed strategy system for spatial prisoner's dilemma games is proposed. As an alternative to the typical mixed strategy system, wherein a behavior of either cooperation or defection is stochastically determined for each neighbor based on the agent's overall strategy, in our mixed strategy system, the agent instead correlates his strategies with those of his neighbors. For example, he tends to offer cooperation more frequently to his neighbor who is cooperative more often. This model provides results with significantly enhanced cooperation compared with those obtained with the conventional mixed strategy model. Interestingly, some of the evolutionary paths followed under strong dilemma situations can be divided into two specific periods: Defector-Enduring (D-END), when the number of defectors rapidly decreases, and the subsequent Defector-Expanding (D-EXP), when the surviving defectors' clusters start to expand, allowing the global cooperation fraction to fall to a lower level. The D-END and D-EXP periods seem analogous to the END and EXP periods presented by the author in previous studies. (C) 2015 Elsevier Ltd. All rights reserved.	Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan	Tanimoto, J (reprint author), Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan.				JSPS [25560165]; Tateishi Science and Technology Foundation	This study was supported by a Grant-in-Aid for Scientific Research by JSPS, awarded to Professor Tanimoto (#25560165). We also acknowledge the support of the Tateishi Science and Technology Foundation.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Miyaji K, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062149; Wang Z, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042145; Tanimoto J, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.022105; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Tanimoto J, 2007, BIOSYSTEMS, V90, P105, DOI 10.1016/j.biosystems.2006.07.005; Axelrod R., 1984, EVOLUTION COOPERATIO; Nowak AM, 2006, EVOLUTIONARY DYNAMIC; Shigaki K, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.031141; Smith M. J., 1982, EVOLUTION THEORY GAM; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Tanimoto J, 2014, MATH ANAL ENV SYSTEM; Tanimoto T, 2007, BIOSYSTEMS, V90, P728; Weibull JW, 1995, GAME THEORY; Zhong W, 2012, BIOSYSTEMS, V107, P89, DOI DOI 10.1016/J.BI0SYSTEMS.2011.10.001	17	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0779	1873-2887		CHAOS SOLITON FRACT	Chaos Solitons Fractals	NOV	2015	80				SI		39	46		10.1016/j.chaos.2015.03.021		8	Mathematics, Interdisciplinary Applications; Physics, Multidisciplinary; Physics, Mathematical	Mathematics; Physics	CV4XB	WOS:000364268700006		
J	Fukuda, E; Tanimoto, J; Akimoto, M				Fukuda, Eriko; Tanimoto, Jun; Akimoto, Mitsuhiro			Influence of breaking the symmetry between disease transmission and information propagation networks on stepwise decisions concerning vaccination	CHAOS SOLITONS & FRACTALS			English	Article							IMITATION DYNAMICS; SELF-INTEREST; BEHAVIOR; GAME; EPIDEMIOLOGY; IMPACT; POLICY	In previous epidemiological studies that address adaptive vaccination decisions, individuals generally act within a single network, which models the population structure. However, in reality, people are typically members of multiplex networks, which have various community structures. For example, a disease transmission network, which directly transmits infectious diseases, does not necessarily correspond with an information propagation network, in which individuals directly or indirectly exchange information concerning health conditions and vaccination strategies. The latter network may also be used for strategic interaction (strategy adaptation) concerning vaccination. Therefore, in order to reflect this feature, we consider the vaccination dynamics of structured populations whose members simultaneously belong to two types of networks: disease transmission and information propagation. Applying intensive numerical calculations, we determine that if the disease transmission network is modeled using a regular graph, such as a lattice population or random regular graph containing individuals of equivalent degrees, individuals should base their vaccination decisions on a different type of network. However, if the disease transmission network is a degree-heterogeneous graph, such as the Barabasi Albert scale-free network, which has a heterogeneous degree according to power low, then using the same network for information propagation more effectively prevents the spread of epidemics. Furthermore, our conclusions are unaffected by the relative cost of vaccination. (C) 2015 Elsevier Ltd. All rights reserved.	[Fukuda, Eriko; Tanimoto, Jun] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Akimoto, Mitsuhiro] Tokyo Univ Sci, Dept Elect Engn, Yamaguchi 7560884, Japan; [Akimoto, Mitsuhiro] Tokyo Univ Sci, Inst Liquid Crystal, Yamaguchi 7560884, Japan	Fukuda, E (reprint author), Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan.				JSPS, Japan [25560165]; Tateishi Science & Technology Foundation	This study was partially supported by a Grant-in-Aid for Scientific Research from JSPS, Japan, awarded to Professor Tanimoto (Grant no. 25560165), Tateishi Science & Technology Foundation. We would like to express our gratitude to these funding sources.	Anderson RM, 1991, INFECT DIS HUMANS DY; Galvani AP, 2007, P NATL ACAD SCI USA, V104, P5692, DOI 10.1073/pnas.0606774104; Wang L, 2014, CHINESE SCI BULL, V59, P3511, DOI 10.1007/s11434-014-0499-8; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Brisson M, 2003, MED DECIS MAKING, V23, P76, DOI 10.1177/0272989X02239651; Zhang GQ, 2013, CHAOS SOLITON FRACT, V51, P31, DOI 10.1016/j.chaos.2013.03.003; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Schimit PHT, 2011, ECOL MODEL, V222, P1651, DOI 10.1016/j.ecolmodel.2011.02.019; Basu S, 2008, P NATL ACAD SCI USA, V105, P19018, DOI 10.1073/pnas.0808114105; Bauch CT, 2007, VACCINE, V25, P8536, DOI 10.1016/j.vaccine.2007.10.001; Ohtsuki H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108106; Zhang HF, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012813; Bauch CT, 2005, P ROY SOC B-BIOL SCI, V272, P1669, DOI 10.1098/rspb.2005.3153; Tanimoto J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.032101; Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101; Wang Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021115; Wang Z, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052813; Wang L, 2013, INT J BIFURCAT CHAOS, V23, DOI 10.1142/S0218127413500958; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Liu XT, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.051132; Wang Z, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042145; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Fu F, 2011, P ROY SOC B-BIOL SCI, V278, P42, DOI 10.1098/rspb.2010.1107; Wang ZG, 2014, CHAOS SOLITON FRACT, V61, P1, DOI 10.1016/j.chaos.2014.01.004; Chapman GB, 1999, PREV MED, V29, P249, DOI 10.1006/pmed.1999.0535; Bauch CT, 2003, P NATL ACAD SCI USA, V100, P10564, DOI 10.1073/pnas.1731324100; Chapman GB, 2006, HEALTH PSYCHOL, V25, P82, DOI 10.1037/0278-6133.25.1.82; Traulsen A, 2007, J THEOR BIOL, V246, P522, DOI 10.1016/j.jtbi.2007.01.002; Isella L, 2011, J THEOR BIOL, V271, P166, DOI 10.1016/j.jtbi.2010.11.033; Ballobas B, 1985, RANDOM GRAPHS; Bauch CT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002452; Fukuda E, P 18 AS PAC S INT EV, V1, P1; Fukuda E, 2014, CHAOS SOLITON FRACT, V68, P1, DOI 10.1016/j.chaos.2014.07.004; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Jin Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep04095; Mbah MLN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002469; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Shigaki K, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.031141; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Vardavas R, 2007, PLOS COMPUT BIOL, V3, P796, DOI 10.1371/journal.pcbi.0030085; Wang L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01468; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021197; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Zhao DW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112018	44	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0779	1873-2887		CHAOS SOLITON FRACT	Chaos Solitons Fractals	NOV	2015	80				SI		47	55		10.1016/j.chaos.2015.04.018		9	Mathematics, Interdisciplinary Applications; Physics, Multidisciplinary; Physics, Mathematical	Mathematics; Physics	CV4XB	WOS:000364268700007		
J	Takeuchi, S; Kojima, T; Hashimoto, K; Saito, B; Sumi, H; Ishikawa, T; Ikeda, Y				Takeuchi, Shoko; Kojima, Takashi; Hashimoto, Kentaro; Saito, Bunnai; Sumi, Hiroyuki; Ishikawa, Tomoyasu; Ikeda, Yukihiro			Screening and Characterization of Hydrate Forms of T-3256336, a Novel Inhibitor of Apoptosis (IAP) Protein Antagonist	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						inhibitor of apoptosis (IAP) protein; T-3256336; hydrate; water activity	CRYSTALLIZING DRUG PHASE; PLUS WATER MIXTURES; ANHYDRATE/HYDRATE; THEOPHYLLINE	Different crystal packing of hydrates from anhydrate crystals leads to different physical properties, such as solubility and stability. Investigation of the potential of varied hydrate formation, and understanding the stability in an anhydrous/hydrate system, are crucial to prevent an undesired transition during the manufacturing process and storage. Only one anhydrous form of T-3256336, a novel inhibitor of apoptosis (IAP) protein antagonist, was discovered during synthesis, and no hydrate form has been identified. In this study, we conducted hydrate screening such as dynamic water vapor sorption/desorption (DVS), and the slurry experiment, and characterized the solid-state properties of anhydrous/hydrate forms to determine the most desirable crystalline form for development. New hydrate forms, both mono-hydrate and hemi-hydrate forms, were discovered as a result of this hydrate screening. The characterization of two new hydrate forms was conducted, and the anhydrous form was determined to be the most desirable development form of T-3256336 in terms of solid-state stability. In addition, the stability of the anhydrous form was investigated using the water content and temperature controlled slurry experiment to obtain the desirable crystal form in the crystallization process. The water content regions of the stable phase of the desired form, the anhydrous form, were identified for the cooling crystallization process.	[Takeuchi, Shoko; Kojima, Takashi; Ikeda, Yukihiro] Takeda Pharmaceut Co Ltd, CMC Ctr, Analyt Dev Labs, Fujisawa, Kanagawa 2518555, Japan; [Hashimoto, Kentaro; Saito, Bunnai; Sumi, Hiroyuki; Ishikawa, Tomoyasu] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa 2518555, Japan	Takeuchi, S (reprint author), Takeda Pharmaceut Co Ltd, CMC Ctr, Analyt Dev Labs, 2-26-1 Muraoka Higashi, Fujisawa, Kanagawa 2518555, Japan.	shoko.takeuchi@takeda.com					Zhu HJ, 1996, INT J PHARM, V139, P33, DOI 10.1016/0378-5173(96)04570-X; Giron D, 2002, J THERM ANAL CALORIM, V68, P453, DOI 10.1023/A:1016031517430; Ticehurst MD, 2002, INT J PHARM, V247, P1, DOI 10.1016/S0378-5173(02)00277-6; Krzyzaniak JF, 2007, J PHARM SCI-US, V96, P1270, DOI 10.1002/jps.20941; Variankaval N, 2007, ORG PROCESS RES DEV, V11, P229, DOI 10.1021/op600277t; [Anonymous], 1999, GENERATION POLYMORPH; Cui Y, 2008, J PHARM SCI-US, V97, P2730, DOI 10.1002/jps.21187; Hashimoto K, 2013, J MED CHEM, V56, P1228, DOI 10.1021/jm301674z; SHEFTER E, 1963, J PHARM SCI, V52, P781, DOI 10.1002/jps.2600520815; Roy S, 2012, CRYST GROWTH DES, V12, P2122, DOI 10.1021/cg300152p; Zhu HJ, 1996, INT J PHARM, V135, P151, DOI 10.1016/0378-5173(95)04466-3; KHANKARI RK, 1995, THERMOCHIM ACTA, V248, P61, DOI 10.1016/0040-6031(94)01952-D; Qu H, 2006, INT J PHARM, V321, P101, DOI 10.1016/j.ijpharm.2006.05.013; Golles F., 1961, MONATSH CHEM, V92, P981, DOI 10.1007/BF00924763; Grant D. J. W., 1990, SOLUBILITY BEHAV ORG, P22; Griesser U. J., 2006, IMPORTANCE SOLVATES, P211; HALEBLIAN JK, 1975, J PHARM SCI, V64, P1269, DOI 10.1002/jps.2600640805; Nyqvist H, 1983, INT J PHARM TECH PRO, V4, P47; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sokolova E. P., 1967, VESTN LENIN U FIZ KH, V3, P110; Stahl H. P., 1980, BETTER SAFETY DRUGS, P265	21	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	NOV	2015	63	11					858	865				8	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CV0AG	WOS:000363908300002		
J	Otoguro, S; Hayashi, Y; Miura, T; Uehara, N; Utsumi, S; Onuki, Y; Obata, Y; Takayama, K				Otoguro, Saori; Hayashi, Yoshihiro; Miura, Takahiro; Uehara, Naoto; Utsumi, Shunichi; Onuki, Yoshinori; Obata, Yasuko; Takayama, Kozo			Numerical Investigation of the Residual Stress Distribution of Flat-Faced and Convexly Curved Tablets Using the Finite Element Method	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						tablet shape; simulation; mathematical model; residual stress; finite element method; multiple linear regression	DENSITY DISTRIBUTIONS; DIAMETRICAL COMPRESSION; PHARMACEUTICAL POWDERS; MECHANICAL-BEHAVIOR; OPTIMAL FORMULATION; TENSILE FAILURE; DIE COMPACTION; BREAK FORCE; SIMULATION; MODEL	The stress distribution of tablets after compression was simulated using a finite element method, where the powder was defined by the Drucker-Prager cap model. The effect of tablet shape, identified by the surface curvature, on the residual stress distribution was investigated. In flat-faced tablets, weak positive shear stress remained from the top and bottom die walls toward the center of the tablet. In the case of the convexly curved tablet, strong positive shear stress remained on the upper side and in the intermediate part between the die wall and the center of the tablet. In the case of x-axial stress, negative values were observed for all tablets, suggesting that the x-axial force always acts from the die wall toward the center of the tablet. In the flat tablet, negative x-axial stress remained from the upper edge to the center bottom. The x-axial stress distribution differed between the flat and convexly curved tablets. Weak stress remained in the y-axial direction of the flat tablet, whereas an upward force remained at the center of the convexly curved tablet. By employing multiple linear regression analysis, the mechanical properties of the tablets were predicted accurately as functions of their residual stress distribution. However, the multiple linear regression prediction of the dissolution parameters of acetaminophen, used here as a model drug, was limited, suggesting that the dissolution of active ingredients is not a simple process; further investigation is needed to enable accurate predictions of dissolution parameters.	[Otoguro, Saori; Uehara, Naoto; Utsumi, Shunichi; Obata, Yasuko; Takayama, Kozo] Hoshi Univ, Dept Pharmaceut, Shinagawa Ku, Tokyo 1428501, Japan; [Hayashi, Yoshihiro; Onuki, Yoshinori] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Pharmaceut Technol, Toyama 9300194, Japan; [Miura, Takahiro] Cybernet Syst Co Ltd, Mech CAE Div, Tokyo 1010022, Japan	Takayama, K (reprint author), Hoshi Univ, Dept Pharmaceut, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.	takayama@hoshi.ac.jp			JSPS KAKENHI [26460047]	We thank Mr. Nobuto Okada, Ms. Haruka Nemoto, Ms. Sayaka Nogi, Ms. Yukiko Yokokura, and Ms. Eri Morii for their technical support and many useful discussions. This study was supported by JSPS KAKENHI Grant Number 26460047.	Sinka IC, 2007, KONA, V25, P4; Eiliazadeh B, 2003, PARTICUL SCI TECHNOL, V21, P303, DOI 10.1080/02726350390240124; Laity PR, 2009, POWDER TECHNOL, V192, P287, DOI 10.1016/j.powtec.2009.01.010; Mazel V, 2014, J PHARM SCI-US, V103, P1305, DOI 10.1002/jps.23898; Sinka IC, 2004, J PHARM SCI-US, V93, P2040, DOI 10.1002/jps.20111; Sinha T, 2010, POWDER TECHNOL, V198, P315, DOI 10.1016/j.powtec.2009.10.025; Djemai A, 2006, INT J PHARM, V319, P55, DOI 10.1016/j.ijpharm.2006.03.049; Diarra H, 2013, INT J PHARMACEUT, V453, P389, DOI 10.1016/j.ijpharm.2013.05.038; Han LH, 2008, INT J SOLIDS STRUCT, V45, P3088, DOI 10.1016/j.ijsolstr.2008.01.024; Sinha T, 2010, POWDER TECHNOL, V202, P46, DOI 10.1016/j.powtec.2010.04.001; Hayashi Y, 2013, J PHARM SCI-US, V102, P3678, DOI 10.1002/jps.23675; Wu CY, 2005, POWDER TECHNOL, V152, P107, DOI 10.1016/j.powtec.2005.01.010; Wu CY, 2008, POWDER TECHNOL, V181, P121, DOI 10.1016/j.powtec.2006.12.017; Cunningham JC, 2004, J PHARM SCI-US, V93, P2022, DOI 10.1002/jps.20110; Michrafy A, 2011, POWDER TECHNOL, V208, P417, DOI 10.1016/j.powtec.2010.08.037; PITT KG, 1988, J MATER SCI, V23, P2723, DOI 10.1007/BF00547442; Shang C, 2013, INT J PHARMACEUT, V442, P57, DOI 10.1016/j.ijpharm.2012.09.005; Podczeck F, 2013, INT J PHARMACEUT, V454, P412, DOI 10.1016/j.ijpharm.2013.06.069; Takayama K, 2003, ADV DRUG DELIVER REV, V55, P1217, DOI 10.1016/S0169-409X(03)00120-0; Arai H, 2007, CHEM PHARM BULL, V55, P586, DOI 10.1248/cpb.55.586; Shang C, 2013, INT J PHARMACEUT, V445, P99, DOI 10.1016/j.ijpharm.2013.01.032; Arai H, 2009, CHEM PHARM BULL, V57, P572; Duong Q. D., 2008, INT J PHARMACEUT, V351, P194; Podczeck F, 2014, INT J PHARMACEUT, V477, P306, DOI 10.1016/j.ijpharm.2014.10.028; Sato Hideaki, 2011, Journal of Computational Science and Technology, V5, DOI 10.1299/jcst.5.120	25	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	NOV	2015	63	11					890	900				11	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CV0AG	WOS:000363908300006		
J	Onuki, Y; Hasegawa, N; Horita, A; Ueno, N; Kida, C; Hayashi, Y; Obata, Y; Takayama, K				Onuki, Yoshinori; Hasegawa, Naoki; Horita, Akihiro; Ueno, Naomi; Kida, Chihiro; Hayashi, Yoshihiro; Obata, Yasuko; Takayama, Kozo			Self-organizing Map Analysis for Understanding Comprehensive Relationships between Formulation Variables, State of Water, and the Physical Stability of Pharmaceutical Emulsions	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						pharmaceutical emulsion; magnetic resonance imaging; physical stability; T-1 relaxation time; diffusion coefficient	PLATE SPLINE INTERPOLATION; MAGNETIC-RESONANCE; MULTIVARIATE DATA; P-GLYCOPROTEIN; INHIBITORS; TIME	The physical stability of pharmaceutical emulsions is an important quality attribute to be considered. To obtain a better understanding of this issue, this study investigated the contribution of the state of water to the physical stability of pharmaceutical emulsions. The key technology to evaluate the state of water was magnetic resonance imaging (MRI). For sample preparation, model emulsions with different formulation variables (surfactant content, water content, and hydrophilic lipophilic balance) were prepared. The T-1 relaxation time, diffusion coefficient, and viscosity were measured as physical properties. The physical stability of the samples was evaluated using apparent diffusion coefficient maps acquired by MRI. Data analysis of the observed data was performed using the nonlinear response surface method and Kohonen's self-organizing map (SOM). It was determined that, depending on the formulation variables, the state of water was substantially changed and it played a significant role in the physical stability. SOM analysis successfully classified the conditions of formulation variables into four distinct clusters in terms of the similarity of the physical properties of the resultant emulsions, and then clarified the characteristics of the stable emulsions. This study provided us with a comprehensive understanding of the formulation variables, physical properties, and stability concerning the preparation of the model emulsion.	[Onuki, Yoshinori; Hasegawa, Naoki; Kida, Chihiro; Hayashi, Yoshihiro; Obata, Yasuko; Takayama, Kozo] Hoshi Univ, Dept Pharmaceut, Shinagawa Ku, Tokyo 1428501, Japan; [Horita, Akihiro; Ueno, Naomi] Ikeda Mohando Co Ltd, Toyama 9300394, Japan	Onuki, Y (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Pharmaceut Technol, 2630 Sugitani, Toyama 9300194, Japan.	onuki@pha.u-toyama.ac.jp			Japan Society for the Promotion of Science [25460045]; Research Foundation for Pharmaceutical Sciences	This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (#25460045) and The Research Foundation for Pharmaceutical Sciences. We thank Mr. Koji Ito at Nikko Chemicals for a generous gift of POE behenyl ether (NIKKOL BB-20), sorbitan stearate (NIKKOL SS-10MV) and glyceryl triisooctanoate (NIKKOL Trifat S-308).	Kingsley PB, 1999, CONCEPT MAGNETIC RES, V11, P243, DOI 10.1002/(SICI)1099-0534(1999)11:4<243::AID-CMR5>3.0.CO;2-C; Schneider G, 2003, J COMB CHEM, V5, P233, DOI 10.1021/cc020092j; Wang YH, 2005, J CHEM INF MODEL, V45, P750, DOI 10.1021/ci050041k; WAYNE RC, 1966, PHYS REV, V151, P264, DOI 10.1103/PhysRev.151.264; Fleysher L, 2007, MAGN RESON MED, V57, P380, DOI 10.1002/mrm.21144; Tadros TF, 2004, ADV COLLOID INTERFAC, V108, P207, DOI 10.1016/j.cis.2003.10.024; Yilmaz A, 2008, MAGN RESON IMAGING, V26, P254, DOI 10.1016/j.mri.2007.05.008; Kaiser D, 2007, J MED CHEM, V50, P1698, DOI 10.1021/jm060604z; Onuki Y, 2012, J PHARM SCI-US, V101, P2372, DOI 10.1002/jps.23134; Yasuda A, 2013, CHEM PHARM BULL, V61, P304; Onuki Y, 2014, DRUG DEV IND PHARM, V40, P937, DOI 10.3109/03639045.2013.790903; Yasuda A, 2010, J PHARM SCI-US, V99, P4535, DOI 10.1002/jps.22155; Kikuchi S, 2011, J PHARM SCI-US, V100, P964, DOI 10.1002/jps.22340; Nishikawa M, 2011, CHEM PHARM BULL, V59, P332, DOI 10.1248/cpb.59.332; Hessien M, 2011, LANGMUIR, V27, P2299, DOI 10.1021/la104728r; Aulton M. E., 2013, AULTONS PHARM DESIGN; Kohonen T., 1995, SPRINGER SERIES INFO; MACEDO J.P.F., 2006, AAPS PHARMSCITECH, V7, P7; Napper D. H., 1983, POLYM STABILIZATION; Onuki Y, 2014, J PHARM SCI-US, V103, P3532, DOI 10.1002/jps.24140; ROBERTSO.B, 1966, PHYS REV, V151, P273, DOI 10.1103/PhysRev.151.273; Wahba G., 1990, SOC IND APPL MATH	22	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	NOV	2015	63	11					901	906				6	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CV0AG	WOS:000363908300007		
J	Fuchi, Y; Sasaki, S				Fuchi, Yasufumi; Sasaki, Shigeki			New NitroG-Grasp Molecules with Enhanced Capture Reactivity for 8-Nitroguanosine in the Aqueous Media	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						8-nitroguanosine; covalent capture; recognition molecule; 1,3-diazaphenoxazine nucleoside	PROTEIN S-GUANYLATION; DNA-DAMAGE; PROBES; 8-OXOGUANOSINE; 8-OXOG-CLAMP; INFLAMMATION; BIOMARKER	8-Nitroguanosine is formed by the nitration of guanosine, and has been conventionally classified as a genotoxic material. Recently, 8-nitroguanosine 3',5'-cyclic monophosphate (8-nitro-cGMP) has become of great interest due to its biological role as an intracellular signaling molecule. In an attempt to develop recognition molecules for 8-nitroguanosine, we have determined a 1,3-diazaphenoxazine nucleoside derivative (nitroG-grasp) bearing a thiol group with a urea linker, which efficiently displaces the nitro group through the formation of multiple hydrogen-bonded complexes with 8-nitroguanosine. However, a drawback of this capture molecule was that the displacement efficiency was not sufficient to capture 8-nitroguanosine in water. Taking into account that both the flexibility of the linker and the pK(a) value of the thiol group are determinants of the reactivity, new nitroG-grasp molecules were designed to have a fixed linker structure with different pK(a) values. Compared to the previous nitroG-grasp, the new compounds with the (2-aminophenyl)-methanethiol or the propylene acetal of 3-amino-1-mercaptopropan-2-one unit have exhibited more than 10-100 times faster reactivity in the aqueous media. These compounds may be potential components to construct new nitroG-grasp molecules to capture 8-nitro-cGMP in the biological systems.	[Fuchi, Yasufumi; Sasaki, Shigeki] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 8128582, Japan	Sasaki, S (reprint author), Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	sasaki@phar.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [15H04633, 26670004]; JSPS [15K18831]	We are grateful for the support provided by a Grant-in-Aid for Scientific Research (B) (No. 15H04633) and a Grant-in-Aid for Challenging Exploratory Research (No. 26670004) from the Japan Society for the Promotion of Science (JSPS). Y.F. also acknowledges a Grant-in-Aid for Young Scientists (B) (No. 15K18831) from JSPS.	Akaike T, 2003, P NATL ACAD SCI USA, V100, P685, DOI 10.1073/pnas.0235623100; Sawa T, 2007, NAT CHEM BIOL, V3, P727, DOI 10.1038/nchembio.2007.33; Fuchi Y, 2014, ORG LETT, V16, P1760, DOI 10.1021/ol500452r; Masuda M, 2002, CHEM-BIOL INTERACT, V139, P187, DOI 10.1016/S0009-2797(01)00299-X; Loft S, 2012, ARCH BIOCHEM BIOPHYS, V518, P142, DOI 10.1016/j.abb.2011.12.026; Ahmed KA, 2011, AMINO ACIDS, V41, P123, DOI 10.1007/s00726-010-0535-1; Asahi T, 2010, J BIOL CHEM, V285, P9282, DOI 10.1074/jbc.M109.054213; Um IH, 2013, J ORG CHEM, V78, P5604, DOI 10.1021/jo4007442; Miller BJ, 2010, J PHYS CHEM A, V114, P12692, DOI 10.1021/jp9112798; Dobrota C, 2012, CHEMBIOCHEM, V13, P80, DOI 10.1002/cbic.201100645; Nasr T, 2009, BIOORG MED CHEM LETT, V19, P727, DOI 10.1016/j.bmcl.2008.12.036; Sassa A, 2013, MUTAGENESIS, V28, P81, DOI 10.1093/mutage/ges056; Saito Y, 2013, CHEMBIOCHEM, V14, P1068, DOI 10.1002/cbic.201300129; Yoshitake J, 2004, J VIROL, V78, P8709, DOI 10.1128/JVI.78.16.8709-8719.2004; YERMILOV V, 1995, FEBS LETT, V376, P207, DOI 10.1016/0014-5793(95)01281-6; Bhamra I, 2012, NUCLEIC ACIDS RES, V40, P11126, DOI 10.1093/nar/gks799; HOLMES RE, 1964, J AM CHEM SOC, V86, P1242, DOI 10.1021/ja01060a057; Fuchi Y, 2015, MOLECULES, V20, P1078, DOI 10.3390/molecules20011078; Hiraku Y., 2009, ENV HLTH PREV MED, V2009, P63; Jena NR, 2012, J BIOSCIENCES, V37, P503, DOI 10.1007/s12038-012-9218-2; Li ZC, 2010, BIOORGAN MED CHEM, V18, P3992, DOI 10.1016/j.bmc.2010.04.025; Nakagawa O, 2007, ANGEW CHEM INT EDIT, V46, P4500, DOI 10.1002/anie.200700671; Nakagawa O, 2007, NUCLEOS NUCLEOT NUCL, V26, P645, DOI 10.1080/15257770701490498; Saito Y, 2008, CHEM COMMUN, P5984, DOI 10.1039/b810771h; Sawa T, 2013, NITRIC OXIDE-BIOL CH, V34, P10, DOI 10.1016/j.niox.2013.04.004; Sawa T, 2006, NITRIC OXIDE-BIOL CH, V14, P91, DOI 10.1016/j.niox.2005.06.005	26	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	NOV	2015	63	11					913	919				7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CV0AG	WOS:000363908300009		
J	Taniguchi, Y; Tomizaki, A; Matsueda, N; Okamura, H; Sasaki, S				Taniguchi, Yosuke; Tomizaki, Akira; Matsueda, Nozomu; Okamura, Hidenori; Sasaki, Shigeki			Enhancement of TFO Triplex Formation by Conjugation with Pyrene via Click Chemistry	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						triplex-forming oligonucleotide; artificial nucleoside; antigene	CG INTERRUPTING SITE; INTERCALATING NUCLEIC-ACIDS; ANTI-PARALLEL TRIPLEX; FORMING OLIGONUCLEOTIDES; SELECTIVE RECOGNITION; NUCLEOSIDE ANALOGS; WNA DERIVATIVES; DNA; BASE; EFFICIENT	This paper reports the preparation of 14-mer triplex-forming oligonucleotides (TFOs) containing a 2-O-methyl-1-beta-phenyl-alpha-propargyl-ribose unit, which was conjugated with azide-modified molecules via a click reaction. Modification of these TFOs with pyrene assisted triplex formation, improving the stability of the triplex DNA and the anti-proliferative effects against A549 cells.	[Taniguchi, Yosuke; Tomizaki, Akira; Matsueda, Nozomu; Okamura, Hidenori; Sasaki, Shigeki] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 8128582, Japan	Taniguchi, Y (reprint author), Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	taniguch@phar.kyushu-u.ac.jp; sasaki@phar.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [15H04633, 24689006, 26670056, 13J04516]; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan	This study was supported by a Grant-in-Aid Scientific Research (B) (Grant No. 15H04633 for S.S), a Grand-in-Aid for Young Scientific (A) (Grant No. 24689006 for Y.T.), a Challenging Exploratory Research (Grant No. 26670056 for Y.T.) and a Grant-in-Aid for JSPS Fellows (Grant No. 13J04516 for H.O.) from the Japan Society for the Promotion of Science (JSPS). This work was supported by Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Shen CX, 2003, CANCER GENE THER, V10, P403, DOI 10.1038/sj.cgt.7700581; BEAL PA, 1992, NUCLEIC ACIDS RES, V20, P2773, DOI 10.1093/nar/20.11.2773; Semenyuk A, 2010, BIOCHEMISTRY-US, V49, P7867, DOI 10.1021/bi100797z; Robles J, 1997, J AM CHEM SOC, V119, P6014, DOI 10.1021/ja963694d; Klysik J, 1997, BIOCONJUGATE CHEM, V8, P318, DOI 10.1021/bc970017f; Lallana E, 2011, ANGEW CHEM INT EDIT, V50, P8794, DOI 10.1002/anie.201101019; Buchini S, 2003, CURR OPIN CHEM BIOL, V7, P717, DOI 10.1016/j.cbpa.2003.10.007; Doluca O, 2011, CHEMBIOCHEM, V12, P2365, DOI 10.1002/cbic.201100354; Taniguchi Y, 2008, TETRAHEDRON, V64, P7164, DOI 10.1016/j.tet.2008.05.096; Sasaki S, 2004, J AM CHEM SOC, V126, P516, DOI 10.1021/ja037211z; Taniguchi Y, 2012, ORG BIOMOL CHEM, V10, P8336, DOI 10.1039/c2ob26431e; Okamura H, 2013, ORG BIOMOL CHEM, V11, P3918, DOI 10.1039/c3ob40472b; Taniguchi Y, 2009, BIOORGAN MED CHEM, V17, P6803, DOI 10.1016/j.bmc.2009.08.040; Bag SS, 2012, TETRAHEDRON LETT, V53, P5875, DOI 10.1016/j.tetlet.2012.08.074; Paramasivam M, 2008, NUCLEIC ACIDS RES, V36, P3494, DOI 10.1093/nar/gkn242; Aoki E, 2012, CHEMBIOCHEM, V13, P1152, DOI 10.1002/cbic.201200066; Brun MA, 2012, J AM CHEM SOC, V134, P7676, DOI 10.1021/ja3002277; Taniguchi Y, 2006, J ORG CHEM, V71, P2115, DOI 10.1021/jo052413u; Taniguchi Y, 2013, TETRAHEDRON, V69, P600, DOI 10.1016/j.tet.2012.11.016; BEAL PA, 1991, SCIENCE, V251, P1360, DOI 10.1126/science.2003222; Mukherjee A, 2011, BIOCHIMIE, V93, P1197, DOI 10.1016/j.biochi.2011.04.001; Nasr T, 2012, NUCLEOS NUCLEOT NUCL, V31, P841, DOI 10.1080/15257770.2012.737970; Rusling DA, 2005, NUCLEIC ACIDS RES, V33, P3025, DOI 10.1093/nar.gki625; Ohkubo A, 2015, NUCLEIC ACIDS RES, V43, P5675, DOI 10.1093/nar/gkv496; Barral K, 2007, ORG LETT, V9, P1809, DOI 10.1021/ol070527h; Muller MK, 2009, ANGEW CHEM INT EDIT, V48, P2921, DOI 10.1002/anie.200900143; Okamura H, 2014, CHEMBIOCHEM, V15, P2374, DOI 10.1002/cbic.201402328; Goddard-Borger ED, 2007, ORG LETT, V9, P3797, DOI 10.1021/ol701581g; Hari Y, 2012, EUR J ORG CHEM, P2875, DOI 10.1002/ejoc.201101821; Loren JC, 2005, SYNLETT, P2847, DOI 10.1055/s-2005-918944; Rogers Faye A., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P319, DOI 10.2174/1568011054222300	31	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	NOV	2015	63	11					920	926				7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CV0AG	WOS:000363908300010		
J	Mibu, N; Yokomizo, K; Aki, H; Ota, N; Fujii, H; Yuzuriha, A; Saneyoshi, S; Tanaka, A; Koga, A; Zhou, JR; Miyata, T; Sumoto, K				Mibu, Nobuko; Yokomizo, Kazumi; Aki, Hatsumi; Ota, Norimasa; Fujii, Hiroyuki; Yuzuriha, Ai; Saneyoshi, Shiori; Tanaka, Aoi; Koga, Airi; Zhou, Jianrong; Miyata, Takeshi; Sumoto, Kunihiro			Synthesis and Antiviral Evaluation of Some C-3-Symmetrical Trialkoxy-Substituted 1,3,5-Triazines and Their Molecular Geometry	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						1,3,5-triazine; C-3 symmetry; anti-herpes simplex virus type 1; structure-activity relationship; plaque reduction assay; isothermal titration calorimetry	TRIS(2-AMINOETHYL)AMINE DERIVATIVES; BIOLOGICAL-ACTIVITIES; RECOGNITION; GLYCOCALYX; RECEPTORS; SYMMETRY; AFFINITY; DRUGS	As one of our projects, we here report some new molecular modifications of 2,4,6-trichloro-1,3,5-triazine (TCTAZ: 1) to symmetrical 2,4,6-trialkoxy- or 2,4,6-triaryloxy-substituted 1,3,5-triazine (TAZ) molecules, as well as the results of anti-herpes simplex virus type 1 (anti-HSV-1) activity evaluation of synthesized 2,4,6-trisubstituted TAZ derivatives. Among the tested 2,4,6-trisubstituted TAZ derivatives, we reconfirmed that a C-3-symmetrical TAZ derivative, 4e, shows the highest level of anti-HSV-1 activity with a good selectivity index. In this paper, we also report the results of the preparation of newly targeted TAZ derivatives and the structure-activity relationships (SARs) of these trialkoxy-substituted TAZ derivatives and related compounds. The sugar recognition properties of C-3-symmetrical TAZ derivative 4e are also described.	[Mibu, Nobuko; Aki, Hatsumi; Ota, Norimasa; Fujii, Hiroyuki; Yuzuriha, Ai; Koga, Airi; Sumoto, Kunihiro] Fukuoka Univ, Fac Pharmaceut Sci, Jonan Ku, Fukuoka 8140180, Japan; [Yokomizo, Kazumi; Saneyoshi, Shiori; Tanaka, Aoi; Zhou, Jianrong; Miyata, Takeshi] Sojo Univ, Fac Pharmaceut Sci, Kumamoto 8620082, Japan	Sumoto, K (reprint author), Fukuoka Univ, Fac Pharmaceut Sci, Jonan Ku, Fukuoka 8140180, Japan.	kunihiro@adm.fukuoka-u.ac.jp					SPIELMAN MA, 1951, J AM CHEM SOC, V73, P1775, DOI 10.1021/ja01148a101; Mibu N, 2011, HETEROCYCLES, V83, P385, DOI 10.3987/COM-10-12105; Fujisaki F, 2011, HETEROCYCLES, V83, P1843, DOI 10.3987/COM-11-12218; Ikeda T, 2005, BIOL PHARM BULL, V28, P1779, DOI 10.1248/bpb.28.1779; Fujisaki F, 2013, J HETEROCYCLIC CHEM, V50, P417, DOI 10.1002/jhet.1522; Oshovsky GV, 2007, ANGEW CHEM INT EDIT, V46, P2366, DOI 10.1002/anie.200602815; KOPPES WM, 1981, J ORG CHEM, V46, P406, DOI 10.1021/jo00315a034; Humblet V, 2009, J MED CHEM, V52, P544, DOI 10.1021/jm801033c; Kolesinska B, 2009, TETRAHEDRON, V65, P3573, DOI 10.1016/j.tet.2009.03.017; Mibu N, 2008, CHEM PHARM BULL, V56, P1052, DOI 10.1248/cpb.56.1052; Fujisaki F, 2013, HETEROCYCLES, V87, P665, DOI 10.3987/COM-12-12654; Mibu N, 2013, CHEM PHARM BULL, V61, P823; Kim HJ, 2001, TETRAHEDRON LETT, V42, P5049, DOI 10.1016/S0040-4039(01)00915-7; Fujisaki F, 2014, CHEM PHARM BULL, V62, P429; Mibu N, 2012, CHEM PHARM BULL, V60, P408; Sansone F, 2013, CHEM SOC REV, V42, P4623, DOI 10.1039/c2cs35437c; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Gibson SE, 2006, ANGEW CHEM INT EDIT, V45, P4718, DOI 10.1002/anie.200600776; Mibu N, 2013, J THERM ANAL CALORIM, V113, P1015, DOI 10.1007/s10973-012-2813-5; Mazik M, 2010, J ORG CHEM, V75, P6416, DOI 10.1021/jo100982x; Moberg C, 2006, ANGEW CHEM INT EDIT, V45, P4721, DOI 10.1002/anie.200601214; SCHINAZI RF, 1982, ANTIMICROB AGENTS CH, V22, P499; Camille G. W., 2008, PRACTICE MED CHEM; Ishii Y., 2007, [No title captured], Patent No. [WO 2007105482, 2007105482]; Mibu N, 2014, CHEM PHARM BULL, V62, P1032; Pearlman Wm M., 1940, J AM CHEM SOC, V71, P1128; Varki A., 2009, ESSENTIALS GLYCOBIOL, P719	27	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	NOV	2015	63	11					935	944				10	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CV0AG	WOS:000363908300012		
J	Zhang, M; Wada, S; Amemiya, F; Watanabe, T; Shibasaki, M				Zhang, Ming; Wada, Shun-ichi; Amemiya, Fuyuki; Watanabe, Takumi; Shibasaki, Masakatsu			Synthesis and Determination of Absolute Configuration of Lentztrehalose A	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						trehalose; natural product synthesis; autophagy-inducing activity; stereochemistry determination		The synthesis of lentztrehalose A, a naturally occurring trehalose derivative exhibiting various biological activities including autophagy-inducing activity, was achieved. The synthesis commenced with the selective protection of hydroxyl groups of commercially available trehalose, followed by the introduction of the side chain moiety by two methods: 1) prenylation and successive diastereoselective dihydroxylation; or 2) etherification by opening of the chiral epoxide. The present synthetic study clarified the unreported absolute configuration of the secondary alcohol part in the side chain portion.	[Zhang, Ming; Wada, Shun-ichi; Amemiya, Fuyuki; Watanabe, Takumi; Shibasaki, Masakatsu] Inst Microbial Chem BIKAKEN, Shinagawa Ku, Tokyo 1410021, Japan	Watanabe, T (reprint author), Inst Microbial Chem BIKAKEN, Shinagawa Ku, 3-14-23 Kamiosaki, Tokyo 1410021, Japan.	twatanabe@bikaken.or.jp; mshibasa@bikaken.or.jp					Nishizaki Y, 2000, NUTR RES, V20, P653, DOI 10.1016/S0271-5317(00)00155-X; Arai C, 2010, NUTR RES, V30, P840, DOI 10.1016/j.nutres.2010.10.009; Olivares-Romero JL, 2013, J AM CHEM SOC, V135, P3411, DOI 10.1021/ja401182a; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; Ohtake S, 2011, J PHARM SCI-US, V100, P2020, DOI 10.1002/jps.22458; Chrti F., 2006, ANNU REV BIOCHEM, V75, P333; Ukawa Y., 2005, Journal of Applied Glycoscience, V52, P367; Wada S, 2014, J ANTIBIOT, V67, P319, DOI 10.1038/ja.2013.143; Wada S, 2015, J ANTIBIOT, V68, P521, DOI 10.1038/ja.2015.23	9	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	NOV	2015	63	11					961	966				6	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CV0AG	WOS:000363908300016		
J	Manatsa, D; Matarira, C; Mushore, TD; Mudavanhu, C				Manatsa, Desmond; Matarira, Caxton; Mushore, Terrence D.; Mudavanhu, Chipo			Southern Africa winter temperature shifts and their link to the Southern Annular Mode	CLIMATE DYNAMICS			English	Article						Southern Africa minimum temperatures; Southern Annular Mode; Mascarene High; Shifts	NORTH PACIFIC; REGIME SHIFTS; PART I; VARIABILITY; CIRCULATION; TRENDS; PRECIPITATION; HEMISPHERE; REANALYSES; RADIOSONDE	The main characteristics of spatial and temporal variability of the winter (June-August) observed surface air minimum temperature (SAMT) of southern Africa (Africa south of the equator) were examined from 1960 to 2011. The empirical orthogonal function (EOF) analysis was used to extract the dominant mode of SAMT variability. Statistically significant shifts were detected in both the index derived from the spatially averaged regional SAMT and its EOF1 time coefficients. These discontinuities displayed a sharp rise followed by an abrupt drop during the periods around 1988 and 2007 respectively. The years corresponded to change points in the Southern Annular Mode index where the 1988 significant alteration to a relatively more positive index polarity was followed by a sudden weakening during the latter shift. The development of the warm phase coincided with the decoupling of SAM from SAMT. This occurred when the strengthening of the western ridge of the Mascarene High appeared to be coupled to the creation of anomalously low pressure systems over Angola and the region pole-ward of South Africa. In this epoch, the meridional wind over southern Africa reversed to become predominantly northerly and hence was symptomatic of warm temperature advection from the lower latitudes. However the post 2007 era, though still of indeterminate length, is characterized by a partial return to the pre-1988 circulation conditions. This implies that the impacts of SAM's epochal alterations have implications not only for the current climate, but also for the interpretation of climate change over southern Africa.	[Manatsa, Desmond; Matarira, Caxton; Mushore, Terrence D.; Mudavanhu, Chipo] Bindura Univ Sci, Dept Geog, Bindura, Zimbabwe; [Manatsa, Desmond] Univ Tokyo, Dept Ocean Technol Policy & Environm, Tokyo, Japan; [Manatsa, Desmond] Abdus Salaam Int Ctr Theoret Phys, I-34151 Trieste, Italy	Manatsa, D (reprint author), Bindura Univ Sci, Dept Geog, Bindura, Zimbabwe.	dmanatsa@gmail.com			Bindura University of Science	The authors wish to thank Bindura University of Science for the partial funding of this work. The climate explorer website is thanked for providing the platform on which the figures were constructed. This work was presented at the Earth Temp Network and Global Temp User Consultation Workshop, University of KIT, Karlsruhe, Germany, in June 2014. The principal author is very grateful for the constructive criticisms from the workshop participants especially the emphasis from Prof Chris Merchant from University of Reading to publish the results.	Figura S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049749; Kushner PJ, 2001, J CLIMATE, V14, P2238, DOI 10.1175/1520-0442(2001)014<0001:SHACRT>2.0.CO;2; Xue F, 2003, CHINESE SCI BULL, V48, P492, DOI 10.1360/03tb9104; Tennant W, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019751; Peterson TC, 1998, J GEOPHYS RES-ATMOS, V103, P25967, DOI 10.1029/98JD01168; NORTH GR, 1982, MON WEATHER REV, V110, P699, DOI 10.1175/1520-0493(1982)110<0699:SEITEO>2.0.CO;2; Christy JR, 2009, J CLIMATE, V22, P3342, DOI 10.1175/2008JCLI2726.1; Marshall GJ, 2002, J CLIMATE, V15, P659, DOI 10.1175/1520-0442(2002)015<0659:TIAGHA>2.0.CO;2; CHENG XH, 1995, J CLIMATE, V8, P1709, DOI 10.1175/1520-0442(1995)008<1709:ROLFCP>2.0.CO;2; Marshall GJ, 2003, J CLIMATE, V16, P4134, DOI 10.1175/1520-0442(2003)016<4134:TITSAM>2.0.CO;2; Kruger AC, 2004, INT J CLIMATOL, V24, P1929, DOI 10.1002/joc.1096; Kang SM, 2011, SCIENCE, V332, P951, DOI 10.1126/science.1202131; Shongwe ME, 2009, J CLIMATE, V22, P3819, DOI 10.1175/2009JCLI2317.1; Manatsa D, 2013, J CLIMATE, V26, P5655, DOI 10.1175/JCLI-D-12-00568.1; Overland J, 2008, PROG OCEANOGR, V77, P92, DOI 10.1016/j.pocean.2008.03.016; IBANEZ F, 1993, CR ACAD SCI III-VIE, V316, P745; Nicholson SE, 2001, CLIM RES, V17, P123, DOI 10.3354/cr017123; Grimwade K, 2004, AIDS, V18, P547, DOI 10.1097/01.aids.0000096909.73209.14; Gillett NP, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027721; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Karpechko AY, 2009, J CLIMATE, V22, P3751, DOI 10.1175/2009JCLI2788.1; Thompson DWJ, 2000, J CLIMATE, V13, P1000, DOI 10.1175/1520-0442(2000)013<1000:AMITEC>2.0.CO;2; Breaker LC, 2007, CONT SHELF RES, V27, P2250, DOI 10.1016/j.csr.2007.05.018; [Anonymous], 2006, GEOPHYS RES LETT, DOI DOI 10.1029/2006GL025904; KAWAMURA R, 1994, J PHYS OCEANOGR, V24, P707, DOI 10.1175/1520-0485(1994)024<0707:AREAOG>2.0.CO;2; Zhang RH, 1998, NATURE, V391, P879, DOI 10.1038/36081; Manatsa D, 2013, NAT GEOSCI, V6, P934, DOI [10.1038/ngeo1968, 10.1038/NGEO1968]; Collins JM, 2011, J CLIMATE, V24, P3649, DOI 10.1175/2011JCLI3753.1; Lanzante JR, 1996, INT J CLIMATOL, V16, P1197, DOI 10.1002/(SICI)1097-0088(199611)16:11<1197::AID-JOC89>3.0.CO;2-L; Fogt RL, 2006, J CLIMATE, V19, P979, DOI 10.1175/JCLI3671.1; Reason C. J. C., 2005, Geophysical Research Letters, V32, DOI 10.1029/2005GL022419; Arntzen J, 1996, CLIMATE CHANGE SO AF; BUISHAND TA, 1982, J HYDROL, V58, P11, DOI 10.1016/0022-1694(82)90066-X; Cattell R. B., 1966, MULTIVARIATE BEHAV R, V1, P629; Laat A. T. J. de, 2013, Atmospheric and Climate Sciences, V3, P291, DOI 10.4236/acs.2013.33031; Dionne G, 2009, CAHIERS DU CIRPEE; DWASS M, 1957, ANN MATH STAT, V28, P181, DOI 10.1214/aoms/1177707045; IFFN, 2000, IFFN, V22, P69; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Manatsa D, 2014, CLIM DYNAM, V42, P1259, DOI 10.1007/s00382-013-1848-z; OneWorld, 2010, INT CLIM CHANG FOOD; Rodionov SN, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019448; Tyson P. D., 2000, WEATHER CLIMATE SO A	43	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-7575	1432-0894		CLIM DYNAM	Clim. Dyn.	NOV	2015	45	9-10					2337	2350		10.1007/s00382-015-2474-8		14	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CV0PE	WOS:000363952100004		
J	Kumar, AB; Masi, S; Ghomashchi, F; Chennamaneni, NK; Ito, M; Scott, CR; Turecek, F; Gelb, MH; Spacil, Z				Kumar, Arun Babu; Masi, Sophia; Ghomashchi, Farideh; Chennamaneni, Naveen Kumar; Ito, Makoto; Scott, C. Ronald; Turecek, Frantisek; Gelb, Michael H.; Spacil, Zdenek			Tandem Mass Spectrometry Has a Larger Analytical Range than Fluorescence Assays of Lysosomal Enzymes: Application to Newborn Screening and Diagnosis of Mucopolysaccharidoses Types II, IVA, and VI	CLINICAL CHEMISTRY			English	Article							DRIED BLOOD SPOTS; STORAGE DISEASES; FILTER-PAPER; MORQUIO; SAMPLES; FABRY	BACKGROUND: There is interest in newborn screening and diagnosis of lysosomal storage diseases because of the development of treatment options that improve clinical outcome. Assays of lysosomal enzymes with high analytical range (ratio of assay response from the enzymatic reaction divided by the assay response due to nonenzymatic processes) are desirable because they are predicted to lead to a lower rate of false positives in population screening and to more accurate diagnoses. METHODS: We designed new tandem mass spectrometry (MS/MS) assays that give the largest analytical ranges reported to date for the use of dried blood spots (DBS) for detection of mucopolysaccharidoses type II (MPS-II), MPS-IVA, and MPS-VI. For comparison, we carried out fluorometric assays of 6 lysosomal enzymes using 4-methylumbelliferyl (4MU)-substrate conjugates. RESULTS: The MS/MS assays for MPS-II, -IVA, and -VI displayed analytical ranges that are 1-2 orders of magnitude higher than those for the corresponding fluorometric assays. The relatively small analytical ranges of the 4MU assays are due to the intrinsic fluorescence of the 4MU substrates, which cause high background in the assay response. CONCLUSIONS: These highly reproducible MS/MS assays for MPS-II, -IVA, and -VI can support multiplex newborn screening of these lysosomal storage diseases. MS/MS assays of lysosomal enzymes outperform 4MU fluorometric assays in terms of analytical range. Ongoing pilot studies will allow us to gauge the impact of the increased analytical range on newborn screening performance. (C) 2015 American Association for Clinical Chemistry	[Kumar, Arun Babu; Masi, Sophia; Ghomashchi, Farideh; Chennamaneni, Naveen Kumar; Turecek, Frantisek; Gelb, Michael H.; Spacil, Zdenek] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Scott, C. Ronald] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Ito, Makoto] Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 812, Japan	Gelb, MH (reprint author), Univ Washington, Dept Chem, Campus Box 351700, Seattle, WA 98195 USA.	gelb@chem.washington.edu; spacil@u.washington.edu	Spacil, Zdenek/N-3515-2015	Spacil, Zdenek/0000-0002-7505-4332	BioMarin Pharmaceuticals; National Institutes of Health [R01 DK067859]; Schire Corp	Schire Corp and research contract from BioMarin Pharmaceuticals; S. Masi, National Institutes of Health (R01 DK067859)	Boustany RMN, 2013, NAT REV NEUROL, V9, P583, DOI 10.1038/nrneurol.2013.163; Civallero G, 2006, CLIN CHIM ACTA, V372, P98, DOI 10.1016/j.cca.2006.03.029; Tan MAF, 2008, CLIN CHEM, V54, P1925, DOI 10.1373/clinchem.2008.108456; Camelier MV, 2011, CLIN CHIM ACTA, V412, P1805, DOI 10.1016/j.cca.2011.06.001; Kim EJ, 2006, J AM CHEM SOC, V128, P4234, DOI 10.1021/ja0582915; BAYLERAN J, 1984, CLIN CHIM ACTA, V143, P73, DOI 10.1016/0009-8981(84)90215-8; Schweighardt B, 2015, CLIN THER, V37, P1012, DOI 10.1016/j.clinthera.2014.11.005; Spacil Z, 2013, CLIN CHEM, V59, P502, DOI 10.1373/clinchem.2012.189936; Chennamaneni NK, 2014, ANAL CHEM, V86, P4508, DOI 10.1021/ac5004135; JENNINGS HJ, 1980, CAN J CHEM, V58, P2610, DOI 10.1139/v80-417; Sumida T, 2011, J BIOL CHEM, V286, P14065, DOI 10.1074/jbc.M110.182592; Chamoles NA, 2001, CLIN CHIM ACTA, V308, P195, DOI 10.1016/S0009-8981(01)00478-8; Khaliq T, 2011, CLIN CHEM, V57, P128, DOI 10.1373/clinchem.2010.149880; VANDIGGELEN OP, 1990, CLIN CHIM ACTA, V187, P131, DOI 10.1016/0009-8981(90)90339-T; Duffey TA, 2010, ANAL CHEM, V82, P9587, DOI 10.1021/ac102090v; Scott CR, 2013, J PEDIATR-US, V163, P498, DOI 10.1016/j.jpeds.2013.01.031; Mechtler TP, 2012, LANCET, V379, P335, DOI 10.1016/S0140-6736(11)61266-X; Spacil Z, 2011, J MASS SPECTROM, V46, P1089, DOI 10.1002/jms.1993; Chen RF, 1968, ANNAL LETT, V1, P423; Gelb MH, 2014, CLIN CHEM, V61, P335; Hopkins P, 2014, 2014 NEWB SCREEN GEN; Kumar AB, CLIN CHIM ACTA; Scriver CR, 2001, METABOLIC MOL BASIS; Ullal A.J., 2014, MOL GENET METAB REP, V1, P465; Voznyi W, 2001, J INHERIT METAB DIS, V24, P675	25	0	0	AMER ASSOC CLINICAL CHEMISTRY	WASHINGTON	2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526 USA	0009-9147	1530-8561		CLIN CHEM	Clin. Chem.	NOV	2015	61	11					1363	1371		10.1373/clinchem.2015.242560		9	Medical Laboratory Technology	Medical Laboratory Technology	CV2UH	WOS:000364112200009		
J	Akiyama, T; Tada, H; Shiokawa, T; Kobayashi, K; Yoshinaga, H				Akiyama, Tomoyuki; Tada, Hiroko; Shiokawa, Tsugumi; Kobayashi, Katsuhiro; Yoshinaga, Harumi			Total folate and 5-methyltetrahydrofolate in the cerebrospinal fluid of children: correlation and reference values	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						folate transport; liquid chromatography-tandem mass spectrometry; 5-methyltetrahydrofolate; reference value; total folate	DEFICIENCY; POPULATION; ASSAY; SERUM; ACID	Background: Cerebral folate deficiency (CFD) may be underdiagnosed, as it manifests with various non-specific neurological symptoms. The diagnosis of CFD requires a determination of 5-methyltetrahydrofolate (5MTHF) in the cerebrospinal fluid (CSF), which is available in a limited number of specialized laboratories. In clinical biochemistry laboratories, total folate (TF) determination in serum or plasma is routinely performed by automated analyzers. The aim of this study is to determine whether the automated assay of CSF TF is a helpful screening tool for CFD. Methods: We analyzed CSF samples collected from 73 pediatric patients. We measured CSF TF, serum TF, and CSF 5MTHF in 73, 70, and 48 patients, respectively. The assay of 5MTHF was conducted by a newly developed system utilizing liquid chromatography-tandem mass spectrometry (LC-MS/ MS). We investigated the correlation between TF and 5MTHF in the CSF. Results: There was a strong positive correlation between CSF TF and 5MTHF (rho=0.930, p<0.0001, n=48). Age was negatively correlated with CSF TF (rho=-0.557, p<0.0001, n=51), serum TF (rho=-0.457, p=0.0008, n=51), and CSF 5MTHF (rho=-0.387, p=0.0263, n=33), but not with the CSF/serum TF ratio. Conclusions: The automated assay of CSF TF is helpful to estimate CSF 5MTHF. The CSF TF assay may have a significant impact on the early diagnosis of CFD, because clinicians have better access to it than the 5MTHF assay.	[Akiyama, Tomoyuki] Okayama Univ Hosp, Dept Child Neurol, Kita Ku, Okayama 7008558, Japan; [Tada, Hiroko; Shiokawa, Tsugumi] Okayama Univ, Adv Sci Res Ctr, Dept Instrumental Anal & Cryogen, Div Instrumental Anal, Okayama, Japan; [Kobayashi, Katsuhiro] Okayama Univ Hosp, Dept Child Neurol, Okayama 7008558, Japan; [Yoshinaga, Harumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Child Neurol, Okayama, Japan	Akiyama, T (reprint author), Okayama Univ Hosp, Dept Child Neurol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	takiyama@okayama-u.ac.jp					SURTEES R, 1990, BIOCHEM MED METAB B, V44, P192, DOI 10.1016/0885-4505(90)90060-E; Blau N, 2003, NEUROLOGY, V61, P642; Hansen FJ, 2005, MOL GENET METAB, V84, P371, DOI 10.1016/j.ymgme.2004.12.001; Verbeek MM, 2008, MOL GENET METAB, V95, P127, DOI 10.1016/j.ymgme.2008.07.004; Garcia-Cazorla A, 2008, NEUROLOGY, V70, P1360, DOI 10.1212/01.wnl.0000309223.98616.e4; Ormazabal A, 2006, CLIN CHIM ACTA, V371, P159, DOI 10.1016/j.cca.2006.03.004; Opladen T, 2006, MOL GENET METAB, V87, P61, DOI 10.1016/j.ymgme.2005.08.011; Ramaekers V, 2013, CLIN CHEM LAB MED, V51, P497, DOI 10.1515/cclm-2012-0543; Ormazabal A, 2011, CLIN BIOCHEM, V44, P719, DOI 10.1016/j.clinbiochem.2011.03.002; Ramaekers VT, 2004, DEV MED CHILD NEUROL, V46, P843, DOI 10.1017/S0012162204001471; Chladek J, 2000, J CHROMATOGR B, V744, P307, DOI 10.1016/S0378-4347(00)00257-7; Ramaekers VT, 2003, NEUROLOGY, V61, P506; Pfeiffer CM, 2004, CLIN CHEM, V50, P423, DOI 10.1373/clinchem.2003.026955; Steinfeld R, 2009, AM J HUM GENET, V85, P354, DOI 10.1016/j.ajhg.2009.08.005; GREENBLATT JM, 1994, PROG NEURO-PSYCHOPH, V18, P647, DOI 10.1016/0278-5846(94)90074-4; Ramaekers VT, 2005, NEW ENGL J MED, V352, P1985, DOI 10.1056/NEJMoa043160	16	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	NOV	2015	53	12					2009	2014		10.1515/cclm-2015-0208		6	Medical Laboratory Technology	Medical Laboratory Technology	CV5LS	WOS:000364312800029		
J	Morita, K; Masuda, N; Tanaka, T; Saruwatari, J; Oniki, K; Kajiwara, A; Otake, K; Ogata, Y; Nakagawa, K				Morita, Kazunori; Masuda, Natsuki; Tanaka, Takahiro; Saruwatari, Junji; Oniki, Kentaro; Kajiwara, Ayami; Otake, Koji; Ogata, Yasuhiro; Nakagawa, Kazuko			A functional variant in the gamma-glutamyltransferase (GGT)1 gene is associated with airflow obstruction in smokers	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Letter						airflow obstruction; genetic association study; GGT1; gamma-glutamyltransferase; smoking	DISEASE; RISK		[Nakagawa, Kazuko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Div Pharmacol & Therapeut, Chuo Ku, Kumamoto 8620973, Japan; [Nakagawa, Kazuko] Kumamoto Univ, Ctr Clin Pharmaceut Sci, Kumamoto 8620973, Japan; [Morita, Kazunori; Masuda, Natsuki; Tanaka, Takahiro; Saruwatari, Junji; Oniki, Kentaro; Kajiwara, Ayami] Kumamoto Univ, Grad Sch Pharmaceut Sci, Div Pharmacol & Therapeut, Kumamoto 8620973, Japan; [Otake, Koji; Ogata, Yasuhiro] Japanese Red Cross Kumamoto Hlth Care Ctr, Kumamoto, Japan	Nakagawa, K (reprint author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Div Pharmacol & Therapeut, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	kazukon@gpo.kumamoto-u.ac.jp					Holme J, 2010, COPD, V7, P126, DOI 10.3109/15412551003631733; Fabbri LM, 2008, EUR RESPIR J, V31, P204, DOI 10.1183/09031936.00114307; Bhatt SP, 2013, TRANSL RES, V162, P237, DOI 10.1016/j.trsl.2013.05.001; Middelberg RP, 2012, HUM MOL GENET, V21, P446, DOI 10.1093/hmg/ddr478; Kim ES, 2012, CLIN CHEM LAB MED, V50, P2053, DOI 10.1515/cclm-2012-0145; Lowry MH, 2008, AM J RESP CELL MOL, V38, P509, DOI 10.1165/rcmb.2007-0128OC; Zhang HQ, 2009, AM J RESP CELL MOL, V41, P509, DOI 10.1165/rcmb.2009-0169TR; Kim YJ, 2011, NAT GENET, V43, P990, DOI 10.1038/ng.939; Brand H, 2013, PANCREAS, V42, P836, DOI 10.1097/MPA.0b013e318279f720; Targher G, 2010, CLIN CHEM LAB MED, V48, P147, DOI 10.1515/CCLM.2010.031; Corti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034772; Jinnouchi H, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0212-5	12	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	NOV	2015	53	12					E339	E341		10.1515/cclm-2015-0331		3	Medical Laboratory Technology	Medical Laboratory Technology	CV5LS	WOS:000364312800006		
J	Akiyama, M; Mawatari, T; Nakashima, Y; Miyahara, H; Yamada, H; Okazaki, K; Fukushi, J; Kondo, M; Kishimoto, J; Hashimura, C; Iwamoto, Y				Akiyama, Mio; Mawatari, Taro; Nakashima, Yasuharu; Miyahara, Hisaaki; Yamada, Hisakata; Okazaki, Ken; Fukushi, Jun-ichi; Kondo, Masakazu; Kishimoto, Junji; Hashimura, Chinami; Iwamoto, Yukihide			Prevalence of dyslipidemia in Japanese patients with rheumatoid arthritis and effects of atorvastatin treatment	CLINICAL RHEUMATOLOGY			English	Article						Atorvastatin; Cholesterol; Dyslipidemia; HMG-CoA reductase inhibitors; Rheumatoid arthritis	CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; LIPID PROFILE; THERAPY; RISK; ATHEROSCLEROSIS; METAANALYSIS; CHOLESTEROL; LIPOPROTEIN; MORTALITY	Few studies have examined dyslipidemia in patients with rheumatoid arthritis (RA), especially in Japanese cohorts. The aims of this study were to investigate the lipid profiles of RA patients, to assess the relationships between lipid profiles and RA activity and treatment, and to elucidate the effects of HMG-CoA reductase inhibitors (statins) in Japanese patients with RA. A multicenter observational study was conducted in 488 patients with RA. Serum total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) levels, and RA activity as assessed by disease activity score 28 (DAS28), and treatment for RA were analyzed retrospectively. In statin-treated patients, drug efficacy was also analyzed. The prevalence of hyper LDL-C, hyper TG, and hypo HDL-C were 29.3, 24.2, and 10.2 %, respectively, and the overall prevalence of dyslipidemia was 56.5 %. The level of HDL-C was inversely correlated with DAS28. Patients treated with low-dose glucocorticoids showed significantly higher levels of HDL-C and lower TC/HDL-C ratios compared with patients not receiving glucocorticoid treatment. Conversely, patients treated with biologic agents showed significantly higher levels of LDL-C, lower levels of HDL-C, and higher TC/HDL-C ratios. Atorvastatin significantly improved lipid profiles after a few months of treatment. The prevalence of dyslipidemia in Japanese patients with RA is higher than that in the non-RA population. Our result suggests that controlling RA disease activity might improve lipid profiles and eventually lower cardiovascular risk. Low-dose atorvastatin was effective for treatment of dyslipidemia in RA patients but had no apparent effect on RA disease activity.	[Akiyama, Mio; Nakashima, Yasuharu; Yamada, Hisakata; Okazaki, Ken; Fukushi, Jun-ichi; Iwamoto, Yukihide] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka 812, Japan; [Mawatari, Taro] Hamanomachi Hosp, Dept Orthopaed Surg, Chuo Ku, Fukuoka 8108539, Japan; [Miyahara, Hisaaki; Hashimura, Chinami] Natl Hosp Org, Kyushu Med Ctr, Dept Orthopaed Surg & Rheumatol, Fukuoka, Japan; [Kondo, Masakazu] Kondo Clin Rheumatol & Orthopaed Surg, Fukuoka, Japan; [Kishimoto, Junji] Kyushu Univ, Fac Med Sci, Dept Res & Dev Next Generat Med, Fukuoka 812, Japan	Mawatari, T (reprint author), Hamanomachi Hosp, Dept Orthopaed Surg, Chuo Ku, 3-3-1 Nagahama, Fukuoka 8108539, Japan.	mawtaro@gmail.com			JSPS KAKENHI [24592269]	None of the authors received financial support for this study. This work was supported in part by a Grant-in-Aid in JSPS KAKENHI (Grant No. 24592269).	Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35; Nakajima A, 2010, SCAND J RHEUMATOL, V39, P360, DOI 10.3109/03009741003604542; Allanore Y, 2006, CLIN CHIM ACTA, V365, P143, DOI 10.1016/j.cca.2005.08.010; Garcia-Gomez C, 2008, EUR J CLIN INVEST, V38, P686, DOI 10.1111/j.1365-2362.2008.01994.x; Dohi T, 2010, ATHEROSCLEROSIS, V210, P497, DOI 10.1016/j.atherosclerosis.2009.12.001; MAXWELL SRJ, 1994, POSTGRAD MED J, V70, P863; Dursunoglu D, 2005, RHEUMATOL INT, V25, P241, DOI 10.1007/s00296-004-0438-0; Fischer LM, 2004, AM J CARDIOL, V93, P198, DOI 10.1016/j.amjcard.2003.09.037; Peters MJL, 2007, ANN RHEUM DIS, V66, P958, DOI 10.1136/ard.2006.059691; Boers M, 2003, ANN RHEUM DIS, V62, P842, DOI 10.1136/ard.62.9.842; Jick SS, 2009, ANN RHEUM DIS, V68, P546, DOI 10.1136/ard.2008.091967; Park YB, 2002, AM J MED, V113, P188, DOI 10.1016/S0002-9343(02)01186-5; Teramoto T, 2007, J ATHEROSCLER THROMB, V14, P45; Nurmohamed MT, 2009, AUTOIMMUN REV, V8, P663, DOI 10.1016/j.autrev.2009.02.015; Choy E, 2009, ANN RHEUM DIS, V68, P460, DOI 10.1136/ard.2008.101964; Sihvonen S, 2004, SCAND J RHEUMATOL, V33, P221, DOI 10.1080/03009740410005845; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Bandyopadhyay P, 2004, DRUGS TODAY, V40, P621, DOI 10.1358/dot.2004.40.7.850479; McCarey DW, 2004, LANCET, V363, P2015, DOI 10.1016/S0140-6736(04)16449-0; Steiner G, 2009, SEMIN ARTHRITIS RHEU, V38, P372, DOI 10.1016/j.semarthrit.2008.01.015; Kinlay S, 2007, J AM COLL CARDIOL, V49, P2003, DOI 10.1016/j.jacc.2007.01.083; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Van Doornum S, 2002, ARTHRITIS RHEUM, V46, P862, DOI 10.1002/art.10089; Abeles AM, 2006, ARTHRITIS RHEUM, V54, P393, DOI 10.1002/art.21521; [Anonymous], 2005, ANN EPIDEMIOL, DOI DOI 10.1016/J.ANNEPIDEM.2005.01.005; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Dixon WG, 2007, ARTHRITIS RHEUM, V56, P2905, DOI 10.1002/art.22809; Arai Yasumichi, 2004, J Atheroscler Thromb, V11, P246; Asano MYN, 2005, RHEUMATOLOGY TOKYO, V34, P131; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Lida Minoru, 2003, J Hum Hypertens, V17, P851; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; van Halm VP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2045; Yamada A, 2003, RHEUMATOLOGY TOKYO, V33, P1	34	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0770-3198	1434-9949		CLIN RHEUMATOL	Clin. Rheumatol.	NOV	2015	34	11					1867	1875		10.1007/s10067-015-3049-0		9	Rheumatology	Rheumatology	CV0QU	WOS:000363957100006		
J	Hwang, YC; Hayashi, T; Fujimoto, WY; Kahn, SE; Leonetti, DL; McNeely, MJ; Boyko, EJ				Hwang, You-Cheol; Hayashi, Tomoshige; Fujimoto, Wilfred Y.; Kahn, Steven E.; Leonetti, Donna L.; McNeely, Marguerite J.; Boyko, Edward J.			Differential Association Between HDL Subclasses and the Development of Type 2 Diabetes in a Prospective Study of Japanese Americans	DIABETES CARE			English	Article							CORONARY-HEART-DISEASE; LIPOPROTEIN CHOLESTEROL LEVELS; APOLIPOPROTEIN-A-I; VISCERAL ADIPOSITY; INSULIN-RESISTANCE; RISK-FACTORS; GLUCOSE; MELLITUS; SUBFRACTIONS; METAANALYSIS	OBJECTIVE Recent studies have suggested that HDL cholesterol is inversely associated with the development of type 2 diabetes. However, little is known about the association between different HDL subclasses and the risk for future type 2 diabetes. RESEARCH DESIGN AND METHODS The study enrolled 406 Japanese Americans (51% male) without diabetes, aged 34-75 years. Oral glucose tolerance tests were performed to determine type 2 diabetes status at baseline, 2.5 years, 5 years, and 10 years after enrollment. HDL2, HDL3, total HDL cholesterol, and visceral adipose tissue (VAT) area by computed tomography were measured at baseline. RESULTS In univariate analysis, total HDL and HDL2 cholesterol were inversely associated with the incidence of type 2 diabetes, but HDL3 cholesterol was not. In multivariate analysis, total HDL cholesterol (odds ratio per 1-SD increment, 0.72 [95% CI 0.52-0.995], P = 0.047) and HDL2 cholesterol (odds ratio per 1-SD increment, 0.64 [95% CI 0.44-0.93], P = 0.018) were inversely associated with the risk for type 2 diabetes independent of age, sex, BM!, waist circumference, family history of diabetes, lifestyle factors, systolic blood pressure, lipid-lowering medication use, triglyceride level, HOMA-insulin resistance, and 2-h glucose; however, HDL3 cholesterol was not associated with diabetes risk. The association between diabetes risk and total HDL and HDL2 cholesterol became insignificant after adjustment for VAT area. CONCLUSIONS Subjects with higher HDL2 cholesterol were at lower risk for incident type 2 diabetes, but this association was confounded by and not independent of VAT. Higher HDL3 cholesterol was not associated with diabetes risk.	[Hwang, You-Cheol; Boyko, Edward J.] VA Puget Sound Hlth Care Syst, Seattle Epidemiol Res & Informat Ctr, Seattle, WA 98108 USA; [Hwang, You-Cheol] Kyung Hee Univ, Sch Med, Hosp Gangdong, Dept Med,Div Endocrinol & Metab, Seoul, South Korea; [Hayashi, Tomoshige] Osaka City Univ, Grad Sch Med, Dept Prevent Med & Environm Hlth, Osaka 558, Japan; [Fujimoto, Wilfred Y.; Kahn, Steven E.; McNeely, Marguerite J.; Boyko, Edward J.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Kahn, Steven E.] VA Puget Sound Hlth Care Syst, Hosp & Specialty Med Serv, Seattle, WA USA; [Leonetti, Donna L.] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA	Boyko, EJ (reprint author), VA Puget Sound Hlth Care Syst, Seattle Epidemiol Res & Informat Ctr, Seattle, WA 98108 USA.	eboyko@uw.edu			National Institute of Diabetes and Digestive and Kidney Diseases [DK-17047, DK-35816]; National Institutes of Health Clinical Center [RR-00037]; VA Puget Sound Health Care System	This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases grants DK-17047 and DK-35816 to the Diabetes Research Center Clinical Nutrition Research Unit for facilities and services, and by National Institutes of Health Clinical Center grant RR-00037 to the General Clinical Research Center at the University of Washington. The VA Puget Sound Health Care System provided support to S.E.K. and E.J.B. for their involvement in this research.	Miwa K, 1998, CARDIOVASC RES, V37, P729, DOI 10.1016/S0008-6363(97)00286-1; Olsson AG, 2005, EUR HEART J, V26, P890, DOI 10.1093/eurheartj/ehi186; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Pirillo A, 2013, CARDIOLOGY, V124, P116, DOI 10.1159/000346463; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Drew BG, 2009, CIRCULATION, V119, P2103, DOI 10.1161/CIRCULATIONAHA.108.843219; FUJIMOTO WY, 1987, DIABETES, V36, P730, DOI 10.2337/diabetes.36.6.730; Krauss RM, 2010, CURR OPIN LIPIDOL, V21, P305, DOI 10.1097/MOL.0b013e32833b7756; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; BERGSTROM RW, 1990, DIABETOLOGIA, V33, P489, DOI 10.1007/BF00405111; Drew BG, 2011, J LIPID RES, V52, P572, DOI 10.1194/jlr.P012518; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Movva R, 2008, CLIN CHEM, V54, P788, DOI 10.1373/clinchem.2007.101923; Boekholdt SM, 2013, CIRCULATION, V128, P1504, DOI 10.1161/CIRCULATIONAHA.113.002670; Garin MCB, 2005, J CLIN ENDOCR METAB, V90, P2264, DOI 10.1210/jc.2004-1295; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Boyko EJ, 1996, INT J OBESITY, V20, P801; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Fagot-Campagna A, 1999, DIABETES CARE, V22, P271, DOI 10.2337/diacare.22.2.271; Ashmaig ME, 2013, CLIN CHIM ACTA, V425, P37, DOI 10.1016/j.cca.2013.07.007; Asztalos BF, 2011, CURR OPIN LIPIDOL, V22, P176, DOI 10.1097/MOL.0b013e3283468061; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Gordon SM, 2011, TRENDS ENDOCRIN MET, V22, P9, DOI 10.1016/j.tem.2010.10.001; PAFFENBARGER RS, 1978, AM J EPIDEMIOL, V108, P161; Gavin JR, 1997, DIABETES CARE, V20, P1183; Turner RC, 1998, BRIT MED J, V316, P823; Hwang YC, 2014, EUR J ENDOCRINOL, V171, P137, DOI 10.1530/EJE-14-0195; Wander PL, 2013, DIABETES CARE, V36, P289, DOI 10.2337/dc12-0198; Gidez LI, 1982, LIPID RES, V23, P1206; HAFFNER SM, 1990, JAMA-J AM MED ASSOC, V263, P2893, DOI 10.1001/jama.263.21.2893; Morgan John, 2004, Curr Atheroscler Rep, V6, P359, DOI 10.1007/s11883-004-0047-0; Warnick G R, 1986, Methods Enzymol, V129, P101	32	0	0	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0149-5992	1935-5548		DIABETES CARE	Diabetes Care	NOV	2015	38	11					2100	2105		10.2337/dc15-0625		6	Endocrinology & Metabolism	Endocrinology & Metabolism	CV5WQ	WOS:000364342500029		
J	Imai, S; Fukui, M; Kajiyama, S				Imai, Saeko; Fukui, Michiaki; Kajiyama, Shizuo			Food Order Has a Significant Impact on Postprandial Glucose and Insulin Levels. Diabetes Care 2015;38:e98-e99	DIABETES CARE			English	Letter							EATING VEGETABLES; FLUCTUATIONS		[Imai, Saeko] Kyoto Womens Univ, Fac Home Econ, Dept Food & Nutr, Kyoto, Japan; [Fukui, Michiaki; Kajiyama, Shizuo] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kyoto, Japan; [Kajiyama, Shizuo] Kajiyama Clin, Kyoto, Japan	Imai, S (reprint author), Kyoto Womens Univ, Fac Home Econ, Dept Food & Nutr, Kyoto, Japan.	imais@kyoto-wu.ac.jp					Imai S, 2011, ASIA PAC J CLIN NUTR, V20, P161; Rizzo MR, 2012, DIABETES CARE, V35, P2076, DOI 10.2337/dc12-0199; Imai S, 2013, DIABETIC MED, V30, P370, DOI 10.1111/dme.12073; Shukla AP, 2015, DIABETES CARE, V38, pe98, DOI 10.2337/dc15-0429; Torimoto K, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-1	5	1	1	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0149-5992	1935-5548		DIABETES CARE	Diabetes Care	NOV	2015	38	11					E196	E196		10.2337/dc15-1472		1	Endocrinology & Metabolism	Endocrinology & Metabolism	CV5WQ	WOS:000364342500013		
J	Amagai, Y; Kaneko, M; Kudo, G				Amagai, Yukihiro; Kaneko, Masami; Kudo, Gaku			Habitat-specific responses of shoot growth and distribution of alpine dwarf-pine (Pinus pumila) to climate variation	ECOLOGICAL RESEARCH			English	Article						Alpine; Climate warming; Pinus pumila; Shoot growth; GIS	ARCTIC TUNDRA; CENTRAL JAPAN; MOUNTAIN-RANGE; NORTHERN JAPAN; GROWING-SEASON; VEGETATION; DYNAMICS; IMPACTS; PHENOLOGY; INVASION	Alpine dwarf-pine (Pinus pumila) in dominant in the alpine regions of Japan, and often forms the krummholz zone of stunted alpine forest. The distribution of P. pumila is strongly related to the distribution of snow, and shoot growth is also sensitive to weather conditions. Changes in temperature and snowmelt regimes may well affect the distribution patterns of the krummholz zone. P. pumila usually occupies the habitat between the fellfield and snowbed communities, and responses to climate change may differ depending on whether plants are close to the fellfield or the snowbed. We compared the distribution and shoot growth patterns of P. pumila close to both surrounding ecosystems in the Taisetsu Mountains, northern Japan. P. pumila has expanded its distribution area by 14 % toward both edges over the last 32 years. Annual shoot growth was positively affected by summer temperature and sunshine duration, but negatively related to spring temperature toward the fellfield side. Shoot growth was greater at the southeastern edge of patches, where snowdrifts were formed. The results indicated that shoot growth and distribution area increased in warm summers. However, warm springs might have a negative influence on shoot growth, probably because the earlier reduction in cold-resistance enhances the risk of frost damage in spring close to the fellfield side. This study suggests the importance of understanding the site-specific responses of shrubs to predict the impacts of climate change on alpine ecosystems.	[Amagai, Yukihiro] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido 0600810, Japan; [Kaneko, Masami] Rakuno Gakuen Univ, Dept Environm & Symbiot Sci, Ebetsu, Hokkaido 0690836, Japan; [Kudo, Gaku] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan	Amagai, Y (reprint author), Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido 0600810, Japan.	amagai@ees.hokudai.ac.jp			Ministry of Environment of Japan from the Global Environmental Research Fund [D-0904]; JSPS KAKENHI Grant [24570015]	We are grateful to Yoko Nakatani, Asako Kida and Kanji Hashimoto for their kind suggestions during GIS analysis and to Yuta Aoshima for his assistance in field work. This study was supported by a Grant-in-Aid from the Ministry of Environment of Japan from the Global Environmental Research Fund (D-0904) and by JSPS KAKENHI Grant Number 24570015.	Wilson SD, 2009, GLOBAL CHANGE BIOL, V15, P1676, DOI 10.1111/j.1365-2486.2009.01896.x; Danby RK, 2007, J ECOL, V95, P352, DOI 10.1111/j.1365-2745.2006.01200.x; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Nakamoto A, 2012, CAN J FOREST RES, V42, P167, DOI [10.1139/X11-153, 10.1139/x11-153]; Bokhorst S, 2011, GLOBAL CHANGE BIOL, V17, P2817, DOI 10.1111/j.1365-2486.2011.02424.x; Wheeler JA, 2014, OECOLOGIA, V175, P219, DOI 10.1007/s00442-013-2872-8; Hoshino B, 2009, INT GEOSCI REMOTE SE, P1856, DOI 10.1109/IGARSS.2009.5417815; Kudo G, 2010, ARCT ANTARCT ALP RES, V42, P438, DOI 10.1657/1938-4246-42.4.438; Choler P, 2001, ECOLOGY, V82, P3295, DOI 10.1890/0012-9658(2001)082[3295:FACOGI]2.0.CO;2; Holtmeier FK, 2005, GLOBAL ECOL BIOGEOGR, V14, P395, DOI 10.1111/j.1466-822x.2005.00168.x; Pajunen AM, 2011, J VEG SCI, V22, P837, DOI 10.1111/j.1654-1103.2011.01285.x; Dullinger S, 2003, ARCT ANTARCT ALP RES, V35, P434, DOI 10.1657/1523-0430(2003)035[0434:POSIIH]2.0.CO;2; Sturm M, 2005, BIOSCIENCE, V55, P17, DOI 10.1641/0006-3568(2005)055[0017:WBPCHC]2.0.CO;2; Horikawa M, 2009, LANDSCAPE ECOL, V24, P115, DOI 10.1007/s10980-008-9289-5; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Penuelas J, 2007, ECOGRAPHY, V30, P829, DOI 10.1111/j.2007.0906-7590.05247.x; CHAPIN FS, 1995, ECOLOGY, V76, P694; Wada N, 2005, PHYTON-ANN REI BOT A, V45, P253; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; Ishida A, 2001, ECOL RES, V16, P107, DOI 10.1046/j.1440-1703.2001.00376.x; KUDO G, 1992, VEGETATIO, V98, P165, DOI 10.1007/BF00045554; SANO Y, 1977, NATURE, V266, P159, DOI 10.1038/266159a0; Kudo G, 2006, POPUL ECOL, V48, P49, DOI 10.1007/s10144-005-0242-z; Takahashi K, 2003, ARCT ANTARCT ALP RES, V35, P1, DOI 10.1657/1523-0430(2003)035[0001:EOCCOS]2.0.CO;2; Kudo G, 2011, ECOL EVOL, V1, P85, DOI 10.1002/ece3.9; Wang T, 2006, GLOBAL ECOL BIOGEOGR, V15, P406, DOI 10.1111/j.1466-822x.2006.00233.x; Inouye DW, 2008, ECOLOGY, V89, P353, DOI 10.1890/06-2128.1; Essery R, 2004, J HYDROMETEOROL, V5, P735, DOI 10.1175/1525-7541(2004)005<0735:VATCOW>2.0.CO;2; OKITSU S, 1984, VEGETATIO, V58, P105, DOI 10.1007/BF00044934; Kullman L, 2002, J ECOL, V90, P68, DOI 10.1046/j.0022-0477.2001.00630.x; Takahashi K, 2009, ECOL RES, V24, P847, DOI 10.1007/s11284-008-0558-1; HADLEY JL, 1987, OECOLOGIA, V73, P82, DOI 10.1007/BF00376981; Choler P, 2005, ARCT ANTARCT ALP RES, V37, P444, DOI 10.1657/1523-0430(2005)037[0444:CSIAPT]2.0.CO;2; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; KAJIMOTO T, 1993, TREE PHYSIOL, V13, P41; Bokhorst S, 2008, GLOBAL CHANGE BIOL, V14, P2603, DOI 10.1111/j.1365-2486.2008.01689.x; BILLINGS WD, 1959, ECOLOGY, V40, P388, DOI 10.2307/1929755; Bates D., 2013, LME4 LINEAR MIXED EF, V1, P1; Fu C, 2007, CLIM CHANG 2007 CONT, P902; Japan Association on Remote Sensing, 2001, REM SENS NOT; Japan Meteorological Agency, 2012, CLIM STAT; KAJIMOTO T, 1990, Ecological Research, V5, P333, DOI 10.1007/BF02347008; KAJIMOTO T, 1989, Ecological Research, V4, P55, DOI 10.1007/BF02346943; Kibe T., 1992, P NIPR S POLAR BIOL, V5, P118; KOIZUMI T, 1974, Japanese Journal of Ecology, V24, P78; Korner C, 2003, ALPINE PLANT LIFE, P54; Maruta E, 1996, P NIPR S POL BIOL, V9, P335; Ohwi J, 1983, NEW FLORA OF JAPAN; OKITSU S, 1988, Japanese Journal of Ecology (Tokyo), V38, P177; OKITSU S, 1985, Japanese Journal of Ecology, V35, P113; Ozeki M, 2011, B NAGANO ENV CONSERV, V7, P39; R Core Team, 2012, R LANG ENV STAT COMP; Sakai A, 1987, FROST SURVIVAL PLANT, P218; Takahashi K, 2006, POLAR BIOSCI, V19, P123; Tatewaki M, 1958, J FAC AGR HOKKAIDO U, V50, P371; Tranquillini W, 1979, PHYSL ECOLOGY ALPINE, P91; Yasuda M, 2001, GEOGRA REV JPN, V74, P709; Yasuda M, 2007, JPN J FOR ENV, V49, P9; Yasuda M, 2012, HORTIC RES, V66, P49	59	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0912-3814	1440-1703		ECOL RES	Ecol. Res.	NOV	2015	30	6					969	977		10.1007/s11284-015-1299-6		9	Ecology	Environmental Sciences & Ecology	CV0RM	WOS:000363959700001		
J	Miura, A; Urabe, J				Miura, Aya; Urabe, Jotaro			Riparian land cover and land use effects on riverine epilithic fungal communities	ECOLOGICAL RESEARCH			English	Article						Aquatic fungal community; Organic matter; Nutrient; Drainage basin; Land use and land cover	DISSOLVED ORGANIC-MATTER; SUBSTRATE PREFERENCES; LITTER DECOMPOSITION; LEAF DECOMPOSITION; STREAMS; DIVERSITY; TEMPERATURE; SPORULATION; NITROGEN; LEAVES	Although fungi are important decomposers in lotic environments, few studies have investigated the spatial and temporal changes in epilithic fungal communities in rivers. If epilithic organisms grow using organic matter and nutrients ultimately discharge into rivers, it is likely that the taxonomic composition of epilithic fungal communities will change spatially depending on the land use and land cover (LULC) in the drainage area. To test this hypothesis, we examined the relationship between the taxonomic composition of fungi on cobbles and the LULC in the fall and in spring. The taxonomic composition of the epilithic fungi was significantly related to ambient water temperatures and concentrations of nutrients and dissolved organic carbon. Supporting our hypothesis, the taxonomic composition of the epilithic fungi differed largely among the reaches covered mainly by different forest types and land uses in both the fall and in spring. The results suggest that the quality of the dissolved organic matter differed among the catchment areas depending on the LULC. Further analyses indicated that the sum of the LULC and within-river variables could explain 36.4 and 41.2 % of the spatial variation in the fungal taxonomic compositions in the fall and in spring, respectively. The LULC variables alone explained 16.1-18.7 % of the variations, and a similar percentage was found for within-river variables. These results suggest that the organic matter from LULC was equally as important as physical and nutrient conditions in the ambient water for determining the community structure of epilithic fungi in rivers.	[Miura, Aya; Urabe, Jotaro] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan	Miura, A (reprint author), Tohoku Univ, Grad Sch Life Sci, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	ayayaya.miu@gmail.com			MEXT Japan [24657010]; Global COE Program "Center for ecosystem management adapting to global change'' from MEXT Japan [J03];  [12J07309]	We are grateful to Satoshi Chiba, Takao Suzuki and Wataru Makino. We also thank Manabu Fukui, Hisaya Kojima, and Masazumi Tsutsumi for DGGE analyses, and Seiji Ishida, Hajime Otsuki, Yasuo Mukai, Takehiro Kaszama, Hitoshi Kumagai, Mika Sou, Takuma Sato, and Ie Ji for statistical analyses and sampling. This research was supported by a Grant-in-Aid for JPSP Fellows (12J07309) to AM, a Grant-in-Aid for Challenging Exploratory Research from MEXT Japan (24657010) to JU and the Global COE Program "Center for ecosystem management adapting to global change'' (J03) from MEXT Japan to AM and JU.	Allan J. D., 2007, STREAM ECOLOGY STRUC; Danger M, 2013, ECOLOGY, V94, P1604, DOI 10.1890/12-0606.1; Wilson HF, 2009, NAT GEOSCI, V2, P37, DOI 10.1038/NGEO391; Miura A, 2015, FRESHWATER BIOL, V60, P673, DOI 10.1111/fwb.12514; Cronan CS, 1999, J ENVIRON QUAL, V28, P953; Krusche AV, 2002, WATER RES, V36, P2743, DOI 10.1016/S0043-1354(01)00495-X; TAYLOR BR, 1989, ECOLOGY, V70, P97, DOI 10.2307/1938416; Goncalves AL, 2013, FUNGAL ECOL, V6, P546, DOI 10.1016/j.funeco.2013.07.002; Frossard A, 2013, APPL ENVIRON MICROB, V79, P4965, DOI 10.1128/AEM.00747-13; Artigas J, 2008, AQUAT BOT, V88, P32, DOI 10.1016/j.aquabot.2007.08.005; Kuehn KA, 2014, ECOLOGY, V95, P749, DOI 10.1890/13-0430.1; Artigas J, 2004, ANN LIMNOL-INT J LIM, V40, P269, DOI 10.1051/limn/2004025; GESSNER MO, 1994, ECOLOGY, V75, P1807, DOI 10.2307/1939639; Gulis V, 2001, MYCOL RES, V105, P1088, DOI 10.1016/S0953-7562(08)61971-1; Mulholland PJ, 2008, NATURE, V452, P202, DOI 10.1038/nature06686; Nikolcheva LG, 2005, ENVIRON MICROBIOL, V7, P270, DOI 10.1111/j.1462-2920.2004.00709.x; Dang CK, 2009, ECOLOGY, V90, P122, DOI 10.1890/07-1974.1; BARLOCHER F, 1981, T BRIT MYCOL SOC, V76, P479; Chauvet E, 1998, APPL ENVIRON MICROB, V64, P1522; Paerl HW, 1998, MAR ECOL PROG SER, V166, P17, DOI 10.3354/meps166017; Battin TJ, 1999, AQUAT MICROB ECOL, V19, P297, DOI 10.3354/ame019297; Hoellein TJ, 2011, BIOGEOCHEMISTRY, V106, P265, DOI 10.1007/s10533-011-9631-x; Barlocher F, 2002, FRESHWATER BIOL, V47, P1123, DOI 10.1046/j.1365-2427.2002.00836.x; Krauss GJ, 2011, FEMS MICROBIOL REV, V35, P620, DOI 10.1111/j.1574-6976.2011.00266.x; Laitung B, 2005, ARCH HYDROBIOL, V164, P217, DOI 10.1127/0003-9136/2005/0164-0217; Barlocher E, 2005, FUNGAL COMMUNITY ITS, P39; Dix NJ, 1995, FUNGAL ECOLOGY; Gessner MO, 2007, ENV MICROBIAL RELATI, V4, P301; Gulis V, 2006, ROLE IMPACT FUNGI BI, P404; Jones EBG, 2008, BR MYCOL SY, V28, P301; Livingstone DA, 1963, 440G US GEOL SURV PR, pG1; McLaughlin DJ, 2001, MYCOTA COMPREHENSI A; Nikolcheva Liliya G., 2004, Mycological Progress, V3, P41, DOI 10.1007/s11557-006-0075-y; R Development Core Team, 2010, R LANG ENV STAT COMP; White T. J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1139/B07-071	35	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0912-3814	1440-1703		ECOL RES	Ecol. Res.	NOV	2015	30	6					1047	1055		10.1007/s11284-015-1303-1		9	Ecology	Environmental Sciences & Ecology	CV0RM	WOS:000363959700008		
J	Tomimatsu, H; Yamagishi, H; Suzuki, SN; Sato, C; Konno, Y				Tomimatsu, Hiroshi; Yamagishi, Hiroki; Suzuki, Satoshi N.; Sato, Chihiro; Konno, Yasuo			Long-term dynamics of small fragmented forests inferred from patterns along a gradient of fragment sizes	ECOLOGICAL RESEARCH			English	Article						Aboveground biomass; Demography; Edge effects; Forest fragmentation; Tree mortality	DOUGLAS-FIR FORESTS; TREE MORTALITY; RAIN-FOREST; TRILLIUM-CAMSCHATCENSE; NORTHERN JAPAN; UNITED-STATES; GROWTH; BIOMASS; CONSEQUENCES; COMMUNITIES	Although forest fragmentation has wide-ranging effects on remnant biota and ecosystem functions, the long-term dynamics of fragmented forests is poorly understood. In 2011, we resurveyed eight fragments (0.3-8.5 ha) of a Japanese temperate deciduous forest, which was fragmented anthropogenically in the 1940s and 1950s and initially surveyed in 1999, to infer the long-term dynamics of these forest fragments. We compared tree size distributions, aboveground biomass, and community composition over the 12-year period between surveys. We also reconstructed the disturbance history using a dendroecological analysis of tree-ring series. Smaller fragments had a lower density of large trees in 1999, and small-scale disturbance events were estimated to be relatively frequent around the same time that the forest was fragmented. These results were consistent with the expectation that tree mortality would increase following fragmentation. While elevated tree mortality in the small fragments suggests a greater loss of biomass density compared with larger fragments, the aboveground biomass recovered more rapidly in the smaller fragments over the 12-year census interval. However, some small fragments showed extraordinary rates of biomass increases, suggesting that they were not simply the result of a recovery from the fragmentation event, but also reflected recoveries from more recent disturbances. As a result, although the species composition of the smaller fragments approached that of the larger fragments over time, the density of large trees was still lower in the smaller fragments in 2011. Our results emphasize the need to consider such complex forest dynamics when predicting functional consequences of fragmentation.	[Tomimatsu, Hiroshi] Yamagata Univ, Dept Biol, Yamagata 9906711, Japan; [Tomimatsu, Hiroshi] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808578, Japan; [Yamagishi, Hiroki] Hirosaki Univ, Shirakami Inst Environm Sci, Hirosaki, Aomori 0368561, Japan; [Suzuki, Satoshi N.] Univ Tokyo, Univ Tokyo Chichibu Forest, Chichibu, Saitama 3680034, Japan; [Sato, Chihiro; Konno, Yasuo] Obihiro Univ Agr & Vet Med, Dept Life Sci & Agr, Obihiro, Hokkaido 0808555, Japan	Tomimatsu, H (reprint author), Yamagata Univ, Dept Biol, Yamagata 9906711, Japan.	htomimatsu@sci.kj.yamagata-u.ac.jp			Japan Society for the Promotion of Science [KAKENHI 24770012]; Ministry of Education, Culture, Sports, Science, and Technology of Japan (Global COE Program) [J03]	We thank the landowners who kindly allowed us to conduct surveys on their properties, and Kiwako Araki, Ayumi Matsuo, Hisashi Fujiwara, and the members of the Konno Laboratory at Obihiro University of Agriculture and Veterinary Medicine for assistance in the field. Financial support was provided by the Japan Society for the Promotion of Science (KAKENHI 24770012), and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Global COE Program J03).	Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Black BA, 2003, ECOL APPL, V13, P1733, DOI 10.1890/02-5122; Houghton RA, 2005, GLOBAL CHANGE BIOL, V11, P945, DOI 10.1111/j.1365-2486.2005.00955.x; Tomimatsu H, 2004, BIOL CONSERV, V117, P509, DOI 10.1016/j.biocon.2003.08.010; Laurance WF, 2001, ECOLOGY, V82, P105, DOI 10.1890/0012-9658(2001)082[0105:RFFATS]2.0.CO;2; Solarik KA, 2012, J APPL ECOL, V49, P145, DOI 10.1111/j.1365-2664.2011.02089.x; CHEN JQ, 1992, ECOL APPL, V2, P387, DOI 10.2307/1941873; Tomimatsu H, 2013, J APPL ECOL, V50, P1124, DOI 10.1111/1365-2664.12116; Nascimento HEM, 2004, ECOL APPL, V14, pS127; Tomimatsu H, 2006, POPUL ECOL, V48, P189, DOI 10.1007/s10144-006-0269-9; Bladon KD, 2006, AGR FOREST METEOROL, V138, P104, DOI 10.1016/j.agrformet.2006.03.015; Zhang W, 2007, ECOL ECON, V64, P253, DOI 10.1016/j.ecolecon.2007.02.024; Bellingham PJ, 2006, CAN J FOREST RES, V36, P910, DOI 10.1139/X05-308; Vaughn NR, 2014, ECOL APPL, V24, P1638, DOI 10.1890/13-1568.1; Laurance WF, 2006, ECOLOGY, V87, P469, DOI 10.1890/05-0064; ESSEEN PA, 1994, BIOL CONSERV, V68, P19, DOI 10.1016/0006-3207(94)90542-8; Scott RE, 2005, FOREST ECOL MANAG, V218, P193, DOI 10.1016/j.foreco.2005.07.012; Laurance WF, 2014, ECOLOGY, V95, P3018, DOI 10.1890/14-0330.1; Laurance WF, 2014, ECOLOGY, V95, P1604, DOI 10.1890/13-1571.1; Jonsson MT, 2007, FOREST ECOL MANAG, V242, P306, DOI 10.1016/j.foreco.2007.01.048; CHEN JQ, 1995, ECOL APPL, V5, P74, DOI 10.2307/1942053; Nowacki GJ, 1997, ECOL MONOGR, V67, P225, DOI 10.1890/0012-9615(1997)067[0225:RGACFR]2.0.CO;2; Tomimatsu H, 2011, PLANT SPEC BIOL, V26, P3, DOI 10.1111/j.1442-1984.2010.00310.x; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Lindenmayer DB, 2014, CONSERV LETT, V7, P61, DOI 10.1111/conl.12013; Jenkins JC, 2003, FOREST SCI, V49, P12; Yoshida T, 2011, J FOREST RES-JPN, V16, P215, DOI 10.1007/s10310-011-0274-5; Laurance WF, 1998, FOREST ECOL MANAG, V110, P173, DOI 10.1016/S0378-1127(98)00291-6; MATLACK GR, 1993, BIOL CONSERV, V66, P185, DOI 10.1016/0006-3207(93)90004-K; Laurance WF, 1997, SCIENCE, V278, P1117, DOI 10.1126/science.278.5340.1117; Suzuki SN, 2013, ECOL RES, V28, P117, DOI 10.1007/s11284-012-0995-8; Fukasawa Y, 2012, FOREST ECOL MANAG, V266, P232, DOI 10.1016/j.foreco.2011.11.027; Remm J, 2011, FOREST ECOL MANAG, V262, P579, DOI 10.1016/j.foreco.2011.04.028; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Konno Y, 2002, GLOBAL PERSPECTIVE F, P39; NAKASHIZUKA T, 1988, Ecological Research, V3, P21, DOI 10.1007/BF02348692; Numata I, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001198; Quinn G. P., 2002, EXPT DESIGN DATA ANA; R Core Team, 2012, R LANG ENV STAT COMP; Sakai T, 1999, PLANT ECOL, V140, P90; Thorpe HC, 2008, ECOLOGICAL APPL, V18, P1626; WILLIAMSLINERA G, 1990, J ECOL, V78, P356, DOI 10.2307/2261117	42	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0912-3814	1440-1703		ECOL RES	Ecol. Res.	NOV	2015	30	6					1057	1064		10.1007/s11284-015-1306-y		8	Ecology	Environmental Sciences & Ecology	CV0RM	WOS:000363959700009		
J	Mochida, S				Mochida, Satoru			PP1 inactivates Greatwall to release PP2A-B55 from mitotic confinement	EMBO REPORTS			English	Editorial Material							M-PHASE; TRANSITIONS; ENTRY	Entry into and exit from mitosis are brought about by the increase and decrease, respectively, in the activity of cyclin-dependent kinases (CDKs). Many examples are known of how the properties of particular proteins can be altered by phosphorylation, promoting processes like nuclear envelope breakdown or assembly of the mitotic spindle. The regulation of protein phosphatases is shedding new light on how this quantitative change of protein phosphorylation is achieved by a tight linkage between CDK activity and CDK-antagonizing phosphatases. On entering mitosis, increasing CDK activity ignites a repressive pathway that acts on PP2A-B55, one of the major phosphatases for CDK substrates in higher eukaryotes. This repression allows rapid and near complete substrate phosphorylation. But this raises a serious bootstrapping problem at mitotic exit. Because the phosphatase responsible for CDK substrates has been shut off, how can the repression pathway, which was activated by CDK, be reversed? In the current issue, Heim and colleagues propose an answer to this question . Their data show that dephosphorylation of Greatwall kinase (Gwl) at its auto-phosphorylation site(s) is targeted by PP1, which leads to significant decrease in Gwl kinase activity. This early action by PP1 seems to be a prerequisite for PP2A-B55 to escape from repression and to return Gwl back to its inactive hypophosphorylated interphase state. This study provides an important piece of evidence for how the repression mechanism of PP2A-B55 is made reversible, and offers a solution to the bootstrap problem.	[Mochida, Satoru] Kumamoto Univ, Prior Org Innovat & Excellence, Kumamoto, Japan; [Mochida, Satoru] Kumamoto Univ, IMEG, Kumamoto, Japan; [Mochida, Satoru] Kumamoto Univ, IRCMS, Kumamoto, Japan; [Mochida, Satoru] Japan Sci & Technol Agcy, PRESTO Program, Tokyo, Japan	Mochida, S (reprint author), Kumamoto Univ, Prior Org Innovat & Excellence, Kumamoto, Japan.	mochida@kumamoto-u.ac.jp					Vigneron S, 2011, MOL CELL BIOL, V31, P2262, DOI 10.1128/MCB.00753-10; Blake-Hodek KA, 2012, MOL CELL BIOL, V32, P1337, DOI 10.1128/MCB.06525-11; Mochida S, 2007, NATURE, V449, P336, DOI 10.1038/nature06121; Wurzenberger C, 2011, NAT REV MOL CELL BIO, V12, P469, DOI 10.1038/nrm3149; Bontron S, 2013, CELL REP, V3, P16, DOI 10.1016/j.celrep.2012.11.025; FANG F, 1991, CELL, V66, P731, DOI 10.1016/0092-8674(91)90117-H; Vinod PK, 2015, FEBS LETT, V589, P667, DOI 10.1016/j.febslet.2015.02.007; Hegarat N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004004; Heim A, 2015, EMBO REP, V16, P1501, DOI 10.15252/embr.201540876; Williams BC, 2014, ELIFE, V3, DOI 10.7554/eLife.01695	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1469-221X	1469-3178		EMBO REP	EMBO Rep.	NOV	2015	16	11					1411	1412				2	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CV5NX	WOS:000364318900003		
J	Kurabayashi, N; Nguyen, MD; Sanada, K				Kurabayashi, Nobuhiro; Nguyen, Minh Dang; Sanada, Kamon			DYRK1A overexpression enhances STAT activity and astrogliogenesis in a Down syndrome mouse model	EMBO REPORTS			English	Article						astrogliogenesis; Down syndrome; DYRK1A; neocortical progenitor; STAT	NEURAL PROGENITOR CELLS; PLURIPOTENT STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; NEURONAL DIFFERENTIATION; OVER-EXPRESSION; BRAIN; PROLIFERATION; NEUROGENESIS; PROTEIN; TS1CJE	Down syndrome (DS) arises from triplication of genes on human chromosome 21 and is associated with anomalies in brain development such as reduced production of neurons and increased generation of astrocytes. Here, we show that differentiation of cortical progenitor cells into astrocytes is promoted by DYRK1A, a Ser/Thr kinase encoded on human chromosome 21. In the Ts1Cje mouse model of DS, increased dosage of DYRK1A augments the propensity of progenitors to differentiate into astrocytes. This tendency is associated with enhanced astrogliogenesis in the developing neocortex. We also find that overexpression of DYRK1A upregulates the activity of the astrogliogenic transcription factor STAT in wild-type progenitors. Ts1Cje progenitors exhibit elevated STAT activity, and depletion of DYRK1A in these cells reverses the deregulation of STAT. In sum, our findings indicate that potentiation of the DYRK1A-STAT pathway in progenitors contributes to aberrant astrogliogenesis in DS.	[Kurabayashi, Nobuhiro; Sanada, Kamon] Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Bunkyo Ku, Tokyo 113, Japan; [Nguyen, Minh Dang] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB T2N 1N4, Canada; [Nguyen, Minh Dang] Univ Calgary, Hotchkiss Brain Inst, Dept Cell Biol & Anat, Calgary, AB T2N 1N4, Canada; [Nguyen, Minh Dang] Univ Calgary, Hotchkiss Brain Inst, Dept Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada	Sanada, K (reprint author), Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Bunkyo Ku, Tokyo 113, Japan.	kamon_sanada@gen.s.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Mitsubishi Foundation, Takeda Science Foundation; Daiichi Sankyo Foundation of Life Science; Canadian Institutes of Health Research	We would like to thank Dr. Kazuhiro Yamakawa for Ts1Cje mice. We also thank Drs. Takahiko Matsuda, Kinichi Nakashima, and Anjen Chenn for plasmids. This work was supported in part by Grants-in-Aid for Young Scientists (B), Scientific Research (C) (N.K.), and Exploratory Research (K.S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and research grants from the Mitsubishi Foundation, Takeda Science Foundation (N.K.), Daiichi Sankyo Foundation of Life Science (K.S.), and the Canadian Institutes of Health Research (M.D.N).	Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; SHOLL DA, 1953, J ANAT, V87, P387; Okano H, 2009, CURR OPIN NEUROBIOL, V19, P112, DOI 10.1016/j.conb.2009.04.003; Dierssen M, 2012, NAT REV NEUROSCI, V13, P844, DOI 10.1038/nrn3314; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Chakrabarti L, 2007, J NEUROSCI, V27, P11483, DOI 10.1523/JNEUROSCI.3406-07.2007; GOLDEN JA, 1994, J NEUROPATH EXP NEUR, V53, P513, DOI 10.1097/00005072-199409000-00011; Guidi S, 2008, BRAIN PATHOL, V18, P180, DOI 10.1111/j.1750-3639.2007.00113.x; Marti E, 2003, BRAIN RES, V964, P250, DOI 10.1016/S0006-8993(02)04069-6; Rajan P, 1998, J NEUROSCI, V18, P3620; Lu J, 2012, HUM MOL GENET, V21, P2330, DOI 10.1093/hmg/dds052; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006; Hatanaka Y, 2004, J COMP NEUROL, V479, P1, DOI 10.1002/ene.20256; Li D, 2010, J BIOL CHEM, V285, P35374, DOI 10.1074/jbc.M110.148445; Contestabile A, 2007, HIPPOCAMPUS, V17, P665, DOI 10.1002/hipo.20308; Trazzi S, 2011, HUM MOL GENET, V20, P1560, DOI 10.1093/hmg/ddr033; MANN DMA, 1987, J NEUROL SCI, V80, P79, DOI 10.1016/0022-510X(87)90223-1; Yabut O, 2010, J NEUROSCI, V30, P4004, DOI 10.1523/JNEUROSCI.4711-09.2010; Chapman RS, 2000, MENT RETARD DEV D R, V6, P84, DOI 10.1002/1098-2779(2000)6:2<84::AID-MRDD2>3.0.CO;2-P; Tanzi RE, 1996, NAT MED, V2, P31, DOI 10.1038/nm0196-31; Briggs JA, 2013, STEM CELLS, V31, P467, DOI 10.1002/stem.1297; Canfield MA, 2006, BIRTH DEFECTS RES A, V76, P747, DOI 10.1002/bdra.20294; Tejedor FJ, 2011, FEBS J, V278, P223, DOI 10.1111/j.1742-4658.2010.07954.x; Yoshimatsu T, 2006, DEVELOPMENT, V133, P2553, DOI 10.1242/dev.02419; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Moldrich RX, 2009, J NEUROSCI RES, V87, P3143, DOI 10.1002/jnr.22131; SCHMIDTSIDOR B, 1990, CLIN NEUROPATHOL, V9, P181; Weitzdoerfer R, 2001, J NEURAL TRANSM-SUPP, P59; Amano K, 2004, HUM MOL GENET, V13, P1333, DOI 10.1093/hmg/ddh154; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Soppa U, 2014, CELL CYCLE, V13, P2084, DOI 10.4161/cc.29104; Breunig JJ, 2011, NEURON, V70, P614, DOI 10.1016/j.neuron.2011.05.005; Matsuo R, 2001, J IMMUNOL METHODS, V247, P141, DOI 10.1016/S0022-1759(00)00313-6; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Haydar TF, 2012, TRENDS NEUROSCI, V35, P81, DOI 10.1016/j.tins.2011.11.001; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Hammerle B, 2008, EUR J NEUROSCI, V27, P1061, DOI 10.1111/j.1460-9568.2008.06092.x; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Guimera J, 1999, GENOMICS, V57, P407, DOI 10.1006/geno.1999.5775; Miyata T, 2010, CURR OPIN NEUROBIOL, V20, P22, DOI 10.1016/j.conb.2010.01.001; Kurabayashi N, 2013, GENE DEV, V27, P2708, DOI 10.1101/gad.226381.113; Becker W, 2011, FEBS J, V278, P246, DOI 10.1111/j.1742-4658.2010.07956.x; Ishihara K, 2010, CEREB CORTEX, V20, P1131, DOI 10.1093/cercor/bhp176; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Chen C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5430; Gräff Johannes, 2011, Physiol Rev, V91, P603, DOI 10.1152/physrev.00012.2010; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Lu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022126; Martynoga B, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008359; Park Joongkyu, 2013, Exp Neurobiol, V22, P244, DOI 10.5607/en.2013.22.4.244; Qi Qian-Rong, 2014, World J Biol Chem, V5, P231, DOI 10.4331/wjbc.v5.i2.231; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9	57	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1469-221X	1469-3178		EMBO REP	EMBO Rep.	NOV	2015	16	11					1548	1562				15	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CV5NX	WOS:000364318900018		
J	Hamada, T; Yasunaga, H; Nakai, Y; Isayama, H; Matsui, H; Horiguchi, H; Fushimi, K; Koike, K				Hamada, Tsuyoshi; Yasunaga, Hideo; Nakai, Yousuke; Isayama, Hiroyuki; Matsui, Hiroki; Horiguchi, Hiromasa; Fushimi, Kiyohide; Koike, Kazuhiko			Bleeding after endoscopic sphincterotomy or papillary balloon dilation among users of antithrombotic agents	ENDOSCOPY			English	Article							BILE-DUCT STONES; DOSE ASPIRIN THERAPY; SECONDARY PREVENTION; ANTIPLATELET AGENTS; RANDOMIZED-TRIAL; RISK; DILATATION; MANAGEMENT; COMPLICATIONS; METAANALYSIS	Background and study aims: Severe bleeding is a potentially lethal complication after endoscopic sphincterotomy (EST) and endoscopic papillary balloon dilation (EPBD) for choledocholithiasis. This study aimed to evaluate the impact of antiplatelet agents and anticoagulants on this complication. Patients and methods: Patients who underwent EST and EPBD were identified in a Japanese nationwide administrative database covering 1090 hospitals. Adjusting for other potential risk factors, we evaluated the association between oral administration of antiplatelet agents and/or anticoagulants (continuation, discontinuation, and non-use) and clinically significant bleeding within 3 days of the procedure. Results: In total, 61002 patients were analyzed (EST, 54493 patients; EPBD, 6509). The rate of severe bleeding was 0.8% in both groups, but EPBD was performed more frequently than EST in patients with chronic renal failure, liver cirrhosis, and in those receiving antiplatelet agents or anticoagulants. The impact of continuation/discontinuation of antiplatelet agents on severe bleeding was not statistically significant in the EST or EPBD groups. The use of anticoagulants was associated with a statistically significant increase in severe bleeding compared with non-use for EST (1.6% 27 of 1688 patients vs. 0.8% 429 of 52 805 patients; adjusted odds ratio [OR] 1.70; 95% confidence interval [CI] 1.10-2.63) and for EPBD (3.0% [8 of 263 patients] vs. 0.7% 46 of 6246 patients; adjusted OR 2.91; 95% CI 1.36-6.24). Conclusions: EST and EPBD can be safely performed in patients receiving antiplatelet agents. Users of anticoagulants are at high risk of bleeding, and the periprocedural management of these should be further investigated.	[Hamada, Tsuyoshi; Nakai, Yousuke; Isayama, Hiroyuki; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo 1138655, Japan; [Yasunaga, Hideo; Matsui, Hiroki] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo 1138655, Japan; [Horiguchi, Hiromasa] Natl Hosp Org Headquarters, Clin Res Ctr, Dept Clin Data Management & Res, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Dept Hlth Care Informat, Tokyo, Japan	Isayama, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	isayama-tky@umin.ac.jp			Ministry of Health, Labour and Welfare, Japan [H26-Policy-011, H26-Special-047]	This study was funded by Grants-in-Aid from the Ministry of Health, Labour and Welfare, Japan (Grant No. H26-Policy-011 and H26-Special-047).	Abdel Samie A Ahmed, 2013, Hepatogastroenterology, V60, P659, DOI 10.5754/hge12356; COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Fujita N, 2003, GASTROINTEST ENDOSC, V57, P151, DOI 10.1067/mge.2003.56; Derogar M, 2013, CLIN GASTROENTEROL H, V11, P38, DOI 10.1016/j.cgh.2012.08.034; NELSON DB, 1994, J CLIN GASTROENTEROL, V19, P283, DOI 10.1097/00004836-199412000-00004; Boustiere C, 2011, ENDOSCOPY, V43, P445, DOI 10.1055/s-0030-1256317; VAIRA D, 1989, LANCET, V2, P431; Hui CK, 2002, ALIMENT PHARM THERAP, V16, P929, DOI 10.1046/j.1365-2036.2002.01251.x; Bergman JJGHM, 1997, LANCET, V349, P1124, DOI 10.1016/S0140-6736(96)11026-6; Tsujino T, 2007, CLIN GASTROENTEROL H, V5, P130, DOI 10.1016/j.cgh.2006.10.013; Onal IK, 2013, CLIN RES HEPATOL GAS, V37, P171, DOI 10.1016/j.clinre.2012.04.010; EKNOYAN G, 1969, NEW ENGL J MED, V280, P677, DOI 10.1056/NEJM196903272801301; Sung JJY, 2010, ANN INTERN MED, V152, P1, DOI 10.7326/0003-4819-152-1-201001050-00179; Amitrano L, 2002, SEMIN LIVER DIS, V22, P83, DOI 10.1055/s-2002-23205; Ito Y, 2008, GASTROINTEST ENDOSC, V68, P477, DOI 10.1016/j.gie.2007.10.066; Sasahira N, 2005, GUT, V54, P698, DOI 10.1136/gut.2003.038331; Desai J, 2013, GASTROINTEST ENDOSC, V78, P227, DOI 10.1016/j.gie.2013.04.179; Baron TH, 2014, CLIN GASTROENTEROL H, V12, P187, DOI 10.1016/j.cgh.2013.05.020; DiSario JA, 2004, GASTROENTEROLOGY, V127, P1291, DOI 10.1053/j.gastro.2004.07.017; Kawabe T, 1996, ENDOSCOPY, V28, P694, DOI 10.1055/s-2007-1005579; Diener HC, 1996, J NEUROL SCI, V143, P1, DOI 10.1016/S0022-510X(96)00308-5; Takahara N, 2012, J GASTROENTEROL, V47, P918, DOI 10.1007/s00535-012-0551-x; Park DH, 2004, GASTROINTEST ENDOSC, V60, P180, DOI 10.1016/S0016-5107(04)01554-8; LAMBERT ME, 1991, BRIT J SURG, V78, P473, DOI 10.1002/bjs.1800780427; Zhao HC, 2013, WORLD J GASTROENTERO, V19, P3883, DOI 10.3748/wjg.v19.i24.3883; Hussain N, 2007, ALIMENT PHARM THERAP, V25, P579, DOI 10.1111/j.1365-2036.2006.03225.x; Collins R, 2009, LANCET, V373, P1849; Baron TH, 2013, NEW ENGL J MED, V368, P2113, DOI 10.1056/NEJMra1206531; Buxbaum James, 2013, Gastrointest Endosc Clin N Am, V23, P251, DOI 10.1016/j.giec.2012.12.003; Committee A SoP, 2009, GASTROINTEST ENDOSC, V70, P1060; Freeman ML, 1996, NEW ENGL J MED, V335, P909, DOI 10.1056/NEJM199609263351301; Mathuna P M, 1995, Gastrointest Endosc, V42, P468, DOI 10.1016/S0016-5107(95)70052-8; Ogoshi K, 2005, GASTROENTEROL ENDOSC, V47, P2691; Yasunaga H, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-129	34	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy	NOV	2015	47	11					997	1004		10.1055/s-0034-1392408		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CV4FA	WOS:000364220900005		
J	Akutsu, D; Narasaka, T; Wakayama, M; Terasaki, M; Kaneko, T; Matsui, H; Suzuki, H; Hyodo, I; Mizokami, Y				Akutsu, Daisuke; Narasaka, Toshiaki; Wakayama, Mariko; Terasaki, Masahiko; Kaneko, Tsuyoshi; Matsui, Hirofumi; Suzuki, Hideo; Hyodo, Ichinosuke; Mizokami, Yuji			Endoscopic detachable snare ligation: a new treatment method for colonic diverticular hemorrhage	ENDOSCOPY			English	Article							BAND LIGATION; EPIDEMIOLOGY; COLONOSCOPY; MANAGEMENT	Background and study aims: Colonic diverticular hemorrhage is the most common cause of lower intestinal bleeding. We tried to develop a convenient and reliable hemostatic method, endoscopic detachable snare ligation (EDSL), to treat diverticular hemorrhage and retrospectively explored its safety and efficacy. Patients and methods: The definitive bleeding diverticulum was ligated with a detachable snare, instead of a rubber band, in a procedure similar to endoscopic band ligation. Removal of the scope to attach a ligation device and reinsertion for treatment are not needed in this method. Results: From November 2013 to September 2014, EDSL was used to treat 8 patients with colonic diverticular hemorrhage. The mean procedure time required for hemostasis after identification of the bleeding diverticulum was 5+/-2 minutes. Sustained hemostasis was achieved in 7 patients (88 %), and early rebleeding occurred in 1 patient, in whom the applied suction seemed inadequate. No complications occurred in any patient. Conclusions: EDSL may be a safe and effective treatment for colonic diverticular hemorrhage. However, additional studies are warranted to confirm these initial exploratory data.	[Akutsu, Daisuke; Terasaki, Masahiko; Kaneko, Tsuyoshi; Matsui, Hirofumi; Hyodo, Ichinosuke] Univ Tsukuba, Dept Gastroenterol, Tsukuba, Ibaraki, Japan; [Narasaka, Toshiaki; Suzuki, Hideo; Mizokami, Yuji] Univ Tsukuba Hosp, Div Endoscopy, Tsukuba, Ibaraki 3058576, Japan; [Wakayama, Mariko] Koyama Mem Hosp, Dept Gastroenterol, Kashima, Ibaraki, Japan	Narasaka, T (reprint author), Univ Tsukuba Hosp, Div Endoscopy, 2-1-1 Amakubo, Tsukuba, Ibaraki 3058576, Japan.	narasaka-gi@umin.ac.jp					Ishii N, 2012, GASTROINTEST ENDOSC, V75, P382, DOI 10.1016/j.gie.2011.07.030; Akimaru Koho, 2008, Journal of Nippon Medical School, V75, P157, DOI 10.1272/jnms.75.157; Setoyama T, 2011, SURG ENDOSC, V25, P3574, DOI 10.1007/s00464-011-1760-8; Kang JY, 2004, DRUG AGING, V21, P211, DOI 10.2165/00002512-200421040-00001; Farrell JJ, 2003, ENDOSCOPY, V35, P823; Chaudhry V, 1998, AM SURGEON, V64, P723; Jensen DM, 2000, NEW ENGL J MED, V342, P78, DOI 10.1056/NEJM200001133420202; Aytac E, 2014, INT J COLORECTAL DIS, V29, P373, DOI 10.1007/s00384-013-1804-8; Longstreth GF, 1997, AM J GASTROENTEROL, V92, P419; MCGUIRE HH, 1994, ANN SURG, V220, P653, DOI 10.1097/00000658-199411000-00008; Shibata S, 2014, ENDOSCOPY, V46, P66, DOI 10.1055/s-0033-1344890	11	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy	NOV	2015	47	11					1039	1042		10.1055/s-0034-1392204		4	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CV4FA	WOS:000364220900011		
J	Tamura, N				Tamura, Naho			My epilepsy story: What is it like to be absent?A message from an "ex"-patient	EPILEPSIA			English	Editorial Material										Tamura, N (reprint author), ICON Japan KK MD Kanda Bldg 6F 7F, Tokyo 1010053, Japan.	naho_tamura1@hotmail.co.uk					Dlugos D, 2013, NEUROLOGY, V81, P150, DOI 10.1212/WNL.0b013e31829a3373; Glauser TA, 2010, NEW ENGL J MED, V362, P790, DOI 10.1056/NEJMoa0902014	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	NOV	2015	56	11					1707	1709		10.1111/epi.13198		3	Clinical Neurology	Neurosciences & Neurology	CU9RZ	WOS:000363884100012		
J	Ikeda, A				Ikeda, Akio			Commentary: We shall not lose past medical documents	EPILEPSIA			English	Editorial Material									[Ikeda, Akio] Kyoto Univ, Dept Epilepsy Movement Disorders & Physiol, Grad Sch Med, Kyoto, Japan	Ikeda, A (reprint author), Kyoto Univ, Dept Epilepsy Movement Disorders & Physiol, Epilepsia, Grad Sch Med, Kyoto, Japan.	akio@kuhp.kyoto-u.ac.jp						0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	NOV	2015	56	11					1712	1713		10.1111/epi.13196		2	Clinical Neurology	Neurosciences & Neurology	CU9RZ	WOS:000363884100014		
J	Otsuki, B; Fujibayashi, S; Takemoto, M; Kimura, H; Shimizu, T; Matsuda, S				Otsuki, Bungo; Fujibayashi, Shunsuke; Takemoto, Mitsuru; Kimura, Hiroaki; Shimizu, Takayoshi; Matsuda, Shuichi			Diffuse idiopathic skeletal hyperostosis (DISH) is a risk factor for further surgery in short-segment lumbar interbody fusion	EUROPEAN SPINE JOURNAL			English	Article						Diffuse idiopathic skeletal hyperostosis; Lumbar interbody fusion; Adjacent segment disease; Pseudoarthrosis; Cox proportional hazards	CERVICAL-SPINE; ADJACENT; DEGENERATION	To elucidate the effect of diffuse idiopathic skeletal hyperostosis (DISH) on the clinical results of short-segment lumbar interbody fusion (LIF) for the treatment of degenerative lumbar spinal diseases. The 208 patients who underwent one- or two-level LIF were selected as the subjects of this study. Patients with prior lumbar fusion surgery or follow-up < 1 year were excluded. Outcome measures were surgery-free survival or the need for further surgery for pseudoarthrosis and/or adjacent segment disease (ASD). The Cox proportional-hazards model was used to identify possible risk factors (DISH, age, sex, number of levels fused, level of the lowest instrumented vertebra, and laminectomy adjacent to the index fused levels) for further surgery. Among the 208 patients (39 with DISH), 21 patients required further surgery during follow-up. Cox analysis showed that DISH (hazard ratio = 5.46) and two-level fusion (hazard ratio = 2.83) were significant independent predictors of further surgery. Age, sex, level of the lowest instrumented vertebra, and laminectomy adjacent to the index fused levels were not significant predictors. DISH after short-segment LIF surgery is a significant risk factor for further surgery because of pseudoarthrosis or ASD.	[Otsuki, Bungo; Fujibayashi, Shunsuke; Takemoto, Mitsuru; Kimura, Hiroaki; Shimizu, Takayoshi; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Kyoto, Kyoto, Japan	Otsuki, B (reprint author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, 54 Kawahara Cho, Kyoto, Kyoto, Japan.	bungo@kuhp.kyoto-u.ac.jp					GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Mader R, 2005, RHEUMATOL INT, V26, P132, DOI 10.1007/s00296-004-0529-y; Mader R, 2009, SEMIN ARTHRITIS RHEU, V38, P361, DOI 10.1016/j.semarthrit.2008.01.010; Min JH, 2008, J SPINAL DISORD TECH, V21, P305, DOI 10.1097/BSD.0b013e318142b960; Greiner-Perth R, 2004, SPINE, V29, P2516, DOI 10.1097/01.brs.0000144833.63581.c1; Mata S, 1998, SEMIN ARTHRITIS RHEU, V28, P88, DOI 10.1016/S0049-0172(98)80041-3; Sears WR, 2011, SPINE J, V11, P11, DOI 10.1016/j.spinee.2010.09.026; Diederichs G, 2011, OSTEOPOROSIS INT, V22, P1789, DOI 10.1007/s00198-010-1409-9; RESNICK D, 1976, RADIOLOGY, V119, P559; Bransford RJ, 2012, SPINE, V37, P1923, DOI 10.1097/BRS.0b013e31825b17fc; Etebar S, 1999, J NEUROSURG, V90, P163, DOI 10.3171/spi.1999.90.2.0163; Carlson ML, 2011, DYSPHAGIA, V26, P34, DOI 10.1007/s00455-009-9264-6; Mader R, 2002, SEMIN ARTHRITIS RHEU, V32, P130, DOI 10.1053/sarh.2002.33726; Gercek E, 2008, SPINE, V33, P2326, DOI 10.1097/BRS.0b013e31818096ea; Gillet P, 2003, J SPINAL DISORD TECH, V16, P338; Al-Herz A, 2008, CLIN RHEUMATOL, V27, P207, DOI 10.1007/s10067-007-0693-z; Holton KF, 2011, SEMIN ARTHRITIS RHEU, V41, P131, DOI 10.1016/j.semarthrit.2011.01.001; Chi DM, 2008, SPINE J, V8, P1019, DOI 10.1016/j.spinee.2007.09.007; Disch AC, 2008, J SPINAL DISORD TECH, V21, P79, DOI 10.1097/BSD.0b013e3180577259; Ghiselli G, 2004, J BONE JOINT SURG AM, V86A, P1497; FORESTIE.J, 1971, CLIN ORTHOP RELAT R, P65; Mannion A F, 2014, Eur Spine J, V23 Suppl 1, pS66, DOI 10.1007/s00586-014-3189-y; Mosher HP, 1926, LARYNGOSCOPE, V36, P181, DOI 10.1288/00005537-192603000-00004; WILTSE LL, 1973, CLIN ORTHOP RELAT R, P48	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	NOV	2015	24	11					2514	2519		10.1007/s00586-014-3603-5		6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CV0UU	WOS:000363969900020		
J	Yamada, K; Ito, M; Akazawa, T; Murata, M; Yamamoto, T; Iwasaki, N				Yamada, Katsuhisa; Ito, Manabu; Akazawa, Toshiyuki; Murata, Masaru; Yamamoto, Toru; Iwasaki, Norimasa			A preclinical large animal study on a novel intervertebral fusion cage covered with high porosity titanium sheets with a triple pore structure used for spinal fusion	EUROPEAN SPINE JOURNAL			English	Article						Biomaterial; Intervertebral cage; Porous titanium; Bone ingrowth; Interbody fusion	LUMBAR INTERBODY FUSION; BLOOD PERMEABILITY; MODEL; SCIENCE; FOAM	To evaluate the osteoconductivity and the bonding strength of the newly developed interbody cage covered with the porous titanium sheet (porous Ti cage) to vertebral bodies in a sheep model. Twelve sheep underwent anterior lumbar interbody fusion at L2-3 and L4-5 using either the new porous Ti cages (Group-P) or conventional Ti cages with autogenous iliac bone (Group-C). The animals were euthanized at 2 or 4 months postoperatively and subjected to radiological, biomechanical, and histological examinations. Computed tomography analyses showed that the ratio of bone contact area in Group-P was significantly increased at 4 months compared with that at 2 months (p = 0.01). Although the ratio of bone contact area in Group-C was significantly higher than Group-P at 2 months (p < 0.001), there was no statistically significant difference between the two groups at 4 months. Biomechanical test showed that there was no significant difference in bonding strength between the two groups at either 2 or 4 months. Histological analyses revealed that the bone apposition ratio increased significantly with time in Group-P (p < 0.001). Although Group-C showed significantly higher bone apposition ratio than Group-P at 2 months (p = 0.001), there was no statistical difference between the two groups at 4 months. There was bone ingrowth into the porous Ti sheet, and bonding capacity of the porous Ti cage to the host bone increased with time. However, the speed of union to the bone with a porous Ti cage was marginally lower than a conventional cage along with an autogenous bone graft. Although it needs further experiment with a larger sample size, the results of the current study suggested that this material could achieve interbody fusion without the need for bone grafts.	[Yamada, Katsuhisa; Iwasaki, Norimasa] Hokkaido Univ, Grad Sch Med, Dept Orthoped Surg, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Ito, Manabu] Natl Hosp Org, Dept Spine & Spinal Cord Disorders, Hokkaido Med Ctr, Sapporo, Hokkaido, Japan; [Akazawa, Toshiyuki] Hokkaido Res Org, Ind Technol Res Dev, Ind Res Inst, Sapporo, Hokkaido, Japan; [Murata, Masaru] Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral & Maxillofacial Surg, Tobetsu, Japan; [Yamamoto, Toru] Hokkaido Univ, Fac Hlth Sci, Div Biomed Engn & Sci, Sapporo, Hokkaido 0608638, Japan	Yamada, K (reprint author), Hokkaido Univ, Grad Sch Med, Dept Orthoped Surg, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	yka2q@yahoo.co.jp			HOYA Pentax Co.; Northern Advancement Center for Science & Technology, and Strategic Promotion of Innovative Research and Development, Japan Science and Technology Agency	We thank Toshio Matsumoto, B.S. and Takehiko Nakajima, B.S., HOYA Pentax Co., for their technical support and providing Ti porous materials and downsized intervertebral spacers for the animals. Furthermore, we thank Ken Nagahama, M.D., Ph.D. for his support in performing the surgery and to Fumio Sasazawa, M.D., Ph.D for capturing CT images. This study was supported by HOYA Pentax Co., Start-up Grant of Northern Advancement Center for Science & Technology, and Strategic Promotion of Innovative Research and Development, Japan Science and Technology Agency.	Rihn JA, 2009, SPINE J, V9, P623, DOI 10.1016/j.spinee.2009.04.004; Hanzlik JA, 2013, J ARTHROPLASTY, V28, P922, DOI 10.1016/j.arth.2013.01.035; Abbushi A, 2009, EUR SPINE J, V18, P1621, DOI 10.1007/s00586-009-1036-3; Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4; Hojo Y, 2005, BIOMATERIALS, V26, P2643, DOI 10.1016/j.biomaterials.2004.07.020; Akazawa T, 2006, J BIOMED MATER RES A, V76A, P44, DOI 10.1002/jbm.a.30439; Colnot C, 2011, TISSUE ENG PART B-RE, V17, P449, DOI [10.1089/ten.TEB.2011.0243, 10.1089/ten.teb.2011.0243]; Assad M, 2003, J BIOMED MATER RES B, V64B, P107, DOI 10.1002/jbm.b.10530; Alvarez K, 2009, MATERIALS, V2, P790, DOI 10.3390/ma2030790; Zhou ZJ, 2011, J NEUROSURG-SPINE, V15, P295, DOI 10.3171/2011.4.SPINE10330; Rihn JA, 2010, SPINE, V35, P1629, DOI 10.1097/BRS.0b013e3181d25803; Ito M, 2007, J NEUROSURG-SPINE, V6, P431, DOI 10.3171/spi.2007.6.5.431; Lee JH, 2010, SPINE, V35, P1460, DOI 10.1097/BRS.0b013e3181c4baf5; Wilke HJ, 1997, SPINE, V22, P2365, DOI 10.1097/00007632-199710150-00009; Sakamoto M, 2007, J BIOMED MATER RES A, V82A, P238, DOI 10.1002/jbm.a.31013; Kato K, 2012, MATER TRANS, V53, P724, DOI 10.2320/matertrans.M2011325; Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002; Murata M, 2007, J BIOMED MATER RES B, V81B, P469, DOI 10.1002/jbm.b.30686; Motomiya M, 2007, EUR SPINE J, V16, P2215, DOI 10.1007/s00586-007-0501-0; Takemoto M, 2007, J NEUROSURG-SPINE, V7, P435, DOI 10.3171/SPI-07/10/435; Kato K, 2013, ACTA BIOMATER, V9, P5802, DOI 10.1016/j.actbio.2012.11.018; Zou XN, 2005, SPINE, V30, pE392, DOI 10.1097/01.brs.0000170588.80377.3f; Sakamoto M, 2012, DEV EVALUATION SUPER, P301; Zou Xuenong, 2004, Spine J, V4, P99, DOI 10.1016/S1529-9430(03)00407-8	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	NOV	2015	24	11					2530	2537		10.1007/s00586-015-4047-2		8	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CV0UU	WOS:000363969900023		
J	Koda, M; Furuya, T; Okawa, A; Aramomi, M; Inada, T; Kamiya, K; Ota, M; Maki, S; Ikeda, O; Takahashi, K; Mannoji, C; Yamazaki, M				Koda, Masao; Furuya, Takeo; Okawa, Akihiko; Aramomi, Masaaki; Inada, Taigo; Kamiya, Koshiro; Ota, Mitsutoshi; Maki, Satoshi; Ikeda, Osamu; Takahashi, Kazuhisa; Mannoji, Chikato; Yamazaki, Masashi			Bone union and remodelling of the non-ossified segment in thoracic ossification of the posterior longitudinal ligament after posterior decompression and fusion surgery	EUROPEAN SPINE JOURNAL			English	Article						OPLL; Bone union; Fusion surgery; Remodelling	SPONTANEOUS REDUCTION; SPINE; CLASSIFICATION; MYELOPATHY	The motion at the non-ossified segment of the ossification of the posterior longitudinal ligament (OPLL) is thought to be highly correlated to aggravation of symptoms of myelopathy. The rationale for posterior decompression with instrumented fusion (PDF) surgery is to limit the motion of the non-ossified segment of OPLL by stabilization. The purpose of the present study was to elucidate the course of bone union and remodelling of the non-ossified segment of thoracic OPLL (T-OPLL) after PDF surgery. A total of 29 patients who underwent PDF surgery for T-OPLL were included in this study. We measured the thickness of the OPLLs by determining the thickest part of the OPLL in the sagittal multi-planer reconstruction CT images pre- and post-operatively. Five experienced spine surgeons independently performed CT measurements of OPLL thickness twice. Japanese Orthopaedic Association score for thoracic myelopathy was measured as clinical outcome measure. Non-ossified segment of OPLLs fused in 24 out of 29 (82.8 %) patients. The average thickness of the OPLL at its thickest segment was 8.0 mm and decreased to 7.3 mm at final follow-up. The decrease in ossification thickness was significantly larger in the patients who showed fusion of non-ossified segments of OPLL compared with that in the patients did not show fusion. There was no significant correlation between the clinical outcome and the decrease in thickness of the OPLLs. The results of this study showed that remodelling of the OPLLs, following fusion of non-ossified segment of OPLLs, resulted in a decreased OPLL thickness, with potential for a reduction of spinal cord compression.	[Koda, Masao; Furuya, Takeo; Okawa, Akihiko; Aramomi, Masaaki; Inada, Taigo; Kamiya, Koshiro; Ota, Mitsutoshi; Maki, Satoshi; Ikeda, Osamu; Takahashi, Kazuhisa] Chiba Univ, Dept Orthopaed Surg, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan; [Mannoji, Chikato] Chiba Aoba Municipal Hosp, Dept Orthopaed Surg, Chiba, Japan; [Yamazaki, Masashi] Univ Tsukuba, Dept Orthopaed Surg, Tsukuba, Ibaraki, Japan	Koda, M (reprint author), Chiba Univ, Dept Orthopaed Surg, Grad Sch Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	masaokod@gmail.com					Yamazaki M, 2006, SPINE, V31, P1452, DOI 10.1097/01.brs.0000220834.22131.fb; Matsumoto M, 2008, SPINE, V33, P1034, DOI 10.1097/BRS.0b013e31816c913b; Kudo H, 2013, EUR SPINE J, V22, P205, DOI 10.1007/s00586-012-2573-8; Matsuyama Y, 2009, EUR SPINE J, V18, P943, DOI 10.1007/s00586-009-0956-2; Kimura H, 2014, SPINE, V39, pE417, DOI 10.1097/BRS.0000000000000187; Yamazaki M, 2010, EUR SPINE J, V19, P691, DOI 10.1007/s00586-009-1266-4; Kawaguchi Y, 2014, J ORTHOP SCI, V19, P530, DOI 10.1007/s00776-014-0577-4; Fujiyoshi T, 2010, J CLIN NEUROSCI, V17, P320, DOI 10.1016/j.jocn.2009.06.023; HIRABAYASHI K, 1981, SPINE, V6, P354, DOI 10.1097/00007632-198107000-00005; Matsumoto M, 2011, J NEUROSURG-SPINE, V15, P380, DOI 10.3171/2011.6.SPINE10816; Miyashita T, 2013, SPINE J, V13, pE7, DOI 10.1016/j.spinee.2013.02.013; Sakou T, 1994, ANN REPORT TASKFORCE, P11; Sjöström L, 1994, Eur Spine J, V3, P312, DOI 10.1007/BF02200143; Smith ZA, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.1.FOCUS10256	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	NOV	2015	24	11					2555	2559		10.1007/s00586-015-3888-z		5	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CV0UU	WOS:000363969900026		
J	Yamamoto, Y; Koma, H; Yagami, T				Yamamoto, Yasuhiro; Koma, Hiromi; Yagami, Tatsurou			Localization of 14-3-3 delta/xi on the neuronal cell surface	EXPERIMENTAL CELL RESEARCH			English	Article						14-3-3 delta/xi; Cortical neurons; Hydroxyl peroxide; 15-Deoxy-Delta(12,14)-prostaglandin J(2); Alzheimer's disease; Catalase	ACTIVATED RECEPTOR-GAMMA; PRIMARY CORTICAL-NEURONS; ALZHEIMERS-DISEASE; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); OXIDATIVE STRESS; 14-3-3 PROTEINS; PPAR-GAMMA; APOPTOSIS; DEATH; BRAIN	14-3-3 proteins are intracellularly expressed as ubiquitous adaptor proteins. Here, we found localization of 14-3-3 delta/xi on the neuronal cell surface. 14-3-3 delta/xi was identified as a membrane target for 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)). 15d-PGJ(2) is a pathological mediator of neurodegenerative diseases including Alzheimer's disease (AD). A causative peptide for AD, amyloid beta, is one of binding partner of 14-3-3 delta/xi. Non-permeabilized neurons were used to avoid the intracellular effects of anti-14-3-3 delta/xi antibody in the present study. The plasmalemmal 14-3-3 delta/xi, but not the cytosolic one, was stimulated by its specific antibody, resulting in neuronal cell death. The neurotoxicity of anti-14-3-3 delta/xi antibody was suppressed by an antioxidant, catalase. Catalase prevented neurons from anti-14-3-3 delta/xi antibody-generating neurotoxic H2O2. The neuroprotective effect of catalase was also detected with the post-treatment of neurons after the application of anti-14-3-3 delta/xi antibody. Activation of mitogen-activated protein kinase signaling cascade is a down-stream consequence of H2O2 exposure. A c-Jun N-terminal kinase inhibitor suppressed anti-14-3-3 delta/xi antibody-induced neuronal cell death. To my knowledge, this is the first report that the antibody-stimulated plasmalemmal 14-3-3 delta/xi induced neuronal cell death. Furthermore, H2O2 and JNK contributed to the neurotoxicity of anti-14-3-3 delta/xi antibody as well as those of amyloid beta and 15d-PGJ(2). (C) 2015 Elsevier Inc. All rights reserved.	[Yamamoto, Yasuhiro; Koma, Hiromi; Yagami, Tatsurou] Himeji Dokkyo Univ, Fac Pharmaceut Sci, Dept Pharmaceut Hlth Care, Div Physiol, Himeji, Hyogo 6708524, Japan	Yagami, T (reprint author), Himeji Dokkyo Univ, Fac Pharmaceut Sci, Dept Pharmaceut Hlth Care, Div Physiol, 2-1,Kami Ohno 7 Chome, Himeji, Hyogo 6708524, Japan.	yagami@himeji-du.ac.jp			Himeji Dokkyo University	The authors thank Miss Asako Ohya, Mr. Yuma Kobayashi, Mr. Kazunori Murakami, Mr. Seiya Hisamura, and Mr. Eisuke Ohta for their technical assistance. The work presented in the submitted manuscript was funded by Himeji Dokkyo University.	Bulliard C, 1997, BIOCHEM J, V324, P555; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Yagami T, 2003, EXP CELL RES, V291, P212, DOI 10.1016/S0014-4827(03)00369-0; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Yagami T, 2006, CURR NEUROPHARMACOL, V4, P87, DOI 10.2174/157015906775203011; IWAMOTO N, 1989, J NEUROL, V236, P80, DOI 10.1007/BF00314401; Heneka MT, 2000, J NEUROSCI, V20, P6862; Kang DS, 2006, TOXICOL APPL PHARM, V216, P426, DOI 10.1016/j.taap.2006.06.008; Yagami T, 2002, J NEUROCHEM, V81, P449, DOI 10.1046/j.1471-4159.2002.00800.x; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Todd A, 1998, BIOCHEMISTRY-US, V37, P14317, DOI 10.1021/bi980768k; Wang JJ, 2011, PROSTAG OTH LIPID M, V94, P104, DOI 10.1016/j.prostaglandins.2011.01.004; BOSTON PF, 1982, J NEUROCHEM, V38, P1475, DOI 10.1111/j.1471-4159.1982.tb07928.x; Yagami T, 2002, MOL PHARMACOL, V61, P114, DOI 10.1124/mol.61.1.114; KIKAWA Y, 1984, P NATL ACAD SCI-BIOL, V81, P1317, DOI 10.1073/pnas.81.5.1317; Musiek ES, 2005, BRAIN PATHOL, V15, P149; Appleby VJ, 2011, J NEUROCHEM, V116, P530, DOI 10.1111/j.1471-4159.2010.07133.x; Aldini G, 2007, BIOCHEMISTRY-US, V46, P2707, DOI 10.1021/bi0618565; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Lee SJ, 2008, TOXICOLOGY, V248, P121, DOI 10.1016/j.tox.2008.03.014; MARTIN H, 1994, J NEUROCHEM, V63, P2259; Shibata T, 2002, J BIOL CHEM, V277, P10459, DOI 10.1074/jbc.M110314200; Yagami T, 2001, BRIT J PHARMACOL, V134, P673, DOI 10.1038/sj.bjp.0704261; Mattson MP, 2002, J NEUROVIROL, V8, P539, DOI 10.1080/13550280290100978; YAGAMI T, 1990, JPN J PHARMACOL, V54, P365, DOI 10.1254/jjp.54.365; Fountoulakis M, 1999, J NEURAL TRANSM-SUPP, P323; Zheng SQ, 2004, MOL PHARMACOL, V65, P1172, DOI 10.1124/mol.65.5.1172; Antunes F, 2000, FEBS LETT, V475, P121, DOI 10.1016/S0014-5793(00)01638-0; Tamagno E, 2003, EXP NEUROL, V180, P144, DOI 10.1016/S0014-4886(02)00059-6; Ha JS, 2010, EXP CELL RES, V316, P1651, DOI 10.1016/j.yexcr.2010.03.021; Butterfield DA, 2002, NEUROBIOL AGING, V23, P655; Nelson TJ, 2007, J BIOL CHEM, V282, P31238, DOI 10.1074/jbc.M705558200; Layfield R, 1996, NEUROSCI LETT, V209, P57, DOI 10.1016/0304-3940(96)12598-2; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; Yamamoto Y, 2015, NEUROTOXICOLOGY, V49, P86, DOI 10.1016/j.neuro.2015.05.008; Koh SH, 2005, TOXICOLOGY, V216, P232, DOI 10.1016/j.tox.2005.08.015; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Arnaud LT, 2009, J NEUROCHEM, V110, P328, DOI 10.1111/j.1471-4159.2009.06142.x; Hata AN, 2003, J PHARMACOL EXP THER, V306, P463, DOI 10.1124/jpet.103.050955; Rohn TT, 2001, NEUROREPORT, V12, P839, DOI 10.1097/00001756-200103260-00043; Hatanaka M, 2010, J PHARMACOL SCI, V113, P89, DOI 10.1254/jphs.10001SC; Ueda K, 1997, J NEUROCHEM, V68, P265; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; FITZPATRICK FA, 1983, J BIOL CHEM, V258, P1713; Yamamoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017552	45	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4827	1090-2422		EXP CELL RES	Exp. Cell Res.	NOV 1	2015	338	2					149	161		10.1016/j.yexcr.2015.09.002		13	Oncology; Cell Biology	Oncology; Cell Biology	CV6BA	WOS:000364354500003		
J	Koyama, T; Kamemura, K				Koyama, Takahiro; Kamemura, Kazuo			Global increase in O-linked N-acetylglucosamine modification promotes osteoblast differentiation	EXPERIMENTAL CELL RESEARCH			English	Article						Osteoblast differentiation; MC3T3-E1; Osteoclast differentiation; RAW264; O-GlcNAc glycosylation	BONE SIALOPROTEIN GENE; IN-VIVO; PROTEIN MODIFICATION; GLCNAC MODIFICATION; TRANSCRIPTIONAL ACTIVITY; CLEIDOCRANIAL DYSPLASIA; CELL-DIFFERENTIATION; BINDING SITES; X-CHROMOSOME; STEM-CELLS	The balance between bone formation and bone resorption is maintained by osteoblasts and osteoclasts, and an imbalance in this bone metabolism leads to osteoporosis. Here, we found that osteoblast differentiation in MC3T3-E1 cells is promoted by the inactivation of O-linked beta-N-acetylglucosaminidase (O-GlcNAcase) and suppressed by the inactivation of O-GlcNAc transferase, as indicated by extracellular matrix calcification. The expression of osteogenic genes such as alp, ocn, and bsp during osteoblast differentiation was positively regulated in a O-GlcNAc glycosylation-dependent manner. Because it was confirmed that Etsl and Runx2 are the two key transcription factors responsible for the expression of these osteogenic genes, their transcriptional activity might therefore be regulated by O-GlcNAc glycosylation. However, osteoclast differentiation of RAW264 cells, as indicated by the expression and activity of tartrate-resistant acid phosphatase, was unaffected by the inactivation of either O-GlcNAcase or O-GlcNAc transferase. Our findings suggest that an approach to manipulate O-GlcNAc glycosylation could be useful for developing the therapeutics for osteoporosis. (C) 2015 Elsevier Inc. All rights reserved.	[Koyama, Takahiro; Kamemura, Kazuo] Nagahama Inst Biosci & Technol, Dept Biosci, Nagahama, Shiga 5260829, Japan	Kamemura, K (reprint author), Nagahama Inst Biosci & Technol, Dept Biosci, 1266 Tamura, Nagahama, Shiga 5260829, Japan.	k_kamemura@nagahama-i-bio.ac.jp			JSPS [15K00412]	We are grateful to Dr. Gerald W. Hart (Johns Hopkins University School of Medicine) for kindly providing the anti-O-GlcNAc (CTD110.6) antibody. We thank Drs. Shintaro Nomura and Shuichi Wada (Nagahama Institute of Bio-Science and Technology) for helpful discussions, and also Mr. Kazuya Hayashi (Nagahama Institute of Bio-Science and Technology) for technical assistance with the construction of Etsl expression plasmids. This work was supported in part by JSPS KAKENHI Grant no. 15K00412 (to K. K.).	Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Nagel AK, 2013, MOL CELL PROTEOMICS, V12, P945, DOI 10.1074/mcp.M112.026633; Ji S, 2012, BIOCHEM BIOPH RES CO, V417, P1158, DOI 10.1016/j.bbrc.2011.12.086; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Golks A, 2007, EMBO J, V26, P4368, DOI 10.1038/sj.emboj.7601845; Gilbert L, 2002, J BIOL CHEM, V277, P2695, DOI 10.1074/jbc.M106339200; Sohn KC, 2014, J DERMATOL SCI, V75, P10, DOI 10.1016/j.jdermsci.2014.04.010; Nagel AK, 2014, MOL CELL PROTEOMICS, V13, P3381, DOI 10.1074/mcp.M114.040691; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Hsieh TJ, 2012, J CELL PHYSIOL, V227, P108, DOI 10.1002/jcp.22707; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Yanagisawa M, 2009, J NEUROSCI RES, V87, P3535, DOI 10.1002/jnr.22170; Wang K, 2009, BIOCHEM BIOPH RES CO, V387, P70, DOI 10.1016/j.bbrc.2009.06.132; Tardio L, 2014, OSTEOARTHR CARTILAGE, V22, P259, DOI 10.1016/j.joca.2013.12.001; Shen R, 2006, J BIOL CHEM, V281, P16347, DOI 10.1074/jbc.M603439200; Suh JH, 2008, BIOCHEM BIOPH RES CO, V367, P97, DOI 10.1016/j.bbrc.2007.12; Ogawa M, 2013, BIOCHEM BIOPH RES CO, V433, P558, DOI 10.1016/j.bbrc.2013.03.033; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Jang H, 2012, CELL STEM CELL, V11, P62, DOI 10.1016/j.stem.2012.03.001; Kim SH, 2007, BIOCHEM BIOPH RES CO, V362, P325, DOI 10.1016/j.bbrc.2007.07.149; Kim HS, 2009, FEBS LETT, V583, P2474, DOI 10.1016/j.febslet.2009.06.052; Roca H, 2005, J BIOL CHEM, V280, P30845, DOI 10.1074/jbc.M503942200; Li X, 2009, J BIOL CHEM, V284, P19248, DOI 10.1074/jbc.M109.005678; Ogawa M, 2012, BBA-GEN SUBJECTS, V1820, P24, DOI 10.1016/j.bbagen.2011.10.011; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI [10.1038/nchembio.520, 10.1038/NCHEMBIO.520]; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Benson MD, 2000, J BIOL CHEM, V275, P13907, DOI 10.1074/jbc.275.18.13907; HELFRICH MH, 1987, CELL TISSUE RES, V249, P125, DOI 10.1007/BF00215426; Maury JJP, 2013, STEM CELL RES, V11, P926, DOI 10.1016/j.scr.2013.06.004; CHEN JK, 1992, J BONE MINER RES, V7, P987; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Heath JM, 2014, CIRC RES, V114, P1094, DOI 10.1161/CIRCRESAHA.114.302968; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; Das S, 2013, DRUG DES DEV THER, V7, P435, DOI 10.2147/DDDT.S31504; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Francisco H, 2009, DEV NEUROBIOL, V69, P162, DOI 10.1002/dneu.20695; Andres-Bergos J, 2012, J BIOL CHEM, V287, P33615, DOI 10.1074/jbc.M112.354241; Wai PY, 2006, J BIOL CHEM, V281, P18973, DOI 10.1074/jbc.M511962200; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Ishihara K, 2010, BIOCHEM BIOPH RES CO, V398, P489, DOI 10.1016/j.bbrc.2010.06.105; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Gupta R., 2002, PAC S BIOCOMPUT, V7, P310, DOI DOI 10.1142/9789812799623_; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Junfeng, 2014, Clin Proteomics, V11, P8, DOI 10.1186/1559-0275-11-8; Maurya JJP, 2015, STEM CELL RES, V15, P182, DOI 10.1016/j.scr.2015.06.007; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Speakman CM, 2014, STEM CELLS, V32, P2605, DOI 10.1002/stem.1761	55	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4827	1090-2422		EXP CELL RES	Exp. Cell Res.	NOV 1	2015	338	2					194	202		10.1016/j.yexcr.2015.08.009		9	Oncology; Cell Biology	Oncology; Cell Biology	CV6BA	WOS:000364354500007		
J	Bahrami, M; Hoshino, M; Pierscionek, B; Yagi, N; Regini, J; Uesugi, K				Bahrami, Mehdi; Hoshino, Masato; Pierscionek, Barbara; Yagi, Naoto; Regini, Justyn; Uesugi, Kentaro			Refractive index degeneration in older lenses: A potential functional correlate to structural changes that underlie cataract formation	EXPERIMENTAL EYE RESEARCH			English	Article						Lens; Human; Cataract; Refractive index; Synchrotron; X-ray Talbot interferometry	HUMAN NUCLEAR CATARACTS; AGE-RELATED CATARACTS; X-RAY-DIFFRACTION; MULTILAMELLAR BODIES; CYTOPLASMIC TEXTURE; ELECTRON-MICROSCOPY; FIBER FOLDS; EYE; CRYSTALLINS; MORPHOLOGY	A major structure/function relationship in the eye lens is that between the constituent proteins, the crystallins and the optical property of refractive index. Structural breakdown that leads to cataract has been investigated in a number of studies; the concomitant changes in the optics, namely increases in light attenuation have also been well documented. Specific changes in the refractive index gradient that cause such attenuation, however, are not well studied because previous methods of measuring refractive index require transparent samples. The X-ray Talbot interferometric method using synchrotron radiation allows for measurement of fine changes in refractive index through lenses with opacities. The findings of this study on older human lenses show disruptions to the refractive index gradient and in the refractive index contours. These disruptions are linked to location in the lens and occur in polar regions, along or close to the equatorial plane or in lamellar-like formations. The disruptions that are seen in the polar regions manifest branching formations that alter with progression through the lens with some similarity to lens sutures. This study shows how the refractive index gradient, which is needed to maintain image quality of the eye, may be disturbed and that this can occur in a number of distinct ways. These findings offer insight into functional changes to a major optical parameter in older lenses. Further studies are needed to elicit how these may be related to structural degenerations reported in the literature. (C) 2015 The Authors. Published by Elsevier Ltd.	[Bahrami, Mehdi; Pierscionek, Barbara] Univ Kingston, Fac Sci Engn & Comp, Kingston Upon Thames KT1 2EE, Surrey, England; [Hoshino, Masato; Yagi, Naoto; Uesugi, Kentaro] Japan Synchrotron Radiat Res Inst SPring 8, Sayo, Hyogo, Japan; [Regini, Justyn] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff CF10 3AX, S Glam, Wales	Pierscionek, B (reprint author), Univ Kingston, Fac Sci Engn & Comp, Kingston Upon Thames KT1 2EE, Surrey, England.	b.pierscionek@kingston.ac.uk			Fight for Sight [1319/1320]; SPring-8 synchrotron [2013A1651, 2014A1710]	This work is supported by Fight for Sight (grant number 1319/1320) and beamtime grant from the SPring-8 synchrotron (grant numbers 2013A1651 and 2014A1710).	Gilliland KO, 2004, EXP EYE RES, V79, P563, DOI 10.1016/j.exer.2004.05.017; Costello MJ, 2008, EXP EYE RES, V87, P147, DOI 10.1016/j.exer.2008.05.009; COSTELLO MJ, 1992, INVEST OPHTH VIS SCI, V33, P3209; Momose A, 2005, JPN J APPL PHYS 1, V44, P6355, DOI 10.1143/JJAP.44.6355; Grey AC, 2008, MOL VIS, V14, P171; Kroger RHH, 1999, J COMP PHYSIOL A, V184, P361, DOI 10.1007/s003590050335; Bassnett S, 2011, PHILOS T R SOC B, V366, P1250, DOI 10.1098/rstb.2010.0302; Pierscionek BK, 2012, PROG RETIN EYE RES, V31, P332, DOI 10.1016/j.preteyeres.2012.03.001; PIERSCIONEK BK, 1995, EXP EYE RES, V60, P325, DOI 10.1016/S0014-4835(05)80114-9; Slingsby C, 1997, PROG RETIN EYE RES, V16, P3, DOI 10.1016/S1350-9462(96)00018-3; BROWN NP, 1993, EYE, V7, P672; Michael R, 2008, VISION RES, V48, P626, DOI 10.1016/j.visres.2007.12.005; PIERSCIONEK BK, 1992, BIOCHIM BIOPHYS ACTA, V1116, P283, DOI 10.1016/0304-4165(92)90041-R; Costello MJ, 2012, EXP EYE RES, V101, P72, DOI 10.1016/j.exer.2012.06.005; BROWN NAP, 1989, EYE, V3, P597; Keenan J, 2008, MOL VIS, V14, P1245; Tang DX, 2003, EXP EYE RES, V76, P605, DOI 10.1016/S0014-4835(03)00026-5; Keenan J, 2009, PROTEOMICS, V9, P5340, DOI 10.1002/pmic.200800986; Kuszak JR, 2004, EXP EYE RES, V78, P673, DOI 10.1016/j.exer.2003.09.016; Regini JW, 2009, CURR EYE RES, V34, P492, DOI 10.1080/02713680902919540; KUSZAK JR, 1994, EXP EYE RES, V59, P521, DOI 10.1006/exer.1994.1138; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI [10.1143/JJAP.42.L866, 10.1143/JJAP.L866]; KUSZAK JR, 1995, PROG RETIN EYE RES, V14, P567, DOI 10.1016/1350-9462(94)00019-C; Bahrami M, 2014, EXP EYE RES, V124, P93, DOI 10.1016/j.exer.2014.05.009; AlGhoul KJ, 1996, EXP EYE RES, V62, P237, DOI 10.1006/exer.1996.0029; SLINGSBY C, 1985, TRENDS BIOCHEM SCI, V10, P281, DOI 10.1016/0968-0004(85)90088-X; VRENSEN G, 1990, INVEST OPHTH VIS SCI, V31, P1582; ALGHOUL KJ, 1993, EXP EYE RES, V57, P469, DOI 10.1006/exer.1993.1149; Vrensen G, 1989, Dev Ophthalmol, V17, P181; Pierscionek BK, 1997, EXP EYE RES, V64, P887, DOI 10.1006/exer.1996.0252; AlGhoul KJ, 1996, CURR EYE RES, V15, P533, DOI 10.3109/02713689609000764; Metlapally S, 2008, EXP EYE RES, V86, P434, DOI 10.1016/j.exer.2007.11.018; Belaidi A, 2007, J VISION, V7, DOI 10.1167/7.11.1; Fisher R F, 1970, Trans Ophthalmol Soc U K, V90, P93; Hoshino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025140; Pau H., 2005, OPHTHALMOLOGICA, V220, P1; PIERSCIONEK BK, 1989, OPTOMETRY VISION SCI, V66, P822, DOI 10.1097/00006324-198912000-00004; Pierscionek BK, 1991, CLIN EXP OPTOM, V74, P223	38	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0014-4835	1096-0007		EXP EYE RES	Exp. Eye Res.	NOV	2015	140						19	27		10.1016/j.exer.2015.08.011		9	Ophthalmology	Ophthalmology	CV4TP	WOS:000364259700004		
J	Iwahashi, C; Fujimoto, M; Nomura, S; Serada, S; Nakai, K; Ohguro, N; Nishida, K; Naka, T				Iwahashi, Chiharu; Fujimoto, Minoru; Nomura, Shintaro; Serada, Satoshi; Nakai, Kei; Ohguro, Nobuyuki; Nishida, Kohji; Naka, Tetsuji			CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6	EXPERIMENTAL EYE RESEARCH			English	Article						T cell; Cytokine; CTLA4; Biologic; Experimental autoimmune uveitis; Uveitis	REGULATORY T-CELLS; ARTHRITIS-ASSOCIATED UVEITIS; RHEUMATOID-ARTHRITIS; ANTI-TNF; REFRACTORY UVEITIS; BONE-MARROW; TH17 CELLS; UVEORETINITIS; COSTIMULATION; ABATACEPT	Recently, a number of biologics have been used in the treatment of autoimmune diseases. However, in the treatment of severe autoimmune uveitis, only TNF-alpha inhibitors are preferably used and the effect of other biologics such as interleukin-6 (IL-6) signaling blockade or cytotoxic T-lymphocyte antigen-4-immunoglobulin fusion protein (CTLA4-Ig) has not been well studied. Previously, we reported that IL-6 blockade effectively suppresses the development of experimental autoimmune uveitis (EAU), a mouse model for uveitis, by inhibiting Th17 cell development. In this study, we investigated the effect of CTLA4-Ig on EAU development and compared it with the effect of anti-IL-6 receptor monoclonal antibody (MR16-1). C57BL/6J mice were immunized with interphotoreceptor retinoid-binding protein (IRBP) and treated once with CTLA4-Ig or MR16-1. Both CTLA4-Ig and MR16-1 administered in the induction phase (the same day as immunization) significantly reduced the clinical and histopathological scores of EAU. Fluorescence-activated cell sorting studies using draining lymph node (LN) cells from EAU mice 10 days after immunization showed that CTLA4-Ig can suppress early T-helper cell activation. CTLA4-Ig administered in the effector phase of the disease (one week after immunization), when IRBP-reactive T cells have been primed, also significantly reduced the clinical and histopathological scores of EAU. In contrast, MR16-1 administered in the effector phase did not ameliorate EAU. To investigate the differences between these biologics in the effector phase, in vitro restimulation analysis of LN cells obtained from EAU mice one week after immunization was performed and revealed that CTLA4-Ig, but not MR16-1, added to culture media could inhibit the proliferation of IRBP-specific CD4(+) T cells which possessed capacities of producing IFN-gamma and/or IL-17. Collectively, CTLA4-Ig ameliorated EAU through preventing initial T-cell activation in the induction phase and suppressing proliferation of IRBP-specific T cells in the effector phase. Blockade of IL-6 signaling did not have such inhibitory effects after T-cell priming. CTLA4-Ig may have therapeutic effects on human chronic uveitis. (C) 2015 Elsevier Ltd. All rights reserved.	[Iwahashi, Chiharu; Fujimoto, Minoru; Serada, Satoshi; Naka, Tetsuji] Natl Inst Biomed Innovat, Lab Immune Signal, Osaka 5670085, Japan; [Iwahashi, Chiharu; Nakai, Kei; Nishida, Kohji] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka 5650871, Japan; [Nomura, Shintaro] Nagahama Inst Biosci & Technol, Dept Anim Biosci, Nagahama, Shiga 5260829, Japan; [Ohguro, Nobuyuki] Japan Community Hlth Care Org, Osaka Hosp, Dept Ophthalmol, Fukushima Ku, Osaka 5530003, Japan	Fujimoto, M (reprint author), Natl Inst Biomed Innovat, Lab Immune Signal, 7-6-8 Saito Asagi, Osaka 5670085, Japan.	mfujimoto@nibio.go.jp			Chugai Pharmaceutical Co., Ltd.	Dr.Naka has received a research grant support from Chugai Pharmaceutical Co., Ltd. The other authors have declared that no competing interests exist.	Silver PB, 2000, J IMMUNOL, V165, P5041; Thurau SR, 1999, IMMUNOL LETT, V68, P205, DOI 10.1016/S0165-2478(99)00071-1; Wang RX, 2012, J BIOL CHEM, V287, P36012, DOI 10.1074/jbc.M112.390625; Nishimoto N, 2009, ANN RHEUM DIS, V68, P1580, DOI 10.1136/ard.2008.092866; NAKAJIMA A, 1995, EUR J IMMUNOL, V25, P3060, DOI 10.1002/eji.1830251112; Sugita S, 2009, J IMMUNOL, V183, P5013, DOI 10.4049/jimmunol.0901623; Adan A, 2013, GRAEF ARCH CLIN EXP, V251, P2627, DOI 10.1007/s00417-013-2436-y; Oh HM, 2011, J IMMUNOL, V187, P3338, DOI 10.4049/jimmunol.1004019; Webb LMC, 1996, EUR J IMMUNOL, V26, P2320, DOI 10.1002/eji.1830261008; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Araki M, 2014, NEUROLOGY, V82, P1302, DOI 10.1212/WNL.0000000000000317; Maini RN, 2004, ARTHRITIS RHEUM, V50, P1051, DOI 10.1002/art.20159; Verwaerde C, 2003, GENE THER, V10, P1970, DOI 10.1038/sj.gt.3302101; Yoshimura T, 2009, RHEUMATOLOGY, V48, P347, DOI 10.1093/rheumatology/ken489; Harris NL, 1999, IMMUNOL CELL BIOL, V77, P304, DOI 10.1046/j.1440-1711.1999.00835.x; Zulian F, 2010, ARTHRIT CARE RES, V62, P821, DOI 10.1002/acr.20115; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Keino H, 2007, BRIT J OPHTHALMOL, V91, P105, DOI 10.1136/bjo.2006.099192; Angeles-Han S, 2008, J RHEUMATOL, V35, P1897; Valencia X, 2007, NAT CLIN PRACT RHEUM, V3, P619, DOI 10.1038/ncprheum0624; CHAN CC, 1990, J AUTOIMMUN, V3, P247, DOI 10.1016/0896-8411(90)90144-H; Schiff M, 2011, ANN RHEUM DIS, V70, P2003, DOI 10.1136/annrheumdis-2011-200316; Kenawy N, 2011, GRAEF ARCH CLIN EXP, V249, P297, DOI 10.1007/s00417-010-1523-6; Hirano T, 2012, MOD RHEUMATOL, V22, P298, DOI 10.1007/s10165-011-0497-5; Okada AA, 2012, ARCH OPHTHALMOL-CHIC, V130, P592, DOI 10.1001/archophthalmol.2011.2698; Commodaro AG, 2010, INVEST OPHTH VIS SCI, V51, P2568, DOI 10.1167/iovs.09-4769; Scarsi M, 2014, J RHEUMATOL, V41, P666, DOI 10.3899/jrheum.130905; Muselier A, 2011, OCUL IMMUNOL INFLAMM, V19, P382, DOI 10.3109/09273948.2011.606593; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; Ruggieri S, 2012, OCUL IMMUNOL INFLAMM, V20, P255, DOI 10.3109/09273948.2012.681830; CASPI RR, 1988, J IMMUNOL, V140, P1490; Siepmann K, 2007, GRAEF ARCH CLIN EXP, V245, P221, DOI 10.1007/s00417-006-0356-9; Avichezer D, 2000, INVEST OPHTH VIS SCI, V41, P127; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Fukai T, 1999, GRAEF ARCH CLIN EXP, V237, P928, DOI 10.1007/s004170050388; Terabe F, 2011, INFLAMM BOWEL DIS, V17, P491, DOI 10.1002/ibd.21384; Hohki S, 2010, EXP EYE RES, V91, P162, DOI 10.1016/j.exer.2010.04.009; Sugita S, 2011, INVEST OPHTH VIS SCI, V52, P476, DOI 10.1167/iovs.10-5916; Haruta H, 2011, INVEST OPHTH VIS SCI, V52, P3264, DOI 10.1167/iovs.10-6272; Tang QZ, 2003, J IMMUNOL, V171, P3348; Xu ZH, 2012, J IMMUNOL, V189, P4470, DOI 10.4049/jimmunol.1201813; Kievit W, 2007, ANN RHEUM DIS, V66, P1473, DOI 10.1136/ard.2007.072447; Luger D, 2008, SEMIN IMMUNOPATHOL, V30, P135, DOI 10.1007/s00281-008-0108-5; Deighton C, 2009, NAT REV RHEUMATOL, V5, P596, DOI 10.1038/nrrheum.2009.212; Perrin PJ, 1999, J IMMUNOL, V163, P1704; Caspi R. R., 2003, CURRENT PROTOCOLS IM, V15, P1; Serada S, 2008, P NATL ACAD SCI USA, V105, P9041, DOI 10.1073/pnas.0802218105	47	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0014-4835	1096-0007		EXP EYE RES	Exp. Eye Res.	NOV	2015	140						53	64		10.1016/j.exer.2015.08.012		12	Ophthalmology	Ophthalmology	CV4TP	WOS:000364259700007		
J	Wurst, S; Ohgushi, T				Wurst, Susanne; Ohgushi, Takayuki			Do plant- and soil-mediated legacy effects impact future biotic interactions?	FUNCTIONAL ECOLOGY			English	Article						above- below-ground interactions; ecosystem function; history; indirect interactions; phyllosphere; plant traits; rhizosphere; soil; temporal aspects; trophic levels	BELOW-GROUND INTERACTIONS; INSECT HERBIVORES; MULTITROPHIC INTERACTIONS; DEFENSE RESPONSES; ROOT HERBIVORES; ABOVEGROUND HERBIVORES; LITTER DECOMPOSITION; NUTRIENT DYNAMICS; FUNGAL ENDOPHYTES; FOLIAR HERBIVORY	1. Biotic interactions of plants can have legacy effects mediated by changes in plant traits and soil characteristics. Legacy effects are defined as effects that persist after the causal biotic interaction ceases, because plant traits and soil characteristics are plastic and modifications may be maintained for long time periods. 2. To date, studies on biotic interactions of plants with above- and below-ground organisms and their plant-mediated interactions have mainly focused on short-term effects in the continuous presence of interacting organisms. 3. Little is known about how long the changes in plant traits and soil characteristics persist after the biotic interaction ceases and indirectly affect future biotic interactions and community assembly. Further, since some organisms switch between above- and below-ground compartments during ontogeny, impacts on soil-dwelling larval stages can have direct legacy effects on their above-ground adult stages and vice versa. 4. Elucidating legacy effects of biotic interactions above and below the ground will provide a deeper insight into a better understanding of the importance of plant trait- and soil characteristic-mediated indirect interactions in shaping community assembly, biodiversity and ecosystem function.	[Wurst, Susanne] Free Univ Berlin, DCPS, Funct Biodivers, D-14195 Berlin, Germany; [Ohgushi, Takayuki] Kyoto Univ, Ctr Ecol Res, Kyoto, Shiga 6068501, Japan	Wurst, S (reprint author), Free Univ Berlin, DCPS, Funct Biodivers, Konigin Luise Str 1-3, D-14195 Berlin, Germany.	s.wurst@fu-berlin.de			German Science Foundation (DFG)	We thank Ilja Sonnemann and Jennifer Schweitzer for helpful comments and suggestions on the manuscript. We gratefully acknowledge the financial support of the German Science Foundation (DFG) for the research stay of SW at the Center for Ecological Research, Kyoto University, Japan.	Vos C, 2012, PLANT SOIL, V354, P335, DOI 10.1007/s11104-011-1070-x; Johnson SN, 2013, J ANIM ECOL, V82, P1021, DOI 10.1111/1365-2656.12070; Stadler B, 2001, OECOLOGIA, V126, P104, DOI 10.1007/s004420000514; Hartley SE, 2009, ANNU REV ENTOMOL, V54, P323, DOI 10.1146/annurev.ento.54.110807.090614; Wackers FL, 2003, ECOL LETT, V6, P9, DOI 10.1046/j.1461-0248.2003.00396.x; Schwachtje J, 2006, P NATL ACAD SCI USA, V103, P12935, DOI 10.1073/pnas.0602316103; Koricheva J, 2009, ECOLOGY, V90, P2088, DOI 10.1890/08-1555.1; Yang CH, 2001, P NATL ACAD SCI USA, V98, P3889, DOI 10.1073/pnas.051633898; Lamb TG, 1996, CAN J MICROBIOL, V42, P1112; Harvey JA, 2010, BIOL CONSERV, V143, P2251, DOI 10.1016/j.biocon.2010.03.004; Bardgett RD, 1998, SOIL BIOL BIOCHEM, V30, P1867, DOI 10.1016/S0038-0717(98)00069-8; Rasmann S, 2007, ECOL LETT, V10, P926, DOI 10.1111/j.1461-0248.2007.01084.x; Saikkonen K, 2013, J CHEM ECOL, V39, P962, DOI 10.1007/s10886-013-0310-3; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Karban R, 2003, OIKOS, V100, P325, DOI 10.1034/j.1600-0706.2003.12075.x; Bezemer TM, 2005, TRENDS ECOL EVOL, V20, P617, DOI 10.1016/j.tree.2005.08.006; Viswanathan DV, 2005, ECOLOGY, V86, P886, DOI 10.1890/04-0313; Erwin AC, 2014, J ECOL, V102, P1038, DOI 10.1111/1365-2745.12248; Haase J, 2008, ECOLOGY, V89, P3072, DOI 10.1890/07-1983.1; Soler R, 2013, TRENDS PLANT SCI, V18, P149, DOI 10.1016/j.tplants.2012.08.010; Poelman EH, 2008, MOL ECOL, V17, P3352, DOI 10.1111/j.1365-294X.2008.03838.x; Schweitzer JA, 2005, OIKOS, V110, P133, DOI 10.1111/j.0030-1299.2005.13650.x; Jani AJ, 2010, ECOL LETT, V13, P106, DOI 10.1111/j.1461-0248.2009.01401.x; Van der Putten WH, 2001, TRENDS ECOL EVOL, V16, P547, DOI 10.1016/S0169-5347(01)02265-0; Utsumi S, 2009, J ANIM ECOL, V78, P953, DOI 10.1111/j.1365-2656.2009.01570.x; Nakamura M, 2003, OECOLOGIA, V136, P445, DOI 10.1007/s00442-003-1285-5; Bezemer TM, 2013, J ECOL, V101, P325, DOI 10.1111/1365-2745.12045; Stadler B, 2000, CAN J FOREST RES, V30, P631, DOI 10.1139/cjfr-30-4-631; Nozawa AK, 2002, POPUL ECOL, V44, P235, DOI 10.1007/s101440200026; MASTERS GJ, 1993, OIKOS, V66, P148, DOI 10.2307/3545209; Bardgett RD, 2003, ECOLOGY, V84, P2258, DOI 10.1890/02-0274; Ando Y, 2011, ECOL ENTOMOL, V36, P643, DOI 10.1111/j.1365-2311.2011.01303.x; Rasmann S, 2012, PLANT PHYSIOL, V158, P854, DOI 10.1104/pp.111.187831; Fornoni J, 2011, FUNCT ECOL, V25, P399, DOI 10.1111/j.1365-2435.2010.01805.x; Tariq M, 2013, OECOLOGIA, V172, P1095, DOI 10.1007/s00442-012-2572-9; Kostenko O, 2012, ECOL LETT, V15, P813, DOI 10.1111/j.1461-0248.2012.01801.x; Perez JL, 2009, MICROB ECOL, V57, P766, DOI 10.1007/s00248-008-9477-5; Whipps JM, 2008, J APPL MICROBIOL, V105, P1744, DOI 10.1111/j.1365-2672.2008.03906.x; Hinsinger P, 2009, PLANT SOIL, V321, P117, DOI 10.1007/s11104-008-9885-9; Omacini M, 2001, NATURE, V409, P78, DOI 10.1038/35051070; Soler R, 2007, OIKOS, V116, P367, DOI 10.1111/j.0030-1299.2007.15501.x; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Frost CJ, 2008, OIKOS, V117, P13, DOI 10.1111/j.2007.0030-1299.16165.x; Schreiber S, 2008, ECOL LETT, V11, P576, DOI 10.1111/j.1461-0248.2008.01171.x; Muller T, 2003, MICROBIOL RES, V158, P291, DOI 10.1078/0944-5013-00207; van Dam NM, 2011, J ECOL, V99, P77, DOI 10.1111/j.1365-2745.2010.01761.x; Miller TEX, 2011, TRENDS ECOL EVOL, V26, P457, DOI 10.1016/j.tree.2011.05.005; GEHRING CA, 1994, TRENDS ECOL EVOL, V9, P251, DOI 10.1016/0169-5347(94)90290-9; Hartmann A, 2008, PLANT SOIL, V312, P7, DOI 10.1007/s11104-007-9514-z; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Rudgers JA, 2008, ECOL LETT, V11, P831, DOI 10.1111/j.1461-0248.2008.01201.x; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; Stadler B, 1996, OECOLOGIA, V108, P771, DOI 10.1007/BF00329054; Junker RR, 2011, PLANT BIOLOGY, V13, P918, DOI 10.1111/j.1438-8677.2011.00454.x; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Wulff EG, 2003, PLANT SOIL, V255, P463, DOI 10.1023/A:1026026917355; Agrawal AA, 2002, ECOLOGY, V83, P3408, DOI 10.2307/3072089; JOHNSON KB, 1993, PHYTOPATHOLOGY, V83, P478, DOI 10.1094/Phyto-83-478; Stadler B, 2001, AGR FOREST ENTOMOL, V3, P253, DOI 10.1046/j.1461-9555.2001.00112.x; Koricheva J, 2000, OECOLOGIA, V125, P271, DOI 10.1007/s004420000450; Grimoldi AA, 2006, NEW PHYTOL, V172, P544, DOI 10.1111/j.1469-8137.2006.01853.x; Rodriguez MA, 1998, ACTA OECOL, V19, P37, DOI 10.1016/S1146-609X(98)80006-4; Utsumi S, 2009, OIKOS, V118, P1805, DOI 10.1111/j.1600-0706.2009.17580.x; Rudolf VHW, 2011, ECOL LETT, V14, P75, DOI 10.1111/j.1461-0248.2010.01558.x; Holeski LM, 2012, TRENDS ECOL EVOL, V27, P618, DOI 10.1016/j.tree.2012.07.011; Poveda Katja, 2007, P147, DOI 10.1017/CBO9780511542701.008; VANDERMEIJDEN E, 1988, OIKOS, V51, P355, DOI 10.2307/3565318; Yang T, 2013, SYMBIOSIS, V59, P1, DOI 10.1007/s13199-012-0190-2; Soler R, 2005, J ANIM ECOL, V74, P1121, DOI 10.1111/j.1365-2656.2005.01006.x; Wurst S, 2008, J CHEM ECOL, V34, P1360, DOI 10.1007/s10886-008-9537-9; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Ohgushi T, 2005, ANNU REV ECOL EVOL S, V36, P81, DOI 10.1146/annurev.ecolsys.36.091704.175523; van Dam NM, 2003, BASIC APPL ECOL, V4, P63, DOI 10.1078/1439-1791-00133; Hamilton EW, 2001, ECOLOGY, V82, P2397, DOI 10.1890/0012-9658(2001)082[2397:CPSSMA]2.0.CO;2; Zamioudis C, 2012, MOL PLANT MICROBE IN, V25, P139, DOI 10.1094/MPMI-06-11-0179; Dicke M, 2000, ENTOMOL EXP APPL, V97, P237, DOI 10.1023/A:1004111624780; Soler R, 2007, OECOLOGIA, V152, P257, DOI 10.1007/s00442-006-0649-z; Nakamura M, 2005, J ANIM ECOL, V74, P683, DOI 10.1111/j.1365-2656.2005.00960.x; Wurst S, 2010, APPL SOIL ECOL, V45, P123, DOI 10.1016/j.apsoil.2010.04.005; Hilker M, 2010, BIOL REV, V85, P267, DOI 10.1111/j.1469-185X.2009.00100.x; STEINGER T, 1992, OECOLOGIA, V91, P141; CHOUDHURY D, 1988, OIKOS, V51, P389, DOI 10.2307/3565324; Wurst S, 2010, PLANT SOIL, V329, P117, DOI 10.1007/s11104-009-0139-2; Yang JW, 2011, J ECOL, V99, P46, DOI 10.1111/j.1365-2745.2010.01756.x; BALDWIN IT, 1989, J CHEM ECOL, V15, P1661, DOI 10.1007/BF01012392; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; DesDeyn G. B., 2005, TRENDS ECOL EVOL, V20, P625; Feeny P., 1979, RECENT ADV PHYTOCHEM, P1; Hiltner L., 1904, ARB DEUT LANDW GES, V98, P59; Karban R., 1997, INDUCED RESPONSES HE; Koltai H., 2002, Plant roots: the hidden half, P933; Ohgushi T., 2007, ECOLOGICAL COMMUNITI; Saari S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009845; Scheu S, 2001, BASIC APPL ECOL, V2, P3, DOI 10.1078/1439-1791-00031; Schultz JC, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00324; Sonnemann I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056524; Tuomi J., 1991, PHYTOCHEMICAL INDUCT, P85; Wurst S., 2012, SOIL ECOLOGY ECOSYST, P28; Wurst S, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00353, 10.3389/fpls.2013.00380]	99	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-8463	1365-2435		FUNCT ECOL	Funct. Ecol.	NOV	2015	29	11					1373	1382		10.1111/1365-2435.12456		10	Ecology	Environmental Sciences & Ecology	CV5LQ	WOS:000364312600002		
J	Davies, S; Cros, T; Richard, D; Meddle, SL; Tsutsui, K; Deviche, P				Davies, Scott; Cros, Thomas; Richard, Damien; Meddle, Simone L.; Tsutsui, Kazuyoshi; Deviche, Pierre			Food availability, energetic constraints and reproductive development in a wild seasonally breeding songbird	FUNCTIONAL ECOLOGY			English	Article						gonad development; gonadotropin-inhibitory hormone; gonadotropin-releasing hormone; hypothalamic-pituitary-gonadal axis; luteinizing hormone; neuropeptide Y; reproductive physiology; seasonal reproduction; testosterone	GONADOTROPIN-INHIBITORY HORMONE; SPARROWS PASSER-DOMESTICUS; STARLINGS STURNUS-VULGARIS; ZONOTRICHIA-LEUCOPHRYS-GAMBELII; RUFOUS-WINGED SPARROWS; WHITE-CROWNED SPARROW; SONORAN DESERT BIRD; MALE JAPANESE-QUAIL; DARK-EYED JUNCOS; MALE BLUE TITS	1. In many organisms, food availability is a proximate cue that synchronizes seasonal development of the reproductive system with optimal environmental conditions. Growth of the gonads and secondary sexual characteristics is orchestrated by the hypothalamic-pituitary-gonadal (HPG) axis. However, our understanding of the physiological mechanisms by which food availability modulates activity of the HPG axis is limited. 2. It is thought that many factors, including energetic status, modulate seasonal reproductive activation. We tested the hypothesis that food availability modulates the activity of the HPG axis in a songbird. Specifically, we food-restricted captive adult male Abert's Towhees Melozone aberti for 2 or 4weeks during photoinduced reproductive development. A third group (control) received adlibitum food throughout. We measured multiple aspects of the reproductive system including endocrine activity of all three levels of the HPG axis [i.e. hypothalamic gonadotropin-releasing hormone-I (GnRH-I), plasma luteinizing hormone (LH) and testosterone (T)], and gonad morphology. Furthermore, because gonadotropin-inhibitory hormone (GnIH) and neuropeptide Y (NPY; a potent orexigenic peptide) potentially integrate information on food availability into seasonal reproductive development, we also measured the brain levels of these peptides. 3. At the hypothalamic level, we detected no effect of food restriction on immunoreactive (ir) GnRH-I, but the duration of food restriction was inversely related to the size of ir-GnIH perikarya. Furthermore, the number of ir-NPY cells was higher in food-restricted than control birds. Food restriction did not influence photoinduced testicular growth, but decreased plasma LH and T, and width of the cloacal protuberance, an androgen-sensitive secondary sexual characteristic. Returning birds to adlibitum food availability had no effect on plasma LH or T, but caused the cloacal protuberance to rapidly increase in size to that of adlibitum-fed birds. 4. Our results support the tenet that food availability modulates photoinduced reproductive activation. However, they also suggest that this modulation is complex and depends upon the level of the HPG axis considered. At the hypothalamic level, our results are consistent with a role for the GnIH and NPY systems in integrating information on energetic status. There also appears to be a role for endocrine function at the anterior pituitary gland and testicular levels in modulating reproductive development in the light of energetic status and independently of testicular growth.	[Davies, Scott; Deviche, Pierre] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Cros, Thomas; Richard, Damien] Univ Poitiers, Fac Sci Fondamentales & Appl, F-86022 Poitiers, France; [Meddle, Simone L.] Univ Edinburgh, Roslin Inst, Royal Dick Sch Vet Studies, Easter Bush EH25 9RG, Midlothian, Scotland; [Tsutsui, Kazuyoshi] Waseda Univ, Dept Biol, Lab Integrat Brain Sci, Tokyo 1628480, Japan; [Tsutsui, Kazuyoshi] Waseda Univ, Ctr Med Life Sci, Tokyo 1628480, Japan	Davies, S (reprint author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	scott.davies@asu.edu			Arizona State University's Central Arizona - Phoenix Long-Term Ecological Research programme (CAP LTER) under National Science Foundation [DEB-0423704]; Roslin Institute Strategic Grant from BBSRC	This research was funded by a research grant to SD from Arizona State University's Central Arizona - Phoenix Long-Term Ecological Research programme (CAP LTER; under National Science Foundation grant no. DEB-0423704) and Roslin Institute Strategic Grant funding from the BBSRC (SLM). We thank Kyle Waites and Kirsten Heller for help with bird husbandry, and two anonymous reviewers who's insightful comments greatly improved the manuscript. We have no conflict of interest to declare.	Tsutsui K, 2000, BIOCHEM BIOPH RES CO, V275, P661, DOI 10.1006/bbrc.2000.3350; Schaper SV, 2012, GEN COMP ENDOCR, V179, P53, DOI 10.1016/j.ygcen.2012.07.021; Clarke IJ, 2012, NEUROENDOCRINOLOGY, V95, P305, DOI 10.1159/000332822; Kurvers RHJM, 2008, HORM BEHAV, V54, P263, DOI 10.1016/j.yhbeh.2008.03.011; Fokidis HB, 2009, GEN COMP ENDOCR, V160, P259, DOI 10.1016/j.ygcen.2008.12.005; Tsutsui K, 2012, GEN COMP ENDOCR, V177, P305, DOI 10.1016/j.ygcen.2012.02.013; STOKES TM, 1974, J COMP NEUROL, V156, P337, DOI 10.1002/cne.901560305; Hasselquist D, 2008, J AVIAN BIOL, V39, P384, DOI 10.1111/j.2008.0908-8857.04427.x; Ciccone NA, 2007, DOMEST ANIM ENDOCRIN, V33, P62, DOI 10.1016/j.domaniend.2006.04.008; Schmidt KA, 2013, BEHAV ECOL SOCIOBIOL, V67, P1837, DOI 10.1007/s00265-013-1593-7; BOYD IL, 1991, CAN J ZOOL, V69, P1135, DOI 10.1139/z91-162; TANABE Y, 1981, GEN COMP ENDOCR, V43, P392, DOI 10.1016/0016-6480(81)90299-9; Dawson A, 1997, J REPROD FERTIL, V111, P1; Oberweger K, 2001, J EXP BIOL, V204, P3379; Davies S, 2014, HORM BEHAV, V66, P41, DOI 10.1016/j.yhbeh.2014.04.003; Tramontin AD, 2003, J NEUROBIOL, V57, P130, DOI 10.1002/neu.10263; Stevenson TJ, 2008, GEN COMP ENDOCR, V156, P385, DOI 10.1016/j.ygcen.2008.01.015; Lynn SE, 2000, ANIM BEHAV, V60, P581, DOI 10.1006/anbe.2000.1510; Bauchinger U, 2008, HORM BEHAV, V54, P312, DOI 10.1016/j.yhbeh.2008.03.007; DAWSON A, 1986, IBIS, V128, P572, DOI 10.1111/j.1474-919X.1986.tb02709.x; Schneider JS, 2008, INTEGR COMP BIOL, V48, P588, DOI 10.1093/icb/icn018; Kuenzel WJ, 2000, POULTRY SCI, V79, P1679; Wingfield JC, 2012, GEN COMP ENDOCR, V178, P485, DOI 10.1016/j.ygcen.2012.07.007; HOSHINO S, 1988, COMP BIOCHEM PHYS A, V90, P355, DOI 10.1016/0300-9629(88)91128-0; Kobayashi M, 2002, ZOOL SCI, V19, P331, DOI 10.2108/zsj.19.331; MEIJER T, 1991, IBIS, V133, P80, DOI 10.1111/j.1474-919X.1991.tb04814.x; Vezina F, 2010, CURR ZOOL, V56, P767; Ward S, 2003, ANIM BEHAV, V66, P893, DOI 10.1006/anbe.2003.2250; Schoech SJ, 1996, CONDOR, V98, P234, DOI 10.2307/1369141; Schoech SJ, 2009, INTEGR COMP BIOL, V49, P480, DOI 10.1093/icb/icp005; Bojkowska K, 2008, HORM BEHAV, V53, P342, DOI 10.1016/j.yhbeh.2007.10.013; Hau M, 2007, BIOESSAYS, V29, P133, DOI 10.1002/bies.20524; Perfito N, 2008, HORM BEHAV, V53, P567, DOI 10.1016/j.yhbeh.2008.01.002; SALDANHA CJ, 1994, GEN COMP ENDOCR, V93, P128; Wingfield JC, 2003, GEN COMP ENDOCR, V131, P143, DOI 10.1016/S0016-6480(02)00648-2; McGuire NL, 2010, GEN COMP ENDOCR, V166, P565, DOI 10.1016/j.ygcen.2010.01.010; Jenkins LK, 2007, REPROD FERT DEVELOP, V19, P461, DOI 10.1071/RD06079; Maney DL, 1997, HORM BEHAV, V32, P11, DOI 10.1006/hbeh.1997.1399; Tsutsui K, 2010, FRONT NEUROENDOCRIN, V31, P284, DOI 10.1016/j.yfrne.2010.03.001; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; Lourdais O, 2002, J ANIM ECOL, V71, P470, DOI 10.1046/j.1365-2656.2002.00612.x; Stevenson TJ, 2005, GEN COMP ENDOCR, V143, P33, DOI 10.1016/j.ygcen.2005.02.019; HAHN TP, 1995, J EXP ZOOL, V272, P213, DOI 10.1002/jez.1402720306; KUENZEL WJ, 1988, PHYSIOL BEHAV, V44, P669, DOI 10.1016/0031-9384(88)90334-4; Small TW, 2008, BRAIN BEHAV EVOLUT, V71, P127, DOI 10.1159/000111459; NAGER RG, 1995, AM NAT, V146, P454, DOI 10.1086/285809; Scheuerlein A, 2002, J BIOL RHYTHM, V17, P171, DOI 10.1177/074873002129002465; Hau M, 2004, OIKOS, V106, P489, DOI 10.1111/j.0030-1299.2004.13206.x; Thomas RJ, 2003, BEHAVIOUR, V140, P387, DOI 10.1163/156853903321826693; Deviche P, 2012, GEN COMP ENDOCR, V177, P1, DOI 10.1016/j.ygcen.2012.02.022; LAL P, 1990, GEN COMP ENDOCR, V77, P239, DOI 10.1016/0016-6480(90)90308-9; LEA RW, 1991, HORM BEHAV, V25, P283, DOI 10.1016/0018-506X(91)90002-Y; Ward S, 2005, J AVIAN BIOL, V36, P280, DOI 10.1111/j.0908-8857.2005.03379.x; Parry DM, 1997, J NEUROENDOCRINOL, V9, P235, DOI 10.1046/j.1365-2826.1997.00575.x; Pralong FP, 2010, MOL CELL ENDOCRINOL, V324, P82, DOI 10.1016/j.mce.2010.01.037; DRENT RH, 1980, ARDEA, V68, P225; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; Qi Y, 2009, J NEUROENDOCRINOL, V21, P690, DOI 10.1111/j.1365-2826.2009.01886.x; Owen-Ashley NT, 2004, AM NAT, V164, P490; Osugi T, 2004, J ENDOCRINOL, V182, P33, DOI 10.1677/joe.0.1820033; Boswell T, 2002, MOL BRAIN RES, V100, P31, DOI 10.1016/S0169-328X(02)00145-6; AMANN RP, 1986, ENVIRON HEALTH PERSP, V70, P149; Strader AD, 2001, J NEUROENDOCRINOL, V13, P386, DOI 10.1046/j.1365-2826.2001.00642.x; Fraley GS, 2013, GEN COMP ENDOCR, V184, P103, DOI 10.1016/j.ygcen.2012.11.026; Hahn TP, 1998, ECOLOGY, V79, P2365, DOI 10.1890/0012-9658(1998)079[2365:RSIAOB]2.0.CO;2; Marty N, 2007, PHYSIOLOGY, V22, P241, DOI 10.1152/physiol.00010.2007; Perfito N, 2011, GEN COMP ENDOCR, V173, P20, DOI 10.1016/j.ygcen.2011.04.016; Calisi RM, 2008, GEN COMP ENDOCR, V157, P283, DOI 10.1016/j.ygcen.2008.05.010; Olsson M, 1998, EVOLUTION, V52, P1861, DOI 10.2307/2411358; Tachibana T, 2005, BRAIN RES, V1050, P94, DOI 10.1016/j.brainres.2005.05.035; O'Brien S, 2005, J ORNITHOL, V146, P332, DOI 10.1007/s10336-005-0013-9; Reed WL, 2006, AM NAT, V167, P667, DOI 10.1086/503054; Olive PJW, 2000, OCEANOL ACTA, V23, P377, DOI 10.1016/S0399-1784(00)00135-3; Deviche P, 2012, HORM BEHAV, V61, P741, DOI 10.1016/j.yhbeh.2012.03.012; Ubuka T, 2009, J COMP NEUROL, V517, P841, DOI 10.1002/cne.22191; Salvante KG, 2007, J EXP BIOL, V210, P1325, DOI 10.1242/jeb.02745; SHARP PJ, 1987, J ENDOCRINOL, V115, P323, DOI 10.1677/joe.0.1150323; Kauffman AS, 2006, ENDOCRINOLOGY, V147, P5069, DOI 10.1210/en.2006-0615; Sharp PJ, 2005, ANN NY ACAD SCI, V1040, P189, DOI 10.1196/annals.1327.024; Meddle SL, 2002, HORM BEHAV, V42, P212, DOI 10.1006/hbeh.2002.1813; Lynn SE, 2010, HORM BEHAV, V58, P214, DOI 10.1016/j.yhbeh.2010.03.015; Foerster K, 2002, J AVIAN BIOL, V33, P269, DOI 10.1034/j.1600-048X.2002.330309.x; LIGON JD, 1974, NATURE, V250, P80, DOI 10.1038/250080a0; GOSLER AG, 1991, BIRD STUDY, V38, P1; Bentley GE, 2009, J NEUROENDOCRINOL, V21, P276, DOI 10.1111/j.1365-2826.2009.01851.x; Bentley GE, 2006, HORM BEHAV, V49, P550, DOI 10.1016/j.yhbeh.2005.12.005; Bruggeman V, 1998, GEN COMP ENDOCR, V112, P200, DOI 10.1006/gcen.1998.7165; Small TW, 2007, HORM BEHAV, V51, P483, DOI 10.1016/j.yhbeh.2007.01.004; Meijer T, 1999, IBIS, V141, P399, DOI 10.1111/j.1474-919X.1999.tb04409.x; Greives TJ, 2008, P ROY SOC B-BIOL SCI, V275, P1943, DOI 10.1098/rspb.2008.0433; Bentley GE, 2003, J NEUROENDOCRINOL, V15, P794; Clarke IJ, 2011, FRONT NEUROENDOCRIN, V32, P367, DOI 10.1016/j.yfrne.2011.01.001; Small TW, 2008, HORM BEHAV, V53, P28, DOI 10.1016/j.yhbeh.2007.08.006; Malecki IA, 1998, ANIM REPROD SCI, V53, P143, DOI 10.1016/S0378-4320(98)00110-9; Harrison TJE, 2010, OECOLOGIA, V164, P311, DOI 10.1007/s00442-010-1645-x; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Clarke IJ, 2009, FRONT NEUROENDOCRIN, V30, P371, DOI 10.1016/j.yfrne.2009.04.001; Tachibana T, 2008, COMP BIOCHEM PHYS A, V150, P21, DOI 10.1016/j.cbpa.2008.02.018; WINGFIELD JC, 1989, J COMP PHYSIOL A, V166, P189; Hill JW, 2008, AM J PHYSIOL-ENDOC M, V294, pE827, DOI 10.1152/ajpendo.00670.2007; Hau M, 2000, J EXP ZOOL, V286, P494, DOI 10.1002/(SICI)1097-010X(20000401)286:5<494::AID-JEZ7>3.0.CO;2-3; Deviche P, 2008, J NEUROENDOCRINOL, V20, P1191, DOI 10.1111/j.1365-2826.2008.01771.x; Kobayashi M, 2002, ZOOL SCI, V19, P449, DOI 10.2108/zsj.19.449; Baker J. R., 1938, P161; Boswell T., 2001, AVIAN ENDOCRINOLOGY, P349; Caro SP, 2009, J EXP BIOL, V212, P1994, DOI 10.1242/jeb.026344; Clarke I.J., 2013, MOL CELL ENDOCRINOL, V385, P36; Follett B. K., 1998, BIOL RHYTHMS PHOTOPE, P231; Hahn T.P., 2005, FUNCTIONAL AVIAN END, P167; Helms C., 1960, BIRDBANDING, V31, P1, DOI DOI 10.2307/4510793; IMS RA, 1990, TRENDS ECOL EVOL, V5, P135, DOI 10.1016/0169-5347(90)90218-3; KING JA, 1982, J BIOL CHEM, V257, P722; Klingerman Candice M, 2011, Front Endocrinol (Lausanne), V2, P101, DOI 10.3389/fendo.2011.00101; Lack D.L, 1968, ECOLOGICAL ADAPTATIO; Maney D. L., 2007, J ORNITHOL, V148, P527, DOI 10.1007/s10336-007-0242-1; McConn B, 2014, NEUROPEPTIDES, V48, P327, DOI 10.1016/j.npep.2014.09.001; McGuire NL, 2013, PEERJ, V1, DOI 10.7717/peerj.139; Morrison A. R., 2002, METH WELF CONS BEH R; Munro AD, 1990, REPROD SEASONALITY T; Murton R.K., 1977, AVIAN BREEDING CYCLE; Pyle P, 1997, IDENTIFICATION GUIDE; Schaper SV, 2012, AM NAT, V179, pE55, DOI 10.1086/663675; Sharp P.J., 2005, FUNCTIONAL AVIAN END, P59; Tsutsui K, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00060; Walsberg G. E., 1983, AVIAN BIOL, P161; Williams T, 2012, PHYSL ADAPTATIONS BR; Wingfield J. C., 1980, AVIAN ENDOCRINOLOGY, P367; Wingfield J. C., 1986, VERTEBRATE ENDOCRINO, P181; WINGFIELD JC, 1985, J ZOOL, V205, P525	129	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-8463	1365-2435		FUNCT ECOL	Funct. Ecol.	NOV	2015	29	11					1421	1434		10.1111/1365-2435.12448		14	Ecology	Environmental Sciences & Ecology	CV5LQ	WOS:000364312600007		
J	Emura, F; Mejia, J; Donneys, A; Ricaurte, O; Sabbagh, L; Giraldo-Cadavid, L; Oda, I; Saito, Y; Osorio, C				Emura, Fabian; Mejia, Juan; Donneys, Alberto; Ricaurte, Orlando; Sabbagh, Luis; Giraldo-Cadavid, Luis; Oda, Ichiro; Saito, Yutaka; Osorio, Camilo			Therapeutic outcomes of endoscopic submucosal dissection of differentiated early gastric cancer in a Western endoscopy setting (with video)	GASTROINTESTINAL ENDOSCOPY			English	Article							NEOPLASTIC LESIONS; N-ACETYLCYSTEINE; RESECTION; PREMEDICATION; VISIBILITY; EXPERIENCE; INVASION; TUMORS; KNIFE	Background: Large multicenter gastric cancer endoscopic submucosal dissection (ESD) studies conducted at major Japanese institutions have reported en bloc resection, en bloc tumor-free margin resection, and curative resection rates of 92.7% to 96.1%, 82.6% to 94.5%, and 73.6% to 85.4%, respectively, with delayed bleeding and perforation rates of 0.6% to 6.0% and 3.6% to 4.7%, respectively. Although ESD is currently an alternative treatment in some countries, particularly in Asia, it remains uncertain whether ESD therapeutic outcomes in Western endoscopy settings can be comparable to those achieved in Japan. Objective: To evaluate the ESD therapeutic outcomes for differentiated early gastric cancer (EGC) in a Western endoscopy setting. Design/Setting: Consecutive case series performed by an expertly trained Western endoscopist. Patients: Fifty-three patients with 54 lesions. Interventions: ESD for early gastric cancers (T1) satisfying expanded inclusion criteria. Main Outcome Measurements: En bloc resection, en bloc tumor-free margin resection, and curative resection rates were 98%, 93%, and 83%, respectively. The delayed bleeding rate was 7%, and the perforation rate was 4%. Results: The mean patient age was 67 years, and the mean tumor size was 19.8mm, with 54% of the lesions located in the lesser curvature. The median procedure time was 61 minutes, with ESD procedures 60 minutes or longer associated with submucosal fibrosis (P <. 001) and tumor size 25 mm or larger (P =. 03). In every ESD procedure, both circumferential incision and submucosal dissection were performed by using a single knife. Two of the 4 delayed bleeding cases required surgery, and all perforations were successfully managed by using endoscopic clips. Limitation: Long-term outcome data are currently unavailable. Conclusion: ESD for differentiated EGC resulted in favorable therapeutic outcomes in a Western endoscopy setting comparable to those achieved at major Japanese institutions.	[Emura, Fabian; Mejia, Juan] EmuraCtr LatinoAmer, Adv Gastrointestinal Endoscopy, Bogota, Colombia; [Emura, Fabian; Donneys, Alberto; Osorio, Camilo] Emura Fdn Promot Canc Res, Bogota, Colombia; [Emura, Fabian; Osorio, Camilo] Univ La Sabana, Div Gastroenterol & Endoscopy, Bogota, Colombia; [Ricaurte, Orlando] Univ Nacl Colombia, Dept Pathol, Bogota, Colombia; [Emura, Fabian; Sabbagh, Luis] Clin Univ Colombia, Ctr Explorac Digest, Bogota, Colombia; [Giraldo-Cadavid, Luis] Univ La Sabana, Dept Internal Med, Bogota, Colombia; [Oda, Ichiro; Saito, Yutaka] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan	Emura, F (reprint author), EmuraCtr LatinoAmer, Adv Gastrointestinal Endoscopy, Calle 134 7-83,Oficina 341,Edificio Altos Bosque, Bogota, Colombia.	fabian@emuracenter.org			Emura Foundation for the Promotion of Cancer Research	This work was supported in part by a grant-in-aid for the Comprehensive Strategy to Control Cancer in the Americas from the Emura Foundation for the Promotion of Cancer Research. All authors disclosed no financial relationships relevant to this article.	Adrada JC, 2008, REV COLOMB GASTROENT, V23, P2009; Onogi F, 2010, ENDOSCOPY, V42, P441, DOI 10.1055/s-0029-1244013; Hotta K, 2010, INTERNAL MED, V49, P253, DOI 10.2169/internalmedicine.49.2816; Numata N, 2013, J GASTROEN HEPATOL, V28, P1632, DOI 10.1111/jgh.12320; Higashimaya M, 2013, GASTRIC CANCER, V16, P404, DOI 10.1007/s10120-012-0203-0; Ono H, 2008, GASTRIC CANCER, V11, P47, DOI 10.1007/s10120-008-0452-0; Kitamura T, 2006, GASTROINTEST ENDOSC, V63, P48, DOI 10.1016/j.gie.2005.08.009; Park JC, 2011, DIGEST LIVER DIS, V43, P958, DOI 10.1016/j.dld.2011.08.008; Oda I, 2011, GASTRIC CANCER, V14, P22, DOI 10.1007/s10120-011-0001-0; Oda I, 2012, DIGEST ENDOSC, V24, P129, DOI 10.1111/j.1443-1661.2012.01265.x; Park CH, 2013, SURG ENDOSC, V27, P2760, DOI 10.1007/s00464-013-2804-z; Yamada T, 2014, GASTRIC CANCER, V17, P692, DOI 10.1007/s10120-013-0323-1; Lu ZS, 2012, WORLD J GASTROENTERO, V18, P7009, DOI 10.3748/wjg.v18.i47.7009; Pimentel-Nunes P, 2014, ENDOSCOPY, V46, P933, DOI 10.1055/s-0034-1377348; Baron TH, 2012, GASTROINTEST ENDOSC, V76, P838, DOI 10.1016/j.gie.2012.04.476; Gotoda T, 2010, BRIT J SURG, V97, P868, DOI 10.1002/bjs.7033; Wang AY, 2010, GASTROINTEST ENDOSC, V72, P1066, DOI 10.1016/j.gie.2010.06.008; Henry ZH, 2010, GASTROINTEST ENDOSC, V72, P118, DOI 10.1016/j.gie.2010.01.048; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354; Iacopini F, 2012, GASTROINTEST ENDOSC, V76, P1188, DOI 10.1016/j.gie.2012.08.024; Chang WK, 2014, J GASTROEN HEPATOL, V29, P769, DOI 10.1111/jgh.12487; Draganov PV, 2013, GASTROINTEST ENDOSC, V78, P677, DOI 10.1016/j.gie.2013.07.033; Choi J, 2010, ENDOSCOPY, V42, P705, DOI 10.1055/s-0030-1255617; Llorens P, 1999, GASTROINTEST ENDOSC, V49, P408, DOI 10.1016/S0016-5107(99)70025-8; Lim CH, 2012, DIGEST DIS SCI, V57, P148, DOI 10.1007/s10620-011-1863-z; Repici A, 2012, J GASTROINTEST LIVER, V21, P303; Goto O, 2010, DIGEST ENDOSC, V22, P45, DOI 10.1111/j.1443-1661.2009.00927.x; Emura F, 2013, GASTROINTEST ENDOSC, V78, P143, DOI 10.1016/j.gie.2013.02.021; Chang CC, 2007, WORLD J GASTROENTERO, V13, P444; Uraoka T, 2005, GASTROINTEST ENDOSC, V61, P736, DOI 10.1016/S0016-5107(05)00321-4; Gotoda T, 2008, GASTROINTEST ENDOSC, V67, P805, DOI 10.1016/j.gie.2008.02.008; Sugimoto T, 2012, J CLIN GASTROENTEROL, V46, P124, DOI 10.1097/MCG.0b013e31822f3988; Schumacher B, 2012, GASTROINTEST ENDOSC, V75, P1166, DOI 10.1016/j.gie.2012.02.027; Canales OM, 2011, GASTROINTEST ENDO S1, V73, pAB438; Emura Fabian, 2013, Rev Gastroenterol Peru, V33, P52; Emura Fabián, 2010, Rev Col Gastroenterol, V25, P19; Gotoda T, 2000, GASTRIC CANCER, V3, P219, DOI 10.1007/PL00011720; Henao FJ, 2001, REV COLOMB CIR, V16, P65; Isotomo H, 2009, GUT, V58, P331; Japanese Gastric Cancer Association, 2011, GASTRIC CANCER, V14, P113, DOI [10.1007/s10120-011-0042-4, DOI 10.1007/S10120-011-0042-4]]; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/S101209800016]; MARUYAMA K, 1989, ANN SURG, V210, P596, DOI 10.1097/00000658-198911000-00005; Mehta A, 2004, DIAGNOSIS MANAGEMENT, P351; Murillo R, 2004, ATLAS MORTALIDAD CAN; Neuhaus Horst, 2014, Gastrointest Endosc Clin N Am, V24, P295, DOI 10.1016/j.giec.2013.11.002; Oda Ichiro, 2006, Gastric Cancer, V9, P262, DOI 10.1007/s10120-006-0389-0; Oda I, 2005, DIGEST ENDOSC, V17, P54, DOI 10.1111/j.1443-1661.2005.00459.x; Pineros M, 2010, ATLAS MORTALIDAD CAN; Sano Y, 2005, DIGEST ENDOSC, V17, P105, DOI 10.1111/j.1443-1661.2005.00483.x; Vargas C Gloria, 2012, Rev Gastroenterol Peru, V32, P297; Workshop. PitP, 2003, GASTROINTEST ENDOS S, V58, pS3	51	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	NOV	2015	82	5					804	811		10.1016/j.gie.2015.03.1960		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CV3NP	WOS:000364166200005		
J	Abe, Y; Kawakami, H; Oba, K; Hayashi, T; Yasuda, I; Mukai, T; Isayama, H; Ishiwatari, H; Doi, S; Nakashima, M; Yamamoto, N; Kuwatani, M; Mitsuhashi, T; Hasegawa, T; Hirose, Y; Yamada, T; Tanaka, M; Sakamoto, N				Abe, Yoko; Kawakami, Hiroshi; Oba, Koji; Hayashi, Tsuyoshi; Yasuda, Ichiro; Mukai, Tsuyoshi; Isayama, Hiroyuki; Ishiwatari, Hirotoshi; Doi, Shinpei; Nakashima, Masanori; Yamamoto, Natsuyo; Kuwatani, Masaki; Mitsuhashi, Tomoko; Hasegawa, Tadashi; Hirose, Yoshinobu; Yamada, Tetsuya; Tanaka, Mariko; Sakamoto, Naoya		Japan EUS-FNA Stylet Study Grp	Effect of a stylet on a histological specimen in EUS-guided fine-needle tissue acquisition by using 22-gauge needles: a multicenter, prospective, randomized, controlled trial	GASTROINTESTINAL ENDOSCOPY			English	Article							SOLID PANCREATIC MASSES; 25-GAUGE NEEDLES; SINGLE-BLIND; ASPIRATION; FNA; DIAGNOSIS; SUCTION; LESIONS; BIOPSY; NUMBER	Background: EUS-guided FNA (EUS-FNA) has become the most efficacious way to obtain specimens from a solid lesion adjacent to the GI tract. Previous reports regarding the use of a stylet during EUS-FNA were all based on cytological diagnosis and have showed no significant superiority in terms of diagnostic yield. Objective: To clarify the noninferiority of EUS-FNA without a stylet (S-) compared with EUS-FNA with a stylet (S+) on histological assessment. Design: A prospective, single-blind, randomized, controlled crossover study. Setting: Five tertiary referral centers in Japan. Patients: Patients referred for EUS-FNA of a solid lesion. Intervention: EUS-FNA S+ and S- in a total of 4 alternate passes with randomization to S+ first or S- first. Main Outcome Measurements: The primary endpoint was the acquisition rate of an appropriate and sufficient specimen for histological assessment. The secondary endpoints were cellularity, contamination, bloodiness, diagnostic ability, and diagnostic accuracy. Results: We enrolled 107 patients (110 lesions) and analyzed 220 specimens each in the S+ and S- groups. The acquisition rate of appropriate and sufficient specimens in the S+ group was 121 of 220 (55.0%) and 122 of 220 (55.5%) in the S- group. The difference in the acquisition rate of the specimen (S- minus S+) based on the generalized estimating equation was 0.42% (95% confidence interval, -6.72% to 7.56%), which was less than 10% of the prespecified noninferiority margin of this study. With regard to cellularity, contamination, bloodiness score, diagnostic ability, and diagnostic accuracy, there were no significant differences between both groups. There were no dropouts in the study. Limitations: A variety of target lesions, multiple pathologists, lack of an assessment of intraobserver and inter-observer variability, and a single-blind study for the pathologists. Conclusion: EUS-FNA S- is noninferior to EUS-FNA S+ on histological assessment.	[Abe, Yoko; Kawakami, Hiroshi; Kuwatani, Masaki; Sakamoto, Naoya] Hokkaido Univ Hosp, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido 060, Japan; [Oba, Koji] Hokkaido Univ Hosp, Res & Clin Trial Ctr, Sapporo, Hokkaido 060, Japan; [Hayashi, Tsuyoshi; Ishiwatari, Hirotoshi] Sapporo Med Univ, Dept Med Oncol & Hematol, Sapporo, Hokkaido, Japan; [Yasuda, Ichiro; Doi, Shinpei] Gifu Univ Hosp, Dept Internal Med 1, Gifu, Japan; [Mukai, Tsuyoshi; Nakashima, Masanori] Gifu Municipal Hosp, Dept Gastroenterol, Gifu, Japan; [Isayama, Hiroyuki; Yamamoto, Natsuyo] Univ Tokyo, Dept Gastroenterol, Tokyo, Japan; [Mitsuhashi, Tomoko] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Hokkaido 060, Japan; [Hasegawa, Tadashi] Sapporo Med Univ, Sch Med, Dept Surg Pathol, Sapporo, Hokkaido, Japan; [Hirose, Yoshinobu] Gifu Univ Hosp, Dept Tumor Pathol, Gifu, Japan; [Yamada, Tetsuya] Gifu Municipal Hosp, Dept Pathol, Gifu, Japan; [Tanaka, Mariko] Univ Tokyo, Dept Pathol, Tokyo, Japan	Kawakami, H (reprint author), Hokkaido Univ Hosp, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido 060, Japan.	hiropon@med.hokudai.ac.jp					LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Wallace MB, 2001, GASTROINTEST ENDOSC, V54, P441, DOI 10.1067/mge.2001.117764; Sahai AV, 2010, ENDOSCOPY, V42, P900, DOI 10.1055/s-0030-1255676; Camellini L, 2011, ENDOSCOPY, V43, P709, DOI 10.1055/s-0030-1256482; Yamao K, 2005, J GASTROENTEROL, V40, P1013, DOI 10.1007/s00535-005-1717-6; Eto K, 2013, BRIT J CANCER, V108, P1488, DOI 10.1038/bjc.2013.108; Rastogi A, 2011, GASTROINTEST ENDOSC, V74, P58, DOI 10.1016/j.gie.2011.02.015; LeBlanc JK, 2004, GASTROINTEST ENDOSC, V59, P475, DOI 10.1016/S0016-5107(03)02863-3; Chin MW, 2010, GASTROINTEST ENDOSC, V71, pAB285; Wani S, 2012, GASTROINTEST ENDOSC, V76, P328, DOI 10.1016/j.gie.2012.03.1395; Hosoda W, 2010, PATHOL INT, V60, P358, DOI 10.1111/j.1440-1827.2010.02527.x; Wani S, 2014, GASTROINTEST ENDOSC, V80, P939, DOI 10.1016/j.gie.2014.07.066; Sakamoto H, 2009, J GASTROEN HEPATOL, V24, P384, DOI 10.1111/j.1440-1746.2008.05636.x; Song TJ, 2010, AM J GASTROENTEROL, V105, P1739, DOI 10.1038/ajg.2010.108; Erickson RA, 2000, GASTROINTEST ENDOSC, V51, P184, DOI 10.1016/S0016-5107(00)70416-0; Kudo T, 2014, GASTROINTEST ENDOSC, V80, P1030, DOI 10.1016/j.gie.2014.04.012; Siddiqui UD, 2009, GASTROINTEST ENDOSC, V70, P1093, DOI 10.1016/j.gie.2009.05.037; Devicente NM, 2009, GASTROINTEST ENDOSC, V69, pAB335; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Wani S, 2011, DIGEST DIS SCI, V56, P2409, DOI 10.1007/s10620-011-1608-z; Gerke H, 2010, CYTOPATHOLOGY, V21, P44, DOI 10.1111/j.1365-2303.2009.00656.x; Varadarajulu S, 2012, CLIN GASTROENTEROL H, V10, P697, DOI 10.1016/j.cgh.2012.03.017; Puri R, 2009, SCAND J GASTROENTERO, V44, P499, DOI 10.1080/00365520802647392; Fabbri C, 2011, DIGEST LIVER DIS, V43, P647, DOI 10.1016/j.dld.2011.04.005; Erickson RA, 2004, GASTROINTEST ENDOSC, V60, P367; Gimeno-Garcia AZ, 2013, DIGEST ENDOSC, V25, P303, DOI 10.1111/j.1443-1661.2012.01374.x; US Food and Drug Administration, 2010, GUID IND NON CLIN TR	27	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	NOV	2015	82	5					837	+		10.1016/j.gie.2015.03.1898		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CV3NP	WOS:000364166200011		
J	Saito, Y; Saito, S; Oka, S; Kakugawa, Y; Matsumoto, M; Aihara, H; Watari, I; Aoyama, T; Nouda, S; Kuramoto, T; Watanabe, K; Ohmiya, N; Higuchi, K; Goto, H; Arakawa, T; Tanaka, S; Tajiri, H				Saito, Yutaka; Saito, Shoichi; Oka, Shiro; Kakugawa, Yasuo; Matsumoto, Minori; Aihara, Hiroyuki; Watari, Ikue; Aoyama, Taiki; Nouda, Sadaharu; Kuramoto, Takanori; Watanabe, Kenji; Ohmiya, Naoki; Higuchi, Kazuhide; Goto, Hidemi; Arakawa, Tetsuo; Tanaka, Shinji; Tajiri, Hisao			Evaluation of the clinical efficacy of colon capsule endoscopy in the detection of lesions of the colon: prospective, multicenter, open study	GASTROINTESTINAL ENDOSCOPY			English	Article							COLORECTAL-CANCER; CONVENTIONAL COLONOSCOPY; POLYPS	Background: Colon capsule endoscopy (CCE) is a new procedure for colon imaging. Limited information is available regarding visualization of flat colon lesions and patient acceptability in Japan. Objective: The aims of this study were to evaluate the sensitivity of CCE in detecting polyps and other lesions compared with optical colonoscopy (OC) and to evaluate its safety and acceptability in a cohort of Japanese patients. Design: A prospective, open-label, clinical study in Japan. Setting: Multicenter. Patients: Patients referred for OC because of personal history of polyps >= 6 mm or any other colon lesion that required endoscopic or surgical treatment. Interventions: CCE followed by therapeutic colonoscopy. Main Outcome Measurements: The primary endpoint was per-patient sensitivity of CCE in detecting significant colon lesion. The secondary endpoints were CCE safety and patient acceptability. Results: Sixty-six of the 72 patients enrolled in the study were evaluated for efficacy. The per-patient sensitivity was 94% (95% confidence interval [CI], 88.2%-99.7%). The per-polyp sensitivity was 86.6% (95% CI, 81.3%-91.9%) when pathology-confirmed polyps were considered true positives. There were no adverse events related to CCE, and the acceptability of CCE was high. Limitations: All patients had previously confirmed colon lesions, which may have falsely elevated the sensitivity of CCE. Conclusion: CCE had a high sensitivity for detecting significant colon lesions. CCE was safe and had a high level of patient acceptability.	[Saito, Yutaka; Kakugawa, Yasuo; Matsumoto, Minori] Natl Canc Ctr, Endoscopy Div, Tokyo 1040045, Japan; [Saito, Shoichi; Aihara, Hiroyuki; Tajiri, Hisao] Tokyo Jikei Univ, Sch Med, Div Gastroenterol & Hepatol Endoscopy, Tokyo, Japan; [Oka, Shiro; Watari, Ikue; Aoyama, Taiki; Tanaka, Shinji] Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima, Japan; [Nouda, Sadaharu; Kuramoto, Takanori; Higuchi, Kazuhide] Osaka Med Coll, Dept Internal Med 2, Osaka, Japan; [Watanabe, Kenji; Arakawa, Tetsuo] Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Osaka 558, Japan; [Ohmiya, Naoki; Goto, Hidemi] Nagoya Univ, Grad Sch Med, Dept Internal Med, Nagoya, Aichi 4648601, Japan	Saito, Y (reprint author), Natl Canc Ctr, Endoscopy Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	ytsaito@ncc.go.jp			Given Imaging Ltd	We thank Given Imaging Ltd, who sponsored this trial, for the statistical analysis of the results. We express our appreciation to Dr Ara Sahakian, University of Southern California Keck School of Medicine, USA, and Dr Mathieu Pioche, Hospital Edouard Herriot, Lyon, France, for their assistance in editing this manuscript.	Eliakim R, 2006, ENDOSCOPY, V38, P963, DOI 10.1055/s-2006-944832; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Van Gossum A, 2009, NEW ENGL J MED, V361, P264, DOI 10.1056/NEJMoa0806347; Sieg A, 2009, AM J GASTROENTEROL, V104, P848, DOI 10.1038/ajg.2008.163; Schoofs N, 2006, ENDOSCOPY, V38, P971, DOI 10.1055/s-2006-944835; Saito Y, 2013, GUT LIVER, V7, P263, DOI 10.5009/gnl.2013.7.3.263; Spada C, 2011, J CLIN GASTROENTEROL, V45, P119, DOI 10.1097/MCG.0b013e3181dac04b; Sacher-Huvelin S, 2010, ALIMENT PHARM THER, V32, P1145, DOI 10.1111/j.1365-2036.2010.04458.x; Eliakim R, 2009, ENDOSCOPY, V41, P1026, DOI 10.1055/s-0029-1215360; Hagel AF, 2014, CAN J GASTROENTEROL, V28, P77; Saito Y, 2010, GASTROINTEST ENDOSC, V72, P1217, DOI 10.1016/j.gie.2010.08.004; Spada C, 2012, ENDOSCOPY, V44, P527, DOI 10.1055/s-0031-1291717; Spada C, 2012, THER ADV GASTROENTER, V5, P173, DOI 10.1177/1756283X12438054; Nakajima T, 2013, SURG ENDOSC, V27, P3262, DOI 10.1007/s00464-013-2903-x; Hartmann D, 2012, ENDOSCOPY, V44, P482, DOI 10.1055/s-0031-1291611; Gay G, 2010, AM J GASTROENTEROL, V105, P1076, DOI 10.1038/ajg.2009.624; Kakugawa Y, 2012, WORLD J GASTROENTERO, V18, P2092, DOI 10.3748/wjg.v18.i17.2092; Spada C, 2011, GASTROINTEST ENDOSC, V74, P581, DOI 10.1016/j.gie.2011.03.1125; Negreanu Lucian, 2013, World J Gastrointest Endosc, V5, P559, DOI 10.4253/wjge.v5.i11.559; Pilz JB, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-66; Sîngeap Ana-Maria, 2012, Rev Med Chir Soc Med Nat Iasi, V116, P145; The 2011 National Summary of Gastrointestinal Cancer Screening, 2011 NAT SUMM GASTR; Urakawa T, 2006, GUT, V55, P1592; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	24	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	NOV	2015	82	5					861	869		10.1016/j.gie.2015.02.004		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CV3NP	WOS:000364166200015		
J	Kudo, SE; Misawa, M; Wada, Y; Nakamura, H; Kataoka, S; Maeda, Y; Toyoshima, N; Hayashi, S; Kutsukawa, M; Oikawa, H; Mori, Y; Ogata, N; Kudo, T; Hisayuki, T; Hayashi, T; Wakamura, K; Miyachi, H; Ishida, F; Inoue, H				Kudo, Shin-ei; Misawa, Masashi; Wada, Yoshiki; Nakamura, Hiroki; Kataoka, Shinichi; Maeda, Yasuharu; Toyoshima, Naoya; Hayashi, Seiko; Kutsukawa, Makoto; Oikawa, Hiromasa; Mori, Yuichi; Ogata, Noriyuki; Kudo, Toyoki; Hisayuki, Tomokazu; Hayashi, Takemasa; Wakamura, Kunihiko; Miyachi, Hideyuki; Ishida, Fumio; Inoue, Haruhiro			Endocytoscopic microvasculature evaluation is a reliable new diagnostic method for colorectal lesions (with video)	GASTROINTESTINAL ENDOSCOPY			English	Article							PIT PATTERN; ULCERATIVE-COLITIS; HISTOLOGY; NEOPLASIA; TUMORS; NORMALIZATION; ARCHITECTURE; VASCULATURE; CARCINOMA; FEATURES	Background: We previously reported on the efficacy of endocytoscopic classification (EC-C). However, the correlation of the endocytoscopic vascular (EC-V) pattern with diagnoses was unclear. Objective: To assess the diagnostic accuracy of the EC-V pattern for colorectal lesions. Design: Retrospective. Setting: A university hospital. Patients: Patients who underwent endocytoscopy between January 2010 and March 2013. Intervention: We evaluated 198 consecutive lesions according to the EC-V pattern (EC-V1, obscure surface microvessels; EC-V2, clearly observed surface microvessels of a uniform caliber and arrangement; and EC-V3, dilated surface microvessels of a nonhomogeneous caliber or arrangement). Main Outcome Measurements: The diagnostic accuracy for predicting hyperplastic polyps and invasive cancer were compared between the EC-V pattern and other modalities (narrow-band imaging, pit pattern, and EC-C). Results: The sensitivity, specificity, and accuracy of the EC-V1 pattern for diagnosing hyperplastic polyps were 95.5%, 99.4%, and 99.0%, respectively. The sensitivity, specificity, and accuracy of the EC-V3 pattern for diagnosing invasive cancer were 74.6%, 97.2%, and 88.6%, respectively. The diagnostic accuracy of the EC-V pattern for predicting hyperplastic polyps was comparable to the other modalities. For predicting invasive cancer, the EC-V pattern was comparable to narrow-band imaging and pit pattern, although EC-C was slightly more accurate (P = .04). In the substudy, the diagnosis time by using the EC-V pattern was shorter than that with the EC-C pattern (P < .001). Limitations: A single-center, retrospective study. Conclusions: The EC-V pattern saved more time than the EC-C pattern and had a diagnostic ability comparable to that of other optical biopsy modalities.	[Kudo, Shin-ei; Misawa, Masashi; Wada, Yoshiki; Nakamura, Hiroki; Kataoka, Shinichi; Maeda, Yasuharu; Toyoshima, Naoya; Hayashi, Seiko; Kutsukawa, Makoto; Oikawa, Hiromasa; Mori, Yuichi; Ogata, Noriyuki; Kudo, Toyoki; Hisayuki, Tomokazu; Hayashi, Takemasa; Wakamura, Kunihiko; Miyachi, Hideyuki; Ishida, Fumio] Showa Univ, Northern Yokohama Hosp, Ctr Digest Dis, Yokohama, Kanagawa 2248503, Japan; [Wada, Yoshiki] Tokyo Med & Dent Univ, Sch Med, Dept Gastroenterol & Hepatol, Tokyo 113, Japan; [Inoue, Haruhiro] Showa Univ, Koto Toyosu Hosp, Ctr Digest Dis, Tokyo, Japan	Kudo, SE (reprint author), Showa Univ, Northern Yokohama Hosp, Ctr Digest Dis, Tsuzuki Ku, 35-1 Chigasaki Chuo, Yokohama, Kanagawa 2248503, Japan.						Lash RH, 2010, J CLIN PATHOL, V63, P681, DOI 10.1136/jcp.2010.075507; Sasajima K, 2006, GASTROINTEST ENDOSC, V63, P1010, DOI 10.1016/j.gie.2006.01.021; KUDO S, 1994, J CLIN PATHOL, V47, P880, DOI 10.1136/jcp.47.10.880; Kudo S, 2001, ENDOSCOPY, V33, P367; Konerding MA, 2001, BRIT J CANCER, V84, P1354, DOI 10.1054/bjoc.2001.1809; Kudo SE, 2008, GASTROINTEST ENDOSC, V68, pS3, DOI 10.1016/j.gie.2008.07.052; Inoue H, 2006, ENDOSCOPY, V38, P891, DOI 10.1055/s-2006-944667; Kanao H, 2009, GASTROINTEST ENDOSC, V69, P631, DOI 10.1016/j.gie.2008.08.028; Wada Y, 2010, DIGEST ENDOSC, V22, P192, DOI 10.1111/j.1443-1661.2010.00983.x; Kudo SE, 2011, ENDOSCOPY, V43, P869, DOI 10.1055/s-0030-1256663; Dixon MF, 2002, GUT, V51, P130, DOI 10.1136/gut.51.1.130; Kudo S, 2014, J GASTROEN HEPATOL, V29, P83, DOI 10.1111/jgh.12374; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Bessho R, 2011, J GASTROENTEROL, V46, P1197, DOI 10.1007/s00535-011-0439-1; Katagiri A, 2008, ALIMENT PHARM THER, V27, P1269, DOI 10.1111/j.1365-2036.2008.03650.x; Mori Y, 2013, ENDOSCOPY, V45, P98, DOI 10.1055/s-0032-1325932; Yan BM, 2008, ENDOSCOPY, V40, P534, DOI 10.1055/s-2007-995776; Cannizzaro R, 2012, GASTROENT RES PRACT, DOI 10.1155/2012/537170; SKINNER SA, 1995, DIGEST DIS SCI, V40, P373, DOI 10.1007/BF02065424; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Gono K, 2004, J BIOMED OPT, V9, P568, DOI 10.1117/1.1695563; Folarin AA, 2010, MICROVASC RES, V80, P89, DOI 10.1016/j.mvr.2010.03.007; Wada Y, 2009, GASTROINTEST ENDOSC, V70, P522, DOI 10.1016/j.gie.2009.01.040; Japanese Research Society for Cancer of the Colon and Rectum, 2009, JAP CLASS COL CARC; Less JR, 1997, MICROCIRCULATION-LON, V4, P25, DOI 10.3109/10739689709148315; Maeda Y, 2015, WORLD J GASTROENTERO, V21, P2108, DOI 10.3748/wjg.v21.i7.2108; Saito S., 2011, INT J SURG ONCOL, V2011, DOI [10.1155/2011/242608, DOI 10.1155/2011/242608]]; Sano Y, 2006, DIGEST ENDOSC, V18, pS44, DOI DOI 10.1111/J.1443-1661.2006.00621.X; Sano Y, 2005, DIGEST ENDOSC, V17, pS43	29	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	NOV	2015	82	5					912	923		10.1016/j.gie.2015.04.039		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CV3NP	WOS:000364166200024		
J	Yane, K; Katanuma, A; Maguchi, H; Takahashi, K; Kin, T				Yane, Kei; Katanuma, Akio; Maguchi, Hiroyuki; Takahashi, Kuniyuki; Kin, Toshifumi			Endoscopic retrieval of a proximally migrated biliary stent after pancreaticoduodenectomy by use of a short-type single-balloon enteroscope	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Yane, Kei; Katanuma, Akio; Maguchi, Hiroyuki; Takahashi, Kuniyuki; Kin, Toshifumi] Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido, Japan	Yane, K (reprint author), Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	NOV	2015	82	5					959	959		10.1016/j.gie.2015.05.051		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CV3NP	WOS:000364166200035		
J	Iwamuro, M; Hori, K; Tanaka, T; Okada, H				Iwamuro, Masaya; Hori, Keisuke; Tanaka, Takehiro; Okada, Hiroyuki			Serrated polyp of the duodenum	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Iwamuro, Masaya] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Dept Gen Med, Okayama 7008530, Japan; [Hori, Keisuke] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama 7008530, Japan; [Tanaka, Takehiro] Okayama Univ Hosp, Dept Pathol, Okayama, Japan; [Okada, Hiroyuki] Okayama Univ Hosp, Dept Endoscopy, Okayama, Japan	Iwamuro, M (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Dept Gen Med, Okayama 7008530, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	NOV	2015	82	5					966	967		10.1016/j.gie.2015.05.021		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CV3NP	WOS:000364166200044		
J	Tonozuka, R; Itoi, T				Tonozuka, Ryosuke; Itoi, Takao			What is the optimal treatment for hepatic abscess and infected biloma? Response	GASTROINTESTINAL ENDOSCOPY			English	Letter							WALLED-OFF NECROSIS; EUS-GUIDED DRAINAGE; PANCREATIC PSEUDOCYST; METAL STENTS		[Tonozuka, Ryosuke; Itoi, Takao] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan	Tonozuka, R (reprint author), Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan.						Tonozuka R, 2015, GASTROINTEST ENDOSC, V81, P1463, DOI 10.1016/j.gie.2015.01.023; Kwon YM, 2013, SURG ENDOSC, V27, P2422, DOI 10.1007/s00464-012-2752-z; Varadarajulu S, 2013, GASTROENTEROLOGY, V145, P583, DOI 10.1053/j.gastro.2013.05.046; Bang JY, 2014, SURG ENDOSC, V28, P2877, DOI 10.1007/s00464-014-3541-7; Mukai S, 2015, ENDOSCOPY, V47, P47, DOI 10.1055/s-0034-1377966; Mukai S, 2014, J HEPATO-BIL-PAN SCI, V21, pE75, DOI 10.1002/jhbp.146; Mukai S, 2015, J GASTROENTEROL, V50, P1	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	NOV	2015	82	5					972	973		10.1016/j.gie.2015.07.001		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CV3NP	WOS:000364166200051		
J	Misawa, K; Ootsuki, R				Misawa, Kazuharu; Ootsuki, Ryo			PAFFT: A new homology search algorithm for third-generation sequencers	GENOMICS			English	Article						Homology search; Third-generation sequencer	BASIC LOCAL ALIGNMENT; CHLOROPLAST GENOME; DNA; REPEATS; READS	DNA sequencers that can conduct real-time sequencing from a single polymerase molecule are known as third-generation sequencers. Third-generation sequencers enable sequencing of reads that are several kilobases long. However, the raw data generated from third-generation sequencers are known to be error-prone. Because of sequencing errors, it is difficult to identify which genes are homologous to the reads obtained using third-generation sequencers. In this study, a new method for homology search algorithm, PAFFT, is developed. This method is the extension of the MAFFT algorithm which was used for multiple alignments. PAFFT detects global homology rather than local homology so that homologous regions can be detected even when the error rate of sequencing is high. PAFFT will boost application of third-generation sequencers. (C) 2015 Elsevier Inc. All rights reserved.	[Misawa, Kazuharu] RIKEN, Adv Ctr Comp & Commun, Wako, Saitama 3510198, Japan; [Ootsuki, Ryo] Japan Womens Univ, Fac Chem & Biol Sci, Tokyo 112, Japan; [Ootsuki, Ryo] Komazawa Univ, Dept Nat Sci, Fac Arts & Sci, Setagaya Ku, Tokyo 1548525, Japan	Misawa, K (reprint author), RIKEN, Adv Ctr Comp & Commun, Hirosawa 2-1, Wako, Saitama 3510198, Japan.	misawa@megabank.tohoku.ac.jp		Misawa, Kazuharu/0000-0002-6277-4330	JSPS KAKENHI Grant [26650146]	We thank Dr. Marcelo Bento Soares and anonymous reviewers for valuable suggestions and comments. We also thank Dr. Ryutaro Himeno for his encouragement and support. This work was supported by JSPS KAKENHI Grant Number 26650146.	Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Fisher RA, 1928, P CAMB PHILOS SOC, V24, P180; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; KOLODNER R, 1979, P NATL ACAD SCI USA, V76, P41, DOI 10.1073/pnas.76.1.41; Njuguna W, 2013, MOL PHYLOGENET EVOL, V66, P17, DOI 10.1016/j.ympev.2012.08.026; Misawa K, 2013, GENOMICS, V102, P35, DOI 10.1016/j.ygeno.2013.03.002; Altschul SF, 2001, NUCLEIC ACIDS RES, V29, P351, DOI 10.1093/nar/29.2.351; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; Ferrarini M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-670; Li Wentian, 2014, Frontiers in Genetics, V5, P381, DOI 10.3389/fgene.2014.00381; Misawa K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-397; Press W.H., 1999, ART SCI COMPUTING; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341	15	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0888-7543	1089-8646		GENOMICS	Genomics	NOV	2015	106	5					265	267		10.1016/j.ygeno.2015.09.005		3	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	CV1YL	WOS:000364053900002		
J	Bahr, A; Kaboth, S; Jimenez-Espejo, FJ; Sierro, FJ; Voelker, AHL; Lourens, L; Rohl, U; Reichart, GJ; Escutia, C; Hernandez-Molina, FJ; Pross, J; Friedrich, O				Bahr, A.; Kaboth, S.; Jimenez-Espejo, F. J.; Sierro, F. J.; Voelker, A. H. L.; Lourens, L.; Roehl, U.; Reichart, G. J.; Escutia, C.; Hernandez-Molina, F. J.; Pross, J.; Friedrich, O.			Persistent monsoonal forcing of Mediterranean Outflow Water dynamics during the late Pleistocene	GEOLOGY			English	Article							MERIDIONAL OVERTURNING CIRCULATION; NORTH-ATLANTIC; CLIMATE; RECORD; CADIZ; GULF; SEA; INSOLATION; EVENTS; KA	The mode and vigor of the global oceanic circulation critically depend on the salinity of (sub) surface water masses advected to the loci of deep-water formation. Within the Atlantic meridional overturning circulation (AMOC), an important supplier of high-salinity waters is the Mediterranean Outflow Water (MOW), discharging into the North Atlantic via the Strait of Gibraltar. Despite its importance for the North Atlantic salinity budget, the long-term dynamics of MOW production have remained poorly understood. Here we present high-resolution records of bottom-current velocity from three drill sites within the Gulf of Cadiz that document a persistent low-latitude forcing of MOW flow speed over the past similar to 150 k.y. We demonstrate that the African monsoon is the predominant driver of orbital-scale MOW variability via its influence on the freshwater budget of the eastern Mediterranean Sea. Consequently, MOW formation fluctuates in concert with orbital precession overprinted by centennial-scale oscillations of high-latitude origin. We further document that Northern Hemisphere summer insolation minima stimulate maximal injection of MOW-derived salt into the North Atlantic, likely strengthening the intermediate AMOC branch. The direct coupling of MOW dynamics to low-latitude climate forcing represents a hitherto neglected process for propagating (sub)tropical climate signals into the high northern latitudes.	[Bahr, A.] Goethe Univ Frankfurt, Inst Geosci, D-60438 Frankfurt, Germany; [Bahr, A.; Pross, J.; Friedrich, O.] Heidelberg Univ, Inst Earth Sci, D-69120 Heidelberg, Germany; [Kaboth, S.; Lourens, L.] Univ Utrecht, Fac Geosci, Dept Earth Sci, NL-3584 CD Utrecht, Netherlands; [Jimenez-Espejo, F. J.] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Biochem, Yokosuka, Kanagawa 2370061, Japan; [Sierro, F. J.] Univ Salamanca, Dept Geol, E-37008 Salamanca, Spain; [Voelker, A. H. L.] Inst Portugues Mar & Atmosfera, Div Geol & Georecursos Marinhos, P-1449006 Lisbon, Portugal; [Roehl, U.] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Reichart, G. J.] Royal Netherlands Inst Sea Res NIOZ, NL-1790 AB Den Burg, Texel, Netherlands; [Escutia, C.] UGR, CSIC, Inst Andaluz Ciencias Tierra, Granada 18100, Spain; [Hernandez-Molina, F. J.] Royal Holloway Univ London, Dept Earth Sci, Egham TW20 0EX, Surrey, England	Bahr, A (reprint author), Goethe Univ Frankfurt, Inst Geosci, Altenhoferallee 1, D-60438 Frankfurt, Germany.	andre.bahr@geow.uni-heidelberg.de	Voelker, Antje/C-5427-2012	Voelker, Antje/0000-0001-6465-6023	German Research Foundation (DFG) [BA 3809/4, RO 1113/6]; Continental Margins Research Group (CMRG) at Royal Holloway University of London [CGL2011-15013-E]; Fundacao de a Tecnologia e a Cencia (FCT) (project MOWCADYN) [PTDC/MAR-PRO/3761/2012];  [CTM 2008-06399-C04/MAR];  [CTM 2012-39599-C03]	We are greatly indebted to the IODP Expedition 339 Science Party for support onboard the DV Joides Resolution. We acknowledge W. Hale and A. Wulbers (Bremen Core Repository) for core handling, and V. Lukies and T. Westerhold (Center of Marine Environmental Sciences, Bremen) for technical assistance. This manuscript greatly benefitted from the comments of three reviewers. Funding was received through the German Research Foundation (DFG) (grant BA 3809/4 to Bahr and grant RO 1113/6 to Rohl), the CTM 2008-06399-C04/MAR (CONTOURIBER) and CTM 2012-39599-C03 (MOWER) projects, the Continental Margins Research Group (CMRG) at Royal Holloway University of London, CGL2011-15013-E (Mediterranean Outflow, IODP Expedition 339) projects to Hernandez-Molina, and the Fundacao de a Tecnologia e a Cencia (FCT) (project MOWCADYN, PTDC/MAR-PRO/3761/2012 to Voelker).	Revel M, 2010, QUATERNARY SCI REV, V29, P1342, DOI 10.1016/j.quascirev.2010.02.006; Toucanne S, 2007, PALAEOGEOGR PALAEOCL, V246, P354, DOI 10.1016/j.palaeo.2006.10.007; Bahr A, 2014, GEOCHEM GEOPHY GEOSY, V15, P3145, DOI 10.1002/2014GC005356; Seierstad IK, 2014, QUATERNARY SCI REV, V106, P29, DOI 10.1016/j.quascirev.2014.10.032; Grant KM, 2012, NATURE, V491, P744, DOI 10.1038/nature11593; Rahmstorf S, 2002, NATURE, V419, P207, DOI 10.1038/nature01090; Toucanne S, 2012, QUATERNARY SCI REV, V33, P55, DOI 10.1016/j.quascirev.2011.11.020; Rogerson M, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2006PA001306; Kotthoff U, 2008, QUATERNARY SCI REV, V27, P832, DOI 10.1016/j.quascirev.2007.12.001; Weldeab S, 2007, SCIENCE, V316, P1303, DOI 10.1126/science.1140461; Rohling EJ, 2015, EARTH-SCI REV, V143, P62, DOI 10.1016/j.earscirev.2015.01.008; ROSSIGNOLSTRICK M, 1983, NATURE, V304, P46, DOI 10.1038/304046a0; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Guihou A, 2011, QUATERNARY SCI REV, V30, P1576, DOI 10.1016/j.quascirev.2011.03.017; Potter RA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018161; Llave E, 2006, MAR GEOL, V227, P241, DOI 10.1016/j.margeo.2005.11.015; Hernandez-Molina FJ, 2014, SCIENCE, V344, P1244, DOI 10.1126/science.1251306; Millot C, 2014, PROG OCEANOGR, V120, P254, DOI 10.1016/j.pocean.2013.09.007; Voelker AHL, 2006, EARTH PLANET SC LETT, V245, P39, DOI 10.1016/j.epsl.2006.03.014; SCHMITZ WJ, 1993, REV GEOPHYS, V31, P29, DOI 10.1029/92RG02583; Tjallingii R, 2008, NAT GEOSCI, V1, P670, DOI 10.1038/ngeo289; Alhammoud B, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001823; Bohm E, 2015, NATURE, V517, P73, DOI 10.1038/nature14059; Hodell D, 2013, PALEOCEANOGRAPHY, V28, DOI 10.1002/palo.20017; Rogerson M, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000376; Stow D., 2012, 339 INT OC DRILL PRO, DOI [10.2204/iodp.pr.339.2012, DOI 10.2204/IODP.PR.339.2012]	26	0	0	GEOLOGICAL SOC AMER, INC	BOULDER	PO BOX 9140, BOULDER, CO 80301-9140 USA	0091-7613	1943-2682		GEOLOGY	Geology	NOV	2015	43	11					951	954		10.1130/G37013.1		4	Geology	Geology	CV1ZW	WOS:000364057700006		
J	Nakamoto, A; Ota, K; Saito, A				Nakamoto, Atsuhiro; Ota, Katsuhiro; Saito, Akira			Preface	GRAPHS AND COMBINATORICS			English	Editorial Material									[Ota, Katsuhiro] Keio Univ, Yokohama, Kanagawa 2238522, Japan; [Saito, Akira] Nihon Univ, Tokyo 1568550, Japan		nakamoto@ynu.ac.jp; ohta@comb.math.keio.ac.jp; asaito@chs.nihon-u.ac.jp						0	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	NOV	2015	31	6					1819	1820		10.1007/s00373-015-1637-z		2	Mathematics	Mathematics	CV0VQ	WOS:000363972100001		
J	Chisaki, S; Miyamoto, N				Chisaki, Shoko; Miyamoto, Nobuko			Difference Systems of Sets with Size 2	GRAPHS AND COMBINATORICS			English	Article						Difference systems of sets; Cyclotomic cosets; Cyclotomic numbers	PARTITIONS; CYCLOTOMY; CODES	Difference systems of sets (DSS) are combinatorial structures introduced by Levenshtein in (Probl Peredachi Inform 7(3):215-222, 1971), which are a generalization of cyclic difference sets and arise in connection with code synchronization. In this paper, we consider a collection of pairs in a finite field of a prime order to be a regular DSS with parameters . We give a lower bound on the parameter using cyclotomic numbers for and 4. In addition, we present a condition for which the collection of pairs forms an optimal DSS for e = 4.	[Chisaki, Shoko] Tokyo Univ Sci, Grad Sch Sci & Technol, Tokyo 162, Japan; [Miyamoto, Nobuko] Tokyo Univ Sci, Dept Informat Sci, Tokyo 162, Japan	Chisaki, S (reprint author), Tokyo Univ Sci, Grad Sch Sci & Technol, Tokyo 162, Japan.	chisaki.s@alumni.tus.ac.jp; miyamoto@is.noda.tus.ac.jp					Mutoh Y, 2008, DISCRETE MATH, V308, P2959, DOI 10.1016/j.disc.2007.08.017; Buratti M, 2009, FINITE FIELDS TH APP, V15, P332, DOI 10.1016/j.ffa.2008.12.007; Fuji-Hara R, 2009, DISCRETE MATH, V309, P3954, DOI 10.1016/j.disc.2008.11.009; Dickson LE, 1935, AM J MATH, V57, P391, DOI 10.2307/2371217; Fujiwara Y, 2013, IEEE T INFORM THEORY, V59, P2328, DOI 10.1109/TIT.2012.2234501; Tonchev VD, 2007, J COMB OPTIM, V14, P165, DOI 10.1007/s10878-007-9064-6; Chisaki S, 2015, FINITE FIELDS TH APP, V34, P75, DOI 10.1016/j.ffa.2015.01.003; Tonchev VD, 2005, FINITE FIELDS TH APP, V11, P601, DOI 10.1016/j.ffa.2005.04.003; Levenshtein VI, 2004, J COMB DES, V12, P184, DOI 10.1002/jcd.10071; Fuji-Hara R, 2006, J COMB THEORY A, V113, P1689, DOI 10.1016/j.jcta.2006.03.014; Levenshtein V.I., 1971, PROBL INFORM TRANSM, V7, P215; Storer T., 1967, LECT AV MATH; Tonchev V., 2003, REND SEM MAT MESSI 2, V9, P217	13	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	NOV	2015	31	6					1867	1881		10.1007/s00373-015-1593-7		15	Mathematics	Mathematics	CV0VQ	WOS:000363972100006		
J	Kano, M; Yan, Z				Kano, Mikio; Yan, Zheng			Spanning Trees Whose Stems are Spiders	GRAPHS AND COMBINATORICS			English	Article						Spanning tree; Spider; Stem		Let T be a tree. The set of leaves of T is denoted by Leaf(T). The subtree is called the stem of T. A spider is a tree having at most one vertex with degree greater than two. In Gargano et al. (Discrete Math 285:83-95, 2004), it is shown that if a connected graph G satisfies (G) >=(vertical bar(G vertical bar - 1)/3, then G has a spanning spider. In this paper, we prove that if , then G has a spanning tree whose stem is a spider, where denotes the minimum degree sum of four vertices of G such that the distance between any two of their vertices are at least four. Moreover, we show that this condition is sharp.	[Kano, Mikio] Ibaraki Univ, Hitachi, Ibaraki, Japan; [Yan, Zheng] Yangtzeu Univ, Jing Zhou, Peoples R China	Yan, Z (reprint author), Yangtzeu Univ, Jing Zhou, Peoples R China.	kano@mx.ibaraki.ac.jp; yanzhenghubei@163.com			JSPS KAKENHI Grant [25400187]; Doctoral Fund of Yangtze University [80107001]; Yangtze Youth Fund	The first author was supported by JSPS KAKENHI Grant Number 25400187. The second author was supported by Doctoral Fund of Yangtze University Grant Number 80107001 and The Yangtze Youth Fund. This work was done while the second author was in Ibaraki University.	Akiyama J, 2011, LECT NOTES MATH, V2031, P1, DOI 10.1007/978-3-642-21919-1; Gargano L, 2004, DISCRETE MATH, V285, P83, DOI 10.1016/j.disc.2004.04.005; Kyaw A, 2009, DISCRETE MATH, V309, P6146, DOI 10.1016/j.disc.2009.04.023; Matsuda H, 2014, GRAPH COMBINATOR, V30, P429, DOI 10.1007/s00373-012-1277-5; Kano M., PREPRINT	5	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	NOV	2015	31	6					1883	1887		10.1007/s00373-015-1618-2		5	Mathematics	Mathematics	CV0VQ	WOS:000363972100007		
J	Kawasaki, Y; Matsumoto, N; Nakamoto, A				Kawasaki, Yuki; Matsumoto, Naoki; Nakamoto, Atsuhiro			N-Flips in 4-Connected Even Triangulations on the Sphere	GRAPHS AND COMBINATORICS			English	Article						Even triangulations; N-flips; Sphere	DIAGONAL TRANSFORMATIONS; SURFACES; QUADRANGULATIONS	An even triangulation is a plane triangulation in which each vertex has even degree. It is well known that every even triangulation has a unique 3-coloring, where the decomposition of the vertices of by the 3-coloring is called the tripartition of . Nakamoto et al. (Graph Theory 51:260-268, 2006) proved that every two even triangulations with the same tripartition can be transformed into each other by -flips, where an -flip is an operation transforming an even triangulation into an even triangulation. In this paper, we prove that every two 4-connected even triangulations and with the same tripartition can be transformed into each other by -flips unless or is isomorphic to a generalized octahedron.	[Kawasaki, Yuki; Nakamoto, Atsuhiro] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Matsumoto, Naoki] Seikei Univ, Dept Comp & Informat Sci, Musashino, Tokyo 1808633, Japan	Matsumoto, N (reprint author), Seikei Univ, Dept Comp & Informat Sci, 3-3-1 Kichijoji Kitamachi, Musashino, Tokyo 1808633, Japan.	kawasaki-yuki-xy@ynu.jp; naoki.matsumo10@gmail.com; nakamoto@ynu.ac.jp					Nakamoto A, 2008, DISCRETE MATH, V308, P5454, DOI 10.1016/j.disc.2007.10.015; Kawarabayashi KI, 2009, J COMB THEORY B, V99, P229, DOI 10.1016/j.jctb.2008.06.006; Nakamoto A, 1996, J GRAPH THEOR, V21, P289, DOI 10.1002/(SICI)1097-0118(199603)21:3<289::AID-JGT3>3.0.CO;2-M; Nakamoto A, 2006, J GRAPH THEOR, V51, P260, DOI 10.1002/jgt.20132; Higuchi Y, 2011, DISCRETE MATH, V311, P1128, DOI 10.1016/j.disc.2010.08.003; NEGAMI S, 1994, DISCRETE MATH, V135, P225, DOI 10.1016/0012-365X(93)E0101-9; Komuro H, 1999, J COMB THEORY B, V76, P68, DOI 10.1006/jctb.1998.1889; Dewdney A. K., 1973, Discrete Mathematics, V4, DOI 10.1016/0012-365X(73)90076-9; Matsumoto N, 2015, DISCRETE MATH, V338, P64, DOI 10.1016/j.disc.2014.08.017; Nakamoto A, 1996, J COMB THEORY B, V67, P202, DOI 10.1006/jctb.1996.0041; Negami S., 1999, YOKOHAMA MATH J, V47, P1; Negami S., 1990, TSUKUBA J MATH, V14, P155; Wagner K., 1936, JBER DTSCH MATH VERE, V46, P26	13	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	NOV	2015	31	6					1889	1904		10.1007/s00373-015-1574-x		16	Mathematics	Mathematics	CV0VQ	WOS:000363972100008		
J	Lu, XN				Lu, Xiao-Nan			On Affine-Invariant Two-Fold Quadruple Systems	GRAPHS AND COMBINATORICS			English	Article						3-Designs; Projective special linear groups; Affine-invariant; Recursive construction	CONSTRUCTIONS; EXISTENCE; DESIGNS	In this paper, we present a direct construction and a recursive construction of the affine-invariant 2-fold quadruple systems of order q (3-(q, 4, 2) designs), where q is a prime power. The direct construction also gives a criterion for the existence of affine-invariant 2-fold quadruple systems of prime order by using 1-factors of graphs. By our recursive construction, an infinite family of affine-invariant 2-fold quadruple systems is established by using our previous direct construction.	Nagoya Univ, Japan Soc Promot Sci, Grad Sch Informat Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Lu, XN (reprint author), Nagoya Univ, Japan Soc Promot Sci, Grad Sch Informat Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	lu@math.cm.is.nagoya-u.ac.jp			JSPS [26011700]	The author would thank the anonymous referees for the valuable comments. The author also would like to express his appreciation to Professor Masakazu Jimbo for his advice and encouragement. This work was supported in part by JSPS under Grant-in-Aid for JSPS Fellows No. 26011700.	Akiyama J, 2011, LECT NOTES MATH, V2031, P1, DOI 10.1007/978-3-642-21919-1; BEHR H, 1968, CANADIAN J MATH, V20, P1432, DOI 10.4153/CJM-1968-144-7; LENZ H, 1991, DISCRETE MATH, V97, P3, DOI 10.1016/0012-365X(91)90416-Y; Feng T, 2008, J COMB THEORY A, V115, P1527, DOI 10.1016/j.jcta.2008.03.003; LINDNER CC, 1978, DISCRETE MATH, V22, P147, DOI 10.1016/0012-365X(78)90122-X; PLESNIK J, 1974, CZECH MATH J, V24, P292; BRAND N, 1993, DISCRETE MATH, V120, P25, DOI 10.1016/0012-365X(93)90562-8; SIEMON H, 1991, DISCRETE MATH, V97, P377, DOI 10.1016/0012-365X(91)90452-8; JIMBO M, 1993, DISCRETE MATH, V116, P79, DOI 10.1016/0012-365X(93)90395-A; BRAND N, 1986, GEOMETRIAE DEDICATA, V21, P169; Colbourn C., 1980, ARS COMBINATORIA, V10, P95; Coxeter H S M, 1984, GENERATORS RELATIONS; Grannel M., 1983, ANN DISCRETE MATH, V18, P409; Hanani H., 1960, CAN J MATH, V12, P145, DOI 10.4153/CJM-1960-013-3; Hartman A., 1992, CONT DESIGN THEORY, P205; Jungnickel D., 1999, DESIGN THEORY, VI; KOHLER E, 1982, LECT NOTES MATH, V969, P212; Kohler E., 1981, LECT NOTES MATH, V893, P195; Kohler E., 1979, ABH MATH SEM HAMBURG, V48, P1, DOI 10.1007/BF02941286; Munemasa A., 2012, J STAT THEO PRACT, V6, P97; Petersen J., 1891, ACTA MATH, V15, P193, DOI [DOI 10.1007/BF02392606, 10.1007/]; Wilson R. M., 1972, J NUMBER THEORY, V4, P17, DOI 10.1016/0022-314X(72)90009-1; Yu QR, 2009, GRAPH FACTORS AND MATCHING EXTENSIONS, P1, DOI 10.1007/978-3-540-93952-8	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	NOV	2015	31	6					1915	1927		10.1007/s00373-015-1595-5		13	Mathematics	Mathematics	CV0VQ	WOS:000363972100010		
J	Negami, S				Negami, Seiya			3-Regular Maps on Closed Surfaces are Nearly Distinguishing 3-Colorable with Few Exceptions	GRAPHS AND COMBINATORICS			English	Article						Distinguishing coloring; 3-regular graphs; Maps on surfaces		A k-coloring of a map M(G) on a closed surface with underlying graph G is said to be distinguishing if no automorphism of M(G) other than the identity map preserves the colors given by the coloring. In particular, if there is a distinguishing k-coloring of M(G) which uses color k at most once, then M(G) is said to be nearly distinguishing ()-colorable. We shall show that any 3-regular map on a closed surface is nearly distinguishing 3-colorable unless it is one of the three exceptions.	Yokohama Natl Univ, Fac Environm & Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan	Negami, S (reprint author), Yokohama Natl Univ, Fac Environm & Informat Sci, Hodogaya Ku, 79-2 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	negami@ynu.ac.jp					Collins KL, 2006, ELECTRON J COMB, V13; Fijavz G, 2011, ARS MATH CONTEMP, V4, P165; Negami S., 2014, BIPARTITE POLY UNPUB; Negami S., 2010, YOKOHAMA MATH J, V55, P179; Sano T., 2010, C NUMER, V206, P131; Sano T., 2011, YOKOHAMA MATH J, V57, P77; Tucker T.W., 2013, ELECT J COMBIN, V20; Tucker TW, 2011, ELECTRON J COMB, V18	8	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	NOV	2015	31	6					1929	1940		10.1007/s00373-015-1620-8		12	Mathematics	Mathematics	CV0VQ	WOS:000363972100011		
J	Noguchi, K; Suzuki, Y				Noguchi, Kenta; Suzuki, Yusuke			Relationship Among Triangulations, Quadrangulations and Optimal 1-Planar Graphs	GRAPHS AND COMBINATORICS			English	Article						Triangulation; Quadrangulation; Optimal 1-planar graph		In this paper, we examine relationship of graphs on surfaces: triangulations, quadrangulations and optimal -planar graphs. For a given quadrangulation of a closed surface can be extended to a triangulation by adding a diagonal edge in every face of . We show that every quadrangulation of with at least six vertices can be extended to a -connected triangulation. Moreover, we show that every -connected triangulation of has a -connected spanning quadrangulation subgraph. As corollaries of these results, we show that every optimal -planar graph has a -connected triangulation subgraph, and that every plane -connected triangulation can be extended to an optimal -planar graph by adding some edges.	[Noguchi, Kenta] Keio Univ, Dept Math, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Suzuki, Yusuke] Niigata Univ, Dept Math, Nishi Ku, Niigata 9502181, Japan	Noguchi, K (reprint author), Keio Univ, Dept Math, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	knoguchi@comb.math.keio.ac.jp; y-suzuki@math.sc.niigata-u.ac.jp					Fabrici I, 2007, DISCRETE MATH, V307, P854, DOI 10.1016/j.disc.2005.11.056; THOMAS R, 1994, J COMB THEORY B, V62, P114, DOI 10.1006/jctb.1994.1058; Suzuki Y, 2010, SIAM J DISCRETE MATH, V24, P1527, DOI 10.1137/090746835; Bauer D, 2006, GRAPH COMBINATOR, V22, P1, DOI 10.1007/s00373-006-0649-0; Suzuki Y, 2010, DISCRETE MATH, V310, P6, DOI 10.1016/j.disc.2009.07.016; Hudak D, 2012, DISCUSS MATH GRAPH T, V32, P737, DOI 10.7151/dmgt.1639; Nakamoto A., SIAM J DISCRETE MATH; Petersen J., 1891, ACTA MATH, V15, P193, DOI [DOI 10.1007/BF02392606, 10.1007/]; Ringel G., 1965, ABH MATH SEM HAMBURG, V29, P107, DOI 10.1007/BF02996313; Tutte William T., 1956, T AM MATH SOC, V82, P99, DOI 10.2307/1992980	10	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	NOV	2015	31	6					1965	1972		10.1007/s00373-015-1568-8		8	Mathematics	Mathematics	CV0VQ	WOS:000363972100013		
J	Nozaki, H				Nozaki, Hiroshi			Linear Programming Bounds for Regular Graphs	GRAPHS AND COMBINATORICS			English	Article						Linear programming bound; Graph spectrum; Expander graph; Ramanujan graph; Distance-regular graph; Moore graph	GENERALIZED QUADRANGLES; MOORE GRAPHS; CODES; DIMENSIONS; UNIQUENESS; ORDER-4; SPHERES; POINTS; NUMBER; SPACES	Delsarte et al. (Geom Dedicata 6:363-388, 1977) used the linear programming method in order to find bounds for the size of spherical codes endowed with prescribed inner products between distinct points in the code. In this paper, we develop the linear programming method to obtain bounds for the number of vertices of connected regular graphs endowed with given distinct eigenvalues. This method is proved by some "dual" technique of the spherical case, motivated from the theory of association scheme. As an application of this bound, we prove that a connected k-regular graph satisfying has the minimum second-largest eigenvalue of all k-regular graphs of the same size, where d is the number of distinct non-trivial eigenvalues, and g is the girth. The known graphs satisfying are Moore graphs, incidence graphs of regular generalized polygons of order (s, s), triangle-free strongly regular graphs, and the odd graph of degree 4.	Aichi Univ Educ, Dept Math Educ, Kariya, Aichi 4488542, Japan	Nozaki, H (reprint author), Aichi Univ Educ, Dept Math Educ, 1 Hirosawa,Igaya Cho, Kariya, Aichi 4488542, Japan.	hnozaki@auecc.aichi-edu.ac.jp			JSPS KAKENHI Grant [25800011, 26400003]	The author would like to thank Noga Alon, Eiichi Bannai, Tatsuro Ito, Jack Koolen, Hajime Tanaka, Sho Suda, and Masato Mimura for useful information and comments. The author is supported by JSPS KAKENHI Grant Numbers 25800011, 26400003.	Abiad A., ARXIV14043973; ALON N, 1985, J COMB THEORY B, V38, P73, DOI 10.1016/0095-8956(85)90092-9; ALON N, 1986, COMBINATORICA, V6, P83, DOI 10.1007/BF02579166; Hoory S, 2006, B AM MATH SOC, V43, P439, DOI 10.1090/S0273-0979-06-01126-8; BROUWER AE, 1993, EUR J COMBIN, V14, P397, DOI 10.1006/eujc.1993.1044; Musin OR, 2008, ANN MATH, V168, P1; BANNAI E, 1973, J FAC SCI U TOKYO 1, V20, P191; BROUWER AE, 1983, J GRAPH THEOR, V7, P455, DOI 10.1002/jgt.3190070411; HALL M, 1953, P AM MATH SOC, V4, P912, DOI 10.2307/2031829; Bachoc C, 2006, IEEE T INFORM THEORY, V52, P2111, DOI 10.1109/TIT.2006.872973; MOON A, 1982, DISCRETE MATH, V42, P91, DOI 10.1016/0012-365X(82)90057-7; Cohn H, 2007, J AM MATH SOC, V20, P99, DOI 10.1090/S0894-0347-06-00546-7; HOFFMAN AJ, 1960, IBM J RES DEV, V4, P497; ODLYZKO AM, 1979, J COMB THEORY A, V26, P210, DOI 10.1016/0097-3165(79)90074-8; DODZIUK J, 1984, T AM MATH SOC, V284, P787, DOI 10.2307/1999107; Veblen O, 1907, T AM MATH SOC, V8, P379, DOI 10.2307/1988781; Bachoc C, 2009, J COMB THEORY A, V116, P195, DOI 10.1016/j.jcta.2008.05.001; HOFFMAN AJ, 1963, AM MATH MON, V70, P30, DOI 10.2307/2312780; Barg A, 2009, MOSC MATH J, V9, P211; Tarnanen H, 1999, EUR J COMBIN, V20, P101, DOI 10.1006/eujc.1998.0272; Musin OR, 2012, DISCRETE COMPUT GEOM, V48, P128, DOI 10.1007/s00454-011-9392-2; LEVENSHTEIN VI, 1992, ACTA APPL MATH, V29, P1, DOI 10.1007/BF00053379; HIGMAN DG, 1968, MATH Z, V105, P110, DOI 10.1007/BF01110435; Martin WJ, 2009, EUR J COMBIN, V30, P1497, DOI 10.1016/j.ejc.2008.11.001; DAMERELL RM, 1981, B LOND MATH SOC, V13, P316, DOI 10.1112/blms/13.4.316; Bannai E., 1984, ALGEBRAIC COMBINATOR, VI; BENSON CT, 1966, CANADIAN J MATH, V18, P1091, DOI 10.4153/CJM-1966-109-8; Brouwer A.E., 1989, DISTANCE REGULAR GRA; Cohen A.M., 1985, EUROP J COMB, V6, P13; Conway J. H., 1999, SPHERE PACKINGS LATT; Damerell R.M., 1973, CAMB PHILOS SOC, V74, P227; Delsarte P., 1973, PHILIPS RES REP    S, V10, P1; Delsarte P., 1977, GEOMETRIAE DEDICATA, V6, P363, DOI 10.1007/BF03187604; Ericson T., 2001, N HOLLAND MATH LIB, V63; Feit W., 1964, J ALGEBRA, V1, P114, DOI DOI 10.1016/0021-8693(64)90028-6; GEWIRTZ A, 1969, CANADIAN J MATH, V21, P915, DOI 10.4153/CJM-1969-101-9; Godsil C., 2001, GRADUATE TEXTS MATH, V207; Godsil C.D., 1995, ELECTRON J COMB, V2, P20; Hall Jr M., 1959, MATH TABLES OTHER AI, V13, P233, DOI 10.2307/2002796; Hall Jr M, 1956, MATH TABLES AIDS COM, V10, P186, DOI 10.2307/2001913; Hora A., 2007, QUANTUM PROBABILITY; Kabatyanskii G. A., 1978, Problems of Information Transmission, V14; Koledin T., 2013, NOVI SAD J MATH, V43, P145; MacInnes C.R, 1907, AM MATH MON, V14, P171; PAYNE SE, 1977, J COMB THEORY A, V22, P280, DOI 10.1016/0097-3165(77)90003-6; PAYNE SE, 1977, J COMB THEORY A, V22, P267, DOI 10.1016/0097-3165(77)90002-4; PAYNE SE, 1975, J COMB THEORY A, V18, P203, DOI 10.1016/0097-3165(75)90009-6; Scott L.L., 1973, NOT AM MATH SOC, V701, P20; Seidel J. J., 1968, LINEAR ALGEBRA APPL, V1, P281, DOI DOI 10.1016/0024-3795(68)90008-6; Singleton R., 1966, J COMB THEORY, V1, P306, DOI DOI 10.1016/S0021-9800(66)80054-6; Tutte W. T., 1967, CONNECTIVITY GRAPHS	51	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	NOV	2015	31	6					1973	1984		10.1007/s00373-015-1613-7		12	Mathematics	Mathematics	CV0VQ	WOS:000363972100014		
J	Bau, S; Matsumoto, N; Nakamoto, A; Zheng, LJ				Bau, Sheng; Matsumoto, Naoki; Nakamoto, Atsuhiro; Zheng, Lijuan			Minor Relations for Quadrangulations on the Sphere	GRAPHS AND COMBINATORICS			English	Article						Contraction; Minor; Planar; Quadrangulation; Reduction; Sphere	SURFACES; GRAPH	We prove that for any quadrangulation G on the sphere with | V(G)| = 5, there exists a sequence of quadrangulations on the sphere G = G(1) > m G(2) >(m) >(m) G(n) = C4 ordered by minor inclusion > m, such that for i = 1,..., n -1, | V(Gi+ 1)| + 1 = | V(Gi)| = | V(Gi+ 1)| + 2, where C-4 similar or equal to K2,2 is a 4-cycle on the sphere. In order to justify Gi+ 1 <(m) Gi, two local reductions for quadrangulations are used, each of which is a combination of edge removals and edge contractions, and transforms a quadrangulation into a quadrangulation.	[Bau, Sheng] Univ Witwatersrand, Sch Math, Johannesburg, South Africa; [Matsumoto, Naoki; Nakamoto, Atsuhiro] Yokohama Natl Univ, Dept Math, Yokohama, Kanagawa 240, Japan; [Zheng, Lijuan] Fuzhou Univ, Ctr Discrete Math, Fuzhou 350002, Peoples R China	Bau, S (reprint author), Univ Witwatersrand, Sch Math, Johannesburg, South Africa.	sheng.bau@wits.ac.za; naoki.matsumo10@gmail.com; nakamoto@ynu.ac.jp		Nakamoto, Atsuhiro/0000-0003-1023-4831			Nakamoto A, 1999, J GRAPH THEOR, V30, P223, DOI 10.1002/(SICI)1097-0118(199903)30:3<223::AID-JGT7>3.0.CO;2-M; Robertson N, 2004, J COMB THEORY B, V92, P325, DOI 10.1016/j.jctb.2004.08.001; Brunet R, 1996, J COMB THEORY B, V68, P295, DOI 10.1006/jctb.1996.0070; Brinkmann G, 2005, DISCRETE MATH, V305, P33, DOI 10.1016/j.disc.2005.10.005; Hasheminezhad M., 2010, DISCUSS MATH GR THEO, V30, P123; Nakamoto A., 1995, YOKOHAMA MATH J, V43, P125; Nakamoto A, 1996, J COMB THEORY B, V67, P183, DOI 10.1006/jctb.1996.0040; Negami S., 1993, SCI REP YOKOHAMA N I, V40, P71; NEGAMI S, 1982, J COMB THEORY B, V32, P69, DOI 10.1016/0095-8956(82)90077-6; SEYMOUR PD, 1980, J COMB THEORY B, V28, P305, DOI 10.1016/0095-8956(80)90075-1; Steinitz E., 1934, VORLESUNGEN THEORIE	11	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	NOV	2015	31	6					2029	2036		10.1007/s00373-014-1489-y		8	Mathematics	Mathematics	CV0VQ	WOS:000363972100019		
J	Furuya, M; Tsuchiya, S				Furuya, Michitaka; Tsuchiya, Shoichi			Claw-Free and N(2,1,0)-Free Graphs are Almost Net-Free	GRAPHS AND COMBINATORICS			English	Article						Forbidden subgraph; Claw-free graph; Hamiltonian cycle		In this paper, we characterize connected {K1,3, N(2, 1, 0)}-free but not N(1, 1, 1)-free graphs. By combining our result and a theorem showed by Duffus et al. (every 2-connected {K1,3, N(1, 1, 1)}-free graph is Hamiltonian), we give an alternative proof of Bedrossian's theorem (every 2-connected {K1,3, N(2, 1, 0)}-free graph is Hamiltonian).	[Furuya, Michitaka] Tokyo Univ Sci, Dept Math Informat Sci, Shinjuku Ku, Tokyo 1628601, Japan; [Tsuchiya, Shoichi] Keio Univ, Dept Math, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Furuya, M (reprint author), Tokyo Univ Sci, Dept Math Informat Sci, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.	michitaka.furuya@gmail.com; wco.liew6.te@gmail.com					Faudree RJ, 1997, DISCRETE MATH, V173, P45, DOI 10.1016/S0012-365X(96)00147-1; SHEPHERD FB, 1991, J COMB THEORY B, V53, P173, DOI 10.1016/0095-8956(91)90074-T; Bedrossian P.M., 1991, THESIS MEMPHIS STATE; Diestel R., 2010, GRADUATE TEXTS MATH, V173; Duffus D., 1981, THEORY APPL GRAPHS, P297	5	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	NOV	2015	31	6					2201	2205		10.1007/s00373-014-1506-1		5	Mathematics	Mathematics	CV0VQ	WOS:000363972100033		
J	Higuchi, Y; Sato, I				Higuchi, Yusuke; Sato, Iwao			A Balanced Signed Digraph	GRAPHS AND COMBINATORICS			English	Article						Balanced signed digraph; Strongly connectivity; Covering; Zeta function	WEIGHTED ZETA-FUNCTIONS; CHARACTERISTIC-POLYNOMIALS; GRAPH COVERINGS; FINITE GRAPHS	We extend a balanced signed graph to a digraph, and present a necessary and sufficient condition for a signed digraph to be balanced. Moreover, we give another necessary and sufficient condition for a signed digraph to be balanced by using zeta functions of . As an application, we discuss the structure of balanced coverings of signed digraphs under consideration of coverings of strongly connected digraphs.	[Higuchi, Yusuke] Showa Univ, Coll Arts & Sci, Math Labs, Fujiyoshida, Yamanashi 4030005, Japan; [Sato, Iwao] Oyama Natl Coll Technol, Oyama, Tochigi 3230806, Japan	Sato, I (reprint author), Oyama Natl Coll Technol, Oyama, Tochigi 3230806, Japan.	isato@oyama-ct.ac.jp					Stark HM, 1996, ADV MATH, V121, P124, DOI 10.1006/aima.1996.0050; Mizuno H, 2002, LINEAR ALGEBRA APPL, V355, P35, DOI 10.1016/S0024-3795(02)00341-5; Deng AP, 2007, EUR J COMBIN, V28, P1099, DOI 10.1016/j.ejc.2006.04.001; GROSS JL, 1977, DISCRETE MATH, V18, P273, DOI 10.1016/0012-365X(77)90131-5; NEGAMI S, 1988, DISCRETE MATH, V70, P159, DOI 10.1016/0012-365X(88)90090-8; Foata D, 1999, T AM MATH SOC, V351, P2257, DOI 10.1090/S0002-9947-99-02234-5; Mizuno H, 2001, LINEAR ALGEBRA APPL, V336, P181, DOI 10.1016/S0024-3795(01)00318-4; Tarfulea A, 2009, LINEAR ALGEBRA APPL, V431, P73, DOI 10.1016/j.laa.2009.02.006; Deng AP, 2005, LINEAR ALGEBRA APPL, V408, P189, DOI 10.1016/j.laa.2005.06.016; Bass H, 1992, INT J MATH, V3, P717, DOI 10.1142/S0129167X92000357; Bowen R., 1970, P S PURE MATH, V14, P43; Gross J. L., 1987, TOPOLOGICAL GRAPH TH; Harary F., 1953, MICH MATH J, V2, P143, DOI [10.1307/mmj/1028989917, DOI 10.1307/MMJ/1028989917]; Hashimoto K, 1989, ADV STUD PURE MATH, V15, P211; IHARA Y, 1966, J MATH SOC JPN, V18, P219; Mizuno H., 2007, FAR E J MATH SCI, V27, P323; Sato I., 2005, FAR E J MATH SCI, V18, P321; Sato I, 2006, ELECTRON J COMB, V13; Sato I., 2006, FAR E J MATH SCI, V23, P281; Serre J.-P., 1977, LINEAR REPRESENTATIO; Terras AA, 2007, ADV MATH, V208, P467, DOI 10.1016/j.aim.2006.03.002; Sunada T., 1988, FUNDAMENTAL GROUPS L; SUNADA T, 1986, LECT NOTES MATH, V1201, P266; Sunada T., 2000, J MATH SCI-U TOKYO, V7, P7	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	NOV	2015	31	6					2215	2230		10.1007/s00373-014-1496-z		16	Mathematics	Mathematics	CV0VQ	WOS:000363972100035		
J	Sakuma, T				Sakuma, Tadashi			On the Balanced Decomposition Number	GRAPHS AND COMBINATORICS			English	Article						Graph decomposition; Coloring; Connectivity; Bipartite matching		A balanced coloring of a graph means a triple of mutually disjoint subsets of the vertex-set such that and . A balanced decomposition associated with the balanced coloring of is defined as a partition of (for some ) such that, for every , the subgraph of is connected and . Then the balanced decomposition number of a graph is defined as the minimum integer such that, for every balanced coloring of , there exists a balanced decomposition such that every element has at most vertices. Fujita and Liu (SIAM J Discret Math 24:1597-1616, 2010) proved an interesting theorem which states that the balanced decomposition number of a graph is at most if and only if is -connected. Unfortunately, their proof is long (about 10 pages) and complicated. Here we give an immediate proof of the theorem. This proof makes clear a relationship between balanced decomposition number and graph matching.	Yamagata Univ, Syst Sci & Informat Studies, Fac Educ Art & Sci, Yamagata 9908560, Japan	Sakuma, T (reprint author), Yamagata Univ, Syst Sci & Informat Studies, Fac Educ Art & Sci, 1-4-12 Kojirakawa, Yamagata 9908560, Japan.	sakuma@e.yamagata-u.ac.jp			JSPS KAKENHI [26400185]	This work was supported by JSPS KAKENHI Grant Number 26400185.	Fujita S, 2010, SIAM J DISCRETE MATH, V24, P1597, DOI 10.1137/090780894; Fujita S, 2008, DISCRETE APPL MATH, V156, P3339, DOI 10.1016/j.dam.2008.01.006; Chang GJ, 2013, DISCRETE MATH, V313, P1511, DOI 10.1016/j.disc.2013.03.012; Diestel R., 2010, GRAPH THEORY; Hall P., 1935, J LOND MATH SOC, V10, P26, DOI DOI 10.1112/JLMS/S1-10.37.26	5	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	NOV	2015	31	6					2377	2380		10.1007/s00373-015-1526-5		4	Mathematics	Mathematics	CV0VQ	WOS:000363972100047		
J	Kim, H; Kim, JH; Lee, YC; Kim, H; Youn, YH; Park, H; Choi, SH; Noh, SH; Gotoda, T				Kim, Hyunki; Kim, Jie-Hyun; Lee, Yong Chan; Kim, Hoguen; Youn, Young Hoon; Park, Hyojin; Choi, Seung Ho; Noh, Sung Hoon; Gotoda, Takuji			Growth Patterns of Signet Ring Cell Carcinoma of the Stomach for Endoscopic Resection	GUT AND LIVER			English	Article						Carcinoma; signet ring cell; Endoscopy; Resection; Stomach neoplasms	EARLY GASTRIC-CANCER; SUBMUCOSAL DISSECTION; CLINICOPATHOLOGICAL FACTORS; FEASIBILITY; LESION	Background/Aims: It is difficult to precisely detect the lateral margin during endoscopic submucosal dissection (ESD) for signet ring cell carcinoma (SRC) because SRC often expands to lateral direction through the lamina propria. Thus, the aim of this study was to classify the intramucosal spreading patterns of SRC and to analyze the patients' clinicopathological findings according to the spreading patterns. Methods: The intramucosal spreading patterns of SRC were classified as expansive or infiltrative types. A total of 100 surgical and 42 ESD specimens were reviewed. Results: In the surgical specimens, the proportions of expansive and infiltrative types were 44% and 56%, respectively. The infiltrative type was more commonly associated with old age, atrophy, and intestinal metaplasia in surrounding mucosa and the absence of Helicobacter pylori compared with the expansive type. In ESD specimens, the proportions of expansive and infiltrative types were each 50%. When lateral margin-positive lesions were compared with -negative lesions, larger size, residual lesion, and the lack of a neutrophil infiltration were more significantly associated with lateral margin-positive lesions. All cases with residual tumors in lateral margin-positive lesions were classified as the infiltrative type. Conclusions: SRC surrounded with atrophy and/or intestinal metaplasia often spreads subepithelially in the margin. This finding may suggest that a larger safety margin is necessary in this type during ESD.	[Kim, Hyunki; Kim, Hoguen] Yonsei Univ, Dept Pathol, Coll Med, Seoul 06273, South Korea; [Kim, Jie-Hyun; Lee, Yong Chan; Youn, Young Hoon; Park, Hyojin] Yonsei Univ, Dept Internal Med, Coll Med, Seoul 06273, South Korea; [Kim, Jie-Hyun; Youn, Young Hoon; Park, Hyojin; Choi, Seung Ho] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Seoul 06273, South Korea; [Choi, Seung Ho; Noh, Sung Hoon] Yonsei Univ, Dept Surg, Coll Med, Seoul 06273, South Korea; [Gotoda, Takuji] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan	Kim, JH (reprint author), Yonsei Univ, Gangnam Severance Hosp, Dept Internal Med, Coll Med, 211 Eonju Ro, Seoul 06273, South Korea.	otilia94@yuhs.ac			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2012R1A1A1042417]	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science, and Technology (2012R1A1A1042417).	Hirasawa T, 2009, GASTRIC CANCER, V12, P148, DOI 10.1007/s10120-009-0515-x; Aihara R, 2004, DIGEST DIS SCI, V49, P417, DOI 10.1023/B:DDAS.0000020496.98711.14; Akahoshi K, 1998, GASTROINTEST ENDOSC, V48, P470, DOI 10.1016/S0016-5107(98)70087-2; Kamada K, 2012, DIGESTION, V85, P111, DOI 10.1159/000334681; Isomoto H, 2009, GUT, V58, P331, DOI 10.1136/gut.2008.165381; Nagahama T, 2011, GASTROINTEST ENDOSC, V74, P1259, DOI 10.1016/j.gie.2011.09.005; Han JS, 2011, SCAND J GASTROENTERO, V46, P1099, DOI 10.3109/00365521.2011.591427; Nitta T, 2009, GASTRIC CANCER, V12, P23, DOI 10.1007/s10120-008-0493-4; [Anonymous], 1981, JPN J SURG, V11, P140; CORREA P, 1988, CANCER RES, V48, P3554; Seo JH, 2010, DIGESTION, V81, P35, DOI 10.1159/000235921; Kumarasinghe MP, 2006, PATHOLOGY, V38, P468, DOI 10.1080/00313020600924542; Hirata I, 2012, DIGESTION, V85, P74, DOI 10.1159/000334642; Okada K, 2012, ENDOSCOPY, V44, P122, DOI 10.1055/s-0031-1291486; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Gotoda T, 2000, GASTRIC CANCER, V3, P219, DOI 10.1007/PL00011720; Kim JH, 2009, GASTROINTEST ENDOSC, V69, pE1, DOI 10.1016/j.gie.2008.10.040	17	1	1	EDITORIAL OFFICE GUT & LIVER	SEOUL	305 LOTTE GOLD ROSE II, 890-59, DAECHI 4-DONG, GANGNAM-GU, SEOUL, 135-839, SOUTH KOREA	1976-2283	2005-1212		GUT LIVER	Gut Liver	NOV	2015	9	6					720	726		10.5009/gnl14203		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CU9ZV	WOS:000363907000008		
J	Yoshioka, H; Minamizaki, T; Yoshiko, Y				Yoshioka, Hirotaka; Minamizaki, Tomoko; Yoshiko, Yuji			The dynamics of DNA methylation and hydroxymethylation during amelogenesis	HISTOCHEMISTRY AND CELL BIOLOGY			English	Article						Epigenetics; Amelogenesis; Ameloblasts; Immunohistochemistry	STEM-CELLS; MAMMALIAN DEVELOPMENT; PROGENITOR CELLS; ES CELLS; 5-HYDROXYMETHYLCYTOSINE; DIFFERENTIATION; INCISOR; TOOTH; DEMETHYLATION; LOCALIZATION	Amelogenesis is a multistep process that relies on specific temporal and spatial signaling networks between the dental epithelium and mesenchymal tissues. Epigenetic modifications of key developmental genes in this process may be closely linked to a network of molecular events. However, the role of epigenetic regulation in amelogenesis remains unclear. Here, we have uncovered the spatial distributions of 5-methylcytosine (5-mC) and 5-hydroxymethylcytosine (5-hmC) to determine epigenetic events in the mandibular incisors of mice. Immunohistochemistry and dot blotting showed that 5-hmC in ameloblasts increased from the secretory stage to the later maturation stage. We also demonstrated the distribution of 5-mC-positive ameloblasts with punctate nuclear labeling from sometime after the initiation of the secretory stage to the later maturation stage; however, dot blotting failed to detect this change. No obvious alteration of 5-mC/5-hmC staining in odontoblasts and dental pulp cells was observed. Concomitant with quantitative expression data, immunohistochemistry showed that maintenance DNA methyltransferase DNMT1 was highly expressed in immature dental epithelial cells and subsequently decreased at later stages of development. Meanwhile, de novo DNA methyltransferase Dnmt3a and Dnmt3b and DNA demethylase Tet family genes were universally expressed, except Tet1 that was highly expressed in immature dental epithelial cells. Thus, DNMT1 may sustain the undifferentiated status of dental epithelial cells through the maintenance of DNA methylation, while the hydroxylation of 5-mC may occur through the whole differentiation process by TET activity. Taken together, these data indicate that the dynamic changes of 5-mC and 5-hmC may be critical for the regulation of amelogenesis.	[Yoshioka, Hirotaka; Minamizaki, Tomoko; Yoshiko, Yuji] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Calcified Tissue Biol, Minami Ku, Hiroshima 7348553, Japan	Yoshiko, Y (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Calcified Tissue Biol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	hirotaka@hiroshima-u.ac.jp; yyuji@hiroshima-u.ac.jp			Japan Society for the Promotion of Science [24791962]	We are grateful to Azusa Onishi, Chieko Niwata, and Rina Ohtake for technical assistance with procedures. This work was supported by the Japan Society for the Promotion of Science (Grants-in-Aid for Young Scientists 24791962 to H. Y.).	Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Juuri E, 2012, DEV CELL, V23, P317, DOI 10.1016/j.devcel.2012.05.012; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Bleicher F, 2014, EXP CELL RES, V325, P65, DOI 10.1016/j.yexcr.2013.12.012; Apostolou E, 2013, NATURE, V502, P462, DOI 10.1038/nature12749; Seidel K, 2010, DEVELOPMENT, V137, P3753, DOI 10.1242/dev.056358; Biehs B, 2013, NAT CELL BIOL, V15, P846, DOI 10.1038/ncb2766; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; BRONCKERS ALJJ, 1983, ARCH ORAL BIOL, V28, P681, DOI 10.1016/0003-9969(83)90102-4; Villagra A, 2002, J CELL BIOCHEM, V85, P112, DOI 10.1002/jcb.10113; Tummers M, 2009, J EXP ZOOL PART B, V312B, P309, DOI 10.1002/jez.b.21280; Couve E, 2013, J DENT RES, V92, P765, DOI 10.1177/0022034513495874; Delgado-Calle J, 2012, J BONE MINER RES, V27, P926, DOI 10.1002/jbmr.1491; Tsai CC, 2012, MOL CELL, V47, P169, DOI 10.1016/j.molcel.2012.06.020; Kawano S, 2004, J DENT RES, V83, P129; Morotomi T, 2005, ARCH ORAL BIOL, V50, P695, DOI 10.1016/j.archoralbio.2004.12.006; Krebsbach PH, 1996, J BIOL CHEM, V271, P4431; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Delgado-Calle J, 2011, BONE, V49, P830, DOI 10.1016/j.bone.2011.06.006; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Simmer JP, 2010, J DENT RES, V89, P1024, DOI 10.1177/0022034510375829; Ruzov A, 2011, CELL RES, V21, P1332, DOI 10.1038/cr.2011.113; Harada H, 1999, J CELL BIOL, V147, P105, DOI 10.1083/jcb.147.1.105; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Nishikawa K, 2015, NAT MED, V21, P281, DOI 10.1038/nm.3774; Szulwach KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002154	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0948-6143	1432-119X		HISTOCHEM CELL BIOL	Histochem. Cell Biol.	NOV	2015	144	5					471	478		10.1007/s00418-015-1353-z		8	Cell Biology; Microscopy	Cell Biology; Microscopy	CV0VU	WOS:000363972500006		
J	You, XY; Koda, K; Yamada, T; Uraki, Y				You, Xiangyu; Koda, Keiichi; Yamada, Tatsuhiko; Uraki, Yasumitsu			Preparation of electrode for electric double layer capacitor from electrospun lignin fibers	HOLZFORSCHUNG			English	Article						electric double layer capacitor; electrospinning; lignin-based activated carbon fibers; pore size distribution; surface area	ACTIVATED CARBON-FIBERS; ELECTROCHEMICAL CAPACITORS; HIGH-PERFORMANCE; MESOPOROUS CARBONS; PORE SIZES; ACID	Lignin-based activated carbon fibers (ACFs) were prepared by electrospinning of hardwood acetic acid lignin (HW-AAL) solution followed by thermostabilization, carbonization, and steam activation. The thermostabilization process was able to be remarkably shortened from 38 h to 3 h with hexamethylenetetramine (hexamine) in binary solvents, AcOH/CCl4 (8/2), when compared with conventional thermostabilization processes. The resultant ACFs possessed higher specific surface area (2185 m(2) g(-1)) than those from commercial activated carbon and electrospun lignin fibers without hexamine. These ACFs also exhibited good electrical capacitance (133.3 F g(-1) at a current density of 1 A g(-1)) as electrodes of electric double layer capacitor (EDLC) are efficient not only due to their large surfaces area but also due to their porous structure with well-developed micropores (diameter: 0.5-1.3 nm). High energy density and power density of this EDLC (42 Wh kg(-1) and 91 kW kg(-1), respectively) were also achieved.	[Koda, Keiichi; Uraki, Yasumitsu] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan; [You, Xiangyu] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan; [Yamada, Tatsuhiko] Forestry & Forest Prod Res Inst, Div Biomass Chem, Tsukuba, Ibaraki 3058687, Japan	Uraki, Y (reprint author), Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan.	uraki@for.agr.hokudai.ac.jp			Ministry of Agriculture, Forestry and Fisheries of Japan	This work was supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan, "Development of Technologies for Biofuel Production Systems in Rural Areas (2012-2015)". We would also like to thank Prof. Aorigele (South China University of Technology, China) for his valuable advice to our work.	Simon P, 2008, NAT MATER, V7, P845, DOI 10.1038/nmat2297; Calvo-Flores FG, 2010, CHEMSUSCHEM, V3, P1227, DOI 10.1002/cssc.201000157; Kubo S, 1998, CARBON, V36, P1119, DOI 10.1016/S0008-6223(98)00086-4; Liu CL, 2007, J ELECTROANAL CHEM, V611, P225, DOI 10.1016/j.jelechem.2007.09.003; Bozell JJ, 2010, GREEN CHEM, V12, P539, DOI 10.1039/b922014c; Bose S, 2012, J MATER CHEM, V22, P767, DOI 10.1039/c1jm14468e; Chmiola J, 2006, SCIENCE, V313, P1760, DOI 10.1126/science.1132195; Imaizumi S, 2009, POLYM J, V41, P1124, DOI 10.1295/polymj.PJ2009160; Uraki Y, 2001, J WOOD SCI, V47, P465, DOI 10.1007/BF00767899; Suhas, 2007, BIORESOURCE TECHNOL, V98, P2301, DOI 10.1016/j.biortech.2006.08.008; Martin C, 2006, J POLYM SCI POL CHEM, V44, P3503, DOI 10.1002/pola.21458; URAKI Y, 1995, HOLZFORSCHUNG, V49, P343, DOI 10.1515/hfsg.1995.49.4.343; Qu DY, 1998, J POWER SOURCES, V74, P99, DOI 10.1016/S0378-7753(98)00038-X; Lai CL, 2014, J POWER SOURCES, V247, P134, DOI 10.1016/j.jpowsour.2013.08.082; Rosas JM, 2009, FUEL, V88, P19, DOI 10.1016/j.fuel.2008.08.004; FITZER E, 1975, CARBON, V13, P63, DOI 10.1016/0008-6223(75)90259-6; Lu HL, 2012, J POWER SOURCES, V209, P243, DOI 10.1016/j.jpowsour.2012.02.041; Ruiz-Rosas R, 2014, CHEMSUSCHEM, V7, P1458, DOI 10.1002/cssc.201301408; Xu B, 2007, ELECTROCHIM ACTA, V52, P4595, DOI 10.1016/j.electacta.2007.01.006; Im JS, 2007, J COLLOID INTERF SCI, V314, P32, DOI 10.1016/j.jcis.2007.05.033; Inagaki M, 2010, J POWER SOURCES, V195, P7880, DOI 10.1016/j.jpowsour.2010.06.036; Neimark AV, 2009, CARBON, V47, P1617, DOI 10.1016/j.carbon.2009.01.050; Zhang LL, 2009, CHEM SOC REV, V38, P2520, DOI 10.1039/b813846j; Babel K, 2008, CARBON, V46, P1948, DOI 10.1016/j.carbon.2008.08.005; Liu CL, 2008, J ELECTROCHEM SOC, V155, pF1, DOI 10.1149/1.2799683; Kim T, 2013, ACS NANO, V7, P6899, DOI 10.1021/nn402077v; Inagaki M, 2009, NEW CARBON MATER, V24, P193, DOI 10.1016/S1872-5805(08)60048-7; Kadla JF, 2002, CARBON, V40, P2913, DOI 10.1016/S0008-6223(02)00248-8; El-Kady MF, 2012, SCIENCE, V335, P1326, DOI 10.1126/science.1216744; Wang GP, 2012, CHEM SOC REV, V41, P797, DOI 10.1039/c1cs15060j; Kim C, 2003, APPL PHYS LETT, V83, P1216, DOI 10.1063/1.1599963; Burke A, 2007, ELECTROCHIM ACTA, V53, P1083, DOI 10.1016/j.electacta.2007.01.011; Feng Y., 2009, PAPER SCI TECHNOL, V28, P29; Kubo S, 2005, J POLYM ENVIRON, V13, P97, DOI 10.1007/s10924-005-2941-0; Liu S., 2012, CARBON, V50, P3963	35	1	1	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0018-3830	1437-434X		HOLZFORSCHUNG	Holzforschung	NOV	2015	69	9					1097	1106		10.1515/hf-2014-0262		10	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CU9ZS	WOS:000363906400007		
J	Tanaka, T				Tanaka, Takashi			Improved method based on dual-energy X-ray absorptiometry for nondestructive evaluation of solid wood moisture content	HOLZFORSCHUNG			English	Article						dual-energy X-ray absorptiometry (DXA); moisture content (MC); nondestructive evaluation; sugi (Cryptomeria japonica); X-ray densitometry	BODY-COMPOSITION	An accurate, rapid, and convenient method is presented for moisture content (MC) determination of solid wood based on dual-energy X-ray absorptiometry (DXA). Poly(methyl methacrylate)-equivalent thicknesses (PMMA-EThs) of sugi (Cryptomeria japonica D. Don) wood blocks and pure water were measured by means of a wide range of X-ray tube voltages (20-100 kV). The ratio of the PMMA-ETh of pure water to that of wood decreased as X-ray tube voltage was increased, suggesting that an appropriate pair of tube voltages for DXA is 20 and 100 kV. According to this result, X-ray images of 30 wood samples were taken at 20- and 100-kV tube voltages, and their average PMMA-Eths from both images was determined. There was a strong negative correlation between the wet-basis MC of the wood sample and the ratio of its PMMAEth at 100 kV to that at 20 kV. A regression equation was developed for estimating the dry-basis MC of wood samples from their PMMA-ETh ratios. The standard error of estimate was 2.2%, which is better than those determined for electric moisture meters. This approach may lead to the development of a practical, nondestructive moisture meter for wood.	Shizuoka Univ, Grad Sch Agr, Suruga Ku, Shizuoka 4228529, Japan	Tanaka, T (reprint author), Shizuoka Univ, Grad Sch Agr, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.	attanak@ipc.shizuoka.ac.jp			JSPS KAKENHI [24780170]	This work was supported by JSPS KAKENHI (grant no. 24780170). I am grateful for the advice and expertise of Dr. Yasuo Kawai at Akita Prefectural University.	Kobori H, 2013, HOLZFORSCHUNG, V67, P307, DOI 10.1515/hf-2012-0054; MAZESS RB, 1990, AM J CLIN NUTR, V51, P1106; SARTORIS DJ, 1989, AM J ROENTGENOL, V152, P241; SVENDSEN OL, 1993, AM J CLIN NUTR, V57, P605; Kullenberg R, 2010, J BIOBASED MATER BIO, V4, P363, DOI 10.1166/jbmb.2010.1101; Telkki VV, 2013, HOLZFORSCHUNG, V67, P291, DOI 10.1515/hf-2012-0057; Hultnas M, 2012, J WOOD SCI, V58, P309, DOI 10.1007/s10086-012-1260-z; Tanaka T, 2013, WOOD SCI TECHNOL, V47, P1213, DOI 10.1007/s00226-013-0569-0; HAARBO J, 1991, CLIN PHYSIOL, V11, P331, DOI 10.1111/j.1475-097X.1991.tb00662.x; Javed MA, 2015, HOLZFORSCHUNG, V69, P899, DOI 10.1515/hf-2014-0183; James W. L., 1968, Forest Products Journal, V18, P23; Kobori H, 2015, HOLZFORSCHUNG, V69, P329, DOI 10.1515/hf-2014-0021; Lanvermann C, 2014, HOLZFORSCHUNG, V68, P113, DOI 10.1515/hf-2012-0171; Siau J. F., 1984, TRANSPORT JF, P132; Siau J. F., 1995, WOOD INFLUENCE MOIST, P86	15	1	1	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0018-3830	1437-434X		HOLZFORSCHUNG	Holzforschung	NOV	2015	69	9					1133	1136		10.1515/hf-2014-0295		4	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CU9ZS	WOS:000363906400011		
J	Seino, Y; Ikeda, Y; Niemoeller, E; Watanabe, D; Takagi, H; Yabe, D; Inagaki, N				Seino, Y.; Ikeda, Y.; Niemoeller, E.; Watanabe, D.; Takagi, H.; Yabe, D.; Inagaki, N.			Efficacy and Safety of Lixisenatide in Japanese Patients with Type 2 Diabetes Insufficiently Controlled with Basal Insulin +/- Sulfonylurea: A Subanalysis of the GetGoal-L-Asia Study	HORMONE AND METABOLIC RESEARCH			English	Article						sulfonylureas; diabetes mellitus type 2; GLP-1 analogues	ONCE-DAILY LIXISENATIDE; RECEPTOR AGONIST LIXISENATIDE; PLACEBO-CONTROLLED TRIAL; BETA-CELL FUNCTION; GLYCEMIC CONTROL; EXENATIDE TWICE; PEPTIDE-1 ANALOG; DOUBLE-BLIND; OPEN-LABEL; LIRAGLUTIDE	The aim of the study was to evaluate the efficacy and safety of once-daily lixisenatide 20g as add-on to basal insulin with or without sulfonylurea in Asian patients with type 2 diabetes mellitus. The study as a subanalysis of the 159 Japanese patients from the 24-week double-blind GetGoal-L-Asia study (NCT00866658) who received once-daily lixisenatide or placebo. The primary endpoint was change from baseline in HbA1c evaluated using analysis of covariance. Once-daily lixisenatide significantly reduced mean HbA1c [least squares mean difference vs. placebo -1.1% (-12mmol/mol); p<0.0001]. Significantly more patients in the lixisenatide group reached HbA1c targets of <7% (53mmol/mol; 31.4 vs. 2.3% for placebo; p<0.0001) and 6.5% (48mmol/mol; 12.9 vs. 1.2% for placebo; p=0.0028). Lixisenatide significantly reduced 2-h postprandial plasma glucose (least squares mean difference vs. placebo-8.64mmol/l; p<0.0001), glucose excursion (least squares mean difference vs. placebo -7.80mmol/l; p<0.0001) and fasting plasma glucose (least squares mean difference vs. placebo -0.96mmol/l; p=0.0126). Body weight was reduced with lixisenatide but with no significant difference vs. placebo. Gastrointestinal adverse events were more frequent with lixisenatide (61.1 vs. 11.5% for placebo) but were generally transient and mild-to-moderate in intensity. The incidence of symptomatic hypoglycemia was 39.0 vs. 13.5% in patients receiving sulfonylureas and 32.3 vs. 22.9% in those not receiving sulfonylureas, for lixisenatide and placebo, respectively. In Japanese patients with type 2 diabetes mellitus, once-daily lixisenatide was well tolerated and led to significant and clinically relevant improvement in glycemic control, with a pronounced effect on postprandial plasma glucose.	[Seino, Y.; Yabe, D.] Kansai Elect Power Hosp, Diabet Clin Nutr & Endocrinol, Osaka 5530003, Japan; [Ikeda, Y.; Watanabe, D.; Takagi, H.] Sanofi, Tokyo, Japan; [Niemoeller, E.] Sanofi, Frankfurt, Germany; [Inagaki, N.] Kyoto Univ, Grad Sch Med, Dept Diabet & Clin Nutr, Kyoto, Japan	Seino, Y (reprint author), Kansai Elect Power Hosp, Diabet Clin Nutr & Endocrinol, Fukushima Ku, 2-1-7 Fukushima, Osaka 5530003, Japan.	seino.yutaka@e2.kepco.co.jp			Sanofi	We would like to thank all of the investigators, coordinators and patients who took part in the GetGoal-L-Asia study. The study was funded and conducted by Sanofi. Editorial support for the initial draft was provided by Medicus International London, with support for subsequent drafts provided by Caudex Medical Ltd., funded by Sanofi.	Edwards CMB, 2001, AM J PHYSIOL-ENDOC M, V281, pE155; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Seino Y, 2012, DIABETES OBES METAB, V14, P910, DOI 10.1111/j.1463-1326.2012.01618.x; Yabe D, 2010, J DIABETES INVEST, V1, P56, DOI 10.1111/j.2040-1124.2010.00010.x; Rosenstock J, 2014, J DIABETES COMPLICAT, V28, P386, DOI 10.1016/j.jdiacomp.2014.01.012; Inagaki N, 2011, J DIABETES INVEST, V2, P448, DOI 10.1111/j.2040-1124.2011.00137.x; Fonseca VA, 2012, DIABETES CARE, V35, P1225, DOI 10.2337/dc11-1935; Usui R, 2013, J DIABETES INVEST, V4, P585, DOI 10.1111/jdi.12111; Neville SE, 2009, DIABETES-METAB RES, V25, P705, DOI 10.1002/dmrr.1012; Degn KB, 2004, DIABETES, V53, P1187, DOI 10.2337/diabetes.53.5.1187; Riddle MC, 2013, DIABETES CARE, V36, P2489, DOI 10.2337/dc12-2454; Kadowaki T, 2009, ENDOCR J, V56, P415; Kaku K, 2010, DIABETES OBES METAB, V12, P341, DOI 10.1111/j.1463-1326.2009.01194.x; Garber AJ, 2012, EXPERT OPIN INV DRUG, V21, P45, DOI 10.1517/13543784.2012.638282; Riddle MC, 2013, DIABETES CARE, V36, P2497, DOI 10.2337/dc12-2462; Shin SJ, 2012, J DIABETES INVEST, V3, P490, DOI 10.1111/j.2040-1124.2012.00241.x; [Anonymous], 2012, DIABETES CARE, DOI [DOI 10.2337/DC12-041.3, 10.2337/dc12-0413]; Bodmer M, 2008, DIABETES CARE, V31, P2086, DOI 10.2337/dc08-1171; Kondo Y, 2013, J DIABETES INVEST, V4, P571, DOI 10.1111/jdi.12082; Yabe D, 2012, J DIABETES INVEST, V3, P347, DOI 10.1111/j.2040-1124.2012.00219.x; [Anonymous], 2012, JAP DIAB SOC TREATM, V1, P50; Seino Y, 2012, J DIABETES INVEST, V3, P388, DOI 10.1111/j.2040-1124.2012.00193.x; Rosenstock J, 2013, DIABETES CARE, V36, P2945, DOI 10.2337/dc12-2709; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Buse John B, 2009, Lancet, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026; Seino Y, 2010, J DIABETES INVEST, V1, P8, DOI 10.1111/j.2040-1124.2010.00022.x; Ahren B, 2013, DIABETES CARE, V36, P2543, DOI 10.2337/dc12-2006; Seino Y, 2011, J DIABETES INVEST, V2, P280, DOI 10.1111/j.2040-1124.2011.00103.x; Lorenz M, 2013, REGUL PEPTIDES, V185, P1, DOI 10.1016/j.regpep.2013.04.001; Kozawa J, 2012, J DIABETES INVEST, V3, P294, DOI 10.1111/j.2040-1124.2011.00168.x; Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; Barnett Anthony H, 2011, Core Evid, V6, P67, DOI 10.2147/CE.S15525; Bolli GB, 2014, DIABETIC MED, V31, P176, DOI 10.1111/dme.12328; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Fukushima M, 2004, DIABETES RES CLIN PR, V66, pS37, DOI 10.1016/j.diabres.2003.11.024; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Pinget M, 2013, DIABETES OBES METAB, V15, P1000, DOI 10.1111/dom.12121; Morimoto A., 2010, JMAJ - Japan Medical Association Journal, V53, P36	40	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0018-5043	1439-4286		HORM METAB RES	Horm. Metab. Res.	NOV	2015	47	12					895	900		10.1055/s-0035-1549875		6	Endocrinology & Metabolism	Endocrinology & Metabolism	CV4FP	WOS:000364222700005		
J	Kai, Y; Stevenson, DE; Ueda, Y; Hamatsu, T; Nakabo, T				Kai, Yoshiaki; Stevenson, Duane E.; Ueda, Yuji; Hamatsu, Tomonori; Nakabo, Tetsuji			Molecular insights into geographic and morphological variation within the Eumicrotremus asperrimus species complex (Cottoidei: Cyclopteridae)	ICHTHYOLOGICAL RESEARCH			English	Article						Mitochondrial DNA; Cyclopteropsis; Lethotremus; North Pacific; Phylogeography; Spiny tubercles	SEA DEMERSAL FISH; FRESH-WATER EELS; MITOCHONDRIAL-DNA; POPULATION-GROWTH; JAPAN SEA; SEQUENCES; EVOLUTION; HISTORIES; PROGRAMS; OKHOTSK	A molecular phylogeny of lumpsukers, Eumicrotremus asperrimus and related species (family Cyclopteridae), is presented on the basis of sequence variations in the cytochrome b and cytochrome c oxidase subunit 1 genes (1,659 base pairs) of mitochondrial DNA using specimens collected from across the North Pacific, including the Sea of Japan, Sea of Okhotsk, Bering Sea, and Gulf of Alaska. Specimens identified as Eumicrotremus phrynoides, Cyclopteropsis bergi, Cyclopteropsis lindbergi, and Lethotremus muticus on the basis of the presence or absence of spiny tubercles and height of the first dorsal fin did not exhibit reciprocal monophyly, but were randomly clustered with E. asperrimus. This collection of forms is therefore referred to as the "E. asperrimus species complex." DNA sequence data presented here divided the E. asperrimus species complex into two distinct clades, corresponding to the eastern North Pacific (the Bering Sea, Aleutian Islands, and Gulf of Alaska) and the western North Pacific (the Seas of Japan and Okhotsk) regions. Slight morphometric differences between eastern and western clades were also evident, indicating that they represent at least two different species. The genetic level of divergence between the two clades suggests that the speciation event occurred during the early Pleistocene to late Pliocene. Although the presence and morphology of tubercles have been used extensively for species discrimination in Cyclopteridae, our results suggest that this character complex is confounded by intraspecific variation. Examined samples showed some sexual dimorphism in the relative development of the tubercles, although the pattern was different between the eastern and western North Pacific clades. These results underscore the need for a thorough re-examination of the taxonomy of Pacific cyclopterids, using molecular data to supplement potentially misleading tubercle morphology.	[Kai, Yoshiaki] Kyoto Univ, Field Sci Educ & Res Ctr, Maizuru Fisheries Res Stn, Maizuru, Kyoto 6250086, Japan; [Stevenson, Duane E.] NOAA, Natl Marine Fisheries Serv, Alaska Fisheries Sci Ctr, Resource Assessment & Conservat Engn Div, Seattle, WA 98115 USA; [Ueda, Yuji] Fisheries Res Agcy, Japan Sea Natl Fisheries Res Inst, Chuo Ku, Niigata 9518121, Japan; [Hamatsu, Tomonori] Fisheries Res Agcy, Hokkaido Natl Fisheries Res Inst, Kushiro, Hokkaido 0850802, Japan; [Nakabo, Tetsuji] Kyoto Univ, Kyoto Univ Museum, Sakyo Ku, Kyoto 6068501, Japan	Kai, Y (reprint author), Kyoto Univ, Field Sci Educ & Res Ctr, Maizuru Fisheries Res Stn, Maizuru, Kyoto 6250086, Japan.	mebaru@kais.kyoto-u.ac.jp			Fisheries Agency of Japan	We sincerely thank K. Fujiwara (Japan Sea National Fisheries Research Institute), the crews of T/V Tanshu-maru (Kasumi High School) and R/V Kaiyo-maru No. 5, A. Yamasaki, T. Miyajima, and the crews of the R/V Heian-maru (Kyoto Prefectural Agriculture, Forestry and Fisheries Technology Center, Japan). We greatly appreciate the loans of specimens and gifts of tissues provided by T.W. Pietsch and K.P. Maslenikov (UW), as well as helpful discussions about statistics with J.W. Orr (AFSC). We also thank T.W. Pietsch and J.W. Orr for critical reviews of the manuscript. This study was supported in part by the Fisheries Agency of Japan under the projects of "Assessment of Fisheries Stocks in the Waters around Japan.''	RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.2307/2409177; Kai Y, 2011, ICHTHYOL RES, V58, P143, DOI 10.1007/s10228-010-0202-2; Shinohara Gento, 2009, National Museum of Nature and Science Monographs, P683; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Grant WS, 2012, MOL PHYLOGENET EVOL, V65, P203, DOI 10.1016/j.ympev.2012.06.006; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Gaither MR, 2013, J BIOGEOGR, V40, P1638, DOI 10.1111/jbi.12126; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Liu JX, 2011, MOL ECOL, V20, P3879, DOI 10.1111/j.1365-294X.2011.05213.x; Aoyama J, 2000, ICHTHYOL RES, V47, P157, DOI 10.1007/BF02684236; Canino MF, 2010, MOL ECOL, V19, P4339, DOI 10.1111/j.1365-294X.2010.04815.x; Wang PX, 1999, MAR GEOL, V156, P5, DOI 10.1016/S0025-3227(98)00172-8; Minegishi Y, 2005, MOL PHYLOGENET EVOL, V34, P134, DOI 10.1016/j.ympev.2004.09.003; Harrison PJ, 1999, PROG OCEANOGR, V43, P205, DOI 10.1016/S0079-6611(99)00015-4; Kodama Y, 2008, MOL PHYLOGENET EVOL, V49, P682, DOI 10.1016/j.ympev.2008.08.022; Tyler PA, 2002, J OCEANOGR, V58, P333, DOI 10.1023/A:1015817910449; ORTI G, 1994, EVOLUTION, V48, P608, DOI 10.2307/2410473; Ishiwatari R, 2001, ORG GEOCHEM, V32, P57, DOI 10.1016/S0146-6380(00)00151-0; Sakuma K, 2014, ZOOL SCI, V31, P375, DOI 10.2108/zs130271; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092; Byrkjedal I, 2007, J FISH BIOL, V71, P111, DOI 10.1111/j.1095-8649.2007.01550.x; Shirai SM, 2006, ICHTHYOL RES, V53, P357, DOI 10.1007/s10228-006-0356-0; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; CANTATORE P, 1994, J MOL EVOL, V39, P589, DOI 10.1007/BF00160404; Dodson JJ, 2007, MOL ECOL, V16, P5030, DOI 10.1111/j.1365-294X.2007.03559.x; ARITA GS, 1969, J FISH RES BOARD CAN, V26, P3262; Belousov A, 2009, ENCY ISLANDS, P520; Bezverkhniy VL, 2002, FLORA FAUNA KURIL IS, P35; Briggs J.C., 1974, MARINE ZOOGEOGRAPHY; Carpenter KE, 2011, J MAR BIOL, DOI DOI 10.1155/2011/396982; Chernova Natalia V., 2004, California Academy of Sciences Annotated Checklists of Fishes, V31, P1; Davenport J, 1985, 147 FAO, V147; HARPENDING HC, 1994, HUM BIOL, V66, P591; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Kai Y, 2014, SPECIES DIV IN PRESS, P19; Kimura M, 1980, J MOL EVOL, V16, P116; Kitagawa D, 2008, FIELD GUIDE FISHES T; Legeza MI, 1955, B ZOOL I ACAD SCI US, V18, P389; Liu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050340; Mecklenburg CW, 2002, FISHES ALASKA; Meyer Axel, 1993, Biochemistry and Molecular Biology of Fishes, V2, P1; Nakabo T, 2013, FISHES JAPAN PICTORI, p[1529, 665]; Nelson J. S., 2006, FISHES WORLD; Palumbi S., 1991, SIMPLE FOOLS GUIDE P; Payne MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030105; Rambaut A., 2009, TRACER V1 5; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sheiko BA, 2003, ANNOTATED CHECKLISTS, P1; Shinohara G, 2011, B NATL MUSEUM NATU A, V37, P35; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ueno T., 1970, FAUNA JAPONICA CYCLO	55	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	NOV	2015	62	4					396	408		10.1007/s10228-014-0453-4		13	Zoology	Zoology	CV0PT	WOS:000363953600002		
J	Sumi, K; Asaoka, R; Nakae, M; Sasaki, K				Sumi, Keina; Asaoka, Ryu; Nakae, Masanori; Sasaki, Kunio			Innervation of the lateral line system in the blind cavefish Astyanax mexicanus (Characidae) and comparisons with the eyed surface-dwelling form	ICHTHYOLOGICAL RESEARCH			English	Article						Neuromast; Nerve; Scale; Lateral line canal; Cyprinidae	CARASSIUS-AURATUS; NEUROMASTS; TELEOSTEI; FISHES; GYMNOTIFORMES; TAXONOMY; GOLDFISH; NERVES	The lateral line system and its innervation were examined in the blind cavefish Astyanax mexicanus (Characidae) and compared with that in the eyed surface-dwelling form of the same species. In both forms, superficial neuromasts occurred on almost the entire surface of the body and caudal fin, the number in the blind form being greater on the head (831) and tail (511) than in the eyed form (531 and 251, respectively), but lower on the trunk (1,305 vs. 2,125). In the blind form, superficial neuromasts were greatly proliferated on the cheek and lower jaw, the mandibular ramus being extensively ramified, including an additional major ramule that was absent in the eyed form. In both forms, superficial neuromasts on the trunk were innervated by a number of dorsal and ventral ramules (roughly corresponding to the number of lateral line scales) derived from the lateral ramus. In both forms, canal neuromasts in the infraorbital and trunk lateral line canals were innervated by nerves without associated elements innervating superficial neuromasts. Accordingly, the lateral line scales each accommodated only a single canal neuromast. This lateral line scale condition was recognized as common in Characidae, being in sharp contrast to the condition in Cyprinidae (both included in Otophysa) in which the lateral line scales each had a vertical row of superficial neuromasts.	[Sumi, Keina; Asaoka, Ryu; Sasaki, Kunio] Kochi Univ, Fac Sci, Marine Biol Lab, Kochi 7808520, Japan; [Nakae, Masanori] Natl Museum Nat & Sci, Dept Zool, Tsukuba, Ibaraki 3050005, Japan	Sasaki, K (reprint author), Kochi Univ, Fac Sci, Marine Biol Lab, 2-5-1 Akebono Cho, Kochi 7808520, Japan.	fishssk@cc.kochi-u.ac.jp			JSPS [257617, 231039]; Kochi University Marine Science Project	G. Hardy (Ngunguru, New Zealand) read the manuscript and offered helpful comments. This study was partly supported by grants-in-aid from JSPS [to RA (no. 257617) and to MN (no. 231039)] and Kochi University Marine Science Project (to KuS).	Jeffery WR, 2001, DEV BIOL, V231, P1, DOI 10.1006/dbio.2000.0121; Yoshizawa M, 2010, CURR BIOL, V20, P1631, DOI 10.1016/j.cub.2010.07.017; Asaoka R, 2011, ICHTHYOL RES, V58, P51, DOI 10.1007/s10228-010-0193-z; TEYKE T, 1990, BRAIN BEHAV EVOLUT, V35, P23, DOI 10.1159/000115853; Northcutt RG, 2000, J COMP NEUROL, V421, P570; VISCHER HA, 1989, J COMP NEUROL, V290, P16, DOI 10.1002/cne.902900103; SCHEMMEL C, 1980, Z TIERPSYCHOL, V53, P9; FRASER TH, 1971, COPEIA, P574, DOI 10.2307/1442465; Nakae M, 2010, J MORPHOL, V271, P559, DOI 10.1002/jmor.10817; Schmitz A, 2014, J MORPHOL, V275, P357, DOI 10.1002/jmor.20219; VISCHER HA, 1989, BRAIN BEHAV EVOLUT, V33, P205, DOI 10.1159/000115929; Schmitz A, 2008, J MORPHOL, V269, P751, DOI 10.1002/jmor.10621; Beckmann M, 2010, INT REV HYDROBIOL, V95, P273, DOI 10.1002/iroh.200911185; Hausdorf B, 2011, MOL PHYLOGENET EVOL, V60, P89, DOI 10.1016/j.ympev.2011.03.009; Mirande JM, 2010, NEOTROP ICHTHYOL, V8, P385, DOI 10.1590/S1679-62252010000300001; Nakae M, 2012, ICHTHYOL RES, V59, P286, DOI 10.1007/s10228-012-0274-2; Asaoka R, 2012, ICHTHYOL RES, V59, P143, DOI 10.1007/s10228-011-0263-x; Protas M, 2012, WIRES DEV BIOL, V1, P823, DOI 10.1002/wdev.61; Asaoka R, 2014, ICHTHYOL RES, V61, P49, DOI 10.1007/s10228-013-0373-8; FILIPSKI GT, 1984, COPEIA, P204, DOI 10.2307/1445054; Freihofer W.C., 1972, Occasional Papers of the California Academy of Sciences, VNo. 95, P1; Miller R.R., 2005, FRESHWATER FISHES ME; Montgomery JC, 2001, ENVIRON BIOL FISH, V62, P87, DOI 10.1023/A:1011873111454; Nakatani M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-177; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; PUZDROWSKI RL, 1989, BRAIN BEHAV EVOLUT, V34, P110, DOI 10.1159/000116496; Reis R.E., 2003, CHECK LIST FRESHWATE; Sasaki K, 2008, J MORPHOL, V268, P674; SCHEMMEL CHRISTIAN, 1967, Z MORPHOL TIERE, V61, P255, DOI 10.1007/BF00400988; Webb JF, 2014, LATERAL LINE SYSTEM, P17; WEITZMAN S H, 1983, Bulletin of the Museum of Comparative Zoology, V150, P339; Wiley E.O., 2010, P123	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	NOV	2015	62	4					420	430		10.1007/s10228-015-0458-7		11	Zoology	Zoology	CV0PT	WOS:000363953600004		
J	Shinohara, G; Katayama, E				Shinohara, Gento; Katayama, Eri			A new species of the clingfish genus Kopua (Gobiesociformes: Gobiesocidae) from Japan	ICHTHYOLOGICAL RESEARCH			English	Article						Japan; Gobiesocidae; Gobiesociformes; New species; Sagami-nada Sea		A new clingfish, Kopua vermiculata, is described on the basis of a single specimen collected from ca. 100 m depth off the Pacific coast of Honshu Island, Japan. The new species is distinguished from its congeners by having the following characters: dorsal fin rays 7; anal fin rays 6; segmented caudal fin rays 15; upper procurrent caudal rays associated with both neural spine of second preural centrum and epural; vertebrae 35; nasal pores 1; lacrymal pores 3; mandibular pores 3; predorsal length about 60 % of standard length; body whitish with distinct reddish-orange blotches on body; no reddish-orange stripes on cheek; belly whitish. A key to the species of Kopua is provided.	[Shinohara, Gento; Katayama, Eri] Natl Museum Nat & Sci, Dept Zool, Tsukuba, Ibaraki 3050005, Japan	Shinohara, G (reprint author), Natl Museum Nat & Sci, Dept Zool, 4-1-1 Amakubo, Tsukuba, Ibaraki 3050005, Japan.	s-gento@kahaku.go.jp			MEXT KAKENHI [24120001]	We are grateful to Hisanori Kohtsuka (Misaki Marine Biological Station, the University of Tokyo) for supplying the holotype specimen, Carl Struthers (Museum of New Zealand Te Papa Tongarewa) for color information on Kopua nuimata, and Rudie Kuiter and Mark McGrouther (Australian Museum, Sydney), and Makoto Okamoto (Seikai National Fisheries Research Institute, Nagasaki) for permission to use unpublished color images of Kopua kuiteri and Kopua japonica, respectively. Satoru Chiba (NSMT) assisted in the preparation of Fig. 1. Graham Hardy (Ngunguru, New Zealand) helped with English language corrections and provided valuable suggestions. This study was partly supported by MEXT KAKENHI Grant number 24120001.	Amante C., 2009, NGDC24 NOAA NESDIS; Moore GI, 2012, ZOOTAXA, P34; Fricke R, 2010, ICHTHYOL RES, V57, P91, DOI 10.1007/s10228-009-0139-5; Saruwatari T, 1997, COPEIA, P840, DOI 10.2307/1447302; Australian Museum, 2014, DEEPW CLINGF KOP KUI; BRIGGS JOHN C., 1955, STANFORD ICHTHYOL BULL, V6, P1; HARDY GS, 1984, B MAR SCI, V34, P244; Hardy GS, 1990, NATL MUSEUM NZ MISCE, V21, P1; Hayashi M, 2013, FISHES JAPAN PICTORI, p[2105, 1326]; Hoese DF, 2006, ZOOLOGICAL CATALOG 1, V35, P1568; Hutchins J. Barry, 1991, Records of the Western Australian Museum, V15, P463; HUTCHINS J B, 1983, Records of the Western Australian Museum, V11, P33; Hutchins JB, 2008, FISHES AUSTR SO COAS, P722; Nelson J. S., 2006, FISHES WORLD; Conway Kevin W., 2011, Check List, V7, P581	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	NOV	2015	62	4					431	438		10.1007/s10228-015-0456-9		8	Zoology	Zoology	CV0PT	WOS:000363953600005		
J	Yokogawa, K				Yokogawa, Koji			Morphological differences between two closely related East Asian flatfish species of the genus Pleuronichthys, with particular emphasis on growth-related changes	ICHTHYOLOGICAL RESEARCH			English	Article						Pleuronichthys lighti; Pleuronichthys cornutus; Morphology; Growth	JAPAN	Morphological differences, including growth-related changes, were examined in two closely related East Asian flatfish species, Pleuronichthys lighti and Pleuronichthys cornutus. Body measurements of both species indicated frequent growth-related proportional changes, head length, pelvic fin length (both fins), eye diameter (both eyes), inter-orbital ridge length and the lengths of both jaws all showing relative decreases with growth. On the other hand, whereas caudal fin length became relatively shorter and snout length relatively greater with growth in P. lighti, those proportions remained unchanged with growth in P. cornutus. Conversely, although body depth became relatively greater and the longest dorsal and anal fin rays relatively shorter with growth in P. cornutus, those proportions remained unchanged with growth in P. lighti. Counts of scales below the lateral line and gill rakers both tended to increase with growth in P. cornutus, but remained stable in P. lighti. New key characters to distinguish between the two species included ocular side pectoral fin length and the area ratio between the upper and lower eyes. The ocular side pectoral fin of P. cornutus was generally longer than in P. lighti, with plots of the fin proportions in the two species showing modest separation. In addition, because both the horizontal and vertical diameters of the upper eye of P. cornutus were generally greater than those of P. lighti, graphical representation of the relationship between the upper and lower eye areas showed almost complete separation of the two species.		Yokogawa, K (reprint author), 13-5 Higashihama, Tadotsu, Kagawa 7640016, Japan.	gargariscus@ybb.ne.jp					Amaoka K, 1993, RESULTATS CAMPAGNES, V11, P377; Yokogawa K, 2011, ICHTHYOL RES, V58, P24, DOI 10.1007/s10228-010-0186-y; YOKOGAWA K, 1995, JPN J ICHTHYOL, V41, P437; Suzuki S, 2009, ICHTHYOL RES, V56, P276, DOI 10.1007/s10228-009-0100-7; Minos G, 2008, BELG J ZOOL, V138, P90; Watanabe K, 1996, NIPPON SUISAN GAKK, V62, P23; Yokogawa K, 2013, ICHTHYOL RES, V60, P48, DOI 10.1007/s10228-012-0310-2; Yokogawa Koji, 2008, Bulletin of the National Museum of Nature and Science Series A-Zoology, P115; Chioma GN, 2007, SCI FOCUS, V12, P76; Fujio Y, 1979, FISH GENET BLEED SCI, V4, P10; HOLM S, 1979, SCAND J STAT, V6, P65; Masaki Y., 1984, Bulletin of Nansei National Fisheries Research Institute, P11; Iwasaki M, 2006, GUIDE STAT DATA ANAL; NOZAWA M, 1981, Bulletin of the Japan Sea National Fisheries Research Institute, P1; Kitada S, 2004, HDB BIOSTATISTICS; Matsuoka M., 1989, Bulletin of the Seikai National Fisheries Research Institute, P23; Ohashi Y, 2011, NATURE KAGOSHIMA, V37, P71; Senou H, 2002, BLACK BASS INVADER R, P11; Yamada U, 2007, FISHES FISHERIES E C; Yokogawa K, 2014, ICHTHYOL RES, V61, P385, DOI 10.1007/s10228-014-0405-z; Yokogawa K, 1996, CENSUS REPORT FISHER, V67, P179; Yokogawa K, 1996, JAPAN J ICHTHYOL, V41, P31; Yokogawa K, 2014, AQUACULT SCI, V62, P361; Zar JH, 2010, BIOSTATISTICAL ANAL; Zhang H, 2011, PERIOD OCEAN U CHINA, V41, P51	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	NOV	2015	62	4					474	486		10.1007/s10228-015-0462-y		13	Zoology	Zoology	CV0PT	WOS:000363953600009		
J	Seo, MY; Kuroki, M; Okamura, A; Tsukamoto, K; Watanabe, S; Kaneko, T				Seo, Mi Young; Kuroki, Mari; Okamura, Akihiro; Tsukamoto, Katsumi; Watanabe, Soichi; Kaneko, Toyoji			Occurrence of larval and adult types of ion-secreting ionocytes in Japanese eel Anguilla japonica	ICHTHYOLOGICAL RESEARCH			English	Article						Anguillia; Japanese eel; Leptocephalus; Ionocytes; Osmoregulation	TILAPIA OREOCHROMIS-MOSSAMBICUS; MITOCHONDRIA-RICH CELLS; FRESH-WATER EELS; GILL CHLORIDE CELLS; CFTR ANION CHANNEL; ENVIRONMENTAL SALINITY; FUNDULUS-HETEROCLITUS; ONTOGENIC CHANGE; WIDE-RANGE; K-ATPASE	The anguillid eels are catadromous fishes that migrate between marine and freshwater habitats. The long migration of eel larvae, called leptocephali, as long as thousands of kilometers in the ocean is important to determine their recruitment successes. The leptocephali in the ocean have a pelagic lifestyle totally different from the benthic one of glass eels and yellow eels in rivers. It is known that eel leptocephali have ionocytes on the body surface that may maintain ionic and osmotic status in the internal environment; however, detailed morphology and function of ionocytes in leptocephali are still unknown. In the present study, we aimed 1) to clarify the morphological features of the epidermis in Japanese eel Anguilla japonica leptocephali cultured in hyper-osmotic condition, and 2) to examine the ion-transporting functions of ionocytes of both leptocephali and yellow eels. Na+/K+-ATPase-immunoreactive ionocytes were distributed all over the body surface of leptocephali. Ionocytes were in contact with external environments through their apical membrane, which was located at the boundary of pavement cells. Na+/K+-ATPase-immunopositive cells were not observed in the skin of seawater-acclimated yellow eels. In ionocytes of the larval skin, the apical membrane appeared as a slightly projecting disk with a microvilli-like structure. Meanwhile, the apical membrane of gill ionocytes of yellow eels formed a concave surface. In ionocytes of leptocephali, mitochondria were enlarged and the tubular system was well developed, as compared with those of the gill of yellow eels. Ionocytes of leptocephali showed CFTR immunoreaction in their apical region and NKCC1 immunoreaction in their basolateral region, suggesting that the skin ionocytes are involved in salt secretion. These results support the notion that Japanese eel maintain their ion balance through skin ionocytes during early life stages, and that the skin ionocytes of leptocephali disappear in yellow eel stages after the formation of functional gills and gill ionocytes.	[Seo, Mi Young; Kuroki, Mari; Watanabe, Soichi; Kaneko, Toyoji] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Tokyo 1138657, Japan; [Okamura, Akihiro; Tsukamoto, Katsumi] IRAGO Inst, Tahara, Aichi 4413605, Japan; [Tsukamoto, Katsumi] Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa 2520880, Japan	Seo, MY (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Tokyo 1138657, Japan.	myseo@marine.fs.a.u-tokyo.ac.jp			KAKEN C from Japan Society for the Promotion of Science [25450270]	We thank Y. Yamada, N. Horie, and N. Mikawa of the IRAGO Institute for their kind support during the experiment. This work was supported in part by KAKEN C (No. 25450270) from Japan Society for the Promotion of Science.	Alderdice D.F., 1988, P163; Kurokawa T, 2008, J WORLD AQUACULT SOC, V39, P726, DOI 10.1111/j.1749-7345.2008.00208.x; McCormick SD, 2003, J EXP BIOL, V206, P4575, DOI 10.1242/jeb.00711; Okamura A, 2014, ECOL FRESHW FISH, V23, P95, DOI 10.1111/eff.12086; Okamura A, 2009, AQUACULTURE, V296, P367, DOI 10.1016/j.aquaculture.2009.08.039; Katoh F, 2000, ZOOL SCI, V17, P11, DOI 10.2108/zsj.17.11; SILVA P, 1977, J EXP ZOOL, V199, P419, DOI 10.1002/jez.1401990316; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Sasai S, 1998, CAN J ZOOL, V76, P1480, DOI 10.1139/cjz-76-8-1480; MARSHALL WS, 1995, AM J PHYSIOL-REG I, V268, pR963; Masuda Y, 2013, FISHERIES SCI, V79, P681, DOI 10.1007/s12562-013-0637-2; PHILPOTT CW, 1980, AM J PHYSIOL, V238, pR171; Tse WKF, 2006, BIOCHEM BIOPH RES CO, V346, P1181, DOI 10.1016/j.bbrc.2006.06.028; Hiroi J, 2005, J EXP BIOL, V208, P2023, DOI 10.1242/jeb.01611; Uchida K, 2000, ZOOL SCI, V17, P149, DOI 10.2108/zsj.17.149; HULET WH, 1978, PHILOS T ROY SOC B, V282, P107, DOI 10.1098/rstb.1978.0010; Shinoda A, 2011, REV FISH BIOL FISHER, V21, P591, DOI 10.1007/s11160-010-9195-1; INGRAM GA, 1980, J FISH BIOL, V16, P23, DOI 10.1111/j.1095-8649.1980.tb03685.x; Schreiber AM, 1999, J EXP BIOL, V202, P2475; Lee KM, 2013, FISHERIES SCI, V79, P77, DOI 10.1007/s12562-012-0576-3; Suzuki Y, 2000, FISHERIES SCI, V66, P636, DOI 10.1046/j.1444-2906.2000.00104.x; ROBERTS RJ, 1973, J FISH BIOL, V5, P103, DOI 10.1111/j.1095-8649.1973.tb04435.x; Katoh F, 2003, J EXP BIOL, V206, P4113, DOI 10.1242/jeb.00659; KARNAKY KJ, 1976, J CELL BIOL, V70, P157, DOI 10.1083/jcb.70.1.157; Hiroi J, 1998, ZOOL SCI, V15, P447, DOI 10.2108/0289-0003(1998)15[447:IOVHIT]2.0.CO;2; Nakamura O, 2002, J FISH BIOL, V61, P822, DOI 10.1006/jfbi.2002.2110; Okamura A, 2009, AQUAC RES, V40, P509, DOI 10.1111/j.1365-2109.2008.02127.x; Sasai S, 2007, MAR BIOL, V150, P487, DOI 10.1007/s00227-006-0355-8; Varsamos S, 2002, ANAT EMBRYOL, V205, P203, DOI 10.1007/s00429-002-0231-3; Seo MY, 2009, FISHERIES SCI, V75, P1147, DOI 10.1007/s12562-009-0144-7; McCormick Stephen D., 1995, V14, P285, DOI 10.1016/S1546-5098(08)60250-2; LEONARD JB, 1976, CELL TISSUE RES, V171, P1; Wilson JM, 2007, J FISH BIOL, V70, P1239, DOI 10.1111/j.1095-8649.2007.01411.x; KANEKO T, 1995, MAR BIOL, V122, P165, DOI 10.1007/BF00349290; Seo MY, 2013, COMP BIOCHEM PHYS A, V166, P323, DOI 10.1016/j.cbpa.2013.07.004; ZADUNAISKY JA, 1984, FISH PHYSIOL, V10, P129; Yanagie R, 2009, COMP BIOCHEM PHYS A, V154, P263, DOI 10.1016/j.cbpa.2009.06.025; Tsukamoto K, 1998, NATURE, V396, P635, DOI 10.1038/25264; Bonhommeau S, 2010, FISH FISH, V11, P289, DOI 10.1111/j.1467-2979.2010.00362.x; SAGLIO P, 1988, J FISH BIOL, V32, P505, DOI 10.1111/j.1095-8649.1988.tb05390.x; Kaneko T, 2003, EEL BIOLOGY, P457; Kuroki M, 2014, CAN J ZOOL, V92, P749, DOI 10.1139/cjz-2013-0303; Seikai Tadahisa, 1994, Journal of the World Aquaculture Society, V25, P78, DOI 10.1111/j.1749-7345.1994.tb00807.x; SHEPHARD KL, 1994, REV FISH BIOL FISHER, V4, P401, DOI 10.1007/BF00042888; Tanaka H, 2014, FISHERIES SCI, V81, P11; Tsukamoto K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1174	46	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	NOV	2015	62	4					487	494		10.1007/s10228-015-0463-x		8	Zoology	Zoology	CV0PT	WOS:000363953600010		
J	Nakayama, N; Endo, H; Schwarzhans, W				Nakayama, Naohide; Endo, Hiromitsu; Schwarzhans, Werner			A new grenadier of the genus Hymenocephalus from Tosa Bay, southern Japan (Actinopterygii: Gadiformes: Macrouridae)	ICHTHYOLOGICAL RESEARCH			English	Article						New species; Kochi; Northwestern Pacific; Otoliths	GENERA HYMENOCEPHALUS; HYMENOGADUS	Hymenocephalus yamasakiorum, a new species of grenadier fishes, is described from a single specimen collected from Tosa Bay off Aki, Kochi, Japan, at a depth of 320-400 m. The species is distinguished from its 26 known congeners in having the following combination of features: pelvic-fin rays nine; pectoral-fin rays i16-i17; first dorsal-fin rays II, 10; chin barbel 55 % of head length (HL), its tip extending beyond the hind margin of orbit when laid back; snout moderately high, not depressed, length 28 % HL; orbit diameter 33 % HL; interorbital width 24 % HL; gill rakers on first arch (outer/inner) 14/20, on second arch 20/19; pyloric caeca 15; dorsal half of posterior part of tail prominently blackish.	[Nakayama, Naohide; Endo, Hiromitsu] Kochi Univ, Fac Sci, Marine Biol Lab, Kochi 7808520, Japan; [Schwarzhans, Werner] Zool Museum, Nat Hist Museum Denmark, DK-2100 Copenhagen, Denmark	Nakayama, N (reprint author), Kochi Univ, Fac Sci, Marine Biol Lab, 2-5-1 Akebono Cho, Kochi 7808520, Japan.	gadiformes@gmail.com			Japan Society for the Promotion of Science, Tokyo [24370041]; Natural Science Cluster, Science Unit, Kochi University; "Kuroshio Sougou Project'' of the National Museum of Nature and Science, Tsukuba	Our sincere thanks go to the captain and crew of F/V Kosei-maru and the staff of the Mimase fish market. We are grateful to Ryu Asaoka, Ryo Misawa, Taiga Naito, Kosei Ajisaka, and other BSKU students who variously supported NN's field surveys at the fish market; Peter McMillan (NIWA) for providing a reference; and Gordon Yearsley (Hobart, Australia) for editing the English text. We also thank Tomio Iwamoto and David Catania (CAS), Masaki Miya (CBM), Jun Hashimoto (FFNU), Hiroyuki Motomura (KAUM), Artem M. Prokofiev (Severtsov Institute of Ecology and Evolution, Russian Academy of Sciences, Moscow), Jeffrey T. Williams (USNM), Susan M. Morrison (WAM), Ekaterina D. Vasil'eva (ZMMU), and Kazuo Sakamoto (ZMUT) for providing opportunities to examine comparative material. This study was partly supported by a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science, Tokyo (24370041), a Grant-in-Aid of the "Marine Science Project'' of the Natural Science Cluster, Science Unit, Kochi University, and the "Kuroshio Sougou Project'' of the National Museum of Nature and Science, Tsukuba.	Akihito, 1993, FISHES JAPAN PICTORI, P1088; Endo Hiromitsu, 2010, Bulletin of the National Museum of Nature and Science Series A-Zoology, P119; Iwamoto T, 2011, B MAR SCI, V87, P513, DOI 10.5343/bms.2011.1004; Mcmillan P, 2014, ZOOTAXA, V3856, P117, DOI 10.11646/zootaxa.3856.1.5; Nakayama N, 2012, ZOOTAXA, P61; Saruwatari T, 1997, COPEIA, P840, DOI 10.2307/1447302; Schwarzhans W, 2014, ZOOTAXA, V3888, P1, DOI 10.11646/zootaxa.3888.1.1; Yamanoue Y, 2001, ICHTHYOL RES, V48, P257, DOI 10.1007/s10228-001-8143-4; Fricke R., 2015, GUIDE FISH COLLECTIO; Giglioli EH, 1884, PELAGOS SAGGI VITA P, P198; Gunther A, 1887, REPT SCI RESULTS VOY, V22; Honda Hitoshi, 2001, National Science Museum Monographs, V20, P345; Horikawa H, 2009, FISHERIES BIOL OC S1, p[1, i]; Hubbs CL, 1920, B US NATL MUSEUM, V1, P369; IWAMOTO T, 1988, Proceedings of the California Academy of Sciences, V45, P35; IWAMOTO T, 1970, STUD TROP OCEANOGR (MIAMI), V4, P316; Jordan DS, 1904, B US FISH COMM, V22, P577; Kamohara T, 1938, OFFSHORE BOTTOM FISH; Kamohara T, 1952, REP KOCHI U NAT SCI, V3, P1; Matsubara K, 1943, J SIGENKAGAKU KENKYU, V1, P37; Matsuura K, 1997, COLLECT BUILD, P171; Nakabo T, 2013, FISHES JAPAN PICTORI, p[1872, 493]; Okamura O, 1982, FISHES KYUSHU PALAU, p[345, 140]; Okamura O, 1970, FAUNA JAPONICA MACRO; Radcliffe L, 1912, P US NATL MUS, V41, P105; Shinohara Gento, 2001, National Science Museum Monographs, V20, P283; Matsubara K., 1943, J Shigenkagaku Kenkyusyo, V1, P83	27	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	NOV	2015	62	4					504	511		10.1007/s10228-015-0464-9		8	Zoology	Zoology	CV0PT	WOS:000363953600012		
J	Fujioka, Y; Saegusa, J				Fujioka, Yasuhiro; Saegusa, Jin			Sex ratios in relation to age and body size in "Honmoroko", Gnathopogon caerulescens	ICHTHYOLOGICAL RESEARCH			English	Article						Sex ratio; Age; Growth difference; "Honmoroko''; Gnathopogon caerulescens; Body size	REPRODUCTIVE RHYTHMS; WATER TEMPERATURE; LAKE BIWA; FISHES	The age composition, and age- and size-dependent sex ratios of mass samples of "Honmoroko", Gnathopogon caerulescens, were examined in Lake Biwa. The fish ranged from 0 to 2 years in age, but were mostly age 0 (97.9 %). The proportion of females was 48.6 % for age 0, 73.2 % for age 1, and 90.0 % for age 2 fish. Age 0 fish were significantly male biased, while ages 1 and 2 were significantly female biased, though the grand total showed a balanced sex ratio. The proportion of females was 48.0 % or less among age 0 fish in size classes of less than 9 cm in standard length (SL) and significantly different from a female:male ratio of 1:1 in such size classes, except for the 4-5.99 class. In size classes of 9 cm SL or greater, the proportion of females among age 0 fish was greater, more than 71.3 %, with significant differences from a balanced sex ratio for all such classes. These results suggest that G. caerulescens can be regarded as essentially an annual fish and that its spawning habits ought to result in a higher mortality for males than females, thus leading to female-biased sex ratios at ages 1 and 2.	[Fujioka, Yasuhiro; Saegusa, Jin] Shiga Prefecture Fisheries Expt Stn, Hikone, Shiga 5220057, Japan	Fujioka, Y (reprint author), Lake Biwa Museum, Oroshimo 1091, Kusatsu, Shiga 5250001, Japan.	yasuhiro@lbm.go.jp					Fujioka Y, 2006, FISHERIES SCI, V72, P1034, DOI 10.1111/j.1444-2906.2006.01253.x; Kikko Takeshi, 2014, Japanese Journal of Ichthyology, V61, P1; OKUZAWA K, 1989, GEN COMP ENDOCR, V75, P139, DOI 10.1016/0016-6480(89)90019-1; Okuzawa K., 1986, Bulletin of the Japanese Society of Scientific Fisheries, V52, P1957; Fujioka Y, 2013, JPN J ICHTHYOL, V60, P57; Fujioka Y, 2013, NIPPON SUISAN GAKK, V79, P31; OKUZAWA K, 1994, FISHERIES SCI, V60, P155; CLUTTONBROCK TH, 1991, NATURE, V351, P58; Fujioka Y, 2001, J FISH BIOL, V59, P851, DOI 10.1006/jfbi.2001.1700; Conover David O., 2004, P11; Fujioka Y, 2001, B SHIGA PREF FISH EX, V48, P47; Fujioka Y, 2011, B SHIGA PREF FISH EX, V54, P167; Fujroka Y, 2008, B SHIGA PREF FISH EX, V52, P27; Godin Jean-Guy J., 1997, P191; Hanson K. C., 2008, REV FISH SCI, V16, P421, DOI DOI 10.1080/10641260802013866; MAKI IWAO, 1966, JAP J ECOL, V16, P183; Nakabo T, 2013, FISHES JAPAN PICTORI, P324; Nakamura M, 1949, NIPPON SUISAN GAKK, V15, P88; Nakamura M, 1969, CYPRINID FISHES JAPA, P117; Saegusa J, 2012, ANN REP SHIGA PREF F, V22, P19	20	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	NOV	2015	62	4					512	515		10.1007/s10228-014-0452-5		4	Zoology	Zoology	CV0PT	WOS:000363953600013		
J	Doi, H; Zenke, Y; Takahashi, H; Sakai, H; Ishibashi, T				Doi, Hiroyuki; Zenke, Yutaro; Takahashi, Hiroshi; Sakai, Harumi; Ishibashi, Toshiaki			Hybridization of burrfish between Chilomycterus antillarum and Chilomycterus schoepfii in captivity revealed by AFLP and mtDNA sequence analyses	ICHTHYOLOGICAL RESEARCH			English	Editorial Material									[Doi, Hiroyuki] Osaka Aquarium Kaiyukan, Minato Ku, Osaka 5520022, Japan; [Zenke, Yutaro; Takahashi, Hiroshi; Sakai, Harumi] Natl Fisheries Univ, Dept Appl Aquabiol, Shimonoseki, Yamaguchi 7596595, Japan; [Ishibashi, Toshiaki] Shimonoseki Acad Marine Sci, Shimonoseki Marine Sci Museum Kaikyokan, Shimonoseki, Yamaguchi 7500036, Japan	Sakai, H (reprint author), Natl Fisheries Univ, Dept Appl Aquabiol, 2-7-1 Nagata Honmachi, Shimonoseki, Yamaguchi 7596595, Japan.	doi@kaiyukan.com; sakaih@fish-u.ac.jp; ishibashi@kaikyokan.com					VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; Ward RD, 2008, J FISH BIOL, V72, P458, DOI 10.1111/j.1095-8649.2007.01703.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Carpenter KE, 2002, LIVING MARINE RESOUR, V3, P2007; Froese R., 2014, FISHBASE	6	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-8998	1616-3915		ICHTHYOL RES	Ichthyol. Res.	NOV	2015	62	4					516	518		10.1007/s10228-015-0460-0		3	Zoology	Zoology	CV0PT	WOS:000363953600014		
J	Ohta, H; Kaneda, N; Horikiri, F; Narita, Y; Yoshida, T; Mishima, T; Nakamura, T				Ohta, Hiroshi; Kaneda, Naoki; Horikiri, Fumimasa; Narita, Yoshinobu; Yoshida, Takehiro; Mishima, Tomoyoshi; Nakamura, Tohru			Vertical GaN p-n Junction Diodes With High Breakdown Voltages Over 4 kV	IEEE ELECTRON DEVICE LETTERS			English	Article						Breakdown voltage; gallium nitride; power semiconductor devices	VOID-ASSISTED SEPARATION; VAPOR-PHASE EPITAXY	Vertical structured GaN power devices have recently been attracting a great interest because of their potential on extremely high-power conversion efficiency. This letter describes increased breakdown voltages in the vertical GaN p-n diodes fabricated on the free-standing GaN substrates. By applying multiple lightly Si doped n-GaN drift layers to the p-n diode, the record breakdown voltages (V-B) of 4.7 kV combined with low specific differential ON-resistance (R-ON) of 1.7 m Omega cm(2) were achieved. With reducing the Si-doping concentration of the top n-GaN drift layer adjacent to the p-n junction using well-controlled metal-organic vapor phase epitaxy systems, the peak electric field at the p-n junction could be suppressed under high negatively biased conditions. The second drift layer with a moderate doping concentration contributed to the low RON. A Baliga's figure of merit (V-B(2)/R-ON) was 13 GW/cm(2). These are the best values ever reported among those achieved by GaN p-n junction diodes on the free-standing GaN substrates.	[Ohta, Hiroshi; Mishima, Tomoyoshi; Nakamura, Tohru] Hosei Univ, Res Ctr Micronano Technol, Tokyo 1840003, Japan; [Kaneda, Naoki] Quantum Spread Co Ltd, Tokyo 1350004, Japan; [Horikiri, Fumimasa; Narita, Yoshinobu; Yoshida, Takehiro] Sciocs Co Ltd, Dept Engn, Hitachi, Ibaraki 3191418, Japan	Mishima, T (reprint author), Hosei Univ, Res Ctr Micronano Technol, Tokyo 1840003, Japan.	tomoyoshi.mishima.67@hosei.ac.jp					Kizilyalli IC, 2014, IEEE ELECTR DEVICE L, V35, P247, DOI 10.1109/LED.2013.2294175; Oshima Y, 2003, JPN J APPL PHYS 2, V42, pL1, DOI 10.1143/JJAP.42.L1; Kizilyalli IC, 2013, IEEE T ELECTRON DEV, V60, P3067, DOI 10.1109/TED.2013.2266664; Yoshida T, 2008, J CRYST GROWTH, V310, P5, DOI 10.1016/j.jcrysgro.2007.10.014; Hatakeyama Y, 2011, IEEE ELECTR DEVICE L, V32, P1674, DOI 10.1109/LED.2011.2167125; Nomoto K, 2011, PHYS STATUS SOLIDI A, V208, P1535, DOI 10.1002/pssa.201000976; Baliga B. J., 2011, FUNDAMENTALS POWER S; Hatakeyama Y., 2013, JPN J APPL PHYS, V52; Mochizuki K., 2013, JPN J APPL PHYS, V52; Mochizuki K., 2013, JPN J APPL PHYS, V52	10	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0741-3106	1558-0563		IEEE ELECTR DEVICE L	IEEE Electron Device Lett.	NOV	2015	36	11					1180	1182		10.1109/LED.2015.2478907		3	Engineering, Electrical & Electronic	Engineering	CV2NV	WOS:000364094300021		
J	Cai, W; Takenaka, M; Takagi, S				Cai, Weili; Takenaka, Mitsuru; Takagi, Shinichi			Effectiveness of Surface Potential Fluctuation for Representing Inversion-Layer Mobility Limited by Coulomb Scattering in MOSFETs	IEEE ELECTRON DEVICE LETTERS			English	Article						Inversion layer mobility; Coulomb scattering; interface charges; conductance method; surface potential fluctuation	INTERFACE; CHARGE; DEVICES	In this letter, the effectiveness of surface potential fluctuation (sigma(s)), experimentally extracted from the conductance method, in representing the mobility limited by Coulomb scattering (mu(coulomb)) due to MOS interface charges has been experimentally examined in Si MOSFETs. It is found that mu(coulomb) can be described as a universal line proportional to sigma(-2)(s), irrespective of the conditions of MOS interface charges, even under the coexistence of positive and negative charges, where threshold voltage shift (Delta V-th) cannot represent mu(coulomb). This result can be explained by considering that sigma(2)(s) more directly corresponds to the total amount of Coulomb scattering centers.	[Cai, Weili; Takenaka, Mitsuru; Takagi, Shinichi] Univ Tokyo, Dept Elect Engn & Informat Syst, Tokyo 1138656, Japan	Cai, W (reprint author), Univ Tokyo, Dept Elect Engn & Informat Syst, Tokyo 1138656, Japan.	caiweili@mosfet.t.u-tokyo.ac.jp			Core Research for Evolutionary Science and Technology, Japan Science and Technology Agency	This work was supported by the Core Research for Evolutionary Science and Technology, Japan Science and Technology Agency. The review of this letter was arranged by Editor L. Selmi.	Koga J, 2004, JPN J APPL PHYS 1, V43, P1699, DOI 10.1143/JJAP.43.1699; BREWS JR, 1972, J APPL PHYS, V43, P2306, DOI 10.1063/1.1661496; CHOW PMD, 1986, IEEE T ELECTRON DEV, V33, P1299, DOI 10.1109/T-ED.1986.22662; Zhu WJ, 2004, IEEE T ELECTRON DEV, V51, P98, DOI 10.1109/TED.2003.821384; STERN F, 1967, PHYS REV, V163, P816, DOI 10.1103/PhysRev.163.816; KOGA JJ, 1994, INTERNATIONAL ELECTRON DEVICES MEETING 1994 - IEDM TECHNICAL DIGEST, P475, DOI 10.1109/IEDM.1994.383365; BREWS JR, 1983, SOLID STATE ELECTRON, V26, P711, DOI 10.1016/0038-1101(83)90030-8; Houssa M, 2000, APPL PHYS LETT, V77, P1885, DOI 10.1063/1.1310635; TAKAGI S, 1994, IEEE T ELECTRON DEV, V41, P2357, DOI 10.1109/16.337449; SODINI CG, 1982, SOLID STATE ELECTRON, V25, P833, DOI 10.1016/0038-1101(82)90170-8; Cai WL, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.04DC07; FLEETWOOD DM, 1993, J APPL PHYS, V73, P5058, DOI 10.1063/1.353777; AKIZAWA M, 1988, IEEE T ELECTRON DEV, V35, P245, DOI 10.1109/16.2445; Nicollian E. H., 2003, MOS PHYS TECHNOLOGY, P235; Nicollian E. H., 2003, MOS PHYS TECHNOLOGY, P212; NICOLLIA.EH, 1967, BELL SYST TECH J, V46, P1055	16	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0741-3106	1558-0563		IEEE ELECTR DEVICE L	IEEE Electron Device Lett.	NOV	2015	36	11					1183	1185		10.1109/LED.2015.2477360		3	Engineering, Electrical & Electronic	Engineering	CV2NV	WOS:000364094300022		
J	Sai, H; Maejima, K; Matsui, T; Koida, T; Matsubara, K; Kondo, M; Takeuchi, Y; Sugiyama, S; Katayama, H; Yoshida, I				Sai, Hitoshi; Maejima, Keigo; Matsui, Takuya; Koida, Takashi; Matsubara, Koji; Kondo, Michio; Takeuchi, Yoshiaki; Sugiyama, Shuichiro; Katayama, Hirotaka; Yoshida, Isao			Effect of Front TCO Layer on Properties of Substrate-Type Thin-Film Microcrystalline Silicon Solar Cells	IEEE JOURNAL OF PHOTOVOLTAICS			English	Article						Conductive films; light trapping; photovoltaic cells; silicon; thin-film devices	CHEMICAL-VAPOR-DEPOSITION; TEMPERATURE	Power conversion efficiency of thin-film microcrystalline silicon solar cells has been remarkably improved recently: from 10.1% to 11.8%. Front transparent conductive oxide (TCO) films have played an important role in this efficiency improvement. In this study, the impact of the front TCO films was investigated by comparing microcrystalline silicon solar cells with In2O3:Sn films grown by sputtering and ZnO:B films grown by metal-organic chemical vapor deposition (MOCVD). Improvement mechanisms in open-circuit voltages and fill factors in solar cells are investigated and discussed.	[Sai, Hitoshi; Matsui, Takuya; Koida, Takashi; Matsubara, Koji] Natl Inst Adv Ind Sci & Technol, Res Ctr Photovolta, Tsukuba, Ibaraki 3058568, Japan; [Maejima, Keigo; Yoshida, Isao] Photovolta Power Generat Technol Res Assoc, Tsukuba, Ibaraki 3058568, Japan; [Kondo, Michio] Natl Inst Adv Ind Sci & Technol, Fukushima Renewable Energy Inst, Koriyama, Fukushima 9630298, Japan; [Takeuchi, Yoshiaki] Mitsubishi Heavy Ind Co Ltd, Isahaya 8540065, Japan; [Sugiyama, Shuichiro] Sharp Co Ltd, Hajikami 6392122, Japan; [Katayama, Hirotaka] Panasonic Corp, Kaizuka 5970094, Japan; [Yoshida, Isao] Photovolta Power Generat Technol Res Assoc, Tsukuba, Ibaraki 3058568, Japan	Sai, H (reprint author), Natl Inst Adv Ind Sci & Technol, Res Ctr Photovolta, Tsukuba, Ibaraki 3058568, Japan.	hitoshi-sai@aist.go.jp; maejima@eee.kagoshima-u.ac.jp; t-matsui@aist.go.jp; t-koida@aist.go.jp; koji.matsubara@aist.go.jp; michio.kondo@aist.go.jp; yoshiaki_takeuchi@mhi.co.jp; sugiyama.shuhichiroh@sharp.co.jp; katayama.hirotaka@jp.panasonic.com			New Energy and Industrial Technology Development Organization, Japan; "Nanotechnology Network Japan" of Ministry of Education, Culture, Sports, Science, and Technology, Japan	This work was supported in part by New Energy and Industrial Technology Development Organization, Japan. The photolithography process was conducted at the AIST Nano-Processing Facility, supported by "Nanotechnology Network Japan" of the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Sai H, 2015, PROG PHOTOVOLTAICS, V23, P1572, DOI 10.1002/pip.2594; Mai Y, 2005, J APPL PHYS, V97, DOI 10.1063/1.1927689; Vetterl O, 2001, SOL ENERG MAT SOL C, V66, P345, DOI 10.1016/S0927-0248(00)00193-8; Antonini A, 2003, SOL ENERG MAT SOL C, V80, P155, DOI 10.1016/j.solmat.2003.07.001; WENAS WW, 1991, JPN J APPL PHYS 2, V30, pL441, DOI 10.1143/JJAP.30.L441; Sato Y, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.061101; Yan BJ, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3638068; Kamikawa-Shimizu Y, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.112303; Kim S, 2013, SOL ENERG MAT SOL C, V119, P26, DOI 10.1016/j.solmat.2013.04.016; Haug FJ, 2015, ENERG ENVIRON SCI, V8, P824, DOI 10.1039/c4ee03346a; Zhang D, 2011, ENRGY PROCED, V8, P207, DOI 10.1016/j.egypro.2011.06.125; Sai H, 2014, IEEE J PHOTOVOLT, V4, P1349, DOI 10.1109/JPHOTOV.2014.2355037; Meier J, 1997, SOL ENERG MAT SOL C, V49, P35, DOI 10.1016/S0927-0248(97)00173-6; STAEBLER DL, 1977, APPL PHYS LETT, V31, P292, DOI 10.1063/1.89674; Maejima K, 2014, THIN SOLID FILMS, V559, P83, DOI 10.1016/j.tsf.2013.11.137; Soderstrom T, 2009, PROG PHOTOVOLTAICS, V17, P165, DOI 10.1002/pip.869; Demaurex B, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4764529; Sai H, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4761956; Hanni S, 2013, PROG PHOTOVOLTAICS, V21, P821, DOI 10.1002/pip.2398; Haug FJ, 2012, PROG PHOTOVOLTAICS, V20, P727, DOI 10.1002/pip.1220; Minami T., 1999, J VAC SCI TECHNOL A, V17, P1795; Sai H, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4790642; Sai H, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.08KB05; Sai H, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4921794; Yamamoto K, 1999, IEEE T ELECTRON DEV, V46, P2041, DOI 10.1109/16.791994	25	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-3381			IEEE J PHOTOVOLT	IEEE J. Photovolt.	NOV	2015	5	6					1528	1533		10.1109/JPHOTOV.2015.2478030		6	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	CV2PJ	WOS:000364098400004		
J	Toprasertpong, K; Tanibuchi, T; Fujii, H; Kada, T; Asahi, S; Watanabe, K; Sugiyama, M; Kita, T; Nakano, Y				Toprasertpong, Kasidit; Tanibuchi, Taizo; Fujii, Hiromasa; Kada, Tomoyuki; Asahi, Shigeo; Watanabe, Kentaroh; Sugiyama, Masakazu; Kita, Takashi; Nakano, Yoshiaki			Comparison of Electron and Hole Mobilities in Multiple-Quantum-Well Solar Cells Using a Time-of-Flight Technique	IEEE JOURNAL OF PHOTOVOLTAICS			English	Article						Carrier transport; charge carrier mobility; measurement techniques; photoluminescence (PL); photovoltaic cells; quantum well devices; time-of-flight (TOF)	CARRIER COLLECTION EFFICIENCY; TRANSPORT; SUPERLATTICES; SWEEP	Understanding of transport dynamics of both electrons and holes in quantum-structure solar cells is essential for their structure design and performance enhancement. By applying our proposed carrier time-of-flight technique on p-on-n and n-on-p configurations, we can separately evaluate electron and hole transport across quantum structures inserted in the i-region of solar cells. Electron and hole behaviors in two sets of InGaAs/GaAsP multiple-quantum-well (MQW) solar cells with different potential barrier heights are investigated in this study. Both types of carriers in In0.21Ga0.79As/GaAs0.75P0.25 MQWs show faster averaged velocities by an order of magnitude than those in In0.21Ga0.79As/GaAs0.59P0.41 MQWs, which have higher potential barriers. Within the same MQW structure, the measured values of electron and hole averaged velocities are very close to each other. This results in the same order of effective mobilities of electrons and holes and the similar tendency of cell performance in p-on-n and n-on-p MQW solar cells. Holes in high-barrier InGaAs/GaAsP MQWs show nonlinear mobility, suggesting that a careful design of high-barrier MQWs is required to avoid the hole bottleneck and enhance charge carrier collection.	[Toprasertpong, Kasidit; Fujii, Hiromasa; Watanabe, Kentaroh; Sugiyama, Masakazu; Nakano, Yoshiaki] Univ Tokyo, Sch Engn, Dept Elect Engn & Informat Syst, Tokyo 1138654, Japan; [Tanibuchi, Taizo; Kada, Tomoyuki; Asahi, Shigeo; Kita, Takashi] Kobe Univ, Grad Sch Engn, Dept Elect & Elect Engn, Kobe, Hyogo 6578501, Japan	Toprasertpong, K (reprint author), Univ Tokyo, Sch Engn, Dept Elect Engn & Informat Syst, Tokyo 1138654, Japan.	toprasertpong@hotaka.t.u-tokyo.ac.jp; 144t242t@stu.kobe-u.ac.jp; fujii@hotaka.t.u-tokyo.ac.jp; kada@stu.kobe-u.ac.jp; 118t803t@stu.kobe-u.ac.jp; kentaroh@hotaka.t.u-tokyo.ac.jp; sugiyama@ee.t.u-tokyo.ac.jp; kita@eedept.kobe-u.ac.jp; nakano@ee.t.u-tokyo.ac.jp	Sugiyama, Masakazu/P-9616-2015	Sugiyama, Masakazu/0000-0002-4303-4038	Research and Development of Innovative Solar Cell program, New Energy and Industrial Technology Development Organization, Japan	This work was supported in part by the Research and Development of Innovative Solar Cell program, New Energy and Industrial Technology Development Organization, Japan.	Adachi S., 2009, PROPERTIES SEMICONDU, P365; Akram MN, 2006, IEEE J QUANTUM ELECT, V42, P713, DOI 10.1109/JQE.2006.876710; Alemu A., 2009, P IEEE 34 IEEE PHOT; Alonso-Alvarez D., 2014, APPL PHYS LETT, V105; Brown GF, 2009, LASER PHOTONICS REV, V3, P394, DOI 10.1002/lpor.200810039; Toprasertpong K, 2014, IEEE J PHOTOVOLT, V4, P607, DOI 10.1109/JPHOTOV.2013.2293877; SCHNEIDER H, 1988, PHYS REV B, V38, P6160, DOI 10.1103/PhysRevB.38.6160; BARNHAM KWJ, 1991, APPL PHYS LETT, V59, P135, DOI 10.1063/1.105553; Toprasertpong K, 2014, IEEE J PHOTOVOLT, V4, P1518, DOI 10.1109/JPHOTOV.2014.2354256; Fujii H, 2014, IEEE J PHOTOVOLT, V4, P237, DOI 10.1109/JPHOTOV.2013.2287994; Fujii H, 2013, IEEE J PHOTOVOLT, V3, P859, DOI 10.1109/JPHOTOV.2013.2240561; HALLIDAY DP, 1992, APPL PHYS LETT, V61, P2497, DOI 10.1063/1.108160; LAMBERT B, 1989, SUPERLATTICE MICROST, V5, P565, DOI 10.1016/0749-6036(89)90386-8; Barnham K, 1997, APPL SURF SCI, V113, P722, DOI 10.1016/S0169-4332(96)00876-8; Ekins-Daukes NJ, 2001, SOL ENERG MAT SOL C, V68, P71, DOI 10.1016/S0927-0248(00)00346-9; CAVAILLES JA, 1992, IEEE J QUANTUM ELECT, V28, P2486, DOI 10.1109/3.159555; FOX AM, 1991, IEEE J QUANTUM ELECT, V27, P2281, DOI 10.1109/3.97272; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Tessler N, 1997, IEEE J SEL TOP QUANT, V3, P315, DOI 10.1109/2944.605673; Norman AG, 2005, IEEE PHOT SPEC CONF, P43, DOI 10.1109/PVSC.2005.1488065; Fujii H., 2013, J APPL PHYS, V114; Fujii H., 2012, JPN J APPL PHYS, V51; Jo M., 2013, APPL PHYS LETT, V103; Kunets V. P., 2012, APPL PHYS LETT, V101; Luque A, 2006, J APPL PHYS, V99, DOI 10.1063/1.2193063; Nozik AJ, 2002, PHYSICA E, V14, P115, DOI 10.1016/S1386-9477(02)00374-0; Toprasertpong K., PROG PHOTOV IN PRESS, DOI [10.1002/pip.2585, DOI 10.1002/PIP.2585]; Toprasertpong K., 2015, APPL PHYS LETT, V107	28	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-3381			IEEE J PHOTOVOLT	IEEE J. Photovolt.	NOV	2015	5	6					1613	1620		10.1109/JPHOTOV.2015.2470131		8	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	CV2PJ	WOS:000364098400017		
J	Fujisawa, T; Saitoh, K				Fujisawa, Takeshi; Saitoh, Kunimasa			Quantum-Confined Stark Effect Analysis of GeSn/SiGeSn Quantum Wells for Mid-Infrared Si-Based Electroabsorption Devices Based on Many-Body Theory	IEEE JOURNAL OF QUANTUM ELECTRONICS			English	Article						Si photonics; GeSn quantum wells; electroabsorption modulators; quantum-confined Stark effect; and many-body theory	LASER; MODULATORS; GERMANIUM; SILICON; STRAIN; POWER	Quantum-confined Stark effect (QCSE) of group IV Ge(Sn)/SiGe(Sn) quantum wells (QWs) on Si substrate is analyzed by microscopic many-body theory for mid-infrared (mid-IR) Si-based electroabsorption devices. To show the validity of the theory, QCSE of Ge/SiGe QW is investigated and very good agreement between theory and reported measured results is obtained. Next, the QCSE of GeSn/SiGeSn QWs is analyzed and the QW design for electroabsorption modulators to obtain large extinction ratio in mid-IR region is presented. It is shown that compressive and tensile strained well and barrier layers is preferable to obtain large extinction ratio due to its large conduction band offset.	[Fujisawa, Takeshi; Saitoh, Kunimasa] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 0600814, Japan	Fujisawa, T (reprint author), Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 0600814, Japan.	fujisawa@ist.hokudai.ac.jp; ksaitoh@ist.hokudai.ac.jp					Kobayashi W, 2010, J LIGHTWAVE TECHNOL, V28, P164, DOI 10.1109/JLT.2009.2036865; Mathews J, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3521391; Kim J, 2011, J APPL PHYS, V110, DOI 10.1063/1.3656688; D'Costa VR, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.107403; Chang GE, 2010, IEEE J QUANTUM ELECT, V46, P1813, DOI 10.1109/JQE.2010.2059000; Grzybowski G, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4745770; Moontragoon P, 2007, SEMICOND SCI TECH, V22, P742, DOI 10.1088/0268-1242/22/7/012; Fujisawa T, 2009, IEEE J QUANTUM ELECT, V45, P1183, DOI 10.1109/JQE.2009.2021776; Soref R, 2010, NAT PHOTONICS, V4, P495, DOI 10.1038/nphoton.2010.171; Kuo YH, 2005, NATURE, V437, P1334, DOI 10.1038/nature04204; VAN DE WALLE CG, 1989, PHYS REV B, V39, P1871, DOI 10.1103/PhysRevB.39.1871; Fujisawa T, 2011, IEEE J QUANTUM ELECT, V47, P60, DOI 10.1109/JQE.2010.2073448; Fujisawa T, 2011, ELECTRON LETT, V47, P708, DOI 10.1049/el.2011.1126; Paul DJ, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.155323; Kuo YH, 2006, IEEE J SEL TOP QUANT, V12, P1503, DOI 10.1109/JSTQE.2006.883146; Hader J, 2005, IEEE J QUANTUM ELECT, V41, P1217, DOI 10.1109/JQE.2005.854127; Fujisawa T, 2010, J APPL PHYS, V107, DOI 10.1063/1.3360937; LOEHR JP, 1990, PHYS REV B, V42, P7154, DOI 10.1103/PhysRevB.42.7154; Arakawa T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.042203; Chen R., 2011, APPL PHYS LETT, V97; Chow W. W., 1993, SEMICONDUCTOR LASER; Corbett B., 2014, P EUR C OPT COMM ECO, P1; D'Costa VR, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.125207; Fujisawa T., 2015, IEEE J QUANTUM ELECT, V51; Fujisawa T, 2012, OPT EXPRESS, V20, P614, DOI 10.1364/OE.20.000614; Wirths S, 2015, NAT PHOTONICS, V9, P88, DOI 10.1038/NPHOTON.2014.321; Haug H., 2008, QUANTUM KINETICS TRA; Roelkens G, 2014, IEEE J SEL TOP QUANT, V20, DOI 10.1109/JSTQE.2013.2294460	28	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9197	1558-1713		IEEE J QUANTUM ELECT	IEEE J. Quantum Electron.	NOV	2015	51	11							8400207	10.1109/JQE.2015.2488363		7	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CV1OU	WOS:000364028500001		
J	Carver, JC; Yamashita, A; Minku, L; Habayeb, M; Kocak, SA				Carver, Jeffrey C.; Yamashita, Aiko; Minku, Leandro; Habayeb, Mayy; Kocak, Sedef Akinli			Software Quality, Energy Awareness, and More	IEEE SOFTWARE			English	Editorial Material									[Carver, Jeffrey C.] Univ Alabama, Dept Comp Sci, Tuscaloosa, AL 35487 USA; [Yamashita, Aiko] Yamashita Res, Tokyo, Japan; [Yamashita, Aiko] Oslo & Akershus Univ Coll Appl Sci, Oslo, Norway; [Minku, Leandro] Univ Leicester, Dept Comp Sci, Leicester LE1 7RH, Leics, England; [Habayeb, Mayy; Kocak, Sedef Akinli] Ryerson Univ, Data Sci Lab, Toronto, ON, Canada	Carver, JC (reprint author), Univ Alabama, Dept Comp Sci, Tuscaloosa, AL 35487 USA.	carver@cs.ua.edu; aiko.fallas@gmail.com; l.l.minku@cs.bham.ac.uk; mayy.habayeb@ryerson.ca; sedef.akinlikocak@ryerson.ca						0	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	0740-7459	1937-4194		IEEE SOFTWARE	IEEE Softw.	NOV-DEC	2015	32	6					98	100				3	Computer Science, Software Engineering	Computer Science	CV1VY	WOS:000364047400019		
J	Wang, HP; Huang, Q; Shi, Q; Yue, T; Chen, SQ; Nakajima, M; Takeuchi, M; Fukuda, T				Wang, Huaping; Huang, Qiang; Shi, Qing; Yue, Tao; Chen, Shaoqi; Nakajima, Masahiro; Takeuchi, Masaru; Fukuda, Toshio			Automated Assembly of Vascular-Like Microtube With Repetitive Single-Step Contact Manipulation	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Automated micromanipulation; cell assembly; image processing; microrobotic; tissue engineering	MICROMANIPULATION; SUBSTRATE; PERFUSION; NETWORKS; SCAFFOLD; SYSTEM; VEIN	Fabricated vessel-mimetic microtubes are essential for delivering sufficient nutrient to engineered composite tissues. In this paper, vascular-like microtubes are engineered by automated assembly of donut-shaped micromodules that embed fibroblast cells. A microrobotic system is set up with dual manipulators of 30-nm positioning resolution under an optical microscope. The system assembles the micromodules by repeated single-step pickup motions. This process is specifically designed to avoid human interference and ensure high reproducibility for automation. We optimized the single-step motion by calibrating the key parameters (the micromodule dimensions) in a force analysis. The optimal motion achieved a 98% pick-up success rate. The automated repetitive single-step assembly is achieved by an algorithm that acquires the 3-D location and tracks the micromanipulator without being affected by low contrast. The accuracy of the acquired 3-D location was experimentally determined as approximately 1 pixel (2 mu m under 4x magnification), and the tracking under different observation conditions is proved effective. Finally, we automatically assembled microtubes at 6 micromodules/min, sufficiently fast for fabricating macroscopic vessel-mimetic substitutes in biological applications.	[Wang, Huaping; Huang, Qiang; Shi, Qing; Chen, Shaoqi; Fukuda, Toshio] Beijing Inst Technol, Intelligent Robot Inst, Key Lab Biomimet Robots & Syst, Sch Mechatron Engn,Minist Educ, Beijing 100081, Peoples R China; [Yue, Tao] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Nakajima, Masahiro; Takeuchi, Masaru] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648601, Japan	Huang, Q (reprint author), Beijing Inst Technol, Intelligent Robot Inst, Key Lab Biomimet Robots & Syst, Sch Mechatron Engn,Minist Educ, Beijing 100081, Peoples R China.	qhuang@bit.edu.cn			National Natural Science Foundation of China [61433010, 61375108]; "111 Project" [B08043]	This work was supported by the National Natural Science Foundation of China under Grant 61433010 and Grant 61375108, "111 Project" under Grant B08043. Asterisk indicates corresponding author.	Hung PJ, 2005, BIOTECHNOL BIOENG, V89, P1, DOI 10.1002/bit.20289; Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h; McGuigan AP, 2008, BIOMATERIALS, V29, P2453, DOI 10.1016/j.biomaterials.2008.02.010; McGuigan AP, 2006, P NATL ACAD SCI USA, V103, P11461, DOI 10.1073/pnas.0602740103; Du YA, 2011, BIOTECHNOL BIOENG, V108, P1693, DOI 10.1002/bit.23102; Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210; Bolopion A, 2012, IEEE-ASME T MECH, V17, P116, DOI 10.1109/TMECH.2010.2090892; Galban CJ, 1999, BIOTECHNOL BIOENG, V65, P121, DOI 10.1002/(SICI)1097-0290(19991020)65:2<121::AID-BIT1>3.0.CO;2-6; Xu QS, 2009, IEEE T AUTOM SCI ENG, V6, P710, DOI 10.1109/TASE.2009.2021980; Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/nmat3357, 10.1038/NMAT3357]; Borenstein JT, 2010, BIOMED MICRODEVICES, V12, P71, DOI 10.1007/s10544-009-9361-1; Ouyang PR, 2007, MECHATRONICS, V17, P578, DOI 10.1016/j.mechatronics.2007.06.002; Saketi P, 2012, J MICROSC-OXFORD, V248, P163, DOI 10.1111/j.1365-2818.2012.03660.x; Banerjee AG, 2013, IEEE T AUTOM SCI ENG, V10, P485, DOI 10.1109/TASE.2013.2260539; Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038; Ramadan AA, 2009, IEEE T IND ELECTRON, V56, P1121, DOI 10.1109/TIE.2008.2008753; Wang WH, 2007, INT J ROBOT RES, V26, P821, DOI 10.1177/0278364907080254; Hashimoto K, 2003, ADV ROBOTICS, V17, P969; Zhang XP, 2012, IEEE T BIO-MED ENG, V59, P1032, DOI 10.1109/TBME.2012.2182673; Ju T, 2014, IEEE T AUTOM SCI ENG, V11, P649, DOI 10.1109/TASE.2013.2289311; Chan V, 2010, LAB CHIP, V10, P2062, DOI 10.1039/c004285d; Schaner PJ, 2004, J VASC SURG, V40, P146, DOI 10.1016/j.jvs.2004.03.033; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Liu J, 2014, IEEE T ROBOT, V30, P125, DOI 10.1109/TRO.2013.2280060; Vaswani N, 2010, IEEE T IMAGE PROCESS, V19, P841, DOI 10.1109/TIP.2009.2037465; Sieber A, 2008, SENSOR ACTUAT A-PHYS, V142, P421, DOI 10.1016/j.sna.2007.02.042; Du D., 2014, BIOFABRICATION, V6, P1; Ferreira A., 2013, IEEE T BIOMED ENG, V60, P2461; James M. D., 2006, TISSUE ENG, V12, P706; Probst M, 2009, IEEE T IND ELECTRON, V56, P2657, DOI 10.1109/TIE.2009.2021173; Salah M., 2012, INT J PHOTOENERGY, V2012, P1; Yue T, 2014, LAB CHIP, V14, P1151, DOI 10.1039/c3lc51134k	32	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	NOV	2015	62	11					2620	2628		10.1109/TBME.2015.2437952		9	Engineering, Biomedical	Engineering	CV4LJ	WOS:000364238100009		
J	Schumann, S; Sato, Y; Nakanishi, Y; Yokota, F; Takao, M; Sugano, N; Zheng, GY				Schumann, Steffen; Sato, Yoshinobu; Nakanishi, Yuki; Yokota, Futoshi; Takao, Masaki; Sugano, Nobuhiko; Zheng, Guoyan			Cup Implant Planning Based on 2-D/3-D Radiographic Pelvis Reconstruction-First Clinical Results	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Cup; 2-D/3-D reconstruction; orthopedics; pelvis; prosthesis; planning; X-ray radiograph	TOTAL HIP-ARTHROPLASTY; X-RAYS; ACCURACY; MAGNIFICATION; SYSTEM	Goal: In the following, we will present a newly developed X-ray calibration phantom and its integration for 2-D/3-D pelvis reconstruction and subsequent automatic cup planning. Two different planning strategies were applied and evaluated with clinical data. Methods: Two different cup planning methods were investigated: The first planning strategy is based on a combined pelvis and cup statistical atlas. Thereby, the pelvis part of the combined atlas is matched to the reconstructed pelvis model, resulting in an optimized cup planning. The second planning strategy analyzes the morphology of the reconstructed pelvis model to determine the best fitting cup implant. Results: The first planning strategy was compared to 3-D CT-based planning. Digitally reconstructed radiographs of THA patients with differently severe pathologies were used to evaluate the accuracy of predicting the cup size and position. Within a discrepancy of one cup size, the size was correctly identified in 100% of the cases for Crowe type I datasets and in 77.8% of the cases for Crowe type II, III, and IV datasets. The second planning strategy was analyzed with respect to the eventually implanted cup size. In seven patients, the estimated cup diameter was correct within one cup size, while the estimation for the remaining five patients differed by two cup sizes. Conclusion: While both planning strategies showed the same prediction rate with a discrepancy of one cup size (87.5%), the prediction of the exact cup size was increased for the statistical atlas-based strategy (56%) in contrast to the anatomically driven approach (37.5%). Significance: The proposed approach demonstrated the clinical validity of using 2-D/3-D reconstruction technique for cup planning.	[Schumann, Steffen; Zheng, Guoyan] Univ Bern, Inst Surg Technol & Biomech, CH-3014 Bern, Switzerland; [Sato, Yoshinobu; Yokota, Futoshi] Nara Inst Sci & Technol, Grad Sch Informat Sci, Imaging Based Computat Biomed Lab, Nara, Japan; [Nakanishi, Yuki] Kobe Univ, Grad Sch Syst Informat, Kobe, Hyogo, Japan; [Nakanishi, Yuki] Nara Inst Sci & Technol, Nara, Japan; [Takao, Masaki; Sugano, Nobuhiko] Osaka Univ, Grad Sch Med, Suita, Osaka 565, Japan	Schumann, S (reprint author), Univ Bern, Inst Surg Technol & Biomech, CH-3014 Bern, Switzerland.	steffen.schumann@ieee.org			Swiss National Science Foundation (SNSF) [IZK0Z3_149048/1]; Swiss KTI Project [13523.1 PFFLR-LS]; KAKENHI [26108004, 25242051]	This work was supported by in part by the Swiss National Science Foundation (SNSF) via the Project IZK0Z3_149048/1, in part by the Swiss KTI Project No. 13523.1 PFFLR-LS, and in part by KAKENHI 26108004 and 25242051. Asterisk indicates corresponding author.	Hassani H, 2014, J ARTHROPLASTY, V29, P1273, DOI 10.1016/j.arth.2013.12.033; Schumann S, 2013, ANN BIOMED ENG, V41, P2077, DOI 10.1007/s10439-013-0822-6; Wimsey S, 2006, J BONE JOINT SURG BR, V88B, P1508, DOI 10.1302/0301-620X.88B11.18017; Kalteis T, 2006, EUR J RADIOL, V58, P294, DOI 10.1016/j.ejrad.2005.10.003; Zheng GY, 2009, MED IMAGE ANAL, V13, P883, DOI 10.1016/j.media.2008.12.003; Widmer KH, 2004, J ORTHOPAED RES, V22, P815, DOI 10.1016/j.orthres.2003.11.001; Journe A, 2012, INT ORTHOP, V36, P2205, DOI 10.1007/s00264-012-1650-2; Unnanuntana A, 2009, J ARTHROPLASTY, V24, P180, DOI 10.1016/j.arth.2007.10.032; Morooka K, 2013, IEICE T INF SYST, VE96D, P784, DOI 10.1587/transinf.E96.D.784; Knight J L, 1992, J Arthroplasty, V7 Suppl, P403, DOI 10.1016/S0883-5403(07)80031-3; Schumann S, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P1204, DOI 10.1109/ISBI.2012.6235777; King RJ, 2009, J BONE JOINT SURG BR, V91B, P1217, DOI 10.1302/0301-620X.91B9.22615; Conn KS, 2002, J BONE JOINT SURG BR, V84B, P269, DOI 10.1302/0301-620X.84B2.12599; The B, 2005, ACTA ORTHOP, V76, P78, DOI 10.1080/00016470510030364; Eggli S, 1998, J BONE JOINT SURG BR, V80B, P382, DOI 10.1302/0301-620X.80B3.7764; Iorio R, 2009, J ARTHROPLASTY, V24, P175, DOI 10.1016/j.arth.2007.11.019; Viel T, 2013, ORTHOP TRAUMATOL-SUR, V99, P517, DOI 10.1016/j.otsr.2013.02.009; Bayne CO, 2009, J ARTHROPLASTY, V24, P407, DOI 10.1016/j.arth.2007.11.020; Bono JV, 2004, J BONE JOINT SURG AM, V86A, P118; Otomaru I, 2012, MED IMAGE ANAL, V16, P415, DOI 10.1016/j.media.2011.10.005; CROWE JF, 1979, J BONE JOINT SURG AM, V61, P15; Folinais D, 2013, ORTHOP TRAUMATOL-SUR, V99, P509, DOI 10.1016/j.otsr.2012.12.023; Fitzgibbon A, 1999, IEEE T PATTERN ANAL, V21, P476, DOI 10.1109/34.765658; The B, 2005, MED PHYS, V32, P2580, DOI 10.1118/1.1984293; Gonzalez Della Valle A, 2008, INT ORTHOP, V32, P289; Otomaru I., 2012, J JPN SOC COMPUT AID, V14, P27; Sugano N, 1998, Comput Aided Surg, V3, P320, DOI 10.3109/10929089809148153; Viceconti M., 2003, Medical Engineering & Physics, V25, P371, DOI 10.1016/S1350-4533(03)00018-3; Whiddon David R, 2011, Am J Orthop (Belle Mead NJ), V40, P395; Yokota F, 2013, LECT NOTES COMPUT SC, V8150, P190, DOI 10.1007/978-3-642-40763-5_24	30	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	NOV	2015	62	11					2665	2673		10.1109/TBME.2015.2441378		9	Engineering, Biomedical	Engineering	CV4LJ	WOS:000364238100014		
J	Nagashima, T; Wei, XQ; Bou, E; Alarcon, E; Kazimierczuk, MK; Sekiya, H				Nagashima, Tomoharu; Wei, Xiuqin; Bou, Elisenda; Alarcon, Eduard; Kazimierczuk, Marian K.; Sekiya, Hiroo			Analysis and Design of Loosely Inductive Coupled Wireless Power Transfer System Based on Class-E-2 DC-DC Converter for Efficiency Enhancement	IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS I-REGULAR PAPERS			English	Article						Class-E-2 dc-dc converter; efficiency enhancement design; loosely inductive coupling; low coupling coefficient; wireless power transfer	CLASS-E AMPLIFIER; GRADING COEFFICIENT; SHUNT CAPACITANCE; DC/DC CONVERTER; LINKS; RECTIFIER	This paper presents a design procedure of high-frequency loosely inductive coupled wireless power transfer (LIC-WPT) system based on class-E-2 dc-dc converter, taking into account the power loss reduction of inverter, coupling part, and rectifier simultaneously. Analytical expressions including the dc-to-dc efficiency of the WPT system are derived and the efficiency deterioration mechanism is explained by the circuit model. Through the analytical expressions, the design procedure for satisfying both the class-E switching conditions and power loss reductions at the coupling part is proposed from the circuit-theory viewpoint. The class-E-2 WPT system designed by the proposed design procedure achieves high dc-to-dc efficiency at low coupling coefficient, in particular, compared with those designed by the previous design strategies. The validity and effectiveness of the proposed design procedure were confirmed by PSpice simulations and circuit experiments.	[Nagashima, Tomoharu; Sekiya, Hiroo] Chiba Univ, Grad Sch Adv Integrat Sci, Chiba 2638522, Japan; [Wei, Xiuqin] Nagasaki Univ, TDK Collaborat Res Course, Nagasaki 8528521, Japan; [Bou, Elisenda; Alarcon, Eduard] UPC BarcelonaTech, Dept Elect Engn, Barcelona 08034, Spain; [Kazimierczuk, Marian K.] Wright State Univ, Dept Elect Engn, Dayton, OH 45435 USA	Nagashima, T (reprint author), Chiba Univ, Grad Sch Adv Integrat Sci, Chiba 2638522, Japan.	nagashima@chiba-u.jp; xiuqinwei@nagasaki-u.ac.jp; elisenda.bou@upc.edu; eduard.alarcon@upc.edu; marian.kazimierczuk@wright.edu; sekiya@faculty.chiba-u.jp			JSPS [13J08797, 25820112, 26289115]; Spanish ministry of Science and Innovation [DPI2013-47799-C2-2-R, RUE CSD2009-00046]	This work was supported in part by the Grant-in-Aid for Scientific Research (No. 13J08797, 25820112, 26289115) of JSPS. Partial funding by projects DPI2013-47799-C2-2-R and RUE CSD2009-00046 (Consolider-Ingenio 2010) from the Spanish ministry of Science and Innovation are acknowledged.	Kendir GA, 2005, IEEE T CIRCUITS-I, V52, P857, DOI 10.1109/TCSI.2005.846208; Kurs A, 2007, SCIENCE, V317, P83, DOI 10.1126/science.1143254; Wei XQ, 2011, IEEE T CIRCUITS-I, V58, P2556, DOI 10.1109/TCSI.2011.2123490; Sakuma K, 2009, ISCAS: 2009 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOLS 1-5, P1965; Sekiya H, 2010, IEEE T POWER ELECTR, V25, P924, DOI 10.1109/TPEL.2009.2030503; JOZWIK JJ, 1990, IEEE T IND ELECTRON, V37, P173, DOI 10.1109/41.52968; Wang GX, 2005, IEEE T CIRCUITS-I, V52, P2109, DOI 10.1109/TCSI.2005.852923; Hayati M, 2014, IEEE T POWER ELECTR, V29, P4989, DOI 10.1109/TPEL.2013.2286160; Nagashima T, 2014, IEEE INT SYMP CIRC S, P113, DOI 10.1109/ISCAS.2014.6865078; Nagashima T, 2014, 2014 IEEE ASIA PACIFIC CONFERENCE ON CIRCUITS AND SYSTEMS (APCCAS), P288, DOI 10.1109/APCCAS.2014.7032776; Hui SY, 2013, P IEEE, V101, P1290, DOI 10.1109/JPROC.2013.2246531; Nagashima T, 2014, IEEE T IND ELECTRON, V61, P1799, DOI 10.1109/TIE.2013.2267693; Sekiya H, 2003, INT J CIRC THEOR APP, V31, P229, DOI 10.1002/cta.229; Suetsugu T, 2004, IEEE T CIRCUITS-I, V51, P1261, DOI 10.1109/TCSI.2004.830695; Suetsugu T, 2003, IEEE T CIRCUITS-I, V50, P1089, DOI 10.1109/TCSI.2003.815208; Fukui K, 2012, IEEE T POWER ELECTR, V27, P3704, DOI 10.1109/TPEL.2012.2184560; Aldhaher S, 2014, IEEE T POWER ELECTR, V29, P2969, DOI 10.1109/TPEL.2013.2272764; Aldhaher S, 2015, IEEE T POWER ELECTR, V30, P1328, DOI 10.1109/TPEL.2014.2316170; Koizumi H, 1996, IEEE T CIRCUITS-I, V43, P51, DOI 10.1109/81.481461; Kazimierczuk Marian K, 2009, Proceedings of the 2009 IEEE Energy Conversion Congress and Exposition. ECCE 2009, DOI 10.1109/ECCE.2009.5316501; Kazimierczuk M. K., 2011, RESONANT POWER CONVE; KAZIMIERCZUK MK, 1990, IEEE T CIRCUITS SYST, V37, P747, DOI 10.1109/31.55033; Kazimierczuk M. K., 1989, IEEE Transactions on Industrial Electronics, V36, DOI 10.1109/41.43017; Luk PCK, 2015, IEEE T POWER ELECTR, V30, P3242, DOI 10.1109/TPEL.2014.2332451; Murthy-Buller D., 2012, P IEEE 55 INT MIDW S, P1164; SOKAL NO, 1975, IEEE J SOLID-ST CIRC, VSC10, P168, DOI 10.1109/JSSC.1975.1050582; Wang C., 2014, IEEE T IND ELECTRON, V61, P1179	27	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1549-8328	1558-0806		IEEE T CIRCUITS-I	IEEE Trans. Circuits Syst. I-Regul. Pap.	NOV	2015	62	11					2781	2791		10.1109/TCSI.2015.2482338		11	Engineering, Electrical & Electronic	Engineering	CV1XO	WOS:000364051600015		
J	Goto, M; Hagiwara, K; Iguchi, Y; Ohtake, H; Saraya, T; Kobayashi, M; Higurashi, E; Toshiyoshi, H; Hiramoto, T				Goto, Masahide; Hagiwara, Kei; Iguchi, Yoshinori; Ohtake, Hiroshi; Saraya, Takuya; Kobayashi, Masaharu; Higurashi, Eiji; Toshiyoshi, Hiroshi; Hiramoto, Toshiro			Pixel-Parallel 3-D Integrated CMOS Image Sensors With Pulse Frequency Modulation A/D Converters Developed by Direct Bonding of SOI Layers	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						3-D integrated circuits; analog-digital conversion; CMOS image sensors; integrated circuit interconnections; photodiodes (PDs); silicon-on-insulator (SOI); wafer bonding	DYNAMIC-RANGE	We have developed for the first time a 3-D integrated CMOS image sensor with pixel-parallel analog-to-digital converters (ADCs). Photodiode (PD) and inverter layers are prepared on separate silicon-on-insulator layers and directly bonded with damascened Au electrodes. The handle layer is then removed by grinding and XeF2 vapor phase etching to expose the PD surface. The developed process is suitable for pixelwise interconnection because it allows the damascened Au electrodes to be 1 mu m in diameter or less. An ADC circuit is designed based on pulse frequency modulation where pulses are generated proportional to the illumination intensity, and contains a PD, inverters, a reset transistor, and counters. A prototype 3-D integrated CMOS image sensor is also developed with 64 pixels, which acquires video images without pixel defects. A wide dynamic range of >80 dB is confirmed for the incident light intensity. The experimental results demonstrate the feasibility of pixel-level 3-D integration for high-performance CMOS image sensors.	[Goto, Masahide; Hagiwara, Kei; Iguchi, Yoshinori; Ohtake, Hiroshi] NHK Sci & Technol Res Labs, Tokyo 1578510, Japan; [Saraya, Takuya; Kobayashi, Masaharu; Higurashi, Eiji; Toshiyoshi, Hiroshi; Hiramoto, Toshiro] Univ Tokyo, Tokyo 1538505, Japan	Goto, M (reprint author), NHK Sci & Technol Res Labs, Tokyo 1578510, Japan.	goto.m-fk@nhk.or.jp; hagiwara.k-he@nhk.or.jp; iguchi.y-hy@nhk.or.jp; ootake.h-ey@nhk.or.jp; saraya@nano.iis.u-tokyo.ac.jp; masa-kobayashi@nano.iis.u-tokyo.ac.jp; eiji@su.t.u-tokyo.ac.jp; hiro@iis.u-tokyo.ac.jp; hiramoto@nano.iis.u-tokyo.ac.jp					Goto M, 2014, IEEE T ELECTRON DEV, V61, P2886, DOI 10.1109/TED.2014.2331975; Goto M, 2014, IEEJ T ELECTR ELECTR, V9, P329, DOI 10.1002/tee.21974; Lee KW, 2013, IEEE T ELECTRON DEV, V60, P3842, DOI 10.1109/TED.2013.2280273; Asano T, 2009, 2009 IEEE 59TH ELECTRONIC COMPONENTS AND TECHNOLOGY CONFERENCE, VOLS 1-4, P40, DOI 10.1109/ECTC.2009.5073994; Fossum ER, 1997, IEEE T ELECTRON DEV, V44, P1689, DOI 10.1109/16.628824; Andoh F, 2000, IEEE T ELECTRON DEV, V47, P2123, DOI 10.1109/16.877174; YANG W, 1994, ISSCC DIG TECH PAP I, V37, P230, DOI 10.1109/ISSCC.1994.344657; Shin MS, 2012, IEEE T ELECTRON DEV, V59, P1693, DOI 10.1109/TED.2012.2190936; Matsuo S, 2009, IEEE T ELECTRON DEV, V56, P2380, DOI 10.1109/TED.2009.2030649; Park JH, 2009, IEEE T ELECTRON DEV, V56, P2414, DOI 10.1109/TED.2009.2030635; Yang DXD, 1999, IEEE J SOLID-ST CIRC, V34, P1821, DOI 10.1109/4.808907; Aoki J., 2013, ISSCC, P482; Goto M., 2013, P IEEE SOI 3D SUBTHR, P1; Goto M., 2014, IEEE INT EL DEV M IE, P421; Hagiwara K., 2013, P C WAF BOND MICR 3D, P125; Kiyoyama K., 2011, IEEE INT 3D SYST INT, P1; Kleinfelder S, 2001, IEEE J SOLID-ST CIRC, V36, P2049, DOI 10.1109/4.972156; Liu J. C., 2014, S VLSI TECHN, P1; Sukegawa S., 2013, ISSCC, P484, DOI DOI 10.1109/ISSCC.2013.6487825; Suntharalingam V., 2009, IEEE INT SOL STAT CI, P38; Watabe Toshihisa, 2012, IEEE ISSCC, P388; Xhakoni A., 2011, P INT IM SENS WORKSH; Yamada T., 2008, IEEE INT SOL STAT CI, V35, P50	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	NOV	2015	62	11					3530	3535		10.1109/TED.2015.2425393		6	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CV4MU	WOS:000364242000011		
J	Murakami, E; Aono, H; Ogasawara, M				Murakami, Eiichi; Aono, Hideki; Ogasawara, Makoto			A Coarse-Graining Approach to Rate Equations of the Composite AC-NBTI Model	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						AC negative bias temperature instability (NBTI); coarse-graining; rate equation; reaction-diffusion (R-D); trap-detrap (T-D)	DEGRADATION	For ac negative bias temperature instability (NBTI), the composite model that combines the reaction-diffusion (R-D) model for permanent component and the trap-detrap (T-D) model for recoverable component has almost been accepted. However, simple analytical formulas, which are useful for product qualification, have not yet been established. In this paper, we present a coarse-graining approach to analyze the rate equations in the T-D and R-D schemes. Here, the time-averaged rate equations are derived from the equations for stress and recovery phases. The analytical solutions obtained by solving this set of equations can explain the essential features of ac-NBTI, such as the duty-cycle dependence and the memory effect of hole-trapping determined by the standby condition. For the T-D scheme, the exact analytical solutions of the original equations verify this approach, whereas for the R-D scheme, the double-interface R-D model rather than the conventional R-D model captures the duty-cycle dependence observed in the experimental universal curve. Our experimental data on the ac-NBTI are also consistent with the developed analytical model providing a general validity of the approach presented here.	[Murakami, Eiichi] Kyushu Sangyo Univ, Dept Elect Engn & Informat Technol, Fukuoka 8138503, Japan; [Aono, Hideki; Ogasawara, Makoto] Renesas Elect Corp, Hitachinaka, Ibaraki 3128504, Japan	Murakami, E (reprint author), Kyushu Sangyo Univ, Dept Elect Engn & Informat Technol, Fukuoka 8138503, Japan.	eiichi@ip.kyusan-u.ac.jp; hideki.aono.yh@renesas.com; makoto.ogasawara.ub@renesas.com					Alam M. A., 2003, IEDM, P1441; TEWKSBURY TL, 1994, IEEE J SOLID-ST CIRC, V29, P239, DOI 10.1109/4.278345; JEPPSON KO, 1977, J APPL PHYS, V48, P2004, DOI 10.1063/1.323909; Mahapatra S, 2013, IEEE T ELECTRON DEV, V60, P901, DOI 10.1109/TED.2013.2238237; Kaczer B, 2008, INT REL PHY, P20, DOI 10.1109/RELPHY.2008.4558858; Tsai YS, 2010, INT REL PHY, P665, DOI 10.1109/IRPS.2010.5488752; Alam MA, 2007, MICROELECTRON RELIAB, V47, P853, DOI 10.1016/j.microrel.2006.10.012; Goel N., 2014, P IEEE INT REL PHYS, p6A41; Grasser T., 2014, BIAS TEMPERATURE INS, P447; Grove A. S., 1967, PHYS TECHNOLOGY SEMI, P127; Krishnan A. T., 2005, IEDM, P681; Kumar S. V., 2006, P IEEE ACM INT C COM, P493, DOI 10.1145/1233501.1233601; LaRosa G., 2009, RELIABILITY WEAROUT, P331; Mahapatra S., 2011, P IEEE INT REL PHYS, p6A31; Pottier N., 2010, NONEQUILIBRIUM STAT, P219; Reif F., 2009, FUNDAMENTALS STAT TH, P567; Reisinger H., 2011, P IEEE INT REL PHYS, p6A11; Reisinger H., 2010, P IEEE INT REL PHYS, P9	18	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	NOV	2015	62	11					3581	3587		10.1109/TED.2015.2478493		7	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CV4MU	WOS:000364242000019		
J	Kushida, T; Ohmori, M; Osanai, S; Kawamoto, D; Noda, T; Sakaki, H				Kushida, Tomoyoshi; Ohmori, Masato; Osanai, Shota; Kawamoto, Daisuke; Noda, Takeshi; Sakaki, Hiroyuki			Electrical Characteristics of AlGaAs/GaAs Heterostructures With a Pair of 2-D Electron and Hole Channels	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						2-D electrons; 2-D holes; AlGaAs/GaAs; AlGaN/GaN; FETs; heterostructures; power devices; superjunctions (SJs); transport properties		To make power devices with lower losses and higher power capabilities, superjunctions (SJs), based on GaN, GaAs, and related materials, are attractive. It is because they have higher breakdown fields than Si and allow the use of heterostructures, where highly conductive layers of 2-D electrons and holes can be formed. As a step toward such SJ devices, we have fabricated AlGaAs/GaAs four-terminal devices in which a pair of electron/hole channels is embedded. Transport properties of electrons and holes are studied by operating the devices as FETs in which the conductance of one channel is controlled by using the other as a gate. Current-voltage and capacitance-voltage characteristics between the two channels are evaluated by operating the devices as p-n diodes. Measured characteristics are examined by comparing them with device simulations with a focus on the carrier depletion process in each channel.	[Kushida, Tomoyoshi] Toyota Motor Co Ltd, Toyota, Aichi 4700309, Japan; [Ohmori, Masato; Osanai, Shota; Kawamoto, Daisuke; Sakaki, Hiroyuki] Toyota Technol Inst, Tenpaku Ku, Nagoya, Aichi 4688511, Japan; [Noda, Takeshi] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan	Kushida, T (reprint author), Toyota Motor Co Ltd, Toyota, Aichi 4700309, Japan.	tomoyoshi_kushida@mail.toyota.co.jp; noda.takeshi@nims.go.jp; h-sakaki@toyota-ti.ac.jp					SCHUBERT EF, 1986, IEEE T ELECTRON DEV, V33, P625, DOI 10.1109/T-ED.1986.22543; Nakajima A, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2372758; SHIROTA S, 1978, J APPL PHYS, V49, P6012, DOI 10.1063/1.324570; Ikeda N, 2010, P IEEE, V98, P1151, DOI 10.1109/JPROC.2009.2034397; Hahn H, 2015, J APPL PHYS, V117, DOI 10.1063/1.4913857; DOHLER GH, 1982, PHYS REV B, V25, P2616, DOI 10.1103/PhysRevB.25.2616; Nakajima A, 2011, IEEE ELECTR DEVICE L, V32, P542, DOI 10.1109/LED.2011.2105242; PLOOG K, 1986, SURF SCI, V174, P120, DOI 10.1016/0039-6028(86)90396-1; Coe D. J., 1982, Europe Patent, Patent No. [0053 854, 0053854]; Fujihira T, 1997, JPN J APPL PHYS 1, V36, P6254, DOI 10.1143/JJAP.36.6254; Ishida H., 2008, P 3 INT C BIOINSP MO, P1; Li G., 2012, P DEV RES C, P153; Lorenz L., 1999, P ISPSD, P3; Ueda D., 2014, P INT C INT POW SYST, P1; Unni V, 2014, PROC INT SYMP POWER, P245, DOI 10.1109/ISPSD.2014.6856022	15	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	NOV	2015	62	11					3619	3626		10.1109/TED.2015.2474735		8	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CV4MU	WOS:000364242000024		
J	Dang, GT; Kawaharamura, T; Furuta, M; Allen, MW				Dang, Giang T.; Kawaharamura, Toshiyuki; Furuta, Mamoru; Allen, Martin W.			Mist-CVD Grown Sn-Doped alpha-Ga2O3 MESFETs	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Ga2O3; MESFETs; mist chemical vapor deposition (Mist-CVD); power devices; UV sensors	FIELD-EFFECT TRANSISTORS; THIN-FILMS; SEMICONDUCTOR; DEPOSITION	This paper demonstrates the use of cost-effective solution-processed alpha-Ga2O3 thin films (TFs) for electronic device applications. MESFETs based on AgOx Schottky diode (SD) gates were fabricated on highly crystalline Sn-doped alpha-Ga2O3 TFs, grown by mist chemical vapor deposition at atmospheric pressure and a substrate temperature of only 400 degrees C. The rectification ratio and reverse breakdown voltage of typical SDs were 6 x 10(6) and 19.6 V, respectively. The ON-OFF ratio of the corresponding transistors was 2 x 10(7). The MESFETs that could withstand drain voltages of up to 48 V were also realized.	[Dang, Giang T.; Allen, Martin W.] Univ Canterbury, MacDiarmid Inst Adv Mat & Nanotechnol, Dept Elect & Comp Engn, Christchurch 8140, New Zealand; [Kawaharamura, Toshiyuki; Furuta, Mamoru] Kochi Univ Technol, Ctr Nanotechnol, Res Inst, Kami 7808502, Japan; [Furuta, Mamoru] Kochi Univ Technol, Dept Environm Sci & Engn, Kami 7808502, Japan	Dang, GT (reprint author), Univ Canterbury, MacDiarmid Inst Adv Mat & Nanotechnol, Dept Elect & Comp Engn, Christchurch 8140, New Zealand.	giang.dang@canterbury.ac.nz; kawaharamura.toshiyuki@kochi-tech.ac.jp; furuta.mamoru@kochi-tech.ac.jp; martin.allen@canterbury.ac.nz			MacDiarmid Institute for Advanced Materials and Nanotechnology; Royal Society of New Zealand Rutherford Discovery Fellowship Scheme, New Zealand	This work was supported in part by The MacDiarmid Institute for Advanced Materials and Nanotechnology and in part by the Royal Society of New Zealand Rutherford Discovery Fellowship Scheme, New Zealand. The review of this paper was arranged by Editor A. Haque.	Frenzel H, 2010, ADV MATER, V22, P5332, DOI 10.1002/adma.201001375; PASSLACK M, 1994, APPL PHYS LETT, V64, P2715, DOI 10.1063/1.111452; Dang GT, 2015, IEEE ELECTR DEVICE L, V36, P463, DOI 10.1109/LED.2015.2412124; Akaiwa K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.070203; Higashiwaki M, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4821858; Allen MW, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2768028; Oshima T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.011202; Fujita S, 2014, J CRYST GROWTH, V401, P588, DOI 10.1016/j.jcrysgro.2014.02.032; Lorenz M, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3525932; Ye Y, 2010, ACS APPL MATER INTER, V2, P2724, DOI 10.1021/am100661x; Oshima T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.040208; Kawaharamura T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.040207; Splith D, 2014, PHYS STATUS SOLIDI A, V211, P40, DOI 10.1002/pssa.201330088; Higashiwaki M., 2012, APPL PHYS LETT, V100; Kaneko K, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.075501; Kawaharamura T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FF08; Schroder D. K., 2006, SEMICONDUCTOR MAT DE; Sze S.M., 2007, PHYS SEMICONDUCTOR D	18	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	NOV	2015	62	11					3640	3644		10.1109/TED.2015.2477438		5	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CV4MU	WOS:000364242000027		
J	Hung, MP; Wang, DP; Furuta, M				Hung, Mai Phi; Wang, Dapeng; Furuta, Mamoru			Investigating Effect of Postannealing Time on Positive Bias Stress Stability of In-Ga-Zn-O TFT by Conductance Method	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Acceptorlike interface defects; amorphous In-Ga-Zn-O (IGZO); conductance method; donorlike interface defects; IGZO/SiOx interface; improve positive bias stress (PBS) stability; PBS; positive gate bias stress; thin-film transistor (TFT)	THIN-FILM TRANSISTORS; ILLUMINATION-STRESS; NEGATIVE-BIAS; QUANTITATIVE-ANALYSIS; INTERFACE STATES; INSULATOR; DENSITY; CHARGE	The conductance method was used to investigate the positive bias stress (PBS) degradation mechanism of In-Ga-Zn-O (IGZO) thin-film transistor (TFT). The effects of postannealing time on the PBS degradation mechanism were investigated. The stabilization of the donor like interface defects was found to be the reason for the threshold voltage instability in the IGZO-TFT under the PBS test. The donorlike defects at the front channel interface and in the plasma-enhanced chemical vapor deposition (PE-CVD)SiOx acted as the electron trapping centers. The electron trapping resistance of the PE-CVD SiOx was improved by increasing the postannealing time, resulting in an improvement in the PBS stability. However, long-time postannealing-induced creation of the deep acceptor like interface defects in the TFT under the PBS. The energy distribution of the created deep acceptorlike interface defects was revealed using the conductance measurement.	[Hung, Mai Phi] Kochi Univ Technol, Grad Sch Engn, Kochi 7828502, Japan; [Wang, Dapeng; Furuta, Mamoru] Kochi Univ Technol, Dept Environm Sci & Engn, Kochi 7828502, Japan	Hung, MP (reprint author), Kochi Univ Technol, Grad Sch Engn, Kochi 7828502, Japan.	maiphihung@gmail.com; wang.dapeng@kochi-tech.ac.jp; furuta.mamoru@kochi-tech.ac.jp					Huang XM, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4805354; Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090; Garetto D, 2012, SOLID STATE ELECTRON, V71, P74, DOI 10.1016/j.sse.2011.10.024; SHIONO N, 1982, J ELECTROCHEM SOC, V129, P1760, DOI 10.1149/1.2124288; Hanyu Y, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4832076; Suresh A, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2824758; Ueoka Y, 2014, ECS J SOLID STATE SC, V3, pQ3001, DOI 10.1149/2.001409jss; Trinh TT, 2011, SEMICOND SCI TECH, V26, DOI 10.1088/0268-1242/26/8/085012; [Anonymous], 2012, P 19 INT WORKSH AM F; SANDS D, 1987, SOLID STATE ELECTRON, V30, P543, DOI 10.1016/0038-1101(87)90210-3; NORAS JM, 1987, SOLID STATE ELECTRON, V30, P433, DOI 10.1016/0038-1101(87)90173-0; Chowdhury MDH, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3580611; Konofaos N, 2001, SEMICOND SCI TECH, V16, P733, DOI 10.1088/0268-1242/16/8/317; Lee J, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3232179; Chowdhury MDH, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4903874; Jimenez-Molinos F, 2001, J APPL PHYS, V90, P3396, DOI 10.1063/1.1398603; Barquinha P, 2009, J ELECTROCHEM SOC, V156, pH824, DOI 10.1149/1.3216049; Kumomi H, 2008, THIN SOLID FILMS, V516, P1516, DOI 10.1016/j.tsf.2007.03.161; Hung MP, 2014, ECS J SOLID STATE SC, V3, pQ3023, DOI 10.1149/2.005409jss; Zou X, 2010, SEMICOND SCI TECH, V25, DOI 10.1088/0268-1242/25/5/055006; Oh SI, 2013, IEEE T ELECTRON DEV, V60, P2537, DOI 10.1109/TED.2013.2265326; FAHRNER W, 1970, APPL PHYS LETT, V17, P16, DOI 10.1063/1.1653234; BUCHANAN DA, 1990, APPL PHYS LETT, V56, P1037, DOI 10.1063/1.103327; Ji KH, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3564882; Nomura K, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3159831; Jiang JX, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.114103; Robertson J, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4872227; Han WH, 2015, PHYS REV APPL, V3, DOI 10.1103/PhysRevApplied.3.044008; Hung MP, 2014, ECS SOLID STATE LETT, V3, pQ13, DOI 10.1149/2.010403ssl; Kang Y., 2015, ADV ELECTRON MATER, V1; Nahm HH, 2014, NPG ASIA MATER, V6, DOI 10.1038/am.2014.103; Kimura M., 2008, APPL PHYS LETT, V92; Lee JM, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2977865; NICOLLIA.EH, 1965, APPL PHYS LETT, V7, P216, DOI 10.1063/1.1754385; Nicollian E H, 1982, MOS METAL OXIDE SEMI; NICOLLIA.EH, 1969, SOLID STATE ELECTRON, V12, P937, DOI 10.1016/0038-1101(69)90014-8; Qiang L, 2015, J DISP TECHNOL, V11, P325, DOI 10.1109/JDT.2014.2387378; Schroder D. K., 2005, SEMICONDUCTOR MAT DE; Toda T, 2014, IEEE T ELECTRON DEV, V61, P3762, DOI 10.1109/TED.2014.2359739; Yamazaki H, 2014, ECS J SOLID STATE SC, V3, pQ20, DOI 10.1149/2.014402jss	40	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	NOV	2015	62	11					3697	3702		10.1109/TED.2015.2478807		6	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CV4MU	WOS:000364242000036		
J	Lee, MY; Li, YM; Samukawa, S				Lee, Ming-Yi; Li, Yiming; Samukawa, Seiji			Miniband Calculation of 3-D Nanostructure Array for Solar Cell Applications	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Ge/Si quantum dot (QD); miniband; solar cell	EFFICIENCY; CRYSTAL; BANDS	Within the envelop-function framework, we propose a more efficient finite-element method to calculate the miniband structure and density of states in an idealistic nanocrystal array with realistic geometrical parameters. This method clearly reveals the miniband formation and accurately calculates the energy dispersion relationship. The calculated result agrees well with the analytical Kronig-Penney method. More importantly, this method surmounts the theoretical approximations of the multidimensional Kronig-Penney method, and provides significant information for 3-D quantum dots solar cell design by simulating an in-plane germanium nanodisk array in bulk silicon.	[Lee, Ming-Yi; Li, Yiming] Natl Chiao Tung Univ, Inst Commun Engn, Dept Elect & Comp Engn, Parallel & Sci Comp Lab, Hsinchu 300, Taiwan; [Li, Yiming] Natl Chiao Tung Univ, Modeling & Simulat Res Ctr, Hsinchu 300, Taiwan; [Samukawa, Seiji] Tohoku Univ, Inst Fluid Sci, Sendai, Miyagi 9808577, Japan; [Samukawa, Seiji] Tohoku Univ, World Premier Int Res Ctr Initiat, Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan	Lee, MY (reprint author), Natl Chiao Tung Univ, Inst Commun Engn, Dept Elect & Comp Engn, Parallel & Sci Comp Lab, Hsinchu 300, Taiwan.	ymli@faculty.nctu.edu.tw			Ministry of Science and Technology, Taiwan [MOST 103-2221-E-009-180, MOST 104-2221-E-009-114]	This work was supported in part by the Ministry of Science and Technology, Taiwan, under Contracts No. MOST 103-2221-E-009-180 and No. MOST 104-2221-E-009-114. The review of this paper was arranged by Editor A. Schenk.	Luque A, 1997, PHYS REV LETT, V78, P5014, DOI 10.1103/PhysRevLett.78.5014; Kechiantz AM, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/40/405401; Lee JH, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.233102; Lazarenkova OL, 2001, J APPL PHYS, V89, P5509, DOI 10.1063/1.1366662; Rau U, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.035211; Hu WG, 2013, MATH COMPUT MODEL, V58, P306, DOI 10.1016/j.mcm.2012.11.012; Budiman MF, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/6/065302; Hu WG, 2013, J APPL PHYS, V114, DOI 10.1063/1.4821114; Luque A, 2012, NAT PHOTONICS, V6, P146, DOI [10.1038/nphoton.2012.1, 10.1038/NPHOTON.2012.1]; Tamura Y, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/28/285301; Jiang CW, 2006, J APPL PHYS, V99, DOI 10.1063/1.2203394; Igarashi M, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4745195; Huang CH, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/10/105301; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Luque A, 2006, PHYSICA B, V382, P320, DOI 10.1016/j.physb.2006.03.006; Hu WG, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/26/265401; BLOCHL PE, 1994, PHYS REV B, V49, P16223, DOI 10.1103/PhysRevB.49.16223; Callahan D. M., 2011, NANO LETT, V12, P214; Cuadra L, 2004, IEEE T ELECTRON DEV, V51, P1002, DOI 10.1109/TED.2004.828161; Fujii T., 2014, P 40 IEEE PHOT SPEC, P1033; Kronig RD, 1931, P R SOC LOND A-CONTA, V130, P499; Okada Y, 2011, J APPL PHYS, V109, DOI 10.1063/1.3533423; Lin AS, 2009, J APPL PHYS, V105, DOI 10.1063/1.3093962; Richter A, 2013, IEEE J PHOTOVOLT, V3, P1184, DOI 10.1109/JPHOTOV.2013.2270351; SCHICK K, 1992, APPL PHYS A-MATER, V54, P109, DOI 10.1007/BF00323895	25	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	NOV	2015	62	11					3709	3714		10.1109/TED.2015.2474161		6	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CV4MU	WOS:000364242000038		
J	Ota, K; Saitoh, M; Tanaka, C; Matsushita, D; Numata, T				Ota, Kensuke; Saitoh, Masumi; Tanaka, Chika; Matsushita, Daisuke; Numata, Toshinori			Experimental Study of Random Telegraph Noise in Trigate Nanowire MOSFETs	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Random telegraph noise (RTN); silicon nanowire transistor (NW Tr.); silicon-on-insulator (SOI)	BIAS TEMPERATURE INSTABILITY; DEGRADATION; TRANSISTORS; MODEL; 1/F	Random telegraph noise (RTN) in trigate nanowire transistors (NW Tr.) is systematically studied with respect to the NW size dependence. Time to capture and emission, which is related to the characteristic of the traps, such as trap energy, is independent of NW size. On the other hand, noise amplitude increases as the NW size decreases showing the similar size dependence to the reported scaled planar Tr. In addition, RTN after hot-carrier injection (HCI) and negative bias stress (NBS) is studied. HCI and NBS induce additional carrier traps, which generate larger noise signals. Since the degradation by HCI or NBS is larger with narrower width, RTN after these stresses is found to be severer in the NW Tr.	[Ota, Kensuke; Saitoh, Masumi; Tanaka, Chika; Matsushita, Daisuke; Numata, Toshinori] Toshiba Co Ltd, Corp Res & Dev Ctr, Adv LSI Technol Lab, Kawasaki, Kanagawa 2128582, Japan	Ota, K (reprint author), Toshiba Co Ltd, Corp Res & Dev Ctr, Adv LSI Technol Lab, Kawasaki, Kanagawa 2128582, Japan.	kensuke.ota@toshiba.co.jp; masumi.saitoh@toshiba.co.jp; chika.tanaka@toshiba.co.jp; daisuke.matsushita@toshiba.co.jp; toshinori.numata@toshiba.co.jp			New Energy and Industrial Technology Development Organization through the Development of Nanoelectronic Device Technology Project	This work was supported by the New Energy and Industrial Technology Development Organization through the Development of Nanoelectronic Device Technology Project. The review of this paper was arranged by Editor Z. Celik-Butler.	Cohen GM, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2746946; HORIUCHI T, 1986, IEEE ELECTR DEVICE L, V7, P337, DOI 10.1109/EDL.1986.26393; Yang T, 2005, IEEE ELECTR DEVICE L, V26, P826, DOI 10.1109/LED.2005.857684; KIRTON MJ, 1989, ADV PHYS, V38, P367, DOI 10.1080/00018738900101122; Shin M, 2007, IEEE T NANOTECHNOL, V6, P230, DOI 10.1109/TNANO.2007.891819; Tega N, 2009, 2009 SYMPOSIUM ON VLSI TECHNOLOGY, DIGEST OF TECHNICAL PAPERS, P50; Ota K, 2013, IEEE ELECTR DEVICE L, V34, P187, DOI 10.1109/LED.2012.2234719; Saitoh M, 2011, IEEE ELECTR DEVICE L, V32, P273, DOI 10.1109/LED.2010.2101043; SUN SW, 1990, IEEE ELECTR DEVICE L, V11, P297, DOI 10.1109/55.56480; TAKEDA E, 1983, IEEE ELECTR DEVICE L, V4, P111, DOI 10.1109/EDL.1983.25667; Doyle BS, 1997, IEEE ELECTR DEVICE L, V18, P51, DOI 10.1109/55.553041; RADOJCIC R, 1984, IEEE T ELECTRON DEV, V31, P1381, DOI 10.1109/T-ED.1984.21720; Schroder DK, 2003, J APPL PHYS, V94, P1, DOI 10.1063/1.1567461; HU CM, 1985, IEEE J SOLID-ST CIRC, V20, P295; UREN MJ, 1985, APPL PHYS LETT, V47, P1195, DOI 10.1063/1.96325; SANGIORGI E, 1988, IEEE ELECTR DEVICE L, V9, P13, DOI 10.1109/55.20398; Stathis JH, 2006, MICROELECTRON RELIAB, V46, P270, DOI 10.1016/j.microrel.2005.08.001; Bangsaruntip S., 2009, IEDM, P1, DOI DOI 10.1109/IEDM.2009.5424364; Liu C., 2011, IEDM; Nagumo T., 2010, IEDM; Ota K., 2014, VLSI, P1; Ota K., 2014, JPN J APPL PHYS, V53; Ota K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.02BC08; Saitoh M., 2011, VLSI TECHN, P132; Saitoh M., 2013, VLSI, pT228; Singh N., 2006, IEDM, P1, DOI DOI 10.1109/IEDM.2006.346840; Xiong HD, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2761254; Yeo K H, 2006, IEDM, P1; Yonezawa A., 2012, P INT REL PHYS S	29	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	NOV	2015	62	11					3799	3804		10.1109/TED.2015.2471840		6	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	CV4MU	WOS:000364242000052		
J	Namerikawa, T; Okubo, N; Sato, R; Okawa, Y; Ono, M				Namerikawa, Toru; Okubo, Norio; Sato, Ryutaro; Okawa, Yoshihiro; Ono, Masahiro			Real-Time Pricing Mechanism for Electricity Market With Built-In Incentive for Participation	IEEE TRANSACTIONS ON SMART GRID			English	Article						Dual decomposition; game theory; real-time pricing; smart grids		This paper proposes a game-theoretic approach to design a distributed real-time electricity pricing mechanism. Our approach is novel in that it guarantees individual rationality, meaning that it provides suppliers and consumers with a guaranteed incentive to participate in the real-time pricing market. Such an incentive is devised by offering a time-varying, situation-dependent subsidy that guarantees that a supplier/consumer profits by switching from a fixed-price contract to the real-time pricing contract. Although we assume that suppliers and consumers decide supply and demand quantities in a fully distributed manner to maximize their own profit, the proposed mechanism guarantees under moderate conditions that the market converges through an iterative process to a Nash equilibrium that maximizes social welfare. Furthermore, in order to guarantee safe operation of an electrical grid, our pricing mechanism increases stability of load frequency control, and at the same time, achieves supply-demand equilibrium by explicitly taking into account an equality constraint through dual decomposition method. We empirically demonstrate by simulations the individual rationality of the proposed mechanism as well as the convergence to supply-demand equilibrium.	[Namerikawa, Toru; Okawa, Yoshihiro] Keio Univ, Dept Syst Design Engn, Yokohama, Kanagawa 2238522, Japan; [Okubo, Norio] Azbil Corp, Tokyo 1006419, Japan; [Sato, Ryutaro] Kubota Corp, Osaka 5568601, Japan; [Ono, Masahiro] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	Namerikawa, T (reprint author), Keio Univ, Dept Syst Design Engn, Yokohama, Kanagawa 2238522, Japan.	namerikawa@sd.keio.ac.jp; ono@jpl.nasa.gov	Namerikawa, Toru/H-4110-2012	Namerikawa, Toru/0000-0001-9907-4234	Japan Science and Technology Agency through the Core Research for Evolutional Science and Technology Program; Jet Propulsion Laboratory, California Institute of Technology, through U.S. Government	This work was supported in part by the Japan Science and Technology Agency through the Core Research for Evolutional Science and Technology Program, and in part by the Jet Propulsion Laboratory, California Institute of Technology, through U.S. Government.	Giselsson P, 2013, AUTOMATICA, V49, P829, DOI 10.1016/j.automatica.2013.01.009; [Anonymous], 2012, P 2012 IEEE 51 ANN C; Miyano Y, 2012, 2012 PROCEEDINGS OF SICE ANNUAL CONFERENCE (SICE), P131; Wei EM, 2013, IEEE T AUTOMAT CONTR, V58, P2162, DOI 10.1109/TAC.2013.2253218; Jokic A, 2009, INT J ELEC POWER, V31, P522, DOI 10.1016/j.ijepes.2009.03.034; Deng RL, 2014, IEEE T SMART GRID, V5, P1340, DOI 10.1109/TSG.2013.2287494; Samadi P, 2010, 2010 IEEE 1ST INTERNATIONAL CONFERENCE ON SMART GRID COMMUNICATIONS (SMARTGRIDCOMM), P415, DOI 10.1109/SMARTGRID.2010.5622077; Tanaka T, 2012, P AMER CONTR CONF, P3705; Senjyu T, 2008, 2008 IEEE 2ND INTERNATIONAL POWER AND ENERGY CONFERENCE: PECON, VOLS 1-3, P79, DOI 10.1109/PECON.2008.4762449; Taylor JA, 2013, IEEE T POWER SYST, V28, P4692, DOI 10.1109/TPWRS.2013.2268391; Tushar W, 2012, IEEE T SMART GRID, V3, P1767, DOI 10.1109/TSG.2012.2211901; Roozbehani M, 2012, IEEE T POWER SYST, V27, P1926, DOI 10.1109/TPWRS.2012.2195037; Samadi P, 2012, IEEE T SMART GRID, V3, P1170, DOI 10.1109/TSG.2012.2203341; BERGER AW, 1989, IEEE T POWER SYST, V4, P920, DOI 10.1109/59.32580; Arrow K., 1958, STUDIES LINEAR NONLI; Basar T., 1999, DYNAMIC NONCOOPERATI; Bevrani H., 2009, ROBUST POWER SYSTEM, P20; Boyd S., 2003, EE392O STANF U; Don L., 2010, P AM CONTR C BALT MD, P1731; Kundur P., 1994, POWER SYSTEM STABILI; Langin Chet, 2009, Proceedings on the ISCA 22nd International Conferenceon Computers and Their Applications in Industry and Engineering. CAINE-2009; Osborne M. J., 2009, INTRO GAME THEORY; Rosen J.B., 1965, ECONOMETRICA, V33, P520, DOI DOI 10.2307/1911749; Stirling W. C., 2012, THEORY CONDITIONAL G; Tarasak P., 2011, P IEEE INT C SMART G, P321	25	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1949-3053	1949-3061		IEEE T SMART GRID	IEEE Trans. Smart Grid	NOV	2015	6	6					2714	2724		10.1109/TSG.2015.2447154		11	Engineering, Electrical & Electronic	Engineering	CV1TF	WOS:000364040300014		
J	Nakao, A; Du, P; Iwai, T				Nakao, Akihiro; Du, Ping; Iwai, Takamitsu			Application Specific Slicing for MVNO through Software-Defined Data Plane Enhancing SDN	IEICE TRANSACTIONS ON COMMUNICATIONS			English	Article						Software-Defined Networking (SDN); Network Functions Virtualisation (NFV); network virtualization		In this paper, we apply the concept of software-defined data plane to defining new services for Mobile Virtual Network Operators (MVNOs). Although there are a large number of MVNOs proliferating all over the world and most of them provide low bandwidth at low price, we propose a new business model for MVNOs and empower them with capability of tailoring fine-grained subscription plans that can meet users' demands. For example, abundant bandwidth can be allocated for some specific applications, while the rest of the applications are limited to low bandwidth. For this purpose, we have recently proposed the concept of application and/or device specific slicing that classifies application and/or device specific traffic into slices and applies fine-grained quality of services (QoS), introducing various applications of our proposed system [9]. This paper reports the prototype implementation of such proposal in the real MVNO connecting customized smartphones so that we can identify applications from the given traffic with 100% accuracy. In addition, we propose a new method of identifying applications from the traffic of unmodified smartphones by machine learning using the training data collected from the customized smartphones. We show that a simple machine learning technique such as random forest achives about 80% of accuracy in applicaton identification.	[Nakao, Akihiro; Du, Ping] Univ Tokyo, Informat Engn, Tokyo 1130033, Japan; [Iwai, Takamitsu] Univ Tokyo, Grad Sch Interdisciplinary Infomat Studies, Tokyo 1130033, Japan	Nakao, A (reprint author), Univ Tokyo, Informat Engn, Tokyo 1130033, Japan.	nakao@iii.u-tokyo.ac.jp; duping@iii.u-tokyo.ac.jp; iwai@nakao-lab.org					Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Fukushima M, 2014, 2014 38TH ANNUAL IEEE INTERNATIONAL COMPUTER SOFTWARE AND APPLICATIONS CONFERENCE WORKSHOPS (COMPSACW 2014), P61, DOI 10.1109/COMPSACW.2014.14; Farhady H, 2014, IEICE T COMMUN, VE97B, P2302, DOI 10.1587/transcom.E97.B.2302; Nakao A., 2014, 2014 1 INT SCI TECHN, P1; Nakao A, 2015, IEICE T COMMUN, VE98B, P12, DOI 10.1587/transcom.E98.B.12; Radhakrishnan S., 2011, P 7 C EM NETW EXPERI, P1	6	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1345			IEICE T COMMUN	IEICE Trans. Commun.	NOV	2015	E98B	11					2111	2120		10.1587/transcom.E98.B.2111		10	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CV6YP	WOS:000364418600003		
J	Ogawa, Y; Hasegawa, G; Murata, M				Ogawa, Yukio; Hasegawa, Go; Murata, Masayuki			Virtual Network Allocation for Fault Tolerance Balanced with Physical Resources Consumption in a Multi-Tenant Data Center	IEICE TRANSACTIONS ON COMMUNICATIONS			English	Article						data center; multi-tenant; virtual network allocation; multiple simultaneous failures; fault tolerance		In a multi-tenant data center, nodes and links of tenants' virtual networks (VNs) share a single component of the physical substrate network (SN). The failure of a single SN component can thereby cause the simultaneous failures of multiple nodes and links in a single VN; this complex of failures must significantly disrupt the services offered on the VN. In the present paper, we clarify how the fault tolerance of each VN is affected by a single SN failure, especially from the perspective of VN allocation in the SN. We propose a VN allocation model for multi-tenant data centers and formulate a problem that deals with the bandwidth loss in a single VN due a single SN failure. We conduct numerical simulations (with the setting that has 1.7 x 10(8) bit/s bandwidth demand on each VN, (denoted by C-i)). When each node in each VN is scattered and mapped to an individual physical server, each VN can have the minimum bandwidth loss (5.3x10(2) bit/s (3.0 x 10(-6) x C-i)) but the maximum required bandwidth between physical servers (1.0 x 10(9) bit/s (5.7 x C-i)). The balance between the bandwidth loss and the required physical resources can be optimized by assigning every four nodes of each VN to an individual physical server, meaning that we minimize the bandwidth loss without over-provisioning of core switches.	[Ogawa, Yukio] Hitachi Ltd, Informat & Telecommun Syst Co, IT Platform Div Grp, Tokyo 1030027, Japan; [Hasegawa, Go; Murata, Masayuki] Osaka Univ, Grad Sch Informat Sci & Technol, Suita, Osaka 5650871, Japan	Ogawa, Y (reprint author), Hitachi Ltd, Informat & Telecommun Syst Co, IT Platform Div Grp, Tokyo 1030027, Japan.	yukio.ogawa.xq@hitachi.com					Andersen D.G., 2002, THEORETICAL APPROACH, P1; Bodik P, 2012, ACM SIGCOMM COMP COM, V42, P431, DOI 10.1145/2377677.2377760; Wong D, 2012, INT SYMP MICROARCH, P119, DOI 10.1109/MICRO.2012.20; Bahl P, 2007, ACM SIGCOMM COMP COM, V37, P13, DOI 10.1145/1282427.1282383; Wang XD, 2012, 2012 PROCEEDINGS IEEE INFOCOM, P1125; Kim DS, 2009, IEEE 15TH PACIFIC RIM INTERNATIONAL SYMPOSIUM ON DEPENDABLE COMPUTING, PROCEEDINGS, P365, DOI 10.1109/PRDC.2009.64; Bari MF, 2013, IEEE COMMUN SURV TUT, V15, P909, DOI 10.1109/SURV.2012.090512.00043; Smith WE, 2008, IBM SYST J, V47, P621; Habib MF, 2012, J LIGHTWAVE TECHNOL, V30, P2563, DOI 10.1109/JLT.2012.2201696; Fischer A, 2013, IEEE COMMUN SURV TUT, V15, P1888, DOI 10.1109/SURV.2013.013013.00155; Sahoo A, 2009, COMPUT COMMUN, V32, P1207, DOI 10.1016/j.comcom.2009.03.009; Gill P, 2011, ACM SIGCOMM COMP COM, V41, P350, DOI 10.1145/2043164.2018477; Wu X, 2012, ACM SIGCOMM COMP COM, V42, P419, DOI 10.1145/2377677.2377759; Meixner CC, 2013, 2013 17TH INTERNATIONAL CONFERENCE ON OPTICAL NETWORKING DESIGN AND MODELING (ONDM), P107; Zhang Q, 2014, IEEE INFOCOM SER, P289; Barroso L. A., 2009, DATACENTER COMPUTER; Cormen T. H., 2001, INTRO ALGORITHMS; Dell Inc, 2014, POWEREDGE R820 RACK; Hasegawa G., 2011, TELECOMMUN SYST, P1001; Heller B., 2010, P 7 USENIX C NETW SY, P17; Hinden R., 2012, VIRTUAL ROUTER REDUN; Hitachi Data Systems,, 2014, HIT UN COMP PLATF SO; Jain R., 1991, ART COMPUTER SYSTEMS; Jarray A, 2015, IEEE T COMPUT, V64, P668, DOI 10.1109/TC.2013.2295612; Luke S, 2009, ESSENTIALS METAHEURI; Mahadevan P, 2009, LECT NOTES COMPUT SC, V5550, P795, DOI 10.1007/978-3-642-01399-7_62; Mahalingam M., 2011, VXLAN FRAMEWORK OVER; Miettinen K., 1998, INT SERIES OPERATION, V12; Ogawa Y., 2014, P 2014 IEEE 6 INT C, P555; Pepelnjak I., 2012, INTRO VIRTUALIZED NE; Potharaju R., 2013, P 4 ANN S CLOUD COMP, P1; Rabbani MG, 2014, IEICE T COMMUN, VE97B, P10, DOI 10.1587/transcom.E97.B.10; Rahman M. R., 2013, IEEE Transactions on Network and Service Management, V10, DOI 10.1109/TNSM.2013.013013.110202; VMware Inc, 2012, VMWARE VSPHERE HIGH; VMware Inc, 2009, PROT MISS CRIT WORKL; Xu JC, 2012, APPL MECH MATER, V204-208, P196, DOI 10.4028/www.scientific.net/AMM.204-208.196; Yeow W.-L., 2010, P 2 ACM SIGCOMM WORK, P33, DOI 10.1145/1851399.1851406; Yu H., 2011, P IEEE ICC, P1	38	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1345			IEICE T COMMUN	IEICE Trans. Commun.	NOV	2015	E98B	11					2121	2131		10.1587/transcom.E98.B.2121		11	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CV6YP	WOS:000364418600004		
J	Himura, Y; Yasuda, Y				Himura, Yosuke; Yasuda, Yoshiko			Bridging the Gap between Tenant CMDB and Device Status in Multi-Tenant Datacenter Networking	IEICE TRANSACTIONS ON COMMUNICATIONS			English	Article						datacenter network; network configuration; configuration management; configuration analysis; multi-tenancy	CONFIGURATION	Multi-tenant datacenter networking, with which multiple customer networks (tenants) are virtualized and consolidated in a single shared physical infrastructure, has recently become a promising approach to reduce device cost, thanks to advances of virtualization technologies for various networking devices (e.g., switches, firewalls, load balancers). Since network devices are configured with low-level commands (no context of tenants), network engineers need to manually manage the context of tenants in different stores such as spreadsheet and/or configuration management database (CMDB). The use of CMDB is also effective in increasing the 'visibility' of tenant configurations (e.g., information sharing among various teams); However, different from the ideal use, only limited portion of network configuration are stored in CMDB in order to reduce the amount of 'double configuration management' between device settings (running information) and CMDB (stored information). In this present work, we aim to bridge the gap between CDMB and device status. Our basic approach is to automatically analyze per-device configuration settings to recover pertenant network-wide configuration (running information) based on a graph-traversal technique applied over abstracted graph representation of device settings (to handle various types of vendor-specific devices); The recovered running information of per-tenant network configurations is automatically uploaded to CMDB. An implementation of this methodology is applied to a datacenter environment that management of about 100 tenants involves approximately 5,000 CMDB records, and our practical experiences are that this methodology enables to double the amount of CMDB records. We also discuss possible use cases enabled with this methodology.	[Himura, Yosuke; Yasuda, Yoshiko] Hitachi Ltd, Yokohama Res Lab, Yokohama, Kanagawa 2440817, Japan	Himura, Y (reprint author), Hitachi Ltd, Yokohama Res Lab, Yokohama, Kanagawa 2440817, Japan.	yosuke.himura.fy@hitachi.com					Sung YWE, 2009, SIGCOMM 2009, P219; Maltz DA, 2004, ACM SIGCOMM COMP COM, V34, P27; Sung YWE, 2009, LECT NOTES COMPUT SC, V5448, P111; Benson T, 2009, IMC'09: PROCEEDINGS OF THE 2009 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P136; Feamster N, 2004, ACM SIGCOMM COMP COM, V34, P87, DOI 10.1145/972374.972390; Xie GG, 2005, IEEE INFOCOM SER, P2170; Edwards A, 2009, WREN 2009, P103; Caldwell D, 2004, ACM SIGCOMM COMP COM, V34, P21, DOI 10.1145/972374.972379; Mudigonda J, 2011, ACM SIGCOMM COMP COM, V41, P62, DOI 10.1145/2043164.2018444; Benson T., 2009, USENIX NSDI 09 APR, P335; Benson T., 2011, P ACM SIGCOMM 2011 C, P302; Cisco Systems Inc, CISC VIRT MULT DAT C; El-Arini K., 2005, P 2005 ACM SIGCOMM W, P221, DOI 10.1145/1080173.1080190; Enck W, 2007, USENIX ASSOCIATION PROCEEDINGS OF THE 2007 USENIX ANNUAL TECHNICAL CONFERENCE, P73; Feamster N, 2005, USENIX Association Proceedings of the 2nd Symposium on Networked Systems Design & Implementation (NSDI '05), P43; Garimella P., 2007, P 2007 SIGCOMM WORKS, P305, DOI 10.1145/1321753.1321772; Himura Y., 2012, COMPUT COMMUN REV, V42, P13; Himura Y., 2013, IEEE IFIP IM; Juniper Networks Inc, CLOUD READ DAT CTR N; Kim H., 2011, P 2011 ACM SIGCOMM C, P499; Le F., 2006, P SIGCOMM WORKSH MIN, P293, DOI 10.1145/1162678.1162681; Le F., 2008, P ACM SIGCOMM, P39, DOI 10.1145/1402958.1402964; Mahimkar A., 2008, P 2008 ACM CONEXT C, P1, DOI 10.1145/1544012.1544014; Mahimkar A.A., 2010, P ACM SIGCOMM NEW YO, P303, DOI 10.1145/1851182.1851219; Ozawa Y., IEEE IFIP MANFI 13; Plonka D., 2009, USENIX LISA 09 NOV, P13; Turner D., 2010, P ACM SIGCOMM NEW YO, P315, DOI 10.1145/1851182.1851220	27	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1345			IEICE T COMMUN	IEICE Trans. Commun.	NOV	2015	E98B	11					2132	2140		10.1587/transcom.E98.B.2132		9	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CV6YP	WOS:000364418600005		
J	Liu, W; Hu, R; Shinkuma, R; Takahashi, T				Liu, Wei; Hu, Rui; Shinkuma, Ryoichi; Takahashi, Tatsuro			A Fair Resource Sharing Mechanism between Mobile Virtual Network Operators	IEICE TRANSACTIONS ON COMMUNICATIONS			English	Article						mobile virtual network operator; fair resource sharing; network functions virtualization		Mobile virtual network operators (MVNOs) are mobile operators without their own infrastructure or government issued spectrum licenses. They purchase spectrum resources from primary mobile network operators (MNOs) to provide communication services under their own brands. MVNOs are expected to play an important role in mobile network markets, as this will increase the competition in retail markets and help to meet the demand of niche markets. However, with the rapidly increasing demand of mobile data traffic, efficient utilization of the limited spectrum resources owned by MVNOs has become an important issue. We propose here a resource sharing mechanism between MVNOs against the background of network functions virtualization (NFV). The proposed mechanism enables MVNOs to improve their quality of service (QoS) by sharing spectrum resources with each other. A nash bargaining solution based decision strategy is also devised to ensure the fairness of resource sharing. Extensive numerical evaluation results validate the effectiveness of the proposed models and mechanisms.	[Liu, Wei; Hu, Rui; Takahashi, Tatsuro] Kyoto Univ, Grad Sch Informat, Commun & Comp Engn, Kyoto 6068501, Japan; [Shinkuma, Ryoichi] Kyoto Univ, Grad Sch Informat, Fac Communicat & Comp Engn, Kyoto 6068501, Japan	Liu, W (reprint author), Kyoto Univ, Grad Sch Informat, Commun & Comp Engn, Kyoto 6068501, Japan.	liu@cube.kuee.kyoto-u.ac.jp			National Institute of Information and Communications Technology (NICT), Japan	The authors wish to express a special acknowledgement to Dr. John Forbes Nash, Jr, the pioneer in the theory of noncooperative games. We are saddened by the death of him and his wife during the revision of this paper. This work was supported in part by the National Institute of Information and Communications Technology (NICT), Japan.	Antoniou I, 2002, PHYSICA D, V167, P72, DOI 10.1016/S0167-2789(02)00431-1; Frisanco T, 2008, IEEE IFIP NETW OPER, P129; Mutlu H, 2009, IEEE ACM T NETWORK, V17, P1794, DOI 10.1109/TNET.2009.2019959; Zhang D, 2010, IEEE T WIREL COMMUN, V9, P2055, DOI 10.1109/TWC.2010.06.091263; PAXSON V, 1995, IEEE ACM T NETWORK, V3, P226, DOI 10.1109/90.392383; ZHAO Y, 1995, OPER RES, V43, P520, DOI 10.1287/opre.43.3.520; Bedhiaf IL, 2009, ANN TELECOMMUN, V64, P339, DOI 10.1007/s12243-009-0108-z; Falowo OE, 2011, TELECOMMUN SYST, V47, P337, DOI 10.1007/s11235-010-9322-2; Baykasoglu A, 2012, INT J ADV MANUF TECH, V58, P693, DOI 10.1007/s00170-011-3430-3; Cadre H.L., 2009, LECT NOTES COMPUTER, V5539, P24; Chiosi M., 2012, SDN OPENFLOW WORLD C; Goldsmith A., 2005, WIRELESS COMMUNICATI; Hong Wang, 2010, 2010 International Conference on Modelling, Identification and Control (ICMIC), DOI 10.1109/CEFC.2010.5481518; LELAND WE, 1994, IEEE ACM T NETWORK, V2, P1, DOI 10.1109/90.282603; NORROS I, 1995, IEEE J SEL AREA COMM, V13, P953, DOI 10.1109/49.400651; Pattanavichai Santi, 2010, 2010 Third International Symposium on Electronic Commerce and Security (ISECS 2010), DOI 10.1109/ISECS.2010.67; Shoham Y, 2009, MULTIAGENT SYSTEMS: ALGORITHMIC, GAME-THEORETIC, AND LOGICAL FOUNDATIONS, P1; Zhao S., 2010, 2010 IEEE 12 INT C C, P958	18	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1345			IEICE T COMMUN	IEICE Trans. Commun.	NOV	2015	E98B	11					2141	2150		10.1587/transcom.E98.B.2141		10	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CV6YP	WOS:000364418600006		
J	Kadohata, A; Tanaka, T; Watanabe, A; Hirano, A; Hasegawa, H; Sato, KI				Kadohata, Akihiro; Tanaka, Takafumi; Watanabe, Atsushi; Hirano, Akira; Hasegawa, Hiroshi; Sato, Ken-ichi			Differential Reliability Path Accommodation Design and Reconfiguration in Virtualized Multi-Layer Transport Network	IEICE TRANSACTIONS ON COMMUNICATIONS			English	Article						multi-layer transport network; network virtualization; robustness and reconfiguration	OPTICAL NETWORKS	Multi-layer transport networks that utilize sub-lambda paths over a wavelength path have been shown to be effective in accommodating traffic with various levels of granularity. For different service requirements, a virtualized network was proposed where the infrastructure is virtually sliced to accommodate different levels of reliability. On the other hand, network reconfiguration is a promising candidate for quasi-dynamic and multi-granular traffic. Reconfiguration, however, incurs some risks such as service disruption and fluctuations in delay. There has not yet been any study on accommodating and reconfiguring paths according to different service classes in multi-layer transport networks. In this paper, we propose differentiated reconfiguration to address the trade-off relationship between accommodation efficiency and disruption risk in virtualized multi-layer transport networks that considers service classes defined as a combination of including or excluding a secondary path and allowing or not allowing reconfiguration. To implement the proposed network, we propose a multi-layer redundant path accommodation design and reconfiguration algorithm. A reliability evaluation algorithm is also introduced. Numerical evaluations show that when all classes are divided equally, equipment cost can be reduced approximately by 6%. The proposed reconfigurable networks are shown to be a cost effective solution that maintains reliability.	[Kadohata, Akihiro; Tanaka, Takafumi; Watanabe, Atsushi; Hirano, Akira] NTT Corp, NTT Network Innovat Labs, Yokosuka, Kanagawa 2390847, Japan; [Hasegawa, Hiroshi] Nagoya Univ, Nagoya, Aichi 4648603, Japan; [Sato, Ken-ichi] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan	Kadohata, A (reprint author), NTT Corp, NTT Network Innovat Labs, Yokosuka, Kanagawa 2390847, Japan.	kadohata.akihiro@lab.ntt.co.jp					Alshaer H., 2012, IEEE Transactions on Network and Service Management, V9, DOI 10.1109/TNSM.2011.110911.110115; PAGE LB, 1988, IEEE T RELIAB, V37, P259, DOI 10.1109/24.3752; Iovanna P, 2012, J OPT COMMUN NETW, V4, P821, DOI 10.1364/JOCN.4.000821; Xia M, 2009, J LIGHTWAVE TECHNOL, V27, P1856, DOI 10.1109/JLT.2009.2021486; [Anonymous], 2013, IMP PERF ASS FIN SER; HAYASHI M, 1991, IEEE T RELIAB, V40, P601, DOI 10.1109/24.106784; Figuerola S, 2009, J OPT COMMUN NETW, V1, pA247, DOI 10.1364/JOCN.1.00A247; Bouillet E, 2005, IEEE ACM T NETWORK, V13, P437, DOI 10.1109/TNET.2005.845540; Ghosh A, 2010, IEEE WIREL COMMUN, V17, P10, DOI 10.1109/MWC.2010.5490974; Yamazaki E, 2012, IEEE COMMUN MAG, V50, pS43, DOI 10.1109/MCOM.2012.6146484; Eramo V, 2014, J OPT COMMUN NETW, V6, P138, DOI 10.1364/JOCN.6.000138; Internet Engineering Task Force Network working group, RFC5317 INT ENG TASK; Kadohata A, 2015, J OPT COMMUN NETW, V7, pA432, DOI 10.1364/JOCN.7.00A432; Premo A.F.  Jr., 1963, IEEE Transactions on Reliability, VR-12; Ratnam K., 2005, P INT C BROADB NETW, V1, P127; Sano A., 2014, OPT FIB COMM C MARCH	16	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1345			IEICE T COMMUN	IEICE Trans. Commun.	NOV	2015	E98B	11					2151	2159		10.1587/transcom.E98.B.2151		9	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CV6YP	WOS:000364418600007		
J	Date, H; Higuchi, K; Katayama, M; Koda, K				Date, Hiroki; Higuchi, Kenichi; Katayama, Masaru; Koda, Katsutoshi			Scalable Centralized Control Architecture of Virtual Switch on Large-Scale Network	IEICE TRANSACTIONS ON COMMUNICATIONS			English	Article						metro network; data center network; network virtualization; scalable centralized control; SDN	ROUTERS	Router virtualization is becoming more common as a method that uses network (NW) equipment effectively and robustly similar to server virtualization. Edge routers, which are gateways of core NWs, should be virtualized because they have many functions and resources just as servers do. To virtualize edge routers, a metro NW, which is a wide area layer-2 NW connecting each user's residential gateway to edge routers, must trace dynamic edge router re-allocation by changing the route of each Ethernet flow. Therefore, we propose a scalable centralized control architecture of a virtual layer-2 switch on a metro NW to trace virtual router reallocation and use metro NW equipment effectively. The proposed scalable control architecture improves the centralized route control performance by processing in parallel on a flow-by-flow basis taking into account route information even in the worst case where edge routers fail. In addition, the architecture can equalize the load among parallel processes dynamically by using two proposed load re-allocation methods to increase the route control performance stably while minimizing the amount of resources for the control. We evaluate the scalability of the proposed architecture through theoretical analysis and experiments on a prototype and show that the proposed architecture increases the number of flows accommodated in a metro NW. Moreover, we evaluate the load re-allocation methods through simulation and show that they can evenly distribute the load among parallel processes. Finally, we show that the proposed architecture can be applied to not only large-scale metro NWs but also to data center NWs, which have recently become an important type of large-scale layer-2 NW.	[Date, Hiroki; Higuchi, Kenichi; Katayama, Masaru; Koda, Katsutoshi] NTT Corp, NTT Network Serv Syst Labs, Musashino, Tokyo 1808585, Japan	Date, H (reprint author), NTT Corp, NTT Network Serv Syst Labs, Musashino, Tokyo 1808585, Japan.	date.hiroki@lab.ntt.co.jp					Wang Y, 2008, ACM SIGCOMM COMP COM, V38, P231, DOI 10.1145/1402946.1402985; Stoica I, 2001, ACM SIGCOMM COMP COM, V31, P149, DOI 10.1145/964723.383071; McKeown N, 2008, ACM SIGCOMM COMP COM, V38, P69, DOI 10.1145/1355734.1355746; Fragni C, 2012, COMPUT NETW, V56, P2249, DOI 10.1016/j.comnet.2012.03.007; Yu ML, 2010, ACM SIGCOMM COMP COM, V40, P351, DOI 10.1145/1851275.1851224; Gude N, 2008, ACM SIGCOMM COMP COM, V38, P105, DOI 10.1145/1384609.1384625; Benson T., 2010, P 10 ANN C INT MEAS, P267, DOI DOI 10.1145/1879141.1879175; Bocci M., 2010, 5921 IETF RFC; Date H., 2013, P 2013 19 AS PAC C C, P362; Date H., 2014, P 2014 IEEE GLOB COM, P1816; Dixit A., 2013, P 2 ACM SIGCOMM WORK, P7; Gladisch A, 2008, P 34 EUR C EXH OPT C, P1; Hattori Kyota, 2013, 39th European Conference and Exhibition on Optical Communication (ECOC 2013); Hattori K., 2012, P EUR C EXH OPT COMM; Liang W., 2014, P 2014 IEEE GLOB COM, P2258; Murakami M, 2014, J LIGHTWAVE TECHNOL, V32, P805, DOI 10.1109/JLT.2013.2293510; Tootoonchian A., P INM WREN 2010; Yang L., 2004, RFC3746 IETF; Zhao M, 2007, P 2 INT WORKSH VIRT, P1	19	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1345			IEICE T COMMUN	IEICE Trans. Commun.	NOV	2015	E98B	11					2160	2170		10.1587/transcom.E98.B.2160		11	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CV6YP	WOS:000364418600008		
J	Muramatsu, S; Kawashima, R; Saito, S; Matsuo, H; Nakayama, H; Hayashi, T				Muramatsu, Shin; Kawashima, Ryota; Saito, Shoichi; Matsuo, Hiroshi; Nakayama, Hiroki; Hayashi, Tsunemasa			A Software Approach of Controlling the CPU Resource Assignment in Network Virtualization	IEICE TRANSACTIONS ON COMMUNICATIONS			English	Article						software-defined networking; network virtualization; network functions virtualizaion; virtual switch; Receive Side Scaling (RSS)		Many public cloud datacenters have adopted the Edge-Overlay model which supports virtual switch-based network virtualization using IP tunneling. However, software-implemented virtual switches can cause performance degradation because the packet processing load can concentrate on a particular CPU core. As a result, such load concentration decreases and destabilizes the performance of virtual networks. Although multi-queue functions like Receive Side Scaling (RSS) can distribute the load onto multiple CPU cores, they still have performance problems such as IRQ core collision between priority flows as well as competitive resource use between host and guest machines for received packet processing. In this paper, we propose Virtual Switch Extension (VSE) that adaptively determines CPU core assignment for SoftIRQ to prevent performance degradation. VSE supports two types of SoftIRQ core selection mechanisms, on-the-fly or predetermined. In the on-the-fly mode, VSE selects a SoftIRQ core based on current CPU load to exploit low-loaded CPU resources. In the predetermined mode, SoftIRQ cores are assigned in advance to differentiate the performance of priority flows. This paper describes a basic architecture and implementation of VSE and how VSE assigns a SoftIRQ cores. Moreover, we evaluate fundamental throughput of various CPU assignment models in the predetermined mode. Finally, we evaluate the performance of a priority VM in two VM usecases, the client-usecase which is receive-oriented and the router-usecase which performs bi-directional communications. In the client-usecase, the throughput of the priority VM was improved by 31% compared with RSS when the priority VM had one dedicated core. In the router-usecase, the throughput was improved by 29% when three dedicated cores were provided for the VM.	[Muramatsu, Shin; Kawashima, Ryota; Saito, Shoichi; Matsuo, Hiroshi] Nagoya Inst Technol, Grad Sch Engn, Nagoya, Aichi 4668555, Japan; [Nakayama, Hiroki; Hayashi, Tsunemasa] BOSCO Technol Inc, Tokyo 1050003, Japan	Kawashima, R (reprint author), Nagoya Inst Technol, Grad Sch Engn, Nagoya, Aichi 4668555, Japan.	muramatsu@matlab.nitech.ac.jp; kawa1983@ieee.org; shoichi@nitech.ac.jp; matsuo@nitech.ac.jp; nakayama@bosco-tech.com; hayashi@bosco-tech.com					McKeown N, 2008, ACM SIGCOMM COMP COM, V38, P69, DOI 10.1145/1355734.1355746; Black D., 2014, ARCHITECTUR IN PRESS; Emmerich Paul, 2014, 2014 IEEE 3rd International Conference on Cloud Networking (CloudNet), DOI 10.1109/CloudNet.2014.6968979; Fall K., 2011, SIGOPS OPER SYST REV, V45, P112; Kawashima R., 2014, P IEEE 6 INT C CLOUD, P929; Mahalingam M., 2014, 7348 RFC; Marian T., 2012, P 8 ACM IEEE S ARCH, P27; Martins J., 2014, P 11 NSDI USENIX, P459; Muramatsu S., 2014, P IEEE 6 INT C CLOUD, P923; Ram K.K., 2013, P USENIX ATC, P13; Sridharan M., 2014, NETWORK VIR IN PRESS; Tanyingyong V., 2012, P 2012 IEEE 13 INT C, P52	12	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1345			IEICE T COMMUN	IEICE Trans. Commun.	NOV	2015	E98B	11					2171	2179		10.1587/transcom.E98.B.2171		9	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CV6YP	WOS:000364418600009		
J	Kawashima, R; Matsuo, H				Kawashima, Ryota; Matsuo, Hiroshi			Accelerating the Performance of Software Tunneling Using a Receive Offload-Aware Novel L4 Protocol	IEICE TRANSACTIONS ON COMMUNICATIONS			English	Article						Software-Defined Networking; network virtualization; Network Function Virtualization; datacenter networks		An L2-in-L3 tunneling technology plays an important role in network virtualization based on the concept of Software-Defined Networking (SDN). VXLAN (Virtual eXtensible LAN) and NVGRE (Network Virtualization using Generic Routing Encapsulation) protocols are being widely used in public cloud datacenters. These protocols resolve traditional VLAN problems such as a limitation of the number of virtual networks, however, their network performances are low without dedicated hardware acceleration. Although STT (Stateless Transport Tunneling) achieves far better performance, it has pragmatic problems in that STT packets can be dropped by network middleboxes like stateful firewalls because of modified TCP header semantics. In this paper, we propose yet another layer 4 protocol (Segment-oriented Connection-less Protocol, SCLP) for existing tunneling protocols. Our previous study revealed that the high-performance of STT mainly comes from 2-level software packet pre-reassembly before decapsulation. The SCLP header is designed to take advantage of such processing without modifying existing protocol semantics. We implement a VXLAN over SCLP tunneling and evaluate its performance by comparing with the original VXLAN (over UDP), NVGRE, Geneve, and STT. The results show that the throughput of the proposed method was comparable to STT and almost 70% higher than that of other protocols.	[Kawashima, Ryota; Matsuo, Hiroshi] Nagoya Inst Technol, Dept Comp Sci & Engn, Nagoya, Aichi 4668555, Japan	Kawashima, R (reprint author), Nagoya Inst Technol, Dept Comp Sci & Engn, Nagoya, Aichi 4668555, Japan.	kawa1983@ieee.org; matsuo@nitech.ac.jp					Al-Shabibi A, 2014, PROC 3RD WORKSHOP HO, P25; Kawashima R, 2014, IEICE T COMMUN, VE97B, P2259, DOI 10.1587/transcom.E97.B.2259; McKeown N, 2008, ACM SIGCOMM COMP COM, V38, P69, DOI 10.1145/1355734.1355746; Belshe M., 2015, 7540 RFC; Davie B., 2014, STATELESS T IN PRESS; Gross J., 2014, GENEVE GENE IN PRESS; Grossman L., 2005, P LIN S OTT CAN JUL, V1, P195; Guenender S., 2015, P 1 ACM SIGCOMM S SO, P1; Kawashima R., 2015, P 2015 1 IEEE C NETW, P1; Kawashima R., 2014, P IEEE 6 INT C CLOUD, P929; Koponen T., 2013, TR2013001E VMWARE; Lasserre M., 2014, 7365 RFC; Mahalingam M., 2014, 7348 RFC; Microsoft Corporation, 2004, TECHNICAL REPORT; Moraes H.M.B., 2014, P 13 INT C NETW ICN, P230; Russell R., 2008, SIGOPS OPER SYST REV, V42, P95, DOI DOI 10.1145/1400097.1400108; Savill J., 2012, MICROSOFT VIRTUALIZA; Sridharan M., 2014, NVGRE NETWO IN PRESS; VMware Inc, VMWARE NSX VSPHERE N; Ye K., 2012, P 2012 IEEE INT C CL, P152	20	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1345			IEICE T COMMUN	IEICE Trans. Commun.	NOV	2015	E98B	11					2180	2189		10.1587/transcom.E98.B.2180		10	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CV6YP	WOS:000364418600010		
J	Fujikawa, S				Fujikawa, Shuichi			Network Clock System that Ensures a High Level of Frequency Accuracy	IEICE TRANSACTIONS ON COMMUNICATIONS			English	Article						clock; synchronization; evaluation; algorithm; MTIE; GPS		This paper proposes a network clock system that detects degradation in the frequency accuracy of network clocks distributed across a network and finds the sources of the degradation. This system uses two factors to identify degradation in frequency accuracy and an algorithm that finds degradation sources by integrating and analyzing the evaluation results gathered from the entire network. Many frequency stability measurement systems have been proposed, and most are based on time synchronization protocols. These systems also realize avoidance of frequency degradation and identification of the sources of the degradation. Unfortunately, the use of time synchronization protocols is impractical if the service provider, such as NTT, has already installed a frequency synchronization system; the provider must replace massive amounts of equipment with new devices that support the time synchronization protocols. Considering the expenditure of installment, this is an excessive burden on service providers. Therefore, a new system that can detect of frequency degradation in network clocks and identify the degradation causes without requiring new equipment is strongly demanded. The proposals made here are implemented by the installation of new circuit cards in current equipment and installing a server that runs the algorithm. This proposed system is currently being installed in NTT's network.	NTT Corp, NTT Access Network Serv Syst Labs, Yokosuka, Kanagawa 2390847, Japan	Fujikawa, S (reprint author), NTT Corp, NTT Access Network Serv Syst Labs, Yokosuka, Kanagawa 2390847, Japan.	fujikawa.shuichi@lab.ntt.co.jp					[Anonymous], 2015, PROD MEAS FREQ TIM S; SHIBATA N, 1983, APPL OPTICS, V22, P979; [Anonymous], 2015, MOD 1083B GPS SAT CO; Wang TK, 2013, IEEE T INSTRUM MEAS, V62, P1563, DOI 10.1109/TIM.2013.2253977; [Anonymous], 2008, 1588 IEEE; Cho J.H., 2010, IEEE T COMMUN, V58, P2824; Ichikawa N., 2009, NTT TECHNICAL J  MAR, P42; Imaoka A., 1994, IEICE T COMMUN, VE77-B, P1565; Kanamitsu H., 2012, NTT TECHNICAL J  FEB, P30; Kasai H., 1993, SDH TRANSMISSION SYS, P116; Mutoh H., 1991, NEC Technical Journal, V44; Ruffini S., 2004, ERICSSON REV, P32; Tsuji H., 1990, NTT R D, V35, P649; Wang S., 2010, US patent, Patent No. [US 7,831,000 B2, 7831000]; Yamasita T., 1998, P IEEE INT C DISTR C, V58, P32	15	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1345			IEICE T COMMUN	IEICE Trans. Commun.	NOV	2015	E98B	11					2212	2226		10.1587/transcom.E98.B.2212		15	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CV6YP	WOS:000364418600013		
J	Gao, MY; Kurosu, T; Solis-Trapala, K; Inoue, T; Namiki, S				Gao, Mingyi; Kurosu, Takayuki; Solis-Trapala, Karen; Inoue, Takashi; Namiki, Shu			Quadrature Squeezing and IQ De-Multiplexing of QPSK Signals by Sideband-Assisted Dual-Pump Phase Sensitive Amplifiers	IEICE TRANSACTIONS ON COMMUNICATIONS			English	Article						optical fiber communication; optical signal processing; optical phase sensitive amplifier; optical phase locked loop	OPTICAL-PHASE; DPSK SIGNAL; AMPLIFICATION; REGENERATION; STATES; TRANSMISSION; GENERATION; CONVERSION	High gain extinction ratio and stable control of the phase in phase sensitive amplification are fundamental to realize either phase regeneration or quadrature squeezing of phase modulated signals in an efficient and robust manner. In this paper, we show that a combination of our previously demonstrated "sideband-assisted" dual-pump phase sensitive amplifier with a gain extinction ratio of more than 25 dB, and a phase-locked loop based stabilization technique, enable efficient QPSK quadrature squeezing. Its stable operation is exploited to realize phase de-multiplexing of QPSK signals into BPSK tributaries. The phase de-multiplexed signals are evaluated through measurement of constellation diagrams, eye diagrams and more importantly, BER curves. The de-multiplexed BPSK signals exhibited an OSNR penalty of less than 1 dB compared to the back-to-back BPSK signals.	[Gao, Mingyi; Kurosu, Takayuki; Solis-Trapala, Karen; Inoue, Takashi; Namiki, Shu] Natl Inst Adv Ind Sci & Technol, Network Photon Res Ctr, Tsukuba, Ibaraki 3058568, Japan; [Gao, Mingyi] Soochow Univ, Sch Elect & Informat Engn, Suzhou 215006, Jiangsu, Peoples R China	Gao, MY (reprint author), Natl Inst Adv Ind Sci & Technol, Network Photon Res Ctr, Tsukuba, Ibaraki 3058568, Japan.	mygao@suda.edu.cn; t.kurosu@aist.go.jp; k.solis-trapala@aist.go.jp; inoue.takashi@aist.go.jp; shu.namik@aist.go.jp			NEDO; Project for Developing Innovation Systems of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; National Natural Science Foundation of China (NSFC) [61307082]; State Key Laboratory of Advanced Optical Communication Systems and Networks, Shanghai Jiao Tong University, China [2013GZKF031305]	Authors acknowledge Dr. Junya Kurumida for his help in the experiment, Dr. Naoya Uchida for valuable discussions and Furukawa Electric Co., Ltd. for lending the HNLF.This work was supported in part by NEDO and Project for Developing Innovation Systems of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. Mingyi Gao is grateful for the support from the National Natural Science Foundation of China (NSFC) (No. 61307082) and the Open Project (2013GZKF031305) from the State Key Laboratory of Advanced Optical Communication Systems and Networks, Shanghai Jiao Tong University, China.	WU LA, 1986, PHYS REV LETT, V57, P2520, DOI 10.1103/PhysRevLett.57.2520; Kurosu T, 2014, OPT EXPRESS, V22, P12177, DOI 10.1364/OE.22.012177; Croussore K, 2008, IEEE J SEL TOP QUANT, V14, P648, DOI 10.1109/JSTQE.2007.915397; Matsumoto M, 2007, OPT EXPRESS, V15, P8094, DOI 10.1364/OE.15.008094; Richter T, 2012, IEEE J SEL TOP QUANT, V18, P988, DOI 10.1109/JSTQE.2011.2155035; Neo R, 2013, OPT EXPRESS, V21, P7926, DOI 10.1364/OE.21.007926; YUEN HP, 1979, OPT LETT, V4, P334, DOI 10.1364/OL.4.000334; Webb RP, 2011, OPT EXPRESS, V19, P20015, DOI 10.1364/OE.19.020015; Gao MY, 2012, OPT LETT, V37, P1439, DOI 10.1364/OL.37.001439; Umeki T, 2013, OPT EXPRESS, V21, P12077, DOI 10.1364/OE.21.012077; Namiki S, 2012, IEEE J SEL TOP QUANT, V18, P717, DOI 10.1109/JSTQE.2011.2122246; Kakande J, 2011, NAT PHOTONICS, V5, P748, DOI 10.1038/nphoton.2011.254; Gao MY, 2011, OPT EXPRESS, V19, P23258, DOI 10.1364/OE.19.023258; SLUSHER RE, 1985, PHYS REV LETT, V55, P2409, DOI 10.1103/PhysRevLett.55.2409; Slavik R, 2012, J LIGHTWAVE TECHNOL, V30, P512, DOI 10.1109/JLT.2011.2174197; Fragkos A, 2012, J LIGHTWAVE TECHNOL, V30, P764, DOI 10.1109/JLT.2011.2178816; Gao M, 2013, ELECTRON LETT, V49, P140, DOI 10.1049/el.2012.3997; Gao M., 2009, C LAS EL INT QUANT E; Gao M., 2013, OPT FIB COMM C NAT F; Gao M., 2013, OPTOELECTRONICS COMM; Gao M., 2013, 39 EUR C EXH OPT COM, P1; Gao M., OPT FIB COMM C OFC N; McCKinstrie C.J., 2006, OPT EXPRESS, V14, P9600; Parmigiani F., 2010, OPT FIB COMM C OSA O; Richter T., 2012, OPT FIB COMM C OSA O; Ros F.D., 2013, OPT EXPRESS, V21, P28743; Sygletos Stylianos, 2011, Opt Express, V19, pB938, DOI 10.1364/OE.19.00B938; Takahashi M., 2008, 34 EUR C OPT COMM 20, P1	28	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1345			IEICE T COMMUN	IEICE Trans. Commun.	NOV	2015	E98B	11					2227	2237		10.1587/transcom.E98.B.2227		11	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CV6YP	WOS:000364418600014		
J	Sakumoto, Y; Aida, M; Shimonishi, H				Sakumoto, Yusuke; Aida, Masaki; Shimonishi, Hideyuki			Autonomous Decentralized Control for Indirectly Controlling System Performance Variable of Large-Scale and Wide-Area Networks	IEICE TRANSACTIONS ON COMMUNICATIONS			English	Article						large-scale and wide-area network; autonomous-decentralized mechanism; data center network; virtual machine placement problem		In this paper, we propose a novel Autonomous Decentralized Control (ADC) scheme for indirectly controlling a system performance variable of large-scale and wide-area networks. In a large-scale and wide-area network, since it is impractical for any one node to gather full information of the entire network, network control must be realized by internode collaboration using information local to each node. Several critical network problems (e.g., resource allocation) are often formulated by a system performance variable that is an amount to quantify system state. We solve such problems by designing an autonomous node action that indirectly controls, via the Markov Chain Monte Carlo method, the probability distribution of a system performance variable by using only local information. Analyses based on statistical mechanics confirm the effectiveness of the proposed node action. Moreover, the proposal is used to implement traffic-aware virtual machine placement control with load balancing in a data center network. Simulations confirm that it can control the system performance variable and is robust against system fluctuations. A comparison against a centralized control scheme verifies the superiority of the proposal.	[Sakumoto, Yusuke] Tokyo Metropolitan Univ, Grad Sch Syst Design, Hino, Tokyo 1910065, Japan; [Aida, Masaki] Tokyo Metropolitan Univ, Fac Syst Design, Hino, Tokyo 1910065, Japan; [Shimonishi, Hideyuki] NEC Corp Ltd, Knowledge Discovery Res Labs, Kawasaki, Kanagawa 2118666, Japan	Sakumoto, Y (reprint author), Tokyo Metropolitan Univ, Grad Sch Syst Design, Hino, Tokyo 1910065, Japan.	sakumoto@tmu.ac.jp; aida@tmu.ac.jp; h-shimonishi@cd.jp.nec.com			JSPS [24700072, 15K15985]	This work was supported by JSPS KAKENHI Grant Number 24700072 and 15K15985.	Aida M, 2012, IEICE T COMMUN, VE95B, P1488, DOI 10.1587/transcom.E95.B.1488; Xu H, 2013, IEEE T PARALL DISTR, V24, P1066, DOI 10.1109/TPDS.2012.308; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Jiang JW, 2012, 2012 PROCEEDINGS IEEE INFOCOM, P2876; Shao ZY, 2013, IEEE INFOCOM SER, P2148; Chen M., 2010, 2010 P IEEE INFOCOM, P1; Cicirello VA, 2001, 5TH INTERNATIONAL SYMPOSIUM ON AUTONOMOUS DECENTRALIZED SYSTEMS, PROCEEDINGS, P383, DOI 10.1109/ISADS.2001.917443; Gilks W.R., 1996, MARKOV CHAIN MONTE C, V2; Hyser C., 2007, HPL2007189; Leibnitz K., 2006, Communications of the ACM, V49, DOI 10.1145/1118178.1118203; Meng X., 2010, 2010 P IEEE INFOCOM, P1; Neglia Giovanni, 2007, 2007 2nd Bio-Inspired Models of Network, Information and Computing Systems (BIONETICS), DOI 10.1109/BIMNICS.2007.4610097; Sakhaee E., 2009, P 2009 2 INT S APPL, P1; Sakumoto Y., 2014, P 2014 16 INT TEL NE, P1; Sakumoto Y., 2012, P 9 AS PAC S INF TEL, P1; Takano C, 2012, IEICE T COMMUN, VE95B, P1529, DOI 10.1587/transcom.E95.B.1529; Tarighi M., 2010, J TELECOMMUNICATIONS, V1, P901; Wang R., 2010, P 7 INT C AUT COMP, P89, DOI 10.1145/1809049.1809066; Zhang S., 2010, P IEEE INT C NETW PR, P253	19	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1345			IEICE T COMMUN	IEICE Trans. Commun.	NOV	2015	E98B	11					2248	2258		10.1587/transcom.E98.B.2248		11	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CV6YP	WOS:000364418600016		
J	Wechtaisong, C; Ikeda, K; Morino, H; Miyoshi, T				Wechtaisong, Chitapong; Ikeda, Kazato; Morino, Hiroaki; Miyoshi, Takumi			Delay-Insertion-Based P2PTV Traffic Localization Using AS-Level Topology Information	IEICE TRANSACTIONS ON COMMUNICATIONS			English	Article						traffic localization; P2PTV; AS hop distance		Most P2PTV systems select a neighbor peer in an overlay network using RTT or a random method without considering the underlying network. Streaming traffic is shared over a network without localization awareness, which is a serious problem for Internet Service Providers. In this paper, we present a novel scheme to achieve P2PTV traffic localization by inserting delay into P2P streaming packets, so that the length of the inserted delay depends on the AS hop distance between a peer and its neighbor peer. Experiments conducted on a real network show that our proposed scheme can perform efficient traffic localization.	[Wechtaisong, Chitapong; Morino, Hiroaki; Miyoshi, Takumi] Shibaura Inst Technol, Grad Sch Engn & Sci, Tokyo 1358548, Japan; [Ikeda, Kazato] NEC Networks & Syst Integrat Corp, Tokyo 1128560, Japan	Wechtaisong, C (reprint author), Shibaura Inst Technol, Grad Sch Engn & Sci, Tokyo 1358548, Japan.	nb13505@shibaura-it.ac.jp			Mobile Information Networking Laboratory, Shibaura Institute of Technology	The authors would like to thank Dr. Hiep Hoang-Van at Hanoi University of Science and Technology for his useful advice and support. We also would like to extend our gratitude to the Mobile Information Networking Laboratory, Shibaura Institute of Technology for their support throughout this study.	Aggarwal V., 2007, COMPUT COMMUN REV, V37, P29; Ali S., 2006, P IEEE C ROB AUT MEC, P1; Seedorf J, 2009, 2009 IEEE NINTH INTERNATIONAL CONFERENCE ON PEER-TO-PEER COMPUTING (P2P 2009), P171, DOI 10.1109/P2P.2009.5284511; Ciullo D, 2010, IEEE T MULTIMEDIA, V12, P54, DOI 10.1109/TMM.2009.2036231; Sun Y, 2013, IEEE J SEL AREA COMM, V31, P379, DOI 10.1109/JSAC.2013.SUP.0513034; Silverston T, 2011, SIGNAL PROCESS-IMAGE, V26, P327, DOI 10.1016/j.image.2011.01.007; Pereira RL, 2012, COMPUT NETW, V56, P642, DOI 10.1016/j.comnet.2011.10.014; Roughan M, 2011, IEEE J SEL AREA COMM, V29, P1810, DOI 10.1109/JSAC.2011.111006; Cisco Systems Inc, 2014, CISC VIS NETW IND FO; Hoang-Van H, 2014, IEICE T COMMUN, VE97B, P29, DOI 10.1587/transcom.E97.B.29; Karagiannis T., 2005, P 5 ACM SIGCOMM C IN, P6; Luckie M., 2013, P ACM SIGCOMM IMC, P243; MaxMind, IP ADDR LOC TECHN; Miyoshi T., 2012, P 4 INT C INT NETW C, P148; Sheng L., 2010, P INT C NETW DISTR C, P387; Xie H B, 2008, Proceedings of the 9th AEPA 2008 - Engineering Plasticity and it's Applications - From Nanoscale to Macroscale, DOI 10.1145/1402958.1402999	16	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1345			IEICE T COMMUN	IEICE Trans. Commun.	NOV	2015	E98B	11					2259	2268		10.1587/transcom.E98.B.2259		10	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CV6YP	WOS:000364418600017		
J	Kamamura, S; Yamamoto, H; Genda, K; Koizumi, Y; Arakawa, S; Murata, M				Kamamura, Shohei; Yamamoto, Hiroshi; Genda, Kouichi; Koizumi, Yuki; Arakawa, Shin'ichi; Murata, Masayuki			Fast Repairing from Large-Scale Failure Using Hierarchical SDN Controllers	IEICE TRANSACTIONS ON COMMUNICATIONS			English	Article						fast repairing; hierarchical architecture; IP over WDM network; network configuration; SDN controller	TRAFFIC MATRICES; TOPOLOGIES; MECHANISM; NETWORKS	This paper proposes fast repairing methods that uses hierarchical software defined network controllers for recovering from massive failure in a large-scale IP over a wavelength-division multiplexing network. The network consists of multiple domains, and slave controllers are deployed in each domain. While each slave controller configures transport paths in its domain, the master controller manages end-to-end paths, which are established across multiple domains. For fast repair of intra-domain paths by the slave controllers, we define the optimization problem of path configuration order and propose a heuristic method, which minimizes the repair time to move from a disrupted state to a suboptimal state. For fast repair of end-to-end path through multiple domains, we also propose a network abstraction method, which efficiently manages the entire network. Evaluation results suggest that fast repair within a few minutes can be achieved by applying the proposed methods to the repairing scenario, where multiple links and nodes fail, in a 10,000-node network.	[Kamamura, Shohei; Yamamoto, Hiroshi; Genda, Kouichi] NTT Corp, NTT Network Serv Syst Labs, Musashino, Tokyo 1808585, Japan; [Koizumi, Yuki; Arakawa, Shin'ichi; Murata, Masayuki] Osaka Univ, Grad Sch Informat Sci & Technol, Suita, Osaka 5650871, Japan	Kamamura, S (reprint author), NTT Corp, NTT Network Serv Syst Labs, Musashino, Tokyo 1808585, Japan.	kamamura.shohei@lab.ntt.co.jp			National Institute of Information and Communications Technology, Japan	This work was supported in part by the National Institute of Information and Communications Technology, Japan.	Medina A, 2001, NINTH INTERNATIONAL SYMPOSIUM ON MODELING, ANALYSIS AND SIMULATION OF COMPUTER AND TELECOMMUNICATION SYSTEMS, PROCEEDINGS, P346; Horie T, 2009, INT CON ADV INFO NET, P951, DOI 10.1109/AINA.2009.46; Nucci A, 2005, ACM SIGCOMM COMP COM, V35, P19, DOI 10.1145/1070873.1070876; Ramaswami R, 1996, IEEE J SEL AREA COMM, V14, P840, DOI 10.1109/49.510907; Shiomoto K, 2003, IEEE J SEL AREA COMM, V21, P1254, DOI 10.1109/JSAC.2003.816620; Koizumi Y, 2010, J LIGHTWAVE TECHNOL, V28, P1720, DOI 10.1109/JLT.2010.2048412; Ohsita Y, 2010, IEEE ACM T NETWORK, V18, P177, DOI 10.1109/TNET.2009.2022263; Berde P, 2014, P 3 WORKSH HOT TOP S, P1; Casellas R., 2014, P OFC 2014 MARCH; Dixit A., 2013, P ACM WORKSH HOT TOP, V43, P7; Fu Y., 2014, P IEEE 22 INT C NETW, P21; Gioregetti A., 2015, P OFC 2015 MARCH; Hassas Yeganeh S., 2012, P 1 WORKSH HOT TOP S, P19; Kamamura S., 2013, IEICE TECHNICAL REPO, V112, P613; Kamamura S., 2014, P 2014 IEICE GEN C M; Kamamura S., 2014, P OFC 2014 MARCH; King D., 2012, 6805 IETF RFC; Krishnamurthy A., 2014, PROC 3RD WORKSHOP HO, P133; Maghbouleh A., 2007, PREPARING FUTURE INT; McCauley J., 2013, ONS; Miyamura T., 2013, P 7 INT C SIGN PROC, P1; Mizumoto K., 2012, P 2012 INT S NONL TH, V1, P731; Murakami T., 2010, IEEE IFIP NETW OP MA, P67; Oshita Y., 2011, P IEEE GLOBECOM 2011, P1; Schmid S, 2013, P 2 ACM SIGCOMM WORK, P121; Tootoocian A., 2010, P ACM INM WREN; Zhang Y., 2003, ACM SIGMETRICS, P206	27	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1345			IEICE T COMMUN	IEICE Trans. Commun.	NOV	2015	E98B	11					2269	2279		10.1587/transcom.E98.B.2269		11	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CV6YP	WOS:000364418600018		
J	Gu, B; Zhang, C; Yamori, K; Zhou, ZY; Liu, S; Tanaka, Y				Gu, Bo; Zhang, Cheng; Yamori, Kyoko; Zhou, Zhenyu; Liu, Song; Tanaka, Yoshiaki			Facilitating Incentive-Compatible Access Probability Selection in Wireless Random Access Networks	IEICE TRANSACTIONS ON COMMUNICATIONS			English	Article						CAC; Stackelberg game; backward induction; pricing; wireless random access network	CALL ADMISSION CONTROL; INTEGRATION; FRAMEWORK; WIMAX; WIFI; GAME	This paper studies the impact of integrating pricing with connection admission control (CAC) on the congestion management practices in contention-based wireless random access networks. Notably, when the network is free of charge, each self-interested user tries to occupy the channel as much as possible, resulting in the inefficient utilization of network resources. Pricing is therefore adopted as incentive mechanism to encourage users to choose their access probabilities considering the real-time network congestion level. A Stackelberg leader-follower game is formulated to analyze the competitive interaction between the service provider and the users. In particular, each user chooses the access probability that optimizes its payoff, while the self-interested service provider decides whether to admit or to reject the user's connection request in order to optimize its revenue. The stability of the Stackelberg leader-follower game in terms of convergence to the Nash equilibrium is established. The proposed CAC scheme is completely distributed and can be implemented by individual access points using only local information. Compared to the existing schemes, the proposed scheme achieves higher revenue gain, higher user payoff, and higher QoS performance.	[Gu, Bo; Tanaka, Yoshiaki] Waseda Univ, Dept Commun & Comp Engn, Tokyo 1690051, Japan; [Gu, Bo; Zhou, Zhenyu; Liu, Song] North China Elect Power Univ, Sch Elect & Elect Engn, Beijing, Peoples R China; [Zhang, Cheng] Waseda Univ, Dept Comp Sci & Commun Engn, Tokyo 1690072, Japan; [Yamori, Kyoko] Asahi Univ, Dept Management Informat, Mizuho 5010296, Japan; [Yamori, Kyoko; Tanaka, Yoshiaki] Waseda Univ, Global Informat & Telecommun Inst, Tokyo 1690051, Japan	Gu, B (reprint author), Waseda Univ, Dept Commun & Comp Engn, Tokyo 1690051, Japan.	bo.gu@akane.waseda.jp					Ahmed M, 2005, IEEE COMMUNICATIONS, V7, P49, DOI 10.1109/COMST.2005.1423334; Kelly F, 1997, EUR T TELECOMMUN, V8, P33, DOI 10.1002/ett.4460080106; Das SK, 2004, IEEE NETWORK, V18, P20, DOI 10.1109/MNET.2004.1355031; Kwon T, 2000, ELECTRON LETT, V36, P852, DOI 10.1049/el:20000639; Hou JK, 2002, IEEE T PARALL DISTR, V13, P898; Niyato D, 2008, IEEE T WIREL COMMUN, V7, P5150, DOI 10.1109/T-WC.2008.070609; Yuen C, 2005, IEEE ACM T NETWORK, V13, P1027, DOI 10.1109/TNET.2005.858448; Shu J, 2006, IEEE J SEL AREA COMM, V24, P1051, DOI 10.1109/JSAC.2006.872887; Lin HT, 2005, IEEE T MOBILE COMPUT, V4, P243; Musacchio J, 2006, IEEE ACM T NETWORK, V14, P289, DOI 10.1109/TNET.2006.872553; Lam RK, 2007, IEEE T COMPUT, V56, P1456, DOI 10.1109/TC.2007.70753; Akkarajitsakul K, 2011, IEEE COMMUN SURV TUT, V13, P372, DOI 10.1109/SURV.2011.122310.000119; Ma RTB, 2009, IEEE ACM T NETWORK, V17, P936, DOI 10.1109/TNET.2008.925633; Rouskas AN, 2006, IEEE WCNC, P205; Niyato D, 2007, IEEE COMMUN MAG, V45, P140, DOI 10.1109/MCOM.2007.358861; Wang CP, 2013, WIREL NETW, V19, P207, DOI 10.1007/s11276-012-0460-1; Boriosi JP, 2011, PEDIATR CRIT CARE ME, V12, P431, DOI 10.1097/PCC.0b013e3181fe329d; Balachandran A., 2002, Proceedings Fourth IEEE Workshop on Mobile Computing Systems and Applications, DOI 10.1109/MCSA.2002.1017487; Bertsekas D. P., 1992, DATA NETWORKS; Bianchi G, 2000, IEEE J SEL AREA COMM, V18, P535, DOI 10.1109/49.840210; Gu B., 2013, P IEEE 14 WORKSH CON, P1; HARDIN G, 1968, SCIENCE, V162, P1243; Nuggehalli P., 2008, IEEE INFOCOM, P1, DOI 10.1109/GLOCOM.2008.ECP.981; Pervaiz H., 2009, P 2009 2 INT C COMP, P1; Roberts JW, 1998, IEICE T COMMUN, VE81B, P824; TIROLE J., 1991, GAME THEORY	26	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1345			IEICE T COMMUN	IEICE Trans. Commun.	NOV	2015	E98B	11					2280	2290		10.1587/transcom.E98.B.2280		11	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CV6YP	WOS:000364418600019		
J	Ouchida, K; Honma, N; Tsunekawa, Y				Ouchida, Kazuma; Honma, Naoki; Tsunekawa, Yoshitaka			Fast MIMO Channel Calculation Technique for Multi-Antenna System Using Signal Modulation for FDTD Method	IEICE TRANSACTIONS ON COMMUNICATIONS			English	Article						FDTD; signal modulation; channel capacity; multi-antenna; MIMO	PROPAGATION	This paper proposes a new method that combines signal modulation and FDTD (Finite-Difference Time-Domain) simulations to reduce the computation time in multiple-antenna analysis. In this method, signals are modulated so as to maintain orthogonality among the excited signals; multiple antennas are excited at the same time. This means just one FDTD simulation is needed whereas the conventional method demands as many simulations as there are transmitting antennas. The simulation of a 2x2 multi-antenna system shows that the proposed method matches the performance of the conventional method even though its computation time is much shorter.	[Ouchida, Kazuma; Honma, Naoki; Tsunekawa, Yoshitaka] Iwate Univ, Grad Sch Engn, Morioka, Iwate 0208551, Japan	Ouchida, K (reprint author), Iwate Univ, Grad Sch Engn, Morioka, Iwate 0208551, Japan.	honma@m.ieice.org			JSPS KAKENHI [25709030]	This research was partially supported by JSPS KAKENHI (25709030).	Wallace JW, 2004, IEEE T WIREL COMMUN, V3, P1317, DOI [10.1109/TWC.2004.830854, 10.1109/twc.2004.830854]; WINTERS JH, 1994, IEEE T COMMUN, V42, P1740, DOI 10.1109/TCOMM.1994.582882; LAMPARD G, 1993, IEEE T VEH TECHNOL, V42, P314, DOI 10.1109/25.231883; PARSONS JD, 1991, IEE PROC-I, V138, P437; Namiki T, 2000, IEEE T MICROW THEORY, V48, P1950, DOI 10.1109/22.883876; YAMAGUCHI Y, 1985, IEEE T MICROW THEORY, V33, P714, DOI 10.1109/TMTT.1985.1133062; Imai T, 1997, IEEE ANTENNAS AND PROPAGATION SOCIETY INTERNATIONAL SYMPOSIUM 1997, VOLS 1-4, P2572, DOI 10.1109/APS.1997.625527; BOONZAAIER JJ, 1990, ELECTRON LETT, V26, P1891, DOI 10.1049/el:19901217; Ouchida K, 2013, ASIA PACIF MICROWAVE, P389, DOI 10.1109/APMC.2013.6695156; Foschini G.J., 1996, P WINLAB WORKSH WIR, V435, P253; Hikage T, 2005, IEICE T COMMUN, VE88B, P3281, DOI 10.1093/ietcom/e88-b.8.3281; Mcjown J.W., 1991, IEEE NETWORK MAG, V5, P27; Obara M, 2012, IEICE T COMMUN, VE95B, P1338, DOI 10.1587/transcom.E95.B.1338; Ouchida K., 2014, IEICE COMMUNICATIONS, V3, P104; SALEH AAM, 1987, IEEE J SEL AREA COMM, V5, P128, DOI 10.1109/JSAC.1987.1146527; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302	16	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1345			IEICE T COMMUN	IEICE Trans. Commun.	NOV	2015	E98B	11					2300	2306		10.1587/transcom.E98.B.2300		7	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CV6YP	WOS:000364418600021		
J	Konno, K; Honma, N; Sasakawa, D; Nishimori, K; Takemura, N; Mitsui, T; Tsunekawa, Y				Konno, Keita; Honma, Naoki; Sasakawa, Dai; Nishimori, Kentaro; Takemura, Nobuyasu; Mitsui, Tsutomu; Tsunekawa, Yoshitaka			Estimating Living-Body Location Using Bistatic MIMO Radar in Multi-Path Environment	IEICE TRANSACTIONS ON COMMUNICATIONS			English	Article						MIMO; living-body location; DOA estimation; microwave sensor; array antenna		This paper proposes a method that uses bistatic Multiple-Input Multiple-Output (MIMO) radar to locate living-bodies. In this method, directions of living-bodies are estimated by the MUltiple SIgnal Classification (MUSIC) method at the transmitter and receiver, where the Fourier transformed virtual Single-Input Multiple-Output (SIMO) channel matrix is used. Body location is taken as the intersection of the two directions. The proposal uses a single frequency and so has a great advantage over conventional methods that need a wide frequency band. Also, this method can be used in multipath-rich environments such as indoors. An experiment is performed in an indoor environment, and the MIMO channels yielded by various subject numbers and positions are measured. The result indicates that the proposed method can estimate multiple living-body locations with high accuracy, even in multipath environments.	[Konno, Keita; Honma, Naoki; Sasakawa, Dai; Tsunekawa, Yoshitaka] Iwate Univ, Grad Sch Engn, Morioka, Iwate 0208551, Japan; [Nishimori, Kentaro] Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan; [Takemura, Nobuyasu] Nippon Inst Technol, Saitama 3458501, Japan; [Mitsui, Tsutomu] Samsung R&D Inst Japan CO LTD, Yokohama, Kanagawa 2300027, Japan	Konno, K (reprint author), Iwate Univ, Grad Sch Engn, Morioka, Iwate 0208551, Japan.	honma@m.ieice.org			Telecommunications Advancement Foundation	This research was partially supported by the Telecommunications Advancement Foundation.	Adib F., 2014, MITCSAILTR2014008; An Yong-Jun, 2010, Journal of Electromagnetic Engineering and Science, V10, P250; Mase A, 2012, 2012 ASIA-PACIFIC MICROWAVE CONFERENCE (APMC 2012), P625, DOI 10.1109/APMC.2012.6421685; [Anonymous], 2001, IEEE MTT S INT MICR, DOI DOI 10.1109/TMTT.2004.823552; Nagae D, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3478017; Avagyan H., 2012, AM J PHYS, V5, P8; Honma N., 2015, IEICE T COMMUN JAP B, VJ98-B, P853; Konno K., 2014, 2014 IEEE INT WORKSH, V2, P90; Konno K, 2014, IEEE ANTENN WIREL PR, V13, P718, DOI 10.1109/LAWP.2014.2315671; Li J., 2008, MIMO RADAR SIGNAL PR; Lin James C., 1975, 1975 IEEE-MTT-S International Microwave Symposium; Nango M., 2013, IEICE COMMUNICATIONS, V2, P36; Park J.M., 2003, 2003 IEEE ANT PROP S, V4, P747; Sasakawa D., 2014, 8 EUR C ANT PROP EUC, P3863; SCHMIDT RO, 1986, IEEE T ANTENN PROPAG, V34, P276, DOI 10.1109/TAP.1986.1143830; Seki H., 2002, IEEJ T IA D, V122, P182	16	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1345			IEICE T COMMUN	IEICE Trans. Commun.	NOV	2015	E98B	11					2314	2321		10.1587/transcom.E98.B.2314		8	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CV6YP	WOS:000364418600023		
